PepID,DRAMP_ID,Sequence,Sequence_Length,Name,Swiss_Prot_Entry,Family,Gene,Source,Activity,Protein_existence,Structure,Structure_Description,PDB_ID,Comments,Target_Organism,Hemolytic_activity,Binding_Target,Pubmed_ID,Reference,Author,Title,Linear/Cyclic/Branched,Stereochemistry,N-terminal_Modification,Cytotoxicity,C-terminal_Modification,Other_Modifications,Binding_Traget,Length
9,DRAMP00089,TTKNYGNGVCNSVNWCQCGNVWASCNLATGCAAWLCKLA,39,Bacteriocin E50-52 (Preclinical),P85148,Belongs to the class IIa bacteriocin,Unknown,Enterococcus faecium (Streptococcus faecium) (Gram-positive bacteria),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Bacteriocin active against the Gram-negative bacteria and the Gram-positive bacteria. When added to the drinking water of chickens, causes a decrease in the levels of Campylobacter jejuni and S. enteritidis in the ceca, and in the levels of S.enteritidis in the liver and spleen.","Gram-negative bacteria: Campylobacter jejuni (MIC=0.025-6.4 μg/ml), Yersinia enterocolitica, Yersinia pseudotuberculosis, Escherichia coli O157:H7 (MIC<1.6 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=0.2-0.8 μg/ml), Staphylococcus epidermidis (MIC=0.2-0.8 μg/ml), Listeria monocytogenes (MIC=2-8 μg/ml), Listeria grayi, Listeria innocua, Listeria ivanovii, Listeria denitrificans (MIC=32 μg/ml), Morganella morganii, Salmonella spp., Shigella dysenteriae.",Unknown,Unknown,18293921,J Agric Food Chem. 2008 Mar 26;56(6):1942-1948.,"Svetoch EA, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, Borzenkov VN, Levchuk VP, Svetoch OE, Kovalev YN, Stepanshin YG, Siragusa GR, Seal BS, Stern NJ.",Diverse antimicrobial killing by Enterococcus faecium E 50-52 bacteriocin.,,,,,,,,
13,DRAMP00107,TNYGNGVGVPDAIMAGIIKLIFIFNIRQGYNFGKKAT,37,Bacteriocin L-1077,No entry found,Belongs to the class IIa bacteriocin,Unknown,Lactobacillus salivarius L-1077 (NRRL B-50053) (Gram-positive bacteria),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Salmonella Enteritidis 1 (MIC=0.19 ug/ml), S. Enteritidis 4 (MIC=0.38 ug/ml), S. Enteritidis 204 (MIC=0.38 ug/ml), S. Enteritidis 237 (MIC=0.19 ug/ml), Salmonella Choleraesuis 434/4 (MIC=0.38 ug/ml), S. Choleraesuis 370 (MIC=0.19 ug/ml), Salmonella Typhimurium 483/6 (MIC=0.19 ug/ml), S. Typhimurium 44/8 (MIC=0.19 ug/ml), Salmonella Gallinarum-Pullorum (MIC=0.19 ug/ml), Escherichia coli HB 101 (MIC=0.19 ug/ml), E. coli-600 (MIC=0.19 ug/ml), E. coli O157:H7 Y-63 (MIC=0.19 ug/ml), E. coli O157:H7 G-35 (MIC=0.19 ug/ml), E. coli O157:H7 OD 30 (MIC=0.19 ug/ml), E. coli O157:H7 T lab 39 (MIC=0.19 ug/ml), Yersinia enterocolitica 03 (MIC=0.76 ug/ml), Y. enterocolitica 09 (MIC=0.76 ug/ml), Y. enterocolitica 11 (MIC=0.76 ug/ml), Citrobacter freundii (MIC=0.76 ug/ml), Klebsiella pneumoniae (MIC=0.76 ug/ml), Shigella dysenteriae (MIC=0.76 ug/ml), Yersinia pseudotuberculosis 4 (MIC=0.76 ug/ml), Y. pseudotuberculosis 99/14 (MIC=0.76 μg/ml), Pseudomonas aeruginosa 508 (MIC=0.38 ug/ml), Proteus mirabilis (MIC=0.38 ug/ml), Morganella morganii (MIC=0.38 μg/ml), Proteus vulgaris 7A (MIC=1.5 ug/ml),Campylobacter jejuni L-4 (MIC=0.09 ug/ml);##Gram-positive bacteria: Clostridium perfringens  13124 (MIC=0.7 ug/ml), Listeria monocytogenes A 9-72 (MIC=0.19 ug/ml), Staphylococcus aureus (MIC=0.76 ug/ml), Staphylococcus epidermidis (MIC=0.76 ug/ml).",Unknown,Unknown,21378051,Appl Environ Microbiol. 2011 Apr;77(8):2749-2754. ,"Svetoch EA, Eruslanov BV, Levchuk VP, Perelygin VV, Mitsevich EV, Mitsevich IP, Stepanshin J, Dyatlov I, Seal BS, Stern NJ.","Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum.",,,,,,,,
18,DRAMP00136,NRWYCNSAAGGVGGAAVCGLAGYVGEAKENIAGEVRKGWGMAGGFTHNKACKSFPGSGWASG,62,Enterocin E-760 (Bacteriocin),P85147,Belongs to the class IIb bacteriocin,Unknown,Enterococcus sp. (Gram-positive bacteria),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: The enterocin demonstrated thermostability by retaining activity after 5 min at 100 degrees C and was stable at pH values between 5.0 and 8.7. However, activity was lost below pH 3.0 and above pH 9.5. No hemolytic activity.","[Ref.18086839]Gram-positive bacteria: Listeria monocytogenes 9-72 (MIC=0.1 μg/ml), Staphylococcus epidermidis (MIC=1.6 μg/ml), S. aureus (MIC=1.6 μg/ml);##Gram-negative bacteria: S. enterica serovar Enteritidis 1 (MIC=0.2 μg/ml), S. enterica serovar Enteritidis 4 (MIC=0.4 μg/ml), S. enterica serovar Enteritidis 204 (MIC=0.2 μg/ml), S. enterica serovar Enteritidis 237 (MIC=0.2 μg/ml), S. enterica serovar Choleraesuis 434/4 (MIC=0.4 μg/ml), S. enterica serovar Choleraesuis 370 (MIC=0.4 μg/ml), S. enterica serovar Typhimurium 383/60 (MIC=0.4 μg/ml), S. enterica serovar Typhimurium 320 (MIC=0.2 μg/ml), S. enterica serovar Gallinarum biovar Pullorum (MIC=0.4 μg/ml), Escherichia coli HB101 (MIC=0.1 μg/ml), E. coli C600 (MIC=0.1 μg/ml), E. coli O157:H7 Y-63 (MIC=1.6 μg/ml), E. coli O157:H7 G-3 (MIC=1.6 μg/ml), E. coli O157:H7 OD-3 (MIC=1.6 μg/ml), E. coli O157:H7 T-39 (MIC=1.6 μg/ml), Yersinia enterocolitica 03 (MIC=0.1 μg/ml), Y. enterocolitica 09 (MIC=0.1 μg/ml), Y. enterocolitica 04 (MIC=0.1 μg/ml), Y. pseudotuberculosis ser 4 (MIC=3.2 μg/ml), Y. pseudotuberculosis 14 (MIC=3.2 μg/ml), Citrobacter freundii (MIC=1.6 μg/ml), Klebsiella pneumoniae (MIC=3.2 μg/ml), Shigella dysenteriae (MIC=0.1 μg/ml), Campylobacter jejuni L4 (MIC=0.1 μg/ml), Campylobacter P 1-R (MIC=0.2 μg/ml), Campylobacter P-45 (MIC=0.4 μg/ml), Campylobacter lari R (MIC=0.2 μg/ml), Campylobacter LB 6-R (MIC=0.1 μg/ml), Campylobacter C/D (MIC=0.2 μg/ml),.",[Ref.18086839]Non-hemolysis,Unknown,18086839,Antimicrob Agents Chemother. 2008 Mar;52(3):1094-1100.,"Line JE, Svetoch EA, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, Levchuk VP, Svetoch OE, Seal BS, Siragusa GR, Stern NJ.",Isolation and purification of enterocin E-760 with broad antimicrobial activity against gram-positive and Gram-negative bacteria.,,,,,,,,
19,DRAMP00171,LIDHLGAPRWAVDTILGAIAVGNLASWVLALVPGPGWAVKAGLATAAAIVKHQGKAAAAAW,61,Lactocyclicin Q (Bacteriocin),B9ZZY0,Belongs to the class IIc bacteriocin,lycQ,Lactococcus sp. strain QU 12 (Gram-positive bacteria),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Lactococcus sp.strain QU 12 (MIC=34.3 μM), Lactococcus lactis subsp.lactis JCM 7638 (MIC=0.141 μM), L. lactis subsp.lactis ATCC 19435 (MIC=0.141 μM), L. lactis subsp.lactis IL1403 (MIC=0.141 μM), L. lactis QU 1 (MIC=0.141 μM), L. lactis subsp.cremoris ATCC 19275 (MIC=0.283 μM), Lactococcus raffinolactis JCM 5706 (MIC=0.71 μM), Lactobacillus sakei subsp.sakei JCM 1157 (MIC=0.015 μM), Lactobacillus casei subsp.casei JCM 1134 (MIC=2.27 μM), Leuconostoc brevis JCM 1059 (MIC=1.14 μM), L. acidophilus JCM 1132 (MIC=2.86 μM), L. coryniformis subsp.coryniformis JCM 1164 (MIC=2.86 μM), L. kimchii JCM 10707 (MIC=0.71 μM), L. mesenteroides subsp.mesenteroides JCM 6124 (MIC=1.03 μM), Weissella cibaria JCM 12495 (MIC=0.71 μM), Pediococcus pentosaceus JCM 5885 (MIC=0.55 μM), P. pentosaceus JCM 5890 (MIC=2.86 μM), P. acidilactici JCM 8797 (MIC=2.86 μM), P. dextrinicus JCM 5887 (MIC=0.141 μM), Enterococcus faecium JCM5804 (MIC=0.71 μM), E. hirae ATCC 10541 (MIC=0.71 μM), E. durans NBRC 100479 (MIC=0.71 μM), E. faecalis JCM 5803 (MIC=0.26 μM), Streptococcus salivarius JCM 5707 (MIC=22.9 μM), S. bovis JCM 5802 (MIC=22.9 μM), Bacillus coagulans JCM 2257 (MIC=0.015 μM), B. circulans JCM 2504 (MIC=0.031 μM), B. subtilis JCM 1465 (MIC=0.064 μM), B. cereus JCM 2152 (MIC=11.4 μM), Micrococcus luteus IFO 12708 (MIC=5.7 μM), Listeria innocua ATCC 33090 (MIC=1.03 μM), L. monocytogenes ATCC BAA-679 (MIC=1.03 μM), Staphylococcus aureus subsp.aureus ATCC 12600 (MIC=91.6 μM);
Gram-negative bacteria: Escherichia coli JM109 (MIC=34.3 μM), E. coli NBRC 3301 (MIC=17.3 μM).",Unknown,Unknown,19139222##21948835,Appl Environ Microbiol. 2009 Mar;75(6):1552-1558.##Appl Environ Microbiol. 2011 Nov;77(22):8164-8170. ,"Sawa N, Zendo T, Kiyofuji J, Fujita K, Himeno K, Nakayama J, Sonomoto K.##Masuda Y, Ono H, Kitagawa H, Ito H, Mu F, Sawa N, Zendo T, Sonomoto K.","Identification and characterization of lactocyclicin Q, a novel cyclic bacteriocin produced by Lactococcus sp. strain QU 12.##Identification and characterization of leucocyclicin Q, a novel cyclic bacteriocin produced by Leuconostoc mesenteroides TK41401.",,,,,,,,
25,DRAMP00191,GGAGHVPEYFVGIGTPISFYG,21,Microcin J25 (MccJ25; Bacteriocin),Q9X2V7,Belongs to the class I microcin,mcjA,Escherichia coli AY25 (Gram-negative bacteria),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Beta strand,"MccJ25 does not have a head-to-tail cyclic structure but rather a side chain to backbone cyclization between Glu8 and the N-terminus. This creates an embedded ring that is threaded by the C-terminal tail of the molecule, forming a noose-like feature. The three-dimensional structure deduced from NMR data suggests that slippage of the noose is prevented by two aromatic residues flanking the embedded ring.","1Q71, 1PP5 resolved by NMR.","Function: Microcin J25 is a 21 amino acid bacterial peptide that has potent antibacterial activity against Gram-negative bacteria, resulting from its interaction with RNA polymerase.
Induction: At the onset of stationary growth phase.
PTM: Isoglutamyl glycine isopeptide between G1 and E8.","Gram-negative bacteria: Escherichia coli BM21 (MIC=0.08 μg/ml), E. coli AB1133 (MIC=0.02 μg/ml), E. coli RYC816 (MIC=0.04 μg/ml), E. coli AY29 (MIC=0.04 μg/ml), Salmonella species, Shigella flexneri.",Unknown,Unknown,1429464##10092860##14531690##14531661,J Bacteriol. 1992 Nov;174(22):7428-7435.##Eur J Biochem. 1999 Feb;259(3):747-755.##J Am Chem Soc. 2003 Oct 15;125(41):12464-74.##J Am Chem Soc. 2003 Oct 15;125(41):12382-3.,"Salomón RA, Farías RN.##Blond A, Péduzzi J, Goulard C, Chiuchiolo MJ, Barthélémy M, Prigent Y, Salomón RA, Farías RN, Moreno F, Rebuffat S.##Rosengren KJ, Clark RJ, Daly NL, Göransson U, Jones A, Craik DJ.##Bayro MJ, Mukhopadhyay J, Swapna GV, Huang JY, Ma LC, Sineva E, Dawson PE, Montelione GT, Ebright RH.","Microcin 25, a novel antimicrobial peptide produced by Escherichia coli.##The cyclic structure of microcin J25, a 21-residue peptide antibiotic from Escherichia coli.##Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone.##Structure of antibacterial peptide microcin J25: a 21-residue lariat protoknot.",,,,,,,,
29,DRAMP00222,GETDPNTQLLNDLGNNMAWGAALGAPGGLGSAALGAAGGALQTVGQGLIDHGPVNVFIPVLIGPSWNGSGSGYNSATSSSGSGS,84,Microcin E492 (MccE492; Bacteriocin),"Q9Z4N4, P82962",Unknown,mceA,Klebsiella pneumoniae RYC492 (Gram-negative bacteria),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Channel-forming bacteriocin. Forms cation-selective channels. Active on enterobacteria, with highest activity against Escherichia coli. The unmodified protein is active against Escherichia coli and S. enteritidis. When the siderophore ester is present at Ser-99, antibacterial activity against these species is increased and activity is also detected against E. cloacae and K. pneumoniae.
PTM: The C-terminal Ser is modified by attachment to a siderophore similar to enterobactin, which can bind one atom of iron. The modification consists of an ester linkage of the serine carboxyl to O6 of a glucose which is linked by a C-glycosidic bond to the 5'-benzoyl of a linear triester of N-(2,3-dihydroxybenzoyl)serine. Presence of the siderophore ester increases the antibacterial activity of the protein.","Gram-negative bacteria: Escherichia coli F (MIC=0.14 μM), Escherichia coli 363 (MIC=0.02 μM), Escherichia coli ML35p (MIC=0.14 μM), Escherichia coli GM1 (MIC=0.04 μM), Escherichia coli GM1 KP1060(MIC=0.65 μM), Escherichia coli W3110 (MIC=0.02 μM), Escherichia coli W3110-KP1344 Pms7 (MIC=0.08 μM), Escherichia coli W3110-6 (MIC=0.32 μM), Escherichia coli C600 (MIC=0.08 μM), Escherichia coli C600 pHX405 (MIC=0.16 μM), Salmonella enteritidis (MIC=0.6 μM), Salmonella typhimurium (MIC=1.2 μM).",Unknown,Unknown,12890026##15102848##7682973,Mol Microbiol. 2003 Aug;49(4):1031-1041.##J Biol Chem. 2004 Jul 2;279(27):28233-28242.##FEBS Lett. 1993 Apr 26;321(2-3):145-148.,"Destoumieux-Garzón D, Thomas X, Santamaria M, Goulard C, Barthélémy M, Boscher B, Bessin Y, Molle G, Pons AM, Letellier L, Peduzzi J, Rebuffat S.##Thomas X, Destoumieux-Garzón D, Peduzzi J, Afonso C, Blond A, Birlirakis N, Goulard C, Dubost L, Thai R, Tabet JC, Rebuffat S.##Lagos R, Wilkens M, Vergara C, Cecchi X, Monasterio O.","Microcin E492 antibacterial activity: evidence for a TonB-dependent inner membrane permeabilization on Escherichia coli.##Siderophore peptide, a new type of post-translationally modified antibacterial peptide with potent activity.##Microcin E492 forms ion channels in phospholipid bilayer membrane.",,,,,,,,
34,DRAMP00336,IPCGESCVWIPCITAIAGCSCKNKVCYT,28,ChaC7 (Chassatide C7; uncyclotides; Plant defensin),No entry found,Unknown,Unknown,Chassalia chartacea,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"IC50=1.2 μM, HD50=11.6 μM.
Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).","Gram-negative bacterium: Escherichia coli (MIC=6.4 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 μM), Staphylococcus epidermidis (MIC>80 μM).",Unknown,Unknown,22467870,J Biol Chem. 2012 May 18;287(21):17598-17607.,"Nguyen GK, Lim WH, Nguyen PQ, Tam JP.",Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.,,,,,,,,
35,DRAMP00337,AIPCGESCVWIPCISTVIGCSCSNKVCYR,29,ChaC8 (Chassatide C8; uncyclotides; Plant defensin),No entry found,Unknown,Unknown,Chassalia chartacea,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"IC50=1.0 μM, HD50=25.5 μM.
Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).","Gram-negative bacterium: Escherichia coli (MIC=6.6 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 μM), Staphylococcus epidermidis (MIC>80 μM).",Unknown,Unknown,22467870,J Biol Chem. 2012 May 18;287(21):17598-17607.,"Nguyen GK, Lim WH, Nguyen PQ, Tam JP.",Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.,,,,,,,,
36,DRAMP00338,IPCGESCVWIPCISGMFGCSCKDKVCYS,28,ChaC11 (Chassatide C11; uncyclotides; Plant defensin),No entry found,Unknown,Unknown,Chassalia chartacea,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"IC50=1.2 μM, HD50=13.3 μM.
Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).","Gram-negative bacterium: Escherichia coli (MIC=8.5 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 μM), Staphylococcus epidermidis (MIC>80 μM).",Unknown,Unknown,22467870,J Biol Chem. 2012 May 18;287(21):17598-17607.,"Nguyen GK, Lim WH, Nguyen PQ, Tam JP.",Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.,,,,,,,,
38,DRAMP00385,QLPICGETCVLGGCYTPNCRCQYPICVR,28,Panitide L2 (plants),No entry found,Unknown,Unknown,Panicum laxum,"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Bridge,Unknown,Unknown,PTM: N-terminus is a pyruglutamyl.,Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=2.5 μM).,Unknown,Unknown,23195955,J Biol Chem. 2013 Feb 1;288(5):3370-3380.,"Nguyen GK, Lian Y, Pang EW, Nguyen PQ, Tran TD, Tam JP.",Discovery of linear cyclotides in monocot plant Panicum laxum of Poaceae family provides new insights into evolution and distribution of cyclotides in plants.,,,,,,,,
44,DRAMP00431,KTCMTKKEGWGRCLIDTTCAHSCRKYGYMGGKCQGITRRCYCLLNC,46,Defensin-like protein 2 (Cp-thionin II; Cp-thionin-2; Gamma-thionin II; Plant defensin),P84920,Belongs to the DEFL family,Unknown,Vigna unguiculata (Cowpea),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli and P. syringae. Does not have antibacterial activity against the phytopathogenic bacteria R. solanacearum, Rhataybacter sp and Erwinia sp. Does not inhibit trypsin, chymotrypsin or alpha-amylases.
Tissue specificity: Present in seeds, cotyledons and leaves. Not found in roots or stems.
Developmental stage: Present in seeds and seedlings, levels decrease with seedling age. Light increases the rate of degradation. Present until 9 days in seedlings kept in the dark, not found after 6 days in seedings kept in the light.
PTM: Contains four disulfide bonds 3-46; 13-33; 19-40; 23-42.","Gram-positive bacterium: Staphylococcus aureus ATTC 25923 (MIC=128 mg/ml);##Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=64 mg/ml), Pseudomonas syringae (MIC=42 mg/ml).",Unknown,Unknown,16824043,FEBS J. 2006 Aug;273(15):3489-3497. ,"Franco OL, Murad AM, Leite JR, Mendes PA, Prates MV, Bloch C Jr.",Identification of a cowpea gamma-thionin with bactericidal activity.,,,,,,,,
49,DRAMP00764,KSLRPRCWIKIKFRCKSLKF,20,Piceain 1 (Plants),No entry found,Unknown,Unknown,Picea sitchensis,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Beta strand (CD),Unknown,Unknown,"Function: Active against both Gram-postive and Gram-negative bacteria, fungi. It showed weak hemolysis activity against human and rabbit red cells.
PTM: Contains one disulfide bond.","Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=9.38 μg/ml), S. aureus ATCC 43300 (MIC=9.38 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=18.75 μg/ml), Escherichia coli ML-35P (MIC=18.75 μg/ml), Escherichia coli 08040722 (CI) (MIC=75 μg/ml), Escherichia coli 08A866 (CI) (MIC=37.5 μg/ml), Pseudomonas aeruginosa PA01 (MIC=9.38 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=9.38 μg/ml), Pseudomonas aeruginosa 08031014 (CI) (MIC=37.5 μg/ml).##Yeast: Candida albicans ATCC 20032 (MIC=9.38 μg/ml).",Unknown,Unknown,21644248,J Pept Sci. 2011 Sep;17(9):627-631.,"Liu R, Mu L, Liu H, Wei L, Yan T, Chen M, Zhang K, Li J, You D, Lai R.",Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis.,,,,,,,,
50,DRAMP00765,RPRCWIKIKFRCKSLKF,17,Piceain 2 (Plants),No entry found,Unknown,Unknown,Picea sitchensis,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Active against both Gram-postive and Gram-negative bacteria, fungi. It showed weak hemolysis activity against human and rabbit red cells.
PTM: Contains one disulfide bond.","Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=9.38 μg/ml), S. aureus ATCC 43300 (MIC=18.75 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=37.5 μg/ml), Escherichia coli ML-35P (MIC=37.5 μg/ml), Escherichia coli 08040722 (CI) (MIC=75 μg/ml), Escherichia coli 08A866 (CI) (MIC=37.5 μg/ml), Pseudomonas aeruginosa PA01 (MIC=9.38 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=18.75 μg/ml), Pseudomonas aeruginosa 08031014 (CI) (MIC=37.5 μg/ml).##Yeast: Candida albicans ATCC 20032 (MIC=18.75 μg/ml).",Unknown,Unknown,21644248,J Pept Sci. 2011 Sep;17(9):627-631.,"Liu R, Mu L, Liu H, Wei L, Yan T, Chen M, Zhang K, Li J, You D, Lai R.",Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis.,,,,,,,,
51,DRAMP00766,KVFLGLK,7,JCpep7 (Plants),No entry found,Unknown,Unknown,Jatropha curcas,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: JCpep7 killed microbes principally via breaking of their cell walls and membranes, followed by cell lysis.","Gram-negative bacteria: Salmonella typhimurium ATCC 50013 (MIC=48 μg/ml), Shigella dysenteriae ATCC 51302 (MIC=48 μg/ml), Pseudomonas aeruginosa ATCC 27553 (MIC=64 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=40 μg/ml), Bacillus subtilis ATCC 23631 (MIC=24 μg/ml), Streptococcus pneumoniae ATCC 49619 (MIC=56 μg/ml).",Unknown,Unknown,21268582,J Agric Food Chem. 2011 Feb 23;59(4):1145-1151.,"Xiao J, Zhang H, Niu L, Wang X.",Efficient Screening of a Novel Antimicrobial Peptide from Jatropha curcas by Cell Membrane Affinity Chromatography.,,,,,,,,
52,DRAMP00774,GTRCGETCFVLPCWSAKFGCYCQKGFCYRN,30,Hedyotide B1 (hB1; Plants),No entry found,Belongs to the cyclotide family,Unknown,Hedyotis biflora (aerial tissues),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=3.4 μM);##Gram-positive bacteria: Streptococcus salivarius(MIC=5.9 μM), Staphylococcus epidermidis (MIC>80 μM), S. aureus (MIC>80 μM).",Unknown,Unknown,21979955,J Biol Chem. 2011 Dec 30;286(52):44833-44844.,"Nguyen GK, Zhang S, Wang W, Wong CT, Nguyen NT, Tam JP.",Discovery of a linear cyclotide from the bracelet subfamily and its disulfide mapping by top-down mass spectrometry.,,,,,,,,
53,DRAMP00795,GIPCGESCVFIPCITAAIGCSCKSKVCYRN,30,Cliotide T1 (cT1; Plant defensin),No entry found,Belongs to the cyclotide family,Unknown,Clitoria ternatea (Butterfly pea),"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Cliotide T1 shows stronger antimicrobial activity against the Gram-negative bacteria than the Gram-positive bacteria. It also has hemolytic activity against human type A erythrocytes (HD50=7.1 μM) and cytotoxicity against HeLa Cells (IC50=0.6 μM).
[Note: HD50 refers to the peptide concentration that causes 50% lysis of red blood cells; IC50 refers to the peptide concentration that causes 50% death of HeLa cells]. ","[Ref.21596752]Gram-positive bacteria: Staphylococcus aureus ATCC12600, Enterococcus faecalis ATCC 47077 (less active);##Gram-negative bacteria: Escherichia coli ATCC 700926 (MIC=1.1 μM), Pseudomonas aeruginosa ATCC 39018 (MIC=2.7 μM), Klebsiella pneumonia ATCC 13883 (MIC=4.7 μM).",[Ref:21596752]HD50=7.1 μM against human type A erythrocytes ,Unknown,21596752,J Biol Chem. 2011 Jul 8;286(27):24275-24287.,"Nguyen GK, Zhang S, Nguyen NT, Nguyen PQ, Chiu MS, Hardjojo A, Tam JP.",Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.,,,,,,,,
54,DRAMP00798,GIPCGESCVFIPCITGAIGCSCKSKVCYRN,30,Cliotide T4 (cT4; Plant defensin),No entry found,Belongs to the cyclotide family,Unknown,Clitoria ternatea (Butterfly pea),"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Cliotide T4 shows stronger antimicrobial activity against the Gram-negative bacteria than the Gram-positive bacteria. It also has hemolytic activity against human type A erythrocytes (HD50=8.4 μM) and cytotoxicity against HeLa Cells (IC50=0.6 μM).
[Note: HD50 refers to the peptide concentration that causes 50% lysis of red blood cells; IC50 refers to the peptide concentration that causes 50% death of HeLa cells]. ","[Ref.21596752]Gram-positive bacteria: Staphylococcus aureus ATCC12600, Enterococcus faecalis ATCC 47077 (less active);##Gram-negative bacteria: Escherichia coli ATCC 700926 (MIC=1.3 μM), Pseudomonas aeruginosa ATCC 39018 (MIC=1.9 μM), Klebsiella pneumonia ATCC 13883 (MIC=1.5 μM).",[Ref:21596752]HD50=8.4 μM against human type A erythrocytes,Unknown,21596752,J Biol Chem. 2011 Jul 8;286(27):24275-24287.,"Nguyen GK, Zhang S, Nguyen NT, Nguyen PQ, Chiu MS, Hardjojo A, Tam JP.",Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.,,,,,,,,
55,DRAMP00856,GLPVCGETCVGGTCNTPGCTCSWPVCTRN,29,Kalata-B1 (Plant defensin),P56254,Belongs to the cyclotide family,OAK1,Oldenlandia affinis ,"Antibacterial, Antifungal, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (3 strands; 7 residues),Unknown,2KHB resolved by NMR.,"Function: Probably participates in a plant defense mechanism. Has antibiotic activity. Has a diuretic effect. Has a uterotonic effect in humans. Active against the Gram-positive S. aureus. Relatively ineffective against Gram-negative bacteria such as E. coli and P. aeruginosa. Inhibitory effect on the growth and development of larvae from H. punctigera. The unmodified form has hemolytic activity, the oxidized form lacks hemolytic activity. If the protein is linearized, hemolytic activity is lost.
MOA: a small number of cyclotides bind to the membrane surface and then insert first into the outer membrane leaflet followed by penetration through the membrane and pore formation. At higher concentrations of cyclotides, destabilization of membranes occurs.
Tissue specificity: Leaves and stems. Lower in roots.
Pharmaceutical use: The uteroactive properties of Kalata have been discovered by African traditional medicine. It is used as an ingredient of a herbal tea to accelerate childbirth.
PTM: Kalata-B1 is a cyclic peptide which contains three disulfide bonds 5-19; 11-21; 14-26.","[Ref.10430870]Gram-positive bacterium: Staphylococcus aureus (MIC=0.26 μM), Micrococcus luteus (MIC=40.4 μM);##Gram-negative bacterium: Klebsiella oxytoca (MIC=54.8 μM);##Fungi: Candida kefyr (MIC=21.4 μM).",[Ref:17534989]20% hemolytic activity at 0.6μM and 75% hemolytic activity at 1.5μM against human type A red blood cells,Cell membrance,10430870##7703226##17534989##12779323##23129773,Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8918.##Biochemistry. 1995 Apr 4;34(13):4147-4158.##Chembiochem. 2007 Jun 18;8(9):1001-1011.##Biochemistry. 2003 Jun 10;42(22):6688-6695.##J Biol Chem. 2012 Dec ,"Tam JP, Lu YA, Yang JL, Chiu KW.##Saether O, Craik DJ, Campbell ID, Sletten K, Juul J, Norman DG.##Plan MR, Göransson U, Clark RJ, Daly NL, Colgrave ML, Craik DJ.##Barry DG, Daly NL, Clark RJ, Sando L, Craik DJ.##Wang CK, Wacklin HP, Craik DJ.","An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.##Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1.##The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides.##Linearization of a naturally occurring circular protein maintains structure but eliminates hemolytic activity.##Cyclotides insert into lipid bilayers to for",,,,,,,,
56,DRAMP00877,GIPCGESCVWIPCISAALGCSCKNKVCYRN,30,Circulin-A (CIRA; Plant defensin),"P56871, P82250",Belongs to the cyclotide family,Unknown,Chassalia parviflora ,"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 4 residues),"The molecule is stabilised by three disulfide bonds, two of which form an embedded loop completed by the backbone fragments connecting the cysteine residues. A third disulfide bond threads through the centre of this loop to form a \cystine-knot\"" motif. This motif is present in a range of other biologically active proteins including omega-contoxin GVIA and Cucurbita maxima trypsin inhibitor.",1BH4 resolved by NMR.,"Function: Probably participates in a plant defense mechanism. Has antibiotic activity. Inhibits the cytopathic effects and replication of the human immunodeficiency virus. Relatively ineffective against Gram-negative bacteria such as E. coli and P. aeruginosa.
PTM: This is a cyclic peptide which contains three disulfide bonds 1-17; 5-19; 10-24.",Gram-positive bacterium: Staphylococcus aureus (MIC=0.19 μM).##Gram-negative bacterium: Proteus vulgaris (MIC=54.6 μM).##Fungi: Candida kefyr (MIC=18.6 μM) and Candida tropicalis (MIC=19.4 μM).##NOTE: Medium with 10 mM phosphate buffer.,Unknown,Unknown,10430870##9878410,Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8918.##J. Mol. Biol. 1999; 285:333-345.,"Tam JP, Lu YA, Yang JL, Chiu KW.##Daly NL, Koltay A, Gustafson KR, Boyd MR, Casas-Finet JR, Craik DJ.",An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.##Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activity.,,,,,,,,
57,DRAMP00878,GVIPCGESCVFIPCISTLLGCSCKNKVCYRN,31,Circulin-B (CIRB; Plant defensin),"P56879, P82255",Belongs to the cyclotide family,Unknown,Chassalia parviflora ,"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (5 strands; 10 residues),Cyclotides are mini-proteins derived from plants that have the characteristic features of a head-to-tail cyclised peptide backbone and a knotted arrangement of their three disulfide bonds.,2ERI resolved by NMR.,"Function: Probably participates in a plant defense mechanism. Has antibiotic activity. Inhibits the cytopathic effects and replication of the human immunodeficiency virus. Active against both Gram-positive and Gram-negative bacteria.
PTM: This is a cyclic peptide which contains three disulfide bonds 5-21; 9-23; 14-28.","Gram-positive bacterium: (L-salt): Staphylococcus aureus (MIC=13.5 μM).##Gram-negative bacteria: (L-salt, H-salt) (MIC μM): Escherichia coli (0.41, >500), Pseudomonas aeruginosa (25.5, 48), Proteus vulgaris (6.8, >500), Klebsiella oxytoca (8.2, 15.6).##Fungi (H-salt): Candida kefyr (MIC=29 μM).##NOTE: L-salt = Medium with 10 mM phosphate buffer; H-salt = L-salt supplemented with 100 mM NaCl.",Unknown,Unknown,10430870##,Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8918.##Int. J. Pept. Protein Res. 2005;11:99-106.,"Tam JP, Lu YA, Yang JL, Chiu KW.##Koltay A, Daly N.L, Gustafson K.R, Craik D.J.",An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.##Structure of circulin B and implications for antimicrobial activity of the cyclotides.,,,,,,,,
58,DRAMP01374,GFLDTFKNLALNAAKSAGVSVLNSLSCKLFKTC,33,"Odorranain-D1 (OdD1; Frogs, amphibians, animals)",A6MBK7,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,Function: Odorranain-D1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Has no hemolytic activity against red cell.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=16.32 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=8.16 μg/ml), Bacillus subtilis (MIC=8.16 μg/ml).##Yeast: Candida albicans (MIC=4.08 μg/ml).",[Ref:17272268]Non-hemolytic activity against rabbit red blood cells,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
59,DRAMP01373,GVLGAVKDLLIGAGKSAAQSVLKTLSCKLSNDC,33,"Odorranain-C1 (OdC1; Frogs, amphibians, animals)",A6MBF6,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,Function: Odorranain-C1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=8.21 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=4.11 μg/ml), Bacillus subtilis (MIC=16.42 μg/ml).##Yeast: Candida albicans (MIC=2.05 μg/ml).",Unknown,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
60,DRAMP01372,AALKGCWTKSIPPKPCFGKR,20,"Odorranain-B1 (Frogs, amphibians, animals)",E7EKD9,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Unknown,Odorrana hainanensis (Odor frog) (Rana hainanensis),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Homology,Unknown,Odorranain-B1 adopts 5.9 % ,Unknown,"Function: Odorranain-B1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Has no hemolytic activity against red cell. 
Tissue specificity: Expressed by the skin glands.","[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=3.21 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=5.83 μg/ml), Bacillus subtilis (MIC=1.85 μg/ml).##Yeast: Candida albicans (MIC=2.4 μg/ml).",[Ref:17272268]Non-hemolytic activity against rabbit red blood cells,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
63,DRAMP01012,RESPSSRMECYEQAERYGYGGYGGGRYGGGYGSGRGQPVGQGVERSHDDNRNQPR,55,Pg-AMP (Gly-rich; Plants),P86030,Unknown,Unknown,Psidium guajava (Guava),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-negative bacteria. Does not have antifungal activity against the human and plant pathogenic fungi F. oxysporum, A. fumigatus and R. solani. 
Subunit structure: Monomer and homodimer. Might act by homodimer formation.","Gram-negative bacteria: Klebsiella sp., Proteus sp., Escherichia coli ATCC 8739 (MIC=72 mg/ml), Klebsiella pneumoniae (MIC=32 mg/ml).",Unknown,Unknown,18448201,Peptides. 2008 Aug;29(8):1271-1279.,"Pelegrini PB, Murad AM, Silva LP, Dos Santos RC, Costa FT, Tagliari PD, Bloch C Jr, Noronha EF, Miller RN, Franco OL.",Identification of a novel storage glycine-rich peptide from guava (Psidium guajava) seeds with activity against Gram-negative bacteria.,,,,,,,,
66,DRAMP01018,SIPCGESCVFIPCTVTALLGCSCKSKVCYKN,31,Cyclopsychotride-A (CPT; Plant defensin),"P56872, P82254",Unknown,Unknown,Psychotria longipes ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Probably participates in a plant defense mechanism. Has antibiotic activity. Inhibits the cytopathic effects and replication of the human immunodeficiency virus. Active against both Gram-positive and Gram-negative bacteria.
PTM: This is a cyclic peptide which may contain three disulfide bonds 4-21; 8-23; 13-28.","Gram-negative bacteria: Escherichia coli (MIC=1.55 μM), Pseudomonas aeruginosa (MIC=13.5 μM), Proteus vulgaris (MIC=13.2 μM), Klebsiella oxytoca (MIC=5.80 μM).##Gram-positive bacteria: Staphylococcus aureus (MIC=39.0 μM), Micrococcus luteus (MIC=48.0 μM).##Fungi: Candida albicans (MIC>500 μM), Candida kefyr (MIC=14.0 μM), Candida tropicalis (MIC=56.5 μM).##NOTE: Medium with 10 mM phosphate buffer.",Unknown,Unknown,10430870##7714530,Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8918.##J Nat Prod. 1994 Dec;57(12):1619-1625.,"Tam JP, Lu YA, Yang JL, Chiu KW.##Witherup KM, Bogusky MJ, Anderson PS, Ramjit H, Ransom RW, Wood T, Sardana M. ","An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.##Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes.",,,,,,,,
68,DRAMP18193,KRFKKFFKKVKKSVKKRLKKIFKKPMVIGVTIPF,34,Cathelicidin-related peptide crotalicidin,U5KJM4,Belongs to the cathelicidin family.,Unknown,Crotalus durissus terrificus (South American rattlesnake),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,alpha helical,Unknown,2MWT resolved by NMR,"Function: Adopts an amphipathic alpha helical conformation, that may allow to partition into the target membrane (By similarity). Hemolytic activities have been observed on mammalian cells. Expressed by the venom gland.","[Ref.25100358]Gram-negative: E.coli ATCC 25922 (MIC=0.25 μg/mL),P.aeruginosa (MIC=1 μg/mL);##Gram-positive: E.faecalis (MIC=32 μg/mL), S.aureus (MIC=32 μg/mL).",[Ref.25100358]10% hemolytic activity at 12.5 μM against red blood cells,cell membrane,25100358,Amino Acids 46:2561-2571(2014),"Falcao C.B., de La Torre B.G., Perez-Peinado C., Barron A.E.,Andreu D., Radis-Baptista G.",Vipericidins: a novel family of cathelicidin-related peptides fromthe venom gland of South American pit vipers.,,,,,,,,
69,DRAMP01064,AWKLFDDGV,9,Anticancerous peptide 1 (Cr-ACP1; Plants),B3EWE7,Unknown,Unknown,Cycas revoluta (Sago palm),"Anticancer, Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: The synthetic peptide inhibits cell proliferation and induces apoptosis in cancer-derived cell lines Hep2 (IC50=1.5 mM) and HCT15 and, to a lesser extent, in non-cancerous NIH/3T3 cells. The mode of action is presumably an arrest in the G0/G1 phase. Antiproliferative, proapoptotic and DNA-binding activities are increased by acetylation at Ala-1 and Lys-3. Has a weak hemolytic activity against mouse erythrocytes. Has antibacterial activity. Antibacterial activity is decreased by acetylation. ","[Ref.21882228]Gram-positive bacteria: Staphylococcus epidermidis (MIC=60 μM), Bacillus subtilis (MIC=30 μM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=30 μM), EEscherichia coli strain ATCC 8739 (MIC=30 μM).",[Ref:21882228]8% hemolytic activity at 1 mM against 6-week-old male BALB/c mice red blood cells,DNA,21882228,J Cell Biochem. 2012 Jan;113(1):184-193.,"Mandal SM, Migliolo L, Das S, Mandal M, Franco OL, Hazra TK.",Identification and characterization of a bactericidal and proapoptotic peptide from Cycas revoluta seeds with DNA binding properties.,,,,,,,,
70,DRAMP01066,PVVDTTGNNPLQQQEEYYV,19,Kunitz-type serine protease inhibitor 1 (Xb-KTI; Plants),P86930,Unknown,Unknown,Xanthosoma sagittifolium (Elephant's ear) (Arum sagittifolium),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Serine protease inhibitor. Displays antimicrobial activity against the Gram-negative bacterium S. typhimurium ATCC 14028. Displays a weak hemolytic activity.,[Ref.21520894]Gram-negative bacterium: Salmonella typhimurium ATCC 14028 (MIC=10 μM).,[Ref:21520894]7% hemolytic activity at 250 μg/mL against human erythrocytes,Unknown,21520894,J Nat Prod. 2011 May 27;74(5):969-975.,"Lima TB, Silva ON, Migliolo L, Souza-Filho CR, Gonçalves EG, Vasconcelos IM, Oliveira JT, Amaral AC, Franco OL.",A Kunitz proteinase inhibitor from corms of Xanthosoma blandum with bactericidal activity.,,,,,,,,
71,DRAMP01081,GLKDIFKAGLGSLVKGIAAHVAN,23,"Alyteserin-1a (toads, amphibians, animals)",No entry found,Unknown,Unknown,Alytes obstetricans (European midwife toad),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: The alyteserin-1 peptides show selective growth inhibitory activity against the Gram-negative bacterium Escherichia coli. The hemolytic activity against human erythrocytes of all peptides tested is relatively weak.
Structural similarity: The alyteserin-1 peptides show limited structural similarity to the ascaphins from the skins of frogs of the family Leiopelmatidae.",[Ref.19463738]Gram-negative bacterium: Escherichia coli (MIC=25 μM).,[Ref:19463738]11% hemolytic activity at 100 μM against human erythrocytes,Unknown,19463738,Peptides. 2009 Jun;30(6):1069-1073.,"Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.",The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).,,,,,,,,
73,DRAMP01083,GLKEIFKAGLGSLVKGIAAHVAN,23,"Alyteserin-1b (toads, amphibians, animals)",No entry found,Unknown,Unknown,Alytes obstetricans (European midwife toad),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Amtimicrobial peptide. (By similarity),Gram-negative bacterium: Escherichia coli (MIC=25 μM).,Unknown,Unknown,19463738,Peptides. 2009 Jun;30(6):1069-1073.,"Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.",The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).,,,,,,,,
74,DRAMP01085,GLKEIFKAGLGSLVKGIAAHVAS,23,"Alyteserin-1c (toads, amphibians, animals)",H0USY4,Unknown,Unknown,Alytes obstetricans (Common midwife toad) (Bufo obstetricans),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,"Solution structural studies in the membrane mimicking environments, sodium dodecyl sulphate (SDS), dodecylphosphocholine (DPC), and 1,2-dihexanoyl-sn-glycero-3-phosphatidylcholine (DHPC) micelles, indicate that these peptides display an alpha helical structure between residues Lys(3) and Val(21).(Ref.1)",2L5R resolved by NMR.,Function: Alyteserin-1c shows selective growth-inhibitory activity against Gram-negative bacteria.,Gram-negative bacterium: Escherichia coli (MIC=25 μM).,Unknown,Unknown,21565166##19463738,Biochim Biophys Acta. 2011 Aug;1808(8):1975-1984.##Peptides. 2009 Jun;30(6):1069-1073.,"Subasinghage AP, O'Flynn D, Conlon JM, Hewage CM.##Conlon JM, Demandt A, Nielsen PF, Leprince J, Vaudry H, Woodhams DC.",Conformational and membrane interaction studies of the antimicrobial peptide alyteserin-1c and its analogue [E4K]alyteserin-1c.##The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae).,,,,,,,,
75,DRAMP01088,GFKEVLKADLGSLVKGIAAHVAN,23,"Alyteserin-1Ma (toads, amphibians, animals)",No entry found,Unknown,Unknown,Alytes maurus (Midwife toad),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Alyteserin-1Ma has lower antimicrobial potencies (MIC>200 μM).,Gram-negative bacterium: Escherichia coli NCTC 10418 (MIC=214 μM) and Gram-positive bacterium: Staphylococcus aureus NCTC 10788 (MIC=214 μM).,Unknown,Unknown,22800568,Toxicon. 2012 Nov;60(6):967-981.,"König E, Zhou M, Wang L, Chen T, Bininda-Emonds OR, Shaw C.","Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): Implications for the evolution of frog skin defensive secretions.",,,,,,,,
76,DRAMP01089,GFKEVLKAGLGSLVKGIPAHVAN,23,"Alyteserin-1Mb (toads, amphibians, animals)",No entry found,Unknown,Unknown,Alytes maurus (Midwife toad),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Alyteserin-2Ma has lower antimicrobial potencies (MIC>200 μM).,Gram-negative bacterium: Escherichia coli NCTC 10418 (MIC=217 μM) and Gram-positive bacterium: Staphylococcus aureus NCTC 10788 (MIC=434 μM).,Unknown,Unknown,22800568,Toxicon. 2012 Nov;60(6):967-981.,"König E, Zhou M, Wang L, Chen T, Bininda-Emonds OR, Shaw C.","Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): Implications for the evolution of frog skin defensive secretions.",,,,,,,,
77,DRAMP01090,FIGKLISAASGLLSHL,16,"Alyteserin-2Ma (toads, amphibians, animals)",No entry found,Unknown,Unknown,Alytes maurus (Midwife toad),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-negative bacteria E. coli and Gram-positive bacteria S. aures. It only inhibits C. albicans at very high concentration of 150 microM.,Gram-negative bacterium: Escherichia coli NCTC 10418 (MIC=38.4 μM) and Gram-positive bacterium: Staphylococcus aureus NCTC 10788 (MIC=9.5 μM).,Unknown,Unknown,22800568,Toxicon. 2012 Nov;60(6):967-981.,"König E, Zhou M, Wang L, Chen T, Bininda-Emonds OR, Shaw C.","Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): Implications for the evolution of frog skin defensive secretions.",,,,,,,,
79,DRAMP01096,GIGSAILSAGKSALKGLAKGLAEHFAN,27,"Bombinin-like peptide 2 (BLP-2; toads, amphibians, animals)",P29003,Belongs to the bombinin family,Unknown,Bombina orientalis (Oriental fire-bellied toad),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Has antimicrobial activity, but no hemolytic activity. Preference on killing Gram-negative non-enteric bacteria.
Tissue specificity: Expressed by the skin glands.","[Ref.1744108]Gram-negative bacterium: 58% inhibition Neisseria meningitidis 118V C (MIC=20 μg/ml), 98% inhibition Neisseria meningitidis 15240 IAI (MIC=20 μg/ml), 98% inhibition Neisseria meningitidis 126E IC1 (MIC=20 μg/ml), 97% inhibition Neisseria gonorrhoeoe F62 (MIC=20 μg/ml), 99% inhibition Neisseria Iactamica 15323 (MIC=20 μg/ml), 100% inhibition Neisseria Iactamica 15215A (MIC=20 μg/ml), 95% inhibition Neisseria cinerea 15461 (MIC=20 μg/ml).",[Ref:1744108]Non-hemolytic activity,Unknown,1744108,J. Biol. Chem. 1991; 266: 23103-23111.,"Gibson BW, Tang D, Mandrell R, Kelly M, Spindel ER.","Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis.",,,,,,,,
80,DRAMP01097,GIGASILSAGKSALKGLAKGLAEHFAN,27,"Bombinin-like peptide 1 (toads, amphibians, animals)",P29002,Belongs to the bombinin family,Unknown,Bombina orientalis (Oriental fire-bellied toad),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Has antimicrobial activity, but no hemolytic activity. Preference on killing Gram-negative non-enteric bacteria.
Tissue specificity: Expressed by the skin glands.","[Ref.1744108]Gram-postive bacterium:Bacillus megaterium BmII(MIC=0.3 μM), Staphylococcus aureus Cowan1 (MIC=3.4 μM);##Gram-negative bacterium: Escherichia coli D21 (MIC=1.7 μM), Escherichia coli D22(MIC=1.5 μM), 82 % inhibition Neisseria meningitidis 118V C (MIC=20 μg/ml), 98 % inhibition Neisseria meningitidis 15240 IAI(MIC=20 μg/ml), 85% inhibition Neisseria meningitidis 126E IC1(MIC=20 μg/ml), 98% inhibition Neisseria gonorrhoeoe F62 (MIC=20 μg/ml), 96% inhibition Neisseria Iactamica 15323(MIC=20 μg/ml), 100% inhibition Neisseria Iactamica 15215A(MIC=20 μg/ml), 98% inhibition Neisseria cinerea 15461 (MIC=20 μg/ml), Yersinia pseudotubercolosis (MIC=0.8 μM), Pseudomonas aeruginosa ATCC 15692(MIC=6.3 μM);##Fungus:Candida albicans(MIC=0.4 μM)",[Ref:1744108]Non-hemolytic activity,Unknown,1744108,J Biol Chem. 1991 Dec 5;266(34):23103-23111.,"Gibson BW, Tang DZ, Mandrell R, Kelly M, Spindel ER.","Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis.",,,,,,,,
81,DRAMP01098,GIGAAILSAGKSALKGLAKGLAEHF,25,"Bombinin-like peptide 3 (BLP-3; toads, amphibians, animals)",P29004,Belongs to the bombinin family,Unknown,Bombina orientalis (Oriental fire-bellied toad),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Has antimicrobial activity, but no hemolytic activity. Preference on killing Gram-negative non-enteric bacteria.
Tissue specificity: Expressed by the skin glands.","[Ref.1744108]Gram-postive bacterium:Bacillus megaterium BmII (MIC=0.3 μM), Staphylococcus aureus Cowan1 (MIC=1.7 μM);##Gram-negative bacterium:59% inhibition Neisseria meningitidis 118V C (MIC=20 μg/ml), 99% inhibition Neisseria meningitidis 15240 IAI (MIC=20 μg/ml), 99% inhibition Neisseria meningitidis 126E IC1 (MIC=20 μg/ml), 99% inhibition Neisseria gonorrhoeoe F62 (MIC=20 μg/ml), 97% inhibitionNeisseria Iactamica 15323 (MIC=20 μg/ml), 100% inhibition Neisseria Iactamica 15215A (MIC=20 μg/ml), 97% inhibition Neisseria cinerea 15461 (MIC=20 μg/ml), Escherichia coli D21 (MIC=1.7 μM), Escherichia coli D22 (MIC=1.5 μM), Yersinia pseudotubercolosis (MIC=0.6 μM), Pseudomonas aeruginosa ATCC 15692 (MIC=9.2 μM);##Fungus:Candida albicans (MIC=0.4 μM).",[Ref:1744108]Non-hemolytic activity,Unknown,1744108,J Biol Chem. 1991 Dec 5;266(34):23103-23111.,"Gibson BW, Tang DZ, Mandrell R, Kelly M, Spindel ER.","Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis.",,,,,,,,
83,DRAMP02090,FLPMLAGLAASMVPKFVCLITKKC,24,"Brevinin-1Lb (Frogs, amphibians, animals)",P82826,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana luteiventris (Spotted frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial activity against  Gram-positive and Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=8 μM);##Gram-negative bacterium: Escherichia coli (MIC=16 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
87,DRAMP01518,GILSLFTGGIKALGKTLFKMAGKAGAEHLACKATNQC,37,"Esculentin-2L (Frogs, amphibians, animals)",P82827,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana luteiventris (Great Basin spotted frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=3 μM);##Gram-negative bacterium: Escherichia coli (MIC=6 μM).##Yeast: Candida albicans (MIC=53 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
89,DRAMP01517,GFSSIFRGVAKFASKGLGKDLARLGVNLVACKISKQC,37,"Esculentin-2P (Frogs, amphibians, animals)",P82846,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana pipiens (northern leopard frog),"Antibacterial, Antiviral , Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial activity against  Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-negative bacterium: Escherichia coli (MIC=10 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
90,DRAMP01516,GLFSILRGAAKFASKGLGKDLTKLGVDLVACKISKQC,37,"Esculentin-2B (Frogs, amphibians, animals)",P82839,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana berlandieri (Rio Grande leopard frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi. 
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=1 μM);##Gram-negative bacterium: Escherichia coli (MIC=1 μM).##Yeast: Candida albicans (MIC=29 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
91,DRAMP02077,FLPIIAGIAAKVFPKIFCAISKKC,24,"Brevinin-1Pb (Frogs, amphibians, animals)",Q8QFQ5,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana pipiens (Northern leopard frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=5 μM);##Gram-negative bacterium: Escherichia coli (MIC=14 μM).##Yeast: Candida albicans (MIC=7 μM).,Unknown,Unknown,10651828##12413397,Eur J Biochem. 2000 Feb;267(3):894-900.##Biochem J. 2003 Apr 1;371(Pt 1):125-130.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.##Chen T, Farragher S.M, Bjourson A.J, Orr D.F, Rao P, Shaw C.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.##Granular gland transcriptomes in stimulated amphibian skin secretions.",,,,,,,,
98,DRAMP01162,AGRGKQGGKVRAKAKTRSSRAGLQFPVGRVHRLLRKGNY,39,"Buforin-1 (Buforin I; Fragment of Histone H2A; toads, amphibians, animals)",P55897,Belongs to the histone H2A family,Unknown,Bufo gargarizans (Asian toad) (Bufo bufo gargarizans),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.
PTM: Monoubiquitination of C-terminus gives a specific tag for epigenetic transcriptional repression. Following DNA double-strand breaks (DSBs), it is ubiquitinated through 'Lys-63' linkage of ubiquitin moieties.","Gram-positive bacteria: Bacillus subtilis (MIC=4 μg/ml), Staphylococcus aureus (MIC=4 μg/ml), Streptococcus mutans (MIC=8 μg/ml), Streptococcus pneumoniae (MIC=4 μg/ml), Pseudomonas putida (MIC=4 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=8 μg/ml), Salmonella typhimurium (MIC=4 μg/ml), Serratia sp. (MIC=8 μg/ml).##Fungi: Candida albicans (MIC=4 μg/ml), Cryptococcus neoformans (MIC=4 μg/ml), Saccharomyces cerevisiae (MIC=4 μg/ml).",Unknown,DNA,8573171##8946958,Biochem Biophys Res Commun. 1996 Jan 5;218(1):408-413.##FEBS Lett. 1996 Nov 25;398(1):87-90.,"Park C.B, Kim M.S, Kim S.C.##Yi G.-S, Park C.B, Kim S.C, Cheong C.",A novel antimicrobial peptide from Bufo bufo gargarizans.##Solution structure of an antimicrobial peptide buforin II.,,,,,,,,
99,DRAMP01163,TRSSRAGLQFPVGRVHRLLRK,21,"Buforin-2 (Buforin II; Fragment of Histone H2A; toads, amphibians, animals)",P55897,Belongs to the histone H2A family,Unknown,Bufo gargarizans (Asian toad) (Bufo bufo gargarizans),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. Both buforin II and its derivative buforin IIb (sequence: RAGLQFPVGRLLRRLLRRLLR) showed selective anticancer activity against 62 cancer cell lines (Lee 2008 Cancer Lett 271: 47-51). Buforin II is more potent than buforin I.
PTM: Monoubiquitination of C-terminus gives a specific tag for epigenetic transcriptional repression. Following DNA double-strand breaks (DSBs), it is ubiquitinated through 'Lys-63' linkage of ubiquitin moieties.","Gram-positive bacteria: Bacillus subtilis (MIC=2 μg/ml), Staphylococcus aureus (MIC=4 μg/ml), Streptococcus mutans (MIC=2 μg/ml), Streptococcus pneumoniae (MIC=4 μg/ml), Pseudomonas putida (MIC=2 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=1 μg/ml), Serratia sp. (MIC=4 μg/ml).##Fungi: Candida albicans (MIC=1 μg/ml), Cryptococcus neoformans (MIC=1 μg/ml), Saccharomyces cerevisiae (MIC=1 μg/ml).",Unknown,DNA,8573171##8946958,Biochem Biophys Res Commun. 1996 Jan 5;218(1):408-413.##FEBS Lett. 1996 Nov 25;398(1):87-90.,"Park C.B, Kim M.S, Kim S.C.##Yi G.-S, Park C.B, Kim S.C, Cheong C.",A novel antimicrobial peptide from Bufo bufo gargarizans.##Solution structure of an antimicrobial peptide buforin II.,,,,,,,,
100,DRAMP01164,GIGALSAKGALKGLAKGLAEHFAN,24,"Bombinin (toads, amphibians, animals)",P01505,Unknown,Unknown,Bombina variegata (Yellow-bellied toad),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial and hemolytic activities.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.
Caution: Residue 20 is assigned as E by similarity to other bombin sequences instead of Z (Glutamic acid or Gutamine) given ",[Ref.8223491]Gram-negative bacterium: Escherichia coli D21 (MIC=3 μM);##Gram-positive bacterium: Staphylococcus aureus Cowan 1 (MIC=14 μM).,[Ref:8223491]Lethal concentration>50μM against human red blood cells,Unknown,PubMed ID is not available##8223491,Monatsh. Chem. 1970;101:182-189.##EMBO J. 1993; 12:4829-4832.,"Csordas A, Michl H.##Mignogna G, Simmaco M, Kreil G, Barra D.",Isolation and structural resolution of a haemolytically active polypeptide from the immune secretion of a European toad.##Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.,,,,,,,,
101,DRAMP01165,FLPVILPVIGKLLNGILGK,19,"Preprotemporin-1SKa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana sakuraii (Japanese brown frog),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacteria: Escherichia coli (MIC>50 μM);##Gram-negative bacteria: Staphylococcus aureus (MIC=25 μM).##Fungi: Candida albicans (MIC>50 μM).,Unknown,Unknown,17174009,Peptides. 2007 Mar;28(3):505-514.,"Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.",Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,,,,,,,,
102,DRAMP01167,GILDAIKAIAKAAG,14,Hylaseptin-P1 (HSP1),P84292,Unknown,Unknown,Hyla punctata (Polka-dot tree frog) (Spotted tree frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,Function: Has antibacterial and antifungal activity. A weak hemolytic activity has been detected.,"[Ref.14715660]Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.1-8.0 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=48.8-64.0 μg/ml), Escherichia coli ATCC 25922 (MIC=24.4-32.0 μg/ml).",[Ref:14715660]4.7% hemolytic activity at 256μg/ml against human blood,Unknown,14715660,J Biol Chem. 2004 Mar 26;279(13):13018-13026. ,"Prates MV, Sforça ML, Regis WC, Leite JR, Silva LP, Pertinhez TA, Araújo AL, Azevedo RB, Spisni A, Bloch C Jr.",The NMR-derived solution structure of a new cationic antimicrobial peptide from the skin secretion of the anuran Hyla punctata.,,,,,,,,
103,DRAMP01170,NLVSGLIEARKYLEQLHRKLKNCKV,25,"Distinctin 2 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Phyllomedusa distincta (Tree frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix (1 helices; 17 residues),Unknown,1XKM resolved by NMR,No comments found on DRAMP database,"Gram-positive bacteria: Enterococcus faecalis (MIC=14.5 μM), Staphylococcus aureus (MIC=28.0 μM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=28.0 μM), Escherichia coli (MIC=14.5 μM).",Unknown,Unknown,11297740,FEBS Lett. 2001 Apr 6;494(1-2):85-89.,"Batista CV, Scaloni A, Rigden DJ, Silva LR, Rodrigues Romero A, Dukor R, Sebben A, Talamo F, Bloch C.",A novel heterodimeric antimicrobial peptide from the tree-frog Phyllomedusa distincta.,,,,,,,,
104,DRAMP01174,GLLDFVTGVGKDIFAQLIKQI,21,"Ocellatin-4 (Frogs, amphibians, animals)",P85090,Unknown,Unknown,Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has hemolytic activity against human erythrocytes (HC50=14.3 μM). Has antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands.",[Ref.17884127]Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=64 μM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=64 μM).,[Ref:17884127]HC50=14.3 μM against human erythrocytes,Unknown,17884127,Toxicon 2007; 50: 1095-1104.,Nascimento A et al Castro MS.,"Purification, characterization and homology analysis of ocellatin 4, a cytolytic peptide from the skin secretion of the frog Leptodactylus ocellatus.",,,,,,,,
105,DRAMP01177,GVVDILKGAAKDIAGHLASKVMNKL,25,"Ocellatin-F1 (Fallaxin; Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Leptodactylus fallax (Mountain chicken frog),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has low hemolytic activity of fallaxin (HC50>200 μM). ,"[Ref.15544856]Gram-negative bacteria: Escherichia coli (MIC=40 μM), Pseudomonas aeruginosa (MIC=80 μM), Enterobacter cloacae (MIC=20 μM), Klebsiella pneumoniae (MIC=80 μM).",[Ref:15544856]HC50>200 μM hemolytic activity of fallaxin,Unknown,15544856,Regul Pept. 2005 Jan 15;124(1-3):173-178.,"Rollins-Smith LA, King JD, Nielsen PF, Sonnevend A, Conlon JM.",An antimicrobial peptide from the skin secretions of the mountain chicken frog Leptodactylus fallax (Anura:Leptodactylidae). ,,,,,,,,
106,DRAMP01182,GLLDTLKGAAKNVVGSLASKVMEKL,25,"Ocellatin-P1 (Pentadactylin; Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Leptodactylus pentadactylus (South American bullfrog) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=25 μM), Klebsiella pneumoniae KK3 9904 (MIC=100 μM), Enterobacter cloacae HNTCC 53001 (MIC=50 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=100 μM);##Gram-positive bacteria: Staphylococcus epidermidis RP62A (MIC=100 μM), Streptococcus Group B HNTCC 80130 (MIC=50 μM).",Unknown,Unknown,16236555,Comp Biochem Physiol C Toxicol Pharmacol. 2005 Aug;141(4):393-397.,"King JD, Al-Ghaferi N, Abraham B, Sonnevend A, Leprince J, Nielsen PF, Conlon JM.",Pentadactylin: an antimicrobial peptide from the skin secretions of the South American bullfrog Leptodactylus pentadactylus.,,,,,,,,
107,DRAMP01184,GVLDILKGAAKDLAGHVATKVI,22,"SPX(1-22)(truncated peptide of Syphaxin; Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Leptodactylus syphax (Burgundy thin-toed frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus ATCC 29213 (MIC=14.6 μM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=40.5 μM).,Unknown,Unknown,17628627,Toxicon. 2007 Sep 15;50(4):572-580.,"Dourado F.S, Leite J.R.S.A, Silva L.P, Melo J.A.T, Bloch C. Jr, Schwartz E.F.",Antimicrobial peptide from the skin secretion of the frog Leptodactylus syphax.,,,,,,,,
108,DRAMP01185,GVLDILKGAAKDLAGH,16,"SPX(1-16)(truncated peptide of Syphaxin; Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Leptodactylus syphax (Burgundy thin-toed frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus ATCC 29213 (MIC=40.5 μM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=10.1 μM).,Unknown,Unknown,17628627,Toxicon. 2007 Sep 15;50(4):572-580.,"Dourado F.S, Leite J.R.S.A, Silva L.P, Melo J.A.T, Bloch C. Jr, Schwartz E.F.",Antimicrobial peptide from the skin secretion of the frog Leptodactylus syphax.,,,,,,,,
109,DRAMP01188,LALKSGGWLRLFGLKDKKH,19,"Chensinin-1ZHa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana zhenhaiensis (Chinese brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=17 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=35 μM), Pseudomonas aeruginosa ATCC 9027 (MIC=9 μM).##Yeast: Candida albicans ATCC 2002 (MIC=35 μM).",Unknown,Unknown,22943778,Zoolog Sci. 2012 Sep;29(9):553-558.,"Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.","Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.",,,,,,,,
110,DRAMP01189,ATNIPFKVHFRCKAAFC,17,"Andersonin-W1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Golden crossband frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=23.5 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC>47 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>47 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=47 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
111,DRAMP01190,AVNIPFKVHFRCKAAFC,17,"Andersonin-W2 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Golden crossband frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=40.4 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10.1 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=20.2 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
112,DRAMP01191,GLFSKFAGKGIVNFLIEGVE,20,"Andersonin-X1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Golden crossband frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30.5 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=15.3 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=15.3 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=30.5 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
113,DRAMP01192,FLPKLFAKITKKNMAHIR,18,"Andersonin-Y1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Golden crossband frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=3.2 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=1.6 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=1.6 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
114,DRAMP01194,TSRCIFYRRKKCS,13,"Andersonin-C1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Golden crossband frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Show hemolytic activity against human red blood cells and obvious insulin-stimulating activity at the concentration of 50 μg/mL.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=30 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>120 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=30 μg/ml).",[Ref:22029824]15.2±2.1% hemolytic activity at 50μg/ml against human red blood cells,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
115,DRAMP01195,FIFPKKNIINSLFGR,15,"Andersonin-D1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Golden crossband frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Weakly active against bacteria and fungi. Andersonin-D1 showes obvious insulin-stimulating activity at the concentration of 50 μg/mL.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>126 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=16 μg/ml); ##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=16 μg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=16 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
116,DRAMP01199,RFIYMKGFGKPRFGKR,16,"Hejiangin-A1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana hejiangensis,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Hejiangin-A1 showes killing effects against the tested strains.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=100 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=25 μg/ml); ##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=25 μg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=50 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
117,DRAMP01200,IPWKLPATFRPVERPFSKPFCRKD,24,"Hejiangin-F1 (frog, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana hejiangensis,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Weakly active against bacteria and fungi and has no hemolytic activity under the test conditions.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>100 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=100 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=100 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=100 μg/ml).",[Ref:22029824]Non-hemolytic activity against human red blood cells,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
118,DRAMP01201,AAPRGGKGFFCKLFKDC,17,"Schmackerin-C1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana schmackeri,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Schmackerin-C1 showes killing effects against the tested strains. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=100 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=50 μg/ml); ##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=50 μg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=100 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
122,DRAMP01208,SIITMTKEAKLPQLWKQIACRLYNTC,26,"Pleurain-A1 (Pleurain A1; Frogs, amphibians, animals)","A8DY01, A8DY00, A8DY02, A8DY03, A8DY04, A8DY09, A8DY10, A8DY15",Unknown,Unknown,Rana pleuraden (Yunnan pond frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has little hemolytic activity on red blood cells.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.17764786]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=60 μg/ml), Helicobacter pylori NCTC 11637 (MIC=30 μg/ml);##Gram-positive bacteria: Bacillus dysenteriae (MIC=120 μg/ml), Staphylococcus aureus ATCC 2592 (MIC=15 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=30 μg/ml)..",[Ref:17764786]Little hemolytic activity on red blood cells even with peptide concentration up to 200 μg/ml,Unknown,17764786,Peptides. 2007 Oct;28(10):2069-2074.,"Wang X, Song Y, Li J, Liu H, Xu X, Lai R, Zhang K.",A new family of antimicrobial peptides from skin secretions of Rana pleuraden,,,,,,,,
123,DRAMP01209,SIITMTKEAKLPQSWKQIACRLYNTC,26,"Pleurain-A2 (Pleurain A2; Frogs, amphibians, animals)",A8B5P0,Unknown,Unknown,Rana pleuraden (Yunnan pond frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has little hemolytic activity on red blood cells.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.17764786]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=60 μg/ml), Helicobacter pylori NCTC 11637 (MIC=30 μg/ml);##Gram-positive bacteria: Bacillus dysenteriae (MIC=60 μg/ml), Staphylococcus aureus ATCC 2592 (MIC=15 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=30 μg/ml).",[Ref:17764786]Little hemolytic activity on red blood cells even with peptide concentration up to 200 μg/ml,Unknown,17764786,Peptides. 2007 Oct;28(10):2069-2074.,"Wang X, Song Y, Li J, Liu H, Xu X, Lai R, Zhang K.",A new family of antimicrobial peptides from skin secretions of Rana pleuraden.,,,,,,,,
124,DRAMP01214,FLGAIAAALPHVINAVTNAL,20,"Kassinatuerin-2Ma (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Kassina maculata (African hyperoliid frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix,"Secondary structure prediction analysis revealed that virtually the entire structure of each kassinatuerin-2 related peptide is composed of alpha-helix, the helix was not amphipathic like many other amphibian skin antimicrobial peptides, in which there is a hydrophobic face and a positively charged faces the latter presumably interacting with the negatively charged glycocalyx of cell membranes.",Unknown,"Function: Natural kassinatuerin-2Ma and their synthetic replicates possessed relatively potent growth inhibitory activity against the Gram-positive bacterium, S. aureus, but were ineffective against the Gram-negative bacterium, E. coli at concentrations up to 200 μM and were relatively ineffective against the pathogenic yeast, C. albicans (120 μM). Also possessed hemolytic activity as demonstrated using horse erythrocytes.",[Ref.19427345]Gram-positive bacterium: Staphylococcus aureus (NCTC 10788) (MIC=16 μM);##Gram-negative bacterium: Escherichia coli (NCTC 10418) (MIC>200 μM) (MIC=120 μM);##Yeast: Candida albicans (NCPF 1467) (MIC=120 μM).,"[Ref:19427345]18% hemolytic activity at 16 μM, 45-50% hemolytic activity at 120 μM against horse erythrocytes",Unknown,19427345,Peptides. 2009 Aug;30(8):1428-1433.,"Wang L, Zhou M, McGrath S, Chen T, Gorman SP, Walker B, Shaw C.","A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",,,,,,,,
125,DRAMP01218,GFMKYIGPLIPHAVKAISDLI,21,"Kassinatuerin-1 (Frogs, amphibians, animals)",P0C010,Unknown,Unknown,Kassina senegalensis (Senegal running frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Shows broad-spectrum antimicrobial activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-negative bacteria: Escherichia coli (MIC=6.25 μM), Klebsiella pneumoniae (MIC=25 μM), Enterobacter cloacae (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=25 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.25 μM), Staphylococcus epidermidis (MIC=6.25 μM), Enterococcus faecalis (MIC=12.5 μM).##Yeast: Candida albicans (MIC=100 μM).",Unknown,Unknown,10679222##15885852,Biochem Biophys Res Commun. 2000 Feb 16;268(2):433-436.##Peptides. 2005 Nov;26(11):2104-2110.,"Mattute B, Knoop FC, Conlon JM.##Conlon JM, Abraham B, Galadari S, Knoop FC, Sonnevend A, Pál T.","Kassinatuerin-1: a peptide with broad-spectrum antimicrobial activity isolated from the skin of the hyperoliid frog, Kassina senegalensis.##Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.",,,,,,,,
127,DRAMP01222,GFMDTAKNVAKNVAVTLIDKLRCKVTGGC,29,"Palustrin-2AJ1 (PL2AJ1; Frogs, amphibians, animals)",G3ETQ3,Unknown,Unknown,Amolops jingdongensis (Chinese torrent frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Displays broad-spectrum antibacterial activity against a range of Gram-positive and Gram-negative bacteria. Has hemolytic activity, low cytotoxicity and low antioxidant activity.
Tissue specificity: Expressed by the skin glands.
PTM: One disulfide bond (C23-C29) and Cleavage on pair of basic residues.","[Ref.21816202]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=20 μM), Enterococcus faecalis ATCC29212 (MIC=20 μM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=13 μM), Bacillus pyocyaneus CMCCB1010 (MIC=20 μM), Pseudomonas aeruginosa ATCC27853 (MIC=33 μM), Bacillus dysenteriae (MIC=50 μM).",[Ref:21816202]IC50=135 μM against human and rabbit erythrocytes,Unknown,21816202,Biochimie. 2012 Feb;94(2):328-334.,"Chen Z, Yang X, Liu Z, Zeng L, Lee W, Zhang Y.","Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis.",,,,,,,,
128,DRAMP01227,ALFSILRGLKKLGNMGQAFVNCKIYKKC,28,"Palustrin-1b (Frogs, amphibians, animals)",P84275,Unknown,Unknown,Rana palustris (Pickerel frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Tissue specificity: Expressed by the skin glands.,Gram-negative bacterium: Escherichia coli (MIC=8 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
129,DRAMP01228,ALSILRGLEKLAKMGIALTNCKATKKC,27,"Palustrin-1c (Frogs, amphibians, animals)","P84276, A7WNV8",Unknown,Unknown,Rana palustris (Pickerel frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-negative bacteria E. coli. Possesses insulin-releasing activity.
Tissue specificity: Expressed by the skin glands.",Gram-negative bacterium: Escherichia coli (MIC=28 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
130,DRAMP01229,ALSILKGLEKLAKMGIALTNCKATKKC,27,"Palustrin-1d (Frogs, amphibians, animals)",P84277,Unknown,Unknown,Rana palustris (Pickerel frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Tissue specificity: Expressed by the skin glands.,Gram-negative bacterium: Escherichia coli (MIC=28 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
131,DRAMP01231,GFFSTVKNLATNVAGTVIDTLKCKVTGGCRS,31,"Palustrin-2b (Frogs, amphibians, animals)","P84279, D3UA82",Unknown,Unknown,Rana palustris (Pickerel frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Tissue specificity: Expressed by the skin glands.,Gram-negative bacterium: Escherichia coli (MIC=78 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
132,DRAMP01232,GFMDTAKNVAKNVAATLLDKLKCKITGGC,29,"Palustrin-2ISc (Frogs, amphibians, animals)",G3XHN9,Unknown,Unknown,Odorrana ishikawae (Ishikawa's frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=100 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=25 μM), Bacillus subtilis (MIC=12.5 μM).",Unknown,Unknown,21867685,Biochem Biophys Res Commun. 2011 Sep 9;412(4):673-677. ,"Iwakoshi-Ukena E, Soga M, Okada G, Fujii T, Sumida M, Ukena K.",Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning.,,,,,,,,
133,DRAMP01233,GFLSTVKNLATNVAGTVIDTLKCKVTGGCRS,31,"Palustrin-2c (Frogs, amphibians, animals)",P84280,Unknown,Unknown,Rana palustris (Pickerel frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Tissue specificity: Expressed by the skin glands.,Gram-negative bacterium: Escherichia coli (MIC=120 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
134,DRAMP01234,GIFPKIIGKGIKTGIVNGIKSLVKGVGMKVFKAGLNNIGNTGCNEDEC,48,"Palustrin-3a (Frogs, amphibians, animals)",P84281,Unknown,Unknown,Rana palustris (Pickerel frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Tissue specificity: Expressed by the skin glands.,Gram-negative bacterium: Escherichia coli (MIC=1 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
135,DRAMP01235,GIFPKIIGKGIKTGIVNGIKSLVKGVGMKVFKAGLSNIGNTGCNEDEC,48,"Palustrin-3b (Frogs, amphibians, animals)",P84262,Unknown,Unknown,Rana palustris (Pickerel frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Tissue specificity: Expressed by the skin glands.,Gram-negative bacterium: Escherichia coli (MIC=1 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
136,DRAMP01237,GFMDTAKNVAKNVAVTLLDKLKCKITGGC,29,"Palustrin-2ISa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana ishikawae,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=100 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=25 μM), Staphylococcus aureus (MRSA) (MIC=100 μM), Bacillus subtilis (MIC=12.5 μM).##Yeast: Candida albicans (MIC=100 μM).",Unknown,Unknown,21193000,Peptides. 2011 Apr;32(4):670-676. ,"Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.",Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
137,DRAMP01238,GLWNSIKIAGKKLFVNVLDKIRCKVAGGCKTSPDVE,36,"Palustrin-2SIb (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana ishikawae,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=6.3 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.3 μM), S. aureus (MRSA) (MIC=100 μM).",Unknown,Unknown,21911019,Peptides. 2011 Oct;32(10):2052-2057.,"Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.2011.",Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
138,DRAMP01244,FFPIGVFCKIFKTC,14,"Japonicin-1 (Frogs, amphibians, animals)",P83305,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana japonica (Japanese brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Tissue specificity: Expressed by the skin dorsal glands.,Gram-negative bacterium: Escherichia coli (MIC=30 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 μM).,Unknown,Unknown,11835990,Peptides. 2002;23:419-425,"Isaacson T, Soto A, Iwamuro S, Knoop FC, Conlon JM.",Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica.,,,,,,,,
139,DRAMP01245,FFPLALLCKVFKKC,14,"Japonicin-1CDYa (Frogs, amphibians, animals)",B3VZU2,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide. Lacks hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.",[Ref.19539775]Gram-positive bacterium: Staphylococcus aureus (MIC>100 μM);##Gram-negative bacterium: Escherichia coli (MIC=25 μM).,[Ref:19539775]HC50>300 μM against human red blood cells,Unknown,19539775,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",,,,,,,,
140,DRAMP01246,FGLPMLSILPKALCILLKRKC,21,"Japonicin-2 (Frogs, amphibians, animals)",P83306,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana japonica (Japanese brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Tissue specificity: Expressed by the skin glands.,Gram-negative bacterium: Escherichia coli (MIC=12 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=20 μM).,Unknown,Unknown,11835990,Peptides. 2002;23:419-425.,"Isaacson T, Soto A, Iwamuro S, Knoop FC, Conlon JM.",Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica.,,,,,,,,
142,DRAMP01249,FLIGMTQGLICLITRKC,17,"Dybowskin-2 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana dybowskii (Korea brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Dybowskin-2 has hemolytic activity against human red blood cells (hRBCs).,"[Ref.17698251]Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=6.25 μg/ml), Staphylococcus aureus KCTC3881 (MIC=15 μg/ml), Bacillus subtilis ATCC6633 (MIC=25 μg/ml), Staphylococcus epidermidis ATCC12228 (MIC=25 μg/ml);##Gram-negative bacteria: Shigella dysenteriae ATCC9752 (MIC=50 μg/ml), Escherichia coli KCTC2433 (MIC=60 μg/ml), Klebsiella pneumoniae ATCC10031 (MIC=60 μg/ml), Proteus mirabilis ATCC25933 (MIC>100 μg/ml);##Yeast: Candida albicans ATCC36232 (MIC=100 μg/ml).",[Ref:17698251]10.99% hemolytic activity at 100 μg/ml against human red blood cells,Unknown,17698251,Peptides 2007; 28: 1532-1539. ,"Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.",Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,,,,,,,,
143,DRAMP01250,GLFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC,33,"Dybowskin-3 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana dybowskii (Korea brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Dybowskin-3 has hemolytic activity against human red blood cells (hRBCs).,"[Ref.17698251]Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=39 μg/ml), Staphylococcus aureus KCTC3881 (MIC=50 μg/ml), Bacillus subtilis ATCC6633 (MIC=60 μg/ml), Staphylococcus epidermidis ATCC12228 (MIC=60 μg/ml);##Gram-negative bacteria: Shigella dysenteriae ATCC9752 (MIC=15 μg/ml), Escherichia coli KCTC2433 (MIC=15 μg/ml), Klebsiella pneumoniae ATCC10031 (MIC>100 μg/ml);##Yeast: Candida albicans ATCC36232 (MIC=100 μg/ml).",[Ref:17698251]1.86% hemolytic activity at 100 μg/ml against human red blood cells,Unknown,17698251,Peptides 2007; 28: 1532-1539. ,"Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.",Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,,,,,,,,
144,DRAMP01251,VWPLGLVICKALKIC,15,"Dybowskin-4 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana dybowskii (Korea brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Dybowskin-4 has relatively greater hemolytic activity against human red blood cells (hRBCs).,"[Ref.17698251]Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=1.56 μg/ml), Staphylococcus aureus KCTC3881 (MIC=3.13 μg/ml), Bacillus subtilis ATCC6633 (MIC=6.25 μg/ml), Staphylococcus epidermidis ATCC12228 (MIC=6.25 μg/ml);##Gram-negative bacteria: Shigella dysenteriae ATCC9752 (MIC=30 μg/ml), Escherichia coli KCTC2433 (MIC=15 μg/ml), Klebsiella pneumoniae ATCC10031 (MIC=15 μg/ml);##Yeast: Candida albicans ATCC36232 (MIC=25 μg/ml).",[Ref:17698251]47.58% hemolytic activity at 100 μg/ml against human red blood cells,Unknown,17698251,Peptides 2007; 28: 1532-1539. ,"Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.",Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,,,,,,,,
145,DRAMP01252,GLFSVVTGVLKAVGKNVAKNVGGSLLEQLKCKKISGGC,38,"Dybowskin-5 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana dybowskii (Korea brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Dybowskin-5 has hemolytic activity against human red blood cells (hRBCs).,"[Ref.17698251]Gram-positive bacteria: Micrococcus luteus ATCC4698 (MIC=6.25 μg/ml), Staphylococcus aureus KCTC3881 (MIC=25 μg/ml), Bacillus subtilis ATCC6633 (MIC=50 μg/ml), Staphylococcus epidermidis ATCC12228 (MIC=50 μg/ml);##Gram-negative bacteria: Shigella dysenteriae ATCC9752 (MIC=50 μg/ml), Escherichia coli KCTC2433 (MIC=60 μg/ml), Klebsiella pneumoniae ATCC10031 (MIC=50 μg/ml);##Yeast: Candida albicans ATCC36232 (MIC=50 μg/ml).",[Ref:17698251]17.84% hemolytic activity at 100 μg/ml against human red blood cells,Unknown,17698251,Peptides 2007; 28: 1532-1539. ,"Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.",Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,,,,,,,,
147,DRAMP01254,IIPLPLGYFAKKT,13,"Dybowskin-1CDYa (Frogs, amphibians, animals)",B5A9S9,Unknown,Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Tissue specificity: Expressed by the skin glands.,Gram-positive bacterium: Staphylococcus aureus (MIC=6 μM);##Gram-negative bacterium: Escherichia coli (MIC=3 μM). ,Unknown,Unknown,19539775,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",,,,,,,,
148,DRAMP01255,SAVGRHGRRFGLRKHRKH,18,"Dybowskin-2CDYa (Chensinin-1; Frogs, amphibians, animals)",B5A9T1,Unknown,Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide. Has activity against the Gram-positive bacteria: S. aureus and the Gram-negative bacteria E. coli. Lacks hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.","[Ref.19539775] Gram-negative bacterium: Escherichia coli (MIC=3 μM);##Gram-negative bacterium: Staphylococcus aureus (MIC=6 μM).##[Ref.19341344] Gram-positive bacteria: Staphylococcus aureus (MIC=14.4 μM), Bacillus cereus (MIC=14.4 μM), Streptococcus lactis (MIC=14.4 μM).",[Ref:19539775]HC50>300 μM against human red blood cells,Unknown,19539775##19341344,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.##Zoolog Sci. 2009 Mar;26(3):220-226.,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.##Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.##Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis.",,,,,,,,
149,DRAMP01257,GLWSKIKAAGKEAAKAAAKAAGKAALNAVSEAV,33,"Dermadistinctin-K (DD K; Frogs, amphibians, animals)",P83638,Unknown,Unknown,Phyllomedusa distincta (Monkey frog),"Antibacterial, Antifungal, Antiprotozoal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,"2K9B, 2JX6 resolved by NMR.","Function: Also has antiprotozoal activity against Trypanosoma cruzi. Decreases viability of murine peritoneal cells. Fuses to, and disrupts liposomes.
Tissue specificity: Expressed by the skin glands.","Gram-positive bacteria: Staphylococcus aureus (MIC=4.7 μM), Enterococcus faecalis (MIC>19 μM);Gram-negative bacteria: Pseudomonas aeruginosa (MIC=2.4 μM), Escherichia coli (MIC=0.6 μM).##Fungi: Candida tropicalis (MIC=10.1 μM), Candida guilliermondii (MIC=20.3 μM), Candida albicans (MIC=20.3 μM), Candida albicans ATCC 1023 (MIC=10.1 μM).",Unknown,liposomes,10477123,Peptides. 1999;20(6):679-686.,"Batista CV, da Silva LR, Sebben A, Scaloni A, Ferrara L, Paiva GR, Olamendi-Portugal T, Possani LD, Bloch C Jr.",Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,,,,,,,,
150,DRAMP01258,ALWKTLLKNVGKAAGKAALNAVTDMVNQ,28,"Dermadistinctin-L (DD L; Frogs, amphibians, animals)",P83639,Unknown,Unknown,Phyllomedusa distincta (Monkey frog),"Antibacterial, Antifungal, Antiprotozoal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Also has antiprotozoal activity against Trypanosoma cruzi. Decreases viability of murine peritoneal cells. Fuses to, and disrupts liposomes. Show little hemolytic activity against human red blood cells.
Tissue specificity: Expressed by the skin glands.","[Ref.10477123]Gram-positive bacteria: Staphylococcus aureus (MIC=1.3 μM), Enterococcus faecalis (MIC=10 μM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=40 μM), Escherichia coli (MIC=2.5 μM);##[Ref.17442605]Fungi: Candida tropicalis (MIC=10.9 μM), Candida guilliermondii (MIC=21.8 μM), Candida albicans (MIC=21.8 μM), Candida albicans ATCC 1023 (MIC=10.9 μM).",[Ref:10477123]Show some hemolytic starting at 12.5 μM against human blood,liposomes,10477123##12379643##17409003##17442605,Peptides. 1999;20(6):679-686.##J Biol Chem. 2002 Dec 20;277(51):49332-49340.##Comp Biochem Physiol A Mol Integr Physiol. 2008 Nov;151(3):329-335.##Comp Biochem Physiol A Mol Integr Physiol. 2008 Nov;151(3):336,"Batista CV, da Silva LR, Sebben A, Scaloni A, Ferrara L, Paiva GR, Olamendi-Portugal T, Possani LD, Bloch C Jr.##Brand GD, Leite JR, Silva LP, Albuquerque S, Prates MV, Azevedo RB, Carregaro V, Silva JS, Sá VC, Branção RA, Bloch C Jr.##Silva LP, Leite JR, Brand GD, Regis WB, Tedesco AC, Azevedo RB, Freitas SM, Bloch C Jr.##Leite JR, Brand GD, Silva LP, Kückelhaus SA, Bento WR, Araújo AL, Martins GR, Lazzari AM, Bloch C Jr.","Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.##Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells.##Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta: liposomes fusion and/or lysis investigated by fluorescence and atomic force microscopy.##Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta: Secondary structure, antimicrobial activity, and mammalian cell ",,,,,,,,
151,DRAMP01259,ALWKTMLKKLGTMALHAGKAAFGAAADTISQ,31,"Dermadistinctin-M (DD M; Frogs, amphibians, animals)",P83640,Unknown,Unknown,Phyllomedusa distincta (Monkey frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands.","Gram-positive bacteria: Staphylococcus aureus (MIC=38 μM), Enterococcus faecalis (MIC>38 μM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=38 μM), Escherichia coli (MIC=9.7 μM).",Unknown,Unknown,10477123,Peptides. 1999;20(6):679-686.,"Batista CV, da Silva LR, Sebben A, Scaloni A, Ferrara L, Paiva GR, Olamendi-Portugal T, Possani LD, Bloch C Jr.",Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,,,,,,,,
152,DRAMP01260,ALWKNMLKGIGKLAGQAALGAVKTLVGAES,30,"Dermadistinctin-Q1 (DD Q1; Frogs, amphibians, animals)",P83641,Unknown,Unknown,Phyllomedusa distincta (Monkey frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands.","Gram-positive bacteria: Staphylococcus aureus (MIC=2.7 μM), Enterococcus faecalis (MIC=22 μM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=5.4 μM), Escherichia coli (MIC=1.3 μM).",Unknown,Unknown,10477123,Peptides. 1999;20(6):679-686.,"Batista CV, da Silva LR, Sebben A, Scaloni A, Ferrara L, Paiva GR, Olamendi-Portugal T, Possani LD, Bloch C Jr.",Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,,,,,,,,
153,DRAMP01261,GLWSKIKEAAKTAGLMAMGFVNDMV,25,"Dermadistinctin-Q2 (DD Q2; Frogs, amphibians, animals)",P83642,Unknown,Unknown,Phyllomedusa distincta (Monkey frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Amphibian defense peptide.
Tissue specificity: Expressed by the skin glands.","Gram-positive bacteria: Staphylococcus aureus (MIC=22 μM), Enterococcus faecalis (MIC=11 μM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=22 μM), Escherichia coli (MIC=5.6 μM).",Unknown,Unknown,10477123,Peptides. 1999;20(6):679-686.,"Batista CV, da Silva LR, Sebben A, Scaloni A, Ferrara L, Paiva GR, Olamendi-Portugal T, Possani LD, Bloch C Jr.",Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,,,,,,,,
155,DRAMP01301,FLSLIPHAINAVSAIAKHN,19,"Phylloseptin-1 (PS-1; Frogs, amphibians, animals)",P84566,Unknown,psn1,Phyllomedusa hypochondrialis (Orange-legged leaf frog),"Antibacterial, Antifungal, Antiprotozoal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 14 residues),The antimicrobial phylloseptin peptides adopt alpha-helical conformations in membrane environments which are stabilized by electrostatic interactions of the helix dipole as well as other contributions such hydrophobic and capping interactions.(Ref.2),2JQ0 resolved by NMR.,"Function: Atomic force microscopy experiments indicated that the bacteriolytic properties of these peptides might be related to their disruptive action on the cell membrane. PS-1 did not exhibit significant hemolytic activity on human erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[Ref.15752569]Gram-positive bacteria: Staphylococcus aureus (MIC=7.9 μM), Enterococcus faecalis (MIC=4.0 μM);##Gram-negative bacteria: Escherichia coli (MIC=7.9 μM), Psecdomonas aeruginosa (MIC=4 μM), Psecdomonas aeruginosa wt (MIC=3 μM).","[Ref:15752569]0.3% hemolytic activity at 4 μM, 0.57% hemolytic activity at 8 μM, 0.6% hemolytic activity at 16 μM, 0.98% hemolytic activity at 32 μM, 1.98% hemolytic activity at 64 μM against human red blood cells",Cell membrane,15752569##18656510,Peptides. 2005 Apr;26(4):565-573.##Peptides. 2008 Oct;29(10):1633-1644. ,"Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr.##Resende JM, Moraes CM, Prates MV, Cesar A, Almeida FC, Mundim NC, Valente AP, Bemquerer MP, Piló-Veloso D, Bechinger B.","Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.##Solution NMR structures of the antimicrobial peptides phylloseptin-1, -2, and -3 and biological activity: the role of charges and hydrogen bonding interactions in stabilizing helix conformations.",,,,,,,,
156,DRAMP01302,FLSLIPHAINAVSTLVHHF,19,"Phylloseptin-2 (PS-2; Frogs, amphibians, animals)","P85881, P84567, Q0VZ43",Unknown,psn2,Phyllomedusa hypochondrialis (Orange-legged leaf frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 14 residues),The antimicrobial phylloseptin peptides adopt alpha-helical conformations in membrane environments which are stabilized by electrostatic interactions of the helix dipole as well as other contributions such hydrophobic and capping interactions.(Ref.2),2JPY resolved by NMR.,"Function: Has antimicrobial activity. PS-2 did not exhibit significant hemolytic activity on human erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[Ref.18656510][ATCC Strains]: Gram-positive bacteria: S. aureus (MIC=15.1 μM);##Gram-negative bacteria: Escherichia coli (MIC=60.4 μM), Klebsiella pneumoniae (MIC=60.4 μM), Pseudomonas aeruginosa (MIC=60.4 μM);##[Wild Type]: Gram-positive bacteria: S. aureus (MIC=7.6 μM), S. agalactiae (MIC=1.9 μM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=60.4 μM), A. calcoaceticus (MIC=3.7 μM);##Fungi: Candida albicans (MIC=15.1 μM).","[Ref:15752569]0.1% hemolytic activity at 4 μM, 0.28% hemolytic activity at 4 μM, 0.7% hemolytic activity at 8 μM, 0.8% hemolytic activity at 16 μM, 1.05% hemolytic activity at 32 μM, 2.05% hemolytic activity at 64 μM against human red blood cells",Cell membrane,16713656##15752569##18656510,Peptides. 2006 Sep;27(9):2129-2136.##Peptides. 2005 Apr;26(4):565-573.##Peptides. 2008 Oct;29(10):1633-1644.,"Chen T, Zhou M, Gagliardo R, Walker B, Shaw C.##Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr.##Resende JM, Moraes CM, Prates MV, Cesar A, Almeida FC, Mundim NC, Valente AP, Bemquerer MP, Piló-Veloso D, Bechinger B.","Elements of the granular gland peptidome and transcriptome persist in air-dried skin of the South American orange-legged leaf frog, Phyllomedusa hypocondrialis.##Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.##Solution NMR structures of the antimicrobial peptides phylloseptin-1, -2, and -3 and biological activity: the role of charges and hydrogen bonding interactions in stabilizing helix conformations.",,,,,,,,
157,DRAMP01303,FLSLIPHAINAVSALANHG,19,"Phylloseptin-3 (PS-3; Frogs, amphibians, animals)",P84568,Unknown,psn3,Phyllomedusa hypochondrialis (Orange-legged leaf frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 11 residues),The antimicrobial phylloseptin peptides adopt alpha-helical conformations in membrane environments which are stabilized by electrostatic interactions of the helix dipole as well as other contributions such hydrophobic and capping interactions.(Ref.2),2JQ1 resolved by NMR.,"Function: Has antimicrobial activity (By similarity).
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[ATCC Strains]: Gram-positive bacteria: S. aureus (MIC=32.9 μM);##Gram-negative bacteria: Escherichia coli (MIC=65.6 μM), Klebsiella pneumoniae (MIC=65.6 μM), Pseudomonas aeruginosa (MIC=65.6 μM). NOTE: Initial inoculum of 108 cells/Ml.##[Wild Type]: Gram-positive bacteria: S. aureus (MIC=8.2 μM), S. agalactiae (MIC=4.1 μM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=32.8 μM), A. calcoaceticus (MIC=4.1 μM).##Fungi: Candida albicans (MIC=8.2 μM).",Unknown,Cell membrane,15752569##18656510,Peptides. 2005 Apr;26(4):565-573.##Peptides. 2008 Oct;29(10):1633-1644. ,"Leite JR, Silva LP, Rodrigues MI, Prates MV, Brand GD, Lacava BM, Azevedo RB, Bocca AL, Albuquerque S, Bloch C Jr.##Resende JM, Moraes CM, Prates MV, Cesar A, Almeida FC, Mundim NC, Valente AP, Bemquerer MP, Piló-Veloso D, Bechinger B.","Phylloseptins: a novel class of anti-bacterial and anti-protozoan peptides from the Phyllomedusa genus.##Solution NMR structures of the antimicrobial peptides phylloseptin-1, -2, and -3 and biological activity: the role of charges and hydrogen bonding interactions in stabilizing helix conformations.",,,,,,,,
158,DRAMP01305,FLSLIPHAINAVSAIAKHFG,20,"Phylloseptin-7 (PS-7; Frogs, amphibians, animals)","P84572, Q0VZ42",Unknown,psn7,Phyllomedusa hypochondrialis (Orange-legged leaf frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-negative bacteria E. coli and P. aeruginosa, and the Gram-positive bacteria: S. aureus. No hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[Ref.16963159]Gram-negative bacteria: Escherichia coli (MIC=6 μM), Pseudomonas aeruginosa (MIC=6 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 μM)",[Ref:16963159]Non-hemolytic activity at 6 μM against human erythrocytes,Unknown,16963159##16713656,Peptides. 2006 Dec;27(12):3092-3999.##Peptides. 2006 Sep;27(9):2129-2136.,"Conceição K, Konno K, Richardson M, Antoniazzi MM, Jared C, Daffre S, Camargo AC, Pimenta DC.##Chen T, Zhou M, Gagliardo R, Walker B, Shaw C.","Isolation and biochemical characterization of peptides presenting antimicrobial activity from the skin of Phyllomedusa hypochondrialis.##Elements of the granular gland peptidome and transcriptome persist in air-dried skin of the South American orange-legged leaf frog, Phyllomedusa hypocondrialis.",,,,,,,,
159,DRAMP01306,FLSLIPHAINAVSAIAKHF,19,"Phylloseptin-7 (PS-7; Frogs, amphibians, animals)",P85882,Unknown,Unknown,Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity but does not inhibit the growth of the fungus C. albicans.
Tissue specificity: Expressed by the skin glands.
PTM: Phenylalanine amide at F19.","Gram-negative bacterium: Escherichia coli ATCC 11775 (MIC=7.2 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 12600 (MIC=3.6 μM), Micrococcus luteus ATCC 49732 (MIC=1.8 μM).",Unknown,Unknown,17553595,Peptides. 2007 Jul;28(7):1331-1343.,"Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.",A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.,,,,,,,,
161,DRAMP01319,RRSRRGRGGGRRGGSGGRGGRGGGGRSGAGSSIAGVGSRGGGGGRHYA,48,"Cathelicidin-AL (Gly-rich; Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Amolops loloensis,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=6.25 μg/ml), Staphylococcus aureus ATCC43300 (MIC=6.25 μg/ml), Bacillus subtilis (MIC=100 μg/ml);##Gram-negative bacteria: Escherichia coli ML-35P (MIC=25 μg/ml), Psecdomonas aeruginosa PA01 (MIC=12.5 μg/ml), Psecdomonas aeruginosa ATCC27853 (MIC=6.25 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=50 μg/ml).",Unknown,Unknown,22009138,Amino Acids. 2012 Aug;43(2):677-685.,"Hao X, Yang H, Wei L, Yang S, Zhu W, Ma D, Yu H, Lai R.",Amphibian cathelicidin fills the evolutionary gap of cathelicidin in vertebrate.,,,,,,,,
163,DRAMP01339,FLPIVGKLLSGLSGLL,16,"Amolopin-2a (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Amolops loloensis (Rufous-spotted torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus (MIC=2.00 μg/ml), Bacillus dysenteriae (MIC=1.50 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=3.00 μg/ml).##Candida albicans (MIC=6.50 μg/ml).",Unknown,Unknown,17000029,Peptides. 2006 Dec;27(12):3085-3091. ,Lu Y et al Lai R2006,"Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis",,,,,,,,
164,DRAMP01341,FLPLAVSLAANFLPKLFCKITKKC,24,"Amolopin-1b (Frogs, amphibians, animals)",A0SN42,Unknown,Unknown,Amolops loloensis (Rufous-spotted torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus (MIC=5.50 μg/ml), Bacillus dysenteriae (MIC=2.20 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=6.50 μg/ml).##Yeast: Candida albicans (MIC=7.50 μg/ml).",Unknown,Unknown,17000029,Peptides. 2006 Dec;27(12):3085-3091. ,"Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.","Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.",,,,,,,,
165,DRAMP01346,VIGSILGALASGLPTLISWIKNR,23,"Prepromelittin-related peptide (Frogs, amphibians, animals)",A7BJK5,Unknown,prMRP,Rana sakuraii (Japanese brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=25 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 μM).##Yeast: Candida albicans (MIC=25 μM).,Unknown,Unknown,12804591##17174009##17826868,Biochem Biophys Res Commun. 2003 Jun 27;306(2):496-500.##Peptides. 2007;28(3):505-514.##Peptides. 2007 Oct;28(10):2061-2068.,"Conlon JM, Sonnevend A, Patel M, Camasamudram V, Nowotny N, Zilahi E, Iwamuro S, Nielsen PF, Pál T.##Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.##Suzuki H, Conlon JM, Iwamuro S.","A melittin-related peptide from the skin of the Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties.##Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.##Evidence that the genes encoding the melittin-related peptides in the skins of the Japanese frogs Rana sakuraii and Rana tagoi are not orthologous to bee venom melittin genes: developmental- and tissue-dependent gene expression.",,,,,,,,
166,DRAMP01347,AIGSILGALAKGLPTLISWIKNR,23,"Prepromelittin-related peptide (Frogs, amphibians, animals)",A7BJK6,Unknown,prMRP,Rana tagoi (Tago frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,Gram-positive bacterium: Staphylococcus aureus (MIC=3.5 μM);##Gram-negative bacterium: Escherichia coli (MIC=20 μM).##Yeast: Candida albicans (MIC=19 μM).##EL4 T-lymphoma cells (MIC=14 μM).,Unknown,Unknown,12804591,Biochem Biophys Res Commun. 2003 Jun 27;306(2):496-500.,"Conlon JM, Sonnevend A, Patel M, Camasamudram V, Nowotny N, Zilahi E, Iwamuro S, Nielsen PF, Pál T.2003","A melittin-related peptide from the skin of the Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties",,,,,,,,
167,DRAMP01350,FCTMIPIPRCY,11,"Tigerinin-1 (Frogs, amphibians, animals)",P82651,Unknown,Unknown,Rana tigerina (Indian bull frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Bacillus subtilis (MIC=30 μg/ml), Staphylococcus aureus ATCC 8530 (MIC=30 μg/ml), Micrococcus luteus MT 166 (MIC=20 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=40 μg/ml), Pseudomonas putida NCIM 2102 (MIC=40 μg/ml).##Fungi: Saccharomyces cerevisiae ATCC 8530 (MIC=80 μg/ml).",Unknown,Cell membrane,11031261,J Biol Chem. 2001 Jan 26;276(4):2701-2707. ,"Sai KP, Jagannadham MV, Vairamani M, Raju NP, Devi AS, Nagaraj R, Sitaram N.",Tigerinins: novel antimicrobial peptides from the Indian frog Rana tigerina.,,,,,,,,
168,DRAMP01351,RVCFAIPLPICH,12,"Tigerinin-2 (Frogs, amphibians, animals)",P82652,Unknown,Unknown,Rana tigerina (Indian bull frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Bacillus subtilis (MIC=20 μg/ml), Staphylococcus aureus ATCC 8530 (MIC=40 μg/ml), Micrococcus luteus MT 166 (MIC=20 μg/ml).##Gram-negative bacteria: Pseudomonas putida NCIM 2102 (MIC=50 μg/ml), Escherichia coli (MIC=50 μg/ml).##Fungi: Saccharomyces cerevisiae ATCC 8530 (MIC=100 μg/ml).",Unknown,Cell membrane,11031261,J Biol Chem. 2001 Jan 26;276(4):2701-2707. ,"Sai KP, Jagannadham MV, Vairamani M, Raju NP, Devi AS, Nagaraj R, Sitaram N.",Tigerinins: novel antimicrobial peptides from the Indian frog Rana tigerina.,,,,,,,,
169,DRAMP01352,RVCYAIPLPICY,12,"Tigerinin-3 (Frogs, amphibians, animals)",P82653,Unknown,Unknown,Rana tigerina (Indian bull frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Bacillus subtilis (MIC=30 μg/ml), Staphylococcus aureus ATCC 8530 (MIC=30 μg/ml), Micrococcus luteus MT 166 (MIC=30 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=40 μg/ml), Pseudomonas putida NCIM 2102 (MIC=40 μg/ml).##Fungi: Saccharomyces cerevisiae ATCC 8530 (MIC=80 μg/ml).",Unknown,Cell membrane,11031261,J Biol Chem. 2001 Jan 26;276(4):2701-2707. ,"Sai KP, Jagannadham MV, Vairamani M, Raju NP, Devi AS, Nagaraj R, Sitaram N.",Tigerinins: novel antimicrobial peptides from the Indian frog Rana tigerina.,,,,,,,,
170,DRAMP01353,RVCYAIPLPIC,11,"Tigerinin-4 (Frogs, amphibians, animals)",P82654,Unknown,Unknown,Rana tigerina (Indian bull frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand-turn,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacterium: Staphylococcus aureus ATCC 8530 (MIC=50 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=60 μg/ml), Pseudomonas putida NCIM 2102 (MIC=60 μg/ml).##Fungi: Saccharomyces cerevisiae ATCC 8530 (MIC=100 μg/ml).",Unknown,Cell membrane,11031261,J Biol Chem. 2001 Jan 26;276(4):2701-2707. ,"Sai KP, Jagannadham MV, Vairamani M, Raju NP, Devi AS, Nagaraj R, Sitaram N.",Tigerinins: novel antimicrobial peptides from the Indian frog Rana tigerina.,,,,,,,,
172,DRAMP01355,FLGGLIKIVPAMICAVTKKC,20,"Ranalexin (Frogs, amphibians, animals)",P39084,Unknown,Unknown,Lithobates catesbeiana (American bullfrog) (Rana catesbeiana),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Potent microbicidal activity, active against S.aureus and E.coli. It acts as well as a membrane-disruptive agent at higher concentrations.
Tissue specificity: Expressed by the skin dorsal glands.
Developmental stage: Expression starts at metamorphosis and continues into adulthood.
PTM: Contains one disulfide bond 14-20.","Gram-positive bacterium: Staphylococcus aureus (MIC=4 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=32 μg/ml), Pseudomonas aeruginosa (MIC=128 μg/ml).",Unknown,Unknown,8144672##9578480,J Biol Chem. 1994 Apr 8;269(14):10849-10855.##Eur J Biochem. 1998 Apr 1;253(1):221-228.,"Clark DP, Durell S, Maloy WL, Zasloff M.##Vignal E, Chavanieu A, Roch P, Chiche L, Grassy G, Calas B, Aumelas A.","Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.##Solution structure of the antimicrobial peptide ranalexin and a study of its interaction with perdeuterated dodecylphosphocholine micelles.",,,,,,,,
173,DRAMP01393,GLFGKSSVWGRKYYVDLAGCAKA,23,"Odorranain-W1 (OdW1; Frogs, amphibians, animals)",A6MBS8,Unknown,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,Function: Odorranain-W1 has hemolytic activity against rabbit red cell.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=12.60 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.30 μg/ml), Bacillus subtilis (MIC=6.30 μg/ml).##Yeast: Candida albicans (MIC=3.15 μg/ml).","[Ref.17272268] RCH=17.6 ± 2.2% using rabbit red blood cells. RCH, red cell hemolysis.",Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
174,DRAMP01358,FLGGLFKLVPSVICAVTKKC,20,"Ranalexin-Vb (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana virgatipes (Ranidae) (Aquarana),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=12 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12 μM).,Unknown,Unknown,15996769,Regul Pept 2005; 131: 38-45.,Conlon JM et al Bevier CR.,"Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). ",,,,,,,,
175,DRAMP01359,FLGGLMKIIPAAFCAVTKKC,20,"Ranalexin-1G (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana grylio (North American pig frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Has growth-inhibitory activity against the gram-positive bacterium Staphylococcus aureus, the gram-negative bacterium Escherichia coli and the yeast, Candida albicans.",Gram-negative bacterium: Escherichia coli (MIC=9 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=18 μM).##Yeast: Candida albicans (MIC=70 μM).,Unknown,Unknown,10828493,Regul Pept. 2000 Jun 30;90(1-3):53-60.,"Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.",Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.,,,,,,,,
178,DRAMP01362,GLMSVLGHAVGNVLGGLFKS,20,"Frenatin-3 (Frogs, amphibians, animals)",P56249,Unknown,Unknown,Litoria infrafrenata (Giant tree frog) (White-lipped tree frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Wide spectrum antimicrobial peptide. Considered to interact with the outer lipid layer of the bacterial cell, penetrate the bacterial membrane, form ion channels, and ultimately kill the cell.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.","Gram-negative bacterium: Escherichia coli (MIC=50 μg/ml);##Gram-positive bacteria: Leuconostoc mesenteroides (MIC=25 μg/ml), Bacillus cereus (MIC=12.5 μg/ml), Micrococcus luteus (MIC=1.5 μg/ml), Pastewella haemolytica (MIC=0.8 μg/ml), Streptococcus uberis (MIC=50 μg/ml).",Unknown,Unknown,9225251,J Pept Sci. 1996 Mar-Apr;2(2):117-124.,"Raftery MJ, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.",The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata.,,,,,,,,
179,DRAMP01364,GLFGVLAKVAAHVVPAIAEHF,21,"Maculatin-1.1 (Frogs, amphibians, animals)",P82066,Unknown,Unknown,Litoria genimaculata (Green-eyed tree frog),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Maculatin-1.1 shows significant antibacterial activity against Gram-positive bacteria, less against Gram-negative bacteria.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=25 μg/ml), Bacillus cereus (MIC=3 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=12 μg/ml), Staphylococcus aureus (MIC=6 μg/ml), Staphylococcus epidermidis (MIC=12 μg/ml), Streptococcus uberis (MIC=3 μg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=50 μg/ml). (Ref.2)",Unknown,Unknown,9620615##15203252,J Pept Sci. 1998 Apr;4(2):111-115.##Peptides. 2004; 25: 1035-1054.,"Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The maculatin peptides from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",,,,,,,,
182,DRAMP01370,MLCKLSMFGAVLGVPACAIDCLPMGKTGGSCEGGVCGCRKLTFKILWDKKFG,52,"Oh-defensin (O. hainana defensin; spiders, animals)",No entry found,Unknown,Unknown,Ornithoctonus hainana (Venoms),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial and antifungal activities.,"Gram-positive bacteria: Staphylococcus aureus (MIC=1.25 μg/ml), Bacillus cereus (MIC=25 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=1.25 μg/ml), Bacillus dysenteriae (MIC=1.25 μg/ml), Pseudomonas aeruginosa (MIC=5 μg/ml).##Yeast: Candida albicans (MIC=1.25 μg/ml).",Unknown,Unknown,21538709,J Pept Sci. 2011 Jul;17(7):540-544. ,"Zhao H, Kong Y, Wang H, Yan T, Feng F, Bian J, Yang Y, Yu H.","A defensin-like antimicrobial peptide from the venoms of spider, Ornithoctonus hainana.",,,,,,,,
183,DRAMP01371,GLLSGILGAGKHIVCGLTGCAKA,23,"Odorranain-NR (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Combine helix and strand structure,"Odorranain-NR has a large proportion of beta-sheet. In Tris HCl + SDS, odorranain-NR has a major conformation of beta-sheet (79.2%) and a minor conformation of beta-turn (1.3%). In Tris HCl, the beta-sheet has been decreased to 57.1% and the beta-turn has been increased to 10.5%. The beta-sheet has been decreased to 39.8% in water.",Unknown,"Function: Odorranain-NR exhibits antimicrobial activity against the tested strains except E. coli ATCC25922. Odorranain-NR has little hemolytic activity on red blood cells even with peptide concentration up to 100 mg/ml.
PTM: Odorranain-NR has an intramolecular disulfide-bridged hexapeptide segment, which is a new type of disulfide-bridge motif in amphibian antimicrobial peptides.","[Ref.18282640]Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=9.375 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>100 μg/ml), Bacillus dysenteriae (MIC=37.5 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=18.75 μg/ml).",[Ref:18282640]Little hemolytic activity at 100 μg/ml against rabbit red blood cells,Unknown,18282640,Peptides. 2008 Apr;29(4):529-535. ,Che Q et al Lai R.,A novel antimicrobial peptide from amphibian skin secretions of Odorrana grahami.,,,,,,,,
184,DRAMP00931,TCSYTMEA,8,Antimicrobial peptide 3 (Cn-AMP3; Plant defensin),P86707,Unknown,Unknown,Cocos nucifera (Coconut palm),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.
Tissue specificity: Found in the liquid endosperm contained in green fruit of coconut palms, also known as coconut water (at protein level).
Subunit structure: Monomer.",[Ref.19111587] Gram-positive bacteria: Bacillus subtilis (MIC=257 μg/ml) and Staphylococcus aureus (MIC=274 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=302 μg/ml) and Pseudomonas aeruginosa (MIC=259 μg/ml).,Unknown,Unknown,19111587,Peptides. 2009 Apr;30(4):633-637.,"Mandal SM, Dey S, Mandal M, Sarkar S, Maria-Neto S, Franco OL.",Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.,,,,,,,,
185,DRAMP00930,TESYFVFSVGM,11,Antimicrobial peptide 2 (Cn-AMP2; Plant defensin),P86706,Unknown,Unknown,Cocos nucifera (Coconut palm),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.
Tissue specificity: Found in the liquid endosperm contained in green fruit of coconut palms, also known as coconut water (at protein level).
Subunit structure: Monomer.","[Ref.19111587] Gram-positive bacteria: Bacillus subtilis (MIC=150 μg/ml), Staphylococcus aureus (MIC=170 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=170 μg/ml), Pseudomonas aeruginosa (MIC=169 μg/ml).",Unknown,Unknown,19111587,Peptides. 2009 Apr;30(4):633-637.,"Mandal SM, Dey S, Mandal M, Sarkar S, Maria-Neto S, Franco OL.",Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.,,,,,,,,
186,DRAMP00929,SVAGRAQGM,9,Antimicrobial peptide 1 (Cn-AMP1; Plant defensin),P86705,Unknown,Unknown,Cocos nucifera (Coconut palm),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Helix,Unknown,2N0V resolved by NMR.,"Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.
Tissue specificity: Found in the liquid endosperm contained in green fruit of coconut palms, also known as coconut water (at protein level).
Subunit structure: Monomer.","[Ref.19111587] Gram-positive bacteria: Bacillus subtilis (MIC=76 μg/ml), Staphylococcus aureus (MIC=80 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=82 μg/ml), Pseudomonas aeruginosa (MIC=79 μg/ml). ",Unknown,Unknown,19111587,Peptides. 2009 Apr;30(4):633-637.,"Mandal SM, Dey S, Mandal M, Sarkar S, Maria-Neto S, Franco OL.",Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.,,,,,,,,
187,DRAMP03542,HKTDSFVGLM,10,"Neurokinin A (NKA; chicken, animals)",P19851,Belongs to the tachykinin family.,Unknown,Gallus gallus (Chicken),"Neuropeptide,Antibacterial,  Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,1N6T resolved by NMR.,"Function: Tachykinins are active peptides which excite neurons, evoke behavioral responses, are potent vasodilators and secretagogues, and contract (directly or indirectly) many smooth muscles. Antibacterial activity is very low.
PTM: Methionine amide at position 10.","[Ref.18603306] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>500 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC>500 μg/ml) ;## Gram-positive bacteria: Streptococcus mutans NCTC 10449 (MIC> 500 μg/ml), Lactobacillus acidophilus NCTC 1723 (MIC>500 μg/ml), Enterococcus faecalis NCTC 12697 (MIC>500 μg/ml), Staphylococcus aureus ATCC 25923 (MIC>500 μg/ml);## Yeast: Candida albicans NCTC 3179 (MIC>500 μg/ml).",Unknown,Unknown,18603306,J Neuroimmunol. 2008 Aug 30;200(1-2):11-6.,"El Karim IA, Linden GJ, Orr DF, Lundy FT.","Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites.",,,,,,,,
188,DRAMP04532,GIHDILKYGKPS,12,"Myxinidin (Hagfish, animals)",No entry found,Unknown,Unknown,Myxine glutinosa (Atlantic hagfish),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,Function: Myxinidin showed activity against a broad range of bacteria and yeast pathogens at minimum bactericidal concentration (MBC) ranging from 1.0 to 10.0. No hemolytic activity.,"[Ref.19330556] Gram-negative bacteria: Escherichia coli D31 (MBC=2.0 μg/mL), Salmonella enterica serovar Typhimurium C610 (MBC=2.5 μg/mL), Pseudomonas aeruginosa Z61 (MBC=7.0μg/mL), Pseudomonas aeruginosa K799 (MBC=10.0 μg/mL), Aeromonas salmonicida sub sp. salmonicida A449 (MBC=2.0 μg/mL), Listonella anguillarum 02-11 (MBC=1.0 μg/mL), Yersinia ruckeri 96-4 (MBC=2.0 μg/mL);##Gram-positive bacterium: Staphylococcus epidermis C621(MBC=8.5 μg/mL);##Yeast: Candida albicans C627 (MBC=10.0 μg/mL).",Non-hemolytic activity using rabbit red blood cells at concentrations 50-fold higher than its antimicrobial activity.,Unknown,19330556,Mar Biotechnol (NY). 2009 Nov-Dec;11(6):748-757.,"Subramanian S, Ross NW, MacKinnon SL.","Myxinidin, a novel antimicrobial peptide from the epidermal mucus of hagfish, Myxine glutinosa L.",,,,,,,,
190,DRAMP02993,YVPLPNVPQPGRRPFPTFPGQGPFNPKIKWPQGY,34,"Abaecin (Pro-rich; insects, arthropods, invertebrates, animals)",P15450,Unknown,Unknown,Apis mellifera (Honeybee),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Rich ,The prolines are in repeated motifs.,Unknown,Function: This peptide has bactericidal activity.,"[Ref.2298215] Gram-negative bacteria: Agrobacterium tumefaciens Gembloux A (MIC=25-50 μg/ml), Erwinia salicis NCPPB 2530 (MIC=25-50 μg/ml), Escherichia coli NCTC 9001 (MIC=25-50 μg/ml), Escherichia coli K514 (MIC=10-25 μg/ml), Pseudomonas syringae pv.tomato NCPPB 1105 (MIC=25-50 μg/ml), Xanthomonas campestris pv. vesicatoria LMG 905 (MIC=5-10 μg/ml);##Gram-positive bacteria: Bacillus megateriurn QMB 1551 (MIC=10-25 μg/ml), Micrococcus lysodeikticus LMG 4050 (MIC=10-25 μg/ml).",Unknown,Unknown,2298215##7961803,Eur J Biochem. 1990 Jan 26;187(2):381-6.##J Biol Chem. 1994 Nov 18;269(46):28569-28575.,"Casteels P, Ampe C, Riviere L, Van Damme J, Elicone C, Fleming M, Jacobs F, Tempst P.##Casteels-Josson K, Zhang W, Capaci T, Casteels P, Tempst P.","Isolation and characterization of abaecin, a major antibacterial response peptide in the honeybee (Apis mellifera).##Acute Transcriptional  Response of the Honeybee Peptide-Antibiotics Gene  Repertoire and Required Post-translational  Conversion of the Precursor Structures.",,,,,,,,
191,DRAMP02997,GNNRPVYIPQPRPPHPRL,18,"Apidaecin-1B (Apidaecin IB; Insects, animals)","P35581, Q06602, Q06601, Q8WSY8",Belongs to the apidaecin family,Unknown,Apis mellifera (Honeybee),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,4E81 resolved by X-ray.,Function: Apidaecins have bactericidal activity; predominantly against Gram-negative bacteria. They seem to interfere with cell propagation.,"[Ref.2676519] Gram-negative bacteria: Agrobacterium tumefaciens (MIC=0.2 μg/ml), Erwinia salicis (MIC=0.02 μg/ml), Escherichia coli (MIC=0.1 μg/ml), Pseudomonas syringae (MIC=0.1 μg/ml), Rhizobium meliloti (MIC=0.02 μg/ml), Salmonella Newport (MIC=0.2 μg/ml), Salmonella typhimurium (MIC=0.1 μg/ml), Shigella flexneri (MIC=0.1 μg/ml);##Gram-positive bacteria: Corynebacterium insidiosum (MIC=50 μg/ml), Bacillus megaterium (MIC=100 μg/ml).##[Ref.2298215] Gram-negative bacteria: Agrobacterium tumefaciens Gembloux A (MIC≤1 μg/ml), Erwinia salicis NCPPB 2530 (MIC≤1 μg/ml), Escherichia coli NCTC 9001 (MIC≤1 μg/ml), Escherichia coli K514 (MIC=25-50 μg/ml), Pseudomonas syringae pv.tomato NCPPB 1105 (MIC≤1 μg/ml), Xanthomonas campestris pv. vesicatoria LMG 905 (MIC≤100 μg/ml);##Gram-positive bacteria: Bacillus megateriurn QMB 1551 (MIC=25-50 μg/ml), Bacillus alvei LMG 6922 (MIC=50-100 μg/ml),Micrococcus lysodeikticus LMG 4050 (MIC=25-50 μg/ml).",Unknown,Unknown,2676519##2298215,EMBO J. 1989 Aug;8(8):2387-2391.##Eur J Biochem. 1990 Jan 26;187(2):381-6.,"Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P.##Casteels P, Ampe C, Riviere L, Van Damme J, Elicone C, Fleming M, Jacobs F, Tempst P.","Apidaecins: antibacterial peptides from honeybees.##Isolation and characterization of abaecin, a major antibacterial response peptide in the honeybee (Apis mellifera).",,,,,,,,
193,DRAMP02840,FKCRRWQWRMKKLGAPSITCVRRAF,25,"Lactoferricin B (Lfcin B; mammals, animals)","P24627, E6YCQ7, B3VTM3, B9VPZ5, C7FE01, Q6LBN7, Q19KS1",Belongs to the transferrin family,LTF,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (4 strands; 8 residues),"Residues 7-9 form beta1 and residues 17-19 form beta2 (in membrane). This contrasts with X-ray structure where residues 1-13 is helical. Thus, this peptide appears to be able to adopt a different conformation depending on environmental conditions. disulfide bond is not required for the antimicrobial potency.",1LFC resolved by NMR.,"Function: Lactoferricin B  function contributes to the antimicrobial activity. Shows a preferential cleavage at -Arg-Ser-Arg-Arg-|- and -Arg-Arg-Ser-Arg-|-, and of Z-Phe-Arg-|-aminomethylcoumarin sites.
Activity regulation: Inhibited by PMSF and Pefabloc.
PTM: Contains one disulfide bond 3-20","[Ref.8980754] Gram-negative bacteria:  Escherichia coli L361 (MIC=4 μM or 12.5 μg/ml), Salmonella Salford (MIC=4 μM or 12.5 μg/ml), Escherichia coli O:9 (MIC=6 μM or 18.8 μg/ml), Pseudomonas fluorescens (MIC=10 μM or 31.3 μg/ml)  ;##Gram-positive bacteria: Listeria monocytogenes (MIC=2 μM or 6.3 μg/ml), Staphylococcus aureus (MIC=6 μM or 18.8 μg/ml), Bacillus cereus (MIC=6 μM or 18.8 μg/ml)",Unknown,Unknown,8980754##9521752##1490908 ,"Antimicrob Agents Chemother. 1997 Jan;41(1):54-59. ##Biochemistry. 1998 Mar 24;37(12):4288-4298.##
J Appl Bacteriol. 1992 Dec;73(6):472-9.","Hoek KS, Milne JM, Grieve PA, Dionysius DA, Smith R. ##Hwang PM, Zhou N, Shan X, Arrowsmith CH, Vogel HJ. ##Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M.1992","Antibacterial activity in bovine lactoferrin-derived peptides. ##Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. ##
Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. ",,,,,,,,
198,DRAMP02246,SMLSVLKNLGKVGLGLVACKINKQC,25,"Ranatuerin-1C (Ranatuerin 1C; Frogs, amphibians, animals)",P82875,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Unknown,Rana clamitans (Green frog) (Lithobates clamitans),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. 
Tissue specificity: Expressed by the skin glands.",[Ref.10822101] Gram-positive bacterium: Staphylococcus aureus (MIC=55 μM);##Gram-negative bacterium: Escherichia coli (MIC=1.5 μM).##Yeast: Candida albicans (MIC=58 μM).,Unknown,Unknown,10822101,Peptides. 2000 Apr;21(4):469-476.,"Halverson T, Basir YJ, Knoop FC, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.,,,,,,,,
199,DRAMP01394,GLLRASSVWGRKYYVDLAGCAKA,23,"Odorranain-W2 (Frogs, amphibians, animals)",A7YL71,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Shows antibacterial and antifungal activities.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 μg/ml), Bacillus dysenteriae (MIC=30 μg/ml), Helicobacter pylori NCTC 11637 (MIC=20 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=5 μg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=25 μg/ml).",Unknown,Unknown,17698252,Peptides. 2007 Aug;28(8):1527-1531. ,"Chen L, Li Y, Li J, Xu X, Lai R, Zou Q.",An antimicrobial peptide with antimicrobial activity against Helicobacter pylori.,,,,,,,,
200,DRAMP01395,VVKCSYRLGSPDSQCN,16,"Odorranain-A-OA1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Weakly active against bacteria and fungi.,"[Ref.22029824]Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=35.2 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=35.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=17.6 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=17.6 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
201,DRAMP01396,GFMDTAKNVAKNMAGNLLDNLKCKITKAC,29,"Odorranain-F-OA1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=10 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=2.5 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=2.5 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
202,DRAMP01397,GFMDTAKNVAKNMAVTLLDNLKCKITKAC,29,"Odorranain-F-OA2 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Weakly active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=7.5 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=7.5 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3.8 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3.8 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
203,DRAMP01398,GFMDTAKNVAKNEAGNLLDNLKCKITKAC,29,"Odorranain-F-OA3 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Weakly active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.6 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=12.6 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.3 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=6.3 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
204,DRAMP01399,GFMATAKNVAKNMDVTLLDNLKCKITKAC,29,"Odorranain-F-OA4 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Weakly active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=4.1 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=4.1 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=4.1 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
206,DRAMP01401,GFMNTAKNVAKNVAVTLLDNLKCKITGGC,29,"Odorranain-F-OW1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana wuchuanensis (Chinese odorous frog),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli (MIC=2 μM), Pseudomonas aeruginosa (MIC=4 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=4 μM).##Yeast: Candida albicans ATCC 2002 (MIC=2 μM).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
207,DRAMP01402,GLFTLIKGAYKLDAPTVACN,20,"Odorranain-J-OA1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Weakly active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=40.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=40.2 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=20.1 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=20.1 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
208,DRAMP01403,GLFTLIKGAYKNDAPTVACN,20,"Odorranain-J-OA2 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Weakly active against bacteria and fungi.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=40.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=40.2 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=20.1 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=20.1 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
209,DRAMP01409,GILSGILGVGKKLVCGLSGLC,21,"Nigrocin-OR1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana rotodora (Chinese odorous frogs),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=7 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=2 μM).##Yeast: Candida albicans (MIC=4 μM).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
210,DRAMP01410,GILSGILGVGKMLVCGLSGLC,21,"Nigrocin-OR2 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana rotodora (Chinese odorous frogs),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3 μM), Bacillus pyocyaneus CMCCB 10104 (MIC=5 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3 μM).##Yeast: Candida albicans ATCC 2002 (MIC=3 μM).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
211,DRAMP01411,GILSGLLGVGKMLVCGLSGLC,21,"Nigrocin-OR3 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana rotodora (Chinese odorous frogs),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3 μM), Bacillus pyocyaneus CMCCB 10104 (MIC=6 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6 μM).##Yeast: Candida albicans ATCC 2002 (MIC=3 μM).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
212,DRAMP01412,GLLGSLFGAGKKVACALSGLC,21,"Nigrocin-2HSa (Frogs, amphibians, animals)",P0C8U0,Unknown,Unknown,Odorrana hosii (Hose's rock frog) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. 
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 15-21.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=56 μM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=28 μM).,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
213,DRAMP01413,GLLGSIFGAGKKIACALSGLC,21,"Nigrocin-2HSb (Frogs, amphibians, animals)",P0C8U1,Unknown,Unknown,Odorrana hosii (Hose's rock frog) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. 
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 15-21.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=28 μM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=14 μM).,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
214,DRAMP01414,GIFSTVFKAGKGIVCGLTGLC,21,"Nigrocin-2ISa (Frogs, amphibians, animals)",F1T156,Unknown,Unknown,Odorrana ishikawae (Ishikawa's frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC=25 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 μM), Staphylococcus aureus (MRSA) (MIC=12.5 μM), Bacillus subtilis (MIC=12.5 μM).##Yeast: Candida albicans (MIC=50 μM).",Unknown,Unknown,21193000,Peptides. 2011 Apr;32(4):670-676. ,"Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.",Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
215,DRAMP01415,GILGTVFKAGKGIVCGLTGLC,21,"Nigrocin-2ISb (Frogs, amphibians, animals)",F1T157,Unknown,Unknown,Odorrana ishikawae (Ishikawa's frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC=50 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 μM), Staphylococcus aureus (MRSA) (MIC=12.5 μM), Bacillus subtilis (MIC=12.5 μM).##Yeast: Candida albicans (MIC=50 μM).",Unknown,Unknown,21193000,Peptides. 2011 Apr;32(4):670-676. ,"Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.",Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
216,DRAMP01416,GILSTVFKAGKGIVCGLSGLC,21,"Nigrocin-2ISc (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana ishikawae (Ishikawa's frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=50 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=3 μM).##Yeast: Candida albicans (MIC=100 μM).,Unknown,Unknown,21867685,Biochem Biophys Res Commun. 2011 Sep 9;412(4):673-677. ,"Iwakoshi-Ukena E, Soga M, Okada G, Fujii T, Sumida M, Ukena K.",Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning.,,,,,,,,
217,DRAMP01417,GLLSGILGAGKHIVCGLSGLC,21,"Nigrocin-2GRa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana grahami (Asian frog),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-negative bacterium E. coli. Also has a weak hemolytic activity against human erythrocytes.,[Ref.16621155]Gram-negative bacterium: Escherichia coli (MIC=25 μM).,[Ref:16621155]LC50=295 μM against human erythrocytes,Unknown,16621155,Peptides. 2006 Sep;27(9):2111-2117.,"Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.","Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",,,,,,,,
218,DRAMP01418,GLFGKILGVGKKVLCGLSGMC,21,"Nigrocin-2GRb (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana grahami (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial against the Gram-negative bacterium E. coli and the Gram-positive bacterium S. aureus. Also has a weak hemolytic activity against human erythrocytes.,[Ref.16621155]Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 μM);##Gram-negative bacterium: Escherichia coli (MIC=3 μM);##Yeast: Candida albicans (MIC=50 μM).,[Ref:16621155]LC50=40 μM against human erythrocytes,Unknown,16621155,Peptides. 2006 Sep;27(9):2111-2117.,"Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.","Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",,,,,,,,
219,DRAMP01419,GLLSGILGAGKNIVCGLSGLC,21,"Nigrocin-2GRc (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana grahami (Asian frog),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-negative bacterium E. coli. Also has a weak hemolytic activity against human erythrocytes.,[Ref.16621155]Gram-negative bacterium: Escherichia coli (MIC=50 μM).,[Ref:16621155]LC50>500 μM against human erythrocytes,Unknown,16621155,Peptides. 2006 Sep;27(9):2111-2117.,"Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.","Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",,,,,,,,
220,DRAMP01420,GLLSGILGAGKHIICGLSGLC,21,"Nigrocin-OG4 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC>100 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC>100 μg/ml), Bacillus subtilis (MIC>100 μg/ml).##Yeast: Candida albicans (MIC=1.10 μg/ml).",Unknown,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
221,DRAMP01421,GLLSGILGAGKQKVCGLSGLC,21,"Nigrocin-OG5 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC=9.37 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=18.75 μg/ml), Bacillus subtilis (MIC=37.50 μg/ml).##Yeast: Candida albicans (MIC=4.68 μg/ml).",Unknown,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
222,DRAMP01422,GLLSGVLGVGKKVLCGLSGLC,21,"Nigrosin-OG21 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC=4.68 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=9.37 μg/ml), Bacillus subtilis (MIC=18.75 μg/ml).##Yeast: Candida albicans (MIC=4.68 μg/ml).",Unknown,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
223,DRAMP01423,GLLSGILGAGKHIVCGLSGLR,21,"Nigrosin-OG13 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana grahami (Yunnanfu frog),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC=4.68 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=9.37 μg/ml), Bacillus subtilis (MIC=18.75 μg/ml).##Yeast: Candida albicans (MIC=1.10 μg/ml).",Unknown,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
224,DRAMP01426,GLLSGVLGVGKKIVCGLSGLC,21,"Nigrocin-1-OA1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=10.4 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10.4 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=5.2 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
225,DRAMP01427,GIFGKILGVGKKTLCELSGMC,21,"Nigrocin-1-OA2 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.3 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=6.3 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.3 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3.2 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
226,DRAMP01428,GIFLKVLGVGKKVLCGVSGLC,21,"Nigrocin-1-OA3 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10.8 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=21.6 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=5.4 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=10.8 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
227,DRAMP01429,GLISGILGVGKKLVCGLSGLC,21,"Nigrocin-1-OR1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.5 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=23 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=5.8 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=11.5 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
228,DRAMP01430,GLISGILGVGKMLVCGLSGLC,21,"Nigrocin-1-OR2 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8.6 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=17.2 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=8.6 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=8.6 μg/ml)",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
229,DRAMP01431,GLISGLLGVGKMLVCGLSGLC,21,"Nigrocin-1-OR3 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=20.4 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=20.4 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=10.2 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
230,DRAMP01432,GILGNIVGMGKKIVCGLSGLC,21,"Nigrocin-1-OW2 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=12.4 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.2 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3.1 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
231,DRAMP01433,GILGNIVGMGKKVVCGLSGLC,21,"Nigrocin-1-OW3 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.3 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=22.6 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11.3 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=6.7 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
232,DRAMP01434,GILSGVLGMGKKIVCGLRGLC,21,"Nigrocin-1-OW4 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=7.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=14.2 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3.6 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=7.2 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
233,DRAMP01435,GILGNIVGMGKQVVCGLSGLC,21,"Nigrocin-1-OW5 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.1 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=10.2 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=5.1 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=5.1 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
234,DRAMP01436,GILSGVLGMGKKIVCGLSGLC,21,"Nigrocin-1-OW1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4.4 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=8.8 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=8.8 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=4.4 μg/ml).",[Ref:22029824]Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely Abundant Antimicrobial Peptides Existed in the Skins of Nine Kinds of Chinese Odorous Frogs.,,,,,,,,
236,DRAMP01438,GIFGKILGAGKKVLCGLSGLC,21,"Nigrocin-2JDa (Frogs, amphibians, animals)",B3A0M6,Unknown,Unknown,Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. Has hemolytic activity against rabbit erythrocytes. 
PTM: contains one disulfide bond 15-21. ","[Ref.22917879]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=16 μM), Staphylococcus aureus CIB 85462 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli ATCC 25992 (MIC=16 μM), Escherichia coli CIB 84492 (MIC=16 μM);##Yeast: Candida albicans (MIC=63 μM).",[Ref:22917879]80.3 ± 5.5% hemolytic activity at 128 μg/ml against rabbit red blood cells,Unknown,22917879,J Proteomics. 2012 Oct 22;75(18):5807-5821.,"Liu J, Jiang J, Wu Z, Xie F.","Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: De novo sequencing and analysis of tandem mass spectrometry data.",,,,,,,,
237,DRAMP01439,GIFGKILGVGKKVLCGLSGMC,21,"Nigrocin-2JDb (Odorranain-H2; Frogs, amphibians, animals)",B3A0M7,Unknown,Unknown,Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. Has hemolytic activity against rabbit erythrocytes.
PTM: contains one disulfide bond 15-21. ","[Ref.22917879]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=15 μM), Staphylococcus aureus CIB 85462 (MIC=15 μM);##Gram-negative bacteria: Escherichia coli ATCC 25992 (MIC=8 μM), Escherichia coli CIB 84492 (MIC=8 μM);##Yeast: Candida albicans (MIC=31 μM).",[Ref:22917879]88.4 ± 4.2% hemolytic activity at 128 μg/ml against rabbit red blood cells,Unknown,22917879,J Proteomics. 2012 Oct 22;75(18):5807-5821.,"Liu J, Jiang J, Wu Z, Xie F.","Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: De novo sequencing and analysis of tandem mass spectrometry data.",,,,,,,,
238,DRAMP01440,GILSGILGMGKKLVCGLSGLC,21,"Nigrocin-2LVb (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana livida (Chinese Odorrana frogs),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. ,Gram-positive bacterium: Staphylococcus aureus (MIC=50 μM);##Gram-negative bacterium: Escherichia coli (MIC=15 μM).,Unknown,Unknown,20158520,FEBS J. 2010 Mar;277(6):1519-1531.,"Wang L, Evaristo G, Zhou M, Pinkse M, Wang M, Xu Y, Jiang X, Chen T, Rao P, Verhaert P, Shaw C.",Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,,,,,,,,
239,DRAMP01441,SILSGNFGVGKKIVCGLSGLC,21,"Nigrocin-2VB (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana livida (Chinese Odorrana frogs),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-negative bacterium E. coli. ,Gram-negative bacterium: Escherichia coli (MIC=25 μM).,Unknown,Unknown,20158520,FEBS J. 2010 Mar;277(6):1519-1531.,"Wang L, Evaristo G, Zhou M, Pinkse M, Wang M, Xu Y, Jiang X, Chen T, Rao P, Verhaert P, Shaw C.",Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,,,,,,,,
240,DRAMP01442,GILSGILGAGKSLVCGLSGLC,21,"Nigrocin-2SCa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana schmackeri (Chinese Odorrana frogs),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-negative bacterium E. coli. ,Gram-negative bacterium: Escherichia coli (MIC=50 μM).,Unknown,Unknown,20158520,FEBS J. 2010 Mar;277(6):1519-1531.,"Wang L, Evaristo G, Zhou M, Pinkse M, Wang M, Xu Y, Jiang X, Chen T, Rao P, Verhaert P, Shaw C.",Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,,,,,,,,
241,DRAMP01443,GILSNVLGMGKKIVCGLSGLC,21,"Nigrocin-2SCc (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana schmackeri (Chinese Odorrana frogs),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-negative bacterium E. coli. ,Gram-negative bacterium: Escherichia coli (MIC=70 μM).,Unknown,Unknown,20158520,FEBS J. 2010 Mar;277(6):1519-1531.,"Wang L, Evaristo G, Zhou M, Pinkse M, Wang M, Xu Y, Jiang X, Chen T, Rao P, Verhaert P, Shaw C.",Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,,,,,,,,
242,DRAMP01447,GFSSIFRGVAKFASKGLGKDLAKLGVDLVACKISKQC,37,"Esculentin-2CHa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Lithobates chiricahuensis,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: E. coli (MIC=5 μM), K. pneumoniae (MIC=5 μM), P. aeruginosa (MIC=5 μM);##Gram-positive bacterium: S. aureus (MIC=5 μM).##Yeast: C. albicans (MIC=10 μM).",Unknown,Unknown,21262304,Peptides. 2011 Apr;32(4):664-669.,"Conlon JM, Mechkarska M, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.",Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,,,,,,,,
243,DRAMP01452,RISFKKGKGSWIKNGLIKGIKGLGKEISLDVIRTGIDIAGCKIKGEC,47,"Esculentin-1LTa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Hylarana latouchii (Broad-folded frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=0.6 μM), Bacillus licheniformis X39 (MIC=10 μM), Staphylococcus carnosus KHS (MIC=1.3 μM), Rhodococcus rhodochrous X15 (MIC=0.3 μM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=5 μM), Serratia rubidaea X01 (MIC=10 μM), Psychrobacter faecalis X29 (MIC=0.6 μM).##Yeast: Candida albicans ATCC2002 (MIC=80 μM).",Unknown,Unknown,22426384,Biochimie. 2012 Jun;94(6):1317-1326.,"Wang H, Yu Z, Hu Y, Yu H, Ran R, Xia J, Wang D, Yang S, Yang X, Liu J.","Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.",,,,,,,,
244,DRAMP01453,MFTMKKSMLLIVLLGIISLSLCEQUERNADEDEQSEM,37,"Esculentin-2LTa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Hylarana latouchii (Broad-folded frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=1.6 μM), Bacillus licheniformis X39 (MIC=3.2 μM), Staphylococcus carnosus KHS (MIC=3.2 μM), Rhodococcus rhodochrous X15 (MIC=0.8 μM);##Gram-negative bacterium: Psychrobacter faecalis X29 (MIC=1.6 μM). ",Unknown,Unknown,22426384,Biochimie. 2012 Jun;94(6):1317-1326.,"Wang H, Yu Z, Hu Y, Yu H, Ran R, Xia J, Wang D, Yang S, Yang X, Liu J.","Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.",,,,,,,,
245,DRAMP01454,GLFTLIKGAAKLIGKTVAKEAGKTGLELMACKITNQC,37,"Esculentin-2JDa (Frogs, amphibians, animals)",B3A0M8,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against E. coli and S. aureus strains (Probable).
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 31-37.","Gram-negative bacteria: Escherichia coli (ATCC 25922) (MIC=34 μg/ml), Extended-spectrum Beta-lactamases E. coli (ESBL) (MIC=34 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (ATCC 25923) (MIC=8 μg/ml), Methicillin-resistant S. aureus (MRSA) (MIC=8 μg/ml). ",Unknown,Unknown,22917879,J Proteomics. 2012 Oct 22;75(18):5807-5821.,"Liu J, Jiang J, Wu Z, Xie F.","Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: de novo sequencing and analysis of tandem mass spectrometry data.",,,,,,,,
246,DRAMP01456,GLFSILKGVGKIALKGLAKNMGKMGLDLVSCKISKEC,37,"Esculentin-2PLa (Frogs, amphibians, animals)","A7WNV5, D3UA57",Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana palustris (Pickerel frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-negative bacterium E. coli, the Gram-positive bacterium: S. aureus and the yeast C. albicans.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 31-37.",Gram-negative bacterium: Escherichia coli (MIC=1 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=10 μM).##Yeast: Candida albicans (MIC=49 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
247,DRAMP01457,GIFSKFAGKGIKDLIIKGVKGIAKEAGMDVIRTGIDIAGCKIKGEC,46,"Esculentin-1V (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana hainanensis (Chinese frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli.,Gram-positive bacterium: Staphylococcus aureus FDA 209P (MIC=4.9 μM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=3.2 μM).,Unknown,Unknown,16427248,Genomics. 2006 May;87(5):638-644.,"Chen T, Zhou M, Chen W, Lorimer J, Rao P, Walker B, Shaw C.",Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,,,,,,,,
248,DRAMP01458,GIFTLFKGAAKLLGKTLAKEAGKTGLELMACKVTNQC,37,"Esculentin-2V (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana hainanensis (Chinese frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli.,Gram-positive bacterium: Staphylococcus aureus FDA 209P (MIC=4.4 μM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=2.8 μM).,Unknown,Unknown,16427248,Genomics. 2006 May;87(5):638-644.,"Chen T, Zhou M, Chen W, Lorimer J, Rao P, Walker B, Shaw C.",Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,,,,,,,,
249,DRAMP01461,GLFSKFAGKGIKNMIIKGIKGIGKEVGMDVIRTGIDVAGCKIKGEC,46,"Esculentin-1S (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana schmackeri (piebald odorous frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli.,Gram-positive bacterium: Staphylococcus aureus FDA 209P (MIC=3 μM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=1.7 μM).,Unknown,Unknown,16427248,Genomics. 2006 May;87(5):638-644.,"Chen T, Zhou M, Chen W, Lorimer J, Rao P, Walker B, Shaw C.",Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,,,,,,,,
250,DRAMP01462,GLFTLIKGAVKMIGKTVAKEAGKTGLELMACKVTNQC,37,"Esculentin-2S (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana schmackeri (piebald odorous frog),"Antibacterial , Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli.,Gram-positive bacterium: Staphylococcus aureus FDA 209P (MIC=2.6 μM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=1.1 μM).,Unknown,Unknown,16427248,Genomics. 2006 May;87(5):638-644.,"Chen T, Zhou M, Chen W, Lorimer J, Rao P, Walker B, Shaw C.",Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,,,,,,,,
251,DRAMP01469,GIFALIKTAAKFVGKNLLKQAGKAGLEHLACKANNQC,37,"Esculentin-2-Ala (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops loloensis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Esculentin-2-Ala exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2.5 μg/mL), Bacillus dysenteriae (MIC=7.5 μg/mL), Bacillus cereus (MIC=7.5 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=12.5 μg/mL), Bacillus pumilus (MIC=2.5 μg/mL), Acinetobacter calcoaceticus (MIC=25 μg/mL), Psecdomonas aeruginosa (MIC=50 μg/mL);##Yeast: Candida albicans ATCC2002 (MIC=2.5 μg/mL)",[Ref:19843479]22% hemolytic activity at 100 μg/mL against rabbit red blood cells,Unknown,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloen.",,,,,,,,
252,DRAMP01470,GIFSLIKTAAKFVGKNLLKQAGKAGVEHLACKANNQC,37,"Esculentin-2-ALb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops loloensis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Esculentin-2-Alb exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=1.25 μg/mL), Bacillus pumilus (MIC=2.5 μg/mL), Bacillus cereus (MIC=7.5 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=12.5 μg/mL), Bacillus dysenteriae (MIC=7.5 μg/mL), Acinetobacter calcoaceticus (MIC=12.5 μg/mL), Psecdomonas aeruginosa (MIC=50 μg/mL);##Yeast: Candida albicans ATCC2002 (MIC=2.5 μg/mL).",[Ref:19843479]17% hemolytic activity at 100 μg/mL against rabbit red blood cells,Unknown,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloen.",,,,,,,,
253,DRAMP01471,GLFPKINKKKAKTGVFNIIKTVGKEAGMDLIRTGIDTIGCKIKGEC,46,"Esculentin-1PLa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana palustris (North American pickerel frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli.,Gram-negative bacterium: Escherichia coli (MIC=1 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
254,DRAMP01472,GIFTKINKKKAKTGVFNIIKTIGKEAGMDVIRAGIDTISCKIKGEC,46,"Esculentin-1PLb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana palustris (North American pickerel frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli.,Gram-negative bacterium: Escherichia coli (MIC=1 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=15 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
256,DRAMP01474,GIFSKINKKKAKTGLFNIIKTVGKEAGMDVIRAGIDTISCKIKGEC,46,"Esculentin-1ARa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana areolata (crawfish frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Esculentin-1ARa has antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. Also exhibits hemolytic activity against human erythrocytes (HC50=180 μM).,[Ref.12429503]Gram-negative bacterium: Escherichia coli (MIC=2 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=13 μM).,[Ref:12429503]HC50=180 μM against human erythrocytes,Unknown,12429503,Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.,"Ali MF, Lips KR, Knoop FC, Fritzsch B, Miller C, Conlon JM.","Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",,,,,,,,
257,DRAMP01475,GLFPKFNKKKVKTGIFDIIKTVGKEAGMDVLRTGIDVIGCKIKGEC,46,"Esculentin-1ARb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana areolata (crawfish frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Esculentin-1ARb has antibacterial against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. Also exhibits hemolytic activity against human erythrocytes (HC50=120 μM).,[Ref.12429503]Gram-negative bacterium: Escherichia coli (MIC=3 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=60 μM).,[Ref:12429503]HC50=120 μM against human erythrocytes,Unknown,12429503,Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.,"Ali MF, Lips KR, Knoop FC, Fritzsch B, Miller C, Conlon JM.","Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",,,,,,,,
258,DRAMP01476,GIFSLIKGAAQLIGKTVAKEAGKTGLELMACKVTKQC,37,"Esculentin-2HSa (Frogs, amphibians, animals)",P0C8T9,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana hosii (Hose's rock frog) (Rana hosii),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 31-37.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=32 μM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=16 μM).,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473.,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
259,DRAMP01477,GIFSKFGGKAIKNLFIKGAKNIGKEVGMDVIRTGIDVAGCKIKGEC,46,"Esculentin-1HSa (Frogs, amphibians, animals)",P0C8T8,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana hosii (Hose's rock frog) (Odorrana hosii),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 40-46.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12 μM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=12 μM).,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
260,DRAMP01479,GLFSKLNKKKIKSGLIKIIKTAGKEAGLEALRTGIDVIGCKIKGEC,46,"Esculentin-1CPa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Lithobates capito (North American New World frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Active against bacteria and fungi.,[Ref.19635516]Gram-negative bacterium: Escherichia coli (MIC=25 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=50 μM);##Yeast: Candida albicans (MIC=25 μM).,Unknown,Unknown,19635516,Peptides. 2009 Oct;30(10):1775-1781.,"Conlon JM, Meetani MA, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.",Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae).,,,,,,,,
261,DRAMP01480,GFFSLIKGVAKIATKGLAKNLGKMGLDLVGCKISKEC,37,"Esculentin-2CPa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Lithobates capito (North American New World frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Active against bacteria and fungi.,[Ref.19635516]Gram-negative bacterium: Escherichia coli (MIC=25 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=50 μM);##Yeast: Candida albicans (MIC=25 μM),Unknown,Unknown,19635516,Peptides. 2009 Oct;30(10):1775-1781.,"Conlon JM, Meetani MA, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.",Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae).,,,,,,,,
262,DRAMP01482,GIFSKFAGKGIKNLLVKGVKNIGKEVGMDVIRTGIDIAGCKIKGEC,46,"Esculentin-1ISa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana ishikawae (Japanese Endangered frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity.,"Gram-negative bacterium: Escherichia coli (MC=6.3 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 μM), Staphylococcus aureus (MRSA) (MIC=25 μM), Bacillus subtilis (MIC=25 μM).",Unknown,Unknown,21193000,Peptides. 2011 Apr;32(4):670-676. ,"Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.",Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
263,DRAMP01483,RIFSKIGGKAIKNLILKGIKNIGKEVGMDVIRTGIDVAGCKIKGEC,46,"Esculentin-1ISb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana ishikawae (Japanese Endangered frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity.,"Gram-negative bacterium: Escherichia coli (MC=3.1 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 μM), Staphylococcus aureus (MRSA) (MIC=12.5 μM), Bacillus subtilis (MIC=12.5 μM).##Yeast: Candida albicans (MIC=50 μM).",Unknown,Unknown,21193000,Peptides. 2011 Apr;32(4):670-676. ,"Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.",Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
264,DRAMP01484,GIFSLIKGAAKLITKTVAKEAGKTGLELMACKVTNQC,37,"Esculentin-2ISa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana ishikawae (Japanese Endangered frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity.,"Gram-negative bacterium: Escherichia coli (MC=12.5 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 μM), Staphylococcus aureus (MRSA) (MIC=25 μM), Bacillus subtilis (MIC=6.3 μM).##Yeast: Candida albicans (MIC=100 μM).",Unknown,Unknown,21193000,Peptides. 2011 Apr;32(4):670-676. ,"Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.",Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
265,DRAMP01486,GLFSKFAGKGIKNLIFKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC,46,"Esculentin-1GRa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana grahami (Odorrana andersonii),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity, also activity against fungus C. albicans.",Gram-negative bacterium: Escherichia coli (MIC=6 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 μM).##Yeast: Candida albicans (MIC>50 μM).,Unknown,Unknown,16621155,Peptides 2006; 27: 2111-2117.,"Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.","Antimicrobial peptides from diverse families isolated from the skin of the Asia frog, Rana Grahami.",,,,,,,,
266,DRAMP01490,GILSLVKGVAKLAGKGLAKEGGKFGLELIACKIAKQC,37,"Esculentin-2A (Frogs, amphibians, animals)",P40845,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (European Edible frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species.,"[Ref.8163497]Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.2 μM), Staphylococcus aureus Cowan 1 (MIC=0.8 μM);##Gram-negative bacteria: Escherichia coli D21 (MIC=0.4 μM), Pseudomonas aeruginosa ATCC15692 (MIC=3.5 μM).",[Ref:8163497]Not determined hemolytic activity against red blood cells,Unknown,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,,,,,,,,
267,DRAMP01491,GIFSKLAGKKLKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC,46,"Esculentin-1B (Frogs, amphibians, animals)",P40844,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (European Edible frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli D21 (MIC=0.2 μM), Pseudomonas aeruginosa ATCC15692 (MIC=0.7 μM);##Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.1 μM), Staphylococcus aureus cowan I (MIC=0.4 μM).##Fungi: Candida albicans (MIC=0.5 μM), Saccharomyces cerevisiae (MIC=0.9 μM).",Unknown,Unknown,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,,,,,,,,
268,DRAMP01493,GLFSKFVGKGIKNFLIKGVKHIGKEVGMDVIRVGIDVAGCKIKGVC,46,"Esculentin-1-OA1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-positive bacteria: Bacillus pyocyaneus CMCCB 10104 (MIC=1.2 μg/mL), Staphylococcus aureus ATCC 25923 (MIC=1.2 μg/mL).##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=1.2 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=2.4 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
269,DRAMP01494,GLFSKFSGKGIKNFLIKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC,46,"Esculentin-1-OA2 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=2.5 μg/mL);##Gram-positive bacteria: Bacillus pyocyaneus CMCCB 10104 (MIC=2.5 μg/mL), Staphylococcus aureus ATCC 25923 (MIC=1.3 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=1.3 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
270,DRAMP01495,GLFSKFAGKGIKDLIFKGVKHIGKEVGMDVIRVGIDVAGCKIKGVC,46,"Esculentin-1-OA3 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=5.4 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=5.4 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=2.7 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=2.7 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
271,DRAMP01496,GLFTKFAGKGIKDLIFKGVKHIGKEVGMDVIRVGIDVAGCKIKGVC,46,"Esculentin-1-OA4 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=5.6 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2.8 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=2.8 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=5.6 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
272,DRAMP01497,GLFSKFAGKGIKNFLIKGVKHIGKEVGMDVIRVGIDVAGCKIKGVC,46,"Esculentin-1-OA5 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=3.4 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=1.7 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=3.4 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=1.7 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
273,DRAMP01499,GIFSKISGKAIKNLFIKGAKNVGKEVGMDVVRTGIDVVGCKIKGEC,46,"Esculentin-1-OR1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=8.8 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4.4 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=17.6 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=8.8 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
274,DRAMP01501,GIFSKISGKAIKNLFIKGAKNVGKRVGMDVVRTGMDVVGCKIKGEC,46,"Esculentin-1-OR3 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=5.5 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=11 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=11 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=11 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
275,DRAMP01502,GIFSKISGKAIKNLFIKGAENVGKHVGIDVVRTGIDVVGCKIKGEC,46,"Esculentin-1-OR4 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=8.6 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=8.6 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=8.6 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=8.6 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
276,DRAMP01503,GIFSKISGKAIKNLFIKGAKNVGKEVGIDVVRTGMDVVGCKIKGEC,46,"Esculentin-1-OR5 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=4.1 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4.1 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=8.2 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=2.1 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
277,DRAMP01504,GIFTLIKGAAKLIGKTVAKEAGKTGLELMACKITNQC,37,"Esculentin-2-OA1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=8.5 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4.3 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=4.3 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=8.5 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
278,DRAMP01505,GLFTLIKGAAKLIGKTTAKEAGKTGKLEMACKITNQC,37,"Esculentin-2-OA2 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=10.8 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=21.6 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=21.6 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
280,DRAMP01507,GVFTLIKGATQLIGKTLGKELGKTGLELMACKITNQC,37,"Esculentin-2-OR1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=10.8 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=21.6 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=21.6 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=10.8 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
281,DRAMP01508,GVFTLIKGATQLIGKTLGKEVGKTGLELMACKITKQC,37,"Esculentin-2-OR2 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=8.1 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4.1 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=16.2 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=8.1 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
282,DRAMP01509,GVFTLLKGATQLIGKTLGKELGKTGLELMACKITNQC,37,"Esculentin-2-OR3 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=7.9 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=7.9 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=7.9 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=15.8 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
283,DRAMP01510,GVFTLIKGATQLIGKTLGKELGKTGLELMACKITEQC,37,"Esculentin-2-OR4 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=3.6 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=3.6 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=3.6 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=3.6 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
284,DRAMP01511,GVFTLIKGATQLIGKTLGKELGKTGLEIMACKITKQC,37,"Esculentin-2-OR5 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=15.8 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=15.8 μg/mL), Bacillus pyocyaneus CMCCB 10104 (MIC=15.8 μg/mL).##Yeast: Candida albicans ATCC 2002 (MIC=7.9 μg/mL).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
285,DRAMP01513,GIFSKLGRKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC,46,"Esculentin-1 (Frogs, amphibians, animals)",P32414,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (Edible frog) (Pelophylax esculentus),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans.  Has hemolytic activity.,"Gram-negative bacteria: Escherichia coli D21 (MIC=0.2 μM), Pseudomonas aeruginosaATCC15692 (MIC=0.7 μM);##Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.1 μM), Staphylococcus aureus Cowan1 (MIC=0.4 μM).##Fungi: Candida albicans (MIC=0.5 μM), Saccharomyces cerevisiae (MIC=0.9 μM).",[Ref. 8163497] LC>100μM,Unknown,8508915,FEBS Lett. 1993 Jun 14;324(2):159-161.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta.,,,,,,,,
286,DRAMP01520,GLLNTFKDWAISIAKGAGKGVLTTLSCKLDKSC,33,"Rugosin-A (Frogs, amphibians, animals)",P80954,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Glandirana rugosa (Japanese wrinkled frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against Gram-positive bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33.","Gram-positive bacteria: Staphylococcus aureus 209P (MIC=6.25 μg/ml), Bacillus subtilis ATCC6633 (MIC=12.5 μg/ml), Micrococcus luteus ATCC9341 (MIC=25 μg/ml), Streptococcus pyogenes COOK (MIC=50 μg/ml);##Gram-negative bacteria: Escherichia coli NIHJ (MIC=100 μg/ml), Pseudomonas aeruginosa PAO-1 (MIC>100 μg/ml).",Unknown,Unknown,7612013,Biochem. Biophys. Res. Commun. 1995; 212: 249-254.,"Suzuki S, Ohe Y, Kagegawa T, Tatemoto K.","Isolation and characterization of novel antimicrobial peptides, rugosins A, B and C, from the skin of the frog, Rana rugosa.",,,,,,,,
287,DRAMP01521,SLFSLIKAGAKFLGKNLLKQGAQYAACKVSKEC,33,"Rugosin-B (Frogs, amphibians, animals)",P80955,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against both Gram-negative and Gram-positive bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33.","Gram-positive bacteria: Staphylococcus aureus 209P (MIC=6.25 μg/ml), Bacillus subtilis ATCC6633 (MIC=6.25 μg/ml), Micrococcus luteus ATCC9341 (MIC=1.56 μg/ml), Streptococcus pyogenes COOK (MIC=12.5 μg/ml);##Gram-negative bacteria: Escherichia coli NIHJ (MIC=12.5 μg/ml), Pseudomonas aeruginosa PAO-1 (MIC=100 μg/ml).",Unknown,Unknown,7612013,Biochem. Biophys. Res. Commun. 1995; 212: 249-254.,"Suzuki S, Ohe Y, Kagegawa T, Tatemoto K.","Isolation and characterization of novel antimicrobial peptides, rugosins A, B and C, from the skin of the frog, Rana rugosa.",,,,,,,,
288,DRAMP01524,SIRDKIKTIAIDLAKSAGTGVLKTLICKLDKSC,33,"Rugosin-RN1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana nigrovittata,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has weak hemolytic activity gainst rabbit red cells.,"[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=4.69 μg/ml), Bacillus subtilis (MIC=9.38 μg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=25.00 μg/ml);##Yeast: Candida albicans ATCC2002 (MIC=5.63 μg/ml)",[Ref:19778602]Show weak hemolytic activity against rabbit red cells,Unknown,19778602,Genomics. 2010 Jan;95(1):66-71.,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",,,,,,,,
289,DRAMP01525,SIRDKIKTIAIDLAKSAGMGILKTLICKLDKSC,33,"Rugosin-RN3 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana nigrovittata,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=16.51 μg/ml), Bacillus subtilis (MIC=18.75 μg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=25.00 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=15.00 μg/ml).",Unknown,Unknown,19778602,Genomics. 2010 Jan;95(1):66-71.,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",,,,,,,,
290,DRAMP01526,SIRDKIKTIAIDLAKSAGTGVLKTLICKLNKSC,33,"Rugosin-RN5 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana nigrovittata,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=15.00 μg/ml), Staphylococcus aureus ATCC43300 (MRSA) (MIC=12.50 μg/ml), Bacillus subtilis (MIC=18.75 μg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=25.00 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=18.75 μg/ml).",Unknown,Unknown,19778602,Genomics. 2010 Jan;95(1):66-71.,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",,,,,,,,
291,DRAMP01533,CVISAGWNHKIRCKLTGNC,19,"Nigroain-B1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana nigrovittata (Black-striped frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Bridge,Unknown,Unknown,PTM: Contains one disulfide bridge.,"Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=4.69 μg/ml), S. aureus ATCC43300 (MIC=50.00 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa PA01 (MIC=25.00 μg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=25.00 μg/ml).",Unknown,Unknown,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",,,,,,,,
292,DRAMP01539,FKTWKRPPFQTSCWGIIKE,19,"Nigroain-C2 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana nigrovittata (Black-striped frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=27.50 μg/ml), S. aureus ATCC43300 (MIC=55.00 μg/ml), Bacillus subtilis (MIC=110.00 μg/ml);##Gram-negative bacteria: Escherichia coli ML-35P (MIC=110.00 μg/ml), Pseudomonas aeruginosa PA01 (MIC=55.00 μg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=55.00 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=13.75 μg/ml).",Unknown,Unknown,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",,,,,,,,
295,DRAMP01546,SLWETIKNAGKGFIQNLDKIR,21,"Nigroain-K1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana nigrovittata (Black-striped frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. Also has hemolytic activity against rabbit red cells.,"[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=9.38 μg/ml), Bacillus subtilis (MIC=21.88 μg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=37.50 μg/ml);##Yeast: Candida albicans ATCC2002 (MIC=32.74 μg/ml).",[Ref:19778602]22.49 ± 4.8% hemolytic activity at 100 μg/ml against rabbit red cells,Unknown,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovitt.",,,,,,,,
297,DRAMP01549,GLLSVLGSVAKHVLPHVVPVIAEHL,25,"Caerin-1.1 (Frogs, amphibians, animals)","P62568, P62569, Q800R2, P56226",Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria splendida (Magnificent tree frog) (Litoria gilleni) (Litoria caerulea),"Antibacterial, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,The peptide adopts two well-defined helices from Leu2 to Lys11 and from Val17 to His24 separated by a region of less-defined helicity and greater flexibility.,Unknown,"Function: Antibacterial and antiviral peptides that adopt an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Secreted by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility.
Miscellaneous: Caerin 1.1 completely inhibits HIV infection of T cells within minutes of exposure to virus at concentrations that were not toxic to target cells (J Virol. 2005 Sep;79(18):11598-606).
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=1.5 μg/ml), Listeria innocua (MIC=25 μg/ml), Micrococcus luteus (MIC=12.5 μg/ml), Staphylococcus aureus (MIC=3-12 μg/ml), Staphylococcus epidermis (MIC=12.5 μg/ml), Streptococcus uberis (MIC=12.5 μg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=25 μg/ml). (Ref.3)",Unknown,Cell membrane,9266696##12709067##15203252,Eur J Biochem. 1997 Jul 15;247(2):545-557.##J. Chem. Soc. Perkin Trans. I. 1992;1:3173-3178.##Peptides. 2004 Jun;25(6):1035-1054.,"Wong H, Bowie JH, Carver JA.##Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The solution structure and activity of caerin 1.1, an antimicrobial peptide from the Australian green tree frog, Litoria splendida.##Peptides from Australian frogs. Structures of the caerins and caeridin 1 from Litoria splendida.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",,,,,,,,
298,DRAMP01550,GLLGAMFKVASKVLPHVVPAITEHF,25,"Caerin-1.11 (Frogs, amphibians, animals)",Q800R9,Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria caerulea (Green tree frog) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Antibacterial and antiviral peptides that adopt an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity (By similarity).
PTM: C-terminal amidation.","Gram-negative bacteria: Escherichia coli B (MIC=25 μM), Enterobacter cloacae (MIC=50 μM), Klebsiella pneumoniae (MIC=25 μM);##Gram-positive bacterium: Staphylococcus haemolyticus (MIC=50 μM).",Unknown,Unknown,12709067##22771617,Eur J Biochem. 2003 May;270(9):2068-2081.##Peptides. 2012 Sep;37(1):174-188.,"Vanhoye D, Bruston F, Nicolas P, Amiche M.##Bowie JH, Separovic F, Tyler MJ.","Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.##Host-defense peptides of Australian anurans. Part 2. Structure, activity, mechanism of action, and evolutionary significance.",,,,,,,,
299,DRAMP01552,GLLSVLGSVAQHVLPHVVPVIAEHL,25,"Caerin-1.3 (Frogs, amphibians, animals)",P56228,Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria caerulea (Australian frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=3 μg/ml), Listeria innocua (MIC=50 μg/ml), Micrococcus luteus (MIC=25 μg/ml), Staphylococcus aureus (MIC=6-12 μg/ml), Staphylococcus epidermis (MIC=12 μg/ml), Streptococcus uberis (MIC=25 μg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=50 μg/ml). (Ref.2)",Unknown,Unknown,PubMed ID is not available##15203252,J. Chem. Res. 1993; 138: 910-936.##Peptides. 2004 Jun;25(6):1035-1054.,"Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Peptides from Australian frogs. The structures of the caerins from Litoria caerula.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",,,,,,,,
300,DRAMP01553,GLLSSLSSVAKHVLPHVVPVIAEHL,25,"Caerin-1.4 (Frogs, amphibians, animals)","P62544, P56229, P62545, P56229",Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria caerulea (Green tree frog) (also Litoria gilleni) (Centralian tree frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=0.4 μg/ml), Staphylococcus aureus (MIC=100 μg/ml), Staphylococcus epidermis (MIC=25 μg/ml), Streptococcus uberis (MIC=100 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=50 μg/ml), Pasteurella multocida (MIC=25 μg/ml). (Ref.2)",Unknown,Unknown,PubMed ID is not available##15203252,J. Chem. Res. 1993; 138: 910-936.##Peptides. 2004 Jun;25(6):1035-1054.,"Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Peptides from Australian frogs. The structures of the caerins from Litoria caerula.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",,,,,,,,
301,DRAMP01555,GLLSVLGSVVKHVIPHVVPVIAEHL,25,"Caerin-1.5 (Frogs, amphibians, animals)",P56230,Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria caerulea (Green tree frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=3 μg/ml), Listeria innocua (MIC=50 μg/ml), Micrococcus luteus (MIC=12 μg/ml), Staphylococcus aureus (MIC=25 μg/ml), Staphylococcus epidermis (MIC=25 μg/ml), Streptococcus uberis (MIC=50 μg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=25 μg/ml). (Ref.2)",Unknown,Unknown,PubMed ID is not available##15203252,J. Chem. Res. 1993; 138: 910-936.##Peptides. 2004 Jun;25(6):1035-1054.,"Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Peptides from Australian frogs. The structures of the caerins from Litoria caerula.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",,,,,,,,
302,DRAMP01560,GLFGVLGSIAKHVLPHVVPVIAEKL,25,"Caerin-1.9 (Frogs, amphibians, animals)",P81252,Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria chloris (Blue-thighed frog) (frog skin active peptide family),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin dorsal glands.
Domain: Contains two amphipathic alpha helix regions separated by a region of less-defined helicity and greater flexibility (By similarity).
PTM: C-terminal amidation.
Miscellaneous: Caerin 1.9 completely inhibited HIV infection of T cells within minutes of exposure to virus at concentrations that were not toxic to target cells (J Virol. 2005 Sep;79(18):11598-606).","Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=50 μg/ml), Micrococcus luteus (MIC=50 μg/ml), Staphylococcus aureus (MIC=100 μg/ml), Staphylococcus epidermis (MIC=25 μg/ml), Streptococcus uberis (MIC=50 μg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=50 μg/ml). (Ref.2)",Unknown,Unknown,9516047##15203252,J Pept Res. 1998 Feb;51(2):121-126.##Peptides. 2004 Jun;25(6):1035-1054.,"Steinborner ST, Currie GJ, Bowie JH, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","New antibiotic caerin 1 peptides from the skin secretion of the Australian tree frog Litoria chloris. Comparison of the activities of the caerin 1 peptides from the genus Litoria.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",,,,,,,,
303,DRAMP01562,GLVSSIGRALGGLLADVVKSKGQPA,25,"Caerin-2.1 (Frogs, amphibians, animals)","P56233, P86485",Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria splendida (Magnificent tree frog) (Emerald spotted tree frog),"Antibacterial , Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.",Gram-negative bacterium: Pasteurella multocida (MIC=25 μg/ml). (Ref.2),Unknown,Unknown,19642086##15203252,Rapid Commun Mass Spectrom. 2009 Sep;23(17):2628-2636.##Peptides. 2004 Jun;25(6):1035-1054.,"Bilusich D, Jackway RJ, Musgrave IF, Tyler MJ, Bowie JH.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The host-defence skin peptide profiles of Peron's Tree Frog Litoria peronii in winter and summer. Sequence determination by electrospray mass spectrometry and activities of the peptides.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",,,,,,,,
304,DRAMP01563,GLVSSIGRALGGLLADVVKSKEQPA,25,"Caerin-2.2 (Frogs, amphibians, animals)","P62570, P62571, P56234",Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria gilleni (Centralian tree frog) (also Litoria caerulea) (Green tree frog),"Antibacterial , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.",Gram-positive bacterium: Micrococcus luteus (MIC=50 μg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=25 μg/ml).,Unknown,Unknown,PubMed ID is not available##15203252,J. Chem. Res. 1993; 138: 910-936.##Peptides. 2004 Jun;25(6):1035-1054.,"Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Peptides from Australian frogs. The structures of the caerins from Litoria caerula.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",,,,,,,,
309,DRAMP01574,GLWQKIKSAAGDLASGIVEGIKS,23,"Caerin-4.1 (Frogs, amphibians, animals)",P56242,Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria caerulea (Green tree frog),"Antibacterial, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"PTM: adopt an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.",Gram-positive bacterium: Micrococcus luteus (MIC=12 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=25 μg/ml).(Ref.2),Unknown,Unknown,PubMed ID is not available##15203252,J. Chem. Res. 1993; 138: 910-936.##Peptides. 2004 Jun;25(6):1035-1054.,"Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Peptides from Australian frogs. The structures of the caerins from Litoria caerula.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",,,,,,,,
310,DRAMP01576,GLWQKIKNAAGDLASGIVEGIKS,23,"Caerin-4.3 (Frogs, amphibians, animals)",P56244,Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria caerulea (Green tree frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial peptide, that adopts an alpha helical conformation which can disrupt bacterial membranes. Each caerin displays a different antimicrobial specificity.
Tissue specificity: Expressed by the skin parotoid and/or rostral glands.
PTM: C-terminal amidation.",Gram-positive bacterium: Micrococcus luteus (MIC=25 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=50 μg/ml).(Ref.2),Unknown,Unknown,PubMed ID is not available##15203252,J. Chem. Res. 1993; 138: 910-936.##Peptides. 2004 Jun;25(6):1035-1054.,"Stone DJM, Waugh RJ, Bowie JH, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","Peptides from Australian frogs. The structures of the caerins from Litoria caerula.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",,,,,,,,
311,DRAMP01577,GLLSVLGSVAKHVLPHVVPVIAEKL,25,"Caerin-1.10 (Frogs, amphibians, animals)","P86502, P82104",Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria rothii (Roth's tree frog); also Litoria splendida (Magnificent tree frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial peptide with wide spectrum of activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","Gram-positive bacteria: Leuconostoc lactis (MIC=6 μg/ml), Listeria innocua (MIC=50 μg/ml), Micrococcus luteus (MIC=25 μg/ml), Streptococcus uberis (MIC=50 μg/ml), Staphylococcus epidermidis (MIC=100 μg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=100 μg/ml).",Unknown,Unknown,16124032##10601876,Rapid Commun Mass Spectrom. 2005;19(18):2716-2724.##Eur J Biochem. 2000 Jan;267(1):269-275.,"Brinkworth CS, Bowie JH, Bilusich D, Tyler MJ.##Wabnitz PA, Bowie JH, Tyler MJ, Wallace JC, Smith BP.","The rothein peptides from the skin secretion of Roth's tree frog Litoria rothii. Sequence determination using positive and negative ion electrospray mass spectrometry.##Differences in the skin peptides of the male and female Australian tree frog Litoria splendida. The discovery of the aquatic male sex pheromone splendipherin, together with phe8 caerulein and a new antibiotic peptide caerin 1.10.",,,,,,,,
316,DRAMP01585,GLFSVLGSVAKHLLPHVVPVIAEKL,25,"Caerin-1.18 (Frogs, amphibians, animals)",P0C2A7,Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria gracilenta (Dainty green tree frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows significant activity against Gram-positive organisms, but is less effective against Gram-negative organisms.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=25 μg/ml), Listeria innocua (MIC=12 μg/ml), Micrococcus luteus (MIC=12 μg/ml), Staphylococcus aureus ATCC 25923 (MIC=12 μg/ml), Staphylococcus aureus ATCC 29213 (MIC=12 μg/ml), Staphylococcus epidermidis (MIC=25 μg/ml), Streptococcus uberis (MIC=25 μg/ml);##Gram-negative bacteria: Pasteurella multocida (MIC=50 μg/ml).",Unknown,Unknown,16554081,Toxicon. 2006 May;47(6):664-675.,"Maclean MJ, Brinkworth CS, Bilusich D, Bowie JH, Doyle JR, Llewellyn LE, Tyler MJ.",New caerin antibiotic peptides from the skin secretion of the Dainty Green Tree Frog Litoria gracilenta. Identification using positive and negative ion electrospray mass spectrometry.,,,,,,,,
317,DRAMP01586,GLFKVLGSVAKHLLPHVAPIIAEKL,25,"Caerin-1.19 (Frogs, amphibians, animals)",P0C2A8,Belongs to the frog skin active peptide family (Caerin subfamily),Unknown,Litoria gracilenta (Dainty green tree frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Caerin-1.19 shows significant activity against Gram-positive organisms, but is less effective against Gram-negative organisms.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=3 μg/ml), Listeria innocua (MIC=12 μg/ml), Micrococcus luteus (MIC=25 μg/ml), Staphylococcus aureus Strain ATCC 25923 (MIC=12 μg/ml), Staphylococcus aureus Strain ATCC 29213 (MIC=12 μg/ml), Staphylococcus epidermidis (MIC=12 μg/ml), Streptococcus uberis (MIC=25 μg/ml);##Gram-negative bacteria: Pasteurella multocida (MIC=50 μg/ml).",Unknown,Unknown,16554081,Toxicon. 2006 May;47(6):664-675.,"Maclean MJ, Brinkworth CS, Bilusich D, Bowie JH, Doyle JR, Llewellyn LE, Tyler MJ.",New caerin antibiotic peptides from the skin secretion of the Dainty Green Tree Frog Litoria gracilenta. Identification using positive and negative ion electrospray mass spectrometry.,,,,,,,,
321,DRAMP01590,GLFDVIAKVASVIKKL,16,"Citropin 1.1 M14 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: E. coli (MIC=53 μM);##Gram-positive bacterium: S. aureus (MIC=3 μM).,Unknown,Unknown,20564028,Biopolymers. 2011;96(2):147-157.,Unknown,"Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, and maculatin.",,,,,,,,
322,DRAMP01591,GLFAVIKKVASVIKKL,16,"Citropin 1.1 M15 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: E. coli (MIC=53 μM);##Gram-positive bacteria: S. aureus (MIC=3 μM), B. subtilis (MIC=3 μM).",Unknown,Unknown,20564028,Biopolymers. 2011;96(2):147-157.,Unknown,"Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, and maculatin.",,,,,,,,
329,DRAMP01607,GLFDIIKKIAESF,13,"Aurein-1.2 (Frogs, amphibians, animals)",P82387,Unknown,Unknown,Litoria raniformis (Southern bell frog),"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 10 residues),Unknown,1VM5 resolved by NMR.,Function: Probably acts by disturbing membrane functions with its amphipathic structure. Aurein 1.2 is HIV active (Wang G et al. 2010 Antimicrob. Agents Chemother. (54) 1343-1346). Aurein 1.2 is also the smallest amphibian peptide to show both antibiotic and anticancer activity. The aurein antibiotics show more activity towards Gram-positive than Gram-negative pathogens. Expressed by the skin dorsal glands.,"Gram-positive bacteria: Bacillus cereus (MIC=100 μg/ml), Leuconostoc lactis (MIC=12 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=50 μg/ml), Staphylococcus aureus (MIC=8 μmol/L);##Gram-negative bacteria: Pasteurella multocida (MIC=100 μg/ml), Escherichia coli (MIC=8 μmol/L);##Fungi: Candida albicans (MIC=32 μmol/L)",Unknown,Cell membrane,10951191##15572363##15203252,Eur J Biochem. 2000 Sep;267(17):5330-5341.##J Biol Chem. 2005 Feb 18;280(7):5803-5811.##Peptides. 2004 Jun;25(6):1035-1054.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Wang G, Li Y, Li X.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",,,,,,,,
335,DRAMP01618,GLFDIVKKIAGHIVSSI,17,"Aurein-3.3 (Frogs, amphibians, animals)",P82396,Unknown,Unknown,Litoria raniformis (blue-thighed treefrog),"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: The aurein antibiotics show more activity towards gram-positive than gram-negative pathogens. Probably acts by disturbing membrane functions with its amphipathic structure. Shows anticancer activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Leuconostoc lactis (MIC=12 μg/ml), Micrococcus luteus (MIC=100 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Streptococcus uberis (MIC=25 μg/ml), Staphylococcus aureus (MIC=100 μg/ml);##Gram-negative bacterium: Pasteurella multocida (MIC=100 μg/ml)",Unknown,Cell membrane,10951191##15203252,Eur J Biochem. 2000 Sep;267(17):5330-5341.##Peptides. 2004 Jun;25(6):1035-1054.,"Rozek T, Wegener KL, Bowie JH, Olver IN, Carver JA, Wallace JC, Tyler MJ.##Apponyi MA, Pukala TL, Brinkworth CS, Maselli VM, Bowie JH, Tyler MJ, Booker GW, Wallace JC, Carver JA, Separovic F, Doyle J, Llewellyn LE.","The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.##Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",,,,,,,,
337,DRAMP01621,IIGPVLGMVGSALGGLLKKI,20,"Bombinin-H1 (Frogs, amphibians, animals)","P82282, P82283",Belongs to the bombinin family,Unknown,Bombina variegata (European frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation and D-amino acid.",[Ref.8223491]Gram-negative bacterium: Escherichia coli D21 (MIC=3.8 μM);##Gram-positive bacterium: Staphylococcus aureus Cowan 1 (MIC=2.1 μM).,[Ref:8223491]Not determined hemolytic activity against human red blood cells.,Unknown,8223491,EMBO J. 1993; 12:4829-4832.,"Mignogna G, Simmaco M, Kreil G, Barra D.",Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.,,,,,,,,
338,DRAMP01623,LIGPVLGLVGSALGGLLKKI,20,"Bombinin-H4 (bombinin H isomers; Frogs, amphibians, animals)",P82284,Belongs to the bombinin family,Unknown,Bombina variegata (European frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: H4 is more potent against Gram-positive than Gram-negative bacterial strains. It also shows hemolytic activities.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",[Ref.8223491]Gram-negative bacterium: Escherichia coli D21 (MIC=4.8 μM);##Gram-positive bacterium: Staphylococcus aureus Cowan 1 (MIC=3.3 μM).,[Ref:8223491]LC50=14.6 μM against human red blood cells.,Unknown,8223491,EMBO J. 1993; 12:4829-4832.,"Mignogna G, Simmaco M, Kreil G, Barra D.",Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.,,,,,,,,
339,DRAMP01626,IIGPVLGLVGSALGGLLKKI,20,"Bombinin-H5 (Frogs, amphibians, animals)",P82285,Belongs to the bombinin family,Unknown,Bombina variegata (European frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 16 residues),Unknown,"2AP7, 2AP8 resolved by NMR.","Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation and D-amino acid.",[Ref.8223491]Gram-negative bacterium: Escherichia coli D21 (MIC=5.0 μM);##Gram-positive bacterium: Staphylococcus aureus Cowan 1 (MIC=3.0 μM).,[Ref:8223491]Unknown,Unknown,8223491##PubMed ID is not available,EMBO J. 1993; 12:4829-4832.##TO BE PUBLISHED,"Mignogna G, Simmaco M, Kreil G, Barra D.##Zangger K, Jilek A, Khatai L.",Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.##Solution structure and orientation of bombinin H2 and H4 in a membrane-mimetic environment.,,,,,,,,
340,DRAMP01627,YPPKPESPGEDASPEEMNKYLTALRHYINLVTRQRY,36,"Skin peptide tyrosine-tyrosine (Skin-PYY; SPYY; Frogs, amphibians, animals)",P80952,Belongs to the NPY family,Unknown,Phyllomedusa bicolor (Two-colored leaf frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows a broad spectrum of antibacterial activity against Gram-positive and Gram-negative bacteria, yeast and fungi.
Tissue specificity: Skin.
PTM: C-terminal amidation (By similarity).","Gram-negative bacteria: Aeromonas caviae (MIC=40 μg/ml), Escherichia coli (MIC=10 μg/ml);##Gram-positive bacteria: Enterococcus faecalis (MIC=10 μg/ml), Nocardia brasiliensis (MIC=20 μg/ml).##Fungi: Cryptococcus neoformans (MIC=20 μg/ml), Candida albicans (MIC=15 μg/ml), Microsporum canis (MIC=10 μg/ml), Tricophyton rubrum (MIC=15 μg/ml), Arthroderma simii (MIC=10 μg/ml), Aspergillus fumigatus (MIC=80 μg/ml), Aspergillus niger (MIC>100 μg/ml).",Unknown,Cell membrane,7937944##8601432,Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10295-10299.##FEBS Lett. 1996 Feb 19;380(3):237-240.,"Mor A, Chartrel N, Vaudry H, Nicolas P.##Vouldoukis I, Shai Y, Nicolas P, Mor A.","Skin peptide tyrosine-tyrosine, a member of the pancreatic polypeptide family: isolation, structure, synthesis, and endocrine activity.##Broad spectrum antibiotic activity of the skin-PYY.",,,,,,,,
341,DRAMP01628,GWMSKIASGIGTFLSGMQQ,19,"Phylloxin (Frogs, amphibians, animals)","P81565, Q9PT74",Belongs to the frog skin active peptide family (Dermaseptin subfamily),PLX,Phyllomedusa bicolor (Two-colored leaf frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Antimicrobial peptide against the Gram-positive bacteria and the Gram-negative-bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","Gram-negative bacteria: Acholeplasma laidlawii A-PG8 (MIC=12.5 μM), Spiroplasma melliferum BC3 (MIC=50 μM), Rhizobium meliloti 102F34 (MIC=12.5 μM), Escherichia coli K12 (MIC=10 μM);##Gram-positive bacteria: Bacillus megaterium KM (MIC=3.12 μM), Corynebacterium glutamicum ATCC 27853 (MIC=1.56 μM), Micrococcus luteus ATCC 27853 (MIC=3.0 μM).",Unknown,Unknown,10632707,Eur J Biochem. 2000 Jan;267(2):370-378.,"Pierre TN, Seon AA, Amiche M, Nicolas P.","Phylloxin, a novel peptide antibiotic of the dermaseptin family of antimicrobial/opioid peptide precursors.",,,,,,,,
342,DRAMP01638,GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS,32,"Dermaseptin-L1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Hylomantis lemur (Lemur leaf frog),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=8 μM).##Fungi: Batrachochytrium dendrobatidis (MIC>100 μM).,Unknown,Unknown,17561225,Toxicon. 2007 Sep 15;50(4):498-506.,"Conlon JM, Woodhams DC, Raza H, Coquet L, Leprince J, Jouenne T, Vaudry H, Rollins-Smith LA.",Peptides with differential cytolytic activity from skin secretions of the lemur leaf frog Hylomantis lemur (Hylidae: Phyllomedusinae).,,,,,,,,
343,DRAMP01639,GLWSTIKNVGKEAAIAAGKAALGAL,25,"Dermaseptin-1 (DShypo01, DPh-1; Frogs, amphibians, animals)",P84596,Unknown,Unknown,Phyllomedusa hypochondrialis (Orange-legged leaf frog),"Antibacterial, Antiprotozoal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. Also has antiprotozoal activity against L. amazonensis. No hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","[Ref.16963159]Gram-positive bacteria: Micrococcus luteus A270 (MIC=6 μM), Staphylococcus aureus ATCC 6538 (MIC=6 μM);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=6 μM), Pseudomonas aeruginosa ATCC 14502 (MIC=6.6 μM).",[Ref:16844081]Non-hemolytic activity upto 53 μM against human red blood cells;##[Ref.16963159]Non-hemolytic activity at 6 μM against erythrocytes,Unknown,16844081##16963159,Biochem Biophys Res Commun. 2006 Sep 1;347(3):739-746.##Peptides. 2006 Dec;27(12):3092-3099.,"Brand GD, Leite JR, de Sá Mandel SM, Mesquita DA, Silva LP, Prates MV, Barbosa EA, Vinecky F, Martins GR, Galasso JH, Kuckelhaus SA, Sampaio RN, Furtado JR Jr, Andrade AC, Bloch C Jr.##Conceição K, Konno K, Richardson M, Antoniazzi MM, Jared C, Daffre S, Camargo AC, Pimenta DC.",Novel dermaseptins from Phyllomedusa hypochondrialis (Amphibia).##Isolation and biochemical characterization of peptides presenting antimicrobial activity from the skin of Phyllomedusa hypochondrialis.,,,,,,,,
344,DRAMP01643,GLWSTIKQKGKEAAIAAAKAAGQAALGAL,29,"Dermaseptin-5 (DShypo05, DS 01; Frogs, amphibians, animals)",P84600,Unknown,Unknown,Phyllomedusa hypochondrialis (Orange-legged leaf frog),"Antibacterial, Antiprotozoal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. Also has antiprotozoal activity against L. amazonensis. No hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.",[Ref.8306981]Gram-negative bacterium: Escherichia coli (MIC=6.4 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=3.2 μM).,[Ref:8306981]Non-hemolytic activity against rabbit red blood cells.,Unknown,8306981,Eur J Biochem. 1994 Jan 15;219(1-2):145-154.,"Mor A, Nicolas P.",Isolation and structure of novel defensive peptides from frog skin.,,,,,,,,
345,DRAMP01646,GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV,33,"Adenoregulin (Dermaseptin BII; Dermaseptin B2; Frogs, amphibians, animals)","P31107, P80283",Belongs to the frog skin active peptide family (Dermaseptin subfamily),ADR,Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Fountion: Enhances binding of agonists to adenosine A1 receptors, adenosine A2a receptors, alpha-2 adrenergic receptors and 5-hydroxytryptamine 1A receptors. Enhances guanyl nucleotide exchange which may result in the conversion of receptors to a high affinity state complexed with guanyl nucleotide free G-protein. Affects human behavior eliciting profound malaise, followed by listlessness and then euphoria. Possesses a potent antimicrobial activity against bacteria, fungi and protozoa. Lack hemolytic activity. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation at V33 (Amidation in vitro increases antimicrobial activity against some microorganisms such as T. album and S. cerevisia).","[Ref.8306981]Fungi: Microsporum canis (IP 1194) (MIC=10 μg/ml), Tricophyton rubrum (IP 1400-82) (MIC=15 μg/ml), Arthroderma simii (IP 1063-74) (MIC=30 μg/ml), Aspergillus fumigatus IP (1025-70) (MIC=125 μg/ml), Aerornonas caviae (IP 67-16 T) (MIC=60 μg/ml), Cryptococcus neoformans (IP 960-67) (MIC=15 μg/ml), Cryptococcus neoformans (IP 962-67) (MIC=15 μg/ml), Candida albicans (IP 884-65) (MIC=15 μg/ml);##Gram-negative bacterium: Escherichia coli (IP 76-24) (MIC=15 μg/ml);##Gram-positive bacterium: Nocardia brasiliensis (IP 16-80) (MIC=30 μg/ml).",[Ref:8306981]Lack hemolytic activity against rabbit red blood cells,Unknown,8306981##1438301##7842473##8565049,"Eur J Biochem 1994, 219 (1-2):145-154.##Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10960-10963.##Cell Mol Neurobiol. 1994 Apr;14(2):133-157.##Cell Mol Neurobiol. 1995 Aug;15(4):465-493.","Mor, A, Nicolas, P.##Daly JW, Caceres J, Moni RW, Gusovsky F, Moos M Jr, Seamon KB, Milton K, Myers CW.##Shin Y, Moni RW, Lueders JE, Daly JW.##Moni RW, Romero FS, Daly JW.","Isolation and structure of novel defensive peptides from frog skin.##Frog secretions and hunting magic in the upper Amazon: identification of a peptide that interacts with an adenosine receptor.##Effects of the amphiphilic peptides mastoparan and adenoregulin on receptor binding, G proteins, phosphoinositide breakdown, cyclic AMP generation, and calcium influx.##The amphiphilic peptide adenoregulin enhances agonist binding to A1-adenosine receptors and [35S]GTP gamma S to brain membranes.",,,,,,,,
347,DRAMP01648,GLVTSLIKGAGKLLGGLFGSVTGGQS,26,"Dermaseptin-like PBN2 (DRP-PBN2; Plasticin-B1a; Frogs, amphibians, animals)",Q800R4,Unknown,Unknown,Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Possesses a potent antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and fungi. Probably acts by disturbing membrane functions with its amphipathic structure.","Gram-negative bacteria: Escherichia coli B (MIC=1.5 μM), Salmonella typhimurium (MIC=3.1 μM), Salmonella enteritidis (MIC=1.5 μM), Enterobacter cloacae (MIC=12.5 μM), Klebsiella pneumoniae (MIC=0.8 μM);##Gram-positive bacteria: Aerococcus viridans (MIC=3.1 μM), Bacillus megaterium (MIC=0.8 μM), Staphylococcus aureus (MIC=3.1 μM), Staphylococcus haemolyticus (MIC=0.8 μM).##Fungi: Saccaromyces cerevisiae (MIC=3.1 μM).",Unknown,Unknown,12709067,Eur J Biochem. 2003 May;270(9):2068-2081.,"Vanhoye D, Bruston F, Nicolas P, Amiche M.",Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.,,,,,,,,
348,DRAMP01649,AMWKDVLKKIGTVALHAGKAALGAVADTISQ,31,"Dermaseptin-BI (Dermaseptin B1; Frogs, amphibians, animals)",P80282,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Unknown,Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Possesses a potent antimicrobial activity against bacteria, fungi and protozoa. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation (Potential).","Gram-negative bacterium: Escherichia coli (IP 76-24) (MIC=15 μg/ml);##Gram-positive bacterium: Nocardia brasiliensis (IP 16-80) (MIC=30 μg/ml).##Fungi: Tricophyton rubrum (IP 1400-82) (MIC=15 μg/ml), Microsporum canis (IP 1194) (MIC=10μg/ml), Arthroderma simii (IP 1063-74) (MIC=30 μg/ml), Cryptococcus neoformans (IP 960-67) (MIC=15 μg/ml), Cryptococcus neofonnans (IP 962-67) (MIC=15 μg/ml), Aspergillus fumigatus (IP 1025-70)(MIC=125 μg/ml), Aerornonas caviae (IP 67-16 T) (MIC=60 μg/ml), Candida albicans (IP 884-65) (MIC=15 μg/ml).",Unknown,Unknown,8306981##8074751,Eur J Biochem. 1994 Jan 15;219(1-2):145-154.##J Biol Chem. 1994 Jul 8;269(27):17847-17852.,"Mor A, Nicolas P.##Amiche M, Ducancel F, Mor A, Boulain JC, Menez A, Nicolas P.","Isolation and structure of novel defensive peptides from frog skin.##Precursors of vertebrate peptide antibiotics dermaseptin b and adenoregulin have extensive sequence identities with precursors of opioid peptides dermorphin, dermenkephalin, and deltorphins.",,,,,,,,
349,DRAMP01650,ALWKNMLKGIGKLAGQAALGAVKTLVGAE,29,"Dermaseptin-B3 (Dermaseptin BIII; Frogs, amphibians, animals)",P81485,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Unknown,Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Possesses a potent antimicrobial activity against Gram-positive and Gram-negative bacteria. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin glands.","Gram-negative bacteria: Pseudomonas aeruginosa CIP A22 (MIC=2.3 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=5 μM), Escherichia coli ATCC 25922 (MIC=2.6 μM), E. coli 54127 (MIC=2.3 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25293 (MIC=1.3 μM).",Unknown,Unknown,9614066,J Biol Chem. 1998 Jun 12;273(24):14690-7.,"Charpentier S, Amiche M, Mester J, Vouille V, Le Caer JP, Nicolas P, Delfour A.","Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics.",,,,,,,,
350,DRAMP01651,ALWKDILKNVGKAAGKAVLNTVTDMVNQ,28,"Dermaseptin-B4 (Dermaseptin BIV; Frogs, amphibians, animals)",P81486,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Unknown,Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Possesses a potent antimicrobial activity against Gram-positive and Gram-negative bacteria. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","Gram-positive bacteria: Staphylococcus aureus ATCC 25293 (MIC=1.3 μM), S. aureus ATCC 25923 (MIC=3.0 μM);##Gram-negative bacteria: Pseudomonas aeruginosa CIP A22 (MIC=4.6 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=11.6 μM), Escherichia coli ATCC 25922 (MIC=5.0 μM), E. coli 54127 (MIC=2.3 μM).",Unknown,Unknown,9614066,J Biol Chem. 1998 Jun 12;273(24):14690-7.,"Charpentier S, Amiche M, Mester J, Vouille V, Le Caer JP, Nicolas P, Delfour A.","Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics.",,,,,,,,
352,DRAMP01668,ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ,34,"Dermaseptin-1 (DS I; Dermaseptin-S1, DS1; Frogs, amphibians, animals)","P24302, P80277",Belongs to the frog skin active peptide family (Dermaseptin subfamily),Unknown,Phyllomedusa sauvagei (Sauvage's leaf frog),"Antibacterial, Antifungal, Antiprotozoal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (CD),Unknown,Unknown,"Function: Possesses a potent antimicrobial activity against bacteria, fungi and protozoa. Probably acts by disturbing membrane functions with its amphipathic structure. This peptide could also inhibit HIV infection at a concentration that is also toxic to T cells (J Virol 2005; 79:11598-11606).
Tissue specificity: Expressed by the skin glands.","Fungi: Microsporum canis (IP 1194) (MIC=50 μg/ml), Tricophyton rubrum (IP 1400-82) (MIC=100 μg/ml), Arthroderma simii (IP 1063-74) (MIC=100 μg/ml), Aspergillus fumigatus (IP 1025-70) (MIC=100 μg/ml), Aerornonas caviae IP (67-16) T (MIC=50 μg/ml), Cryptococcus neoformans (IP 960-67) (MIC=15 μg/ml), Cryptococcus neoformans (IP 962-67) (MIC=15 μg/ml), Candida albicans (IP 884-65) (MIC=60 μg/ml); ##Gram-negative bacterium: Escherichia coli (IP 76-24) (MIC=5 μg/ml);##Gram-positive bacterium: Nocardia brasiliensis (IP 16-80) (MIC=200 μg/ml).",Unknown,Cell membrane,1909573##8306981,Biochemistry. 1991 Sep 10;30(36):8824-8830.##Eur J Biochem. 1994 Jan 15;219(1-2):145-154. ,"Mor A, Nguyen VH, Delfour A, Migliore-Samour D, Nicolas P.##Mor A, Nicolas P.","Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin.##Isolation and structure of novel defensive peptides from frog skin.",,,,,,,,
357,DRAMP01702,GLWSTIKNVGKEAAIAAGKAVLGSL,25,"Dermaseptin-H5 (Dermaseptin-like peptide 5, DMS5; Frogs, amphibians, animals)",Q1EJP4,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Unknown,Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea),"Antibacterial , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).,"Gram-negative bacterium: Escherichia coliEscherichia coli ATCC 11775 (MIC=0.5 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 12600 (MIC=0.5 μM), Micrococcus luteus ATCC 49732 (MIC=2.0 μM).",Unknown,Unknown,17553595,Peptides. 2007 Jul;28(7):1331-43.,"Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.",A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.,,,,,,,,
359,DRAMP01730,FLPLIGRVLSGIL,13,"Temporin-A (Frogs, amphibians, animals)",P56917,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana temporaria (European common frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Antimicrobial activity against the Gram-positive bacteria.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","Gram-positive bacteria: Bacillus megaterium BM11 (MIC=1.2 μM), Staphylococcus aureus Cowanl (MIC=2.3 μM), Yersinia pseudotuberculosis (MIC=2.0 μM), Streptococcus pyogenes betahemolytic group A (MIC=2.0 μM);##Gram-negative bacteria: Escherichia coli D21 (MIC=11.9 μM), Pseudomonas aeruginosa ATCC15692 (MIC>360 μM).##Yeast: Candida albicans ATCC 10261 (MIC=3.4 μM)",Unknown,Unknown,9022710,Eur J Biochem. 1996 Dec 15;242(3):788-792.,"Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D.","Temporins, antimicrobial peptides from the European red frog Rana temporaria.",,,,,,,,
360,DRAMP01731,FLPIAGKLLSGLSGLL,16,"Temporin-ALd (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops loloensis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Temporin-ALd exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=1.25 μg/mL), Bacillus pumilus (MIC=2.5 μg/mL), Bacillus cereus (MIC=15 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=1.25 μg/mL), Bacillus dysenteriae (MIC=5 μg/mL), Acinetobacter calcoaceticus (MIC=15 μg/mL), Psecdomonas aeruginosa (MIC=5 μg/mL);##Yeast: Candida albicans ATCC2002 (MIC=1.25 μg/mL).",[Ref:19843479]12% hemolytic activity at 100 μg/mL against rabbit red blood cells,Unknown,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",,,,,,,,
361,DRAMP01732,FFPIVGKLLFGLSGLL,16,"Temporin-ALe (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops loloensis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Temporin-ALe exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=1.25 μg/mL), Bacillus pumilus (MIC=5 μg/mL), Bacillus cereus (MIC=15 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=1.25 μg/mL), Bacillus dysenteriae (MIC=5 μg/mL), Acinetobacter calcoaceticus (MIC=15 μg/mL), Psecdomonas aeruginosa (MIC=5 μg/mL);##Yeast: Candida albicans ATCC2002 (MIC=1.25 μg/mL).",[Ref:19843479]10% hemolytic activity at 100 μg/mL against rabbit red blood cells,Unknown,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",,,,,,,,
362,DRAMP01733,FFPIVGKLLSGLSGLL,16,"Temporin-ALf (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops loloensis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Temporin-ALf exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2.5 μg/mL), Bacillus pumilus (MIC=5 μg/mL), Bacillus cereus (MIC=30 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=2.5 μg/mL), Bacillus dysenteriae (MIC=5 μg/mL), Acinetobacter calcoaceticus (MIC=30 μg/mL), Psecdomonas aeruginosa (MIC=5 μg/mL);##Yeast: Candida albicans ATCC2002 (MIC=2.5 μg/mL).",[Ref:19843479]7% hemolytic activity at 100 μg/mL against rabbit red blood cells.,Unknown,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",,,,,,,,
363,DRAMP01734,FFPIVGKLLFGLFGLL,16,"Temporin-ALg (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops loloensis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Temporin-ALg exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2.5 μg/mL), Bacillus pumilus (MIC=2.5 μg/mL), Bacillus cereus (MIC=30 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=5 μg/mL), Bacillus dysenteriae (MIC=10 μg/mL), Acinetobacter calcoaceticus (MIC=30 μg/mL), Psecdomonas aeruginosa (MIC=7.5 μg/mL);##Yeast: Candida albicans ATCC2002 (MIC=1.25 μg/mL).",[Ref:19843479]16% hemolytic activity at 100 μg/mL against rabbit red blood cells.,Unknown,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",,,,,,,,
364,DRAMP01735,FLPIVGKLLSGLSGLS,16,"Temporin-ALh (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops loloensis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Temporin-ALh exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2.5 μg/mL), Bacillus pumilus (MIC=7.5 μg/mL), Bacillus cereus (MIC=75 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=5 μg/mL), Bacillus dysenteriae (MIC=20 μg/mL), Acinetobacter calcoaceticus (MIC=60 μg/mL), Psecdomonas aeruginosa (MIC=2.5 μg/mL);##Yeast: Candida albicans ATCC2002 (MIC=2.5 μg/mL).",[Ref:19843479]13% hemolytic activity at 100 μg/mL against rabbit red blood cells.,Unknown,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",,,,,,,,
365,DRAMP01736,FFPIVGKLLSGLL,13,"Temporin-ALi (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops loloensis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Temporin-ALi exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=7.5 μg/mL), Bacillus pumilus (MIC=7.5 μg/mL), Bacillus cereus (MIC=75 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=7.5 μg/mL), Bacillus dysenteriae (MIC=20 μg/mL), Acinetobacter calcoaceticus (MIC=60 μg/mL), Psecdomonas aeruginosa (MIC=5 μg/mL);##Yeast: Candida albicans ATCC2002 (MIC=5 μg/mL).",[Ref:19843479]21% hemolytic activity at 100 μg/mL against rabbit red blood cells,Unknown,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",,,,,,,,
366,DRAMP01737,FFPIVGKLLFGLL,13,"Temporin-ALj (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops loloensis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Temporin-ALg exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=7.5 μg/mL), Bacillus pumilus (MIC=15 μg/mL), Bacillus cereus (MIC=75 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=15 μg/mL), Bacillus dysenteriae (MIC=30 μg/mL), Acinetobacter calcoaceticus (MIC=60 μg/mL), Psecdomonas aeruginosa (MIC=7.5 μg/mL);##Yeast: Candida albicans ATCC2002 (MIC=5 μg/mL).",[Ref:19843479]19% hemolytic activity at 100 μg/mL against rabbit red blood cells.,Unknown,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",,,,,,,,
367,DRAMP01738,FFPIVGKLLS,10,"Temporin-ALk (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops loloensis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Temporin-ALk exhibits hemolytic activity against rabbit red blood cells.,"[Ref.19843479]Gram-positive bacterium: Staphylococcus aureus ATCC2592 (MIC=15 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=30 μg/mL), Bacillus dysenteriae (MIC=60 μg/mL), Acinetobacter calcoaceticus (MIC=75 μg/mL), Psecdomonas aeruginosa (MIC=25 μg/mL);##Yeast: Candida albicans ATCC2002 (MIC=15 μg/mL).",[Ref:19843479]25% hemolytic activity at 100 μg/mL against rabbit red blood cells.,Unknown,19843479,Comp Biochem Physiol B Biochem Mol Biol. 2010 Jan;155(1):72-76.,"Wang M, Wang Y, Wang A, Song Y, Ma D, Yang H, Ma Y, Lai R.","Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis.",,,,,,,,
368,DRAMP01739,LLPIVGNLLKSLL,13,"Temporin-B (Frogs, amphibians, animals)",P79874,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana temporaria (European common frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,Function: Antimicrobial activity against the Gram-positive bacteria. Tissue specificity: Expressed by the skin glands. PTM: Leucine amide at position 13.,"Gram-positive bacteria: Bacillus megaterium BM11 (MIC=2.8 μg/ml), Staphylococcus aureus Cowanl (MIC=6.0 μg/ml), Streptococcus pyogenes betahemolytic group A (MIC=7.0 μg/ml);##Gram-negative bacteria: Escherichia coli D21(MIC=21.0 μg/ml), Yersinia pseudotuberculosis (MIC=7.0 μg/ml), Pseudomonas aeruginosa ATCC15692 (MIC>360 μM).##Yeast: Candida albicans (MIC=4.0 μg/ml).",Unknown,Unknown,9022710,Eur J Biochem. 1996 Dec 15;242(3):788-792.,"Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni M.L, Barra D.","Temporins, antimicrobial peptides from the European red frog Rana temporaria",,,,,,,,
372,DRAMP01753,FVDLKKIANIINSIFGK,17,"Temporin-1CEa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana chensinensis (Chinese brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix ,Unknown,Unknown,Function: Temporin-1CEa exhibits the greatest ability to inhibit the growth of MCF-7 cells. Also temporin-1CEa shows hemolytic effect to human erythrocytes and has no significant cytotoxicity to normal HUVSMCs at concentrations showed potent antitumor activity. ,"[Ref.21871946]Gram-positive bacteria: Staphylococcus aureus (MIC=14.4 μM), Bacillus cereus (MIC=14.4 μM), Streptococcus lactis (MIC=14.4 μM);##Gram-negative bacterium: Escherichia coli (MIC>100 μM).",[Ref:21871946]LD50=99.08 μM against human erythrocytes,Unknown,21871946##19341344,Biochimie. 2012 Feb;94(2):434-441.##Zoolog Sci. 2009 Mar;26(3):220-326.,"Wang C, Li HB, Li S, Tian LL, Shang DJ.##Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y.","Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis).##Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis.",,,,,,,,
373,DRAMP01754,ILPILSLIGGLLGK,14,"Temporin-1CEb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana chensinensis (Chinese brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus (MIC=41 μM), Bacillus cereus (MIC=41 μM), Streptococcus lactis (MIC=41 μM);##Gram-negative bacterium: Escherichia coli (MIC>100 μM).",Unknown,Unknown,19341344,Zoolog Sci. 2009 Mar;26(3):220-226.,"Shang D, Yu F, Li J, Zheng J, Zhang L, Li Y.","Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis.",,,,,,,,
374,DRAMP01755,FLGALAKIISGIF,13,"Temporin-1TSa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana tsushimensis (Tsushima brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=4 μM);##Gram-negative bacterium: Escherichia coli (MIC>100 μM).,Unknown,Unknown,16413829,Comp Biochem Physiol C Toxicol Pharmacol. 2006 May;143(1):42-49. ,"Conlon JM, Al-Ghaferi N, Abraham B, Sonnevend A, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.",Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis.,,,,,,,,
376,DRAMP01764,FLPILGKLLSGIL,13,"Temporin-1TGa (Frogs, amphibians, animals)",Q2PGA8,Belongs to the frog skin active peptide family (Brevinin subfamily),tmpTGa,Rana tagoi (Tago frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=15 μM);##Gram-negative bacterium: Escherichia coli (MIC>100 μM).##Yeast: Candida albicans.,Unknown,Unknown,12804591##16675060,Biochem Biophys Res Commun. 2003 Jun 27;306(2):496-500.##Peptides. 2006 Sep;27(9):2124-2128.,"Conlon JM, Sonnevend A, Patel M, Camasamudram V, Nowotny N, Zilahi E, Iwamuro S, Nielsen PF, Pál T.##Iwamuro S, Nakamura M, Ohnuma A, Conlon JM.","A melittin-related peptide from the skin of the Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties.##Molecular cloning and sequence analyses of preprotemporin mRNAs containing premature stop codons from extradermal tissues of Rana tagoi.",,,,,,,,
377,DRAMP01765,AVDLAKIANKVLSSLF,16,"Temporin-1TGb (Frogs, amphibians, animals)",Q2PGA7,Belongs to the frog skin active peptide family (Brevinin subfamily),tmpTGb,Rana tagoi (Tago frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC>150 μM);##Gram-negative bacterium: Escherichia coli (MIC=37.5 μM).,Unknown,Unknown,16675060,Peptides. 2006 Sep;27(9):2124-2128.,"Iwamuro S, Nakamura M, Ohnuma A, Conlon JM.",Molecular cloning and sequence analyses of preprotemporin mRNAs containing premature stop codons from extradermal tissues of Rana tagoi.,,,,,,,,
378,DRAMP01766,FLPVILPVIGKLLSGIL,17,"Temporin-1TGc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana tagoi (Tago's brown frog); also Rana sakuraii,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=37.5 μM);##Gram-negative bacterium: Escherichia coli (MIC>150 μM).,Unknown,Unknown,16675060,Peptides. 2006 Sep;27(9):2124-2128.,"Iwamuro S, Nakamura M, Ohnuma A, Conlon JM.",Molecular cloning and sequence analyses of preprotemporin mRNAs containing premature stop codons from extradermal tissues of Rana tagoi.,,,,,,,,
381,DRAMP01771,FLPLLASLFSRLL,13,"Temporin-1Oa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana ornativentris (Japanese mountain brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=70 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=2 μM).,Unknown,Unknown,17147973,Peptides. 2007 Mar;28(3):524-532.,"Ohnuma A, Conlon JM, Yamaguchi K, Kawasaki H, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.",Antimicrobial peptides from the skin of the Japanese mountain brown frog Rana ornativentris: evidence for polymorphism among preprotemporin mRNAs.,,,,,,,,
383,DRAMP01775,FLSGIVGMLGKLFGK,15,"Temporin-1Sa (Frogs, amphibians, animals)",B3KYH4,Belongs to the frog skin active peptide family (Brevinin subfamily),preproTemp-1Sa,Pelophylax saharicus (Sahara frog) (Rana saharica),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Activity against Gram-positive and Gram-negative bacteria, and has hemolytic activity against human erythrocytes.","[Ref.18584916]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=3 μM), Enterococcus faecalis ATCC 29212 (MIC=10 μM), Bacillus megaterium (MIC=2 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10 μM), Escherichia coli ATCC 35218 (MIC=10 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=31 μM);##Fungi: Candida albicans ATCC 90028 (MIC=16 μM), Candida parapsilosis ATCC 22019 (MIC=31 μM), Saccharomyces cerevisiae (MIC=8 μM).",[Ref:18584916]LC50=25 μM against human erythrocytes,Unknown,18584916,Peptides. 2008 Sep;29(9):1526-1523.,"Abbassi F, Oury B, Blasco T, Sereno D, Bolbach G, Nicolas P, Hani K, Amiche M, Ladram A","Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica.",,,,,,,,
384,DRAMP01776,FLPIVTNLLSGLLGK,15,"Temporin-1Sb (Temporin-SHb; Frogs, amphibians, animals)",B3KYH5,Belongs to the frog skin active peptide family (Brevinin subfamily),preproTemp-1Sb,Pelophylax saharicus (Sahara frog) (Rana saharica),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Activity against Gram-positive and Gram-negative bacteria, and has strong hemolytic activity against human erythrocytes.","[Ref.18584916]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=58 μM), Enterococcus faecalis ATCC 29212 (MIC>116 μM), Bacillus megaterium (MIC=46 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=231 μM), Escherichia coli ATCC 35218 (MIC>116 μM);##Fungi: Aspergillus flavus (MIC=58 μM).",[Ref:18584916]LC50>116 μM against human erythrocytes,Unknown,18584916,Peptides. 2008 Sep;29(9):1526-1523.,"Abbassi F, Oury B, Blasco T, Sereno D, Bolbach G, Nicolas P, Hani K, Amiche M, Ladram A","Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica.",,,,,,,,
385,DRAMP01777,FLSHIAGFLSNLFGK,15,"Temporin-1Sc (Temporin-SHc; Frogs, amphibians, animals)",B3KYH6,Belongs to the frog skin active peptide family (Brevinin subfamily),preproTemp-1Sc,Pelophylax saharicus (Sahara frog) (Rana saharica),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Alpha helix,Unknown,Unknown,"Function: Activity against a range of Gram-positive and Gram-negative bacteria, and has hemolytic activity against human erythrocytes.","[Ref.18584916]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=10 μg/ml), Enterococcus faecalis ATCC 29212 (MIC>80 μg/ml), Bacillus megaterium (MIC=4 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=161 μg/ml), Escherichia coli ATCC 35218 (MIC>80 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC>161 μg/ml);##Fungi: Aspergillus flavus (MIC=10 μg/ml), Candida albicans ATCC 90028 (MIC=20 μg/ml), Candida parapsilosis ATCC 22019 (MIC=20 μg/ml), Saccharomyces cerevisiae (MIC=10 μg/ml).",[Ref:18584916]LC50>80 μM against human erythrocytes,Unknown,18584916,Peptides. 2008 Sep;29(9):1526-1523.,"Abbassi F, Oury B, Blasco T, Sereno D, Bolbach G, Nicolas P, Hani K, Amiche M, Ladram A","Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica.",,,,,,,,
386,DRAMP01779,FFFLSRIFGK,10,"Temporin-SHf (Frogs, amphibians, animals)",D4YWD1,Belongs to the frog skin active peptide family (Brevinin subfamily),preproTemp-SHf,Pelophylax saharicus (Sahara frog) (Rana saharica),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 μM);##Gram-negative bacterium: Escherichia coli (MIC=25-200 μM).,Unknown,Unknown,20308076,J Biol Chem. 2010 May 28;285(22):16880-16892.,"Abbassi F, Lequin O, Piesse C, Goasdoue N, Foulon T, Nicolas P, Ladram A.","Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide.",,,,,,,,
387,DRAMP01780,FLSGIVGMLGKLF,13,"Temporin-SHa (Temporin-1Sa; Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Pelophylax saharica (North Africa),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus (MIC=3 μM), Bacillus megaterium (MIC=2 μM);##Gram-negative bacterium: Escherichia coli (MIC=10 μM).##Yeast: Candida albicans (MIC=16 μM).",Unknown,Unknown,18584916,Peptides. 2008 Sep;29(9):1526-1523.,"Abbassi F, Oury B, Blasco T, Sereno D, Bolbach G, Nicolas P, Hani K, Amiche M, Ladram A.","Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica.",,,,,,,,
390,DRAMP01784,SLSRFLSFLKIVYPPAF,17,"Temporin-LTc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Hylarana latouchii (broad-folded frog),"Antibacterial, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,A mutant of the peptide is also HIV inhibitory (Wang G et al. 2010 Antimicrob. Agents Chemother. 54: 1343-1346).,"Gram-positive bacteria: Staphylococcus aureus (MIC=50 μg/ml), Bacillus subtilis (MIC=50 μg/ml);##Gram-negative bacterium: Pseudomonas fluorescens (MIC=100 μg/ml).",Unknown,Unknown,19022312,Peptides. 2009 Feb;30(2):273-282.,"Wang H, Lu Y, Zhang X, Hu Y, Yu H, Liu J, Sun J.","The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae).",,,,,,,,
391,DRAMP01785,IPPFIKKVLTTVF,13,"Temporin-CPa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Lithobates capito (New World frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: For this series of peptides, there were not enough material for antimicrobial assays. It displayed hemolytic activity (human red blood cells) at LC50=220 uM. ",[Ref.19635516]Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=25 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=50 μM);##Yeast: Candida albicans ATCC 90028 (MIC=25 μM).,[Ref:19635516]LC50=220 μM against human erythrocytes,Unknown,19635516,Peptides. 2009 Oct;30(10):1775-1781.,"Conlon JM, Meetani MA, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.",Antimicrobial peptides from the skin secretions of the New World frogs Lithobates capito and Lithobates warszewitschii (Ranidae).,,,,,,,,
392,DRAMP01787,AILTTLANWARKFL,14,"Temporin-HN1 (Frogs, amphibians, animals)",E7EKD0,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana hainanensis (Hainan odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has hemolytic activity against washed human erythrocytes (IC50=75 μM).,"[Ref.22450466]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=37.5 μM), Staphylococcus carnosus KHS (MIC=37.5 μM), Bacillus licheniformis X39 (MIC=19 μM), Rhodococcus rhodochrous X15 (MIC=4.8 μM);##Gram-negative bacteria: Psychrobacter faecalis X29 (MIC=75 μM);##Fungi: Slime mould 090223 (MIC=19 μM), Candida albicans ATCC2002 (MIC=75 μM).",[Ref:22450466]IC50=75 μM against washed human erythrocytes,Unknown,22450466,Peptides. 2012 Jun;35(2):285-290. ,"Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.","Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",,,,,,,,
393,DRAMP01788,NILNTIINLAKKIL,14,"Temporin-HN2 (Frogs, amphibians, animals)",E7EKD4,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana hainanensis (Hainan odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=4.8 μM), Staphylococcus carnosus KHS (MIC=19 μM), Bacillus licheniformis X39 (MIC=19 μM),Rhodococcus rhodochrous X15 (MIC=2.4 μM);##Gram-negative bacterium: Psychrobacter faecalis X29 (MIC=37.5 μM).##Fungi: Slime mould 090223 (MIC=9.5 μM) and Candida albicans ATCC2002 (MIC=9.5 μM).",Unknown,Unknown,22450466,Peptides. 2012 Jun;35(2):285-290. ,"Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.","Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",,,,,,,,
394,DRAMP01789,FLSSIGKILGNLL,13,"Temporin-1Va (Temporin 1Va; Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana virgatipes (Ranidae) (Aquarana),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: It also has weak hemolytic activty.,"[Ref.15996769]Gram-positive bacteria: Staphylococcus aureus NCTC8325 (MIC=10 μM), S. aureus (MRSA) T7/20 (MIC=20 μM), S. epidermidis RP62A (MIC=20 μM), Enterococcus faecalis ATCC 29212 (MIC=40 μM), Streptococcus group B HNTCC 80130 (MIC=20 μM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=40 μM), Klebsiella pneumoniae KK3 9904 (MIC=80 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=160 μM), Enterobacter cloacae HNTCC 53001 (MIC=40 μM);##Yeast: Candida albicans ATCC 90028 (MIC=160 μM).",[Ref:15996769]LD50=120 μM against washed human erythrocytes,Unknown,15996769,Regul Pept 2005; 131: 38-45.,Conlon JM et al Bevier CR.,"Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). ",,,,,,,,
396,DRAMP01791,FLPLVTMLLGKLF,13,"Temporin-1Vc (Temporin 1Vc; Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana virgatipes (Ranidae) (Aquarana),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: It also has weak hemolytic activty.,"[Ref.15996769]Gram-positive bacteria: Staphylococcus aureus NCTC8325 (MIC=5 μM), S. aureus (MRSA) T7/20 (MIC=10 μM), S. epidermidis RP62A (MIC=10 μM), Enterococcus faecalis ATCC 29212 (MIC=40 μM), Streptococcus group B HNTCC 80130 (MIC=40 μM);##Gram-negative bacteria: Klebsiella pneumoniae KK3 9904 (MIC=80 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=160 μM), Enterobacter cloacae HNTCC 53001 (MIC=40 μM).",[Ref:15996769]LD50=30 μM against washed human erythrocytes,Unknown,15996769,Regul Pept 2005; 131: 38-45.,Conlon JM et al Bevier CR.,"Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). ",,,,,,,,
397,DRAMP01807,FLPLVLGALSGILPKIL,17,"Temporin-RN1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana nigrovittata,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=4.69 μg/ml);##Gram-negative bacterium: Pseudomonas aeruginosa PAO1 (MIC=4.7 μg/ml).,Unknown,Unknown,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",,,,,,,,
398,DRAMP01808,FFPLLFGALSSHLPKLF,17,"Temporin-RN3 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana nigrovittata,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=3.75 μg/ml);##Gram-negative bacterium: Pseudomonas aeruginosa PAO1 (MIC=3.75 μg/ml).,Unknown,Unknown,19778602,Genomics. 2010 Jan;95(1):66-71. ,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",,,,,,,,
399,DRAMP01811,FLKPLFNAALKLLP,14,"Temporin-Ra (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana ridibunda (marsh frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"At 60 ug/ml, the peptide showed about 1.3% hemolysis.","Gram-negative bacteria: Escherichia coli (MIC=24.2 μg/ml), Klebsiella pneumoniae PTCC 1388 (MIC=31.2 μg/ml);##Gram-positive bacteria: Streptococcus dysgalactiae PTCC 1074 (MIC=33.2 μg/ml), Streptococcus agalactiae PTCC 1365 (MIC=24.7 μg/ml) and Staphylococcus aureus PTCC 1431 (MIC=35.2 μg/ml).",Unknown,Unknown,21956830,J Pept Sci. 2012 Jan;18(1):10-16.,"Asoodeh A, Zardini HZ, Chamani J.","Identification and characterization of two novel antimicrobial peptides, temporin-Ra and temporin-Rb, from skin secretions of the marsh frog (Rana ridibunda).",,,,,,,,
400,DRAMP01812,FLPVLAGVLSRA,12,"Temporin-Rb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana ridibunda (marsh frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"At 60 ug/ml, the peptide showed about 1.1% hemolysis. ","Gram-positive bacteria: Streptococcus dysgalactiae PTCC 1074 (MIC=21.8 μg/ml), Streptococcus agalactiae PTCC 1365 (MIC=30.5 μg/ml), Staphylococcus aureus PTCC 1431 (MIC=42.1 μg/ml), Staphylococcus typhimurium (MIC=31.8 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=34.5 μg/ml), Klebsiella pneumoniae PTCC 1388 (MIC=35.1 μg/ml).",Unknown,Unknown,21956830,J Pept Sci. 2012 Jan;18(1):10-16.,"Asoodeh A, Zardini HZ, Chamani J.","Identification and characterization of two novel antimicrobial peptides, temporin-Ra and temporin-Rb, from skin secretions of the marsh frog (Rana ridibunda).",,,,,,,,
402,DRAMP01816,FLPIIGKLLSGLL,13,"Temporin-1CSb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana cascadae (Cascades frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=128 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=8 μM).,Unknown,Unknown,17451843,Peptides 2007; 28: 1268-1274.,"Conlon JM, Al-Dhaheri A, Al-Mutawa E, Al-Kharrge R, Ahmed E, Kolodziejek J, Nowotny N, Nielsen PF, Davidson C.",Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.,,,,,,,,
403,DRAMP01817,FLPLVTGLLSGLL,13,"Temporin-1CSc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana cascadae (Cascades frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC>128 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=64 μM).,Unknown,Unknown,17451843,Peptides 2007; 28: 1268-1274.,"Conlon JM, Al-Dhaheri A, Al-Mutawa E, Al-Kharrge R, Ahmed E, Kolodziejek J, Nowotny N, Nielsen PF, Davidson C.",Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.,,,,,,,,
404,DRAMP01818,NFLGTLVNLAKKIL,14,"Temporin-1CSd (Temporin-1DRb; Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana cascadae (Cascades frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=64 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=16 μM).,Unknown,Unknown,17451843,Peptides 2007; 28: 1268-1274.,"Conlon JM, Al-Dhaheri A, Al-Mutawa E, Al-Kharrge R, Ahmed E, Kolodziejek J, Nowotny N, Nielsen PF, Davidson C.",Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.,,,,,,,,
405,DRAMP01392,GLLSGTSVRGSI,12,"Odorranain-V1 (OdV1; Frogs, amphibians, animals)",A6MBS7,Unknown,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,Function: Odorranain-V1 exhibites moderate antimicrobial activities against all of the tested microbes. Also has hemolytic activity against rabbit red cells,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=36.00 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=18.00 μg/ml), Bacillus subtilis (MIC=18.00 μg/ml).##Yeast: Candida albicans (MIC=9.00 μg/ml).","[Ref.17272268] RCH=23.9 ± 4.7% using rabbit red blood cells. RCH, red cell hemolysis.",Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
406,DRAMP01391,GCSRWIIGIHGQICRD,16,"Odorranain-U1 (OdU1; Frogs, amphibians, animals)",A6MBS4,Unknown,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Odorranain-U1 adopts 60.2% ,Unknown,Function: Odorranain-U1 exhibites moderate antimicrobial activities against all of the tested microbes.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC>100 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=75.00 μg/ml), Bacillus subtilis (MIC=9.37 μg/ml).##Yeast: Candida albicans (MIC=9.37 μg/ml).",Unknown,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
407,DRAMP01832,FLPGLLAGLL,10,"Temporin-Eca (Frogs, amphibians, animals)",C0HJB9,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Euphlyctis cyanophlyctis (Skittering frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity. Has no or very limited (<3%) hemolytic activity at concentrations of 15 μg/ml and 60 μg/ml, respectively.
Tissue specificity: Expressed by the skin glands.","[Swiss_Prot Entry C0HJB9]Gram-negative bacteria: Escherichia coli HP101BA (MIC=12.3 μM), Klebsiella pneumoniae PTCC1388 (MIC=9.8 μM);##Gram-positive bacteria: Micrococcus luteus PTCC1625 (MIC=8.3 μM), Staphylococcus aureus PTCC1431 (MIC=10.6 μM).",[Ref.Int J Pept Res Ther(2012)18;107.]<3% hemolytic activity at 60 μg/ml against human red blood cells,Unknown,PubMed ID is not available,Int. J. Pept. Res. Ther. 2012;18:107-115.,"Asoodeh A, Ghorani-Azam A, Chamani JK.",Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.,,,,,,,,
408,DRAMP01833,RAGLKFPVGRVHRLLR,16,"Buforin-EC (Frogs, amphibians, animals)",C0HJB7,Belongs to the histone H2A family,Unknown,Euphlyctis cyanophlyctis (Skittering frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity. Has no or very limited (<3%) hemolytic activity at concentrations of 15 μg/ml and 60 μg/ml, respectively.
Tissue specificity: Expressed by the skin glands.","[Swiss_Prot Entry C0HJB7]Gram-negative bacteria: Escherichia coli HP101BA (MIC=9.6 μM), Klebsiella pneumoniae PTCC1388 (MIC=10.6 μM);##Gram-positive bacteria: Micrococcus luteus PTCC1625 (MIC=6.0 μM), Staphylococcus aureus PTCC1431 (MIC=8.1 μM).",[Ref.Int J Pept Res Ther(2012)18;107.]<3% hemolytic activity at 60 μg/ml against human red blood cells,Unknown,PubMed ID is not available,Int. J. Pept. Res. Ther. 2012;18:107-115.,"Asoodeh A, Ghorani-Azam A, Chamani JK.",Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.,,,,,,,,
409,DRAMP01834,FLNALKNFAKTAGKRLKSLLN,21,"Cyanophlyctin (Frogs, amphibians, animals)",C0HJB8,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Euphlyctis cyanophlyctis (Skittering frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity. Has no or very limited (<3%) hemolytic activity at concentrations of 15 μg/ml and 60 μg/ml.
Tissue specificity: Expressed by the skin glands.","[Swiss_Prot Entry C0HJB8]Gram-negative bacteria: Escherichia coli HP101BA (MIC=6.4 μM), Klebsiella pneumoniae PTCC1388 (MIC=7.3 μM);##Gram-positive bacteria: Micrococcus luteus PTCC1625 (MIC=4.7 μM), Staphylococcus aureus PTCC1431 (MIC=5.3 μM).",[Ref.Int J Pept Res Ther(2012)18;107.]<3% hemolytic activity at 60 μg/ml against human red blood cells,Unknown,PubMed ID is not available,Int. J. Pept. Res. Ther. 2012;18:107-115.,"oodeh A, Ghorani-Azam A, Chamani JK.",Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.,,,,,,,,
410,DRAMP01840,GFRDVLKGAAKAFVKTVAGHIAN,23,"Ascaphin-1 (Frogs, amphibians, animals)",P0CJ25,Belongs to the ascaphin family,Unknown,Ascaphus truei (Coastal tailed frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Has a very weak hemolytic activity. Tissue specificity: Expressed by the skin glands. PTM: Asparagine amide at position 23.,[Ref.15207717]Gram-negative bacterium: Escherichia coli (MIC=6 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>50 μM).,[Ref.15207717]HC50>200 μM against human erythrocytes,Unknown,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",,,,,,,,
411,DRAMP01842,GFRDVLKGAAKAFVKTVAGHIANI,24,"Ascaphin-3 (Frogs, amphibians, animals)",P0CJ27,Belongs to the ascaphin family,Unknown,Ascaphus truei (Coastal tailed frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Has a very weak hemolytic activity. Tissue specificity: Expressed by the skin glands.,[Ref.15207717]Gram-negative bacterium: Escherichia coli (MIC=6 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>50 μM).,[Ref.15207717]HC50>200 μM against human erythrocytes,Unknown,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",,,,,,,,
412,DRAMP01844,GIKDWIKGAAKKLIKTVASNIANQ,24,"Ascaphin-5 (Frogs, amphibians, animals)",P0CJ29,Belongs to the ascaphin family,Unknown,Ascaphus truei (Coastal tailed frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.,"[Ref.15207717]Gram-negative bacteria: Escherichia coli (MIC=6 μM), Pseudomonas aeruginosa (MIC=13 μM), Enterobacter cloacae (MIC=6 μM), Klebsiella pneumoniae (MIC=13 μM), Proteus mirabilis (MIC>100 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=50 μM), Staphylococcus epidermidis (MIC=13 μM), Enterococcus faecalis (MIC>100 μM), Streptococcus Group B (MIC=6 μM);##Yeast: Candida albicans (MIC=100 μM).",[Ref.15207717]Unknown,Unknown,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",,,,,,,,
413,DRAMP01846,GFKDWIKGAAKKLIKTVASSIANQ,24,"Ascaphin-7 (Frogs, amphibians, animals)",P0CJ31,Belongs to the ascaphin family,Unknown,Ascaphus truei (Coastal tailed frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Has a very weak hemolytic activity. Tissue specificity: Expressed by the skin glands.,[Ref.15207717]Gram-negative bacterium: Escherichia coli (MIC=3 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=25 μM).,[Ref.15207717]HC50>200 μM against human erythrocytes,Unknown,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",,,,,,,,
414,DRAMP01847,GFKDLLKGAAKALVKTVLF,19,"Ascaphin-8 (Frogs, amphibians, animals)",P0CJ32,Belongs to the ascaphin family,Unknown,Ascaphus truei (Coastal tailed frog),"Antibacterial, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antimicrobial peptide that shows similar potency against Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity. Tissue specificity: Expressed by the skin glands. PTM: Phenylalanine amide at position 19.,[Ref.15207717]Gram-negative bacterium: Escherichia coli (MIC=6 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 μM).,[Ref.15207717]HC50=50 μM against human erythrocytes,Cell membrane,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",,,,,,,,
415,DRAMP01849,DSMGAVKLAKLLIDKMKCEVTKAC,24,"Jindongenin-1a (JD1a; Frogs, amphibians, animals)",G3ETQ2,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops jingdongensis (Chinese torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Displays broad-spectrum antibacterial activity against a range of Gram-positive and Gram-negative bacteria. Also displays antifungal activity against C. albicans ATCC 2002. Has hemolytic activity, low cytotoxicity and low antioxidant activity.","[Ref.21816202]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=17 μM), Enterococcus faecalis ATCC29212 (MIC=60 μM), Staphylococcus aureus (IS 10#)(MIC=40 μM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=10 μM), Enterobacter cloacae ATCC13047 (MIC=40 μM), Klebsiella pneumoniae ATCC700603 (MIC=15 μM), Bacillus pyocyaneus CMCCB1010 (MIC=17 μM), Pseudomonas aeruginosa ATCC27853 (MIC=23 μM), Bacillus dysenteriae (MIC=40 μM);##Yeast: Candida albicans ATCC2002 (MIC=60 μM).",[Ref.21816202]IC50=150 μM against washed human erythrocytes,Unknown,21816202,Biochimie. 2012 Feb;94(2):328-334.,"Chen Z, Yang X, Liu Z, Zeng L, Lee W, Zhang Y.","Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis.",,,,,,,,
416,DRAMP01869,FFPIIAGMAAKLIPSLFCKITKKC,24,"Brevinin-1SPa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana septentrionalis (mink frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes.,[Ref.15556063]Gram-negative bacterium: Escherichia coli (MIC=13 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 μM);##Yeast: Candida albicans (MIC=7 μM).,[Ref.15556063]HC50=7 μM against human erythrocytes,Unknown,15556063,Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.,"Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,,,,,,,,
417,DRAMP01870,FLPIIAGMAAKVICAITKKC,20,"Brevinin-1SPb (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana septentrionalis (mink frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes.,[Ref.15556063]Gram-negative bacterium: Escherichia coli (MIC=50 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=13 μM);##Yeast: Candida albicans (MIC=25 μM).,[Ref.15556063]HC50=25 μM against human erythrocytes,Unknown,15556063,Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.,"Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,,,,,,,,
418,DRAMP01872,FFPIIAGMAAKVICAITKKC,20,"Brevinin-1SPd (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana septentrionalis (mink frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes.,[Ref.15556063]Gram-negative bacterium: Escherichia coli (MIC=13 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=3 μM);##Yeast: Candida albicans (MIC=8 μM).,[Ref.15556063]HC50=8 μM against human erythrocytes,Unknown,15556063,Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.,"Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,,,,,,,,
419,DRAMP01873,GIWDTIKSMGKVFAGKILQNL,21,"Brevinin-2-related peptide (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana septentrionalis (mink frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Has inhibitory activity towards reference strains of bacteria and an opportunistic yeast pathogen. Also has hemolytic activity against human erythrocytes.
Sequence similarity: This peptide shows limited structural similarity with the N-terminal region of brevinin-2 peptides previously isolated from R. temporaria skin but lacks the C-terminal cyclic heptapeptide domain associated with this family.
PTM: C-terminal amidation.",[Ref.15556063]Gram-negative bacterium: Escherichia coli (MIC=13 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=25 μM);##Yeast: Candida albicans (MIC=70 μM).,[Ref.15556063]HC50=70 μM against human erythrocytes,Unknown,15556063,Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.,"Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,,,,,,,,
420,DRAMP01875,GLMSLFKGVLKTAGKHIFKNVGGSLLDQAKCKITGEC,37,"Brevinin-2PRa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana pirica (Hokkaido frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: E. coli (MIC=6 μM), P. aeruginosa (MIC=3 μM);##Gram-positive bacterium: S. aureus (MIC=25 μM).",Unknown,Unknown,15003829,Regul Pept. 2004 May 15;118(3):135-141.,"Conlon JM, Sonnevend A, Patel M, Al-Dhaheri K, Nielsen PF, Kolodziejek J, Nowotny N, Iwamuro S, Pál T.","A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",,,,,,,,
421,DRAMP01876,GLMSLFRGGVLKTAGKHIFKNVGGSLLDQAKCKITGEC,38,"Brevinin-2PRb (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana pirica (Hokkaido frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: E. coli (MIC=6 μM), P. aeruginosa (MIC=3 μM);##Gram-positive bacterium: S. aureus (MIC=25 μM).",Unknown,Unknown,15003829,Regul Pept. 2004 May 15;118(3):135-141.,"Conlon JM, Sonnevend A, Patel M, Al-Dhaheri K, Nielsen PF, Kolodziejek J, Nowotny N, Iwamuro S, Pál T.","A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",,,,,,,,
422,DRAMP01877,GLMSVLKGVLKTAGKHIFKNVGGSLLDQAKCKITGQC,37,"Brevinin-2PRd (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana pirica (Hokkaido frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: E. coli (MIC=6 μM), P. aeruginosa (MIC=6 μM);##Gram-positive bacterium: S. aureus (MIC=25 μM).",Unknown,Unknown,15003829,Regul Pept. 2004 May 15;118(3):135-141.,"Conlon JM, Sonnevend A, Patel M, Al-Dhaheri K, Nielsen PF, Kolodziejek J, Nowotny N, Iwamuro S, Pál T.","A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",,,,,,,,
423,DRAMP01878,GLLSVLKGVLKTAGKHIFKNVGGSLLDQAKCKISGQC,37,"Brevinin-2PRe (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana pirica (Hokkaido frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: E. coli (MIC=6 μM), P. aeruginosa (MIC=3 μM);##Gram-positive bacterium: S. aureus (MIC=25 μM).",Unknown,Unknown,15003829,Regul Pept. 2004 May 15;118(3):135-141.,"Conlon JM, Sonnevend A, Patel M, Al-Dhaheri K, Nielsen PF, Kolodziejek J, Nowotny N, Iwamuro S, Pál T.","A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",,,,,,,,
424,DRAMP01879,GAFGDLLKGVAKEAGMKLLNMAQCKLSGKC,30,"Brevinin-2LTa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Hylarana latouchii (Broad-folded frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=2 μM), Bacillus licheniformis X39 (MIC=8 μM), Staphylococcus carnosus KHS (MIC=2 μM), Rhodococcus rhodochrous X15 (MIC=0.5 μM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=32.5 μM), Serratia rubidaea X01 (MIC=130 μM), Pseudomonas aeruginosa 1.50 (MIC=65 μM), Psychrobacter faecalis X29 (MIC=0.5 μM).",Unknown,Unknown,22426384,Biochimie. 2012 Jun;94(6):1317-1326.,"Wang H, Yu Z, Hu Y, Yu H, Ran R, Xia J, Wang D, Yang S, Yang X, Liu J.","Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.",,,,,,,,
425,DRAMP01880,SILDKIKNVALGVARGAGTGILKALLCKLDKSC,33,"Brevinin-2LTb (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Hylarana latouchii (Broad-folded frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=3.8 μM), Bacillus licheniformis X39 (MIC=3.8 μM), Staphylococcus carnosus KHS (MIC=1.9 μM), Rhodococcus rhodochrous X15 (MIC=1.9 μM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=30 μM), Serratia rubidaea X01 (MIC=60 μM), Pseudomonas aeruginosa 1.50 (MIC=30 μM), Psychrobacter faecalis X29 (MIC=1.9 μM).",Unknown,Unknown,22426384,Biochimie. 2012 Jun;94(6):1317-1326.,"Wang H, Yu Z, Hu Y, Yu H, Ran R, Xia J, Wang D, Yang S, Yang X, Liu J.","Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.",,,,,,,,
426,DRAMP01881,GVLDTFKDVAIGVAKGAGTGVLKALLCKLDKSC,33,"Brevinin-2LTc (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Hylarana latouchii (Broad-folded frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=60 μM), Rhodococcus rhodochrous X15 (MIC=30 μM);##Gram-negative bacterium: Psychrobacter faecalis X29 (MIC=15 μM).",Unknown,Unknown,22426384,Biochimie. 2012 Jun;94(6):1317-1326.,"Wang H, Yu Z, Hu Y, Yu H, Ran R, Xia J, Wang D, Yang S, Yang X, Liu J.","Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.",,,,,,,,
427,DRAMP01885,FFGPLIKIATGVLPNLICKALGKC,24,"Brevinin-1TEa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Hylarana temporalis (Indian bronzed frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Showes higher antimicrobial activity against Gram-negative than against Gram-positive bacteria.,"Gram-negative bacteria: E. coli (NCLM 2064) (MIC=30 μg/ml), P. aeruginosa (ATCC 10145) (MIC=150 μg/ml), V. cholerae (PL 91) (MIC=150 μg/ml);##Gram-positive bacteria: B. cereus (NCLM 2156) (MIC=100 μg/ml), S. aureus (ATCC25923) (MIC>150 μg/ml).",Unknown,Unknown,21412958,J Pept Sci. 2011 May;17(5):342-347.,"Reshmy V, Preeji V, Parvin A, Santhoshkumar K, George S.",Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).,,,,,,,,
428,DRAMP01886,GIGSMLLGLAKNVGMSLLNKAQCKISGKC,29,"Brevinin-2TEa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Hylarana temporalis (Indian bronzed frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Showes higher antimicrobial activity against Gram-negative than against Gram-positive bacteria.,"Gram-negative bacteria: E. coli (NCLM 2064) (MIC=40 μg/ml), P. aeruginosa (ATCC 10145) (MIC=100 μg/ml), V. cholerae (PL 91) (MIC=150 μg/ml);##Gram-positive bacteria: B. cereus (NCLM 2156) (MIC>150 μg/ml), S. aureus (ATCC25923) (MIC>150 μg/ml).",Unknown,Unknown,21412958,J Pept Sci. 2011 May;17(5):342-347.,"Reshmy V, Preeji V, Parvin A, Santhoshkumar K, George S.",Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).,,,,,,,,
429,DRAMP01887,GFMGDTLKGIARNAALALMNAAQCKLSGKC,30,"Brevinin-2TEb (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Hylarana temporalis (Indian bronzed frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Showes higher antimicrobial activity against Gram-negative than against Gram-positive bacteria.,"Gram-negative bacteria: E. coli (NCLM 2064) (MIC=20 μg/ml), P. aeruginosa (ATCC 10145) (MIC=40 μg/ml), V. cholerae (PL 91) (MIC=60 μg/ml);##Gram-positive bacteria: B. cereus (NCLM 2156) (MIC=150 μg/ml), S. aureus (ATCC25923) (MIC=40 μg/ml).",Unknown,Unknown,21412958,J Pept Sci. 2011 May;17(5):342-347.,"Reshmy V, Preeji V, Parvin A, Santhoshkumar K, George S.",Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).,,,,,,,,
430,DRAMP01888,FFPTIAGLTKLFCAITKKC,19,"Brevinin-1CHc (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana chiricahuensis,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: E. coli (MIC=80 μM);##Gram-positive bacterium: S. aureus (MIC=20 μM).##Yeast: C. albicans (MIC=20 μM).,Unknown,Unknown,21262304,Peptides. 2011 Apr;32(4):664-669.,"Conlon JM, Mechkarska M, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.",Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,,,,,,,,
431,DRAMP01889,GIGSILGVIAKGLPTLISWIKNR,23,"Brevinin-1TOa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana tagoi okiensis,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: E. coli (MIC=20 μM);##Gram-positive bacterium: S. aureus (MIC=5 μM).##Yeast: C. albicans (MIC=20 μM).,Unknown,Unknown,19799928,Toxicon. 2010 Feb-Mar;55(2-3):430-435.,"Conlon JM, Coquet L, Jouenne T, Leprince J, Vaudry H, Iwamuro S.",Evidence from the primary structures of dermal antimicrobial peptides that Rana tagoi okiensis and Rana tagoi tagoi (Ranidae) are not conspecific subspecies.,,,,,,,,
432,DRAMP01890,FLGAIAGVAAKFLPKVFCFITKKC,24,"Brevinin-1VLa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana vaillanti (Central American frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Brevinin-1VLa showes particularly high growth-inhibitory potency against a Gram-positive microorganism Staphylococcus aureus and the opportunistic yeast pathogen Candida albicans and potent cytolytic activity against both human erythrocytes and HepG2 hepatoma-derived cells. The peptide ia also active against a Gram-negative microorganism Escherichia coli .,Gram-negative bacterium: E. coli (MIC=25 μM);##Gram-positive bacterium: S. aureus (MIC=3 μM).##Yeast: C. albicans (MIC=3 μM).,Unknown,Unknown,19379837,Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.,"Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",,,,,,,,
433,DRAMP01891,FLPVIASVAAKVLPKVFCFITKKC,24,"Brevinin-1VLc (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana vaillanti (Central American frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Brevinin-1VLc showes particularly high growth-inhibitory potency against a Gram-positive microorganism Staphylococcus aureus and the opportunistic yeast pathogen Candida albicans and potent cytolytic activity against both human erythrocytes and HepG2 hepatoma-derived cells. The peptide ia also active against a Gram-negative microorganism Escherichia coli.,Gram-negative bacterium: E. coli (MIC=50 μM);##Gram-positive bacterium: S. aureus (MIC=1.5 μM).##Yeast: C. albicans (MIC=3 μM).,Unknown,Unknown,19379837,Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.,"Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",,,,,,,,
434,DRAMP01892,FLPLIAGVAANFLPKIFCLISKKC,24,"Brevinin-1VLd (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana vaillanti (Central American frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Inhibits the growth of reference strains of S. aureus, E. coli and C. albicans and to lyse human erythrocytes from a healthy donor and HepG2 human hepatoma-derived cells",Gram-negative bacterium: E. coli (MIC>100 μM);##Gram-positive bacterium: S. aureus (MIC=3 μM).##Yeast: C. albicans (MIC=3 μM).,Unknown,Unknown,19379837,Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.,"Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",,,,,,,,
435,DRAMP01893,FLPLIAGVAASILPKIFCFITKKC,24,"Brevinin-1VLe (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana vaillanti (Central American frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Inhibits the growth of reference strains of S. aureus, E. coli and C. albicans and to lyse human erythrocytes from a healthy donor and HepG2 human hepatoma-derived cells",Gram-negative bacterium: E. coli (MIC>100 μM);##Gram-positive bacterium: S. aureus (MIC=3 μM).##Yeast: C. albicans (MIC=3 μM).,Unknown,Unknown,19379837,Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.,"Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",,,,,,,,
436,DRAMP01896,FLSTALKVAANVVPTLFCKITKKC,24,"Brevinin-1CG1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Amolops chunganensis (Chungan torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=9 μM), Bacillus licheniformis X39 (IS) (MIC=75 μM);##Gram-negative bacterium: Escherichia coli (ATCC 25922) (MIC=150 μM).##Fungi: Slime mold 090223 (IS) (MIC=75 μM).",Unknown,Unknown,22951323,Peptides. 2012 Nov;38(1):41-53.,"Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.",Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.,,,,,,,,
437,DRAMP01897,FLPIVAGLAANFLPKIVCKITKKC,24,"Brevinin-1CG2 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Amolops chunganensis (Chungan torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=9 μM), Bacillus licheniformis X39 (IS) (MIC=75 μM), Enterococcus faecalis 981 (MIC=19 μM), Staphylococcus carnosus KHS (IS) (MIC=9 μM), Staphylococcus aureus (ATCC 25923) (MIC=9 μM);##Gram-negative bacteria: Escherichia coli (ATCC 25922) (MIC=150 μM), Psychrobacter faecalis X29 (IS) (MIC=19 μM), Serratia rubidaea X01 (IS) (MIC=19 μM).##Fungi: Slime mold 090223 (IS) (MIC=4.5 μM), Candida albicans (ATCC 10231) (MIC=150 μM).",Unknown,Unknown,22951323,Peptides. 2012 Nov;38(1):41-53.,"Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.",Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.,,,,,,,,
438,DRAMP01898,FLSTLLNVASNVVPTLICKITKKC,24,"Brevinin-1CG3 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Amolops chunganensis (Chungan torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Primarily active against Gram-positive bacteria. Also highly active against Gram-negative P. faecalis X29 and S. rubidaea.,"Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=2.3 μM), Bacillus licheniformis X39 (IS) (MIC=9 μM), Enterococcus faecalis 981 (MIC=75 μM), Staphylococcus carnosus KHS (IS) (MIC=19 μM), Staphylococcus aureus (ATCC 25923) (MIC=19 μM);##Gram-negative bacteria: Escherichia coli (ATCC 25922) (MIC=150 μM), Psychrobacter faecalis X29 (IS) (MIC=4.5 μM), Serratia rubidaea X01 (IS) (MIC=9 μM).##Fungi: Slime mold 090223 (IS) (MIC=9 μM).",Unknown,Unknown,22951323,Peptides. 2012 Nov;38(1):41-53.,"Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.",Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.,,,,,,,,
439,DRAMP01899,FLSTLLNVASKVVPTLFCKITKKC,24,"Brevinin-1CG4 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Amolops chunganensis (Chungan torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=2.3 μM), Bacillus licheniformis X39 (IS) (MIC=9 μM), Enterococcus faecalis 981 (MIC=9 μM), Staphylococcus carnosus KHS (IS) (MIC=9 μM), Staphylococcus aureus (ATCC 25923) (MIC=9 μM);##Gram-negative bacterium: Escherichia coli (ATCC 25922) (MIC=150 μM), Pseudomonas aeruginosa 11053 (IS) (MIC=75 μM), Psychrobacter faecalis X29 (IS) (MIC=9 μM), Serratia rubidaea X01 (IS) (MIC=9 μM).##Fungi: Slime mold 090223 (IS) (MIC=9 μM), Candida albicans (ATCC 10231) (MIC=150 μM).",Unknown,Unknown,22951323,Peptides. 2012 Nov;38(1):41-53.,"Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.",Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.,,,,,,,,
440,DRAMP01900,FLPMLAGLAANFLPKIVCKITKKC,24,"Brevinin-1CG5 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Amolops chunganensis (Chungan torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Primarily active against Gram-positive bacteria, escecially R. rhodochrous. Also highly active against Gram-negative P. faecalis X29 and S. rubidaea.","Gram-positive bacteria: Rhodococcus rhodochrous X15 (MIC=0.6 μM), Bacillus licheniformis X39 (IS) (MIC=2.3 μM), Enterococcus faecalis 981 (MIC=9 μM), Staphylococcus carnosus KHS (IS) (MIC=1.2 μM), Staphylococcus aureus (ATCC 25923) (MIC=9 μM);##Gram-negative bacteria: Escherichia coli (ATCC 25922) (MIC=75 μM), Pseudomonas aeruginosa (CGMCC 1.50) (MIC=75 μM), Pseudomonas aeruginosa 11053 (IS) (MIC=75 μM), Klebsiella pneumoniae 08040724 (IS) (MIC=150 μM), Psychrobacter faecalis X29 (IS) (MIC=9 μM), Serratia rubidaea X01 (IS) (MIC=4.6 μM).##Fungi: Slime mold 090223 (IS) (MIC=4.5 μM), Candida albicans (ATCC 10231) (MIC=437.5 μM).",Unknown,Unknown,22951323,Peptides. 2012 Nov;38(1):41-53.,"Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.",Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.,,,,,,,,
442,DRAMP01910,GVITDALKGAAKTVAAELLRKAHCKLTNSC,30,"Brevinin-2GHb (AMP-2; Frogs, amphibians, animals)",A0AEI5,Belongs to the frog skin active peptide family (Brevinin subfamily),br2GHb,Rana guentheri (Gunther's frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Problely contains one disulfide bond 24-30. ","Gram-positive bacteria: Staphylococcus aureus FDA209P (MIC=16.5 μg/ml), Bacillus subtilis ATCC 6633 (MIC>64 μg/ml);##Gram-negative bacteria: Escherichia coli O111 (MIC=8.2 μg/ml), Escherichia coli ATCC 25922 (MIC=8.2 μg/ml).",Unknown,Unknown,16979798,Peptides. 2006 Dec;27(12):3077-3084.,"Zhou J, McClean S, Thompson A, Zhang Y, Shaw C, Rao P, Bjourson AJ.",Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri.,,,,,,,,
443,DRAMP01911,SIWEGIKNAGKGFLVSILDKVRCKVAGGCNP,31,"Brevinin-2GHc (AMP-4; Frogs, amphibians, animals)",A0AEI6,Belongs to the frog skin active peptide family (Brevinin subfamily),br2GHc,Rana guentheri (Gunther's frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Problely contains one disulfide bond 24-30. ","Gram-positive bacteria: Staphylococcus aureus FDA209P (MIC=9.8 μg/ml), Bacillus subtilis ATCC 6633 (MIC>64 μg/ml);##Gram-negative bacteria: Escherichia coli O111 (MIC=19.6 μg/ml), Escherichia coli ATCC 25922 (MIC=9.8 μg/ml).",Unknown,Unknown,16979798,Peptides. 2006 Dec;27(12):3077-3084.,"Zhou J, McClean S, Thompson A, Zhang Y, Shaw C, Rao P, Bjourson AJ.",Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri.,,,,,,,,
444,DRAMP01913,FLPLLAGLAANFLPKIFCKITKKC,24,"Brevinin-1GRa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana grahami (Asian frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=25 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 μM).,Unknown,Unknown,16621155,Peptides. 2006 Sep;27(9):2111-2117.," Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H. ","Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami. ",,,,,,,,
445,DRAMP01914,GLLDTFKNLALNAAKSAGVSVLNSLSCKLSKTC,33,"Brevinin-2GRa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana grahami (Asian frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=12.5 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=50 μM).##Yeast: Candida albicans (MIC>100 μM).,Unknown,Unknown,16621155##17272268,Peptides. 2006 Sep;27(9):2111-2117.##Mol Cell Proteomics. 2007 May;6(5):882-894. ,"Conlon JM, Al-Ghaferi N, Abraham B, Jiansheng H, Cosette P, Leprince J, Jouenne T, Vaudry H.##Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.","Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.##Anti-infection peptidomics of amphibian skin.",,,,,,,,
446,DRAMP01918,FLPLIAGLAANFLPKIFCAITKKC,24,"Brevinin-1PLb (Frogs, amphibians, animals)",A7WNV3,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana palustris (Pickerel frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity.
Tissue specificity: Expressed by the skin glands.",Gram-positive bacterium: Staphylococcus aureus (MIC=9 μM);##Gram-negative bacterium: Escherichia coli(MIC=26 μM).##Yeast: Candida albicans (MIC=6 μM).,Unknown,Unknown,17698247##11087945,Peptides. 2007 Aug;28(8):1605-1610.##Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Zhou M, Wang L, Owens DE, Chen T, Walker B, Shaw C.##Basir YJ, Knoop FC, Dulka J, Conlon JM.","Rapid identification of precursor cDNAs encoding five structural classes of antimicrobial peptides from pickerel frog (Rana palustris) skin secretion by single step shotgun cloning.##Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
447,DRAMP01919,FLPVIAGVAAKFLPKIFCAITKKC,24,"Brevinin-1PLc (Frogs, amphibians, animals)",A7WNV4,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana palustris (Pickerel frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=4 μM);##Gram-negative bacterium: Escherichia coli(MIC=7 μM).##Yeast: Candida albicans (MIC=8 μM).,Unknown,Unknown,17698247##11087945,Peptides. 2007 Aug;28(8):1605-1610.##Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Zhou M, Wang L, Owens DE, Chen T, Walker B, Shaw C.##Basir YJ, Knoop FC, Dulka J, Conlon JM.","Rapid identification of precursor cDNAs encoding five structural classes of antimicrobial peptides from pickerel frog (Rana palustris) skin secretion by single step shotgun cloning.##Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
448,DRAMP01920,FLPILAGLAAKIVPKLFCLATKKC,24,"Brevinin-1CSa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana cascadae (Cascades frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Brevinin-1CSa was strongly hemolytic against human erythrocytes. ,[Ref.17451843]Gram-negative bacterium: Escherichia coli (MIC=32 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=2 μM).,[Ref.17451843]LD50=5 μM against human erythrocytes,Unknown,17451843,Peptides. 2007 Jun;28(6):1268-1274.,"Conlon JM, Al-Dhaheri A, Al-Mutawa E, Al-Kharrge R, Ahmed E, Kolodziejek J, Nowotny N, Nielsen PF, Davidson C.",Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.,,,,,,,,
450,DRAMP01922,GLFNVFKKVGKNVLKNVAGSLMDNLKCKVSGEC,33,"Brevinin-2SKb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana sakuraii (Japanese brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=3 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>50 μM).,Unknown,Unknown,17174009,Peptides. 2007 Mar;28(3):505-514.,"Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.",Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,,,,,,,,
451,DRAMP01933,GIMDTLKNLAKTAGKGALQSLVKMASCKLSGQC,33,"Brevinin-2Ef (Frogs, amphibians, animals)",P40842,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (Edible frog) (Pelophylax esculentus),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity ",[Swiss_Prot Entry P40842]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.8163497]LC50>100 μM against human erythrocytes,Unknown,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,,,,,,,,
452,DRAMP01934,GILSTIKDFAIKAGKGAAKGLLEMASCKLSGQC,33,"Brevinin-2Ei (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta complex,"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli. No peptide, at concentrations up to 100 μM, inhibited the growth of the fungal pathogen C. albicans.
Sequence similarity: This peptide shows limited amino acid sequence similarity to the homologous exon gene products that encode the N-terminal flanking peptides of preprocaerulein, preproxenopsin, and preprolevitide.",Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=3 μM).,Unknown,Unknown,14499272,Peptides. 2003 Jul;24(7):955-961.,"Ali MF, Knoop FC, Vaudry H, Conlon JM.",Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,,,,,,,,
453,DRAMP01935,GIFLDKLKNFAKGVAQSLLNKASCKLSGQC,30,"Brevinin-2Ej (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta complex,"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli. No peptide, at concentrations up to 100 μM, inhibited the growth of the fungal pathogen C. albicans.
Sequence similarity: This peptide shows limited amino acid sequence similarity to the homologous exon gene products that encode the N-terminal flanking peptides of preprocaerulein, preproxenopsin, and preprolevitide.",Gram-negative bacterium: Escherichia coli (MIC=2 μM).,Unknown,Unknown,14499272,Peptides. 2003 Jul;24(7):955-961.,"Ali MF, Knoop FC, Vaudry H, Conlon JM.",Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,,,,,,,,
454,DRAMP01937,GLGSILGKILNVAGKVGKTIGKVADAVGNKE,31,"CPRF-Ea (caerulein precursor-related fragment; Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana esculenta complex,"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli. No peptide, at concentrations up to 100 μM, inhibited the growth of the fungal pathogen C. albicans.
Sequence similarity: This peptide shows limited amino acid sequence similarity to the homologous exon gene products that encode the N-terminal flanking peptides of preprocaerulein, preproxenopsin, and preprolevitide.",Gram-negative bacterium: Escherichia coli (MIC=4 μM).,Unknown,Unknown,14499272,Peptides. 2003 Jul;24(7):955-961.,"Ali MF, Knoop FC, Vaudry H, Conlon JM.",Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,,,,,,,,
455,DRAMP01938,GLGSFLKNAIKIAGKVGSTIGKVADAIGNKE,31,"CPRF-Eb (caerulein precursor-related fragment; Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana esculenta complex,"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli. No peptide, at concentrations up to 100 μM, inhibited the growth of the fungal pathogen C. albicans.
Sequence similarity: This peptide shows limited amino acid sequence similarity to the homologous exon gene products that encode the N-terminal flanking peptides of preprocaerulein, preproxenopsin, and preprolevitide.",Gram-negative bacterium: Escherichia coli (MIC=5 μM).,Unknown,Unknown,14499272,Peptides. 2003 Jul;24(7):955-961.,"Ali MF, Knoop FC, Vaudry H, Conlon JM.",Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,,,,,,,,
456,DRAMP01939,GLGSFFKNAIKIAGKVGSTIGKVADAIGNKE,31,"CPRF-Ec (caerulein precursor-related fragment; Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana esculenta complex,"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli. No peptide, at concentrations up to 100 μM, inhibited the growth of the fungal pathogen C. albicans.
Sequence similarity: This peptide shows limited amino acid sequence similarity to the homologous exon gene products that encode the N-terminal flanking peptides of preprocaerulein, preproxenopsin, and preprolevitide.",Gram-negative bacterium: Escherichia coli (MIC=4 μM).,Unknown,Unknown,14499272,Peptides. 2003 Jul;24(7):955-961.,"Ali MF, Knoop FC, Vaudry H, Conlon JM.",Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,,,,,,,,
457,DRAMP01940,FLPIIAGVAAKVLPKLFCAITKKC,24,"Brevinin-1CHa (Frogs, amphibians, animals)",A7YJE2,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana chiricahuensis,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,PTM: Contains disulfide bond.,"Gram-negative bacteria: E. coli (MIC=10 μM), K. pneumoniae (MIC=40 μM), P. aeruginosa (MIC=20 μM);##Gram-positive bacterium: S. aureus (MIC=2.5 μM).##Yeast: C. albicans (MIC=2.5 μM).(Ref.2)",Unknown,Unknown,17938991##21262304,J Mol Evol. 2007 Nov;65(5):605-615.##Peptides. 2011 Apr;32(4):664-669.,"Tennessen JA, Blouin MS.##Conlon JM, Mechkarska M, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.",Selection for antimicrobial peptide diversity in frogs leads to gene duplication and low allelic variation.##Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,,,,,,,,
458,DRAMP01941,FLPVIAGLAAKVLPKLFCAITKKC,24,"Brevinin-1CHb (Frogs, amphibians, animals)",A7YJE4,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana chiricahuensis ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,PTM: Contains disulfide bond.,"Gram-negative bacteria: E. coli (MIC=10 μM), K. pneumoniae (MIC=40 μM), P. aeruginosa (MIC=10 μM);##Gram-positive bacterium: S. aureus (MIC=2.5 μM).##Yeast: C. albicans (MIC=2.5 μM).(Ref.2)",Unknown,Unknown,17938991##21262304,J Mol Evol. 2007 Nov;65(5):605-615.##Peptides. 2011 Apr;32(4):664-669.,"Tennessen JA, Blouin MS.##Conlon JM, Mechkarska M, Coquet L, Jouenne T, Leprince J, Vaudry H, Kolodziejek J, Nowotny N, King JD.",Selection for antimicrobial peptide diversity in frogs leads to gene duplication and low allelic variation.##Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,,,,,,,,
459,DRAMP01942,FLPAIVGAAGQFLPKIFCAISKKC,24,"Brevinin-1Sa (Frogs, amphibians, animals)",P82904,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana sphenocephala (Southern leopard frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=55 μM).,Unknown,Unknown,10604597,J Pept Res. 1999 Dec;54(6):522-527.,"Conlon JM, Halverson T, Dulka J, Platz JE, Knoop FC.","Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala.",,,,,,,,
460,DRAMP01943,FLPAIVGAAGKFLPKIFCAISKKC,24,"Brevinin-1Sb (Frogs, amphibians, animals)",P82905,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana sphenocephala (Southern leopard frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=17 μM).,Unknown,Unknown,10604597,J Pept Res. 1999 Dec;54(6):522-527.,"Conlon JM, Halverson T, Dulka J, Platz JE, Knoop FC.","Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala.",,,,,,,,
461,DRAMP01944,FFPIVAGVAGQVLKKIYCTISKKC,24,"Brevinin-1Sc (Frogs, amphibians, animals)",P82906,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana sphenocephala (Southern leopard frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=14 μM).,Unknown,Unknown,10604597,J Pept Res. 1999 Dec;54(6):522-527.,"Conlon JM, Halverson T, Dulka J, Platz JE, Knoop FC.","Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala.",,,,,,,,
462,DRAMP01949,FLPAVLRVAAKIVPTVFCAISKKC,24,"Brevinin-1HSa (Frogs, amphibians, animals)",P0C8S7,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana hosii (Hose's rock frog) (Odorrana hosii),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3 μM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=24 μM).,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
463,DRAMP01950,FLPAVLRVAAQVVPTVFCAISKKC,24,"Brevinin-1HSb (Brevinin-1JDb; Frogs, amphibians, animals)",P0C8S8,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana hosii (Hose's rock frog) (Odorrana hosii),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3 μM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC>48 μM).,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
464,DRAMP01951,FMGGLIKAATKIVPAAYCAITKKC,24,"Brevinin-1PTa (Frogs, amphibians, animals)",P0C8T1,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana picturata (Malaysian fire frog) (Hylarana picturata),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3 μM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=24 μM).,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
465,DRAMP01953,GLLDSLKNLAINAAKGAGQSVLNTLSCKLSKTC,33,"Brevinin-2HSa (Frogs, amphibians, animals)",P0C8S9,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana hosii (Hose's rock frog) (Rana hosii),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=18 μM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=36 μM).,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
466,DRAMP01955,GAIKDALKGAAKTVAVELLKKAQCKLEKTC,30,"Brevinin-2PTa (Frogs, amphibians, animals)",P0C8T3,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana picturata (Malaysian fire frog) (Hylarana picturata),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 24-30.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=18 μM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=18 μM).,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
467,DRAMP01956,GFKGAFKNVMFGIAKSAGKSALNALACKIDKSC,33,"Brevinin-2PTb (Frogs, amphibians, animals)",P0C8T4,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana picturata (Malaysian fire frog) (Hylarana picturata),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=9 μM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=9 μM).,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
468,DRAMP01957,GLLDSFKNAMIGIAKSAGKTALNKIACKIDKTC,33,"Brevinin-2PTc (Frogs, amphibians, animals)",P0C8T5,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana picturata (Malaysian fire frog) (Hylarana picturata),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>72 μM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=18 μM).,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
469,DRAMP01959,GFLDSFKNAMIGVAKSVGKTALSTLACKIDKSC,33,"Brevinin-2PTe (Frogs, amphibians, animals)",P0C8T7,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana picturata (Malaysian fire frog) (Hylarana picturata),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=36 μM);##Gram-negative bacterium: Escherichia coli ATCC 25726 (MIC=18 μM).,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
470,DRAMP01963,FLPAIVGAAAKFLPKIFCAISKKC,24,"Brevinin-1BLa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Lithobates blairi (leopard frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans (MIC=6-25 μM).,Unknown,Unknown,19254736,Toxicon. 2009 Jun;53(7-8):699-705.,"Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",,,,,,,,
471,DRAMP01965,FLPIIAGIAAKFLPKIFCTISKKC,24,"Brevinin-1BLc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Lithobates blairi (leopard frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: It shows no hemolytic activity.,[Ref.19254736]Gram-negative bacterium: Escherichia coli (MIC=25 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=1.5 μM);##Yeast: Candida albicans (MIC=3 μM);##Cancer cells HepG2: (LC50=6 μM)..,[Ref.14531844]Non-hemolytic activity against human erythrocytes,Unknown,19254736,Toxicon. 2009 Jun;53(7-8):699-705.,"Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",,,,,,,,
472,DRAMP01968,FLPIIAGAAAKVVEKIFCAISKKC,24,"Brevinin-1Yc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Lithobates yavapaiensis (North American leopard frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=100 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=6 μM).##Yeast: Candida albicans (MIC=6 μM).##cancer cells HepG2 (LC50=14 μM). ,Unknown,Unknown,19254736,Toxicon. 2009 Jun;53(7-8):699-705.,"Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",,,,,,,,
473,DRAMP01969,FLGSLIGAAIPAIKQLLGLKK,21,"Brevinin-1Ja (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana japonica (Japanese brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,It can produced cell death of mammalian COS7 cells (LD50=28 μM).,Gram-positive bacterium: Staphylococcus aureus (MIC=15 μM);##Gram-negative bacterium: Escherichia coli (MIC=119 μM).,Unknown,Unknown,18558801,Zoolog Sci 2008; 25: 487-491.,"Koyama T, Iwamuro S.","Molecular cloning of a cDNA encoding atypical antimicrobial and cytotoxic brevinin-1Ja from the skin of the Japanese brown frog, Rana japonica.",,,,,,,,
474,DRAMP01970,FLPFLLSALPKVFCFFSKKC,20,"Brevinin-1ZHa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana zhenhaiensis (Chinese brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16 μM), Pseudomonas aeruginosa ATCC 9027 (MIC=32 μM).##Yeast: Candida albicans ATCC 2002 (MIC>43 μM).",Unknown,Unknown,22943778,Zoolog Sci. 2012 Sep;29(9):553-558.,"Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.","Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.",,,,,,,,
475,DRAMP01971,FLPLLLSALPSFLCLVFKKC,20,"Brevinin-1ZHb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana zhenhaiensis (Chinese brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=17 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=33 μM), Pseudomonas aeruginosa ATCC 9027 (MIC>44 μM).##Yeast: Candida albicans ATCC 2002 (MIC>44 μM).",Unknown,Unknown,22943778,Zoolog Sci. 2012 Sep;29(9):553-558.,"Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.","Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.",,,,,,,,
476,DRAMP01974,GIMRVFKGVLKTAGKSVAKNVAGSFLDRLKCKISGGC,37,"Brevinin-2ZHa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana zhenhaiensis (Chinese brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=1 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5 μM), Pseudomonas aeruginosa ATCC 9027 (MIC=5 μM).##Yeast: Candida albicans ATCC 2002 (MIC=3 μM).",Unknown,Unknown,22943778,Zoolog Sci. 2012 Sep;29(9):553-558.,"Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.","Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.",,,,,,,,
477,DRAMP01986,SLLGTVKDLLIGAGKSAAQSVLKGLSGKLSKDC,33,"Brevinin-2HS2 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Huia schmackeri (Chinese piebald odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: It shows poor hemolycity activity (LC50=300 uM). ,"Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=19 μM), Bacillus licheniformis X39 (MIC=39 μM), Rhodococcus rhodochrous X15 (MIC=9.5 μM);##Gram-negative bacterium: Psychrobacter faecalis X29 (MIC=9.5 μM).##Fungi: Slime mould 090223 (MIC=37.5 μM), Candida albicans ATCC2002 (MIC=19 μM).",Unknown,Unknown,18423796,Peptides. 2008 Aug;29(8):1456-1460.,"Quan Z, Zhou M, Chen W, Chen T, Walker B, Shaw C.",Novel brevinins from Chinese piebald odorous frog (Huia schmackeri) skin deduced from cloned biosynthetic precursors.,,,,,,,,
478,DRAMP01990,FMGSALRIAAKVLPAALCQIFKKC,24,"Brevinin-1LT1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Hylarana latouchii (Chinese broad-folded frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity against rabbit red blood cells.","[Ref.19340924]Gram-positive bacteria: Staphylococcus aureus (MIC=6.25 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacterium: Pseudomonas fluorescens (MIC=100 μM);##Yeast: Candida albicans (MIC=50 μM).",[Ref.19340924]LC50>200 μg/ml against rabbit red blood cells,Unknown,19340924,Biochimie. 2009 Apr;91(4):540-547.,"Wang H, Yan X, Yu H, Hu Y, Yu Z, Zheng H, Chen Z, Zhang Z, Liu J.","Isolation, characterization and molecular cloning of new antimicrobial peptides belonging to the brevinin-1 and temporin families from the skin of Hylarana latouchii (Anura: Ranidae).",,,,,,,,
479,DRAMP01994,SLLDTFKNLAVNAAKSAGVSVLNALSCKISRTC,33,"Brevinin-2ISa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana ishikawae (Endangered frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,"Gram-negative bacterium: Escherichia coli (MIC=50 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μM), S. aureus (MRSA) (MIC=100 μM), Bacillus subtilis (MIC=12.5 μM).",Unknown,Unknown,21193000,Peptides. 2011 Apr;32(4):670-676. ,"Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.",Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
480,DRAMP01995,SFLTTFKDLAIKAAKSAGQSVLSTLSCKLSNTC,33,"Brevinin-2ISb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana ishikawae (Endangered frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,"Gram-negative bacterium: Escherichia coli (MIC=12.5 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.3 μM), Bacillus subtilis (MIC=25 μM).",Unknown,Unknown,21193000,Peptides. 2011 Apr;32(4):670-676. ,"Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.",Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
481,DRAMP01996,SVLGTVKDLLIGAGKSAAQSVLTTLSCKLSNSC,33,"Brevinin-2ISc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana ishikawae (Endangered frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Escherichia coli (MIC=50 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=25 μM).,Unknown,Unknown,21193000,Peptides. 2011 Apr;32(4):670-676. ,"Iwakoshi-Ukena E, Ukena K, Okimoto A, Soga M, Okada G, Sano N, Fujii T, Sugawara Y, Sumida M.",Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
482,DRAMP02001,FLPLIASLAANFVPKIFCKITKKC,24,"Brevinin-1HN1 (Frogs, amphibians, animals)",E7EKC4,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana hainanensis (Hainan odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antimicrobial activity against Gram-positive bacteria and fungi but has weak or no activity against a range of Gram-negative bacteria except P. faecalis. Has hemolytic activity against human erythrocytes (LC50=75 μM).\\nTissue specificity: Expressed by the skin glands.\\nPTM: Contains one disulfide bond.,"[Ref.22450466]Gram-positive bacteria: Enterococcus faecium 091299 (MIC=19 μM), Enterococcus faecalis 981 (MIC=19 μM), Staphylococcus aureus ATCC2592 (MIC=1.2 μM), Staphylococcus carnosus KHS (MIC=4.8 μM), Bacillus licheniformis X39 (MIC=2.4 μM), Rhodococcus rhodochrous X15 (MIC=1.2 μM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=150 μM), Psychrobacter faecalis X29 (MIC=4.8 μM);##Fungi: Slime mould 090223 (MIC=1.2 μM), Candida albicans ATCC2002 (MIC=2.4 μM).",[Ref.22450466]LC50=75 μM against human erythrocytes,Unknown,22450466,Peptides. 2012 Jun;35(2):285-290.,"Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.","Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",,,,,,,,
483,DRAMP02004,FLPLIASVAANLVPKIFCKITKKC,24,"Brevinin-1V (Frogs, amphibians, animals)","Q2UXV8, E7EKC5",Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana versabilis (Chinese bamboo leaf odorous frog) (Rana versabilis),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against Gram-positive bacteria and fungi but has weak or no activity against a range of Gram-negative bacteria except P. faecalis. Has hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond.","[Ref.22450466]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=19 μM), Bacillus licheniformis X39 (MIC=37.5 μM), Rhodococcus rhodochrous X15 (MIC=9.5 μM), Enterococcus faecium 091299 (MIC=19 μM), E. faecalis 981 (MIC=19 μM);##Gram-negative bacterium: Psychrobacter faecalis X29 (MIC=9.5 μM);##Fungi: Slime mould 090223 (MIC=1.2 μM), Candida albicans ATCC2002 (MIC=19-37.5 μM).",[Ref.22450466]LC50=75 μM against human erythrocytes,Unknown,16139929##22450466,Peptides. 2006 Jan;27(1):42-48.##Peptides. 2012 Jun;35(2):285-290.,"Chen T, Li L, Zhou M, Rao P, Walker B, Shaw C.##Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.","Amphibian skin peptides and their corresponding cDNAs from single lyophilized secretion samples: identification of novel brevinins from three species of Chinese frogs.##Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",,,,,,,,
484,DRAMP02006,GIWDTLKNVGKAVLGKVLENV,21,"Brevinin-2Va (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana virgatipes (Ranidae) (Aquarana),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=12 μM).,Unknown,Unknown,15996769,Regul Pept. 2005 Nov;131(1-3):38-45.,"Conlon JM, Abraham B, Sonnevend A, Jouenne T, Cosette P, Leprince J, Vaudry H, Bevier CR.","Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana). ",,,,,,,,
485,DRAMP02009,FLPVLAGIAAKVVPALFCKITKKC,24,"Brevinin-1 (Frogs, amphibians, animals)",P32423,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana brevipoda porsa (Japanese frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and a very high hemolytic activity.",[Ref.1449472]Gram-positive bacterium: Staphylococcus aureus (MIC=8 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=34 μg/ml).,[Ref.1449472]high hemolytic activity,Unknown,1449472,Biochem Biophys Res Commun. 1992 Nov 30;189(1):184-190.,"Morikawa N, Hagiwara K, Nakajima T.","Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa.",,,,,,,,
486,DRAMP02010,GLLDSLKGFAATAGKGVLQSLLSTASCKLAKTC,33,"Brevinin-2 (Frogs, amphibians, animals)",P32424,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana brevipoda porsa (Japanese frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and a very high hemolytic activity.",[Ref.1449472]Gram-positive bacterium: Staphylococcus aureus (MIC=8 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=4 μg/ml).,[Ref.1449472]high hemolytic activity,Unknown,1449472,Biochem Biophys Res Commun. 1992 Nov 30;189(1):184-190.,"Morikawa N, Hagiwara K, Nakajima T.","Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa.",,,,,,,,
487,DRAMP02019,GLFDVVKGVLKGAGKNVAGSLLEQLKCKLSGGC,33,"Brevinin-2DYb (Frogs, amphibians, animals)",P0C5X2,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 27-33.",Gram-positive bacterium: Staphylococcus aureus (MIC=30 μM);##Gram-negative bacterium: Escherichia coli (MIC=30 μM).,Unknown,Unknown,17688900,Toxicon. 2007 Nov;50(6):746-756.,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.","Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",,,,,,,,
490,DRAMP02023,GIFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC,33,"Brevinin-2DYd (Frogs, amphibians, animals)",P0C5X4,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 27-33.",Gram-positive bacterium: Staphylococcus aureus (MIC=15 μM);##Gram-negative bacterium: Escherichia coli (MIC=15 μM).##NOTE: mixture of Brevinin-2DYc/2DYd,Unknown,Unknown,17688900,Toxicon. 2007 Nov;50(6):746-756.,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.","Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",,,,,,,,
492,DRAMP02025,GLFSVVTGVLKAVGKNVAKNVGGSLLEQLKCKISGGC,37,"Brevinin-2DYe (Brevinin-2CDYa; Frogs, amphibians, animals)",P0C5X5,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Active against the Gram-positive bacteria: S. aureus and Gram-negative bacteria E. coli. Tissue specificity: Expressed by the skin glands. PTM: contains one disulfide bond 31-37.,Gram-positive bacterium: Staphylococcus aureus (MIC=15 μM);##Gram-negative bacterium: Escherichia coli (MIC=30 μM).,Unknown,Unknown,17688900##17698251,Toxicon. 2007 Nov;50(6):746-756.##Peptides. 2007 Aug;28(8):1532-1539.,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.##Kim SS, Shim MS, Chung J, Lim DY, Lee BJ.","Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.##Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.",,,,,,,,
493,DRAMP02026,LLSLALAALPKLFCLIFKKC,20,"Brevinin-1CDYa (Frogs, amphibians, animals)",B3VZU0,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has low activity against the Gram-positive bacteria: S. aureus and Gram-negative bacteria E. coli. Has hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 14-20.",[Swiss_Prot Entry B3VZU0]Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 μM);##Gram-negative bacterium: Escherichia coli (MIC=25 μM),[Ref.19539775]HC50=125 μM against human red blood cells,Unknown,19539775,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",,,,,,,,
495,DRAMP02031,ILPLLLGKVVCAITKKC,17,"Brevinin-1Da (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana dalmatina (European frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Sequence alignment suggests that the peptide is derived from brevinin-1 by multiple residue deletions.,Gram-positive bacterium: Staphylococcus aureus (MIC=7 μM);##Gram-negative bacterium: Escherichia coli (MIC=30 μM).,Unknown,Unknown,15050930,Comp Biochem Physiol C Toxicol Pharmacol. 2004 Feb;137(2):191-196.,"Conlon JM, Seidel B, Nielsen PF.",An atypical member of the brevinin-1 family of antimicrobial peptides isolated from the skin of the European frog Rana dalmatina.,,,,,,,,
496,DRAMP02032,FLGSIVGALASALPSLISKIRN,22,"Brevinin-1TSa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana tsushimensis (Tsushima brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Activity against a range of Gram-positive and Gram-negative bacteria, but hemolytic activity against human erythrocytes.","[Ref.16413829]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=25 μM), Klebsiella pneumoniae KK3 9904 (MIC>100 μM), Enterobacter cloacae HNTCC 53001 (MIC=50 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=50 μM), Proteus mirabilis ATCC 25933 (MIC>100 μM);##Gram-positive bacteria: Staphylococcus aureus NCTC 8325 (MIC=25 μM), Methicillin-resistant Staphylococcus aureus T7/20 (MIC=25 μM), Staphylococcus epidermidis RP62A (MIC=12.5 μM), Enterococcus faecalis ATCC 29212 (MIC=50 μM), Streptococcus group B HNTCC 80130 (MIC=50 μM);##Yeast: Candida albicans ATCC 90028 (MIC=50 μM)",[Ref.16413829]LD50=12 μM against human erythrocytes,Unknown,16413829,Comp Biochem Physiol C Toxicol Pharmacol. 2006 May;143(1):42-49. ,"Conlon JM, Al-Ghaferi N, Abraham B, Sonnevend A, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.",Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis.,,,,,,,,
497,DRAMP02033,GIMSLFKGVLKTAGKHVAGSLVDQLKCKITGGC,33,"Brevinin-2TSa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana tsushimensis (Tsushima brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Activity against a range of Gram-positive and Gram-negative bacteria, but relatively low hemolytic activity against human erythrocytes.","[Ref.16413829]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3 μM), Klebsiella pneumoniae KK3 9904 (MIC=6 μM), Enterobacter cloacae HNTCC 53001 (MIC=6 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=6 μM), Proteus mirabilis ATCC 25933 (MIC>100 μM);##Gram-positive bacteria: Staphylococcus aureus NCTC 8325 (MIC=12.5 μM), Methicillin-resistant Staphylococcus aureus T7/20 (MIC=25 μM), Staphylococcus epidermidis RP62A (MIC=12.5 μM), Enterococcus faecalis ATCC 29212 (MIC=25 μM);##Yeast: Candida albicans ATCC 90028 (MIC=100 μM).",[Ref.16413829]LD50=100 μM against human erythrocytes,Unknown,16413829,Comp Biochem Physiol C Toxicol Pharmacol. 2006 May;143(1):42-49. ,"Conlon JM, Al-Ghaferi N, Abraham B, Sonnevend A, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.",Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis.,,,,,,,,
498,DRAMP02034,FLPILAGLAAKLVPKVFCSITKKC,24,"Brevinin-1AUa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana aurora aurora (Northern red-legged frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Activity against a range of Gram-positive and Gram-negative bacteria, and also shows hemolytic. ","[Ref.15325526]Gram-negative bacteria: Escherichia coli (MIC=13 μM), Pseudomonas aeruginosa (MIC=25 μM), Enterobacter cloacae (MIC=13 μM), Klebsiella pneumoniae (MIC=50 μM), Proteus mirabilis (MIC>50 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3 μM), Staphylococcus epidermidis (MIC=6 μM), Enterococcus faecalis (MIC=13 μM), Streptococcus Group B (MIC=13 μM);##Yeast: Candida albicans (MIC>40 μM).",[Ref.15325526]HC50=5 μM against human erythrocytes,Unknown,15325526,Dev Comp Immunol. 2005;29(1):83-90.,"Conlon JM, Sonnevend A, Davidson C, Demandt A, Jouenne T.",Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.,,,,,,,,
499,DRAMP02035,FLPILAGLAANILPKVFCSITKKC,24,"Brevinin-1AUb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana aurora aurora (Northern red-legged frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Activity against a range of Gram-positive and Gram-negative bacteria, and also shows hemolytic activity. ","[Ref.15325526]Gram-negative bacteria: Escherichia coli (MIC=25 μM), Pseudomonas aeruginosa (MIC=25 μM), Enterobacter cloacae (MIC=25 μM), Klebsiella pneumoniae (MIC>50 μM), Proteus mirabilis (MIC>50 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3 μM), Staphylococcus epidermidis (MIC=6 μM), Enterococcus faecalis (MIC=6 μM), Streptococcus Group B (MIC=13 μM);##Yeast: Candida albicans (MIC=3 μM).",[Ref.15325526]HC50=7 μM against human erythrocytes,Unknown,15325526,Dev Comp Immunol. 2005;29(1):83-90.,"Conlon JM, Sonnevend A, Davidson C, Demandt A, Jouenne T.",Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.,,,,,,,,
500,DRAMP02036,GAFGNFLKGVAKKAGLKILSIAQCKLSGTC,30,"Brevinin-2-RN1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana nigrovittata,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Brevinin-2-RN1 and -RN2 could induce 17 and 21% Rabbit red blood cell hemolysis, respectively.","Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=3.10 μg/ml), Staphylococcus aureus ATCC43300 (MIC=3.10 μg/ml), Bacillus subtilis (MIC=12.5 μg/ml);##Gram-negative bacteria: Escherichia coli ML-35P (MIC=25 μg/ml), Pseudomonas aeruginosa PA01 (MIC=12.5 μg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=25 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=6.25 μg/ml).",Unknown,Unknown,21171145,J Pept Sci. 2011 Jan;17(1):68-72.,"Liu X, Liu R, Wei L, Yang H, Zhang K, Liu J, Lai R.","Two novel antimicrobial peptides from skin secretions of the frog, Rana nigrovittata.",,,,,,,,
501,DRAMP02037,GAFGNFLKGVAKKAGLKILSIAQCKLFGTC,30,"Brevinin-2-RN2 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana nigrovittata,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Brevinin-2-RN1 and -RN2 could induce 17 and 21% Rabbit red blood cell hemolysis, respectively.","Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=6.25 μg/ml), Staphylococcus aureus ATCC43300 (MIC=6.25 μg/ml), Bacillus subtilis (MIC=12.5 μg/ml);##Gram-negative bacteria: Escherichia coli ML-35P (MIC=50 μg/ml), Pseudomonas aeruginosa PA01 (MIC=12.5 μg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=12.5 μg/ml). Yeast: Candida albicans ATCC2002 (MIC=3.1 μg/m).",Unknown,Unknown,21171145,J Pept Sci. 2011 Jan;17(1):68-72.,"Liu X, Liu R, Wei L, Yang H, Zhang K, Liu J, Lai R.","Two novel antimicrobial peptides from skin secretions of the frog, Rana nigrovittata.",,,,,,,,
502,DRAMP02038,VIVFVASVAAEMMQHVYCAASKKC,24,"Brevinin-1-OA1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12.4 μg/ml);##Gram-negative bacteria: Bacillus pyocyaneus CMCCB 10104 (MIC=12.4 μg/ml), Escherichia coli ATCC 25922 (MIC=6.2 μg/ml).##Yeast: Candida albicans (MIC=24.8 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
504,DRAMP02040,FLPAVIRVAANVLPTAFCAISKKC,24,"Brevinin-1-OA12 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.6 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.6 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=13.2 μg/ml).##Yeast: Candida albicans (MIC=3.3 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
505,DRAMP02041,LPFVAGVAAEMMQHVYCAASKKC,23,"Brevinin-1-OR1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.3 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=42.4 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10.6 μg/ml).##Yeast: Candida albicans (MIC=10.6 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
506,DRAMP02042,IDPFVAGVAAEMMQHVYCAASKKC,24,"Brevinin-1-OR3 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=9.1 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=18.2 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=18.2 μg/ml).##Yeast: Candida albicans (MIC=18.2 μg/ml). ",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
507,DRAMP02043,INPFVAGVAAEMMQHVYCAASKKC,24,"Brevinin-1-OR4 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8.6 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=8.6 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=8.6 μg/ml).##Yeast: Candida albicans (MIC=8.6 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
508,DRAMP02044,ILPFVAGVAAEMMKHVYCAASKKC,24,"Brevinin-1-OR5 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,It differs from AP1824 only at position 14: Q vs. K.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=30.4 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=15.2 μg/ml).##Yeast: Candida albicans (MIC=7.6 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
509,DRAMP02045,IIPFVAGVAAEMMEHVYCAASKKC,24,"Brevinin-1-OR6 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,It differs from AP1827 at two positions: 2: I vs. L and 14: K vs. E.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.1 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=22.2 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=22.2 μg/ml).##Yeast: Candida albicans (MIC=11.1 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
510,DRAMP02046,QLPFVAGVACEMCQCVYCAASKKC,24,"Brevinin-1-OR7 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.7 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=5.7 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11.4 μg/ml).##Yeast: Candida albicans (MIC=11.4 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
511,DRAMP02047,ILPFVAGVAAEMMEHVYCAASKKC,24,"Brevinin-1-OR8 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=13.1 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=52.4 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=26.2 μg/ml).##Yeast: Candida albicans (MIC=13.1 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
512,DRAMP02048,ILPFVAGVAAMEMEHVYCAASKKC,24,"Brevinin-1-OR9 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=9.8 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=9.8 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=4.9 μg/ml).##Yeast: Candida albicans (MIC=9.8 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
513,DRAMP02049,FLPAVLLVATHVLPTVFCAITRKC,24,"Brevinin-1-OR10 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.4 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=27.2 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.8 μg/ml).##Yeast: Candida albicans (MIC=6.8 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
514,DRAMP02050,LAFVAGVAAEMMQHVYCAASKKC,23,"Brevinin-1-OR11 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=12.4 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12.4 μg/ml).##Yeast: Candida albicans (MIC=12.4 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
515,DRAMP02051,ILPFVAGVAAEMMQHVYCAASKKC,24,"Lividin-1 (Brevinin-1-OR2; Frogs, amphibians, animals)",Q2UXR4,Belongs to the frog skin active peptide family (Brevinin subfamily),lividin-1,Odorrana rotodora (Chinese odorous frog) (Odorrana livida),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains disulfide bond.","Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.8 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=11.6 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11.6 μg/ml).##Yeast: Candida albicans (MIC=5.8 μg/ml).",Unknown,Unknown,16713657##22029824,Peptides. 2006 Sep;27(9):2118-2123.##J Proteome Res. 2012 Jan 1;11(1):306-319.,"Zhou M, Chen T, Walker B, Shaw C.##Yang X, Lee WH, Zhang Y.","Lividins: novel antimicrobial peptide homologs from the skin secretion of the Chinese Large Odorous frog, Rana (Odorrana) livida. Identification by shotgun cDNA cloning and sequence analysis.##Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.",,,,,,,,
516,DRAMP02052,SFLDTLKNLAISAAKGAGQSVLSTLSCKLSKTC,33,"Lividin-2 (Brevinin-2-OR8; Frogs, amphibians, animals)",Q2UXR3,Belongs to the frog skin active peptide family (Brevinin subfamily),lividin-2,Odorrana rotodora (Chinese odorous frog) (Odorrana livida),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains disulfide bond.","Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=13.1 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=13.1 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=13.1 μg/ml).##Yeast: Candida albicans (MIC=13.1 μg/ml).",Unknown,Unknown,16713657##22029824,Peptides. 2006 Sep;27(9):2118-2123.##J Proteome Res. 2012 Jan 1;11(1):306-319.,"Zhou M, Chen T, Walker B, Shaw C.##Yang X, Lee WH, Zhang Y.","Lividins: novel antimicrobial peptide homologs from the skin secretion of the Chinese Large Odorous frog, Rana (Odorrana) livida. Identification by shotgun cDNA cloning and sequence analysis.##Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.",,,,,,,,
517,DRAMP02053,SVLGTVKDLLIGAGKSAAQSVLTALSCKLSNSC,33,"Lividin-3 (Brevinin-2-OR1; Frogs, amphibians, animals)",Q2UXR2,Belongs to the frog skin active peptide family (Brevinin subfamily),lividin-3,Odorrana rotodora (Chinese odorous frog) (Odorrana livida),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Amphibian defensive peptide.
Tissue specificity: Expressed by the skin glands.
PTM: Contains disulfide bond.","Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.5 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=22 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11 μg/ml).##Yeast: Candida albicans (MIC=11 μg/ml).",Unknown,Unknown,16713657##22029824,Peptides. 2006 Sep;27(9):2118-2123.##J Proteome Res. 2012 Jan 1;11(1):306-319.,"Zhou M, Chen T, Walker B, Shaw C.##Yang X, Lee WH, Zhang Y.","Lividins: novel antimicrobial peptide homologs from the skin secretion of the Chinese Large Odorous frog, Rana (Odorrana) livida. Identification by shotgun cDNA cloning and sequence analysis.##Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.",,,,,,,,
518,DRAMP02054,GILDTFKNMALNAAKSAGVSVLNALSCKLSKTC,33,"Brevinin-2-OA1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.1 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=12.1 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12.1 μg/ml).##Yeast: Candida albicans (MIC=6.0 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
519,DRAMP02055,GLLDTFKNMALNAAKSAGVSVLNALSCKLSKTC,33,"Brevinin-2-OA2 (Brevinin-2E-OG1; Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Found in multiple species.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=13.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=6.6 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.6 μg/ml).##Yeast: Candida albicans (MIC=6.6 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
520,DRAMP02056,GLLDTFKNMAINAAHGAGVSVLNALSCKLKKTC,33,"Brevinin-2-OA3 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.3 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=12.6 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6.3 μg/ml).##Yeast: Candida albicans (MIC=3.2 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
521,DRAMP02057,GLLDTFKNLAINAAESAGVSVLNSLSCKLSKTC,33,"Brevinin-2-OA4 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=20 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10 μg/ml).##Yeast: Candida albicans (MIC=10 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
522,DRAMP02058,GLLDGILNANFNAAKSAGTSVLNALSCKLSKTC,33,"Brevinin-2-OA5 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30.6 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=30.6 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=30.6 μg/ml).##Yeast: Candida albicans (MIC=30.6 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
523,DRAMP02059,GVLATVKNLLIGTGDGAAQSVLKTLSCKLSNDC,33,"Brevinin-2-OA6 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=44.8 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=22.4 μg/ml).##Yeast: Candida albicans (MIC=11.2 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
524,DRAMP02060,GVLGTVKDLLIGAGKSAAQSTLKTLSCKISNDC,33,"Brevinin-2-OA7 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.8 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=23.2 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=11.6 μg/ml).##Yeast: Candida albicans (MIC=5.8 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
525,DRAMP02061,GVLATVKNLLNGTGDGAAQSVLKTLSCKLSNDC,33,"Brevinin-2-OA8 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana andersonii (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=7.9 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=15.8 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=4.0 μg/ml).##Yeast: Candida albicans (MIC=4.0 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
526,DRAMP02062,GLLDTIKNMALNAAKSAGVSVLNSLSCKLSKTC,33,"Brevinin-2-OR2 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.1 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=6.0 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12.1 μg/ml).##Yeast: Candida albicans (MIC=12.1 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
527,DRAMP02063,GLIDTIKNMALNAAKSAGVSVLNTLSCKLSKTC,33,"Brevinin-2-OR3 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20.6 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=41.2 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=20.6 μg/ml).##Yeast: Candida albicans (MIC=10.3 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
528,DRAMP02064,SVLGTVKDLLIGAGKSAAQSVLTANSCKLSNSC,33,"Brevinin-2-OR4 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.8 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=11.8 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=5.9 μg/ml).##Yeast: Candida albicans (MIC=11.8 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
529,DRAMP02065,SFLDTLKNLAISAAKGAGQSVLSTLSCKLSETC,33,"Brevinin-2-OR5 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=13.2 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=6.6 μg/ml).##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=6.6 μg/ml).##Fungi: Candida albicans (MIC=6.6 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
530,DRAMP02066,GLLDTIKNMALNAAKSAGVSVLNSLSCKDSKTC,33,"Brevinin-2-OR6 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.8 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=11.6 μg/ml).##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=5.8 μg/ml).##Fungi: Candida albicans (MIC=11.6 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
531,DRAMP02067,GLLDTIKNMALNAAKSAGVSVLNTLSCKLSKTC,33,"Brevinin-2-OR7 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8.6 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=8.6 μg/ml).##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=8.6 μg/ml).##Fungi: Candida albicans (MIC=17.2 μg/ml)",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
532,DRAMP02068,SFLSTFKELAINAAKNAGQSILHTLSCKLDKTC,33,"Brevinin-2-OR9 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20.4 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=20.4 μg/ml).##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=10.2 μg/ml).##Fungi: Candida albicans (MIC=5.1 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
533,DRAMP02069,SFLSTFKELAINAAKNAGQSLLHTLSCKLDKTC,33,"Brevinin-2-OR10 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana rotodora (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: It differs from AP1850 only at position 21: L vs. I, so they are predicted to have essentially identical structure and activity.","Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15.8 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=7.9 μg/ml).##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=7.9 μg/ml).##Fungi: Candida albicans (MIC=15.8 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
534,DRAMP02070,SVMGTVKDLLIGAGKSAAQSVLKSLSCKISNDC,33,"Brevinin-2-OW1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana wuchuanensis (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4.7 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=4.7 μg/ml).##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=9.4 μg/ml).##Fungi: Candida albicans (MIC=4.7 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
535,DRAMP02071,SVMGTVKDLLIGAGKSAAQSVLKSLSCKLSNDC,33,"Brevinin-2-OW2 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana wuchuanensis (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.6 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=6.6 μg/ml).##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=3.3 μg/ml).##Fungi: Candida albicans (MIC=3.3 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
536,DRAMP02072,SVMGTVKDLLIGAGKSAAQSVLKALSCKLSKDC,33,"Brevinin-2-OW3 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana wuchuanensis (Chinese odorous frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. ,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10.5 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=21.0 μg/ml).##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10.5 μg/ml).##Fungi: Candida albicans (MIC=10.5 μg/ml).",Unknown,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319. ,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
537,DRAMP02073,FLPAVIRVAANVLPTVFCAISKKC,24,"Brevinin-1JDa (Frogs, amphibians, animals)",B3A0M4,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial and antifungal activity. Has hemolytic activity against rabbit erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bonds.","[Ref.22917879]Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml), S. aureus (MRSA) (MIC=32 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=128 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml).",[Ref.22917879]79.2 ± 6.8% hemolytic activity at 128 μg/mL against rabbit red blood cells,Unknown,22917879,J Proteomics. 2012 Oct 22;75(18):5807-5821.,"Liu J, Jiang J, Wu Z, Xie F.","Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: De novo sequencing and analysis of tandem mass spectrometry data.",,,,,,,,
538,DRAMP02075,FLPAVLRVAAKVVPTVFCLISKKC,24,"Brevinin-1JDc (Frogs, amphibians, animals)",B3A0N0,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana jingdongensis (Jingdong frog) (Rana jingdongensis),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial and antifungal activity. Has hemolytic activity against rabbit erythrocytes.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bonds.","[Ref.22917879]Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml), S. aureus (MRSA) (MIC=8 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=128 μg/ml).",[Ref.22917879]11.7 ± 3.2% hemolytic activity at 64 μg/mL and 88.4 ± 4.2% hemolytic activity at 128 μg/mL against rabbit red blood cells,Unknown,22917879,J Proteomics. 2012 Oct 22;75(18):5807-5821.,"Liu J, Jiang J, Wu Z, Xie F.","Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: De novo sequencing and analysis of tandem mass spectrometry data.",,,,,,,,
543,DRAMP02078,FLPVVAGLAAKVLPSIICAVTKKC,24,"Brevinin-1SY (Frogs, amphibians, animals)",P82871,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana sylvatica (Wood frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MIC=7 μM);##Gram-negative bacterium: Escherichia coli (MIC=45 μM).,Unknown,Unknown,11042268,FEBS Lett. 2000 Oct 20;483(2-3):135-138.,"Matutte B, Storey KB, Knoop FC, Conlon JM.","Induction: of synthesis of an antimicrobial peptide in the skin of the freeze-tolerant frog, Rana sylvatica, in response to environmental stimuli.",,,,,,,,
544,DRAMP02081,FLPLLAGLAANFLPKIFCKITRKC,24,"Brevinin-1E (Frogs, amphibians, animals)",P32412,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (Edible frog) (Pelophylax esculentus),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and a very high hemolytic activity.
Tissue specificity: Expressed by the skin glands.","[Ref.8163497]Gram-negative bacteria: Escherichia coliD21 (MIC=1.8 μM), Pseudomonas aeruginosa ATCC15692 (MIC=30.6 μM);##Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.4 μM), Staphylococcus aureus Cowan1 (MIC=0.6 μM);##Fungi: Candida albicans (MIC=4.7 μM), S. cerevisiae (MIC=3.8 μM).",[Ref.8508915]LC50=0.5 μM against human red blood cells,Unknown,8508915##8163497,FEBS Lett. 1993 Jun 14;324(2):159-161.##J Biol Chem. 1994 Apr 22;269(16):11956-11961. ,"Simmaco M, Mignogna G, Barra D, Bossa F.##Simmaco M, Mignogna G, Barra D, Bossa F.",Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta.##Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,,,,,,,,
545,DRAMP02084,GIMDTLKNLAKTAGKGALQSLLNKASCKLSGQC,33,"Brevinin-2E (Frogs, amphibians, animals)",P32413,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (Edible frog) (Pelophylax esculentus),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.","[Ref.8508915]Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.2 μM), Staphylococcus aureus Cowan 1 (MIC=2.0 μM);##Gram-negative bacteria: Escherichia coli D21 (MIC=0.5 μM), Pseudomonas aeruginosa ATCC 15692 (MIC>30 μM).",[Ref.8508915]LC50>100 μM against human red blood cells ,Unknown,8508915,FEBS Lett. 1993 Jun 14;324(2):159-161.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta.,,,,,,,,
546,DRAMP02101,FLPLLAGVVANFLPQIICKIARKC,24,"Brevinin-1RTa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops ricketti (Chinese sucker frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Brevinin-2RTb has antibacterial activity and hemolytic activity against rabbit red blood cells in vitro.
PTM: Contains one disulfide bond 27-33.","[Ref.22100518]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=6.3 μg/ml), Bacillus licheniformis X39 (MIC=25.0 μg/ml), Rhodococcus rhodochrous X15 (MIC=3.1 μg/ml);##Gram-negative bacteria: Serratia rubidaea X01 (MIC=NA μg/ml), Pseudomonas aeruginosa 1.50 (MIC=NA μg/ml), Psychrobacter faecalis X29 (MIC=12.5 μg/ml).",[Ref.22100518]LD50=100 μg/ml against rabbit red blood cells,Unknown,22100518,Peptides. 2012 Jan;33(1):27-34.,"Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.",Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,,,,,,,,
547,DRAMP02102,FLGSLLGLVGKVVPTLFCKISKKC,24,"Brevinin-1RTb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops ricketti (Chinese sucker frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Brevinin-2RTb has antibacterial activity and hemolytic activity against rabbit red blood cells in vitro.
PTM: Contains one disulfide bond 27-33.","[Ref.22100518]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=3.1 μg/ml), Bacillus licheniformis X39 (MIC=25.0 μg/ml), Staphylococcus carnosus KHS (MIC=12.5 μg/ml), Rhodococcus rhodochrous X15 (MIC=3.1 μg/ml);##Gram-negative bacteria: Psychrobacter faecalis X29 (MIC=12.5 μg/ml)",[Ref.22100518]LD50=200 μg/ml against rabbit red blood cells,Unknown,22100518,Peptides. 2012 Jan;33(1):27-34.,"Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.",Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,,,,,,,,
548,DRAMP02104,GLMSTLKDFGKTAAKEIAQSLLSTASCKLAKTC,33,"Brevinin-2RTa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops ricketti (Chinese sucker frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Brevinin-2RTb has antibacterial activity and hemolytic activity against rabbit red blood cells in vitro.
PTM: Contains one disulfide bond 27-33.","[Ref.22100518]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=12.5 μg/ml), Bacillus licheniformis X39 (MIC=50.0 μg/ml), Staphylococcus carnosus KHS (MIC=6.3 μg/ml), Rhodococcus rhodochrous X15 (MIC=1.6 μg/ml);##Gram-negative bacteria: Serratia rubidaea X01 (MIC=100.0 μg/ml), Psychrobacter faecalis X29 (MIC=6.3 μg/ml).",[Ref.22100518]LD50>400 μg/ml against rabbit red blood cells,Unknown,22100518,Peptides. 2012 Jan;33(1):27-34.,"Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.",Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,,,,,,,,
549,DRAMP02105,GILDTLKEFGKTAAKGIAQSLLSTASCKLAKTC,33,"Brevinin-2RTb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Amolops ricketti (Chinese sucker frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Brevinin-2RTb has antibacterial activity and relatively low hemolytic activity (>400 μg/ml) against rabbit red blood cells in vitro.
PTM: Contains one disulfide bond 27-33.","[Ref.22100518]Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=50.0 μg/ml), Bacillus licheniformis X39 (MIC=200.0 μg/ml), Staphylococcus carnosus KHS (MIC=100.0 μg/ml), Rhodococcus rhodochrous X15 (MIC=12.5 μg/ml);##Gram-negative bacteria: Psychrobacter faecalis X29 (MIC=12.5 μg/ml).",[Ref.22100518]LD50>400 μg/ml against rabbit red blood cells,Unknown,22100518,Peptides. 2012 Jan;33(1):27-34.,"Wang H, Ran R, Yu H, Yu Z, Hu Y, Zheng H, Wang D, Yang F, Liu R, Liu J.",Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,,,,,,,,
550,DRAMP02114,AWLDKLKSLGKVVGKVALGVAQNYLNPQQ,29,"Raniseptin-1 (Rsp-1; Frogs, amphibians, animals)",P86037,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Unknown,Hypsiboas raniceps (Chaco tree frog) (Hyla roeschmanni),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against Gram-negative as well as Gram-positive bacteria. And has hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.","[Ref.18976634]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=10 μM), Xanthomonas citri (MIC<2 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 29313 (MIC=20 μM).",[Ref.18976634]20% hemolytic activity at 80 μM against human red blood cells,Unknown,18976634,Biochem Biophys Res Commun. 2008 Dec 26;377(4):1057-1061.,"Magalhães BS, Melo JA, Leite JR, Silva LP, Prates MV, Vinecky F, Barbosa EA, Verly RM, Mehta A, Nicoli JR, Bemquerer MP, Andrade AC, Bloch C Jr.",Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.,,,,,,,,
551,DRAMP02125,IFGAILPLALGALKNLIK,18,"Hylin-a1 (Hy-a1; Frogs, amphibians, animals)",P85982,Unknown,Unknown,Hypsiboas albopunctatus (Spotted tree frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,2N0O resolved by NMR.,"Function: Has antibacterial activity against the Gram-positive bacteria and the Gram-negative bacteria. Has hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.","[Ref.19056441]Gram-positive bacteria: Staphylococcus aureus ATCC 25926 (MIC=8 μM), Enterococcus faecalis ATCC 29212 (MIC=16 μM), Bacillus subtilis ATCC 19659 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=32 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=64 μM);##Fungi: Candida albicans ATCC 90028 (MIC=16.7 μM), C. krusei ATCC 6258 (MIC=16.7 μM), C. parapsilosis ATCC 22019 (MIC=67 μM), Cryptococcus neoformans ATCC 90012 (MIC=33.5 μM)",[Ref.19056441]HC50=18 μM against human erythrocytes,Unknown,19056441,Peptides. 2009 Feb;30(2):291-296.,"Castro MS, Ferreira TC, Cilli EM, Crusca E Jr, Mendes-Giannini MJ, Sebben A, Ricart CA, Sousa MV, Fontes W.","Hylin a1, the first cytolytic peptide isolated from the arboreal South American frog Hypsiboas albopunctatus (spotted treefrog).",,,,,,,,
552,DRAMP02127,GLLGGLLGPLLGGGGGGGGGLL,22,"Leptoglycin (Gly-rich; Frogs, amphibians, animals)",P86267,Unknown,Unknown,Leptodactylus pentadactylus (Smokey jungle frog) (Rana pentadactyla),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial protein. Has antibacterial activity but not against Gram-positive bacteria Staphylococcus aureus, Micrococcus luteus and Enterococcus faecalis, yeasts Candida albicans and Candida tropicalis and dermatophytes fungi Microsporum canis and Trichophyton rubrum. No hemolytic activity was observed at the 2-200 microM range concentration.
Tissue specificity: Expressed by the skin glands.","[Ref.19298834]Gram-negative bacteria: Escherichia coli ATCC 28922 (MIC=50 μM), Pseudomonas aeruginosa ATCC 9027 (MIC=8 μM);##Fungi: Citrobacter freundii ATCC 8090 (MIC=75 μM)",[Ref.19298834]Non-hemolytic activity was observed at 2-200 μM concentration,Unknown,19298834,Toxicon. 2009 Jul;54(1):23-32.,"Sousa JC, Berto RF, Gois EA, Fontenele-Cardi NC, Honório JE Jr, Konno K, Richardson M, Rocha MF, Camargo AA, Pimenta DC, Cardi BA, Carvalho KM.",Leptoglycin: a new glycine/leucine-rich antimicrobial peptide isolated from the skin secretion of the South American frog Leptodactylus pentadactylus (Leptodactylidae).,,,,,,,,
554,DRAMP02129,FIKELLPHLSGIIDSVANAIK,21,"Kasstasin (Frogs, amphibians, animals)",G0LWV9,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Kassina maculata (African rhacophorid frog) (Hylambates maculatus),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Peptide with potent vasoconstrictor properties. Has moderate antimicrobial activity. Not active against fungus C. albicans. Has hemolytic activity against horse erythrocytes.
Tissue specificity: Expressed by the skin dorsal glands.
Miscellaneous: Kasstasin is a derivation of Kassina, the taxon of origin, and the Ancient Greek word 'stasis' meaning 'stoppage of flow'.",[Ref.21624426]Gram-positive bacterium: Staphylococcus aureus (MIC=55 μM);##Gram-negative bacterium: Escherichia coli (MIC=110 μM).,[Ref.21624426]12.8% hemolytic activity at 125 μM against defibrinated horse blood,Unknown,21624426,Biochimie. 2011 Sep;93(9):1537-1542.,"Li X, Feng W, Zhou M, Ma C, Chen T, Zeller M, Hornshaw M, Wang L, Shaw C.","Kasstasin: A novel potent vasoconstrictor peptide from the skin secretion of the African red-legged running frog, Kassina maculata.",,,,,,,,
555,DRAMP02130,GFLGPLLKLAAKGVAKVIPHLIPSRQQ,27,"Antimicrobial peptide 1 (XT-1; Frogs, amphibians, animals)",P84387,Unknown,Unknown,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against Gram-positive bacterium S. aureus and Gram-negative bacterium E.coli and stronger activity against yeast C. albicans. Enhances the antibacterial activity of XT3. Has hemolytic activity against human red blood cells .
Tissue specificity: Expressed by the skin glands.",[Ref.11738090]Gram-positive bacteria: Staphylococcus aureus (MIC=5 μM);##Gram-negative bacteria: Escherichia coli (MIC=6 μM);##Fungi: Candida albicans (MIC=50 μM),[Ref.11738090]HC50=90 μM against human erythrocytes,Unknown,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",,,,,,,,
556,DRAMP02131,GVWSTVLGGLKKFAKGGLEAIVNPK,25,"Antimicrobial peptide 2 (XT-2; Frogs, amphibians, animals)",P84382,Unknown,Unknown,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has very strong antibacterial activity against Gram-positive bacterium S. aureus and very weak activity against Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands.",Gram-positive bacteria: Staphylococcus aureus (MIC>100 μM);##Gram-negative bacteria: Escherichia coli (MIC=8 μM).,Unknown,Cell membrane,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",,,,,,,,
557,DRAMP02133,GVFLDALKKFAKGGMNAVLNPK,22,"Antimicrobial peptide 4 (XT-4; Frogs, amphibians, animals)",P84384,Unknown,Unknown,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against Gram-positive bacterium S. aureus and yeast C. albicans, and very weak activity against Gram-negative bacterium E.coli. Has strong hemolytic activity against human red blood cells.
Tissue specificity: Expressed by the skin glands.",[Ref.11738090]Gram-positive bacteria: Staphylococcus aureus (MIC>100 μM);##Gram-negative bacteria: Escherichia coli (MIC=18 μM);##Fungi: Candida albicans (MIC>100 μM).,[Ref.11738090]HC50>150 μM against human erythrocytes,Cell membrane,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",,,,,,,,
558,DRAMP02135,GFLGSLLKTGLKVGSNLL,18,"Antimicrobial peptide 6 (XT-6; Frogs, amphibians, animals)",P84386,Unknown,Unknown,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against Gram-positive bacterium S. aureus and Gram-negative bacterium E.coli and strong activity against yeast C. albicans. Enhances the antibacterial activity of XT3. Has hemolytic activity against human red blood cells.
Tissue specificity: Expressed by the skin glands.","[Ref.11738090]Gram-positive bacterium: Staphylococcus aureus (MIC=5 μM);##Gram-negative bacterium: Escherichia coli (MIC=5 μM);##Yeast: Candida albicans (MIC=40 μM);##Clinical isolates: Staphylococcus aureus 8325 (MIC=6 μM), Staphylococcus aureus (MRSA) (MIC=7 μM), Staphylococcus epidermidis 1420129 (MIC=3 μM), S. saprophyticus 1950556 (MIC=13 μM), Escherichia coli 25922 (MIC=6 μM), Streptococcus group C 1541035 (MIC=3 μM), Shigella sonnei 1840187 (MIC=35 μM), Pseudomonas aeruginosa 0380972 (MIC=60 μM), Enterobacter cloacae 1441323 (MIC=35 μM)",[Ref.11738090]HC50=70 μM against human erythrocytes,Cell membrane,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",,,,,,,,
559,DRAMP02136,GLLGPLLKIAAKVGSNLL,18,"Antimicrobial peptide 7 (XT-7; Frogs, amphibians, animals)",P84381,Unknown,Unknown,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Has very strong antibacterial activity against many Gram-negative bacteria and the Gram-positive bacteria S.pneumoniae and Enterococcus sp. There is moderate antimicrobial activity against the Gram-negative bacterium P.aeruginosa and yeast C. albicans and weaker activity against the Streptococcal strains and E.coli. Has hemolytic activity against human red blood cells (HC50=70 μM). Seems to disrupt the membranes by adopting an alpha-helical conformation.
Tissue specificity: Expressed by the skin glands.
PTM: Amidation on Leu-18 is required to adopt an alpha-helical conformation in a hydrophobic solvent. The absence of amidation leads to a decrease in cationicity leading to a more than a 10-fold decrease in antimicrobial activities.","Gram-positive bacterium: Staphylococcus aureus (MIC=5 μM);##Gram-negative bacterium: Escherichia coli (MIC=5 μM);##yeast Candida albicans (MIC=40 μM).##Clinical isolates: Staphylococcus aureus 8325 (MIC=6 μM), Staphylococcus aureus (MRSA) (MIC=7 μM), Staphylococcus epidermidis 1420129 (MIC=3 μM), S. saprophyticus 1950556 (MIC=13 μM), Escherichia coli 25922 (MIC=6 μM), Streptococcus group C 1541035 (MIC=3 μM), Shigella sonnei 1840187 (MIC=35 μM), Pseudomonas aeruginosa 0380972 (MIC=60 μM), Enterobacter cloacae 1441323 (MIC=35 μM).",Unknown,Cell membrane,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",,,,,,,,
561,DRAMP02219,GILSSFKGVAKGVAKNLAGKLLDELKCKITGC,32,"Ranatuerin-2AUa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana aurora aurora (Northern red-legged frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,Function: Activity against a range of Gram-positive and Gram-negative bacteria (minimum inhibitory concentrations<20 μM) but low hemolytic activity against human erythrocytes. ,"[Ref.15325526]Gram-negative bacteria: Escherichia coli (MIC=5 μM), Pseudomonas aeruginosa (MIC=5 μM), Enterobacter cloacae (MIC=5 μM), Klebsiella pneumoniae (MIC=10 μM), P. mirabilis (MIC>40 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=20 μM), Staphylococcus epidermidis (MIC=20 μM), Enterococcus faecalis (MIC>40 μM), Streptococcus Group B (MIC=20 μM);##Yeast: Candida albicans (MIC>40 μM)",[Ref.15325526]HC50=290 μM against human erythrocytes,Unknown,15325526,Dev Comp Immunol. 2005;29(1):83-90.,"Conlon JM, Sonnevend A, Davidson C, Demandt A, Jouenne T.",Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.,,,,,,,,
562,DRAMP02220,GIMDTVKNVAKNLAGQLLDKLKCKITAC,28,"Ranatuerin-2PLa (Frogs, amphibians, animals)",A7WNV6,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana palustris (North America pickerel frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: May have antimicrobial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 23-28.",Gram-negative bacterium: Escherichia coli (MIC=25 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
563,DRAMP02221,GIMDTVKNAAKDLAGQLLDKLKCRITGC,28,"Ranatuerin-2PLb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana palustris (North America pickerel frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: May have antimicrobial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands.",Gram-negative bacterium: Escherichia coli (MIC=3 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
564,DRAMP02222,GLLDTIKNTAKNLAVGLLDKIKCKMTGC,28,"Ranatuerin-2PLc (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana palustris (North America pickerel frog),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: May have antimicrobial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands.",Gram-negative bacterium: Escherichia coli (MIC=3 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
565,DRAMP02223,GIMDSVKNVAKNIAGQLLDKLKCKITGC,28,"Ranatuerin-2PLd (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana palustris (North America pickerel frog),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: May have antimicrobial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands.",Gram-negative bacterium: Escherichia coli (MIC=16 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
566,DRAMP02224,GIMDSVKNAAKNLAGQLLDTIKCKITAC,28,"Ranatuerin-2PLe (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana palustris (North America pickerel frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: May have antimicrobial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands.",Gram-negative bacterium: Escherichia coli (MIC=25 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
567,DRAMP02225,GIMDTVKNAAKDLAGQLDKLKCRITGC,27,"Ranatuerin-2PLf (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana palustris (North America pickerel frog),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: May have antimicrobial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin glands.",Gram-negative bacterium: Escherichia coli (MIC=23 μM).,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
568,DRAMP02228,SMLSVLKNLGKVGLGFVACKINKQC,25,"Ranatuerin-1 (Frogs, amphibians, animals)",P82741,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Lithobates catesbeiana (American bullfrog) (Rana catesbeiana),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial activity against Gram-positive bacterium S. aureus and Gram-negative bacterium E. coli. Has activity against C. albicans.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bonds 19-25 (By similarity).",Gram-positive bacterium: Staphylococcus aureus (MIC=50 μM);##Gram-negative bacterium: Escherichia coli (MIC=2 μM).##Yeast: Candida albicans (MIC=70 μM).,Unknown,Unknown,9784389,Biochem Biophys Res Commun. 1998 Sep 29;250(3):589-592.,"Goraya J, Knoop FC, Conlon JM.","Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana.",,,,,,,,
576,DRAMP02237,GLMDTIKGVAKTVAASWLDKLKCKITGC,28,"Ranatuerin-2Ya (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Unknown,"Cytolytic,Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Ranatuerin-2Ya showed appreciably greater cytolytic activity against HepG2 cells (LC(50)=20microM) than against erythrocytes (LC(50)>100microM).,Gram-negative bacterium: Escherichia coli (MIC=50 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=50 μM).,Unknown,Unknown,19254736,Toxicon. 2009 Jun;53(7-8):699-705. ,"Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",,,,,,,,
577,DRAMP02238,GLADYWRTAFRANFANLGPGIRCKSARC,28,"Ranatuerin-2ZHa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana zhenhaiensis (Chinese brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=1 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 μM), Pseudomonas aeruginosa ATCC 9027 (MIC=6 μM).##Yeast: Candida albicans ATCC 2002 (MIC>32 μM).",Unknown,Unknown,22943778,Zoolog Sci. 2012 Sep;29(9):553-558.,"Xu B, Che H, Kang L, Zheng S, Mu S, Wan F.","Molecular Cloning and Functional Characterization of Novel Antimicrobial Peptides from the Skin of Brown Frog, Rana zhenhaiensis.",,,,,,,,
578,DRAMP02239,SMISVLKNLGKVGLGFVACKVNKQC,25,"Ranatuerin-1Ga (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana grylio (North American pig frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=3.5 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=60 μM).##Yeast: Candida albicans (MIC=110 μM).,Unknown,Unknown,10828493,Regul Pept. 2000 Jun 30;90(1-3):53-60.,"Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.",Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.,,,,,,,,
579,DRAMP02241,GLLLDTLKGAAKDIAGIALEKLKCKITGCKP,31,"Ranatuerin-2G (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana grylio (North American pig frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=19 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=150 μM).,Unknown,Unknown,10828493,Regul Pept. 2000 Jun 30;90(1-3):53-60.,"Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, Conlon JM.",Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.,,,,,,,,
580,DRAMP01390,TSRCYIGYRRKVVCS,15,"Odorranain-T1 (OdT1; Frogs, amphibians, animals)",A6MBS1,Unknown,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Odorranain-T1 adopts 28.2% turn structure in water solution.,Unknown,Function: Odorranain-T1 exhibites moderate antimicrobial activities against all of the tested microbes.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=17.50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=35.00 μg/ml), Bacillus subtilis (MIC=17.50 μg/ml).##Yeast: Candida albicans (MIC=8.75 μg/ml).",Unknown,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
581,DRAMP01389,FLPPSPWKETFRTS,14,"Odorranain-S1 (OdS1; Frogs, amphibians, animals)","A6MBS0, A6MBR9",Unknown,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,Function: Odorranain-S1 exhibites moderate antimicrobial activities against all of the tested microbes.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=42.50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=21.25 μg/ml), Bacillus subtilis (MIC=85.00 μg/ml).##Yeast: Candida albicans (MIC=21.25 μg/ml).",Unknown,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
582,DRAMP02251,GILSSFKGVAKGVAKDLAGKLLETLKCKITGC,32,"Ranatuerin-2CSa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana cascadae (Cascades frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix (4 helices; 25 residues),"In a 2,2,2-trifluoroethanol (TFE-d(3))-H(2)O solvent mixture, the structure is characterised by a full length helix-turn-helix conformation between residues I(2)-L(21), L(22)-L(25) and K(26)-T(30), respectively.",2K10 resolved by NMR.,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has Hemolytic activity against human erythrocytes. ,[Ref.17451843]Gram-negative bacterium:Escherichia coli ATCC 25726 (MIC=5 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=10 μM),[Ref.17451843]LD50=150 μM against human erythrocytes,Unknown,17451843##18387372,Peptides. 2007 Jun;28(6):1268-1274.##Biochim Biophys Acta. 2008 Jun;1784(6):924-929.,"Conlon JM, Al-Dhaheri A, Al-Mutawa E, Al-Kharrge R, Ahmed E, Kolodziejek J, Nowotny N, Nielsen PF, Davidson C.##Subasinghage AP, Conlon JM, Hewage CM.","Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.##Conformational analysis of the broad-spectrum antibacterial peptide, ranatuerin-2CSa: identification of a full length helix-turn-helix motif.",,,,,,,,
583,DRAMP02252,GLLDAIKDTAQNLFANVLDKIKCKFTKC,28,"Ranatuerin 2SKa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana sakuraii (Japanese brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=50 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>50 μM).##Yeast: Candida albicans (MIC>50 μM).,Unknown,Unknown,17174009,Peptides. 2007 Mar;28(3):505-514.,"Suzuki H, Iwamuro S, Ohnuma A, Coquet L, Leprince J, Jouenne T, Vaudry H, Taylor CK, Abel PW, Conlon JM.",Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,,,,,,,,
584,DRAMP01108,GIGTKILGGVKTALKGALKELASTYVN,27,"Maximin-2 (Toads, amphibians, animals)","P83081, P83086, Q58T49",Belongs to the bombinin family,Unknown,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Maximins are linear cationic peptides and easy to form membrane pore and they may induce a detergent-type disruption of sperm membrane like in the case of magainins.,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. 
Tissue specificity: Expressed by the skin glands.","[Ref.11835991] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=19.5 μg/ml), Klebsiella pneumoniae (MIC=9 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=19.5 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=19.5 μg/ml), Bacillus megatherium (MIC=19.5 μg/ml), Bacillus dysenteriae (MIC=2.7 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3 μg/ml).",[Ref:11835991]Little hemolytic activity at 50 μg/ml against red blood cells,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,,,,,,,,
585,DRAMP03998,RKKWFW,6,PAF26 (Trp-rich; combinatorial library),No entry found ,Unknown,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal, Anti-Gram-, ",Synthetic,Rich,"In general, positively charged residues (arginine or lysine) and residues with aromatic rings (tryptophan or phenylalanine) rendered antifungal activity.",Unknown,"Function: Antibacterial against Gram-negative bacterium. The antifungal mixture is also antibacterial, with a predominance of basic and aromatic residues.","[Ref.11976121] Gram-negative bacterium: Escherichia coli DH5α (MIC=160 μM, IC50>80 μM);##Fungi: Penicillium digitatum PHI-26 (MIC=20 μM, IC50=11 ± 1 μM), Penicillium italicum PHI-1 (MIC=40 μM,  IC50=22 ± 3 μM), Botrytis cinerea CECT2100 (MIC=60 μM, IC50=38 ± 24 μM), Fusarium oxysporum CECT2866 (MIC=80 μM, IC50=45 ± 4 μM).",Unknown,Unknown,11976121,Appl Environ Microbiol. 2002 May;68(5):2453-60.,"López-García B, Pérez-Payá E, Marcos JF.",Identification of novel hexapeptides bioactive against phytopathogenic fungi through screening of a synthetic peptide combinatorial library.,,,,,,,,
586,DRAMP01107,GIGTKILGGVKTALKGALKELASTYAN,27,"Maximin-1 (Toads, amphibians, animals)","P83080, Q58T87",Belongs to the bombinin family,Unknown,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal, Antiviral, Anticancer, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Maximins are linear cationic peptides and easy to form membrane pore and they may induce a detergent-type disruption of sperm membrane like in the case of magainins.,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. Possess a significant cytotoxicity against tumor cell lines. Possess a significant anti-HIV activity. High spermicidal activity.
Toxic dose: LD50 is 8.2 mg/kg by intraperitoneal injection into mice.
Tissue specificity: Expressed by the skin glands.","[Ref.11835991] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=19.5 μg/ml), Klebsiella pneumoniae (MIC=9 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=19.5 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=19.5 μg/ml), Bacillus megatherium (MIC=19.5 μg/ml), Bacillus dysenteriae (MIC=2.7 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=3 μg/ml);##Virus: HIV-1 (IC50=15.5 μg/ml, EC50=21.4 μg/ml);##Cancer cell lines: C8166 (IC50=15.3 μg/ml), Molt-4 (IC50=24.3 μg/ml), BIU-87 (IC50=20.5 μg/ml), T24 (IC50=35.4 μg/ml).",[Ref:11835991]Little hemolytic activity at 50 μg/ml against red blood cells,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,,,,,,,,
587,DRAMP02268,GWASKIGQTLGKIAKVGLKELIQPK,25,"Xenopsin precursor fragment (XPF; Frogs, amphibians, animals)",P07198,Belongs to the magainin family,Unknown,Xenopus laevis (African clawed frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: XPF has antimicrobial activity.
Tissue specificity: XPF is synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa, it is stored as active, processed peptides in large granules within the granular gland secretions of the skin.","Gram-negative bacteria: Escherichia coli (MIC=16-31 μg/ml), K. Pneumonae (MIC=62-125 μg/ml), Pseudomonas aeruginosa (MIC=125-250 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=250-500 μg/ml), Streptococcus faecalis (MIC=250-500 μg/ml).##Yeast: Candida albicans (MIC=250-500 μg/ml).",Unknown,Unknown,1717472,J Biol Chem. 1991 Oct 15;266(29):19851-19857.,"Moore KS, Bevins CL, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M.",Antimicrobial peptides in the stomach of Xenopus laevis.,,,,,,,,
588,DRAMP02269,GVLSNVIGYLKKLGTGALNAVLKQ,24,"Antimicrobial peptide PGQ (PGQ; Frogs, amphibians, animals)",P39080,Belongs to the magainin family,pgq,Xenopus laevis (African clawed frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix(potential),Unknown,Unknown,"Function: Antimicrobial peptide.
Tissue specificity: Is synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. It is stored as active, processed peptides in large granules within the granular gland secretions of the skin.","Gram-negative bacteria: Escherichia coli (MIC=62-250 μg/ml), K. Pneumonae (MIC=125-250 μg/ml), Pseudomonas aeruginosa (MIC=250-500 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=250-500 μg/ml), Streptococcus faecalis (MIC=250-500 μg/ml).##Yeast: Candida albicans (MIC=250-500 μg/ml).",Unknown,Unknown,1717472,J Biol Chem. 1991 Oct 15;266(29):19851-19857.,"Moore KS, Bevins CL, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M.",Antimicrobial peptides in the stomach of Xenopus laevis.,,,,,,,,
589,DRAMP02271,GIGKFLHSAKKFGKAFVGEIMNS,23,"Magainin-2 (Magainin II; chain of Magainins; Frogs, amphibians, animals)",P11006,Belongs to the magainin family,magainins,Xenopus laevis (African clawed frog),"Antibacterial, Antifungal, Antiprotozoal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,"The secondary structure is shown to be helical in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution.","2MAG, 2LSA resolved by NMR.","Function: Antimicrobial peptides that inhibit the growth of numerous species of bacteria and fungi and induce osmotic lysis of protozoa. Magainins are membrane lytic agents.
Tissue specificity: Synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. It is stored as active, processed peptides in large granules within the granular gland secretions of the skin.","Gram-negative bacteria: Escherichia coli D31 (MIC=5 μg/ml), Klebsiella pneumoniae (MIC=10 μg/ml), Escherichia coli (MIC=50 μg/ml), Pseudomonas putida (MIC=10 μg/ml), Citrobacter freundii (MIC=30 μg/ml), Enterobacter cloacae (MIC=50 μg/ml), Pseudomonas aeruginosa (MIC=100 μg/ml), Serratia marcescens (MIC=100 μg/ml), Proteus mirabilis (MIC>100 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis (MIC=10 μg/ml), Staphylococcus aureus (MIC=50 μg/ml), Streptococcus fecalis (MIC>100 μg/ml).##Protozoa: Paramecium caudatum (MIC=10 μg/ml).##Yeast: Candida albicans (MIC=80 μg/ml).",Unknown,Unknown,3299384##9090128##PubMed ID is not available,Proc Natl Acad Sci U S A. 1987 Aug;84(15):5449-5453.##J Biomol NMR. 1997 Feb;9(2):127-135.##To be Published.,"Zasloff M.##Gesell J, Zasloff M, Opella SJ.##Vermeer LS, Kozlowska J, Lorenz CD, Mason JA.","Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.##Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution.##All Atom Simulations of the Initial Binding of Magainin and Pleurocidin to Membranes Comprising a Mixture of Anionic and Zwitterionic",,,,,,,,
590,DRAMP02272,GMASKAGAIAGKIAKVALKAL,21,"PGLa (chain of PYLa/PGLa A; Frogs, amphibians, animals)","Q99134, B7ZSG6, Q91826",Belongs to the gastrin/cholecystokinin family (Magainin subfamily),pgla-a AND pgla-b,Xenopus laevis (African clawed frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: PGLa display a broad-spectrum of antibacterial activity against a range of Gram-positive and Gram-negative bacteria. PGLa also displays antifungal activity against C. albicans ATCC 14053.
Tissue specificity: Expressed by the skin glands. Synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. Stored as active, processed peptides in large granules within the granular gland secretions of the skin.
PTM: Leucine amide at position 21.","Gram-negative bacteria: Escherichia coli 25922 (MIC=62-125 μg/ml), Klebsiella pneumoniae 13883 (MIC=250-500 μg/ml), Pseudomonas aeruginosa 27853 (MIC=250-500 μg/ml);##Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=125-500 μg/ml), Strepococcus faecalis (MIC>500 μg/ml).##Yeast: Candida albicans 14053 (MIC=250-500 μg/ml).",Unknown,Unknown,3606567##1717472,Biochem J. 1987 Apr 1;243(1):113-120.##J Biol Chem. 1991 Oct 15;266(29):19851-19857.,"Giovannini MG, Poulter L, Gibson BW, Williams DH.##Moore KS, Bevins CL, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M.",Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones.##Antimicrobial peptides in the stomach of Xenopus laevis.,,,,,,,,
591,DRAMP02273,KIAKVALKAL,10,"PGLa-H (chain of PYLa/PGLa A; Frogs, amphibians, animals)","Q99134, B7ZSG6, Q91826",Belongs to the gastrin/cholecystokinin family (Magainin subfamily),pgla-a AND pgla-b,Xenopus laevis (African clawed frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: PGLa-H display a broad-spectrum of antibacterial activity against a range of Gram-positive and Gram-negative bacteria. PGLa-H shows moderate antibacterial activity against the multidrug-resistant methicillin-resistant S. aureus (MRSA) but exhibits hemolytic activity.
Tissue specificity: Expressed by the skin glands. Synthesized in the stomach and stored in a novel granular multinucleated cell in the gastric mucosa. Stored as active, processed peptides in large granules within the granular gland secretions of the skin.
PTM: Leucine amide at position 10.","[Ref.22014884]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=8.7 μg/ml), Bacillus subtilis (MIC=14.4 μg/ml), Staphylococcus aureus (MRSA) (MIC=67.8 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=23.6 μg/ml)","[Ref.22014884]3.15% hemolytic activity at 100 μg/mL, 7.95% hemolytic activity at 200 μg/mL against rabbit red blood cells",Unknown,22014884##1717472,Int J Antimicrob Agents. 2011 Dec;38(6):510-515.##J Biol Chem. 1991 Oct 15;266(29):19851-19857.,"Hou F, Li J, Pan P, Xu J, Liu L, Liu W, Song B, Li N, Wan J, Gao H.##Moore KS, Bevins CL, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M.",Isolation and characterisation of a new antimicrobial peptide from the skin of Xenopus laevis.##Antimicrobial peptides in the stomach of Xenopus laevis.,,,,,,,,
592,DRAMP02274,SAPRGCWTKSYPPKPCK,17,"Ranacyclin-E (Frogs, amphibians, animals)",P83663,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (Edible frog) (Pelophylax esculentus),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity. The mature peptide inserts into the hydrophobic core of the bacterial cell membrane and increases permeability without disrupting membrane integrity. Probably binds to the outer membrane surface before aggregating to form transmembrane pores. Has hemolytic activity. Probably binds to the outer membrane surface before aggregating to form transmembrane pores.
Tissue specificity: Expressed by the skin granular glands.","[Ref.14636071]Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3 μM), Staphylococcus lentus (MIC=7 μM), Micrococcus luteus (MIC=5 μM);##Gram-negative bacteria: Yersinia pseudotuberculosis YP III (MIC=9 μM), Pseudomonas syringae pv tabaci (MIC=80 μM);##Fungi: Candida tropicalis (MIC=7.4 μM), C. guillermondii (MIC=3.4 μM), Phytophthora nicotianae spores (MIC=32 μM).",[Ref.14636071]55% Hemolytic activity at 100 μM against human erythrocytes,Cell membrane,14636071,Biochemistry. 2003 Dec 2;42(47):14023-14035.,"Mangoni ML, Papo N, Mignogna G, Andreu D, Shai Y, Barra D, Simmaco M.","Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity.",,,,,,,,
593,DRAMP02275,GALRGCWTKSYPPKPCK,17,"Ranacyclin-T (Frogs, amphibians, animals)",P83719,Belongs to the frog skin active peptide family (Brevinin subfamily),RNCT,Rana temporaria (European common frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,MOA: The mature peptide inserts into the hydrophobic core of the bacterial cell membrane and increases permeability without disrupting membrane integrity. Probably binds to the outer membrane surface before aggregating to form transmembrane pores. Has hemolytic activity.,"[Ref.14636071]Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3 μM), Staphylococcus lentus (MIC=10 μM), Micrococcus luteus (MIC=8 μM);##Gram-negative bacteria: Escherichia coli D21 (MIC=30 μM), Yersinia pseudotuberculosis YP III (MIC=5 μM), Pseudomonas syringae pv tabaci (MIC=16 μM);##Fungi: Candida albicans ATCC 10231 (MIC=22 μM), Candida tropicalis (MIC=14 μM), C. guillermondii (MIC=1 μM), Phytophthora nicotianae spores (MIC=16 μM).",[Ref.14636071]20% Hemolytic activity at 100 μM against human erythrocytes,Cell membrane,14636071,Biochemistry. 2003 Dec 2;42(47):14023-14035.,"Mangoni ML, Papo N, Mignogna G, Andreu D, Shai Y, Barra D, Simmaco M.","Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity.",,,,,,,,
596,DRAMP02278,AALRGCWTKSIPPKPCPGKR,20,"Ranacyclin-B-RL1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana livida (Ranidae frogs),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus (MIC=5.8 μM), Bacillus subtilis (MIC=46.2 μM);##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.",Unknown,Unknown,21927839,Amino Acids. 2012 Jul;43(1):309-316.,"Yan X, Liu H, Yang X, Che Q, Liu R, Yang H, Liu X, You D, Wang A, Li J, Lai R.",Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,,,,,,,,
602,DRAMP02288,FIGPVLKIAAGILPTAICKIFKKC,24,"Gaegurin-RN1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana nigrovittata ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has hemolytic activity against rabbit red cells..,"[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=2.34 μg/ml), Staphylococcus aureus ATCC43300 (MIC=9.38 μg/ml), Bacillus subtilis (MIC=4.69 μg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=18.75 μg/ml);##Yeast: Candida albicans ATCC2002 (MIC=4.69 μg/ml)",[Ref.19778602]46.13 ± 1.49% hemolytic activity at 100 μg/ml against rabbit red blood cells ,Unknown,19778602,Genomics. 2010 Jan;95(1):66-71.,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",,,,,,,,
604,DRAMP02290,FLGPIIKIATGILPTAICKFLKKC,24,"Gaegurin-RN5 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana nigrovittata ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has hemolytic activity against rabbit red cells.,"[Ref.19778602]Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=3.75 μg/ml), Staphylococcus aureus ATCC43300 (MIC=62.50 μg/ml), Bacillus subtilis (MIC=4.69 μg/ml);##Gram-negative bacterium: Escherichia coli ML-35P (MIC=37.50 μg/ml);##Yeast: Candida albicans ATCC2002 (MIC=4.69 μg/ml).",Unknown,Unknown,19778602,Genomics. 2010 Jan;95(1):66-71.,"Ma Y, Liu C, Liu X, Wu J, Yang H, Wang Y, Li J, Yu H, Lai R.","Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata.",,,,,,,,
605,DRAMP02291,SLFSLIKAGAKFLGKNLLKQGACYAACKASKQC,33,"Gaegurin-1 (Gaegurin 1; GGN1; Frogs, amphibians, animals)",P80395,Belongs to the frog skin active peptide family (Brevinin subfamily),GGN1,Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has hemolytic activity against rabbit red cells.,"[Ref.7999137]Gram-positive bacteria: Micrococcus luteus (MIC=5 μg/ml), Staphylococcus epidermidis (MIC=50 μg/ml), Bacillus subtilis (MIC=50 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=100 μg/ml), Shigella dysentariae (MIC=25 μg/ml), Pseudomonas putida (MIC=50 μg/ml), Pseudomonas aeruginosa (MIC=50 μg/ml), Eshchericia coli (MIC=25 μg/ml).","[Ref.7999137]0.04% hemolytic activity at 0.1 μg/ml, 0.14% hemolytic activity at 1 μg/ml, 0.51% hemolytic activity at 10 μg/ml, 0.59% hemolytic activity at 100 μg/ml against human red blood cells.",Unknown,7999137,Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.,"Park JM, Jung JE, Lee BJ.","Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",,,,,,,,
606,DRAMP02292,GIMSIVKDVAKNAAKEAAKGALSTLSCKLAKTC,33,"Gaegurin-2 (Gaegurin 2; GGN2; Frogs, amphibians, animals)",P80396,Belongs to the frog skin active peptide family (Brevinin subfamily),GGN2,Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Micrococcus luteus (MIC=2.5 μg/ml), Staphylococcus epidermidis (MIC=10 μg/ml), Bacillus subtilis (MIC=10 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=25 μg/ml), Shigella dysentariae (MIC=25 μg/ml), Pseudomonas putida (MIC=50 μg/ml), Pseudomonas aeruginosa (MIC=50 μg/ml), Eshchericia coli (MIC=75 μg/ml).##Fungi: Saccharomyces cerevisiae (MIC=150 μg/ml), Candida albicans (MIC=150 μg/ml), Salmonella typhimurium (MIC=150 μg/ml), Proteus mirabilis (MIC>200 μg/ml), Serratia marcescens (MIC>200 μg/ml).",Unknown,Unknown,7999137,Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.,"Park JM, Jung JE, Lee BJ.","Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",,,,,,,,
607,DRAMP02293,GIMSIVKDVAKTAAKEAAKGALSTLSCKLAKTC,33,"Gaegurin-3 (Gaegurin 3; GGN3; Frogs, amphibians, animals)",P80397,Belongs to the frog skin active peptide family (Brevinin subfamily),GGN3,Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Micrococcus luteus (MIC=2.5 μg/ml), Staphylococcus epidermidis (MIC=10 μg/ml), Bacillus subtilis (MIC=10 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=25 μg/ml), Shigella dysentariae (MIC=25 μg/ml), Pseudomonas putida (MIC=50 μg/ml), Pseudomonas aeruginosa (MIC=50 μg/ml), Eshchericia coli (MIC=75 μg/ml).##Fungi: Saccharomyces cerevisiae (MIC>200 μg/ml), Candida albicans (MIC>200 μg/ml), Salmonella typhimurium (MIC=150 μg/ml), Proteus mirabilis (MIC>200 μg/ml), Serratia marcescens (MIC>200 μg/ml).",Unknown,Unknown,7999137,Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.,"Park JM, Jung JE, Lee BJ.","Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",,,,,,,,
608,DRAMP02294,GILDTLKQFAKGVGKDLVKGAAQGVLSTVSCKLAKTC,37,"Gaegurin-4 (Gaegurin 4; GGN4; Frogs, amphibians, animals)","P80398, Q91328, Q98TA6",Belongs to the frog skin active peptide family (Brevinin subfamily),GGN4,Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa),"Antibacterial, Antifungal, Antiprotozoal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (3 helices; 22 residues),"In 100% H2O, Gaegurin 4 contains a nascent turn near its C-terminal Rana box. Under a more hydrophobic condition it forms two amphipathic helices, one long encompassing residues 2-23 and the other consisting of residues 25-34 (Ref.2).",2G9L resolved by NMR.,"Function: Has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, fungi and protozoa. Has hemolytic activity against rabbit red cells.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 31-37.","[Ref.7999137]Gram-positive bacteria: Micrococcus luteus (MIC=2.5 μg/ml), Staphylococcus epidermidis (MIC=10 μg/ml), Bacillus subtilis (MIC=10 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=25 μg/ml), Shigella dysentariae (MIC=25 μg/ml), Pseudomonas putida (MIC=100 μg/ml), Pseudomonas aeruginosa (MIC=100 μg/ml), Eshchericia coli (MIC=75 μg/ml);##Fungi: Saccharomyces cerevisiae (MIC=200 μg/ml), Candida albicans (MIC=200 μg/ml), Salmonella typhimurium (MIC=200 μg/ml), Proteus mirabilis (MIC>200 μg/ml), Serratia marcescens (MIC>200 μg/ml).","[Ref.7999137]0.50% hemolytic activity at 0.1 μg/ml, 0.74% hemolytic activity at 1 μg/ml, 0.78% hemolytic activity at 10 μg/ml, 1.67% hemolytic activity at 100 μg/ml against human red blood cells",Unknown,7999137##17141187##11004488,Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.##Biochem Biophys Res Commun. 2007 Jan 19;352(3):592-597.##Biochim Biophys Acta. 2000 Jun 21;1492(1):185-190.,"Park JM, Jung JE, Lee BJ.##Chi SW, Kim JS, Kim DH, Lee SH, Park YH, Han KH.##Kwon SY, Carlson BA, Park JM, Lee BJ.","Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.##Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4.##Structural organization and expression of the gaegurin 4 gene of Rana rugosa.",,,,,,,,
609,DRAMP02295,FLGALFKVASKVLPSVFCAITKKC,24,"Gaegurin-5 (Gaegurin 5; GGN5; Brevinin-1EMa; Frogs, amphibians, animals)","P80399, Q91329",Belongs to the frog skin active peptide family (Brevinin subfamily),GGN5,Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa),"Antibacterial, Antifungal, Antiprotozoal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has low hemolytic activity. Has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, fungi and protozoa. PTM: Problely contains one disulfide bond 18-24.","[Ref.7999137]Gram-positive bacteria: Micrococcus luteus (MIC=2.5 μg/ml), Staphylococcus epidermidis (MIC=10 μg/ml), Bacillus subtilis (MIC=10 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=50 μg/ml), Shigella dysentariae (MIC=50 μg/ml), Pseudomonas putida (MIC=50 μg/ml), Pseudomonas aeruginosa (MIC=100 μg/ml), Eshchericia coli (MIC=50 μg/ml);##Fungi: Saccharomyces cerevisiae (MIC=50 μg/ml), Candida albicans (MIC=50 μg/ml), Salmonella typhimurium (MIC=200 μg/ml), Proteus mirabilis (MIC>200 μg/ml).","[Ref.7999137]0.19% hemolytic activity at 0.1 μg/ml, 0.31% hemolytic activity at 1 μg/ml, 0.78% hemolytic activity at 10 μg/ml, 1.01% hemolytic activity at 100 μg/ml against human red blood cells",Unknown,7999137,Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.,"Park JM, Jung JE, Lee BJ.","Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",,,,,,,,
610,DRAMP02296,FLPLLAGLAANFLPTIICKISYKC,24,"Gaegurin-6 (Gaegurin 6; GGN6; Frogs, amphibians, animals)",P80400,Belongs to the frog skin active peptide family (Brevinin subfamily),GGN6,Glandirana rugosa (Japanese wrinkled frog) (Rana rugosa),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has low hemolytic activity. Has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, fungi and protozoa. PTM: Problely contains one disulfide bond 18-24.","[Ref.7999137]Gram-positive bacteria: Micrococcus luteus (MIC=2.5 μg/ml), Staphylococcus epidermidis (MIC=10 μg/ml), Bacillus subtilis (MIC=10 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=50 μg/ml), Shigella dysentariae (MIC=50 μg/ml), Pseudomonas putida (MIC=50 μg/ml), Pseudomonas aeruginosa (MIC=100 μg/ml), Eshchericia coli (MIC=50 μg/ml);##Fungi: Saccharomyces cerevisiae (MIC=50 μg/ml), Candida albicans (MIC=50 μg/ml), Salmonella typhimurium (MIC=200 μg/ml), Proteus mirabilis (MIC>200 μg/ml), Serratia marcescens (MIC>200 μg/ml).","[Ref.7999137]0.39% hemolytic activity at 0.1 μg/ml, 0.62% hemolytic activity at 1 μg/ml, 0.78% hemolytic activity at 10 μg/ml, 0.86% hemolytic activity at 100 μg/ml against human red blood cells",Unknown,7999137,Biochem Biophys Res Commun. 1994 Nov 30;205(1):948-954.,"Park JM, Jung JE, Lee BJ.","Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",,,,,,,,
616,DRAMP02314,RCRFCCRCCPRMRGCGICCRF,21,"Hepcidin (fish, chordates, animals)",A1Z0M0,Belongs to the hepcidin family,hamp,Larimichthys crocea (Croceine croaker) (Pseudosciaena crocea),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages.
Tissue specificity: Expressed in all tissues tested, with highest levels of expression in kidney and lowest levels in liver. Intra-peritoneal injection of lipopolysaccharide results in increased expression in heart, spleen and stomach, but not in kidney or liver.
PTM: Contains four disulfide bonds 2-19; 5-8; 6-15; 9-18.","Gram-negative bacteria: Vibrio alginolyticus(MIC=24 μM), V. fluvialis, V. harveyis (MIC=12 μM) and Vibrio parahaemolyticus (MIC=6 μM), Aeromonas hydrophila (MIC=6 μM), Escherichia coli (MIC=24 μM), Escherichia coli BL21(DE3)plysS (MIC=6 μM);##Gram-positive bacteria: Bacillus cereus (MIC=24 μM), Bacillus subtilis (MIC=6 μM), C. glutamicum (MIC=3 μM), Micrococcus luteus (MIC=3 μM), M. lysodeikticus, Staphylococcus aureus (MIC=6 μM) and S.epidermis (MIC=12 μM).##Fungi: Aspergillus niger (MIC=24 μM), F;##Graminearum (MIC=24 μM) and Fusarium solani (MIC=24 μM).",Unknown,Unknown,19150638##19344770,Peptides. 2009 Apr;30(4):638-646.##Fish Shellfish Immunol. 2009 Jun;26(6):864-870.,"Wang KJ, Cai JJ, Cai L, Qu HD, Yang M, Zhang M.##Zhang J, Yan Q, Ji R, Zou W, Guo G.","Cloning and expression of a hepcidin gene from a marine fish (Pseudosciaena crocea) and the antimicrobial activity of its synthetic peptide.##Isolation and characterization of a hepcidin peptide from the head kidney of large yellow croaker, Pseudosciaena crocea.",,,,,,,,
617,DRAMP02315,FFGWLIKGAIHAGKAIHGLIHRRRH,25,"Chrysophsin-1 (fish, chordates, animals)",P83545,Belongs to the pleurocidin family,Unknown,Chrysophrys major (Red sea bream) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,Function: Shows hemolytic activity human red blood cells.,"[Ref.12581207]Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=0.25 μM), Lactococcus garvieae ATCC 49156 (MIC=10 μM), S.iniae F-8502 (MIC=2.5 μM);##Gram-negative bacteria: Escherichia coli WT-2 (MIC=0.25 μM), Vibrio anguillarum ATCC 19264 (MIC=2.5 μM), Vibriopenaeicida KHA (MIC=10 μM), V. harveyi ATCC 14126 (MIC=2.5 μM), V. vulnificus ATCC 33148 (MIC=5 μM), Aeromonas salmonicida NCMB 1102 (MIC=10 μM), Pseudomonas putida ATCC 12633 (MIC=40 μM).","[Ref.12581207]10% hemolytic activity at 0.25 μM, 80% hemolytic activity at 1 μM against human erythrocytes",Cell membrane,12581207,Eur J Biochem. 2003 Feb;270(4):675-686.,"Iijima N, Tanimoto N, Emoto Y, Morita Y, Uematsu K, Murakami T, Nakai T.","Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major.",,,,,,,,
618,DRAMP02316,FFGWLIRGAIHAGKAIHGLIHRRRH,25,"Chrysophsin-2 (fish, chordates, animals)",P83546,Belongs to the pleurocidin family,Unknown,Chrysophrys major (Red sea bream) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,Function: Shows hemolytic activity human red blood cells.,"[Ref.12581207]Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=0.25 μM), Lactococcus garvieae ATCC 49156 (MIC=5 μM), S.iniae F-8502 (MIC=1.5 μM);##Gram-negative bacteria: Escherichia coli WT-2 (MIC=0.25 μM), Vibrio anguillarum ATCC 19264 (MIC=1.25 μM), Vibriopenaeicida KHA (MIC=5 μM), V. harveyi ATCC 14126 (MIC=5 μM), V. vulnificus ATCC 33148 (MIC=2.5 μM).","[Ref.12581207]10% hemolytic activity at 0.25 μM, 70% hemolytic activity at 1 μM against human erythrocytes",Cell membrane,12581207,Eur J Biochem. 2003 Feb;270(4):675-686.,"Iijima N, Tanimoto N, Emoto Y, Morita Y, Uematsu K, Murakami T, Nakai T.","Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major.",,,,,,,,
619,DRAMP02317,FIGLLISAGKAIHDLIRRRH,20,"Chrysophsin-3 (fish, chordates, animals)",P83547,Belongs to the pleurocidin family,Unknown,Chrysophrys major (Red sea bream) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,Function: Shows hemolytic activity human red blood cells.,"[Ref.12581207]Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=0.25 μM), Lactococcus garvieae ATCC 49156 (MIC=10 μM), S.iniae F-8502 (MIC=10 μM);##Gram-negative bacteria: Escherichia coli WT-2 (MIC=0.25 μM), Vibrio anguillarum ATCC 19264 (MIC=10 μM), Vibriopenaeicida KHA (MIC=10 μM), V. harveyi ATCC 14126 (MIC=5 μM), V. vulnificus ATCC 33148 (MIC=10 μM), Aeromonas salmonicida NCMB 1102 (MIC=10 μM), Pseudomonas putida ATCC 12633 (MIC=40 μM).","[Ref.12581207]0% hemolytic activity at 0.25 μM, 10% hemolytic activity at 1 μM against human erythrocytes.",Cell membrane,12581207,Eur J Biochem. 2003 Feb;270(4):675-686.,"Iijima N, Tanimoto N, Emoto Y, Morita Y, Uematsu K, Murakami T, Nakai T.","Purification and characterization of three isoforms of chrysophsin, a novel antimicrobial peptide in the gills of the red sea bream, Chrysophrys major.",,,,,,,,
620,DRAMP02318,FIGGIISFFKRLF,13,"Grammistin Pp1 (Group II grammistin; fish, chordates, animals)",P69842,Belongs to the grammistin family (Group 2 subfamily),Unknown,Pogonoperca punctata (Clown grouper) (Bearded grouper),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=3.13 μg/ml), Staphylococcus aureus IAM 1011 (MIC=3.13 μg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=50 μg/ml), Escherichia coli JCM 1649 (MIC>50 μg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=6.25 μg/ml), Salmonella typhimurium S1 (MIC>50 μg/ml), S. putrefaciens IAM 1509 (MIC=6.25 μg/ml), Vibrio anguillarum NCIBM 829 (MIC=12.5 μg/ml), Vibrio parahaemolyticus (MIC=25 μg/ml).",Unknown,Unknown,PubMed ID is not available,Fish. Sci. 2001 Oct;67:928-933.,"Yokota H, Nagashima Y, Shiomi K.",Interaction of grammistins with lipids and their antibacterial activity.,,,,,,,,
621,DRAMP02320,FIGGIISFIKKLF,13,"Grammistin PpIIb (Group II grammistin; fish, chordates, animals)",P69844,Belongs to the grammistin family (Group 2 subfamily),Unknown,Pogonoperca punctata (Clown grouper) (Bearded grouper),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antibacterial activities.,"[Ref.Fish. Sci. 2001 Feb;67:163-169.]Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=6.25 μg/ml), Staphylococcus aureus IAM 1011 (MIC=3.13 μg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC>50 μg/ml), Escherichia coli JCM 1649 (MIC=50 μg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=12.5 μg/ml), Salmonella typhimurium S1 (MIC>50 μg/ml), S. putrefaciens IAM 1509 (MIC=6.25 μg/ml), Vibrio anguillarum NCIBM 829 (MIC=12.5 μg/ml), Vibrio parahaemolyticus (MIC=25 μg/ml).",Unknown,Phospholipids,PubMed ID is not available,Fish. Sci. 2001 Feb;67:163-169.,"Shiomi K, Yokota H, Nagashima Y, Ishida M.","Primary and secondary structures of grammistins, peptide toxins isolated from the skin secretion of the soapfish Pogonoperca punctata.",,,,,,,,
622,DRAMP02321,NWRKILGQIASVGAGLLGSLLAGYE,25,"Grammistin Pp3 (Group III grammistin; fish, chordates, animals)",P69847,Belongs to the grammistin family (Group 3 subfamily),Unknown,Pogonoperca punctata (Clown grouper) (Bearded grouper),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function:  Has hemolytic activity. Thanks to its abundant amphiphilic alpha-helices, it may integrate into membrane phospholipids, leading to lysis of the membrane.","[Ref.Fish. Sci. 2001 Oct;67:928-933.]Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=50 μg/ml), Staphylococcus aureus IAM 1011 (MIC=50 μg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=50 μg/ml), Escherichia coli JCM 1649 (MIC>50 μg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=25 μg/ml), Salmonella typhimurium S1 (MIC>50 μg/ml), S. putrefaciens IAM 1509 (MIC=12.5 μg/ml), Vibrio anguillarum NCIBM 829 (MIC=50 μg/ml), Vibrio parahaemolyticus (MIC=50 μg/ml).",[Ref.Fish. Sci. 2001 Oct;67:928-933.]75 HU/mg hemolytic activity against horse erythrocytes(1 HU was defined as the amount of peptide causing 50% hemolysis),Unknown,PubMed ID is not available,Fish. Sci. 2001 Oct;67:928-933.,"Yokota H, Nagashima Y, Shiomi K.",Interaction of grammistins with lipids and their antibacterial activity.,,,,,,,,
623,DRAMP02324,AEVAPAPAAAAPAKAPKKKAAAKPKKAGPS,30,"SAMP H1 (fish, chordates, animals)","P84408, Q5GMQ6","Belongs to the histone H1/H5 family
",Unknown,Salmo salar (Atlantic salmon),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli (MIC=2 μM), Aeromonas salmonicida subsp salmonicida (MIC=4 μM), Vibrio anguillarum (MIC=1 μM) Salmonella typhimurium (MIC=4 μM);##Gram-positive bacteria: Bacillus subtilis (MIC=2 μM), Listeria ivanovii (MIC=4 μM).",Unknown,Unknown,15917539,Antimicrob Agents Chemother. 2005 Jun;49(6):2399-2406.,"Luders T, Birkemo G.A, Nissen-Meyer J, Andersen O, Nes I.F.",Proline conformation-dependent antimicrobial activity of a proline-rich histone H1 N-terminal peptide fragment isolated from the skin mucus of Atlantic salmon.,,,,,,,,
624,DRAMP02330,FFHHIFRGIVHVGKTIHRLVTG,22,"Piscidin-1 (Pis-1; Piscidin 1; fish, chordates, animals)",Q8UUG0,Belongs to the pleurocidin family,Unknown,Morone saxatilis (Striped bass),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,"2JOS, 2OJM resolved by NMR.",Function: Exhibits broad spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria. Also has hemolytic activity. Seems to disrupt the membranes by adopting an alpha helical conformation and forming toroidal pores.,"[Ref.11713517]Gram-positive bacteria: Enterococcus faecalis VRE (MIC=5-10 μM), E. faecalis (MIC=2.5-5 μM), Listeria monocytogenes (MIC=2.5-5 μM), Micrococcus luteus (MIC=10-20 μM), Staphylococcus aureus MRSA (MIC=1.25-2.5 μM), S. epidermitis (MIC=5-10 μM), S. saprophiticus (MIC=5-10 μM), Staphylococcus xylosus (MIC>20 μM), S. agalactiae (MIC=1.25-2.5 μM), S. bovis (MIC=1.25-2.5 μM), S. equisimilis (MIC=2.5-5 μM), S. mitis (MIC=1.25-2.5 μM), S. Pneumonae (MIC=1.25-2.5 μM), S. pyrogenes (MIC=1.25-2.5 μM), Streptococcus iniae KST740 ak (MIC=1.25-2.5 μM), S. iniae KSTSi 6P (MIC=1.25-2.5 μM);##Gram-negative bacteria: Aeromonas hydrophila (MIC>20 μM), Burkholderia cepacia (MIC>20 μM), Vibrio Cholera (MIC=2.5-5 μM), Escherichia coli (MIC=5-10 μM), Enterobacter cloacae (MIC=10-20 μM), E. Aerogenes (MIC=10-20 μM), Klebsiella pneumoniae (MIC=2.5-5 μM), K. oxytoca (MIC=5-10 μM), Salmonella choleraesuis (MIC=10-20 μM), S. typhimurium (MIC=10-20 μM), S. arizonae (MIC=10-20 μM), Serratia marcescens (MIC>20 μM), Shigella flexneri (MIC=2.5-5 μM), S. sonnei (MIC=5-10 μM), Yersinia enterocolitica (MIC=2.5-5 μM); Fungi: Neurospora crassa (MIC=1.56-3.12 μM), A. fumigatus (MIC=50-100 μM), F. axysporum (MIC=0.78-1.56 μM), F. culmorum (MIC=0.39-0.78 μM), C. ablicans (MIC=10-20 μM), C. glabrata (MIC=10-20 μM), C. lusitania (MIC=10-20 μM), C. tropacalis (MIC=10-20 μM).","[Ref.11713517]10% hemolytic activity at 5 μg/mL, 60% hemolytic activity at 10 μg/mL, 100% hemolytic activity at 50 μg/mL against human erythrocytes ",Cell membrane,11713517,Nature. 2001 Nov 15;414(6861):268-269.,"Silphaduang U, Noga EJ.",Peptide antibiotics in mast cells of fish.,,,,,,,,
625,DRAMP02331,FFHHIFRGIVHVGKTIHKLVTG,22,"Piscidin-2 (Pis-2; fish, chordates, animals)",Q8UUG2,Belongs to the pleurocidin family,Unknown,Morone chrysops (White bass),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Exhibits broad spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria as well as against a variety of fungi. Seems to disrupt the membranes by adopting an alpha helical conformation.
Tissue specificity: Expressed in gill, skin, intestine, spleen, anterior kidney, and blood cells.","Gram-positive bacteria: Enterococcus faecalis (MIC=5-10 μM), E. faecalis (MIC=2.5-5 μM), Listeria monocytogenes (MIC=2.5-5 μM), Micrococcus luteus (MIC=10-20 μM), Staphylococcus aureus (MIC=1.25-2.5 μM), S. epidermidis (MIC=5-10 μM), S. saprophiticus (MIC=5-10 μM), S. xylosus (MIC>20 μM), Streptococcus agalactiae (MIC=1.25-2.5 μM), S. bovis (MIC=1.25-2.5 μM), S. equisimilis (MIC=2.5-5 μM), S. mitis (MIC=1.25-2.5 μM), Streptococcus pneumoniae (MIC=1.25-2.5 μM), Streptococcus pyogenes (MIC=1.25-2.5 μM), S. iniae KST740ak (MIC=1.25-2.5 μM), S. iniae KSTSi 6P (MIC=1.25-2.5 μM);##Gram-negative bacteria: Aeromonas hydrophila (MIC>20 μM), Burkholderia cepacia (MIC>20 μM), Vibrio cholera (MIC=2.5-5 μM), Escherichia coli (MIC=5-10 μM), Moraxella catarrhalis (MIC=2.5-5 μM), Neisseria gonorrhoeae (MIC>20 μM), Pseudomonas aeruginosa (MIC=5-10 μM), Enterobacter cloacae (MIC=10-20 μM), E. aerogenes (MIC=10-20 μM), Klebsiella pneumoniae (MIC=2.5-5 μM), K. oxytoca (MIC=5-10 μM), Salmonella choleraesuis (MIC=10-20 μM), Salmonella typhimurium (MIC=10-20 μM), S. arizonae (MIC=10-20 μM), Serratia marcescens (MIC>20 μM), Shigella flexneri (MIC=2.5-5 μM), S. sonnei (MIC=5-10 μM), Yersinia enterocolitica (MIC=2.5-5 μM).##Fungi: Neurospora crassa (MIC=1.56-3.12 μM), Aspergillus fumigatus (MIC=50-100 μM), Fusarium oxysporum (MIC=0.78-1.56 μM), F. culmorum (MIC=0.39-0.78 μM), Candida albicans (MIC=10-20 μM), C. glabrata (MIC=10-20 μM), C. lusitania (MIC=10-20 μM), C. tropicalis (MIC=10-20 μM).",Unknown,Cell membrane,11739390,J Biol Chem. 2002 Feb 15;277(7):5030-5039.,"Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Nizet V, Taylor SW, Shimizu C, Bulet P.","Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass.",,,,,,,,
626,DRAMP02336,KAVAAKKSPKKAKKPATPKKAAKSPKKVKKPAAAAKKAAKSPKKATKAAKPKAAKPKAAKAKKAAPKKK,69,"Oncorhyncin II (Oncorhyncin 2; fish, chordates, animals)","P06350, P83374","Belongs to the histone H1/H5 family
",Unknown,Oncorhynchus mykiss (Rainbow trout),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Potentially important role in mucosal defense. ,"Gram-positive bacteria: Planococcus citreus (MIC=0.2-0.4 μM), Micrococcus luteus (MIC=0.2-0.4 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.4-0.8 μM), Listonella anguillarum (MIC=0.4-0.8 μM).",Unknown,Unknown,12969798,Dev Comp Immunol. 2004 Feb;28(2):127-138. ,"Fernandes JM, Molle G, Kemp GD, Smith VJ.","Isolation and characterisation of oncorhyncin II, a histone H1-derived antimicrobial peptide from skin secretions of rainbow trout, Oncorhynchus mykiss.",,,,,,,,
627,DRAMP02337,PKRKSATKGDEPARRSARLSARPVPKPAAKPKKAAAPKKAVKGKKAAENGDAKAEAKVQAAGDGAG,66,"Oncorhyncin III (Oncorhyncin 3; fish, chordates, animals)","P02315, P83338",Belongs to the HMGN family,Unknown,Oncorhynchus mykiss (Rainbow trout),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Plays a role in mucosal innate host defence.,"Gram-positive bacteria: Aerococcus viridans (MIC=0.06-0.12 μM), Bacillus subtilis (MIC=0.25-0.5 μM), Micrococcus luteus (MIC=0.12-0.25 μM), Planococcus citreus (MIC=0.06-0.12 μM);##Gram-negative bacteria: Aeromonas hydrophila (MIC>0.5 μM), Aeromonas salmonicida 004 (MIC>0.5 μM), Escherichia coli (MIC=0.25-0.5 μM), Listonella anguillarum (MIC=0.25-0.5 μM).",Unknown,DNA,12713443,Biochem J. 2003 Jul 15;373(Pt 2):621-628.,"Fernandes J.M.O, Saint N, Kemp G.D, Smith V.J.","Oncorhyncin III: a potent antimicrobial peptide derived from the non-histone chromosomal protein H6 of rainbow trout, Oncorhynchus mykiss.",,,,,,,,
628,DRAMP02347,GKGRWLERIGKAGGIIIGGALDHL,24,"NRC-1 (fish, chordates, animals)",No entry found,Unknown,Unknown,Pseudopleuronectes americanus (Winter flounder 1),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"C-terminal NH2, this NRC seris of peptides was identified by gene analysis and biological activity verified using synthetic peptides. ","Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=64 μg/ml), Aeromonas salmonicida 97-4 (MIC=64 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=16 μg/ml), Salmonella enterica serovar Typhimurium 14028s (MIC>64 μg/ml), Pseudomonas aeruginosa K799 (MIC>64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=32 μg/ml), Escherichia coli CGSC 4908 (MIC=32 μg/ml), Escherichia coli UB1005 (MIC=32 μg/ml), Escherichia coli DC2 (MIC=32 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 μg/ml).##Yeast: Candida albicans C627 (MIC=64 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
629,DRAMP02348,WLRRIGKGVKIIGGAALDHL,20,"NRC-2 (fish, chordates, animals)",No entry found,Unknown,Unknown,Pseudopleuronectes americanus (Winter flounder 1a),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>128 μg/ml), Aeromonas salmonicida 97-4 (MIC=128 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=64 μg/ml), S. enterica serovar Typhimurium 14028s (MIC>64 μg/ml), Pseudomonas aeruginosa K799 (MIC=64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=32 μg/ml), Escherichia coli CGSC 4908 (MIC=64 μg/ml), E. coli UB1005 (MIC=64 μg/ml), E. coli DC2 (MIC=64 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 μg/ml).##Yeast: Candida albicans C627 (MIC>64 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
630,DRAMP02349,GRRKRKWLRRIGKGVKIIGGAALDHL,26,"NRC-3 (fish, chordates, animals)",No entry found,Unknown,Unknown,Pseudopleuronectes americanus (Winter flounder 1a-1),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=2 μg/ml), Aeromonas salmonicida 97-4 (MIC=4 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=2 μg/ml), Salmonella enterica serovar Typhimurium 14028s (MIC=8 μg/ml), Pseudomonas aeruginosa K799 (MIC=2 μg/ml), Pseudomonas aeruginosa Z61 (MIC=1 μg/ml), Escherichia coli CGSC 4908 (MIC=2 μg/ml), Escherichia coli UB1005 (MIC=8 μg/ml), Escherichia coli DC2 (MIC=2 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=8 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC=8 μg/ml).##Yeast: Candida albicans C627 (MIC=4 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
631,DRAMP02350,GWGSFFKKAAHVGKHVGKAALTHYL,25,"Pleurocidin (NRC-4; fish, chordates, animals)","P81941, P81619, Q9PRJ9, Q90ZY0, Q90VW6",Belongs to the pleurocidin family,ple1 AND ple2,Pseudopleuronectes americanus (Winter flounder 2-2.1),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 19 residues),"From NMR structural studies with the uniformly (15)N-labeled peptide, a structure of pleurocidin is determined to be in a random coil conformation in aqueous solution whereas it assumes an alpha-helical structure in TFE and in dodecylphosphocholine (DPC) micelles.(Ref.2)",1Z64àresolved by NMR.,May play a role in innate host defense.,"Gram-negative bacteria: Escherichia coli (MIC=2.2-3.3 μM), Leucothrix mucor (MIC>35.0 μM), Serratia marcescens (MIC>35.0 μM), Pseudomonas aeruginosa (MIC>35.0 μM), Aeromonas salmonicida (MIC=17.7-35.0 μM), Cytophaga aquatilis (MIC=2.2-4.4 μM), Pasteurella haemolytica (MIC=4.4-8.8 μM), Salmonella typhimurium I (MIC=8.8-17.7 μM), Salmonella typhimurium II (MIC=8.8-17.7 μM);##Gram-positive bacteria: Bacillus subtilis (MIC=1.1-2.2 μM), Staphylococcus aureus (MIC=17.7-35.0 μM).",Unknown,Unknown,9115266,J Biol Chem. 1997 May 2;272(18):12008-12013.,"Cole A.M, Weis P, Diamond G.","Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder.",,,,,,,,
632,DRAMP02351,FFRLLFHGVHHVGKIKPRA,19,"NRC-10 (fish, chordates, animals)",No entry found,Unknown,Unknown,Pseudopleuronectes americanus (Winter flounder Z),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>64 μg/ml), Aeromonas salmonicida 97-4 (MIC=32 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=16 μg/ml), Salmonella enterica serovar Typhimurium 14028s (MIC>64 μg/ml), Pseudomonas aeruginosa K799 (MIC=32 μg/ml), Pseudomonas aeruginosa Z61 (MIC=8 μg/ml), Escherichia coli CGSC 4908 (MIC=32 μg/ml), Escherichia coli UB1005 (MIC=32 μg/ml), Escherichia coli DC2 (MIC=32 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=32 μg/ml), Staphylococcus aureus C623 (MRSA) (MIC=64 μg/ml).##Yeast: Candida albicans C627 (MIC>64 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
633,DRAMP02352,GWKKWLRKGAKHLGQAAIK,19,"NRC-16 (fish, chordates, animals)",No entry found,Unknown,Unknown,Glyptocephalus cynoglossus (Witch flounder GC3.8-t),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=2 μg/ml), A. salmonicida 97-4 (MIC=1 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=0.5 μg/ml), S. enterica serovar Typhimurium 14028s (MIC=16 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=1 μg/ml), Escherichia coli CGSC 4908 (MIC=1 μg/ml), E. coli UB1005 (MIC=2 μg/ml), E. coli DC2 (MIC=0.5 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=16 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC=32 μg/ml).##Yeast: Candida albicans C627 (MIC=8 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
634,DRAMP02354,FFRLLFHGVHHGGGYLNAA,19,"Pleurocidin-like peptide WFY (fish, chordates, animals)",No entry found,Unknown,Unknown,Pseudopleuronectes americanus (Winter flounder) (Pleuronectes americanus),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida A449 field isolate (MIC>64 μg/ml), A. salmonicida 97-4 field isolate (MIC>64 μg/ml), Pseudomonas aeruginosa K799 (MIC>64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=64 μg/ml), Escherichia coli CGSC4908 triple (MIC=64 μg/ml), Salmonella typhimurium 14028s (MIC>64 μg/ml), Salmonella typhimurium MS7953s (MIC=64 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis (human clinical isolates) (MIC>64 μg/ml), Staphylococcus aureus (MRSA) (MIC>64 μg/ml).##Fungi: Candida albica (MIC>64 μg/ml).",Unknown,Unknown,12950255,Eur J Biochem. 2003 Sep;270(18):3720-3730.,"Douglas SE, Patrzykat A, Pytyck J, Gallant JW.","Identification, structure and differential expression of novel pleurocidins clustered on the genome of the winter flounder, Pseudopleuronectes americanus (Walbaum).",,,,,,,,
635,DRAMP02357,FLGALIKGAIHGGRFIHGMIQNHH,24,"Pleurocidin-like peptide WF3 (NRC-5; fish, chordates, animals)",Q90VW7,Belongs to the pleurocidin family,ple3,Pseudopleuronectes americanus (Winter flounder 3),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>64 μg/ml), A. salmonicida 97-4 (MIC>64 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=64 μg/ml), Salmonella enterica serovar Typhimurium 14028s (MIC>64 μg/ml), Pseudomonas aeruginosa K799 (MIC>64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=32 μg/ml), Escherichia coli CGSC 4908 (MIC=64 μg/ml), Escherichia coli UB1005 (MIC=64 μg/ml), Escherichia coli DC2 (MIC>64 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=32 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC=32 μg/ml).##Yeast: Candida albicans C627 (MIC>64 μg/ml).",Unknown,Unknown,12878506##11113283,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.##Dev Comp Immunol. 2001 Mar;25(2):137-147.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.##Douglas SE, Gallant JW, Gong Z, Hew C.","Novel antimicrobial peptides derived from flatfish genes.##Cloning and developmental expression of a family of pleurocidin-like antimicrobial peptides from winter flounder, Pleuronectes americanus (Walbaum).",,,,,,,,
636,DRAMP02358,GWGSIFKHGRHAAKHIGHAAVNHYL,25,"Pleurocidin-like peptide WF4 (NRC-6; fish, chordates, animals)","Q90ZX8, Q90ZX9",Belongs to the pleurocidin family,ple4,Pseudopleuronectes americanus (Winter flounder 4-1.1),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=4 μg/ml), A. salmonicida 97-4 (MIC=4 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=4 μg/ml), S. enterica serovar Typhimurium 14028s (MIC=64 μg/ml), Pseudomonas aeruginosa K799 (MIC=16 μg/ml), Pseudomonas aeruginosa Z61 (MIC=4 μg/ml), Escherichia coli CGSC 4908 (MIC=4 μg/ml), E. coli UB1005 (MIC=4 μg/ml), E. coli DC2 (MIC=2 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC=32 μg/ml).##Yeast: Candida albicans C627 (MIC=32 μg/ml).",Unknown,Unknown,12878506##11113283,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.##Dev Comp Immunol. 2001 Mar;25(2):137-147.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.##Douglas SE, Gallant JW, Gong Z, Hew C.","Novel antimicrobial peptides derived from flatfish genes.##Cloning and developmental expression of a family of pleurocidin-like antimicrobial peptides from winter flounder, Pleuronectes americanus (Walbaum).",,,,,,,,
637,DRAMP02359,RWGKWFKKATHVGKHVGKAALTAYL,25,"Pleurocidin-like peptide YT2 (NRC-7; fish, chordates, animals; Predicted)",Q7SZH1,Unknown,ple,Limanda ferruginea (Yellowtail flounder YT2),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=4 μg/ml), A. salmonicida 97-4 (MIC=2 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=2 μg/ml), S. enterica serovar Typhimurium 14028s (MIC=8 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=2 μg/ml), Escherichia coli CGSC 4908 (MIC=4 μg/ml), E. coli UB1005 (MIC=4 μg/ml), E. coli DC2 (MIC=4 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=64 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC=64 μg/ml).##Yeast: Candida albicans C627 (MIC=16 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
638,DRAMP02360,GWKSVFRKAKKVGKTVGGLALDHYLG,26,"Pleurocidin-like peptide AP1 (NRC-11; fish, chordates, animals; Predicted)",Q7SZH4,Unknown,ple,Hippoglossoides platessoides (American plaice AP1),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=8 μg/ml), A. salmonicida 97-4 (MIC=8 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=4 μg/ml), S. enterica serovar Typhimurium 14028s (MIC=32 μg/ml), Pseudomonas aeruginosa K799 (MIC=32 μg/ml), Pseudomonas aeruginosa Z61 (MIC=4 μg/ml), Escherichia coli CGSC 4908 (MIC=4 μg/ml), E. coli UB1005 (MIC=16μg/ml), E. coli DC2 (MIC=4 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=64 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 μg/ml).##Yeast: Candida albicans C627 (MIC=32 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
639,DRAMP02361,GWKKWFNRAKKVGKTVGGLAVDHYLG,26,"Pleurocidin-like peptide AP2 (NRC-12; fish, chordates, animals; Predicted)",Q7SZH3,Unknown,ple,Hippoglossoides platessoides (American plaice AP2),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=2 μg/ml), A. salmonicida 97-4 (MIC=2 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=2 μg/ml), S. enterica serovar Typhimurium 14028s (MIC=8μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=1 μg/ml), Escherichia coli CGSC 4908 (MIC=2 μg/ml), E. coli UB1005 (MIC=8 μg/ml), E. coli DC2 (MIC=2 μg/ml);##Gram-positive bacteria: S. epidermidis C621 (MIC=8 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC=16 μg/ml).##Yeast: Candida albicans C627 (MIC=4 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
640,DRAMP02362,GWRTLLKKAEVKTVGKLALKHYL,23,"Pleurocidin-like peptide AP3 (NRC-13; fish, chordates, animals; Predicted)",Q7SZH2,Unknown,ple,Hippoglossoides platessoides (American plaice AP3),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=4 μg/ml), A. salmonicida 97-4 (MIC=2 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=2 μg/ml), S. enterica serovar Typhimurium 14028s (MIC=8 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=1 μg/ml), Escherichia coli CGSC 4908 (MIC=2 μg/ml), E. coli UB1005 (MIC=4 μg/ml), E. coli DC2 (MIC=2 μg/ml).##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=4 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC=4 μg/ml).##Yeast: Candida albicans C627 (MIC=4 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
641,DRAMP02363,AGWGSIFKHIFKAGKFIHGAIQAHND,26,"Pleurocidin-like peptide GcSc4C5 (NRC-14; fish, chordates, animals)",Q7SZH0 ,Unknown,ple,Glyptocephalus cynoglossus (Witch flounder GcSc4C5),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=32 μg/ml), A. salmonicida 97-4 (MIC=16 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=16 μg/ml), S. enterica serovar Typhimurium 14028s (MIC>64 μg/ml), Pseudomonas aeruginosa K799 (MIC=32 μg/ml), Pseudomonas aeruginosa Z61 (MIC=8 μg/ml), Escherichia coli CGSC 4908 (MIC=16 μg/ml), E. coli UB1005 (MIC=16 μg/ml), E. coli DC2 (MIC=16 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=16 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC=16 μg/ml).##Yeast: Candida albicans C627 (MIC>64 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
642,DRAMP02364,GFWGKLFKLGLHGIGLLHLHL,21,"Pleurocidin-like peptide GcSc4B7 (NRC-15; fish, chordates, animals; Predicted)",Q7SZG9,Unknown,ple,Glyptocephalus cynoglossus (Witch flounder GcSc4B7),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=8 μg/ml), A. salmonicida 97-4 (MIC=16 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=4 μg/ml), S. enterica serovar Typhimurium 14028s (MIC=16 μg/ml), Pseudomonas aeruginosa K799 (MIC=8 μg/ml), Pseudomonas aeruginosa Z61 (MIC=4 μg/ml), Escherichia coli CGSC 4908 (MIC=8 μg/ml), E. coli UB1005 (MIC=8 μg/ml), E. coli DC2 (MIC=8 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=4 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC=4 μg/ml).##Yeast: Candida albicans C627 (MIC=16 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
643,DRAMP02365,GWKKWLRKGAKHLGQAAIKGLAS,23,"Pleurocidin-like peptide GC3.8 (NRC-17; fish, chordates, animals; Predicted)",Q7SZG8,Unknown,ple,Glyptocephalus cynoglossus (Witch flounder GC3.8),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=2 μg/ml), A. salmonicida 97-4 (MIC=1 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=1 μg/ml), S. enterica serovar Typhimurium 14028s (MIC=8 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=2 μg/ml), Escherichia coli CGSC 4908 (MIC=1 μg/ml), E. coli UB1005 (MIC=4 μg/ml), E. coli DC2 (MIC=1 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=32 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC=16 μg/ml).##Yeast: Candida albicans C627 (MIC=8 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
644,DRAMP02366,GWKKWFTKGERLSQRHFA,18,"Pleurocidin-like peptide GC3.2 (NRC-18; fish, chordates, animals; Predicted)",Q7SZG7,Unknown,ple,Glyptocephalus cynoglossus (Witch flounder GC3.2),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>64 μg/ml), A. salmonicida 97-4 (MIC=128 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=32 μg/ml), S. enterica serovar Typhimurium 14028s (MIC>64 μg/ml), Pseudomonas aeruginosa K799 (MIC>64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=64 μg/ml), Escherichia coli CGSC 4908 (MIC=64 μg/ml), E. coli UB1005 (MIC=64 μg/ml), E. coli DC2 (MIC=64 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 μg/ml).##Yeast: Candida albicans C627 (MIC>64 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
645,DRAMP02367,FLGLLFHGVHHVGKWIHGLIHGHH,24,"Pleurocidin-like peptide Hb26 (NRC-19; fish, chordates, animals; Predicted)",Q7SZG6,Unknown,ple,Hippoglossus hippoglossus (Halibut Hb26),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC=64 μg/ml), A. salmonicida 97-4 (MIC>64 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC=16 μg/ml), S. enterica serovar Typhimurium 14028s (MIC=64 μg/ml), Pseudomonas aeruginosa K799 (MIC=32 μg/ml), Pseudomonas aeruginosa Z61 (MIC=8 μg/ml), Escherichia coli CGSC 4908 (MIC=32 μg/ml), E. coli UB1005 (MIC=16 μg/ml), E. coli DC2 (MIC=32 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC=8 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC=8 μg/ml).##Yeast: Candida albicans C627 (MIC=64 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
646,DRAMP02368,GFLGILFHGVHHGRKKALHMNSERRS,26,"Pleurocidin-like peptide Hb18 (NRC-20; fish, chordates, animals; Predicted)",Q7SZG5,Unknown,ple,Hippoglossus hippoglossus (Halibut Hb18),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Aeromonas salmonicida 99-1 (MIC>64 μg/ml), A. salmonicida 97-4 (MIC>64 μg/ml), Salmonella enterica serovar Typhimurium MS7953s (MIC>64 μg/ml), S. enterica serovar Typhimurium 14028s (MIC>64 μg/ml), Pseudomonas aeruginosa K799 (MIC>64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=64 μg/ml), Escherichia coli CGSC 4908 (MIC>64 μg/ml), E. coli UB1005 (MIC>64 μg/ml), E. coli DC2 (MIC>64 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis C621 (MIC>64 μg/ml), Staphylococcus aureus (MRSA) C623 (MIC>64 μg/ml).##Yeast: Candida albicans C627 (MIC>64 μg/ml).",Unknown,Unknown,12878506,Antimicrob Agents Chemother. 2003 Aug;47(8):2464-2470.,"Patrzykat A, Gallant JW, Seo JK, Pytyck J, Douglas SE.",Novel antimicrobial peptides derived from flatfish genes.,,,,,,,,
647,DRAMP02374,GCRFCCNCCPNMSGCGVCCRF,21,"Bass hepcidin (fish, chordates, animals)",P82951,Belongs to the hepcidin family,hamp,Morone chrysops x Morone saxatilis (white bass x striped sea-bass),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Beta strand (2 strands; 6 residues),"Solution structure by NMR indicates that bass hepcidin is very similar to that of human hepcidin, including the presence of an antiparallel beta-sheet, a conserved disulfide-bonding pattern, and a rare vicinal disulfide bond.",1S6W resolved by NMR.,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages (By similarity). Synthetic bass hepcidin is active in vitro against Gram-negative pathogens and fungi but showes no activity against key Gram-positive pathogens and a single yeast strain tested.
Tissue specificity: Predominantly expressed in liver.
Induction: By bacterial challenge.
PTM: Contains four disulfide bonds 2-19; 5-8; 6-15; 9-18.","Gram-negative bacteria: Escherichia coli ATCC 25,922,351,50 (MIC=22 μM), Escherichia coli ATCC D31K (MIC=11 μM), Klebsiella pneumoniae ATCC 10,031 (MIC=22 μM), P. shigelloides ATCC KST (MIC=11 μM), S. flexneri ATCC 12,022 (MIC=22 μM), Shigella sonnei ATCC 9290 (MIC=44 μM), Y. enterocolitica ATCC 23,715 (MIC=22 μM).##Fungi: Aspergillus niger (MIC=44 μM).",Unknown,Unknown,11985602##15546886,Eur J Biochem. 2002 Apr;269(8):2232-2237.##J Biol Chem. 2005 Mar 11;280(10):9272-9282.,"Shike H, Lauth X, Westerman ME, Ostland VE, Carlberg JM, Van Olst JC, Shimizu C, Bulet P, Burns JC.##Lauth X, Babon JJ, Stannard JA, Singh S, Nizet V, Carlberg JM, Ostland VE, Pennington MW, Norton RS, Westerman ME.","Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge.##Bass hepcidin synthesis, solution structure, antimicrobial activities and synergism, and in vivo hepatic response to bacterial infections.",,,,,,,,
648,DRAMP02376,LFGFLIKLIPSLFGALSNIGRNRNQ,25,"Grammistin Gs 1 (Grammistin Gs F; Group I grammistin; soapfish, chordates, animals)",P69835,Belongs to the grammistin family (Group 1 subfamily),Unknown,Grammistes sexlineatus (Sixline soapfish) (Golden stripe soapfish),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=25 μg/ml), Staphylococcus aureus IAM 1011 (MIC=6.25 μg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=50 μg/ml), Escherichia coli JCM 1649 (MIC=50 μg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=12.5 μg/ml), Salmonella typhimurium S1 (MIC>50 μg/ml), S. putrefaciens IAM 1509 (MIC=12.5 μg/ml), Vibrio anguillarum NCIBM 829 (MIC=50 μg/ml), Vibrio parahaemolyticus (MIC=25 μg/ml).",Unknown,Unknown,PubMed ID is not available,Fish. Sci. 2001 Oct;67:928-933.,"Yokota H, Nagashima Y, Shiomi K.",Interaction of grammistins with lipids and their antibacterial activity.,,,,,,,,
649,DRAMP02377,LFGFLIPLLPHIIGAIPQVIGAIR,24,"Grammistin Gs 2 (Grammistin Gs G; Group I grammistin; soapfish, chordates, animals)",P69836,Belongs to the grammistin family (Group 1 subfamily),Unknown,Grammistes sexlineatus (Sixline soapfish) (Golden stripe soapfish),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=12.5 μg/ml), Staphylococcus aureus IAM 1011 (MIC=6.25 μg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=50 μg/ml), Escherichia coli JCM 1649 (MIC=50 μg/ml), Photobacterium damselae subsp. Piscicida Sp 9587 (MIC=6.25 μg/ml), Salmonella typhimurium S1 (MIC>50 μg/ml), S. putrefaciens IAM 1509 (MIC=6.25 μg/ml), Vibrio anguillarum NCIBM 829 (MIC=25 μg/ml), Vibrio parahaemolyticus (MIC=25 μg/ml).",Unknown,Unknown,PubMed ID is not available,Fish. Sci. 2001 Oct;67:928-933.,"Yokota H, Nagashima Y, Shiomi K.",Interaction of grammistins with lipids and their antibacterial activity.,,,,,,,,
650,DRAMP02378,WWRELLKKLAFTAAGHLGSVLAAKQSGW,28,"Grammistin Gs A (Group III grammistin; soapfish, chordates, animals)",P69845,Belongs to the grammistin family (Group 3 subfamily),Unknown,Grammistes sexlineatus (Sixline soapfish) (Golden stripe soapfish),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=25 μg/ml), Staphylococcus aureus IAM 1011 (MIC=12.5 μg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=25 μg/ml), Escherichia coli JCM 1649 (MIC=50 μg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=25 μg/ml), Salmonella typhimurium S1 (MIC>50 μg/ml), S. putrefaciens IAM 1509 (MIC=6.25 μg/ml), Vibrio anguillarum NCIBM 829 (MIC=50 μg/ml), Vibrio parahaemolyticus (MIC=50 μg/ml).",Unknown,Unknown,15777955,Toxicon. 2005 Apr;45(5):595-601.,"Sugiyama N, Araki M, Ishida M, Nagashima Y, Shiomi K.",Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,,,,,,,,
651,DRAMP02379,IGGIISFFKRLF,12,"Grammistin Gs B (Group II grammistin; soapfish, chordates, animals)",P69839,Belongs to the grammistin family (Group 2 subfamily),Unknown,Grammistes sexlineatus (Sixline soapfish) (Golden stripe soapfish),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=6.25 μg/ml), Staphylococcus aureus IAM 1011 (MIC=6.25 μg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=25 μg/ml), Escherichia coli JCM 1649 (MIC=12.5 μg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=6.25 μg/ml), Salmonella typhimurium S1 (MIC=12.5 μg/ml), S. putrefaciens IAM 1509 (MIC=3.13 μg/ml), Vibrio anguillarum NCIBM 829 (MIC=6.25 μg/ml), Vibrio parahaemolyticus (MIC=12.5 μg/ml).",Unknown,Unknown,15777955,Toxicon. 2005 Apr;45(5):595-601.,"Sugiyama N, Araki M, Ishida M, Nagashima Y, Shiomi K.",Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,,,,,,,,
652,DRAMP02380,NWRKILGKIAKVAAGLLGSMLAGYQV,26,"Grammistin Gs C (Group III grammistin; soapfish, chordates, animals)",P69846,Belongs to the grammistin family (Group 3 subfamily),Unknown,Grammistes sexlineatus (Sixline soapfish) (Golden stripe soapfish),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"MOA: Thanks to its amphiphilic alpha-helice(s), it may integrate into membrane phospholipids, leading to lysis of the membrane.","Gram-positive bacteria: Bacillus subtilis IAM 1026 (MIC=6.25 μg/ml), Staphylococcus aureus IAM 1011 (MIC=12.5 μg/ml);##Gram-negative bacteria: Aeromonas salmonicida NCIBM 1102 (MIC=25 μg/ml), Escherichia coli JCM 1649 (MIC=12.5 μg/ml), P. dameselae subsp. Piscicida Sp 9587 (MIC=6.25 μg/ml), Salmonella typhimurium S1 (MIC=12.5 μg/ml), S. putrefaciens IAM 1509 (MIC=6.25 μg/ml), Vibrio anguillarum NCIBM 829 (MIC=12.5 μg/ml), Vibrio parahaemolyticus (MIC=25 μg/ml).",Unknown,Unknown,15777955,Toxicon. 2005 Apr;45(5):595-601.,"Sugiyama N, Araki M, Ishida M, Nagashima Y, Shiomi K.",Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,,,,,,,,
654,DRAMP18373,CMSYGGSCQRSCNGGFRLGGHCGHPKIRCCRRK,33,mBD-6 (Murine beta-defensin 6),Not Entry found,Belongs to the beta-defensin family.,Unknown,Mus musculus,"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,bridge,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacteria: E. coli.,Unknown,Unknown,11408484,J Biol Chem. 2001 Aug 24;276(34):31510-4,"Yamaguchi Y, Fukuhara S, Nagase T, Tomita T, Hitomi S, Kimura S, Kurihara H, Ouchi Y.","A novel mouse beta-defensin, mBD-6, predominantly expressed in skeletal muscle.",,,,,,,,
655,DRAMP18374,FFDEKCNKLKGTCKNNCGKNEELIALCQKSLKCCRTIQPSGSIID,45,hBD-6 (human beta-defensin 6),Not Entry found,Belongs to the beta-defensin family.,Unknown,Homo sapiens,"Antibacterial, Chemotactic, Anti-Gram-, Antimicrobial",Unknown,beta ,Unknown,2LWL ,No comments found on DRAMP database,Gram-negative bacteria: E. coli K12.,Unknown,Unknown,12193721,J Immunol. 2002 Sep 1;169(5):2516-23,"Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T, Kurihara H, Ouchi Y.",Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice.,,,,,,,,
657,DRAMP02390,RPRPNYRPRPIYRP,14,"Astacidin 2 (crayfish, Arthropods, animals)",Q0PJU7,Unknown,Unknown,Pacifastacus leniusculus (signal crayfish),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Rich,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Shigella flexneri ATCC 203 (MIC=0.98 μg/ml), Proteus vulgaris OX19 ATCC 6380 (MIC=7.8 μg/ml), Escherichia coli D21 (MIC=3.9 μg/ml), Psedomonas aeruginosa OT 97 (MIC=7.8 μg/ml).##Gram-positive bacteria: Bacillus megateriun B11 (MIC=1.9 μg/ml), Bacillus subtilis ATCC 6633 (MIC=1.95 μg/ml), Staphylococcus aureus JC-1 (MIC=7.8 μg/ml), Micrococcus luteus Ml 11 (MIC=10 μg/ml).",Unknown,Unknown,17049601,Dev Comp Immunol. 2007;31(5):441-455. ,"Jiravanichpaisal P, Lee SY, Kim YA, Andrén T, Söderhäll I.",Antibacterial peptides in hemocytes and hematopoietic tissue from freshwater crayfish Pacifastacus leniusculus: characterization and expression pattern.,,,,,,,,
658,DRAMP02391,GWFKKAWRKVKHAGRRVLDTAKGVGRHYLNNWLNRYRG,38,"Hematopoietic antimicrobial peptide-37 (MgCath37; hagfishes, chordates, animals)",Q71MD7,Unknown,CATH37,Myxine glutinosa (Atlantic hagfish),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Propionibacterium acnes ATCC 11827 and 33179 (MIC=2 μg/ml), Staphylococcus epidermidi (MIC=2-4 μg/ml), Streptococcus pyogenes (MIC=4 μg/ml), Enterococcus faecium (MIC=4-8 μg/ml), Staphylococcus aureus ATCC 29213 (MIC=8 μg/ml), Clostridium perfringens ATCC 9081 and 13124 (MIC=4-32 μg/ml), Enterococcus faecalis (MIC=32 μg/ml);##Gram-negative bacteria: Bacteroides spp. ATCC 29771, 43935, 12290 (MIC=0.5-4 μg/ml), Shigella sonnei (MIC=2-4 μg/ml), Xanthomonas maltophilia (MIC=2-8 μg/ml), Salmonella Group B (MIC=4-8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Acinetobacter baumannii (MIC=8-16 μg/ml), Escherichia coli ATCC 25922 (MIC=8 μg/ml), Enterobacter aerogenes (MIC=8-16 μg/ml), Enterobacter cloacae (MIC=8-16 μg/ml), Klebsiella pneumoniae (MIC=8-16 μg/ml).",Unknown,Unknown,15019197,Peptides. 2003 Nov;24(11):1655-1667.,"Uzzell T, Stolzenberg ED, Shinnar AE, Zasloff M.",Hagfish intestinal antimicrobial peptides are ancient cathelicidins.,,,,,,,,
659,DRAMP02393,GFFKKAWRKVKHAGRRVLDTAKGVGRHYVNNWLNRYRZ,38,"HFIAP-1 (HFIAP-2; hagfishes, chordates, animals)",No entry found,Unknown,Unknown,Myxine glutinosa (Atlantic hagfish),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Has antibacterial against a bank of Gram-negative and Gram-positive bacteria as well as a representative fungal species.
Sequence similarity: Sequences for HFIAP-1 and -2 are identical, but HFIAP-2 is brominated only at residue 7; they differ from MgCath37 by conservative replacements.","Gram-positive bacteria: Propionibacterium acnes ATCC 11827/33179 (MIC=2 μg/ml), Staphylococcus epidermidi (MIC=2-4 μg/ml), Streptococcus pyogenes (MIC=4 μg/ml), Enterococcus faecium (MIC=4-8 μg/ml), Staphylococcus aureus ATCC 29213 (MIC=8 μg/ml), Clostridium perfringens ATCC 9081/13124 (MIC=4-32 μg/ml), Enterococcus faecalis (MIC=32 μg/ml);##Gram-negative bacteria: Bacteroides spp. ATCC 29771/43935/12290 (MIC=0.5-4 μg/ml), Shigella sonnei (MIC=2-4 μg/ml), Xanthomonas maltophilia (MIC=2-8 μg/ml), Salmonella Group B (MIC=4-8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Acinetobacter baumannii (MIC=8-16 μg/ml), Escherichia coli ATCC 25922 (MIC=8 μg/ml), Enterobacter aerogenes (MIC=8-16 μg/ml), Enterobacter cloacae (MIC=8-16 μg/ml), Klebsiella pneumoniae (MIC=8-16 μg/ml).",Unknown,Unknown,15019197,Peptides. 2003 Nov;24(11):1655-1667.,"Uzzell T, Stolzenberg ED, Shinnar AE, Zasloff M.",Hagfish intestinal antimicrobial peptides are ancient cathelicidins.,,,,,,,,
660,DRAMP02394,GWFKKAWRKVKNAGRRVLKGVGIHYGVGLIZ,31,"HFIAP-3 (hagfishes, chordates, animals)",No entry found,Unknown,Unknown,Myxine glutinosa (Atlantic hagfish),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial against a bank of Gram-negative and Gram-positive bacteria as well as a representative fungal species. HFIAP-1 and HFIAP-3 exhibit similar inhibitory activity.,"Gram-positive bacteria: Propionibacterium acnes ATCC 11827/33179 (MIC=2 μg/ml), Staphylococcus epidermidi (MIC=2-4 μg/ml), Streptococcus pyogenes (MIC=4 μg/ml), Enterococcus faecium (MIC=4-8 μg/ml), Staphylococcus aureus ATCC 29213 (MIC=8 μg/ml), Clostridium perfringens ATCC 9081/13124 (MIC=4-32 μg/ml), Enterococcus faecalis (MIC=32 μg/ml);##Gram-negative bacteria: Bacteroides spp. ATCC 29771/43935/12290 (MIC=0.5-4 μg/ml), Shigella sonnei (MIC=2-4 μg/ml), Xanthomonas maltophilia (MIC=2-8 μg/ml), Salmonella Group B (MIC=4-8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Acinetobacter baumannii (MIC=8-16 μg/ml), Escherichia coli ATCC 25922 (MIC=8 μg/ml), Enterobacter aerogenes (MIC=8-16 μg/ml), Enterobacter cloacae (MIC=8-16 μg/ml), Klebsiella pneumoniae (MIC=8-16 μg/ml).",Unknown,Unknown,15019197,Peptides. 2003 Nov;24(11):1655-1667.,"Uzzell T, Stolzenberg ED, Shinnar AE, Zasloff M.",Hagfish intestinal antimicrobial peptides are ancient cathelicidins.,,,,,,,,
661,DRAMP02395,AACSDRAHGHICESFKSFCKDSGRNGVKLRANCKKTCGLC,40,"Aurelin (jellyfish, chordates, animals)","Q0MWV8, P84891",Belongs to ShKT domain family,Unknown,Aurelia aurita (Moon jellyfish),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,Unknown,2LG4 resolved by NMR.,"Function: Antimicrobial peptide exhibits activity against Gram-positive and Gram-negative bacteria.
Domian: Contains 1 ShKT domain.
PTM: Contains three disulfide bonds (By similarity).",Gram-positive bacterium: Listeria monocytogenes EGD (MIC=22.64 μg/ml);##Gram-negative bacterium: Escherichia coli ML-35p (MIC=7.66 μg/ml).,Unknown,Unknown,16890198##PubMed ID is not available ,Biochem Biophys Res Commun. 2006 Sep 22;348(2):514-523.##To be Published.,"Ovchinnikova TV, Balandin SV, Aleshina GM, Tagaev AA, Leonova YF, Krasnodembsky ED, Men'shenin AV, Kokryakov VN.##Shenkarev Z, Altukhov D, Gizatullina A, Arseniev A, Ovchinnikova T.","Aurelin, a novel antimicrobial peptide from jellyfish Aurelia aurita with structural features of defensins and channel-blocking toxins.##Solution structure of aurelin, a novel antimicrobial peptide.",,,,,,,,
662,DRAMP02397,AVPDVAFNAYG,11,Big defensin (RPD-1),P86316,Belongs to the big defensin family,Unknown,Venerupis philippinarum (Japanese carpet shell) (Tapes japonica),"Anticancer, Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Significantly inhibits the growth of Gram-negative and Gram-positive bacteria and fungi in vitro. Has antibacterial activity.,"Gram-positive bacteria: Staphylococcus aureus (MIC=9.6 mg/L), Bacillus subtilis (MIC=76.8 mg/L), Micrococcus tetragenus (MIC=38.4 mg/L);##Gram-negative bacteria: Escherichia coli (MIC=76.8 mg/L), Vibrio parahaemolyticus (MIC=19.2 mg/L), Vibrio anguillarum (MIC=19.2 mg/L).",Unknown,Unknown,14673509,Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Dec;35(12):1145-8.,"Wei YX, Guo DS, Li RG, Chen HW, Chen PX.",Purification of a big defensin from Ruditapes philippinesis and its antibacterial activity.,,,,,,,,
663,DRAMP02402,FLPKMSTKLRVPYRRGTKDYH,21,Antimicrobial peptide scolopin-1,P0CH48,Unknown,Unknown,Scolopendra mutilans (Chinese red-headed centipede) (Scolopendrasubspinipes mutilans),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide against both Gram-positive, Gram-positive and yeast. Also induces histamine release by mast cells and shows hemolytic activities against both human and rabbit red cells.
Tissue specificity: Expressed by the venom gland.","[Ref.19716842]Gram-negative bacteria: Escherichia coli standard strain (MIC=12.5 μg/ml), E. coli drug-resistant strain (MIC=15 μg/ml);##Gram-positive bacteria: Staphylococcus aureus standard strain (MIC=1.2 μg/ml), S. aureus drug-resistant strain (MIC=5.0 μg/ml), Bacillus dysenteriae standard and drug-resistant strains (MIC=7.5 μg/ml);##Yeast: Candida albicans (MIC=15 μg/ml).",[Ref.19716842]25 ± 2% hemolytic activity at 50 μg/ml against human red blood cells,Unknown,19716842,Toxicon. 2010 Feb-Mar;55(2-3):274-279.,"Peng K, Kong Y, Zhai L, Wu X, Jia P, Liu J, Yu H.",Two novel antimicrobial peptides from centipede venoms.,,,,,,,,
664,DRAMP02403,GILKKFMLHRGTKVYKMRTLSKRSH,25,Antimicrobial peptide scolopin-2,P0CH49,Unknown,Unknown,Scolopendra mutilans (Chinese red-headed centipede) (Scolopendrasubspinipes mutilans),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide against both Gram-positive, -negative and yeast. Also induces histamine release by mast cells and shows hemolytic activities against both human and rabbit red cells.
Tissue specificity: Expressed by the venom gland.","[Ref.19716842]Gram-negative bacteria: Escherichia coli standard and drug-resistant strains (MIC=5.0 μg/ml);##Gram-positive bacteria: Staphylococcus aureus standard strain (MIC=0.5 μg/ml), S. aureus drug-resistant strain (MIC=1.0 μg/ml), Bacillus dysenteriae standard strain (MIC=2.5 μg/ml), B. dysenteriae drug-resistant strain (MIC=5.0 μg/ml);##Yeast: Candida albicans (MIC=7.5 μg/ml).",[Ref.19716842]32 ± 7% hemolytic activity at 50 μg/ml against human red blood cells,Unknown,19716842,Toxicon. 2010 Feb-Mar;55(2-3):274-279.,"Peng K, Kong Y, Zhai L, Wu X, Jia P, Liu J, Yu H.",Two novel antimicrobial peptides from centipede venoms.,,,,,,,,
665,DRAMP02409,GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSF,34,M-theraphotoxin-Gr1a (M-TRTX-Gr1a; GsMTx-4),"Q7YT39, Q7M3T1",Belongs to the huwentoxin-1 family,Unknown,Grammostola rosea (Chilean rose tarantula) (Grammostola spatulata),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (5 strands; 9 residues),Unknown,"1LU8, 1TYK resolved by NMR.","Function: This cationic hydrophobic peptide inhibits a lot of different channels and has an antimicrobial activity. It blocks mechanosensitive ion channels (also named stretch-activated channels or SACs), without having effect on whole-cell voltage-sensitive currents. Acts by partitioning into the membrane and perturbing the interface between the channel and the lipid bilayer without necessarily being in physical contact with the channel. Inhibits atrial fibrillation as well as the membrane motor of outer hair cells at low doses. GsMTx-4 exhibites antimicrobial properties and was more active against Gram-positive than Gram-negative bacteria.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: This toxin does not inhibit potassium channels Kv1.1/KCNA1 (IC50>85 μM), Kv1.4/KCNA4 (IC50>85 μM) and Kv11.3/KCNH7 (IC50=53 μM).
PTM: Contains three disulfide bonds.","Gram-positive bacteria: Bacillus subtilis (MIC=0.5 μM), Staphylococcus aureus (MIC=2-4 μM), Staphylococcus epidermidis (MIC=4-8 μM);##Gram-negative bacteria: Salmonella typhimurium (MIC=32.64 μM), Pseudomonas aeruginosa (MIC=8-16 μM), Escherichia coli (MIC=8-16 μM). ",Unknown,Unknown,PubMed ID is not available##12082099##10779316##163768,Submitted (MAY-2002) to the PDB data bank##J Biol Chem. 2002 Sep 13;277(37):34443-50.##J Gen Physiol. 2000 May;115(5):583-598.##Biochem Biophys Res Commun. 2006 Feb 10;340(2):633-638.,"Jung HJ, Lee CW, Earm YE, Kim JI.##Oswald RE, Suchyna TM, McFeeters R, Gottlieb P, Sachs F.##Suchyna TM, Johnson JH, Hamer K, Leykam JF, Gage DA, Clemo HF, Baumgarten CM, Sachs F.##Jung HJ, Kim PI, Lee SK, Lee CW, Eu YJ, Lee DG, Earm YE, Kim JI.","Solution structure of GsMTx-4, a peptide blocker of cation-selective stretch-activated channels.##Solution structure of peptide toxins that block mechanosensitive ion channels.##Identification of a peptide toxin from Grammostola spatulata spider venom that blocks cation-selective stretch-activated channels.##Lipid membrane interaction and antimicrobial activity of GsMTx-4, an inhibitor of mechanosensitive channel.",,,,,,,,
666,DRAMP02410,FSKYERQKDKRPYSERKNQYTGPQFLYPPERIPPQKVIKWNEEGLPIYEIPGEGGHAEPAAA,62,Antimicrobial peptide lumbricin-1 ,O96447,Unknown,Unknown,Lumbricus rubellus (Humus earthworm),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Displays antimicrobial activity and weak hemolytic activity.
Developmental stage: Adult-specific. Not detected in eggs or 1-week-old worms but abundant in 6-month-old worms.
Induction: Constitutively expressed. Not induced by bacterial infection.","[Ref.9784609]Gram-positive bacteria: Bacillus subtilis ATCC 62037 (MIC=12 μg/ml), Staphylococcus aureus ATCC 15752 (MIC=16 μg/ml), Streptococcus mutans ATCC 25175 (MIC=30 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 27325 (MIC=12 μg/ml), Pseudomonas putidaATCC 17426 (MIC=16 μg/ml), Serratia sp. ATCC 21074 (MIC=16 μg/ml);##Fungi: Candida albicans ATCC 10231 (MIC=16 μg/ml), Cryptococcus neoformance ATCC 34881 (MIC=25 μg/ml), Saccharomyces cerevisiae ATCC 44774 (MIC=12 μg/ml).##NOTE: Minimal inhibitory concentrations were determined by incubating approximately 10^4-10^5 CFU/ml of cells with serial dilutions of each peptide in a 96-well microtiter plate.","[Ref.9784609]0.02% hemolytic activity at 5 μg/ml, 0.06% hemolytic activity at 10 μg/ml, 0.14% hemolytic activity at 25 μg/ml, 0.19% hemolytic activity at 50 μg/ml, 0.23% hemolytic activity at 100 μg/ml against human erythrocytes ",Unknown,9784609,Biochim Biophys Acta. 1998 Oct 22;1408(1):67-76.,"Cho JH, Park CB, Yoon YG, Kim SC.","Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization.",,,,,,,,
667,DRAMP02411,GHLGRPYIGGGGGFNRGGGFHRGGGFHRGGGFHSGGGFHRGGGFHSGGSFGYR,53,Armadillidin (Glyc-rich),Q64HC7,Unknown,Unknown,Armadillidium vulgare (Pillbug) (Pill woodlouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive bacterium B. megaterium LM101.
Tissue specificity: Expressed in hemocytes and at very low levels in ovary. Not expressed in adipose tissue, brain, caecum, gut, heart and nervous chain.
PTM C-terminal amidation.","Gram-positive bacteria: Bacillus megaterium LM101 (MIC=0.5-1.25 μM), Enterococcus faecalis LM002, Micrococcus luteus LM610, Listeria ivanovii BUG496;##Gram-negative bacteria: Escherichia coli JM83, Salmonella thyphimurium LM122, Enterobacter cloacae LM111, Citrobacter freundii LM457.##NOTE: Because of the low amount of the purified peptide, this minimal concentration activity is only tested on B. megaterium.",Unknown,Unknown,15752546,Dev Comp Immunol. 2005;29(6):489-499.,"Herbinière J, Braquart-Varnier C, Grève P, Strub JM, Frère J, Van Dorsselaer A, Martin G.","Armadillidin: a novel glycine-rich antibacterial peptide directed against Gram-positive bacteria in the woodlouse Armadillidium vulgare (terrestrial isopod, crustacean).",,,,,,,,
668,DRAMP02412,SYVGDCGSNGGSCVSSYCPYGNRLNYFCPLGRTCCRHAYV,40,"Panusin (Defensin-like peptide 7, PaD7) ",F6KSI8,Belongs to the beta-defensin family,Unknown,Panulirus argus (Caribbean spiny lobster) (Palinurus argus),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide. Has antibacterial activity.
PTM: Contains two disulfide bonds (By similarity).",Gram-positive bacterium: Staphylococcus aureus ATCC 29737 (MIC=3.46 μM);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=4.8 μM).,Unknown,Unknown,22885029##PubMed ID is not available,Fish Shellfish Immunol. 2012 Oct;33(4):872-879.##Submitted (FEB-2012) to UniProtKB,"Montero-Alejo V, Acosta-Alba J, Perdomo-Morales R, Perera E, Hernández-Rodríguez EW, Estrada MP, Porto-Verdecia M.##Montero-Alejo V, Pacios-Michelena A, Perdomo-Morales R, Crozo G, Vega-Hurtado Y.","Defensin like peptide from Panulirus argus relates structurally with beta defensin from vertebrates.##Panusin, a new defensin-like antimicrobial peptide from the hemocytes of spiny lobster Panulirus argus.",,,,,,,,
670,DRAMP02421,ACHAHCQSVGRRGGYCGNFRMTCYCY,26,"Hlgut-defensin (H. longicornis midgut defensin; Ticks, Arthropods, animals)",A4GUC3,Unknown,Unknown,Haemaphysalis longicornis (Bush tick),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,"Function: Both Hlgut-defensin and Hlsal-defensin sequences have antibactrrial activity against a variety of Gram-positive and Gram-negative bacteria.
Induction: By a lipopolysaccharide (LPS) injection.",Gram-positive bacterium: Staphylococcus aureus (MIC=5-25 mg/mL);##Gram-negative bacterium: Escherichia coli (MIC=10-25 mg/mL).,Unknown,Unknown,17521774,Peptides. 2007 Jun;28(6):1304-1310.,"Zhou J, Liao M, Ueda M, Gong H, Xuan X, Fujisaki K.",Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis.,,,,,,,,
671,DRAMP02422,NCIQQCVSKGAQGGYCTNEKCTCY,24,"Hlsal-defensin (H. longicornis salivary gland defensin; Ticks, Arthropods, animals)",A4GUC4,Unknown,Unknown,Haemaphysalis longicornis (Bush tick),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,"Function: Both Hlgut-defensin and Hlsal-defensin sequences have antibactrrial activity against a variety of Gram-positive and Gram-negative bacteria.
Induction: By a lipopolysaccharide (LPS) injection.",Gram-positive bacterium: Staphylococcus aureus (MIC=5-25 mg/mL);##Gram-negative bacterium: Escherichia coli (MIC=10-25 mg/mL).,Unknown,Unknown,17521774,Peptides. 2007 Jun;28(6):1304-1310.,"Zhou J, Liao M, Ueda M, Gong H, Xuan X, Fujisaki K.",Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis.,,,,,,,,
672,DRAMP02423,DFGCARGMIFVCMRRCARMYPGSTGYCQGFRCMCDTMIPIRRPPFIMG,48,"HlMS-defensin (Ticks, Arthropods, animals)",No entry found,Unknown,Unknown,Haemaphysalis longicornis (Tick),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus ATCC2592 (MIC=18.8 μg/ml), Bacillus licheniformis (MIC=9.4 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=28.1 μg/ml), Pseudomonas aeruginosa ATCC27853 (MIC=37.5 μg/ml), Serratia rubidaea (MIC=28.1 μg/ml), Psychrobacter faecalis (MIC=2.3 μg/ml).##Fungi: Candida albicans ATCC2002 (MIC=18.8 μg/ml).",Unknown,Unknown,22033149,Dev Comp Immunol. 2012 May;37(1):207-211.,"Zheng H, Zhou L, Yang X, Wang D, Liu J.",Cloning and characterization of a male-specific defensin-like antimicrobial peptide from the tick Haemaphysalis longicornis.,,,,,,,,
673,DRAMP02425,QLKVDLWGTRSGIQPEQHSSGKSDVRRWRSRY,32,"Ixosin-B (Ticks, Arthropods, animals)",A7UDM9,Unknown,Unknown,Ixodes sinensis (Hard tick),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antifungal and antibacterial activity. Ixosin-B has little hemolytic activity on red blood cells even with peptide
concentrations up to 200 μg/mL.",[Ref.18295522]Gram-positive bacterium: Staphylococcus aureus (MIC=2.5 μg/mL);##Gram-negative bacterium: Escherichia coli (MIC=15 μg/mL);##Yeast: Candida albicans (MIC=7.5 μg/mL).,[Ref.18295522]Little hemolytic activity on rabbit red blood cells up to 200 μg/mL,Unknown,18295522,Comp Biochem Physiol B Biochem Mol Biol. 2008 Apr;149(4):557-561.,"Liu Z, Liu H, Liu X, Wu X.","Purification and cloning of a novel antimicrobial peptide from salivary glands of the hard tick, Ixodes sinensis.",,,,,,,,
677,DRAMP02430,GLHKVMREVLGYERNSYKKFFLR,23,"Ixosin (Ticks, Arthropods, animals)",Q2LKX9,Unknown,Unknown,Ixodes sinensis (Hard tick),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antifungal activity against C. albicans. Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacterium E. coli. Little hemolytic activity against rabbit erythrocytes.,[Ref.16087274]Gram-postive bacteria: Staphylococcus aureus (MIC=3.7 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=30 μg/ml);##Fungi: Candida albicans (MIC=7.5 μg/ml).,[Ref.16087274]Little hemolytic activity on rabbit red blood cells up to 50 μg/mL,Unknown,16087274,Peptides. 2006 Jan;27(1):31-5.,"Yu D, Sheng Z, Xu X, Li J, Yang H, Liu Z, Rees HH, Lai R.","A novel antimicrobial peptide from salivary glands of the hard tick, Ixodes sinensis.",,,,,,,,
678,DRAMP02432,PDPGQPWQVKAGRPPCYSIPCRKHDECRVGSCSRCNNGLWGDRTCR,46,"Antimicrobial peptide ISAMP (Ticks, Arthropods, animals)",Q8MVA6,Unknown,Unknown,Ixodes scapularis (Black-legged tick) (Deer tick),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity and weak hemolytic.
Tissue specificity: Expressed in the fat body, hemocytes and salivary glands of partially-fed female ticks. Not expressed in the midgut.","[Ref.19852941]Gram-positive bacteria: Bacillus cereus (MIC=5.8 μg/ml), Bacillus subtilis (MIC=12.3 μg/ml), Staphylococcus aureus (MIC=10.4 μg/ml);##Gram-negative bacteria: Escherichia coli Edl 933 (MIC=3.2 μg/ml), E. coli MG/655 (MIC=4.2 μg/ml).",[Ref.19852941]Insignificant hemolytic activity even up to 150 μg/ml against rabbit red blood cells,Unknown,12177149##19852941,J Exp Biol. 2002 Sep;205(Pt 18):2843-2864.##Biochem Biophys Res Commun. 2009 Dec 18;390(3):511-515.,"Valenzuela JG, Francischetti IM, Pham VM, Garfield MK, Mather TN, Ribeiro JM.##Pichu S, Ribeiro JM, Mather TN.","Exploring the sialome of the tick Ixodes scapularis.##Purification and characterization of a novel salivary antimicrobial peptide from the tick, Ixodes scapularis.",,,,,,,,
680,DRAMP02434,FSRYARMRDSRPWSDRKNNYSGPQFTYPPEKAPPEKLIKWNNEGSPIFEMPAEGGHIEP,59,Antimicrobial peptide lumbricin-PG (Lumbricin-PG),P86929,Unknown,Unknown,Pheretima guillelmi (Earthworm) (Metaphire guillelmi),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Displays stronger activity against P. aeruginosa and S. aureus than E. coli. At the concentration of 200 g/ml, it induces 1.5 and 2.1% hemolysis of human and rabbit red blood cells, respectively.","Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=5 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=2.5 μg/m).##Fungi: Candida albicans ATCC 2002.",Unknown,Unknown,21539875,Peptides. 2011 Jun;32(6):1146-1150.,"Li W, Li S, Zhong J, Zhu Z, Liu J, Wang W.","A novel antimicrobial peptide from skin secretions of the earthworm, Pheretima guillelmi (Michaelsen).",,,,,,,,
683,DRAMP02445,LYKLVKVVLNM,11,Antimicrobial protein BL-A60,B3EWC5,Unknown,Unknown,Brevibacillus laterosporus (Bacillus laterosporus),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial and antifungal activity. In P.capsici, inhibits mycelial growth (EC50=7.89 μg/ml), formation of sporangia (EC50=0.6 μg/ml) and cytospore germination (EC50=21.96 μg/ml).
PTM: Contains a choline moiety at the N-terminus and a tenuazonic acid moiety at the C-terminus.
Biophysicochemical properties: pH dependence (Active between pH 3 and 11); Temperature dependence (Retains >80% activity after 15 min at 100 degrees Celsius).","Gram-negative bacterium: Pseudomonas solanacearum (MIC=10 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=5 μM).##Fungi: Phytophthora capsici (MIC=15 μM), Botrytis cinerea (MIC=25 μM), Verticillium dahliae (MIC=200 μM), Fusarium oxysporum (MIC=50 μM), Xerocomus vesicolor (MIC=100 μM). ",Unknown,Unknown,22244810,Peptides. 2012 Feb;33(2):206-211.,"Zhao J, Guo L, Zeng H, Yang X, Yuan J, Shi H, Xiong Y, Chen M, Han L, Qiu D.",Purification and characterization of a novel antimicrobial peptide from Brevibacillus laterosporus strain A60.,,,,,,,,
684,DRAMP02446,YSKSLPLSVLNP,12,Antimicrobial protein 1 (Antimicrobial protein AN5-1),B3EWQ6,Unknown,Unknown,Paenibacillus alvei (Bacillus alvei),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has a broad inhibitory spectrum against both Gram-positive and -negative bacterial strains.
Miscellaneous: A synthetic peptide has no antibacterial activity against S. agalactiae ATCC 12386, S. epidermidis, P. aeruginosa and methicillin-resistant S. aureus (MRSA).
Biophysicochemical properties: pH dependence (Active between pH 2 and 12); Temperature dependence (Active between 37 and 90 degrees Celsius. Activity is reduced at 100 degrees Celsius and absent at 110 degrees Celsius. Activity is unaffected by storage at -20 degrees Celsius).","Gram-positive bacteria: Lactobacillus plantarum strain ATCC 8014 (MIC=32 μg/ml), Lactococcus lactis ATCC 11454 (MIC>128 μg/ml), Bacillus cereus strain ATCC 14579 (MIC=64 μg/ml), Staphylococcus aureus (MIC=64 μg/ml), Bacillus subtilis (MIC=32 μg/ml), Bacillus anthracis (MIC=128 μg/ml) and Bacillus licheniformis (MIC>128 μg/ml), Bacillus subtilis (MIC=32 μg/ml);##Gram-negative bacteria: Escherichia coli strain ATCC 13076 (MIC=8 μg/ml), Salmonella enteritidis ATCC 13076 (MIC=4 μg/ml), Enterobacter spp. (MIC=16 μg/ml), Serratia marcescens (MIC=32 μg/ml).",Unknown,Unknown,23508455,J Ind Microbiol Biotechnol. 2013 Jun;40(6):571-579.,"Alkotaini B, Anuar N, Kadhum AA, Sani AA.",Detection of secreted antimicrobial peptides isolated from cell-free culture supernatant of Paenibacillus alvei AN5.,,,,,,,,
687,DRAMP02470,SCTTCECCCSCS,12,Nosiheptide (NOS; Antibiotic 9671-RP),C6FX52,Belongs to the thiocillin family,nosM,Streptomyces actuosus,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Inhibits bacterial protein biosynthesis by binding to ribosomes. Specifically, binds to the complex of 23S rRNA and ribosomal protein L11 (RPLK) in the 50S ribosomal subunit. While allowing a weak binding of elongation factor G (EF-G) to the ribosome and subsequent GTP-hydrolysis, probably impairs conformational changes in both the ribosome and EF-G which are necessary for translocation. In vitro, inhibits a variety of Gram-positive bacteria and inhibits Gram-negative bacterium P. multocida strain A125 (MIC=0.0024 μg/ml). Does not inhibit Gram-negative bacterium E. coli strain ATCC 9637 but does inhibit purified ribosomes from E. coli. In vivo, has no systemic effect in mice infected with staphylococci or streptococci when applied orally or subcutaneously. Has a local effect in mice infected subcutaneously or intraperitoneally with staphylococci when applied immediately afterwards. Is not toxic to mice.
Miscellaneous: The mature peptide is identical to multhiomycin from S. antibioticus strain 8446CC1 (PMID 681244). Used as an antibiotic growth promotant in poultry and pig farming in parts of Asia.","Gram-positive bacteria: Staphylococcus aureus strain 209P (MIC=0.0009 μg/ml), S. aureus strain 133 (MIC=0.0019 μg/ml), S. aureus strain B3 (MIC=0.003 μg/ml), S. aureus strain Hb (MIC=0.003 μg/ml), Micrococcus citreus strain ATCC 8411 (MIC=0.0038 μg/ml), M. lysodeikticus strain ATCC 4698 (MIC=0.003 μg/ml), Sarcina Lutea strain ATCC 9341 (MIC=0.0011 μg/ml), Streptococcus faecalis strain ATCC 9790 (MIC=0.0007 μg/ml), S. viridans (MIC=0.0065 μg/ml), Streptococcus pyogenes hemolyticus strain Dig7 (MIC=0.00028 μg/ml), Diplococcus pneumoniae strain Til (MIC=0.00015 μg/ml), N. catrrhalis (MIC=0.0017 μg/ml), Lactobacillus casei strain ATCC 6633 (MIC=0.003 μg/ml), Bacillus cereus ATCC 6630 (MIC=0.0071 μg/ml) and various isolates of Listeria monocytogenes.##Gram-negative bacterium: P. multocida strain A125 (MIC=0.0024 μg/ml).",Unknown,Unknown,19678698##18406324,ACS Chem Biol. 2009 Oct 16;4(10):855-864.##Mol Cell. 2008 Apr 11;30(1):26-38.,"Yu Y, Duan L, Zhang Q, Liao R, Ding Y, Pan H, Wendt-Pienkowski E, Tang G, Shen B, Liu W.##Harms JM, Wilson DN, Schluenzen F, Connell SR, Stachelhaus T, Zaborowska Z, Spahn CM, Fucini P.",Nosiheptide biosynthesis featuring a unique indole side ring formation on the characteristic thiopeptide framework.##Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin.,,,,,,,,
688,DRAMP02473,KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF,30,"Cathelicidin-BF (Cathelicidin-related protein; Snakes, reptiles, animals)",B6D434,Unknown,Unknown,Bungarus fasciatus (Banded krait),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Adopts an amphipathic alpha helical conformation, that may allow to partition into the target membrane. No hemolytic and cytotoxic activities have been observed on mammalian cells.
Tissue specificity: Expressed by the venom gland, stomach, trachea, skin, muscle, heart, kidney, lung, brain, intestine, spleen, liver, and ovary.
Miscellaneous: A predicted cleavage site is located at position Val-157-158-Lys, giving a peptide of 34 residues instead of the 30 residues found for the purified protein. The 30 residues cathelicidin-BF could result from a further processing.","[Ref.18795096]Gram-negative bacteria: Pseudomonas aeruginosa ATCC27853 (MIC=1.2 μg/ml), P. aeruginosa IS/DR (MIC=2.3 μg/ml), P. aeruginosa 08031205 IS/DR (MIC=9.4 μg/ml), P. aeruginosa 08031014 IS/DR (MIC=18.7 μg/ml), Escherichia coli ATCC25922 (MIC=2.3 μg/ml), E. coli 08A852 IS/DR (MIC=1.2 μg/ml), E. coli 08A866 IS/DR (MIC=0.6 μg/ml), E. coli 08031017 IS/DR (MIC=2.3 μg/ml), E. coli 08032813 IS/DR (MIC=2.3 μg/ml), E. coli 08040726 IS/DR (MIC=0.6 μg/ml), E. coli 08040722 IS/DR (MIC=0.6 μg/ml), Klebsiella pneumoniae IS/DR (MIC=4.7 μg/ml), K. pneumoniae 08031012 IS/DR (MIC=9.4 μg/ml), K. pneumoniae 08040202 IS/DR (MIC=0.6 μg/ml), K. pneumoniae 08040724 IS/DR (MIC=0.3 μg/ml), Pseudomonas luteola (MIC=1.2 μg/ml), Salmonella Typhi IS/DR (MIC=1.2 μg/ml), Acinetobacter calcoaceticus (MIC=2.3 μg/ml), Sphingobacterium siyangense (MIC=9.4 μg/ml), Saccharibacillus kuerlensis (MIC=4.7 μg/ml);##Gram-positive bacteria: Bacillus subtilis (MIC=9.4 μg/ml), B. pumilus (MIC=9.4 μg/ml), B. cereus (MIC=1.2 μg/ml), Staphylococcus aureus ATCC2592 (MIC=4.7 μg/ml), S. aureus 08A875 IS/DR (MIC=75 μg/ml), S. aureus 08031002 IS/DR (MIC>100 μg/ml), S. aureus 08031013 IS/DR (MIC>100 μg/ml), S. aureus 08032706 IS/DR (MIC>100 μg/ml), S. aureus 08032712 IS/DR (MIC>100 μg/ml), S. aureus 08032810 IS/DR (MIC>100 μg/ml), Enterococcus faecium IS/DR (MIC=150 μg/ml);##Fungi: Aspergillus terreus GIM3.34 (MIC=18.7 μg/ml), Aspergillus nidulans (MIC=18.7 μg/ml), Candida albicans ATCC2002 (MIC=4.7 μg/ml), Pichia pastoris (MIC=0.3 μg/ml).",[Ref.18795096]Non-hemolytic activity at 400 μg/ml against human red blood cells,Cell membrane,18795096##18620012,PLoS One. 2008 Sep 16;3(9):e3217.##Peptides. 2008 Oct;29(10):1685-1691.,"Wang Y, Hong J, Liu X, Yang H, Liu R, Wu J, Wang A, Lin D, Lai R.##Zhao H, Gan TX, Liu XD, Jin Y, Lee WH, Shen JH, Zhang Y.",Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics.##Identification and characterization of novel reptile cathelicidins from elapid snakes.,,,,,,,,
689,DRAMP02474,KFFRKLKKSVKKRAK,15,"cathelicidin-BF15 (Snakes, reptiles, animals)",B6D434,Unknown,Unknown,Bungarus fasciatus (Banded krait),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Pseudomonas aeruginosa ATCC27853 (MIC=4.7 μg/ml), P. aeruginosa IS/DR (MIC=37.5 μg/ml), P. aeruginosa 08031205 IS/DR (MIC=18.7 μg/ml), P. aeruginosa 08031014 IS/DR (MIC=75 μg/ml), Escherichia coli ATCC25922 (MIC=18.7 μg/ml), E. coli 08A852 IS/DR (MIC=18.7 μg/ml), E. coli 08A866 IS/DR (MIC=18.7 μg/ml), E. coli 08031017 IS/DR (MIC=37.5 μg/ml), E. coli 08040722 IS/DR (MIC=9.4 μg/ml), K. pneumoniae 08040202 IS/DR (MIC=75 μg/ml), Salmonella Typhi IS/DR (MIC=1.2 μg/ml), Saccharibacillus kuerlensis (MIC=4.7 μg/ml).##Gram-positive bacteria: Bacillus subtilis (MIC=75 μg/ml), Staphylococcus aureus ATCC2592 (MIC=75 μg/ml), S. aureus 08A875 IS/DR (MIC=75 μg/ml), S. aureus 08031002 IS/DR (MIC>100 μg/ml).##Fungi: Candida albicans ATCC2002 (MIC=18.7 μg/ml).",Unknown,Unknown,18795096,PLoS One. 2008 Sep 16;3(9):e3217.,"Wang Y, Hong J, Liu X, Yang H, Liu R, Wu J, Wang A, Lin D, Lai R.",Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics.,,,,,,,,
690,DRAMP02478,IKFEPPLPPKKAHKKFWEDDGIYYPPNHNFP,31,"L-amino-acid oxidase (Bm-LAO; LAAO; LAO; Snakes, reptiles, animals)",B3EWI9,Belongs to the flavin monoamine oxidase family (FIG1 subfamily),Unknown,Bothropoides matogrossensis (Pitviper) (Bothrops neuwiedimatogrossensis),"Antibacterial, Antiparasitic, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, antibacterial and antiparasitic activities, as well as regulation of platelet aggregation. Its effect on platelets is controversial, since it either induces aggregation or inhibits agonist-induced aggregation. These different effects are probably due to different experimental conditions (By similarity).
Tissue specificity: Expressed by the venom gland.","Gram-positive bacteria: Bacillus subtilis strain ATCC 6633 (MIC=32 μM), Enterococcus faecalis strain ATCC 12953 (MIC=32 μM), Staphylococcus aureus strain ATCC 29213 (MIC=32 μM), Streptococcus pyogenes strain ATCC 19615 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli strain ATCC 8739 (MIC=4 μM), Klebsiella pneumoniaee strain ATCC 13885 (MIC=2 μM), Proteus mirabilis strain ATCC 25933 (MIC=2 μM), Pseudomonas aeruginosa strain ATCC 15442 (MIC=8 μM), Salmonella typhimurium strain ATCC 14028 (MIC=8 μM).",Unknown,Unknown,22438972,PLoS One. 2012;7(3):e33639.,"Okubo BM, Silva ON, Migliolo L, Gomes DG, Porto WF, Batista CL, Ramos CS, Holanda HH, Dias SC, Franco OL, Moreno SE.",Evaluation of an antimicrobial L-amino acid oxidase and peptide derivatives from Bothropoides mattogrosensis pitviper venom.,,,,,,,,
691,DRAMP02520,KRFKKFFKKLKNSVKKRAKKFFKKPRVIGVSIPF,34,"OH-CATH (Snakes, reptiles, animals)",No entry found,Unknown,Unknown,Ophiophagus hannah (King cobra) (Naja hannah),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8 μg/ml), E. coli ML-35P (MIC=6 μg/ml), E. coli clinic strain (MIC=20 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=4 μg/ml), Pseudomonas aeruginosa PA 01 (MIC=2 μg/ml), Pseudomonas aeruginosa clinic strain (MIC=2 μg/ml), Enterobacter aerogenes clinic strain (MIC=2 μg/ml), E. cloacae clinic strain (MIC=1 μg/ml).",Unknown,Unknown,18620012,Peptides. 2008 Oct;29(10):1685-1691.,"Zhao H, Gan TX, Liu XD, Jin Y, Lee WH, Shen JH, Zhang Y.",Identification and characterization of novel reptile cathelicidins from elapid snakes.,,,,,,,,
692,DRAMP02522,HVINLEESFQEPEYENHLA,19,"L-amino-acid oxidase (LAAO, LAO, Oh-LAAO; Snakes, reptiles, animals)","P81383, A8QL50",Unknown,Unknown,Ophiophagus hannah (King cobra) (Naja hannah),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: It binds to bacteria and shows antibacterial activities by generating hydrogen peroxide. Binding and antibacterial activities are higher against Gram-positive than against Gram-negative bacteria. May also have an ability to induce hemorrhage, hemolysis, edema, apoptosis.
Tissue specificity: Expressed by the venom gland.
Toxic dose: LD50 is 5 mg/kg by intravenous injection into mice.
Temperature dependence: Exhibits unusual thermal stability. At pH 7.4, the enzyme retains full activity after incubation at 25 degrees Celsius for 30 days. Is stable at alkaline condition and is not inactivated by freezing.","Gram-negative bacteria: Klebsiella pneumonia (MIC=0.4 μM), Pseudomonas aeruginosa (MIC=0.2 μM), Escherichia coli (MIC=0.4 μM), Escherichia coli ATCC 25922 (MIC=0.8 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=0.006 μM), S. epidermidis (MIC=0.012 μM).",Unknown,Bacterial cell,9304806##2619759##2044840##7886693##21059402,Int J Biochem Cell Biol. 1997 Jun;29(6):911-919.##Biochem Int. 1989 Oct;19(4):937-944.##Int J Biochem. 1991;23(3):323-327.##Toxicon. 1994 Nov;32(11):1349-1358.##Comp Biochem Physiol C Toxicol Pharmacol. 2011 M,"Ahn MY, Lee BM, Kim YS.##Tan NH, Saifuddin MN.##Tan NH, Saifuddin MN.##Li ZY, Yu TF, Lian EC.##Lee ML, Tan NH, Fung SY, Sekaran SD.",Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah).##Isolation and characterization of an unusual form of L-amino acid oxidase from King cobra (Ophiophagus hannah) venom.##Substrate specificity of king cobra (Ophiophagus hannah) venom L-amino acid oxidase.##Purification and characterization of L-amino acid oxidase from king cobra (Ophiophagus hannah) venom and its effects on human platelet aggregation.##Antibacterial action of a heat-stabl,,,,,,,,
693,DRAMP02573,QVYKGGYTRPIPRPPPFVRPLPGGPIGPYNGCPVSCRGISFSQARSCCSRLGRCCHVGKGYS,62,"Penaeidin-3a (Pen-3a; shrimps, Arthropods, animals)",P81058,Belongs to the penaeidin family,Unknown,Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Tissue specificity: Higher expression in hemocytes and to a lesser extent in heart, testis, gills, intestine, lymphonoid organ and hepatopancreas. Traces in eyes and subcuticular epithelium. Not present in the brain.
Developmental stage: Expression decreases 3 hours after microbial challenge to return to control levels after 12 hours and slightly increases after 24 hours.
PTM: C-terminal amidation and contains three disulfide bonds 32-47; 36-54; 48-55.","Gram-positive bacteria: Aerococcus viridans (MIC=0.3-0.6 μM), Micrococcus luteus (MIC=1.25-2.5 μM), Bacillus megaterium (MIC=2.5-5 μM), Enterococcus fecalis (MIC>20 μM), Saphylococcus aureus (MIC>40 μM);##Gram-negative bacteria: Escherichia coli 363 (MI=10-20 μM), Vibrio vulnificus (MIC>20 μM), Salmonella thyphimurium (MIC>40 μM), Klebsiella pneumoniae (MIC>40 μM).##Fungi: Fusarium oxysporum (MIC=5-10 μM), Botrytis cinerea (MIC=5-10 μM), Neurospora crassa (MIC=1.25-2.5 μM), Aspergillus fumigatus (MIC>20 μM).",Unknown,Chitin-binding,9353298##10561573##12842879,J Biol Chem. 1997 Nov 7;272(45):28398-28406.##Eur J Biochem. 1999 Dec;266(2):335-346.##J Biol Chem. 2003 Sep 19;278(38):36859-36867.,"Destoumieux D, Bulet P, Loew D, Van Dorsselaer A, Rodriguez J, Bachère E.##Destoumieux D, Bulet P, Strub JM, Van Dorsselaer A, Bachère E.##Yang Y, Poncet J, Garnier J, Zatylny C, Bachère E, Aumelas A.","Penaeidins, a new family of antimicrobial peptides isolated from the shrimp Penaeus vannamei (Decapoda).##Recombinant expression and range of activity of penaeidins, antimicrobial peptides from penaeid shrimp.##Solution structure of the recombinant penaeidin-3, a shrimp antimicrobial peptide.",,,,,,,,
694,DRAMP02574,QVYKGGYARPIPRPPPFVRPLPGGPIGPYNGCPVSCRGISFSQARSCCSRLGRCCHVGKGYSG,63,"[T8A]-Penaeidin-3a ([T8A]-Pen-3a; shrimps, Arthropods, animals)",P81058,Belongs to the penaeidin family,Unknown,Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 11 residues),"[T8A]-Pen-3a structure consists of an unconstrained and a constrained part, which roughly match with the proline-rich (1-28 residues) and the cysteine-rich (29-58 residues) domains, respectively. The proline-rich domain does not adopt a constrained structure, whereas the cysteine-rich domain adopts a well-defined structure that consists of a helix (41-50 residues) tightly bound to the upstream (27-40 residues) and the downstream (51-63 ",1UEO resolved by NMR.,"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
PTM: Contains three disulfide bonds.","Gram-positive bacteria: Aerococcus viridans (MIC=0.4-0.8 μM), Micrococcus luteus (MIC=0.8-1.6 μM), Bacillus megaterium (MIC=3.12-6.25 μM);##Gram-negative bacteria: Escherichia coli 363 (MI=3.12-6.25 μM), Vibrio vulnificus (MIC>50 μM), Salmonella thyphimurium (MIC>50 μM), Klebsiella pneumoniae (MIC>50 μM).##Fungi: Fusarium oxysporum (MIC=3.12-6.25 μM).",Unknown,Unknown,12842879,J Biol Chem. 2003 Sep 19;278(38):36859-36867.,"Yang Y, Poncet J, Garnier J, Zatylny C, Bachère E, Aumelas A.","Solution structure of the recombinant penaeidin-3, a shrimp antimicrobial peptide.",,,,,,,,
697,DRAMP02584,HSSGYTRPLPKPSRPIFIRPIGCDVCYGIPSSTARLCCFRYGDCCHR,47,"Penaeidin-4a (Pen-4a; shrimps, Arthropods, animals)",Q95NT0,Belongs to the penaeidin family,Unknown,Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity (By similarity).
PTM: Contains three disulfide bonds 23-37; 26-44; 38-45 and C-terminal amidation.","Gram-positive bacteria: Aerococcus viridans (MIC=1.9-2.92 μM), Micrococcus luteus (MIC=1.9-2.92 μM), Bacillus megaterium (MIC>50 μM), Saphylococcus aureus (MIC>50 μM);##Gram-negative bacteria: Escherichia coli 363 (MIC=22-33 μM), Vibrio vulnificus (MIC>50 μM), Salmonella thyphimurium (MIC>50 μM), Klebsiella pneumoniae (MIC>50 μM).##Fungi: Fusarium oxysporum (MIC=0.84-1.26 μM), Botrytis cinerea (MIC=4.38-6.57 μM).",Unknown,Chitin-binding,12242595##15084144,Immunogenetics. 2002 Sep;54(6):442-445.##Biochem J. 2004 Jul 1;381(Pt 1):79-86.,"Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.##Cuthbertson BJ, Bullesbach EE, Fievet J, Bachère E, Gross PS.",Diversity of the penaeidin antimicrobial peptides in two shrimp species.##A new class (penaeidin class 4) of antimicrobial peptides from the Atlantic white shrimp (Litopenaeus setiferus) exhibits target specificity and an independent proline-rich-domain function.,,,,,,,,
698,DRAMP02586,QRGGFTGPIPRPPPHGRPPLGPICNACYRLSFSDVRICCNFLGKCCHLVK,50,"Penaeidin-2d (Pen-2d; shrimps, Arthropods, animals)",Q962A9,Belongs to the penaeidin family,Unknown,Litopenaeus setiferus (Atlantic white shrimp) (Penaeus setiferus),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Antibacterial and antifungal activity. Presents chitin-binding activity (By similarity).
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser.","Gram-positive bacteria: Aerococcus viridans (MIC=1.25-2.5 μM), Micrococcus luteus (MIC=2.5-5 μM), Bacillus megaterium (MIC=2.5-5 μM), Enterococcus fecalis (MIC>20 μM), Saphylococcus aureus (MIC>20 μM);##Gram-negative bacteria: Escherichia coli 363 (MIC>40 μM), Vibrio vulnificus (MIC>20 μM), Salmonella thyphimurium (MIC>20 μM), Klebsiella pneumoniae (MIC>20 μM).##Fungi: Fusarium oxysporum (MIC=5-10 μM), Botrytis cinerea (MIC=5-10 μM), Neurospora crassa (MIC=2.5-5 μM), Aspergillus fumigatus (MIC>20 μM).",Unknown,Chitin-binding,12242595##10561573,Immunogenetics. 2002 Sep;54(6):442-445.##Eur J Biochem. 1999 Dec;266(2):335-346.,"Cuthbertson BJ, Shepard EF, Chapman RW, Gross PS.##Destoumieux D, Bulet P, Strub JM, Van Dorsselaer A, Bachère E.","Diversity of the penaeidin antimicrobial peptides in two shrimp species.##Recombinant expression and range of activity of penaeidins, antimicrobial peptides from penaeid shrimp.",,,,,,,,
700,DRAMP02603,AALRGALRAVARVGKAILPHVAIANPYVRTPYVHNNP,37,"Putative antimicrobial peptide A Northern Europe Heligoland (chordates, animals)",No entry found,Unknown,Unknown,Ciona intestinalis ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus megaterium (MIC=0.1 μM), Bacillus subtilis (MIC=3.1 μM), Staphylococcus aureus (MIC>25 μM), Staphylococcus epidermidis (MIC=25 μM).##Gram-negative bacteria: Escherichia coli K12 D31 (MIC=0.8 μM), Y. enterocolitica (MIC=3.1 μM), Klebsiella pneumoniae (MIC>25μM), Pseudomonas aeruginosa (MIC=12.5 μM), Serratia marcescens(MIC>25 μM).##Fungi: Candida albicans ATCC 10261 (MIC=6.3 μM), Candida albicans SC 5314 (MIC=6.3 μM).",Unknown,Unknown,17658598,Dev Comp Immunol. 2008;32(3):286-298. ,"Fedders H, Leippe M.",A reverse search for antimicrobial peptides in Ciona intestinalis: identification of a gene family expressed in hemocytes and evaluation of activity.,,,,,,,,
702,DRAMP02650,APIIRRIPYYPEVESDLRIVDCKRSEGFCQEYCNYLETQVGYCSKKKDACCLH,53,"Sperm associated antigen 11 isoform C (primates, mammals, animals)",No entry found,Unknown,Unknown,Macaca mulatta (Rhesus monkey),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=50-100 μg/ml).,Unknown,Unknown,15229135,Biol Reprod. 2004 Nov;71(5):1453-1460. ,"Avellar MC, Honda L, Hamil KG, Yenugu S, Grossman G, Petrusz P, French FS, Hall SH.",Differential expression and antibacterial activity of epididymis protein 2 isoforms in the male reproductive tract of human and rhesus monkey (Macaca mulatta).,,,,,,,,
705,DRAMP02740,YDLSKNCRLRGGICYIGKCPRRFFRSGSCSRGNVCCLRFG,40,"TBD-1 (Turtle beta-defensin 1; Reptiles, animals)",P86253,Belongs to the beta-defensin family,Unknown,Emys orbicularis (European pond turtle),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacteria methicillin-resistant S. aureus ATCC 33591 and L. monocytogenes EGD, the Gram-negative bacterium E. coli ML53p and the yeast C. albicans 820. Has no hemolytic activity towards human erythrocytes.
PTM: Contains three disulfide bonds 7-35; 14-29; 19-36.","[Ref.19253295]Gram-negative bacterium (LS, HS): Escherichia coli ML35p (MIC=0.65, >20 μmol/L);##Gram-positive bacteria: (LS, HS): Listeria monocytogenes EGD (MIC=0.65, >20 μmol/L), Methicillin-resistant Staphylococcus aureus ATCC 33591 (MIC=5.6, >20 μmol/L).##Yeast: Candida albicans (MIC=5.2, >20 μmol/L).##NOTE: LS (low salt): 10 mmol/L sodium phosphate buffer (pH 7.4) and HS (high salt): 10 mmol/L sodium-phosphate buffer (pH 7.4), 0.1 mol/L sodium chloride.",[Ref.19253295]Non-hemolytic activity against human erythrocytes up to 25 mmol/L,Unknown,19253295,Proteomics. 2009 Mar;9(5):1364-1373.,"Stegemann C, Kolobov A Jr, Leonova YF, Knappe D, Shamova O, Ovchinnikova TV, Kokryakov VN, Hoffmann R.","Isolation, purification and de novo sequencing of TBD-1, the first beta-defensin from leukocytes of reptiles.",,,,,,,,
706,DRAMP02768,GLGSVFGRLARILGRVIPKVAKKLGPKVAKVLPKVMKEAIPMAVEMAKSQEEQQPQ,56,"Pilosulin-1 (Myr b I; ants, insects, animals)","Q07932, Q9TWC1",Belongs to the pilosulin family,Unknown,Myrmecia banksi (Jack jumper ant) (Australian jumper ant),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Has strong cytotoxic and hemolytic activities. Is more potent against mononuclear leukocytes than against granulocytes. The synthesized peptide 57-76 shows a potent and broad spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria, and also against the fungus C. albicans. Adopts an alpha-helical structure.
Tissue specificity: Expressed by the venom gland.
Allergenic properties: Causes an allergic reaction in human.","[Ref.9813247]Gram-positive bacteria: Micrococcus luteus (MIC=0.5 μM), Enterococcus spp.I-11305b (MIC=2 μM), Enterococcus spp. I-11054 (MIC=2 μM), Staphylococcus simulans 22 (MIC=2 μM), S. haemolyticus I-10925 (MIC=2 μM), S. epidermidis LT1324 (MIC=2 μM), S. aureuss 5185 (MI=2 μM), S. aureuss methicillin-sensitive I-11574 (MIC=2 μM), S. aureuss (MRSA) LT1338 (MIC=3 μM), S. aureuss (MRSA) LT1334 (MIC=1.5 μM);##Gram-negative bacteria: Citrobacter freundii I-11090 (MIC=2 μM), Klebsiella pneumoniae I-10910 (MIC=2 μM), Escherichia coli I-11276b (MIC=4 μM), E. coli O-19592 (MIC=2 μM), Stenotrophomonas maltophilia O-16451 (MIC=2 μM), S. maltophila I-10717 (MIC=2 μM), Pseudomonas aeruginosa 4991 (MIC=4 μM), Pseudomonas aeruginosa I-10968 (MIC=4 μM);##Fungi: Candida albicans I-11301 (MIC=4 μM), Candida albicans I-11134 (MIC>4 μM).",[Ref.9813247]Complete lysis in the presence of pilosulin 1 was obtained at a concentration of 40 μM with evidence of partial lysis visible down to 1.25 μM,IgE,9813247##9701394##15639237##8866004,Arch Biochem Biophys. 2005 Feb 15;434(2):358-364.##Cytometry. 1998 Aug 1;32(4):268-273.##Arch Biochem Biophys. 2005 Feb 15;434(2):358-364.##Biochem Mol Biol Int. 1996 Aug;39(5):877-885.,"Zelezetsky I, Pag U, Antcheva N, Sahl HG, Tossi A.##King MA, Wu QX, Donovan GR, Baldo BA.##Zelezetsky I, Pag U, Antcheva N, Sahl HG, Tossi A.##Donovan GR, Street MD, Tetaz T, Smith AI, Alewood D, Alewood P, Sutherland SK, Baldo BA.",Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin.##Flow cytometric analysis of cell killing by the jumper ant venom peptide pilosulin 1.##Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin.##Expression of jumper ant (Myrmecia pilosula) venom allergens: post-translational processing of allergen gene products.,,,,,,,,
709,DRAMP02777,SLQPGAPNFPMPGSQLPTSITSNIEKQGPNTAATINAQHKTDRYDVGATWSKVIRGPGRSKPNWSIGGTYRW,72,"Rhinocerosin (Insects, animals)",O76145,Belongs to the coleoptericin family,Unknown,Oryctes rhinoceros (Coconut rhinoceros beetle),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has strong antibacterial activity against Escherichia coli, Streptococcus pyogenes, Staphylococcus aureus but not against Pseudomonas aeruginosa.","Gram-positive bacteria: Staphylococcus aureus (MIC=1 μg/ml), Streptococcus pyogenes (MIC=1 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=1 μg/ml).",Unknown,Unknown,9738915,Eur J Biochem. 1998 Aug 1;255(3):734-738.,"Yang J, Yamamoto M, Ishibashi J, Taniai K, Yamakawa M.","Isolation, cDNA cloning and gene expression of an antibacterial protein from larvae of the coconut rhinoceros beetle, Oryctes rhinoceros.",,,,,,,,
710,DRAMP02778,AHCLAIGRK,9,"Defensin (Insects, animals)",O96049,Belongs to the invertebrate defensin family (Type 1 subfamily),Unknown,Oryctes rhinoceros (Coconut rhinoceros beetle),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,Function: Shows very strong activity against S. aureus.,"Gram-positive bacteria: Staphylococcus aureus (MIC=25 μg/ml), Staphylococcus aureus (MRSA) (MIC>50 μg/ml).##Gram-negative bacteria: Escherichia coli (MIC=25 μg/ml), Pseudomonas aeruginosa (MIC>50 μg/ml).",Unknown,Unknown,10561605,Eur. J. Biochem. 1999;266:616-623.,"Ishibashi J, Yang J, Saido-Sakanaka H, Nakazawa H, Yamamoto M, Yamakawa M.","Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros.",,,,,,,,
711,DRAMP02779,VTCDLLSFEAKGFAANHSICAAHCLAIGRKGGSCQNGVCVCRN,43,"Defensin-A (Defensin A; Insects, animals)",P83669,Belongs to the invertebrate defensin family (Type 1 subfamily),Unknown,Anomala cuprea (Cupreous chafer beetle),"Antibacterial , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Strong activity against the Gram-positive bacteria M.luteus, B.megaterium and S. aureus. Reduced activity against Gram-positive bacterium B.subtilis and weak activity against Gram-negative bacterium X.japonicus.
PTM: Problely contains three disulfide bonds 3-34; 20-39; 24-41.","Gram-positive bacteria: Bacillus megaterium (MIC=1.2-2.5 μM), Bacillus subtilis (MIC>40 μM), Micrococcus luteus (MIC=1.2-2.5 μM), Staphylococcus aureus (MIC=2.5-5 μM).##Gram-negative bacteria: Enterobacter asbriae (MIC>40 μM), Escherichia coli (MIC>40 μM), Pseudomonas aeruginosa (MIC>40 μM), Serratia marcescens (MIC>40 μM), Xenorhabdus japonicus (MIC>40 μM).",Unknown,Unknown,11719071,Insect Biochem Mol Biol. 2001 Dec;32(1):75-84.,Yamauchi H.,"Two novel insect defensins from larvae of the cupreous chafer, Anomala cuprea: purification, amino acid sequences and antibacterial activity.",,,,,,,,
712,DRAMP02780,VTCDLLSFEAKGFAANHSICAAHCLVIGRKGGACQNGVCVCRN,43,"Defensin-B (Defensin B; Insects, animals)",P83668,Belongs to the invertebrate defensin family (Type 1 subfamily),Unknown,Anomala cuprea (Cupreous chafer beetle),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has antibacterial activity against Gram-positive bacteria and the Gram-negative bacterium X. japonicus.
PTM: Problely contains three disulfide bonds 3-34; 20-39; 24-41.","Gram-positive bacteria: Bacillus megaterium (MIC=1.2-2.5 μM), Bacillus subtilis (MIC=20-40 μM), Micrococcus luteus (MIC=1.2-2.5 μM), Staphylococcus aureus (MIC=2.5-5 μM);##Gram-negative bacterium: X. japonicus (MIC=20-40 μM).",Unknown,Unknown,11719071,Insect Biochem Mol Biol. 2001 Dec;32(1):75-84.,Yamauchi H.,"Two novel insect defensins from larvae of the cupreous chafer, Anomala cuprea: purification, amino acid sequences and antibacterial activity.",,,,,,,,
713,DRAMP02802,AREASKSLIGTASCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR,46,"Paneth cell-specific alpha-defensin 1 (DEFA1; horse defensin; houses, mammals, animals）",A6YB85,Unknown,DEFA1,Equus caballus (Horse),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,2MXQ resolved by NMR.,Function: Membrane permeabilization is at least an essential part of the peptide's mode of action.,"Gram-negative bacteria: Escherichia coli [ATCC 11775 (MBC=0.4 μM); ATCC 25922 (MBC=0.4 μM); ATCC 35218 (MBC=0.4 μM)], E. coli D31 (MBC=0.8 μM), Pseudomonas aeruginosa ATCC 11440 (MBC=3 μM);##Gram-positive bacteria: Staphylococcus aureus [ATCC 6538 (MBC=0.8 μM); ATCC 12600 (MBC=1.5 μM)], Staphylococcus epidermidis ATCC 14990 (MBC=1.5 μM), Enterococcus faecalis ATCC 29212 (MBC=6.1 μM), E. faecalis PEG 205 (wild-type) (MBC=3 μM), Streptococcus pyogenes ATCC 12344 (MBC=0.8 μM), Bacillus megaterium ATCC 14581 (MBC=0.2 μM).##Yeast: Candida albicans ATCC 24433 (MIC=0.8 μM).",Unknown,Unknown,17620056,Biochem J. 2007 Oct 15;407(2):267-276.,"Bruhn O, Regenhard P, Michalek M, Paul S, Gelhaus C, Jung S, Thaller G, Podschun R, Leippe M, Grtzinger J, Kalm E.","A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function.",,,,,,,,
714,DRAMP02809,HPHVCTSYYCSKFCGTAGCTRYGCRNLHRGKLCFCLHCSR,40,"Myticin-B (Myt B; Cys-rich; molluscas, animals)",P82102,Unknown,Unknown,Mytilus galloprovincialis (Mediterranean mussel),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Rich,Unknown,Unknown,"Function: Bacteriolytic activity against Gram-positive bacteria and Gram-negative bacteria. Also possesses antifungal activity against F. oxysporum.
PTM: contains four disulfide bonds.","Gram-positive bacteria: Micrococcus luteus (MBC=1-2 μM), Bacillus megaterium (MBC=1-2 μM), Aerococcus viridans (MBC=2-4 μM).##Gram-negative bacteria: Escherichia coli D31 (MBC=20-10 μM).##Fungi: Fusarium oxysporum (MIC=5-10 μM).",Unknown,Unknown,10491159,Eur J Biochem. 1999 Oct 1;265(1):71-78.,"Mitta G, Hubert F, Nol T, Roch P.","Myticin, a novel cysteine-rich antimicrobial peptide isolated from haemocytes and plasma of the mussel Mytilus galloprovincialis.",,,,,,,,
715,DRAMP02811,GFGCPNNYQCHRHCKSIPGRCGGYCGGWHRLRCTCYRC,38,"Defensin MGD-1 (molluscas, animals)","P80571, Q9Y0B0",Unknown,FH3,Mytilus galloprovincialis (Mediterranean mussel),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,"The three-dimensional solution structure of MGD-1 has been established using (1)H NMR and mainly consists of a helical part (Asn7-Ser16) and two antiparallel beta-strands (Arg20-Cys25 and Cys33-Arg37), together giving rise to the common cystine-stabilized alpha-beta motif frequently observed in scorpion toxins. In MGD-1, the cystine-stabilized alpha-beta motif is stabilized by four disulfide bonds (Cys4-Cys25, Cys10-Cys33, Cys14-Cys35, ",1FJN resolved by NMR.,"Function: Active against both Gram-positive and Gram-negative bacteria but is not cytotoxic towards human erythrocytes or protozoa.
Transgenic plants: expression of this peptide in tobacco improves resistance to pathogens.
PTM: Contains four disulfide bonds 4-25; 10-33; 14-35; 21-38.","Gram-positive bacteria: Micrococcus luteus (MIC=0.4 μM)&(MBC=1.5 μM), Bacillus megaterium (MIC=0.8 μM)&(MBC=1.5 μM), Staphylococcus aureus (MIC=0.6 μM)&(MBC=1.2 μM), Staphylococcus epidermidis (MIC=3.1 μM)&(MBC=6.2 μM), Enterococcus fecalis (MIC=0.6 μM)&(MBC=1.2 μM), Aerococcus viridans (MIC=0.4 μM)&(MBC=1.5 μM);##Gram-negative bacteria: Escherichia coli D31 (MIC=1.2 μM)&(MBC=1.2 μM), E. coli 363 (MIC=1.2 μM)&(MBC=1.2 μM), Salmonella newport (MIC>100 μM)&(MBC>100 μM), Vibrio alginolyticus (MIC=50 μM)&(MBC>100 μM), Vibrio harveyi (MIC=50 μM)&(MBC=100 μM), Vibrio metshnikovii (MIC>100 μM)&(MBC>100 μM).##NOTE: MIC=minimal inhibitory concentration; MBC = minimal bactericidal concentration.",Unknown,Unknown,10564642##8925841##11087396,J. Cell Sci. 1999;112:4233-4242.##Eur. J. Biochem. 1996;240:302-306.##Biochemistry 2000 Nov 28;39(47):14436-47.,"Mitta G, Vandenbulcke F, Hubert F, Roch P.##Hubert F, Noeel T, Roch P.##Yang YS, Mitta G, Chavanieu A, Calas B, Sanchez JF, Roch P, Aumelas A.",Mussel defensins are synthesised and processed in granulocytes then released into the plasma after bacterial challenge.##A member of the arthropod defensin family from edible Mediterranean mussels (Mytilus galloprovincialis).##Solution structure and activity of the synthetic four-disulfide bond Mediterranean mussel defensin (MGD-1).,,,,,,,,
717,DRAMP02817,VDKGSYLPRPTPPRPIYNRN,20,Pyrrhocoricin,"P37362, P80307",Belongs to the drosocin family,Unknown,Pyrrhocoris apterus (Sap sucking bug) (Cimex apterus),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,Unknown,4EZN resolved by X-ray.,"Function: Antibacterial peptide. Affects Gram-negative bacteria E.coli 1106, P.aeruginosa, E.coli D22 and E.cloacae and Gram-positive bacteria M.luteus and B.subtilis.","Gram-positive bacteria: Micrococcus luteus (MIC>80 μM in L.B, P.B), Bacillus megaterium (MIC>80 μM in L.B, P.B);##Gram-negative bacteria: Escherichia coliD22 (MIC=0.3 μM in L.B, P.B), A.tumefaciens (MIC=1.25 μM in LB and 3 μM in PB), Salmonella typhimurium (MIC=5 μM in L.B and 10 μM in P.B).",Unknown,Unknown,10076062##8002963##23562829,Biochim Biophys Acta. 1999 Feb 2;1426(3):459-467.##Biochem J. 1994 Jun 1;300 (Pt 2):567-575.##J Mol Biol. 2013 Jul 24;425(14):2463-2479.,"Hoffmann R, Bulet P, Urge L, Otvs L Jr.##Cociancich S, Dupont A, Hegy G, Lanot R, Holder F, Hetru C, Hoffmann JA, Bulet P.##Zahn M, Berthold N, Kieslich B, Knappe D, Hoffmann R, Strter N.","Range of activity and metabolic stability of synthetic antibacterial glycopeptides from insects.##Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus.##Structural Studies on the Forward and Reverse Binding Modes of Peptides to the Chaperone DnaK.",,,,,,,,
719,DRAMP01381,GLFTLIKGAAKLIGKTVPKKQARLGMNLWLVKLPTNVKT,39,"Odorranain-K1 (OdK1; Frogs, amphibians, animals)",A6MBN8,Unknown,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,Function: Odorranain-K1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=4.68 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=4.68 μg/ml), Bacillus subtilis (MIC=1.10 μg/ml).##Yeast: Candida albicans (MIC=1.10 μg/ml).",Unknown,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
720,DRAMP01383,ATAWDFGPHGLLPIRPIRIRPLCGKDKS,28,"Odorranain-M1 (OdM1; Frogs, amphibians, animals)",A6MBP6,Unknown,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,Function: Odorranain-M1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=9.37 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=4.68 μg/ml), Bacillus subtilis (MIC=75 μg/ml).##Yeast: Candida albicans (MIC=18.75 μg/ml). ",Unknown,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
721,DRAMP02841,RQKDKRPYSERKNQYTGPQFLYPPERIPPQKVIK,34,Lumbricin I(6-34),O96447,Unknown,Unknown,Synthetic construct (derived from residues 6-34 of lumbricin I),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Lumbricin I(6-34) has marginally stronger antimicrobial activities than lumbricin I. Has weak hemolytic activity  when tested against human erythrocytes.,"[Ref.9784609]Gram-positive bacteria: Bacillus subtilis ATCC 62037 (MIC=8 μg/ml), Staphylococcus aureus ATCC 15752 (MIC=12 μg/ml), Streptococcus mutans ATCC 25175 (MIC=20 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 27325 (MIC=8 μg/ml), Pseudomonas putidaATCC 17426 (MIC=12 μg/ml), Serratia sp. ATCC 21074 (MIC=12 μg/ml).##Fungi: Candida albicans ATCC 10231 (MIC=12 μg/ml), Cryptococcus neoformance ATCC 34881 (MIC=16 μg/ml), Saccharomyces cerevisiae ATCC 44774 (MIC=8 μg/ml).##NOTE: Minimal inhibitory concentrations were determined by incubating approximately 10^4-10^5 CFU/ml of cells with serial dilutions of each peptide in a 96-well microtiter plate..","[Ref.9784609]0.03% hemolytic activity at 5 μg/ml, 0.07% hemolytic activity at 10 μg/ml, 0.13% hemolytic activity at 25 μg/ml, 0.17% hemolytic activity at 50 μg/ml, 0.21% hemolytic activity at 100 μg/ml against human erythrocytes",Unknown,9784609,Biochim Biophys Acta. 1998 Oct 22;1408(1):67-76.,"Cho JH, Park CB, Yoon YG, Kim SC.","Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization.",,,,,,,,
722,DRAMP02843,ILKKWPWWPWRRKX,14,"chain a, Structure Of An Indolicidin Peptide Derivative",No entry found,Unknown,Unknown,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Non helix or strand structure,Unknown,1QXQ resolved by NMR.,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli (MIC=8 μg/ml), Pseudomonas aeruginosa (MIC=16 μg/ml), Salmonella typhimurium (MIC=64 μg/ml), S. typhimurium defensin sensitive (MIC=2 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml), Staphylococcus aureus (MRSA) (MIC=16 μg/ml), S. epidermidis (MIC=4 μg/ml), Enterococcus faecalis (MIC>64 μg/ml).",Unknown,Unknown,11123901,Biochemistry. 2000 Dec 26;39(51):15765-15774.,"Rozek A, Friedrich CL, Hancock RE.",Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles.,,,,,,,,
724,DRAMP02845,ICLKKWPWWPWRRCKX,16,"CP-11 (cathelicidin; mammals, animals)",No entry found,Unknown,Unknown,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Non helix or strand structure,Unknown,1QX9 resolved by NMR.,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli (MIC=16 μg/ml), Pseudomonas aeruginosa (MIC=64 μg/ml), Salmonella typhimurium(MIC=64 μg/ml), S. typhimurium defensin sensitive (MIC=4 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml), Staphylococcus aureus (MRSA) (MIC=16 μg/ml), S. epidermidis(MIC=8 μg/ml), Enterococcus faecalis (MIC=64 μg/ml).",Unknown,Unknown,11123901##14640680 ,Biochemistry. 2000 Dec 26;39(51):15765-15774.##Biochemistry. 2003 Dec 9;42(48):14130-14138.,"Rozek A, Friedrich CL, Hancock RE.##Rozek, A.; Powers, JP.; Friedrich, CL.; Hancock, RE. ",Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles.##Structure-based design of an indolicidin peptide analogue with increased protease stability. ,,,,,,,,
725,DRAMP02849,RFRPPIRRPPIRPPFYPPFRPPIRPPIFPPIRPPFRPPLRFP,42,"Bactenecin 5 (mammals, animals)",No entry found,Unknown,Unknown,Bos taurus (Bovine),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Salmonella typhimurium (MIC=2-10 μM), Klebsiella pneumoniae, Escherichia coli.",Unknown,Unknown,2229048,J Biol Chem. 1990 Nov 5;265(31):18871-18874.,"Frank RW, Gennaro R, Schneider K, Przybylski M, Romeo D.",Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils.,,,,,,,,
726,DRAMP02851,RLCRIVVIRVCR,12,"Cathelicidin-1 (Bactenecin-1, Bac1; Cyclic dodecapeptide; mammals, animals)","P22226, A5PJA3, Q24JY5",Belongs to the cathelicidin family,CATHL1,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Three disulfide bonds.,Unknown,"Function: Potent microbicidal activity; active against S.aureus and E.coli.
Tissue specificity: Large granules of neutrophils.
PTM: Contains three disulfide bonds.",Gram-positive bacterium: Staphylococcus aureus (MIC=1-8 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=8-25 μg/ml).,Unknown,Unknown,3290210,J Biol Chem. 1988 Jul 15;263(20):9573-9575.,"Romeo D, Skerlavaj B, Bolognesi M, Gennaro R.",Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils.,,,,,,,,
727,DRAMP02854,GGLRSLGRKILRAWKKYGPIIVPIIRIG,28,Cathelicidin-5 (Antibacterial peptide BMAP-28),"P54229, A5PJ96, B9UKL6",Belongs to the cathelicidin family,CATHL5,Bos taurus (Bovine),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Exerts a potent antimicrobial activity against Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, and fungi.
PTM: Contains two disulfide bonds. (By similarity)","Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 μM), E. coli ML35 (MIC=2 μM), E. coli D21 (MIC=0.5 μM), Salmonella typhimurium ATCC 14028 (MIC=1 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1 μM), Serratia marcescens ATCC 8100 (MIC=2 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 μM), Staphylococcus aureus Cowan 1 (MIC=1 μM), Staphylococcus aureus (MRSA) (MIC=4 μM), Staphylococcus epidermidis ATCC 12228 (MIC=1 μM), Bacillus megaterium Bm11 (MIC=2 μM).##Fungi: Candida albicans (MIC=8 μM), Cryptococcus neoformans (MIC=4 μM).",Unknown,Unknown,8910461##8706679,J Biol Chem. 1996 Nov 8;271(45):28375-28381.##Eur J Biochem. 1996 Jun 15;238(3):769-776.,"Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M.##Storici P, Tossi A, Lenarcic B, Romeo D.","Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.##Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides.",,,,,,,,
728,DRAMP02855,GRFKRFRKKFKKLFKKLSPVIPLLHLG,27,Cathelicidin-6 (Antibacterial peptide BMAP-27),"P54228, B9UKM5",Belongs to the cathelicidin family,CATHL6,Bos taurus (Bovine),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (2 helices; 19 residues),Unknown,2KET resolved by NMR.,"Function: Exerts a potent antimicrobial activity against Gram-negative and Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, and fungi.
PTM: Contains two disulfide bonds. (By similarity)","Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=1 μg/ml), E. coli ML35 (MIC=1 μg/ml), E. coli D21 (MIC=0.25 μg/ml), Salmonella typhimurium ATCC 14028 (MIC=1 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=1 μg/ml), Serratia marcescens ATCC 8100 (MIC=2 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 μg/ml), Staphylococcus aureus Cowan 1 (MIC=2 μg/ml), Staphylococcus aureus (MRSA) (MIC=4 μg/ml), S. epidermidis ATCC 12228 (MIC=1 μg/ml), Bacillus megaterium Bm11 (MIC=2 μg/ml).##Fungi: Candida albicans (MIC=8 μg/ml), Cryptococcus neoformans (MIC=4 μg/ml).",Unknown,Unknown,8910461##19136450##PubMed ID is not available,J. Biol. Chem. 1996;271:28375-28381.##J. Hered. 2009;100:241-245.##To be Published,"Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M.##Gillenwaters EN, Seabury CM, Elliott JS, Womack JE.##Yang S, Jung H, Kim J.",Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.##Sequence analysis and polymorphism discovery in 4 members of the bovine cathelicidin gene family.##solution structure of BMAP-27.,,,,,,,,
729,DRAMP02858,DFASCHTNGGICLPNRCPGHMIQIGICFRPRVKCCRSW,38,"Bovine Beta-defensin 1 (bBD-1; BNBD-1; BNDB-1; mammals, animals)",P46159 ,Belongs to the beta-defensin family,DEFB1,Bos taurus (Bovine),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Bridge ,Unknown,Unknown,"Function: Has bactericidal activity. Active against E. coli ML35 but not against S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35. (By similarity)",Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 μg/ml).,Unknown,Unknown,16777238,Vet Immunol Immunopathol. 2006 Sep 15;113(1-2):181-190. ,"Aono S, Li C, Zhang G, Kemppainen RJ, Gard J, Lu W, Hu X, Schwartz DD, Morrison EE, Dykstra C, Shi J.",Molecular and functional characterization of bovine beta-defensin-1.,,,,,,,,
730,DRAMP02859,VRNHVTCRINRGFCVPIRCPGRTRQIGTCFGPRIKCCRSW,40,"Bovine Beta-defensin 2 (bBD-2; BNBD-2; BNDB-2; mammals, animals)",P46160,Belongs to the beta-defensin family,DEFB2,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge ,Unknown,Unknown,"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 7-36; 14-29; 19-37. (By similarity)",Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 μg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 μg/ml).,Unknown,Unknown,8454635,J Biol Chem. 1993 Mar 25;268(9):6641-6648.,"Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.","Purification, primary structures, and antibacterial activities of Beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.",,,,,,,,
731,DRAMP02860,EGVRNHVTCRINRGFCVPIRCPGRTRQIGTCFGPRIKCCRSW,42,"Bovine Beta-defensin 3 (bBD-3; BNBD-3; BNDB-3; mammals, animals)",P46161,Belongs to the beta-defensin family,DEFB3,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge ,Unknown,Unknown,"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)",Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 μg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 μg/ml).,Unknown,Unknown,8454635##9488394,J Biol Chem. 1993 Mar 25;268(9):6641-6648.##Infect Immun. 1998 Mar;66(3):1045-1056.,"Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.##Tarver AP, Clark DP, Diamond G, Russell JP, Erdjument-Bromage H, Tempst P, Cohen KS, Jones DE, Sweeney RW, Wines M, Hwang S, Bevins CL.","Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.##Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.",,,,,,,,
732,DRAMP02861,QRVRNPQSCRWNMGVCIPFLCRVGMRQIGTCFGPRVPCCRR,41,"Bovine Beta-defensin 4 (bBD-4; BNBD-4; BNDB-4; mammals, animals)",P46162,Belongs to the beta-defensin family,DEFB4,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)",Gram-positive bacterium: Staphylococcus aureus 520A (MIC=10-300 μg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 μg/ml).,Unknown,Unknown,PubMed ID is not available##8454635,Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.##J Biol Chem. 1993 Mar 25;268(9):6641-6648.,"Yount N.Y, Yuan J, Diamond G, Tarver A, McGuire P.A, McCullough C, Cullor J.S, Bevins C.L, Selsted M.E.##Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.","Molecular cloning and expression of an antimicrobial beta-defensin from bovine neutrophils. Characterization of BNBD-4 cDNA and genomic sequences and localization of the peptide to large granules of mature neutrophils.##Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.",,,,,,,,
733,DRAMP02862,QVVRNPQSCRWNMGVCIPISCPGNMRQIGTCFGPRVPCCRRW,42,"Bovine Beta-defensin 5 (bBD-5; BNBD-5; BNDB-5; mammals, animals)","P46163, O97533",Belongs to the beta-defensin family,DEFB5,Bos taurus (Bovine),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has bactericidal activity. Active against E. coli ML35 but not against S. aureus 502A.
Tissue specificity: Neutrophilic granules. Alveolar macrophages.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)",Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 μg/ml).,Unknown,Unknown,8454635,J Biol Chem. 1993 Mar 25;268(9):6641-6648.,"Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.","Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.",,,,,,,,
734,DRAMP02863,QGVRNHVTCRIYGGFCVPIRCPGRTRQIGTCFGRPVKCCRRW,42,"Bovine Beta-defensin 6 (bBD-6; BNBD-6; BNDB-6; mammals, animals)",P46164,Belongs to the beta-defensin family,DEFB6,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)",Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 μg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 μg/ml).,Unknown,Unknown,8454635,J Biol Chem. 1993 Mar 25;268(9):6641-6648.,"Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.","Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.",,,,,,,,
735,DRAMP02865,VRNFVTCRINRGFCVPIRCPGHRRQIGTCLGPQIKCCR,38,"Bovine Beta-defensin 8 (bBD-8; BNBD-8; BNDB-8; mammals, animals)",P46166,Belongs to the beta-defensin family,DEFB8,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 7-36; 14-29; 19-37. (By similarity)",Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 μg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 μg/ml).,Unknown,Unknown,8454635,J Biol Chem. 1993 Mar 25;268(9):6641-6648.,"Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.","Purification, primary structures, and antibacterial activities of Beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.",,,,,,,,
736,DRAMP02866,QGVRNFVTCRINRGFCVPIRCPGHRRQIGTCLAPQIKCCR,40,"Bovine Beta-defensin 9 (bBD-9; BNBD-9; BNDB-9; mammals, animals)","P46167, O18814",Belongs to the beta-defensin family,DEFB9,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)",Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 μg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-301 μg/ml).,Unknown,Unknown,8454635##9488394,J Biol Chem. 1993 Mar 25;268(9):6641-6648.##Infect Immun. 1998 Mar;66(3):1045-1056.,"Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.##Tarver AP, Clark DP, Diamond G, Russell JP, Erdjument-Bromage H, Tempst P, Cohen KS, Jones DE, Sweeney RW, Wines M, Hwang S, Bevins CL.","Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.##Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.",,,,,,,,
737,DRAMP02867,QGVRSYLSCWGNRGICLLNRCPGRMRQIGTCLAPRVKCCR,40,"Bovine Beta-defensin 10 (bBD-10; BNBD-10; BNDB-10; mammals, animals)","P46168, Q5W5G8",Belongs to the beta-defensin family,DEFB10,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)",Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 μg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 μg/ml).,Unknown,Unknown,8454635##15520886,J Biol Chem. 1993 Mar 25;268(9):6641-6648.##Mamm Genome. 2004 Oct;15(10):834-842.,"Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.##Roosen S, Exner K, Paul S, Schröder JM, Kalm E, Looft C.","Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.##Bovine beta-defensins: identification and characterization of novel bovine beta-defensin genes and their expression in mammary gland tissue.",,,,,,,,
738,DRAMP02868,GPLSCRRNGGVCIPIRCPGPMRQIGTCFGRPVKCCRSW,38,"Bovine Beta-defensin 11 (bBD-11; BNBD-11; BNDB-11; mammals, animals)","P46169, Q5W5G7",Belongs to the beta-defensin family,DEFB11,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35. (By similarity)",Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 μg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 μg/ml).,Unknown,Unknown,8454635##15520886,J Biol Chem. 1993 Mar 25;268(9):6641-6648.##Mamm Genome. 2004 Oct;15(10):834-842.,"Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.##Roosen S, Exner K, Paul S, Schröder JM, Kalm E, Looft C.","Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.##Bovine beta-defensins: identification and characterization of novel bovine beta-defensin genes and their expression in mammary gland tissue.",,,,,,,,
739,DRAMP02869,GPLSCGRNGGVCIPIRCPVPMRQIGTCFGRPVKCCRSW,38,"Bovine Beta-defensin 12 (bBD-12; BNBD-12; BNDB-12; mammals, animals)",P46170,Belongs to the beta-defensin family,DEFB12,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand,Unknown,1BNB resolved by NMR.,"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35. (By similarity)",Gram-positive bacterium: Staphylococcus aureus 502A (MIC=10-300 μg/ml);##Gram-negative bacterium: Escherichia coli ML35 (MIC=10-300 μg/ml).,Unknown,Unknown,8454635##8454636,J Biol Chem. 1993 Mar 25;268(9):6641-6648.##J Biol Chem. 1993 Mar 25;268(9):6649-6653.,"Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.##Tang YQ, Selsted ME.","Purification, primary structures, and antibacterial activities of Beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.##Characterization of the disulfide motif in BNBD-12, an antimicrobial beta-defensin peptide from bovine neutrophils.",,,,,,,,
740,DRAMP02870,SGISGPLSCGRNGGVCIPIRCPVPMRQIGTCFGRPVKCCRSW,42,"Bovine Beta-defensin 13 (bBD-13; BNBD-13; BNDB-13; mammals, animals)",P46171,Belongs to the beta-defensin family,DEFB13,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)",Gram-positive bacterium: Staphylococcus aureus (MIC=10-300 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=10-300 μg/ml).,Unknown,Unknown,8454635,J Biol Chem. 1993 Mar 25;268(9):6641-6648.,"Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.","Purification, primary structures, and antibacterial activities of Beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.",,,,,,,,
741,DRAMP02872,GRFKRFRKKFKKLFKKLS,18,"Myeloid antimicrobial peptide BMAP-27 (1-18) (mammals, animals)",No entry found,Unknown,Unknown,Bos taurus (Bovine),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Also has antifungal activity.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 μM), Escherichia coli ML35 (MIC=4 μM), Escherichia coli D21 (MIC=4 μM), Salmonella typhimurium ATCC 14028 (MIC=4 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1 μM), Serratia marcescens ATCC 8100 (MIC=2 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 μM), Staphylococcus aureus Cowan 1 (MIC=2 μM), Staphylococcus aureus (MRSA) (MIC=4 μM), Staphylococcus epidermidis ATCC 12228 (MIC=1 μM), Bacillus megaterium Bm11 (MIC=2 μM).##Fungi: Candida albicans (MIC=16 μM), Cryptococcus neoformans (MIC=4 μM).",Unknown,Unknown,8910461,J Biol Chem. 1996 Nov 8;271(45):28375-28381.,"Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M.",Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.,,,,,,,,
742,DRAMP02873,GGLRSLGRKILRAWKKYG,18,"Myeloid antimicrobial peptide BMAP-28 (1-18) (mammals, animals)",No entry found,Unknown,Unknown,Bos taurus (Bovine),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Also has antifungal activity.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 μM), Escherichia coli ML35 (MIC=0.5 μM), Escherichia coli D21 (MIC=0.5 μM), Salmonella typhimurium ATCC14028 (MIC=2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1 μM), Serratia marcescens ATCC 8100 (MIC=2 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 μM), Staphylococcus aureus Cowan 1 (MIC=1 μM), Staphylococcus aureus (MIC=4 μM), Staphylococcus epidermidis ATCC 12228 (MIC=1 μM), Bacillus megaterium Bm11 (MIC=2 μM).##Fungi: Candida albicans (MIC=16 μM), Cryptococcus neoformans (MIC=2 μM).",Unknown,Unknown,8910461,J Biol Chem. 1996 Nov 8;271(45):28375-28381.,"Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M.",Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.,,,,,,,,
744,DRAMP02877,GGLRSLGRKILRAWKKYGPQATPATRQ,27,"mBMAP28 (mammals, animals)",No entry found,Unknown,Unknown,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 μM), Escherichia coli ML35 (MIC=0.5 μM), Salmonella typhimurium ATCC 14028 (MIC=1 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=0.5 μM), Serratia marcescens ATCC 8100 (MIC=4 μM).##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=8 μM), Staphylococcus aureus (MRSA) (MIC>64 μM), Staphylococcus epidermidis ATCC 12228 (MIC=2 μM), Bacillus megaterium Bm11 (MIC=2 μM).##Fungi: Candida albicans (MIC=8 μM), Cryptococcus neoformans (MIC=4 μM).",Unknown,Unknown,8910461,J. Biol. Chem. 1996; 271:28375-28381,"Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, Zanetti M.1996",Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities.,,,,,,,,
745,DRAMP02878,NPVSCVRNKGICVPIRCPGSMKQIGTCVGRAVKCCRKK,38,"Tracheal antimicrobial peptide (TAP; mammals, animals)","P25068, O97532",Belongs to the beta-defensin family (LAP/TAP subfamily),Unknown,Bos taurus (Bovine),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity in vitro. In addition, the peptide is active against Candida albicans, indicating a broad spectrum of activity.
Tissue specificity: Tracheal epithelium.
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35. (By similarity)","Gram-negative bacteria: Escherichia coli D31 (MIC=12-25 μg/ml), Klebsiella pneumoniae 13883 (MIC=12-25 μg/ml), Pseudomonas aeruginosa 27853 (MIC=25-50 μg/ml).##Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=25-50 μg/ml).##Fungi: Candida ablicans (MIC=6-12 μg/ml).",Unknown,Unknown,2023943##8506305,Proc Natl Acad Sci U S A. 1991 May 1;88(9):3952-3956.##Proc Natl Acad Sci U S A. 1993 May 15;90(10):4596-4600. ,"Diamond G, Zasloff M, Eck H, Brasseur M, Maloy WL, Bevins CL.##Diamond G, Jones DE, Bevins CL.","Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA.##Airway epithelial cells are the site of expression of a mammalian antimicrobial peptide gene.",,,,,,,,
746,DRAMP02903,ILGPILGLVSNALGGLL,17,Bombin H7,No entry found,Unknown,Unknown,Bombina orientalis ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Bacillus megaterium Bm11 (MIC=3.3 μM);##Gram-negative bacterium: Escherichia coli D22 (MIC=3.7 μM).,Unknown,Unknown,10333736,Biopolymers. 1998;47(6):435-450.,"Simmaco M, Mignogna G, Barra D.",Antimicrobial peptides from amphibian skin: what do they tell us?,,,,,,,,
747,DRAMP02910,LRRIIRKIIHIIKK,14,"Ovispirin-2 (OV-2; mammals, animals)",No entry found,Unknown,Unknown,Ovis aries (Sheep),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=0.03-16 μg/ml).,Unknown,Unknown,11557478,Antimicrob Agents Chemother. 2001 Oct;45(10):2838-2844.,"Saiman L, Tabibi S, Starner TD, San Gabriel P, Winokur PL, Jia HP, McCray PB Jr, Tack BF.",Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,,,,,,,,
748,DRAMP02911,IRRIIRKIIHIIKK,14,"Ovispirin-3 (OV-3; mammals, animals)",No entry found,Unknown,Unknown,Ovis aries (Sheep),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=1-8 μg/ml).,Unknown,Unknown,11557478,Antimicrob Agents Chemother. 2001 Oct;45(10):2838-2844.,"Saiman L, Tabibi S, Starner TD, San Gabriel P, Winokur PL, Jia HP, McCray PB Jr, Tack BF.",Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,,,,,,,,
751,DRAMP02922,KCWNLRGSCREKCIKNEKLYIFCTSGKLCCLKPK,34,"Canine beta-defensin (dogs, mammals, animals)",No entry found,Unknown,Unknown,Canis lupus familiaris (Dog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli 25922 (MIC=20 μg/ml), Escherichia coli 700336 (MIC=50 μg/ml);##Gram-positive bacteria: Klebsiella pneumoniae 10031 (MIC=20 μg/ml), Listeria monocytogenes 19115 (MIC=10 μg/ml), Staphylococcus aureus 10832 (MIC=100 μg/ml), N. gonorrhoeae 10150 (MIC=50 μg/ml).##Fungi: Candida albicans 14053 (MIC=50 μg/ml), Candida albicans 11006 (MIC=5 μg/ml).",Unknown,Unknown,15845463,Infect Immun. 2005 May;73(5):2611-2620.,"Sang Y, Ortega MT, Blecha F, Prakash O, Melgarejo T.",Molecular cloning and characterization of three beta-defensins from canine testes.,,,,,,,,
752,DRAMP02923,KCWNLRGSCREKCIKNEKLYIFCTSGKLCCLKPKFQPNMLQR,42,"cBD-1 (Canine beta-defensin 1; dogs, mammals, animals)",No entry found,Unknown,Unknown,Canis Lupis (Dog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Listeria monocytogenes(MIC=6 mμg/ml), Staphylococcus aureus (MIC=100 mμg/ml);##Gram-negative bacteria: Escherichia coli (MIC=20-25 mμg/ml), Klebsiella pneumoniae (MIC=20 mμg/ml), Neisseria gonorrhoeae (MIC=50 mμg/ml).##Yeast: Candida albicans (MIC=5-50 mμg/ml).",Unknown,Unknown,15845463,Infect Immun. 2005 May;73(5):2611-2620.,"Sang Y, Ortega MT, Blecha F, Prakash O, Melgarejo T.",Molecular cloning and characterization of three beta-defensins from canine testes.,,,,,,,,
755,DRAMP02925,RLKELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS,38,"Cathelicidin (dogs, mammals, animals)",No entry found,Unknown,Unknown,Canis lupus familiaris (Dog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli (MIC=1.25 μM), Klebsiella pneumoniae (MIC=1.25 μM), Salmonella serotype Typhimurium (MIC=1.25 μM), Pseudomonas aeruginosa (MIC=1.25 μM), Proteus mirabilis (MIC=1.25 μM), Salmonella serotype Enteritidis (MIC=0.5 μM), Neisseria gonorrhoeae (MIC=0.06 μM).##Gram-positive bacteria: Listeria monocytogenes (MIC=0.5 μM), Staphylococcus aureus (MIC=50 μM).##Fungi: Candida albicans (MIC=12.5-50 μM).",Unknown,Unknown,17462733,Dev Comp Immunol. 2007;31(12):1278-1296.,"Sang Y, Teresa Ortega M, Rune K, Xiau W, Zhang G, Soulages JL, Lushington GH, Fang J, Williams TD, Blecha F, Melgarejo T.","Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide.",,,,,,,,
756,DRAMP02931,SPRVSRRYGRPFGGRPFVGGQFGGRPGCVCIRSPCPCANYG,41,"Arasin-likeSp (crabs, Arthropods, animals)",No entry found,Unknown,Unknown,Scylla paramamosain (Mud crab),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus haemolyticus (MIC=6.25-12.5 μM), Aerococcus viridans (MIC=0.19-0.39 μM), Micrococcus luteus (MIC=0.39-0.78 μM), Bacillus subtilis (MIC=6.25-12.5 μM);##Gram-negative bacteria: Escherichia coli 363 (MIC>50 μM), Aeromonas hydrophila (MIC>50 μM), V. harveyi (MIC=0.78-1.56 μM), Vibrio anguillarum (MIC=3.125-6.25 μM).",Unknown,Unknown,21220028,Fish Shellfish Immunol. 2011 Feb;30(2):706-712.,"Imjongjirak C, Amparyup P, Tassanakajon A.","Two novel antimicrobial peptides, arasin-likeSp and GRPSp, from the mud crab Scylla paramamosain, exhibit the activity against some crustacean pathogenic bacteria.",,,,,,,,
758,DRAMP02933,RRWCFRVCYRGFCYRKCR,18,"Polyphemusin-1 (PM1; crabs, Arthropods, animals)",P14215,Belongs to the tachyplesin/polyphemusin family,Unknown,Limulus polyphemus (Atlantic horseshoe crab),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (2 strands; 4 residues),"The solution structure of polyphemusin I is determined using (1)H-NMR spectroscopy. Polyphemusin I is found to be an amphipathic, beta-hairpin connected by a type I' beta-turn.",1RKK resolved by NMR.,"Function: PM1 showes high antimicrobial activity against the Gram-negative, Gram-positive and fungal specimens tested.
Tissue specificity: Hemocytes.
PTM: Contains two disulfide bonds 4-17; 8-13 and C-terminal amidation.","Gram-negative bacteria: Escherichia coli UB1005 (MIC=0.5 μg/ml), E. coli DC2 (MIC=1 μg/ml), Salmonella typhimurium (defensin-sensitive) (MIC=0.25 μg/ml), S. typhimurium (MIC=1 μg/ml), Pseudomonas aeruginosa K799 (MIC=2 μg/ml), P. aeruginosa Z61 (MIC=1 μg/ml);##Gram-positive bacteria: Staphylococcus aureus SAP0017 (MIC=2 μg/ml), Staphylococcus epidermidis (MIC=1 μg/ml), Enterococcus faecalis (MIC=1 μg/ml).##Yeasy: Candida albicans (MIC=4 μg/ml).",Unknown,Unknown,2514185##15134657,J Biochem. 1989 Oct;106(4):663-668.##Biochim Biophys Acta. 2004 May 6;1698(2):239-250.,"Miyata T, Tokunaga F, Yonega T, Yoshikawa K, Iwanaga S, Niwa M, Takao T, Shimonishi Y.##Powers JP, Rozek A, Hancock RE.","Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity.##Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I.",,,,,,,,
759,DRAMP02934,RRWSFRVSYRGFSYRKSR,18,PM1-S (linear derivative of PM1),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,No secondary structure (CD),"The CD spectra of PM1-S indicates that, in all environments (phosphate buffer, TFE, and liposomes), the peptide displays no observable patterns that could be related to structural features. This indicates that PM1-S is a flexible molecule with no favoured conformation.",Unknown,Function: PM1-S remaines active against Gram-negative bacteria but displayed poor activity to both Gram-positive and fungal microorganisms.,"Gram-negative bacteria: Escherichia coli UB1005 (MIC=4 μg/ml), E. coli DC2 (MIC=4 μg/ml), Salmonella typhimurium (defensin-sensitive) (MIC=2 μg/ml), S. typhimurium (MIC=8 μg/ml), Pseudomonas aeruginosa K799 (MIC=32 μg/ml), P. aeruginosa Z61 (MIC=16 μg/ml);##Gram-positive bacteria: Staphylococcus aureus SAP0017 (MIC=32 μg/ml), Staphylococcus epidermidis (MIC=16 μg/ml), Enterococcus faecalis (MIC=2 μg/ml).##Yeasy: Candida albicans (MIC=64 μg/ml).",Unknown,Unknown,15134657,Biochim Biophys Acta. 2004 May 6;1698(2):239-250.,"Powers JP, Rozek A, Hancock RE.",Structure-activity relationships for the beta-hairpin cationic antimicrobial peptide polyphemusin I.,,,,,,,,
760,DRAMP02950,YVDREINLFDHYCIISRSPHISRWELKWQATVTCPGWTPVKGKVRGYSNPLSAEREATRDFVQRIVQRGLVTRDEASEWL,80,"PtALF5 (Portunus trituberculatus anti-lipopolysaccharide factor isoform 5; crabs, Arthropods, animals)",No entry found,Unknown,Unknown,Portunus trituberculatus (Swimming Crab),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Contains a signal peptide and an LPS-binding Domain: (CIISRSPHISRWELKWQATVTC) and two conserved cysteine residues which can form a disulfide bridge. PtALF5 transcript in hemocytes showes a clear time-dependent response expression pattern with obvious decrease at 6 h and significant increase at 24 h. The recombinant PtALF5 has antimicrobial activity against Gram-negative bacteria Vibrio alginolyticus and Pseudomonas aeruginosa.,"Gram-negative bacteria: Vibrio alginolyticus (MIC=3.89-7.78 μM), Edwardsiella tarda (MIC=7.78-15.54 μM), Pseudomonas aeruginosa (MIC=15.54-31.08 μM).",Unknown,Lipopolysaccharide (LPS)-binding,21362485##22516300,Fish Shellfish Immunol. 2011 Jul;31(1):29-42.##Fish Shellfish Immunol. 2012 Jul;33(1):85-91.,"Liu Y, Cui Z, Song C, Wang S, Li Q.##Liu Y, Cui Z, Li X, Song C, Li Q, Wang S.","Multiple isoforms of immune-related genes from hemocytes and eyestalk cDNA libraries of swimming crab Portunus trituberculatus.##Molecular cloning, expression pattern and antimicrobial activity of a new isoform of anti-lipopolysaccharide factor from the swimming crab Portunus trituberculatus.",,,,,,,,
761,DRAMP02951,MARVSLLLIVLSIALVAPSQGFLKDLLFGEAKTALLEDGTTEILDHVCNFRVMPRLRSWELYFRGDVWCPGWTVIKGESL,80,"PtALF6 (Portunus trituberculatus anti-lipopolysaccharide factor isoform 6; crabs, Arthropods, animals)",No entry found,Unknown,Unknown,Portunus trituberculatus (Swimming Crab),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Contains a signal peptide and an LPS-binding Domain: (CNFPVMPRLRSWELYFRGDVWC) and two conserved cysteine residues which can form a disulfide bridge.,"Gram-negative bacteria: Vibrio alginolyticus L59 (MIC=1.17-2.33 μM), Pseudomonas aeruginosa P25 (MIC=9.32-18.64 μM);##Gram-positive bacteria: Micrococcus luteus M2 (MIC=9.32-18.64 μM), Staphylococcus aureus S7 (MIC=9.32-18.64 μM).##Fungi: Pichia pastoris GS115 (MIC>74.57 μM).",Unknown,Lipopolysaccharide (LPS)-binding,21362485##23257203,Fish Shellfish Immunol. 2011 Jul;31(1):29-42.##Fish Shellfish Immunol. 2013 Feb;34(2):463-470.,"Liu Y, Cui Z, Song C, Wang S, Li Q.##Liu Y, Cui Z, Li X, Song C, Shi G.",Multiple isoforms of immune-related genes from hemocytes and eyestalk cDNA libraries of swimming crab Portunus trituberculatus.##A newly identified anti-lipopolysaccharide factor from the swimming crab Portunus trituberculatus with broad spectrum antimicrobial activity.,,,,,,,,
762,DRAMP02952,MRKGVVTGLFVALVVMCLYLPQPCEAQYEALTAAILTKLSKMWHSDTLNFLGHTCHVSRTPTVKRFKLYWKGKFWCPGWA,80,"PtALF7 (Portunus trituberculatus anti-lipopolysaccharide factor isoform 7; crabs, Arthropods, animals)",No entry found,Unknown,Unknown,Portunus trituberculatus (Swimming Crab),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Contains a signal peptide and an LPS-binding Domain: (CHVSRTPTVKRFKLYWKGKFWC) and two conserved cysteine residues which can form a disulfide bridge.,"Gram-negative bacteria: Vibrio alginolyticus (MIC=0.51-1.02 μM), Edwardsiella tarda (MIC=2.04-4.07 μM), Pseudomonas aeruginosa (MIC=1.02-2.04 μM);##Gram-positive bacteria: Micrococcus luteus (MIC=32.59-65.19 μM), Staphylococcus aureus (MIC=8.15-16.30 μM).##Fungi: Pichia pastoris (MIC>130.37 μM).",Unknown,Lipopolysaccharide (LPS)-binding,21362485##23261507,Fish Shellfish Immunol. 2011 Jul;31(1):29-42.##Fish Shellfish Immunol. 2013 Feb;34(2):652-659.,"Liu Y, Cui Z, Song C, Wang S, Li Q.##Liu Y, Cui Z, Li X, Song C, Shi G, Wang C.","Multiple isoforms of immune-related genes from hemocytes and eyestalk cDNA libraries of swimming crab Portunus trituberculatus.##Molecular cloning, genomic structure and antimicrobial activity of PtALF7, a unique isoform of anti-lipopolysaccharide factor from the swimming crab Portunus trituberculatus.",,,,,,,,
763,DRAMP02953,SRWPSPGRPRPFPGRPKPIFRPRPCNCYAPPCPCDRW,37,"Arasin-1 (Pro-rich, Arg-rich; crabs, Arthropods, animals)",A6XMY0,Unknown,Unknown,Hyas araneus (Great spider crab) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Corynebacterium glutamicum (MIC=0.8 μM), Listonella anguillarum (MIC=6.3 μM);##Gram-negative bacterium: Escherichia coli (MIC=12.5 μM).",Unknown,Unknown,17658600,Dev Comp Immunol. 2008;32(3):275-285.,"Stensvag K, Haug T, Sperstad S.V, Rekdal O, Indrevoll B, Styrvold O.B.","Arasin 1, a proline-arginine-rich antimicrobial peptide isolated from the spider crab, Hyas araneus.",,,,,,,,
764,DRAMP02956,SHQDCYEALHKCMASHSKPFSCSMKFHMCLQQQ,33,Dolabellanin B2,P83376,Unknown,Unknown,Dolabella auricularia (Sea hare),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. Also possesses antifungal activity.
PTM: Contains two disulfide bonds. Up to two of the methionines may be oxidized to methionine sulfoxides.","Gram-positive bacteria: Bacillus subtilis RIMD0225014 (MIC=2.5 μg/ml), Staphylococcus aureus IID1677 (MRSA) (MIC=20.0 μg/ml), Listeria monocytogenes VIU206 (MIC=40.0 μg/ml).##Gram-negative bacteria: Haemophilus influenzae IID983 (MIC=5.0 μg/ml), V. vulnificus RIMD2219009 (MIC=5.0 μg/ml), Escherichia coli JM109 (MIC=20.0 μg/ml), E. coli DH5α± (MIC=40.0 μg/ml).##Fungi: Candida albicans ATCC36232, Candida tropicalis TIMM0313, S. pombe IFO1628, Saccharomyces cerevisiae A581A.",Unknown,Unknown,12590964,Dev. Comp. Immunol. 2003;27:305-311.,"Iijima R, Kisugi J, Yamazaki M.",A novel antimicrobial peptide from the sea hare Dolabella auricularia.,,,,,,,,
765,DRAMP02959,RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP,39,"Antibacterial protein PR-39 (pigs, mammals, animals)","P80054, Q9TR84",Belongs to the cathelicidin family,PR39,Sus scrofa (Pig),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Rich,Unknown,Unknown,"Tissue specificity: Small intestine and bone marrow.
PTM: Proline amide at P39.","Gram-negative bacteria: Escherichia coli K12 D21 (MIC=0.3 μM), Escherichia coli Bd2221175 (MIC=0.3 μM), Salmonella typhimurium LT2 (MIC=1μM), Proteus vulgaris Pvll (MIC=300 μM), Pseudomonas aeruginosa OT97 (MIC=200 μM), Acinetobacter calcoaceticus Acl 1 (MIC=3 μM).##Gram-positive bacteria: Bacillus megaterium (MIC=0.3 μM), Bacillus subtilis (MIC=15 μM), Staphylococcus aureus (MIC=200 μM), Streptococcus pyogenes (MIC=2 μM).",Unknown,Unknown,1765098##7624374,Eur J Biochem. 1991 Dec 18;202(3):849-854.##Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):7085-7089.,"Agerberth B, Lee JY, Bergman T, Carlquist M, Boman HG, Mutt V, Jrnvall H.##Gudmundsson GH, Magnusson KP, Chowdhary BP, Johansson M, Andersson L, Boman HG.","Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides.##Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39.",,,,,,,,
766,DRAMP02960,RIIDLLWRVRRPQKPKFVTVWVR,23,"Antibacterial peptide PMAP-23 (Myeloid antibacterial peptide 23; pigs, mammals, animals)",P49930,Belongs to the cathelicidin family,PMAP23,Sus scrofa (Pig),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Alpha helix ,Unknown,Unknown,"Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria at concentrations of 2-16 micro molar. Its activity appears to be mediated by its ability to damage bacterial membranes.
PTM: Contains two disulfide bonds (By similarity).","Gram-negative bacteria: Escherichia coli ML35 (MIC=2 μM), Escherichia coli ATCC 25922 (MIC=4 μM), Salmonella typhimurium ATCC 14028 (MIC=8 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μM).##Gram-positive bacteria: Bacillus megaterium (MIC=2 μM), Staphylococcus aureus ATCC 25923 (MIC=4 μM).",Unknown,Cell membrane,8132502,J Biol Chem. 1994 Mar 18;269(11):7855-7858.,"Zanetti M, Storici P, Tossi A, Scocchi M, Gennaro R.",Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells.,,,,,,,,
767,DRAMP02961,GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSEFFQS,37,"Antibacterial peptide PMAP-37 (Myeloid antibacterial peptide 37; pigs, mammals, animals)",P49932,Belongs to the cathelicidin family,PMAP37,Sus scrofa (Pig),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Alpha helix ,Unknown,Unknown,"Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria with minimal inhibitory concentrations ranging over 1-4 micro molar. Its activity appears to be mediated by its ability to damage bacterial membranes.
PTM: Contains two disulfide bonds (By similarity).","Gram-negative bacteria: Escherichia coli ML35 (MIC=2 μM), Escherichia coli ATCC 25922 (MIC=1 μM), Escherichia coli D21 (MIC=2 μM), Salmonella typhimurium ATCC 14028 (MIC=4 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=2 μM).##Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=4 μM), Bacillus megaterium local isolate (IC=4 μM), Staphylococcus aureus ATCC 25923 (MIC=32 μM), Staphylococcus aureus Cowan 1 (MIC=64 μM).",Unknown,Cell membrane,7737198,Eur J Biochem. 1995 Mar 15;228(3):941-946.,"Tossi A, Scocchi M, Zanetti M, Storici P, Gennaro R.","PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity.",,,,,,,,
768,DRAMP02962,GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG,36,"Antibacterial peptide PMAP-36 (Myeloid antibacterial peptide 36; pigs, mammals, animals)",P49931,Belongs to the cathelicidin family,PMAP36,Sus scrofa (Pig),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria. Its activity appears to be mediated by its ability to damage bacterial membranes.
PTM: Contains two disulfide bonds (By similarity).","Gram-negative bacteria: Escherichia coli ML 35 (MIC=12 μM), Escherichia coli ATCC 25922 (MIC=12 μM), Salmonella typhimurium ATCC 14028 (MIC=48 μM), Pseudomonas aeruginosa ATCC 25873 (MIC=3 μM).##Gram-positive bacteria: Bacillus megaterium local isolate (MIC=3 μM), Staphylococcus aureus ATCC 25923 (MIC=6 μM).",Unknown,Cell membrane,8293820,FEBS Lett. 1994 Jan 17;337(3):303-307.,"Storici P, Scocchi M, Tossi A, Gennaro R, Zanetti M.",Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA.,,,,,,,,
769,DRAMP02963,GRFRRLRKKTRKRLKKIGKV,20,PMAP-36(1-20),No entry found,Unknown,Unknown,Sus scrofa (Pig),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria. ,"Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=6 μM), Bacillus megaterium Bm11 (MIC=3 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12 μM), E. coli ML35 (MIC=12 μM), S. enterica ser. Typhimurium ATCC 14028 (MIC=48 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=3 μM).##Fungi: Candida albicans c.i. (MIC>64 μM).",Unknown,Unknown,16128809,FEBS J. 2005 Sep;272(17):4398-4406.,"Scocchi M, Zelezetsky I, Benincasa M, Gennaro R, Mazzoli A, Tossi A.",Structural aspects and biological properties of the cathelicidin PMAP-36.,,,,,,,,
770,DRAMP02964,GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLG,34,PMAP-36(1-34),No entry found,Unknown,Unknown,Sus scrofa (Pig),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria. ,"Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=1 μM), S. aureus 710A (MIC=2 μM), S. aureus SA-62 (MRSA) (MIC=4 μM), Bacillus megaterium Bm11 (MIC=1 μM), S. epidermidis ATCC 12228 (MIC=1 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 μM), E. coli ML35 (MIC=1 μM), E. coli D21 (MIC=1 μM), E. coli D22 (MIC=0.5 μM), S. enterica ser. Typhimurium ATCC 14028 (MIC=1 μM), S. enterica ser. Enteritidis H2 (MIC=1 μM), P. aeruginosa ATCC 27853 (MIC=1 μM), S. marcescens ATCC 8100 (MIC=2 μM).##Fungi: Candida albicans c.i. (MIC=8 μM), Cryptococcus neoformans c.i.(MIC=2 μM).",Unknown,Unknown,16128809,FEBS J. 2005 Sep;272(17):4398-4406.,"Scocchi M, Zelezetsky I, Benincasa M, Gennaro R, Mazzoli A, Tossi A.",Structural aspects and biological properties of the cathelicidin PMAP-36.,,,,,,,,
771,DRAMP02965,GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGC,35,PMAP-36(1-35)2,No entry found,Unknown,Unknown,Sus scrofa (Pig),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Exerts antimicrobial activity against both Gram-positive and negative bacteria. ,"Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 μM), S. aureus 710A (MIC=2 μM), S. aureus SA-62 (MRSA) (MIC=4 μM), Bacillus megaterium Bm11 (MIC=1 μM), S. epidermidis ATCC 12228 (MIC=1 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 μM), E. coli ML35 (MIC=0.5 μM), E. coli D21 (MIC=0.5 μM), E. coli D22 (MIC=0.5 μM), S. enterica ser. Typhimurium ATCC 14028 (MIC=1 μM), S. enterica ser. Enteritidis H2 (MIC=0.5 μM), P. aeruginosa ATCC 27853 (MIC=1 μM), S. marcescens ATCC 8100 (MIC=2 μM).##Fungi: Candida albicans c.i. (MIC=16 μM), Cryptococcus neoformans c.i.(MIC=2 μM).",Unknown,Unknown,16128809,FEBS J. 2005 Sep;272(17):4398-4406.,"Scocchi M, Zelezetsky I, Benincasa M, Gennaro R, Mazzoli A, Tossi A.",Structural aspects and biological properties of the cathelicidin PMAP-36.,,,,,,,,
772,DRAMP02966,KQATVGDINTERPGILDLKGKAKWDAWNGLKGTSKEDAMKAYINKVEELKKKYGI,55,"DBI(32-86) (pigs, mammals, animals)","P12026, A7YB23, Q9TSG2",Belongs to the ACBP family,DBI,Sus scrofa (Pig),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: DBI(32-86) has antibacterial properties.,Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=0.69 μM);##Gram-negative bacteria: Escherichia coli D22 (MIC=30 μM).,Unknown,Unknown,8375398##3289918,Eur J Biochem. 1993 Sep 1;216(2):623-629.##Eur J Biochem. 1988 Jun 1;174(2):239-245.,"Agerberth B, Boman A, Andersson M, Jrnvall H, Mutt V, Boman HG.##Chen ZW, Agerberth B, Gell K, Andersson M, Mutt V, Ostenson CG, Efendi S, Barros-Sderling J, Persson B, Jrnvall H.","Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910.##Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release.",,,,,,,,
773,DRAMP02970,RGGRLCYCRRRFCVCVGR,18,"Protegrin-1 (Protegrin 1; PG-1; pigs, mammals, animals)",P32194,Belongs to the cathelicidin family,NPG1,Sus scrofa (Pig),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand,Unknown,1PG1 resolved by NMR.,The sequence of IB-367 is RGGLCYCRGRFCVCVGR and the peptide is active against bacteria and fungi. This peptide showed synergistic effect with LL-37 against P. aeruginosa and E. coli (Yan H & Hancock REW 2001 Antimicrob Agents Chemother 45: 1558-60). PG-1 derivatives were subjected to clinical trials. ,"Gram-negative bacteria: Escherichia coli (MIC=64 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=64 μg/ml), Staphylococcus epidermidis (MIC=2 μg/ml).",Unknown,Cell membrane,8647100,Chem Pharm Bull (Tokyo). 1995 May;43(5):853-858.,"Tamamura H, Murakami T, Horiuchi S, Sugihara K, Otaka A, Takada W, Ibuka T, Waki M, Yamamoto N, Fujii N.",Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity.,,,,,,,,
774,DRAMP02975,VRRFPWWWPFLRR,13,"Tritrpticin (Trp-rich; pigs, mammals, animals)",No entry found,Belongs to the cathelicidin family,Unknown,Sus scrofa (Pig),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix (1 helices; 3 residues),Unknown,1D6X resolved by NMR.,Function: Tritrpticin has strong antimicrobial activity with a wide spectrum.,"Gram-negative bacteria: Escherichia coli (5 mm), Pseudomonas aeruginosa (3 mm), Klebsiella pneumonia (7 mm), Proteus mirabilis (1 mm);##Gram-positive bacteria: Staphylococcus epidermidis (5 mm), Streptococcus group D (4 mm). [inhibit zones in mm]##Fungi: Aspergillus fumigatus (MIC=250 μg/ml).",Unknown,Unknown,8706838##10606506,FEBS Lett. 1996 Jul 15;390(1):95-98.##Biochemistry. 1999 Dec 21;38(51):16749-55.,"Lawyer C, Pai S, Watabe M, Borgia P, Mashimo T, Eagleton L, Watabe K.Schibli DJ, Hwang PM, Vogel HJ.##Schibli DJ, Hwang PM, Vogel HJ.",Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides.##Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membrane-bound peptide fold.,,,,,,,,
776,DRAMP01376,GFMDTAKNAAKNVAVTLLDNLKCKITKAC,29,"Odorranain-F1 (OdF1; Frogs, amphibians, animals)",A6MBL3,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Odorranain-F1 adopts 55% ,Unknown,Function: Odorranain-F1 exhibites antimicrobial activities against the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Also has hemolytic activity against rabbiit red cell.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=4.20 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=2.10 μg/ml), Bacillus subtilis (MIC=8.40 μg/ml).##Yeast: Candida albicans (MIC=1.05 μg/ml).","[Ref.17272268] RCH=15.4 ± 3.5% using rabbit red blood cells. RCH, red cell hemolysis.",Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
777,DRAMP01377,FMPILSCSRFKRC,13,"Odorranain-G1 (OdG1; Frogs, amphibians, animals)","A6MBL7, A6MBL8",Unknown,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Odorranain-G1 adopts 44.1% β-sheet structure in water solution.,Unknown,Function: Odorranain-G1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Has no hemolytic activity against red cell.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=4.68 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=9.37 μg/ml), Bacillus subtilis (MIC=37.5 μg/ml).##Yeast: Candida albicans (MIC=1.10 μg/ml).",[Ref:17272268] Non-hemolytic activity against rabbit red blood cells,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
778,DRAMP02995,QERGSIVIQGTKEGKSRPSLDIDYKQRVYDKNGMTGDAYGGLNIRPGQPSRQHAGFEFGKEYKNGFIKGQSEVQRGPGGRLSPYFGINGGFRF,93,"Hymenoptaecin (Insects, animals)",Q10416,Unknown,Unknown,Apis mellifera (Honeybee),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli K514 (MIC=0.5-1 μM), E. coli K514 anaerobic, E. coli NCTC9001 (MIC=1-5 μM), Xanthomonas campestris (MIC=0.5-1 μM), Pseudomonas solanacearum (MIC>10 μM), Erwinia carotovora ssp.(MIC=1-5 μM);##Gram-positive bacteria: Micrococcus lysodeikticus (MIC=1-5 μM), Bacillus megaterium (MIC=0.5-1 μM).",Unknown,Unknown,8463238,J Biol Chem. 1993 Apr 5;268(10):7044-7054.,"Casteels P, Ampe C, Jacobs F, Tempst P.","Functional and chemical characterization of Hymenoptaecin, an antibacterial polypeptide that is infection-inducible in the honeybee (Apis mellifera).",,,,,,,,
779,DRAMP02996,GNNRPIYIPQPRPPHPRL,18,"Apidaecin-2 (Apidaecin II; Insects, animals)","Q06601, P11525, P11526, P11527",Belongs to the apidaecin family,APID14,Apis mellifera (Honeybee),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Agrobacterium tumefaciens (MIC=0.2 μg/ml), Erwinia salicis (MIC=0.02 μg/ml), Escherichia coli (MIC=0.2 μg/ml), Pseudomonas syringae (MIC=0.1 μg/ml), Rhizobium meliloti (MIC=0.02 μg/ml), Salmonella Newport (MIC=0.2 μg/ml), Salmonella typhimurium (MIC=0.1 μg/ml);##Gram-positive bacteria: Shigella flexneri (MIC=0.1 μg/ml), Corynebacterium insidiosum (MIC=100 μg/ml), Bacillus megaterium (MIC=100 μg/ml)",Unknown,Unknown,2676519,EMBO J. 1989 Aug;8(8):2387-2391.,"Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P.",Apidaecins: antibacterial peptides from honeybees.,,,,,,,,
780,DRAMP01378,GIFGKILGVGKKVLCGLSGVC,21,"Odorranain-H1 (OdH1; Frogs, amphibians, animals)",A6MBN4,Unknown,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Odorranain-H1 adopts 50.3 β-sheet structure in water solution.,Unknown,Function: Odorranain-H1 exhibites antimicrobial activities against Gram-positive and Gram-negative bacteria and fungi. Also has hemolytic activity against rabbit red cell.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=23.60 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=5.90 μg/ml), Bacillus subtilis (MIC=5.90 μg/ml).##Yeast: Candida albicans (MIC=11.80 μg/ml).","[Ref.17272268] RCH=21.6 ± 7.3% using rabbit red blood cells. RCH, red cell hemolysis.",Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
781,DRAMP02998,GNNRPVYIPQPRPPHPRI,18,"Apidaecin-1A (Apidaecin IA; Insects, animals)","Q06602, P11525, P11526",Belongs to the apidaecin family,APID73,Apis mellifera (Honeybee),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Agrobacterium tumefaciens (MIC=0.2 μg/ml), Erwinia salicis (MIC=0.02 μg/ml), Escherichia coli (MIC=0.1 μg/ml), Pseudomonas syringae (MIC=0.2 μg/ml), Rhizobium meliloti (MIC=0.1 μg/ml), Salmonella Newport (MIC=0.2 μg/ml), Salmonella typhimurium (MIC=0.1 μg/ml), Shigella flexneri (MIC=0.1 μg/ml);##Gram-positive bacteria: Corynebacterium insidiosum (MIC=50 μg/ml), Bacillus megaterium (MIC=150 μg/ml)",Unknown,Unknown,2676519,EMBO J. 1989 Aug;8(8):2387-2391.,"Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P.",Apidaecins: antibacterial peptides from honeybees.,,,,,,,,
782,DRAMP02999,PFKISIHL,8,"Jellein-1 (Jelleine-I; chain of Major royal jelly protein 1; Insects, animals)","O18330, Q548D6",Belongs to the major royal jelly protein family,MRJP1,Apis mellifera (Honeybee),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Jellein-1 has antibacterial and antifungal activity.
Tissue specificity: Found in the hypopharyngeal glands of the worker honeybee.
Developmental stage: Produced in the cephalic glands of both the nurse bee and the forager bee. This bee milk protein changes to alpha-glucosidase in accordance with the age-dependent role change of the worker bee.
Miscellaneous: Exhibits a growth factor-like action on primary-cultured rat hepatocytes by stimulating DNA synthesis and protecting cells from apoptosis induced by serum deprivation. Also activates mitogen-activated protein kinase, as well as protein kinase B, a key regulator of cell survival. Degraded proportionally to the period of storage, and is completely lost during storage at 40 degrees Celsius for 30 days. PTM: Histidine amide at H7.","Gram-positive bacteria: Staphylococcus aureus ATCC 6535 (MIC=10 μg/ml), S. saprophyticus (MIC=15 μg/ml), Bacillus subtilis CCT 2471 (MIC=10 μg/ml).##Gram-negative bacteria: Escherichia coli CCT 1371 (MIC=2.5 μg/ml), Enterobacter cloacae ACCT 23355 (MIC=10 μg/ml), Klebsiella pneumoniae ACCT 13883 (MIC=10 μg/ml), Pseudomonas aeruginosa ACCT 27853 (MIC=10 μg/ml).##Yeast: Candida albicans (MIC=2.5 μg/ml).",Unknown,Unknown,15203237##9395329##21516106,Peptides. 2004 Jun;25(6):919-928.##Eur J Biochem. 1997 Nov 1;249(3):797-802.##Nature. 2011 May 26;473(7348):478-483.,"Fontana R, Mendes MA, de Souza BM, Konno K, César LM, Malaspina O, Palma MS.##Ohashi K, Natori S, Kubo T.##Kamakura M.",Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera).##Change in the mode of gene expression of the hypopharyngeal gland cells with an age-dependent role change of the worker honeybee Apis mellifera L.##Royalactin induces queen differentiation in honeybees.,,,,,,,,
783,DRAMP03000,TPFKISIHL,9,"Jellein-2 (Jelleine-II; chain of Major royal jelly protein 1; Insects, animals)","O18330, Q548D6",Belongs to the major royal jelly protein family,MRJP1,Apis mellifera (Honeybee),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Jellein-2 has antibacterial and antifungal activity. Jellein-2 is probably processed to yield jellein-1 and jellein-4.
Tissue specificity: Found in the hypopharyngeal glands of the worker honeybee.
Developmental stage: Produced in the cephalic glands of both the nurse bee and the forager bee. This bee milk protein changes to alpha-glucosidase in accordance with the age-dependent role change of the worker bee.
Miscellaneous: Exhibits a growth factor-like action on primary-cultured rat hepatocytes by stimulating DNA synthesis and protecting cells from apoptosis induced by serum deprivation. Also activates mitogen-activated protein kinase, as well as protein kinase B, a key regulator of cell survival. Degraded proportionally to the period of storage, and is completely lost during storage at 40 degrees Celsius for 30 days. PTM: Leucine amide at L9.","Gram-positive bacteria: Staphylococcus aureus ATCC 6535 (MIC=15 μg/ml), S. saprophyticus (MIC=10 μg/ml), Bacillus subtilis CCT 2471 (MIC=30 μg/ml);##Gram-negative bacteria: Escherichia coli CCT 1371 (MIC=15 μg/ml), Enterobacter cloacae ACCT 23355 (MIC=15 μg/ml), Klebsiella pneumoniae ACCT 13883 (MIC=15 μg/ml), Pseudomonas aeruginosa ACCT 27853 (MIC=15 μg/ml).##Yeast: Candida albicans (MIC=2.5 μg/ml).",Unknown,Unknown,15203237##9395329##21516106,Peptides. 2004 Jun;25(6):919-928.##Eur J Biochem. 1997 Nov 1;249(3):797-802.##Nature. 2011 May 26;473(7348):478-483.,"Fontana R, Mendes MA, de Souza BM, Konno K, César LM, Malaspina O, Palma MS.##Ohashi K, Natori S, Kubo T.##Kamakura M.",Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera).##Change in the mode of gene expression of the hypopharyngeal gland cells with an age-dependent role change of the worker honeybee Apis mellifera L.##Royalactin induces queen differentiation in honeybees.,,,,,,,,
784,DRAMP03001,EPFKISIHL,9,"Jellein-3 (Jelleine-III; Insects, animals)",P84759,Unknown,MRJP1,Apis mellifera (Honeybee),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Jellein-3 has antibacterial and antifungal activity.
Tissue specificity: Found in the hypopharyngeal glands of the worker honeybee.
PTM: Leucine amide at L9.","Gram-positive bacteria: Staphylococcus aureus ATCC 6535 (MIC=30 μg/ml), S. saprophyticus (MIC=30 μg/ml);##Gram-negative bacteria: Escherichia coli CCT1371 (MIC=15 μg/ml), Enterobacter cloacae ATCC 23355, Klebsiella pneumoniae ATCC 13883, Pseudomonas aeruginosa ATCC 27853 (MIC=30 μg/ml).##Yeast: Candida albicans.",Unknown,Unknown,15203237,Peptides. 2004 Jun;25(6):919-928.,"ntana R, Mendes MA, de Souza BM, Konno K, César LM, Malaspina O, Palma MS.",Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera).,,,,,,,,
785,DRAMP03002,GIGAVLKVLTTGLPALISWIKRKRQQ,26,"Melittin (Allergen Api m 3; Allergen Api m III; Insects, animals)","P01501, P01503",Belongs to the melittin family,MELT,Apis mellifera (Honeybee),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,"2MLT, 3QRX resolved by X-ray.##1BH1 resolved by NMR.","Function: Main toxin of bee venom with strong hemolytic activity. Forms a pore in the cell membrane by inserting into lipid bilayers in an alpha-helical conformation and has multiple effects, probably, as a result of its interaction with negatively charged phospholipids. It inhibits well known transport pumps such as the Na+-K+-ATPase and the H+-K+-ATPase. It increases the permeability of cell membranes to ions, particularly Na+ and indirectly Ca2+, because of the Na+-Ca2+-exchange. It acts synergistically with phospholipase A2.","[Ref.20472009]Gram-negative bacteria: Escherichia coli D21 (MIC=0.8 μM), Pseudomonas aeruginosa OT97 (MIC=3 μM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.2 μM), Bacillus megaterium Bm11 (MIC=0.6 μM), Staphylococcus aureus Cowan 1 (MIC=0.2 μM), Streptococcus pyogenes (MIC=0.5 μM).",[Ref.20472009]95% hemolytic activity at 3 μM against erythrocytes,Cell membrane (forms a transmembrane alpha-helix in the Cell membrane.,6309516##20472009##20403370,Eur J Biochem. 1983 Sep 1;135(1):123-126.##Peptides. 2010 Aug;31(8):1473-1479.##Toxicon. 2010 Sep 1;56(3):355-362.,"Vlasak R, Unger-Ullmann C, Kreil G, Frischauf AM.##Sciani JM, Marques-Porto R, Loureno Junior A, Orsi Rde O, Ferreira Junior RS, Barraviera B, Pimenta DC.##Ferreira Junior RS, Sciani JM, Marques-Porto R, Junior AL, Orsi Rde O, Barraviera B, Pimenta DC.",Nucleotide sequence of cloned cDNA coding for honeybee prepromelittin.##Identification of a novel melittin isoform from Africanized Apis mellifera venom.##Africanized honey bee (Apis mellifera) venom profiling: Seasonal variation of melittin and phospholipase A(2) levels.,,,,,,,,
786,DRAMP03003,GFLSILKKVLPKVMAHMK,18,"Melectin (MEP; Insects, animals)",P86170,Unknown,Unknown,Melecta albifrons (Cuckoo bee) (Melecta punctata),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against Gram-positive bacteria as well as Gram-negative bacteria. Stimulates degranulation from rat peritoneal mast cells with an EC50 of 19.4 μM. Has weak hemolytic activity towards rat erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.","[Ref.18942691]Gram-positive bacteria: Bacillus subtilis (MIC=0.8 μM), Staphylococcus aureus (MIC=6.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.0 μM), Pseudomonas aeruginosa (MIC=18.5 μM).",[Ref.18942691]LC50>100 μM against rat red blood cells,Unknown,18942691,Chembiochem. 2008 Nov 24;9(17):2815-2821.,"Cerovský V, Hovorka O, Cvacka J, Voburka Z, Bednárová L, Borovicková L, Slaninová J, Fucík V.",Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons.,,,,,,,,
787,DRAMP03007,GFLSALKKYLPIVLKHV,17,"Osmin (Insects, animals)",P0CD70,Unknown,Unknown,Osmia rufa (Red mason bee),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (CD),"In absence of TFE, the spectrum shows a random coil type structure. When increasing the concentration of TFE from 0 to 20%, a transition into an α-helix structure is observed.",Unknown,"Function: Synthetic peptide exhibits hemolytic activity to human erythrocytes and inhibits bacterial and fungal growth at micromolar concentrations. A synthetic peptide with a free C-terminus shows weaker hemolytic (5.0 HU/mg), antibacterial and antifungal activities.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.",[Ref.19109988]Gram-positive bacterium: Micrococcus luteus (MIC=1.56-0.78 μM);##Gram-negative bacterium: Escherichia coli SBS363 (MIC=3.125-1.56 μM);##fungi: Fusarium oxysporum (MIC=0.78-0.39 μM).,[Ref.19109988]5.0 HU/mg hemolytic activity against human erythrocytes,Unknown,19109988,Toxicon. 2010 Jan;55(1):20-27.,"cklin R, Favreau P, Thai R, Pflugfelder J, Bulet P, Mebs D.",Structural identification by mass spectrometry of a novel antimicrobial peptide from the venom of the solitary bee Osmia rufa (hymenoptera: megachilidae).,,,,,,,,
788,DRAMP03019,INWLKLGKKILGAL,14,Mastoparan PDD-B,No entry found,Belongs to the mastoparan family,Unknown,Polistes dorsalis dorsolis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial activity. PDD-B has hemolytic activity.,[Ref.18375018]Gram-positive bacterium: Bacillus subtilis (MIC=70 μM);##Gram-negative bacterium: Escherichia coli (MIC=15.5 μM).,[Ref.18375018]IC50=45 μM against rat red blood cells,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
789,DRAMP03020,INWKKIFEKVKNLV,14,Mastoparan PDD-A,No entry found,Belongs to the mastoparan family,Unknown,Polistes dorsalis dorsolis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial activity. PDD-A shows little hemolytic activity.,[Ref.18375018]Gram-positive bacterium: Bacillus subtilis (MIC=11.8 μM);##Gram-negative bacterium: Escherichia coli (MIC=7.5 μM).,[Ref.18375018]IC50>100 μM against rat red blood cells,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
790,DRAMP03021,INWKKIASIGKEVLKAL,17,Mastoparan PMM,No entry found,Belongs to the mastoparan family,Unknown,Polistes major major,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial activity. Shows hemolytic activity.,[Ref.18375018]Gram-positive bacterium: Bacillus subtilis (MIC=7.3 μM);##Gram-negative bacterium: Escherichia coli (MIC=25.8 μM).,[Ref.18375018]IC50=80 μM against rat red blood cells,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
791,DRAMP03022,INWLKLGKKMMSAL,14,Mastoparan MP,No entry found,Belongs to the mastoparan family,Unknown,Mischocyttarus phthisicus,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Has antibacterial activity. Has hemolytic activity.,[Ref.18375018]Gram-positive bacterium: Bacillus subtilis (MIC=9 μM);##Gram-negative bacterium: Escherichia coli (MIC=65 μM).,[Ref.18375018]IC50=100 μM against rat red blood cells,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
792,DRAMP03028,IDWKKLLDAAKQIL,14,"Mastoparan-1 (MP-1; Venom protein MP-1; Insects, animals)","P0C1Q4, P84878",Unknown,Unknown,Polybia paulista (Neotropical social wasp) (Swarm-founding polistine wasp),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Chemotactic peptide for polymorphonucleated leukocytes (PMNL), but causing no hemolysis to rat erythrocytes and no mast cell degranulation activity at physiological concentrations.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14)","Gram-positive bacteria: Bacillus subtilis CCT 2576 (MIC=4 μg/ml), Staphylococcus aureus ATCC 6538 (MIC=15 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 15422 (MIC=8 μg/ml).",Unknown,Unknown,16129513,Peptides. 2005 Nov;26(11):2157-2164.,"Souza BM, Mendes MA, Santos LD, Marques MR, César LM, Almeida RN, Pagnocca FC, Konno K, Palma MS.",Structural and functional characterization of two novel peptide toxins isolated from the venom of the social wasp Polybia paulista.,,,,,,,,
793,DRAMP03033,INWKGIAAMAKKLL,14,"Mastoparan-like peptide 12a (Insects, animals)",P0C1M4,Unknown,Unknown,Vespa magnifica (Hornet),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Mast cell degranulating peptide. Has little hemolytic activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14). ",[Ref.17046111]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=7.5 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.7 μg/ml);##Fungi: Candida albicans ATCC 2002 (MIC=3.7 μg/ml).,[Ref.16330062]Little hemolytic activity at 50 μg/ml against rabbit red blood cells,Unknown,16330062##17046111,Toxicon. 2006 Feb;47(2):249-253.##Peptides. 2006 Dec;27(12):3053-3057.,"Xu X, Li J, Lu Q, Yang H, Zhang Y, Lai R.##Xu X, Yang H, Yu H, Li J, Lai R.",Two families of antimicrobial peptides from wasp (Vespa magnifica) venom.##The mastoparanogen from wasp.,,,,,,,,
794,DRAMP03034,INWKGIAAMKKLL,13,"Mastoparan-like peptide 12b (Insects, animals)",P0C1M5,Unknown,Unknown,Vespa magnifica (Hornet),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Mast cell degranulating peptide. Has little hemolytic activity. Shows antimicrobial activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L13).",[Ref.16330062]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.7 μg/ml);##Fungi: Candida albicans ATCC 2002 (MIC=7.5 μg/ml).,[Ref.16330062]Little hemolytic activity at 50 μg/ml against rabbit red blood cells,Unknown,16330062,Toxicon. 2006 Feb;47(2):249-53. Epub 2005 Dec 5. Peptides. 2006 Dec;27(12):3053-7. Epub 2006 Oct 13.,"Xu X, Li J, Lu Q, Yang H, Zhang Y, Lai R.Xu X, Yang H, Yu H, Li J, Lai R.",Two families of antimicrobial peptides from wasp (Vespa magnifica) venomThe mastoparanogen from wasp.,,,,,,,,
795,DRAMP03035,INLKAIAALAKKLLG,15,"Mastoparan-like peptide 12c (Insects, animals)",A0SPI0,Unknown,Unknown,Vespa magnifica (Hornet),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows mast cell degranulation and antimicrobial activities.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14). ",Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.0 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.0 μg/ml).##Fungi: Candida albicans ATCC 2002 (MIC=12.0 μg/ml).,Unknown,Unknown,17046111,Peptides. 2006 Dec;27(12):3053-3057.,"Xu X, Yang H, Yu H, Li J, Lai R.",The mastoparanogen from wasp.,,,,,,,,
796,DRAMP03036,INLKAIAAMAKKLL,14,"Mastoparan-like peptide 12d (Insects, animals)",P0C5G7,Unknown,Unknown,Vespa magnifica (Hornet),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows mast cell degranulation and antimicrobial activities.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14). ",Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.0 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=1.5 μg/ml).##Fungi: Candida albicans ATCC 2002 (MIC=12.0 μg/ml).,Unknown,Unknown,17046111,Peptides. 2006 Dec;27(12):3053-3057.,"Xu X, Yang H, Yu H, Li J, Lai R.",The mastoparanogen from wasp.,,,,,,,,
797,DRAMP03037,LNLKGIFKKVASLLT,15,"Eumenitin (Er-12; Insects, animals)",P0C931,Unknown,Unknown,Eumenes rubronotatus (Solitary wasp),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Cationic linear alpha-helical antimicrobial peptide that binds preferentially to charged lipid membranes as compared with zwitterionic ones. It exhibits inhibitory activity against both Gram-positive and Gram-negative bacteria, and moderately stimulates degranulation from the rat peritoneal mast cells. Does not show hemolytic activity. May play a role in preventing infection by microorganisms during prey consumption by their larvae.
Tissue specificity: Expressed by the venom gland.","[Ref.16762455]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC>60 μM), Staphylococcus aureus ATCC 25923 (MIC=6 μM), Staphylococcus saprophytius (CS) (MIC=6 μM), Staphylococcus epidermius (CS) (MIC>60 μM), Bacillus subtilis CCT 2471 (MIC=60 μM), Bacillus thuringiensis (WT) (MIC>60 μM);##Gram-negative bacteria: Escherichia coli CCT 1371 (MIC=6 μM), Escherichia coli ATCC 25922 (MIC=6 μM), Escherichia cloacae ATCC 23355 (MIC>60 μM), Proteus mirabilis (CS) (MIC>60 μM), Pseudomonas aeruginosa ATCC 15442 (MIC=30 μM).",[Ref.16762455]Non-hemolytic activity against human erythrocytes,Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen,16762455##18206199,Peptides. 2006 Nov;27(11):2624-2631.##Toxicon. 2008 Apr;51(5):736-745.,"Konno K, Hisada M, Naoki H, Itagaki Y, Fontana R, Rangel M, Oliveira JS, Cabrera MP, Neto JR, Hide I, Nakata Y, Yasuhara T, Nakajima T.##Arcisio-Miranda M, dos Santos Cabrera MP, Konno K, Rangel M, Procopio J.","Eumenitin, a novel antimicrobial peptide from the venom of the solitary eumenine wasp Eumenes rubronotatus.##Effects of the cationic antimicrobial peptide eumenitin from the venom of solitary wasp Eumenes rubronotatus in planar lipid bilayers: surface charge and pore formation activity.",,,,,,,,
798,DRAMP03038,LNLKGLIKKVASLLN,15,"Eumenitin-R (Insects, animals)",P0CJ36,Unknown,Unknown,Eumenes rubrofemoratus (Solitary wasp),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Linear cationic alpha-helical peptide that acts as antimicrobial peptide by forming pore in membrane. Has antibacterial activities against both Gram-positive and Gram-negative strains. Has more potent activities against the yeast C.albicans. Shows moderate mast cell degranulation and leishmanicidal activities. Has a very low hemolytic activity against mice erythrocytes.
Tissue specificity: Expressed by the venom sac.","[Ref.21549739]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=60 μM), Staphylococcus epidermidis (clinical sample) (MIC=30 μM), Micrococcus luteus ATCC 10240 (MIC=15 μM), Streptococcus pyogenes (clinical sample) (MIC=15 μM), Bacillus subtilis ATCC 6633 (MIC=7.5 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 μM), Proteus mirabilis (clinical sample) (MIC=60 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=30 μM), Stenotrophomonas maltophilia ATCC 13637 (MIC=15 μM);##Fungi: Candida albicans ATCC 90112 (MIC<7.5 μM).",[Ref.21549739]EC50=530.3 μM against mice erythrocytes,Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen,21549739,Toxicon. 2011 Jun;57(7-8):1081-1092.,"Rangel M, Cabrera MP, Kazuma K, Ando K, Wang X, Kato M, Nihei K, Hirata IY, Cross TJ, Garcia AN, Faquim-Mauro EL, Franzolin MR, Fuchino H, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.",Chemical and biological characterization of four new linear cationic α-helical peptides from the venoms of two solitary eumenine wasps.,,,,,,,,
799,DRAMP03039,LNLKGLFKKVASLLT,15,"Eumenitin-F (Insects, animals)",P0CJ37,Unknown,Unknown,Eumenes fraterculus (Solitary wasp),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Linear cationic alpha-helical peptide that acts as antimicrobial peptide by forming pore in membrane. Has antibacterial activities against both Gram-positive and Gram-negative strains. Has more potent activities against the yeast C.albicans. Shows moderate mast cell degranulation and leishmanicidal activities. Has a very low hemolytic activity against mice erythrocytes.
Tissue specificity: Expressed by the venom sac.","[Ref.21549739]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>60 μM), Staphylococcus epidermidis (clinical sample) (MIC=30 μM), Micrococcus luteus ATCC 10240 (MIC=30 μM), Streptococcus pyogenes (clinical sample) (MIC=30 μM), Bacillus subtilis ATCC 6633 (MIC=30 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 μM), Proteus mirabilis (clinical sample) (MIC>60 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=30 μM), Stenotrophomonas maltophilia ATCC 13637 (MIC=15 μM);##Fungi: Candida albicans ATCC 90112 (MIC=7.5 μM).",[Ref.21549739]EC50=353.4 μM against mice erythrocytes,Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen,21549739,Toxicon. 2011 Jun;57(7-8):1081-1092.,"Rangel M, Cabrera MP, Kazuma K, Ando K, Wang X, Kato M, Nihei K, Hirata IY, Cross TJ, Garcia AN, Faquim-Mauro EL, Franzolin MR, Fuchino H, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.",Chemical and biological characterization of four new linear cationic α-helical peptides from the venoms of two solitary eumenine wasps.,,,,,,,,
800,DRAMP03040,FDVMGIIKKIAGAL,14,"Eumenine mastoparan-EF (EMP-EF; Insects, animals)",P0CJ39,Unknown,Unknown,Eumenes fraterculus (Solitary wasp),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Linear cationic alpha-helical peptide that acts as antimicrobial peptide by forming pore in membrane. Has antibacterial activities against both Gram-positive and Gram-negative strains. Has more potent activities against the yeast C.albicans. Shows moderate mast cell degranulation and leishmanicidal activities. Has a very low hemolytic activity against mice erythrocytes.
Tissue specificity: Expressed by the venom sac.
PTM: C-terminal amidation (Leucine amide: L14).","[Ref.21549739]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=30 μM), Staphylococcus epidermidis (clinical sample) (MIC=30 μM), Micrococcus luteus ATCC 10240 (MIC=30 μM), Streptococcus pyogenes (clinical sample) (MIC>30 μM), Bacillus subtilis ATCC 6633 (MIC=30 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 μM), Proteus mirabilis (clinical sample) (MIC=60 μM), Pseudomonas aeruginosa ATCC 27853 (MIC>30 μM), Stenotrophomonas maltophilia ATCC 13637 (MIC>30 μM);##Fungi: Candida albicans ATCC 90112 (MIC=7.5 μM).",[Ref.21549739]EC50=181.1 μM against mice erythrocytes,Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen,21549739,Toxicon. 2011 Jun;57(7-8):1081-1092.,"Rangel M, Cabrera MP, Kazuma K, Ando K, Wang X, Kato M, Nihei K, Hirata IY, Cross TJ, Garcia AN, Faquim-Mauro EL, Franzolin MR, Fuchino H, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.",Chemical and biological characterization of four new linear cationic α-helical peptides from the venoms of two solitary eumenine wasps.,,,,,,,,
801,DRAMP03041,FDIMGLIKKVAGAL,14,"Eumenine mastoparan-ER (EMP-ER; Insects, animals)",P0CJ38,Unknown,Unknown,Eumenes rubrofemoratus (Solitary wasp),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Linear cationic alpha-helical peptide that acts as antimicrobial peptide by forming pore in membrane. Has antibacterial activities against both Gram-positive and Gram-negative strains. Has more potent activities against the yeast C.albicans. Shows moderate mast cell degranulation and leishmanicidal activities. Has a very low hemolytic activity against mice erythrocytes.
Tissue specificity: Expressed by the venom sac.
PTM: C-terminal amidation (Leucine amide: L14).","[Ref.21549739]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=30 μM), Staphylococcus epidermidis (clinical sample) (MIC=30 μM), Micrococcus luteus ATCC 10240 (MIC>30 μM), Streptococcus pyogenes (clinical sample) (MIC>30 μM), Bacillus subtilis ATCC 6633 (MIC=30 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=30 μM), Proteus mirabilis (clinical sample) (MIC=60 μM), Pseudomonas aeruginosa ATCC 27853 (MIC>30 μM), Stenotrophomonas maltophilia ATCC 13637 (MIC>30 μM);##Fungi: Candida albicans ATCC 90112 (MIC=7.5 μM).",[Ref.21549739]EC50=200 μM against mice erythrocytes,Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen,21549739,Toxicon. 2011 Jun;57(7-8):1081-1092.,"Rangel M, Cabrera MP, Kazuma K, Ando K, Wang X, Kato M, Nihei K, Hirata IY, Cross TJ, Garcia AN, Faquim-Mauro EL, Franzolin MR, Fuchino H, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.",Chemical and biological characterization of four new linear cationic α-helical peptides from the venoms of two solitary eumenine wasps.,,,,,,,,
802,DRAMP03042,INLLKIAKGIIKSL,14,"Eumenine mastoparan-AF (EMP-AF; Af-113; Insects, animals)",P0C022,Unknown,Unknown,Anterhynchium flavomarginatum micado (Solitary wasp),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Mast cell degranulating peptide. Also permeates anionic liposomes. Has hemolytic activity. Has an amphiphilic alpha-helix conformation. Shows broad-spectrum antimicrobial activity. Blocks the lobster neuromuscular transmission. Induces the depolarization of the muscle membrane.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14).","[Ref.15317499]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC=5 μg/ml), S. saprophyticus CS (MIC=5 μg/ml), S. epidermidis CS (MIC=5 μg/ml), Bacillus subtilis CCT 2471 (MIC=40 μg/ml);##Gram-negative bacteria: Escherichia coli CCT 1371 (MIC=20 μg/ml), Escherichia coli ATCC 25922 (MIC=50 μg/ml), Pseudomonas aeruginosa ATCC 15442 (MIC=20 μg/ml).",[Ref.10775751]100% hemolytic activity against human erythrocytes at 10^-4 M,Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen,15317499##11006592##10775751,J Pept Res. 2004 Sep;64(3):95-103.##Rapid Commun Mass Spectrom. 2000;14(19):1828-1834.##Toxicon. 2000 Nov;38(11):1505-1015.,"dos Santos Cabrera M.P, de Souza B.M, Fontana R, Konno K, Palma M.S, de Azevedo W.F. Jr, Neto J.R.##Hisada M, Konno K, Itagaki Y, Naoki H, Nakajima T.##Konno K, Hisada M, Naoki H, Itagaki Y, Kawai N, Miwa A, Yasuhara T, Morimoto Y, Nakata Y.","Conformation and lytic activity of eumenine mastoparan: a new antimicrobial peptide from wasp venom.##Advantages of using nested collision induced dissociation/post-source decay with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: sequencing of novel peptides from wasp venom.##Structure and biological activities of eumenine mastoparan-AF (EMP-AF), a new mast cell degranulating peptide in the venom of the solitary wasp (Anterhynchium flavomarginatum micado).",,,,,,,,
803,DRAMP03043,INWLKLGKAIIDAL,14,"Agelaia-mastoparan (Agelaia-MP; Insects, animals)",P69436,Unknown,Unknown,Agelaia pallipes pallipes (Neotropical social wasp),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Hemolytic mast cell degranulator, presenting no antimicrobial action and no chemotaxis for polymorphonucleated leukocytes (PMNL).
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14).","[Ref.15225564]Gram-negative bacteria: Escherichia coli (MIC=382 μg/ml), Pseudomonas aeruginosa (MIC=257 μg/ml);##Gram-positive bacteria: Bacillus subtilis (MIC=237 μg/ml), Staphylococcus aureus (MIC=191 μg/ml).",[Ref.15225564]70% hemolytic activity at 156 ng/ml against rat erythrocytes,Unknown,15225564##15052574,Toxicon. 2004 Jul;44(1):67-74.##Rapid Commun Mass Spectrom. 2004;18(6):636-642.,"Mendes MA, de Souza BM, Marques MR, Palma MS.##Mendes MA, Monson de Souza B, Delazari dos Santos L, Palma MS.",Structural and biological characterization of two novel peptides from the venom of the neotropical social wasp Agelaia pallipes pallipes.##Structural characterization of novel chemotactic and mastoparan peptides from the venom of the social wasp Agelaiapallipes pallipes by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.,,,,,,,,
804,DRAMP03044,ILGTILGLLKGL,12,"Protonectin (Agelaia-chemotactic peptide, Agelaia-CP; Insects, animals)",P69437,Unknown,Unknown,Agelaia pallipes pallipes (Neotropical social wasp),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Mast cell degranulator that induces a potent chemotaxis in polymorphonucleated leukocyte (PMNL) cells. Shows potent antimicrobial action against both Gram-positive and Gram-negative bacteria. Shows no hemolytic activity.,"[Ref.15225564]Gram-negative bacteria: Escherichia coli (MIC=25 μg/ml), Pseudomonas aeruginosa (MIC=1.7 μg/ml);##Gram-positive bacteria: Bacillus subtilis (MIC=3.1 μg/ml), Staphylococcus aureus (MIC=12.5 μg/ml).",[Ref.15052574]Non-hemolytic activity against rat red blood cell,Unknown,15225564##15052574,Toxicon. 2004 Jul;44(1):67-74.##Rapid Commun Mass Spectrom. 2004;18(6):636-642.,"Mendes MA, de Souza BM, Marques MR, Palma MS.##Mendes MA, Monson de Souza B, Delazari dos Santos L, Palma MS.",Structural and biological characterization of two novel peptides from the venom of the neotropical social wasp Agelaia pallipes pallipes.##Structural characterization of novel chemotactic and mastoparan peptides from the venom of the social wasp Agelaiapallipes pallipes by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.,,,,,,,,
805,DRAMP03045,VTCELLMFGGVVGDSACAANCLSMGKAGGSCNGGLCDCRKTTFKELWDKRFG,52,"Defensin-NV (Insects, animals)",No entry found,Unknown,Unknown,Nasonia vitripennis (Ectoparasitic wasp),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Bridge,Unknown,Unknown,"Function: Defensin-NV had little hemolytic activity to rabbit red blood cells and has antimicrobial activity against Gram-positive, Gram-negative bacteria, and Fungi.","[Ref.20362606]Gram-positive bacteria: Staphylococcus aureus (MIC=0.93 μM), Bacillus cereus (MIC=0.93 μM), B. dysenteriae (MIC=0.46 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.86 μM), Pseudomonas aeruginosa (MIC=9.3 μM).##Yeast: Candida albicans (MIC=1.86 μM).",[Ref.20362606]5% hemolytic activity at 200 μg/ml against rabbit red blood cells,Unknown,20362606,Toxicon. 2010 Aug 1;56(1):101-106.,"Ye J, Zhao H, Wang H, Bian J, Zheng R.",A defensin antimicrobial peptide from the venoms of Nasonia vitripennis.,,,,,,,,
807,DRAMP03047,EPILGIITSLLKSL,14,"Venom peptide 2-long (OdVP2L; analog of OdVP2; Insects, animals)","P86147, C7DT08",Belongs to the MCD family (Protonectin subfamily),VP2,Orancistrocerus drewseni (Solitary wasp),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has potent hemolytic activity against ovine erythrocytes at micromolar concentrations.
Tissue specificity: Expressed by the venom gland.","[Swiss_Prot Entry P86147]Fungi: Botrytis cinerea (MIC=0.5 μg/ml), Candida albicans (MIC=100 μg/ml);##Gram-positive bacterium: S. aureus (MIC=25 μg/ml);##Gram-negative bacterium: Escherichia coli.",[Swiss_Prot Entry P86147]has potent hemolytic activity against ovine erythrocytes at micromolar concentrations,Unknown,19857508##18695936,Toxicon. 2010 Apr 1;55(4):711-718.##Amino Acids. 2009 Jul;37(2):389-394.,"Baek JH, Lee SH.##Murata K, Shinada T, Ohfune Y, Hisada M, Yasuda A, Naoki H, Nakajima T.","Isolation and molecular cloning of venom peptides from Orancistrocerus drewseni (Hymenoptera: Eumenidae).##Novel mastoparan and protonectin analogs isolated from a solitary wasp, Orancistrocerus drewseni drewseni.",,,,,,,,
808,DRAMP03050,INWKKIAEVGGKILSSL,17,"Dominulin-A (Insects, animals)",P0C1M6,Belongs to the MCD family (Mastoparan subfamily),Unknown,Polistes dominulus (European paper wasp),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Shows antimicrobial activity.,Gram-positive bacterium: Bacillus subtilis ATCC 6633 (MIC=2 μg/ml);##Gram-negative bacterium: Escherichia coli JM109 (MIC=8 μg/ml).,Unknown,Unknown,16446098,J Am Soc Mass Spectrom. 2006 Mar;17(3):376-383.,"Turillazzi S, Mastrobuoni G, Dani FR, Moneti G, Pieraccini G, la Marca G, Bartolucci G, Perito B, Lambardi D, Cavallini V, Dapporto L.","Dominulin A and B: two new antibacterial peptides identified on the cuticle and in the venom of the social paper wasp Polistes dominulus using MALDI-TOF, MALDI-TOF/TOF, and ESI-ion trap.",,,,,,,,
809,DRAMP03051,INWKKIAEIGKQVLSAL,17,"Dominulin-B (Insects, animals)",P0C1M7,Belongs to the MCD family (Mastoparan subfamily),Unknown,Polistes dominulus (European paper wasp),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Shows antimicrobial activity.,Gram-positive bacterium: Bacillus subtilis ATCC 6633 (MIC=2 μg/ml);##Gram-negative bacterium: Escherichia coli JM109 (MIC=8 μg/ml).,Unknown,Unknown,16446098,J Am Soc Mass Spectrom. 2006 Mar;17(3):376-383.,"Turillazzi S, Mastrobuoni G, Dani FR, Moneti G, Pieraccini G, la Marca G, Bartolucci G, Perito B, Lambardi D, Cavallini V, Dapporto L.","Dominulin A and B: two new antibacterial peptides identified on the cuticle and in the venom of the social paper wasp Polistes dominulus using MALDI-TOF, MALDI-TOF/TOF, and ESI-ion trap.",,,,,,,,
813,DRAMP03055,YVPPVQKPHPNGPKFPTFP,19,"PP30 (Pro-rich; abaecin-like; Insects, animals)",No entry found,Unknown,Unknown,Pteromalus puparum (wasp),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=23.3±2.1 μM);##Gram-positive bacteria: Bacillus subtilis (MIC=16.7±2.1 μM), Staphylococcus aureus (MIC=133.3±11.6 μM), Sarcina lutea (MIC=13.3±1.2 μM), Bacillus pumilu (MIC=13.3±2.1 μM).",Unknown,Unknown,20466006,J Invertebr Pathol. 2010 Sep;105(1):24-29.,"Shen X, Ye G, Cheng X, Yu C, Altosaar I, Hu C.",Characterization of an abaecin-like antimicrobial peptide identified from a Pteromaluspuparum cDNA clone.,,,,,,,,
814,DRAMP03056,SLLSLIRKLIT,11,"Decoralin (Insects, animals)",P85870,Unknown,Unknown,Oreumenes decoratus (Potter wasp),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Linear cationic alpha-helical peptide that acts as antimicrobial peptide. At high concentrations exhibits activity in stimulating degranulation from rat peritoneal mast cells. Inhibits the growth of L.major promastigotes in vitro with an IC50 of 72 μM. Has hemolytic activity towards human and mouse erythrocytes.
Tissue specificity: Expressed by the venom gland.","[Ref.17981364]Gram-positive bacteria: Staphylococcus aureus CCT 6538 (MIC=40 μM), S. saprophyticus (MIC=40 μM), Bacillus subtilis CCT 2471 (MIC=40 μM), B. thuringiensis (MIC=40 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=80 μM), Escherichia coli CCT 1371 (MIC=160 μM), Klebsiella pneumoniae ATCC 13883 (MIC=80 μM), A. faecalis ATCC 8750 (MIC=40 μM);##Fungi: Candida albicans (MIC=40 μM), L. major promastigotes (IC50=72 μM).",[Ref.17981364]EC50=1 mM against mouse erythrocytes,Cell membrane,17981364,Peptides. 2007 Dec;28(12):2320-2327.,"Konno K, Rangel M, Oliveira JS, Dos Santos Cabrera MP, Fontana R, Hirata IY, Hide I, Nakata Y, Mori K, Kawano M, Fuchino H, Sekita S, Neto JR.","Decoralin, a novel linear cationic alpha-helical peptide from the venom of the solitary eumenine wasp Oreumenes decoratus.",,,,,,,,
815,DRAMP03057,GSKKPVPIIYCNRRTGKCQRM,21,"Thanatin (Insects, animals)",P55788,Unknown,Unknown,Podisus maculiventris (Spined soldier bug),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand,"Thanatin adopts a well-defined anti-parallel beta-sheet structure from residue 8 to the C-terminus, including the disulfide bridge. In spite of the presence of two proline residues, there is a large degree of structural variability in the N-terminal segment.",8TFVàresolved by NMR.,"Function: Insect defense peptide with a broad spectrum of activity against Gram-positive and Gram-negative bacteria and fungi. Stops respiration in bacteria but does not permeabilize their inner membranes.
PTM: Contains one disulfide bonds 11-18.
Trangenic plants: the thanatin transformant acquired a sufficient level of resistance to the rice blast fungus, Magnaporthe oryzae, presumably due to the repressive activity of thanatin to its initial stage of infection (Imamura T et al. 2010 Transgenic Res. 19:415-24).","Gram-positive bacteria: Aerococcus viridans (MIC=0.6-1.2 μM), Micrococcus luteus (MIC=1.2-2.5 μM), Bacillus megaterium (MIC=2.5-5 μM), Bacillus subtilis (MIC=2.5-5 μM), Pediococcus acidilactici (MIC=20-40 μM);##Gram-negative bacteria: Escherichia coli D22 (MIC=0.3-0.6 μM), Escherichia coli D31 (MIC=0.3-0.6 μM), Escherichia coli 1106 (MIC=0.6-1.2 μM), Salmonella typhimurium (MIC=0.6-1.2 μM), Klebsiella pneumoniae (MIC=0.6-1.2 μM), Enterobacter cloacae (MIC=1.2-2.5 μM), E. carotovora (MIC=10-20 μM), P. aeuroginosa (MIC=20-40 μM).##Fungi: Neurospora crassa (MIC=0.6-1.2 μM), Botrytis cinerea (MIC=1.2-2.5 μM), Nectria haematococca (MIC=1.2-2.5 μM), Trichoderma viride (MIC=1.2-2.5 μM), Alternaria brassicicola (MIC=2.5-5 μM), Fusarium culmorum (MIC=2.5-5 μM), A. pisi (MIC=5-10μM), Fusarium oxysporum (MIC=10-20 μM).(ref.1)",Unknown,Unknown,8577744##9760181,Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.##Eur J Biochem. 1998 Sep 1;256(2):404-410.,"Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.##Mandard N, Sodano P, Labbe H, Bonmatin JM, Bulet P, Hetru C, Ptak M, Vovelle F.","Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.##Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data.",,,,,,,,
818,DRAMP03075,WNPFKELERAGQRVRDAIISAGPAVATVAQATALAK,36,Cecropin-D,P01511,Belongs to the cecropin family,Unknown,Antheraea pernyi (Chinese oak silk moth),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
PTM: C-terminal amidation.","Gram-negative bacteria: Escherichia coli D21 (MIC=0.37 μM), E. coli D31 (MIC=0.21 μM), Serratia marsescens (MIC=6.1 μM), S. marsescens Strain 122 (MIC=75 μM), Pseudomonas aeruginosa OT97 (MIC>81 μM), Xenorhabdus nematophilus Xn21 (MIC=16 μM);##Gram-positive bacteria: Bacillus subtilis Bsll (MIC>81 μM), Bacillus megaterium Bmll (MIC=24 μM), Bacillus thuringiensis Btll (MIC>81 μM), Streptococcus fecalis Ds16 (MIC>81 μM), S. fecalis AD-4 (MIC>81 μM), Micrococcus luteus MI11 (MIC=4 μM).",Unknown,Unknown,6754375,Eur J Biochem. 1982 Sep;127(1):219-224.,"Qu Z, Steiner H, Engström A, Bennich H, Boman HG.","Insect immunity: isolation and structure of cecropins B and D from pupae of the Chinese oak silk moth, Antheraea pernyi.",,,,,,,,
819,DRAMP03089,GWLKKIGKKIERVGQHTRDATIQGLGIAQQAANVAATAR,39,"Drosophila cecropin-A1/A2 (Insects, animals)","P14954, B3DN02, B3DN08, O16815, O16816, O16817, O16818, O16819, O16820",Belongs to the cecropin family,CecA1 AND CecA2,Drosophila melanogaster (Fruit fly),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Strongly expressed in larval, pupal and adult fat body and hemocytes after injection of bacteria. Maximal expression in the adult involves fat body cells of the head, thorax and abdomen.
Induction: Induced as part of the humoral response to a bacterial invasion. Transcripts appear within one hour after injection of bacteria into the hemocoel, reach a maximum after 2-6 hours and have almost disappeared after 24 hours. Similar response is seen when flies ingest bacteria present in their food.
PTM: C-terminal amidation (By similarity).","Gram-negative bacteria: Escherichia coli D21 (MIC=0.3 μM), Enterobacter cloacae β12 (MIC=0.4 μM), Pseudomonas aeruginosa OT97 (MIC=2.2 μM), Serratia marcescens Db11 (MIC=93 μM);##Gram-positive bacteria: Bacillus megatherium Bm11 (MIC=2.6 μM), Bacillus subtilis Bsll (MIC=16 μM), Micrococcus luteus MI11 (MIC=8.5 μM). ",Unknown,Unknown,2104802##2390977##9725836,EMBO J. 1990 Jan;9(1):217-224.##EMBO J. 1990 Sep;9(9):2969-2976.,"Kylsten P, Samakovlis C, Hultmark D.##Samakovlis C, Kimbrell DA, Kylsten P, Engström A, Hultmark D.",The cecropin locus in Drosophila; a compact gene cluster involved in the response to infection.##The immune response in Drosophila: pattern of cecropin expression and biological activity.,,,,,,,,
820,DRAMP03090,GWLRKLGKKIERIGQHTRDASIQVLGIAQQAANVAATAR,39,"Drosophila cecropin B (CecB; Insects, animals)","P14956, O16826, O16827, O16828, O18647, O61274, Q9V425",Belongs to the cecropin family,CecB,Drosophila melanogaster (Fruit fly),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Induced as part of the humoral response to a bacterial invasion. Transcripts appear within one hour after injection of bacteria into the hemocoel, reach a maximum after 2-6 hours and have almost disappeared after 24 hours. Similar response is seen when flies ingest bacteria present in their food. [Ref.1]","Gram-negative bacteria: Escherichia coli D21 (MIC=1.8 μM), Enterobacter cloacae b12 (MIC=1.0 μM), Pseudomonas aeruginosa OT97 (MIC=4.2 μM);##Gram-positive bacteria: Bacillus megatherium Bm11 (MIC=3.7 μM), Bacillus subtilis Bsll (MIC=3.2 μM), Micrococcus luteus MI11 (MIC=59 μM).",Unknown,Unknown,2390977##2104802,EMBO J. 1990 Sep;9(9):2969-2976.##EMBO J. 1990 Jan;9(1):217-224.,"Samakovlis C, Kimbrell DA, Kylsten P, Engström A, Hultmark D.##Kylsten P, Samakovlis C, Hultmark D.",The immune response in Drosophila: pattern of cecropin expression and biological activity.##The cecropin locus in Drosophila; a compact gene cluster involved in the response to infection.,,,,,,,,
821,DRAMP03095,VFIDILDKVENAIHNAAQVGIGFAKPFEKLINPK,34,"Andropin (Insects, animals)","P21663, A9UNE4, O16822, O16823, O16824, Q6LAI1, Q9VA90",Unknown,Anp,Drosophila melanogaster (Fruit fly),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Andropin is constitutively expressed in the adult male ejaculatory duct in response to mating not bacterial infection. Andropin is less fungicidal than the cecropins (Insect Biochem Mol Biol. 1999;29:965-72). Along with other antimicrobial proteins, this peptide sterilizes the reproduction system of insects and protects sperms from being infected by bacteria (J Insect Physiol. 2001 Jun;47(6):617-622). Similarly, ceratotoxins are expressed in the female reproductive accesary glands and expressed during mating.","Gram-negative bacteria: Escherichia coli D21 (MIC=140 μM), Enterobacter cloacae b312 (MIC>300 μM), Pseudomonas aeruginosa OT97 (MIC>300 μM), Serratia marcescens Db 11 (MIC>127 μM), Serratia marcescens Db 1140 (MIC>127 μM);##Gram-positive bacteria: Bacillus megatherium Bml1 (MIC=11 μM), Bacillus subtilis Bs11 (MIC=17 μM), Micrococcus luteus MIll (MIC=20 μM). ",Unknown,Unknown,1899226,EMBO J. 1991; 10:163-169.,"Samakovlis, C, Kylsten, P, Kimbrell, DA, Engstroem, A, Hultmark, D.","The andropin gene and its product, a male-specific antibacterial peptide in Drosophila melanogaster.",,,,,,,,
823,DRAMP18495,QCRRLCYKQRCVTYCRGR,18,"Gomesin (Gm; Spiders, arachnids, Chelicerata, arthropods, invertebrates, animals)",P82358 ,Belongs to the tachyplesin family,Unknown,Acanthoscurria gomesiana (Tarantula spider) (Phormictopus pheopygus),"Antimicrobial, Antibacterial, Antifungal, Antiparasitic, Antimalarial, Antic, Anti-Gram+, Anti-Gram-, ",Protein level,Beta sheet,Unknown,1KFP resolved by NMR.,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi. It shows hemolytic activity.
Tissue specificity: In hemocytes only, but not in all hemocytes observed.","[Ref.10942757] Gram-positive bacteria: Aerococcus viridans (MIC=0.8-1.6 μM), Bacillus cereus (MIC=6.25-12.5 μM), Bacillus megaterium (MIC=0.2-0.4 μM), Bacillus thuringiensis (MIC=1.6-3.15 μM), Enterococcus faecalis (MIC=6.2-12.5 μM), Listeria monocytogenes (MIC=0.8-1.6 μM), Micrococcus luteus (MIC=0.4-0.8 μM), Pediococcus acidolacrici (MIC=3.15-6.25 μM), Staphylococcus aureus (MIC=1.6-3.15 μM), Staphylococcus epidermidis (MIC=0.8-1.6 μM), Staphylococcus haemolyticus (MIC=0.8-1.6 μM), Staphylococcus saprophyticus (MIC=0.8-1.6 μM), Streptococcus pyogenes (MIC=1.6-3.15 μM), Nocardia asteroides (MIC=1.6-3.15 μM);##Gram-negative bacteria: Escherichia coli 1106 (MIC=0.8-1.6 μM), Escherichia coli D22 (MIC=0.4-0.8 μM), Escherichia coli D31 (MIC=0.8-1.6 μM), Escherichia coli SBS363 (MIC=0.4-0.8 μM), Erwinia carolovora (MIC=3.15-6.25 μM), Enterobacter cloacae β12 (MIC=3.15-6.25 μM), Klebsiella pneumoniae (MIC=3.15-6.25 μM), Pseudomonas aeruginosa (MIC=1.6-3.15 μM), Salmonella thyphinurium (MIC=0.8-1.6 μM), Xhantomonas campestris pv. orizae (MIC=3.15-6.25 μM);##Fungi: Alternaria brassicola (MIC=0.4-0.8 μM), Aspergillus fumigatus (MIC=1.6-3.15 μM), Beauveria bassiana (MIC=12.5-25 μM), Fusarium culmorum (MIC=0.4-0.8 μM), Fusarium oxysporum (MIC=0.4-0.8 μM), Neurospora crassa (MIC=0.4-0.8 μM), Nectria haematococca (MIC=0.2-0.4 μM), Tricoderma viridae (MIC=0.4-0.8 μM), Tricophvton mentagrophytes (MIC=0.8-1.6 μM);##Yeasts: Candida albicans (MIC=0.15-0.3 μM), Candida glabrata (MIC=12.5-25 μM), Candida tropicalis (MIC=3.15-6.25 μM), Cryptococcus neoformans (MIC=0.8-1.6 μM), Saccharomyces cerevisiae (MIC=1.6-3.15 μM).",[Ref.10942757]16% hemolytic activity at 1 μM and 100 μM against human erythrocytes ,Unknown,10942757,J Biol Chem. 2000 Oct 27;275(43):33464-70.,"Silva PI Jr, Daffre S, Bulet P.","Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family.",,,,,,,,
825,DRAMP03104,ATCDLLSGTGINHSACAAHCLLRGNRGGYCNGKAVCVCRN,40,"Sapecin (defensins; Insects, animals)",P18313,Belongs to the invertebrate defensin family (Type 1 subfamily),Unknown,Sarcophaga peregrina (Flesh fly),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,Unknown,1L4V resolved by NMR.,"Function: Sapecins, which are potent bactericidal proteins, are produced in response to injury. Sapecin is cytotoxic to Gram-positive bacteria, and to a lesser extent against Gram-negative bacteria.
Tissue specificity: Hemocytes and fat body. Induction: By injury to the larval cell wall.
PTM: Contains three disulfide bonds 3-30; 16-36; 20-38.","Gram-positive bacteria: Staphylococcus aureus FDA209P (MIC=5.0 μg/ml), Staphylococcus smith (MIC=5.0 μg/ml), Micrococcus luteus FDA16 (MIC=1.2 μg/ml), Micrococcus luteus IF03333 (MIC=1.2 μg/ml), Micrococcus luteus PC11001 (MIC=10.0 μg/ml), Bacillus subtilis NRRI B-558 (MIC=39.0 μg/ml), Bacillus subtilis PC1219 (MIC=20.0 μg/ml), Mycobacterium smegmatis ATCC607 (MIC=78.0 μg/ml), Corynebacterium bouis 1810 (MIC=2.5 μg/ml), Corynebacterium michiganense (MIC=2.5 μg/ml).##Gram-negative bacteria: Xantbmonas oryzae (MIC=20.0 μg/ml), Pseudomonas lachrymans (MIC=78.0 μg/ml), Escherichia coli NIHJ (MIC>78.0 μg/ml), Shigella sonnei JS11746 (MIC>78.0 μg/ml), Proteus vulgaris O X19 (MIC>78.0 μg/ml) ",Unknown,Unknown,3182836##3182836##2358424,J Biol Chem. 1988 Nov 15;263(32):17117-17121.##J Biol Chem. 1988 Nov 15;263(32):17112-17116.##J Biochem. 1990 Apr;107(4):514-518.,"Matsuyama K, Natori S.##Matsuyama K, Natori S.##Kuzuhara T, Nakajima Y, Matsuyama K, Natori S.","Molecular cloning of cDNA for sapecin and unique expression of the sapecin gene during the development of Sarcophaga peregrina.##Purification of three antibacterial proteins from the culture medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina.##Determination of the disulfide array in sapecin, an antibacterial peptide of Sarcophaga peregrina (flesh fly).",,,,,,,,
827,DRAMP03116,SLGGVISGAKKVAKVAIPIGKAVLPVVAKLVG,32,"Ceratotoxin-C (Insects, animals)",Q17313,Unknown,CTXC1 AND CTCX2,Ceratitis capitata (Mediterranean Fruit fly),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Has hemolytic activity.Temperature dependence: Thermostable. Still active at 100 degrees Celsius.,"[Ref.9569644]Gram-negative bacteria: Escherichia coli 23739 (MIC=13.6 μM), Escherichia coli LE 392 (MIC=5 μM), Pseudomonas aeruginosa 27853 (MIC>50 μM), P. vulgaris 6380 (MIC>50 μM), S. typhymurium 23853 (MIC>5 μM);##Gram-positive bacteria: E. cloacae 13047 (MIC>5 μM), E. jaecalis 29212 (MIC>50 μM), Staphylococcus aureus 25923 (MIC>50 μM), B. cereus 9634 (MIC>5 μM), Bacillus subtilis 6633 (MIC=5.9 μM).",[Swiss_Prot Entry Q17313]has hemolytic activity,Unknown,9569644,Eur. J. Biochem. 1996; 241:330-337.,"Rosetto M, Manetti AGO, Giordano PC, Marri L, Amons R, Baldari CT, Marchini D, Dallai R.","Molecular characterization of ceratotoxin C, a novel antibacterial female-specific peptide of the ceratotoxin family from the medfly Ceratitis capitata.",,,,,,,,
828,DRAMP03117,QSEAGWLKKIGKKIERVGQHTRDATIQGLGVAQQAPNVAATAR,43,"Drosophila cecropin-A1 (Insects, animals)",O61272,Belongs to the cecropin family,CecA1,Drosophila simulans (Fruit fly),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.
PTM: C-terminal amidation (By similarity).","Gram-negative bacteria: Alcaligenes faecalis (MIC=10-25 μM), Escherichia coli 1106 (MIC=0.25-0.5 μM), Escherichia coli D22 (MIC=0.1-0.25 μM), Escherichia coli D31 (MIC=0.1-0.25 μM), Escherichia coli SBS363 (MIC=0.1-0.25 μM), Enterobacter cloacae β12 (MIC=0.5-1 μM), Erwinia carotovora (MIC=0.5-1 μM), Klebsiella pneumoniae (MIC=1-2.5 μM), Pseudomonas aeruginosa (MIC=1-2.5 μM), Salmonella typhimurium (MIC=0.5-1 μM), Xanthomonas campestris (MIC=0.5-1 μM); ##Gram-positive bacteria: Aerococcus viridans (MIC=5-10 μM), Bacillus megaterium (MIC=1-2.5 μM), Micrococcus luteus (MIC=5-10 μM).##Fungi: Botrytis cinerea (MIC=5-10 μM), Fusarium culmorum (MIC=1-2.5 μM), Fusarium oxysporum (MIC=1-2.5 μM), Neurospora crassa (MIC=2.5-10 μM).",Unknown,Unknown,9553148##9725836,Immunogenetics. 1998 May;47(6):417-429.##Genetics. 1998 Sep;150(1):157-171.##Insect Mol Biol. 2000 Feb;9(1):75-84.,"Date A, Satta Y, Takahata N, Chigusa S.I.##Ramos-Onsins S, Aguade M.##Vizioli J, Bulet P, Charlet M, Lowenberger C, Blass C, Müller HM, Dimopoulos G, Hoffmann J, Kafatos FC, Richman A.","Evolutionary history and mechanism of the Drosophila cecropin gene family.##Molecular evolution of the Cecropin multigene family in Drosophila: functional genes vs pseudogenes.##Cloning and analysis of a cecropin gene from the malaria vector mosquito, Anopheles gambiae.",,,,,,,,
830,DRAMP03138,GGLKKLGKKLEGAGKRVFNAAEKALPVVAGAKAL,34,"Cecropin-A (Insects, animals)","P82592, Q17NR3, Q95PI9",Belongs to the cecropin family,CECA,Aedes aegypti (Yellowfever mosquito),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli D22 (MIC=0.25-0.5 μg/ml), E. coli D31 (MIC=0.25-0.5 μg/ml), E. coli SBS363 (MIC=0.1-0.25 μg/ml), E. coli 1106 (MIC=0.25-0.5 μg/ml), Enterobacter cloacae b12 (MIC=50-100 μg/ml), E. carotovora (MIC=0.25-0.5 μg/ml), Klebsiella pneumoniae (MIC=1-2.5 μg/ml), Pseudomonas aeruginosa (MIC=10-25 μg/ml), Salmonella typhimurium (MIC=1-2.5 μg/ml), X. campestris (MIC=0.5-1 μg/ml);##Gram-positive bacteria: Aerococcus viridans (MIC=2.5-5 μg/ml), Bacillus megaterium (MIC=1-2.5 μg/ml), Micrococcus luteus (MIC=10-25 μg/ml), Streptococcus pyogenes (MIC=10-25 μg/ml).##Fungi: Fusarium culmorum (MIC=1-2.5 μg/ml), Fusarium oxysporum (MIC=2.5-5 μg/ml), Neurospora crassa (MIC=5-10 μg/ml), Candida albicans (MIC=25-50 μg/ml), Cryptococcus neoformans (MIC=25-50 μg/ml), Saccharomyces cerevisiae (MIC=50-100 μg/ml) ",Unknown,Unknown,10400619,J Biol Chem. 1999 Jul 16;274(29):20092-20097.,"Lowenberger C, Charlet M, Vizioli J, Kamal S, Richman A, Christensen BM, Bulet P.","Antimicrobial activity spectrum, cDNA cloning, and mRNA expression of a newly isolated member of the cecropin family from the mosquito vector Aedes aegypti.",,,,,,,,
831,DRAMP03140,GRLKKLGKKIEGAGKRVFKAAEKALPVVAGVKALG,35,"Anopheles cecropin-A amidated isoform (Insects, animals)","P82290, A7XAX5, A7XAX7, A7XAY1, A7XAY8, A7XAZ7, A7XB12, A7XB23, Q7QEE3",Belongs to the cecropin family,CecA,Anopheles gambiae (African malaria mosquito),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial activity against several Gram-positive and Gram-negative bacteria. Also has antifungal activity.
Tissue specificity: Relatively abundant in head, thorax and to a lesser extent in abdominal carcass and anterior midgut.
Developmental stage: In young pupae, expressed within 2 hours of infection and continued to accumulate over 16 hours.
Induction: By bacterial infection.
PTM: C-terminal amidation.","Gram-negative bacteria: Alcaligenes faecalis (MIC=1-2.5 μM), Escherichia coli 1106 (MIC=0.5-1 μM), E. coli D22 (MIC=0.1-0.25 μM), E. coli D31 (MIC=0.1-0.25 μM), E. coli SBS363 (MIC=0.05-0.1 μM), Enterobacter cloacae β12 (MIC=0.5-1 μM), Erwinia carotovora (MIC=0.5-1 μM), Klebsiella pneumoniae (MIC=1-2.5 μM), Pseudomonas aeruginosa (MIC=1-2.5 μM), Salmonella typhimurium (MIC=0.1-0.25 μM), Xanthomonas campestris (MIC=0.5-1 μM); ##Gram-positive bacteria: Aerococcus viridans (MIC=0.5-1 μM), Bacillus cereus (MIC=50-100 μM), Bacillus megaterium (MIC=0.5-1 μM), Listeria monocytogenes (MIC=50-100 μM), Micrococcus luteus (MIC=0.5-1 μM), Staphylococcus aureus (MIC=50-100 μM), Staphylococcus epidermidis (MIC=10-25 μM), Staphylococcus haemolyticus (MIC=1-2.5 μM), Staphylococcus saprophyticus (MIC=1-2.5 μM), Streptococcus pyogenes (MIC=0.1-0.25 μM).##Fungi: Aspergillus fumigatus (MIC=5-10 μM), Botrytis cinerea (MIC=1-2.5 μM), Fusarium culmorum (MIC=0.5-1 μM), Fusarium oxysporum (MIC=1-2.5 μM), Neurospora crassa (MIC=1-2.5 μM), Candida albicans (MIC=1-2.5 μM), Cryptococcus neoformans (MIC=5-10 μM), Saccharomyces cerevisiae (MIC=25-50 μM).",Unknown,Unknown,10672074##12421409,Insect Mol Biol. 2000 Feb;9(1):75-84.##Insect Mol Biol. 2002 Dec;11(6):517-525.,"Vizioli J, Bulet P, Charlet M, Lowenberger C, Blass C, Müller HM, Dimopoulos G, Hoffmann J, Kafatos FC, Richman A.##Zheng XL, Zheng AL.","Cloning and analysis of a cecropin gene from the malaria vector mosquito, Anopheles gambiae.##Genomic organization and regulation of three cecropin genes in Anopheles gambiae.",,,,,,,,
832,DRAMP03150,MVFAYAPTCARCKSIGARYCGYGYLNRKGVSCDGQTTINSCEDCKRKFGRCSDGFITECFL,61,"Gambicin (Insects, animals)",No entry found,Unknown,Unknown,Anopheles albimanus (mosquito),"Antibacterial, Antifungal, Antiparasitic, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Bridge,Unknown,Unknown,"Function: In vitro experiments showed that the 6.8-kDa mature peptide can kill both Gram-positive and Gram-negative bacteria, has a morphogenic effect on a filamentous fungus, and is marginally lethal to Plasmodium berghei ookinetes.
Induction: Predominantly expressed in the anterior part.
PTM: Contains four disulfide bridges.",Gram-negative bacterium: E. coli (MIC=6.25-12.5 μM);##Gram-positive bacterium: M. luteus (MIC=25-50 μM).##Fungus: N. crassa.,Unknown,Unknown,11606751,Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12630-5.,"Vizioli J, Bulet P, Hoffmann JA, Kafatos FC, Müller HM, Dimopoulos G.",Gambicin: a novel immune responsive antimicrobial peptide from the malaria vector Anopheles gambiae.,,,,,,,,
833,DRAMP03153,GIGGKPVQTAFVDNDGIYD,19,27 kDa antibacterial protein,P81925,Unknown,Unknown,Cyprinus carpio (common carp),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antibacterial activity. Forms large ion channels responsible for disrupting the cellular envelope of bacteria leading to cell lysis.,"Gram-positive bacteria: Staphylococcus aureus (MIC=5 μg/ml), Micrococcus luteus (MIC=0. 5 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=5 μg/ml), Pseudomonas fluorescens (MIC=10 μg/ml), Aeromonas hydrophila (MIC=5 μg/ml).",Unknown,Cell membrane,8797847,Eur J Biochem. 1996 Aug 15;240(1):143-149.,"Lematre C, Orange N, Saglio P, Saint N, Gagnon J, Molle G.",Characterization and ion channel activities of novel antibacterial proteins from the skin mucosa of carp (Cyprinus carpio).,,,,,,,,
835,DRAMP03166,IRNSLTCRFNFGICLPKRCPGRMRQIGTCF,30,"P15 (deer beta-defensin; ruminant, animals)",No entry found,Unknown,Unknown,Cervus elaphus (New Zealand deer),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: It shows strong activity against Gram-negative bacteria, but lesser activity against Gram-positive bacteria and yeast.
Caution: the sequence displayed is N-terminal sequence of P15. ",Gram-negative bacterium: Escherichia coli O111 (MIC=0.3 μg/mL);##Gram-positive bacterium: Staphylococcus aureus NCTC 4163 (MIC=1 μg/mL).##Fungi: Candida albicans 3135A (MIC=3 μg/mL).,Unknown,Unknown,16011891,Int J Antimicrob Agents. 2005 Aug;26(2):165-169.,"Treffers C, Chen L, Anderson RC, Yu PL.",Isolation and characterisation of antimicrobial peptides from deer neutrophils.,,,,,,,,
837,DRAMP03173,RWCVYAYVRVRGVLVRYRRCW,21,"Arenicin-1 (Ar-1; marine polychaeta, animals)","Q5SC60, P84105",Unknown,Unknown,Arenicola marina (Lugworm) (Lumbricus marinus),"Antibacterial, Antifungal, Cytotoxicity, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (2 strands; 16 residues),"Arenicin-1 is a two-stranded antiparallel β-sheet (Cys3-Val10 and Val13-Cys20) stabilized by nine intra-backbone hydrogen bonds and a disulfide bond between Cys3 and Cys20. The strands of the β-sheet are connected by a type I麓 β-turn. The surface of arenicin is amphiphilic, with distinct hydrophobic and hydrophilic areas (ref.2).",2JSB resolved by NMR.,"Function: Has antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteriua as well as yeast C. albicans. Bacterial killing occurs within minutes and is accompanied by membrane permeabilization, membrane detachment and release of cytoplasm. Interaction of arenicin with reconstituted membranes that mimic the lipopolysaccharide-containing outer membrane or the phospholipid-containing plasma membrane of Gram-negative bacteria exhibited no pronounced lipid specificity.
PTM: Contains one disulfide bond 3-20.
Domian: Contains 1 BRICHOS domain.","Gram-positive bacterium: Listeria monocytogenes EGD (MIC=0.6 μg/ml);##Gram-negative bacteria: Escherichia coli ML-35p (MIC=4 μg/ml), E. coli WBB01 (MIC=0.3 mM), E. coli ATCC 23716 (MIC=0.6 mM), Salmonella enterica R595 (MIC=0.3 mM), S. enterica R60 (MIC=1.25 mM), Proteus mirabilis R45 (MIC=0.6 mM).##Yeast: Candida albicans 820 (MIC=20 μg/ml).##Human Jurkat T-cells: LD50>40 mM (35.5% lysis at 30 mM).",Unknown,Anionic lipid vesicles,15527787##17935487,FEBS Lett. 2004 Nov 5;577(1-2):209-214.##Biochem J. 2008 Feb 15;410(1):113-122.,"Ovchinnikova TV, Aleshina GM, Balandin SV, Krasnosdembskaya AD, Markelov ML, Frolova EI, Leonova YF, Tagaev AA, Krasnodembsky EG, Kokryakov VN.##Andr J, Jakovkin I, Grtzinger J, Hecht O, Krasnosdembskaya AD, Goldmann T, Gutsmann T, Leippe M.","Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina.##Structure and mode of action of the antimicrobial peptide arenicin.",,,,,,,,
839,DRAMP03181,HVDKKVADKVLLLKQLRIMRLLTRL,25,"Spinigerin (Insects, animals)",P82357,Unknown,Unknown,Pseudacanthotermes spiniger (Termite),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,"1ZRW, 1ZRV resolved by NMR.",Function: Active against Gram-positive bacteria and Gram-negative bacteria and fungi.,"Gram-positive bacteria: Bacillus megaterium (MIC=0.8-1.5 μM), Micrococcus luteus (MIC=0.8-1.5 μM);##Gram-negative bacteria: Escherichia coli SBS363 (MIC=3-6 μM), E. coli D22 (MIC=3-6 μM), Klebsiella pneumoniae (MIC=50-100 μM), Salmonella typhimurium (MIC=3-6 μM), Pseudomonas aeruginosa (MIC=50-100 μM).##Fungi: Trichoderma viride (MIC=1.5-3 μM), Neurospora crassa (MIC=3-6 μM), Fusarium culmorum (MIC=1.5-3 μM), Nectria haematococca (MIC=0.4-0.8 μM), Candida albicans (MIC=3-6 μM).",Unknown,Unknown,11053427##16170803,J Biol Chem. 2001 Feb 9;276(6):4085-4092.##Biopolymers. 2006 Feb 5;81(2):92-103. ,"Lamberty M, Zachary D, Lanot R, Bordereau C, Robert A, Hoffmann JA, Bulet P.##Landon C, Meudal H, Boulanger N, Bulet P, Vovelle F.","Insect immunity. Constitutive expression of a cysteine-rich antifungal and a linear antibacterial peptide in a termite insect.##Solution structures of stomoxyn and spinigerin, two insect antimicrobial peptides with an alpha-helical conformation.",,,,,,,,
840,DRAMP03186,SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,38,"Spheniscin-2 (Sphe-2; penguin avian beta-defensin 103b; birds ,animals)",P83430,Belongs to the beta-defensin family,Unknown,Aptenodytes patagonicus (King penguin),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (3 strands; 14 residues),"The overall fold of Sphe-2 includes a three-stranded antiparallel beta-sheet stabilized by three disulfide bridges with a pairing typical of beta-defensins. In addition, the N-terminal segment shows helical features on most structures.(Ref.2)",1UT3 resolved by NMR.,"Function: Has antimicrobial activity. Has insecticidal and hemolytic activities. Probably acts by disturbing membrane Function: with its amphipathic structure.
PTM: Contains three disulfide bond: 5-33; 12-27; 17-34.
Preserving food in the bird somach for several weeks during egg incubation. The disulfide bond pattern is identical to canonical beta-defensins from mammals. The high potency is related to its high cationicity as well as a hydrophobic patch, which is not observed in mammalian defensins. ","[Ref.14525994]Gram-positive bacteria: Micrococcus luteus (MIC=1.5-3.0 μM), Bacillus subtilis (MIC=0.8-1.5 μM), Bacillus cereus ATCC 11778 (MIC=3-6 μM), Bacillus megaterium (MIC=0.4-0.8 μM), Staphylococcus aureus (MIC=1.5-3.0 μM), Staphylococcus saprophyticus (MIC=1.5-3.0 μM), Staphylococcus haemolyticus (MIC=1.5-3.0 μM), Nocardia asteroides (MIC=0.8-1.5 μM), Aerococcus viridans (MIC=0.4-0.8 μM), Listeria monocytogenes (MIC=6-12 μM);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=0.8-1.5 μM), Escherichia coli 1106 (MIC=1.5-3.0 μM), Salmonella typhimurium (MIC=6-12 μM), Klebsiella pneumoniae (MIC=50-100 μM), Pseudomonas aeruginosa ATCC 82118 (MIC=6-12 μM), Vibrio metschnikovii NCTC 8483 (MIC=25-50 μM), Vibrio anguillarum ATCC 19264 (MIC=25-50 μM);##Fungi: Candida glabrata (MIC>100 μM), Candida albicans IHEM 8060 (MIC=50-100 μM), Candida tropicalis (MIC=1.5-3.0 μM), Neurospora crassa (MIC=3-6 μM),Aspergillus fumigatus (MIC=3-6 μM).",[Swiss_Prot Entry P83430]has hemolytic activity,Unknown,14525994##15123713,J Biol Chem. 2003 Dec 19;278(51):51053-51058.##J Biol Chem. 2004 Jul 16;279(29):30433-30439.,"Thouzeau C, Le Maho Y, Froget G, Sabatier L, Le Bohec C, Hoffmann JA, Bulet P.##Landon C, Thouzeau C, Labbé H, Bulet P, Vovelle F.","Spheniscins, avian beta-defensins in preserved stomach contents of the king penguin, Aptenodytes patagonicus.##Solution structure of spheniscin, a beta-defensin from the penguin stomach.",,,,,,,,
841,DRAMP03187,QRYFCRVRGGRCAALTCLPRETQIGRCSVKGRKCCR,36,"Beta defensin 1(BD-1; mammals, animals)",P83943,Belongs to the beta-defensin family,DEFB1,Chinchilla lanigera (Long-tailed chinchilla) ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity. May have a role in maintaining sterility in the middle ear.,Gram-negative bacterium: Moraxella catarrhalis (MIC=5 μg/ml);##Gram-positive bacterium: Streptococcus pneumoniae (MIC=5 μg/ml).##Fungi: Candida albicans (MIC=12.5-20 μg/ml).,Unknown,Unknown,14996845,J Biol Chem. 2004 May 7;279(19):20250-20256.,"Harris RH, Wilk D, Bevins CL, Munson RS Jr, Bakaletz LO.",Identification and characterization of a mucosal antimicrobial peptide expressed by the chinchilla (Chinchilla lanigera) airway.,,,,,,,,
845,DRAMP03198,ACYCRIPACFAGERRYGTCFYLGRVWAFCC,30,"Alpha-defensin PhD-4 (primates, mammals, animals)",P86724,Belongs to the alpha-defensin family,Unknown,Papio hamadryas (Hamadryas baboon),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity in low salt conditions, and the antimicrobial activity decreases significantly at high physiological salt concentrations.
PTM: Contains three disulfide bonds (By similarity).","In low salt conditions: Gram-negative bacterium: E. coli ML35p (MIC=2.4 μM),;##Gram-positive bacteria: Listeria monocytogenes EGD (MIC=2.2 μM), methicillin-resistant S. aureus ATCC 33591 (MIC=3.5 μM).##Fungi: Candida albicans 820 (MIC=3.9 μM).##At high physiological salt concentrations: E. coli ML35p (MIC=7.1 μM), L. monocytogenes EGD (MIC=1.8 μM), S. aureus ATCC 33591 (MIC>50 μM), Candida albicans 820 (MIC>50 μM).",Unknown,Unknown,20155756,Rapid Commun Mass Spectrom. 2010 Mar 15;24(5):599-604.,"Stegemann C, Tsvetkova EV, Aleshina GM, Lehrer RI, Kokryakov VN, Hoffmann R.",De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.,,,,,,,,
846,DRAMP03215,ZCRRLCYKQRCVTYCRGR,18,"Gomesin (Gm; spiders, Arthropods, animals)","P82358, Q86RA2",Unknown,Unknown,Acanthoscurria gomesiana (Tarantula spider),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand,Unknown,1KFP resolved by NMR.,"Function: Gomesin bound to the cell surface of cryptococci neoformans, which resulted in cell death associated with membrane permeabilization (FEMS Microbiol Lett. 2007 Sep;274(2):279-86). Also, this peptide triggers SH-SY5Y cell death through L-type channel calcium influx, MAPK/ERK, PKC and PI3K signaling and generation of reactive oxygen species (Soletti RC et al 2010 Chem Biol Interact 186: 135-43). Although represented by E, the N-terminal residue is a pyroglutamate. In hemocytes only, but not in all hemocytes observed.","Gram-positive bacteria: Aerococcus viridans (MIC=0.8-1.6 μM), Bacillus cereus (MIC=6.25-12.5 μM), Bacillus megaterium (MIC=0.2-0.4 μM), Bacillus thuringiensis (MIC=1.6-3.15 μM), Enterococcus faecalis (MIC=6.2-12.5 μM), Listeria monocytogenes (MIC=0.8-1.6 μM), Micrococcus luteus (MIC=0.4-0.8 μM), Pediococcus acidolacrici (MIC=3.15-6.25 μM), Staphylococcus aureus (MIC=1.6-3.15 μM), S. epidermidis (MIC=0.8-1.6 μM), S. haemolyticus (MIC=0.8-1.6 μM), S. saprophyticus (MIC=0.8-1.6 μM), Streptococcus pyogenes (MIC=1.6-3.15 μM), Nocardia asteroides (MIC=1.6-3.15 μM);##Gram-negative bacteria: Alcaligenes faecalis (MIC>100 μM), Escherichia coli 1106 (MIC=0.8-1.6 μM), E. coli D22 (MIC=0.4-0.8 μM), E. coli D31 (MIC=0.8-1.6 μM), E. coli SBS363 (MIC=0.4-0.8 μM), Erwinia carolovora carolovora (MIC=3.15-6.25 μM), Enterobacter cloacae beta 12 (MIC=3.15-6.25 μM), Klebsiella pneumoniae (MIC=3.15-6.25 μM), Pseudomonas aeruginosa (MIC=1.6-3.15 μM), Salmonella typhimurium (MIC=0.8-1.6 μM), Xhantomonas campestris pv. orizae (MIC=3.15-6.25 μM).##Fungi: Alternaria brassicola (MIC=0.4-0.8 μM), Aspergillus fumigatus (MIC=1.6-3.15 μM), Beauveria bassiana (MIC=12.5-25 μM), Fusarium culmorum (MIC=0.4-0.8 μM), F. oxysporum (MIC=0.4-0.8 μM), Neurospora crassa (MIC=0.4-0.8 μM), Nectria haematococca (MIC=0.2-0.4 μM), Tricoderma viridae (MIC=0.4-0.8 μM), Tricophvton mentagrophytes (MIC=0.8-1.6 μM), C. albicans (MIC=0.15-0.3 μM), C. glabrata (MIC=12.5-25 μM), C. tropicalis (MIC=3.15-6.25 μM), C. neoformans (MIC=0.8-1.6 μM), Saccharomyces cerevisiae (MIC=1.6-3.15 μM).",Unknown,Unknown,10942757,J Biol Chem. 2000 Oct 27;275(43):33464-33470.,"Silva PI Jr, Daffre S, Bulet P.","Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family.",,,,,,,,
847,DRAMP03216,GIRCPKSWKCKAFKQRVLKRLLAMLRQHAF,30,"Oxyopinin-4a (Oxt-4a; spiders, Arthropods, animals)","F8J4S0, P86350",Unknown,Unknown,Oxyopes takobius (Lynx spider) (Oxyopes foliiformis),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,2L3I resolved by NMR.,"Function: Disrupts cell membranes through the formation of pores Probable. Has antibacterial activity. Has hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: Contains one disulfide bond 4-10.",[Ref.21933345]Gram-positive bacteria: S. aureus (MIC=10 μM) and Bacillus subtilis (MIC=0.5 μM);##Gram-negative bacteria: P. fluorescens (MIC=1 μM) and E. coli (MIC=0.5 μM).,[Ref.21933345]EC50=7 μm against human erythrocytes,Cell membrane (Probable),21933345,FEBS J. 2011 Nov;278(22):4382-4393.,"Dubovskii PV, Vassilevski AA, Samsonova OV, Egorova NS, Kozlov SA, Feofanov AV, Arseniev AS, Grishin EV.",Novel lynx spider toxin shares common molecular architecture with defense peptides from frog skin.,,,,,,,,
848,DRAMP03217,FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ,48,"M-oxotoxin-Ot1a (Oxyopinin-1, Oxki1; spiders, Arthropods, animals)",P83247,Unknown,Unknown,Oxyopes takobius (Lynx spider) (Oxyopes foliiformis),"Antibacterial, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Disrupts cell membranes, particularly those rich in phosphocholine, through formation of pores. Has antimicrobial activity against Gram-negative bacterium E. coli, Gram-positive bacteria B. subtilis and S. aureus, and hemolytic activity against sheep erythrocytes. Has insecticidal activity against S. frugiperda ovarian cells by opening non-selective ion channels. Enhances the insecticidal activity of spider venom neurotoxic peptides.","[Ref.11976325]Gram-negative bacterium: Escherichia coli (MIC=1.6 μM);##Gram-positive bacteria: Bacillus subtilis, Staphylococcus aureus (MIC=6.2 μM).",[Ref.11976325]100% hemolytic activity at 50 μM against sheep red blood cells,Cell membrane,11976325##15328050,J Biol Chem. 2002 Jun 28;277(26):23627-23637.##Biochim Biophys Acta. 2004 Aug 30;1664(2):182-188.,"Corzo G, Villegas E, Gómez-Lagunas F, Possani LD, Belokoneva OS, Nakajima T.##Belokoneva OS, Satake H, Mal'tseva EL, Pal'mina NP, Villegas E, Nakajima T, Corzo G.","Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins.##Pore formation of phospholipid membranes by the action of two hemolytic arachnid peptides of different size.",,,,,,,,
849,DRAMP03222,GFGALFKFLAKKVAKTVAKQAAKQGAKYVVNKQME,35,"M-ctenitoxin-Cs1a (M-CNTX-Cs1a; Cupiennin-1a; spiders, Arthropods, animals)",P83619,Belongs to the cupiennin family,Unknown,Cupiennius salei (Wandering spider),"Antibacterial, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (3 helices; 11 residues),"The peptide adopts a helix-hinge-helix structure in a membrane mimicking solvent. The hinge may play a role in allowing the amphipathic N-terminal helix and polar C-terminal helix to orient independently upon membrane binding, in order to achieve maximal antibacterial efficacy.(Ref.2)",2K38 resolved by NMR.,"Function: Has antimicrobial activity. Has insecticidal and hemolytic activities. Probably acts by disturbing membrane Function: with its amphipathic structure. Synergistically increases the insecticidal activity of CSTX-1, CSTX-9, and CSTX-13 by up to 65%. Also inhibits the formation of nitric oxide by neuronal nitric oxide synthase. LD50 is 5.9 pmol/mg on Drosophila. ","[Ref.11792701]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=0.31-0.63 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=0.31-0.63 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=0.31-0.63 μM), Enterococcus faecalis ATCC 29212 (MIC=2.50-5.00 μM).",[Ref.11792701]EC50=24.4 μM against human red blood cells.,calcium calmodulin,11792701##17319697,J Biol Chem. 2002 Mar 29;277(13):11208-11216.##Biochemistry. 2007 Mar 20;46(11):3576-3585.,"Kuhn-Nentwig L, Muller J, Schaller J, Walz A, Dathe M, Nentwig W.##Pukala TL, Boland MP, Gehman JD, Kuhn-Nentwig L, Separovic F, Bowie JH.","Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae).##Solution structure and interaction of cupiennin 1a, a spider venom peptide, with phospholipid bilayers.",,,,,,,,
850,DRAMP03225,GFGSLFKFLAKKVAKTVAKQAAKQGAKYVANKHME,35,"M-ctenitoxin-Cs1d (M-CNTX-Cs1d; Cupiennin-1d; spiders, Arthropods, animals)",P83622,Belongs to the cupiennin family,Unknown,Cupiennius salei (Wandering spider),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity. Has insecticidal activity. Probably acts by disturbing membrane Function: with its amphipathic structure.
Tissue specificity: Expressed by the venom gland.
Toxic dose: LD50 is 6.4 pmol/mg on Drosophila.","[Ref.11792701]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=0.08-0.16 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=0.16-0.31 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=0.63-1.25 μM), Enterococcus faecalis ATCC 29212 (MIC=1.25-2.50 μM).",[Ref.11792701]Not determined,Unknown,11792701##10669026,J Biol Chem. 2002 Mar 29;277(13):11208-11216.##Toxicon. 2000 Mar;38(3):373-380.,"Kuhn-Nentwig L, Muller J, Schaller J, Walz A, Dathe M, Nentwig W.##Haeberli S, Kuhn-Nentwig L, Schaller J, Nentwig W.","Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae).##Characterisation of antibacterial activity of peptides isolated from the venom of the spider Cupiennius salei (Araneae: Ctenidae).",,,,,,,,
851,DRAMP03226,SMWSGMWRRKLKKLRNALKKKLKGE,25,"M-zodatoxin-Lt1a (M-ZDTX-Lt1a; Latarcin-1, Ltc-1, Ltc1; spiders, Arthropods, animals)",Q1ELT9,Belongs to the latarcin family,Unknown,Lachesana tarabaevi (Spider),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 16 residues),The Ltc1 molecule is found to form a straight uninterrupted amphiphilic helix comprising 8-23 residues. The hydrophobic surface of the Ltc1 helix is narrow-shaped and extends with no gradient along the axis. (Ref.2),2PCO resolved by NMR.,"Function: Has hemolytic activity against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.","[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.5 μM), Bacillus subtilis VKM B-501 (MIC=1.0 μM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=1.0 μM), Escherichia coli MH1 (MIC=0.7μM), Pseudomonas aeruginosa PAO1 (MIC=4.1 μM);##Fungi: Pichia pastoris GS115 (MIC=17 μM), Saccharomyces cerevisiae Y190 (MIC>33 μM).",[Ref.16735513]20% hemolytic activity at 80 μM against rabbit erythrocytes ,Unknown,16735513##18293934,J Biol Chem. 2006 Jul 28;281(30):20983-20992.##Biochemistry. 2008 Mar 18;47(11):3525-3533.,"Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.##Dubovskii PV, Volynsky PE, Polyansky AA, Karpunin DV, Chupin VV, Efremov RG, Arseniev AS.","Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.##Three-dimensional structure/hydrophobicity of latarcins specifies their mode of membrane activity.",,,,,,,,
852,DRAMP03227,GLFGKLIKKFGRKAISYAVKKARGKH,26,"M-zodatoxin-Lt2a (M-ZDTX-Lt2a; Latarcin-2a, Ltc-2a, Ltc2a; spiders, Arthropods, animals)",Q1ELU1,Belongs to the latarcin family,Unknown,Lachesana tarabaevi (Spider),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (2 helices; 18 residues),The molecule of Ltc2a is found to consist of two helical regions (residues 3-9 and 13-21) connected via a poorly ordered fragment.,2G9P resolved by NMR.,"Function: Has hemolytic activity against Rabbit erythrocytes and has toxicity to ovarian insect Sf9 cells (EC50=20 μM). Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae. ","[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.7 μM), Bacillus subtilis VKM B-501 (MIC=0.4 μM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=1.0 μM), Escherichia coli MH1 (MIC=0.7 μM), Pseudomonas aeruginosa PAO1 (MIC=6.7 μM);##Fungi: Pichia pastoris GS115 (MIC=6.7 μM), Saccharomyces cerevisiae Y190 (MIC=54 μM).",[Ref.16735513]20% hemolytic activity at 6 μM against rabbit erythrocytes ,Unknown,16735513##16939228,J Biol Chem. 2006 Jul 28;281(30):20983-20992.##Biochemistry. 2006 Sep 5;45(35):10759-10767.,"Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.##Dubovskii PV, Volynsky PE, Polyansky AA, Chupin VV, Efremov RG, Arseniev AS.","Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.##Spatial structure and activity mechanism of a novel spider antimicrobial peptide.",,,,,,,,
853,DRAMP03229,SWKSMAKKLKEYMEKLKQRA,20,"M-zodatoxin-Lt3a (M-ZDTX-Lt3a; Latarcin-3a, Ltc-3a; spiders, Arthropods, animals)",Q1ELU3,Belongs to the latarcin family,Unknown,Lachesana tarabaevi (Spider),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Has hemolytic activity against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland.","[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.3 μM), Bacillus subtilis VKM B-501 MIC=1.2 μM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=2.5 μM), Escherichia coli MH1 (MIC=6.0 μM), Pseudomonas aeruginosa PAO1 (MIC>40 μM);##Fungi: Pichia pastoris GS115 (MIC=20 μM), Saccharomyces cerevisiae Y190 (MIC=20 μM).",[Ref.16735513]20% hemolytic activity at >120 μM against rabbit erythrocytes ,Unknown,16735513,J Biol Chem. 2006 Jul 28;281(30):20983-209892.,"Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.","Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",,,,,,,,
854,DRAMP03230,SWASMAKKLKEYMEKLKQRA,20,"M-zodatoxin-Lt3b (M-ZDTX-Lt3b; Latarcin-3b, Ltc-3b; spiders, Arthropods, animals)",Q1ELU2,Belongs to the latarcin family,Unknown,Lachesana tarabaevi (Spider),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Has hemolytic against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland.","[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.7 μM), Bacillus subtilis VKM B-501 (MIC=2.9 μM);Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=23 μM), Escherichia coli MH1 (MIC=28 μM), Pseudomonas aeruginosa PAO1 (MIC>45 μM);##Fungi: Pichia pastoris GS115 (MIC=23 μM), Saccharomyces cerevisiae Y190 (MIC=23 μM).",[Ref.16735513]20% hemolytic activity at >120 μM against rabbit erythrocytes ,Unknown,16735513,J Biol Chem. 2006 Jul 28;281(30):20983-209892.,"Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.","Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",,,,,,,,
855,DRAMP03231,GLKDKFKSMGEKLKQYIQTWKAKF,24,"M-zodatoxin-Lt4a (M-ZDTX-Lt4a; Latarcin-4a, Ltc-4a; spiders, Arthropods, animals)",Q1ELU5,Belongs to the latarcin family,Unknown,Lachesana tarabaevi (Spider),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Has hemolytic activity against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland.","[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.3 μM), Bacillus subtilis VKM B-501 (MIC=1.1 μM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=4.5 μM), Escherichia coli MH1 (MIC=3.2 μM), Pseudomonas aeruginosa PAO1 (MIC>35 μM);##Fungi: Pichia pastoris GS115 (MIC=36 μM), Saccharomyces cerevisiae Y190 (MIC=18 μM).",[Ref.16735513]20% hemolytic activity at >120 μM against rabbit erythrocytes ,Unknown,16735513,J Biol Chem. 2006 Jul 28;281(30):20983-209892.,"Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.","Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",,,,,,,,
856,DRAMP03232,SLKDKVKSMGEKLKQYIQTWKAKF,24,"M-zodatoxin-Lt4b (M-ZDTX-Lt4b; Latarcin-4b, Ltc-4b; spiders, Arthropods, animals)",Q1ELU4,Belongs to the latarcin family,Unknown,Lachesana tarabaevi (Spider),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Has hemolytic activity against Rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland.","[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.3 μM), Bacillus subtilis VKM B-501 (MIC=1.1 μM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=4.4 μM), Escherichia coli MH1 (MIC=4.4 μM), Pseudomonas aeruginosa PAO1 (MIC>35 μM);##Fungi: Pichia pastoris GS115 (MIC>35 μM), Saccharomyces cerevisiae Y190 (MIC=35 μM).",[Ref.16735513]20% hemolytic activity at >120 μM against rabbit erythrocytes ,Unknown,16735513,J Biol Chem. 2006 Jul 28;281(30):20983-209892.,"Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV.","Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",,,,,,,,
857,DRAMP03233,GFFGKMKEYFKKFGASFKRRFANLKKRL,28,"M-zodatoxin-Lt5a (M-ZDTX-Lt5a; Latarcin-5, Ltc-5; spiders, Arthropods, animals)",Q1ELU9,Belongs to the latarcin family,Unknown,Lachesana tarabaevi (Spider),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Has antimicrobial activity against Gram-positive bacteria and Gram-negative bacteria and and yeasts. Also has hemolytic activity against rabbit erythrocytes. Causes paralysis, but is not lethal when injected into insect (Musca domestica) larvae.
Tissue specificity: Expressed by the venom gland. PTM: Leucine amide at L28.","[Ref.16735513]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=1.1 μM), Bacillus subtilis VKM B-501 (MIC=0.6 μM);##Gram-negative bacteria: Escherichia coli DH5-alpha (MIC=0.6 μM), Escherichia coli MH1 (MIC=0.6 μM), Pseudomonas aeruginosa PAO1 (MIC=18 μM);##Fungi: Pichia pastoris GS115 (MIC>37 μM), Saccharomyces cerevisiae Y190 (MIC>37 μM).",[Ref.16735513]20% hemolytic activity at 40 μM against rabbit erythrocytes ,Unknown,16735513,J Biol Chem. 2006 Jul 28;281(30):20983-20992. ,"Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV. ","Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",,,,,,,,
858,DRAMP03236,GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYLLKYYGKKALQKASEKL,69,"M-zodatoxin-Lt8a (M-ZDTX-Lt8a; Cytoinsectotoxin-1a, CIT-1a; spiders, Arthropods, animals)","P85253, B3W6H9",Belongs to the cytoinsectotoxin family,cit 1-1,Lachesana tarabaevi (Spider),"Antibacterial, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Insecticidal, cytolytic and antimicrobial peptide. Has insecticidal activity against the flesh fly S. carnaria, and against the cockroach N. cinerea. CIT 1a Has hemolytic activity against human erythrocytes, and cytolytic activity against insect Sf9 cells in the same concentration range. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland.
Toxic dose: LD50 is 5 μg/g for adult and 20 μg/g for larvae of flesh fly S. carnaria. LD50 is 500 μg/g for cockroach N. cinerea.","[Ref.18215128]Gram-positive bacteria: Arthrobacter globiformis VKM Ac-1112 (MIC=0.5 μM), Bacillus subtilis VKM B-501 (MIC=0.9 μM), Micrococcus luteus (MIC>30 μM), Staphylococcus aureus (MIC>30 μM);##Gram-negative bacteria: Escherichia coli C600 (MIC=0.5 μM), E. coli DH5alpha (MIC=0.9 μM), E. coli MH1 (MIC=0.5 μM), Pseudomonas aeruginosa PAO1 (MIC=1.9 μM), Pseudomonas fluorescens VKM B-894 (MIC=3.8 μM).",[Ref.18215128]EC50=6 μM against human erythrocytes ,Unknown,18215128,Biochem J. 2008 May 1;411(3):687-696.,"Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.","Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.",,,,,,,,
859,DRAMP03253,GKLQAFLAKMKEIAAQTL,18,"M-lycotoxin-Ls3a (M-LCTX-Ls3a; Lycocitin-1; spiders, Arthropods, animals)",P0C2U6,Unknown,Unknown,Lycosa singoriensis (Wolf spider) (Aranea singoriensis),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Inhibits growth of Gram-positive and Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.","Gram-positive bacteria: Staphylococcus aureus, Bacillus subtilis ATCC6633 (MIC=1.6-3.2 μM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=3.2-6.4 μM), Pseudomonas aeruginosa.##Yeast: Candida albicans.",Unknown,Unknown,14991689,J Mass Spectrom. 2004 Feb;39(2):193-201.,"Budnik BA, Olsen JV, Egorov TA, Anisimova VE, Galkina TG, Musolyamov AK, Grishin EV, Zubarev RA.",De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis.,,,,,,,,
860,DRAMP03254,GRLQAFLAKMKEIAAQTL,18,"M-lycotoxin-Ls3b (M-LCTX-Ls3b; Lycocitin-2; spiders, Arthropods, animals)",P0C2U7,Unknown,Unknown,Lycosa singoriensis (Wolf spider) (Aranea singoriensis),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Inhibits growth of Gram-positive and Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.","Gram-positive bacteria: Staphylococcus aureus 209P, Bacillus subtilis ATCC 6633 (MIC=1.57-3.14 μM);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=3.14-6.29 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=5.02-10.05 μM).##Fungi: Candida albicans. ",Unknown,Unknown,14991689,J Mass Spectrom. 2004 Feb;39(2):193-201.,"Budnik BA, Olsen JV, Egorov TA, Anisimova VE, Galkina TG, Musolyamov AK, Grishin EV, Zubarev RA.",De novo sequencing of antimicrobial peptides isolated from the venom glands of the wolf spider Lycosa singoriensis.,,,,,,,,
861,DRAMP03278,IWLTALKFLGKHAAKHLAKQQLSKL,25,"M-lycotoxin-Hc1a (M-LCTX-Hc1a; Lycotoxin I; spiders, Arthropods, animals)",P61507,Unknown,Unknown,Hogna carolinensis (Carolina wolf spider) (Lycosa carolinensis) ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Forms pore that permeabilize the cell membrane. Promotes efflux of calcium from synaptosomes, causes hemolysis, and dissipates voltage gradients across muscle membrane. Potently inhibits the growth of bacteria, yeast and Leishmania. Is lethal to lepidopteran larvae. May Function: both in the prey capture strategy as well as protection from infectious organisms arising from prey ingestion.","Gram-positive bacteria: Bacillus thuringiensis subsp. Israelensis (MIC<5.0 μM);##Gram-negative bacteria: Escherichia coli D31 (MIC=10-20 μM), Escherichia coli DH5 (MIC=80-150 μM).##Fungi: Candida glabrata ATCC 2001 (MIC=100-150 μM), Candida albicans clinical isolate (MIC=100-200 μM).",Unknown,Cell membrane,9442044##18098329 ,J Biol Chem. 1998 Jan 23;273(4):2059-2066.##J Pept Sci. 2008 Apr;14(4):528-534.,"Yan L, Adams ME.##Adão R, Seixas R, Gomes P, Pessoa JC, Bastos M.","Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis.##Membrane structure and interactions of a short Lycotoxin I analogue.",,,,,,,,
862,DRAMP03279,KIKWFKTMKSIAKFIAKEQMKKHLGGE,27,"M-lycotoxin-Hc2a (M-LCTX-Hc2a; Lycotoxin-2; Lycotoxin II; spiders, Arthropods, animals)",P61508,Unknown,Unknown,Hogna carolinensis (Carolina wolf spider) (Lycosa carolinensis) ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Forms pore that permeabilize the cell membrane. Promotes efflux of calcium from synaptosomes, causes hemolysis, and dissipates voltage gradients across muscle membrane. Potently inhibits the growth of bacteria, yeast and Leishmania. May Function: both in the prey capture strategy as well as protection from infectious organisms arising from prey ingestion.","Gram-positive bacteria: Bacillus thuringiensis subsp. Israelensis (MIC=10-60 μM);##Gram-negative bacteria: Escherichia coli D31 (MIC<10 μM), Escherichia coli DH5 (MIC<40 μM).##Fungi: Candida glabrata ATCC 2001 (MIC=100-150 μM)",Unknown,Cell membrane,9442044##18098329,J Biol Chem. 1998 Jan 23;273(4):2059-2066.##J Pept Sci. 2008 Apr;14(4):528-534.,"Yan L, Adams ME.##Adão R, Seixas R, Gomes P, Pessoa JC, Bastos M.","Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis.##Membrane structure and interactions of a short Lycotoxin I analogue.",,,,,,,,
863,DRAMP03280,ATYDGKCYKKDNICKYKAQSGKTAICKCYVKVCPRDGAKCEFDSYKGKCYC,51,AcAMP (A. clavatus antimicrobial peptide),No entry found,Unknown,Unknown,Aspergillus clavatus ES1,"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"This basic, Cys-rich antifungal peptide is also active against bacteria. AcAMP was sensitive to proteolytic enzymes, stable between pH 5.0 and 10.0, and heat resistant (15 min at 100 degrees C). ","Gram-positive bacteria: Staphylococcus aureus (MIC=20 μg/ml), Bacillus cereus (MIC=10 μg/ml), Micrococcus luteus (MIC=10 μg/ml), Enterococcus faecalis (MIC=50 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=30 μg/ml), Pseudomonas aeruginosa (MIC=50 μg/ml).##Fungi: Aspergillus niger, Fusarium solani, Fusarium oxysporum.",Unknown,Unknown,20440534,J Ind Microbiol Biotechnol. 2010 Aug;37(8):805-813.,"Hajji M, Jellouli K, Hmidet N, Balti R, Sellami-Kamoun A, Nasri M.",A highly thermostable antimicrobial peptide from Aspergillus clavatus ES1: biochemical and molecular characterization.,,,,,,,,
864,DRAMP03285,LFCRKGTCHFGGCPAHLVKVGSCFGFRACCKWPWDV,36,"Ostricacin-1 (Beta-defensin 2; Birds, animals)",P85113,Belongs to the beta-defensin family,Unknown,Struthio camelus (Ostrich),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,PTM: Contains three disulfide bonds 3-29; 8-23; 13-30.,"Gram-positive bacteria: Staphylococcus aureus 1056-MRSA (MIC=1.25 μg/ml), S. aureus NCTC 4163 (MIC=6.7 μg/ml);##Gram-negative bacteria: Escherichia coli O157:H7 (MIC=0.96 μg/ml), E. coli 0111 (MIC=6.7 μg/ml).",Unknown,Unknown,16459058,Biotechnol Lett 2001; 23: 207-210.##Int J Antimicrob Agents. 2006 Mar;27(3):229-235.,"Yu, PL, Choudhury SD, Ahrens K.##Sugiarto H, Yu PL.","Purification and characterization of the antimicrobial peptide, ostricacin.##Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.",,,,,,,,
865,DRAMP03286,APGNKAECEREKGYCGFLKCSFPFVVSGKCSRFFFCCKNIW,41,"Ostricacin-2 (Beta-defensin 1; Birds, animals)",P85114,Belongs to the beta-defensin family,Unknown,Struthio camelus (Ostrich),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,PTM: Contains three disulfide bonds 8-36; 15-30; 20-37.,Gram-positive bacterium: Staphylococcus aureus 1056-MRSA (MIC=1.25 μg/ml);##Gram-negative bacterium: Escherichia coli O157:H7 (MIC=0.96 μg/ml);##Yeast: Candida albicans 3153A (MIC=6.2 μg/ml).,Unknown,Unknown,16459058,Int J Antimicrob Agents. 2006 Mar;27(3):229-235.,"Sugiarto H, Yu PL.",Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.,,,,,,,,
866,DRAMP03287,IPRPLDPCIAQNGRCFTGICRYPYFWIGTCRNGKSCCRRR,40,"Ostricacin-3 (Beta-defensin 7; Birds, animals)",P85115,Belongs to the beta-defensin family,Unknown,Struthio camelus (Ostrich),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,PTM: Contains three disulfide bonds 8-36; 15-30; 20-37.,Gram-positive bacterium: Staphylococcus aureus 1056-MRSA (MIC=2.78 μg/ml);##Gram-negative bacterium: Escherichia coli O157:H7 (MIC=2.41 μg/ml).,Unknown,Unknown,16459058,Int J Antimicrob Agents. 2006 Mar;27(3):229-235.,"Sugiarto H, Yu PL.",Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.,,,,,,,,
867,DRAMP03288,LPVNEAQCRQVGGYCGLRICNFPSRFLGLCTRNHPCCSRVWV,42,"Ostricacin-4 (Beta-defensin 8; Birds, animals)",P85116,Belongs to the beta-defensin family,Unknown,Struthio camelus (Ostrich),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,PTM: Contains three disulfide bonds 8-36; 15-30; 20-37.,Gram-positive bacterium: Staphylococcus aureus 1056-MRSA (MIC=11.48 μg/ml);##Gram-negative bacterium: Escherichia coli O157:H7 (MIC=12.03 μg/ml).,Unknown,Unknown,16459058,Int J Antimicrob Agents. 2006 Mar;27(3):229-235.,"Sugiarto H, Yu PL.",Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.,,,,,,,,
868,DRAMP03311,RGFRKHFNKLVKKVKHTISETAHVAKDTAVIAGSGAAVVAAT,42,"Stomoxyn (Insects, animals)",Q8T9R8,Unknown,Unknown,Stomoxys calcitrans (Stable fly),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (4 helices; 32 residues),"Stomoxyn adoptS a flexible random coil structure in water while both assume a stable helical structure in the presence of TFE. In 50% TFE, the structure of stomoxyn is typical of cecropins, including an amphipathic helix at the N-terminus and a hydrophobic C-terminus with helical features that probably fold in a helical conformation at higher TFE concentration. (Ref.2)",1ZRX resolved by NMR.,"Function: Has antimicrobial activity against most Gram-positive and Gram-negative bacteria, filamentous fungi and yeasts tested. Has trypanolytic effect on T.b.rhodesiense and hemolytic activity against bovine red blood cells. May play an important role in protecting the stored blood in the anterior midgut from microorganisms prior to digestion. Adopts an amphipathic alpha-helical structure only in the presence of an organic solvent that mimics a phospholipid membrane.
Tissue specificity: Constitutively expressed in the adult anterior midgut; proventriculus, thoracic and reservoir regions.","[Ref.12372834]Gram-negative bacteria: Escherichia coli K12 RM148 (MIC=0.19-0.39 μM), E. coli D22 (MIC=0.19-0.39 μM), E. coli D31(MIC=0.19-0.39 μM), E. coli SBS363 (MIC<0.19 μM), E. coli 1106 (MIC=0.19-0.39 μM), Enterobacter cloacae b12 (MIC=3.12-6.25 μM), Erwinia carotovora (MIC=0.78-1.56 μM), Klebsiella pneumoniae (MIC=0.78-1.56 μM), Pseudomonas aeruginosa (MIC=0.39-0.78 μM), Salmonella typhimurium (MIC=0.39-0.78 μM), Xanthomonas campestris ( MIC=0.39-0.78 μM);##Gram-positive bacteria: Aerococcus viridans (MIC=0.78-1.56 μM), Bacillus megaterium (MIC=0.78-1.56 μM), Bacillus subtilis (MIC=6.25-12.5 μM), Enterococcus faecalis (MIC=0.78-1.56 μM), Micrococcus luteus (MIC=0.78-1.56 μM), Streptococcus pyogenes (MIC=1.56-3.12 μM);##Fungi: Aspergillus fumigatus (MIC=50-100 μM), Fusarium culmorum (MIC=0.39-0.78 μM), Fusarium oxysporum (MIC=0.78-1.56 μM), Nectria haematococca (MIC=0.39-0.78 μM), N. crassa (MIC=3.12-6.25 μM), Trichoderma viride (MIC=1.56-3.12 μM), Trichophyton mentagrophytes (MIC=3.12-6.25 μM), Candida albicans (MIC=25-50 μM), C. glabrata (MIC=25-50 μM), C. neoformans (MIC=0.78-1.56 μM).","[Ref.12372834]2% hemolytic activity at 10 μM, 9% hemolytic activity at 100 μM against bovine red blood cells",Unknown,12372834##16170803,J. Biol. Chem. 2002; 277: 49921-49926.##Biopolymers. 2006 Feb 5;81(2):92-103.,"Nathalie Boulanger, Rebecca J. L. Munks, Joanne V. Hamilton, Franoise Vovelle, Reto Brun, Mike J. Lehane, and Philippe Bulet.##Landon C, Meudal H, Boulanger N, Bulet P, Vovelle F.","Epithelial innate immunity. A novel antimicrobial peptide with antiparasitic activity in the blood-sucking insect Stomoxys calcitrans.##Solution structures of stomoxyn and spinigerin, two insect antimicrobial peptides with an alpha-helical conformation.",,,,,,,,
869,DRAMP03312,VDKPDYRPRPRPPNM,15,"Metalnikowin-1 (Metalnikowin I; Insects, animals)",P80408,Unknown,Unknown,Palomena prasina (Green shield bug) (Cimex prasinus),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Rich,Unknown,Unknown,"Function: Antibacterial peptide active against Gram-negative bacteria.
Induction: By bacterial infection.","Gram-negative bacteria: Escherichia coli D22 (MIC=50-100 μM), Salmonella typhimurium (MIC=50-100 μM), Alcaligenes faecalis (MIC=50-100 μM).",Unknown,Unknown,PubMed ID is not available,J. Insect Physiol. 1996; 42: 81-89.,"Chernysh S, Cociancich S, Briand JP, Hetru C, Bulet P.",The inducible antibacterial peptides of the hemipteran insect Palomena prasina: identification of a unique family of proline-rich peptides and of a novel insect defensin.,,,,,,,,
872,DRAMP03370,QLINSPVTCMSYGGSCQRSCNGGFRLGGHCGHPKIRCCRRK,41,"Beta-defensin 6 (BD-6, mBD-6; Defensin, beta 6; Rodents, mammals, animals)",Q91VD6,Belongs to the beta-defensin family,Defb6,Mus musculus (Mouse),"Antibacterial, Anti-Gram-, Antimicrobial",Transcript level,Bridge,Unknown,Unknown,"PTM: Contains three disulfide bonds 9-37; 16-30; 20-38.
Predominantly expressed in skeletal muscle, also expressed in esophagus, tongue, and trachea. Also expressed in lung when induced by lipopolysaccharide. Expressed constitutively and induced by lipopolysaccharide (LPS).",Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=20 μg/ml).,Unknown,Unknown,11408484,J Biol Chem. 2001 Aug 24;276(34):31510-31514.,"Yamaguchi Y, Fukuhara S, Nagase T, Tomita T, Hitomi S, Kimura S, Kurihara H, Ouchi Y.","A novel mouse beta-defensin, mBD-6, predominantly expressed in skeletal muscle.",,,,,,,,
873,DRAMP03405,GLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE,33,"mCRAMP-1 (mouse cathelin-related antimicrobial peptide 1; cathelicidin; Rodents, mammals, animals)","P51437, Q0VB78",Unknown,Camp,Mus musculus (Mouse),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Alpha helix (CD),The spectra of 10-25 μm synthetic CRAMP-1 in buffer suggest that the peptide is in a random coil configuration and that it will assume a helical structure in the presence of 15-45% (v/v) trifluoroethanol.,Unknown,"Function: Acts as a potent antimicrobial peptide.
Tissue specificity: Expressed in testis, spleen, stomach, and intestine. Very low expression found in heart, lung and skeletal muscle. No expression in brain, kidney or liver.","Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 μM), Escherichia coli ML35 (MIC=2 μM), Escherichia coli D21 (MIC=8 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=4 μM), Serratia marcescens ATCC 8100 (MIC=4 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=32 μM), Staphylococcus aureus Cowan I (MIC=32 μM), Staphylococcus aureus (MRSA) (MIC>64 μM), Staphylococcus aureus (MRSA) (MIC=64 μM), Staphylococcus epidermidis ATCC 12228 (MIC=16 μM), Streptococcus faecalis ATCC 29212 (MIC=16 μM), Bacillus megaterium Bm11 (MIC=4 μM).##Fungi: Candida albicans (MIC>64 μM), Cryptococcus neoformans (MIC=16 μM).",Unknown,Unknown,9148921##8706928,J Biol Chem. 1997 May 16;272(20):13088-13093.##FEBS Lett. 1996 Aug 5;391(1-2):5-8.,"Gallo RL, Kim KJ, Bernfield M, Kozak CA, Zanetti M, Merluzzi L, Gennaro R.##Popsueva AE, Zinovjeva MV, Visser JW, Zijlmans JM, Fibbe WE, Belyavsky AV.","Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse.##A novel murine cathelin-like protein expressed in bone marrow.",,,,,,,,
874,DRAMP03406,ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE,38,"mCRAMP-2 (mouse cathelin-related antimicrobial peptide 2; cathelicidin; Rodents, mammals, animals)","P51437, Q0VB78",Unknown,Camp,Mus musculus (Mouse),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Alpha helix (CD),The CD spectra of CRAMP-2 (not shown) were similar to CRAMP-1.,Unknown,"Function: Acts as a potent antimicrobial peptide.
Tissue specificity: Expressed in testis, spleen, stomach, and intestine. Very low expression found in heart, lung and skeletal muscle. No expression in brain, kidney or liver.","Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1 μM), Escherichia coli ML35 (MIC=2 μM), Escherichia coli D21 (MIC=8 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=4 μM), Serratia marcescens ATCC 8100 (MIC=4 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=32 μM), Staphylococcus aureus Cowan I (MIC=32 μM), Staphylococcus aureus (MRSA) (MIC>64 μM), Staphylococcus aureus (MRSA) (MIC=64 μM), Staphylococcus epidermidis ATCC 12228 (MIC=16 μM), Streptococcus faecalis ATCC 29212 (MIC=32 μM), Bacillus megaterium Bm11 (MIC=4 μM).##Fungi: Candida albicans (MIC>64 μM), Cryptococcus neoformans (MIC=16 μM).",Unknown,Unknown,9148921##8706928,J Biol Chem. 1997 May 16;272(20):13088-13093.##FEBS Lett. 1996 Aug 5;391(1-2):5-8.,"Gallo RL, Kim KJ, Bernfield M, Kozak CA, Zanetti M, Merluzzi L, Gennaro R.##Popsueva AE, Zinovjeva MV, Visser JW, Zijlmans JM, Fibbe WE, Belyavsky AV.","Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse.##A novel murine cathelin-like protein expressed in bone marrow.",,,,,,,,
875,DRAMP03419,VTCYCRRTRCGFRERLSGACGYRGRIYRLCCR,32,"Neutrophil antibiotic peptide NP-1 (RatNP-1; Rodents, mammals, animals)",Q62716,Belongs to the alpha-defensin family,Unknown,Rattus norvegicus (Rat),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Active in vitro against S. aureus, fungi, Gram-positive and Gram-negative bacteria and to a lesser extent against an enveloped virus.","Gram-positive bacterium: Staphylococcus aureus 502A [18 h] (MIC<100 cfu/ml);##Gram-negative bacterium: Escherichia coli ML-35 [18 h] (MIC<100 cfu/ml).##Fungi: Candida albicans 820 [18 h] (MIC<100 cfu/ml), Cryptococcus neoformans A-383 [18 h] (MIC=1.7 x 102 cfu/ml). ",Unknown,Unknown,2543629##7594610,Infect. Immun. 1989;57:2021-2027.##J. Immunol. 1995;155:4476-4484.,"Eisenhauer P.B, Harwig S.S.S.L, Szklarek D, Ganz T, Selsted M.E, Lehrer R.I.##Yount N.Y, Wang MS.C, Yuan J, Banaiee N, Ouellette A.J, Selsted M.E.",Purification and antimicrobial properties of three defensins from rat neutrophils.##Rat neutrophil defensins. Precursor structures and expression during neutrophilic myelopoiesis.,,,,,,,,
876,DRAMP03422,ACYCRIGACVSGERLTGACGLNGRIYRLCCR,31,"Neutrophil antibiotic peptide NP-4 (RatNP-4; Rodents, mammals, animals)",Q62714,Belongs to the alpha-defensin family,Np4,Rattus norvegicus (Rat),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Active in vitro against S. aureus, fungi, Gram-positive and Gram-negative bacteria and to a lesser extent against an enveloped virus.","Gram-positive bacterium: Staphylococcus aureus 502A (MIC=50 μg/ml);##Gram-negative bacteria: Escherichia coli ML-35, Acinetobacter calcoaceticus (MIC=50 μg/ml).Fungi: Cryptococcus neoformans (MIC=10 μg/ml), Candida albicans.",Unknown,Unknown,2543629##7594610,Infect. Immun. 1989;57:2021-2027.##J. Immunol. 1995;155:4476-4484.,"Eisenhauer P.B, Harwig S.S.S.L, Szklarek D, Ganz T, Selsted M.E, Lehrer R.I.##Yount N.Y, Wang MS.C, Yuan J, Banaiee N, Ouellette A.J, Selsted M.E.",Purification and antimicrobial properties of three defensins from rat neutrophils.##Rat neutrophil defensins. Precursor structures and expression during neutrophilic myelopoiesis.,,,,,,,,
878,DRAMP03464,GLLNGLALRLGKRALKKIIKRLCR,24,"Cryptonin (Insects, animals)",P85028,Unknown,Unknown,Cryptotympana dubia (Korean horse cicada),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,Function: Has very low hemolytic activity on rat erythrocytes. ,"[Ref.18000874]Gram-positive bacteria: Bacillus subtilis KCTC 3086 (MIC=3.12 μg/ml), Staphylococcus aureus KCTC 1928 (MIC=25 μg/ml), Micrococcus luteus KCTC 3063 (MIC=1.56 μg/ml), Staphylococcus aureus (MRSA) (MIC=25 μg/ml), VRE (MIC=25 μg/ml);##Gram-negative bacteria: Escherichia coli K12-594 (MIC=3.12 μg/ml);##Fungi: Candida albicans KCTC 7965 (MIC=50 μg/ml), Candida tropicalis KCTC 1925 (MIC=3.12 μg/ml).",[Ref.18000874]<5% hemolytic activity at 25-200 μg/ml against rat erythrocytes,Unknown,18000874,Arch Insect Biochem Physiol. 2007 Dec;66(4):204-213.,"Leem JY, Park DS, Suh EY, Hur JH, Oh HW, Park HY.","Isolation and functional analysis of a 24-residue linear alpha-helical antimicrobial peptide from Korean blackish cicada, Cryptotympana dubia (Homoptera).",,,,,,,,
880,DRAMP03467,PAQPFRFPKHPQGPQTRPPI,20,Antibacterial napin (Plants),P84529,Belongs to the 2S seed storage albumins family,Unknown,Brassica rapa subsp. chinensis (Pak-choi),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: The small, basic, water-soluble napins are one of the two major kinds of storage proteins synthesized in the seed during its maturation. Inhibits cell-free protein synthesis. Has antibacterial activity against Gram-negative bacterium P. fluorescens, and the Gram-positive bacteria B. subtilis, B. cereus, B. megaterium and M. phei. No antibacterial activity against the Gram-positive bacterium S. aureus or the Gram-negative bacteria E. coli, E. aerogenes and P. aeruginosa.
Subunit structure: The mature protein consists of a small and a large chain linked by disulfide bonds.","Gram-negative bacterium: Pseudomonas fluorescens (MIC=66±3.7 μM);##Gram-positive bacteria: Bacillus subtilis (MIC=236±10.2 μM), Bacillus cereus (MIC=222±9.1 μM), Bacillus megaterium (MIC=215±6.8 μM).",Unknown,Unknown,15062997,Peptides. 2004 Feb;25(2):171-176.,"Ngai PH, Ng TB.","A napin-like polypeptide from dwarf Chinese white cabbage seeds with translation-inhibitory, trypsin-inhibitory, and antibacterial activities.",,,,,,,,
881,DRAMP03471,GFGCPGNQLKCNNHCKSISCRAGYCDAATLWLRCTCTDCNGKK,43,"Recombinant Crassostrea Gigas Defensin (Cg-Def; molluscs, animals)",Q4GWV4,Unknown,def,Crassostrea gigas (Pacific oyster),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,Unknown,2B68 resolved by NMR.,Function: Has antibacterial activity (By similarity).,"Gram-positive bacteria: Micrococcus lysodeikticus (MIC=0.005-0.01 μM), Staphylococcus aureus (MIC=1.25-2.5 μM), Microbacterium maritypicum (MIC=0.5-1 μM), Bacillus megaterium (MIC>20 μM);##Gram-negative bacteria: Escherichia coli 363 (MIC=35-20 μM), Vibrio alginolyticus (MIC>20 μM), Salmonella typhimurium (MIC>20 μM).##Fungi: Fusarium oxysporum (MIC=9-4.5 μM), Botrytis cinerea (MIC>20 μM), Penicillium crustosum (MIC>20 μM).",Unknown,Lipid II,16246846,J Biol Chem. 2006 Jan 6;281(1):313-323.,"Gueguen Y, Herpin A, Aumelas A, Garnier J, Fievet J, Escoubas JM, Bulet P, Gonzalez M, Lelong C, Favrel P, Bachère E.","Characterization of a defensin from the oyster Crassostrea gigas. Recombinant production, folding, solution structure, antimicrobial activities, and gene expression.",,,,,,,,
882,DRAMP03472,MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLR,74,cgUbiquitin,No entry found,Unknown,Unknown,Crassostrea gigas (Pacific oyster),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Combine helix and strand structure,"According to the homology modeling, this peptide is composed of three secondary structural motifs including three α-helices and four β-strands separated by 7 loops regions.",Unknown,"Function: cgUbiquitin shows broad potent antimicrobial activity against Gram-positive and -negative bacteria, without hemolytic activity.","[Ref.22858580]Gram-positive bacteria: B. subtilis KCTC1021 (MIC=0.4 μM), S. aureus RM4220 (MIC=4.7 μM), S. iniae FP5229 (MIC=0.9 μM);##Gram-negative bacteria: E. coli D31 (MIC=0.2 μM), E. coli ML35p (MIC=1.4 μM), P. aeruginosa KCTC2004 (MIC=0.6 μM), S. flexneri KCTC2517 (MIC=0.7 μM), S. sonnei KCTC2009 (MIC=1.2 μM), A. hydrophila KCTC2358 (MIC=0.7 μM), V. parahemolyticus KCCM41664 (MIC=1.1 μM);##Yeast: C. albicans KCTC7965 (MIC=9.4 μM).",[Ref.22858580]Non-hemolytic against human red blood cells up to 100 μg/mL,Unknown,22858580,Mol Immunol. 2013 Jan;53(1-2):88-98.,"Seo JK, Lee MJ, Go HJ, Kim GD, Jeong HD, Nam BH, Park NG.","Purification and antimicrobial function of ubiquitin isolated from the gill of Pacific oyster, Crassostrea gigas.",,,,,,,,
885,DRAMP03486,GKIPVKAIKQAGKVIGKGLRAINIAGTTHDVVSFFRPKKKKH,42,"Manduca Sexta Moricin (MS moricin; Insects, animals)",Q86MA1,Unknown,Unknown,Manduca sexta (Tobacco hornworm),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 31 residues),The tertiary structure is composed of an eight-turn alpha-helix spanning almost the entire peptide. Insights of relationships between the structure and function are also presented. (Ref.1),2JR8 resolved by NMR.,"Function: Exhibits potent antimicrobial activities against a broad spectrum of Gram-positive and Gram-negative bacteria with a minimum inhibitory concentration of 1.4 microM.
Tissue specificity: expressed in Manduca sexta fat body.","Gram-negative bacteria: Klebsiella pneumoniae (MIC=6.25 μg/ml), Salmonella typhimurium (MIC=6.25 μg/ml), S. typhimurium DT104 (MIC=6.25 μg/ml), Escherichia coli O157:H7 (MIC=6.25 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25 923 (MIC=6.25 μg/ml), Methicillin-resistant S. aureus ATCC 43 300 (MIC=6.25 μg/ml), Methicillin-resistant S. aureus ATCC BAA-39 (MIC=12.5 μg/ml), Listeria monocytogenes (MIC=6.25 μg/ml).##NOTE: MIC is de茂卢聛ned as the lowest peptide concentration that gives no visible growth after overnight incubation in 100% Muller-Hinton broth.",Unknown,Unknown,18265434##12706633,J Pept Sci. 2008 Jul;14(7):855-863.##Insect Biochem Mol Biol. 2003 May;33(5):541-59.,"Dai H, Rayaprolu S, Gong Y, Huang R, Prakash O, Jiang H.##Zhu Y, Johnson TJ, Myers AA, Kanost MR.","Solution structure, antibacterial activity, and expression profile of Manduca sexta moricin.##Identification by subtractive suppression hybridization of bacteria-induced genes expressed in Manduca sexta fat body.",,,,,,,,
887,DRAMP03507,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,35,"Cecropin-B (Insects, animals)",P01509,Belongs to the cecropin family,Unknown,Antheraea pernyi (Chinese oak silkmoth),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=0.36 μM), Escherichia coli D31 (MIC=0.30 μM), Serratia marsescens (MIC=2.6 μM), Serratia marsescens Strain 122 (MIC=12 μM), Pseudomonas aeruginosa OT97 (MIC=2.9 μM), Xenorhabdus nematophilus Xn21 (MIC=1.6 μM);##Gram-positive bacteria: Bacillus subtilis Bsll (MIC=17 μM), Bacillus megaterium Bmll (MIC=0.64 μM), Bacillus thuringiensis Btll (MIC>88 μM), Streptococcus fecalis Ds16 (MIC>88 μM), Streptococcus fecalis AD-4 (MIC>88 μM), Micrococcus luteus MI11 (MIC=0.29 μM).",Unknown,Unknown,6754375##2962676,Eur J Biochem. 1982 Sep;127(1):219-224.##Biomed Environ Mass Spectrom. 1987 Nov;14(11):669-673.,"Qu Z, Steiner H, Engstrm A, Bennich H, Boman HG.##Craig AG, Engstrm A, Bennich H, Kamensky I.","Insect immunity: isolation and structure of cecropins B and D from pupae of the Chinese oak silk moth, Antheraea pernyi.##Plasma desorption mass spectrometry coupled with conventional peptide sequencing techniques.",,,,,,,,
888,DRAMP03513,KVNVNAIKKGGKAIGKGFKVISAASTAHDVYEHIKNRRH,39,"G. mellonella moricin-like peptide A (Gm-mlpA; Insects, animals; Predicted)",A5JSU5,Unknown,mor,Galleria mellonella (Greater wax moth),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=10 μM);##Gram-positive bacterium: Micrococcus luteus (MIC=10 μM).##Fungi: Fusarium graminearum mycelia (MIC=70 μM), F;##Graminearum spores (MIC=0.7 μM), Fusarium oxysporum mycelia (MIC=7 μM), F. oxysporum spores (MIC=10 μM), Ascochyta rabiei spores (MIC=7 μM), Leptosphaeria maculans spores (MIC=7 μM).",Unknown,Unknown,18207081,Insect Biochem Mol Biol. 2008;38:201-212.,"Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.",The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,,,,,,,,
889,DRAMP03514,GKIPVKAIKKGGQIIGKALRGINIASTAHDIISQFKPKKKKNH,43,"G. mellonella moricin-like peptide B (Gm-mlpB; Insects, animals; Predicted)",A5JSU6,Unknown,mor,Galleria mellonella (Greater wax moth),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=100 μM);##Gram-positive bacterium: Micrococcus luteus (MIC=100 μM).##Fungi: Fusarium graminearum spores (MIC=10 μM), F;##Graminearum mycelia (MIC=280 μM), Fusarium oxysporum spores (MIC=100 μM), F. oxysporum mycelia (MIC=280 μM), Leptosphaeria maculans spores (MIC=100 μM).",Unknown,Unknown,18207081,Insect Biochem Mol Biol. 2008;38:201-212.,"Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.",The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,,,,,,,,
890,DRAMP03515,KVPIGAIKKGGKIIKKGLGVIGAAGTAHEVYSHVKNRH,38,"Moricin-like peptide C1 (Gm-mlpC1; Insects, animals; Predicted)",A5JSU7,Unknown,mor,Galleria mellonella (Greater wax moth),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=10 μM);##Gram-positive bacterium: Micrococcus luteus (MIC=100 μM).##Fungi: Fusarium graminearum spores (MIC=1 μM), Fusarium oxysporum spores (MIC=10 μM), Ascochyta rabiei spores (MIC=100 μM), Leptosphaeria maculans spores (MIC=6 μM).",Unknown,Unknown,18207081,Insect Biochem Mol Biol. 2008;38:201-212.,"Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.",The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,,,,,,,,
891,DRAMP03516,KVPIGAIKKGGKIIKKGLGVLGAAGTAHEVYNHVRNRQ,38,"Moricin-like peptide C2 (Gm-mlpC2; Insects, animals; Predicted)",A5JSU8,Unknown,mor,Galleria mellonella (Greater wax moth),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=10 μM);##Gram-positive bacterium: Micrococcus luteus (MIC=100 μM).##Fungi: Fusarium graminearum spores (MIC=1 μM), Fusarium oxysporum spores (MIC=10 μM), Ascochyta rabiei spores (MIC=100 μM), Leptosphaeria maculans spores (MIC=8 μM), Fusarium graminearum mycelia (MIC=8 μM), Fusarium oxysporum mycelia (MIC=8 μM).",Unknown,Unknown,18207081,Insect Biochem Mol Biol. 2008;38:201-212.,"Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.",The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,,,,,,,,
892,DRAMP03517,KVPIGAIKKGGKIIKKGLGVIGAAGTAHEVYSHVKNRQ,38,"Moricin-like peptide C3 (Gm-mlpC3; Insects, animals; Predicted)",A5JSU9,Unknown,mor,Galleria mellonella (Greater wax moth),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=100 μM);##Gram-positive bacterium: Micrococcus luteus (MIC=100 μM).##Fungi: Fusarium graminearum spores (MIC=10 μM), Fusarium oxysporum spores (MIC=100 μM).",Unknown,Unknown,18207081,Insect Biochem Mol Biol. 2008;38:201-212.,"Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.",The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,,,,,,,,
893,DRAMP03518,KVPVGAIKKGGKAIKTGLGVVGAAGTAHEVYSHIRNRH,38,"Moricin-like peptide C4/C5 (Gm-mlpC4/C5; Insects, animals; Predicted)",A5JSV1,Unknown,mor,Galleria mellonella (Greater wax moth),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (MIC=100 μM).##Fungi: Fusarium graminearum spores (MIC=100 μM).,Unknown,Unknown,18207081,Insect Biochem Mol Biol. 2008;38:201-212.,"Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.",The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,,,,,,,,
894,DRAMP03519,KGIGSALKKGGKIIKGGLGALGAIGTGQQVYEHVQNRQ,38,"Moricin-like peptide D (Gm-mlpD; Insects, animals; Predicted)",A5JSV2,Unknown,mor,Galleria mellonella (Greater wax moth),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=10 μM).##Fungi: Fusarium graminearum spores (MIC=10 μM), Fusarium oxysporum spores (MIC=100 μM), Ascochyta rabiei spores(MIC=100 μM), Leptosphaeria maculans spores (MIC=100 μM).",Unknown,Unknown,18207081,Insect Biochem Mol Biol. 2008;38:201-212.,"Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD.",The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,,,,,,,,
903,DRAMP03532,AKIPIKAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKH,42,"Moricin-1 (Insects, animals)",P82818,Belongs to the moricin family,MOR1,Bombyx mori (Silk moth),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 30 residues),"The solution structure reveals an unique structure comprising of a long alpha-helix containing eight turns along nearly the full length of the peptide except for four N-terminal residues and six C-terminal residues. The electrostatic surface map shows that the N-terminal segment of the alpha-helix, residues 5-22, is an amphipathic alpha-helix with a clear separation of hydrophobic and hydrophilic faces, and that the C-terminal segment o",1KV4 resolved by NMR.,Function: Has antibacterial activity against Gram-positive and Gram-negative bacteria. Probably acts by disturbing membrane functions with its amphipathic structure.,"Gram-negative bacteria: Escherichia coli JM109 (MIC=0.31 μM), Acinetobacter sp. NISL B-4653 (MIC=0.27 μM), Pseudomonas fluorescens IAM1179 (MIC=0.53 μM), Pseudomonas aeruginosa IAM15140 (MIC=0.81 μM);##Gram-positive bacteria: Bacillus subtilis IAM1107 (MIC=0.19 μM), Bacillus megaterium IAM1030 (MI=0.09 μM), Bacillus cereus IFO3457 (MIC=0.38 μM), Staphylococcus aureus ATCC6538P (MIC=0.21 μM), Staphylococcus aureus ATCC6538P (MIC=0.22 μM), Staphylococcus aureus IFO3083 (MIC=0.46 μM), Staphylococcus xylosus IAM1312 (MIC=0.27 μM), Staphylococcus epidermidis IFO12993 (MIC=0.18 μM), Streptococcus pyogenes ATCC21547 (MIC=0.25 μM).",Unknown,Unknown,8530391##11997013,J Biol Chem. 1995 Dec 15;270(50):29923-29927.##FEBS Lett. 2002 May 8;518(1-3):33-38.,"Hara S, Yamakawa M.##Hemmi H, Ishibashi J, Hara S, Yamakawa M.","Moricin, a novel type of antibacterial peptide isolated from the silkworm, Bombyx mori.##Solution structure of moricin, an antibacterial peptide, isolated from the silkworm Bombyx mori.",,,,,,,,
908,DRAMP03567,KRIVQRIKDFLRNLVPRTES,20,KR-20 (Derived from LL-37),No entry found,Unknown,Unknown,Homo sapiens (Human sweat),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix ,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus mprF (MIC=16 μM), Staphylococcus aureus ATCC 25923 (MIC>64 μM), Staphylococcus aureus (GAS) (MIC=4 μM);##Gram-negative bacterium: Escherichia coli O29 (MIC>64 μM).##Yeast: Candida albicans ATCC 14053 (MIC=10 μM).",Unknown,Lipopolysaccharide (LPS)-binding,14978112,J Immunol 2004; 172: 3070-3077.,"Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL.",Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense.,,,,,,,,
909,DRAMP03568,RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,31,RK-31 (Derived from LL-37),No entry found,Unknown,Unknown,Homo sapiens (Human sweat),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix ,Unknown,Unknown,Function: Has hemolytic activity against human erythrocytes .,"[Ref.14978112]Gram-positive bacteria: Staphylococcus aureus mprF (MIC=8 μM), Staphylococcus aureus ATCC 25923 (MIC=16 μM), Group A Staphylococcus aureus (GAS) (MIC=8 μM);##Gram-negative bacterium: Escherichia coli O29 (MIC=8 μM);##Yeast: Candida albicans ATCC 14053 (MIC=4 μM).",[Ref.14978112]6% hemolytic activity at 44 μM against human erythrocytes,Lipopolysaccharide (LPS)-binding,14978112,J Immunol 2004; 172: 3070-3077.,"Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL.",Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense.,,,,,,,,
910,DRAMP03569,KSKEKIGKEFKRIVQRIKDFLRNLVPRTES,30,KS-30 (Derived from LL-37),No entry found,Unknown,Unknown,Homo sapiens (Human sweat),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix ,Unknown,Unknown,Function:Has hemolytic activity against human erythrocytes.,"[Ref.14978112]Gram-positive bacteria: Staphylococcus aureus mprF (MIC=8 μM), Staphylococcus aureus ATCC 25923 (MIC=16 μM), Group A Staphylococcus aureus (GAS) (MIC=4 μM);##Gram-negative bacterium: Escherichia coli O29 (MIC=8 μM);##Yeast: Candida albicans ATCC 14053 (MIC=2 μM)",[Ref.14978112]23% hemolytic activity at 88 μM against human erythrocytes,Lipopolysaccharide (LPS)-binding,14978112,J Immunol 2004; 172: 3070-3077.,"Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL.",Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense.,,,,,,,,
911,DRAMP03570,LLGDFFRKSKEKIGKEFKRIVQR,23,LL-23 (Derived from LL-37),"P49913, Q71SN9",Unknown,Unknown,Homo sapiens (Human sweat),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 19 residues),"The Ser9 site splits the hydrophobic surface of the amphipathic helix into two domains, which explains its poor antimicrobial activity (active against only susceptible bacterial strains). ",2LMF resolved by NMR.,"Its structure, dynamics, and antimicrobial and immune modulating activities have been characterized (Biochemistry 2012).","Gram-negative bacterium: Escherichia coli DC2 (MIC=9 μM);##Gram-positive bacteria: Staphylococcus aureus mprF (presence of carbonate) (MIC=3 μM), S. aureu mprF (absence of carbonate) (MIC=24 μM).",Unknown,Unknown,17012259##22185690,"FASEB J 2006; 20, 2068-2080.##Biochemistry. 2012 Jan 17;51(2):653-664. ","Yamasaki K et al. Gallo RL.##Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.","Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin.##Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",,,,,,,,
912,DRAMP03571,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,37,"Antibacterial protein LL-37 (one chain of hCAP-18; Human, mammals, animals)","P49913, Q71SN9",Belongs to the cathelicidin family,CAMP,Homo sapiens (Human),"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 30 residues),"The structure of LL-37 in SDS micelles is composed of a curved amphipathic helix-bend-helix motif spanning residues 2-31 followed by a disordered C-terminal tail. The helical bend is located between residues Gly-14 and Glu-16. The aromatic rings of Phe-5, Phe-6, Phe-17, and Phe-27 of LL-37, as well as arginines, showed intermolecular NOE cross-peaks with D8PG, providing direct evidence for the association of the entire amphipathic helix",2K6O resolved by NMR.,"Function: Has antibacterial activity.
Tissue specificity: Expressed in bone marrow and testis and neutrophils.
PTM: The N-terminus is blocked.","Gram-positive bacteria: Staphylococcus aureus mprF (MIC=32 μM), Staphylococcus aureus ATCC 25923 (MIC>64 μM), Group A Staphylococcus aureus (GAS) (MIC=8 μM);##Gram-negative bacterium: Escherichia coli O29 (MIC=64 μM).##Yeast: Candida albicans ATCC 14053 (MIC=20 μM).",Unknown,Lipopolysaccharide (LPS)-binding,16637646##18818205,J Am Chem Soc. 2006 May 3;128(17):5776-5785.##J Biol Chem. 2008 Nov 21;283(47):32637-32643.,"Li X, Li Y, Han H, Miller DW, Wang G.##Wang G.",Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.##Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.,,,,,,,,
913,DRAMP03573,IGKEFKRIVQRIKDFLRNLVPRTES,25,"LL-37(13-37)(C-terminal fragment of LL-37; Human, mammals, animals)","P49913, Q71SN9",Unknown,Unknown,Homo sapiens (Human),"Antibacterial, Anticancer, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 14 residues),Residues 17-29 of LL-37(13-37) are helical.,2FCG resolved by NMR.,The slightly lower activity of LL-37(13-37) may result from the interference of the disordered regions with membrane binding of the peptide.,"Gram-negative bacterium: Escherichia coli K12 (MIC=80 μM).##Drug-resistant KBv cancer cells (LC50=39 μM), Drug-sensitive KB cancer cells (LC50=40 μM).",Unknown,Unknown,16637646,J Am Chem Soc. 2006 May 3;128(17):5776-5785.,"Li X, Li Y, Han H, Miller DW, Wang G. ",Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. ,,,,,,,,
914,DRAMP03574,FKRIVQRIKDFLRNLV,16,"LL-37(17-32)(C-terminal fragment of LL-37; Human, mammals, animals)","P49913, Q71SN9",Unknown,Unknown,Homo sapiens (Human),"Antibacterial, Anticancer, Anti-Gram-, Antimicrobial",Protein level,Unknown,"To achieve selective membrane targeting, D-amino acids were incorporated into LL-37(17-32). The D-peptide showed similar antibacterial activity to the L-diastereomer, it lost toxicity to human cells. ",Unknown,Antibacterial and anticancer assays found that LL-37(17-32) was more active than LL-37(13-37). ,"Gram-negative bacteria: Escherichia coli K12(MIC=20 μM).##Drug-resistant KBv cancer cells (LC50=30 μM), Drug-sensitive KB cancer cells (LC50=30 μM).",Unknown,Unknown,16637646,J Am Chem Soc. 2006 May 3;128(17):5776-5785.,"Li X, Li Y, Han H, Miller DW, Wang G. ",Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. ,,,,,,,,
915,DRAMP03598,GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP,41,"Human beta-defensin 2 (hBD-2; Defensin, beta 2; Beta-defensin 4A; Human, mammals, animals)","O15263, Q52LC0",Belongs to the beta-defensin family,DEFB4A AND DEFB4B,Homo sapiens (Human),"Antibacterial, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,The structure (one N-terminal helix and 3 beta strands) was found to be monomer in solution (PDB ID: 1E4Q) but a dimer in the crystal (PDB ID: 1FD3). ,"1FD4, 1FD3 resolved by X-ray. 1FQQ resolved by NMR.","Function: Has anti-HIV and antibacterial activity.
Tissue specificity: Expressed in the skin and respiratory tract.
Induction: By inflammation.
PTM: Contains three disulfide bonds 8-37, 15-30, 20-38.
Transgenic plants: expression of this peptide in Arabidopsis thaliana reduced fungal infection.","Gram-negative bacteria: Escherichia coli D31(MIC=62 μg/ml), Escherichia coli ATCC (MIC=62 μg/ml), Pseudomonas aeruginosa ATCC (MIC=62 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC (MIC=62 μg/ml), Enterococcus faecalis ATCC (MIC=15 μg/ml).",Unknown,Unknown,9202117##10906336##17340092,Nature. 1997 Jun 26;387(6636):861.##J Biol Chem. 2000 Oct 20;275(42):32911-32918.##Plant Cell Rep. 2007 Aug;26(8):1391-1398.,"Harder J, Bartels J, Christophers E, Schrder JM.##Hoover DM, Rajashankar KR, Blumenthal R, Puri A, Oppenheim JJ, Chertov O, Lubkowski J.##Aerts AM, Thevissen K, Bresseleers SM, Sels J, Wouters P, Cammue BP, Franois IE.",A peptide antibiotic from human skin.##The structure of human beta-defensin-2 shows evidence of higher order oligomerization.##Arabidopsis thaliana plants expressing human beta-defensin-2 are more resistant to fungal attack: functional homology between plant and human defensins.,,,,,,,,
916,DRAMP03599,GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,45,"Human beta-defensin 3 (BD-3, hBD-3; Hbd3; Beta-defensin 103; Human, mammals, animals)","P81534, Q8NFG6, Q9NPF6",Belongs to the beta-defensin family,DEFB103A AND DEFB103,Homo sapiens (Human),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,Contains three disulfide bonds and a short helical segment preceding a three-stranded antiparallel beta-sheet. ,1KJ6 resolved by NMR.,"Function: Exhibits antimicrobial activity against Gram-positive bacteria and the Gram-negative bacteria and the yeast C.albicans. Kills multiresistant S. aureus and vancomycin-resistant E. faecium. Has hemolytic activity.
Tissue specificity: Highly expressed in skin and tonsils, and to a lesser extent in trachea, uterus, kidney, thymus, adenoid, pharynx and tongue. Low expression in salivary gland, bone marrow, colon, stomach, polyp and larynx. No expression in small intestine.
Induction: By bacterial infection and by IFNG/IFN-gamma.
PTM: Contains three disulfide bonds 11-40; 18-33; 23-41.","[Ref.11085990]Gram-negative bacteria: Escherichia coli DSM1103 (MIC=9.4 μg/ml), Klebsiella pneumoniae DSM681 (MIC=25 μg/ml), Pseudomonas aeruginosa DSM1128 (MIC=18.75 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=4.7 μg/ml), Streptococcus pneumoniae DSM11865 (MIC=4.7 μg/ml).","[Ref.11085990]9% hemolytic at 250 μg/ml, 15% hemolytic activity at 500 μg/ml against human erythrocytes",Unknown,15625724##11085990,Biopolymers. 2005;80(1):34-49.##J Biol Chem. 2001 Feb 23;276(8):5707-5713.,"Schulz A, Klüver E, Schulz-Maronde S, Adermann K.##Harder J, Bartels J, Christophers E, Schroder JM.","Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins.##Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic.",,,,,,,,
917,DRAMP03600,EFELDRICGYGTARCRKKCRSQEYRIGRCPNTYACCLRKWDESLLNRTKP,50,"Human beta-defensin 4 (hBD-4, BD-4; Beta-defensin 104; Human, mammals, animals)","Q8WTQ1, Q496I2, Q496I3, Q496I4",Belongs to the beta-defensin family,DEFB104A,Homo sapiens (Human),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Bridge ,Unknown,Unknown,"Function: Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103.
Tissue specificity: High expression in the testis. Gastric antrum exhibited relatively high levels. A lower expression is observed in uterus and neutrophils thyroid gland, lung, and kidney. No detectable expression in other tissues tested.
Induction: Antimicrobial activity is decreased when the sodium chloride concentration is increased.
PTM: Contains three disulfide bonds (By similarity).","Gram-positive bacterium: Staphylococcus carnosus TM300 (MIC=4.5 μg/ml);##Gram-negative bacteria: Escherichia coli BL21 (MIC>100 μg/ml), Pseudomonas aeruginosa (MIC=4.1 μg/ml).##Yeast: Saccharomyces cerevisiae ATCC9763 (MIC>100 μg/ml).",Unknown,Unknown,11481241,FASEB J. 2001 Aug;15(10):1819-1821.,"García JR, Krause A, Schulz S, Rodríguez-Jiménez FJ, Klüver E, Adermann K, Forssmann U, Frimpong-Boateng A, Bals R, Forssmann WG.",Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity.,,,,,,,,
918,DRAMP03603,ARLKKCFNKVTGYCRKKCKVGERYEIGCLSGKLCCAN,37,"Human beta-defensin 28 (hBD-28; hBD28; Human, mammals, animals)",No entry found,Belongs to the beta-defensin family,Unknown,Homo sapiens (Human),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Bridge ,Unknown,Unknown,Function: Has antibacterial activity gaginst Gram-positive and the Gram-negative bacteria. ,"Gram-negative bacteria: Escherichia coli DSM1103 (MIC=37.5 μg/ml), Klebsiella pneumoniae DSM681 (MIC=50 μg/ml), Pseudomonas aeruginosa DSM1128 (MIC=37.5 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC25923 (MIC=25 μg/ml), Streptococcus pneumoniae DSM11865 (MIC=37.5 μg/ml).",Unknown,Unknown,15625724,Biopolymers. 2005;80(1):34-49.,"Schulz A, Klüver E, Schulz-Maronde S, Adermann K.",Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins.,,,,,,,,
919,DRAMP03638,LCLDQKPEMEPFRKDAQQALEPSRQRRWLHRRCLSGRGFCRAICSIFEEPVRGNIDCYFGYNCCRRMFSHYRTS,74,VpBD (V.philippinarum beta defensin; big defensin),No entry found,Unknown,Unknown,Venerupis philippinarum (The manila clam),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: The rVpBD displays broad-spectrum inhibitory activity towards all tested bacteria with the highest activity against Staphyloccocus aureus and Pseudomonas putida.,"Gram-positive bacteria: Staphyloccocus aureus (MIC=1.64-3.28 μM), Micrococcus luteus (MIC>26.26 μM), Bacillus sp. (MIC=13.13-26.26 μM);##Gram-negative bacteria: Vibrio anguillarum (MIC=13.13-26.26 μM), Entherobacter cloacae (MIC>26.26 μM), Vibrio ichthyoenteri (MIC=3.28-6.56 μM), Pseudomonas putida (MIC=1.64-3.28 μM), Proteus mirabilis (MIC>26.26 μM), Enterobacter sp. (MIC=13.13-26.26 μM)",Unknown,Unknown,20975988,PLoS One. 2010 Oct 20;5(10):e13480.,"Zhao J, Li C, Chen A, Li L, Su X, Li T.",Molecular characterization of a novel big defensin from clam Venerupis philippinarum.,,,,,,,,
920,DRAMP03642,GRKSDCFRKSGFCAFLKCPSLTLISGKCSRFYLCCKRIR,39,"Chicken heterophil peptides 1 (Antimicrobial peptide CHP1; Birds, animals)",P80389,Belongs to the beta-defensin family,Unknown,Gallus gallus (Chicken),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge ,Unknown,Unknown,"Function: Bactericidal activity; inhibits S. aureus and E. coli.
PTM: Contains three disulfide bonds 6-28; 13-34; 18-35.",Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=2.7 μg/ml);##Gram-positive bacterium: Staphylococcus aureus (MIC=0.7 μg/ml).,Unknown,Unknown,7964174,J Leukoc Biol. 1994 Nov;56(5):661-665.,"Evans EW, Beach GG, Wunderlich J, Harmon BG.",Isolation of antimicrobial peptides from avian heterophils.,,,,,,,,
921,DRAMP03645,LVQRGRFGRFLRKIRRFRPKVTITIQGSARFG,32,"Cathelicidin-2 (CATH-2; Fowlicidin-2; Birds, animals)","Q2IAL7, Q56QZ4",Unknown,CATHL2,Gallus gallus (Chicken),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response.
Tissue specificity: Detected in trachea, lung, proventriculus, duodenum, jejunum, ileum, caeca, colon, caecal tonsil, bursa of Fabricius, kidney, ovary, testis, thymus, liver, spleen, bone marrow, skin, uropygial gland, muscle and brain.","[Ref.16326712]Gram-negative bacteria: [No NaCl]Escherichia coli 25922 (MIC=2.66 μM), Escherichia coli O157:H7 700728 (MIC=0.66 μM), Salmonella typhimurium 14028 (MIC=1.33 μM), Salmonella typhimurium DT104 700408 (MIC=0.66 μM), Klebsiella pneumoniae 13883 (MIC=0.66 μM), Pseudomonas aeruginosa 27853 (MIC=5.32 μM);##[100mM NaCl]Escherichia coli 25922 (MIC=2.66 μM), Escherichia coli O157:H7 700728 (MIC=1.33 μM), Salmonella typhimurium 14028 (MIC=1.33 μM), Salmonella typhimurium DT104 700408 (MIC=1.33 μM), Klebsiella pneumoniae 13883 (MIC=1.33 μM), Pseudomonas aeruginosa 27853 (MIC=2.66 μM);##Gram-positive bacteria: [No NaCl]Listeria monocytogenes 19115 (MIC=1.33 μM), Staphylococcus aureus 25923 (MIC=0.66 μM), Staphylococcus aureus (MRSA) BAA-39 (MIC=0.66 μM), Staphylococcus aureus (MRSA) 43300 (MIC=0.33 μM);##[100mM NaCl]Listeria monocytogenes 19115 (MIC=1.33 μM), Staphylococcus aureus 25923 (MIC=1.33 μM), Staphylococcus aureus (MRSA) BAA-39 (MIC=1.33 μM), Staphylococcus aureus (MRSA) 43300 (MIC=2.66 μM).","[Ref.16326712]15% hemolytic activity at 10 μM, 70% hemolytic activity at 100 μM against human erythrocytes",Lipopolysaccharide (LPS)-binding,15963828##16326712,Vet Immunol Immunopathol. 2005 Jul 15;106(3-4):321-327.##J Biol Chem. 2006 Feb 3;281(5):2858-2867. ,"van Dijk A, Veldhuizen EJ, van Asten AJ, Haagsman HP.##Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, Zhang G.","CMAP27, a novel chicken cathelicidin-like antimicrobial protein.##Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity.",,,,,,,,
922,DRAMP03646,RVKRFWPLVPVAINTVAAGINLYKAIRRK,29,"Cathelicidin-3 (CATH-3; Fowlicidin-3; Birds, animals)",Q2IAL6,Unknown,CATHL3,Gallus gallus (Chicken) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 9 residues),NMR spectroscopy reveales that fowlicidin-3 comprises 27 amino-acid residues and adopts a predominantly alpha-helical structure extending from residue 9 to 25 with a slight kink induced by a glycine at position 17..,2HFR resolved by NMR.,"Function: May have antimicrobial activity and play a role in the innate immune response.
Tissue specificity: Detected in bone marrow, liver and lung.","Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM), Salmonella typhimurium 14028 (MIC=2 μM), S. typhimurium DT104 700408 (MIC=2 μM), Salmonella enteritidis 13076 (MIC=2 μM), Klebsiella pneumoniae 13883 (MIC=1 μM);##Gram-positive bacteria: Listeria monocytogenes 19115 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=1 μM), S. aureus (MRSA) 43300 (MIC=1 μM), S. aureus (MRSA) BAA-39 (MIC=1 μM).",Unknown,Lipopolysaccharide (LPS)-binding,17827276##16326712##17229147,Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15063-15068.##J Biol Chem. 2006 Feb 3;281(5):2858-2867.##FEBS J. 2007 Jan;274(2):418-428.,"Goitsuka R, Chen CL, Benyon L, Asano Y, Kitamura D, Cooper MD.##Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, Zhang G.##Bommineni YR, Dai H, Gong YX, Soulages JL, Fernando SC, Desilva U, Prakash O, Zhang G.","Chicken cathelicidin-B1, an antimicrobial guardian at the mucosal M cell gateway.##Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity.##Fowlicidin-3 is an alpha-helical cationic host defense peptide with potent antibacterial and lipopolysaccharide-neutralizing activities.",,,,,,,,
923,DRAMP03647,PIRNWWIRIWEWLNGIRKRLRQRSPFYVRGHLNVTSTPQP,40,"Cathelicidin-B1 (CATH-B1; cathelicidin; Birds, animals)","Q5F378, A7M6V2",Unknown,CATHB1,Gallus gallus (Chicken) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli (MIC=2.5 μM), Pseudomonas aeruginosa (MIC=0.63 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=1.25 μM).",Unknown,Unknown,17827276##15642098,Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15063-15068.##Genome Biol. 2005;6(1):R6.,"Goitsuka R, Chen CL, Benyon L, Asano Y, Kitamura D, Cooper MD.##Caldwell RB, Kierzek AM, Arakawa H, Bezzubov Y, Zaim J, Fiedler P, Kutter S, Blagodatski A, Kostovska D, Koter M, Plachy J, Carninci P, Hayashizaki Y, Buerstedde JM.","Chicken cathelicidin-B1, an antimicrobial guardian at the mucosal M cell gateway.##Full-length cDNAs from chicken bursal lymphocytes to facilitate gene function analysis.",,,,,,,,
924,DRAMP03659,LPRDTSRCVGYHGYCIRSKVCPKPFAAFGTCSWRQKTCCVDTTSDFHTCQDKGGHCVSPKIRCLEEQLGLCPLKRWTCCKEI,82,"Gallinacin-11 (Gal-11; Beta-defensin 11; Birds, animals)","Q6IV20, A0A1W6, Q09MT4, Q9PS49",Belongs to the beta-defensin family,GAL11,Gallus gallus (Chicken),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Tissue specificity: Detected in outer membrane of the vitelline layer of the egg (at protein level). Expressed in the liver, gall bladder, kidney, testis, ovary and male and female reproductive tracts. Expressed in the ovarian stroma, but not in the ovarian follicles. No expression is detected in bone marrow. PTM: Contains three disulfide bonds 8-38; 15-31; 21-39.",Gram-negative bacterium: Escherichia coli (MIC=50 nM).,Unknown,Unknown,17244739##1520265,Reproduction. 2007 Jan;133(1):127-133.##Biochem J. 1992 Aug 15;286 (Pt 1):17-22.,"Subedi K, Isobe N, Nishibori M, Yoshimura Y.##Kido S, Morimoto A, Kim F, Doi Y.","Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).##Isolation of a novel protein from the outer layer of the vitelline membrane.",,,,,,,,
925,DRAMP03676,APRKNVRWCAISLPEWSKCYQWQRRMRKLGAPSITCIRRTS,41,GLFcin (Lactoferrin fragment),"Q29477, Q29479",Belongs to the transferrin family,LTF,Capra hircus (Goat),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: GLFcin is thermal-stable and with high antibacterial activity.,"Gram-negative bacteria: Escherichia coli (MIC=4.07 μg/ml), Propioni bacterium acnes (MIC=12.32 μg/ml), Pseudemonas aeruginosa (MIC=4.07 μg/ml);##Gram-positive bacteria: Bacillus cereus (MIC=12.32 μg/ml), Staphylococcus aureus (MIC=4.07 μg/ml), Listeria monocytogene (MIC=4.07 μg/ml).",Unknown,Unknown,19780544,J Agric Food Chem. 2009 Oct 28;57(20):9509-9515.,"Chen GH, Chen WM, Huang GT, Chen YW, Jiang ST.",Expression of recombinant antibacterial lactoferricin-related peptides from Pichia pastoris expression system.,,,,,,,,
926,DRAMP03677,SKCYQWQRRMRKLGAPSITCIRRTS,25,GLFcin II (Lactoferrin fragment),"Q29477, Q29479",Belongs to the transferrin family,LTF,Capra hircus (Goat),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: GLFcin is thermal-stable and with high antibacterial activity.,"Gram-negative bacteria: Escherichia coli (MIC=6.80 μg/ml), Propioni bacterium acnes (MIC=10.50 μg/ml), Pseudemonas aeruginosa (MIC=14.50 μg/ml);##Gram-positive bacteria: Bacillus cereus (MIC=16.00 μg/ml), Staphylococcus aureus (MIC=6.80 μg/ml), Listeria monocytogene (MIC=9.92 μg/ml).",Unknown,Unknown,19780544,J Agric Food Chem. 2009 Oct 28;57(20):9509-9515.,"Chen GH, Chen WM, Huang GT, Chen YW, Jiang ST.",Expression of recombinant antibacterial lactoferricin-related peptides from Pichia pastoris expression system.,,,,,,,,
927,DRAMP03679,RFRPPIRRPPIRPPFNPPFRPPVRPPFRPPFRPPFRPPIGPFP,43,"Cathelicidin-2 (Bactenecin-5, Bac5; ChBac5; ruminant, animals)","P82018, Q4JFB9",Unknown,CATHL2,Capra hircus (Goat),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli (MIC=1 μg/ml), Salmonella typhimurium (MIC=1 μg/ml), Pseudomonas aeruginosa (MIC=1 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC<2 μg/ml), Listeria monocytogenes (MIC<2 μg/ml) and Bacillus subtilis (MIC<2 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10417180,nfect Immun. 1999 Aug;67(8):4106-4111.,"Shamova O, Brogden KA, Zhao C, Nguyen T, Kokryakov VN, Lehrer RI.",Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes.,,,,,,,,
928,DRAMP03682,FLPIIAKLLGGLL,13,"Vespid chemotactic peptide 5e (VCP 5e; Insects, animals)",P0C1M1,Belongs to the MCD family (Crabrolin subfamily),Unknown,Vespa magnifica ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Mast cell degranulating peptide (By similarity). Has little hemolytic activity. Shows antimicrobial activity against the Gram-negative bacteria and the Gram-positive bacteria. Also has antifungal activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (By similarity).",[Ref.16330062]Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=30 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=5 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=25 μg/ml).,[Ref.16330062]Little hemolytic activity up to 50 μg/ml against rabbit red blood cells,Unknown,16330062,Toxicon. 2006 Feb;47(2):249-53.,"Xu X, Li J, Lu Q, Yang H, Zhang Y, Lai R.",Two families of antimicrobial peptides from wasp (Vespa magnifica) venom.,,,,,,,,
929,DRAMP03683,FLIIRRPIVLGLL,13,"Vespid chemotactic peptide 5g (VCP 5g; Insects, animals)",P0C1M3,Belongs to the MCD family (Crabrolin subfamily),Unknown,Vespa magnifica ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Mast cell degranulating peptide (By similarity). Has little hemolytic activity. Shows antimicrobial activity against the Gram-negative bacteria and the Gram-positive bacteria. Also has antifungal activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (By similarity).",[Ref.16330062]Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=30 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=10 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=12.5 μg/ml).,[Ref.16330062]Little hemolytic activity up to 50 μg/ml against rabbit red blood cells,Unknown,16330062,Toxicon. 2006 Feb;47(2):249-53.,"Xu X, Li J, Lu Q, Yang H, Zhang Y, Lai R.",Two families of antimicrobial peptides from wasp (Vespa magnifica) venom.,,,,,,,,
930,DRAMP03684,FLPIPRPILLGLL,13,"Vespid chemotactic peptide 5f (VCP 5f; Insects, animals)",P0C1M2,Belongs to the MCD family (Crabrolin subfamily),Unknown,Vespa magnifica ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Mast cell degranulating peptide (By similarity). Has little hemolytic activity. Shows antimicrobial activity against the Gram-negative bacteria and the Gram-positive bacteria. Also has antifungal activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (By similarity).",[Ref.16330062]Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=30 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 2592 (MIC=5 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=25 μg/ml).,[Ref.16330062]Little hemolytic activity up to 50 μg/ml against rabbit red blood cells,Unknown,16330062,Toxicon. 2006 Feb;47(2):249-53. ,"Xu X, Li J, Lu Q, Yang H, Zhang Y, Lai R.",Two families of antimicrobial peptides from wasp (Vespa magnifica) venom.,,,,,,,,
931,DRAMP03687,FLSLIPSLVGGSISAFK,17,"TsAP-1 (T. serrulatus antimicrobial peptide 1; scorpions, arachnids, invertebrates, animals)",No entry found,Unknown,Unknown,Tityus serrulatus (Brazilian yellow scorpion),"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: TsAP-1 was of low potency against S. aureus, E. coli and C. albicans.",Gram-positive bacterium: Staphylococcus aureus (MIC=120 uM);##Gram-negative bacterium: Escherichia coli (MIC=160 uM).##Yeast: Candida albicans (MIC=160 uM).,Unknown,Unknown,23770440,Biochimie. 2013 Jun 14. pii: S0300-9084(13)00164-8.,"Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, Chen T, Shaw C.","Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",,,,,,,,
933,DRAMP03691,FSFKRLKGFAKKLWNSKLARKIRTKGLKYVKNFAKDMLSEGEEAPPAAEPPVEAPQ,56,"Im-1 (Arthropods, animals)",P0CF38,Belongs to the scorpion BPP family,Unknown,Isometrus maculatus (Lesser brown scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Causes cytolysis by the formation of pores in the membrane. Causes rapid and reversible paralysis in crickets. Has antibacterial activity.
Tissue specificity: Expressed by the venom gland.
Toxic dose: PD50 is 38 mg/kg into the insect A. domestica.","Gram-negative bacterium: Escherichia coli NBRC 3972 (MIC=0.4-0.8 μM);##Gram-positive bacteria: Staphylococcus aureus NBRC 13276 (MIC=13-25 μM), Bacillus subtilis NBRC 3009 (MIC=0.8-1.6 μM).",Unknown,Cell membrane,20139620,Biosci Biotechnol Biochem. 2010;74(2):364-369. ,"Miyashita M, Sakai A, Matsushita N, Hanai Y, Nakagawa Y, Miyagawa H.",A novel amphipathic linear peptide with both insect toxicity and antimicrobial activity from the venom of the scorpion Isometrus maculatus.,,,,,,,,
934,DRAMP03693,KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC,61,"Bactridin-1 (Bact1; Bactridine 1; Arthropods, animals)",P0CF39,Belongs to the long (4 C-C) scorpion toxin superfamily Sodiu,Unknown,Tityus discrepans (Venezuelan scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity. Modifies membrane sodium permeability on Y.enterocolitica. Is toxic to cockroaches and crabs, but is not to mice. Does not induce haemolysis in human erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity) and C- terminal amidation.","Gram-positive bacteria: Bacillus subtillis ICTA-07 (MIC=22 μM), Microccocus luteus ATCC 4698 (MIC=43 μM), Enterococcus faecalis WHO14 (MIC=34 μM);##Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=77 μM), Yersinia enterocolitica ATCC 9610 (MIC=49 μM), Acinetobacter calcoaceticus ATCC 2305-5 (MIC=43 μM).",Unknown,Unknown,19540868##22355312,Toxicon. 2009 Nov;54(6):802-817.##PLoS One. 2012;7(2):e30478.,"Díaz P, D'Suze G, Salazar V, Sevcik C, Shannon JD, Sherman NE, Fox JW.##Guerrero-Vargas JA, Mourão CB, Quintero-Hernández V, Possani LD, Schwartz EF.",Antibacterial activity of six novel peptides from Tityus discrepans scorpion venom. A fluorescent probe study of microbial membrane Na+ permeability changes.##Identification and phylogenetic analysis of Tityus pachyurus and Tityus obscurus novel putative Na+-channel scorpion toxins.,,,,,,,,
935,DRAMP03694,KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR,64,"Bactridin-2 (Bact2, Bactridine 2; P-Mice-Antm-beta* NaTx14.8; Arthropods, animals)",P0CF37,Belongs to the long (4 C-C) scorpion toxin superfamily Sodiu,Unknown,Tityus discrepans (Venezuelan scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against both Gram-positive bacteria (B.subtilis, M.luteus, E.faecalis) and Gram-negative bacteria (P.aeruginosa, Y.enterocolitica, A.calcoaceticus). Modifies membrane sodium permeability on Y.enterocolitica. Is toxic to mice, but is not to crabs. Induces concentration dependent haemolysis in human erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: Contains four disulfide bonds (By similarity) and C-terminal amidation.","Gram-positive bacteria: Bacillus subtillis ICTA-07 (MIC=30 μM), Microccocus luteus ATCC 4698 (MIC=27 μM), Enterococcus faecalis WHO14 (MIC=65 μM);##Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=54 μM), Yersinia enterocolitica ATCC 9610 (MIC=46 μM), Acinetobacter calcoaceticus ATCC 2305-5 (MIC=27 μM).",Unknown,Unknown,19540868##22355312,Toxicon. 2009 Nov;54(6):802-817.##PLoS One. 2012;7(2):e30478.,"Díaz P, D'Suze G, Salazar V, Sevcik C, Shannon JD, Sherman NE, Fox JW.##Guerrero-Vargas JA, Mourão CB, Quintero-Hernández V, Possani LD, Schwartz EF.",Antibacterial activity of six novel peptides from Tityus discrepans scorpion venom. A fluorescent probe study of microbial membrane Na+ permeability changes.##Identification and phylogenetic analysis of Tityus pachyurus and Tityus obscurus novel putative Na+-channel scorpion toxins.,,,,,,,,
937,DRAMP03702,LFGLIPSLIGGLVSAFK,17,"Mucroporin (Antimicrobial peptide 36.21; Arthropods, animals)",B9UIY3,Belongs to the short cationic antimicrobial peptide family,Unknown,Lychas mucronatus (Chinese swimming scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Function: Cationic host defense peptide that have antibacterial activity by breaking membranes. Is more effective on Gram-positive than on Gram-negative bacteria. Its synthetic analog mucroporin-M1 is more effective.
Tissue specificity: Expressed by the venom gland. 
Miscellaneous: Minimum inhibitory concentrations (MIC) for Mucroporin-1 analog are the following: MIC=12.5 μg/ml against E.coli AB94012, MIC=100 μg/ml against P.aeruginosa AB93066, MIC=25 μg/ml against B.thuringiensis AB92037, MIC=25 μg/ml against B.subtilis AB91021, MIC=5 μg/ml against S.aureus AB94004, and MIC=5 μg/ml against the methicillin-resistant coagulase-negative Staphylococcus. Furthermore, this analog is as effective against antibiotic-resistant pathogens as it is against antibiotic-sensitive pathogens.","Gram-negative bacteria: Escherichia coli AB94012 (MIC>100 μg/ml), Pseudomonas aeruginosa AB93066 (MIC>100 μg/ml);##Gram-positive bacteria: Bacillus thuringiensis AB92037 (MIC=25 μg/ml), Bacillus subtilis AB91021 (MIC=50 μg/ml), Staphylococcus aureus AB94004 (MIC=25 μg/ml), Methicillin-resistant coagulase-negative S. aureus (MIC=25 μg/ml).",Unknown,Cell membrane,20663230##18779362,BMC Genomics. 2010 Jul 28;11:452.##Antimicrob Agents Chemother. 2008 Nov;52(11):3967-3972.,"Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.##Dai C, Ma Y, Zhao Z, Zhao R, Wang Q, Wu Y, Cao Z, Li W.","Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.##Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus.",,,,,,,,
938,DRAMP03706,FLFSLIPHAIGGLISAFK,18,"Antimicrobial peptide 1 (AamAP1; Arthropods, animals)",G8YYA5,Unknown,ap1,Androctonus amoreuxi (African fattail scorpion),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial and antifungal activity. Causes hemolysis on horse erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: C-termianal amidation.",Gram-positive bacterium: Staphylococcus aureus (MIC=20 μM);##Gram-negative bacterium: Escherichia coli (MIC=150 μM).##Yeast: Candida albicans (MIC=64 μM).,Unknown,Cell membrane,22484288,Peptides. 2012 Jun;35(2):291-299.,"Almaaytah A, Zhou M, Wang L, Chen T, Walker B, Shaw C.","Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog.",,,,,,,,
939,DRAMP03707,FPFSLIPHAIGGLISAIK,18,"Antimicrobial peptide 2 (AamAP2; Arthropods, animals)",G8YYA6,Unknown,ap2,Androctonus amoreuxi (African fattail scorpion),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial and antifungal activity. Causes hemolysis on horse erythrocytes.
Tissue specificity: Expressed by the venom gland.
PTM: C-termianal amidation.",Gram-positive bacterium: Staphylococcus aureus (MIC=48 μM);##Gram-negative bacterium: Escherichia coli (MIC=120 μM).##Yeast: Candida albicans (MIC=64 μM).,Unknown,Cell membrane,22484288,Peptides. 2012 Jun;35(2):291-299.,"Almaaytah A, Zhou M, Wang L, Chen T, Walker B, Shaw C.","Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog.",,,,,,,,
940,DRAMP03714,FLGALWNVAKSVF,13,"Amphiphatic peptide CT1 (VmCT1; Non-disulfide-bridged peptide 5.13, NDBP-5.13; Arthropods, animals)",I0DEB3,Belongs to the scorpion NDBP 5 family,Unknown,Vaejovis mexicanus smithi (Scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Amphipatic peptide that shows antibacterial activities against both Gram-positive and Gram-negative bacteria. Has hemolytic against human erythrocytes, with a maximum of 12% lysis, even at the highest concentration tested (50 μM).
Tissue specificity: Expressed by the venom gland.","[Ref.22342498]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=10 μM), Bacillus subtilis ATCC 6633 (MIC=20 μM), Streptococcus agalactiae (clinical isolate) (MIC=20 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=25 μM), Salmonella typhi ATCC 6399 (MIC=5 μM), Pseudomonas aeruginosa ATCC 9027 (MIC=10 μM).",[Ref.22342498]10% hemolytic activity at 50 μM against human erythrocytes,Cell membrane,22342498,Peptides. 2012 Apr;34(2):290-295.,"Ramírez-Carreto S, Quintero-Hernández V, Jiménez-Vargas JM, Corzo G, Possani LD, Becerril B, Ortiz E.",Gene cloning and functional characterization of four novel antimicrobial-like peptides from scorpions of the family Vaejovidae.,,,,,,,,
941,DRAMP03715,FLSTLWNAAKSIF,13,"Amphiphatic peptide CT2 (VmCT2; Non-disulfide-bridged peptide 5.14, NDBP-5.14; Arthropods, animals)",I0DEB4,Belongs to the scorpion NDBP 5 family,Unknown,Vaejovis mexicanus smithi (Scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Amphipatic peptide that shows antibacterial activities against both Gram-positive and Gram-negative bacteria. Has hemolytic at its MIC range, but shows a strong cytotoxic activity at higher concentrations, reaching 84% lysis at 50 μM.
Tissue specificity: Expressed by the venom gland.","[Ref.22342498]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=10 uM), Bacillus subtilis ATCC 6633 (MIC=20 μM), Streptococcus agalactiae (clinical isolate) (MIC=20 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=20 μM), Salmonella typhi ATCC 6399 (MIC=10 μM), Pseudomonas aeruginosa ATCC 9027 (MIC=10 μM).","[Ref.22342498]25% hemolytic activity at 25 μM, 84% hemolytic activity at 50 μM against human erythrocytes",Cell membrane,22342498,Peptides. 2012 Apr;34(2):290-295.,"Ramírez-Carreto S, Quintero-Hernández V, Jiménez-Vargas JM, Corzo G, Possani LD, Becerril B, Ortiz E.",Gene cloning and functional characterization of four novel antimicrobial-like peptides from scorpions of the family Vaejovidae.,,,,,,,,
942,DRAMP03721,ILGKIWEGIKSLF,13,"Cytotoxic linear peptide IsCT (IsCT; NDBP-5.2; Arthropods, animals)",Q8MMJ7,Belongs to the scorpion NDBP 5 family,Unknown,Opisthacanthus madagascariensis (Scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,"Residue 6 is important for antibacterial activity, and hemolysis activity.","1T51, 1T52, 1T54, 1T55 resolved by NMR.","Function: IsCT shows hemolytic activity and antibacterial activity against both Gram-positive and Gram-negative bacteria probably by forming pores in the cell membrane. IsCT adopts an amphipathic alpha-helical structure.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.","[Ref.15369808]Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=4 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=2 μM), Salmonella typhimurium KCTC 1926 (MIC=2 μM);##Gram-positive bacteria: Staphylococcus epidermidis KCTC 1917 (MIC=2 μM), Staphylococcus aureus KCTC 1621 (MIC=2 μM);##Antibiotic-resistant bacteria: Methicillin-resistant Staphylococcus aureus (MRSA) CCARM 3001 (MIC=1 μM), multidrug-resistant Pseudomonas aeruginosa (MDRPA) (CCARM 3543) (MIC=0.5 μM), Multidrug-resistant Pseudomonas aeruginosa (MDRPA) CCARM 2095 (MIC=1 μM).","[Ref.15369808]40% hemolytic activity at 25 μM, 72% hemolytic activity at 50 μM, 80% hemolytic activity at 100 μM against human erythrocytes",Cell membrane,11520071##15369808,Biochem Biophys Res Commun. 2001 Aug 31;286(4):820-825.##Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-719.,"Dai L, Yasuda A, Naoki H, Corzo G, Andriantsiferana M, Nakajima T.##Lee K, Shin S.Y, Kim K, Lim S.S, Hahm K.-S, Kim Y.","IsCT, a novel cytotoxic linear peptide from scorpion Opisthacanthus madagascariensis.##Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs.",,,,,,,,
943,DRAMP03723,GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT,44,"Pandinin-1 (Pin1; Arthropods, animals)",P83239,Belongs to the Scorpion family,Unknown,Pandinus imperator (Emperor scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,MOA: Disrupts cell membranes through formation of pores.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC>20.8 μM), Escherichia coli (MIC=20.8 μM);##Gram-positive bacteria: Enterococcus faecalis (MIC=1.3 μM), Bacillus subtilis (MIC=5.2 μM), Staphylococcus epidermidis (MIC=5.2 μM), Staphylococcus aureus (MIC=2.6 μM).",Unknown,Cell membrane,11563967##16199510,Biochem J. 2001 Oct 1;359(Pt 1):35-45.##Biophys J. 2005 Dec;89(6):4067-4080. ,"Corzo G, Escoubas P, Villegas E, Barnham KJ, He W, Norton RS, Nakajima T.##Nomura K, Ferrat G, Nakajima T, Darbon H, Iwashita T, Corzo G.",Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator.##Induction of morphological changes in model lipid membranes and the mechanism of membrane disruption by a large scorpion-derived pore-forming peptide.,,,,,,,,
944,DRAMP03724,FWGALAKGALKLIPSLFSSFSKKD,24,"Pandinin-2 (Pin2; Arthropods, animals)",P83240,Belongs to the scorpion NDBP 4 family,Unknown,Pandinus imperator (Emperor scorpion),"Antibacterial, Hemolytic activity, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Disrupts cell membranes through formation of pores. Has strong antimicrobial activity against Gram-positive bacteria and less active against Gram-negative bacteria. Possesses antifungal activity against C. albicans and hemolytic activity against sheep and pig erythrocytes.
Tissue specificity: Expressed by the venom gland.","[Ref.11563967]Gram-negative bacteria: Pseudomonas aeruginosa (MIC=38.2 μM), Escherichia coli (MIC=19.1 μM);#Gram-positive bacteria: Enterococcus faecalis (MIC=2.4 μM), Bacillus subtilis (MIC=4.8 μM), Staphylococcus epidermidis (MIC=4.8 μM), Staphylococcus aureus (MIC=2.4 μM);##Yeast: Candida albicans (MIC=19.1 μM).",[Ref.11563967]Strong hemolytic activity (11.1-44.5 microM) against sheep erythrocytes,Cell membrane,11563967##15328050##15298871,Biochem J. 2001 Oct 1;359(Pt 1):35-45.##Biochim Biophys Acta. 2004 Aug 30;1664(2):182-188.##Biophys J. 2004 Oct;87(4):2497-507. ,"Corzo G, Escoubas P, Villegas E, Barnham KJ, He W, Norton RS, Nakajima T.##Belokoneva OS, Satake H, Mal'tseva EL, Pal'mina NP, Villegas E, Nakajima T, Corzo G.##Nomura K, Corzo G, Nakajima T, Iwashita T.",Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator.##Pore formation of phospholipid membranes by the action of two hemolytic arachnid peptides of different size.##Orientation and pore-forming mechanism of a scorpion pore-forming peptide bound to magnetically oriented lipid bilayers.,,,,,,,,
945,DRAMP03729,KWFNEKSIQNKIDEKIGKNFLGGMAKAVVHKLAKNEFMCVANVDMTKSCDTHCQKASGEKGYCHGTKCKCGVPLSY,76,"Opiscorpine-1 (Arthropods, animals)","Q5WR03, Q5WQZ8",Belongs to the long chain scorpion toxin family (Class 3 subfamily),Unknown,Opistophthalmus carinatus (African yellow leg scorpion),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: The short amino-terminal segment of opiscorpine 1 (residues 1-35), named Jan-f3, has antimicrobial activity against fungi and the Gram-negative bacteria.
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity).","Fungi: Fusarium culmorum IMI180420 (IC50=8.8 μM), Fusarium oxysporum MUCL39789 (IC50=10.04 μM).##Gram-negative bacterium: Escherichia coli JM109 (MIC=12 μM).",Unknown,Unknown,15241551,Cell Mol Life Sci. 2004 Jul;61(14):1751-1763.,"Zhu S, Tytgat J.","The scorpine family of defensins: gene structure, alternative polyadenylation and fold recognition.",,,,,,,,
946,DRAMP03734,FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ,45,"Parabutoporin (PP; Non-disulfide-bridged peptide 3.2, NDBP-3.2; Arthropods, animals)",P83312,Belongs to the scorpion BPP family,Unknown,Parabuthus schlechteri (Scorpion),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: At high concentrations, acts as pore former in cellular membranes and causes the leakage of the cells. At submicromolar concentrations, degranulates granulocytes and has hemolytic activity against human red blood cells. Also strongly inhibits the production of superoxide anions. Has a strong antibacterial activity against Gram-negative bacteria but is less active against Gram-positive bacteria. Also has antifungal activity. Induces reversible G-protein dependent Ca2+ release from intracellular stores and increase Ca2+ influx in HL-60 cells. Induces the activation of the Rac pathway in granulocytes. Synergistically enhances the excitatory effects of short and long chain ion-channel-specific neurotoxins by interaction with the neuronal membranes.
Tissue specificity: Expressed by the venom gland.
NOTE: residue 11, 44, 55 are uncertainty.","[Ref.12354111]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.1 μM), Escherichia coli DH5a (MIC=3.1 μM), Pseudomonas aeruginosa ATCC 257853 (MIC=6.3 μM), Klebsiella pneumoniae ATCC 13833 (MIC=1.6 μM), Salmonella choleraesuis ATCC 13311 (MIC=3.1 μM), Haemophilus influenzae ATCC 19418 (MIC=3.1 μM);##Gram-positive bacteria: Bacillus subtilis ATCC 6051 (MIC=6.3 μM), Listeria monocytogenes NCTC 11994 (MIC=6.3 μM), Micrococcus luteus ATCC 9341 (MIC=25 μM);##Fungi: Neurospora crassa (MIC=2.5 μM), Botrytis cinerea (MIC=3.5 μM), Fusarium culmorum (MIC=0.3 μM), Saccharomyces cerevisiae (MIC=2 μM).",[Ref.12354111]50% hemolysis is induced by about 38 μM against human red blood cells,Cell membrane,12354111##12457879##14575699##15245865,Eur J Biochem. 2002 Oct;269(19):4799-4810.##Toxicon. 2002 Dec;40(12):1679-1683.##iochem Biophys Res Commun. 2003 Nov 7;311(1):90-97.##Peptides. 2004 Jul;25(7):1079-1084.,"Moerman L, Bosteels S, Noppe W, Willems J, Clynen E, Schoofs L, Thevissen K, Tytgat J, Van Eldere J, Van Der Walt J, Verdonck F.Willems J, Noppe W, Moerman L, van der Walt J, Verdonck F.##Moerman L, Verdonck F, Willems J, Tytgat J, Bosteels S.##Willems J, Moerman L, Bosteels S, Bruyneel E, Ryniers F, Verdonck F.","Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa.##Cationic peptides from scorpion venom can stimulate and inhibit polymorphonuclear granulocytes.##Antimicrobial peptides from scorpion venom induce Ca(2+) signaling in HL-60 cells.##Parabutoporin--an antibiotic peptide from scorpion venom--can both induce activation and inhibition of granulocyte cell functions.",,,,,,,,
947,DRAMP03735,GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNLVAEKIGATPS,44,"Opistoporin-1 (OP1; Non-disulfide-bridged peptide 3.5; Opistoporin-3, OP3; Arthropods, animals)","P83313, Q5VJS8, Q5VJT0",Belongs to the antimicrobial peptide scorpion family,Unknown,Opistophthalmus carinatus (African yellow leg scorpion),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: At high concentrations, acts as pore former in cellular membranes and causes the leakage of the cells. At submicromolar concentrations, degranulates granulocytes and has hemolytic activity against human red blood cells. Also strongly inhibits the production of superoxide anions. Has a strong antibacterial activity against Gram-negative bacteria but is less active against Gram-positive bacteria. Also has antifungal activity.
Tissue specificity: Expressed by the venom gland.","[Ref.12354111]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.5 μM), Escherichia coli DH5a (MIC=6.3 μM), Serratia marcescens ATCC 133880 (MIC=50 μM), Pseudomonas aeruginosa ATCC 257853 (MIC=12.5 μM), Klebsiella pneumoniae ATCC 13833 (MIC=6.3 μM), Salmonella choleraesuis ATCC 13311 (MIC=25 μM), Haemophilus influenzae ATCC 19418 (MIC=1.6 μM);##Gram-positive bacteria: Bacillus subtilis ATCC 6051 (MIC=12.5 μM), Bacillus subtilis IP 5832 (MIC=12.5 μM), Listeria monocytogenes NCTC 11994 (MIC=12.5 μM), Micrococcus luteus ATCC 9341 (MIC>50 μM), Enterococcus faecalis ATCC 19433 (MIC=12.5 μM), Staphylococcus aureus ATCC 292136.3 (MIC>50 μM), Streptococcus pneumoniae ATCC 33400 (MIC=12.5 μM), Nocardia asteroides ATCC 3308 (MIC>50 μM);##Fungi: Neurospora crassa (IC50=0.8 μM), Botrytis cinerea (IC50=3.1 μM), Fusarium culmorum (IC50=0.8 μM), Saccharomyces cerevisiae (IC50=2 μM).","[Ref.12354111]10% hemolytic activity at 10 μM, 30% hemolytic activity at 100 μM against human red blood cells",Cell membrane,12354111##12457879##14575699,Eur J Biochem. 2002 Oct;269(19):4799-4810.##Toxicon. 2002 Dec;40(12):1679-1683.##iochem Biophys Res Commun. 2003 Nov 7;311(1):90-97.,"Moerman L, Bosteels S, Noppe W, Willems J, Clynen E, Schoofs L, Thevissen K, Tytgat J, Van Eldere J, Van Der Walt J, Verdonck F.Willems J, Noppe W, Moerman L, van der Walt J, Verdonck F.##Moerman L, Verdonck F, Willems J, Tytgat J, Bosteels S.","Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa.##Cationic peptides from scorpion venom can stimulate and inhibit polymorphonuclear granulocytes.##Antimicrobial peptides from scorpion venom induce Ca(2+) signaling in HL-60 cells.",,,,,,,,
948,DRAMP03738,GWINEEKIQKKIDERMGNTVLGGMAKAIVHKMAKNEFQCMANMDMLGNCEKHCQTSGEKGYCHGTKCKCGTPLSY,75,"Scorpine (defensins; Arthropods, animals)",P56972,Belongs to the long chain scorpion toxin family (Class 3 subfamily),Unknown,Pandinus imperator (Emperor scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antibacterial activity and a potent inhibitory effect on the ookinete (ED(50) 0.7 uM) and gamete (ED(50) 10 uM) stages of Plasmodium berghei development.,Gram-positive bacterium: Bacillus subtilis (MIC=1.0 μM);##Gram-negative bacterium: Klebsiella pneumoniae (MIC=10 μM).,Unknown,Unknown,10767415,FEBS Lett. 2000 Apr 14;471(2-3):165-168.,"Conde R, Zamudio FZ, Rodríguez MH, Possani LD.","Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom.",,,,,,,,
949,DRAMP02828,GLFRRLRDSIRRGQQKILEKARRIGERIKDIFRG,34,"BMAP-34 (BMAP 34, bovine cathelicidin, cattle, ruminant, mammals, animals)",P56425,Belongs to the cathelicidin family.,CATHL7,Bos taurus (Bovine),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Alpha helix,Unknown,Unknown,"Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. 
Tissue specificity: Expressed in bone marrow myeloid cells, spleen and testis.","[Ref.9795251] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=3 μM), Staphylococcus aureus Cowan 1 (MIC=3 μM), Staphylococcus aureus (MRSA, clinical isolate) (MIC=6 μM), Staphylococcus epidermidis ATCC 12228 (MIC=1.5 μM), Bacillus megaterium Bm 11 (MIC=3 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1.5 μM), Escherichia coli ML-35 (MIC=1.5 μM), Escherichia coli D21 (MIC=1.5 μM), Escherichia coli D22 (MIC=1.5 μM), Salmonella typhimurium ATCC 14028 (MIC=3 μM), Salmonella enteritidis (clinical isolate) (MIC=3 μM), Serratia marcescens ATCC 8100 (MIC=1.5 μM), Pseudomonas aeruginosa ATCC 27853 (MIC≤18 μM);##Fungus: Candida albicans (clinical isolate) (MIC>96 μM).",Unknown,Unknown,9409740##9795251,FEBS Lett. 1997 Nov 17;417(3):311-5.##Biochim Biophys Acta. 1998 Oct 23;1425(2):361-368.,"Scocchi M, Wang S, Zanetti M.##Gennaro R, Scocchi M, Merluzzi L, Zanetti M.",Structural organization of the bovine cathelicidin gene family and identification of a novel member.##Biological characterization of a novel mammalian antimicrobial peptide.,,,,,,,,
951,DRAMP03746,FIGAIARLLSKIF,13,"Peptide BmKn2 (Biologically active peptide 4; NDBP-5.1; Arthropods, animals)",Q6JQN2,Unknown,Kn2,Mesobuthus martensii (Buthus martensii),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.","Gram-positive bacteria: Staphylococcus aureus (MIC=0.6 μg/ml), Micrococcus luteus(MIC=8 μg/ml), Bacillus subtilis (MIC=5 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=1.5 μg/ml), Pseudomonas aeruginosa (MIC=21.3 μg/ml).",Unknown,Unknown,15062994,Peptides. 2004 Feb;25(2):143-150.,"Zeng XC, Wang SX, Zhu Y, Zhu SY, Li WX.",Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch.,,,,,,,,
952,DRAMP03748,FRFGSFLKKVWKSKLAKKLRSKGKQLLKDYANKVLNGPEEEAAAPAE,47,"Bradykinin-potentiating peptide BmK3 (Bpp BmK3; NDBP-3.3; Arthropods, animals)",Q9Y0X4,Belongs to the scorpion BPP family,Unknown,Mesobuthus martensii (Manchurian scorpion) (Buthus martensii),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Alpha helix (predict),"The secondary structure prediction for BmKbpp reveals that BmKbpp is composed of an α-helical structure from amino residues 3-35, followed by a coil-coiled region of three residues (NGP), and ended with an α-helical region of 9 residues (ref.2).",Unknown,"Function: Amphipathic peptide that shows bradykinin potentiating activity and antimicrobial activities against bacteria and fungi. Has higher antibacterial activities against Gram-negative than against Gram-positive bacteria. Also inhibits NADPH oxidase-dependent superoxide production (IC50 is 0.4 μM on granulocytes stimulated with PMA, IC50 is 0.51 μM on HL-60 cells undifferentiated and IC50 is 0.53 μM on HL-60 cells treated with DMSO). The C-terminal peptide shows a higher bradykinin potentiating activity than the complete peptide.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: Shows hemolytic activity. Shows a alpha-helical structure. The genomic DNA coding for this protein is not a continuous sequence in the genome. The transcript of this protein may be generated by trans-splicing, by which exons from two independently transcribed pre-mRNAs are joined to form a single mature transcript.","[Ref.22115565]Gram-negative bacteria: Escherichia coli DH 5-α (MIC=2.3 μM), Haemophilus influenzae ATCC 31517 (MIC=3.2 μM), Klebsiella pneumoniae ATCC 13882 (MIC=2.8 μM), Salmonella enterica ATCC 8090 (MIC=2.3 μM), Pseudomonas aeruginosa ATCC 9229 (MIC=4.7 μM), Serratia marcescens ATCC 13880 (MIC=68.2 μM);##Gram-positive bacteria: Bacillus subtilis ATCC 6051 (MIC=24.4 μM), Listeria monocytogenes ATCC 35152 (MIC=5.7 μM), Micrococcus luteus ATCC 9341 (MIC=20.3 μM), Enterococcus faecalis ATCC 14508 (MIC=57.1 μM), Nocardia asteroides ATCC 3308 (MIC>70 μM), Staphylococcus aureus ATCC 14458 (MIC>70 μM);##Fungi: Neurospora crassa FGSC 2489 (IC50=2 μM), Botrytis cinerea ATCC 28387 (IC50=3.1 μM), Fusarium culmorum ATCC 32973 (IC50=0.2 μM).","[Ref.22115565]3.5% hemolytic activity at 6 μM, 11.2% hemolytic activity at 10 μM, 22.5% hemolytic activity at 30 μM, 33.9% hemolytic activity at 50 μM against human red blood cells",Unknown,10868911##22115565,IUBMB Life. 2000 Mar;49(3):207-210.##Peptides. 2012 Jan;33(1):44-51.,"Zeng XC, Li WX, Peng F, Zhu ZH.##Zeng XC, Wang S, Nie Y, Zhang L, Luo X.","Cloning and characterization of a novel cDNA sequence encoding the precursor of a novel venom peptide (BmKbpp) related to a bradykinin-potentiating peptide from Chinese scorpion Buthus martensii Karsch.##Characterization of BmKbpp, a multifunctional peptide from the Chinese scorpion Mesobuthus martensii Karsch: gaining insight into a new mechanism for the functional diversification of scorpion venom peptides.",,,,,,,,
953,DRAMP03750,IFGAIAGLLKNIF,13,"Venom antimicrobial peptide-6 (Meucin-13; NDBP-5; Arthropods, animals)","E4VP07, E4VP35",Belongs to the scorpion NDBP 5 family,Unknown,Mesobuthus eupeus (Lesser Asian scorpion),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Amphipathic peptide that exhibits extensive cytolytic activities against both prokaryotic and eukaryotic cells. Is more potent against Gram-positive bacteria (lethal concentration (LC=0.25-2.9 μM) than against Gram-negative bacteria (LC=6.2->50 μM), and fungi (LC=14.1->50 μM). Shows hemolytic activity against rabbit erythrocytes and cytolysis against rat dorsal root ganglions. In vivo, intravenous injection into mice tail provokes uncomfortable symptoms with a death rate of 12.5%.
Tissue specificity: Expressed by the venom gland.","[Ref.19088182]Gram-positive bacteria: Bacillus sp. DM-1 (MIC=2 μM), Micrococcus luteus (MIC=2.9 μM), Bacillus megaterium (MIC=0.25 μM);##Gram-negative bacteria: Agrobacterium tumefaciens (MIC=11.8 μM), Escherichia coli (MIC=7.90 μM), Shewanella oneidensis (MIC=6.20 μM), Stenotrophomonus sp. YC-1 (MIC=6.20 μM);##Fungi: Beauveria spp. (MIC=14.1 μM), Neurospora crassa (MIC=18.3 μM), Candida albicans (MIC=42.8 μM), Saccharomyces cerevisiae (MIC=18.3 μM).","[Ref.19088182]37.7% hemolytic activity at 6.25 M, 59.2% hemolytic activity at 12.5 M against rabbit red blood cells",Cell membrane,19088182,FASEB J. 2009 Apr;23(4):1230-1245.,"Gao B, Sherman P, Luo L, Bowie J, Zhu S.",Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides.,,,,,,,,
954,DRAMP03751,FFGHLFKLATKIIPSLFQ,18,"Venom antimicrobial peptide-9 (Meucin-18; NDBP-5; Arthropods, animals)",E4VP50,Belongs to the ponericin-W family,Unknown,Mesobuthus eupeus (Lesser Asian scorpion),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Amphipathic peptide that exhibits extensive cytolytic activities against both prokaryotic and eukaryotic cells. Is more potent against Gram-positive bacteria (lethal concentration (LC=1.5-10.9 μM) than against Gram-negative bacteria (LC=6.2-50 μM), and fungi (LC=25.1-8.3 μM). Is lethal to the fungus Beauveria sp (LC=1.9 μM), a highly lethal pathogenic fungus to insects and resistant to many AMPs. Shows hemolytic activity against rabbit erythrocytes and cytolysis against rat dorsal root ganglions. In vivo, intravenous injection into mice tail provokes uncomfortable symptoms with a death rate of 12.5%.
Tissue specificity: Expressed by the venom gland.","[Ref.19088182]Gram-positive bacteria: Bacillus sp. DM-1 (MIC=0.60 μM), Micrococcus luteus (MIC=0.60 μM), Bacillus megaterium (MIC=0.25 μM);##Gram-negative bacteria: Agrobacterium tumefaciens (MIC=6.00 μM), Escherichia coli (MIC=2.40 μM), Shewanella oneidensis (MIC=1.50 μM), Stenotrophomonus sp. YC-1(MIC=2.60 μM), Salmonella typhimurium (MIC=10.9 μM);##Fungi: Beauveria spp.(MIC=1.9 μM), Neurospora crassa (MIC=5.2 μM), Candida albicans (MIC=25.1 μM), Saccharomyces cerevisiae (MIC=25.1 μM), Aspergillus fumigatus (MIC=8.3 μM), Geotrichum candidum (MIC=3.5 μM).","[Ref.19088182]74% hemolytic activity at 6.25 M, 100% hemolytic activity at 12.5 M against rabbit red blood cells",Cell membrane,19088182,FASEB J. 2009 Apr;23(4):1230-1245.,"Gao B, Sherman P, Luo L, Bowie J, Zhu S.",Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides.,,,,,,,,
955,DRAMP03752,FLFSLIPSAISGLISAFK,18,"Peptide BmKb1 (Non-disulfide-bridged peptide 4.2, NDBP-4.2; Arthropods, animals)","Q718F4, Q2M5D6 Q95P85",Unknown,Kb1,Mesobuthus martensii (Manchurian scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation.","Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml), Micrococcus luteus(MIC=81.5 μg/ml), Bacillus subtilis (MIC=48.8 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=18.1 μg/ml), Pseudomonas aeruginosa (MIC=90.8 μg/ml).",Unknown,Cell membrane (Forms a helical membrane channel in the prey),15062994##16040157,Peptides. 2004 Feb;25(2):143-150.##Peptides. 2005 Dec;26(12):2427-2433.,"Zeng XC, Wang SX, Zhu Y, Zhu SY, Li WX.##Luo F, Zeng XC, Hahin R, Cao ZJ, Liu H, Li WX.",Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch.##Genomic organization of four novel nondisulfide-bridged peptides from scorpion Mesobuthus martensii Karsch: gaining insight into evolutionary mechanism.,,,,,,,,
956,DRAMP03753,GFWGSLWEGVKSVV,14,"Amphipathic peptide CT1 (StCT1; Non-disulfide-bridged peptide 5, NDBP-5; Arthropods, animals)",P0DJO3,Unknown,Unknown,Scorpiops tibetanus (Scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide that is rapidly bactericidal against Gram-positive bacteria (MIC=12.5 μg/ml against S.aureus, and MIC=100 μg/ml against M. luteus). Is also active against clinical antibiotics-resistant bacterial strains.
PTM: C-terminal amidation and Cleavage on pair of basic residues.
Miscellaneous: Is highly capable of inhibiting antibiotic-resistant pathogen growth, including methicillin-resistant S.aureus. In vivo, shows high antimicrobial activity on a S.aureus-infected mouse model.","Gram-positive bacteria: Staphylococcus aureus AB94004 (MIC=12.5 μg/ml), Bacillus thuringensis AB92037 (MIC>100 μg/ml), Bacillus subtilis AB91021 (MIC>100 μg/ml), Micrococcus luteus AB93113 (MIC=100 μg/ml), MRSA P1374 (MIC=200 μg/ml), MRSA P1386 (MIC=250 μg/ml);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=100 μg/ml), Pseudomonas aeruginosa AB93066 (MIC=100 μg/ml).",Unknown,Cell membrane,19854232,Peptides. 2010 Jan;31(1):22-26.,"Yuan W, Cao L, Ma Y, Mao P, Wang W, Zhao R, Wu Y, Cao Z, Li W.",Cloning and functional characterization of a new antimicrobial peptide gene StCT1 from the venom of the scorpion Scorpiops tibetanus.,,,,,,,,
957,DRAMP03754,GFWGKLWEGVKSAI,14,"Amphipathic peptide CT2 (StCT2; Non-disulfide-bridged peptide 5, NDBP-5; Arthropods, animals)",P0DJO4,Unknown,Unknown,Scorpiops tibetanus (Scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"PTM: C-terminal amidation and Cleavage on pair of basic residues.
Miscellaneous: Is highly capable of inhibiting antibiotic-resistant pathogen growth, including methicillin-resistant S.aureus. In vivo, shows high antimicrobial activity on a S.aureus-infected mouse model.","Gram-positive bacteria: Staphylococcus aureus AB94004 (MIC=6.25 μg/ml), Bacillus thuringensis AB92037 (MIC=50 μg/ml), Bacillus subtilis AB91021 (MIC=25 μg/ml), Micrococcus luteus AB93113 (MIC=25 μg/ml), PRSA P1383 (MIC=12.5 μg/ml), PRSE P1389 (MIC=12.5 μg/ml), MRCNS P1369 (MIC=6.25 μg/ml), MRSA P1374 (MIC=6.25 μg/ml), MRSA P1386 (MIC=12.5 μg/ml), MRSA P1381 (MIC=25 μg/ml), MSSE P1111 (MIC=6.25 μg/ml);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=50 μg/ml), Pseudomonas aeruginosa AB93066 (MIC>100 μg/ml).",Unknown,Cell membrane,22542475,Peptides. 2012 Aug;36(2):213-220.,"Cao L, Li Z, Zhang R, Wu Y, Li W, Cao Z.","StCT2, a new antibacterial peptide characterized from the venom of the scorpion Scorpiops tibetanus.",,,,,,,,
958,DRAMP03774,GFWGKLWEGVKNAI,14,"UyCT1 (Arthropods, animals)",No entry found,Unknown,Unknown,Urodacus yaschenkoi (Scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows minimum inhibitory concentration against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.23182832]Gram-positive bacterium: Staphylococcus aureus ATCC 25953 (MIC=15 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10 μM), Pseudomonas aeruginosa ATCC 9027 (MIC=10 μM).","[Ref.23182832]20% hemolytic activity at 12.5 μM, 45% hemolytic activity at 25 μM, 80% hemolytic activity at 50 μM, 90% hemolytic activity at 100 μM against human erythrocytes",Unknown,23182832,Toxicon. 2013 Mar 1;63:44-54.,"Luna-Ramírez K, Quintero-Hernández V, Vargas-Jaimes L, Batista CV, Winkel KD, Possani LD.","Characterization of the venom from the Australian scorpion Urodacus yaschenkoi: Molecular mass analysis of components, cDNA sequences and peptides with antimicrobial activity.",,,,,,,,
959,DRAMP03775,FWGKLWEGVKNAI,13,"UyCT2 (Arthropods, animals)",No entry found,Unknown,Unknown,Urodacus yaschenkoi (Scorpion),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows minimum inhibitory concentration against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.23182832]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=25 μM), Pseudomonas aeruginosa ATCC 9027 (MIC=40 μM).","[Ref.23182832]3% hemolytic activity at 12.5 μM, 6% hemolytic activity at 25 μM, 5% hemolytic activity at 50 μM, 35% hemolytic activity at 100 μM against human erythrocytes",Unknown,23182832,Toxicon. 2013 Mar 1;63:44-54.,"Luna-Ramírez K, Quintero-Hernández V, Vargas-Jaimes L, Batista CV, Winkel KD, Possani LD.","Characterization of the venom from the Australian scorpion Urodacus yaschenkoi: Molecular mass analysis of components, cDNA sequences and peptides with antimicrobial activity.",,,,,,,,
960,DRAMP03776,ILSAIWSGIKSLF,13,"UyCT3 (Arthropods, animals)",No entry found,Unknown,Unknown,Urodacus yaschenkoi (Scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows minimum inhibitory concentration against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.23182832]Gram-positive bacterium: Staphylococcus aureus ATCC 25953 (MIC=10 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15 μM), Pseudomonas aeruginosa ATCC 9027 (MIC=6 μM).","[Ref.23182832]30% hemolytic activity at 12.5 μM, 90% hemolytic activity at 25 μM, 92% hemolytic activity at 50 μM, 90% hemolytic activity at 100 μM against human erythrocytes",Unknown,23182832,Toxicon. 2013 Mar 1;63:44-54.,"Luna-Ramírez K, Quintero-Hernández V, Vargas-Jaimes L, Batista CV, Winkel KD, Possani LD.","Characterization of the venom from the Australian scorpion Urodacus yaschenkoi: Molecular mass analysis of components, cDNA sequences and peptides with antimicrobial activity.",,,,,,,,
961,DRAMP03777,IWSAIWSGIKGLL,13,"UyCT5 (Arthropods, animals)",No entry found,Unknown,Unknown,Urodacus yaschenkoi (Scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows minimum inhibitory concentration against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.23182832]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15 μM), Pseudomonas aeruginosa ATCC 9027 (MIC=2 μM).##Gram-positive bacterium: Staphylococcus aureus ATCC 25953 (MIC=1 μM).","[Ref.23182832]27% hemolytic activity at 12.5 μM, 65% hemolytic activity at 25 μM, 95% hemolytic activity at 50 μM, 90% hemolytic activity at 100 μM against human erythrocytes",Unknown,23182832,Toxicon. 2013 Mar 1;63:44-54.,"Luna-Ramírez K, Quintero-Hernández V, Vargas-Jaimes L, Batista CV, Winkel KD, Possani LD.","Characterization of the venom from the Australian scorpion Urodacus yaschenkoi: Molecular mass analysis of components, cDNA sequences and peptides with antimicrobial activity.",,,,,,,,
963,DRAMP03814,GILDTLKQFAKGVGKWLVKGAAQGVLSTVSCKLAKTC,37,D16W (GGN4 analogue peptide with single substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix,Unknown,Unknown,Function: Single substitution of aspartic acid 16 by tryptophan (D16W) in the native GGN4. Has hemolytic activity as well as the antimicrobial activity.,"[Ref.12199716]Gram-positive bacteria: Micrococcus luteus (MIC=25 μg/ml), Bacillus subtilis (MIC=2.5 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=10 μg/ml), Shigella dysentariae (MIC=10 μg/ml), Pseudomonas putida (MIC=100 μg/ml), Pseudomonas aeruginosa (MIC=50 μg/ml), Eshchericia coli (MIC=10 μg/ml), Salmonella typhimurium (MIC=50 μg/ml).","[Ref.12199716]1.97% hemolytic activity at 10 μg/mL, 52.9% hemolytic activity at 100 μg/mL against human red blood cells",Unknown,12199716,Eur J Biochem. 2002 Sep;269(17):4367-4374.,"Won HS, Park SH, Kim HE, Hyun B, Kim M, Lee BJ, Lee BJ.",Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,,,,,,,,
964,DRAMP03815,GILDTLKQFAKGVGKWLVKGAAQ,23,D16W-N23 (single amino acid substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Comment: Single substitution of aspartic acid 16 by tryptophan (D16W) in the Delta24-37 GGN4, which is a peptide analogue with 14 residues truncated from the C-terminus of GGN4.","Gram-positive bacteria: Micrococcus luteus (MIC=2.5 μg/ml), Bacillus subtilis (MIC=25 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=25 μg/ml), Shigella dysentariae (MIC=50 μg/ml), Pseudomonas aeruginosa (MIC=125 μg/ml), Eshchericia coli (MIC=25 μg/ml), Salmonella typhimurium (MIC=125 μg/ml).",Unknown,Unknown,12199716,Eur J Biochem. 2002 Sep;269(17):4367-4374.,"Won HS, Park SH, Kim HE, Hyun B, Kim M, Lee BJ, Lee BJ.",Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,,,,,,,,
965,DRAMP03816,GILDTLKQFAKGVGKFLVKGAAQ,23,D16F-N23 (single amino acid substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Comment: Single substitution of aspartic acid 16 by phenylalanine (D16F) in the Delta24-37 GGN4, which is a peptide analogue with 14 residues truncated from the C-terminus of GGN4.","Gram-positive bacterium: Bacillus subtilis (MIC=25 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae (MIC=100 μg/ml), Shigella dysentariae (MIC=50 μg/ml), Pseudomonas aeruginosa (MIC=200 μg/ml), Eshchericia coli (MIC=25 μg/ml).",Unknown,Unknown,12199716,Eur J Biochem. 2002 Sep;269(17):4367-4374.,"Won HS, Park SH, Kim HE, Hyun B, Kim M, Lee BJ, Lee BJ.",Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,,,,,,,,
966,DRAMP03823,ALWKTLLKKVLKA,13,Dermaseptin derivative K4-S4-(1-13),P80280,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 5 residues),"The Ramachandran plot of P showes that residues 2 and 4-13 are all in α-helix regions of the plot; the residues in all of the structures are in the core α-helix region for residues 2, 3, and 6-11, and both residue 5 and 12 had over 60% in the core and the rest in allowed α-helix regions.",2DD6 resolved by NMR.,Function: Has antibacterial activity. Also has hemolytic activity against red blood cells (RBCs).,[Ref.15917541]Gram-negative bacterium: Escherichia coli U16318 (MIC=9-3 μM);##Gram-positive bacterium: Staphylococcus aureus B38302 (MIC=4.5-1.5 μM).,[Ref.15917541]LC50=50 μM against human red blood cells,Cell membrane,16407175##15917541,J Biol Chem. 2006 Apr 7;281(14):9432-9438.##Antimicrob Agents Chemother. 2005 Jun;49(6):2412-2420.,"Shalev DE, Rotem S, Fish A, Mor A.##Radzishevsky IS, Rotem S, Zaknoon F, Gaidukov L, Dagan A, Mor A.",Consequences of N-acylation on structure and membrane binding properties of dermaseptin derivative K4-S4-(1-13).##Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides.,,,,,,,,
967,DRAMP03824,FKCRRWQWR,9,CNBr-cleaved lactoferricin Subfragment 1,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: The antibacterial activity of this subfragment 1 is not as potent as that of intact lactoferricin, having an MIC of 10 to 50 μM for most of the bacteria tested.","Gram-negative bacteria: Escherichia coli L361 (MIC=10 μM), Pseudomonas fluorescens (MIC=50 μM), Salmonella Salford (MIC>50 μM), Escherichia coli O:9 (MIC=15 μM);##Gram-positive bacteria: Bacillus cereus (MIC=20 μM), Listeria monocytogenes (MIC=10 μM), Staphylococcus aureus (MIC>50 μM).",Unknown,Unknown,8980754,Antimicrob Agents Chemother. 1997 Jan;41(1):54-59.,"Hoek KS, Milne JM, Grieve PA, Dionysius DA, Smith R.",Antibacterial activity in bovine lactoferrin-derived peptides.,,,,,,,,
968,DRAMP03825,KKLGAPSITCVRRAFA,16,CNBr-cleaved lactoferricin Subfragment 2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Subfragment 2 had weak antibacterial activity against L. monocytogenes and both E. coli isolates, being effective in the range of 40 to 60 μM.","Gram-negative bacteria: Escherichia coli L361 (MIC=50 μM), Pseudomonas fluorescens (MIC>100 μM), Salmonella Salford (MIC>100 μM), Escherichia coli O:9 (MIC=60 μM);##Gram-positive bacteria: Bacillus cereus (MIC>100 μM), Listeria monocytogenes (MIC=40 μM), Staphylococcus aureus (MIC>100 μM).",Unknown,Unknown,8980754,Antimicrob Agents Chemother. 1997 Jan;41(1):54-59.,"Hoek KS, Milne JM, Grieve PA, Dionysius DA, Smith R.",Antibacterial activity in bovine lactoferrin-derived peptides.,,,,,,,,
969,DRAMP03826,KNLRRIIRKIIHIIKKYG,18,Ovispirin-1 (OV-1; N-terminal 18 amino acids of SMAP-29),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Cytotoxicity, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 13 residues),Ovispirin-1 is a uniform α-helix over residues 4-16. ,1HU5 resolved by NMR.,"Function: Possess potently antimicrobial activity. It is also highly cytotoxic to human epithelial cells (ME-180 cervical cells: 100% at 200 μg/ml, 93.6% at 50 μg/ml, 55.3% at 25 μg/ml) and A-549 pulmonary cells: 99.7% at 200 μg/ml, 99.4% at 50 μg/ml, 90.9% at 25 μg/ml) and hemolytic for human Human red blood cells.","[Ref.11932493]Gram-negative bacteria: Pseudomonas aeruginosa 9 strains (MIC=0.7-5.6 μg/ml), Stenotrophomonas maltophilia 5 strains (MIC=0.5-2.2 μg/ml);##Gram-positive bacteria: Listeria monocytogenes EGD [n=3] (MIC=1.5±0.3 μg/ml), Staphylococcus aureus 930918 [n=3] (MIC=1.0±0.13 μg/ml).","[Ref.11932493]55% hemolytic at 40 μg/mL, 70.2% hemolytic activity at 80 μg/mL against human red blood cells",Unknown,11932493,Protein Eng. 2002 Mar;15(3):225-232.,"Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF.",Impact of single-residue mutations on the structure and Function: of ovispirin/novispirin antimicrobial peptides.,,,,,,,,
970,DRAMP03827,KNLRRIIRKGIHIIKKYG,18,Novispirin G-10 (mutation of Ovispirin-1),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Cytotoxicity, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (2 helices; 11 residues),"Novispirin G-10 shows an α-helix-hinge-310 helix structural motif with residues 4-11 forming the α-helix, residues 12 and 13 forming the hinge and residues 14-16 forming the 310 helix.",1HU6 resolved by NMR.,"Function: Possess potently antimicrobial activity. Also has hemolytic activity against Human red blood cells, and has cytotoxicity activity against ME-180 cervical cells (33.2% at 200 μg/ml, 5.0% at 50 μg/ml, 7.1% at 25 μg/ml) and A-549 pulmonary cells (33.2% at 200 μg/ml, 14.6% at 50 μg/ml, 10.0% at 25 μg/ml).","[Ref.11932493]Gram-negative bacteria: Pseudomonas aeruginosa 9 strains (MIC=0.11-12.7 μg/ml), Stenotrophomonas maltophilia 5 strains (MIC=0.29-3.6 μg/ml);##Gram-positive bacteria: Listeria monocytogenes EGD [n=3] (MIC=1.4±0.4 μg/ml), Staphylococcus aureus 930918 [n=3] (MIC=4.6±1.7 μg/ml).","[Ref.11932493]1.8% hemolytic at 40 μg/mL, 2.5% hemolytic activity at 80 μg/mL against human red blood cells",Unknown,11932493,Protein Eng. 2002 Mar;15(3):225-232.,"Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF.",Impact of single-residue mutations on the structure and Function: of ovispirin/novispirin antimicrobial peptides.,,,,,,,,
971,DRAMP03828,KNLRRITRKIIHIIKKYG,18,Novispirin T-7 (mutation of Ovispirin-1),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Cytotoxicity, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 11 residues),Novispirin T-7 is a well-defined α-helix over residues 7-17 with residues 3-6 forming a type IV turn.,1HU7 resolved by NMR.,"Function: Possess potently antimicrobial activity. Also has hemolytic activity against Human red blood cells, and has cytotoxicity activity against ME-180 cervical cells (81.5% at 200 μg/ml, 28.4% at 50 μg/ml, 15.6% at 25 μg/ml) and A-549 pulmonary cells (81.5% at 200 μg/ml, 22.9% at 50 μg/ml, 15.4% at 25 μg/ml).","[Ref.11932493]Gram-negative bacteria: Pseudomonas aeruginosa 9 strains (MIC=0.26-27.8 μg/ml), Stenotrophomonas maltophilia 5 strains (MIC=0.32-1.75 μg/ml);##Gram-positive bacteria: Listeria monocytogenes EGD (MIC=2.4±1.5 [n=3] μg/ml), Staphylococcus aureus 930918 (MIC=3.3±1.5 [n=3] μg/ml).","[Ref.11932493]3% hemolytic at 40 μg/mL, 10% hemolytic activity at 80 μg/mL against human red blood cells",Unknown,11932493,Protein Eng. 2002 Mar;15(3):225-232.,"Sawai MV, Waring AJ, Kearney WR, McCray PB Jr, Forsyth WR, Lehrer RI, Tack BF.",Impact of single-residue mutations on the structure and Function: of ovispirin/novispirin antimicrobial peptides.,,,,,,,,
972,DRAMP03829,GLKKLLGKLLKKLGKLLLK,19,GLK-19,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anticancer, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: GLK-19 showed a higher activity against Escherichia coli than human LL-37.,Gram-negative bacterium: Escherichia coli K12 (MIC=10 μM).,Unknown,Unknown,18957441,Nucleic Acids Res. 2009 Jan;37(Database issue):D933-937.,"Wang G, Li X, Wang Z.",APD2: the updated antimicrobial peptide database and its application in peptide design.,,,,,,,,
973,DRAMP03830,GLWNSIKIAGKKLFVNVLDKIRCKVAGGCKTSPDVEYHK,39,Palustrin-2ISb + 3aa,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=6.3 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.3 μM), S. aureus (MRSA) (MIC=100 μM).",Unknown,Unknown,21911019,Peptides. 2011 Oct;32(10):2052-2057.,"Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.",Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-3 family isolated from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
974,DRAMP03831,GLWNSIKIAGKKLFVNVLDKIRCKVAGGC,29,Palustrin-2ISb-des-C7,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=6.3 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=1.6 μM), S. aureus (MRSA) (MIC=12.5 μM).##Yeast: Candida albicans (MIC=100 μM).",Unknown,Unknown,21911019,Peptides. 2011 Oct;32(10):2052-2057.,"Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.",Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-4 family isolated from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
975,DRAMP03832,GLWDSIKIAGKKLFVNVLDKIRCKVAGGC,29,Palustrin-2ISb-des-C7-4D,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=12.5 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 μM), S. aureus (MRSA) (MIC=12.5 μM);##yeast Candida albicans (MIC=100 μM).",Unknown,Unknown,21911019,Peptides. 2011 Oct;32(10):2052-2057.,"Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.",Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-5 family isolated from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
976,DRAMP03833,GLWNSIKIAGKNLFVNVLDKIRCKVAGGC,29,Palustrin-2ISb-des-C7-12N,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=12.5 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 μM), S. aureus (MRSA) (MIC=12.5 μM);##yeast Candida albicans (MIC=100 μM).",Unknown,Unknown,21911019,Peptides. 2011 Oct;32(10):2052-2057.,"Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.",Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-6 family isolated from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
977,DRAMP03834,GLWNSIKIAGKKLFVNVLDKIRSKVAGGS,29,"Palustrin-2ISb-des-C7-23,29S",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=3.1 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.3 μM), S. aureus (MRSA) (MIC=25 μM);##yeast Candida albicans (MIC=100 μM).",Unknown,Unknown,21911019,Peptides. 2011 Oct;32(10):2052-2057.,"Iwakoshi-Ukena E, Okada G, Okimoto A, Fujii T, Sumida M, Ukena K.",Identification and structure-activity relationship of an antimicrobial peptide of the palustrin-7 family isolated from the skin of the endangered frog Odorrana ishikawae.,,,,,,,,
979,DRAMP03852,GLARIVVIRVAR,12,G1 (Bac2A variant through single amino acid substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=125 μg/ml), Escherichia coli (MIC=16 μg/ml), Salmonella typhimurium (MIC=63 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=63 μg/ml), Staphylococcus epidermidis (MIC=16 μg/ml), Enterococcus faecalis (MIC=31 μg/ml).##Yeast: Candida albicans (MIC=125 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
980,DRAMP03853,RGARIVVIRVAR,12,G2 (Bac2A variant through single amino acid substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=31 μg/ml), Escherichia coli (MIC=8 μg/ml), Salmonella typhimurium (MIC=31 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=31 μg/ml), Staphylococcus epidermidis (MIC=16 μg/ml), Enterococcus faecalis (MIC=31 μg/ml).##Yeast: Candida albicans (MIC=16 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
981,DRAMP03854,RRARIVVIRVAR,12,R2 (Bac2A variant through single amino acid substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=8 μg/ml), Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=8 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml), Staphylococcus epidermidis (MIC=2 μg/ml), Enterococcus faecalis (MIC=16 μg/ml).##Yeast: Candida albicans (MIC=8 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
982,DRAMP03855,RLRRIVVIRVAR,12,R3 (Bac2A variant through single amino acid substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=8 μg/ml), Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=8 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=8 μg/ml), Staphylococcus epidermidis (MIC=2 μg/ml), Enterococcus faecalis (MIC=8 μg/ml).##Yeast: Candida albicans (MIC=16 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
983,DRAMP03856,RLWRIVVIRVAR,12,W3 (Bac2A variant through single amino acid substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=8 μg/ml), Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=8 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=2 μg/ml), Staphylococcus epidermidis (MIC=0.5 μg/ml), Enterococcus faecalis (MIC=2 μg/ml).##Yeast: Candida albicans (MIC=8 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
984,DRAMP03857,RLARRVVIRVAR,12,R5 (Bac2A variant through single amino acid substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=63 μg/ml), Escherichia coli (MIC=16 μg/ml), Salmonella typhimurium (MIC=31 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=63 μg/ml), Staphylococcus epidermidis (MIC=16 μg/ml), Enterococcus faecalis (MIC=125 μg/ml).##Yeast: Candida albicans (MIC=125 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
985,DRAMP03858,RLARIVKIRVAR,12,K7 (Bac2A variant through single amino acid substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=31 μg/ml), Escherichia coli (MIC=16 μg/ml), Salmonella typhimurium (MIC=63 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=125 μg/ml), Staphylococcus epidermidis (MIC=31 μg/ml), Enterococcus faecalis (MIC=125 μg/ml).##Yeast: Candida albicans (MIC=31 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
986,DRAMP03859,RLARIVVIRWAR,12,W10 (Bac2A variant through single amino acid substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=16 μg/ml), Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=8 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=8 μg/ml), Staphylococcus epidermidis (MIC=2 μg/ml), Enterococcus faecalis (MIC=4 μg/ml).##Yeast: Candida albicans (MIC=8 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
987,DRAMP03860,RLARIVVIRVRR,12,R11 (Bac2A variant through single amino acid substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=16 μg/ml), Escherichia coli (MIC=8 μg/ml), Salmonella typhimurium (MIC=8 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=8 μg/ml), Staphylococcus epidermidis (MIC=2 μg/ml), Enterococcus faecalis (MIC=8 μg/ml).##Yeast: Candida albicans (MIC=8 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
988,DRAMP03861,RLARIVVIRVAG,12,G12 (Bac2A variant through single amino acid substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=63 μg/ml), Escherichia coli (MIC=16 μg/ml), Salmonella typhimurium (MIC=63 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=63 μg/ml), Staphylococcus epidermidis (MIC=31 μg/ml), Enterococcus faecalis (MIC=31 μg/ml).##Yeast: Candida albicans (MIC=63 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
989,DRAMP03862,RLRRIVVIRVRR,12,Sub2 (Bac2A variant through two amino acids substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=8 μg/ml), Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=8 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=8 μg/ml), Staphylococcus epidermidis (MIC=2 μg/ml), Enterococcus faecalis (MIC=4 μg/ml).##Yeast: Candida albicans (MIC=31 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
990,DRAMP03863,RRWRIVVIRVRR,12,Sub3 (Bac2A variant through three amino acids substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=2 μg/ml), Escherichia coli (MIC=2.5 μg/ml), Salmonella typhimurium (MIC=4 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=2 μg/ml), Staphylococcus epidermidis (MIC=0.2 μg/ml), Enterococcus faecalis (MIC=4 μg/ml).##Yeast: Candida albicans (MIC=4 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
991,DRAMP03864,RRWKIVVIRWRR,12,Sub5 (Bac2A variant through five amino acids substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=2 μg/ml), Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=8 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=2 μg/ml), Staphylococcus epidermidis (MIC=0.5 μg/ml), Enterococcus faecalis (MIC=2 μg/ml).##Yeast: Candida albicans (MIC=4 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
992,DRAMP03865,RWWKIWVIRWWR,12,Sub6 (Bac2A variant through six amino acids substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Optimized 12-mer peptides shows broad spectrum antibacterial activity against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=31 μg/ml), Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=16 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=8 μg/ml), Staphylococcus epidermidis (MIC=1 μg/ml), Enterococcus faecalis (MIC=8 μg/ml).##Yeast: Candida albicans (MIC=31 μg/ml)..",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
993,DRAMP03866,KIWVIRWR,8,Bac8a (Bac2A variant),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: 8-mer substituted peptide that showes broad spectrum activity against bacteria and the yeast C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=16 μg/ml), Escherichia coli (MIC=8 μg/ml), Salmonella typhimurium (MIC=31 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml), Staphylococcus epidermidis (MIC=4 μg/ml), Enterococcus faecalis (MIC=16 μg/ml).##Yeast: Candida albicans (MIC=16 μg/ml)",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
994,DRAMP03867,RIWVIRWR,8,Bac8b (Bac2A variant),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: 8-mer substituted peptide that showes broad spectrum activity against bacteria and the yeast C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=16 μg/ml), Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=16 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=4 μg/ml), Staphylococcus epidermidis (MIC=4 μg/ml), Enterococcus faecalis (MIC=8 μg/ml).##Yeast: Candida albicans (MIC=16 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
995,DRAMP03868,RIWVIWRR,8,Bac8c (Bac2A variant),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: 8-mer substituted peptide that showes broad spectrum activity against bacteria and the yeast C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=8 μg/ml), Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=8 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=2 μg/ml), Staphylococcus epidermidis (MIC=2 μg/ml), Enterococcus faecalis (MIC=2 μg/ml).##Yeast: Candida albicans (MIC=8 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
996,DRAMP03869,RRWVIWRR,8,Bac8d (Bac2A variant),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: 8-mer substituted peptide that showes broad spectrum activity against bacteria and the yeast C. albicans.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Pseudomonas aeruginosa (MIC=250 μg/ml), Escherichia coli (MIC=16 μg/ml), Salmonella typhimurium (MIC=31 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml), Staphylococcus epidermidis (MIC=8 μg/ml), Enterococcus faecalis (MIC=32 μg/ml).##Yeast: Candida albicans (MIC=63 μg/ml).",Unknown,Unknown,16041366,Nat Biotechnol. 2005 Aug;23(8):1008-1012.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.,,,,,,,,
997,DRAMP03870,RLARIVVIRVAR,12,Bac2A (a linear variant of bovine dodecapeptide),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=50 μg/ml), Escherichia coli (MIC=17 μg/ml), Salmonella (MIC=34 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=17 μg/ml), Staphylococcus epidermidis (MIC=4 μg/ml), Enterococcus faecalis (MIC=17 μg/ml).##Yeast: Candida albicans (MIC=9 μg/ml).",Unknown,Unknown,16041366##17052614,Nat Biotechnol. 2005 Aug;23(8):1008-1012.Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Volkmer-Engert R, Walter T, Hancock RE. Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",High-throughput generation of small antibacterial peptides with improved activity.Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
998,DRAMP03871,YQWQRRMRKL,10,"cLf 20-29 (fragment of caprine lalctoferricin, residues 20-29)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=308 μM), Escherichia coli (wild strain) (MIC>300 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=308 μM), Enterococcus faecalis ATCC 29212 (MIC>300 μM).",Unknown,Unknown,13677384,Am J Vet Res. 2003 Sep;64(9):1088-1092.,"Chen PW, Shyu CL, Mao FC.",Antibacterial activity of short hydrophobic and basic-rich peptides.,,,,,,,,
999,DRAMP03875,RRWQWRMKKL,10,"bLf 20-29 (fragment of bovine lactoferricin, residues 20-29)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.25 μM), Escherichia coli (wild strain) (MIC=5.63 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=11.25 μM), Enterococcus faecalis ATCC 29212 (MIC=15 μM).",Unknown,Unknown,13677384,Am J Vet Res. 2003 Sep;64(9):1088-1092.,"Chen PW, Shyu CL, Mao FC.",Antibacterial activity of short hydrophobic and basic-rich peptides.,,,,,,,,
1000,DRAMP03876,RRWWWRWRRW,10,LFB-RW (derivative of bovine lactoferrin with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15 μM), Escherichia coli (wild strain) (MIC=5.63 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=7.5 μM), Enterococcus faecalis ATCC 29212 (MIC=11.25 μM).",Unknown,Unknown,13677384,Am J Vet Res. 2003 Sep;64(9):1088-1092.,"Chen PW, Shyu CL, Mao FC.",Antibacterial activity of short hydrophobic and basic-rich peptides.,,,,,,,,
1001,DRAMP03877,KKWWWKWKKW,10,LFB-KW (derivative of bovine lactoferrin with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=11.25 μM), Escherichia coli (wild strain) (MIC=7.50 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=11.25 μM), Enterococcus faecalis ATCC 29212 (MIC=22.5 μM).",Unknown,Unknown,13677384,Am J Vet Res. 2003 Sep;64(9):1088-1092.,"Chen PW, Shyu CL, Mao FC.",Antibacterial activity of short hydrophobic and basic-rich peptides.,,,,,,,,
1002,DRAMP03878,RRWWRRWRRW,10,LFB-Rwa (derivative of bovine lactoferrin with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=15 μM), Escherichia coli (wild strain) (MIC=5.63 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=7.5 μM), Enterococcus faecalis ATCC 29212 (MIC=22.5 μM).",Unknown,Unknown,13677384,Am J Vet Res. 2003 Sep;64(9):1088-1092.,"Chen PW, Shyu CL, Mao FC.",Antibacterial activity of short hydrophobic and basic-rich peptides.,,,,,,,,
1003,DRAMP03879,RRFFFRFRRF,10,LFB-RF (derivative of bovine lactoferrin with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=22.5 μM), Escherichia coli (wild strain) (MIC=15 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=15 μM), Enterococcus faecalis ATCC 29212 (MIC=22.5 μM).",Unknown,Unknown,13677384,Am J Vet Res. 2003 Sep;64(9):1088-1092.,"Chen PW, Shyu CL, Mao FC.",Antibacterial activity of short hydrophobic and basic-rich peptides.,,,,,,,,
1004,DRAMP03880,RRIIIRWRRI,10,LFB-RI (derivative of bovine lactoferrin with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=5.63 μM), Escherichia coli (wild strain) (MIC=3.75 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=11.25 μM), Enterococcus faecalis ATCC 29212 (MIC=15 μM).",Unknown,Unknown,13677384,Am J Vet Res. 2003 Sep;64(9):1088-1092.,"Chen PW, Shyu CL, Mao FC.",Antibacterial activity of short hydrophobic and basic-rich peptides.,,,,,,,,
1005,DRAMP03881,RRWWWR,6,LFB-6RW (derivative of bovine lactoferrin with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=22.5 μM), Escherichia coli (wild strain) (MIC=22.5 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=11.25 μM), Enterococcus faecalis ATCC 29212 (MIC=30 μM).",Unknown,Unknown,13677384,Am J Vet Res. 2003 Sep;64(9):1088-1092.,"Chen PW, Shyu CL, Mao FC.",Antibacterial activity of short hydrophobic and basic-rich peptides.,,,,,,,,
1006,DRAMP03882,SKCYQWQRRMRKLGA,15,"LFC (fragment of mature caprine lactoferrin, residues 17 to 31)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=252 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>500 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1007,DRAMP03883,TKCFQWQWNMRKVRG,15,LFH W8 (tryptophan-modified human lactoferricin derivative),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=74 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>500 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1008,DRAMP03884,SKCYQWQWRMRKLGA,15,LFC W8 (tryptophan-modified caprine lactoferricin derivative),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=174 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>500 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1009,DRAMP03885,SKCRQWQWKIRRTNP,15,LFP W8 (tryptophan-modified porcine lactoferricin derivative),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=219 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>500 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1010,DRAMP03886,FKCRRWQWRMKKLGA,15,"LFB (fragment of bovine lalctoferricin, residues 17 to 31)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=24 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=48 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives.,,,,,,,,
1011,DRAMP03887,AKCRRWQWRMKKLGA,15,"LFB A1 (derivative of LFB, residue substitution with alanine at position 1)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=35 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1012,DRAMP03888,FACRRWQWRMKKLGA,15,"LFB A2 (derivative of LFB, residue substitution with alanine at position 2)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=40 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1013,DRAMP03889,FKARRWQWRMKKLGA,15,"LFB A3 (derivative of LFB, residue substitution with alanine at position 3)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=51 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=4 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1014,DRAMP03890,FKCARWQWRMKKLGA,15,"LFB A4 (derivative of LFB, residue substitution with alanine at position 4)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=35 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1015,DRAMP03891,FKCRAWQWRMKKLGA,15,"LFB A5 (derivative of LFB, residue substitution with alanine at position 5)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=61 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1016,DRAMP03892,FKCRRWAWRMKKLGA,15,"LFB A7 (derivative of LFB, residue substitution with alanine at position 7)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=15 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=75 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1017,DRAMP03893,FKCRRWQWAMKKLGA,15,"LFB A9 (derivative of LFB, residue substitution with alanine at position 9)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=28 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1018,DRAMP03894,FKCRRWQWRAKKLGA,15,"LFB A10 (derivative of LFB, residue substitution with alanine at position 10)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=70 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1019,DRAMP03895,FKCRRWQWRMAKLGA,15,"LFB A11 (derivative of LFB, residue substitution with alanine at position 11)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=35 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1020,DRAMP03896,FKCRRWQWRMKALGA,15,"LFB A12 (derivative of LFB, residue substitution with alanine at position 12)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=25 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1021,DRAMP03897,FKCRRWQWRMKKAGA,15,"LFB A13 (derivative of LFB, residue substitution with alanine at position 13)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=25 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC>100 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1022,DRAMP03898,FKCRRWQWRMKKLAA,15,"LFB A14 (derivative of LFB, residue substitution with alanine at position 14)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=12 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=77 μM).,Unknown,Unknown,11095180,J Pept Res. 2000 Nov;56(5):265-274.,"Strøm MB, Rekdal O, Svendsen JS.",Antibacterial activity of 15-residue lactoferricin derivatives,,,,,,,,
1023,DRAMP03899,AKCLRWQWEMRKVGG,15,LFM A1 W8 (LFM W8 derivative with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=391 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1024,DRAMP03900,AKCLRWQWAMRKVGG,15,"LFM A1,9 W8 (LFM W8 derivative with residues substitution)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=134 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1025,DRAMP03901,RKCLRWQWEMRKVGG,15,LFM R1 W8 (LFM W8 derivative with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=37 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=374 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1026,DRAMP03902,EKCLRWQWRMRKVGG,15,LFM R9 W8 (LFM W8 derivative with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=100 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1027,DRAMP03903,AKCLRWQWRMRKVGG,15,LFM A1 R9 W8 (LFM W8 derivative with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=31 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=257 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1028,DRAMP03904,RKCLRWQWAMRKVGG,15,LFM A9 R1 W8 (LFM W8 derivative with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=31 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=257 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1029,DRAMP03905,RKCLRWQWRMRKVGG,15,"LFM R1,9 W8 (LFM W8 derivative with residues substitution)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=10 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=37 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1030,DRAMP03906,AKCLRWQWEMRKYGG,15,LFM A1 W8 Y13 (LFM W8 derivative with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=151 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1031,DRAMP03907,AKCLRWQWAMRKYGG,15,"LFM A1,9 W8 Y13 (LFM W8 derivative with residues substitution)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=88 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1032,DRAMP03908,RKCLRWQWEMRKYGG,15,LFM R1 W8 Y13 (LFM W8 derivative with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=19 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=73 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1033,DRAMP03909,EKCLRWQWRMRKYGG,15,LFM R9 W8 Y13 (LFM W8 derivative with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=63 μM),Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1034,DRAMP03910,AKCLRWQWRMRKYGG,15,LFM A1 R9 W8 Y13 (LFM W8 derivative with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=25 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=40 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1035,DRAMP03911,RKCLRWQWAMRKYGG,15,LFM A9 R1 W8 Y13 (LFM W8 derivative with residues substitution),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=12 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=25 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1036,DRAMP03912,RKCLRWQWRMRKYGG,15,"LFM R1,9 W8 Y13 (LFM W8 derivative with residues substitution)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacterium S. aureus and the Gram-negative bacteria E. coli.,Gram-negative bacterium: Escherichia coli (MIC=10 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=12 μM).,Unknown,Unknown,11168896,J Pept Res. 2001 Feb;57(2):127-139.,"Strøm MB, Rekdal O, Stensen W, Svendsen JS.",Increased antibacterial activity of 15-residue murine lactoferricin derivatives.,,,,,,,,
1037,DRAMP03920,KWKLFKKIEKVGQGIGAVLKVLTTGL,26,Cecropin A (1-8)-melittin (1-13)hybrid peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.7 μM), Staphylococcus aureus Cowan 1 (MIC=2 μM), Streptococcus pyogenes (MIC=1 μM);##Gram-negative bacteria: Escherichia coli D21 (MIC=0.5 μM), Pseudomonas aeruginosa OT97 (MIC=1 μM).",Unknown,Unknown,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,,,,,,,,
1038,DRAMP03921,KWKLFKKIGIGAVLKVLTTGLPALIS,26,Cecropin A (1-8)-melittin (1-18)hybrid peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=0.3 μM), Pseudomonas aeruginosa OT97 (MIC=0.7 μM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.4 μM), Bacillus megaterium Bm11 (MIC=0.4 μM), Staphylococcus aureus Cowan 1 (MIC=1 μM), Streptococcus pyogenes (MIC=2 μM).",Unknown,Unknown,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,,,,,,,,
1039,DRAMP03922,KWKLFKKIGIGAVLKVLTTG,20,Cecropin A (1-8)-melittin (1-12)hybrid peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=0.4 μM), Pseudomonas aeruginosa OT97 (MIC=0.9 μM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.3 μM), Bacillus megaterium Bm11 (MIC=0.2 μM), Staphylococcus aureus Cowan 1 (MIC=2 μM), Streptococcus pyogenes (MIC=0.1 μM).",Unknown,Unknown,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,,,,,,,,
1040,DRAMP03923,KWKLFKKIGIGAVLKVLT,18,Cecropin A (1-8)-melittin (1-10)hybrid peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=0.5 μM), Pseudomonas aeruginosa OT97 (MIC=3 μM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.3 μM), Bacillus megaterium Bm11 (MIC=0.5 μM), Staphylococcus aureus Cowan 1 (MIC=7 μM), Streptococcus pyogenes (MIC=0.8 μM).",Unknown,Unknown,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,,,,,,,,
1041,DRAMP03924,KWKLFKKGIGAVLKV,15,Cecropin A (1-7)-melittin (1-8)hybrid peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=4 μM), Pseudomonas aeruginosa OT97 (MIC=15 μM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=1.4 μM), Bacillus megaterium Bm11 (MIC=0.8 μM), Staphylococcus aureus Cowan 1 (MIC=29 μM), Streptococcus pyogenes (MIC=0.7 μM).",Unknown,Unknown,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,,,,,,,,
1042,DRAMP03925,KWKLFKKGAVLKVLT,15,Cecropin A (1-7)-melittin (3-10)hybrid peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=3 μM), Pseudomonas aeruginosa OT97 (MIC=15 μM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=3 μM), Bacillus megaterium Bm11 (MIC=0.9 μM), Staphylococcus aureus Cowan 1 (MIC>200 μM), Streptococcus pyogenes (MIC=1 μM).",Unknown,Unknown,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,,,,,,,,
1043,DRAMP03927,KWKLFKKIGAVLKVL,15,Cecropin A (1-7)-melittin (2-9)hybrid peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 10 residues),Adopts an amphipathic helix almost parallel to the surface of the micelle.,2JMY resolved by NMR.,CAMEL is also a hybrid peptide obtained by combining residues 1-7 of cecropin (CA) and residues 2-9 of melittin (M).,"Gram-negative bacteria: Escherichia coli D21 (MIC=1 μM), Pseudomonas aeruginosa OT97 (MIC=4 μM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.5 μM), Bacillus megaterium Bm11 (MIC=0.7 μM), Staphylococcus aureus Cowan 1 (MIC=2 μM), Streptococcus pyogenes (MIC=0.5 μM).",Unknown,Unknown,1733777##17397158,FEBS Lett. 1992 Jan 20;296(2):190-194.##J Am Chem Soc. 2007 Apr 25;129(16):5228-5234.,"Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB, Boman HG.##Respondek M, Madl T, Gbl C, Golser R, Zangger K.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.##Mapping the orientation of helices in micelle-bound peptides by paramagnetic relaxation waves.,,,,,,,,
1044,DRAMP03928,KWKLFKKAVLKVLTT,15,Cecropin A (1-7)-melittin (4-11)hybrid peptide (CAM),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=0.6 μM), Pseudomonas aeruginosa OT97 (MIC=4 μM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.6 μM), Bacillus megaterium Bm11 (MIC=0.5 μM), Staphylococcus aureus Cowan 1 (MIC=8 μM), Streptococcus pyogenes (MIC=0.7 μM).",Unknown,Unknown,1733777##20111863,FEBS Lett. 1992 Jan 20;296(2):190-194.##Curr Microbiol. 2010 Sep;61(3):169-175.,"Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB, Boman HG.##Cao Y, Yu RQ, Liu Y, Zhou HX, Song LL, Cao Y, Qiao DR.","Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.##Design, recombinant expression, and antibacterial activity of the cecropins-melittin hybrid antimicrobial peptides.",,,,,,,,
1045,DRAMP03929,KWKLFKKVLKVLTTG,15,Cecropin A (1-7)-melittin (5-12)hybrid peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=0.5 μM), Pseudomonas aeruginosa OT97 (MIC=2 μM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=0.3 μM), Bacillus megaterium Bm11 (MIC=0.5 μM), Staphylococcus aureus Cowan 1 (MIC=8 μM), Streptococcus pyogenes (MIC=0.4 μM).",Unknown,Unknown,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,,,,,,,,
1046,DRAMP03930,KWKLFKKLKVLTTGL,15,Cecropin A (1-7)-melittin (6-13)hybrid peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MIC=2 μM), Pseudomonas aeruginosa OT97 (MIC=8 μM);##Gram-positive bacteria: Bacillus subtilis Bs11 (MIC=1 μM), Bacillus megaterium Bm11 (MIC=0.5 μM), Staphylococcus aureus Cowan 1 (MIC=51 μM), Streptococcus pyogenes (MIC=0.4 μM).",Unknown,Unknown,1733777,FEBS Lett. 1992 Jan 20;296(2):190-194.,"Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB, Boman HG.",Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.,,,,,,,,
1048,DRAMP03933,IIYCNRRTGKCQRM,14,"I14M (truncated isoform of thanatin, residue 8-21)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity.,"Gram-positive bacteria: Aerococcus viridans (MIC=1.2-2.5 μM), Micrococcus luteus (MIC=5-10 μM), Bacillus megaterium (MIC=10-20 μM);##Gram-negative bacteria: Escherichia coli D22 (MIC=20-40 μM), Escherichia coli D31 (MIC=20-40 μM), Klebsiella pneumoniae (MIC=20-40 μM).##Fungi: Neurospora crassa (MIC=20-40 μM), Botrytis cinerea (MIC=10-20 μM), Alternaria brassicicola (MIC=5-10 μM), Fusarium culmorum (MIC=20-40 μM).",Unknown,Unknown,8577744,Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.,"Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.","Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",,,,,,,,
1050,DRAMP03935,VPIIYCNRRTGKCQRM,16,"V16M (truncated isoform of thanatin, residue 6-21)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity.,"Gram-positive bacteria: Aerococcus viridans (MIC=1.2-2.5 μM), Micrococcus luteus (MIC=2.5-5 μM), Bacillus megaterium (MIC=5-10 μM), Bacillus subtilis (MIC=20-40 μM), Pediococcus acidilactici (MIC=20-40 μM);##Gram-negative bacteria: Escherichia coli D22 (MIC=0.6-1.2 μM), Escherichia coli D31 (MIC=0.6-1.2 μM), Klebsiella pneumoniae (MIC=2.5-5 μM), Enterobacter cloacae (MIC=5-10 μM), E. carotovora (MIC=20-40 μM).##Fungi: Neurospora crassa (MIC=10-20 μM), Botrytis cinerea (MIC=10-20 μM), Nectria haematococca (MIC=5-10 μM), Trichoderma viride (MIC=20-40 μM), Alternaria brassicicola (MIC=5-10 μM), Fusarium culmorum (MIC=10-20 μM), A. pisi (MIC=20-40 μM).",Unknown,Unknown,8577744,Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.,"Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.","Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",,,,,,,,
1051,DRAMP03936,KPVPIIYCNRRTGKCQRM,18,"K18M (truncated isoform of thanatin, residue 4-21)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity.,"Gram-positive bacteria: Aerococcus viridans (MIC=0.6-1.2 μM), Micrococcus luteus (MIC=1.2-2.5 μM), Bacillus megaterium (MIC=2.5-5 μM), Bacillus subtilis (MIC=20-40 μM), Pediococcus acidilactici (MIC=20-40 μM);##Gram-negative bacteria: Escherichia coli D22 (MIC=0.3-0.6 μM), Escherichia coli D31 (MIC=0.3-0.6 μM), Escherichia coli 1106 (MIC=0.6-1.2 μM), Salmonella typhimuriumn (MIC=1.2-2.5 μM), Klebsiella pneumoniae (MIC=1.2-2.5 μM), Enterobacter cloacae (MIC1.2-2.5 μM), E. carotovora (MIC=20-40 μM), Pseudomonas aeruginosa (MIC=20-40 μM).##Fungi: Neurospora crassa (MIC=2.5-5 μM), Botrytis cinerea (MIC=1.2-2.5 μM), Nectria haematococca (MIC=5-10 μM), Trichoderma viride (MIC=2.5-5 μM), Alternaria brassicicola (MIC=2.5-5 μM), Fusarium culmorum (MIC=5-10 μM), A. pisi (MIC=10-20 μM), Fusarium oxysporumn (MIC=20-40 μM).",Unknown,Unknown,8577744,Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-1225.,"Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA.","Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",,,,,,,,
1055,DRAMP03945,LIKIVPAMICAVTKKC,16,Del 1-4 (Ranalexin analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacterium: Staphylococcus aureus (MIC=256 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=256 μg/ml), Pseudomonas aeruginosa (MIC=256 μg/ml).",Unknown,Unknown,8144672,J Biol Chem. 1994 Apr 8;269(14):10849-10855.,"Clark DP, Durell S, Maloy WL, Zasloff M.","Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",,,,,,,,
1056,DRAMP03947,GGLIKIVPAMICAVTKKC,18,Del 1-2 (Ranalexin analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacterium: Staphylococcus aureus (MIC=256 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC>256 μg/ml), Pseudomonas aeruginosa (MIC>256 μg/ml).",Unknown,Unknown,8144672,J Biol Chem. 1994 Apr 8;269(14):10849-10855.,"Clark DP, Durell S, Maloy WL, Zasloff M.","Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",,,,,,,,
1057,DRAMP03948,LGGLIKIVPAMICAVTKKC,19,Del 1 (Ranalexin analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacterium: Staphylococcus aureus (MIC=256 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=256 μg/ml), Pseudomonas aeruginosa (MIC>256 μg/ml).",Unknown,Unknown,8144672,J Biol Chem. 1994 Apr 8;269(14):10849-10855.,"Clark DP, Durell S, Maloy WL, Zasloff M.","Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",,,,,,,,
1058,DRAMP03949,FLGGLIKIVPAMICAVTKK,19,Del 20 (Ranalexin analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacterium: Staphylococcus aureus (MIC=128 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=256 μg/ml), Pseudomonas aeruginosa (MIC=128 μg/ml).",Unknown,Unknown,8144672,J Biol Chem. 1994 Apr 8;269(14):10849-10855.,"Clark DP, Durell S, Maloy WL, Zasloff M.","Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",,,,,,,,
1065,DRAMP03967,KWKLFKKIPKFLHLAKKF,18,P18 (Cecropin A(1-8)-Magainin 2(1-12) hybrid peptide analogue),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,MOA: P18 kills cancer cells by disrupting membranes (Tang C et al 2010 Org Biomol Che 8:984-7). ,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 μM), Proteus vulgaris (MIC=3.125 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 μM), Staphylococcus aureus KCTC 1621 (MIC=1.56 μM), Bacillus megaterium KCTC 1096 (MIC=0.78 μM).##Tumor cells: MDA-MB-361 (IC50=8.0 μM), Jurkat (IC50=4.0 μM), K-562 (IC50=3.5 μM), Normal cells NIH 3T3 (IC50=75.0 μM).",Unknown,Cell membrane,12005420##12370027,J Pept Res. 2001 Dec;58(6):504-514.##Protein Pept Lett. 2002 Oct;9(5):395-402.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.##Lee SH, Lee DG, Yang ST, Kim Y, Kim JI, Hahm KS, Shin SY.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.##Antibiotic activity of reversed peptides of alpha-helical antimicrobial peptide, P18.",,,,,,,,
1066,DRAMP03968,KWKLFKKILKFLHLAKKF,18,[L9]-P18 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=3.125 μM), Proteus vulgaris (MIC=6.25 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 μM), Staphylococcus aureus KCTC 1621 (MIC=3.125 μM), Bacillus megaterium KCTC 1096 (MIC=1.56 μM).##Tumor cells: MDA-MB-361 (IC50=3.0 μM), Jurkat (IC50=9.0 μM), K-562 (IC50=3.0 μM), Normal cells NIH 3T3 (IC50=70.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1067,DRAMP03969,KWKLFKKISKFLHLAKKF,18,[S9]-P18 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=25.0 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 μM), Proteus vulgaris (MIC=6.25 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 μM), Staphylococcus aureus KCTC 1621 (MIC=6.25 μM), Bacillus megaterium KCTC 1096 (MIC=3.125 μM).##Tumor cells: MDA-MB-361 (IC50=4.0 μM), Jurkat (IC50=7.0 μM), K-562 (IC50=3.0 μM), Normal cells NIH 3T3 (IC50=50.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1068,DRAMP03970,WKLFKKIPKFLHLAKKF,17,N-1 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 μM), Proteus vulgaris (MIC=1.56 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 μM), Staphylococcus aureus KCTC 1621 (MIC=3.125 μM), Bacillus megaterium KCTC 1096 (MIC=1.56 μM).##Tumor cells: MDA-MB-361 (IC50=9.5 μM), Jurkat (IC50=12.0 μM), K-562 (IC50=6.0 μM), Normal cells NIH 3T3 (IC50=75.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1069,DRAMP03971,FKLFKKIPKFLHLAKKF,17,N-2 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 μM), Proteus vulgaris (MIC=1.56 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 μM), Staphylococcus aureus KCTC 1621 (MIC=3.125 μM), Bacillus megaterium KCTC 1096 (MIC=0.78 μM).##Tumor cells: MDA-MB-361 (IC50=11.0 μM), Jurkat (IC50=11.0 μM), K-562 (IC50=7.0 μM), Normal cells NIH 3T3 (IC50=70.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1070,DRAMP03972,KWFKKIPKFLHLAKKF,16,N-3 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 μM), Proteus vulgaris (MIC=3.125 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 μM), Staphylococcus aureus KCTC 1621 (MIC=3.125 μM), Bacillus megaterium KCTC 1096 (MIC=1.56 μM).##Tumor cells: MDA-MB-361 (IC50=17.0 μM), Jurkat (IC50=17.0 μM), K-562 (IC50=11.0 μM), Normal cells NIH 3T3 (IC50=50.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1071,DRAMP03973,WFKKIPKFLHLAKKF,15,N-4 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 μM), Proteus vulgaris (MIC=1.56 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 μM), Staphylococcus aureus KCTC 1621 (MIC=3.125 μM), Bacillus megaterium KCTC 1096 (MIC=1.56 μM).##Tumor cells: MDA-MB-361 (IC50=32.0 μM), Jurkat (IC50=23.0 μM), K-562 (IC50=24.0 μM), Normal cells NIH 3T3 (IC50=100.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1072,DRAMP03974,WKKIPKFLHLAKKF,14,N-5 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=3.125 μM), Proteus vulgaris (MIC=3.125 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 μM), Staphylococcus aureus KCTC 1621 (MIC=3.125 μM), Bacillus megaterium KCTC 1096 (MIC=1.56 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1073,DRAMP03975,KWFKKIPKFLHLLKKF,16,N-3L (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=3.125 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=3.125 μM), Proteus vulgaris (MIC=3.125 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 μM), Staphylococcus aureus KCTC 1621 (MIC=1.56 μM), Bacillus megaterium KCTC 1096 (MIC=0.78 μM).##Tumor cells: MDA-MB-361 (IC50=5.0 μM), Jurkat (IC50=4.0 μM), K-562 (IC50=4.2 μM), Normal cells NIH 3T3 (IC50=50.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1074,DRAMP03976,WFKKIPKFLHLLKKF,15,N-4L (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=3.125 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=1.56 μM), Proteus vulgaris (MIC=12.5 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 μM), Staphylococcus aureus KCTC 1621 (MIC=3.125 μM), Bacillus megaterium KCTC 1096 (MIC=0.78 μM).##Tumor cells: MDA-MB-361 (IC50=5.0 μM), Jurkat (IC50=6.0 μM), K-562 (IC50=3.0 μM), Normal cells NIH 3T3 (IC50=50.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1075,DRAMP03977,WKKIPKFLHLLKKF,14,N-5L (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=3.125 μM), Proteus vulgaris (MIC=12.5 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 μM), Staphylococcus aureus KCTC 1621 (MIC=3.125 μM), Bacillus megaterium KCTC 1096 (MIC=1.56 μM).##Tumor cells: MDA-MB-361 (IC50=17.0 μM), Jurkat (IC50=14.0 μM), K-562 (IC50=10.0 μM), Normal cells NIH 3T3 (IC50=50.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1076,DRAMP03978,KWKLFKKIPFLHLAKKF,17,C-1 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 μM), Proteus vulgaris (MIC=1.56 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 μM), Staphylococcus aureus KCTC 1621 (MIC=3.125 μM), Bacillus megaterium KCTC 1096 (MIC=1.56 μM).##Tumor cells: MDA-MB-361 (IC50=26.0 μM), Jurkat (IC50=32.0 μM), K-562 (IC50=31.0 μM), Normal cells NIH 3T3 (IC50=100.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1077,DRAMP03979,KWKLFKKIPKFLHLAKK,17,C-2 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 μM), Proteus vulgaris (MIC=1.56 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 μM), Staphylococcus aureus KCTC 1621 (MIC=3.125 μM), Bacillus megaterium KCTC 1096 (MIC=1.56 μM).##Tumor cells: MDA-MB-361 (IC50=38.0 μM), Jurkat (IC50=26.0 μM), K-562 (IC50=23.0 μM), Normal cells NIH 3T3 (IC50=100.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1078,DRAMP03980,KWKLFKKIPLHLAKKF,16,C-3 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25-12.5 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 μM), Proteus vulgaris (MIC=1.56 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78-1.56 μM), Staphylococcus aureus KCTC 1621 (MIC=3.125 μM), Bacillus megaterium KCTC 1096 (MIC=3.125 μM).##Tumor cells: MDA-MB-361 (IC50=79.0 μM), Jurkat (IC50=74.0 μM), K-562 (IC50=62.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1079,DRAMP03981,KWKLFKKIPKFLHLAK,16,C-4 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=3.125-6.25 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 μM), Proteus vulgaris (MIC=1.56 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 μM), Staphylococcus aureus KCTC 1621 (MIC=3.125 μM), Bacillus megaterium KCTC 1096 (MIC=3.125 μM).##Tumor cells: MDA-MB-361 (IC50=54.0 μM), Jurkat (IC50=31.0 μM), K-562 (IC50=25.0 μM), Normal cells NIH 3T3 (IC50=50.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1080,DRAMP03982,KWKLFKKIPHLAKKF,15,C-5 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=12.5 μM), Proteus vulgaris (MIC=1.56 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 μM), Staphylococcus aureus KCTC 1621 (MIC=6.25 μM), Bacillus megaterium KCTC 1096 (MIC=1.56 μM).##Tumor cells: MDA-MB-361 (IC50=100.0 μM), Jurkat (IC50=81.0 μM), K-562 (IC50=67.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1081,DRAMP03983,KWKLFKKIPKFLHLA,15,C-6 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25-12.5 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 μM), Proteus vulgaris (MIC=3.125 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=0.78 μM), Staphylococcus aureus KCTC 1621 (MIC=6.25 μM), Bacillus megaterium KCTC 1096 (MIC=3.125 μM).##Tumor cells: MDA-MB-361 (IC50=47.0 μM), Jurkat (IC50=21.0 μM), K-562 (IC50=27.0 μM), Normal cells NIH 3T3 (IC50=100.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1082,DRAMP03984,KWKLFKKIPLAKKF,14,C-7 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25-12.5 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=12.5 μM), Proteus vulgaris (MIC=3.125 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 μM), Staphylococcus aureus KCTC 1621 (MIC=6.25 μM), Bacillus megaterium KCTC 1096 (MIC=3.125 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1083,DRAMP03985,KWKLFKKIPKFLHL,14,C-8 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria. Also has antitumor activity.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25 μM), Proteus vulgaris (MIC=3.125 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 μM), Staphylococcus aureus KCTC 1621 (MIC=6.25 μM), Bacillus megaterium KCTC 1096 (MIC=3.125 μM).##Tumor cells: MDA-MB-361 (IC50=83.0 μM), Jurkat (IC50=54.0 μM), K-562 (IC50=30.0 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1084,DRAMP03986,KWKLFKKIPLKKF,13,C-9 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=12.5 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=12.5 μM), Proteus vulgaris (MIC=3.125 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 μM), Staphylococcus aureus KCTC 1621 (MIC=12.5 μM), Bacillus megaterium KCTC 1096 (MIC=3.125 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1085,DRAMP03987,KWKLFKKIPKFLH,13,C-10 (analog of P18),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antitumour, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=6.25 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=6.25-12.5 μM), Proteus vulgaris (MIC=3.125 μM).##Gram-positive bacteria: Bacillus subtilis KCTC 1918 (MIC=1.56 μM), Staphylococcus aureus KCTC 1621 (MIC=6.25 μM), Bacillus megaterium KCTC 1096 (MIC=3.125 μM).",Unknown,Unknown,12005420,J Pept Res. 2001 Dec;58(6):504-514.,"Shin SY, Lee SH, Yang ST, Park EJ, Lee DG, Lee MK, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Antibacterial, antitumor and hemolytic activities of alpha-helical antibiotic peptide, P18 and its analogs.",,,,,,,,
1088,DRAMP03990,LLKWLKKL,8,L4K3W4 (LlKmWn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=50 μg/ml), Staphylococcus aureus ATCC 6538p (MIC=25 μg/ml);##Gram-negative bacterium: Pseudomonas aeruginosa ATCC 27853 (MIC=50 μg/ml).",Unknown,Unknown,19544481,J Pept Sci. 2009 Sep;15(9):583-588.,"Kang SJ, Won HS, Choi WS, Lee BJ.",De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.,,,,,,,,
1090,DRAMP03992,KLLKWLLKL,9,L5K3W5 (LlKmWn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=12.5 μg/ml), Staphylococcus aureus ATCC 6538p (MIC=3.1 μg/ml), Staphylococcus epidermis ATCC 12228 (MIC=12.5 μg/ml), Micrococcus luteus ATCC 10240 (MIC=25 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.5 μg/ml), Shigella dysentariae ATCC 9752 (MIC=12.5 μg/ml), Salmonella typhomurium ATCC 14028 (MIC=25 μg/ml), Klebsiella pneumoniae ATCC 10031 (MIC=6.3 μg/ml), Pseudomonas aeruginosa ATCC 27 853 (MIC=50 μg/ml).",Unknown,Unknown,19544481,J Pept Sci. 2009 Sep;15(9):583-588.,"Kang SJ, Won HS, Choi WS, Lee BJ.",De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.,,,,,,,,
1091,DRAMP03993,KKLLKWLKKLL,11,L5K5W6 (LlKmWn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=6.3 μg/ml), Staphylococcus aureus ATCC 6538p (MIC=6.3 μg/ml), Staphylococcus epidermis ATCC 12228 (MIC=6.3 μg/ml), Micrococcus luteus ATCC 10240 (MIC=6.3 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.5 μg/ml), Shigella dysentariae ATCC 9752 (MIC=6.3 μg/ml), Salmonella typhomurium ATCC 14028 (MIC=25 μg/ml), Klebsiella pneumoniae ATCC 10031 (MIC=6.3 μg/ml), Pseudomonas aeruginosa ATCC 27 853 (MIC=25 μg/ml).",Unknown,Unknown,19544481,J Pept Sci. 2009 Sep;15(9):583-588.,"Kang SJ, Won HS, Choi WS, Lee BJ.",De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.,,,,,,,,
1092,DRAMP03994,KKLLKWLLKLL,11,L6K4W6 (LlKmWn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=1.6 μg/ml), Staphylococcus aureus ATCC 6538p (MIC=1.6 μg/ml), Staphylococcus epidermis ATCC 12228 (MIC=1.6 μg/ml), Micrococcus luteus ATCC 10240 (MIC=1.6 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.3 μg/ml), Shigella dysentariae ATCC 9752 (MIC=3.1 μg/ml), Salmonella typhomurium ATCC 14028 (MIC=25 μg/ml), Klebsiella pneumoniae ATCC 10031 (MIC=3.1 μg/ml), Pseudomonas aeruginosa ATCC 27 853 (MIC=50 μg/ml).",Unknown,Unknown,19544481,J Pept Sci. 2009 Sep;15(9):583-588.,"Kang SJ, Won HS, Choi WS, Lee BJ.",De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.,,,,,,,,
1093,DRAMP03995,LKLLKWLLKLL,11,L7K3W6 (LlKmWn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=1.6 μg/ml), Staphylococcus aureus ATCC 6538p (MIC=3.1 μg/ml), Staphylococcus epidermis ATCC 12228 (MIC=3.1 μg/ml), Micrococcus luteus ATCC 10240 (MIC=3.1 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=50 μg/ml), Shigella dysentariae ATCC 9752 (MIC=12.5 μg/ml), Klebsiella pneumoniae ATCC 10031 (MIC=50 μg/ml).",Unknown,Unknown,19544481,J Pept Sci. 2009 Sep;15(9):583-588.,"Kang SJ, Won HS, Choi WS, Lee BJ.",De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface.,,,,,,,,
1096,DRAMP03999,ILGKIAEGIKSLF,13,[A6]-IsCT (Mutant: W6A; IsCT analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: [A6]-IsCT did not cause any hemolysis at peptide concentrations as high as 100 μM, indicating that Trp6 is important for both the hemolytic activity and antibacterial activity of IsCT.
Chemical modification: C-terminal amidation.","[Ref.15369808]Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=64 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=32 μM), Salmonella typhimurium KCTC 1926 (MIC>64 μM);##Gram-positive bacteria: Staphylococcus epidermidis KCTC 1917 (MIC>64 μM), Staphylococcus aureus KCTC 1621 (MIC>64 μM).",[Ref.15369808]Non-hemolytic activity,Cell membrane,15369808,Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-719.,"Lee K, Shin SY, Kim K, Lim SS, Hahm KS, Kim Y.",Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs.,,,,,,,,
1097,DRAMP04000,ILGKILEGIKSLF,13,[L6]-IsCT (Mutant: W6L; IsCT analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Drastic reduction in antibacterial activity against both Gram-positive and Gram-negative bacteria, and big loss of hemolysis activity.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=16 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=16 μM), Salmonella typhimurium KCTC 1926 (MIC=16 μM);##Gram-positive bacteria: Staphylococcus epidermidis KCTC 1917 (MIC=32 μM), Staphylococcus aureus KCTC 1621 (MIC=4 μM).",Unknown,Cell membrane,15369808,Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-719.,"Lee K, Shin SY, Kim K, Lim SS, Hahm KS, Kim Y.",Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs.,,,,,,,,
1098,DRAMP04001,ILGKIWKGIKSLF,13,[K7]-IsCT (Mutant: E7K; IsCT analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: [K7]-IsCT displays a similar or 2-fold increase in antibacterial activity against both Gram-positive and Gram-negative bacteria, and complete loss of hemolysis activity.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=2 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=2 μM), Salmonella typhimurium KCTC 1926 (MIC=1 μM);##Gram-positive bacteria: Staphylococcus epidermidis KCTC 1917 (MIC=1 μM), Staphylococcus aureus KCTC 1621 (MIC=1 μM)",Unknown,Cell membrane,15369808,Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-719.,"Lee K, Shin SY, Kim K, Lim SS, Hahm KS, Kim Y.",Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs.,,,,,,,,
1099,DRAMP04002,ILGKILKGIKKLF,13,"[L6, K11]-IsCT (IsCT analog through amino acids substitution)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: [L6, K11]-IsCT displays a similar or 2-fold higher antibacterial activity relative to that of native IsCT.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=2 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=2 μM), Salmonella typhimurium KCTC 1926 (MIC=1 μM);##Gram-positive bacteria: Staphylococcus epidermidis KCTC 1917 (MIC=1 μM), Staphylococcus aureus KCTC 1621 (MIC=2 μM).",Unknown,Cell membrane,15369808,Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-719.,"Lee K, Shin SY, Kim K, Lim SS, Hahm KS, Kim Y.",Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs.,,,,,,,,
1100,DRAMP04003,ILGKIWKIKKLF,12,"[K7, P8, K11]-IsCT (IsCT analog through amino acids substitution)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: [K7, P8, K11]-IsCT exhibited more potent antibacterial activity than native IsCT but no hemolytic activity, even at concentrations as high as 100 μM. [K7, P8, K11]-IsCT displays a similar or 2-fold higher antibacterial activity relative to that of native IsCT.
Chemical modification: C-terminal amidation.","[Ref.15369808]Gram-negative bacteria: Escherichia coli KCTC 1682 (MIC=2 μM), Pseudomonas aeruginosa KCTC 1637 (MIC=2 μM), Salmonella typhimurium KCTC 1926 (MIC=1 μM);##Gram-positive bacteria: Staphylococcus epidermidis KCTC 1917 (MIC=1 μM), Staphylococcus aureus KCTC 1621 (MIC=2 μM);##Antibiotic-resistant bacteria: Methicillin-resistant Staphylococcus aureus (MRSA) CCARM 3001 (MIC=1 μM), multidrug-resistant Pseudomonas aeruginosa (MDRPA) (CCARM 3543) (MIC=1 μM) and multidrug-resistant Pseudomonas aeruginosa (MDRPA) CCARM 2095 (MIC=1 μM).",[Ref.15369808]Non-hemolytic activity,Cell membrane,15369808,Biochem Biophys Res Commun. 2004 Oct 15;323(2):712-719.,"Lee K, Shin SY, Kim K, Lim SS, Hahm KS, Kim Y.",Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs.,,,,,,,,
1101,DRAMP04004,VSLFPVXLFP,10,Gramicidin analogue ([Scr2]-GS),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Staphylococcus aureus ATCC 6538 P(MIC=25 μg/ml), Streptococcus pyogenes N.Y.5 (MIC=25 μg/ml), Myotis flavus ATCC 10240 (MIC=3.1 μg/ml), Bacillus subtilis ATCC 6633 (MIC=6.3 μg/ml);##Gram-negative bacteria: Corynebacterium diphtheriae P.W.8 (MIC=3.1 μg/ml).",Unknown,Unknown,8791160,Int J Pept Protein Res. 1996 May;47(5):369-375.,"Tamaki M, Akabori S, Muramatsu I.",Properties of synthetic analogs of gramicidin S containing L-serine or L-glutamic acid residue in place of L-ornithine residue.,,,,,,,,
1102,DRAMP04005,VSLFPVSLFP,10,"Gramicidin analogue ([Ser2,2']-GS)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Streptococcus pyogenes N.Y.5 (MIC=25 μg/ml), Myotis flavus ATCC 10240 (MIC=12.5 μg/ml);##Gram-negative bacteria: Corynebacterium diphtheriae P.W.8 (MIC=12.5 μg/ml).",Unknown,Unknown,8791160,Int J Pept Protein Res. 1996 May;47(5):369-375.,"Tamaki M, Akabori S, Muramatsu I.",Properties of synthetic analogs of gramicidin S containing L-serine or L-glutamic acid residue in place of L-ornithine residue.,,,,,,,,
1103,DRAMP04011,GVVTDLLKTAGKLLGNLFGSLSG,23,Plasticin PD36 KF (analog of PD36),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy. The hemolytic activity of the peptides was determined using fresh rat erythrocytes.,"[Ref.17128968]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=6.5 μM), Bacillus megaterium ATCC 9885 (MIC=50.25 μM);##Gram-negative bacteria: Escherichia coli ATCC 11775 (MIC=6.5 μM), Salmonella typhimurium CIP 6062 (MIC=25.25 μM), Enterobacter cloacae ATCC 11775 (MIC=12.5 μM).","[Ref.17128968]25% hemolytic at 50 μM, 50% hemolytic activity at 100 μM against rat red blood cells",Unknown,17128968,Biochemistry 2006; 45: 14285-14297.,Amri CE et al Bruston F.,"The plasticins: membrane adsortpion, lipid disorders, and biological activity.",,,,,,,,
1104,DRAMP04012,GVVTDLLKTAGKLLGNLVGSLSG,23,Plasticin PD36 K (analog of PD36),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy. The hemolytic activity of the peptides was determined using fresh rat erythrocytes.,"[Ref.17128968]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=50.5 μM), Bacillus megaterium ATCC 9885 (MIC=12.5 μM);##Gram-negative bacteria: Escherichia coli ATCC 11775 (MIC=12.5 μM).","[Ref.17128968]35% hemolytic at 50 μM, 71% hemolytic activity at 100 μM against rat red blood cells",Unknown,17128968,Biochemistry 2006; 45: 14285-14297.,Amri CE et al Bruston F.,"The plasticins: membrane adsortpion, lipid disorders, and biological activity.",,,,,,,,
1105,DRAMP04013,GLVTGLLKTAGKLLGDLFGSLTG,23,Plasticin ANC KF (analog of natural peptide ANC),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy. The hemolytic activity of the peptides was determined using fresh rat erythrocytes.,"[Ref.17128968]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=12.5 μM), Bacillus megaterium ATCC 9885 (MIC=12.5 μM);##Gram-negative bacteria: Escherichia coli ATCC 11775 (MIC=25 μM).","[Ref.17128968]22% hemolytic at 50 μM, 48% hemolytic activity at 100 μM against rat red blood cells",Unknown,17128968,Biochemistry 2006; 45: 14285-14297.,Amri CE et al Bruston F.,"The plasticins: membrane adsortpion, lipid disorders, and biological activity.",,,,,,,,
1106,DRAMP04014,LLGDFFRKAKEKIGKEFKRIVQRIKDFLRNLVPRTES,37,LL-37A9 (LL-37 variants),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against the Gram-negative bacterium E. coli.,"Gram-negative bacteria: Escherichia coli DC2 (MIC=6 μM), Escherichia coli K12 (MIC=15 μM).",Unknown,Unknown,22185690,Biochemistry. 2012 Jan 17;51(2):653-664. ,"Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.","Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",,,,,,,,
1107,DRAMP04015,LLGDFFRKVKEKIGKEFKRIVQRIKDFLRNLVPRTES,37,LL-37V9 (LL-37 variants),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against the Gram-negative bacterium E. coli.,"Gram-negative bacteria: Escherichia coli DC2 (MIC=12 μM), Escherichia coli K12 (MIC=25 μM).",Unknown,Unknown,22185690,Biochemistry. 2012 Jan 17;51(2):653-664. ,"Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.","Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",,,,,,,,
1109,DRAMP04017,LLGDFFRKVKEKIGKEFKRIVQR,23,LL-23V9 (LL-23 variants),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli DC2 (MIC=2 μM), Escherichia coli K12 (MIC=40 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 μM), S. aureus mprF (presence of carbonate) (MIC=0.35-0.7 μM), S. aureus mprF (absence of carbonate) (MIC=6 μM).",Unknown,Unknown,22185690,Biochemistry. 2012 Jan 17;51(2):653-664. ,"Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE.","Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",,,,,,,,
1110,DRAMP04019,RAVAVIIRLRRV,12,Bac014 (Scrambled Variants of Bac2A),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=23 μg/ml), Escherichia coli (MIC=11 μg/ml), Salmonella (MIC=11 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=23 μg/ml), Staphylococcus epidermidis (MIC=6 μg/ml).##Yeast: Candida albicans (MIC=6 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1111,DRAMP04020,RRAAVVLIVIRR,12,Bac020 (Scrambled Variants of Bac2A),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=11 μg/ml), Escherichia coli (MIC=6 μg/ml), Salmonella (MIC=23 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=11 μg/ml), Staphylococcus epidermidis (MIC=1.5 μg/ml).##Yeast: Candida albicans (MIC=11 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1112,DRAMP04021,VRLRIRVAVIRA,12,Bac034 (Scrambled Variants of Bac2A),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=25 μg/ml), Escherichia coli (MIC=3 μg/ml), Salmonella (MIC=12 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=25 μg/ml), Staphylococcus epidermidis (MIC=3 μg/ml).##Yeast: Candida albicans (MIC=12 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1113,DRAMP04022,VRFRIRVAVIRA,12,"F3 (single amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=6 μg/ml), Escherichia coli (MIC=1.6 μg/ml), Salmonella (MIC=6 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 μg/ml), Staphylococcus epidermidis (MIC=1.6 μg/ml).##Yeast: Candida albicans (MIC=6 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1114,DRAMP04023,VRWRIRVAVIRA,12,"W3 (single amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=6 μg/ml), Escherichia coli (MIC=1.6 μg/ml), Salmonella (MIC=6 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 μg/ml), Staphylococcus epidermidis (MIC=1.6 μg/ml).##Yeast: Candida albicans (MIC=12 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1115,DRAMP04024,VRLWIRVAVIRA,12,"W4 (single amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC>50 μg/ml), Escherichia coli (MIC=6 μg/ml), Salmonella (MIC>50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=50 μg/ml), Staphylococcus epidermidis (MIC=3 μg/ml).##Yeast: Candida albicans (MIC=50 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1116,DRAMP04025,VRLRIRVAVRRA,12,"R10 (single amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=12 μg/ml), Escherichia coli (MIC=6 μg/ml), Salmonella (MIC=6 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 μg/ml), Staphylococcus epidermidis (MIC=1.6 μg/ml).##Yeast: Candida albicans (MIC=6 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1117,DRAMP04026,VRLRIRVAVIRK,12,"K12 (single amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=6 μg/ml), Escherichia coli (MIC=3 μg/ml), Salmonella (MIC=6 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6 μg/ml), Staphylococcus epidermidis (MIC=1.6 μg/ml).##Yeast: Candida albicans (MIC=3 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1118,DRAMP04027,VQLRIRVRVIRK,12,"opt1 (multiple amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=6 μg/ml), Escherichia coli (MIC=3 μg/ml), Salmonella (MIC=6 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 μg/ml), Staphylococcus epidermidis (MIC=1.6 μg/ml).##Yeast: Candida albicans (MIC=6 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1119,DRAMP04028,VRLRIRVRVIRK,12,"opt2 (multiple amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=3 μg/ml), Escherichia coli (MIC=1.6 μg/ml), Salmonella (MIC=6 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6 μg/ml), Staphylococcus epidermidis (MIC=0.8 μg/ml).##Yeast: Candida albicans (MIC=3 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1120,DRAMP04029,KQFRIRVRVIRK,12,"opt3 (multiple amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=6 μg/ml), Escherichia coli (MIC=3 μg/ml), Salmonella (MIC=6 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12 μg/ml), Staphylococcus epidermidis (MIC=1.6 μg/ml).##Yeast: Candida albicans (MIC=6 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1121,DRAMP04030,KRFRIRVRVIRK,12,"opt4 (multiple amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=6 μg/ml), Escherichia coli (MIC=1.6 μg/ml), Salmonella (MIC=3 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6 μg/ml), Staphylococcus epidermidis (MIC=0.8 μg/ml).##Yeast: Candida albicans (MIC=12 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1122,DRAMP04031,KRWRIRVRVIRK,12,"opt5 (multiple amino acid substitution of Bac034, which is a scrambled Variant of Bac2A)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (MIC=3 μg/ml), Escherichia coli (MIC=1.6 μg/ml), Salmonella (MIC=3 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=3 μg/ml), Staphylococcus epidermidis (MIC=0.8 μg/ml).##Yeast: Candida albicans (MIC=6 μg/ml).",Unknown,Unknown,17052614,Chem Biol. 2006 Oct;13(10):1101-1107.,"Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE.",Sequence requirements and an optimization strategy for short antimicrobial peptides.,,,,,,,,
1123,DRAMP04032,ALRLAIRKR,9,Modified defensin,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Staphylococcus aureus (MIC=5 μg/ml), Staphylococcus aureus (MRSA) (MIC>48 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=4 μg/ml), Pseudomonas aeruginosa (MIC=15 μg/ml).",Unknown,Unknown,10561605,Eur J Biochem. 1999 Dec;266(2):616-623.,"Ishibashi J, Saido-Sakanaka H, Yang J, Sagisaka A, Yamakawa M.","Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros.",,,,,,,,
1124,DRAMP04033,ALLLAIRKR,9,Modified defensin,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Staphylococcus aureus (MIC=4 μg/ml), Staphylococcus aureus (MRSA) (MIC=40 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=6 μg/ml), Pseudomonas aeruginosa (MIC=4 μg/ml).",Unknown,Unknown,10561605,Eur J Biochem. 1999 Dec;266(2):616-623.,"Ishibashi J, Saido-Sakanaka H, Yang J, Sagisaka A, Yamakawa M.","Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros.",,,,,,,,
1125,DRAMP04034,AWLLAIRKR,9,Modified defensin,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Staphylococcus aureus (MIC=3 μg/ml), Staphylococcus aureus (MRSA) (MIC=25 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=5 μg/ml), Pseudomonas aeruginosa (MIC=4 μg/ml).",Unknown,Unknown,10561605,Eur J Biochem. 1999 Dec;266(2):616-623.,"Ishibashi J, Saido-Sakanaka H, Yang J, Sagisaka A, Yamakawa M.","Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros.",,,,,,,,
1126,DRAMP04035,ALYLAIRKR,9,Modified defensin,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Staphylococcus aureus (MIC=3 μg/ml), Staphylococcus aureus (MRSA) (MIC=30 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=4 μg/ml), Pseudomonas aeruginosa (MIC=4 μg/ml).",Unknown,Unknown,10561605,Eur J Biochem. 1999 Dec;266(2):616-623.,"Ishibashi J, Saido-Sakanaka H, Yang J, Sagisaka A, Yamakawa M.","Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros.",,,,,,,,
1127,DRAMP04036,ALWLAIRKR,9,Modified defensin,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacteria: Staphylococcus aureus (MIC=4 μg/ml), Staphylococcus aureus (MRSA) (MIC=40 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=10 μg/ml), Pseudomonas aeruginosa (MIC=10 μg/ml). ",Unknown,Unknown,10561605,Eur J Biochem. 1999 Dec;266(2):616-623.,"Ishibashi J, Saido-Sakanaka H, Yang J, Sagisaka A, Yamakawa M.","Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros.",,,,,,,,
1128,DRAMP04048,RRLCRIVVIRVCRR,14,BacR (cyclic derivative of bactenecin),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli K-12 (MIC=2 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Salmonella typhimurium 14028s (MIC=4 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=64 μg/ml), Staphylococcus epidermidis C621 (MIC=8 μg/ml), Enterococcus faecalis ATCC 29212 (MIC=32 μg/ml), Listeria monocytogenes (MIC<0.125 μg/ml), Corynebacterium xerosis (MIC=1 μg/ml), Streptococcus pyogenes ATCC 19615 (MIC=8 μg/ml), S. mitis (MIC=0.5 μg/ml), Streptococcus pneumoniae ATCC 49619 (MIC>64 μg/ml).",Unknown,Unknown,10223951,Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.,"Wu M, Hancock RE.","Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",,,,,,,,
1129,DRAMP04049,RRRCPIVVIRVCRR,14,BacP3R (cyclic derivative of bactenecin),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli K-12 (MIC=2 μg/ml), Pseudomonas aeruginosa K799 (MIC=8 μg/ml), Salmonella typhimurium 14028s (MIC=8 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>64 μg/ml), Staphylococcus epidermidis C621 (MIC=16 μg/ml), Enterococcus faecalis ATCC 29212 (MIC=32 μg/ml), Listeria monocytogenes (MIC+0.5 μg/ml), Corynebacterium xerosis (MIC=4 μg/ml), Streptococcus pyogenes ATCC 19615 (MIC=8 μg/ml), S. mitis (MIC=1 μg/ml), Streptococcus pneumoniae ATCC 49619 (MIC>64 μg/ml).",Unknown,Unknown,10223951,Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.,"Wu M, Hancock RE.","Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",,,,,,,,
1130,DRAMP04050,RRRLCPIVIRVCRR,14,BacP3R-V (cyclic derivative of bactenecin),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli K-12 (MIC=2 μg/ml), Pseudomonas aeruginosa K799 (MIC=8 μg/ml), Salmonella typhimurium 14028s (MIC=8 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>64 μg/ml), Staphylococcus epidermidis C621 (MIC=16 μg/ml), Enterococcus faecalis ATCC 29212 (MIC>64 μg/ml), Listeria monocytogenes (MIC=1 μg/ml), Corynebacterium xerosis (MIC=4 μg/ml), Streptococcus pyogenes ATCC 19615 (MIC=4 μg/ml), S. mitis (MIC=1 μg/ml), Streptococcus pneumoniae ATCC 49619 (MIC>64 μg/ml).",Unknown,Unknown,10223951,Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.,"Wu M, Hancock RE.","Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",,,,,,,,
1131,DRAMP04051,RICRIVVIRCIR,12,Bac2I-NH2 (cyclic derivative of bactenecin),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli K-12 (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=16 μg/ml), Salmonella typhimurium 14028s (MIC=8 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=32 μg/ml), Staphylococcus epidermidis C621 (MIC=8 μg/ml), Enterococcus faecalis ATCC 29212 (MIC>32 μg/ml).",Unknown,Unknown,10223951,Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.,"Wu M, Hancock RE.","Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",,,,,,,,
1132,DRAMP04052,RLCPRVRIRVCR,12,BacP2R-NH2 (cyclic derivative of bactenecin),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli K-12 (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=16 μg/ml), Salmonella typhimurium 14028s (MIC=32 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>32 μg/ml), Staphylococcus epidermidis C621 (MIC=16 μg/ml), Enterococcus faecalis ATCC 29212 (MIC>32 μg/ml).",Unknown,Unknown,10223951,Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.,"Wu M, Hancock RE.","Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",,,,,,,,
1133,DRAMP04053,RLCRIVPVIRVCR,13,BacP1 (cyclic derivative of bactenecin),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli K-12 (MIC=32 μg/ml), Pseudomonas aeruginosa K799 (MIC>64 μg/ml), Salmonella typhimurium 14028s (MIC>64 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=64 μg/ml), Staphylococcus epidermidis C621 (MIC=64 μg/ml), Enterococcus faecalis ATCC 29212 (MIC>64 μg/ml), Listeria monocytogenes (MIC=2 μg/ml), Corynebacterium xerosis (MIC=8 μg/ml), Streptococcus pyogenes ATCC 19615 (MIC=64 μg/ml), S. mitis (MIC=4 μg/ml), Streptococcus pneumoniae ATCC 49619 (MIC>64 μg/ml).",Unknown,Unknown,10223951,Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.,"Wu M, Hancock RE.","Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",,,,,,,,
1134,DRAMP04054,RLCRIVWVIRVCR,13,BacW (cyclic derivative of bactenecin),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli K-12 (MIC=8 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Salmonella typhimurium 14028s (MIC=4 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4 μg/ml), Staphylococcus epidermidis C621 (MIC=2 μg/ml), Enterococcus faecalis ATCC 29212 (MIC=8 μg/ml), Listeria monocytogenes (MIC=0.5 μg/ml), Corynebacterium xerosis (MIC=1 μg/ml), Streptococcus pyogenes ATCC 19615 (MIC=2 μg/ml), S. mitis (MIC=1 μg/ml), Streptococcus pneumoniae ATCC 49619 (MIC=16 μg/ml).",Unknown,Unknown,10223951,Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.,"Wu M, Hancock RE.","Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",,,,,,,,
1135,DRAMP04055,RRLCRIVWVIRVCRR,15,BacW2R (cyclic derivative of bactenecin),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli K-12 (MIC=2 μg/ml), Pseudomonas aeruginosa K799 (MIC=2 μg/ml), Salmonella typhimurium 14028s (MIC=2 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2 μg/ml), Staphylococcus epidermidis C621 (MIC=1 μg/ml), Enterococcus faecalis ATCC 29212 (MIC=2 μg/ml), Listeria monocytogenes (MIC=0.25 μg/ml), Corynebacterium xerosis (MIC=0.25 μg/ml), Streptococcus pyogenes ATCC 19615 (MIC=1 μg/ml), S. mitis (MIC=0.25 μg/ml), Streptococcus pneumoniae ATCC 49619 (MIC=8 μg/ml).",Unknown,Unknown,10223951,Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.,"Wu M, Hancock RE.","Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",,,,,,,,
1136,DRAMP04056,RLSRIVVIRVSR,12,Lin Bac2S-NH2 (linear derivative of bactenecin),No entry found,Unknown,Unknown,Synthetic construct ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli K-12 (MIC=2 μg/ml), Pseudomonas aeruginosa K799 (MIC=16 μg/ml), Salmonella typhimurium 14028s (MIC=32 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=4 μg/ml), Staphylococcus epidermidis C621 (MIC=1 μg/ml), Enterococcus faecalis ATCC 29212 (MIC=4 μg/ml), Listeria monocytogenes (MIC=0.25 μg/ml), Corynebacterium xerosis (MIC=0.25 μg/ml), Streptococcus pyogenes ATCC 19615 (MIC=2 μg/ml), S. mitis (MIC=0.125 μg/ml), Streptococcus pneumoniae ATCC 49619 (MIC=16 μg/ml)",Unknown,Unknown,10223951,Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.,"Wu M, Hancock RE.","Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",,,,,,,,
1137,DRAMP04057,RLSRIVVIRVCR,12,Lin BacS-NH2 (linear derivative of bactenecin),No entry found,Unknown,Unknown,Synthetic construct ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli K-12 (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=16 μg/ml), Salmonella typhimurium 14028s (MIC>64 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcus epidermidis C621 (MIC=2 μg/ml), Enterococcus faecalis ATCC 29212 (MIC=16 μg/ml), Listeria monocytogenes (MIC=0.5 μg/ml), Corynebacterium xerosis (MIC=0.5 μg/ml), Streptococcus pyogenes ATCC 19615 (MIC=8 μg/ml), S. mitis (MIC=0.5 μg/ml), Streptococcus pneumoniae ATCC 49619 (MIC=8 μg/ml).",Unknown,Unknown,10223951,Antimicrob Agents Chemother. 1999 May;43(5):1274-1276.,"Wu M, Hancock RE.","Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",,,,,,,,
1146,DRAMP04064,CVKCKCKCGSGVKVKVKVC,19,Cyclic cationic V1 peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activiy. Has hemolytic activity against human erythrocytes, and also Cytotoxic activity against THP-1 cells (EC50=0.045 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=5 nM), Pseudomonas aeruginosa ATTC 27853 (MIC>619 nM), Klebsiella pneumoniae ATTC 13883 (MIC=145 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=5 nM), Shigella sonnei ATTC 25931 (MIC=5 nM).",[Ref.15328096]EC50=880000 nM against human erythrocytes,Unknown,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,,,,,,,,
1147,DRAMP04065,CVKVSVKVGSGVKVSVKVC,19,Cyclic cationic V2 peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=5.6 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=5 nM), Pseudomonas aeruginosa ATTC 27853 (MIC>643 nM), Klebsiella pneumoniae ATTC 13883 (MIC=643 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=5 nM), Shigella sonnei ATTC 25931 (MIC=5 nM).",[Ref.15328096]EC50=589000 nM against human erythrocytes,Unknown,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,,,,,,,,
1148,DRAMP04066,CVKVRVKVGSGVKVRVKVC,19,Cyclic cationic V3 peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.042 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=300 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=5 nM), Klebsiella pneumoniae ATTC 13883 (MIC=10 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=300 nM), Shigella sonnei ATTC 25931 (MIC=5 nM).",[Ref.15328096]EC50=590000 nM against human erythrocytes,Unknown,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,,,,,,,,
1149,DRAMP04067,CVKVQVKVGSGVKVQVKVC,19,Cyclic cationic V4 peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.047 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=10 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=5 nM), Klebsiella pneumoniae ATTC 13883 (MIC<5 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=5 nM), Shigella sonnei ATTC 25931 (MIC=10 nM).",[Ref.15328096]EC50=3226000 nM against human erythrocytes,Unknown,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,,,,,,,,
1150,DRAMP04068,CAKAKAKAGSGAKAKAKAC,19,Cyclic cationic V5 peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.14 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=173 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=5 nM), Klebsiella pneumoniae ATTC 13883 (MIC>692 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=5 nM), Shigella sonnei ATTC 25931 (MIC=692 nM).",[Ref.15328096]EC50=1055000 nM against human erythrocytes,Unknown,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,,,,,,,,
1151,DRAMP04069,CFKFKFKFGSGFKFKFKFC,19,Cyclic cationic V6 peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.045 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=518 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=4 nM), Klebsiella pneumoniae ATTC 13883 (MIC=4 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=528 nM), Shigella sonnei ATTC 25931 (MIC=4 nM).",[Ref.15328096]EC50=35000 nM against human erythrocytes,Unknown,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,,,,,,,,
1152,DRAMP04070,CWKWKWKWGSGWKWKWKWC,19,Cyclic cationic V7 peptide,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activiy. Has hemolytic activity for human erythrocytes, and also Cytotoxic activity for THP-1 cells (EC50=0.085 mM).","[Ref.15328096]Gram-negative bacteria: Escherichia coli ATTC 25922 (MIC=114 nM), Pseudomonas aeruginosa ATTC 27853 (MIC=4 nM), Klebsiella pneumoniae ATTC 13883 (MIC=458 nM), Salmonella enterica serovar Typhimurium ATTC 14028 (MIC=4 nM), Shigella sonnei ATTC 25931 (MIC=7 nM).",[Ref.15328096]EC50=45000 nM against human erythrocytes,Unknown,15328096,Antimicrob Agents Chemother. 2004 Sep;48(9):3349-3357.,"Frecer V, Ho B, Ding JL.",De Novo Design of Potent Antimicrobial Peptides.,,,,,,,,
1153,DRAMP04075,AKKVFKRLEKLFSKIQNDK,19,Antimicrobial peptide HP (2-20),P56029,Unknown,rplA,Synthetic construct (amino acid substitution),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 11 residues),Unknown,1P0G resolved by NMR.,Function: Peptides originating from the N-terminal end of L1 have antibacterial activity against bacteria such as E. coli and Bacillus megaterium and modest antifungal activities. Has no effect on H. pylori itself. Peptides are not hemolytic against mammalian cells. These peptides may be released in the stomach during altruistic lysis to kill other fast growing bacteria.,"[Ref.16255716]Gram-positive bacteria: Bacillus subtilis (MIC=3.13 μg/ml), Staphylococcus epidermidis (MIC=6.25 μg/ml), Staphylococcus aureus (MIC=12.5 μg/ml), Listeria monocytogenes (MIC=6.25 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=3.13 μg/ml), Salmonella typhimurium (MIC=1.56 μg/ml), Proteus vulgaris (MIC=6.25 μg/ml), Pseudomonas aeruginosa (MIC=6.25 μg/ml), Escherichia coli O157 (MIC=12.5 μg/ml);##Fungi: Trichosporon beigelii (MIC=3.13 μg/ml), Candida albicans (MIC>25 μg/ml), Saccharomyces cerevisiae (MIC>25 μg/ml), Aspergillus flavus (MIC=50 μg/ml), Aspergillus fumigatus (MIC>50 μg/ml), Botrytis cinerea (MIC=12.5 μg/ml), Fusarium moniliforme (MIC=25 μg/ml).",[Swiss_Prot Entry P56029]Non-hemolytic against mammalian cells,Phospholipids,16255716##PubMed ID is not available##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##Submitted (SEP-2004) to the PDB data bank.##To be published,"Lee KH, Lee DG, Park YK, Harm KS, Kim YM.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Structure of antimicrobial peptide, HP (2-20) and its analogues derived from Helicobacter pylori, as determined by 1H NMR spectroscopy.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",,,,,,,,
1154,DRAMP04076,AKKVFKRLEKLFSKIQNWK,19,Anal 1 (antimicrobial peptide HP (2-20)analogue),P56029,Unknown,Unknown,Synthetic construct (amino acid substitution),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 14 residues),Unknown,1P0J resolved by NMR.,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=1.56 μg/ml), Staphylococcus epidermidis (MIC=3.13 μg/ml), Staphylococcus aureus (MIC=3.13 μg/ml), Listeria monocytogenes (MIC=0.78 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=0.78 μg/ml), Salmonella typhimurium (MIC=0.39 μg/ml), Proteus vulgaris (MIC=3.13 μg/ml), Pseudomonas aeruginosa (MIC=3.13 μg/ml), Escherichia coli O157 (MIC=6.25 μg/ml).##Fungi: Trichosporon beigelii (MIC=1.56 μg/ml), Candida albicans (MIC=25 μg/ml), Saccharomyces cerevisiae (MIC=25 μg/ml), Aspergillus flavus (MIC=50 μg/ml), Aspergillus fumigatus (MIC>50 μg/ml), Botrytis cinerea (MIC=6.25 μg/ml), Fusarium moniliforme (MIC=12.5 μg/ml).",Unknown,Unknown,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",,,,,,,,
1155,DRAMP04077,AKKVFKRLEKLFSKIWNDK,19,Anal 2 (antimicrobial peptide HP (2-20)analogue),P56029,Unknown,Unknown,Synthetic construct (amino acid substitution),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 14 residues),Unknown,1P0L resolved by NMR.,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=1.56 μg/ml), Staphylococcus epidermidis (MIC=3.13 μg/ml), Staphylococcus aureus (MIC=6.25 μg/ml), Listeria monocytogenes (MIC=1.56 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=3.13 μg/ml), Salmonella typhimurium (MIC=0.78 μg/ml), Proteus vulgaris (MIC=3.13 μg/ml), Pseudomonas aeruginosa (MIC=6.25 μg/ml), Escherichia coli O157 (MIC=6.25 μg/ml).##Fungi: Trichosporon beigelii (MIC=1.56 μg/ml), Candida albicans (MIC=25 μg/ml), Saccharomyces cerevisiae (MIC=25 μg/ml), Aspergillus flavus (MIC=50 μg/ml), Aspergillus fumigatus (MIC>50 μg/ml), Botrytis cinerea (MIC=6.25 μg/ml), Fusarium moniliforme (MIC=25 μg/ml).",Unknown,Unknown,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",,,,,,,,
1156,DRAMP04078,AKKVFKRLEKLFSKIWNWK,19,Anal 3 (antimicrobial peptide HP (2-20)analogue),P56029,Unknown,Unknown,Synthetic construct (amino acid substitution),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 14 residues),Unknown,1P0O resolved by NMR.,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=1.56 μg/ml), Staphylococcus epidermidis (MIC=3.13 μg/ml), Staphylococcus aureus (MIC=1.56 μg/ml), Listeria monocytogenes (MIC=0.39 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=1.56 μg/ml), Salmonella typhimurium (MIC=0.39 μg/ml), Proteus vulgaris (MIC=3.13 μg/ml), Pseudomonas aeruginosa (MIC=3.13 μg/ml), Escherichia coli O157 (MIC=3.13 μg/ml).##Fungi: Trichosporon beigelii (MIC=1.56 μg/ml), Candida albicans (MIC=12.5 μg/ml), Saccharomyces cerevisiae (MIC=25 μg/ml), Aspergillus flavus (MIC=25 μg/ml), Aspergillus fumigatus (MIC=25 μg/ml), Botrytis cinerea (MIC=3.13 μg/ml), Fusarium moniliforme (MIC=12.5 μg/ml).",Unknown,Unknown,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",,,,,,,,
1157,DRAMP04079,AKKVFKRLEKSFSKIQNDK,19,Anal 4 (antimicrobial peptide HP (2-20)analogue),P56029,Unknown,Unknown,Synthetic construct (amino acid substitution),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 13 residues),Unknown,1P5K resolved by NMR.,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=6.25 μg/ml), Staphylococcus epidermidis (MIC>12.5 μg/ml), Staphylococcus aureus (MIC>12.5 μg/ml), Listeria monocytogenes (MIC>12.5 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=12.5 μg/ml), Salmonella typhimurium (MIC=12.5 μg/ml), Proteus vulgaris (MIC>12.5 μg/ml), Pseudomonas aeruginosa (MIC=12.5 μg/ml), Escherichia coli O157 (MIC>12.5 μg/ml).##Fungi: Trichosporon beigelii (MIC=12.5 μg/ml), Candida albicans (MIC>25 μg/ml), Saccharomyces cerevisiae (MIC>25 μg/ml), Aspergillus flavus (MIC>50 μg/ml), Aspergillus fumigatus (MIC>50 μg/ml), Botrytis cinerea (MIC>50 μg/ml), Fusarium moniliforme (MIC>50 μg/ml).",Unknown,Unknown,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",,,,,,,,
1158,DRAMP04080,AKKVSKRLEKLFSKIQNDK,19,Anal 5 (antimicrobial peptide HP (2-20)analogue),P56029,Unknown,Unknown,Synthetic construct (amino acid substitution),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 12 residues),Unknown,1P5L resolved by NMR.,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=3.13 μg/ml), Staphylococcus epidermidis (MIC=12.5 μg/ml), Staphylococcus aureus (MIC>12.5 μg/ml), Listeria monocytogenes (MIC>12.5 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=6.25 μg/ml), Salmonella typhimurium (MIC=12.5 μg/ml), Proteus vulgaris (MIC>12.5 μg/ml), Pseudomonas aeruginosa (MIC=12.5 μg/ml), Escherichia coli O157 (MIC=6.25 μg/ml).##Fungi: Trichosporon beigelii (MIC=12.5 μg/ml), Candida albicans (MIC>25 μg/ml), Saccharomyces cerevisiae (MIC>25 μg/ml), Aspergillus flavus (MIC>50 μg/ml), Aspergillus fumigatus (MIC>50 μg/ml), Botrytis cinerea (MIC>50 μg/ml), Fusarium moniliforme (MIC>50 μg/ml).",Unknown,Unknown,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",,,,,,,,
1159,DRAMP04081,AKKVFKRLEKLFSKIFNFK,19,Anal 6 (antimicrobial peptide HP (2-20)analogue),P56029,Unknown,Unknown,Synthetic construct (amino acid substitution),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=1.56 μg/ml), Staphylococcus epidermidis (MIC=6.25 μg/ml), Staphylococcus aureus (MIC=3.13 μg/ml), Listeria monocytogenes (MIC=0.78 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=3.13 μg/ml), Salmonella typhimurium (MIC=0.39 μg/ml), Proteus vulgaris (MIC=3.125 μg/ml), Pseudomonas aeruginosa (MIC=6.25 μg/ml), Escherichia coli O157 (MIC=6.25 μg/ml).##Fungi: Trichosporon beigelii (MIC=3.13 μg/ml), Candida albicans (MIC>25 μg/ml), Saccharomyces cerevisiae (MIC=25 μg/ml), Aspergillus flavus (MIC=50 μg/ml), Aspergillus fumigatus (MIC=50-25 μg/ml), Botrytis cinerea (MIC=12.5 μg/ml), Fusarium moniliforme (MIC=12.5 μg/ml).",Unknown,Unknown,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",,,,,,,,
1160,DRAMP04082,AKKVFKRLEKLFSKIYNYK,19,Anal 7 (antimicrobial peptide HP (2-20)analogue),P56029,Unknown,Unknown,Synthetic construct (amino acid substitution),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Has antibacterial and antifungal activiy. ,"Gram-positive bacteria: Bacillus subtilis (MIC=1.56 μg/ml), Staphylococcus epidermidis (MIC=3.13 μg/ml), Staphylococcus aureus (MIC=3.13 μg/ml), Listeria monocytogenes (MIC=0.78 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=3.13 μg/ml), Salmonella typhimurium (MIC=0.39 μg/ml), Proteus vulgaris (MIC=6.25-3.13 μg/ml), Pseudomonas aeruginosa (MIC=3.13 μg/ml), Escherichia coli O157 (MIC=3.13 μg/ml).##Fungi: Trichosporon beigelii (MIC=1.56 μg/ml), Candida albicans (MIC=12.5 μg/ml), Saccharomyces cerevisiae (MIC=25 μg/ml), Aspergillus flavus (MIC=50 μg/ml), Aspergillus fumigatus (MIC=50-25 μg/ml), Botrytis cinerea (MIC=6.25 μg/ml), Fusarium moniliforme (MIC=12.5 μg/ml).",Unknown,Unknown,16255716##PubMed ID is not available,Biochem J. 2006 Feb 15;394(Pt 1):105-114.##To be published,"Lee KH, Lee DG, Park Y, Kang DI, Shin SY, Hahm KS, Kim Y.##Lee KH, Lee DG, Park YK, Harm KS, Kim YM.","Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.##Interactions between antimicrobial peptide, HP(2-20) derived from helicobacter pylori, and membrain studied by nmr spectroscopy.",,,,,,,,
1161,DRAMP04083,GIGKFLKKAKKFGKAFVKILKK,22,D-amino-acid pexiganan (MSI-214),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,MSI-214 is a peptide identical in sequence to pexiganan but comprising all D-amino acids.,"Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=16 μg/ml), Enterococcus faecium ATCC 51559 (vancomycin resistant) (MIC=4 μg/ml), Enterococcus faecalis ATCC 29212 (MIC=16 μg/ml), Streptococcus bovis ATCC 49133 (MIC=4 μg/ml), Micrococcus luteus ATCC 4698 (MIC=2-4 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8-16 μg/ml), Proteus mirabilis ATCC 29245 (MIC>256 μg/ml), Serratia marcescens ATCC 8100 (MIC>256 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16-32 μg/ml).",Unknown,Unknown,10103181,Antimicrob Agents Chemother. 1999 Apr;43(4):782-788.,"Ge Y, MacDonald DL, Holroyd KJ, Thornsberry C, Wexler H, Zasloff M.","In vitro antibacterial properties of pexiganan, an analog of magainin.",,,,,,,,
1162,DRAMP04095,GFGSLFKFLAKKVAKTVAKQAAKQGAKYVANKHMQ,35,"Cupiennin-1D (spiders, Arthropods, animals)",P83622,Belongs to the cupiennin family,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity. Has insecticidal and hemolytic activities. Probably acts by disturbing membrane Function: with its amphipathic structure.
Tissue specificity: Expressed by the venom gland.
Toxic dose: LD50 is 6.4 pmol/mg on Drosophila.","[Ref.11792701]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=0.31-0.63 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=0.31-0.63 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=0.31-0.63 μM), Enterococcus faecalis ATCC 29212 (MIC=1.25-2.50 μM).",[Swiss_Prot Entry P83622]has hemolytic activity,Unknown,11792701##10669026,J Biol Chem. 2002 Mar 29;277(13):11208-11216.##Toxicon. 2000 Mar;38(3):373-380.,"Kuhn-Nentwig L, Muller J, Schaller J, Walz A, Dathe M, Nentwig W.##Haeberli S, Kuhn-Nentwig L, Schaller J, Nentwig W.","Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae).##Characterisation of antibacterial activity of peptides isolated from the venom of the spider Cupiennius salei (Araneae: Ctenidae).",,,,,,,,
1163,DRAMP04096,EQEENVVKIQAFWKGYKQRKEYM,23,2IQ2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Displays antimicrobial activity against bacteria and yeast C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=2.1 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=32 μM).##Yeast: Candida albicans (MIC=28 μM).,Unknown,Unknown,23238369,Biochimie. 2013 Apr;95(4):875-880.,"McLean DT, Lundy FT, Timson DJ.",IQ-motif peptides as novel anti-microbial agents.,,,,,,,,
1164,DRAMP04097,DNTDSVVKIQSWFRMATARKSYL,23,2IQ3,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Displays antimicrobial activity against bacteria and yeast C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=1.2 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=26 μM).##Yeast: Candida albicans (MIC=25 μM).,Unknown,Unknown,23238369,Biochimie. 2013 Apr;95(4):875-880.,"McLean DT, Lundy FT, Timson DJ.",IQ-motif peptides as novel anti-microbial agents.,,,,,,,,
1165,DRAMP04098,ANVGFVIQLQARLRGFLVRQKFA,23,3IQ1,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Displays antimicrobial activity against bacteria and yeast C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=1.7 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=1.7 μM).##Yeast: Candida albicans (MIC>94 μM).,Unknown,Unknown,23238369,Biochimie. 2013 Apr;95(4):875-880.,"McLean DT, Lundy FT, Timson DJ.",IQ-motif peptides as novel anti-microbial agents.,,,,,,,,
1166,DRAMP04099,TWLPAVIKIQAHWRGYRQRKIYL,23,3IQ2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Displays antimicrobial activity against bacteria and yeast C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=1.9 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=1.6 μM).##Yeast: Candida albicans (MIC=25 μM).,Unknown,Unknown,23238369,Biochimie. 2013 Apr;95(4):875-880.,"McLean DT, Lundy FT, Timson DJ.",IQ-motif peptides as novel anti-microbial agents.,,,,,,,,
1167,DRAMP04100,ANLDAIIKIQAWARMWAARRQYL,23,3IQ3,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Displays antimicrobial activity against bacteria and yeast C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=2 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=11 μM).##Yeast: Candida albicans (MIC>89 μM).,Unknown,Unknown,23238369,Biochimie. 2013 Apr;95(4):875-880.,"McLean DT, Lundy FT, Timson DJ.",IQ-motif peptides as novel anti-microbial agents.,,,,,,,,
1168,DRAMP04101,KNVNSIVKIQAFFRARKAQDDYR,23,3IQ4,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Displays antimicrobial activity against bacteria and yeast C. albicans.,Gram-negative bacterium: Escherichia coli (MIC=3.5 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=4.6 μM).##Yeast: Candida albicans (MIC=30 μM).,Unknown,Unknown,23238369,Biochimie. 2013 Apr;95(4):875-880.,"McLean DT, Lundy FT, Timson DJ.",IQ-motif peptides as novel anti-microbial agents.,,,,,,,,
1169,DRAMP04102,KWKSFIKKLTSKFLHLAKKF,20,CP-P,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity. Also has hemolytic activity against human erythrocytes.,[Ref.22518150]Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 μg/ml).,[Ref.22518150]MHC=250 μg/mL against human erythrocytes,Unknown,Unknown,Unknown,Unknown,Unknown,,,,,,,,
1170,DRAMP04103,KWKSFIKKLTSKFLHSAKKF,20,S16 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,"Gram-negative bacterium: Pseudomonas aeruginosa (MIC=3.125 μg/ml).##Clinical isolates: Acinetobacter baumannii b-01 (MIC=3.125 μg/mL), Acinetobacter baumannii b-02 (MIC=6.25 μg/mL), Acinetobacter baumannii b-03 (MIC=6.25 μg/mL), Acinetobacter baumannii b-04 (MIC=3.125 μg/mL).",Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1171,DRAMP04104,KFKSFIKKLTSKFLHSAKKF,20,F2 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity. Also has hemolytic activity against human erythrocytes.,[Ref.22518150]Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 μg/ml).,[Ref.22518150]MHC=250 μg/mL against human erythrocytes,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1172,DRAMP04105,KWNSFIKKLTSKFLHSAKKF,20,N3 (derivative of CP-P),No entry found,Derived from the peptide CP-P,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 μg/ml),Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1173,DRAMP04106,KWKSFKKKLTSKFLHSAKKF,20,K6 (derivative of CP-P),No entry found,Derived from the peptide CP-P,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 μg/ml),Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1174,DRAMP04107,KWKSFINKLTSKFLHSAKKF,20,N7 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 μg/ml),Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1175,DRAMP04108,KWKSFIKKAKTSFLHSAKKF,20,A9 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=25 μg/ml),Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1176,DRAMP04111,KWKSFIKKSTSKFLHSAKKF,20,S9 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=50 μg/ml),Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1177,DRAMP04112,KWKSFIKKLLSKFLHSAKKF,20,L10 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity. Also has hemolytic activity against human erythrocytes.,[Ref.22518150]Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 μg/ml).,[Ref.22518150]MHC<125 μg/mL against human erythrocytes,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1178,DRAMP04113,KWKSFIKKLASKFLHSAKKF,20,A10 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity. Also has hemolytic activity against human erythrocytes.,[Ref.22518150]Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 μg/ml).,[Ref.22518150]MHC=250 μg/mL against human erythrocytes,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1179,DRAMP04114,KWKSFIKKLTDKFLHSAKKF,20,D11 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=25 μg/ml),Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1180,DRAMP04115,KWKSFIKKLTKKFLHSAKKF,20,K11 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (CD),Unknown,Unknown,Function: Has antibacterial activity.,"Gram-positive bacteria: Staphylococcus aureus CMCC26003 (MIC=0.5 μg/mL), Bacillus subtilis DB430 (MIC=2 μg/mL), Bacillus pumilus CMCC63202 (MIC=0.5 μg/mL), Soluble wall Micrococcus S1.634 (MIC=1 μg/mL), Micrococcus luteus CMCC28001 (MIC=2 μg/mL).##Gram-negative bacteria: E. coli ATCC8099 (MIC=0.5 μg/mL), Klebsiella pneumoniae CMCC46117 (MIC=2 μg/mL), Salmonella paratyphi BCMCC50094 (MIC=2 μg/mL), Pseudomonas aeruginosa CMCC10104 (MIC=4 μg/mL).##Clinical isolates: Acinetobacter baumannii b-01 (MIC=0.8 μg/mL), Acinetobacter baumannii b-02 (MIC=3.125 μg/mL), Acinetobacter baumannii b-03 (MIC=3.25 μg/mL), Acinetobacter baumannii b-04 (MIC=1.6 μg/mL).",Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1181,DRAMP04117,KWKSFIKKLTSKALHSAKKF,20,A13 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=6.25 μg/ml),Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1182,DRAMP04119,KWKSFIKKLTSKFLHSKKKF,20,K17 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=12.5 μg/ml),Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1183,DRAMP04120,KWKSFIKKLTSKFLHSADKF,20,D18 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=25 μg/ml),Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1184,DRAMP04121,KWKSFIKKLTSKFLHSANKF,20,N18 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=6.25 μg/ml),Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1185,DRAMP04122,KWKSFIKKLTSKFLHSAKKN,20,N20 (derivative of CP-P),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Pseudomonas aeruginosa (MIC=6.25 μg/ml),Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1186,DRAMP04123,SGKLCCRRKK,10,D0-NH2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive and -negative bacteria.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Escherichia coli (MIC=12±0.17 μM), Pseudomonas aeruginosa ATCC 27853 (MIC>100 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>100 μM).",Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1187,DRAMP04124,SGKLYYRRKK,10,D1-NH2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive and -negative bacteria.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Escherichia coli (MIC=12±0.01 μM), Pseudomonas aeruginosa ATCC 27853 (MIC>100 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>100 μM).",Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1188,DRAMP04125,SGKLWWRRKK,10,D2-NH2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive and -negative bacteria.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Escherichia coli (MIC=6±0.012 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=12±0.01 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=12±0.01 μM).",Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1189,DRAMP04126,SGKRWWRRKK,10,D3-NH2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive and -negative bacteria.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Escherichia coli (MIC=6±0.012 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=6±0.078 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=25±0.01 μM).",Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1190,DRAMP04127,RGKRWWRRKK,10,D4-NH2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive and -negative bacteria.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Escherichia coli (MIC=3±0.012 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=6±0.04 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6±0.01 μM).",Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1191,DRAMP04128,RWKRWWRRKK,10,D5-NH2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive and -negative bacteria.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Escherichia coli (MIC=3±0.012 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=3±0.012 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6±0.012 μM).",Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1192,DRAMP04129,RKKRWWRRKK,10,D6-NH2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive and -negative bacteria.
Chemical modification: C-terminal amidation.","Gram-negative bacteria: Escherichia coli (MIC=3±0.07 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=3±0.012 μM);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC=6±0.012 μM).",Unknown,Unknown,22518150,Int J Microbiol. 2012;2012:764834.,"Jin-Jiang H, Jin-Chun L, Min L, Qing-Shan H, Guo-Dong L.",The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide.,,,,,,,,
1193,DRAMP04136,LRRLWLRANRL,11,LRR-1,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: E. coli ATCC 25922 (MIC=128 μM), P. aeruginosa ATCC 27853 (MIC>128 μM), S. typhimurium C7731 (MIC>128 μM);##Gram-positive bacteria: S. epidermidis ATCC12228 (MIC>128 μM), E. faecalis ATCC 29212 (MIC>128 μM), S. aureus ATCC 29213 (MIC=128 μM).",Unknown,Unknown,23430306,Amino Acids. 2013 Apr;44(4):1215-1224.,"Ma QQ, Lv YF, Gu Y, Dong N, Li DS, Shan AS.",Rational design of cationic antimicrobial peptides by the tandem of leucine-rich repeat.,,,,,,,,
1194,DRAMP04137,LRRLWLRANRLLRRLWLRANRL,22,LRR-2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: E. coli ATCC 25922 (MIC=4 μM), P. aeruginosa ATCC 27853 (MIC=4 μM), S. typhimurium C7731 (MIC=2 μM);##Gram-positive bacteria: S. epidermidis ATCC12228 (MIC=2 μM), E. faecalis ATCC 29212 (MIC=2 μM), S. aureus ATCC 29213 (MIC=2 μM).",Unknown,Unknown,23430306,Amino Acids. 2013 Apr;44(4):1215-1224.,"Ma QQ, Lv YF, Gu Y, Dong N, Li DS, Shan AS.",Rational design of cationic antimicrobial peptides by the tandem of leucine-rich repeat.,,,,,,,,
1195,DRAMP04138,APRKNVRW,8,L1 (first 8 N-terminal residues of bovine LF),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=62.36 μM).,Unknown,Unknown,23026014,Biochim Biophys Acta. 2013 Feb;1828(2):677-686.,"Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.","A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.",,,,,,,,
1196,DRAMP04139,APRKNVRF,8,L2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=129.66 μM).,Unknown,Unknown,23026014,Biochim Biophys Acta. 2013 Feb;1828(2):677-686.,"Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.","A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.",,,,,,,,
1197,DRAMP04140,APRKNVKW,8,L3,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=64.11 μM).,Unknown,Unknown,23026014,Biochim Biophys Acta. 2013 Feb;1828(2):677-686.,"Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.","A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.",,,,,,,,
1198,DRAMP04141,APRKNLKW,8,L4,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=31.61 μM).,Unknown,Unknown,23026014,Biochim Biophys Acta. 2013 Feb;1828(2):677-686.,"Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.","A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.",,,,,,,,
1199,DRAMP04142,APRKQLKW,8,L5,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=7.79 μM).,Unknown,Unknown,23026014,Biochim Biophys Acta. 2013 Feb;1828(2):677-686.,"Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.","A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.",,,,,,,,
1200,DRAMP04143,APRRQLKW,8,L6,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=15.17 μM).,Unknown,Unknown,23026014,Biochim Biophys Acta. 2013 Feb;1828(2):677-686.,"Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.","A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.",,,,,,,,
1201,DRAMP04144,APKKQLKW,8,L7,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=16.02 μM).,Unknown,Unknown,23026014,Biochim Biophys Acta. 2013 Feb;1828(2):677-686.,"Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.","A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.",,,,,,,,
1202,DRAMP04145,AFRKQLKW,8,L8,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=3.71 μM).,Unknown,Unknown,23026014,Biochim Biophys Acta. 2013 Feb;1828(2):677-686.,"Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.","A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.",,,,,,,,
1203,DRAMP04146,LFRKQLKW,8,L9,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Escherichia coli ATCC 25923 (MIC=1.78 μM).,Unknown,Unknown,23026014,Biochim Biophys Acta. 2013 Feb;1828(2):677-686.,"Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.","A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.",,,,,,,,
1204,DRAMP04147,WFRKQLKW,8,L10,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity.,"Gram-negative bacteria: Escherichia coli ATCC 25923 (MIC=0.8 μM), Klebsiella pneumoniae (MIC=3.35 μM), Acinetobacter sp. (MIC=3.35 μM), Psudomonas aruginosa (MIC=6.71 μM).##Fungi: Candida albicans ATCC SC5314 (MIC=10.49 μM), C. tropicalis ATCC 13803 (MIC=20.98 μM), C. parapsilosis ATCC 22019 (MIC=5.24 μM).",Unknown,Lipopolysaccharide (LPS)-binding,23026014,Biochim Biophys Acta. 2013 Feb;1828(2):677-686.,"Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, Xess I, Dinda A, Kapil A, Patro IK, Dey S.","A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida.",,,,,,,,
1205,DRAMP04159,RIKRFWPVVIRTVVAGYNLYRAIKK,25,LR2 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 μg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 μg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 μg/ml).",Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1206,DRAMP04160,RIKRFWPVVIRTVVAGYNLYRAIK,24,LR3 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 μg/ml), Staphylococcus aureus ATCC25923 (MIC=7.032 μg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=2.344 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=0.586 μg/ml).",Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1207,DRAMP04161,RIKRFWPVVIRTVVAGYNLYRAI,23,LR4 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=37.5 μg/ml), Staphylococcus aureus ATCC25923 (MIC=37.5 μg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=9.375 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 μg/ml).",Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1208,DRAMP04162,RIKRFWPVVIRTVVAGYNLYRA,22,LR5 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus ATCC25923 (MIC=75 μg/ml);##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=4.688 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=4.688 μg/ml).,Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1209,DRAMP04163,RIKRFWPVVIRTVVAGYNLYR,21,LR6 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 μg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 μg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 μg/ml).",Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1210,DRAMP04164,RIKRFWPVVIRTVVAGYNLY,20,LR7 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 μg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 μg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 μg/ml).",Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1211,DRAMP04165,RIKRFWPVVIRTVVAGYNL,19,LR8 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 μg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 μg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 μg/ml).",Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1212,DRAMP04166,RIKRFWPVVIRTVVAGYN,18,LR9 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 μg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 μg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 μg/ml).",Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1213,DRAMP04167,RIKRFWPVVIRTVVAGY,17,LR10 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct,"Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 μg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 μg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 μg/ml).",Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1214,DRAMP04168,RIKRFWPVVIRTVVAG,16,LR11 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct,"Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 μg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 μg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 μg/ml).",Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1215,DRAMP04169,RIKRFWPVVIRTVV,14,LR13 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct,"Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 μg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 μg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 μg/ml).",Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1216,DRAMP04170,RIKRFWPVVIRT,12,LR15 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct,"Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 μg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 μg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 μg/ml).",Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1217,DRAMP04171,RIKRFWPVVIR,11,LR16 (homologue of Pc-CATH1),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis (MIC=4.688 μg/ml), Staphylococcus aureus ATCC25923 (MIC=9.375 μg/ml).##Gram-negative bacterium: Escherichia coli ATCC25922 (MIC=3.516 μg/ml).##Yeast: Candida albicans ATCC2002 (MIC=2.344 μg/ml).",Unknown,Unknown,PubMed ID is not available,Natural Products and Bioprospecting. 2012 Apr;2(2):81-86.,"Li Dong, Juan-Juan Yang, Ying Wang, Huan Liu, Li-Xian Mu, Dong-Hai Lin, Ren Lai.",Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1.,,,,,,,,
1218,DRAMP04174,KWLKKWL,7,L2K3W2 (LlKmW2 model peptides),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: B. subtilis (MIC=80 μg/ml), S. aureus (MIC=80 μg/ml), S. epidermis (MIC>80 μg/ml), M. luteus (MIC>80 μg/ml), S. aureus (MRSA) (MIC>80 μg/ml).##Gram-negative bacteria: E. coli (MIC>80 μg/ml), S. dysentariae (MIC>80 μg/ml), S. typhimorium (MIC>80 μg/ml), K. pneumoniae (MIC>80 μg/ml), P. aeruginosa (MIC>80 μg/ml).",Unknown,Unknown,20736034,Regul Pept. 2011 Jan 17;166(1-3):36-41.,"Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.",De novo generation of short antimicrobial peptides with simple amino acid composition.,,,,,,,,
1219,DRAMP04175,KWLLKWL,7,L3K2W2 (LlKmW2 model peptides),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: B. subtilis (MIC=20 μg/ml), S. aureus (MIC=20 μg/ml), S. epidermis (MIC=80 μg/ml), M. luteus (MIC=80 μg/ml), S. aureus (MRSA) (MIC>80 μg/ml).##Gram-negative bacteria: E. coli (MIC=40 μg/ml), S. dysentariae (MIC>80 μg/ml), S. typhimorium (MIC>80 μg/ml), K. pneumoniae (MIC=80 μg/ml), P. aeruginosa (MIC=80 μg/ml).",Unknown,Unknown,20736034,Regul Pept. 2011 Jan 17;166(1-3):36-41.,"Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.",De novo generation of short antimicrobial peptides with simple amino acid composition.,,,,,,,,
1220,DRAMP04176,KKWLKKWLK,9,L2K5W2 (LlKmW2 model peptides),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: B. subtilis (MIC=80 μg/ml), S. aureus (MIC=40 μg/ml), S. epidermis (MIC>80 μg/ml), M. luteus (MIC>80 μg/ml), S. aureus (MRSA) (MIC>80 μg/ml).##Gram-negative bacteria: E. coli (MIC=40 μg/ml), S. dysentariae (MIC>80 μg/ml), S. typhimorium (MIC>80 μg/ml), K. pneumoniae (MIC>80 μg/ml), P. aeruginosa (MIC=80 μg/ml).",Unknown,Unknown,20736034,Regul Pept. 2011 Jan 17;166(1-3):36-41.,"Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.",De novo generation of short antimicrobial peptides with simple amino acid composition.,,,,,,,,
1221,DRAMP04177,LKWLKKWLK,9,L3K4W2 (LlKmW2 model peptides),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: B. subtilis (MIC=40 μg/ml), S. aureus (MIC=10 μg/ml), S. epidermis (MIC=40 μg/ml), M. luteus (MIC=80 μg/ml), S. aureus (MRSA) (MIC>80 μg/ml).##Gram-negative bacteria: E. coli (MIC=40 μg/ml), S. dysentariae (MIC>80 μg/ml), S. typhimorium (MIC>80 μg/ml), K. pneumoniae (MIC>80 μg/ml), P. aeruginosa (MIC=80 μg/ml).",Unknown,Unknown,20736034,Regul Pept. 2011 Jan 17;166(1-3):36-41.,"Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.",De novo generation of short antimicrobial peptides with simple amino acid composition.,,,,,,,,
1222,DRAMP04178,LKWLLKWLK,9,L4K3W2 (LlKmW2 model peptides),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: B. subtilis (MIC=5 μg/ml), S. aureus (MIC=2.5 μg/ml), S. epidermis (MIC=5 μg/ml), M. luteus (MIC=10 μg/ml), S. aureus (MRSA) (MIC=20 μg/ml).##Gram-negative bacteria: E. coli (MIC=5 μg/ml), S. dysentariae (MIC=40 μg/ml), S. typhimorium (MIC=20 μg/ml), K. pneumoniae (MIC=20 μg/ml), P. aeruginosa (MIC=40 μg/ml).",Unknown,Unknown,20736034,Regul Pept. 2011 Jan 17;166(1-3):36-41.,"Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.",De novo generation of short antimicrobial peptides with simple amino acid composition.,,,,,,,,
1223,DRAMP04179,LKWLLKWLL,9,L5K2W2 (LlKmW2 model peptides),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: B. subtilis (MIC<1.3 μg/ml), S. aureus (MIC<1.3 μg/ml), S. epidermis (MIC<1.3 μg/ml), M. luteus (MIC=2.5 μg/ml), S. aureus (MRSA) (MIC=2.5 μg/ml).##Gram-negative bacteria: E. coli (MIC=5 μg/ml), S. dysentariae (MIC=2.5 μg/ml), S. typhimorium (MIC=10 μg/ml), K. pneumoniae (MIC=5 μg/ml), P. aeruginosa (MIC=10 μg/ml).",Unknown,Unknown,20736034,Regul Pept. 2011 Jan 17;166(1-3):36-41.,"Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.",De novo generation of short antimicrobial peptides with simple amino acid composition.,,,,,,,,
1224,DRAMP04180,LKKWLKKWLKK,11,L3K6W2 (LlKmW2 model peptides),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: B. subtilis (MIC=20 μg/ml), S. aureus (MIC=10 μg/ml), S. epidermis (MIC=40 μg/ml), M. luteus (MIC=40 μg/ml), S. aureus (MRSA) (MIC>80 μg/ml).##Gram-negative bacteria: E. coli (MIC=20 μg/ml), S. dysentariae (MIC=80 μg/ml), S. typhimorium (MIC>80 μg/ml), K. pneumoniae (MIC>80 μg/ml), P. aeruginosa (MIC=40 μg/ml).",Unknown,Unknown,20736034,Regul Pept. 2011 Jan 17;166(1-3):36-41.,"Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.",De novo generation of short antimicrobial peptides with simple amino acid composition.,,,,,,,,
1225,DRAMP04181,LLKWLKKWLKK,11,L4K5W2 (LlKmW2 model peptides),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: B. subtilis (MIC=2.5 μg/ml), S. aureus (MIC=2.5 μg/ml), S. epidermis (MIC=2.5 μg/ml), M. luteus (MIC=2.5 μg/ml), S. aureus (MRSA) (MIC=40 μg/ml).##Gram-negative bacteria: E. coli (MIC=40 μg/ml), S. dysentariae (MIC=80 μg/ml), S. typhimorium (MIC=40 μg/ml), K. pneumoniae (MIC=40 μg/ml), P. aeruginosa (MIC=20 μg/ml).",Unknown,Unknown,20736034,Regul Pept. 2011 Jan 17;166(1-3):36-41.,"Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.",De novo generation of short antimicrobial peptides with simple amino acid composition.,,,,,,,,
1226,DRAMP04182,LLKWLLKWLKK,11,L5K4W2 (LlKmW2 model peptides),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: B. subtilis (MIC<1.3 μg/ml), S. aureus (MIC<1.3 μg/ml), S. epidermis (MIC<1.3 μg/ml), M. luteus (MIC<1.3 μg/ml), S. aureus (MRSA) (MIC=5 μg/ml).##Gram-negative bacteria: E. coli (MIC=10 μg/ml), S. dysentariae (MIC=10 μg/ml), S. typhimorium (MIC=20 μg/ml), K. pneumoniae (MIC=20 μg/ml), P. aeruginosa (MIC=10 μg/ml).",Unknown,Unknown,20736034,Regul Pept. 2011 Jan 17;166(1-3):36-41.,"Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.",De novo generation of short antimicrobial peptides with simple amino acid composition.,,,,,,,,
1227,DRAMP04183,LLKWLLKWLLK,11,L6K3W2 (LlKmW2 model peptides),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: B. subtilis (MIC<1.3 μg/ml), S. aureus (MIC=2.5 μg/ml), S. epidermis (MIC<1.3 μg/ml), M. luteus (MIC=2.5 μg/ml), S. aureus (MRSA) (MIC=5 μg/ml).##Gram-negative bacteria: E. coli (MIC>80 μg/ml), S. dysentariae (MIC>80 μg/ml), S. typhimorium (MIC>80 μg/ml), K. pneumoniae (MIC>80 μg/ml), P. aeruginosa (MIC>80 μg/ml).",Unknown,Unknown,20736034,Regul Pept. 2011 Jan 17;166(1-3):36-41.,"Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.",De novo generation of short antimicrobial peptides with simple amino acid composition.,,,,,,,,
1229,DRAMP04185,GLLPLLSLLGKLL,13,DFTamP1-p,No entry found,Unknown,Unknown,Synthetic construct (Ab Initio Design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antimicrobial activities.,"Gram-positive bacteria: S. aureus USA300 (MIC=1.56 μM), B. subtilis (MIC=3.12 μM).##Gram-negative bacteria: E. coli K12 (MIC=25 μM), P. aeruginosa (MIC>100 μM).",Unknown,Unknown,22803960,J Am Chem Soc. 2012 Aug 1;134(30):12426-9.,"Mishra B, Wang G.","Ab Initio Design of Potent Anti-MRSA Peptides Based on Database
Filtering Technology.",,,,,,,,
1230,DRAMP04186,WLKKLLKKLLK,11,L5K5W1 (L5K5Wn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 μg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 μg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 μg/mL), Micrococcus luteus ATCC 10240 (MIC=4 μg/mL), MRSA-TK784 (MIC=8 μg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4 μg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 μg/mL), Salmonella typhimurium ATCC 14028 (MIC=2 μg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/mL).",Unknown,Unknown,23344198,Molecules. 2013 Jan 11;18(1):859-876.,"Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.",Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.,,,,,,,,
1231,DRAMP04187,KWLKKLLKKLL,11,L5K5W2 (L5K5Wn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 μg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 μg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 μg/mL), Micrococcus luteus ATCC 10240 (MIC=4 μg/mL), MRSA-TK784 (MIC=8 μg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 μg/mL), Shigella dysenteriae ATCC 9752 (MIC=1 μg/mL), Salmonella typhimurium ATCC 14028 (MIC=2 μg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/mL).",Unknown,Unknown,23344198,Molecules. 2013 Jan 11;18(1):859-876.,"Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.",Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.,,,,,,,,
1232,DRAMP04188,LKWLKKLLKKL,11,L5K5W3 (L5K5Wn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 μg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 μg/mL), Staphylococcus epidermis ATCC 12228 (MIC=4 μg/mL), Micrococcus luteus ATCC 10240 (MIC=4 μg/mL), MRSA-TK784 (MIC=8 μg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4 μg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 μg/mL), Salmonella typhimurium ATCC 14028 (MIC=4 μg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/mL).",Unknown,Unknown,23344198,Molecules. 2013 Jan 11;18(1):859-876.,"Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.",Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.,,,,,,,,
1233,DRAMP04189,LLKWLKKLLKK,11,L5K5W4 (L5K5Wn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 μg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 μg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 μg/mL), Micrococcus luteus ATCC 10240 (MIC=4 μg/mL), MRSA-TK784 (MIC=16 μg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4 μg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 μg/mL), Salmonella typhimurium ATCC 14028 (MIC=4 μg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=4 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=4 μg/mL).",Unknown,Unknown,23344198,Molecules. 2013 Jan 11;18(1):859-876.,"Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.",Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.,,,,,,,,
1234,DRAMP04190,KLLKWLKKLLK,11,L5K5W5 (L5K5Wn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 μg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 μg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 μg/mL), Micrococcus luteus ATCC 10240 (MIC=2 μg/mL), MRSA-TK784 (MIC=8 μg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 μg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 μg/mL), Salmonella typhimurium ATCC 14028 (MIC=2 μg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/mL).",Unknown,Unknown,23344198,Molecules. 2013 Jan 11;18(1):859-876.,"Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.",Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.,,,,,,,,
1236,DRAMP04192,LKKLLKWLKKL,11,L5K5W7 (L5K5Wn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 μg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 μg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 μg/mL), Micrococcus luteus ATCC 10240 (MIC=4 μg/mL), MRSA-TK784 (MIC=16 μg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 μg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 μg/mL), Salmonella typhimurium ATCC 14028 (MIC=4 μg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/mL).",Unknown,Unknown,23344198,Molecules. 2013 Jan 11;18(1):859-876.,"Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.",Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.,,,,,,,,
1237,DRAMP04193,LLKKLLKWLKK,11,L5K5W8 (L5K5Wn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=4 μg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 μg/mL), Staphylococcus epidermis ATCC 12228 (MIC=4 μg/mL), Micrococcus luteus ATCC 10240 (MIC=4 μg/mL), MRSA-TK784 (MIC=16 μg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4 μg/mL), Shigella dysenteriae ATCC 9752 (MIC=4 μg/mL), Salmonella typhimurium ATCC 14028 (MIC=4 μg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=4 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/mL).",Unknown,Unknown,23344198,Molecules. 2013 Jan 11;18(1):859-876.,"Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.",Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.,,,,,,,,
1238,DRAMP04194,KLLKKLLKWLK,11,L5K5W9 (L5K5Wn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 μg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 μg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 μg/mL), Micrococcus luteus ATCC 10240 (MIC=4 μg/mL), MRSA-TK784 (MIC=8 μg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 μg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 μg/mL), Salmonella typhimurium ATCC 14028 (MIC=2 μg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=4 μg/mL).",Unknown,Unknown,23344198,Molecules. 2013 Jan 11;18(1):859-876.,"Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.",Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.,,,,,,,,
1239,DRAMP04195,KKLLKKLLKWL,11,L5K5W10 (L5K5Wn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=1 μg/mL), Staphylococcus aureus ATCC 6538p (MIC=1 μg/mL), Staphylococcus epidermis ATCC 12228 (MIC=1 μg/mL), Micrococcus luteus ATCC 10240 (MIC=2 μg/mL), MRSA-TK784 (MIC=4 μg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 μg/mL), Shigella dysenteriae ATCC 9752 (MIC=1 μg/mL), Salmonella typhimurium ATCC 14028 (MIC=1 μg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=2 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=4 μg/mL).",Unknown,Unknown,23344198,Molecules. 2013 Jan 11;18(1):859-876.,"Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.",Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.,,,,,,,,
1240,DRAMP04196,LKKLLKKLLKW,11,L5K5W11 (L5K5Wn model peptide),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-positive, Gram-negative bacteria and a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: Bacillus subtilis ATCC 6633 (MIC=2 μg/mL), Staphylococcus aureus ATCC 6538p (MIC=2 μg/mL), Staphylococcus epidermis ATCC 12228 (MIC=2 μg/mL), Micrococcus luteus ATCC 10240 (MIC=4 μg/mL), MRSA-TK784 (MIC=16 μg/mL).##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4 μg/mL), Shigella dysenteriae ATCC 9752 (MIC=2 μg/mL), Salmonella typhimurium ATCC 14028 (MIC=4 μg/mL), Klebsiella pneumoniae ATCC 10031 (MIC=4 μg/mL), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/mL).",Unknown,Unknown,23344198,Molecules. 2013 Jan 11;18(1):859-876.,"Kim SJ, Kim JS, Lee YS, Sim DW, Lee SH, Bahk YY, Lee KH, Kim EH, Park SJ, Lee BJ, Won HS.",Structural characterization of de novo designed L5K5W model peptide isomers with potent antimicrobial and varied hemolytic activities.,,,,,,,,
1244,DRAMP04237,GLFDIVKKLVSDF,13,Antibacterial peptide A4,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 8 residues),Unknown,1VM4 resolved by NMR.,Function: Has antibacterial activity against the Gram-negative bacterium E. coli.,Gram-negative bacterium: Escherichia coli (MIC=100 μM).,Unknown,Unknown,15572363,J Biol Chem. 2005 Feb 18;280(7):5803-5811.,"Wang G, Li Y, Li X.",Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor.,,,,,,,,
1245,DRAMP04240,KLKLLLLL,8,Synthetic 1,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Staphylococcus aureus (MIC=8 μg/ml), S. aureus (MRSA) (MIC>35 μg/ml).##Gram-negative bacterium: Escherichia coli (MIC=20 μg/ml).",Unknown,Unknown,8093007,Biochem J. 1994 Sep 1;302 ( Pt 2):535-538.,"Alvarez-Bravo J, Kurata S, Natori S.",Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus.,,,,,,,,
1246,DRAMP04241,KLKLLLLLKLK,11,Synthetic 2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Staphylococcus aureus (MIC=2 μg/ml), S. aureus (MRSA) (MIC=30 μg/ml).##Gram-negative bacterium: Escherichia coli (MIC=20 μg/ml).",Unknown,Unknown,8093007,Biochem J. 1994 Sep 1;302 ( Pt 2):535-538.,"Alvarez-Bravo J, Kurata S, Natori S.",Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus.,,,,,,,,
1247,DRAMP04242,RLKLLLLLRLK,11,Synthetic 3,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Staphylococcus aureus (MIC=1 μg/ml), S. aureus (MRSA) (MIC=30 μg/ml).##Gram-negative bacterium: Escherichia coli (MIC=20 μg/ml).",Unknown,Unknown,8093007,Biochem J. 1994 Sep 1;302 ( Pt 2):535-538.,"Alvarez-Bravo J, Kurata S, Natori S.",Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus.,,,,,,,,
1248,DRAMP04243,RLKLLLLRLK,10,Synthetic 4,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Staphylococcus aureus (MIC=2 μg/ml), S. aureus (MRSA) (MIC>35 μg/ml).##Gram-negative bacterium: Escherichia coli (MIC=20 μg/ml).",Unknown,Unknown,8093007,Biochem J. 1994 Sep 1;302 ( Pt 2):535-538.,"Alvarez-Bravo J, Kurata S, Natori S.",Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus.,,,,,,,,
1249,DRAMP04244,RLKLLLRLK,9,Synthetic 5,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Staphylococcus aureus (MIC=2 μg/ml), S. aureus (MRSA) (MIC>35 μg/ml).##Gram-negative bacterium: Escherichia coli (MIC=20 μg/ml).",Unknown,Unknown,8093007,Biochem J. 1994 Sep 1;302 ( Pt 2):535-538.,"Alvarez-Bravo J, Kurata S, Natori S.",Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus.,,,,,,,,
1250,DRAMP04264,KWKSFIKKLTSAAKKVVTTAKPLISS,26,CP26,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=1 μg/ml), Salmonella typhimurium (MIC=3 μg/ml), Pseudomonas aeruginosa K799 (MIC=1 μg/ml), Pseudomonas aeruginosa Z61 (MIC=1 μg/ml), Pseudomonas aeruginosa H744 (MIC=1 μg/ml), Pseudomonas aeruginosa H374 (MIC=1 μg/ml), Pseudomonas aeruginosa H547 (MIC=1 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
1251,DRAMP04265,KWKSFIKKLTTAVKKVLTTGLPALIS,26,CP29,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=2 μg/ml), Pseudomonas aeruginosa K799 (MIC=6 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=2 μg/ml), Pseudomonas aeruginosa H374 (MIC=2 μg/ml), Pseudomonas aeruginosa H547 (MIC=2 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
1253,DRAMP04359,INWKKIFQKVKNLV,14,PDD-A-1 (PDD-A analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli. PDD-A also shows hemolytic activity.,[Ref.18375018]Gram-negative bacterium: Escherichia coli (MIC=8 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=45 μM).,[Ref.18375018]IC50 = 100 μM against rat red blood cells,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1254,DRAMP04360,INWKKIFEKVKDLV,14,PDD-A-2 (PDD-A analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=9 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=5 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1255,DRAMP04361,IDWKKIFEKVKNLV,14,PDD-A-3 (PDD-A analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=13 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=8.5 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1256,DRAMP04362,IDWKKIFEKVKDLV,14,PDD-A-4 (PDD-A analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=47.5 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=17.5 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1257,DRAMP04363,INWSKIFEKVKNLV,14,PDD-A-5 (PDD-A analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=12.5 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=17 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1258,DRAMP04364,INWSSIFEKVKNLV,14,PDD-A-6 (PDD-A analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=35 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=40 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1259,DRAMP04365,INWSSIFESVKNLV,14,PDD-A-7 (PDD-A analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=87.5 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1260,DRAMP04367,INWKKIFEKVSNLV,14,PDD-A-9 (PDD-A analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=12.5 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=22.5 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1261,DRAMP04368,INWKKIFESVKNLV,14,PDD-A-10 (PDD-A analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=10 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=10 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1262,DRAMP04369,INWKSIFEKVKNLV,14,PDD-A-11 (PDD-A analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=15 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=15 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1263,DRAMP04370,NIWKKIFEKVKNLV,14,PDD-A-12 (PDD-A analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=25 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=20 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1264,DRAMP04371,INWLKLGKKILGAI,14,PDD-B-1 (PDD-B analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=67.5 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=25 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1265,DRAMP04372,INWLRLGRRILGAL,14,PDD-B-2 (PDD-B analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC>100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=17.5 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1266,DRAMP04373,INFLKLGKKILGAL,14,PDD-B-3 (PDD-B analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC>100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=22.5 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1267,DRAMP04374,INWKKLGKKILGAL,14,PDD-B-4 (PDD-B analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=43 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=15.5 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1268,DRAMP04376,INWLKLGKKIISAL,14,MP-1 (MP analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=15 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1269,DRAMP04377,INWLKLGKKLLSAL,14,MP-2 (MP analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=25 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1270,DRAMP04378,INWLKLGKKMMSAI,14,MP-5 (MP analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=70 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=35 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1271,DRAMP04379,SNWLKLGKKMMSAL,14,MP-6 (MP analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=40 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1272,DRAMP04380,INWKKIASIGKEVLKAI,17,PMM-1 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=5.5 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=27.2 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1273,DRAMP04381,NWKKIASIGKEVLKAL,16,PMM-2 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=21 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=46 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1274,DRAMP04382,WKKIASIGKEVLKAL,15,PMM-3 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=62 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=125 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1275,DRAMP04383,KKIASIGKEVLKAL,14,PMM-4 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC>100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=75 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1276,DRAMP04385,INWKKIASIGKEVLKA,16,PMM-6 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=75 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=70 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1277,DRAMP04386,INWKKIASIGKEVLK,15,PMM-7 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=100 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1278,DRAMP04387,INWKKIASIGKEVL,14,PMM-8 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC>100 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1279,DRAMP04389,IWNKIAKSIGKVLEKAL,17,PMM-10 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=15 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=35 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1280,DRAMP04390,INWKKGKEVLKAL,13,PMM-11 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC>100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=100 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1281,DRAMP04391,NIWKKIASIAKEVLKAL,17,PMM-12 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=6.25 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=10 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1282,DRAMP04392,KNWKKIASIGKEVLKAL,17,PMM-13 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=12.5 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=60 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1283,DRAMP04393,SNWKKIASIGKEVLKAL,17,PMM-14 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC=25 μM);##Gram-positive bacterium: Bacillus subtilis (MIC=30 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
1285,DRAMP04542,IDWKKLLDAAKQIL,14,"Polybia-MP-I (insects, vertebrates, animals)",No entry found,Unknown,Unknown,Polybia paulista (Neotropical social wasp),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli (MIC=5 μM), Pseudomonas aeruginosa (MIC=5 μM).##Gram-positive bacterium: Staphylococcus aureus (MIC=9 μM).",Unknown,Unknown,19463874,Peptides. 2009 Aug;30(8):1387-1395.,"de Souza BM, da Silva AV, Resende VM, Arcuri HA, Dos Santos Cabrera MP, Ruggiero Neto J, Palma MS.",Characterization of two novel polyfunctional mastoparan peptides from the venom of the social wasp Polybia paulista.,,,,,,,,14
1286,DRAMP04543,IDWLKLGKMVIDAL,14,"Polybia-MP-II (insects, vertebrates, animals)",No entry found,Unknown,Unknown,Polybia paulista (Neotropical social wasp),"Antibacterial, Cytotoxicity, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix,It forms amphipathic alpha-helical conformations under membrane-mimetic conditions.,Unknown,"Function: Both peptides (Polybia-MP-II and -III) are polyfunctional, causing pronounced cell lysis of rat mast cells and erythrocytes, in addition to having antimicrobial activity against both Gram-positive and Gram-negative bacteria.
PTM: C-terminal amidation.","Gram-negative bacteria: Escherichia coli (MIC=5 μM), Pseudomonas aeruginosa (MIC=38 μM).##Gram-positive bacteria: Staphylococcus aureus (MIC=2 μM), Bacillus cereus (MIC=5 μM).",Unknown,Unknown,19463874,Peptides. 2009 Aug;30(8):1387-1395.,"de Souza BM, da Silva AV, Resende VM, Arcuri HA, Dos Santos Cabrera MP, Ruggiero Neto J, Palma MS.",Characterization of two novel polyfunctional mastoparan peptides from the venom of the social wasp Polybia paulista.,,,,,,,,
1287,DRAMP04544,IDWLKLGKMVMDVL,14,"Polybia-MP-III (insects, vertebrates, animals)",No entry found,Unknown,Unknown,Polybia paulista (Neotropical social wasp),"Antibacterial, Cytotoxicity, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix,It forms amphipathic alpha-helical conformations under membrane-mimetic conditions.,Unknown,"Function: Both peptides (Polybia-MP-II and -III) are polyfunctional, causing pronounced cell lysis of rat mast cells and erythrocytes, in addition to having antimicrobial activity against both Gram-positive and Gram-negative bacteria.
PTM: C-terminal amidation.","Gram-negative bacteria: Escherichia coli (MIC=38 μM), Pseudomonas aeruginosa (MIC=310 μM).##Gram-positive bacteria: Staphylococcus aureus (MIC=19 μM), Bacillus cereus (MIC=38 μM).",Unknown,Unknown,19463874,Peptides. 2009 Aug;30(8):1387-1395.,"de Souza BM, da Silva AV, Resende VM, Arcuri HA, Dos Santos Cabrera MP, Ruggiero Neto J, Palma MS.",Characterization of two novel polyfunctional mastoparan peptides from the venom of the social wasp Polybia paulista.,,,,,,,,
1288,DRAMP04545,SFPFFPPGICKRLKRC,16,"Limnonectin-1Fa (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Limnonectes fujianensis (Fujian large-headed frog),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Possesses relatively potent growth inhibitory activity against the Gram-negative bacterium E. coli. Ineffective against the Gram-positive bacterium S. aureus and the potentially pathogenic yeast C. albicans at concentrations up to 160 μM.,Gram-negative bacterium: Escherichia coli (MIC=35 μM),Unknown,Unknown,21396976,Biochimie. 2011 Jun;93(6):981-987.,"Wu Y, Wang L, Zhou M, Ma C, Chen X, Bai B, Chen T, Shaw C.",Limnonectins: A new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis).,,,,,,,,
1289,DRAMP04546,SFHVFPPWMCKSLKKC,16,"Limnonectin-1Fb (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Limnonectes fujianensis (Fujian large-headed frog),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Possesses relatively potent growth inhibitory activity against the Gram-negative bacterium E. coli. Ineffective against the Gram-positive bacterium S. aureus and the potentially pathogenic yeast C. albicans at concentrations up to 160 μM.,Gram-negative bacterium: Escherichia coli (MIC=70 μM),Unknown,Unknown,21396976,Biochimie. 2011 Jun;93(6):981-987.,"Wu Y, Wang L, Zhou M, Ma C, Chen X, Bai B, Chen T, Shaw C.",Limnonectins: A new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis).,,,,,,,,
1290,DRAMP04553,GVIKSVLKGVAKTVALGML,19,H. erythraea B2RP,No entry found,Unknown,Unknown,Hylarana erythraea,"Antimicrobial, Antibacterial, Antifungal,, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli (MIC=12.5 microM);##Gram-poaitive bacteria: Staphylococcus aureus (MIC=12.5 microM), multidrug-resistant clinical isolates of Acetinobacter baumannii (MIC in the range 6-12.5 microM).##Yeast: Candida albicans (MIC=50 microM).",Unknown,Unknown,20015460,Peptides. 2010 Apr;31(4):548-554.,"Al-Ghaferi N, Kolodziejek J, Nowotny N, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD, Conlon JM.",Antimicrobial peptides from the skin secretions of the South-East Asian frog Hylarana erythraea (Ranidae).,,,,,,,,
1291,DRAMP04640,GMASKAGSVLGKLAKVAIGAL,21,PGLa-AN2,No entry found,Unknown,Unknown,Xenopus andrei,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: E. coli (MIC=25 μM);##Gram-positive bacterium: S. aureus (MIC=100 μM).,Unknown,Unknown,21498136,Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-212.,"Mechkarska M, Eman A, Coquet L, Jér么me L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.",Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,,,,,,,,
1292,DRAMP04665,KPFKKLEKVGRNIRDGIIKAGPAVAVIGQATSIARPTGK,39,Px-cec1,No entry found,Unknown,Unknown,Plutella xylostella (Diamondback moth),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix (CD),A circular dichroism (CD) analysis revealed that the recombinant Px-cec1 mainly contained α-helixes.,Unknown,"Function: Recombinant Px-cec1 exhibites a broad spectrum of anti-microbial properties against fungi, Gram-positive and Gram-negative bacteria, but it does not exhibit hemolytic activity against human erythrocytes.","[Ref.22921836]Gram-positive bacterium: S. aureus (MIC=2 μM);##Gram-negative bacteria: E. coli (MIC=0.1 μM), Pseudomonas fluorescent (MIC=1.1 μM), Salmonella choleraesuis (MIC=2.1 μM);##Fungi: Aureobasidium pullulans (MIC=4.0 μM), Aspergillus flavus (MIC=14.5 μM), Aspergillus fumigatus (MIC=16.0 μM), Aspergillus niger (MIC=14.6 μM), Fusarium oxysporum (MIC=8.0 μM).",[Ref.22921836]Non-hemolytic activity against human erythrocytes.,Unknown,22921836,Protein Expr Purif. 2012 Oct;85(2):230-238. ,"Jin F, Sun Q, Xu X, Li L, Gao G, Xu Y, Yu X, Ren S.","cDNA cloning and characterization of the antibacterial peptide cecropin 1 from the diamondback moth, Plutella xylostella L.",,,,,,,,
1293,DRAMP04670,KNIGNSVSCLRNKGVCMPGKCAPKMKQIGTCGMPQVKCCKRK,42,PBD1-42,No entry found,Unknown,Unknown,Boletus edulis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: The recombinant pBD142 exhibited antimicrobial activity against both Gram-positive Staphylococcus aureus and Gram-negative E. coli including the multi-resistant E. coli. Shows hemolytic activity and high thermal stability. ,[Ref.23220638]Gram-negative bacterium: Escherichia coli (MIC=100 μg/mL);##Gram-positive bacterium: Staphylococcus aureus (MIC=80 μg/mL).,"[Ref.23220638]5% hemolytic activity at 10 μg/mL, 10% hemolytic activity at 20 μg/mL, 10% hemolytic activity at 100 μg/mL against porcine fresh blood",Unknown,23220638,Protein Expr Purif. 2013 Mar;88(1):47-53.,"Li CL, Xu TT, Chen RB, Huang XX, Zhao YC, Bao YY, Zhao WD, Zheng ZY.","Cloning, expression and characterization of antimicrobial porcine b defensin 1 in Escherichia coli.",,,,,,,,
1294,DRAMP04671,TDHQMAQSACIGVSQDNAYASAIPRDCHGG,30,Myticusin-1,No entry found,Unknown,Unknown,Mytilus coruscus,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Myticusin-1 exhibites stronger anti-microbial properties against Gram-positive bacteria more than Gram-negative bacteria and fungus.,"Gram-negative bacteria: Escherichia coli (MIC=6.7-12.5 μM), Vibrio Parahaemolyticus (MIC>25.0 μM), Pseudomonas aeruginosa (MIC>25.0 μM), Vibrio.harveyi (MIC=12.5-25.0 μM).##Gram-positive bacteria: Bacillus subtilis (MIC=1.2-2.5 μM), Staphylococcus aureus (MIC=2.5-5.0 μM), Sarcina luteus (MIC=1.2-2.5 μM), Bacillus megaterium (MIC=2.5-5.0 μM).##Fungi: Candida albicans (MIC=6.7-12.5 μM), Monilia albican (MIC=12.5-25.0 μM).",Unknown,Unknown,23247103,Fish Shellfish Immunol. 2013 Feb;34(2):610-616.,"Liao Z, Wang XC, Liu HH, Fan MH, Sun JJ, Shen W.",Molecular characterization of a novel antimicrobial peptide from Mytilus coruscus.,,,,,,,,
1295,DRAMP04676,MFTLKKPLLLLFFLGTISLSLCQEERDADEEEGEMIEEEVKRSLLGTVKDLLIGAGKSAAQSVLKGLSCKLSKDC,75,Brevinin-2HS2A,E7EKE0,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana hainanensis (Odor frog) (Rana hainanensis),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against some Gram-positive bacteria and fungi but has no activity against a range of Gram- negative bacteria except P.faecalis. Has extremely low hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.","[Ref.22450466]Gram-positive bacteria: S.aureus ATCC 25923 (MIC=19 μM), B.licheniformis X39 (MIC=37.5 μM) and R.rhodochrous X15 (MIC=9.5 μM);##Gram-negative bacterium: P. faecalis X29 (MIC=9.5 μM);##Fungi: C. albicans ATCC 2002 (MIC=19 μM), slime mold 090223 (MIC=37.5 μM).",[Ref.22450466]LC50=300 μM against human erythrocytes,Unknown,22450466,Peptides. 2012 Jun;35(2):285-290.,"Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.","Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",,,,,,,,
1296,DRAMP04677,MFTMKKPLLLIVLLGIISLSLCEQERAADEEEGEMIEEEVKRSLLGTVKDLLIGAGKSAAQSVLKGLSCKLSKDC,75,Brevinin-2HS2B,E7EKE1,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana hainanensis (Odor frog) (Rana hainanensis),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against some Gram-positive bacteria and fungi but has no activity against a range of Gram- negative bacteria except P. faecalis. Has low hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.","[Ref.22450466]Gram-positive bacteria: S.aureus ATCC 25923 (MIC=19 μM), B. licheniformis X39 (MIC=37.5 μM) and R. rhodochrous X15 (MIC=9.5 μM);##Gram-negative bacterium: P. faecalis X29 (MIC=9.5 μM);##Fungi: C. albicans ATCC 2002 (MIC=19 μM), slime mold 090223 (MIC=37.5 μM).",[Ref.22450466]LC50=300 μM against human erythrocytes,Unknown,22450466,Peptides. 2012 Jun;35(2):285-290.,"Wang H, Yu Z, Hu Y, Li F, Liu L, Zheng H, Meng H, Yang S, Yang X, Liu J.","Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",,,,,,,,
1346,DRAMP00052,NRWWQGVVPTVSYECRMNSWQHVFTCC,27,Mutacin-2 (Mutacin II mutacin H-29B; Bacteriocin),"O54329, P84110",Belongs to the type A lantibiotic family (Class I bacteriocin),mutA,Streptococcus mutans (Gram-positive bacteria),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Rich,Unknown,Unknown,"Function: Mutacin-2 inhibits other mutans streptococci as well as many gram-positive exogenous pathogens. Transiently and partially depolarizes the transmembrane electrical potential and pH gradient of susceptible cells, inhibits the uptake of amino acids and depletes the intracellular ATP pool.
Biophysicochemical properties: pH dependence (Stable from pH 4.0 to 10.0); Temperature dependence (Thermostable).
PTM: There are one didehydrobutyrine (T25), two lanthionines (S12-C26; S19-C27) and one Beta-methyllanthionine (T10-C15).","Gram-positive bacteria: Micrococcus luteus, Staphylococcus aureus, Peptostreptococcus micros, Pediococcus acidilactici, Clostridium sporogenes, Corynebacterium diphtheriae, Actinomyces viscosus, Gardnerella vaginalis, Propionibacterium acnes, Listeria monocytogenes, Mycobacterium smegmatis.##Gram-negative bacteria: Campylobacter jejuni, Helicobacter pylori, Neisseria gonorrhoeae.",Unknown,Unknown,10821848##8592997##16626493##8021218,J Biol Chem. 2000 May 26;275(21):15845-15850.##Antimicrob Agents Chemother. 1995 Dec;39(12):2656-2660.##BMC Microbiol. 2006 Apr 20;6:36.##J Bacteriol. 1994 Jul;176(14):4316-4320.,"Krull RE, Chen P, Novak J, Kirk M, Barnes S, Baker J, Krishna NR, Caufield PW.##Chikindas ML, Novák J, Driessen AJ, Konings WN, Schilling KM, Caufield PW.##Nicolas G, Morency H, LaPointe G, Lavoie MC.##Novák J, Caufield PW, Miller EJ.","Biochemical structural analysis of the lantibiotic mutacin II.##Mutacin II, a bactericidal antibiotic from Streptococcus mutans.##Mutacin H-29B is identical to mutacin II (J-T8).##Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans.",,,,,,,,
1349,DRAMP00055,ITSVSWCTPGCTSEGGGSGCSHCC,24,Bacteriocin 97518,No entry found,Belongs to the type A lantibiotic family (Class I bacteriocin),Unknown,Planomonospora sp. (Gram-positive bacteria),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Rich ,Unknown,Unknown,"Function: It inhibits cell wall synthesis of Gram-positive bacteria, including Staphylococcus aureus (MRSA).","Gram-negative bacteria: Escherichia coli, Moraxella catarrhalis.##Yeast: Candida albicans.",Unknown,Unknown,17469849,Biochemistry. 2007 May 22;46(20):5884-5895.,"Castiglione F, Cavaletti L, Losi D, Lazzarini A, Carrano L, Feroggio M, Ciciliato I, Corti E, Candiani G, Marinelli F, Selva E.",A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.,,,,,,,,
1354,DRAMP00064,MSKRDCNLMKACCAGQAVTYAIHSLLNRLGGDSSDPAGCNDIVRKYCK,48,Enterocin 96 (Bacteriocin),Q82YI9,Belongs to the class II bacteriocin,Unknown,Enterococcus faecalis (strain ATCC 700802 / V583) (Gram-positive bacteria),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,Search in protein databases revealed that enterocin 96 was identical to the C-terminal part of a putative uncharacterized protein from Enterococcus faecalis V583 (accession number EF_B0056) identified after complete genome sequencing of this strain. The amino acid sequence of this protein contains an N-terminal extension of 26 amino acids with two C-terminal 1 glycyl residues. The likely presence of such an extension for enterocin 96 was investigated by sequencing its structural gene.,"Gram-positive bacteria: Enterococcus faecalis, E. faecium WHE, E. hirae, E. pseudoavium, E. sulfureus, E. saccharolyticus, E. columbae, Lactobacillus plantarum, L. acidophilus, Lactobacillus sakeii subsp. sakei, L. paracasei subsp. paracasei, Lactococcus lactis, Lactococcus lactis subsp. cremoris, Leuconostoc mesenteroides, Bacillus subtilis, Bacillus cereus, Listeria innocua, Listeria monocytogenes, Staphylococcus xylosus, Staphylococcus aureus;##Gram-negative bacteria: Salmonella enterica serovar Typhimurium, S. enterica serovar Infantis, Klebsiella pneumoniae, Serratia liquefaciens, Proteus vulgaris, Enterobacter cloacae, Escherichia coli.",Unknown,Unknown,12663927,Science. 2003 Mar 28;299(5615):2071-2074.,"Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, Fouts DE, Eisen JA, Gill SR, Heidelberg JF, Tettelin H, Dodson RJ, Umayam L, Brinkac L, Beanan M, Daugherty S, DeBoy RT, Durkin S, Kolonay J, Madupu R, Nelson W, Vamathevan J, Tran B, Upton J, Hansen T, Shetty J, Khouri H, Utterback T, Radune D, Ketchum KA, Dougherty BA, Fraser CM.",Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis.,,,,,,,,
1358,DRAMP00070,ACQCPDAISGWTHTDYQCHGLENKMYRHVYAICMNGTQVYCRTEWGSSC,49,Laterosporulin (Bacteriocin),No entry found,Belongs to the class II bacteriocin,Unknown,Brevibacillus sp. Strain GI-9 (Gram-positive bacteria),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"The bacteriocin was produced after 12 hours in the lag phase and the use of Diaion HP-20 hydrophobic resin increased yield. Partial sequence was determined and the entire sequence was deduced. This peptide is thermal stable, pH tolerant, and resistant to proteases. Reducing agent DTT had no effect on peptide activity or migration on gel.","Gram-positive bacteria: Bacillus subtilis, Staphylococcus aureus, Listeria monocytogenesa;##Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa.",Unknown,Unknown,22403615,PLoS One. 2012;7(3):e31498. ,"Singh PK, Chittpurna, Ashish, Sharma V, Patil PB, Korpole S.","Identification, Purification and Characterization of Laterosporulin, a Novel Bacteriocin Produced by Brevibacillus sp. Strain GI-9.",,,,,,,,
1372,DRAMP00085,TSYGNGVHCNKSKCWIDVSELETYKAGTVSNPKDILWSLKE,41,Bacteriocin,P86291,Belongs to the class IIa bacteriocin,Unknown,Lactococcus sp,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has bacteriocin active.,"Gram-positive bacteria: Streptococcus aureus, Bacillus thuringiensis;##Gram-negative bacteria: Salmonella typhi, Klebsiella sp., Escherichia coli KL16 and Escherichia coli Gj137.",Unknown,Unknown,PubMed ID is not available,Submitted (APR-2009) to UniProtKB,Ingale A.G.,Molecular characterisation of bacteriocin from microflora associated with radish and ginger.,,,,,,,,
1434,DRAMP00169,MAKEFGIPAAVAGTVINVVEAGGWVTTIVSILTAVGSGGLSLLAAAGRESIKAYLKKEIKKKGKRAVIAW,70,Enterocin AS-48 (AS-48; Bacteriocin),Q47765,Belongs to the class IIc bacteriocin,as-48,Enterococcus faecalis S-48 (Gram-positive bacteria),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (6 helices; 54 residues),The NMR structure of AS-48 at pH 3 showed that AS-48 is a monomer consisting of a bundle of five helices arranged with the topology of the saposin fold.,"1E68 resolved by NMR.##1O82,1O83,1O84 resolved by X-ray.","Function: The bacteriocin AS-48 is a membrane-interacting peptide, which displays a broad anti-microbial spectrum against Gram-positive and Gram-negative bacteria. The antimicrobial effect of AS-48 is due to its ability to form pores in the membranes of sensitive bacteria, leading to the efflux of small molecules and the depletion of the membrane electrical potential and ultimately leading to cell death.","Gram-positive bacteria: Bacillus subtilus, Bacillus cereus, Bacillus circulans, Bacillus megaterium, Corynebacterium glutamicum, Corynebacterium bovis, Mycobacterium phlei, Nocardia corrallina, Micrococcus luteus, Micrococcus lysodeikticus, Staphylococcus aureus, Streptococcus faecalis, Streptococcus faecium;##Gram-negative bacteria: Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Proteus inconstans, Salmonella typhimurium, Shigella sonnei, Pseudomonas fluorescens, Pseudomonas aeruginosa, Pseudomonas reptilivora.",Unknown,Cell membrane,2501837##14623193##11005847,Res Microbiol. 1989 Jan;140(1):57-68.##J Mol Biol. 2003 Nov 28;334(3):541-549.##Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11221-6.,"Gálvez A, Maqueda M, Martínez-Bueno M, Valdivia E.##Sánchez-Barrena MJ, Martínez-Ripoll M, Gálvez A, Valdivia E, Maqueda M, Cruz V, Albert A.##González C, Langdon GM, Bruix M, Gálvez A, Valdivia E, Maqueda M, Rico M.","Bactericidal and bacteriolytic action of peptide antibiotic AS-48 against gram-positive and Gram-negative bacteria and other organisms.##Structure of bacteriocin AS-48: from soluble state to membrane bound state.##Bacteriocin AS-48, a microbial cyclic polypeptide structurally and functionally related to mammalian NK-lysin.",,,,,,,,
1438,DRAMP18338,STNCFCYICCSCSS,14,Thiocillin GE37468 (Bacteriocin),P0C8P9,Belongs to the class I bacteriocin,getA,Streptomyces ATCC 55365,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Has bacteriocidal activity against both aerobic and anaerobic Gram-positive bacteria. Has poor activity against Gram-negative bacteria, with the exception of B.fragilis. Inhibits bacterial protein biosynthesis by acting on elongation factor Tu. Full antibiotic activity depends on the presence of the modified residue Ile-50.","Gram-positive, Gram-negative",Unknown,Elongation Factor Tu  (EF-Tu),21788474,Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13053-8. ,"Young TS, Walsh CT.","Identification of the thiazolyl peptide GE37468 gene cluster from Streptomyces ATCC 55365 and heterologous expression in Streptomyces lividans.
",,,,,,,,
1444,DRAMP00182,DWTXWSXLVXAACSVELL,18,Thuricin-S (Bacteriocin),P84763,Belongs to the class IId bacteriocin,Unknown,Bacillus thuringiensis subsp. entomocidus (Gram-positive bacteria),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Thuricin S has the same N-terminal sequence (DWTXWSXL) as bacthuricin F4 and thuricin 17, produced by Bacillus thuringiensis strains BUPM4 and NEB17, respectively, and could therefore be classified as a new subBelongs to the class IId bacteriocin.","Gram-positive bacteria: Listeria monocytogenes, Bacillus subtilis and other Bacillus, Enterobacter cloacae, L. acidophilus, Lactococcus lactis, Pediococcus acidilactici, S. thermophilus;##Gram-negative bacteria: S. cholerae, Shigella flexneri and Pseudomonas aeruginosa.",Unknown,Unknown,17496978,Can J Microbiol. 2007 Feb;53(2):284-290.,"Chehimi S, Delalande F, Sablé S, Hajlaoui MR, Van Dorsselaer A, Limam F, Pons AM.","Purification and partial amino acid sequence of thuricin S, a new anti-Listeria bacteriocin from Bacillus thuringiensis.",,,,,,,,
1448,DRAMP00186,KRKCPKTPFDNTPGAWFAHLILGC,24,LSEI_2163 (m2163; Bacteriocin),No entry found,Belongs to the class IId bacteriocin,Unknown,Lactobacillus casei ATCC 334 (Gram-positive bacteria),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: mature LSEI_2163 peptide was a class IId bacteriocin that exhibited antimicrobial activity against some lactobacilli and several Listeria species. The activities of both peptides tolerat 121℃ for 30 min but not treatment with proteinase K or trypsin.,"Gram-negative bacteria: Lactobacillus casei ATCC 393 (++), L. casei ATCC 27139 (++), Lactobacillus rhamnosus ATCC 21052 (+++++), L. rhamnosus ATCC 14957 (+), Lactobacillus plantarum ATCC 8014 (+), Listeria innocua ATCC 33091 (++), L. innocua CIP 78.44 (++), Listeria monocytogens ATCC 19112 (+++), Listeria welshimeri ATCC 43551 (++), Listeria seeligeri CIP79.46 (++++).##Note: + indistinct inhibit zone with diameter 8-12 mm, ++ indistinct inhibit zone with diameter ≤12 mm, +++ clear inhibit zone with diameter 12-16 mm, ++++ clear inhibit zone with diameter 16-20 mm, and +++++ clear inhibit zone with diameter ≤10 mm.",Unknown,Unknown,22688903,Appl Microbiol Biotechnol. 2012 Jun 12.,"Kuo YC, Liu CF, Lin JF, Li AC, Lo TC, Lin TH.",Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.,,,,,,,,
1449,DRAMP00187,DSIRDVSPTFNKIRRWFDGLFK,22,LSEI_2386 (m2386; Bacteriocin),No entry found,Belongs to the class IId bacteriocin,Unknown,Lactobacillus casei ATCC 334 (Gram-positive bacteria),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: mature LSEI_2386 was a putative pheromone peptide that also had significant bacteriocin activity against several Listeria species. The activities of both peptides tolerat 121℃ for 30 min but not treatment with proteinase K or trypsin.,"Gram-negative bacteria: Listeria innocua ATCC 33091 (++++), L. innocua CIP 78.44 (++++), Listeria monocytogens ATCC 19112 (+++++), Listeria welshimeri ATCC 43551 (+++++), Listeria seeligeri CIP79.46 (+++++).##Note: ++++ clear inhibit zone with diameter 16-20 mm, and +++++ clear inhibit zone with diameter ≤10 mm.",Unknown,Unknown,22688903,Appl Microbiol Biotechnol. 2012 Jun 12.,"Kuo YC, Liu CF, Lin JF, Li AC, Lo TC, Lin TH.",Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.,,,,,,,,
1451,DRAMP00192,MRTGNAN,7,"Microcin C7 (MccC7; Microcin C51, MccC51; Bacteriocin)",Q47505,Belongs to the class I microcin,mccA,Escherichia coli (Gram-negative bacteria),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Beta strand,Unknown,"3H5R, 3H9J, 3H9Q, 3H9G resolved by X-ray.","Function: Inhibits protein translation by blocking aspartyl-tRNA synthetase Function: and inhibiting production of aminoacetylated tRNA-Asp. PTM: The peptide moiety allows entry into the bacterial cell, where it undergoes proteolytic cleavage to release the aspartyl adenylate analog, which is responsible for aspartyl-tRNA synthetase inhibition. Can be processed by the non-specific oligopeptidases pepA, pepB and pepN.","Gram-negative bacteria: Enterobacteria including species of Klebsiella, Salmonella, Shigella, Yersinia and Proteus, strains of Escherichia coli.",Unknown,It targets the aspartyl-tRNA synthetase ,17827970##17711420##19494832,J Mol Microbiol Biotechnol. 2007;13(4):200-209.##Mol Microbiol. 2007 Sep;65(6):1380-1394.##EMBO J. 2009 Jul 8;28(13):1953-1964.,"Duquesne S, Petit V, Peduzzi J, Rebuffat S.##Severinov K, Semenova E, Kazakov A, Kazakov T, Gelfand MS.##Regni CA, Roush RF, Miller DJ, Nourse A, Walsh CT, Schulman BA.","Structural and functional diversity of microcins, gene-encoded antibacterial peptides from enterobacteria.##Low-molecular-weight post-translationally modified microcins.##How the MccB bacterial ancestor of ubiquitin E1 initiates biosynthesis of the microcin C7 antibiotic.",,,,,,,,
1454,DRAMP00195,ASGRDIAMAIGTLSGQFVAGGIGAAAGGVAGGAIYDYASTHKPNPAMSPSGLGGTIKQKPEGIPSEAWNYAAGRLCNWSPNNLSDVCL,88,Colicin-V (Microcin-V; Bacteriocin),P22522,Belongs to the class IIa microcin,cvaC,Escherichia coli (Gram-negative bacteria),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Colicin V kills sensitive cells by disrupting the membrane potential. It targets bacterial membranes and induces ion channel formation, leading to the disruption of the proton-motive force and hence ATP production.
PTM: Contains one disulfide bond between 76-87.","Gram-negative bacteria: Escherichia coli (also closely related bacteria), Enterobacteriaceae.",Unknown,Cell membrane,8204625##7952189##2249654,Biochemistry. 1994 Jun 7;33(22):6911-6917.##Microbiology. 1994 Sep;140 (Pt 9):2383-2389.##EMBO J. 1990 Dec;9(12):3875-3884.,"Fath MJ, Zhang LH, Rush J, Kolter R.##Håvarstein LS, Holo H, Nes IF.##Gilson L, Mahanty HK, Kolter R.",Purification and characterization of colicin V from Escherichia coli culture supernatants.##The leader peptide of colicin V shares consensus sequences with leader peptides that are common among peptide bacteriocins produced by Gram-positive bacteria.##Genetic analysis of an MDR-like export system: the secretion of colicin V.,,,,,,,,
1455,DRAMP00196,GDVNWVDVGKTVATNGAGVIGGAFGAGLCGPVCAGAFAVGSSAAVAALYDAAGNSNSAKQKPEGLPPEAWNYAEGRMCNWSPNNLSDVCL,90,Microcin L (MccL; Bacteriocin),Q841V4,Belongs to the class IIa microcin,mclC,Escherichia coli (Gram-negative bacteria),"Antibacterial, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,"It targets bacterial membranes and induces ion channel formation, leading to the disruption of the proton-motive force and hence ATP production.","Gram-negative bacteria: Escherichia coli, Klebsiella oxytoca CIP666, Salmonella enterica serovar Agon, S. enterica serovar Braenderup, S. enterica serovar Brandenburg, S. enterica serovar Bredeney, S. enterica serovar Derby, S. enterica serovar Dublin, S. enterica serovar Enteritidis ATCC 13076, S. enterica serovar Hadar, S. enterica serovar Heildeberg, S. enterica serovar Indiana, S. enterica serovar Kottbus, S. enterica serovar Newport, S. enterica serovar St.Paul, S. enterica serovar Typhimurium CIP5858, S. enterica serovar Virchow, Shigella sonnei CIP5236, Shigella flexneri CIP5236, Pseudomonas aeruginosa CIP100720T, Pseudomonas aeruginosa ATCC 27853.",Unknown,Cell membrane,14742202##12897830,Antimicrob Agents Chemother. 2004 Feb;48(2):505-513.##Can J Microbiol. 2003 May;49(5):357-361.,"Pons AM, Delalande F, Duarte M, Benoit S, Lanneluc I, Sablé S, Van Dorsselaer A, Cottenceau G.##Sablé S, Duarte M, Bravo D, Lanneluc I, Pons AM, Cottenceau G, Moreno F.","Genetic analysis and complete primary structure of microcin L.##Wild-type Escherichia coli producing microcins B17, D93, J25, and L; cloning of genes for microcin L production and immunity.",,,,,,,,
1456,DRAMP00197,AGDPLADPNSQIVRQIMSNAAWGPPLVPERFRGMAVGAAGGVTQTVLQGAAAHMPVNVPIPKVPMGPSWNGSKG,74,Microcin 24 (Mcc24; Bacteriocin),Q46971,Belongs to the class IIa microcin,mtfS,Escherichia coli (Gram-negative bacteria),"Antibacterial, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"MOA: It targets bacterial membranes and induces ion channel formation, leading to the disruption of the proton-motive force and hence ATP production.","Gram-negative bacteria: Escherichia coli, Salmonella typhimurium.",Unknown,Unknown,PubMed ID is not available,Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases.,"O'Brien G.J, Mahanty H.K.",Complete nucleotide sequence of microcin 24 genetic region and analysis of a new ABC transporter.,,,,,,,,
1502,DRAMP00250,DYHHGVRVL,9,Bacteriocin serracin-P 43 kDa subunit (Bacteriocin),P83375,Unknown,Unknown,Serratia plymuthica (Gram-negative bacteria),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Major component of a prophage tail sheath. Antibacterial activity against Gram-negative bacteria E.amylovora.,Gram-negative bacterium: Erwinia amylovora.,Unknown,Unknown,12406768,Appl Environ Microbiol. 2002 Nov;68(11):5704-5710.,"Jabrane A, Sabri A, Compère P, Jacques P, Vandenberghe I, Van Beeumen J, Thonart P.","Characterization of serracin P, a phage-tail-like bacteriocin, and its activity against Erwinia amylovora, the fire blight pathogen.",,,,,,,,
1503,DRAMP00251,ALPKKLKYLNLFNDGFNYMGVV,22,Bacteriocin serracin-P 23 kDa subunit (Bacteriocin),P83378,Unknown,Unknown,Serratia plymuthica J7 (Gram-negative bacteria),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Major component of a prophage tail tube. Antibacterial activity against Gram-negative bacteria E.amylovora.,Gram-negative bacterium: Erwinia amylovora.,Unknown,Unknown,12406768,Appl Environ Microbiol. 2002 Nov;68(11):5704-5710.,"Jabrane A, Sabri A, Compère P, Jacques P, Vandenberghe I, Van Beeumen J, Thonart P.","Characterization of serracin P, a phage-tail-like bacteriocin, and its activity against Erwinia amylovora, the fire blight pathogen.",,,,,,,,
1574,DRAMP00341,ANTAFVSSAHNTQKIPAGAPFNRNLRAMLADLRQNAAFAG,40,"Antifungal protein ginkbilobin-1 (Ginkbilobin, GNL; Plants)",P83171,Unknown,GNK1,Ginkgo biloba (Ginkgo) (Maidenhair tree),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Also inhibits HIV-1 reverse transcriptase and proliferation of murine splenocytes.,"Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacteria: Pseudomonas aeruginosa, Escherichia coli.##Fuungi: Botrytis cinerea, Mycosphaerella arachidicola, Fusarium oxysporum, Rhizoctonia solani, Coprinus comatus,",Unknown,Unknown,11118300,Biochem Biophys Res Commun. 2000 Dec 20;279(2):407-411.,"Wang H, Ng T.B.","Ginkbilobin, a novel antifungal protein from Ginkgo biloba seeds with sequence similarity to embryo-abundant protein.",,,,,,,,
1609,DRAMP00393,IQCGESCVWIPCISSAWGCSCKNKICSS,28,Hedyotide B2 (hB2; Uncyclotides; Plants),No entry found,Unknown,Unknown,Hedyotis biflora (aerial tissues),"Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Possesses antifungal activity.,"Gram-negative bacterium: Escherichia coli (MIC>80 μM);##Gram-positive bacteria: Streptococcus salivarius(MIC>80 μM), Staphylococcus epidermidis (MIC>80 μM), Streptococcus aureus (MIC>80 μM).",Unknown,Unknown,21979955,J Biol Chem. 2011 Dec 30;286(52):44833-44844.,"Nguyen GK, Zhang S, Wang W, Wong CT, Nguyen NT, Tam JP.",Discovery of a linear cyclotide from the bracelet subfamily and its disulfide mapping by top-down mass spectrometry.,,,,,,,,
1612,DRAMP00397,KFCEKPSGTWSGVCGNSGACKDQCIRLEGAKHGSCNYKPPAHRCICYYEC,50,Defensin D1 (Ns-D1; Plant defensin),P86972,Belongs to the DEFL family,Unknown,Nigella sativa (Black cumin),"Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Antimicrobial peptide active against fungi, Gram-positive and Gram-negative bacteria. Has no effect on spore germination. Destroys spores in germinated conidia by disruption of cell walls and membranes in A. niger and B. sorokiniana. Causes vacuolization of germinated macro- and microconidia in F. oxysporum, F. graminearum and F. culmorum. Strongly inhibits growth of P. infestans on potato tubers above concentrations of 13.6 μg/ml.
PTM: Contains four disulfide bonds.","Fungi: Aspergillus niger (IC50=3.5 μg/ml), Bipolaris sorokiniana (IC50=3.0 μg/ml), Fusarium oxysporum (IC50=9.5 μg/ml), Fusarium graminearum (IC50=6.9 μg/ml), Fusarium culmorum (IC50=6.9 μg/ml) and Botrytis cinerea (IC50=27.4 μg/ml).##Gram-positive bacteria: Clavibacter michiganensis (1.4 cm) and Bacillus subtilis (1.3 cm);##Gram-negative bacteria: Pseudomonas syringae (0.9 cm), Erwinia carotovora (0.7 cm) and Escherichia coli (1.2 cm).##NOTE: Inhibition zone; Defensin concentration (11 μg in 50 μl).",Unknown,Unknown,21144761,Plant Physiol Biochem. 2011 Feb;49(2):131-137.,"Rogozhin EA, Oshchepkova YI, Odintsova TI, Khadeeva NV, Veshkurova ON, Egorov TA, Grishin EV, Salikhov SI.",Novel antifungal defensins from Nigella sativa L. seeds.,,,,,,,,
1613,DRAMP00398,KFCEKPSGTWSGVCGNSGACKDQCIRLEGAKHGSCNYKLPAHRCICYYEC,50,Defensin D2 (Ns-D2; Plant defensin),P86973,Belongs to the DEFL family,Unknown,Nigella sativa (Black cumin),"Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Antimicrobial peptide active against fungi, Gram-positive and Gram-negative bacteria. Has no effect on spore germination. Destroys spores in germinated conidia by disruption of cell walls and membranes in Aspergillus niger and B.sorokiniana. Causes vacuolization of germinated macro- and microconidia in Fusarium oxysporum, F.graminearum and F.culmorum. Strongly inhibits growth of P.infestans on potato tubers above concentrations of 3.4 μg/ml.
PTM: Contains four disulfide bonds.","Fungi: Aspergillus niger (IC50=3.5 μg/ml), Bipolaris sorokiniana (IC50=1.8 μg/ml), Fusarium oxysporum (IC50=5.3 μg/ml), Fusarium graminearum (IC50=6.9 μg/ml), Fusarium culmorum (IC50=6.9 μg/ml) and Botrytis cinerea (IC50=13.7 μg/ml).##Gram-positive bacteria: Clavibacter michiganensis (1.5 cm) and Bacillus subtilis (1.3 cm);##Gram-negative bacteria: Pseudomonas syringae (1.3 cm), Erwinia carotovora (0.7 cm) and Escherichia coli (1.4 cm).##NOTE: Inhibition zone; Defensin concentration (11 μg in 50 μl).",Unknown,Unknown,21144761,Plant Physiol Biochem. 2011 Feb;49(2):131-137.,"Rogozhin EA, Oshchepkova YI, Odintsova TI, Khadeeva NV, Veshkurova ON, Egorov TA, Grishin EV, Salikhov SI.",Novel antifungal defensins from Nigella sativa L. seeds.,,,,,,,,
1617,DRAMP00402,XTCESPSHKFKGPCATNRNCES,22,Defensin D1 (So-D1; Antimicrobial peptide D1; Plant defensin),P81572,Belongs to the DEFL family,Unknown,Spinacia oleracea (Spinach),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antimicrobial peptide. Active against Gram-positive and Gram-negative bacterial pathogens.,Gram-positive bacterium: Clavibacter michiganensis;##Gram-negative bacterium: Ralstonia solanacearum.,Unknown,Unknown,9762899,FEBS Lett. 1998; 435: 159-162.,"Segura A, Moreno M, Molina A, García-Olmedo F.",Novel defensin subfamily from spinach (Spinacia oleracea).,,,,,,,,
1618,DRAMP00403,GIFSSRKCKTPSKTFKGICTRDSNCDTSCRYEGYPAGDCKGIRRRCMCSKPC,52,Defensin D2 (So-D2; Antimicrobial peptide D2; Plant defensin),P81571,Belongs to the DEFL family,Unknown,Spinacia oleracea (Spinach),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf.
PTM: Contains four disulfide bonds (By similarity).",Gram-positive bacterium: Clavibacter michiganensis;##Gram-negative bacterium: Ralstonia solanacearum.##Fungi: Fusarium culmorum.,Unknown,Unknown,9762899,FEBS Lett. 1998; 435: 159-162.,"Segura A, Moreno M, Molina A, García-Olmedo F.",Novel defensin subfamily from spinach (Spinacia oleracea).,,,,,,,,
1621,DRAMP00406,MFFSSKKCKTVXKTFRGPCVRNAN,24,Defensin D5 (So-D5; Antimicrobial peptide D5; Plant defensin),P81568,Belongs to the DEFL family,Unknown,Spinacia oleracea (Spinach),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf.","Gram-positive bacterium: Clavibacter michiganensis;##Gram-negative bacterium: Ralstonia solanacearum.##Fungi: Fusarium culmorum, Fusarium solani, Bipolaris maydis and Colletotrichum lagenarium.",Unknown,Unknown,9762899,FEBS Lett. 1998; 435: 159-162.,"Segura A, Moreno M, Molina A, Garcia-Olmedo F.",Novel defensin subfamily from spinach (Spinacia oleracea).,,,,,,,,
1622,DRAMP00407,GIFSNMYXRTPAGYFRGPXGYXXN,24,Defensin D6 (So-D6; Antimicrobial peptide D6; Plant defensin),P81567,Belongs to the DEFL family,Unknown,Spinacia oleracea (Spinach),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide. Active against Fusarium spp., Gram-positive and Gram-negative bacterial pathogens.
Tissue specificity: Distributed in the epidermal cell layer of leaves and in the subepidermal layer region of stems. Not in roots.
Developmental stage: Present throughout the life of the leaf.",Gram-positive bacterium: Clavibacter michiganensis (EC50=1 μM);##Gram-negative bacterium: Ralstonia solanacearum (EC50=6 μM).##Fungi: Fusarium solani (EC50=11 μM). ,Unknown,Unknown,9762899,FEBS Lett. 1998; 435: 159-162.,"Segura A, Moreno M, Molina A, Garcia-Olmedo F.",Novel defensin subfamily from spinach (Spinacia oleracea).,,,,,,,,
1624,DRAMP00409,KTCENLADTY,10,Defensin-like protein (Sesquin; Plant defensin),P84868,Belongs to the DEFL family,Unknown,Vigna unguiculata subsp. sesquipedalis (Yard-Long bean) ,"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antifungal and antibacterial activity. Has mitogenic activity towards murine splenocytes. Inhibits the proliferation of M1 leukemia and MCF-7 breast cancer cells in vitro. Inhibits human immunodeficiency virus-1 (HIV-1) reverse transcriptase.,"Fungi: Botrytis cinerea (IC50=2.5±0.01 μM), Fusarium oxysporum (IC50=1.4±0.02 μM), Mycosphaerella arachidicola (IC50=0.15±0.002 μM).##Gram-positive bacteria: Bacillus megaterium, Mycobacterium phlei;##Gram-negative bacteria: Escherichia coli, Proteus vulgaris.",Unknown,Unknown,15949629,Peptides. 2005 Jul;26(7):1120-1126.,"Wong JH, Ng TB","Sesquin, a potent defensin-like antimicrobial peptide from ground beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase.",,,,,,,,
1661,DRAMP00455,LLGRCKVKSNRFNGPCLTDTHCSTVCRGEGYKGGDCHGLRRRCMCLC,47,Defensin-like protein 2 (Fabatin-2; Plant defensin),P81457,Belongs to the DEFL family,Unknown,Vicia faba (Broad bean),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Fabatins have antibacterial activity against Gram-positive and Gram-negative bacteria, but were inactive against the yeasts Saccharomyces cerevisiae and Candida albicans. High activity against P. aeruginosa.
PTM: Contains four disulfide bonds 5-47; 16-36; 22-43; 26-45.","Gram-positive bacteria: Bacillus subtilis, Enterococcus hirae;##Gram-negative bacterium: Pseudomonas aeruginosa.",Unknown,Cell membrane,9103978,FEMS Microbiol Lett. 1997 Apr 1;149(1):59-64.,"Zhang Y, Lewis K.",Fabatins: new antimicrobial plant peptides.,,,,,,,,
1662,DRAMP00456,LLGRCKVKSNRFHGPCLTDTHCSTVCRGEGYKGGDCHGLRRRCMCLC,47,Defensin-like protein 1 (Fabatin-1; Plant defensin),P81456,Belongs to the DEFL family,Unknown,Vicia faba (Broad bean),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Fabatins have antibacterial activity against Gram-positive and Gram-negative bacteria, but were inactive against the yeasts Saccharomyces cerevisiae and Candida albicans. High activity against P. aeruginosa.
PTM: Contains four disulfide bonds 5-47; 16-36; 22-43; 26-45.","Gram-positive bacteria: Bacillus subtilis, Enterococcus hirae;##Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa. ",Unknown,Cell membrane,9103978,FEMS Microbiol Lett. 1997 Apr 1;149(1):59-64.,"Zhang Y, Lewis K.",Fabatins: new antimicrobial plant peptides.,,,,,,,,
1952,DRAMP00746,RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,47,Flower-specific defensin (NaD1; Plant defensin),Q8GTM0,Belongs to the DEFL family,D1,Nicotiana alata (Winged tobacco) (Persian tobacco),"Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,NaD1 adopts the cysteine-stabilized αβ (CSαβ) motif formed by a triple-stranded antiparallel β-sheet and a single α-helix that is tethered to the sheet via three disulfide bonds. The fourth disulfide bond reinforces the N- and C-terminal regions of the molecule. ,"4AAZ, 4AB0 resolved by X-ray.","Function: NaD1 is a member of a family of cationic peptides that displays growth inhibitory activity against several filamentous fungi, including Fusarium oxysporum.
PTM: Contains four disulfide bonds 3-47; 14-34; 20-41; 24-43.
Tissue specificity: Most abundant in the epidermal cell layers of the petals and sepals, within the connective cells of the anthers, and the cortical cells of the style. Not detected in the tapetum, pollen mother cells, the transmitting tissue, the vascular bundles of the anther and style or in leaves. Expressed also in ovaries, but barley detectable in roots.
Biophysicochemical properties: pH dependence (Stable under extremes of pH); Temperature dependence (Stable under extremes of temperature.","Fungi: Fusarium oxysporum f. sp. Vasinfectum (IC50=1 μM), Thielaviopsis basicola (IC50=0.80 μM), Verticillium dahliae (IC50=0.75 μM), Leptosphaeria maculans (IC50=0.80 μM), Aspergillus nidulans (IC50=0.80 μM), Candida albicans (IC50>10 μM), Pichia pastoris (IC50>10 μM), Saccharomyces cerevisiae (IC50>10 μM).##Gram-negative bacteria: Escherichia coli (IC50>10 μM), Pseudomonas aeruginosa (IC50>10 μM);##Gram-positive bacteria: Staphylococcus aureus (IC50>10 μM), Bacillus cereus (IC50>10 μM).##HeLa cells (IC50>10 μM).",Unknown,Unknown,12644678##12473460##22511788##18339623,Plant Physiol. 2003 Mar;131(3):1283-1293.##J Mol Biol. 2003 Jan 3;325(1):175-188.##J Biol Chem. 2012 Jun 8;287(24):19961-72.##J Biol Chem. 2008 May 23;283(21):14445-52.,"Lay FT, Brugliera F, Anderson MA.##Lay FT, Schirra HJ, Scanlon MJ, Anderson MA, Craik DJ.##Lay FT, Mills GD, Poon IK, Cowieson NP, Kirby N, Baxter AA, van der Weerden NL, Dogovski C, Perugini MA, Anderson MA, Kvansakul M, Hulett MD.##van der Weerden NL, Lay FT, Anderson MA.","Isolation and properties of floral defensins from ornamental tobacco and petunia.##The three-dimensional solution structure of NaD1, a new floral defensin from Nicotiana alata and its application to a homology model of the crop defense protein alfAFP.##Dimerization of plant defensin NaD1 enhances its antifungal activity.##The plant defensin, NaD1, enters the cytoplasm of Fusarium oxysporum hyphae.",,,,,,,,
1969,DRAMP00767,GDACGETCFTGICFTAGCSCNPWPTCTRN,29,ChaC1 (Chassatide C1; Plant defensin),No entry found,Belongs to the cyclotide family,Unknown,Chassalia chartacea,"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"IC50=9.8 μM, HD50=51.9 μM.##Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).","Gram-negative bacterium: Escherichia coli (MIC>80 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 μM), Staphylococcus epidermidis (MIC>80 μM).",Unknown,Unknown,22467870,J Biol Chem. 2012 May 18;287(21):17598-17607.,"Nguyen GK, Lim WH, Nguyen PQ, Tam JP.",Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.,,,,,,,,
1970,DRAMP00768,GIPCAESCVWIPPCTITALMGCSCKNNVCYNN,32,ChaC2 (Chassatide C2; Plant defensin),No entry found,Belongs to the cyclotide family,Unknown,Chassalia chartacea,"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"IC50=2.4 μM, HD50>25 μM.##Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).","Gram-negative bacterium: Escherichia coli (MIC>80 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 μM), Staphylococcus epidermidis (MIC>80 μM).",Unknown,Unknown,22467870,J Biol Chem. 2012 May 18;287(21):17598-17607.,"Nguyen GK, Lim WH, Nguyen PQ, Tam JP.",Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.,,,,,,,,
1971,DRAMP00769,GASCGETCFTGICFTAGCSCNPWPTCTRN,29,ChaC4 (Chassatide C4; Plant defensin),No entry found,Belongs to the cyclotide family,Unknown,Chassalia chartacea,"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"IC50=9.8 μM, HD50=51.9 μM.##Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).","Gram-negative bacterium: Escherichia coli (MIC>80 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 μM), Staphylococcus epidermidis (MIC>80 μM).",Unknown,Unknown,22467870,J Biol Chem. 2012 May 18;287(21):17598-17607.,"Nguyen GK, Lim WH, Nguyen PQ, Tam JP.",Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.,,,,,,,,
1972,DRAMP00770,GEYCGESCYLIPCFTPGCYCVSRQCVNKN,29,ChaC10 (Chassatide C10; Plant defensin),No entry found,Belongs to the cyclotide family,Unknown,Chassalia chartacea,"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"IC50=5.0 μM, HD50>25 μM.##Note: IC50 (concentration that gives a survival index of 50%) and HD50 (concentration that causes 50% lysis of red blood cells).","Gram-negative bacterium: Escherichia coli (MIC>80 μM);##Gram-positive bacteria: Staphylococcus aureus (MIC>80 μM), Staphylococcus epidermidis (MIC>80 μM).",Unknown,Unknown,22467870,J Biol Chem. 2012 May 18;287(21):17598-17607.,"Nguyen GK, Lim WH, Nguyen PQ, Tam JP.",Novel Cyclotides and Uncyclotides with Highly Shortened Precursors from Chassalia chartacea and Effects of Methionine Oxidation on Bioactivities.,,,,,,,,
1976,DRAMP18325,MAADIISTIGDLVKLIINTVKKFQK,25,delta-lysin I (Bacteriocin),No entry found,Unknown,Unknown,Staphylococcus warneri RK,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Warnericin RK and delta-lysin I displayed the same antibacterial spectrum, which is almost restricted to the Legionella genus. Also, both peptides have a hemolytic activity.","[Ref.18339450]Gram-positive bacteria: Bacillus megaterium F04(+), Bacillus subtilis(-), Enterococcus faecalis V583(-), Listeria monocytogenes EGDe(-), Micrococcus luteus(-), Pediococcus acidilactici 583(-), Staphylococcus aureus 971(-), Staphylococcus chromogenes(-), Staphylococcus cohnii 898(-), Staphylococcus epidermidis 567(-), Staphylococcus haemolyticus 694(-), Staphylococcus hominis 373(-), Staphylococcus lentus 982(-), Staphylococcus lugdunensis 967(-), Staphylococcus saprophyticus 715(-), Staphylococcus warneri 447(-), Staphylococcus warneri RK(-);## Gram-negative bacteria:  Enterobacter cloacae D03(-), Escherichia coli MG1655(-), Hafnia alvei(-), Klebsiella pneumoniae 0502083(-), Legionella bozemanii ATCC 33217(+),  Legionella dumofii ATCC 33279(+), Legionella feeleii ATCC 35072(+), Legionella like bacteria (LLAP10)(+), Legionella longbeachae ATCC 33484(+), Legionella micdadei ATCC 33218(+), Legionella oakridgensis ATCC 33761(+), Legionella pneumophila Corby (sg1)(+), Legionella pneumophila Lens (sg1)(+), Legionella pneumophila Paris (sg1)(+), Legionella pneumophila ATCC 33155 (sg3)(+), Legionella pneumophila ATCC 33216 (sg5)(+), Legionella pneumophila ATCC 33215 (sg6)(+), Proteus mirabilis ATCC 35659(-), Pseudomonas aeruginosa DSMZ1128(-), Pseudomonas aeruginosa 910704(-), Salmonella typhimurium(-)","[Ref.18339450]10% hemolytic activity at 1.56 μM, 40% hemolytic activity at 6.25 μM, 62% hemolytic activity at 25 μM, 80% hemolytic activity at 50 μM against human erythrocytes ",Unknown,18339450,Peptides. 2008 Jun;29(6):978-84. ,"Verdon J, Berjeaud JM, Lacombe C, H","Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri.
",,,,,,,,
1977,DRAMP00796,GEFLKCGESCVQGECYTPGCSCDWPICKKN,30,Cliotide T2 (cT2; Plant defensin),No entry found,Belongs to the cyclotide family,Unknown,Clitoria ternatea (Butterfly pea),"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Cliotide T2 shows stronger antimicrobial activity against the Gram-negative bacteria than the Gram-positive bacteria. Cliotide T2 was relatively nonhemolytic (HD50>100 μM) .,"[Ref.21596752]Gram-positive bacteria: Staphylococcus aureus ATCC12600, Enterococcus faecalis ATCC 47077 (less active);##Gram-negative bacteria: Escherichia coli ATCC 700926 (MIC>100 μM), Pseudomonas aeruginosa ATCC 39018 (MIC>100 μM), Klebsiella pneumonia ATCC 13883 (MIC>100 μM).",[Ref:21596752]HD50>100 μM against human type A erythrocytes,Unknown,21596752,J Biol Chem. 2011 Jul 8;286(27):24275-24287.,"Nguyen GK, Zhang S, Nguyen NT, Nguyen PQ, Chiu MS, Hardjojo A, Tam JP.",Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.,,,,,,,,
1978,DRAMP00797,GLPTCGETCTLGTCYVPDCSCSWPICMKN,29,Cliotide T3 (cT3; Plant defensin),No entry found,Belongs to the cyclotide family,Unknown,Clitoria ternatea (Butterfly pea),"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Cliotide T3 shows stronger antimicrobial activity against the Gram-negative bacteria than the Gram-positive bacteria. It also has hemolytic activity against human type A erythrocytes (HD50=13.1 μM) and cytotoxicity against HeLa Cells (IC50=2.0 μM).
[Note: HD50 refers to the peptide concentration that causes 50% lysis of red blood cells; IC50 refers to the peptide concentration that causes 50% death of HeLa cells]. ","[Ref.21596752]Gram-positive bacteria: Staphylococcus aureus ATCC12600, Enterococcus faecalis ATCC 47077 (less active);##Gram-negative bacteria: Escherichia coli ATCC 700926 (MIC>100 μM), Pseudomonas aeruginosa ATCC 39018 (MIC>100 μM), Klebsiella pneumonia ATCC 13883 (MIC>100 μM).",[Ref:21596752]HD50=13.1 μM against human type A erythrocytes,Unknown,21596752,J Biol Chem. 2011 Jul 8;286(27):24275-24287.,"Nguyen GK, Zhang S, Nguyen NT, Nguyen PQ, Chiu MS, Hardjojo A, Tam JP.",Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.,,,,,,,,
1984,DRAMP18324,MQFITDLIKKAVDFFKGLFGNK,22,Warnericin RK (Bacteriocin),No entry found,Unknown,Unknown,Staphylococcus warneri RK,"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Alpha Helix,Unknown,Unknown,Warnericin RK acts as a specific anti-Legionella AMP by permeabilizing the bacterial membrane.,Gram-negative(Narrow),Unknown,Unknown,18339450##19804724 ,Peptides. 2008 Jun;29(6):978-84.##Biophys J. 2009 Oct 7;97(7):1933-40. ,"Verdon J, Berjeaud JM, Lacombe C, H","Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri.##Detergent-like activity and alpha-helical structure of warnericin RK, an anti-Legionella peptide.

",,,,,,,,
2071,DRAMP00937,KSCCRNTVARNCYNVCRIPGTPRPVCAATCDCKLITGTKCPPGYEK,46,Tu-AMP1 (Plant defensin),No entry found,Belongs to the thionin family,Unknown,Tulipa gesneriana L. ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Bacteria: Erwinia carotovora (IC50=11 μg/ml), Agrobacterium radiobacter (IC50=15 μg/ml), Agrobacterium rhizogenes (IC50=20 μg/ml);##Gram-positive bacteria: Clavibacter michiganensis (IC50=14 μg/ml), Curtobacterium flaccumfaciens (IC50=13 μg/ml).##Fungi: Fusarium oxysporum (IC50=2 μg/ml), Geotrichum candidum (IC50=2 μg/ml).",Unknown,Chitin-binding,15056889,Biosci Biotechnol Biochem. 2004 Mar;68(3):571-577.,"Fujimura M, Ideguchi M, Minami Y, Watanabe K, Tadera K.","Purification, characterization, and sequencing of novel antimicrobial peptides, Tu-AMP 1 and Tu-AMP 2, from bulbs of tulip (Tulipa gesneriana L.).",,,,,,,,
2072,DRAMP00938,KSCCRNTTARNCYNVCRIPG,20,Tu-AMP2 (Plant defensin),No entry found,Belongs to the thionin family,Unknown,Tulipa gesneriana L. ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Erwinia carotovora (IC50=15 μg/ml), Agrobacterium radiobacter (IC50=17 μg/ml), Agrobacterium rhizogenes (IC50=20 μg/ml);##Gram-positive bacteria: Clavibacter michiganensis (IC50=17 μg/ml), Curtobacterium flaccumfaciens (IC50=15 μg/ml).##Fungi: Fusarium oxysporum (IC50=2 μg/ml), Geotrichum candidum (IC50=2 μg/ml).",Unknown,Unknown,15056889,Biosci Biotechnol Biochem. 2004 Mar;68(3):571-577.,"Fujimura M, Ideguchi M, Minami Y, Watanabe K, Tadera K.","Purification, characterization, and sequencing of novel antimicrobial peptides, Tu-AMP 1 and Tu-AMP 2, from bulbs of tulip (Tulipa gesneriana L.).",,,,,,,,
2077,DRAMP00957,KSCCRSTQARNIYNAPRFAGGSRPLCALGSGCKIVDDKKTPPND,44,Pp-AMP1 (P. pubescens AMP1; Plant defensin),No entry found,Belongs to the thionin family,Unknown,Phyllostachys pubescens (Japanese bamboo shoots),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Bridge ,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Erwinia carotovora (IC50=22 μg/ml), Agrobacterium radiobacter (IC50=15 μg/ml), Agrobacterium rhizogenes (IC50=15 μg/ml);##Gram-positive bacteria: Clavibacter michiganensis (IC50=14 μg/ml), Curtobacterium flaccumfaciens (IC50=25 μg/ml).##Fungi: Fusarium oxysporum (IC50=2 μg/ml), Geotrichum candidum (IC50=2 μg/ml).",Unknown,Chitin-binding,15784998,Biosci Biotechnol Biochem. 2005 Mar;69(3):642-645.,"Fujimura M, Ideguchi M, Minami Y, Watanabe K, Tadera K.","Amino acid sequence and antimicrobial activity of chitin-binding peptides, Pp-AMP 1 and Pp-AMP 2, from Japanese bamboo shoots (Phyllostachys pubescens).",,,,,,,,
2078,DRAMP00958,KSCCRSTTARNIYNGCRVPGTARPVCAKKSGCKIQEAKKCEPPYD,45,Pp-AMP2 (P. pubescens AMP2; Plant defensin),No entry found,Belongs to the thionin family,Unknown,Phyllostachys pubescens (Japanese bamboo shoots),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Bridge ,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Erwinia carotovora (IC50=20 μg/ml), Agrobacterium radiobacter (IC50=13 μg/ml), Agrobacterium rhizogenes (IC50=15 μg/ml);##Gram-positive bacteria: Clavibacter michiganensis (IC50=18 μg/ml), Curtobacterium flaccumfaciens (IC50=20 μg/ml).##Fungi: Fusarium oxysporum (IC50=2 μg/ml), Geotrichum candidum (IC50=2 μg/ml).",Unknown,Chitin-binding,15784998,Biosci Biotechnol Biochem. 2005 Mar;69(3):642-645.,"Fujimura M, Ideguchi M, Minami Y, Watanabe K, Tadera K.","Amino acid sequence and antimicrobial activity of chitin-binding peptides, Pp-AMP 1 and Pp-AMP 2, from Japanese bamboo shoots (Phyllostachys pubescens).",,,,,,,,
2081,DRAMP01380,GLFTLIKCAYQLIAPTVACN,20,"Odorranain-J1 (OdJ1; Frogs, amphibians, animals)",A6MBN6,Unknown,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Odorranain-J1 adopts 50.1% β-sheet and 13.7% turn structure in water solution.,Unknown,Function: Odorranain-J1 exhibites moderate antimicrobial activities against Gram-positive and Gram-negative bacteria and fungi.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=35.60 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=17.80 μg/ml), Bacillus subtilis (MIC=35.60 μg/ml).##Yeast: Candida albicans (MIC=8.90 μg/ml).",Unknown,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
2090,DRAMP00980,AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGAGSCQSQCRGC,44,Antimicrobial peptide 1a (WAMP-1a; Plant defensin),P85966,Belongs to the hevein-like family,Unknown,Triticum kiharae (wheat),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,Unknown,2LB7 resolved by NMR.,PTM: Contains five disulfide bonds 4-19; 13-25; 16-44; 18-32; 37-41.,"Fungi: Bipolaris sorokiniana (IC50=5 μg/ml), Botrytis cinerea (IC50=20 μg/ml), Fusarium oxysporum (IC50=5 μg/ml), Fusarium solani (IC50=5 μg/ml), Fusarium verticillioides (IC50=30 μg/ml), Neurospora crassa (IC50=10 μg/ml);##Gram-positive bacterium: Clavibacter michiganensis (1.3cm inhibition for 2.5 μg/50μl);##Gram-negative bacteria: Erwinia carotovora (1.1cm for 2.5 μg/50μl), Pseudomonas syringae (0.9cm for 2.5 μg/50μl).",Unknown,Chitin-binding,19583772##16269343,FEBS J. 2009 Aug;276(15):4266-4275.##Peptides. 2005 Nov;26(11):2064-2073.,"Odintsova TI, Vassilevski AA, Slavokhotova AA, Musolyamov AK, Finkina EI, Khadeeva NV, Rogozhin EA, Korostyleva TV, Pukhalsky VA, Grishin EV, Egorov TA.##Egorov TA, Odintsova TI, Pukhalsky VA, Grishin EV.",A novel antifungal hevein-type peptide from Triticum kiharae seeds with a unique 10-cysteine motif.##Diversity of wheat anti-microbial peptides.,,,,,,,,
2091,DRAMP00981,AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGAGSCQSQCRGCR,45,Antimicrobial peptide 1b (WAMP-1b; Plant defensin),P85966,Belongs to the hevein-like family,Unknown,Triticum kiharae (wheat),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,PTM: Contains five disulfide bonds 4-19; 13-25; 16-44; 18-32; 37-41.,"Fungi: Bipolaris sorokiniana (IC50=5 μg/ml), Botrytis cinerea (IC50=20 μg/ml), Fusarium oxysporum (IC50=5 μg/ml), F. solani (IC50=5 μg/ml), F. verticillioides (IC50=30 μg/ml), Neurospora crassa (IC50=10 μg/ml);##Gram-positive bacterium: Clavibacter michiganensis (1.3cm inhibition for 2.5 μg/50μl);##Gram-negative bacteria: Erwinia carotovora (1.1cm for 2.5 μg/50μl), Pseudomonas syringae (0.9cm for 2.5 μg/50μl).",Unknown,Chitin-binding,19583772##16269343,FEBS J. 2009 Aug;276(15):4266-4275.##Peptides. 2005 Nov;26(11):2064-2073.,"Odintsova TI, Vassilevski AA, Slavokhotova AA, Musolyamov AK, Finkina EI, Khadeeva NV, Rogozhin EA, Korostyleva TV, Pukhalsky VA, Grishin EV, Egorov TA.##Egorov TA, Odintsova TI, Pukhalsky VA, Grishin EV.",A novel antifungal hevein-type peptide from Triticum kiharae seeds with a unique 10-cysteine motif.##Diversity of wheat anti-microbial peptides.,,,,,,,,
2092,DRAMP00982,AQCGAQGGGATCPGGLCCSQWGWCGSTPKYCGAGCQSNCK,40,Fa-AMP1 (Fagopyrum antimicrobial peptide 1; hevein-type; Plant defensin),No entry found,Belongs to the hevein-like family,Unknown,Fagopyrum esculentum Moench (buckwheat),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Has antibacterial avtivity against Gram-positive bacteria and Gram-negative bacteria, also has antifungal activity.","Gram-positive bacteria: Clavibacter michiganensis (IC50=14 μg/ml), Curtobacterium accumfaciens (IC50=13 μg/ml);##Gram-negative bacteria: Erwinia carotovora (IC50=11 μg/ml), Agrobacterium radiobacter (IC50=24 μg/ml), Agrobacterium rhizogenes (IC50=20 μg/ml).##Fungi: Fusarium oxysporum (IC50=19 μg/ml), Geotrichum candidum (IC50=36 μg/ml).",Unknown,Unknown,12951494,Biosci Biotechnol Biochem. 2003 Aug;67(8):1636-1642.,"Fujimura M, Minami Y, Watanabe K, Tadera K.","Purification, characterization, and sequencing of a novel type of antimicrobial peptides, Fa-AMP1 and Fa-AMP2, from seeds of buckwheat (Fagopyrum esculentum Moench.).",,,,,,,,
2093,DRAMP00983,AQCGAQGGGATCPGGLCCSQWGWCGSTPKYCGAGCQSNCR,40,Fa-AMP2 (Fagopyrum antimicrobial peptide 2; hevein-type; Plant defensin),No entry found,Belongs to the hevein-like family,Unknown,Fagopyrum esculentum Moench (buckwheat),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Has antibacterial avtivity against Gram-positive bacteria and Gram-negative bacteria, also has antifungal activity.","Gram-positive bacteria: Clavibacter michiganensis (IC50=17 μg/ml), Curtobacterium accumfaciens (IC50=15 μg/ml);##Gram-negative bacteria: Erwinia carotovora (IC50=15 μg/ml), Agrobacterium radiobacter (IC50=17 μg/ml), Agrobacterium rhizogenes (IC50=24 μg/ml).##Fungi: Fusarium oxysporum (IC50=29 μg/ml), Geotrichum candidum (IC50=25 μg/ml).",Unknown,Unknown,12951494,Biosci Biotechnol Biochem. 2003 Aug;67(8):1636-1642.,"Fujimura M, Minami Y, Watanabe K, Tadera K.","Purification, characterization, and sequencing of a novel type of antimicrobial peptides, Fa-AMP1 and Fa-AMP2, from seeds of buckwheat (Fagopyrum esculentum Moench.).",,,,,,,,
2103,DRAMP00993,QAGGQTCPGGICCSQWGYCGTTADYCSPNNNCQSNCWASG,40,WjAMP-1 (C-terminal domain of hevein; Plant defensin),No entry found,Unknown,WjAMP-1,Wasabia japonica L. (Wasabi plant) (Wasabia japonica) ,"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: WjAMP-1 showed antimicrobial activity against both fungi and bacteria.,"Gram-negative bacteria: Escherichia coli (IC50=27.5 μg/ml), Pseudomonas cichorii (IC50=13.8 μg/ml), Pseudomonas glumae (IC50=20 μg/ml), Pseudomonas plantarii (IC50=22.5 μg/ml), Agrobacterium tumefaciens (IC50=12.5 μg/ml).##Fungi: Alternaria alternata (IC50=5.8 μg/ml), Botrytis cinerea (IC50=15 μg/ml), Fusarium solani (IC50=8.4 μg/ml), Magnaporte grisea (IC50=80 μg/ml).",Unknown,Chitin-binding,12668776,Plant Cell Physiol. 2003 Mar;44(3):296-303.,"Kiba A, Saitoh H, Nishihara M, Omiya K, Yamamura S.",C-terminal domain of a hevein-like protein from Wasabia japonica has potent antimicrobial activity.,,,,,,,,
2107,DRAMP00997,QWGRRCCGWGPGRRYCRRWC,20,IB-AMP4 (IBAMP4; Basic peptide AMP4; Plants),O24006,Unknown,Unknown,Impatiens balsamina (Balsam),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,Developmental stage: Highly expressed in dry mature seed and by the stages 2-5 of developing seed. PTM: Contains two disulfide bonds C6-C16; C7-C20 and Pyrrolidone carboxylic acid at position 1 (Probable). Note: Peptide IB-AMP4 has a higher antifungal act,"Gram-positive bacteria: Bacillus subtilis (IC50=5 μg/ml), Micrococcus luteus (IC50=5 μg/ml), Staphylococcus aureus (IC50=20 μg/ml), Streptococcus faecalis (IC50=5 μg/ml);##Gram-negative bacteria: Xanthomonas campestris (IC50=6 μg/ml), Xanthomonas oryzae (IC50=15 μg/ml).##Fungi: Alternaria longipes (IC50=3 μg/ml), Botrytis cinerea (IC50=6 μg/ml), Cladosporium sphaerospermum (IC50=1 μg/ml), Fusarium culmorum (IC50=1 μg/ml), Penicillium digitatum (IC50=3 μg/ml), Trichoderma viride (IC50=6 μg/ml), Verticillium alboatrum (IC50=6 μg/ml).",Unknown,Unknown,9305910##9454588,J Biol Chem. 1997 Sep 26;272(39):24480-24487.##Biochemistry. 1998 Jan 27;37(4):983-990.,"Tailor RH, Acland DP, Attenborough S, Cammue BP, Evans IJ, Osborn RW, Ray JA, Rees SB, Broekaert WF.##Patel SU, Osborn R, Rees S, Thornton JM.",A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein.##Structural studies of Impatiens balsamina antimicrobial protein (Ib-AMP1).,,,,,,,,
2108,DRAMP00998,RSGRGECRRQCLRRHEGQPWETQECMRRCRRRG,33,Antimicrobial peptide MBP-1 (Maize Basic Peptide 1; Plant defensin),P28794,Unknown,Unknown,Zea mays (Maize),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Inhibitor of both bacterial and fungal growth in vitro.,"Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Corynebacterium nebraskense ssp.##Fungi: Fusarium graminearum, Fusarium moniliforme, Aspergillus flavus, Alonina longipes, Sclerotinia sclerotiorum, Sclerotinia trifoliorum. ",Unknown,Unknown,1527010,J. Biol. Chem. 1992; 267:18814-18820,"Duvick JP, Rood T, Rao AG, Marshak DR.1992",Purification and characterization of a novel antimicrobial peptide from maize (Zea mays L.) kernels.,,,,,,,,
2118,DRAMP01009,DDFLCAGGCL,10,Alliumin (Plants),P84796,Unknown,Unknown,Allium sativum (Garlic),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antifungal activity against M.arachidicola with an IC50 of 1.3 μM. Has antibacterial activity against the Gram-negative bacteria P. fluorescens. Has antiproliferative activity towards L1210 leukemia cells with an IC50 of 8.33 μM.,Fungi: Mycosphaerella arachidicola (IC50=1.3 μM).##Gram-negative bacterium: Pseudomonas fluorescens.,Unknown,Unknown,15629528,Peptides. 2005 Feb;26(2):177-183.,"Xia L, Ng TB.","Isolation of alliumin, a novel protein with antimicrobial and antiproliferative activities from multiple-cloved garlic bulbs.",,,,,,,,
2119,DRAMP01010,KTCENLADTFRGPCFATSNC,20,Lunatusin (Plants),No entry found,Unknown,Unknown,Phaseolus lunatus L.(Chinese lima bean),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: It also inhibited proliferation in the breast cancer cell line MCF-7. Lunatusin reduced the activity of HIV-1 reverse transcriptase and it also inhibited translation in a cell-free rabbit reticulocyte lysate system. Its anti-fungal activity was ,"Fungi: Fusarium oxysporum, Mycosphaerella arachidicola and Botrytis cinerea.##Gram-positive bacteria: Bacillus megaterium, Bacillus subtilis;##Gram-negative bacteria: Proteus vulgaris, Mycobacterium phlei.",Unknown,Unknown,16269344,Peptides. 2005 Nov;26(11):2086-2092.,"Wong JH, Ng TB.","Lunatusin, a trypsin-stable antimicrobial peptide from lima beans (Phaseolus lunatus L.).",,,,,,,,
2123,DRAMP01015,RTCMKKEGWGKCLIDTTCAHSCKNRGYIGGNCKGMTRTCYCLVNC,45,VaD1 (Plant defensin),No entry found,Unknown,Unknown,Vigna angularis Kao Hsiung No.6 (Seeds),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Fungi: Fusarium oxysporum, Fusarium oxysporum f. sp. Pisi.##Gram-positive bacterium: Staphylococcus epidermidis;##Gram-negative bacterium: Salmonella typhimurium.",Unknown,Unknown,15713009,J Agric Food Chem 2005; 53: 982-988.,"Chen G.-H. et al. Chen, C.-S.",Cloning and characterization of a plant defensin VaD1 from Azuki Bean.,,,,,,,,
2126,DRAMP01022,KGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGFCGSGPQYCG,44,Cy-AMP1 (Plant defensin),No entry found,Unknown,Unknown,Cycas revoluta (cycad seeds),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Cy-AMP1 has antimicrobial activity against various plant-pathogenic fungi and bacteria.,"Gram-positive bacteria: Clavibacterium michiganensis (IC50=7.3 μg/ml), Curtobacterium Flaccumfaciens (IC50=8.9 μg/ml);##Gram-negative bacteria: Agrobacterium radiobacter (IC50=8.3 μg/ml), Agrobacterium rhizogenes (IC50=8.5 μg/ml), Erwinia carobora (IC50=8.0 μg/ml).##Fungi: Fusarium oxysporum (IC50=6.0 μg/ml), Geotrichum candidum (IC50=7.4 μg/ml).",Unknown,Lipid-binding,18778743,Peptides. 2008 Dec;29(12):2110-2117.,"Yokoyama S, Kato K, Koba A, Minami Y, Watanabe K, Yagi F.","Purification, characterization, and sequencing of antimicrobial peptides, Cy-AMP1, Cy-AMP2, and Cy-AMP3, from the Cycad (Cycas revoluta) seeds.",,,,,,,,
2127,DRAMP01023,KGGPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGFCGSGPQYCG,44,Cy-AMP2 (Plant defensin),No entry found,Unknown,Unknown,Cycas revoluta (cycad seeds),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Cy-AMP2 has antimicrobial activity against various plant-pathogenic fungi and bacteria.,"Gram-positive bacteria: Clavibacterium michiganensis (IC50=7.6 μg/ml), Curtobacterium Flaccumfaciens (IC50=8.3 μg/ml);##Gram-negative bacteria: Agrobacterium radiobacter (IC50=7.8 μg/ml), Agrobacterium rhizogenes (IC50=8.2 μg/ml), Erwinia carobora (IC50=8.1 μg/ml).##Fungi: Fusarium oxysporum (IC50=7.1 μg/ml), Geotrichum candidum (IC50=7.0 μg/ml).",Unknown,Lipid-binding,18778743,Peptides. 2008 Dec;29(12):2110-2117.,"Yokoyama S, Kato K, Koba A, Minami Y, Watanabe K, Yagi F.","Purification, characterization, and sequencing of antimicrobial peptides, Cy-AMP1, Cy-AMP2, and Cy-AMP3, from the Cycad (Cycas revoluta) seeds.",,,,,,,,
2128,DRAMP01024,AVTCNTVVSSLAPCVPFFAGSAAQPTAACCNGVRSLNSAARTTPDRRTACNCIKSSASSIGLNYNKAAKLPSRCTVNVTVPISPSVNCAT,90,Cy-AMP3 (Plant defensin),No entry found,Unknown,Unknown,Cycas revoluta (cycad seeds),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Cy-AMP3 has weak antimicrobial activity against various plant-pathogenic fungi and bacteria.,"Gram-positive bacteria: Clavibacterium michiganensis (IC50=235 μg/ml), Curtobacterium Flaccumfaciens (IC50=195 μg/ml);##Gram-negative bacteria: Agrobacterium radiobacter (IC50=260 μg/ml), Agrobacterium rhizogenes (IC50=235 μg/ml), Erwinia carobora (IC50=230 μg/ml).##Fungi: Fusarium oxysporum (IC50=250 μg/ml), Geotrichum candidum (IC50=200 μg/ml).",Unknown,Lipid-binding,18778743,Peptides. 2008 Dec;29(12):2110-2117.,"Yokoyama S, Kato K, Koba A, Minami Y, Watanabe K, Yagi F.","Purification, characterization, and sequencing of antimicrobial peptides, Cy-AMP1, Cy-AMP2, and Cy-AMP3, from the Cycad (Cycas revoluta) seeds.",,,,,,,,
2149,DRAMP01046,GYGGHGGHGGHGGHGGHGGHGHGGGGHG,28,Shepherin I (fragement of shep-GRP; Plants),No entry found,Unknown,GRP,Capsella bursa-pastoris (shepherd's purse),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Unknown,Unknown,"Circular dichroism (CD) spectra of shepherin I showes that shepherin I in 50% trifluoroethanol has 66.7% random coils, without any alpha-helices.",Unknown,"Function: These antimicrobial peptides exhibit antimicrobial activity against Gram-negative bacteria and fungi.
Tissue specificity: Expressed in roots but not in leaves and stems.","Gram-negative bacteria: Erwinia herbicola (IC50=62 μg/ml), Escherichia coli (IC50<2.5 μg/ml), Pseudomonas putida (IC50<2.5 μg/ml), Pseudomonas syringae (IC50<2.5 μg/ml), Salmonella typhimurium (IC50<2.5 μg/ml), Serratia sp. (IC50=8 μg/ml).##Fungi: Candida albicans (IC50=8 μg/ml), Cryptococcus neoformans (IC50<2.5 μg/ml), Saccharomyces cerevisiae (IC50<7 μg/ml), Alternaria alternata (IC50<7 μg/ml), Aspergillus flavus (IC50=65 μg/ml), Fusarium culmorum (IC50=72 μg/ml).",Unknown,Unknown,11117262,Plant Mol Biol. 2000 Sep;44(2):187-197.,"Park CJ, Park CB, Hong SS, Lee HS, Lee SY, Kim SC.","Characterization and cDNA cloning of two glycine- and histidine-rich antimicrobial peptides from the roots of shepherd's purse, Capsella bursa-pastoris.",,,,,,,,
2150,DRAMP01047,GYHGGHGGHGGGYNGGGGHGGHGGGYNGGGHHGGGGHG,38,shepherin II (fragement of shep-GRP; Plants),No entry found,Unknown,GRP,Capsella bursa-pastoris (shepherd's purse),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Unknown,Unknown,"Circular dichroism (CD) spectra of shepherin II showes that shepherin II in 50% trifluoroethanol has 75% random coils, without any alpha-helices.",Unknown,"Function: These antimicrobial peptides exhibit antimicrobial activity against Gram-negative bacteria and fungi.
Tissue specificity: Expressed in roots but not in leaves and stems.","Gram-negative bacteria: Erwinia herbicola (IC50=25 μg/ml), Escherichia coli (IC50<2.5 μg/ml), Pseudomonas putida (IC50<2.5 μg/ml), Pseudomonas syringae (IC50<2.5 μg/ml), Salmonella typhimurium (IC50=65 μg/ml), Serratia sp. (IC50<2.5 μg/ml).##Fungi: Candida albicans (IC50=5 μg/ml), Cryptococcus neoformans (IC50<2.5 μg/ml), Saccharomyces cerevisiae (IC50=3 μg/ml), Aspergillus flavus (IC50=60 μg/ml), Fusarium culmorum (IC50=68 μg/ml).",Unknown,Unknown,11117262,Plant Mol Biol. 2000 Sep;44(2):187-197.,"Park CJ, Park CB, Hong SS, Lee HS, Lee SY, Kim SC.","Characterization and cDNA cloning of two glycine- and histidine-rich antimicrobial peptides from the roots of shepherd's purse, Capsella bursa-pastoris.",,,,,,,,
2186,DRAMP01099,GIGAAILSAGKSIIKGLANGLAEHF,25,"Bombinin-like peptide 4 (BLP-4; toads, amphibians, animals)",P29005,Belongs to the bombinin family,Unknown,Bombina orientalis (Oriental fire-bellied toad),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Has antimicrobial activity, but no hemolytic activity. Preference on killing Gram-negative non-enteric bacteria.
Tissue specificity: Expressed by the skin glands.","[Ref.1744108]Gram-negative bacteria: Neisseria meningitidis, Neisseria gonorrhoeoe, Neisseria Iactamica, Neisseria cinerea.",[Ref:1744108]Non-hemolytic activity,Unknown,1744108,J Biol Chem. 1991 Dec 5;266(34):23103-23111.,"Gibson BW, Tang DZ, Mandrell R, Kelly M, Spindel ER.","Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis.",,,,,,,,
2187,DRAMP01100,GIGGALLSAAKVGLKGLAKGLAEHFAN,27,"Bombinin-like peptide 1 (Contains: Bombinin H; toads, amphibians, animals)",P29006,Belongs to the bombinin family,Unknown,Bombina variegata (Yellow-bellied toad),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity, but low hemolytic activity. Preliminary evidence indicates that this peptide does not lyse and thus kill the bacteria by its antimicrobial activity. Bombinin H has antibacterial and hemolytic activity.
Tissue specificity: Expressed by the skin glands.","[Ref.1712299]Gram-positive bacteria: Staphylococcus species;##Gram-negative bacteria: Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Pseudomonas aeruginosa, Pseudomonas maltophilia, Alcaligenes denitrificans.",[Ref:8223491]Has low hemolytic activity,Unknown,1712299##8223491,Eur J Biochem. 1991 Jul 1;199(1):217-222.##EMBO J. 1993 Dec;12(12):4829-4832.,"Simmaco M, Barra D, Chiarini F, Noviello L, Melchiorri P, Kreil G, Richter K.##Mignogna G, Simmaco M, Kreil G, Barra D.",A family of bombinin-related peptides from the skin of Bombina variegata.##Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata.,,,,,,,,
2217,DRAMP01140,GFVDLAKKVVGGIRNALGI,19,"Uperin-2.2 (toads, amphibians, animals)",P82028,Unknown,Unknown,Uperoleia inundata (Floodplain toadlet),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows a weak antibacterial activity.
Tissue specificity: Expressed by the skin dorsal glands.","Gram-positive bacteria: Bacillus cereus, Leuconostoc mesenteroides, L. innocua, Micrococcus luteus, Staphylococcus aureus and Streptococcus uberis.##Gram-negative bacteria: Pasteurella haemolytica, Escherichia coli.",Unknown,Unknown,PubMed ID is not available,Aust. J. Chem. 1996; 49:475-484.,"Bradford AM, Raftery MJ, Bowie JH, Tyler MJ, Wallace JC, Adams GW, Severini C.",Novel uperin peptides from the dorsal glands of the australian floodplain toadlet Uperoleia inundata.,,,,,,,,
2237,DRAMP01171,GVVDILKGAGKDLLAHLVGKISEKV,25,"Ocellatin-1 (Frogs, amphibians, animals)",P83951,Unknown,Unknown,Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has hemolytic activity against human erythrocytes and antibacterial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin dorsal glands.",[Swiss_Prot Entry P83951]Gram-negative bacterium: Escherichia coli,[Ref:15648972]Show hemolytic activity against human red blood cells,Unknown,15648972,Protein J. 2004 Nov;23(8):501-508.,"Nascimento AC, Zanotta LC, Kyaw CM, Schwartz EN, Schwartz CA, Sebben A, Sousa MV, Fontes W, Castro MS.",Ocellatins: new antimicrobial peptides from the skin secretion of the South American frog Leptodactylus ocellatus (Anura: Leptodactylidae).,,,,,,,,
2238,DRAMP01172,GVLDIFKDAAKQILAHAAEKQI,22,"Ocellatin-2 (Frogs, amphibians, animals)",P83866,Unknown,Unknown,Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has hemolytic activity against human erythrocytes and antibacterial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin dorsal glands.",[Swiss_Prot Entry P83866]Gram-negative bacterium: Escherichia coli,[Ref:15648972]Show hemolytic activity against human red blood cells,Unknown,15648972,Protein J. 2004 Nov;23(8):501-508.,"Nascimento AC, Zanotta LC, Kyaw CM, Schwartz EN, Schwartz CA, Sebben A, Sousa MV, Fontes W, Castro MS.",Ocellatins: new antimicrobial peptides from the skin secretion of the South American frog Leptodactylus ocellatus (Anura: Leptodactylidae).,,,,,,,,
2239,DRAMP01173,GVLDILKNAAKNILAHAAEQI,21,"Ocellatin-3 (Frogs, amphibians, animals)",P83867,Unknown,Unknown,Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has hemolytic activity against human erythrocytes and antibacterial activity against the Gram-negative bacterium E. coli.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: C-terminal amidation.",[Swiss_Prot Entry P83867]Gram-negative bacterium: Escherichia coli,[Ref:15648972]Show hemolytic activity against human red blood cells,Unknown,15648972,Protein J. 2004 Nov;23(8):501-508.,"Nascimento AC, Zanotta LC, Kyaw CM, Schwartz EN, Schwartz CA, Sebben A, Sousa MV, Fontes W, Castro MS.",Ocellatins: new antimicrobial peptides from the skin secretion of the South American frog Leptodactylus ocellatus (Anura: Leptodactylidae).,,,,,,,,
2240,DRAMP01175,AVLDILKDVGKGLLSHFMEKV,21,"Ocellatin-5 (Frogs, amphibians, animals)",P85443,Unknown,Unknown,Leptodactylus ocellatus (Argus frog) (Leptodactylus macrosternum),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has hemolytic and antibacterial activities.
Tissue specificity: Expressed by the skin dorsal glands.",[Ref.19739090]Gram-postive bacterium: Staphylococcus aureus(100% inhibition at 64μg/mL);##Gram-negative bacterium: Escherichia coli(100% inhibition at 32μg/mL).,[Ref:19739090]Show hemolytic activity,Unknown,19739090##,"J Exp Zool A Ecol Genet Physiol. 2010 Jan 1;313(1):1-8.##Thesis (2007), University of Brasilia, Brazil","Leite JM Jr, Silva LP, Silva-Leite RR, Ferrari AS, Noronha SE, Silva HR, Bloch C Jr, Leite JR.##Nascimento A.C.C.",Leptodactylus ocellatus (Amphibia): mechanism of defense in the skin and molecular phylogenetic relationships.##Cytolytic peptides and proteases from the skin secretion of the frog Leptodactylus ocellatus).,,,,,,,,
2250,DRAMP01196,KEKLKLKCKAPKCYNDKLACT,21,"Andersonin-G1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Golden crossband frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Weakly active against bacteria and fungi and has no hemolytic activity under the test conditions.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>200 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC>200 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>200 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC>200 μg/ml).",[Ref:22029824]Non-hemolytic activity against human red blood cells,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
2251,DRAMP01197,ENMFNIKSSVESDSFWG,17,"Andersonin-N1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Golden crossband frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Weakly active against bacteria and fungi and has no hemolytic activity under the test conditions.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>200 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC>200 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>200 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC>200 μg/ml).",[Ref:22029824]Non-hemolytic activity against human red blood cells,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
2252,DRAMP01198,EMLKKKKEVKMERKT,15,"Andersonin-Q1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Odorrana andersonii (Golden crossband frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Weakly active against bacteria and fungi and has no hemolytic activity under the test conditions.,"[Ref.22029824]Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>200 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC>200 μg/ml);##Gram-positive bacterium: Staphylococcus aureus ATCC 25923 (MIC>200 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC>200 μg/ml).",[Ref:22029824]Non-hemolytic activity against human red blood cells,Unknown,22029824,J Proteome Res. 2012 Jan 1;11(1):306-319.,"Yang X, Lee WH, Zhang Y.",Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,,,,,,,,
2255,DRAMP01207,CYSAAKYPGFQEFINRKYKSSRF,23,"Galensin (Frogs, amphibians, animals)",Q90W78,Unknown,Unknown,Kassina senegalensis (Senegal running frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial activity against the Gram-positive bacteria: M. luteus and the Gram-negative bacteria E. coli. 
Tissue specificity: Expressed by the skin dorsal glands.",Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.,Unknown,Unknown,PubMed ID is not available,Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases,"Reid C.N, Bjourson A.J, Shaw C.","Galensin, a novel homodimeric antimicrobial peptide from the defensive skin secretion of Kassina senegalensis: isolation, structural characterisation and cloning of precursor cDNA.",,,,,,,,
2258,DRAMP01212,SIITMTREAKLPQLWKQIACRLYNTC,26,"Pleurain-A3 (Pleurain A3; Frogs, amphibians, animals)",A8B5P7,Unknown,Unknown,Rana pleuraden (Yunnan pond frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Has little hemolytic activity on red blood cells.
Tissue specificity: Expressed by the skin dorsal glands.","[Swiss_Prot Entry A8B5P7]has activity against Gram-positive and -negative bacteria, and fungi",[Ref:17764786]Little hemolytic activity on red blood cells even with peptide concentration up to 200 μg/ml,Unknown,17764786,Peptides. 2007 Oct;28(10):2069-2074.,"Wang X, Song Y, Li J, Liu H, Xu X, Lai R, Zhang K.",A new family of antimicrobial peptides from skin secretions of Rana pleuraden.,,,,,,,,
2259,DRAMP01213,SIITTTKEAKLPQLWKQIACRLYNTC,26,"Pleurain-A4 (Pleurain A4; Frogs, amphibians, animals)",A8B5Q0,Unknown,Unknown,Rana pleuraden (Yunnan pond frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Has little hemolytic activity on red blood cells.
Tissue specificity: Expressed by the skin dorsal glands.","[Swiss_Prot Entry A8B5Q0]has activity against Gram-positive and -negative bacteria, and fungi",[Ref:17764786]Little hemolytic activity on red blood cells even with peptide concentration up to 200 μg/ml,Unknown,17764786,Peptides. 2007 Oct;28(10):2069-2074.,"Wang X, Song Y, Li J, Liu H, Xu X, Lai R, Zhang K.",A new family of antimicrobial peptides from skin secretions of Rana pleuraden.,,,,,,,,
2264,DRAMP01223,GFMDTAKQVAKNVAVTLIDKLRCKVTGGC,29,"Palustrin-2AJ2 (PL2AJ12; Frogs, amphibians, animals)",G3F828,Unknown,Unknown,Amolops jingdongensis (Chinese torrent frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Displays broad-spectrum antibacterial activity against a range of Gram-positive and Gram-negative bacteria. Has low hemolytic activity, low cytotoxicity and low antioxidant activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 23-29 and Cleavage on pair of basic residues.",[Swiss_Prot Entry G3F828]broad-spectrum antibacterial activity against a range of Gram-positive and Gram-negative bacteria,[Ref:21816202]Show slight hemolytic activity against human and rabbit erythrocytes,Unknown,21816202,Biochimie. 2012 Feb;94(2):328-334.,"Chen Z, Yang X, Liu Z, Zeng L, Lee W, Zhang Y.","Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis.",,,,,,,,
2265,DRAMP01224,GFISTVKNLATNVAGTVIDTIKCKVTGGC,29,"Palustrin-2AR (Palustrin-2ARa; Ranatuerin-2SEa; Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Rana areolata (North American crawfish frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,It is also discovered in another frog species and named as Ranatuerin-2SEa (Graham C et al. 2006 Peptides 27:1313-9). ,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.,Unknown,Unknown,12429503,Biochim Biophys Acta. 2002 Nov 19;1601(1):55-63.,"Ali MF, Lips KR, Knoop FC, Fritzsch B, Miller C, Conlon JM.","Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",,,,,,,,
2267,DRAMP01226,ALFSILRGLKKLGKMGQAFVNCEIYKKC,28,"Palustrin-1a (Frogs, amphibians, animals)",P84274,Unknown,Unknown,Rana palustris (Pickerel frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Tissue specificity: Expressed by the skin glands.,Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
2268,DRAMP01230,GFLSTVKNLATNVAGTVLDTIRCKVTGGCRP,31,"Palustrin-2a (Frogs, amphibians, animals)",P84278,Unknown,Unknown,Rana palustris (Pickerel frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Tissue specificity: Expressed by the skin glands.,Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,11087945,Biochim Biophys Acta. 2000 Nov 30;1543(1):95-105.,"Basir YJ, Knoop FC, Dulka J, Conlon JM.","Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",,,,,,,,
2285,DRAMP18404,"INWLKLGKMVIDAL 
",14,"Polybia-MPII (mastoparan; insects, arthropods, invertebrates, animals)",Not Entry found,Unknown,Unknown,"venom, the social wasp, Pseudopolybia vespiceps testacea","Antibacterial, antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Fuction: It demonstrated a potent ability to suppress endotoxin lipopolysaccharide (LPS)-mediated induction of the pro-inflammatory cytokine TNF-a in human peripheral blood mononuclear cells by 94%. It also completely protected mice against an invasive S. aureus infection when given I.P. to mice at 8 mg/kg 4 hr prior to initiation of the infection. Surface immobilization led to enhanced antimicrobial activity against P. aeruginosa.,Gram-positive bacteria: S. aureus(MIC 2.3 ug/ml);##Gram-negative bacteria: P. aeruginosa (MIC 9 ug/ml).,Unknown,Unknown,28108242,Int J Antimicrob Agents. 2017 Feb;49(2):167-175. 2017,"Silva JC, Neto LM, Neves RC, Gonalves JC, Trentini MM, Mucury-Filho R, Smidt KS, Fensterseifer IC, Silva ON, Lima LD, Clissa PB, Vilela N, Guilhelmelli F, Silva LP, Rangel M, Kipnis A, Silva-Pereira I, Franco OL, Junqueira-Kipnis AP, Bocca AL, Mortari MR.","Evaluation of the antimicrobial activity of the mastoparan Polybia-MPII isolated from venom of the social wasp Pseudopolybia vespiceps testacea (Vespidae, Hymenoptera)",,,,,,,,
2287,DRAMP18402,"GKGSWSKKIEVIA 
",13,Tridecaptin B1 (TriB1; lipopeptides; nonribosomally synthesized peptide antibiotic),Not Entry found,Unknown,Unknown,"Paenibacillus polymyxa NRRL B-30507
","Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Active against multidrug resistant Gram-negative bacteria.,Unknown,Unknown,25959079,Org Biomol Chem. 2015 Jun 7;13(21):6073-81. doi: 10.1039/c5ob00780a.,"Cochrane SA, Lohans CT, van Belkum MJ, Bels MA, Vederas JC.","Studies on tridecaptin B(1), a lipopeptide with activity against multidrug resistant Gram-negative bacteria",,,,,,,,
2343,DRAMP01338,FLPMLAGLAANFLPKLFCKITKKC,24,"Amolopin-1a (Frogs, amphibians, animals)","A0SN41, A0SN38, A0SN39",Unknown,Unknown,Amolops loloensis (Rufous-spotted torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.",Unknown,Unknown,17000029,Peptides. 2006 Dec;27(12):3085-3091. ,"Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.","Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.",,,,,,,,
2345,DRAMP01342,FLPIVGKLLSGLL,13,"Amolopin-2b (Frogs, amphibians, animals)","A0SN47, A0SN48",Unknown,Unknown,Amolops loloensis (Rufous-spotted torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.",Unknown,Unknown,17000029,Peptides. 2006 Dec;27(12):3085-3091. ,"Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.","Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.",,,,,,,,
2346,DRAMP01343,FLPMLAGLAANLLPKLFCKITKKC,24,"Amolopin-1c (Frogs, amphibians, animals)",A0SN43,Unknown,Unknown,Amolops loloensis (Rufous-spotted torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.",Unknown,Unknown,17000029,Peptides. 2006 Dec;27(12):3085-3091. ,"Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.","Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.",,,,,,,,
2347,DRAMP01344,LLPIVGKLLSGLL,13,"Amolopin-2c (Frogs, amphibians, animals)",A0SN50,Unknown,Unknown,Amolops loloensis (Rufous-spotted torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.",Unknown,Unknown,17000029,Peptides 2006; 27: 3085-3091.,Lu Y et al Lai R2006,"Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis",,,,,,,,
2348,DRAMP01345,FLPMLAGLAANFLPELFCKITKKC,24,"Amolopin-1d (Frogs, amphibians, animals)",A0SN44,Unknown,Unknown,Amolops loloensis (Rufous-spotted torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Has antibacterial against Gram-positive and Gram-negative bacteria. Also has antifungal activity against C. albicans.,"Gram-positive bacteria: Staphylococcus aureus, Bacillus dysenteriae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.",Unknown,Unknown,17000029,Peptides. 2006 Dec;27(12):3085-3091. ,"Lu Y, Li J, Yu H, Xu X, Liang J, Tian Y, Ma D, Lin G, Huang G, Lai R.","Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis.",,,,,,,,
2363,DRAMP01444,GLLDSIKGMAISAGKGALQNLLKVASCKLDKTC,33,"Nigrocin-1 (Frogs, amphibians, animals)",P0C008,Unknown,Unknown,Pelophylax nigromaculatus (Black-spotted frog) (Rana nigromaculata) (frog skin active peptide),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. Has weak hemolytic activity.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: Contains one disulfide bond 27-33. (By similarity)","[Ref.11682065]Gram-positive bacterium: Micrococcus luteus(MIC=2.5μg/ml);##Gram-negative bacteria: Shigella dysenteriae(MIC=10μg/ml), Klebsiella pneumoniae(MIC=10μg/ml), Pseudomonas aeruginosa(MIC=75μg/ml), Salmonella typhimurium(MIC=22.5μg/ml), Proteus mirabilis(MIC>200μg/ml), Serratia marcescens(MIC>200μg/ml);##Yeast: Candida albicans(MIC=100μg/ml).",[Ref:11682065]1.1% hemolytic activity at 100μg/ml against human red blood cells,Unknown,11682065,FEBS Lett. 2001 Oct 19;507(1):95-100.,"Park S, Park SH, Ahn HC, Kim S, Kim SS, Lee BJ, Lee BJ.","Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata.",,,,,,,,
2364,DRAMP01445,GLLSKVLGVGKKVLCGVSGLC,21,"Nigrocin-2 (Nigrocin-2LVa; Frogs, amphibians, animals)",P0C009,Unknown,Unknown,Rana nigromaculata (Black-spotted frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Thanks to its single linear amphipathic alpha-helix, may integrate into membrane phospholipids, leading to lysis of the membrane. Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. Has weak hemolytic activity.
Tissue specificity: Expressed by the skin dorsal glands.
PTM: Contains one disulfide bond 15-21. (By similarity)","[Ref.11682065]Gram-positive bacterium: Micrococcus luteus(MIC=2.5μg/ml);##Gram-negative bacteria: Shigella dysenteriae(MIC=10μg/ml), Klebsiella pneumoniae(MIC=10μg/ml), Pseudomonas aeruginosa(MIC=100μg/ml), Salmonella typhimurium(MIC=22.5μg/ml), Proteus mirabilis(MIC>200μg/ml), Serratia marcescens(MIC>200μg/ml);##Yeast: Candida albicans(MIC=150μg/ml).",[Ref:11682065]0.9% hemolytic activity at 100μg/ml against human red blood cells,Cell membrane,11682065,FEBS Lett. 2001 Oct 19;507(1):95-100.,"Park S, Park SH, Ahn HC, Kim S, Kim SS, Lee BJ, Lee BJ.","Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata.",,,,,,,,
2365,DRAMP01446,VIEPKCYKYEGKKCPPDINPVCGTDKRTYYNECALCVFIRQSTKKADKAIKIKKWGKC,58,"Proteinase inhibitor PSKP-1 (Frogs, amphibians, animals)",P83578,Unknown,Unknown,Phyllomedusa sauvagei (Sauvage's leaf frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows hemagglutinating activity, inhibits prolyl endopeptidase. May have a role in mucosal defense against microbes by interacting directly with their membranes.",Gram-negative bacterium: Escherichia coli (EC50=3 μM).,Unknown,Unknown,15153102,Eur J Biochem. 2004 Jun;271(11):2117-2126.,"Gebhard L.G, Carrizo F.U, Stern A.L, Burgardt N.I, Faivovich J, Lavilla E, Ermacora M.R.",A Kazal prolyl endopeptidase inhibitor isolated from the skin of Phyllomedusa sauvagii.,,,,,,,,
2372,DRAMP01463,GLFSKFNKKKIKSGLIKIIKTAGKEAGLEALRTGIDVIGCKIKGEC,46,"Esculentin-1SEa (Frogs, amphibians, animals)",P85059,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana sevosa (Dusky gopher frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Mast cell degranulating peptide. Causes histamine release from rat peritoneal mast cells in vitro. Has antibacterial activity.
Tissue specificity: Expressed by the skin glands. 
PTM: Problely contains one dislfide bond 40-46.",Gram-negative bacterium: Escherichia coli K12;##Gram-positive bacterium: Micrococcus luteus NCT C2665.,Unknown,Unknown,16386333,Peptides. 2006 Jun;27(6):1313-1319.,"Graham C, Richter SC, McClean S, O'Kane E, Flatt PR, Shaw C.","Histamine-releasing and antimicrobial peptides from the skin secretions of the dusky gopher frog, Rana sevosa.",,,,,,,,
2373,DRAMP01464,GLFSKFNKKKIKSGLFKIIKTAGKEAGLEALRTGIDVIGCKIKGEC,46,"Esculentin-1SEb (Frogs, amphibians, animals)",P85054,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana sevosa (Dusky gopher frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Mast cell degranulating peptide. Causes histamine release from rat peritoneal mast cells in vitro. Has antibacterial activity.
Tissue specificity: Expressed by the skin glands. 
PTM: Problely contains one dislfide bond 40-46.",Gram-negative bacterium: Escherichia coli K12;##Gram-positive bacterium: Micrococcus luteus NCT C2665.,Unknown,Unknown,16386333,Peptides. 2006 Jun;27(6):1313-1319.,"Graham C, Richter SC, McClean S, O'Kane E, Flatt PR, Shaw C.","Histamine-releasing and antimicrobial peptides from the skin secretions of the dusky gopher frog, Rana sevosa.",,,,,,,,
2374,DRAMP01465,GIFSKLAGKKLKNLLISGLKSVGKEVGMDVVRTGIDIAGCKIKGEC,46,"Esculentin-1R (Frogs, amphibians, animals)",P86018,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana ridibunda (Laughing frog) (Marsh frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 40-46.",[Swiss_Prot Entry P86018]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref:18855342]Low hemolytic activity,Unknown,18855342,Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.,"Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.",De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.,,,,,,,,
2382,DRAMP01489,GIFSKLAGKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC,46,"Esculentin-1A (Frogs, amphibians, animals)",P40843,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (European Edible frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 40-46.",[Swiss_Prot Entry P40843]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref:8163497]Unknown,Unknown,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,,,,,,,,
2383,DRAMP01492,GIFSLVKGAAKLAGKGLAKEGGKFGLELIACKIAKQC,37,"Esculentin-IIb (Frogs, amphibians, animals)",P40846,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (European Edible frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species.,[Swiss_Prot Entry P40846]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref:8163497]Unknown,Unknown,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,,,,,,,,
2388,DRAMP18312,MTDANVDARRARAPHGISGAIAGVVAGCAATIEIGCVEGAIAGIGPSGIASMIAALWTCRSKYRRFSSGSGYVMLLSWSAEFVFGYFIGCRCGFLLSQK,99,Propionicin PLG-1(Bacteriocin),I2HA02,Unknown,plg-1,Propionibacterium thoeniiP127,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",,Unknown,Unknown,Unknown,"Propionicin PLG-1 is active against a variety of microorganisms such as propionibacteria, as well as many other gram-positive and gram-negative bacteria and even fungi.Propionicin PLG-1 is stable after long-term storage in a dry or frozen state and rapidly kills sensitive cells upon exposure in culture medium or skim milk.","Gram-positive, Gram-negative",Unknown,Unknown,11010864,"Appl Environ Microbiol. 2000 Oct;66(10):4230-6.
","Faye T, Langsrud T, Nes IF, Holo H.
","Biochemical and genetic characterization of propionicin T1, a new bacteriocin from Propionibacterium thoenii.
",,,,,,,,
2392,DRAMP01519,GVFSFLKTGAKLLGSTLLKMAGKAGAEHLACKATNQC,37,"Esculentin-2PRa (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana pretiosa (North American oregon spotted frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans. ,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans.,Unknown,Unknown,21295070,Dev Comp Immunol. 2011 Jun;35(6):644-649.,"Conlon JM, Mechkarska M, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, Hayes MP, Padgett-Flohr G.",Host defense peptides in skin secretions of the Oregon spotted frog Ranapretiosa: implications for species resistance to chytridiomycosis.,,,,,,,,
2475,DRAMP01671,ALWMTLLKKVLKAAAKALNAVLVGANA,27,"Dermaseptin-4 (DS IV; Dermaseptin-S4, DS4; Frogs, amphibians, animals)",P80280,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Unknown,Phyllomedusa sauvagei (Sauvage's leaf frog),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine strand and Turn structure,Unknown,Unknown,"Function: Possesses a potent antimicrobial activity against Gram-negative and Gram-positive bacteria, fungi, protozoa, and the enveloped herpes simplex virus type 1. Probably acts by disturbing membrane functions with its amphipathic structure. Has strong hemolytic activity. Does not bind to P. falciparum infected erythrocytes, but accumulates within the parasite.
Tissue specificity: Expressed by the skin glands.
Pharmaceutical use: Derivatives of this peptide may be used as therapeutic agents to treat bacterial infections and malaria, and to prevent infection by herpes simplex virus type 1 and HIV-1.","[Swiss_Prot Entry P80280]Possesses a potent antimicrobial activity against Gram-negative and Gram-positive bacteria, fungi, protozoa, and the enveloped herpes simplex virus type 1",[Ref:11850249]IC50=20 μM against human erythrocytes,healthy erythrocytes (this binding is receptor independent).,8306981##11850249##9395500,Eur J Biochem. 1994 Jan 15;219(1-2):145-154.##Antimicrob Agents Chemother. 2002 Mar;46(3):689-694.##J Biol Chem. 1997 Dec 12;272(50):31609-31616.,"Mor A, Nicolas P.##Navon-Venezia S, Feder R, Gaidukov L, Carmeli Y, Mor A.##Ghosh JK, Shaool D, Guillaud P, Cicéron L, Mazier D, Kustanovich I, Shai Y, Mor A.",Isolation and structure of novel defensive peptides from frog skin.##Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.##Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis.,,,,,,,,
2501,DRAMP01697,GMWSKIKNAGKAAKAAAKAAGKAALGAVSEAM,32,"Dermaseptin-DA4 (DRS-DA4; Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Dermaseptin subfamily),Unknown,Pachymedusa dacnicolor (Mexican frog),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,It shows selective activity against gram-negative bacteria and not toxic to fresh rat erythrocytes. DRS-DA4 is a potent chemoattractant for human leukocytes and is devoid of hemolytic activity.,"[Ref.FEBS J. 2009 Nov;276(22):6773-6786.]Gram-negative bacteria:Escherichia coli ML35p(MIC=5 μM), Escherichia coli 363 ATCC 11775(MIC=5 μM), Peudomonas aeruginosa ATCC 27853(MIC=40 μM).",[Ref. FEBS J. 2009 Nov;276(22):6773-6786.]Show no hemolytic activity against rat blood cells.,Unknown,PubMed ID is not available,FEBS J. 2009 Nov;276(22):6773-6786.,"Auvynet C, Joanne P, Bourdais J, Nicolas P, Lacombe C, Rosenstein Y.","Dermaseptin DA4, although closely related to dermaseptin B2, presents chemotactic and Gram-negative selective bactericidal activities.",,,,,,,,
2503,DRAMP01700,GLWSTIKNVAAAAGKAALGAL,21,"Dermaseptin-H3 (Dermaseptin-like peptide 3, DMS3; Frogs, amphibians, animals)",Q17UY8,Belongs to the frog skin active peptide family (Dermaseptin subfamily),dpp-H3,Phyllomedusa azurea (Orange-legged monkey frog) (Phyllomedusa hypochondrialis azurea),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,MOA: Probably acts by disturbing membrane functions with its amphipathic structure (By similarity).,"Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Staphylococcus aureus, Micrococcus luteus.",Unknown,Unknown,17553595,Peptides. 2007 Jul;28(7):1331-43.,"Thompson AH, Bjourson AJ, Orr DF, Shaw C, McClean S.",A combined mass spectrometric and cDNA sequencing approach to the isolation and characterization of novel antimicrobial peptides from the skin secretions of Phyllomedusa hypochondrialis azurea.,,,,,,,,
2518,DRAMP01717,SLGSFLKGVGTTLASVGKVVSDQFGKLLQAGQ,32,"Dermatoxin (Frogs, amphibians, animals)","Q9PT75, P81566",Belongs to the frog skin active peptide family (Dermaseptin subfamily),DRT,Phyllomedusa bicolor (Two-colored leaf frog) (Rana bicolor),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Possesses a potent antimicrobial activity against Gram-positive bacteria and less active against Gram-negative bacteria. Probably acts by disturbing membrane functions with its amphipathic structure.
Tissue specificity: Highest expression in skin and to a lesser extent in brain and intestine.
Miscellaneous: The sequence shown corresponds to the dermatoxin isolated from frog skin. A variant of it is present in frog brain.","Gram-positive bacteria: Bacillus megaterium, Corynebacterium glutamicumm, Staphylococcus aureus (++);##Gram-negative bacteria: mollicutes Acholeplasma laidlawii, Spiroplasma melliferum (++); Burkholderia cepacia, Pseudomonas aeruginosa, Salmonella typhimurium and S. meliloti (+).",Unknown,Unknown,10880984,Eur J Biochem. 2000 Jul;267(14):4583-4592.,"Amiche M, Seon AA, Wroblewski H, Nicolas P.","Isolation of dermatoxin from frog skin, an antibacterial peptide encoded by a novel member of the dermaseptin genes family.",,,,,,,,
2530,DRAMP02857,ILPWKWPWWPWRR,13,"Indolicidin (Cathelicidin-4; mammals, animals)","P33046, A3KN14",Belongs to the cathelicidin family,CATHL4,Bos taurus (Bovine) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,No secondary structure,"The backbone structure in DPC, well defined between residues 3 and 11, is extended, with two half-turns at residues Lys-5 and Trp-8. The backbone structure in SDS, well defined between residues 5 and 11, is also extended, but lackes the bend in the C-terminal half. Indolicidin in complexes with DPC has a central hydrophobic core composed of proline and tryptophan, which is bracketed by positively charged regions near the peptide termini","1G8C, 1G89 resolved by NMR.","Function: Potent microbicidal activity; active against Staphylococcus aureus, Escherichia coli and Candida albicans.
Tissue specificity: Large granules of neutrophils.
PTM: Contains two disulfide bonds and C-terminal amidation.",[Ref.12074933] Gram-positive bacterium: Staphylococcus aureus (MIC=0.003%);##Gram-negative bacterium: Escherichia coli (MIC=0.007%);##Fungus: Candida albicans (MIC=0.015%),Unknown,Unknown,1537821##11123901##12074933,J Biol Chem. 1992 Mar 5;267(7):4292-4295.##Biochemistry. 2000 Dec 26;39(51):15765-74.##Life Sci. 2002 Jul 5;71(7):747-50.,"Selsted ME, Novotny MJ, Morris WL, Tang YQ, Smith W, Cullor JS.##Rozek A, Friedrich CL, Hancock RE.##Kowalska K, Carr DB, Lipkowski AW.","Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils.##Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles.##Direct antimicrobial properties of substance P.",,,,,,,,
2532,DRAMP02819,GLLKRIKTLL,10,"Anoplin (Insects, arthropods, invertebrates, animals)",P0C005,Unknown,Unknown,Anoplius samariensis (Solitary wasp),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Alpha helix ,The peptide adopts a random coil structure in water and tends to fold into an ,"2MJQ,2MJR,2MJS,2MJT","Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.",[Ref.29614317] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=26 μg/mL);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=13 μg/mL);##Fungi: Candida albicans ATCC 10231 (MIC=19.5 μg/mL).,Unknown,Unknown,29614317,Peptides. 2018 Jun;104:7-14.,"Salas RL, Garcia JKDL, Miranda ACR, Rivera WL, Nellas RB, Sabido PMG.",Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin.,,,,,,,,
2533,DRAMP04395,AMVGT,5,"EP3 (Earthworm,animals)",No entry found,Belongs to the antibacterial vermipeptides family (AVPF),Unknown,Eisenia foetida (Common brandling worm),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.,"[Ref.European Journal of Soil Biology, 2007, 43 S127-S134] Gram-negative bacteria: Pseudomonas pyocyanea (IC=12.58 μg/ml), Acinetobacter baumanii (IC=12.58 μg/ml), Klebsiella terrigena (IC=12.58 μg/ml);## Gram-positive bacteria: Enterococcus gallinarum (IC=12.58 μg/ml), Enterococcus faecalis (IC=25.68 μg/ml).",Unknown,Unknown,PubMed ID is not available,"European Journal of Soil Biology, 2007, 43:S127-S134","C Wang, Z Suna, X Zhang, G Xu## Ito Y, Yoshikawa A, Hotani T, Fukuda S, Sugimura K, Imoto T.",A novel antimicrobial vermipeptide family from earthworm Eisenia fetida.,,,,,,,,
2534,DRAMP04394,AMVSS,5,"EP2 (Earthworm,animals)",No entry found,Belongs to the antibacterial vermipeptides family (AVPF),Unknown,Eisenia foetida (Common brandling worm),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative and Gram-positive bacteria.,"[Ref.European Journal of Soil Biology, 2007, 43 S127-S134] Gram-negative bacteria: Pseudomonas pyocyanea (IC=11.4 μg/ml), Acinetobacter baumanii (IC=11.4 μg/ml), Klebsiella terrigena (IC=11.4 μg/ml);##Gram-positive bacteria: Enterococcus gallinarum (IC=11.4 μg/ml), Enterococcus faecalis (IC=22.8 μg/ml).",Unknown,Unknown,PubMed ID is not available,"European Journal of Soil Biology, 2007, 43:S127-S134.","C Wang, Z Suna, X Zhang, G Xu## Ito Y, Yoshikawa A, Hotani T, Fukuda S, Sugimura K, Imoto T.",A novel antimicrobial vermipeptide family from earthworm Eisenia fetida.,,,,,,,,
2548,DRAMP01772,FLPLIGKILGTILGK,15,"Temporin-1Ob (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana ornativentris (Japanese mountain brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.,Unknown,Unknown,17147973,Peptides. 2007 Mar;28(3):524-532.,"Ohnuma A, Conlon JM, Yamaguchi K, Kawasaki H, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S.",Antimicrobial peptides from the skin of the Japanese mountain brown frog Rana ornativentris: evidence for polymorphism among preprotemporin mRNAs.,,,,,,,,
2560,DRAMP01799,ILPILGNLLNGLL,13,"Temporin-1PRa (Temporin 1PRa; Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana pirica (Hokkaido frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: It shows only very weak antimicrobial and hemolytic activity.,[Ref.15003829]Gram-positive bacteria: Staphylococcus aureus (MIC>100 μM);##Gram-negative bacteria:Escherichia coli (MIC>100 μM);##Fungi:Candida albicans (MIC>100 μM),[Ref:15003829]HC50>300 μM against washed human erythrocytes,Unknown,15003829,Regul. Pept 2004; 118: 135-141.,Conlon JM et al Pal T.,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",,,,,,,,
2561,DRAMP01800,ILPILGNLLNSLL,13,"Temporin-1PRb (Temporin 1PRb; Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana pirica (Hokkaido frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans (MIC>100 μM).,Unknown,Unknown,15003829,Regul. Pept 2004; 118: 135-141.,Conlon JM et al Pal T.,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",,,,,,,,
2562,DRAMP01801,FIGPIISALASLFG,14,"Temporin-1DYa (Frogs, amphibians, animals)",P0C5X6,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Active against the Gram-positive bacteria: S. aureus and Gram-negative bacteria E.coli. Tissue specificity: Expressed by the skin glands. PTM: Glycine amide at position 14.,Gram-positive bacterium: Staphylococcus aureus (MIC>60 μM);##Gram-negative bacterium: Escherichia coli (MIC>60 μM).,Unknown,Unknown,17688900,Toxicon. 2007 Nov;50(6):746-756.,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.","Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",,,,,,,,
2563,DRAMP01802,FFGSVLKLIPKIL,13,"Temporin-PTa (Frogs, amphibians, animals)",P0C8U2,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana picturata (Malaysian fire frog) (Hylarana picturata),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,Function: Has antibacterial activity against the Gram-positive bacteria: S. aureus ATCC 25923 and the Gram-negative bacteria E.coli ATCC 25726. Tissue specificity: Expressed by the skin glands. PTM: Leucine amide at position 13.,Gram-positive bacterium: Staphylococcus aureus ATCC 25923;##Gram-negative bacterium: Escherichia coli ATCC 25726,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473.,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
2565,DRAMP01804,ILPILAPLIGGLL,13,"Temporin-CDYb (Brevinin-1CDYb; Frogs, amphibians, animals)",B3VZU4,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,Function: Has low activity against the Gram-positive bacteria: S. aureus and Gram-negative bacteria E.coli. Has weak hemolytic activity against human erythrocytes. Tissue specificity: Expressed by the skin glands. PTM: Leucine amide at position 13.,[Swiss_Prot Entry B3VZU4]Gram-positive bacterium: Staphylococcus aureus (MIC>100 μM);##Gram-negative bacterium: Escherichia coli (MIC>100 μM).,[Ref:19539775]HC50=180 μM against human red blood cells,Unknown,19539775,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178. ,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",,,,,,,,
2571,DRAMP01387,GLLSGILGAGKHIVCGLSGPCQSLNRKSSDVEYHLAKC,38,"Odorranain-P2a (OdP2a; Frogs, amphibians, animals)",A6MBR1,Unknown,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,Function: Odorranain-P2a exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Has no hemolytic activity against red cell.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=6.25 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.12 μg/ml), Bacillus subtilis (MIC=12.5 μg/ml).##Yeast: Candida albicans (MIC=3.12 μg/ml).",[Ref:17272268]Non-hemolytic activity against rabbit red blood cells,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
2572,DRAMP01386,VIPFVASVAAEMMQHVYCAASKKC,24,"Odorranain-P1a (OdP1a; Brevinin-1HS1; Brevinin-1-OA2; Frogs, amphibians, animals)","A6MBQ8, A6MBQ6",Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,Function: Odorranain-P1a exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Also has hemolytic activity against rabbit red cell. ,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=3.50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.50 μg/ml), Bacillus subtilis (MIC=1.75 μg/ml).##Yeast: Candida albicans (MIC=1.75 μg/ml).","[Ref.17272268] RCH=11.2 ± 2.9% using rabbit red blood cells. RCH, red cell hemolysis.",Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
2573,DRAMP01824,ILPLVGNLLNDLL,13,"Temporin-1Ja (Frogs, amphibians, animals)",P83307,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana japonica (Japanese reddish frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antibacterial activity against the Gram-negative bacteria E. coli and the Gram-positive bacteria: S. aureus. Tissue specificity: Expressed by the skin glands. PTM: Leucine amide at position 13. ,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.,Unknown,Unknown,11835990,Peptides. 2002 Mar;23(3):419-425.,"Isaacson T, Soto A, Iwamuro S, Knoop FC, Conlon JM.",Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica.,,,,,,,,
2576,DRAMP01126,ILGPVISKIGGVLGGLLKNL,20,"Maximin-H4 (Toads, amphibians, animals)","P83084, Q58T61, Q58T60",Belongs to the bombinin family,Unknown,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Shows strong hemolytic activity. ","[Ref.11835991] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=12 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=6 μg/ml), Bacillus pyocyaneus CMCCB 1010 (MIC=12 μg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=6 μg/ml).",[Ref:11835991]90-100% hemolytic activity at 50 μg/ml against rabbit red blood cells,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,,,,,,,,
2577,DRAMP01125,ILGPVLGLVGNALGGLIKKI,20,"Maximin-H3 (Toads, amphibians, animals)","P83083, Q58T42, Q58T44, Q58T45, Q58T52, Q58T55, Q58T62, Q58T68, Q58T70",Belongs to the bombinin family,Unknown,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Shows strong hemolytic activity.","[Ref.11835991] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=20 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=10 μg/ml), Bacillus pyocyaneus CMCCB 1010 (MIC=20 μg/ml);##Fungi: Candida albicans ATCC 2002 (MIC=5 μg/ml).",[Ref:11835991]90-100% hemolytic activity at 50 μg/ml against rabbit red blood cells,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,,,,,,,,
2584,DRAMP01841,GFRDVLKGAAKQFVKTVAGHIANI,24,"Ascaphin-2 (Frogs, amphibians, animals)",P0CJ26,Belongs to the ascaphin family,Unknown,Ascaphus truei (Coastal tailed frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.,[Ref.15207717]Gram-negative bacterium: Escherichia coli,[Ref.15207717]Unknown,Unknown,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",,,,,,,,
2585,DRAMP01843,GFKDWIKGAAKKLIKTVAANIANQ,24,"Ascaphin-4 (Frogs, amphibians, animals)",P0CJ28,Belongs to the ascaphin family,Unknown,Ascaphus truei (Coastal tailed frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Tissue specificity: Expressed by the skin glands.,[Ref.15207717]Gram-negative bacterium: Escherichia coli,[Ref.15207717]Unknown,Unknown,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",,,,,,,,
2586,DRAMP01845,GFKDWIKGAAKKLIKTVASSIANE,24,"Ascaphin-6 (Frogs, amphibians, animals)",P0CJ30,Belongs to the ascaphin family,Unknown,Ascaphus truei (Coastal tailed frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide that shows higher potency against Gram-negative bacteria than against Gram-positive bacteria. Tissue specificity: Expressed by the skin glands. 
Caution: May represent an artifactually modified form of ascaphin-7 arising from hydrolysis during the purification procedure.",[Ref.15207717]Gram-negative bacterium: Escherichia coli,[Ref.15207717]Unknown,Unknown,15207717,Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.,"Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF.","The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",,,,,,,,
2609,DRAMP01901,GILDKLKEFGISAARGVAQSLLNTASCKLAKTC,33,"Brevinin-2CG1 (Frogs, amphibians, animals)",No entry found,Unknown,Unknown,Amolops chunganensis,"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Primarily active against Gram-positive bacteria. Also highly active against Gram-negative P. faecalis X29 and S. rubidaea.,"Gram-negative bacteria: P. faecalis X29, S. rubidaea.",Unknown,Unknown,22951323,Peptides. 2012 Nov;38(1):41-53.,"Yang X, Xia J, Yu Z, Hu Y, Li F, Meng H, Yang S, Liu J, Wang H.",Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis.,,,,,,,,
2621,DRAMP01924,FLPAIFRMAAKVVPTIICSITKKC,24,"Brevinin-1Ea (Frogs, amphibians, animals)",P40835,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (European frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.",[Swiss_Prot Entry P40835]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.8163497]LC50=0.5 μM against human erythrocytes,Unknown,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,,,,,,,,
2622,DRAMP01925,VIPFVASVAAEMQHVYCAASRKC,23,"Brevinin-1Eb (Frogs, amphibians, animals)",P40836,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (European frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.",[Swiss_Prot Entry P40836]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.8163497]LC50=0.5 μM against human erythrocytes,Unknown,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,,,,,,,,
2623,DRAMP01926,FLPLLAGLAANFFPKIFCKITRKC,24,"Brevinin-1Ec (Frogs, amphibians, animals)",P86150,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana ridibunda (Laughing frog) (Marsh frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.",[Swiss_Prot Entry P86150]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.18855342]show hemolytic activity,Unknown,18855342,Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.,"Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.",De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.,,,,,,,,
2624,DRAMP01927,GILDTLKNLAISAAKGAAQGLVNKASCKLSGQC,33,"Brevinin-2Ea (Frogs, amphibians, animals)",P40837,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (Edible frog) (Pelophylax esculentus),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity ",[Swiss_Prot Entry P40837]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.8163497]LC50>100 μM against human erythrocytes,Unknown,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,,,,,,,,
2625,DRAMP01928,GILDTLKNLAKTAGKGALQGLVKMASCKLSGQC,33,"Brevinin-2Eb (Frogs, amphibians, animals)",P40838,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (Edible frog) (Pelophylax esculentus),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity ",[Swiss_Prot Entry P40838]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.8163497]LC50>100 μM against human erythrocytes,Unknown,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,,,,,,,,
2626,DRAMP01929,GILLDKLKNFAKTAGKGVLQSLLNTASCKLSGQC,34,"Brevinin-2Ec (Frogs, amphibians, animals)","P40839, P84842",Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (Edible frog) (Pelophylax esculentus) (Rana saharica) (Sahara frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity ",[Swiss_Prot Entry P40839]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.8163497]LC50>100 μM against human erythrocytes,Unknown,8163497##16394170,J Biol Chem. 1994 Apr 22;269(16):11956-11961.##J Endocrinol. 2006 Jan;188(1):1-9.,"Simmaco M, Mignogna G, Barra D, Bossa F.##Marenah L, Flatt PR, Orr DF, Shaw C, Abdel-Wahab YH.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.##Skin secretions of Rana saharica frogs reveal antimicrobial peptides esculentins-1 and -1B and brevinins-1E and -2EC with novel insulin releasing activity.,,,,,,,,
2628,DRAMP01931,GILDSLKNLAKNAGQILLNKASCKLSGQC,29,"Brevinin-2Ed (Frogs, amphibians, animals)",P40840,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (Edible frog) (Pelophylax esculentus),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity ",[Swiss_Prot Entry P40840]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.8163497]LC50>100 μM against human erythrocytes,Unknown,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,,,,,,,,
2629,DRAMP01932,GIFDKLKNFAKGVAQSLLNKASCKLSGQC,29,"Brevinin-2Ee (Frogs, amphibians, animals)",P40841,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta (Edible frog) (Pelophylax esculentus),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity ",[Swiss_Prot Entry P40841]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.8163497]LC50>100 μM against human erythrocytes,Unknown,8163497,J Biol Chem. 1994 Apr 22;269(16):11956-11961.,"Simmaco M, Mignogna G, Barra D, Bossa F.",Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,,,,,,,,
2630,DRAMP01936,GLWNTKLEAGLLFAMGKLDLKRCLKAGGC,29,"Brevinin-2Ek (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana esculenta complex,"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli (By similarity).
Sequence similarity: This peptide shows limited amino acid sequence similarity to the homologous exon gene products that encode the N-terminal flanking peptides of preprocaerulein, preproxenopsin, and preprolevitide.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,14499272,Peptides. 2003 Jul;24(7):955-961.,"Ali MF, Knoop FC, Vaudry H, Conlon JM.",Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,,,,,,,,
2631,DRAMP01945,FLPLVRGAAKLIPSVVCAISKRC,23,"Brevinin-1SE (Frogs, amphibians, animals)",P85056,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana sevosa (Dusky gopher frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Mast cell degranulating peptide. Causes histamine release from rat peritoneal mast cells in vitro.,Gram-negative bacterium: Escherichia coli K12;##Gram-positive bacterium: Micrococcus luteus NCT C2665.,Unknown,Unknown,16386333,Peptides. 2006 Jun;27(6):1313-1319.,"Graham C, Richter SC, McClean S, O'Kane E, Flatt PR, Shaw C.","Histamine-releasing and antimicrobial peptides from the skin secretions of the dusky gopher frog, Rana sevosa.",,,,,,,,
2632,DRAMP01946,GLFNVFKGLKTAGKHVAGSLLNQLKCKVSGGC,32,"Brevinin-20a (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana Ornativentris (Japanese mountain brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.,Unknown,Unknown,11892844,J Pept Res. 2001 Nov;58(5):349-356.,Kim JB et al Conlon JM.,"Antimicrobial peptides from the skin of the Japanese mountain brown frog, Rana ornativentris.",,,,,,,,
2633,DRAMP01947,GIFNVFKGALKTAGKHVAGSLLNQLKCKVSGEC,33,"Brevinin-20b (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana Ornativentris (Japanese mountain brown frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.,Unknown,Unknown,11892844,J Pept Res. 2001 Nov;58(5):349-356.,Kim JB et al Conlon JM.,"Antimicrobial peptides from the skin of the Japanese mountain brown frog, Rana ornativentris.",,,,,,,,
2634,DRAMP18294,ALQFIQNTASGALYYNTKTHKYQYQQTSGA,30,lactococcin Z(Bacteriocin),No entry found,Belongs to the class IId bacteriocin,lczA,Lactococcus lactis QU 7,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,"Lactococcin Z showed homology to lactococcins A, B and M.",Unknown,No comments found on DRAMP database,"Gram-positive, Gram-negative",Unknown,Unknown,26093857,Probiotics Antimicrob Proteins. 2015 Sep;7(3):222-31. ,"Ishibashi N, Seto H, Koga S, Zendo T, Sonomoto K.
","Identification of Lactococcus-Specific Bacteriocins Produced by Lactococcal Isolates, and the Discovery of a Novel Bacteriocin, Lactococcin Z.
",,,,,,,,
2635,DRAMP01952,FMGGLIKAATKALPAAFCAITKKC,24,"Brevinin-1PTb (Frogs, amphibians, animals)",P0C8T2,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana picturata (Malaysian fire frog) (Hylarana picturata),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 18-24.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923;##Gram-negative bacterium: Escherichia coli ATCC 25726.,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
2636,DRAMP01954,GLLDTLKNMAINAAKGAGQSVLNTLSCKLSKTC,33,"Brevinin-2HSb (Frogs, amphibians, animals)",P0C8T0,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Odorrana hosii (Hose's rock frog) (Rana hosii),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923;##Gram-negative bacterium: Escherichia coli ATCC 25726.,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
2637,DRAMP01958,GFLDSFKNAMIGVAKSAGKTALNTLACKIDKTC,33,"Brevinin-2PTd (Frogs, amphibians, animals)",P0C8T6,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana picturata (Malaysian fire frog) (Hylarana picturata),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the skin glands.
PTM: Contains one disulfide bond 27-33.",Gram-positive bacterium: Staphylococcus aureus ATCC 25923;##Gram-negative bacterium: Escherichia coli ATCC 25726.,Unknown,Unknown,18621071,Toxicon. 2008 Sep 1;52(3):465-473. ,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, King JD.","Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",,,,,,,,
2638,DRAMP01960,FLPILASLAAKFGPKLFCLVTKKC,24,"Brevinin-1BYa (Frogs, amphibians, animals)",P84111,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana boylii (Foothill yellow-legged frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has hemolytic activity.,[Ref.14531844]Gram-positive bacterium: Staphylococcus aureus(MIC=2 μM);##Gram-negative bacterium: Escherichia coli(MIC=17 μM);##Yeast: Candida albicans(MIC=3 μM),[Ref.14531844]HC50=4 μM against human erythrocytes,Unknown,14531844,J Pept Res. 2003 Nov;62(5):207-213.,"Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, Pál T, Rollins-Smith LA.",Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,,,,,,,,
2639,DRAMP01961,FLPILASLAAKLGPKLFCLVTKKC,24,"Brevinin-1BYb (Frogs, amphibians, animals)",P84112,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana boylii (Foothill yellow-legged frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has hemolytic activity.,[Ref.14531844]Gram-positive bacterium: Staphylococcus aureus(MIC=4 μM);##Gram-negative bacterium: Escherichia coli(MIC=16 μM);##Yeast: Candida albicans(MIC=16 μM).,[Ref.14531844]HC50=4 μM against human erythrocytes,Unknown,14531844,J Pept Res. 2003 Nov;62(5):207-213.,"Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, Pál T, Rollins-Smith LA.",Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,,,,,,,,
2642,DRAMP01966,FLPVIAGVAANFLPKLFCAISKKC,24,"Brevinin-1Ya (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Lithobates yavapaiensis (North America leopard frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown, Cancer cells HepG2. ,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans.,Unknown,Unknown,19254736,Toxicon. 2009 Jun;53(7-8):699-705.,"Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",,,,,,,,
2643,DRAMP01967,FLPIIAGAAAKVVQKIFCAISKKC,24,"Brevinin-1Yb (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Lithobates yavapaiensis (North America leopard frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,", cancer cells HepG2. ",Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium:Staphylococcus aureus.##Yeast: Candida albicans.,Unknown,Unknown,19254736,Toxicon. 2009 Jun;53(7-8):699-705.,"Conlon JM, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.","Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",,,,,,,,
2647,DRAMP01976,GIMDTLKNLAKTAGKGALQSLLNHASCKLSGQC,33,"Brevinin-2Eg (Frogs, amphibians, animals)",P86154,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Pelophylax ridibundus (Marsh frog) (Rana ridibunda),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species, and hemolytic activity.",[Swiss_Prot Entry P86154]Shows antibacterial activity against representative Gram-negative and Gram-positive bacterial species,[Ref.18855342]show hemolytic activity,Unknown,18855342,Rapid Commun Mass Spectrom. 2008 Nov;22(22):3517-3525.,"Samgina TY, Artemenko KA, Gorshkov VA, Ogourtsov SV, Zubarev RA, Lebedev AT.",De novo sequencing of peptides secreted by the skin glands of the Caucasian Green Frog Rana ridibunda.,,,,,,,,
2654,DRAMP18291,LAMVKYYGNGVSCNWRKHSCKKGLSVDWVYFGLLHNLGALRWYQHR,46,Garviecin LG34(Bacteriocin),No entry found,Belongs to the class IIa bacteriocin,Unknown,Lactococcus garvieae LG34,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Garviecin LG34 showed resistance to heat and low pH, and was sensitive to proteolytic enzymes but not to lipase and amylase.","Gram-positive, Gram-negative",Unknown,Unknown,PubMed ID is not available,Food Control. 2015 Apr;50:896-900.,"Gao YR,Li DP,Liu S,Zhang LY.","Garviecin LG34, a novel bacteriocin produced by Lactococcus garvieae isolated from traditional Chinese fermented cucumber.",,,,,,,,
2674,DRAMP02012,VNPIILGVLPKFVCLITKKC,20,"Brevinin-1T (Brevinin-2T; Frogs, amphibians, animals)",P82232,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana temporaria (European common frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antibacterial activity against representative Gram-negative and Gram-positive bacteria: and exhibits a very high hemolytic activity.,[Swiss_Prot Entry P82232]Antibacterial activity against representative Gram-negative and Gram-positive bacteria,[Ref.10333736]Unknown,Cell membrane,10333736,Biopolymers. 1998;47(6):435-450.,"Simmaco M, Mignogna G, Barra D.",Antimicrobial peptides from amphibian skin: what do they tell us?,,,,,,,,
2675,DRAMP02013,FITLLLRKFICSITKKC,17,"Brevinin-1Ta (Frogs, amphibians, animals)",P82233,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana temporaria (European common frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antibacterial activity against representative Gram-negative and Gram-positive bacteria: and exhibits no hemolytic activity.,[Swiss_Prot Entry P82233]Antibacterial activity against representative Gram-negative and Gram-positive bacteria,[Ref.10333736]Non-hemolytic,Cell membrane,10333736,Biopolymers. 1998;47(6):435-450.,"Simmaco M, Mignogna G, Barra D.",Antimicrobial peptides from amphibian skin: what do they tell us?,,,,,,,,
2678,DRAMP02016,FLSLALAALPKFLCLVFKKC,20,"Brevinin-1DYa (Frogs, amphibians, animals)",P0C5W6,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antimicrobial peptide. Has hemolytic activity. Tissue specificity: Expressed by the skin glands. PTM: contains one disulfide bond 14-20.,[Swiss_Prot Entry P0C5W6]Gram-positive bacterium: Staphylococcus aureus (low activity);##Gram-negative bacterium: Escherichia coli (MIC<15 μM).,[Ref.17688900]LC50<5 μM against human erythrocytes,Unknown,17688900,Toxicon. 2007 Nov;50(6):746-756.,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.","Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",,,,,,,,
2679,DRAMP02017,GLLSAVKGVLKGAGKNVAGSLMDKLKCKLFGGC,33,"Brevinin-2DYa (Frogs, amphibians, animals)",P0C5X1,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 27-33.",Gram-negative bacterium: Escherichia coli (MIC<15 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC<15 μM).,Unknown,Unknown,17688900,Toxicon. 2007 Nov;50(6):746-756.,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.","Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",,,,,,,,
2680,DRAMP02018,FLSLALAALPKLFCLIFKKC,20,"Brevinin-1DYb (Brevinin-1CDYb; Frogs, amphibians, animals)",P0C5W7,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has low activity against the Gram-positive bacteria: S. aureus and the Gram-negative bacteria E. coli. Has hemolytic activity. Has a strong hemolytic activity.
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 14-20.",[Swiss_Prot Entry P0C5W7]Gram-positive bacterium: Staphylococcus aureus (low activity);##Gram-negative bacterium: Escherichia coli (MIC<15 μM).,[Ref.17688900]LC50<6 μM against human erythrocytes,Unknown,19539775##17688900,Comp Biochem Physiol B Biochem Mol Biol. 2009 Oct;154(2):174-178.##Toxicon. 2007 Nov;50(6):746-756. ,"Jin LL, Li Q, Song SS, Feng K, Zhang DB, Wang QY, Chen YH.##Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.","Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.##Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",,,,,,,,
2681,DRAMP02020,FLPLLLAGLPKLLCLFFKKC,20,"Brevinin-1DYc (Frogs, amphibians, animals)",P0C5W8,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana dybowskii (Dybovsky's frog) (Korean brown frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide. Has low activity against the Gram-positive bacteria: S. aureus and the Gram-negative bacteria E.coli (MIC<15 μM). Has hemolytic activity. 
Tissue specificity: Expressed by the skin glands.
PTM: contains one disulfide bond 14-20.",[Swiss_Prot Entry P0C5W8]Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli (MIC<15 μM).,[Ref.17688900]LC50<7 μM against human erythrocytes,Unknown,17688900,Toxicon. 2007 Nov;50(6):746-756.,"Conlon JM, Kolodziejek J, Nowotny N, Leprince J, Vaudry H, Coquet L, Jouenne T, Iwamuro S.","Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",,,,,,,,
2684,DRAMP18281,GRADYNFGYGLGRGTRKFFNGIGRWVRKTF,30,Plantaricin KL-1Y (Bacteriocin),No entry found,Belongs to the class IIb bacteriocin,Unknown,Lactobacillus plantarum KL-1,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"It showed synergistic effects with KL-1X and KL-1Z, two additional peptides whose sequences have not been established.","Gram-positive, Gram-negative (broad-spectrum)",Unknown,Unknown,25862353,World J Microbiol Biotechnol. 2015 Jun;31(6):983-94. ,"Rumjuankiat K, Perez RH, Pilasombut K, Keawsompong S, Zendo T, Sonomoto K, Nitisinprasert S.
","Purification and characterization of a novel plantaricin, KL-1Y, from Lactobacillus plantarum KL-1.
",,,,,,,,
2694,DRAMP02089,FLPMLAGLAASMVPKLVCLITKKC,24,"Brevinin-1La (Brevinin-1PRd; Frogs, amphibians, animals)",P82825,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana luteiventris (Spotted frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Brevinin-1PRd isolated from the Oregon spotted frog shares the same sequence with this entry.,Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
2695,DRAMP01124,ILGPVLSMVGSALGGLIKKI,20,"Maximin-H2 (Toads, amphibians, animals)",P83082,Belongs to the bombinin family,Unknown,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi.Shows strong hemolytic activity. ","[Ref.11835991] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=20 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=2 μg/ml), Bacillus pyocyaneus CMCCB 1010 (MIC=4 μg/ml);##Fungi: Candida albicans ATCC 2002 (MIC=2 μg/ml).",[Ref:11835991]90-100% hemolytic activity at 50 μg/ml against rabbit red blood cells,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,,,,,,,,
2696,DRAMP01123,ILGPVISTIGGVLGGLLKNL,20,"Maximin-H1 (Toads, amphibians, animals)","P83080, P83081, Q58T74, Q58T41",Belongs to the bombinin family,Unknown,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Shows strong hemolytic activity. ","[Ref.11835991] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=9 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=4.5 μg/ml), Bacillus pyocyaneus CMCCB 1010 (MIC=9 μg/ml).##Yeast: Candida albicans ATCC 2002 (MIC=4.5 μg/ml).",[Ref:11835991]90-100% hemolytic activity at 50 μg/ml against rabbit red blood cells,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,,,,,,,,
2697,DRAMP01111,SIGAKILGGVKTFFKGALKELASTYLQ,27,"Maximin-5 (Toads, amphibians, animals)","P83084, Q58T60, Q58T61",Belongs to the bombinin family,Unknown,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal, Antiviral, Anticancer, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Maximins are linear cationic peptides and easy to form membrane pore and they may induce a detergent-type disruption of sperm membrane like in the case of magainins.,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. No amidation at the C-terminus.
Tissue specificity: Expressed by the skin glands.","[Ref.11835991] Gram-negative bacterium: Klebsiella pneumoniae (MIC=3.6 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.6 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=7.2 μg/ml), Bacillus megatherium (MIC=12 μg/ml), Bacillus dysenteriae (MIC=12 μg/ml).##Fungi: Candida albicans ATCC 2002 (MIC=1.2 μg/ml), Aspergillus flavus IFFI 4015 (MIC=12 μg/ml), Penicillium uticale IFFI 2001 (MIC=12 μg/ml);##Virus: HIV-1 (IC50=34.4 μg/ml, EC50=39.8 μg/ml);##Cancer cell lines: C8166 (IC50=34.4 μg/ml).",[Ref:11835991]Little hemolytic activity at 50 μg/ml against red blood cells,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,,,,,,,,
2698,DRAMP01110,GIGGVLLSAGKAALKGLAKVLAEKYAN,27,"Maximin-4 (Toads, amphibians, animals)","P83083, Q58T42, Q58T44, Q58T52, Q58T62, Q58T77, Q58T79",Belongs to the bombinin family,Unknown,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal, Antiviral, Anticancer, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Maximins are linear cationic peptides and easy to form membrane pore and they may induce a detergent-type disruption of sperm membrane like in the case of magainins.,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. Possess a significant cytotoxicity against tumor cell lines. Possess a significant anti-HIV activity. High spermicidal activity.","[Ref.11835991] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2.7 μg/ml), Klebsiella pneumoniae (MIC=15 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=2.7 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=2.7 μg/ml), Bacillus megatherium (MIC=1.5 μg/ml), Bacillus dysenteriae (MIC=2.7 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=15 μg/ml);##Virus: HIV-1 (IC50=24.2 μg/ml, EC50=21.9 μg/ml);##Cancer cell lines: C8166 (IC50=24.2 μg/ml), Molt-4 (IC50=35.4 μg/ml).",[Ref:11835991]Little hemolytic activity at 50 μg/ml against red blood cells,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,,,,,,,,
2699,DRAMP01109,GIGGKILSGLKTALKGAAKELASTYLH,27,"Maximin-3 (Toads, amphibians, animals)","P83082, Q58T40, Q58T43, Q58T46, Q58T48, Q58T64, Q58T65, Q58T68, Q58T69",Belongs to the bombinin family,Unknown,Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad),"Antimicrobial, Antibacterial, Antifungal, Antiviral, Anticancer, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Maximins are linear cationic peptides and easy to form membrane pore and they may induce a detergent-type disruption of sperm membrane like in the case of magainins.,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. Has little hemolytic activity. Possess a significant cytotoxicity against tumor cell lines. Possess a significant anti-HIV activity. High spermicidal activity. No amidation at the C-terminus.
Toxic dose: LD50 is 4.3 mg/kg by intraperitoneal injection into mice.
Tissue specificity: Expressed by the skin glands.","[Ref.11835991] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=0.9 μg/ml), Klebsiella pneumoniae (MIC=3.1 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 2592 (MIC=3.1 μg/ml), Bacillus pyocyaneus CMCCB 10104 (MIC=1.5 μg/ml), Bacillus megatherium (MIC=0.9 μg/ml), Bacillus dysenteriae (MIC=0.9 μg/ml);##Yeast: Candida albicans ATCC 2002 (MIC=15 μg/ml);##Virus: HIV-1 (IC50=11.4 μg/ml, EC50=1.5 μg/ml);##Cancer cell lines: C8166 (IC50=11.4 μg/ml), Molt-4 (IC50=25.2 μg/ml), BIU-87 (IC50=28 μg/ml), T24 (IC50=18 μg/ml).",[Ref:11835991]Little hemolytic activity at 50 μg/ml against red blood cells,Cell membrane,15770703##11835991,Eur J Immunol. 2005 Apr;35(4):1220-9.##Peptides. 2002 Mar;23(3):427-435.,"Lee WH, Li Y, Lai R, Li S, Zhang Y, Wang W.##Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y.",Variety of antimicrobial peptides in the Bombina maxima toad and evidence of their rapid diversification.##Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,,,,,,,,
2700,DRAMP02100,FLPIIASVAAKVFPKIFCAISKKC,24,"Brevinin-1Pe (Frogs, amphibians, animals)",P82845,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana pipiens (Northern leopard frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
2706,DRAMP18272,MAKEFGIPAAVAGTVINVVVAGGWVTTIVSILTAVGSGGLSLLAAAGRESIKAYLKKEIKKKGKRAVIAW,70,Enterocin AS-48RJ (Bacteriocin),No entry found,Belongs to the class IIc bacteriocin,Unknown,Enterococcus faecium RJ16,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,1E68 by NMR,"This is a natural variant of AS-48, where residue 20 is a Glu (Val in As-48RJ). It has the same activity spectrum as  AS-48 . ","Gram-positive, Gram-negative (broad-spectrum)",Unknown,Unknown,16094865,Syst Appl Microbiol. 2005 Jul;28(5):383-97.,"Abriouel H, Lucas R, Ben Omar N, Valdivia E, Maqueda M, Mart",Enterocin AS-48RJ: a variant of enterocin AS-48 chromosomally encoded by Enterococcus faecium RJ16 isolated from food.,,,,,,,,
2718,DRAMP02132,GLASTLGSFLGKFAKGGAQAFLQPK,25,"Antimicrobial peptide 3 (XT-3; Levitide-like peptide; Frogs, amphibians, animals)",P84383,Belongs to the gastrin/cholecystokinin family (Magainin subfamily),Unknown,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against Gram-positive bacterium S.aureus and Gram-negative bacterium E.coli, when in combination with XT1 and XT6.",Gram-positive bacteria: Staphylococcus aureus;##Gram-negative bacteria: E.coli (Combination with XT1 and XT6).,Unknown,Cell membrane,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",,,,,,,,
2719,DRAMP02134,GMATKAGTALGKVAKAVIGAAL,22,"Antimicrobial peptide 5 (XT-5; PGLa-like peptide; Frogs, amphibians, animals)",P84385,Unknown,Unknown,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against Gram-positive bacterium S. aureus, Gram-negative bacterium E.coli and yeast C. albicans. Has strong hemolytic activity against human red blood cells.
Tissue specificity: Skin.",[Ref.11738090]Gram-positive bacteria: Staphylococcus aureus (MIC>100 μM);##Gram-negative bacteria: Escherichia coli (MIC>100 μM);##Fungi: Candida albicans (MIC>100 μM),[Ref.11738090]HC50>150 μM against human erythrocytes,Cell membrane,11738090,Biochim Biophys Acta. 2001 Nov 26;1550(1):81-89.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",,,,,,,,
2806,DRAMP02243,GLLSGLKKVGKHVAKNVAVSLMDSLKCKISGDC,33,"Ranatuerin-1T (Brevinin-2T; Frogs, amphibians, animals)","P82740, P82236",Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana temporaria (European common frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.,Unknown,Unknown,10422869##10333736,Peptides. 1999;20(2):159-163.##Biopolymers. 1998;47(6):435-450.,"Goraya J, Knoop FC, Conlon JM.##Simmaco M, Mignogna G, Barra D.","Ranatuerin 1T: an antimicrobial peptide isolated from the skin of the frog, Rana temporaria.##Antimicrobial peptides from amphibian skin: what do they tell us?",,,,,,,,
2810,DRAMP02249,AIMDTIKDTAKTVAVGLLNKLKCKITGC,28,"Ranatuerin-2SEB (Frogs, amphibians, animals)",P85058,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana sevosa (dusky gopher frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli K12;##Gram-positive bacterium: Micrococcus luteus NCT C2665.,Unknown,Unknown,16386333,Peptides. 2006 Jun;27(6):1313-1319.,"Graham C, Richter SC, McClean S, O'Kane E, Flatt PR, Shaw C.","Histamine-releasing and antimicrobial peptides from the skin secretions of the dusky gopher frog, Rana sevosa.",,,,,,,,
2811,DRAMP02250,GIMDTIKDTAKTVAVGLLNKLKCKITGC,28,"Ranatuerin-2SEC (Frogs, amphibians, animals)",P85053,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana sevosa (dusky gopher frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli K12;##Gram-positive bacterium: Micrococcus luteus NCT C2665.,Unknown,Unknown,16386333,Peptides. 2006 Jun;27(6):1313-1319.,"Graham C, Richter SC, McClean S, O'Kane E, Flatt PR, Shaw C.","Histamine-releasing and antimicrobial peptides from the skin secretions of the dusky gopher frog, Rana sevosa.",,,,,,,,
2812,DRAMP02253,GIMDSVKGLAKNLAGKLLDSLKCKITGC,28,"Ranatuerin-IIbYb (Ranatuerin-2bYa; Frogs, amphibians, animals)",P84115,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana boylii (Foothill yellow-legged frog),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,14531844,J Pept Res. 2003 Nov;62(5):207-213.,"Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, Pál T, Rollins-Smith LA.",Isolation of peptides of the brevinin-2 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,,,,,,,,
2813,DRAMP02258,GILSTFKGLAKGVAKDLAGNLLDKFKCKITGC,32,"Ranatuerin-IIbYa (Ranatuerin-2bYa; Frogs, amphibians, animals)",P84114,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana boylii (Foothill yellow-legged frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Show weak hemolytic activity.,[Ref.14531844]Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus,[Ref.14531844]HC50=120 μM against human erythrocytes,Unknown,14531844,J Pept Res. 2003 Nov;62(5):207-213.,"Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, Pál T, Rollins-Smith LA.",Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,,,,,,,,
2818,DRAMP02284,GLNTLKKVFQGLHEAIKLINNHVQ,24,"Pseudin-1 (Pseudin 1; Frogs, amphibians, animals)",P83188,Unknown,Unknown,Pseudis paradoxa (Paradoxical frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Possesses antifungal activity against C. albicans and is also active against E. coli and S. aureus.
Tissue specificity: Expressed by the skin glands.",Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans.,Unknown,Unknown,11689009,Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-1005.,"Olson L 3rd, Soto AM, Knoop FC, Conlon JM.",Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.,,,,,,,,
2819,DRAMP02285,GLNALKKVFQGIHEAIKLINNHVQ,24,"Pseudin-2 (Pseudin 2; Frogs, amphibians, animals)",P83189,Unknown,Unknown,Pseudis paradoxa (Paradoxical frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Possesses antifungal activity against C. albicans and is also active against E. coli and S. aureus. Has low hemolytic activity against human erythrocytes.
Tissue specificity: Expressed by the skin glands.",[Ref.11689009]Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus;##Yeast: Candida albicans,[Ref.11689009]50% hemolysis of human erythrocytes is >300 μM,Unknown,11689009,Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-1005.,"Olson L 4rd, Soto AM, Knoop FC, Conlon JM.",Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.,,,,,,,,
2820,DRAMP02286,GINTLKKVIQGLHEVIKLVSNHE,23,"Pseudin-3 (Pseudin 3; Frogs, amphibians, animals)",P83190,Unknown,Unknown,Pseudis paradoxa (Paradoxical frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Possesses antifungal activity against C. albicans and is also active against E. coli and S. aureus.
Tissue specificity: Expressed by the skin glands.",Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus;##yeast Candida albicans.,Unknown,Unknown,11689009,Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-1005.,"Olson L 5rd, Soto AM, Knoop FC, Conlon JM.",Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.,,,,,,,,
2821,DRAMP02287,GINTLKKVIQGLHEVIKLVSNHA,23,"Pseudin-4 (Pseudin 4; Frogs, amphibians, animals)",P83191,Unknown,Unknown,Pseudis paradoxa (Paradoxical frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Possesses antifungal activity against C. albicans and is also active against E. coli and S. aureus.
Tissue specificity: Expressed by the skin glands.",Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus;##yeast Candida albicans.,Unknown,Unknown,11689009,Biochem Biophys Res Commun. 2001 Nov 9;288(4):1001-1005.,"Olson L 6rd, Soto AM, Knoop FC, Conlon JM.",Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.,,,,,,,,
2829,DRAMP02309,IIGHLIKTALGFLGL,15,"Signiferin-2.2 (Frogs, amphibians, animals)",P86132,Unknown,Unknown,Crinia signifera (Common eastern froglet),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against a wide spectrum of Gram-positive bacteria. Lacks antibacterial activity against the Gram-negative bacteria E. cloacae and E. coli.
Tissue specificity: Expressed by the skin glands.
PTM: C-terminal amidation.","Gram-negative bacteria: Enterobacter cloacae ATCC 13047 (MIC≤100 μM), Escherichia coli ATCC3 5218 (MIC≤100 μM)",Unknown,Unknown,15317042##16470724##18601958,Rapid Commun Mass Spectrom. 2004;18(18):2155-2161.##Rapid Commun Mass Spectrom. 2006;20(5):797-803.##Regul Pept. 2008 Nov 29;151(1-3):80-87.,"Maselli VM, Brinkworth CS, Bowie JH, Tyler MJ.##Maselli VM, Bilusich D, Bowie JH, Tyler MJ.##Jackway RJ, Pukala TL, Maselli VM, Musgrave IF, Bowie JH, Liu Y, Surinya-Johnson KH, Donnellan SC, Doyle JR, Llewellyn LE, Tyler MJ.","Host-defence skin peptides of the Australian Common Froglet Crinia signifera: sequence determination using positive and negative ion electrospray mass spectra.##Host-defence skin peptides of the Australian Streambank Froglet Crinia riparia: isolation and sequence determination by positive and negative ion electrospray mass spectrometry.##Disulfide-containing peptides from the glandular skin secretions of froglets of the genus Crinia: structure, activity and evolutionary trends.",,,,,,,,
2841,DRAMP02332,FIHHIFRGIVHAGRSIGRFLTG,22,"Piscidin-3 (Pis-3; fish, chordates, animals)",P0C006,Belongs to the pleurocidin family,Unknown,Morone chrysops x Morone saxatilis (white bass x striped sea-bass),"Antibacterial, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Exhibits broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria. Has hemolytic activity.
Tissue specificity: Mast cells in gill, skin and gut, and in lining blood vessels in the viscera.",[Swiss_Prot Entry P0C006]broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria,[Ref.11713517]5% hemolytic activity at 100 μg/mL against human erythrocytes,Unknown,11713517,Nature. 2001 Nov 15;414(6861):268-269.,"Silphaduang U, Noga EJ.",Peptide antibiotics in mast cells of fish.,,,,,,,,
2851,DRAMP01375,GLGGAKKNFIIAANKTAPQSVKKTFSCKLYNG,32,"Odorranain-E1 (OdE1; Frogs, amphibians, animals)",A6MBK8,Unknown,Unknown,Odorrana grahami (Yunnanfu frog) (Rana grahami),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Odorranain-E1 adopts 100% turn structure in water solution.,Unknown,Function: Odorranain-E1 exhibites antimicrobial activities against all of the tested microbes including Gram-positive and Gram-negative bacteria and fungi. Has no hemolytic activity against red cell.,"[Ref.17272268] Gram-negative bacterium: Escherichia coli (MIC=9.37 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=4.68 μg/ml), Bacillus subtilis (MIC=4.68 μg/ml).##Yeast: Candida albicans (MIC=9.37 μg/ml).",[Ref:17272268]Non-hemolytic activity against rabbit red blood cells,Unknown,17272268,Mol Cell Proteomics. 2007 May;6(5):882-894.,"Li J, Xu X, Xu C, Zhou W, Zhang K, Yu H, Zhang Y, Zheng Y, Rees HH, Lai R, Yang D, Wu J.",Anti-infection peptidomics of amphibian skin.,,,,,,,,
2854,DRAMP02353,RSTEDIIKSISGGGFLNAMNA,21,"Pleurocidin-like peptide WFX (fish, chordates, animals; Predicted)",Q7T053,Unknown,ple6,Pseudopleuronectes americanus (Winter flounder) (Pleuronectes americanus),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,Function: Has antibacterial and antifungal activity.,"Gram-negative bacteria: Aeromonas salmonicida A449 field isolate (MIC>64 μg/ml), A. salmonicida 97-4 field isolate (MIC>64 μg/ml), Pseudomonas aeruginosa K799 (MIC>64 μg/ml), Pseudomonas aeruginosa Z61 (MIC>64 μg/ml), Escherichia coli (MIC>64 μg/ml), Salmonella typhimurium 14028s (MIC>64 μg/ml), S. typhimurium MS7953s (MIC>64 μg/ml);##Gram-positive bacteria: Staphylococcus epidermidis (human clinical isolates) (MIC>64 μg/ml), Staphylococcus aureus (MRSA) (MIC>64 μg/ml).##Fungi: Candida albica (MIC>64 μg/ml).",Unknown,Unknown,12950255,Eur J Biochem. 2003 Sep;270(18):3720-3730.,"Douglas SE, Patrzykat A, Pytyck J, Gallant JW.","Identification, structure and differential expression of novel pleurocidins clustered on the genome of the winter flounder, Pseudopleuronectes americanus (Walbaum).",,,,,,,,
2857,DRAMP02369,LLAWCLVFLVIVQQVTSSPVPQSDTPLTSVQEVQRSLKRTARMTPLWRIMGTKPHGAYCQNHYECSTGICRKGHCSYS,78,"Liver-expressed antimicrobial peptide 2 (fish, chordates, animals)",D0Q093,Unknown,LEAP-2,Ctenopharyngodon idella (Grass carp) (Leuciscus idella),"Antimicrobial , Anti-Gram-, ",Predicted,Unknown,Unknown,Unknown,"Grass carp LEAP-2 gene is expressed in a wide range of tissues except blood, with the highest level of transcripts found in liver. ",Gram-negative bacteria: Escherichia coli XC-1 and Aeromonas hydrophila S2.,Unknown,Unknown,19716607,Vet Immunol Immunopathol. 2010 Feb 15;133(2-4):133-143.,"Liu F, Li JL, Yue GH, Fu JJ, Zhou ZF.",Molecular cloning and expression analysis of the liver-expressed antimicrobial peptide 2 (LEAP-2) gene in grass carp.,,,,,,,,
2868,DRAMP02245,GLFLDTLKGLAGKLLQGLKCIKAGCKP,27,"Ranatuerin-2Cb (Ranatuerin 2Cb; Frogs, amphibians, animals)",P82879,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Unknown,Rana clamitans (Green frog) (Lithobates clamitans),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. 
Tissue specificity: Expressed by the skin glands.",[Ref.10822101] Gram-positive bacterium: Staphylococcus aureus (MIC=40 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=2 μg/ml).##Yeast: Candida albicans (MIC=46 μg/ml).,Unknown,Unknown,10822101,Peptides. 2000 Apr;21(4):469-476.,"Halverson T, Basir YJ, Knoop FC, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.,,,,,,,,
2869,DRAMP02398,GPVGLLSSPGSLPPVGGAP,19,Antimicrobial peptide GP-19 (GP-19),B3A0L2,Unknown,Unknown,Xenorhabdus budapestensis,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: GP-19 displays broad-spectrum antimicrobial activity against the tested bacteria and fungi.,"Gram-positive bacteria: Bacillus subtilis (IZ=19.04±0.2 mm), Bacillus megaterium (IZ=7.3±0.28 mm), Prototheca wickerhamii (IZ=10.3±0.33 mm);##Gram-negative bacteria: Xanthomonas campestris pv. vesicatoria (IZ=16.47±0.35 mm), Pseudomonas solanacearum (IZ=10.75±0.41 mm).##fungi: Phytophthora capsici (CD=16.62±1.07 mm), Verticillium dahlia (EC50=17.54 μg/ml), Fusarium graminearum (CD=12.04±0.87 mm), Fusarium omysporum (CD=21.64±0.4 mm).##NOTE: IZ = Inhibition Zone and CD = Colony diameter.",Unknown,Unknown,22497806,Peptides. 2012 Jun;35(2):253-260.,"Xiao Y, Meng F, Qiu D, Yang X.",Two novel antimicrobial peptides purified from the symbiotic bacteria Xenorhabdus budapestensis NMC-10.,,,,,,,,
2871,DRAMP02400,GCPQTPRCTNYAEKGQCPPN,20,Antimicrobial peptide AJN-10 (AJN-10),P0DJ30,Unknown,Unknown,Anguilla japonica (Japanese eel),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Displays antimicrobial activity against the Gram-negative bacterium A.hydrophila.,Gram-negative bacterium: Aeromonas hydrophila.,Unknown,Unknown,21796440,Protein J. 2011 Aug;30(6):413-421.,"Liang Y, Guan R, Huang W, Xu T.","Isolation and identification of a novel inducible antibacterial peptide from the skin mucus of Japanese eel, Anguilla japonica.",,,,,,,,
2876,DRAMP02407,PAQPFRIKKRQGPFERP,17,Napin-like polypeptide (Contains: Napin-like polypeptide small chain and large chain),P84782,Belongs to the 2S seed storage albumins family,Unknown,Brassica oleracea var. alboglabra (Chinese kale) (Brassicaalboglabra),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Inhibits cell-free protein synthesis. Inhibits trypsin and chymotrypsin. Does not inhibit ribonuclease of protease activity. Has antibacterial activity except Gram-positive bacterium S. aureus or the Gram-negative bacteria E. coli, E. aerogenes, P. aeruginosa and P. vulgaris. Inhibits the proliferation of leukemia cells in vitro.
Subunit structure: The mature protein consists of a small and a large chain linked by disulfide bonds (sequence shown is small chain).
Biophysicochemical properties: This activity is preserved between pH 5 and pH 11, and between 10 and 40 degrees C. It falls to a low level at pH 3 and pH 13 and at 70 degrees C.","Gram-negative bacterium: Pseudomonas fluorescens (IC50=89±6.1 μM);##Gram-positive bacteria: Bacillus subtilis (IC50=278±12.9 μM), B. cereus (IC50=145±83 μM), Bacillus megaterium (IC50=156±8.4 μM), Megabacterium phlei (IC50=104±27 μM).",Unknown,Unknown,15485558,J Pept Res. 2004 Nov;64(5):202-208.,"A napin-like polypeptide with translation-inhibitory, trypsin-inhibitory, antiproliferative and antibacterial activities from kale seeds.","A napin-like polypeptide with translation-inhibitory, trypsin-inhibitory, antiproliferative and antibacterial activities from kale seeds.",,,,,,,,
2890,DRAMP02437,GFWKKVGSAAWGGVKAAAKGAAVGGLNALAKHIQ,34,Papillosin,P86416,Unknown,Unknown,Halocynthia papillosa (Red sea-squirt),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has strong antibacterial activity against the Gram-positive bacteria M. luteus, S. aureus, B. megaterium, A. viridans and E. faecalis, and against the Gram-negative bacteria K. pneumoniae, E. coli DH5alpha, S. typhimurium, P. aeruginosa and E. aerogenes. Lacks hemolytic activity against sheep erythrocytes.","[Ref.19085906]Gram-positive bacteria (Native, Synthetic): Micrococcus luteus A270 (MBC=0.13-0.25, 0.19-0.39 μM), Aerococcus viridans 54.145 T (MBC=ND, 0.19-0.39 μM), Bacillus megaterium 66.20 T (MBC=ND, 0.05-0.10 μM), Staphylococcus aureus 65.8 T (MBC=0.5-1.00, 1.56-3.13 μM), Enterococcus faecalis 103015 T (MBC=ND, 0.78-1.56 μM);##Gram-negative bacteria (Native, Synthetic): Enterobacter aerogenes 30.86 T (MBC=ND, 0.78-1.56 μM), Pseudomonas aeruginosa 100720 T (MBC=ND, 3.13-6.25 μM), Salmonella thyphimurium 60.62 T (MBC=ND, 0.78-1.56 μM), Klebsiella pneumoniae 82.91 T (MBC=ND, 0.39-0.78 μM), Escherichia coli (MBC=0.25-0.50, 0.78-1.56 μM)",[Ref.19085906]0% hemolytic activity at 50 μM against sheep erythrocytes,Unknown,19085906,J Pept Sci. 2009 Jan;15(1):48-55.,"Galinier R, Roger E, Sautiere PE, Aumelas A, Banaigs B, Mitta G.","Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa.",,,,,,,,
2891,DRAMP02438,FWGHIWNAVKRVGANALHGAVTGALS,26,Halocyntin,P86415,Unknown,Unknown,Halocynthia papillosa (Red sea-squirt),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has strong antibacterial activity against the Gram-positive bacteria M. luteus, S. aureus, B. megaterium, A. viridans and E. faecalis, and against the Gram-negative bacterium K. pneumoniae. Has less potent antibacterial activity against the Gram-negative bacteria E. coli DH5alpha, S. typhimurium, P. aeruginosa, E. aerogenes and N. gonorrhoeae. Has moderate hemolytic activity against sheep erythrocytes.","[Ref.19085906]Gram-positive bacteria (Native, Synthetic): Micrococcus luteus A270 (MBC=0.39-0.78, 0.39-0.78 μM), Aerococcus viridans 54.145 T (MBC=3.13-6.25, 0.78-1.56 μM), Bacillus megaterium 66.20 T (MBC=0.75-1.56, 0.39-0.78 μM), Staphylococcus aureus 65.8 T (MBC=6.25-12.50, 1.56-3.13 μM), Enterococcus faecalis 103015 T (MBC=6.25-12.50, 1.56-3.13 μM);##Gram-negative bacteria (Native, Synthetic): Enterobacter aerogenes 30.86 T (MBC=25-50, 6.25-12.50 μM), Pseudomonas aeruginosa 100720 T (MBC>100, 25-50 μM), Salmonella thyphimurium 60.62 T (MBC=50-100, 12.50-25 μM), Klebsiella pneumoniae 82.91 T (MBC=12.50-25, 1.56-3.13 μM), Neisseria gonorrhoeae 103711 (MBC=25-50, ND μM), Escherichia coli (MBC=6.25-12.50, 6.25-12.50 μM).","[Ref.19085906]8% hemolytic activity at 6.25 μM, 13% hemolytic activity at 12.5 μM, 14% hemolytic activity at 25 μM, 22% hemolytic activity at 50 μM against sheep erythrocytes ",Unknown,19085906,J Pept Sci. 2009 Jan;15(1):48-55.,"Galinier R, Roger E, Sautiere PE, Aumelas A, Banaigs B, Mitta G.","Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa.",,,,,,,,
2896,DRAMP02447,FCKSLPLPLSVK,12,Antimicrobial protein 2 (Antimicrobial protein AN5-2),B3EWQ7,Unknown,Unknown,Paenibacillus alvei (Bacillus alvei),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antibacterial activity Gram-positive bacteria as well as against Gram-negative bacteria.,Gram-positive bacteria: Lactobacillus plantarum strain ATCC 8014 and Bacillus cereus strain ATCC 14579;##Gram-negative bacteria: Escherichia coli strain ATCC 25922 and Salmonella enteritidis strain ATCC 13076.,Unknown,Unknown,PubMed ID is not available,Submitted (JUL-2012) to UniProtKB,"Alkotaini B, Anuar N, Kadhum AAH.",Unknown,,,,,,,,
2901,DRAMP02453,GKIPVKAIKKAGAAIGKGLRAINIASTAHDVYSFFKPKHKKK,42,"S. litura moricin (Sl moricin; Insects, animals)",Q7YZB4,Unknown,Unknown,Spodoptera litura (Lepidopteran insect),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (1 helices; 31 residues),"The solution structure of Sl moricin is determined by two-dimensional (2D) 1H-nuclear magnetic resonance (NMR) spectroscopy and hybrid distance geometry-simulated annealing calculation. The tertiary structure reveales a long alpha-helix containing eight turns along nearly the full length of the peptide like that of moricin, confirming that Sl moricin is a new moricin-like antibacterial peptide.",1X22 resolved by NMR. ,Function: Sl moricin showes a broad antibacterial spectrum against Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa (LD50=67.4 μg/ml), Escherichia coli JM109 (LD50=5.2 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (LD50=2.7 μg/ml), Methicillin-resistant S. aureus (LD50=9.8 μg/ml), Micrococcus luteus (LD50=28.4 μg/ml), Bacillus thuringiensis HD-1 (LD50=0.5 μg/ml), Enterococcus faecium IFO3128 (LD50=6.2 μg/ml). ",Unknown,Unknown,16115804,Biochim Biophys Acta. 2005 Aug 31;1752(1):83-92.,"Oizumi Y, Hemmi H, Minami M, Asaoka A, Yamakawa M.","Isolation, gene expression and solution structure of a novel moricin analogue, antibacterial peptide from a lepidopteran insect, Spodoptera litura.",,,,,,,,
2902,DRAMP02454,GCFEDWSRCSPSTASATGVLWRSCDSYCKVCFKADRGECYDSPSLNCPHRLPNNKQCRCINARTAKDNRNPTCWA,75,"Theromacin (Arthropods, animals)","A8I0L8, A8IK85",Unknown,Unknown,Hirudo medicinalis (Medicinal leech),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,Structural features of Theromacin: the characteristic additional N-terminal helix and two long flexible loops separating the two helices.,2LN8 resolved by NMR.,"Function: It showes antimicrobial activity against Gram-positive bacteria and Gram-negative bacteria in the low microgram concentration range.
PTM: Problely contains five disulfide bonds 2-9; 24-28; 31-73; 39-47; 57-59.","Gram-negative bacterium: Escherichia coli ATCC 35218 (LD90=6.25 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 12600 (LD90=25 μg/ml), Bacillus megaterium ATCC 14581 (MBC=0.2-0.39 μg/ml).",Unknown,Unknown,22396551##PubMed ID is not available,J Biol Chem. 2012 Apr 20;287(17):14246-58.##Submitted (SEP-2007) to the EMBL/GenBank/DDBJ databases,"Jung S, Snnichsen FD, Hung CW, Tholey A, Boidin-Wichlacz C, Haeusgen W, Gelhaus C, Desel C, Podschun R, Waetzig V, Tasiemski A, Leippe M, Grtzinger J.##Schikorski D, Salzet M, Tasiemski A.",Macin family of antimicrobial proteins combines antimicrobial and nerve repair activities.##Antimicrobial peptides isolated from the medicinal leech.,,,,,,,,
2904,DRAMP02457,ADVRNPLEEFRETDYEVL,18,"L-amino-acid oxidase (Balt-LAAO-I; LAAO; LAO; snakes, reptils, animals)",P0DI86,Belongs to the flavin monoamine oxidase family (FIG1 subfamily),Unknown,Bothrops alternatus (Urutu),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as slight hemorrhage, Induction: of platelet aggregation, edema in the mouse paw and bactericidal activity against both Gram-positive (S.aureus) and Gram-negative (E.coli) bacteria. May also induce hemolysis, apoptosis of vascular endothelial cells or tumor cell lines, and may have antiparasitic activities. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. 
Tissue specificity: Expressed by the venom gland.",Gram-positive bacterium: S. aureus;##Gram-negative bacterium: E. coli.,Unknown,Unknown,15142548,Bioorg Med Chem. 2004 Jun 1;12(11):2881-2886.,"Stábeli RG, Marcussi S, Carlos GB, Pietro RC, Selistre-de-Araújo HS, Giglio JR, Oliveira EB, Soares AM.",Platelet aggregation and antibacterial effects of an L-amino acid oxidase purified from Bothrops alternatus snake venom.,,,,,,,,
2909,DRAMP02462,DDRRSPLEECFQQNDYEEFLEIARNSQLYQESLREDSSYHLSFIESLKSDALFSYEKKFWEADGIHGGKVINDLSLIHDLPKREIQALCYPSIKK,95,"L-amino-acid oxidase (LAAO; LAO; snakes, reptils, animals)",P0DI91,Belongs to the flavin monoamine oxidase family (FIG1 subfamily),Unknown,Naja oxiana (Central Asian cobra) (Oxus cobra),"Antibacterial, Antiparasitic, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as antibacterial activity against both Gram-positive (B.subtilis) and Gram-negative (E.coli) bacteria, and inhibition of ADP- or collagen-induced platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions. This protein may also induce hemorrhage, hemolysis, edema, apoptosis, and have antiparasitic activities.
Tissue specificity: Expressed by the venom gland.
Biophysicochemical properties: Kinetic parameters (KM=0.885 mM for L-Met; KM=0.051 mM for L-Phe; KM=0.147 mM for L-Trp; KM=0.75 mM for L-Leu)",Gram-positive bacterium: Bacillus subtilis;##Gram-negative bacterium: E. coli.,Unknown,Unknown,18294891,Comp Biochem Physiol B Biochem Mol Biol. 2008 Apr;149(4):572-580.,"Samel M, Tõnismägii K, Rönnholm G, Vija H, Siigur J, Kalkkinen N, Siigur E.",L-Amino acid oxidase from Naja naja oxiana venom.,,,,,,,,
2925,DRAMP02483,KFFKKLKNSVKKRAKKFFKKPKVIGVTFPF,30,"Cathelicidin-NA (Cathelicidin-related protein; Snakes, reptiles, animals)",B6S2X0,Unknown,Unknown,Naja atra (Chinese cobra),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Transcript level,Alpha helix ,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922, Escherichia coli ML-35P, Escherichia coli clinic strain, Pseudomonas aeruginosa ATCC 27853, Pseudomonas aeruginosa PA 01, Pseudomonas aeruginosa clinic strain, Enterobacter aerogenes clinic strain, Enterobacter cloacae clinic strain.",Unknown,Cell membrane,18620012,Peptides. 2008 Oct;29(10):1685-91. ,"Zhao H, Gan TX, Liu XD, Jin Y, Lee WH, Shen JH, Zhang Y.",Identification and characterization of novel reptile cathelicidins from elapid snakes.,,,,,,,,
2951,DRAMP02511,YKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWKCCKKGSG,42,"Crotamine (defensin-like toxin; Snakes, reptiles, animals)",Q9PWF3,Belongs to the crotamine-myotoxin family,CRO2,Crotalus durissus terrificus (South American rattlesnake),"Antibacterial, Antifungal, Cytotoxicity, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,"Crotamine contains an alpha-helix with residues 1-7 and a two-stranded anti-parallel beta-sheet with residues 9-13 and 34-38 as the only regular secondary structures. These are connected with each other and the remainder of the polypeptide chain by the three disulfide bonds, which also form part of a central hydrophobic core (Ref.2).",1Z99 resolved by NMR.,"Function: It exhibits antimicrobial activities, hind limb paralysis, and severe muscle necrosis by a non-enzymatic mechanism. As a cell-penetrating peptide, crotamine has high specificity for actively proliferating cells, and interacts inside the cell with subcellular and subnuclear structures, like vesicular compartments, chromosomes and centrioles. Crotamine has marked activity against the eukaryotic pathogen Candida albicans at pH 7.5 or 5.5.
Tissue specificity: Expressed by the venom gland.
Toxic dose: LD50 is 1.5 mg/kg by intravenous injection. LD50 is 32.8 mg/kg by intraperitoneal injection into mice.(Ref.3)(Ref.4)
Pharmaceutical use: Has high potential for use as an anticancer agent. In vivo treatment with this protein significantly delays tumor implantation, inhibits tumor growth and prolongs the lifespan of the mice with melanoma tumors. It has also potent and specific toxicity against tumor cell lines of aggressive mouse and human tumors, but low cytotoxicity against non-tumoral cell lines. In addition, this protein can act as a carrier capable of delivering DNA into replicating cells with low cytotoxicity against normal proliferative cells.(Ref.5)(Ref.6)
Miscellaneous: Has no hemolytic activity .",[Swiss_Prot Entry Q9PWF3]Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacteria: Escherichia coli;##Yeast: Candida albicans,[Ref.210622]Non-hemolytic activity,Eukaryotic ion channels,19706485##16185738##1176086##9839677##22142367##210622,Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14972-14977.##Toxicon. 2005 Dec 1;46(7):759-767.##Hoppe Seylers Z Physiol Chem. 1975 Feb;356(2):213-215.##Toxicon. 1998 Dec;36(12):1927-1937.##Mol Pharm. 2012 Feb 6,"Yount NY, Kupferwasser D, Spisni A, Dutz SM, Ramjan ZH, Sharma S, Waring AJ, Yeaman MR.##Fadel V, Bettendorff P, Herrmann T, de Azevedo WF Jr, Oliveira EB, Yamane T, Wüthrich K.##Laure CJ.##Mancin AC, Soares AM, Andrio-Escarso SH, Faa VM, Greene LJ, Zuccolotto S, Pelá IR, Giglio JR.##Nascimento FD, Sancey L, Pereira A, Rome C, Oliveira V, Oliveira EB, Nader HB, Yamane T, Kerkis I, Tersariol IL, Coll JL, Hayashi MA.##Kerkis I, Silva ","Selective reciprocity in antimicrobial activity versus cytotoxicity of hBD-2 and crotamine.##Automated NMR structure determination and disulfide bond identification of the myotoxin crotamine from Crotalus durissus terrificus.##The primary structure of crotamine (author's transl).##he analgesic activity of crotamine, a neurotoxin from Crotalus durissus terrificus (South American rattlesnake) venom: a biochemical and pharmacological study.##The natural cell-penetrating peptide crotamine targets tu",,,,,,,,
2954,DRAMP02521,KFFKKLKNSVKKRAKKFFKKPRVIGVSIPF,30,"Cathelicidin-OH (Cathelicidin-related protein; Snakes, reptiles, animals)",B6S2X2,Unknown,Unknown,Ophiophagus hannah (King cobra) (Naja hannah),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Transcript level,Alpha helix ,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli ATCC 25922, Escherichia coli ML-35P, Escherichia coli clinic strain, Pseudomonas aeruginosa ATCC 27853, Pseudomonas aeruginosa PA 01, Pseudomonas aeruginosa clinic strain, Enterobacter aerogenes clinic strain, Enterobacter cloacae clinic strain.",Unknown,Cell membrane,18620012,Peptides. 2008 Oct;29(10):1685-91. ,"Zhao H, Gan TX, Liu XD, Jin Y, Lee WH, Shen JH, Zhang Y.",Identification and characterization of novel reptile cathelicidins from elapid snakes.,,,,,,,,
2999,DRAMP18253,KYYGNGLSXNKKGXTVDWGTAIGIIGNNAAANXATGGAAGXNK,43,Piscicocin CS526(Bacteriocin),No entry found,Belongs to the class IIa bacteriocin,Unknown,Carnobacterium piscicola CS526,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",,Unknown,"In this study, we found that piscicocin CS526, which possessed YGNGL sequence, had anti-Listeria activity typical of class IIa bacteriocins. Accordingly, the presence of Val7 within the YGNGV7 motif could not be a prerequisite for the antimicrobial activity of class IIa bacteriocins.",Unknown,"The bacteriocin piscicocin CS526 was inactivated by proteolytic enzymes, was stable at 100 Celsius degree for 30 min, had a pH range of 2 to 8, and was active against Enterococcus, Listeria, Pediococcus, and Leuconostoc. ","Gram-positive, Gram-negative",Unknown,Unknown,15640235##15836484,"Appl Environ Microbiol. 2005 Jan;71(1):554-7.##J Appl Microbiol. 2005;98(5):1146-51.
","Yamazaki K, Suzuki M, Kawai Y, Inoue N, Montville TJ.##Suzuki M, Yamamoto T, Kawai Y, Inoue N, Yamazaki K.
","Purification and characterization of a novel class IIa bacteriocin, piscicocin CS526, from surimi-associated Carnobacterium piscicola CS526.##Mode of action of piscicocin CS526 produced by Carnobacterium piscicola CS526.
",,,,,,,,
3003,DRAMP02570,YRGGYTGPIPRPPPIGRPPLRLVVCACYRLSVSDARNCCIKFGSCCHLVK,50,"Penaeidin-1 (Pen-1; shrimps, Arthropods, animals)",P81056,Belongs to the penaeidin family,Unknown,Litopenaeus vannamei (Whiteleg shrimp),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
Tissue specificity: Higher expression in hemocytes and to a lesser extent in heart, testis, gills, intestine, lymphonoid organ and hepatopancreas. Traces in eyes and subcuticular epithelium. Not present in the brain.
Developmental stage: Expression decreases 3 hours after microbial challenge to return to control levels after 12 hours and slightly increases after 24 hours.
PTM: Contains three disulfide bonds 25-38; 27-45; 39-46.","Gram-positive bacterium: Micrococcus luteus;##Gram-negative bacterium: Escherichia coli.##Fungi: Neurospora crassa, Fusarium oxysporum.",Unknown,Chitin-binding,9353298##10639333,Biol Chem. 1997 Nov 7;272(45):28398-28406.##J Cell Sci. 2000 Feb;113 (Pt 3):461-469.,"Destoumieux D, Bulet P, Loew D, Van Dorsselaer A, Rodriguez J, Bachère E.##Destoumieux D, Muoz M, Cosseau C, Rodriguez J, Bulet P, Comps M, Bachère E.","Penaeidins, a new family of antimicrobial peptides isolated from the shrimp Penaeus vannamei (Decapoda).##Penaeidins, antimicrobial peptides with chitin-binding activity, are produced and stored in shrimp granulocytes and released after microbial challenge.",,,,,,,,
3004,DRAMP02571,YRGGYTGPIPRPPPIGRPPFRPVCNACYRLSVSDARNCCIKFGSCCHLVK,50,"Penaeidin-2a (Pen-2a; shrimps, Arthropods, animals)",P81057,Belongs to the penaeidin family,Unknown,Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
Tissue specificity: Higher expression in hemocytes and to a lesser extent in heart, testis, gills, intestine, lymphonoid organ and hepatopancreas. Traces in eyes and subcuticular epithelium. Not present in the brain.
Developmental stage: Expression decreases 3 hours after microbial challenge to return to control levels after 12 hours and slightly increases after 24 hours.
PTM: Contains three disulfide bonds 24-38; 27-45; 39-46 and Lysine amide at position 50.","Gram-positive bacterium: Micrococcus luteus;##Gram-negative bacterium: Escherichia coli.##Fungi: Neurospora crassa, Fusarium oxysporum, Saccharomyces cerevisiae TGY.",Unknown,Chitin-binding,11028917##9353298##10561573,Cell Mol Life Sci. 2000 Aug;57(8-9):1260-1271.##J Biol Chem. 1997 Nov 7;272(45):28398-28406.##Eur J Biochem. 1999 Dec;266(2):335-346.,"Destoumieux D, Munoz M, Bulet P, Bachère E.##Destoumieux D, Bulet P, Loew D, Van Dorsselaer A, Rodriguez J, Bachère E.##Destoumieux D, Bulet P, Strub JM, Van Dorsselaer A, Bachère E.","Penaeidins, a family of antimicrobial peptides from penaeid shrimp (Crustacea, Decapoda).##Penaeidins, a new family of antimicrobial peptides isolated from the shrimp Penaeus vannamei (Decapoda).##Recombinant expression and range of activity of penaeidins, antimicrobial peptides from penaeid shrimp.",,,,,,,,
3006,DRAMP02575,QVYKGGYTRPVPRPPPFVRPLPGGPIGPYNGCPVSCRGISFSQARSCCSRLGRCCHVGKGYS,62,"Penaeidin-3b (Pen-3b; shrimps, Arthropods, animals)",P81059,Belongs to the penaeidin family,Unknown,Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
Tissue specificity: Higher expression in hemocytes and to a lesser extent in heart, testis, gills, intestine, lymphonoid organ and hepatopancreas. Traces in eyes and subcuticular epithelium. Not present in the brain.
Developmental stage: Expression decreases 3 hours after microbial challenge to return to control levels after 12 hours and slightly increases after 24 hours.
PTM: Contains three disulfide bonds 32-47; 36-54; 48-55, Pyrrolidone carboxylic acid and Lysine amide at position 1 and 62 respectively.","Gram-positive bacterium: Micrococcus luteus;##Gram-negative bacterium: Escherichia coli.##Fungi: Neurospora crassa, Fusarium oxysporum.",Unknown,Chitin-binding,11028917##10639333,Cell Mol Life Sci. 2000 Aug;57(8-9):1260-1271.##J Cell Sci. 2000 Feb;113 (Pt 3):461-469.,"Destoumieux D, Munoz M, Bulet P, Bachère E.##Destoumieux D, Muoz M, Cosseau C, Rodriguez J, Bulet P, Comps M, Bachère E.","Penaeidins, a family of antimicrobial peptides from penaeid shrimp (Crustacea, Decapoda).##Penaeidins, antimicrobial peptides with chitin-binding activity, are produced and stored in shrimp granulocytes and released after microbial challenge.",,,,,,,,
3007,DRAMP02576,QVYKGGYTRPIPRPPFVRPVPGGPIGPYNGCPVSCRGISFSQARSCCSRLGRCCHVGKGYS,61,"Penaeidin-3c (Pen-3c; shrimps, Arthropods, animals)",P81060,Belongs to the penaeidin family,Unknown,Litopenaeus vannamei (Whiteleg shrimp) (Penaeus vannamei),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Posesses antibacterial and antifungal activity. Presents chitin-binding activity.
Subcellular location: Cytoplasmic granule. Note: Cytoplasmic granules of hemocytes and to a lesser extent in small granules of hemocytes.
Tissue specificity: Higher expression in hemocytes and to a lesser extent in heart, testis, gills, intestine, lymphonoid organ and hepatopancreas. Traces in eyes and subcuticular epithelium. Not present in the brain.
Developmental stage: Expression decreases 3 hours after microbial challenge to return to control levels after 12 hours and slightly increases after 24 hours.
PTM: Contains three disulfide bonds 31-46; 35-53; 47-54, Pyrrolidone carboxylic acid and Lysine amide at position 1 and 62 respectively.","Gram-positive bacterium: Micrococcus luteus;##Gram-negative bacterium: Escherichia coli.##Fungi: Neurospora crassa, Fusarium oxysporum.",Unknown,Chitin-binding,11028917##10639333,Cell Mol Life Sci. 2000 Aug;57(8-9):1260-1271.##J Cell Sci. 2000 Feb;113 (Pt 3):461-469.,"Destoumieux D, Munoz M, Bulet P, Bachère E.##Destoumieux D, Muoz M, Cosseau C, Rodriguez J, Bulet P, Comps M, Bachère E.","Penaeidins, a family of antimicrobial peptides from penaeid shrimp (Crustacea, Decapoda).##Penaeidins, antimicrobial peptides with chitin-binding activity, are produced and stored in shrimp granulocytes and released after microbial challenge.",,,,,,,,
3023,DRAMP02597,VFQFLGKIIHHVGNFVHGFSHVF,23,"Clavanin-A (His-rich; chordates, animals)","P80710, O18490",Unknown,Unknown,Styela clava (Sea squirt),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,Function: Has antimicrobial activity.,Gram-negative bacterium: Escherichia coli;##yeast Candida albicans.,Unknown,Unknown,9001389##9237689,FEBS Lett. 1997 Jun 30;410(2-3):490-492.##FEBS Lett. 1997 Jan 3;400(2):158-162.,"Lee IH, Zhao C, Cho Y, Harwig SSL, Cooper EL, Lehrer RI.##Zhao C, Lian H, Lee I.H, Lehrer R.I.","Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.##cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemocytes.",,,,,,,,
3025,DRAMP02599,VFHLLGKIIHHVGNFVYGFSHVF,23,"Clavanin-C (His-rich; chordates, animals)","O18493, P80712",Unknown,Unknown,Styela clava (Sea squirt),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Has antimicrobial activity.
Tissue specificity: Hemocytes and pharyngeal tissues.",Gram-negative bacterium: Escherichia coli;##yeast Candida albicans.,Unknown,Unknown,9001389##9237689,FEBS Lett. 1997 Jun 30;410(2-3):490-492.##FEBS Lett. 1997 Jan 3;400(2):158-162.,"Lee IH, Zhao C, Cho Y, Harwig SSL, Cooper EL, Lehrer RI.##Zhao C, Lian H, Lee I.H, Lehrer R.I.","Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.##cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemocytes.",,,,,,,,
3026,DRAMP02600,AFKLLGRIIHHVGNFVYGFSHVF,23,"Clavanin-D (His-rich; chordates, animals)","P80713, O18491",Unknown,Unknown,Styela clava (Sea squirt),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: Has antimicrobial activity.
Tissue specificity: Hemocytes and pharyngeal tissues.",Gram-negative bacterium: Escherichia coli;##yeast Candida albicans.,Unknown,Unknown,9237689##9001389,FEBS Lett. 1997 Jun 30;410(2-3):490-492.##FEBS Lett. 1997 Jan 3;400(2):158-162.,"Zhao C, Liaw L, Lee IH, Lehrer RI.##Lee IH, Zhao C, Cho Y, Harwig SS, Cooper EL, Lehrer RI.","cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemocytes.##Clavanins, alpha-helical antimicrobial peptides from tunicate hemocytes.",,,,,,,,
3027,DRAMP02601,LFKLLGKIIHHVGNFVHGFSHVF,23,"Clavanin E (His-rich; chordates, animals)",O18492,Unknown,Unknown,Styela clava (Sea squirt),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antimicrobial activity.,Gram-negative bacterium: Escherichia coli;##yeast Candida albicans.,Unknown,Unknown,9237689,FEBS Lett. 1997 Jun 30;410(2-3):490-492. ,"Zhao C, Liaw L, Lee IH, Lehrer RI.",cDNA cloning of Clavanins: antimicrobial peptides of tunicate hemocytes. ,,,,,,,,
3028,DRAMP02602,FLRFIGSVIHGIGHLVHHIGVAL,23,"Clavaspirin (chordates, animals)",O97395,Unknown,Unknown,Styela clava (Sea squirt),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Alpha helix ,Unknown,Unknown,Function: Has potent hemolytic activity. ,[Swiss_Prot Entry O97395]Exhibits broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria,[Ref.12005415]has potent hemolytic activity,Unknown,12005415,J Pept Res. 2001 Dec;58(6):445-456.,"Lee IH, Zhao C, Nguyen T, Menzel L, Waring AJ, Sherman MA, Lehrer RI.","Clavaspirin, an antibacterial and haemolytic peptide from Styela clava.",,,,,,,,
3050,DRAMP18250,MACQCPDAISGWTHTDYQCHGLENKMYRHVYAICMNGTQVYCRTEWGSSC,50,Laterosporulin (Bacteriocin),H1ZZ98,Belongs to the class IId bacteriocin,laterosporulin,Brevibacillus sp. Strain GI-9,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Beta strand,"The crystal structure of LS at 2.0 A resolution reveals an all-bconformation of this peptide, with four beta-strands forming a twisted b-sheet. All six intrinsic cysteines are intramolecularly disulfide-bonded, with two disulfides constraining the N terminus of the peptide and the third disulfide crosslinking the extreme C terminus, resulting in the formation of a closed structure. Despite a low overall sequence similarity, LS has disul",4OZK by X-ray,"This peptide is thermal stable, pH tolerant, and resistant to proteases. Reducing agent DTT had no effect on peptide activity or migration on gel.","Gram-positive, Gram-negative (broad spectrum)",Unknown,Unknown,22403615##25345978,PLoS One. 2012;7(3):e31498. doi: 10.1371/journal.pone.0031498.##FEBS J. 2015 Jan;282(2):203-14.,"Singh PK, Chittpurna, Ashish, Sharma V, Patil PB, Korpole S.##Singh PK, Solanki V, Sharma S, Thakur KG, Krishnan B, Korpole S.","Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. strain GI-9.##The intramolecular disulfide-stapled structure of laterosporulin, a class IId bacteriocin, conceals a human defensin-like structural module.",,,,,,,,
3052,DRAMP18248,KYGDVPLY,8,Bifidin I(Bacteriocin),No entry found,Belongs to the class IIa bacteriocin,Unknown,Bifidobacterium infantis BCRC 14602,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,The N-terminal sequencing may also be blocked partially or totally which could be due to the structure of the peptide (circular) or N terminal capping.,"Gram-positive, Gram-negative",Unknown,Unknown,PubMed ID is not available,Food Control. 2010 May;21(5):746-753.,"Cheikhyoussef A,Cheikhyoussef N,Chen HQ,Zhao JX,Tang J,Zhang H,Chen W.",Bifidin I - A new bacteriocin produced by Bifidobacterium infantis BCRC 14602: Purification and partial amino acid sequence,,,,,,,,
3053,DRAMP18249,DWTFANWSCLVCDDCSVNLTV,21,Bac-GM100  (Bacteriocin),No entry found,Belongs to the class IId bacteriocin,Unknown,Brevibacillus brevis strain GM100,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,The 21 N-terminal residues of Bac-GM100 displayed 65% homology with thurincin H from Bacillus thuringiensis. Bac-GM100 was extremely heat-stable and was stable within a pH range of 3-10. It proved sensitive to various proteases.,"Gram-positive, Gram-negative",Unknown,Unknown,23291759,Biosci Biotechnol Biochem. 2013;77(1):151-60.,"Ghadbane M, Harzallah D, Laribi AI, Jaouadi B, Belhadj H.",Purification and biochemical characterization of a highly thermostable bacteriocin isolated from Brevibacillus brevis strain GM100.,,,,,,,,
3059,DRAMP18247,DWTXWSXL,8,Bacthuricin F4(Bacteriocin),No entry found,Belongs to the class IId bacteriocin,Unknown,Bacillus thuringiensis subsp. kurstaki strain BUPM4,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,No proteins were shown to have similar sequences in either their N-terminal regions or any other region.,Unknown,This bacteriocin was heat-stable up to 70 degrees C and resisted up to pH 3.0. Bacthuricin F4 was sensitive to proteases demonstrating its proteinaceous nature. ,"Gram-positive, Gram-negative",Unknown,Unknown,15752334,J Appl Microbiol. 2005;98(4):881-8.,"Kamoun F, Mejdoub H, Aouissaoui H, Reinbolt J, Hammami A, Jaoua S.
","Purification, amino acid sequence and characterization of Bacthuricin F4, a new bacteriocin produced by Bacillus thuringiensis.",,,,,,,,
3065,DRAMP02642,GFCRCLCRRGVCRCICTR,18,"Rhesus theta-defensin 1 (RTD-1; primates, mammals, animals)","P82271, P82270, Q9TU01",Belongs to the alpha-defensin family (Theta subfamily),Unknown,Macaca mulatta (Rhesus macaque),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (4 strands; 10 residues),Unknown,1HVZ resolved by NMR.,"Function: RTD-1 and RTD-2 have similar antimicrobial activities against the Gram-positive bacteria S. aureus 502A and L. monocytogenes, the Gram-negative bacterium S. typhimurium, and the fungi C. albicans 16820 and C. neoformans 271A. RTD-2 is 2-3-fold less active than RTD-1 against E. coli ML35.
Subunit structure: RTD-1 is a cyclic heterodimer composed of subunits A and B; disulfide-linked.
Tissue specificity: RTD-1 is expressed in bone marrow. Detected in promyelocytes, myelocytes and mature neutrophils and monocytes.
Developmental stage: RTD-1 expression begins early during granulocyte myelopoiesis.
PTM: Forms a cyclic peptide with 1 subunit B (RTD-2) or with 1 subunit A (RTD-1). An additional intersubunit disulfide bond is formed.
Miscellaneous: RTD-1 is 10-fold more present in cells than RTD-2.","Gram-positive bacteria: Staphylococcus aureus 502a and Listeria monocytogenes;##Gram-negative bacteria: Salmonella typhimurium, Escherichia coli ML35.##Fungi: Candida albicans 16820, Cryptococcus neoformans 271A (the activity of RTD-2 against Escherichia coli ML35 was 2-3-fold less than those of RTD-1 and RTD-3).",Unknown,Unknown,10521339##1152799##11675394,Science. 1999 Oct 15;286(5439):498-502.##J Leukoc Biol. 2001 Sep;70(3):461-464.##J Biol Chem. 2002 Feb 1;277(5):3079-3084.,"Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME.##Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.##Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME.","A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.##Circular minidefensins and posttranslational generation of molecular diversity.##Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.",,,,,,,,
3066,DRAMP02643,RCLCRRGVCRCLCRRGVC,18,"Rhesus theta-defensin 2 (RTD-2; primates, mammals, animals)",P82271,Belongs to the alpha-defensin family (Theta subfamily),Unknown,Macaca mulatta (Rhesus macaque),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: RTD-1 and RTD-2 have similar antimicrobial activities against the Gram-positive bacteria S. aureus 502A and L. monocytogenes, the Gram-negative bacterium S. typhimurium, and the fungi C. albicans 16820 and C. neoformans 271A. RTD-2 is 2-3-fold less active than RTD-1 against E. coli ML35.
Subunit structure: RTD-2 is a cyclic homodimer composed of two subunits B; disulfide-linked.
PTM: Forms a cyclic peptide with 1 subunit B (RTD-2) or with 1 subunit A (RTD-1). An additional intersubunit disulfide bond is formed.
Miscellaneous: RTD-1 is 10-fold more present in cells than RTD-2.","Gram-positive bacteria: Staphylococcus aureus 502a, Listeria monocytogenes; ##Gram-negative bacteria: Salmonella typhimurium, Escherichia coli ML35.##Fungi: Candida albicans 16820, Cryptococcus neoformans 271A (the activity of RTD-2 against Escherichia coli ML35 was 2-3-fold less than those of RTD-1 and RTD-3).",Unknown,Unknown,10521339##1152799##11675394,Science. 1999 Oct 15;286(5439):498-502.##J Leukoc Biol. 2001 Sep;70(3):461-464.##J Biol Chem. 2002 Feb 1;277(5):3079-3084.,"Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME.##Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.##Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME.","A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.##Circular minidefensins and posttranslational generation of molecular diversity.##Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.",,,,,,,,
3067,DRAMP02644,RCICTRGFCRCICTRGFC,18,"Rhesus theta-defensin 3 (RTD-3; primates, mammals, animals)","P82270, Q9TU01",Belongs to the alpha-defensin family (Theta subfamily),Unknown,Macaca mulatta (Rhesus macaque),"Antibacterial, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: RTD-1 and RTD-3 have similar antimicrobial activities against the Gram-positive bacteria, the Gram-negative bacteria and the fungi C. albicans 16820 and C. neoformans 271A.
Subunit structure RTD-1 is a cyclic heterodimer composed of subunits A and B; disulfide-linked. RTD-3 is a cyclic homodimer composed of two subunits A; disulfide-linked.
PTM: Forms a cyclic peptide with subunit A (RTD-3) or with subunit B (RTD-1). An additional intersubunit disulfide bond is formed.
Miscellaneous: RTD-1 is 10-fold more present in cells than RTD-3.","Gram-positive bacteria: Staphylococcus aureus 502a, Listeria monocytogenes;##Gram-negative bacteria: Salmonella typhimurium, Escherichia coli ML35.##Fungi: Candida albicans 16820, Cryptococcus neoformans 271A (the activity of RTD-2 against Escherichia coli ML35 was 2-3-fold less than those of RTD-1 and RTD-3).",Unknown,Unknown,10521339##1152799##11675394,Science. 1999 Oct 15;286(5439):498-502.##J Leukoc Biol. 2001 Sep;70(3):461-464.##J Biol Chem. 2002 Feb 1;277(5):3079-3084.,"Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME.##Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.##Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME.","A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.##Circular minidefensins and posttranslational generation of molecular diversity.##Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.",,,,,,,,
3075,DRAMP02653,ACYCRIPACLAGERRYGTCFYLGRVWAFCC,30,"Neutrophil defensin 1 (RMAD-1; primates, mammals, animals)",P60030,Belongs to the alpha-defensin family,Unknown,Macaca mulatta (Rhesus macaque) ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,Function: Has antibacterial and antifungal activiy. ,Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacterium: Escherichia coli.##Fungi: Cryptococcus neoformans.,Unknown,Unknown,10531277,Infect Immun. 1999 Nov;67(11):6139-6144.,"Tang YQ, Yuan J, Miller CJ, Selsted ME.","Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.",,,,,,,,
3076,DRAMP02654,ACYCRIPACLAGERRYGTCFYMGRVWAFCC,30,"Neutrophil defensin 2 (RMAD-2; primates, mammals, animals)",P82317,Belongs to the alpha-defensin family,Unknown,Macaca mulatta (Rhesus macaque) ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,Function: Has antibacterial and antifungal activiy. ,Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacterium: Escherichia coli.##Fungi: Cryptococcus neoformans.,Unknown,Unknown,10531277,Infect Immun. 1999 Nov;67(11):6139-6144.,"Tang YQ, Yuan J, Miller CJ, Selsted ME.","Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.",,,,,,,,
3081,DRAMP02659,ACYCRIPACLAGERRYGTCFYRRRVWAFCC,30,"Neutrophil defensin 3 (RMAD-3; primates, mammals, animals)","P60031, P82318",Belongs to the alpha-defensin family,Unknown,Macaca mulatta (Rhesus monkey),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has bacteriostatic and antifungal activity.
PTM: Contains three disulfide bonds: 2-30; 4-19; 9-29.",Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacteria: Escherichia coli.##Fungi: Cryptococcus neoformans.,Unknown,Unknown,10531277,Infect Immun. 1999 Nov;67(11):6139-6144.,"Tang YQ, Yuan J, Miller CJ, Selsted ME.","Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.",,,,,,,,
3082,DRAMP02660,RRTCRCRFGRCFRRESYSGSCNINGRIFSLCCR,33,"Neutrophil defensin 4 (RMAD-4; primates, mammals, animals)",P82319,Belongs to the alpha-defensin family,Unknown,Macaca mulatta (Rhesus monkey),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Defensins 4 has bacteriostatic and antifungal activity.
PTM: Contains three disulfide bonds 4-32; 6-21; 11-31.",Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacteria: Escherichia coli.##Fungi: Cryptococcus neoformans.,Unknown,Unknown,10531277,Infect Immun. 1999 Nov;67(11):6139-6144.,"Tang YQ, Yuan J, Miller CJ, Selsted ME.","Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.",,,,,,,,
3083,DRAMP02661,RTCRCRFGRCFRRESYSGSCNINGRIFSLCCR,32,"Neutrophil defensin 5 (RMAD-5; primates, mammals, animals)",P82319,Belongs to the alpha-defensin family,Unknown,Macaca mulatta (Rhesus monkey),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Defensins 5 has bacteriostatic and antifungal activity.
PTM: Contains three disulfide bonds 3-31; 5-20; 10-30.",Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacteria: Escherichia coli.##Fungi: Cryptococcus neoformans.,Unknown,Unknown,10531277,Infect Immun. 1999 Nov;67(11):6139-6144.,"Tang YQ, Yuan J, Miller CJ, Selsted ME.","Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.",,,,,,,,
3084,DRAMP02662,RRTCRCRFGRCFRRESYSGSCNINGRISSLCCR,33,"Neutrophil defensin 6 (RMAD-6; primates, mammals, animals)",P82320,Belongs to the alpha-defensin family,Unknown,Macaca mulatta (Rhesus monkey),"Antibacterial, Antifungal , Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Defensins 6 has bacteriostatic and antifungal activity.
PTM: Contains three disulfide bonds 65-93; 67-82; 72-92.",Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacteria: Escherichia coli.##Fungi: Cryptococcus neoformans.,Unknown,Unknown,10531277,Infect Immun. 1999 Nov;67(11):6139-6144.,"Tang YQ, Yuan J, Miller CJ, Selsted ME.","Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.",,,,,,,,
3085,DRAMP02663,RTCRCRFGRCFRRESYSGSCNINGRISSLCCR,32,"Neutrophil defensin 7 (RMAD-7; primates, mammals, animals)",P82320,Belongs to the alpha-defensin family,Unknown,Macaca mulatta (Rhesus monkey),"Antibacterial, Antifungal, Antimicrobial, Anti-Gram+, Anti-Gram-, ",Protein level,Bridge ,Unknown,Unknown,"Function: Defensins 7 has bacteriostatic and antifungal activity.
PTM: Contains three disulfide bonds 65-93; 67-82; 72-93.",Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes;##Gram-negative bacteria: Escherichia coli.##Fungi: Cryptococcus neoformans.,Unknown,Unknown,10531277,Infect Immun. 1999 Nov;67(11):6139-6144.,"Tang YQ, Yuan J, Miller CJ, Selsted ME.","Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.",,,,,,,,
3119,DRAMP02698,RRTCHCRSRCLRRESNSGSCNINGRIFSLCCR,32,"Rhesus macaque oral alpha-defensins (ROADs; primates, mammals, animals)",B5AKV3,Belongs to the alpha-defensin family,Unknown,Macaca mulatta (Rhesus monkey),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (3 strands; 19 residues),NMR spectroscopy shows that Synthetic ROAD-1 adopts the canonical disulfide pairing and alpha-defensin fold.,2K1I resolved by NMR.,"Function: ROAD-1 is active against Staphylococcus aureus, Escherichia coli, and Candida albicans in a concentration-dependent manner. The antimicrobial mechanism of defensins has been correlated with their ability to disrupt and permeabilize the cell envelope, activities that depend on the surface features of the folded peptide.
PTM: Contains three disulfide bonds.",Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.##Fungi: Candida albicans.,Unknown,Unknown,18930922,J Biol Chem. 2008 Dec 19;283(51):35869-35877.,"Vasudevan S, Yuan J, Osapay G, Tran P, Tai K, Liang W, Kumar V, Selsted ME, Cocco MJ.","Synthesis, structure, and activities of an oral mucosal alpha-defensin from rhesus macaque.",,,,,,,,
3128,DRAMP18242,EKYTEVPEYV,10,Fengycin B2 (Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus thuringiensis ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,K2 is Orn. The C-terminal V forms an ester bond with the side chain of Y3.,Unknown,Fuction: Active against fungi C. Albicans and A.niger. ,"Gram-positive, Gram-negative",Unknown,Unknown,24312083##22847390 ,Front Microbiol. 2013 Nov 21;4:332.##J Am Soc Mass Spectrom. 2012 Oct;23(10):1716-28. Epub 2012 Jul 31. ,"Roy A, Mahata D, Paul D, Korpole S, Franco OL, Mandal SM.##Pathak KV, Keharia H, Gupta K, Thakur SS, Balaram P.","Purification, biochemical characterization and self-assembled structure of a fengycin-like antifungal peptide from Bacillus thuringiensis strain SM1.##Lipopeptides from the banyan endophyte, Bacillus subtilis K1: mass spectrometric characterization of a library of fengycins.",,,,,,,,
3130,DRAMP18240,EKYTEIPEYV,10,Fengycin C(Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis K1,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,K2 is Orn.,Unknown,No comments found on DRAMP database,"Gram-positive, Gram-negative",Unknown,Unknown,22847390,J Am Soc Mass Spectrom. 2012 Oct;23(10):1716-28. Epub 2012 Jul 31.,"Pathak KV, Keharia H, Gupta K, Thakur SS, Balaram P.","Lipopeptides from the banyan endophyte, Bacillus subtilis K1: mass spectrometric characterization of a library of fengycins.",,,,,,,,
3131,DRAMP18241,TWATIGKTIVQSVKKCRTFTCGCSLGSCSNCN,32,Subtilomycin(Bacteriocin),No entry found,Belongs to the lantibiotics family (Class I bacteriocin),subA,Bacillus subtilis MMA7 ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,"There are extensive post-translational modifications: T1, T4 and T8 are dehydrated into Dhb. The N-terminal Dhb was unstable and further oxidized by deamination into 2-oxo butyrate. In addition, thioether or methylthioether bonds occur between the following residue pairs: S11-C15, T17-C21, T20-C23, S24-C28, and S27-C31.",Unknown,"Therefore the most likely sequence for the lantibiotic is Dhb*-W-A-Dhb-I-G-K-Dhb-I-V-Q-Dha-V-K-K-C-R-Dhb-F-Dhb-C-G-C-Dha-L-G-Dha-C-Dha-N-C-N, where the underlined amino acids have been experimentally confirmed by mass spectrometric analysis and the subsequent sequence predicted from the genomic sequence of strain MMA7.","Gram-positive, Gram-negative (broad spectrum)",Unknown,Unknown,23736764,Mar Drugs. 2013 Jun 3;11(6):1878-98.,"Phelan RW, Barret M, Cotter PD, O'Connor PM, Chen R, Morrissey JP, Dobson AD, O'Gara F, Barbosa TM.",Subtilomycin: a new lantibiotic from Bacillus subtilis strain MMA7 isolated from the marine sponge Haliclona simulans.,,,,,,,,
3132,DRAMP18239,EKYTEAPEYV,10,Fengycin A2(Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis K1,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,K2 is Orn. The C-terminal V forms an ester bond with the side chain of Y3.,Unknown,No comments found on DRAMP database,"Gram-positive, Gram-negative",Unknown,Unknown,22847390,J Am Soc Mass Spectrom. 2012 Oct;23(10):1716-28. Epub 2012 Jul 31.,"Pathak KV, Keharia H, Gupta K, Thakur SS, Balaram P.","Lipopeptides from the banyan endophyte, Bacillus subtilis K1: mass spectrometric characterization of a library of fengycins.",,,,,,,,
3133,DRAMP18238,EKYTEVPEYI,10,Fengycin B(Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis K1,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,K2 is Orn. The structure consists of a cyclic peptide lactone formed between the phenolic -OH of Tyr3 and the C-terminal -COOH of an amino acid at position 10. The N-terminus of the decapeptide segment is acylated with a beta-hydroxy fatty acid (beta-OH FA).,Unknown,No comments found on DRAMP database,"Gram-positive, Gram-negative",Unknown,Unknown,22847390,J Am Soc Mass Spectrom. 2012 Oct;23(10):1716-28. Epub 2012 Jul 31.,"Pathak KV, Keharia H, Gupta K, Thakur SS, Balaram P.","Lipopeptides from the banyan endophyte, Bacillus subtilis K1: mass spectrometric characterization of a library of fengycins.",,,,,,,,
3144,DRAMP18237,EKYTEAPEYI,10,Fengycin A(Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis K1,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",,Unknown,K2 is Orn. The structure consists of a cyclic peptide lactone formed between the phenolic -OH of Tyr3 and the C-terminal -COOH of an amino acid at position 10. The N-terminus of the decapeptide segment is acylated with a beta-hydroxy fatty acid (beta-OH FA).,Unknown,No comments found on DRAMP database,"Gram-positive, Gram-negative",Unknown,Unknown,22847390,J Am Soc Mass Spectrom. 2012 Oct;23(10):1716-28. Epub 2012 Jul 31.,"Pathak KV, Keharia H, Gupta K, Thakur SS, Balaram P.","Lipopeptides from the banyan endophyte, Bacillus subtilis K1: mass spectrometric characterization of a library of fengycins.",,,,,,,,
3157,DRAMP02739,EKKCPGRCTLKCGKHERPTLPYNCGKYICCVPVKVK,36,"TEWP (turtle egg-white protein; Reptiles, animals)",No entry found,Unknown,Unknown,Caretta caretta (Loggerhead turtle),"Antibacterial, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Beta strand (2 strands; 2 residues),The protein has no α-helix and consists of two antiparallel β-sheets. ,2B5B resolved by NMR.,"Function: The protein showes strong antibacterial activity against Escherichia coli and Salmonella typhimurium. The protein also showes significant antiviral activity against an enveloped rhabdovirus, Chandipura virus,","Gram-negative bacteria: Escherichia coli (IC50=2.3 μM), Salmonella typhimurium (IC50=2.8 μM);##Gram-positive bacterium: Staphylococcus aureus (IC50=5.1 μM).##Virus: enveloped rhabdovirus, Chandipura virus, Vesicular stomatitis virus.",Unknown,Unknown,16700051,Proteins. 2006 Aug 1;64(2):524-531.,"Chattopadhyay S, Sinha NK, Banerjee S, Roy D, Chattopadhyay D, Roy S.",Small cationic protein from a marine turtle has beta-defensin-like fold and antibacterial and antiviral activity.,,,,,,,,
3158,DRAMP02741,DDTPSSRCGSGGWGPCLPIVDLLCIVHVTVGCSGGFGCCRIG,42,"Pelovaterin (defensin-like AMP; Gly-rich; Reptiles, animals)",P84818,Unknown,Unknown,Pelodiscus sinensis (Chinese softshell turtle) (Trionyx sinensis),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,"An analysis of the ensemble of pelovaterin structures reveals that hydrophilic residues Asp1 Arg7 begin with a random coil structure leading to a short 310 helix between Cys8 and Gly12, whereas antiparallel â-strands are formed by the residues Leu17 Val20 (β), His27 Val28 (â2), and Gly34 Cys39 (â3) arranged in a βâ2â3 topology.",2JR3 resolved by NMR.,"Function: Induces the nucleation and stabilization of vaterite, one of the crystalline polymorphs of calcium carbonate. Exhibits strong antimicrobial activity against Pseudomonas aeruginosa and Proteus vulgaris.
PTM: Contains three disulfide bonds 8-38; 16-32; 24-39.","Gram-negative bacteria: Pseudomonas aeruginosa (EC50=0.42 μg/mL), Proteus vulgaris (EC50=0.37 μg/mL), Proteus mirabilis (EC50=8.4 μg/mL);##Gram-positive bacterium: Staphylococcus aureus (EC50=42 μg/mL).",Unknown,Unknown,15877362##18341335,Biomacromolecules. 2005 May-Jun;6(3):1429-37.##J Am Chem Soc. 2008 Apr 9;130(14):4660-8.,"Lakshminarayanan R, Chi-Jin EO, Loh XJ, Kini RM, Valiyaveettil S.##minarayanan R, Vivekanandan S, Samy RP, Banerjee Y, Chi-Jin EO, Teo KW, Jois SD, Kini RM, Valiyaveettil S.","Purification and characterization of a vaterite-inducing peptide, pelovaterin, from the eggshells of Pelodiscus sinensis (Chinese soft-shelled turtle).##Structure, self-assembly, and dual role of a beta-defensin-like peptide from the Chinese soft-shelled turtle eggshell matrix.",,,,,,,,
3159,DRAMP02742,QKKCPGRCTLKCGKHERPTLPYNCGKYICCVPVKVK,36,"Defensin-like turtle egg white protein TEWP (TEWP; Reptiles, animals)",P0CAP0,Belongs to the beta-defensin family,Unknown,Caretta caretta (Loggerhead sea turtle),"Antibacterial, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (2 strands; 2 residues),Three-dimensional structure of TEWP was determined by distance geometry and simulated annealing. The protein has no α-helix and consists of two antiparallel β-sheets. The secondary structure is consistent with the previously obtained circular dichroism spectra. ,2B5B resolved by NMR.,"Function: The protein showes strong antibacterial activity against Escherichia coli and Salmonella typhimurium and also showes significant antiviral activity against an enveloped rhabdovirus, Chandipura virus, which is an emerging human pathogen.
Tissue specificity: Detected in egg white (at protein level).","Gram-negative bacteria: Escherichia coli (IC50=3.3 μM), Salmonella typhimurium (IC50=2.8 μM);##Gram-positive bacterium: Staphylococcus aureus (IC50=5. 1μM).",Unknown,Unknown,16700051,Proteins. 2006 Aug 1;64(2):524-531.,"Chattopadhyay S, Sinha NK, Banerjee S, Roy D, Chattopadhyay D, Roy S.",Small cationic protein from a marine turtle has beta-defensin-like fold and antibacterial and antiviral activity.,,,,,,,,
3168,DRAMP03743,RSVCRQIKICRRRGGCYYKCTNRPY,25,"Androctonin (Arthropods, animals)",P56684,Unknown,Unknown,Androctonus australis (Sahara scorpion),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Beta strand (2 strands; 8 residues),The structure of androctonin involves a well-defined highly twisted anti-parallel beta-sheet with strands connected by a more variable positively charged turn.,1CZ6 resolved by NMR.,"Function: Androctonin is a highly cationic antimicrobial peptide from scorpion exhibiting a broad spectrum of activities against bacteria (Gram-positive and Gram-negative) and filamentous fungi. Acts on the membrane of the bacterial cells. It destabilize a membrane by modifying its properties.
PTM: Contains two disulfide bonds 4-20; 10-16.","[Ref.10942757] Gram-positive bacteria: Micrococcus luteus (MIC=0.6-1.5 μM), Aerococcus viridans (MIC=0.3-0.6 μM), Staphylococcus aureus (MIC=15-30 μM);##Gram-negative bacteria: Escherichia coli D31 (MIC=3-6 μM),  Escherichia coli D22 (MIC=6-15 μM),  Escherichia coli 1106 (MIC=6-15 μM), Salmonella typhimurium (MIC=3-6 μM).##Fungi: Alternaria brassicola (MIC=3-6 μM), Fusarium culmorum (MIC=3-6 μM), Fusarium oxysporum (MIC=6-12 μM), Neurospora crassa (MIC=6-12 μM), Nectria haematococca (MIC=6-12 μM), Trichoderma viridae (MIC=6-12 μM);##Yeast: Candida albicans (MIC=1.6-3.15 μM).##[Ref.8939880] Gram-positive bacteria: Bacillus subtilis (MIC=1.5-3.0 μM);##Gram-negative bacteria: Escherichia coli D22 (MIC>30 μM), Pseudomonas syringae (MIC=1.5-3.0 μM), Pseudomonas syringae pv.syringae (MIC=15-22 μM), Pseudomonas syringae phaseoli (MIC=1.5-3.0 μM), Pseudomonas syringae pv.pisi (MIC=6-15 μM), Pseudomonas syringae pv. maculicola (MIC=3-6 μM), Phoma valerianella (MIC=15-22 μM), Xanthomonas compestris pv.compestris (MIC=3-6 μM), Xanthomonas vesicatoria 687.3 (MIC=1.5-3.0 μM), Xanthomonas vesicatoria B229RI (MIC=1.5-3.0 μM);##Fungi: Alternaria dauci (MIC=8-16 μM), Stemphylium (MIC=4-8 μM),  Fusarium oxysporum M. (MIC=2-4 μM), Fusarium oxysporum L. (MIC=2-4 μM), Botrytis cinerea (MIC=6-12 μM), B. petunia (MIC=4-8 μM), Verticilium toreilis (MIC=2-4 μM), Aspergillus fumigatus (MIC=25-50 μM).",Unknown,Cell membrane,8939880##10563585##10942757,J Biol Chem. 1996 Nov 22;271(47):29537-29544.##J Biomol Struct Dyn. 1999 Oct;17(2):367-380.##J Biol Chem. 2000 Oct 27;275(43):33464-70.,"Ehret-Sabatier L, Loew D, Goyffon M, Fehlbaum P, Hoffmann JA, van Dorsselaer A, Bulet P.##Mandard N, Sy D, Maufrais C, Bonmatin JM, Bulet P, Hetru C, Vovelle F.##Silva PI Jr, Daffre S, Bulet P.","Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood.##Androctonin, a novel antimicrobial peptide from scorpion Androctonus australis: solution structure and molecular dynamics simulations in the presence of a lipid monolayer.##Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family.",,,,,,,,
3171,DRAMP02755,GWKDWLNKGKEWLKKKGPGIMKAALKAATQ,30,"Ponericin G3 (ants, insects, animals)",P82416,Unknown,Unknown,Pachycondyla goeldii (Ponerine ant),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,MOA: The comparison of ponericins with those well-studied peptides suggests that ponericins may adopt an amphipathic alpha-helical structure on cell membranes.,"Gram-positive bacteria: Bacillus cereus CIP 6624a, B. megaterium ATCC 9885b, B. stearothermophilus CIP 675, B. stearothermophilus CIP 675, B. subtilis ATCC 6623, Enterococcus faecalis CIP 636, Lactococcus lactis ssp. cremoris I116, Streptococcus pyogenes CIP 561, S. sanguinis CIP 55128, Listeria ivanovii LMA 94d, Listeria monocytogenes ATCC 15313, Micrococcus luteus CIP 5345, Staphylococcus aureus CIP 677, Staphylococcus aureus LMA, S. epidermidis CIP 53134;##Gram-negative bacteria: Escherichia coli, Enterobacter cloacae CIP 6085, Klebsiella pneumoniae CIP 8291, Proteus mirabilis LMA TP, Salmonella enterica CIP 813, Serratia marcescens LMA TP, Alcaligenes faecalis CIP 6723, Pseudomonas aeruginosa CIP A22, Proteus mirabilis LMA TP, Flavobacterium meningosepticum CIP 6057, Pseudomonas aeruginosa CIP A22, Yersinia entericolitica CIP 6529, P. putida LMA, Saccharomyces cerevisiae LMA 720.",Unknown,Unknown,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chafotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",,,,,,,,
3172,DRAMP02756,DFKDWMKTAGEWLKKKGPGILKAAMAAAT,29,"Ponericin G4 (ants, insects, animals)",P82417,Unknown,Unknown,Pachycondyla goeldii (Ponerine ant),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,MOA: The comparison of ponericins with those well-studied peptides suggests that ponericins may adopt an amphipathic alpha-helical structure on cell membranes.,"Gram-positive bacteria: B. cereus CIP 6624a, Bacillus megaterium ATCC 9885b, B.stearothermophilus CIP 675, B.stearothermophilus CIP 675, Bacillus subtilis ATCC 6623, Lactococcus lactis ssp. cremoris I116, Streptococcus pyogenes CIP 561, S. sanguinis CIP 55128, Micrococcus luteus CIP 5345;##Gram-negative bacteria: Klebsiella pneumoniae CIP 8291, Pseudomonas aeruginosa CIP A22, Saccharomyces cerevisae.",Unknown,Unknown,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chafotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",,,,,,,,
3174,DRAMP02758,GLVDVLGKVGGLIKKLLP,18,"Ponericin G6 (ants, insects, animals)",P82419,Unknown,Unknown,Pachycondyla goeldii (Ponerine ant),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has activity against Gram-positive bacteria and S. cerevisiae. Has non-hemolytic activity.
Tissue specificity: Expressed by the venom gland.","[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a, B. megaterium ATCC 9885b, B. stearothermophilus CIP 675, B. stearothermophilus CIP 675, B. subtilis ATCC 6623, Lactococcus lactis ssp. cremoris I116, Streptococcus pyogenes CIP 561, S. sanguinis CIP 55128, Listeria monocytogenes ATCC 15313, Micrococcus luteus CIP 5345, Staphylococcus aureus CIP 677, S. epidermidis CIP 53134;##Gram-negative bacteria: Klebsiella pneumoniae CIP 8291, Pseudomonas aeruginosa CIP A22, Saccharomyces cerevisiae LMA 720.",[Ref.11279030]Non-hemolytic activity against horse and sheep erythrocytes,Unknown,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chafotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",,,,,,,,
3176,DRAMP02760,LLKELWTKMKGAGKAVLGKIKGLL,24,"Ponericin-L1 (ants, insects, animals)",P82421,Unknown,Unknown,Pachycondyla goeldii (Ponerine ant),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the venom gland.",[Swiss_Prot Entry P82421]Broad spectrum of activity against both Gram-positive and Gram-negative bacteria,Unknown,Unknown,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",,,,,,,,
3177,DRAMP02761,LLKELWTKIKGAGKAVLGKIKGLL,24,"Ponericin-L2 (ants, insects, animals)",P82422,Unknown,Unknown,Pachycondyla goeldii (Ponerine ant),"Antibacterial, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria. 
Tissue specificity: Expressed by the venom gland.","[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 6.5mm), B. megaterium ATCC 9885b(Inhibition zone = 14mm), B. stearothermophilus CIP 675(Inhibition zone = 21mm), B. subtilis ATCC 6623(Inhibition zone = 13.5mm), Enterococcus faecalis CIP 636(Inhibition zone = 4mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 15.5mm), Streptococcus pyogenes CIP 561(Inhibition zone = 12.5mm), S. sanguinis CIP 55128(Inhibition zone = 6mm), Listeria ivanovii LMA 94d(Inhibition zone = 9.5mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 9.5mm), Micrococcus luteus CIP 5345(Inhibition zone = 10.5mm), Staphylococcus aureus CIP 677(Inhibition zone = 4.5mm), Staphylococcus aureus LMA(Inhibition zone = 11mm), S. epidermidis CIP 53134(Inhibition zone = 11.5mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 4mm), Enterobacter cloacae CIP 6085(Inhibition zone = 5mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 3.5mm), Proteus mirabilis LMA TP(Inhibition zone = 9mm), Salmonella enterica CIP 813(Inhibition zone = 1.5mm), Serratia marcescens LMA TP(Inhibition zone = 9mm), Flavobacterium meningosepticum CIP 6057(Inhibition zone = 7mm), Pseudomonas aeruginosa CIP A22(Inhibition zone = 14mm).",[Ref.11279030]Unknown,Unknown,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",,,,,,,,
3178,DRAMP02762,WLGSALKIGAKLLPSVVGLFKKKKQ,25,"Ponericin-W1 (ants, insects, animals)",P82423,Belongs to the ponericin-W family,Unknown,Pachycondyla goeldii (Ponerine ant),"Antibacterial, Antifungal, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities. 
Tissue specificity: Expressed by the venom gland.","[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 10mm), B. megaterium ATCC 9885b(Inhibition zone = 12.5mm), B. stearothermophilus CIP 675(Inhibition zone = 17mm), B. subtilis ATCC 6623(Inhibition zone = 12mm), Enterococcus faecalis CIP 636(Inhibition zone = 6mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 15mm), Streptococcus pyogenes CIP 561(Inhibition zone = 10mm), S. sanguinis CIP 55128(Inhibition zone = 7.5mm), Listeria ivanovii LMA 94d(Inhibition zone = 11.5mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 9.5mm), Micrococcus luteus CIP 5345(Inhibition zone = 11.5mm), Staphylococcus aureus CIP 677(Inhibition zone = 10mm), Staphylococcus aureus LMA(Inhibition zone = 13.5mm), S. epidermidis CIP 53134(Inhibition zone = 13.5mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 8mm), Enterobacter cloacae CIP 6085(Inhibition zone = 3mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 6.5mm), Proteus mirabilis LMA TP(no detected), Salmonella enterica CIP 813(Inhibition zone = 3mm), Serratia marcescens LMA TP(no detected), Flavobacterium meningosepticum CIP 6057(Inhibition zone = 6mm), Pseudomonas aeruginosa CIP A22(Inhibition zone = 16mm).",[Ref.11279030]2mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent),Unknown,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",,,,,,,,
3180,DRAMP02764,GIWGTLAKIGIKAVPRVISMLKKKKQ,26,"Ponericin-W3 (ants, insects, animals)",P82425,Unknown,Unknown,Pachycondyla goeldii (Ponerine ant),"Antibacterial, Antifungal, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities. 
Tissue specificity: Expressed by the venom gland.","[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 10mm), B. megaterium ATCC 9885b(Inhibition zone = 13.5mm), B. stearothermophilus CIP 675(Inhibition zone = 17mm), B. subtilis ATCC 6623(Inhibition zone = 13mm), Enterococcus faecalis CIP 636(Inhibition zone = 8mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 17.5mm), Streptococcus pyogenes CIP 561(Inhibition zone = 11.5mm), S. sanguinis CIP 55128(Inhibition zone = 10mm), Listeria ivanovii LMA 94d(Inhibition zone = 14mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 11mm), Micrococcus luteus CIP 5345(Inhibition zone = 11mm), Staphylococcus aureus CIP 677(Inhibition zone = 13mm), Staphylococcus aureus LMA(Inhibition zone = 18mm), S. epidermidis CIP 53134(Inhibition zone = 15mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 10mm), Enterobacter cloacae CIP 6085(Inhibition zone = 4mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 7.5mm), Proteus mirabilis LMA TP(no detected), Salmonella enterica CIP 813(Inhibition zone = 4mm), Serratia marcescens LMA TP(Inhibition zone = 11mm), Flavobacterium meningosepticum CIP 6057(no detected), Pseudomonas aeruginosa CIP A22(Inhibition zone = 18.5mm).",[Ref.11279030]1mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent),Unknown,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",,,,,,,,
3181,DRAMP02765,GIWGTALKWGVKLLPKLVGMAQTKKQ,26,"Ponericin-W4 (ants, insects, animals)",P82426,Unknown,Unknown,Pachycondyla goeldii (Ponerine ant),"Antibacterial, Antifungal, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities. 
Tissue specificity: Expressed by the venom gland.","[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 8.5mm), B. megaterium ATCC 9885b(Inhibition zone = 13.5mm), B. stearothermophilus CIP 675(Inhibition zone = 18mm), B. subtilis ATCC 6623(Inhibition zone = 13mm), Enterococcus faecalis CIP 636(Inhibition zone = 3mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 14mm), Streptococcus pyogenes CIP 561(Inhibition zone = 8mm), S. sanguinis CIP 55128(Inhibition zone = 7mm), Listeria ivanovii LMA 94d(Inhibition zone = 10mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 10mm), Micrococcus luteus CIP 5345(Inhibition zone = 12.5mm), Staphylococcus aureus CIP 677(Inhibition zone = 11.5mm), Staphylococcus aureus LMA(Inhibition zone = 13.5mm), S. epidermidis CIP 53134(Inhibition zone = 11.5mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 8.5mm), Enterobacter cloacae CIP 6085(Inhibition zone = 16.5mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 9mm), Proteus mirabilis LMA TP(no detected), Salmonella enterica CIP 813(no detected), Serratia marcescens LMA TP(Inhibition zone = 13mm), Flavobacterium meningosepticum CIP 6057(no detected), Pseudomonas aeruginosa CIP A22(Inhibition zone = 17mm).",[Ref.11279030]2mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent),Unknown,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",,,,,,,,
3182,DRAMP02766,FWGALIKGAAKLIPSVVGLFKKKQ,24,"Ponericin-W5 (ants, insects, animals)",P82427,Belongs to the ponericin-W family,Unknown,Pachycondyla goeldii (Ponerine ant),"Antibacterial, Antifungal, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities. 
Tissue specificity: Expressed by the venom gland.","[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 7mm), B. megaterium ATCC 9885b(Inhibition zone = 12mm), B. stearothermophilus CIP 675(Inhibition zone = 17mm), B. subtilis ATCC 6623(Inhibition zone = 13mm), Enterococcus faecalis CIP 636(Inhibition zone = 3mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 11mm), Streptococcus pyogenes CIP 561(Inhibition zone = 6.5mm), S. sanguinis CIP 55128(Inhibition zone = 4.5mm), Listeria ivanovii LMA 94d(Inhibition zone = 8mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 6.5mm), Micrococcus luteus CIP 5345(Inhibition zone = 11mm), Staphylococcus aureus CIP 677(Inhibition zone = 7.5mm), Staphylococcus aureus LMA(Inhibition zone = 9mm), S. epidermidis CIP 53134(Inhibition zone = 7.5mm);##Gram-negative bacteria: Escherichia coli(Inhibition zone = 3mm), Enterobacter cloacae CIP 6085(Inhibition zone = 11mm), Klebsiella pneumoniae CIP 8291(Inhibition zone = 6.5mm), Proteus mirabilis LMA TP(no detected), Salmonella enterica CIP 813(no detected), Serratia marcescens LMA TP(Inhibition zone = 11mm), Flavobacterium meningosepticum CIP 6057(Inhibition zone = 5mm), Pseudomonas aeruginosa CIP A22(Inhibition zone = 14mm).",[Ref.11279030]4mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent),Unknown,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",,,,,,,,
3183,DRAMP02767,FIGTALGIASAIPAIVKLFK,20,"Ponericin-W6 (ants, insects, animals)",P82428,Unknown,Unknown,Pachycondyla goeldii (Ponerine ant),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Activity against Gram-positive bacteria. Has insecticidal and hemolytic activities.
Tissue specificity: Expressed by the venom gland.","[Ref.11279030]Gram-positive bacteria: Bacillus cereus CIP 6624a(Inhibition zone = 9.5mm), B. megaterium ATCC 9885b(Inhibition zone = 17mm), B. stearothermophilus CIP 675(Inhibition zone = 18mm), B. subtilis ATCC 6623(Inhibition zone = 15mm), Enterococcus faecalis CIP 636(Inhibition zone = 3mm), Lactococcus lactis ssp. cremoris I116(Inhibition zone = 11mm), Streptococcus pyogenes CIP 561(Inhibition zone = 9.5mm), S. sanguinis CIP 55128(Inhibition zone = 4mm), Listeria ivanovii LMA 94d(Inhibition zone = 5mm), Listeria monocytogenes ATCC 15313(Inhibition zone = 4mm), Micrococcus luteus CIP 5345(Inhibition zone = 11mm), Staphylococcus aureus CIP 677(Inhibition zone = 7mm), Staphylococcus aureus LMA(Inhibition zone = 10mm), S. epidermidis CIP 53134(Inhibition zone = 7mm);##Gram-negative bacteria: Serratia marcescens LMA TP(Inhibition zone = 13mm), Pseudomonas aeruginosa CIP A22(Inhibition zone = 14mm).",[Ref.11279030]3mm in test condition against horse erythrocytes (A 12-ml sample of blood agar medium was supplemented with 1 ml of sheep or horse erythrocytes. Wells 5 mm in diameter were filled with 20 μl of the peptide solution and placed overnight at 4℃ to allow the diffusion of the hemolytic agent),Unknown,11279030,J. Biol. Chem. 2001; 276: 17823-17829.,"Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J.","Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",,,,,,,,
3184,DRAMP02770,IIGLVSKGTCVLVKTVCKKVLKQG,24,"Pilosulin 3 (ants, insects, animals)",Q68Y23,Belongs to the pilosulin family,Unknown,Myrmecia banksi (Jack jumper ant) (Australian jumper ant),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Shows moderate activity against E. coli and S. aureus (MIC<25 μM), slight activity against B. subtilis (MIC<50 μM), and no activity against L. garvieae, P. aeruginosa, C. albicans, and S. cerevisiae. Has no hemolytic nor cytolytic activity. Causes an IgE-independent histamine release. 
Tissue specificity: Expressed by the venom gland.","[Ref.15246874]Gram-negative bacteria: Escherichia coli (MIC<25 μM);##Gram-positive bacteria: Staphylococcus aureus(MIC<25 μM), Bacillus subtilis (MIC<50 μM).",[Ref.15246874]Non-hemolytic activity at 50 μM against human whole blood,IgE,15246874,Arch Biochem Biophys. 2004 Aug 15;428(2):170-178.,"Inagaki H, Akagi M, Imai HT, Taylor RW, Kubo T.","Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia.",,,,,,,,
3185,DRAMP02771,FDITKLNIKKLTKATCKVISKGASMCKVLFDKKKQE,36,"Pilosulin 4 (ants, insects, animals)",Q68Y22,Belongs to the pilosulin family,Unknown,Myrmecia banksi (Jack jumper ant) (Australian jumper ant),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Shows activity against E.coli and S.aureus, moderate activity against P.aeruginosa, weak activity against B.subtilis, and has no effect against L.garvieae, C.albicans, and S.cerevisiae. Has no hemolytic nor cytolytic activity. Causes an IgE-independent histamine release. 
Tissue specificity: Expressed by the venom gland.","[Ref.15246874]Gram-positive bacteria: Staphylococcus aureus (MIC<6.25 μM), Bacillus subtilis (MIC<50 μM);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC<25 μM), Escherichia coli (MIC<6.25 μM).",[Ref.15246874]Non-hemolytic activity at 50 μM against human whole blood, IgE ,15246874,Arch Biochem Biophys. 2004 Aug 15;428(2):170-178.,"Inagaki H, Akagi M, Imai HT, Taylor RW, Kubo T.","Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 5, from a species of the Australian ant genus Myrmecia.",,,,,,,,
3189,DRAMP02781,SLQGGAPNFPQPSQQNGGWQVSPDLGRDDKGNTRGQIEIQNKGKDHDFNAGWGKVIRGPNKAKPTWHVGGTYRR,74,"Coleoptericin (Insects, animals)",P80032,Belongs to the coleoptericin family,Unknown,Zophobas atratus (Giant mealworm beetle) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Responsible for the anti Gram-negative activity of immune hemolymph of Z. atratus.,"Gram-negative bacteria: Escherichia coli D31, E. coli D22 (highly activity), Acinetobacter baumannii, Pseudomonas maltophilia (lower activity);##Gram-positive bacterium: Micrococcus luteus.",Unknown,Unknown,1761552,J Biol Chem. 1991 Dec 25;266(36):24520-24525.,"Bulet P, Cociancich S, Dimarcq JL, Lambert J, Reichhart JM, Hoffmann D, Hetru C, Hoffmann JA.",Insect immunity. Isolation from a coleopteran insect of a novel inducible antibacterial peptide and of new members of the insect defensin family.,,,,,,,,
3191,DRAMP02783,FTCDVLGFEIAGTKLNSAACGAHCLALGRTGGYCNSKSVCVCR,43,"Peptide C (Insects, animals)",No entry found,Unknown,Unknown,Zophobas atratus (Giant mealworm beetle) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli D22;##Gram-positive bacteria: Micrococcus luteus, Corynebacterium D2, Streptococcus pyogenes, Bacillus subtilis QB935.",Unknown,Unknown,1761552,J Biol Chem. 1991 Dec 25;266(36):24520-24525.,"Bulet P, Cociancich S, Dimarcq JL, Lambert J, Reichhart JM, Hoffmann D, Hetru C, Hoffmann JA.",Insect immunity. Isolation from a coleopteran insect of a novel inducible antibacterial peptide and of new members of the insect defensin family.,,,,,,,,
3192,DRAMP02784,SLQPGAPNVNNKDQPWQVSPHISRDDSGNTRTDINVQRHGENNDFEAGWSKVVRGPNKAKPTWHIGGTHRW,71,"Acaloleptin-A1 (chain of Acaloleptin A; Insects, animals)","P81592, Q76K70",Belongs to the coleoptericin family,Unknown,Acalolepta luxuriosa (Udo longhorn beetle),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Acaloleptins A1 show antibacterial activity against Gram-negative bacteria but not against Gram-positive bacteria.
Tissue specificity: Hemolymph (at protein level). Larval fat body.
Induction: By bacterial infection. Expression detected 2 hours post-injection, with expression increasing until 48 hours post-injection and remaining considerably high at least until 72 hours post-injection.","Gram-negative bacteria: Escherichia coli, Aeromonas hydrophila, Erwinia persicinus, Serratia marcescens, Aeromonas hydrophila. ",Unknown,Unknown,10077828##19527748,Arch Insect Biochem Physiol. 1999;40(2):88-98.##Dev Comp Immunol. 2009 Oct;33(10):1120-1127. ,"Imamura M, Wada S, Koizumi N, Kadotani T, Yaoi K, Sato R, Iwahana H.##Imamura M, Wada S, Ueda K, Saito A, Koizumi N, Iwahana H, Sato R.","Acaloleptins A: inducible antibacterial peptides from larvae of the beetle, Acalolepta luxuriosa.##Multipeptide precursor structure of acaloleptin A isoforms, antibacterial peptides from the Udo longicorn beetle, Acalolepta luxuriosa.",,,,,,,,
3193,DRAMP02785,SLQPGAPNINNKDQPWQVSPHISRDDNGNTRTNINVQRHGENNDFEAGWSKVVRGPNKAKPTWHIGGTHRW,71,"Acaloleptin-A2 (chain of Acaloleptin A; Insects, animals)","P81592, Q76K70",Belongs to the coleoptericin family,Unknown,Acalolepta luxuriosa (Udo longhorn beetle),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Acaloleptins A2 show antibacterial activity against Gram-negative bacteria but not against Gram-positive bacteria.
Induction: By bacterial infection. Expression detected 2 hours post-injection, with expression increasing until 48 hours post-injection and remaining considerably high at least until 72 hours post-injection.","Gram-negative bacteria: Escherichia coli, Aeromonas hydrophila, Erwinia persicinus, Serratia marcescens, Aeromonas hydrophila. ",Unknown,Unknown,10077828##19527748,Arch Insect Biochem Physiol. 1999;40(2):88-98.##Dev Comp Immunol. 2009 Oct;33(10):1120-1127. ,"Imamura M, Wada S, Koizumi N, Kadotani T, Yaoi K, Sato R, Iwahana H.##Imamura M, Wada S, Ueda K, Saito A, Koizumi N, Iwahana H, Sato R.","Acaloleptins A: inducible antibacterial peptides from larvae of the beetle, Acalolepta luxuriosa.##Multipeptide precursor structure of acaloleptin A isoforms, antibacterial peptides from the Udo longicorn beetle, Acalolepta luxuriosa.",,,,,,,,
3194,DRAMP02786,SLQPGAPNVNNKDQPWQVSPHISRDDSGNTRTNINVQRHGENNDFEAGWSKVVRGPNKAKPTWHIGGTHRW,71,"Acaloleptin-A3 (chain of Acaloleptin A; Insects, animals)","P81592, Q76K70",Belongs to the coleoptericin family,Unknown,Acalolepta luxuriosa (Udo longhorn beetle),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Acaloleptins A3 show antibacterial activity against Gram-negative bacteria but not against Gram-positive bacteria.
Induction: By bacterial infection. Expression detected 2 hours post-injection, with expression increasing until 48 hours post-injection and remaining considerably high at least until 72 hours post-injection.","Gram-negative bacteria: Escherichia coli, Aeromonas hydrophila, Erwinia persicinus, Serratia marcescens, Aeromonas hydrophila. ",Unknown,Unknown,10077828##19527748,Arch Insect Biochem Physiol. 1999;40(2):88-98.##Dev Comp Immunol. 2009 Oct;33(10):1120-1127. ,"Imamura M, Wada S, Koizumi N, Kadotani T, Yaoi K, Sato R, Iwahana H.##Imamura M, Wada S, Ueda K, Saito A, Koizumi N, Iwahana H, Sato R.","Acaloleptins A: inducible antibacterial peptides from larvae of the beetle, Acalolepta luxuriosa.##Multipeptide precursor structure of acaloleptin A isoforms, antibacterial peptides from the Udo longicorn beetle, Acalolepta luxuriosa.",,,,,,,,
3195,DRAMP02787,SLQPGAPNVNNKDQPWQVSPHISRDDSGNTNTDINLQRHGENHDFDAGWSKVVRGPNKAKPTWHVGGTYRW,71,"Acaloleptin-A4 (chain of Acaloleptin A; Insects, animals)","P81592, Q76K70",Belongs to the coleoptericin family,Unknown,Acalolepta luxuriosa (Udo longhorn beetle),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Acaloleptins A4 show antibacterial activity against Gram-negative bacteria but not against Gram-positive bacteria.
Induction: By bacterial infection. Expression detected 2 hours post-injection, with expression increasing until 48 hours post-injection and remaining considerably high at least until 72 hours post-injection.","Gram-negative bacteria: Escherichia coli, Aeromonas hydrophila, Erwinia persicinus, Serratia marcescens, Aeromonas hydrophila. ",Unknown,Unknown,10077828##19527748,Arch Insect Biochem Physiol. 1999;40(2):88-98.##Dev Comp Immunol. 2009 Oct;33(10):1120-1127. ,"Imamura M, Wada S, Koizumi N, Kadotani T, Yaoi K, Sato R, Iwahana H.##Imamura M, Wada S, Ueda K, Saito A, Koizumi N, Iwahana H, Sato R.","Acaloleptins A: inducible antibacterial peptides from larvae of the beetle, Acalolepta luxuriosa.##Multipeptide precursor structure of acaloleptin A isoforms, antibacterial peptides from the Udo longicorn beetle, Acalolepta luxuriosa.",,,,,,,,
3196,DRAMP02788,SDDEDEEEEEDQPWQLNPNIARGDDGNTRADVNIKRRGENHDFEAGWSKVVDGPDRAKPTWHVGGTFRW,69,"Acaloleptin-A5 (chain of Acaloleptin A; Insects, animals)","P81592, Q76K70",Belongs to the coleoptericin family,Unknown,Acalolepta luxuriosa (Udo longhorn beetle),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Acaloleptin A5 shows antibacterial activity against Gram-positive bacteria but not against Gram-negative bacteria, and may also have antifungal activity.
Induction: By bacterial infection. Expression detected 2 hours post-injection, with expression increasing until 48 hours post-injection and remaining considerably high at least until 72 hours post-injection.","Gram-negative bacteria: Escherichia coli, Aeromonas hydrophila, Erwinia persicinus, Serratia marcescens, Aeromonas hydrophila. ",Unknown,Unknown,10077828##19527748,Arch Insect Biochem Physiol. 1999;40(2):88-98.##Dev Comp Immunol. 2009 Oct;33(10):1120-1127. ,"Imamura M, Wada S, Koizumi N, Kadotani T, Yaoi K, Sato R, Iwahana H.##Imamura M, Wada S, Ueda K, Saito A, Koizumi N, Iwahana H, Sato R.","Acaloleptins A: inducible antibacterial peptides from larvae of the beetle, Acalolepta luxuriosa.##Multipeptide precursor structure of acaloleptin A isoforms, antibacterial peptides from the Udo longicorn beetle, Acalolepta luxuriosa.",,,,,,,,
3210,DRAMP02803,GCASRCKAKCAGRRCKGWASASFRGRCYCKCFRC,34,"Mytilin-A (molluscas, animals)",P81612,Unknown,Unknown,Mytilus edulis (Blue mussel),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity. It is active against the marine species Alteromonas carrageenovora, Pseudomonas alginovora and Cytophaga drobachiensis.","Gram-positive bacteria: Aerococcus viridans, Bacillus megaterium, Micrococcus luteus, Enterococcus faecalis, Staphylococcus aureus;##Gram-negative bacteria: Escherichia coli, Alteromonas carrageenovora, Pseudomonas alginovora, Cytophaga drobachiensis.",Unknown,Unknown,8702979,J Biol Chem. 1996 Sep 6;271(36):21808-21813.,"Charlet M, Chernysh S, Philippe H, Hetru C, Hoffmann JA, Bulet P.","Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis.",,,,,,,,
3211,DRAMP02804,GFGCPNDYPCHRHCKSIPGRYGGYCGGXHRLRCTC,35,"Mytilus defensin-B (molluscas, animals)",P81611,Belongs to the invertebrate defensin family (Type 2 subfamily),Unknown,Mytilus edulis (Blue mussel),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,Function: Has antibacterial activity.,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.,Unknown,Unknown,8702979,J Biol Chem. 1996 Sep 6;271(36):21808-21813.,"Charlet M, Chernysh S, Philippe H, Hetru C, Hoffmann JA, Bulet P.","Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis.",,,,,,,,
3219,DRAMP18235,LLEL,4,Gageopeptide D(Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis,"Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",,Unknown,"Leu-Leu-Glu-Leu-3-beta-hydroxy-9,11-dimethyltetradecanoic acid",Unknown,"Non-cytotoxic antifungal agents. It was revealed that compounds 1 and 2 exhibited stronger antifungal activity than 3 and 4. Compounds 1 and 2 were structurally different from compounds 3 and 4 in terms of having less side chains in the fatty acid units, suggesting that the side chain length and the additional methyl group in the aliphatic chain are important for antifungal activity. These compounds also showed potent antimicrobial activity against Gram positive and Gram negative bacteria.","Gram-positive, Gram-negative",Unknown,Unknown,2485741,Yan Ke Xue Bao. 1989 Jun;5(1-2):32-5.,"Lin N, Gong XM, Xie QJ, Shao MR.",Study in cytotoxicity of gentamycin to corneal epithelium and endothelium in tissue culture.,,,,,,,,
3220,DRAMP02816,RQKDKRPYSERKNQYTGPQFLYPPERIPP,29,Lumbrican,No entry found,Unknown,Unknown,Lumbricus rubellus (humus earthworm),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis ATCC 62037, Staphylococcus aureus ATCC 15752, Streptococcus mutans ATCC 25175;##Gram-negative bacteria: Escherichia coli ATCC 27325, Pseudomonas putida ATCC 17426, Serratia sp. ATCC 21074.##Fungi: Candida albicans ATCC 10231, Cryptococcus neoformans ATCC 34881, Saccharomyces cerevisiae ATCC 44774.",Unknown,Unknown,9784609,Biochim Biophys Acta. 1998 Oct 22;1408(1):67-76.,"Cho JH, Park CB, Yoon YG, Kim SC.","Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization.",,,,,,,,
3221,DRAMP02818,ILQKAVLDCLKAAGSSLSKAAITAIYNKIT,30,Dicynthaurin,P0C007,Unknown,Unknown,Halocynthia aurantium (Sea peach),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (CD),"CD spectra of the cynthaurin monomer (Fig. 5A) and homodimer (Fig. 5B) in PBS showes properties characteristic of helical peptides. In structure-promoting environments, such as TFE:phosphate buffer or SDS micelles, the helical conformations are enhanced and accounted for the dominant structural component of both the monomeric and the homodimeric peptides.",Unknown,"Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria. Its antimicrobial activity is optimal at NaCl concentrations below 100 mM, suggesting that the antimicrobial actions of this peptide may take place intracellularly rather than extracellularly. Has no activity against the fungus C.albicans. Has hemolytic activity.
PTM: Contians one disulfide bond and C-terminal amidation.","[Ref.11479030]Gram-positive bacteria: Micrococcus luteus, Staphylococcus aureus(50 units at 100ug/ml), Listeria monocytogenes(50 units at 40ug/ml);##Gram-negative bacteria: Escherichia coli(50 units at 10ug/ml), Pseudomonas aeruginosa(25 units at 20ug/ml).","[Ref.11479030]10% hemolytic activity at 50 μg/ml, 20% hemolytic activity at 100 μg/ml against human red blood cells",Unknown,11479030,Biochim Biophys Acta. 2001 Aug 15;1527(3):141-148.,"Lee IH, Lee YS, Kim CH, Kim CR, Hong T, Menzel L, Boo LM, Pohl J, Sherman MA, Waring A, Lehrer RI.","Dicynthaurin: an antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium.",,,,,,,,
3234,DRAMP02832,MPVAVGPYGQSQPSCFDRVKMGFVMGCAVGMAAGALFGTFSCLRIGMRGRELMGGIGKTMMQSGGTFGTFMAIGMGIRC,79,"Reactive oxygen species modulator 1 (ROS modulator 1; mammals, animals)",Q3SZV8,Belongs to the MGR2 family,ROMO1,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against a variety of bacteria. Acts by inducing bacterial membrane breakage (By similarity).
Induces production of reactive oxygen species (ROS) which are necessary for cell proliferation. May play a role in inducing oxidative DNA damage and replicative senescence. May play a role in the coordination of mitochondrial morphology and cell proliferation.","Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacteria: Pseudomonas aeruginosa, Mycobacterium tuberculosis.",Unknown,Unknown,PubMed ID is not available,Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases,Unknown,NIH - Mammalian Gene Collection (MGC) project,,,,,,,,
3236,DRAMP02834,SDEKASPDKHHRFSLSRYAKLANRLANPKLLETFLSKWIGDRGNRSVK,48,"Seminalplasmin (Calcium transport inhibitor; Peptide YY-2; mammals, animals)",P06833 ,Unknown,PYY2,Bos taurus (Bovine),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Inhibits calcium transport into spermatozoa; it does not bind directly to calcium. Binds to calmodulin. Inhibits the growth of microorganisms. Seem to act as an antibiotic by permeabilizing the bacterial membrane.,"Gram-negative bacterium: Escherichia coli.##Fungi: Saccharomyces cerevisiae, Candida ablicans.",Unknown,Does not bind directly to calcium. It binds to calmodulin in the presence of Ca2+.,16453469##2334517##3863108,EMBO J. 1983;2(7):1159-1163.##Biol Chem Hoppe Seyler. 1990 Feb;371(2):111-116.##Proc Natl Acad Sci U S A. 1985 Oct;82(19):6490-6491.,"Theil R, Scheit KH.##Krauhs E, Preuss KD, Scheit KH.##Lewis RV, Agustin JS, Kruggel W, Lardy HA.","Amino acid sequence of seminalplasmin, an antimicrobial protein from bull semen.##Functional properties of peptides derived from seminalplasmin: binding to monospecific anti-seminalplasmin immunoglobulins G and calmodulin.##The structure of caltrin, the calcium-transport inhibitor of bovine seminal plasma.",,,,,,,,
3238,DRAMP02837,PLSCRRKGGICILIRCPGPMRQIGTCFGRPVKCCR,35,"Beta-defensin C7 (BBD(C7); mammals, animals)",O18815,Belongs to the beta-defensin family,Unknown,Bos taurus (Bovine),"Antibacterial, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,9488394,Infect Immun. 1998 Mar;66(3):1045-1056.,"Tarver AP, Clark DP, Diamond G, Russell JP, Erdjument-Bromage H, Tempst P, Cohen KS, Jones DE, Sweeney RW, Wines M, Hwang S, Bevins CL.",Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.,,,,,,,,
3239,DRAMP18233,LLLE,4,Gageopeptide B(Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis,"Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",,Unknown,Leu-Leu-Leu-OMeGlu-3-beta-hydroxy-12-methyltetradecanoic acid,Unknown,"Non-cytotoxic antifungal agents. It was revealed that compounds 1 and 2 exhibited stronger antifungal activity than 3 and 4. Compounds 1 and 2 were structurally different from compounds 3 and 4 in terms of having less side chains in the fatty acid units, suggesting that the side chain length and the additional methyl group in the aliphatic chain are important for antifungal activity. These compounds also showed potent antimicrobial activity against Gram positive and Gram negative bacteria.","Gram-positive, Gram-negative",Unknown,Unknown,2485741,Yan Ke Xue Bao. 1989 Jun;5(1-2):32-5.,"Lin N, Gong XM, Xie QJ, Shao MR.",Study in cytotoxicity of gentamycin to corneal epithelium and endothelium in tissue culture.,,,,,,,,
3240,DRAMP18234,LLEL,4,Gageopeptide C(Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis,"Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",,Unknown,"Leu-Leu-Glu-Leu-3-beta-hydroxy-9,11-dimethyltridecanoic acid",Unknown,"Non-cytotoxic antifungal agents. It was revealed that compounds 1 and 2 exhibited stronger antifungal activity than 3 and 4. Compounds 1 and 2 were structurally different from compounds 3 and 4 in terms of having less side chains in the fatty acid units, suggesting that the side chain length and the additional methyl group in the aliphatic chain are important for antifungal activity. These compounds also showed potent antimicrobial activity against Gram positive and Gram negative bacteria.","Gram-positive, Gram-negative",Unknown,Unknown,2485741,Yan Ke Xue Bao. 1989 Jun;5(1-2):32-5.,"Lin N, Gong XM, Xie QJ, Shao MR.",Study in cytotoxicity of gentamycin to corneal epithelium and endothelium in tissue culture.,,,,,,,,
3247,DRAMP02853,RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRP,59,"Cathelicidin-3 (Bactenecin-7, Bac7; PR-59; mammals, animals)","P19661, A5PJ95",Belongs to the cathelicidin family,CATHL3,Bos taurus (Bovine),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Exerts, in vitro, a potent antimicrobial activity. Probably due to an impairment of the function of the respiratory chain and of energy-dependent activities in the inner membrane of susceptible microorganisms.
Tissue specificity: Large granules of neutrophils.
PTM: Contains two disulfide bonds.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,2229048,J Biol Chem. 1990 Nov 5;265(31):18871-18874.,"Frank RW, Gennaro R, Schneider K, Przybylski M, Romeo D.",Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils.,,,,,,,,
3249,DRAMP01356,FLGGLMKAFPALICAVTKKC,20,"Ranalexin-1Ca (Ranatuerin 1Ca; Frogs, amphibians, animals)",P82876,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Unknown,Rana clamitans (Green frog) (Lithobates clamitans),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. 
Tissue specificity: Expressed by the skin glands.",[Ref.10822101] Gram-positive bacterium: Staphylococcus aureus (MIC=17 μM);##Gram-negative bacterium: Escherichia coli (MIC=4 μM).##Yeast: Candida albicans (MIC=14 μM).,Unknown,Unknown,10822101,Peptides. 2000 Apr;21(4):469-476.,"Halverson T, Basir YJ, Knoop FC, Conlon JM.",Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.,,,,,,,,
3250,DRAMP02864,QGVRNFVTCRINRGFCVPIRCPGHRRQIGTCLGPRIKCCR,40,"Bovine Beta-defensin 7 (bBD-7; BNBD-7; BNDB-7; mammals, animals)","P46165, Q32P80",Belongs to the beta-defensin family,DEFB7,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has bactericidal activity. Active against E. coli ML35 and S. aureus 502A.
Tissue specificity: Neutrophilic granules.
PTM: Contains three disulfide bonds 9-38; 16-31; 21-39. (By similarity)",Gram-positive bacterium: Staphylococcus aureus 502A;##Gram-negative bacterium: Escherichia coli ML35,Unknown,Unknown,8454635,J Biol Chem. 1993 Mar 25;268(9):6641-6648.,"Selsted ME, Tang YQ, Morris WL, McGuire PA, Novotny MJ, Smith W, Henschen AH, Cullor JS.","Purification, primary structures, and antibacterial activities of Beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.",,,,,,,,
3251,DRAMP02871,RRHMLRCMGDLGICRPACRQSEEPYLYCRNYQPCCLPFYVRIDISGKEGKNDWSRENRWPKVS,63,"Beta-defensin 119 (Defensin, beta 119; mammals, animals)","Q32P86, A7LM95",Belongs to the beta-defensin family,DEFB119,Bos taurus (Bovine),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Bridge,Unknown,Unknown,"Function Has antibacterial activity (Potential).
PTM: Contains three disulfide bonds (By similarity).","Gram-negative bacteria: Escherichia coli, Salmonella typhimurium;##Gram-positive bacteria: Staphylococcus aureus and Listeria monocytogenes.",Unknown,Unknown,PubMed ID is not available,Submitted (JUL-2007) to the EMBL/GenBank/DDBJ databases,"Cormican P, Meade K.G, Lloyd A.T, Cahalane S, Narciandi F, O'Farrelly C.","Novel bovine AMPs exhibit constitutive tissue-specific gene expression and significant in vitro antimicrobial efficacy against Escherichia coli, Salmonella typhimurium, Stapylococcus aureus and Listeria monocytogenes.",,,,,,,,
3276,DRAMP02902,ADDKNPLEEFRETNYEVFLEIAKNGLKATSNPKRVVIVGAGMAGLSAAY,49,"L-amino-acid oxidase (LAAO, LAO; BpirLAAO-I; reptilia, animals)",P0C2D1,Belongs to the flavin monoamine oxidase family (FIG1 subfamily),Unknown,Bothrops pirajai (Piraja's lance head),"Antibacterial, Antiparasitic, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"FunctionCatalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. This protein may also have activities in hemorrhage, hemolysis, and apoptosis.
Tissue specificity: Expressed by the venom gland.
Miscellaneous: Has parasiticidal activities against leishmania, as a result of enzyme-catalyzed hydrogen peroxide production.","Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa. Leishmania sp..",Unknown,Unknown,16809041,Bioorg Med Chem. 2006 Oct 15;14(20):7034-7043.,"Izidoro LF, Ribeiro MC, Souza GR, Sant'Ana CD, Hamaguchi A, Homsi-Brandeburgo MI, Goulart LR, Beleboni RO, Nomizo A, Sampaio SV, Soares AM, Rodrigues VM.",Biochemical and functional characterization of an L-amino acid oxidase isolated from Bothrops pirajai snake venom.,,,,,,,,
3281,DRAMP02914,RICRIIFLRVCR,12,"Cathelicidin-1 (Bactenecin-1, Bac1; Cyclic dodecapeptide; mammals, animals)",P54230,Belongs to the cathelicidin family,CATHL1A,Ovis aries (Sheep),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Bridge,Unknown,Unknown,Function: Potent microbicidal activity; active against S. aureus and E. coli (By similarity).,Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,7498547##9461419,FEBS Lett. 1995 Dec 4;376(3):225-228.##Gene. 1998 Jan 5;206(1):85-91.,"Bagella L, Scocchi M, Zanetti M.##Huttner KM, Lambeth MR, Burkin HR, Burkin DJ, Broad TE.",cDNA sequences of three sheep myeloid cathelicidins.##Localization and genomic organization of sheep antimicrobial peptide genes.,,,,,,,,
3291,DRAMP02929,GQALNKLMPKIVSAIIYMIGQPNAGVTFLGHQCLVESTRQPDGFYTAKMWCTSWTSDNPIVGEGRSRVELEALKGSIRNFVQTASDYKKFTIEEVEDWIAS,102,Antimicrobial protein 1,A1YV58,Unknown,AP,Scylla serrata (Mud crab),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Tissue specificity: Strongly expressed in gills, hemocytes and reproductive tract, with weaker expression in muscle, heart and digestive tract. Not detected in eyes and hepatopancreas (at protein level).","Gram-positive bacteria: Escherichia coli (MIC<50 μg/ml), Pseudomonas aeruginosa (MIC<25 μg/ml);##Gram-negative bacteria: Staphylococcus aureus (MIC<100 μg/ml), Streptococcus pyogenes (MIC<50 μg/ml).",Unknown,Unknown,19219229,Acta Biochim Pol. 2009;56(1):71-82.,"Yedery RD, Reddy KV.","Purification and characterization of antibacterial proteins from granular hemocytes of Indian mud crab, Scylla serrata.",,,,,,,,
3292,DRAMP02930,HSPGGA,6,"Antimicrobial protein 2 (crabs, Arthropods, animals)",B3A0L8,Unknown,Unknown,Scylla serrata (Mud crab),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,"Gram-positive bacterium: Bacillus flexus;##Gram-negative bacteria: Escherichia coli, Vibrio harveyi.",Unknown,Unknown,PubMed ID is not available,Submitted (SEP-2011) to UniProtKB,"Meiyalagan V, Arumugam M.",Antibacterial protein (Scylla serrata).,,,,,,,,
3294,DRAMP02936,NPLIPAIYIGATVGPSVWAYLVALVGAAAVTAANIRRASSDNHSCAGNRGWCRSKCFRHEYVDTYYSAVCGRYFCCRSR,79,"Big defensin (crabs, Arthropods, animals)",P80957,Belongs to the big defensin family,Unknown,Tachypleus tridentatus (Japanese horseshoe crab),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,Unknown,2RNG resolved by NMR.,"Function: Significantly inhibits the growth of Gram-negative and Gram-positive bacteria and fungi in vitro.
Tissue specificity: Expressed in all tissues examined, including hemocytes, heart, hepatopancreas, stomach, intestine and skeletal muscle.
PTM: Contains three disulfide bonds.","Gram-negative bacteria: Escherichia coli 09:K39 (IC50=5 μg/ml), Salmonella typhimurium LT2 (IC50=20 μg/ml), S. minnesota R595 (IC50=1.3 μg/ml), Klebsiella pneumoniae (IC50>10 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (IC50<2.5 μg/ml).##Yeast: Candida albicans (IC50>20 μg/ml)(Ref.1).##Note: Washed with a phosphate buffered saline (PBS, pH 7.0).",Unknown,Lipopolysaccharide (LPS)-binding,8586631##18785751,J Biochem. 1995 May;117(5):1131-1137.##Biochemistry. 2008 Oct 7;47(40):10611-9.,"Saito T, Kawabata S, Shigenaga T, Takayenoki Y, Cho J, Nakajima H, Hirata M, Iwanaga S.##Kouno T, Fujitani N, Mizuguchi M, Osaki T, Nishimura S, Kawabata S, Aizawa T, Demura M, Nitta K, Kawano K.","A novel big defensin identified in horseshoe crab hemocytes: isolation, amino acid sequence, and antibacterial activity.##A novel beta-defensin structure: a potential strategy of big defensin for overcoming resistance by Gram-positive bacteria.",,,,,,,,
3295,DRAMP02937,YLAFRCGRYSPCLDDGPNVNLYSCCSFYNCHKCLARLENCPKGLHYNAYLKVCDWPSKAGCTSVNKECHLWKT,73,"Tachycitin (crabs, Arthropods, animals)",P91818,Unknown,Unknown,Tachypleus tridentatus (Japanese horseshoe crab),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand,Unknown,1DQC resolved by NMR.,No comments found on DRAMP database,"Gram-positive bacteria: Staphylococcus aureus (IC50=56 μg/ml);##Gram-negative bacteria: Escherichia coli 363 (IC50=33 μg/ml), Escherichia coli B (IC50=2 μg/ml), Salmonella typhimurium LT2 (IC50=44 μg/ml), S. minnesota R595 (IC50=41 μg/ml), Klebsiella pneumoniae (IC50=32 μg/ml).##Yeast: Candida albicans (IC50=52 μg/ml).",Unknown,Chitin-binding,9010778##10770921,J Biochem. 1996 Dec;120(6):1253-1260.##J Biol Chem. 2000 Jun 16;275(24):17929-17932.,"Kawabata S, Nagayama R, Hirata M, Shigenaga T, Agarwala KL, Saito T, Cho J, Nakajima H, Takagi T, Iwanaga S.##Suetake T, Tsuda S, Kawabata S, Miura K, Iwanaga S, Hikichi K, Nitta K, Kawano K.","Tachycitin, a small granular component in horseshoe crab hemocytes, is an antimicrobial protein with chitin-binding activity.##Chitin-binding proteins in invertebrates and plants comprise a common chitin-binding structural motif.",,,,,,,,
3296,DRAMP18230,LLLE,4,Gageotetrin B  (Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis,"Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",,Unknown,Leu-Leu-Leu-OMeGlu-3-hydroxy-11-methyltridecanoic acid (HTDA),Unknown,Noncytotoxic Antimicrobial Linear Lipopeptides,"Gram-positive, Gram-negative",Unknown,Unknown,24502521,Org Lett. 2014 Feb 7;16(3):928-31. ,"Tareq FS, Lee MA, Lee HS, Lee YJ, Lee JS, Hasan CM, Islam MT, Shin HJ.","Gageotetrins A-C, noncytotoxic antimicrobial linear lipopeptides from a marine bacterium Bacillus subtilis.",,,,,,,,
3297,DRAMP18231,LLLE,4,Gageotetrin C (Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis,"Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",,Unknown,"Leu-Leu-Leu-Glu-3-hydroxy-8,10-dimethyldodecanoic acid (HDDA)",Unknown,Noncytotoxic Antimicrobial Linear Lipopeptides,"Gram-positive, Gram-negative",Unknown,Unknown,24502521,Org Lett. 2014 Feb 7;16(3):928-31. ,"Tareq FS, Lee MA, Lee HS, Lee YJ, Lee JS, Hasan CM, Islam MT, Shin HJ.","Gageotetrins A-C, noncytotoxic antimicrobial linear lipopeptides from a marine bacterium Bacillus subtilis.",,,,,,,,
3298,DRAMP18232,LLEL,4,Gageopeptide A(Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis,"Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",,Unknown,Leu-Leu-Glu-Leu-3-beta-hydroxy-11-methyltridecanoic acid,Unknown,"Non-cytotoxic antifungal agents. It was revealed that compounds 1 and 2 exhibited stronger antifungal activity than 3 and 4. Compounds 1 and 2 were structurally different from compounds 3 and 4 in terms of having less side chains in the fatty acid units, suggesting that the side chain length and the additional methyl group in the aliphatic chain are important for antifungal activity. These compounds also showed potent antimicrobial activity against Gram positive and Gram negative bacteria.","Gram-positive, Gram-negative",Unknown,Unknown,2485741,Yan Ke Xue Bao. 1989 Jun;5(1-2):32-5.,"Lin N, Gong XM, Xie QJ, Shao MR.",Study in cytotoxicity of gentamycin to corneal epithelium and endothelium in tissue culture.,,,,,,,,
3301,DRAMP02941,YSRCQLQGFNCVVRSYGLPTIPCCRGLTCRSYFPGSTYGRCQRF,44,"Tachystatin-A1 (crabs, Arthropods, animals)",P0C1Z7,Unknown,Unknown,Tachypleus tridentatus (Japanese horseshoe crab),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Exhibits stronger antimicrobial activity against the Gram-positive bacterium S. aureus and fungi C. albicans and P. pastoris than Gram-negative bacterium E. coli. Binds to chitin (8.4 μM are required to obtain 50% of binding). Does not cause hemolysis on sheep erythrocytes. Has no blocking activity on the P-type calcium channel.
Tissue specificity: Granular hemocytes, small secretory granules.
PTM: Contains three disulfide bonds (By similarity).","Gram-negative bacterium: Escherichia coli (IC50=25 μg/ml);##Gram-positive bacterium: Staphylococcus aureus (IC50=4.2 μg/ml).##Fungi: Candida albicans (IC50=3.0 μg/ml), Pichia pastoris (IC50=0.5 μg/ml).",Unknown,Chitin-binding,10473569,J Biol Chem. 1999 Sep 10;274(37):26172-26178.,"Osaki T, Omotezako M, Nagayama R, Hirata M, Iwanaga S, Kasahara J, Hattori J, Ito I, Sugiyama H, Kawabata S.","Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins.",,,,,,,,
3302,DRAMP02942,YSRCQLQGFNCVVRSYGLPTIPCCRGLTCRSYFPGSTYGRCQRY,44,"Tachystatin-A2 (crabs, Arthropods, animals)",Q9U8X3,Unknown,Unknown,Tachypleus tridentatus (Japanese horseshoe crab),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand,Unknown,1CIX resolved by NMR.,"Function: Exhibits stronger antimicrobial activity against the Gram-positive bacterium S. aureus and fungi C. albicans and P. pastoris than Gram-negative bacterium E. coli. Binds to chitin (8.4 μM are required to obtain 50% of binding). Does not cause hemolysis on sheep erythrocytes. Has no blocking activity on the P-type calcium channel.
Tissue specificity: Granular hemocytes, small secretory granules.
PTM: Contains three disulfide bonds.","Gram-positive bacterium: Staphylococcus aureus (IC50=4.2 μg/ml);##Gram-negative bacterium: Escherichia coli (IC50=25 μg/ml).##Fungi: Candida albicans (IC50=3.0 μg/ml), Pichia pastoris (IC50=0.5 μg/ml).",Unknown,Chitin-binding,10473569##11959852,J Biol Chem. 1999 Sep 10;274(37):26172-26178.##J Biol Chem. 2002 Jun 28;277(26):23651-23657.,"Osaki T, Omotezako M, Nagayama R, Hirata M, Iwanaga S, Kasahara J, Hattori J, Ito I, Sugiyama H, Kawabata S.##Fujitani N, Kawabata S, Osaki T, Kumaki Y, Demura M, Nitta K, Kawano K.","Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins.##Structure of the antimicrobial peptide tachystatin A.",,,,,,,,
3305,DRAMP02945,DYDWSLRGPPKCATYGQKCRTWSPPNCCWNLRCKAFRCRPR,41,"Tachystatin-C (crabs, Arthropods, animals)",P0C200,Unknown,Unknown,Tachypleus tridentatus (Japanese horseshoe crab),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Causes hemolysis on sheep erythrocytes, probably by forming ion-permeable pores.","Gram-negative bacterium: Escherichia coli (IC50=1.2 μg/ml);##Gram-positive bacterium: Staphylococcus aureus (IC50=0.8 μg/ml).##Fungi: Candida albicans (IC50=0.9 μg/ml), Pichia pastoris (IC50=0.3 μg/ml).",Unknown,Chitin-binding,10473569,J Biol Chem. 1999 Sep 10;274(37):26172-26178.,"Osaki T, Omotezako M, Nagayama R, Hirata M, Iwanaga S, Kasahara J, Hattori J, Ito I, Sugiyama H, Kawabata S.","Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins.",,,,,,,,
3308,DRAMP18228,LLDVLLE,7,Gageostatin C (Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis,"Antibacterial, antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,"Leu-Leu-Asp-Val-Leu-Leu-Glu-(E)-7,9-dimethylundec-2-enoic acid",Unknown,"surfactin like heptapeptides, cytotoxic. It is noteworthy that these compounds 1","Gram-positive, Gram-negative",Unknown,Unknown,24492520,Mar Drugs. 2014 Jan 31;12(2):871-85. ,"Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.","Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis.",,,,,,,,
3309,DRAMP18229,LE,2,Gageotetrin A (Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis,"Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Leu-Glu-3-hydroxy-11-methyltridecanoic acid (HTDA),Unknown,Noncytotoxic Antimicrobial Linear Lipopeptides,"Gram-positive, Gram-negative",Unknown,Unknown,24502521,Org Lett. 2014 Feb 7;16(3):928-31. ,"Tareq FS, Lee MA, Lee HS, Lee YJ, Lee JS, Hasan CM, Islam MT, Shin HJ.","Gageotetrins A-C, noncytotoxic antimicrobial linear lipopeptides from a marine bacterium Bacillus subtilis.

",,,,,,,,
3312,DRAMP02955,LGAWLAGKVAGTVATYAWNRYV,22,"Hedistin (marine annelid, Metazoa)",Q1PG44,Unknown,Unknown,Hediste diversicolor,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus (MRSA);##Gram-negative bacterium: Vibrio alginolyticus.,Unknown,Unknown,17210178,Dev Comp Immunol. 2007;31(8):749-762. ,"Tasiemski A, Schikorski D, Le Marrec-Croq F, Pontoire-Van Camp C, Boidin-Wichlacz C, Sautière PE.","Hedistin: A novel antimicrobial peptide containing bromotryptophan constitutively expressed in the NK cells-like of the marine annelid, Nereis diversicolor.",,,,,,,,
3316,DRAMP02968,AFPPPNVPGPRFPPPNFPGPRFPPPNFPGPRFPPPNFPGPRFPPPNFPGPPFPPPIFPGPWFPPPPPFRPPPFGPPRFP,79,"Prophenin-1 (C6, PF-1; Pro-rich; pigs, mammals, animals)",P51524,Belongs to the cathelicidin family,Unknown,Sus scrofa (Pig),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Exerts antimicrobial activity. It is more effective against Gram-negative bacteria than Gram-positive bacteria.,Gram-positive bacterium: Listeria monocytogenes;##Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,7698355##7576250,FEBS Lett. 1995 Mar 27;362(1):65-69.##Biol Chem Hoppe Seyler. 1995 Aug;376(8):507-510.,"Harwig SS, Kokryakov VN, Swiderek KM, Aleshina GM, Zhao C, Lehrer RI.##Strukelj B, Pungercar J, Kopitar G, Renko M, Lenarcic B, Berbić S, Turk V.","Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes.##Molecular cloning and identification of a novel porcine cathelin-like antibacterial peptide precursor.",,,,,,,,
3317,DRAMP02969,AFPPPNVPGPRFPPPNVPGPRFPPPNFPGPRFPPPNFPGPRFPPPNFPGPPFPPPIFPGPWFPPPPPFRPPPFGPPRFP,79,"Prophenin-2 (C12, PF-2, PR-2; Pro-rich; pigs, mammals, animals)",P51525,Belongs to the cathelicidin family,Unknown,Sus scrofa (Pig),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,Function: Exerts antimicrobial activity. It is more effective against Gram-negative bacteria than Gram-positive bacteria.,Gram-positive bacterium: Listeria monocytogenes;##Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,8262247##7498526,FEBS Lett. 1993 Dec 27;336(2):284-288.##FEBS Lett. 1995 Dec 4;376(3):130-134.,"Pungercar J, Strukelj B, Kopitar G, Renko M, Lenarcic B, Gubensek F, Turk V.##Zhao C, Ganz T, Lehrer RI.",Molecular cloning of a putative homolog of proline/arginine-rich antibacterial peptides from porcine bone marrow.##Structures of genes for two cathelin-associated antimicrobial peptides: prophenin-2 and PR-39.,,,,,,,,
3318,DRAMP02971,RGGRLCYCRRRFCICV,16,"Protegrin-2 (Protegrin 2; PG-2; pigs, mammals, animals)",P32195,Belongs to the cathelicidin family,NPG2,Sus scrofa (Pig),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,2MUH resolved by NMR.,"Function: Microbicidal activity. Active against E.coli, Listeria monocytogenes and C.albicans, in vitro.
PTM: Contains two disulfide bonds 6-15; 8-13 and Valine amide at V16.",Gram-positive bacterium: Listeria moncyrogenes strain EGD (MIC>25 μg/ml);##Gram-negative bacterium: Escherichia coli ML-35 (MIC>25 μg/ml).##Yeast: Candida albicans strain 820 (MIC>25 μg/ml).,Unknown,Unknown,8335113##8250892,FEBS Lett. 1993 Jul 26;327(2):231-236.##Biochem Biophys Res Commun. 1993 Nov 15;196(3):1363-1368.,"Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, Korneva HA, Lehrer RI.##Storici P, Zanetti M.",Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.##A novel cDNA sequence encoding a pig leukocyte antimicrobial peptide with a cathelin-like pro-sequence.,,,,,,,,
3319,DRAMP02972,RGGGLCYCRRRFCVCVGR,18,"Protegrin-3 (Protegrin 3; PG-3; pigs, mammals, animals)",P32196,Belongs to the cathelicidin family,NPG3,Sus scrofa (Pig),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,2MZ6 resolved by NMR.,"Function: Microbicidal activity. Active against E.coli, Listeria monocytogenes and C.albicans, in vitro.
PTM: Probablely contains two disulfide bonds 6-15; 8-13 and Arginine amide at R18.",Gram-positive bacterium: Listeria moncyrogenes strain EGD;##Gram-negative bacterium: Escherichia coli ML-35.##Yeast: Candida albicans strain 820.,Unknown,Unknown,8335113,FEBS Lett. 1993 Jul 26;327(2):231-236.,"Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, Korneva HA, Lehrer RI.",Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.,,,,,,,,
3322,DRAMP02976,NIGNSVSCLRNKGVCMPGKCAPKMKQIGTCGMPQVKCCKRK,41,"Beta-defensin 1 (BD-1; Defensin, beta 1; pigs, mammals, animals)",O62697,Belongs to the beta-defensin family,DEFB1,Sus scrofa (Pig),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Has bactericidal activity (By similarity).
PTM: Contains three disulfide bonds 8-37; 15-30; 20-38 (By similarity).","Gram-positive bacteria: Listeria monocytogenes, Streptococcus suis, Actinobacillus pleuropneumoniae;##Gram-negative bacterium: Escherichia coli.##Yeast: Candida albicans.",Unknown,Unknown,16552064##9537511##10446172,Infect Immun. 2006 Apr;74(4):2338-2352.##FEBS Lett. 1998 Mar 6;424(1-2):37-40.## Biol Chem. 1999 Aug 20;274(34):24031-24037.,"Elahi S, Buchanan RM, Attah-Poku S, Townsend HG, Babiuk LA, Gerdts V.##Zhang G, Wu H, Shi J, Ganz T, Ross CR, Blecha F.##Zhang G, Hiraiwa H, Yasue H, Wu H, Ross CR, Troyer D, Blecha F.","The host defense peptide Beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets.##Molecular cloning and tissue expression of porcine beta-defensin-1.##Cloning and characterization of the gene for a new epithelial beta-defensin. Genomic structure, chromosomal localization, and evidence for its constitutive expression.",,,,,,,,
3327,DRAMP02982,MPVAVGPYGQSQPSCFDRVKMGFVMGCAVGMAAGALFGPFSCLRIGMRGRELMGGIGKTMMQSGGTFGPFMAIGMGIRC,79,"Reactive oxygen species modulator 1 (ROS modulator 1; pigs, mammals, animals)",A1XQR6,Belongs to the MGR2 family,romo1,Sus scrofa (Pig),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against a variety of bacteria. Acts by inducing bacterial membrane breakage (By similarity).
Induces production of reactive oxygen species (ROS) which are necessary for cell proliferation. May play a role in inducing oxidative DNA damage and replicative senescence. May play a role in the coordination of mitochondrial morphology and cell proliferation (By similarity).
Domain: Contains a transmembrane helix.","Gram-positive bacteria: Staphylococcus aureus, Mycobacterium tuberculosis;##Gram-negative bacterium: Pseudomonas aeruginosa.",Unknown,Unknown,PubMed ID is not available,Submitted (MAY-2006) to the EMBL/GenBank/DDBJ databases,"Cai G, Chen Y, Wang C, Li J, Peng G, Zhang H.",Generation and analysis of cDNA sequences derived from a porcine skeletal muscle library.,,,,,,,,
3329,DRAMP02984,GLRKKFRKTRKRIQKLGRKIGKTGRKVWKAWREYGQIPYPCRI,43,"Neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11; pigs, mammals, animals)",Q91X12,Unknown,CAP11,Cavia porcellus (Domestic guinea pig),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against the Gram-positive bacteium S. aureus and Gram-negative bacterium E. coli.,Gram-negative bacterium: Escherichia coli (ED50=30-35 nM);##Gram-positive bacterium: Staphylococcus aureus (ED50=90-120 nM).,Unknown,Unknown,8644997,Arch Biochem Biophys. 1996 Apr 15;328(2):219-226.,"Yomogida S, Nagaoka I, Yamashita T.",Purification of the 11- and 5-kDa antibacterial polypeptides from guinea pig neutrophils.,,,,,,,,
3330,DRAMP02985,RRCICTTRTCRFPYRRLGTCLFQNRVYTFCC,31,"Neutrophil cationic peptide 2 (CP-2; GNCP-2; pigs, mammals, animals)","P49112, Q9R0Z5",Belongs to the alpha-defensin family,Unknown,Cavia porcellus (Guinea pig),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Bridge,Unknown,Unknown,"Function: Has antibiotic, anti-fungi and antiviral activity.
PTM: Contains three disulfide bonds (By similarity).",Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.,Unknown,Unknown,8173076##10738945,DNA Seq. 1993;4(2):123-128.##Inflamm Res. 2000 Feb;49(2):73-79.,"Nagaoka I, Nonoguchi A, Yamashita T.##Nagaoka I, Hirota S, Yomogida S, Ohwada A, Hirata M.",Cloning and characterization of the guinea pig neutrophil cationic peptide-1 and -2 genes.##Synergistic actions of antibacterial neutrophil defensins and cathelicidins.,,,,,,,,
3331,DRAMP02986,RRCICTTRTCRFPYRRLGTCIFQNRVYTFCC,31,"Neutrophil cationic peptide 1 (GPNP; Antiviral defensin; pigs, mammals, animals)","Q64365, P11478",Belongs to the alpha-defensin family,Unknown,Cavia porcellus (Guinea pig),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has antibiotic, anti-fungi and antiviral activity.
Tissue specificity: Bone marrow.","Gram-positive bacteria: Staphylococcus aureus, Streptococcus;##Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa.##Yeast: Candida albicans.",Unknown,Unknown,2473036##3623703,Infect Immun. 1989 Aug;57(8):2405-2409.##Infect Immun. 1987 Sep;55(9):2281-2286.,"Yamashita T, Saito K.##Selsted ME, Harwig SS.","Purification, primary structure, and biological activity of guinea pig neutrophil cationic peptides.##Purification, primary structure, and antimicrobial activities of a guinea pig neutrophil defensin.",,,,,,,,
3334,DRAMP02989,VNWKKVLGKIIKVAK,15,"Lasioglossin LL-I (Insects, animals)",No entry found,Unknown,Unknown,Lasioglossum laticeps (Eusocial Bee),"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Active against B. subtilis, S. aureus, P. aeruginosa, and E. coli. Low hemolytic toxicity.","[Ref.19591185]Gram-positive bacteria: B. subtilis(MIC=0.8 μM), S. aureus(MIC=14.3 μM);##Gram-negative bacteria: P. aeruginosa(MIC=15.8 μM), E. coli(MIC=1.7 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2099.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
3335,DRAMP02990,VNWKKILGKIIKVAK,15,"Lasioglossin LL-II (Insects, animals)",No entry found,Unknown,Unknown,Lasioglossum laticeps (Eusocial Bee),"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Active against B. subtilis, S. aureus, P. aeruginosa, and E. coli. Low hemolytic toxicity.","[Ref.19591185]Gram-positive bacteria: B. subtilis(MIC=0.7 μM), S. aureus(MIC=9.0 μM);##Gram-negative bacteria: P. aeruginosa(MIC=14.4 μM), E. coli(MIC=1.4 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2099.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
3336,DRAMP02991,VNWKKILGKIIKVVK,15,"Lasioglossin LL-III (Insects, animals)",No entry found,Unknown,Unknown,Lasioglossum laticeps (Eusocial Bee),"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Active against B. subtilis, S. aureus, P. aeruginosa, and E. coli. Low hemolytic toxicity.","[Ref.19591185]Gram-positive bacteria: B. subtilis(MIC=0.7 μM), S. aureus(MIC=3.9 μM);##Gram-negative bacteria: P. aeruginosa(MIC=18.7 μM), E. coli(MIC=1.4 μM).",[Ref.19591185]LC50>220 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2099.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
3339,DRAMP03004,FVPYNPPRPGQSKPFPSFPGHGPFNPKIQWPYPLPNPGH,39,"Abaecin (Insects, animals)",P81463,Unknown,Unknown,Bombus pascuorum (Brown bumblebee),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial peptide against Gram-positive and Gram-negative bacteria.
Induction: By bacterial infection.",Gram-negative bacteria: Micrococcus luteus;##Gram-negative bacteria: Escherichia coli D22.,Unknown,Unknown,9219367,Insect Biochem Mol Biol. 1997 May;27(5):413-22.,"Rees JA, Moniatte M, Bulet P.","Novel antibacterial peptides isolated from a European bumblebee, Bombus pascuorum (Hymenoptera, Apoidea).",,,,,,,,
3340,DRAMP03005,GNRPVYIPPPRPPHPRL,17,"Apidaecin (Insects, animals)",P81464,Belongs to the apidaecin family,Unknown,Bombus pascuorum (Brown bumblebee),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial peptide against Gram-positive and Gram-negative bacteria.
Induction: By bacterial infection.",Gram-negative bacteria: Micrococcus luteus;##Gram-negative bacteria: Escherichia coli D22.,Unknown,Unknown,9219367,Insect Biochem Mol Biol. 1997 May;27(5):413-422.,"Rees JA, Moniatte M, Bulet P.","Novel antibacterial peptides isolated from a European bumblebee, Bombus pascuorum (Hymenoptera, Apoidea).",,,,,,,,
3341,DRAMP03006,VTCDLLSIKGVAEHSACAANCLSMGKAGGRCENGICLCRKTTFKELWDKRF,51,"Defensin (Insects, animals)",P81462,Belongs to the invertebrate defensin family (Type 1 subfamily),Unknown,Bombus pascuorum (Brown bumblebee),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial peptide against Gram-positive and Gram-negative bacteria and fungi.
Induction: By bacterial infection.",Gram-negative bacteria: Micrococcus luteus;##Gram-negative bacteria: Escherichia coli D22.,Unknown,Unknown,9219367,Insect Biochem Mol Biol. 1997 May;27(5):413-422.,"Rees JA, Moniatte M, Bulet P.","Novel antibacterial peptides isolated from a European bumblebee, Bombus pascuorum (Hymenoptera, Apoidea).",,,,,,,,
3348,DRAMP03023,INWKALLDAAKKVL,14,"Mastoparan (Protonectarina-MP; Insects, animals)",P0C1Q5,Unknown,Unknown,Protonectarina sylveirae (Brazilian wasp),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Shows potent antimicrobial action against both Gram-positive and Gram-negative bacteria By similarity. This peptide shows potent histamine releasing activities on rat peritoneal mast cells. Also Has hemolytic and cytolytic activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14).",[Swiss_Prot Entry P0C1Q5]Potent antimicrobial peptide against both Gram-positive and Gram-negative bacteria (By similarity),[Ref.20108158]ED50 =3.4 × 10-5 M against rat red blood cells,Unknown,7513243##19857508##20108158,Nat Toxins. 1993;1(5):271-276.##Toxicon. 2010 Apr 1;55(4):711-718.##Amino Acids. 2011 Jan;40(1):77-90.,"Dohtsu K, Okumura K, Hagiwara K, Palma MS, Nakajima T.##Baek JH, Lee SH.##de Souza BM, Dos Santos Cabrera MP, Neto JR, Palma MS.",Isolation and sequence analysis of peptides from the venom of Protonectarina sylveirae (Hymenoptera-Vespidae).##Isolation and molecular cloning of venom peptides from Orancistrocerus drewseni (Hymenoptera: Eumenidae).##Investigating the effect of different positioning of lysine residues along the peptide chain of mastoparans for their secondary structures and biological activities.,,,,,,,,
3349,DRAMP18227,LLDVLLE,7,Gageostatin B (Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis,"Antibacterial, antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,"Leu-Leu-Asp-Val-Leu-Leu-Glu-3-beta-hydroxy-9, 11-dimethyltridecanoic acid",Unknown,"surfactin like heptapeptides, cytotoxic. It is noteworthy that these compounds 1","Gram-positive, Gram-negative",Unknown,Unknown,24492520,Mar Drugs. 2014 Jan 31;12(2):871-85. ,"Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.","Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis.",,,,,,,,
3355,DRAMP03049,GRILSFIKGLAEHL,14,"Eumenine mastoparan-OD (EMP-OD; Venom peptide 1, OdVP1; Insects, animals)","P86146, C7DT07",Belongs to the MCD family (Mastoparan subfamily),VP1,Orancistrocerus drewseni (Solitary wasp),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has hemolytic activity against ovine erythrocytes at micromolar concentrations. Also exhibits strong antimicrobial activity.
Tissue specificity: Expressed by the venom gland.
PTM: C-terminal amidation (Leucine amide: L14).","[Ref.19857508]Fungi: Candida albicans, Botrytis cinerea (++);##Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: S. aureus (+)",[Ref.18695936]42% hemolytic activity at 50 μM against sheep blood cells,Cell membrane (Note: Assumes an amphipathic alpha-helical conformation in a lipid environmen,19857508##18695936,Toxicon. 2010 Apr 1;55(4):711-718.##Amino Acids. 2009 Jul;37(2):389-394.,"Baek JH, Lee SH.##Murata K, Shinada T, Ohfune Y, Hisada M, Yasuda A, Naoki H, Nakajima T.","Isolation and molecular cloning of venom peptides from Orancistrocerus drewseni (Hymenoptera: Eumenidae).##Novel mastoparan and protonectin analogs isolated from a solitary wasp, Orancistrocerus drewseni drewseni.",,,,,,,,
3360,DRAMP03062,VTGELKRDKRVTCNIGEWVCVAHCNSKSKKSGYCSRGVCYCTN,43,"Defensin-A (DefA; GmDefA; Insects, animals)",Q8WTD4,Belongs to the invertebrate defensin family (Type 1 subfamily),Unknown,Glossina morsitans morsitans (Savannah tsetse fly),"Antibacterial, Antiprotozoal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial peptide mostly active against Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemolymph and fat body.
Induction: By bacterial infection. 
PTM: Contains three disulfide bonds (By similarity).","Protozoan: Procyclic trypanosomes (IC50=10 μM).##Gram-negative bacteria: Sodalis (IC50=2 μM), Escherichia coli DH5α (IC50=0.2 μM).",Unknown,Unknown,11592981##11886771,Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12648-12653.##Insect Biochem Mol Biol. 2002 Apr;32(4):369-375.,"Hao Z, Kasumba I, Lehane MJ, Gibson WC, Kwon J, Aksoy S.##Boulanger N, Brun R, Ehret-Sabatier L, Kunz C, Bulet P.",Tsetse immune responses and trypanosome transmission: implications for the development of tsetse-based strategies to reduce trypanosomiasis.##Immunopeptides in the defense reactions of Glossina morsitans to bacterial and Trypanosoma brucei brucei infections.,,,,,,,,
3366,DRAMP18226,LLDVLLE,7,Gageostatin A (Bacteriocin),No entry found,Belongs to the lipopeptides family,Unknown,Bacillus subtilis,"Antibacterial, antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Leu-Leu-Asp-Val-Leu-Leu-Glu-3-beta-hydroxy-11-methyltridecanoic acid,Unknown,"Fuction: Surfactin like heptapeptides, cytotoxic. It is noteworthy that these compounds 1","Gram-positive, Gram-negative",Unknown,Unknown,24492520,Mar Drugs. 2014 Jan 31;12(2):871-85. ,"Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ.","Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis.",,,,,,,,
3367,DRAMP03071,DEKPKLILPTPAPPNLPQLVGGGGGNRKDGFGVSVDAHQKVWTSDNGGHSIGVSPGYSQHLPGPYGNSRPDYRIGAGYSYNF,82,"Diptericin-A (Insects, animals)",P10836,Belongs to the attacin/sarcotoxin-2 family,Unknown,Protophormia terraenovae (Northern blowfly),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has activity against E.coli.
Miscellaneous: There seems to be a family of diptericin in protophormia. Diptericin A is the predominant member.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,3276515,Eur J Biochem. 1988 Jan 15;171(1-2):17-22.,"Dimarcq JL, Keppi E, Dunbar B, Lambert J, Reichhart JM, Hoffmann D, Rankine SM, Fothergill JE, Hoffmann JA.","Insect immunity. Purification and characterization of a family of novel inducible antibacterial proteins from immunized larvae of the dipteran Phormia terranovae and complete amino-acid sequence of the predominant member, diptericin A.",,,,,,,,
3368,DRAMP03072,DEKPKLILPTPAPPNLPQLVGGGGGNRKDGFGVSVDAHQKVWTSDNGRHSIGVTPGYSQHLGGPYGNSRPDYRIGAGYSYNF,82,"Diptericin-D (Insects, animals)",P18684,Belongs to the attacin/sarcotoxin-2 family,Unknown,Protophormia terraenovae (Northern blowfly),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has activity against E.coli.
Induction: By bacterial infection.
Miscellaneous: There seems to be a family of diptericin in protophormia. Diptericin A is the predominant member.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,2544427,Eur J Biochem. 1989 Jun 15;182(2):423-437.,"Reichhart JM, Essrich M, Dimarcq JL, Hoffmann D, Hoffmann JA, Lagueux M.","Insect immunity. Isolation of cDNA clones corresponding to diptericin, an inducible antibacterial peptide from Phormia terranovae (Diptera). Transcriptional profiles during immunization.",,,,,,,,
3369,DRAMP03073,ATCDLLSGIGVQHSACALHCVFRGNRGGYCTGKGICVCRN,40,"Sapecin-C (Sapecin C; defensins; Insects, animals)",P31530,Belongs to the invertebrate defensin family (Type 1 subfamily),Unknown,Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Sapecins, which are potent bactericidal proteins, are produced in response to body injury. Thus, sapecin is probably a defense protein synthesized by Sarcophaga to prevent bacterial infection through the damaged body wall. This gene was also found to be activated in the embryonic and early pupal stages, suggesting that sapecin also plays a role in the ontogenetic processes of Sarcophaga.","Gram-negative bacteria: Escherichia coli, Proteus mirabilis, Klebsiella Pneumoniae;##Gram-positive bacteria: Staphylococcus spps., Streptococcus spps, Bacillus megaterium, Bacillus circulans, Corynebacterium glutamicum.",Unknown,Unknown,8471044,Biochem J. 1993 Apr 1;291 (Pt 1):275-279.,"Yamada K, Natori S.","Purification, sequence and antibacterial activity of two novel sapecin homologues from Sarcophaga embryonic cells: similarity of sapecin B to charybdotoxin.",,,,,,,,
3378,DRAMP03083,LTCEIDRSLCLLHCRLKGYLRAYCSQQKVCRCVQ,34,"Sapecin-B (defensins; Insects, animals)",P31529,Belongs to the invertebrate defensin family (Type 1 subfamily),Unknown,Sarcophaga peregrina (Flesh fly),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Sapecins, which are potent bactericidal proteins, are produced in response to body injury. Thus, sapecin is probably a defense protein synthesized by Sarcophaga to prevent bacterial infection through the damaged body wall. This gene was also found to be activated in the embryonic and early pupal stages, suggesting that sapecin also plays a role in the ontogenetic processes of Sarcophaga.","Gram-negative bacteria: Escherichia coli, Proteus mirabilis, Klebsiella pneumoniae;##Gram-positive bacteria: Staphylococcus spps., Streptococcus spps, Bacillus megaterium, Bacillus circulans, Corynebacterium glutamicum.",Unknown,Unknown,7635204##8471044,FEBS Lett. 1995 Jul 24;368(3):485-487.##Biochem J. 1993 Apr 1;291 (Pt 1):275-279.,"Lee SR, Kurata S, Natori S.##Yamada K, Natori S.","Molecular cloning of cDNA for sapecin B, an antibacterial protein of Sarcophaga, and its detection in larval brain.##Purification, sequence and antibacterial activity of two novel sapecin homologues from Sarcophaga embryonic cells: similarity of sapecin B to charybdotoxin.",,,,,,,,
3379,DRAMP03084,SIGSAFKKALPVAKKIGKAALPIAKAALP,29,"Ceratotoxin-B (Insects, animals)",P36191,Unknown,CTXB,Ceratitis capitata (Mediterranean Fruit fly),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Female-specific peptides with potent activity against Gram-positive and Gram-negative bacteria. They have as well hemolytic activity.
Temperature dependence: Thermostable. Still active at 100 degrees Celsius.",[Swiss_Prot Entry P36191]Female-specific peptides with potent activity against Gram-positive and Gram-negative bacteria,[Swiss_Prot Entry P36191]has hemolytic activity,Unknown,8353519,Insect Biochem Mol Biol. 1993 Jul;23(5):591-598.,"Marchini D, Giordano PC, Amons R, Bernini LF, Dallai R.","Purification and primary structure of ceratotoxin A and B, two antibacterial peptides from the female reproductive accessory glands of the medfly Ceratitis capitata (Insecta:Diptera).",,,,,,,,
3380,DRAMP03085,SIGSALKKALPVAKKIGKIALPIAKAALP,29,"Ceratotoxin-A (Insects, animals)","P36190, O17512",Unknown,CTXA1,Ceratitis capitata (Mediterranean Fruit fly),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: Female-specific peptides with potent activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.
Temperature dependence: Thermostable. Still active at 100 degrees Celsius.",[Swiss_Prot Entry P36190]Female-specific peptides with potent activity against Gram-positive and Gram-negative bacteria,[Swiss_Prot Entry P36190]has hemolytic activity,Unknown,8353519##7890755,Insect Biochem Mol Biol. 1993 Jul;23(5):591-598.##J Biol Chem. 1995 Mar 17;270(11):6199-6204.,"Marchini D, Giordano PC, Amons R, Bernini LF, Dallai R.##Marchini D, Manetti AG, Rosetto M, Bernini LF, Telford JL, Baldari CT, Dallai R. ","Purification and primary structure of ceratotoxin A and B, two antibacterial peptides from the female reproductive accessory glands of the medfly Ceratitis capitata (Insecta:Diptera).##cDNA sequence and expression of the ceratotoxin gene encoding an antibacterial sex-specific peptide from the medfly Ceratitis capitata (diptera).",,,,,,,,
3381,DRAMP03086,SIGTAVKKAVPIAKKVGKVAIPIAKAVLSVVGQLVG,36,"Ceratotoxin-D (Insects, animals)",O17513,Unknown,CTXD,Ceratitis capitata (Mediterranean Fruit fly) (Tephritis capitata),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Female-specific peptides with potent activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.
Biophysicochemical properties: Temperature dependence (Thermostable. Still active at 100 degrees Celsius).",[Swiss_Prot Entry O17513]Female-specific peptides with potent activity against Gram-positive and Gram-negative bacteria,[Swiss_Prot Entry O17513]has hemolytic activity,Unknown,9569644,Insect Biochem Mol Biol. 1997 Dec;27(12):1039-1046.,"Rosetto M, De Filippis T, Manetti AG, Marchini D, Baldari CT, Dallai R.",The genes encoding the antibacterial sex-specific peptides ceratotoxins are clustered in the genome of the medfly Ceratitis capitata.,,,,,,,,
3390,DRAMP03101,GWLRKIGKKIERVGQHTRDATIQVLGIAQQAANVAATAR,39,"Sarcotoxin-1C (Sarcotoxin IC; Insects, animals)",P08377,Belongs to the cecropin family,Unknown,Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Sarcotoxins, which are potent bactericidal proteins, are produced in response to injury. They are cytotoxic to both Gram-positive and Gram-negative bacteria.
PTM: Problely Arginine amide at R39.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,3888997,J Biol Chem. 1985 Jun 25;260(12):7174-7177.,"Okada M, Natori S.","Primary structure of sarcotoxin I, an antibacterial protein induced in the hemolymph of Sarcophaga peregrina (flesh fly) larvae.",,,,,,,,
3391,DRAMP03102,GWLKKIGKKIERVGQHTRDATIQVIGVAQQAANVAATAR,39,"Sarcotoxin-1B (Sarcotoxin IB; Insects, animals)",P08376,Belongs to the cecropin family,Unknown,Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Sarcotoxins, which are potent bactericidal proteins, are produced in response to injury. They are cytotoxic to both Gram-positive and Gram-negative bacteria.
PTM: Problely Arginine amide at R39.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,3888997##2689214,J Biol Chem. 1985 Jun 25;260(12):7174-7177.##FEBS Lett. 1989 Dec 4;258(2):199-202.,"Okada M, Natori S.##Kanai A, Natori S.","Primary structure of sarcotoxin I, an antibacterial protein induced in the hemolymph of Sarcophaga peregrina (flesh fly) larvae.##Cloning of gene cluster for sarcotoxin I, antibacterial proteins of Sarcophaga peregrina.",,,,,,,,
3400,DRAMP18223,CWSCMGHSCWSCMGHSCWSCAGHSCWSCMGHSCWSCMGHSCWSCAGHCCGSCWHGGM,57,Sonorensin(Bacteriocin),X2CRH8,Belongs to the class I bacteriocin,Unknown,Bacillus sonorensis MT93,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"The Clustal W alignment of the N terminus of sonorensin revealed homology with the leader sequences of protoxins from various Bacillus strains. This indicated that sonorensin, produced initially as a protoxin, was posttransitionally modified to active bacteriocin. The purified sonorensin was also found to be heat stable, stable at low temperature, biologically active over a wide pH range, and not affected in the presence of organic solvents, surfactants, and reducing agents. However, sonoresin was protease-sensitive.","Gram-positive, Gram-negative (broad spectrum)",Unknown,Unknown,24610839,Appl Environ Microbiol. 2014 May;80(10):2981-90. ,"Chopra L, Singh G, Choudhary V, Sahoo DK.","Sonorensin: an antimicrobial peptide, belonging to the heterocycloanthracin subfamily of bacteriocins, from a new marine isolate, Bacillus sonorensis MT93.",,,,,,,,
3418,DRAMP03134,ATCDLLSGFGVGDSACAAHCIARGNRGGYCNSKKVCVCPI,40,"Defensin-D (AaeDefD; Insects, animals)",No entry found,Unknown,Unknown,Aedes aegypti (Yellowfever mosquito),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli D31;##Gram-positive bacterium: Micrococcus luteus.,Unknown,Unknown,10469248,Insect Mol Biol. 1999 Aug;8(3):311-318.,"Gao Y, Hernandez VP, Fallon AM.",Immunity proteins from mosquito cell lines include three defensin A isoforms from Aedes aegypti and a defensin D from Aedes albopictus.,,,,,,,,
3433,DRAMP03154,GILDTIKSIASKVWNSKTVQDLKRKGINWVANKLGVSPQAA,41,Hadrurin (Non-disulfide-bridged peptide 3.1),P82656,Belongs to the antimicrobial peptide scorpion family,Unknown,Hadrurus aztecus ,"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antimicrobial activity. Also shows cytolytic activity when tested in human erythrocytes.,"Gram-negative bacteria: Salmonella typhimurium, Klebsiella pneumoniae, Enterobacter cloacae, Pseudomonas aeruginosa, Escherichia coli, Serratia marcescens.",Unknown,Unknown,10931184,Eur J Biochem. 2000 Aug;267(16):5023-5031.,"Torres-Larios A, Gurrola GB, Zamudio FZ, Possani LD.","Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus.",,,,,,,,
3436,DRAMP03157,ALLHHGLNCAKGVLA,15,Halocidin subunit B,P83706,Unknown,Unknown,Halocynthia aurantium (Sea peach),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity, possibly by attacking the bacterial cell membrane.",Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Pseudomonas aeruginosa.,Unknown,Unknown,12067731,FEBS Lett. 2002 Jun 19;521(1-3):81-86.,"Jang WS, Kim KN, Lee YS, Nam MH, Lee IH.","Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium.",,,,,,,,
3437,DRAMP03158,WLNALLHHGLNCAKGVLA,18,"Halocidin subunit A (invertebrates, animals; Preclinical)",P83705,Unknown,Unknown,Halocynthia aurantium (Sea peach),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against S.aureus and P.aeruginosa, possibly by attacking the bacterial cell membrane. Mouse model: A single intravenous injection of the modified chain A by itself into mice resulted in an significant therapeutic effect (Jang et al. 2007;51: 4148-4156).",Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Pseudomonas aeruginosa.,Unknown,Unknown,12067731,FEBS Lett. 2002 Jun 19;521(1-3):81-86.,"Jang WS, Kim KN, Lee YS, Nam MH, Lee IH.","Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium.",,,,,,,,
3441,DRAMP03163,ATCDLFSFRSKWVTPNHAACAAHCLLRGNRGGRCKGTICHCRK,43,"R. prolixus defensin A (RprDefA; insect defensin; Insects, animals)",No entry found,Unknown,Unknown,Rhodnius prolixus,"Antibacterial, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Combine helix and strand structure,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.,Unknown,Unknown,12650692,Insect Biochem Mol Biol. 2003 Apr;33(4):439-447.,"Lopez L, Morales G, Ursic R, Wolff M, Lowenberger C.","Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease.",,,,,,,,
3442,DRAMP03164,ATCDLLSFRSKWVTPNHAGCAAHCLLRGNRGGHCKGTICHCRK,43,"R. prolixus defensin B (RprDefB; insect defensin; Insects, animals)",No entry found,Unknown,Unknown,Rhodnius prolixus,"Antibacterial, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Combine helix and strand structure,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.,Unknown,Unknown,12650692,Insect Biochem Mol Biol. 2003 Apr;33(4):439-447.,"Lopez L, Morales G, Ursic R, Wolff M, Lowenberger C.","Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease.",,,,,,,,
3443,DRAMP03165,ATCDLFSFRSKWVTPNHAGCAAHCIFLGNRGGRCVGTVCHCRK,43,"R. prolixus defensin C (RprDefC; insect defensin; Insects, animals)",No entry found,Unknown,Unknown,Rhodnius prolixus,"Antibacterial, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Combine helix and strand structure,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.,Unknown,Unknown,12650692,Insect Biochem Mol Biol. 2003 Apr;33(4):439-447.,"Lopez L, Morales G, Ursic R, Wolff M, Lowenberger C.","Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease.",,,,,,,,
3449,DRAMP03174,RWCVYAYVRIRGVLVRYRRCW,21,"Arenicin-2 (Ar-2; marine polychaeta, animals)","Q5SC59, P84106",Unknown,Unknown,Arenicola marina (Lugworm) (Lumbricus marinus),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (2 strands; 16 residues),"NMR investigation shows that in water solution arenicin-2 displays a prolonged beta-hairpin, formed by two antiparallel beta-strands and stabilized by one disulfide and nine hydrogen bonds. A significant right-handed twist in the beta-sheet is deprived the peptide surface of amphipathicity. CD spectroscopic analysis indicates that arenicin-2 binds to the SDS and DPC micelles, and conformation of the peptide is significantly changed upon","2JNI, 2L8X resolved by NMR.","Function: Has antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteriua as well as yeast C. albicans. Bacterial killing occurs within minutes and is accompanied by membrane permeabilization, membrane detachment and release of cytoplasm. Interaction of arenicin with reconstituted membranes that mimic the lipopolysaccharide-containing outer membrane or the phospholipid-containing plasma membrane of Gram-negative bacteria exhibited no pronounced lipid specificity.
PTM: Contains one disulfide bond 3-20.
Domian: Contains 1 BRICHOS domain.",Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacterium: Escherichia coli ML-35p.##Yeast: Candida albicans 820.,Unknown,Anionic lipid vesicles,15527787##17935487##17585874,FEBS Lett. 2004 Nov 5;577(1-2):209-214.##Biochem J. 2008 Feb 15;410(1):113-122.##Biochem Biophys Res Commun. 2007 Aug 17;360(1):156-162.,"Ovchinnikova TV, Aleshina GM, Balandin SV, Krasnosdembskaya AD, Markelov ML, Frolova EI, Leonova YF, Tagaev AA, Krasnodembsky EG, Kokryakov VN.##Andr J, Jakovkin I, Grtzinger J, Hecht O, Krasnosdembskaya AD, Goldmann T, Gutsmann T, Leippe M.##Ovchinnikova TV, Shenkarev ZO, Nadezhdin KD, Balandin SV, Zhmak MN, Kudelina IA, Finkina EI, Kokryakov VN, Arseniev AS.","Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina.##Structure and mode of action of the antimicrobial peptide arenicin.##Recombinant expression, synthesis, purification, and solution structure of arenicin.",,,,,,,,
3450,DRAMP03175,FNKLKQGSSKRTCAKCFRKIMPSVHELDERRRGANRWAAGFRKCVSSICRY,51,Perinerin,"P84117, P83551",Unknown,Unknown,Nereis aibuhitensis (Clamworm) (Perinereis aibuhitensis),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antibacterial activity against both Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas aeruginosa, Escherichia coli K-12, Proteus vulgaris;##Gram-positive bacteria: Bacillus megaterium, Aerococcus viridans, Staphylococcus aureus, Micrococcus luteus.",Unknown,Unknown,15113828,J Biochem. 2004 Mar;135(3):297-304.,"Pan W, Liu X, Ge F, Han J, Zheng T.","Perinerin, a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization.",,,,,,,,
3454,DRAMP03180,AVDFSSCARMDVPGLSKVAQGLCISSCKFQNCGTGHCEKRGGRPTCVCDRCGRGGGEWPSVPMPKGRSSRGRRHS,75,"ASABF-alpha (ASABF; nematodes, animals)",P90683,Unknown,asabf-alpha,Ascaris suum (Pig roundworm) (Ascaris lumbricoides),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,Unknown,2D56 resolved by NMR.,Slight hemolytic activity against human erythrocytes. ,"[Ref.10991847]Gram-negative bacteria: Escherichia coli JM109 (IC50=50 μg/ml), Proteus vulgaris ATCC 13315 (IC50=10 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC6538P (IC50=0.6 μg/ml), Bacillus subtilis ATCC6633 (IC50=1.2 μg/ml), Micrococcus luteus ATCC398 (IC50=0.8 μg/ml).",[Ref.10991847]4.5% hemolytic activity at 1000 μg/ml against human red blood cells,Unknown,8940016##10991847,J Biol Chem. 1996 Nov 29;271(48):30493-30498.##Antimicrob Agents Chemother. 2000 Oct;44(10):2701-2715.,"Kato Y, Komatsu S.##Zhang H, Yoshida S, Aizawa T, Murakami R, Suzuki M, Koganezawa N, Matsuura A, Miyazawa M, Kawano K, Nitta K, Kato Y.","ASABF, a novel cysteine-rich antibacterial peptide isolated from the nematode Ascaris suum. Purification, primary structure, and molecular cloning of cDNA.##In vitro antimicrobial properties of recombinant ASABF, an antimicrobial peptide isolated from the nematode Ascaris suum.",,,,,,,,
3456,DRAMP03183,DAECEICKFVIQQVEAFIESNHSQAEIQKELNKL,34,Naegleriapore A ,Q95X03,Unknown,NP-A,Naegleria fowleri (Brain eating amoeba),"Antibacterial, Antiprotozoal, Cytotoxicity, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Alpha helix ,It is characterized by a structure of amphipathic α-helices and an invariant framework of cysteine residues involved in disulfide bonds.,Unknown,"Function: Posesses antibacterial, cytotoxicity and pore-forming activity. In concentrations up to 10 μm, naegleriapore A is inactive against the Gram-negative bacterium E. coli D31. The specific pore-forming activities of naegleriapore A and B.",Gram-negative bacterium: Escherichia coli K-12 D31;##Gram-positive bacterium: Bacillus subtilis strain 60015.,Unknown,Unknown,11948186,J Biol Chem. 2002 Jun 21;277(25):22353-22360.,"Herbst R, Ott C, Jacobs T, Marti T, Marciano-Cabral F, Leippe M.",Pore-forming polypeptides of the pathogenic protozoon Naegleria fowleri.,,,,,,,,
3457,DRAMP03184,SVIGCEICEWLVATAEGFVNKTKPQIEQELLQICAKLGPYEQICDQLVLMELPDIIDQIIAKEPPAIVCSQVKICNG,77,Naegleriapore B ,Q95X02,Unknown,NP-B,Naegleria fowleri (Brain eating amoeba) ,"Antibacterial, Antiprotozoal, Cytotoxicity, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Alpha helix ,It is characterized by a structure of amphipathic α-helices and an invariant framework of cysteine residues involved in disulfide bonds.,Unknown,"Function: Posesses antibacterial, cytotoxicity and pore-forming activity. Naegleriapore B does not exert any antibacterial activity in concentration up to 10 μm against the bacteria tested. The specific pore-forming activities of naegleriapore A and B.",Gram-negative bacterium: Escherichia coli K-12 D31;##Gram-positive bacterium: Bacillus subtilis strain 60015.,Unknown,Unknown,11948186,J Biol Chem. 2002 Jun 21;277(25):22353-22360.,"Herbst R, Ott C, Jacobs T, Marti T, Marciano-Cabral F, Leippe M.",Pore-forming polypeptides of the pathogenic protozoon Naegleria fowleri.,,,,,,,,
3459,DRAMP03188,RLGGILRKAGEKIGGGLKKIGQKIKDFFGKLAPRTES,37,"Antibacterial protein LL-37 (primates, mammals, animals)",Q1KLX0,Belongs to the cathelicidin family,CAMP,Saguinus oedipus (Cotton-top tamarin),"Antibacterial, Anti-Gram-, Antimicrobial",Homology,Bridge,Unknown,Unknown,Function: Has antibacterial activity (By similarity).,"Gram-negative bacteria: Escherichia coli ML-35, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus 710A, Enterococcus faecalis A16.##Yeast: Candida albicans clinical isolate.",Unknown,Lipopolysaccharide (LPS)-binding,16720578,J Biol Chem. 2006 Jul 21;281(29):19861-19871.,"Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A.",Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.,,,,,,,,
3465,DRAMP03199,RRICRCRIGRCLGLEVYFGVCFLHGRLARRCCR,33,"PhD1 (PhD-1; Defensin-1; primates, mammals, animals)",P84757,Unknown,Unknown,Papio hamadryas (Hamadryas baboon),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Listeria monocytogenes, Staphylococcus aureus.##Yeast: Candida albicans.",Unknown,Unknown,16978151,Biochemistry (Mosc). 2006 Aug;71(8):879-883.,"Tsvetkova EV, Aleshina GM, Shamova OV, Leonova LE, Lehrer RI, Kokryakov VN.",alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.,,,,,,,,
3466,DRAMP03200,RICRCRIGRCLGLEVYFGVCFLHGRLARRCCR,32,"PhD2 (PhD-2; Defensin-2; primates, mammals, animals)",P84757,Belongs to the alpha-defensin family,Unknown,Papio hamadryas (Hamadryas baboon),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Listeria monocytogenes, Staphylococcus aureus.##Yeast: Candida albicans.",Unknown,Unknown,16978151,Biochemistry (Mosc). 2006 Aug;71(8):879-83.,"Tsvetkova EV, Aleshina GM, Shamova OV, Leonova LE, Lehrer RI, Kokryakov VN.",alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.,,,,,,,,
3467,DRAMP03201,RTCRCRLGRCSRRESYSGSCNINGRIYSLCCR,32,"PhD3 (PhD-3; Defensin-3; primates, mammals, animals)",P84758,Belongs to the alpha-defensin family,Unknown,Papio hamadryas (Hamadryas baboon),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Listeria monocytogenes, Staphylococcus aureus.##Yeast: Candida albicans.",Unknown,Unknown,16978151,Biochemistry (Mosc). 2006 Aug;71(8):879-883.,"Tsvetkova EV, Aleshina GM, Shamova OV, Leonova LE, Lehrer RI, Kokryakov VN.",alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.,,,,,,,,
3473,DRAMP03208,RCVCTRGFCRCVCRRGVC,18,"BTD-1 (theta-defensin; primates, mammals, animals)","B6ULW4, P86031, B6ULW5, P86032",Unknown,Unknown,Papio anubis (Olive baboon),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: BTD-1 has antimicrobial activity against the Gram-negative bacterium E. coli ML35 and the Gram-positive bacterium S. aureus 502a, and the fungus C. albicans 16820. ",Gram-positive bacterium: Staphylococcus aureus 502a;##Gram-negative bacterium: Escherichia coli ML35.##Fungi: Candida albicans 16820.,Unknown,Cell membrane,18852242,Infect Immun. 2008 Dec;76(12):5883-5891.,"Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.","Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",,,,,,,,
3474,DRAMP03209,RCVCRRGVCRCVCRRGVC,18,"BTD-2 (theta-defensin; primates, mammals, animals)","B6ULW5, P86032",Unknown,Unknown,Papio anubis (Olive baboon),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: BTD-2 has antimicrobial activity against the Gram-negative bacterium E. coli ML35 and the Gram-positive bacterium S. aureus 502a, and the fungus C. albicans 16820. Among the five BTDs detected, the most potent peptide is BTD-2. BTD-2 is more effective against E. coli than BTD-1.",Gram-positive bacterium: Staphylococcus aureus 502a;##Gram-negative bacterium: Escherichia coli ML35.##Fungi: Candida albicans 16820.,Unknown,Cell membrane,18852242,Infect Immun. 2008 Dec;76(12):5883-5891.,"Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.","Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",,,,,,,,
3476,DRAMP03211,RCVCTRGFCRCICLLGIC,18,"BTD-4 (theta-defensin; primates, mammals, animals)","B6ULW4, B6ULW6",Unknown,Unknown,Papio anubis (Olive baboon),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: BTD-4 has antimicrobial activity against the Gram-negative bacterium E. coli ML35 and the Gram-positive bacterium S. aureus 502a, and the fungus C. albicans 16820. Among the five BTD detected, BTD-4 is least positively charged (net charge +2). This may be responsible for its weaker antimicrobial activity observed in vitro. It disrupts E. coli membranes.",Gram-positive bacterium: Staphylococcus aureus 502a;##Gram-negative bacterium: Escherichia coli ML35.##Fungi: Candida albicans 16820.,Unknown,Cell membrane,18852242,Infect Immun. 2008 Dec;76(12):5883-5891.,"Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.","Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",,,,,,,,
3477,DRAMP03212,RCVCTRGFCRCFCRRGVC,18,"BTD-7 (theta-defensin; primates, mammals, animals)","B6ULW4, B6ULW7",Unknown,Unknown,Papio anubis (Olive baboon),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: BTD-7 has antimicrobial activity against the Gram-negative bacterium E. coli ML35 and the Gram-positive bacterium S. aureus 502a, and the fungus C. albicans 16820. ",Gram-positive bacterium: Staphylococcus aureus 502a;##Gram-negative bacterium: Escherichia coli ML35.##Fungi: Candida albicans 16820.,Unknown,Cell membrane,18852242,Infect Immun. 2008 Dec;76(12):5883-5891.,"Garcia AE, Osapay G, Tran PA, Yuan J, Selsted ME.","Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",,,,,,,,
3485,DRAMP03224,GFGSLFKFLAKKVAKTVAKQAAKQGAKYIANKQTE,35,"M-ctenitoxin-Cs1c (M-CNTX-Cs1c; Cupiennin-1c; spiders, Arthropods, animals)",P83621,Belongs to the cupiennin family,Unknown,Cupiennius salei (Wandering spider),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antimicrobial activity. Probably acts by disturbing membrane Function: with its amphipathic structure.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853;##Gram-positive bacteria: Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212.",Unknown,Unknown,11792701,J Biol Chem. 2002 Mar 29;277(13):11208-11216.,"Kuhn-Nentwig L, Muller J, Schaller J, Walz A, Dathe M, Nentwig W.","Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae).",,,,,,,,
3489,DRAMP03238,GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYVLKYYGKKALQKASEKL,69,"M-zodatoxin-Lt8c (M-ZDTX-Lt8c; Cytoinsectotoxin-1c, CIT-1c; spiders, Arthropods, animals)","P85255, B3W6I1",Belongs to the cytoinsectotoxin family,cit 1-3,Lachesana tarabaevi (Spider),"Antibacterial, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Insecticidal, cytolytic and antimicrobial peptide. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis(By similarity).
Tissue specificity: Expressed by the venom gland.","Gram-positive bacteria: Micrococcus luteus VKM Ac-2230, Staphylococcus aureus 209P, Arthrobacter globiformis VKM Ac-1112, Bacillus subtilis VKM B-501;##Gram-negative bacteria: Escherichia coli C600, E. coli DH5α±, E. coli MH1, Pseudomonas aeruginosa PAO1, Pseudomonas fluorescens VKM B-894, Serratia marcescens VKM B-1248.",Unknown,Unknown,18215128,Biochem J. 2008 May 1;411(3):687-696.,"Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.","Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.",,,,,,,,
3492,DRAMP03241,GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYLLKHYGKKALQKASEKL,69,"M-zodatoxin-Lt8f (M-ZDTX-Lt8f; Cytoinsectotoxin-1f, CIT-1f; spiders, Arthropods, animals)","P85258, B3W6I4",Belongs to the cytoinsectotoxin family,cit 1-7,Lachesana tarabaevi (Spider),"Antibacterial, Insecticidal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Insecticidal, cytolytic and antimicrobial peptide. Has insecticidal activity against the flesh fly S. carnaria. Has antibacterial activity against the Gram-negative bacteria E.coli. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,18215128,Biochem J. 2008 May 1;411(3):687-696.,"Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.","Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.",,,,,,,,
3493,DRAMP03242,GFFGNTWKKIKGKADKIMLKKAVKIMVKKEGISKEEAQAKVDAMSKKQIRLYVLKHYGKKALQKASEKL,69,"M-zodatoxin-Lt8g (M-ZDTX-Lt8g; Cytoinsectotoxin-1g, CIT-1g; spiders, Arthropods, animals)","P85259, B3W6I5",Belongs to the cytoinsectotoxin family,cit 1-8,Lachesana tarabaevi (Spider),"Antibacterial, Insecticidal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has insecticidal activity against the flesh fly S. carnaria. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,18215128,Biochem J. 2008 May 1;411(3):687-696.,"Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.","Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.",,,,,,,,
3494,DRAMP03243,GFFGNAWKKIKGKAEKFFRKKAAKIIAKKEGITKEEAEAKVDTMSKKQIKVYLLKHYGKKALQKASEKL,69,"M-zodatoxin-Lt8h (M-ZDTX-Lt8h; Cytoinsectotoxin-1h, CIT-1h; spiders, Arthropods, animals)","P85247, B3W6I6",Belongs to the cytoinsectotoxin family,cit 1-11,Lachesana tarabaevi (Spider),"Antibacterial, Insecticidal, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has insecticidal activity against the flesh fly S. carnaria. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Tissue specificity: Expressed by the venom gland.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,18215128,Biochem J. 2008 May 1;411(3):687-696.,"Vassilevski A.A, Kozlov S.A, Samsonova O.V, Egorova N.S, Karpunin D.V, Pluzhnikov K.A, Feofanov A.V, Grishin E.V.","Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.",,,,,,,,
3514,DRAMP18213,VKLFPVKLFP,10,Gramicidin S(Bacteriocin),No entry found,Unknown,Unknown,Bacillus brevis,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",,Beta sheet,"The second and seventh residues of this cyclic peptide are Ornithines, an analog of lysine (one CH2 shorter). They are represented here with lysines. In addition, residue F is a D-amino acid.",Unknown,"Function: This is the first cyclic peptide antibiotic used clinically. For gram-negative bacteria, however,  activity  was strongly dependent on whether the assay was carried out in solution or in agar. It was found that GS was active against gram-negative microorganisms in the solution-based  assay, but inactive against these using an agar-based  assay. GS was also found to have antifungal activity when measured using a  liquid-broth assay. ","Gram-positive, Gram-negative (broad-spectrum)",Unknown,Cell membrane,8836773##24388950,Int J Pept Protein Res. 1996 Jun;47(6):460-6.##Biochim Biophys Acta. 2014 May;1838(5):1420-9. ,"Kondejewski LH, Farmer SW, Wishart DS, Hancock RE, Hodges RS.##Abraham T, Prenner EJ, Lewis RN, Mant CT, Keller S, Hodges RS, McElhaney RN.","Gramicidin S is active against both gram-positive and gram-negative bacteria.##Structure-activity relationships of the antimicrobial peptide gramicidin S and its analogs: aqueous solubility, self-association, conformation, antimicrobial activity and interaction with model lipid membranes.",,,,,,,,
3525,DRAMP03282,GKREKCLRRNGFCAFLKCPTLSVISGTCSRFQVCC,35,"Turkey Heterophil Peptide 1 (Antimicrobial peptide THP1; Birds, animals)",P80391,Belongs to the beta-defensin family,Unknown,Meleagris gallopavo (Common turkey),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge ,Unknown,Unknown,PTM: Contains two disulfide bonds ,Gram-negative bacterium: Escherichia coli ATCC 25922;##Gram-positive bacterium: Staphylococcus aureus.,Unknown,Unknown,7964174,J Leukoc Biol. 1994 Nov;56(5):661-665.,"Evans EW, Beach GG, Wunderlich J, Harmon BG.",Isolation of antimicrobial peptides from avian heterophils.,,,,,,,,
3543,DRAMP03304,QIVDCWETWSRCTKWSQGGTGTLWKSCNDRCKELGRKRGQCEEKPSRCPLSKKAWTCICY,60,"Hydramacin-1 (Hm-1; annelida, animals)",B3RFR8,Belongs to the macin family,Unknown,Hydra vulgaris (Hydra) (Hydra attenuata),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,The molecule possesses two short α-helices (residues 10-14 and 27-33) at the N terminus which are separated by a long flexible loop. The C-terminal region contains two β-strands (residues 38-42 and 56-60) in an antiparallel arrangement separated by a long flexible loop. ,2K35 resolved by NMR.,"Function: Hydramacin-1 is potently active against Gram-positive and Gram-negative bacteria including multi-resistant human pathogenic strains. Is not active against the Gram-positive Coccus species, Gram-negative non-fermentation species and against the fungus C.albicans. It leads to aggregation of bacteria as an initial step of its bactericidal mechanism. Aggregated cells are connected via electron-dense contacts and adopt a thorn apple-like morphology. Hydramycin contains a belt of positively charged residues that separate two hydrophobic areas. This structure may explain the observed aggregation of bacteria, since each of these areas can immerse into the outer leaflets of the membranes of two individual bacteria. Is able to permeabilize membranes of viable bacteria at low and neutral pH values, but no pore-forming activity is not detected.
Tissue specificity: Expressed in the endodermal epithelium.
Induction: By bacterial lipopolysaccharides (LPS).
PTM: Contains four disulfide bonds.","Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MBC=7.1 μM), Burkholderia cepacia ATCC 25416 (MBC>14.3 μM),Burkholderia cepacia ATCC 17759 (MBC>14.3 μM), B. cepacia LMG 16654 (MBC>14.3 μM), Citrobacter freundii NCTC 9750 (MBC=7.1 μM), C. freundii C7 (MBC=0.9 μM), Enterobacter cloacae Va11263/03 (MBC>14.3 μM), E. cloacae Va12270/03 (MBC=0.9 μM), Escherichia coli ATCC 25922 (MBC=0.9 μM), Klebsiella pneumoniae ATCC 13883 (MBC=0.9 μM), Klebsiella oxytoca ATCC 13182 (MBC=0.9 μM), Proteus mirabilis ATCC 21100 (MBC=14.3 μM), P. vulgaris ATCC 13315 (MBC>14.3 μM), Providencia rettgeri NCTC 7475 (MBC>14.3 μM), Pseudomonas aeruginosa NCTC 11446 (MBC>14.3 μM), Salmonella typhimurium 10003442 (MBC=0.9 μM), S. typhimurium 10003630 (MBC=0.9 μM), Serratia marcescens Mero060/148 (MBC>14.3 μM), S. marcescens Mero103/013 (MBC>14.3 μM), S. marcescens NCTC 10211 (MBC>14.3 μM), Yersinia enterocolitica NCTC 11176 (MBC=0.9 μM).##Multi-resistant Gram-negative bacteria: Escherichia coli Co 86 ESBL (MBC=3.6 μM), Klebsiella oxytoca ESBL 33 (MBC=7.1 μM), K. oxytoca ESBL 37 (MBC=3.6 μM), Klebsiella pneumoniae ATCC 700603 (MBC=3.6 μM).##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MBC>14.3 μM), Staphylococcus haemolyticus ATCC 29970 (MBC=1.8 μM), Streptococcus pyogenes ATCC 12344 (MBC>14.3 μM).##Multi-resistant Gram-positive bacteria: Staphylococcus aureus ATCC 33593 (MRSA) (MBC>14.3 μM), Enterococcus faecalis ATCC 51299 (MBC>14.3 μM).",Unknown,cell membrane,19013190##19019828,Dev Comp Immunol. 2009 Apr;33(4):559-569.##J Biol Chem. 2009 Jan 16;284(3):1896-1905.,"Bosch TC, Augustin R, Anton-Erxleben F, Fraune S, Hemmrich G, Zill H, Rosenstiel P, Jacobs G, Schreiber S, Leippe M, Stanisak M, Grtzinger J, Jung S, Podschun R, Bartels J, Harder J, Schrder JM.##Jung S, Dingley AJ, Augustin R, Anton-Erxleben F, Stanisak M, Gelhaus C, Gutsmann T, Hammer MU, Podschun R, Bonvin AM, Leippe M, Bosch TC, Grtzinger J.","Uncovering the evolutionary history of innate immunity: the simple metazoan Hydra uses epithelial cells for host defence.##Hydramacin-1, structure and antibacterial activity of a protein from the basal metazoan Hydra.",,,,,,,,
3554,DRAMP03317,AKRGGFWRKVGRKLGKGIRKIGKTIKSQLGKFRPRLQYRYQF,42,Cathelicidin-related antimicrobial peptide (AMPs),Q0R5P1,Unknown,CRAMP,Chinchilla lanigera (Long-tailed chinchilla) (Chinchilla villidera) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: Escherichia coli, Moraxella catarrhalis 1857;##Gram-positive bacterium: Streptococcus pneumoniae serotype 14.",Unknown,Unknown,17113647,Mol Immunol. 2007 Mar;44(9):2446-2458.,"McGillivary G, Ray WC, Bevins CL, Munson RS Jr, Bakaletz LO.",A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media.,,,,,,,,
3565,DRAMP03329,LRDLVCYCRSRGCKGRERMNGTCRKGHLLYTLCCR,35,"Alpha-defensin cryptdin-1 (Crp1; Rodents, mammals, animals)","P11477, Q61448",Belongs to the alpha-defensin family,Defa1,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa. Has antibacterial activity against attenuated mutants of S. typhimurium.
Tissue specificity: Paneth cells of the small bowel. 
Developmental stage: Accumulates to high levels in mouse intestinal crypt epithelium during postnatal development.
PTM: Contains three disulfide bonds (By similarity). ","Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacteria: Escherichia coli ML-35p, mouse-avirulent Salmonella typhimurium 7953.",Unknown,Unknown,1500431,J Cell Biol. 1992 Aug;118(4):929-936.,"Selsted ME, Miller SI, Henschen AH, Ouellette AJ.",Enteric defensins: antibiotic peptide components of intestinal host defense.,,,,,,,,
3566,DRAMP03330,LRDLVCYCRTRGCKRRERMNGTCRKGHLMYTLCCR,35,"Alpha-defensin cryptdin-2 (Defensin-related cryptdin-2; Rodents, mammals, animals)","P28309, P82293, Q60616, Q62537",Belongs to the alpha-defensin family,Defa2,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge ,Unknown,Unknown,"Function: Has broad-spectrum antibacterial activity. Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel.
PTM: Contains three disulfide bonds 6-34; 8-23; 13-33 (By similarity).","Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacteria: Escherichia coli ML-35p, mouse-avirulent Salmonella typhimurium 7953.",Unknown,Unknown,1500431##1500163,J Cell Biol. 1992 Aug;118(4):929-936.##Infect Immun. 1992 Sep;60(9):3556-3565.,"Selsted ME, Miller SI, Henschen AH, Ouellette AJ.##Eisenhauer PB, Harwig SS, Lehrer RI.",Enteric defensins: antibiotic peptide components of intestinal host defense.##Cryptdins: antimicrobial defensins of the murine small intestine.,,,,,,,,
3567,DRAMP03331,LRDLVCYCRKRGCKRRERMNGTCRKGHLMYTLCCR,35,"Alpha-defensin cryptdin-3 (Defensin-related cryptdin-3; Rodents, mammals, animals)","P28310, Q499K7",Belongs to the alpha-defensin family,Defa3,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel.
PTM: Contains three disulfide bonds (By similarity). ","Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacteria: Escherichia coli ML-35p, mouse-avirulent Salmonella typhimurium 7953.",Unknown,Unknown,1500431,J Cell Biol. 1992 Aug;118(4):929-936.,"Selsted ME, Miller SI, Henschen AH, Ouellette AJ.",Enteric defensins: antibiotic peptide components of intestinal host defense.,,,,,,,,
3568,DRAMP03332,LRGLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR,34,"Alpha-defensin cryptdin-4 (Defensin-related cryptdin4; Rodents, mammals, animals)","P28311, A3KPC1, Q9QZL4",Belongs to the alpha-defensin family,Defa4,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (3 strands; 18 residues),Unknown,"2GW9, 1TV0, 2GWP, 2LEW, 2LEY resolved by NMR.","Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel.
PTM: Contains three disulfide bonds. ","Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacteria: Escherichia coli ML-35p, mouse-avirulent Salmonella typhimurium 7953.",Unknown,Phospholipid,15595831##7927786##16857681,Biochemistry. 2004 Dec 21;43(50):15759-15766.##Infect Immun. 1994 Nov;62(11):5040-5047.##J Biol Chem. 2006 Sep 22;281(38):28068-78.,"Jing W, Hunter HN, Tanabe H, Ouellette AJ, Vogel HJ.##Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Rosengren KJ, Daly NL, Fornander LM, Jnsson LM, Shirafuji Y, Qu X, Vogel HJ, Ouellette AJ, Craik DJ.","Solution structure of cryptdin-4, a mouse paneth cell alpha-defensin.##Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Structural and functional characterization of the conserved salt bridge in mammalian paneth cell alpha-defensins: solution structures of mouse CRYPTDIN-4 and (E15D)-CRYPTDIN-4.",,,,,,,,
3569,DRAMP03333,SKKLICYCRIRGCKRRERVFGTCRNLFLTFVFCCS,35,"Alpha-defensin cryptdin-5 (Defensin-related cryptdin5; Rodents, mammals, animals)","P28312, Q64382",Belongs to the alpha-defensin family,Defa5,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
PTM: Contains three disulfide bonds.","Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacteria: Escherichia coli ML-35p, mouse-avirulent Salmonella typhimurium 7953.",Unknown,Unknown,1500431,J Cell Biol. 1992 Aug;118(4):929-936.,"Selsted ME, Miller SI, Henschen AH, Ouellette AJ.",Enteric defensins: antibiotic peptide components of intestinal host defense.,,,,,,,,
3570,DRAMP03334,DLVCYCRARGCKGRERMNGTCRKGHLLYMLCCR,33,"Alpha-defensin cryptdin-6/12 (Defensin-related cryptdin-6/12; Rodents, mammals, animals)","P50704, P50710, P82294",Belongs to the alpha-defensin family,Defa6 AND Defa12,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Has broad-spectrum antibacterial activity. Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.
Tissue specificity: Paneth cells of the small bowel.
PTM: Contains three disulfide bondss 4-32; 6-21; 11-31. Probably contributes to the antimicrobial barrier Function: of the small bowel mucosa.","Gram-positive bacterium: Listeria monocytogenes EGD;##Gram-negative bacteria: Escherichia coli ML-35p, mouse-avirulent Salmonella typhimurium 7953.",Unknown,Unknown,7927786##1500163,Infect. Immun. 1994;62:5040-5047.##Infect. Immun. 1992;60:3556-3565.,"Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME.##Eisenhauer P.B, Harwig S.S.S.L, Lehrer R.I.",Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.##Cryptdins: antimicrobial defensins of the murine small intestine.,,,,,,,,
3593,DRAMP03357,LQDAALGWGRRCPQCPRCPSCPSCPRCPRCPRCKCNPK,38,"Cryptdin related sequence peptide (CRS4C-1a; Rodents, mammals, animals)","Q70LV2, Q70LV8, Q70LV7, Q70LV6, Q70LV4",Unknown,Defa-rs2,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide that defense response to Gram-negative bacterium and Gram-positive bacterium.
MOA: CRS peptides were able to bind LPS and to reduce its immunostimulatory activity, leading to a substantial reduction in cellular activation.","Gram-positive bacteria: Enterococcus faecalis (LC=1.9 μM), Lactobacillus fermentum DSM 20052 (LC=1.1 μM), Strepococcus pyogenes clinical isolate (LC=0.4 μM), Listeria monocytogenes type 1 clinical isolate (LC=1.4 μM);##Gram-negative bacteria: Escherichia coli strain D21 (LC=2.4 μM), Salmonella typhimurium ATCC 14028 (LC=1.7 μM).##NOTE: Dimerized peptide was two- to fourfold more potent than monomeric peptide. LC, Lethal concentrations.",Unknown,Lipopolysaccharide (LPS)-binding,15235601,Nat Immunol. 2004 Aug;5(8):836-843.,"Hornef MW, Pütsep K, Karlsson J, Refai E, Andersson M.",Increased diversity of intestinal antimicrobial peptides by covalent dimer formation.,,,,,,,,
3594,DRAMP03358,LQDAAVGWGRRCPQCPRCPSCPSCPRCPRCPRCKCNPK,38,"Cryptdin related sequence peptide (CRS4C-1d; Rodents, mammals, animals)","Q70LV9, Q70LV5, Q70LV3",Unknown,Defa-rs4,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide that defense response to Gram-negative bacterium and Gram-positive bacterium.
MOA: CRS peptides were able to bind LPS and to reduce its immunostimulatory activity, leading to a substantial reduction in cellular activation.","Gram-negative bacterium: Salmonella typhimurium ATCC 14028;##Gram-positive bacteria: Enterococcus faecalis, Listeria monocytogenes type 1 clinical isolate, Streptococcus pyogenes clinical isolate.",Unknown,Lipopolysaccharide (LPS)-binding,15235601,Nat Immunol. 2004 Aug;5(8):836-843.,"Hornef MW, Pütsep K, Karlsson J, Refai E, Andersson M.",Increased diversity of intestinal antimicrobial peptides by covalent dimer formation.,,,,,,,,
3595,DRAMP03359,LQDAALGWGRRCPRCPPCPRCSWCPRCPTCPRCNCNPK,38,"Cryptdin related sequence peptide (CRS4C-2; Rodents, mammals, animals)","Q70LV0, Q70LU3",Unknown,Defa-rs7,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide that defense response to Gram-negative bacterium and Gram-positive bacterium.
MOA: CRS peptides were able to bind LPS and to reduce its immunostimulatory activity, leading to a substantial reduction in cellular activation.","Gram-negative bacterium: Salmonella typhimurium ATCC 14028;##Gram-positive bacteria: Enterococcus faecalis, Listeria monocytogenes type 1 clinical isolate, Streptococcus pyogenes clinical isolate.",Unknown,Lipopolysaccharide (LPS)-binding,15235601,Nat Immunol. 2004 Aug;5(8):836-843.,"Hornef MW, Pütsep K, Karlsson J, Refai E, Andersson M.",Increased diversity of intestinal antimicrobial peptides by covalent dimer formation.,,,,,,,,
3596,DRAMP03360,LQDAALGWGRRCPRCPPCPRCSWCPRCPTCPGCNCNPK,38,"Cryptdin related sequence peptide (CRS4C-2b; Rodents, mammals, animals)",Q70LV1,Unknown,Defa-rs7,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide that defense response to Gram-negative bacterium and Gram-positive bacterium.
MOA: CRS peptides were able to bind LPS and to reduce its immunostimulatory activity, leading to a substantial reduction in cellular activation.","Gram-negative bacterium: Salmonella typhimurium ATCC 14028;##Gram-positive bacteria: Enterococcus faecalis, Listeria monocytogenes type 1 clinical isolate, Streptococcus pyogenes clinical isolate.",Unknown,Lipopolysaccharide (LPS)-binding,15235601,Nat Immunol. 2004 Aug;5(8):836-843.,"Hornef MW, Pütsep K, Karlsson J, Refai E, Andersson M.",Increased diversity of intestinal antimicrobial peptides by covalent dimer formation.,,,,,,,,
3598,DRAMP03362,LQDAALGWSRRCPRCPPCPNCRRCPRCPTCPSCNCNPK,38,"CRS4C-3c (Cryptdin related sequence peptide; Rodents, mammals, animals)",No entry found,Unknown,Unknown,Mus musculus (Mouse),"Antimicrobial , Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide that defense response to Gram-negative bacterium and Gram-positive bacterium.
MOA: CRS peptides were able to bind LPS and to reduce its immunostimulatory activity, leading to a substantial reduction in cellular activation.","Gram-negative bacterium: Salmonella typhimurium ATCC 14028;##Gram-positive bacteria: Enterococcus faecalis, Listeria monocytogenes type 1 clinical isolate, Streptococcus pyogenes clinical isolate.",Unknown,Lipopolysaccharide (LPS)-binding,15235601,Nat Immunol. 2004 Aug;5(8):836-843.,"Hornef M.W, Putsep K, Karlsson J, Refai E, Andersson M.",Increased diversity of intestinal antimicrobial peptides by covalent dimer formation.,,,,,,,,
3602,DRAMP03366,DQYKCLQHGGFCLRSSCPSNTKLQGTCKPDKPNCCKS,37,"Beta-defensin 1 (BD-1; mBD-1; Defensin, beta 1; Rodents, mammals, animals)",P56386,Belongs to the beta-defensin family,Unknown,Mus musculus (Mouse),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Bridge,Unknown,Unknown,PTM: Contains three disulfide bonds 5-34; 12-27; 17-35.,"Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa;##Gram-positive bacterium: Staphylococcus aureus.",Unknown,Unknown,9287114,FEBS Lett. 1997 Aug 11;413(1):45-49.,"Huttner KM, Kozak CA, Bevins CL.",The mouse genome encodes a single homolog of the antimicrobial peptide human beta-defensin 1.,,,,,,,,
3604,DRAMP03368,KKINNPVSCLRKGGRCWNRCIGNTRQIGSCGVPFLKCCKRK,41,"Beta-defensin 3 (BD-3, mBD-3; Defensin, beta 3; Rodents, mammals, animals)","Q9WTL0, Q29R78",Belongs to the beta-defensin family,Defb3,Mus musculus (Mouse),"Antibacterial, Anti-Gram-, Antimicrobial",Transcript level,Bridge,Unknown,Unknown,"PTM: Contains three disulfide bonds 9-37; 17-30; 20-38. Highest expression in salivary glands, epididymis, ovary and pancreas and to a lesser extent in lung, liver and brain. Low or no expression in skeletal muscle and tongue. By bacterial infection.","Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa.",Unknown,Unknown,10377137,Infect Immun. 1999 Jul;67(7):3542-3547.,"Bals R, Wang X, Meegalla R.L, Wattler S, Weiner D.J, Nehls M.C, Wilson J.M.",Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs.,,,,,,,,
3605,DRAMP03369,QIINNPITCMTNGAICWGPCPTAFRQIGNCGHFKVRCCKIR,41,"Beta-defensin 4 (BD-4, mBD-4; Defensin, beta 4; Rodents, mammals, animals)",P82019,Belongs to the beta-defensin family,Defb4,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Bridge,Unknown,Unknown,"PTM: Contains three disulfide bonds 9-37; 16-30; 20-38. When expressed as a fusion protein, mBD-4 showed activity against both E. coli and S. aureus at 1ug/ml as well as chemotactic activity via CCR6-expressing cells (Rohrl J et al. J Biol Chem. 2010 Mar 5;285(10):7028-34). ",Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Staphylococcus aureus.,Unknown,Unknown,10922379,J Biol Chem. 2000 Oct 27;275(43):33314-33320.,"Jia HP, Wowk SA, Schutte BC, Lee SK, Vivado A, Tack BF, Bevins CL, McCray PB Jr.","A novel murine beta-defensin expressed in tongue, esophagus, and trachea.",,,,,,,,
3608,DRAMP03373,NEPVSCIRNGGICQYRCIGLRHKIGTCGSPFKCCK,35,"Beta-defensin 8 (BD-8, mBD-8; Defensin, beta 8; Rodents, mammals, animals)","Q91V82, Q8R556",Belongs to the beta-defensin family,Defb8,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,Unknown,1E4R resolved by NMR.,"PTM: Contains three disulfide bonds 6-33; 13-27; 17-34.
Function: The antimicrobial activity against S. aureus, E. coli and B.cepacia is reduced in raised concentration of NaCl, but its action against Pseudomonas aeruginosa is independent of NaCl concentration.","Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacteria: Pseudomonas aeruginosa, Escherichia coli, Burkholderia cepacia.",Unknown,Unknown,PubMed ID is not available##11714914,Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.##Protein Sci. 2001 Dec;10(12):2470-2479.,"Conejo-Garcia JR, Nehls MC, Wattler S, Bals R, Heitland A, Kluever E, Liepke C, Adermann K, Forssmann WG.##Bauer F, Schweimer K, Klüver E, Conejo-Garcia JR, Forssmann WG, Rsch P, Adermann K, Sticht H.","Cloning and characterization of mBD-7 and mBD-8, two novel mouse beta-defensins.##Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity.",,,,,,,,
3628,DRAMP03393,IGPDTKKCVQRKNACHYFECPWLYYSVGTCYKGKGKCCQKRY,42,"Beta-defensin 38 (BD-38, mBD-38; Defensin, beta 38; Rodents, mammals, animals)",Q7TNV7,Belongs to the beta-defensin family,Defb38,Mus musculus (Mouse),"Antibacterial, Anti-Gram-, Antimicrobial",Transcript level,Bridge,Unknown,Unknown,PTM: Contains three disulfide bonds 8-37; 15-30; 20-38.,"Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa, Enterococcus faecium.",Unknown,Unknown,14718547,J Biol Chem. 2004 Mar 26;279(13):12421-12426.,"Zaballos A, Villares R, Albar JP, Martínez-A C, Márquez G.",Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ.,,,,,,,,
3634,DRAMP03399,PGDIPPGIRNTVCLMQQGHCRLFMCRSGERKGDICSDPWNRCCVPYSVKDRR,52,"Sperm-associated antigen 11 (Rodents, mammals, animals)","Q8K4N2, Q2HPE4, Q30KM3",Belongs to the beta-defensin family,Spag11,Mus musculus (Mouse),"Antibacterial, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Is also responsible for sperm maturation, storage, and protection. ",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,16033865##12193721,Physiol Genomics. 2005 Sep 21;23(1):5-17.##J Immunol. 2002 Sep 1;169(5):2516-2523.,"Patil A.A, Cai Y, Sang Y, Blecha F, Zhang G.##Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T, Kurihara H, Ouchi Y.",Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.##Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice.,,,,,,,,
3635,DRAMP03400,GGVKGEEKRVCPPDYVRCIRQDDPQCYSDNDCGDQEICCFWQCGFKCVLPVKDNSEEQIPQSKV,64,"WAP four-disulfide core domain protein 12 (Rodents, mammals, animals)",Q9JHY3,Unknown,Wfdc12,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (IC90=10 μM);##Gram-positive bacterium: Staphylococcus aureus (IC90=10 μM).,Unknown,Unknown,12574366,J Immunol. 2003 Feb 15;170(4):1973-1979.,"Hagiwara K, Kikuchi T, Endo Y, Huqun, Usui K, Takahashi M, Shibata N, Kusakabe T, Xin H, Hoshi S, Miki M, Inooka N, Tokue Y, Nukiwa T.",Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif.,,,,,,,,
3637,DRAMP03402,RPEIKKKNVFSKPGYCPEYRVPCPFVLIPKCRRDKGCKDALKCCFFYCQMRCVDPWESPE,60,"WAP four-disulfide core domain protein 15B (Elafin-like protein I; Rodents, mammals, animals)","Q9JHY4, A2A5M6, Q8BVC0",Unknown,Wfdc15b,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli (IC90=10 μM);##Gram-positive bacterium: Staphylococcus aureus (IC90=10 μM).,Unknown,Unknown,12574366,J Immunol. 2003 Feb 15;170(4):1973-1979.,"Hagiwara K, Kikuchi T, Endo Y, Huqun, Usui K, Takahashi M, Shibata N, Kusakabe T, Xin H, Hoshi S, Miki M, Inooka N, Tokue Y, Nukiwa T.",Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif.,,,,,,,,
3639,DRAMP03407,DPVTYIRNGGICQYRCIGLRHKIGTCGSPFKCCK,34,"Defr1 (Murine beta-defensin related peptide; Rodents, mammals, animals)",No entry found,Belongs to the beta-defensin family,Unknown,Mus musculus (Mouse),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"The antimicrobial activity of Defr1 against S. aureus, E. coli, and B. cepacia was found to be reduced in raised concentration of NaCl, but its action against P. aeruginosa was independent of NaCl concentration. ","Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacteria: Pseudomonas aeruginosa, Escherichia coli, Burkholderia cepacia.",Unknown,Unknown,12226710,Mamm Genome. 2002 Aug;13(8):445-451.,"Morrison GM, Rolfe M, Kilanowski FM, Cross SH, Dorin JR.",Identification and characterization of a novel murine beta-defensin-related gene.,,,,,,,,
3640,DRAMP03408,VTCFCRRRGCASRERHIGYCRFGNTIYRLCCRR,33,"Neutrophil defensin 1 (HANP-1; alpha-defensin; Rodents, mammals, animals)",P81465,Belongs to the alpha-defensin family,Unknown,Mesocricetus auratus (Golden hamster),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Anti-fungal and bactericidal activity, greater against Gram-positive bacteria.","Gram-positive bacteria: Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecalis;##Gram-negative bacteria: Escherichia coli, Salmonella serotype krefeld, Klebsiella oxytoca, Pseudomonas aeruginosa.##Fungi: Candida albicans, Cryptococcus neoformans.",Unknown,Unknown,8890190,Infect Immun. 1996 Nov;64(11):4444-4449.,"Mak P, Wójcik K, Thogersen IB, Dubin A.","Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins.",,,,,,,,
3641,DRAMP03409,CFCKRPVCDSGETQIGYCRLGNTFYRLCCRQ,31,"Neutrophil defensin 2 (HANP-2; alpha-defensin; Rodents, mammals, animals)",P81466,Belongs to the alpha-defensin family,Unknown,Mesocricetus auratus (Golden hamster),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Bactericidal activity, greater against Gram-positive bacteria. Low anti-fungi activity","Gram-positive bacteria: Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecalis;##Gram-negative bacteria: Escherichia coli, Salmonella serotype krefeld, Klebsiella oxytoca, Pseudomonas aeruginosa.##Fungi: Candida albicans, Cryptococcus neoformans.",Unknown,Unknown,8890190,Infect Immun. 1996 Nov;64(11):4444-4449.,"Mak P, Wójcik K, Thogersen IB, Dubin A.","Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins.",,,,,,,,
3642,DRAMP03410,VTCFCRRRGCASRERLIGYCRFGNTIYGLCCRR,33,"Neutrophil defensin 3 (HANP-3; alpha-defensin; Rodents, mammals, animals)",P81467,Belongs to the alpha-defensin family,Unknown,Mesocricetus auratus (Golden hamster),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Anti-fungal and bactericidal activity, greater against Gram-positive bacteria.","Gram-positive bacteria: Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecalis;##Gram-negative bacteria: Escherichia coli, Salmonella serotype krefeld, Klebsiella oxytoca, Pseudomonas aeruginosa.##Fungi: Candida albicans, Cryptococcus neoformans.",Unknown,Unknown,8890190,Infect Immun. 1996 Nov;64(11):4444-4449.,"Mak P, Wójcik K, Thogersen IB, Dubin A.","Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins.",,,,,,,,
3643,DRAMP03411,VTCFCKRPVCDSGETQIGYCRLGNTFYRLCCRQ,33,"Neutrophil defensin 4 (HANP-4; alpha-defensin; Rodents, mammals, animals)",P81468,Belongs to the alpha-defensin family,Unknown,Mesocricetus auratus (Golden hamster),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Function: Bactericidal activity, greater against Gram-positive bacteria. Low anti-fungi activity.","Gram-positive bacteria: Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecalis;##Gram-negative bacteria: Escherichia coli, Salmonella serotype krefeld, Klebsiella oxytoca, Pseudomonas aeruginosa.##Fungi: Candida albicans, Cryptococcus neoformans.",Unknown,Unknown,8890190,Infect Immun. 1996 Nov;64(11):4444-4449.,"Mak P, Wójcik K, Thogersen IB, Dubin A.","Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins.",,,,,,,,
3651,DRAMP03420,VTCYCRSTRCGFRERLSGACGYRGRIYRLCCR,32,"Neutrophil antibiotic peptide NP-2 (RatNP-2; Rodents, mammals, animals)",Q62715,Belongs to the alpha-defensin family,Defa,Rattus norvegicus (Rat),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Active in vitro against S. aureus, fungi, Gram-positive and Gram-negative bacteria and to a lesser extent against an enveloped virus.",Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Salmonella typhimurium.,Unknown,Unknown,2254017##7594610,Infect. Immun. 1990;58:3899-3902.##J. Immunol. 1995;155:4476-4484. ,"Eisenhauer P.B, Harwig S.S.S.L, Szklarek D, Ganz T, Lehrer R.I.##Yount N.Y, Wang MS.C, Yuan J, Banaiee N, Ouellette A.J, Selsted M.E.",Polymorphic expression of defensins in neutrophils from outbred rats.##Rat neutrophil defensins. Precursor structures and expression during neutrophilic myelopoiesis.,,,,,,,,
3652,DRAMP03421,CSCRTSSCRFGERLSGACRLNGRIYRLCC,29,"Neutrophil antibiotic peptide NP-3 (RatNP-3a, RatNP-3b; Rodents, mammals, animals)","Q62713, Q9Z1F1",Belongs to the alpha-defensin family,Unknown,Rattus norvegicus (Rat),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,"Active in vitro against S. aureus, fungi, Gram-positive and Gram-negative bacteria and to a lesser extent against an enveloped virus.","Gram-positive bacterium: Staphylococcus aureus 502A;##Gram-negative bacterium: Escherichia coli ML-35.##Fungi: Candida albicans 820, Cryptococcus neoformans A-383.",Unknown,Unknown,2254017##7594610,Infect. Immun. 1990;58:3899-3902.##J. Immunol. 1995;155:4476-4484. ,"Eisenhauer P.B, Harwig S.S.S.L, Szklarek D, Ganz T, Lehrer R.I.##Yount N.Y, Wang MS.C, Yuan J, Banaiee N, Ouellette A.J, Selsted M.E.",Polymorphic expression of defensins in neutrophils from outbred rats.##Rat neutrophil defensins. Precursor structures and expression during neutrophilic myelopoiesis.,,,,,,,,
3653,DRAMP03423,DIPPGIRNTVCFMQRGHCRLFMCRSGERKGDICSDPWNRCCVSSSIKNR,49,"BIN1b (Sperm-associated antigen 11; Antimicrobial-like protein Bin-1b; Rodents, mammals, animals)",Q8VBV2,Belongs to the beta-defensin family,Spag11,Rattus norvegicus (Rat),"Antibacterial, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide against E.coli. Is also responsible for sperm maturation, storage, and protection.
Tissue specificity: Only expressed in epididymis (middle part of the caput).
Developmental stage: Its expression starts at 30 days of age, reaches a maximum during the sexually mature period, and then decreased in old rats.
PTM: Contains three disulfide bonds 11-40; 18-33; 23-41.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,11230693,J Biotechnol. 2009 Jan 1;139(1):33-37##Science. 2001 Mar 2;291(5509):1783-1785.,"Guo C, Diao H, Lian Y, Yu H, Gao H, Zhang Y, Lin D.##Li P, Chan HC, He B, So SC, Chung YW, Shang Q, Zhang YD, Zhang YL.",Recombinant expression and characterization of an epididymis-specific antimicrobial peptide BIN1b/SPAG11E.##An antimicrobial peptide gene found in the male reproductive system of rats.,,,,,,,,
3654,DRAMP03424,DQYRCLQNGGFCLRSSCPSHTKLQGTCKPDKPNCCRS,37,"Beta-defensin 1 (BD-1, RBD-1; Defensin, beta 1; Rodents, mammals, animals)",O89117,Belongs to the beta-defensin family,Defb1,Rattus norvegicus (Rat),"Antibacterial, Anti-Gram-, Antimicrobial",Transcript level,Bridge,Unknown,Unknown,"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 5-34; 12-27; 17-35.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,PubMed ID is not available##10456937,Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.##Infect Immun. 1999 Sep;67(9):4827-4833.,"Page R.A, Malik A.N.##Jia HP, Mills JN, Barahmand-Pour F, Nishimura D, Mallampali RK, Wang G, Wiles K, Tack BF, Bevins CL, McCray PB Jr.",Rat beta defensin-1 peptide: candidate marker for diabetic nephropathy.##Molecular cloning and characterization of rat genes encoding homologues of human beta-defensins.,,,,,,,,
3675,DRAMP03445,GVNMYIRQIYDTCWKLKGHCRNVCGKKEIFHIFCGTQFLCCIERKEMPVLFVK,53,"Beta-defensin 30 (BD-30, RBD-30; Defensin, beta 30; Rodents, mammals, animals)",Q32ZG2,Belongs to the beta-defensin family,Defb30,Rattus norvegicus (Rat),"Antibacterial, Anti-Gram-, Antimicrobial",Homology,Bridge,Unknown,Unknown,"Function Has antibacterial activity (By similarity).
PTM: Contains three disulfide bonds 13-40; 20-34; 24-41.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,16033865,Physiol Genomics. 2005 Sep 21;23(1):5-17.,"Patil AA, Cai Y, Sang Y, Blecha F, Zhang G.",Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.,,,,,,,,
3696,DRAMP03470,GFGCPWNRYQCHSHCRSIGRLGGYCAGSLRLTCTCYRS,38,"Defensin-1 (American oyster defensin, AOD; molluscs, animals)",P85008,Belongs to the invertebrate defensin family (Type 2 subfamily),Unknown,Crassostrea virginica (American oyster) ,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,PTM: Contains three disulfide bond: 4-25; 11-33; 15-35.,"Gram-positive bacteria: Lactococcus lactis subsp. lactis (MECs=2.4 μg/ml), Staphylococcus aureus (MECs=3 μg/ml);##Gram-negative bacteria: Escherichia coli D31 (MECs=7.6 μg/ml), Vibrio parahaemolyticus (MECs=15 μg/ml).",Unknown,Unknown,16297885,Biochem Biophys Res Commun. 2005 Dec 30;338(4):1998-2004.,"Seo JK, Crawford JM, Stone KL, Noga EJ.","Purification of a novel arthropod defensin from the American oyster, Crassostrea virginica.",,,,,,,,
3712,DRAMP03491,YDNVNLDEILANDRLLVPYIKCLLDEGKKAPDAKELKEHIRXAL,44,"Viresin (Insects, animals)",P86354,Unknown,Unknown,Heliothis virescens (Tobacco budworm moth),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity against the Gram-negative bacteria E. coli and E. cloacae, but not against the Gram-negative bacteria P. aeruginosa, P. vulgaris, K. pneumoniae and S. enteritidis or the Gram-positive bacteria S. aureus, S. epidermidis and S. salivarius.","Gram-negative bacteria: E. coli K12 D31, E. coli and E. cloacae.",Unknown,Unknown,10651803,Eur J Biochem. 2000 Feb;267(3):677-683.,Viresin. A novel antibacterial protein from immune hemolymph of Heliothis virescens pupae.,Viresin. A novel antibacterial protein from immune hemolymph of Heliothis virescens pupae.,,,,,,,,
3721,DRAMP03501,AIGCNTVASKMAPCLPYVTGKGPLGGCCGGVKGLIDAARTTPDRQAVCNCLKTLAKSYSGINLGNAAGLPGKCGVSIPYQISPNTDCSKVH,91,"La-LTP (LJAFP; Insects, animals)",Q52RN7,Unknown,Afp,Leonurus japonicus (Chinese motherwort) (Leonurus artemisia),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Plant non-specific lipid-transfer proteins transfer phospholipids as well as galactolipids across membranes. May play a role in wax or cutin deposition in the cell walls of expanding epidermal cells and certain secretory tissues (By similarity).,"Gram-positive Bacteria: Bacillus subtilis (IC50>15 μM). ##Gram-negative Bacteria: Pseudomonas solanacearum (IC50=7.5-15 μM), Ralstonia solanacearum (IC50=15 μM).##Fungi: Alternaria alternate (IC50<7.5 μM), Alternaria brassicae (IC50<7.5 μM), Aspergillus niger (IC50<7.5 μM), Bipolaris maydis (IC50<7.5 μM), Botrytis cinerea (IC50=7.5-15 μM), Cerospora personata (IC50=7.5-15 μM), Colletotrichum gloeosporiodes (IC50<7.5 μM), Fusarium graminearum (IC50=7.5-15 μM), Fusarium oxysporum (IC50=7.5-15 μM), Penicillium digitatum (IC50>15 μM), Pyricularia grisea (IC50=7.5-15 μM), Rhizoctonia solani (IC50<7.5 μM), Rhizoctonia cerealis (IC50=7.5-15 μM), Saccharomyces cerevisiae (IC50>15 μM), Sclerotinia sclerotiorum (IC50>15 μM), Trichoderma harzianum (IC50=7.5-15 μM), Verticillium dahliae (IC50=7.5-15 μM).",Unknown,Lipid-binding,PubMed ID is not available,Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases,"Yang X, Xiao Y, Pei Y, Zhen C.","LJAFP, a novel non-specific lipid transfer protein-like antimicrobial protein from motherwort (Leonurus japonicus) confers disease resistance against phytopathogenic fungi and bacterium in transgenic tobacco.",,,,,,,,
3728,DRAMP03510,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,37,"Cecropin-A (Insects, animals)",P01507,Belongs to the cecropin family,Unknown,Hyalophora cecropia (Cecropia moth),"Antibacterial, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"MOA: It also inhibits HIV by suppressing viral gene expression (J Gen Virol 1998; 79:731-40).
Transgenic plants: expression of this peptide in rich improved plant resistance to pathogens (Plant Biotechnol J. 2008 Aug;6(6):585-608).","Gram-negative bacteria: Escherichia coli D21 (LC=0.19 μM), E. coli D31 (LC=0.21 μM), Serratia marcescens Db11 (LC=4.2 μM), Serratia marcescens Db1108 (LC=2.5 μM), Serratia marcescens Db1121 (LC=4.4 μM), Serratia marcescens Strain 122 (LC=3.2 μM), Pseudomonas aeruginosa OT97 (LC=4.8 μM), Xenorhabdus nematophilus Xn21 (LC=1.4 μM);##Gram-positive bacteria: Bacillus megaterium Bmll (LC=0.70 μM), Bacillus subtilis Bs11 (LC=61 μM), Bacillus thuringiensis Bt11 (MIC>80 μM), Streptococcus fecalis AD-4 (LC=15 μM), Streptococcus fecalis DS16 (LC=74 μM), Micrococcus luteus M111 (LC=4.6 μM).",Unknown,Unknown,7140755,Eur J Biochem. 1982 Sep;127(1):207-217.,"Hultmark D, Engstrm A, Bennich H, Kapur R, Boman HG.",Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae.,,,,,,,,
3729,DRAMP03511,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,35,"Cecropin-B (Immune protein P9; Insects, animals)",P01508,Belongs to the cecropin family,Unknown,Hyalophora cecropia (Cecropia moth),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli D21 (MLC=0.32 μM), Escherichia coli D31 (MLC=0.32 μM), Serratia marcescens Db11 (MLC=4.5 μM), Serratia marcescens Db1108 (MLC=2.4 μM), Serratia marcescens Db1121 (MLC=2.2 μM), Serratia marcescens Strain 122 (MLC=2.9 μM), Pseudomonas aeruginosa OT97 (MLC=1.9 μM), Xenorhabdus nematophilus Xn21 (MLC=1.6 μM);##Gram-positive bacteria: Bacillus megaterium Bmll (MLC=0.44 μM), Bacillus subtilis Bs11 (MLC=18 μM), B.thuringiensis Bt11 (MLC>133 μM), Streptococcus fecalis AD-4 (MLC=7.3 μM), Streptococcus fecalis DS16 (MLC>24 μM), Micrococcus luteus M111 (MLC=1.3 μM).",Unknown,Unknown,7140755,Eur J Biochem. 1982 Sep;127(1):207-217.,"Hultmark D, Engstrm A, Bennich H, Kapur R, Boman HG.",Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae.,,,,,,,,
3730,DRAMP03512,WNPFKELEKVGQRVRDAVISAGPAVATVAQATALAK,36,"Cecropin-D (Cecropin D; Insects, animals)",P01510,Belongs to the cecropin family,Unknown,Hyalophora cecropia (Cecropia moth),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Cecropins have lytic and antibacterial activity against several Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli D21 (LC=0.43 μM), Escherichia coli D31 (LC=0.40 μM), Serratia marcescens Db11 (LC=14 μM), Serratia marcescens Db1108 (LC=12 μM), Serratia marcescens Db1121 (LC=12 μM), Strain 122 (LC=19 μM), Pseudomonas aeruginosa OT97 (LC=100 μM), Xenorhabdus nematophilus Xn21 (LC=19 μM);##Gram-positive bacteria: Bacillus megaterium Bmll (LC=41 μM), Bacillus subtilis Bs11 (LC>95 μM), B.thuringiensis Bt11 (LC>95 μM), Streptococcus fecalis AD-4 (LC>95 μM), Streptococcus fecalis DS16 (LC=88 μM), Micrococcus luteus M111 (LC=21 μM).",Unknown,Unknown,7140755##1711035,Eur J Biochem. 1982 Sep;127(1):207-217.##J Biol Chem. 1991 Jun 25;266(18):11510-11517.,"Hultmark D, Engstrm A, Bennich H, Kapur R, Boman HG.##Gudmundsson GH, Lidholm DA, Asling B, Gan R, Boman HG.",Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae.##The cecropin locus. Cloning and expression of a gene cluster encoding three antibacterial peptides in Hyalophora cecropia.,,,,,,,,
3737,DRAMP03534,PWNIFKEIERAVARTRDAVISAGPAVRTVAAATSVAS,37,"Antibacterial peptide enbocin (Moricin; Insects, animals)",P48821,Belongs to the cecropin family,Unknown,Bombyx mori (Silk moth),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,Function: Has antibacterial activity against Gram-positive and Gram-negative bacteria.,"Gram-positive bacteria: Bacillus subtilis, Bacillus thuringiensis, Staphyllococcus aureus;##Gram-negative bacteria: Psedomonas solanacearum, Salmonellar typhimurium, Escherichia coli.",Unknown,Unknown,9610369,Biochem Biophys Res Commun. 1998 May 19;246(2):388-392.,"Kim SH, Park BS, Yun EY, Je YH, Woo SD, Kang SW, Kim KY, Kang SK.","Cloning and expression of a novel gene encoding a new antibacterial peptide from silkworm, Bombyx mori.",,,,,,,,
3738,DRAMP03535,DLRFLYPRGKLPVPTPPPFNPKPIYIDMGNRY,32,"Lebocin-1/2 (Pro-rich; Insects, animals)",P54684,Belongs to the lebocin family,Unknown,Bombyx mori (Silk moth),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Rich,Unknown,Unknown,"Function: Antibacterial peptide.
Tissue specificity: Hemolymph. Produced in fat body.
Induction: By bacterial infection.
PTM: O-glycosylation is important for the antibacterial activity of lebocin, O-linked glycan structure is a disaccharide (Gal-GalNAc) in case of lebocin 1 and a monosaccharide (GalNAc) in case of lebocin 2.","Gram-negative bacteria: Acinetobacter sp. NISL B-4653, Escherichia coli HB1ll, Pseudomonas fluorescens IAM1179;##Gram-positive bacterium: Staphylococcus aureus ATCC6538P.",Unknown,Unknown,7654207##7545395,Biochem J. 1995 Sep 1;310 (Pt 2):651-656.##Biochem Biophys Res Commun. 1995 Sep 5;214(1):271-278. ,"Hara S, Yamakawa M.##Chowdhury S, Taniai K, Hara S, Kadono-Okuda K, Kato Y, Yamamoto M, Xu J, Choi SK, Debnath NC, Choi HK, et al.","A novel antibacterial peptide family isolated from the silkworm, Bombyx mori.##cDNA cloning and gene expression of lebocin, a novel member of antibacterial peptides from the silkworm, Bombyx mori.",,,,,,,,
3739,DRAMP03536,DLRFLYPRGKLPVPTLPPFNPKPIYIDMGNRY,32,"Lebocin-3 (LEB 3; Insects, animals)",P55796,Belongs to the lebocin family,LEB3,Bombyx mori (Silk moth),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,A unique threonine residue in each peptide was O-glycosylated and the modification seemed to be important for expression of antibacterial activity. ,Unknown,Function: Antibacterial peptide.,"Gram-negative bacteria: Acinetobacter sp. NISL B-4653, Escherichia coli HB1ll, Pseudomonas fluorescens IAM1179;##Gram-positive bacterium: Staphylococcus aureus ATCC 6538P.",Unknown,Cell membrane,7654207##9325165,Biochem J. 1995 Sep 1;310 (Pt 2):651-656.##Biochem Biophys Res Commun. 1997 Sep 29;238(3):769-774.,"Hara S, Yamakawa M.##Furukawa S, Taniai K, Ishibashi J, Hara S, Shono T, Yamakawa M.","A novel antibacterial peptide family isolated from the silkworm, Bombyx mori.##A novel member of lebocin gene family from the silkworm, Bombyx mori.",,,,,,,,
3742,DRAMP03554,ASNFDCCLGYTDRILHPKFIVGFTRQLANEGCDINAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKV,67,"CCL20(1-67) (Human, mammals, animals)",P78556,Belongs to the intercrine beta (chemokine CC) family,CCL20,Homo sapiens (Human),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge (2 disulfide bonds),Unknown,Unknown,"Function: Chemotactic factor that attracts lymphocytes and, slightly, neutrophils, but not monocytes. Inhibits proliferation of myeloid progenitors in colony formation assays. May be involved in formation and function of the mucosal lymphoid tissues by attracting lymphocytes and dendritic cells towards epithelial cells. C-terminal processed forms have been shown to be equally chemotactically active for leukocytes. Possesses antibacterial activity E. coli ATCC 25922 and S. aureus ATCC 29213.","Gram-negative bacterium: Escherichia coli ATCC 25922,##Gram-positive bacterium: Staphylococcus aureus ATCC 29213.",Unknown,Unknown,12149255,J Biol Chem. 2002 Oct 4;277(40):37647-54.,"Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J.",The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins.,,,,,,,,
3743,DRAMP03555,SNFDCCLGYTDRILHPKFIVGFTRQLANEGCDINAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKVKNM,69,"CCL20(2-70) (Human, mammals, animals)",P78556,Belongs to the intercrine beta (chemokine CC) family,CCL20,Homo sapiens (Human),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge (2 disulfide bonds),Unknown,Unknown,"Function: Chemotactic factor that attracts lymphocytes and, slightly, neutrophils, but not monocytes. Inhibits proliferation of myeloid progenitors in colony formation assays. May be involved in formation and function of the mucosal lymphoid tissues by attracting lymphocytes and dendritic cells towards epithelial cells. C-terminal processed forms have been shown to be equally chemotactically active for leukocytes. Possesses antibacterial activity E. coli ATCC 25922 and S. aureus ATCC 29213.","Gram-negative bacterium: Escherichia coli ATCC 25922,##Gram-positive bacterium: Staphylococcus aureus ATCC 29213.",Unknown,Unknown,12149255,J Biol Chem. 2002 Oct 4;277(40):37647-54.,"Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J.",The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins.,,,,,,,,
3744,DRAMP03556,ASNFDCCLGYTDRILHPKFIVGFTRQLANEGCDINAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKVKNM,70,"C-C motif chemokine 20 (Human, mammals, animals)",P78556,Belongs to the intercrine beta (chemokine CC) family,CCL20,Homo sapiens (Human),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: May be involved in formation and function of the mucosal lymphoid tissues by attracting lymphocytes and dendritic cells towards epithelial cells. C-terminal processed forms have been shown to be equally chemotactically active for leukocytes. Possesses antibacterial activity E. coli ATCC 25922 and S. aureus ATCC 29213.,"Gram-negative bacterium: Escherichia coli ATCC 25922,##Gram-positive bacterium: Staphylococcus aureus ATCC 29213.",Unknown,Unknown,12149255,J Biol Chem. 2002 Oct 4;277(40):37647-54.,"Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J.",The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins.,,,,,,,,
3749,DRAMP03564,ICIFCCGCCHRSKCGMCCKT,20,"Human hepcidin-20 (Hepc20; one chain of Hepcidin; Human, mammals, animals)","P81172, Q1HE14, Q9BY68",Unknown,HAMP,Homo sapiens (Human),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand,Unknown,1M4E resolved by NMR.,"Function: Seems to act as a signaling molecule involved in the maintenance of iron homeostasis. Seems to be required in conjunction with HFE to regulate both intestinal iron absorption and iron storage in macrophages. Has strong antimicrobial activity against E.coli ML35P N.cinerea and weaker against S.epidermidis, S.aureus and group b streptococcus bacteria. Active against the fungus C.albicans. No activity against P.aeruginosa.
Tissue specificity: Highest expression in liver and to a lesser extent in heart and brain. Low levels in lung, tonsils, salivary gland, trachea, prostate gland, adrenal gland and thyroid gland. Secreted into the urine.
PTM: Contains four disulfide bonds 2-18; 5-17; 6-14; 8-9.","Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Staphylococcus aureus, S. epidermidis, group B Streptococcus.##Fungi: Candida albicans, Aspergillus fumigatus, Aspergillus niger.",Unknown,Unknown,11113131##12138110##11034317,J Biol Chem. 2001 Mar 16;276(11):7806-7810.##J Biol Chem. 2002 Oct 4;277(40):37597-37603.##FEBS Lett. 2000 Sep 1;480(2-3):147-150.,"Park CH, Valore EV, Waring AJ, Ganz T.##Hunter HN, Fulton DB, Ganz T, Vogel HJ.##Krause A et al Adermann K.","Hepcidin, a urinary antimicrobial peptide synthesized in the liver.##The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis.##LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. ref2) Hepcidin, a rinary antimicrobial peptide synthesized in the liver.",,,,,,,,
3750,DRAMP03565,DTHFPICIFCCGCCHRSKCGMCCKT,25,"Human hepcidin-25 (Hepc25; one chain of Hepcidin; Human, mammals, animals)","P81172, Q1HE14, Q9BY68",Unknown,HAMP,Homo sapiens (Human),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand,N-terminus is a metal-binding site. disulfide bonds are essential for antibacterial activity by probably binding to DNA.,"1M4F, 2KEF resolved by NMR.##3H0T resolved by X-ray.","PTM: Contains four disulfide bonds 7-22; 10-13; 11-19; 14-22.
Tissue specificity: Highest expression in liver and to a lesser extent in heart and brain. Low levels in lung, tonsils, salivary gland, trachea, prostate gland, adrenal gland and thyroid gland. Secreted into the urine.
Function: It showed antimicrobial activities in vitro, this peptide might be the long-sought hormone that regulates iron homeostasis in humans. A pathogen will survive if it can figure out a way to steal iron from the host.","Gram-negative bacterium: Escherichia coli;##Gram-positive bacteria: Staphylococcus aureus, S. epidermidis, group B Streptococcus.##Fungi: Candida albicans, Aspergillus fumigatus, Aspergillus niger.",Unknown,DNA,11034317##11113131##12138110##19553669,FEBS Lett. 2000 Sep 1;480(2-3):147-150.##J Biol Chem. 2001 Mar 16;276(11):7806-7810.##J Biol Chem. 2002 Oct 4;277(40):37597-37603.##J Biol Chem. 2009 Sep 4;284(36):24155-24167.,"Krause A et al Adermann K.##Park CH, Valore EV, Waring AJ, Ganz T.##Hunter HN, Fulton DB, Ganz T, Vogel HJ.##Jordan JB, Poppe L, Haniu M, Arvedson T, Syed R, Li V, Kohno H, Kim H, Schnier PD, Harvey TS, Miranda LP, Cheetham J, Sasu BJ.","LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. ref2) Hepcidin, a rinary antimicrobial peptide synthesized in the liver.##Hepcidin, a urinary antimicrobial peptide synthesized in the liver.##The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis.##Hepcidin revisited, disulfide connectivity, dynamics, and structure.",,,,,,,,
3751,DRAMP03566,MHDFWVLWVLLEYIYNSACSVLSATSSVSSRVLNRSLQVKVVKITN,46,"Salvic (Human, mammals, animals)",No entry found,Unknown,Unknown,Homo sapiens (Human),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,PubMed ID is not available,J Hard Tissue Biol 2005; 14: 258-260.,Kim YS et al Chung SI.,"Cloning and identification of a new antimicrobial peptide, salvic, from human salivary gland.",,,,,,,,
3762,DRAMP03585,AELRCMCIKTTSGIHPKNIQSLEVIGKGTHCNQVEVIATLKDGRKICLDPDAPRIKKIVQKKLAGDES,68,"Human TC-1 (Chain of Platelet basic protein; Human, mammals, animals)","P02775, B2R5F3, Q6IBJ8",Unknown,PPBP,Homo sapiens (Human),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,Unknown,1TVX resolved by X-ray.,PTM: Contains two disulfide bonds 5-31; 7-46.,"Gram-positive bacteria: Bacillus subtilis (MBC=0.4 μM), Staphylococcus aureus (MBC=6.8 μM);##Gram-negative bacterium: Escherichia coli (MBC=3.4 μM).##Fungi: Cryptococcus neoformans (MFC=1.9 μM).",Unknown,Unknown,10877842##8034022,J Biol Chem. 2000 Jul 7;275(27):20374-20381.##FEBS Lett. 1994 Jun 27;347(2-3):300-303.,"Krijgsveld J, Zaat SA, Meeldijk J, van Veelen PA, Fang G, Poolman B, Brandt E, Ehlert JE, Kuijpers AJ, Engbers GH, Feijen J, Dankert J.##Kungl AJ, Machius M, Huber R, Schwer C, Lam C, Aschauer H, Ehn G, Lindley IJ, Auer M.","Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines.##Purification, crystallization and preliminary X-ray diffraction analysis of recombinant human neutrophil-activating peptide 2 (rhNAP-2).",,,,,,,,
3763,DRAMP03586,NLAKGKEESLDSDLYAELRCMCIKTTSGIHPKNIQSLEVIGKGTHCNQVEVIATLKDGRKICLDPDAPRIKKIVQKKLAGDES,83,"Human TC-2 (Chain of Platelet basic protein; Human, mammals, animals)","P02775, B2R5F3, Q6IBJ8",Unknown,PPBP,Homo sapiens (Human),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,Unknown,1F9P resolved by X-ray.,PTM: Contains two disulfide bonds 19-46; 22-62.,"Gram-positive bacteria: Bacillus subtilis ATCC6633 (MBC=0.7 μM), Staphylococcus aureus 42D (MBC=11 μM);##Gram-negative bacterium: Escherichia coli ML35 (MBC=2.7 μM).##Fungi: Cryptococcus neoformans (MFC=30 μM).",Unknown,Unknown,10877842##8034022,J Biol Chem. 2000 Jul 7;275(27):20374-20381.##FEBS Lett. 1994 Jun 27;347(2-3):300-303.,"Krijgsveld J, Zaat SA, Meeldijk J, van Veelen PA, Fang G, Poolman B, Brandt E, Ehlert JE, Kuijpers AJ, Engbers GH, Feijen J, Dankert J.##Kungl AJ, Machius M, Huber R, Schwer C, Lam C, Aschauer H, Ehn G, Lindley IJ, Auer M.","Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines.##Purification, crystallization and preliminary X-ray diffraction analysis of recombinant human neutrophil-activating peptide 2 (rhNAP-2).",,,,,,,,
3764,DRAMP03587,SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSV,47,"DCD-1 (chain of Dermcidin; Human, mammals, animals)","P81605, A5JHP2, A5JHP3, P58461, Q53YJ2",Unknown,DCD,Homo sapiens (Human),"Antibacterial, Antifungal, Proteolytic, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,"Structural analysis of dermcidin-1L in 50% TFE using an N15-labeled recombinant peptide reveals a long helix-hinge-helix motif, allowing it to associate with bacterial membranes (Jung et al. 2010 BMB Rep. 43: 362-8). ",2KSG resolved by NMR.##2YMK resolved by X-ray.,"Function: DCD-1 displays antimicrobial activity thereby limiting skin infection by potential pathogens in the first few hours after bacterial colonization. Highly effective against E.coli, E.faecalis, S.aureus and C.albicans. Optimal pH and salt concentration resemble the conditions in sweat. Also exhibits proteolytic activity. Survival-promoting peptide promotes survival of neurons and displays phosphatase activity.
Catalytic activity: Preferential cleavage: Arg-|-Xaa, Lys-|-Xaa.
Cofactor: Manganese. Required for survival-promoting peptide.
Tissue specificity: Specifically and constitutively expressed in eccrine sweat gland cells. Secreted into the sweat at a concentration of 1-10 micrograms/ml.","Gram-negative bacteria: Escherichia coli, Enterococcus faecalis;##Gram-positive bacterium: Staphylococcus aureus.##Yeast: Candida albicans.",Unknown,May bind IgG,11694882##17448443##20510021,Nat Immunol. 2001 Dec;2(12):1133-1137.##Biochem Biophys Res Commun. 2007 Jun 15;357(4):828-833.##BMB Rep. 2010 May;43(5):362-368.,"Schittek B, Hipfel R, Sauer B, Bauer J, Kalbacher H, Stevanovic S, Schirle M, Schroeder K, Blin N, Meier F, Rassner G, Garbe C.##Lee Motoyama JP, Kim-Motoyama H, Kim P, Nakagama H, Miyagawa K, Suzuki K.##Jung HH, Yang ST, Sim JY, Lee S, Lee JY, Kim HH, Shin SY, Kim JI.",Dermcidin: a novel human antibiotic peptide secreted by sweat glands.##Identification of dermcidin in human gestational tissue and characterization of its proteolytic activity.##Analysis of the solution structure of the human antibiotic peptide dermcidin and its interaction with phospholipid vesicles.,,,,,,,,
3765,DRAMP03588,LAHQKPFIRKSYKCLHKRCR,20,"Human MUC7 20-Mer (Human, mammals, animals)",No entry found,Unknown,Unknown,Homo sapiens (Human),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix ,Unknown,Unknown,"Function: MUC7 20-mer showes potent activity against a variety of fungi, including C. albicans, C. glabrata, C. krusei, C. neoformans, and S. cerevisae. In addition, it is also active against several drug-resistant strains, including azole-resistant C. albicans, fluconazole-resistant C. glabrata, and amphotericin B-resistant C. neoformans.","Gram-positive bacteria: Streptococcus mutans (EC50=1.39 μM), Streptococcus gordonii (EC50=2.43 μM);##Gram-negative bacteria: Escherichia coli (EC50=1.61 μM), Pseudomonas aeruginosa (EC50=4.41 μM), Porphyromonas gingivalis (EC50<1 μM).##Fungi: Candida albicans (DIS) (EC50=5.85 μM), C. albicans (azole resistant) (EC50=2.40 μM), Candida glabrata (EC50=5.02 μM), C. glabrata (fluconazole resistant) (EC50=12.3 μM), Candida krusei (EC50=5.16 μM), Cryptococcus neoformans (EC50=4.05 μM), Cryptococcus neoformans (amphotericin B resistant) (EC50=4.29 μM), Saccharomyces cerevisiae (EC50=5.23 μM).",Unknown,Unknown,12543672,Antimicrob Agents Chemother 2003 Feb;47(2):643-652.,"Bobek LA, Situ H.","MUC7 20-Mer: Investigation of Antimicrobial Activity, Secondary Structure, and Possible Mechanism of Antifungal Action.",,,,,,,,
3767,DRAMP03590,VAIALKAAHYHTHKE,15,"Calcitermin (Human, mammals, animals)","P80511, P83219, Q5SY66",Belongs to the S-101 family,S100A12,Homo sapiens (Human),"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,Unknown,"Function: S100A12 is a calcium-, zinc- and copper-binding protein which plays a prominent role in the regulation of inflammatory processes and immune response. Possesses antifungal activity against C. albicans and is also active against E. coli and P. aeruginosa but not L. monocytogenes and S. aureus.
Tissue specificity: Predominantly expressed by neutrophils, monocytes and activated macrophages. Expressed by eosinophils and macrophages in asthmatic airways in regions where mast cells accumulate. Found in high concentrations in the serum of patients suffering from various inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and Kawasaki disease.
Domain: The hinge Domain: contributes significantly to its chemotactic properties.","Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa.##Yeast: Candida albicans at pH 5.4.",Unknown,Unknown,11522286,FEBS Lett. 2001 Aug 24;504(1-2):5-10.,"Cole AM, Kim YH, Tahk S, Hong T, Weis P, Waring AJ, Ganz T.","Calcitermin, a novel antimicrobial peptide isolated from human airway secretions.",,,,,,,,
3768,DRAMP03591,ACYCRIPACIAGERRYGTCIYQGRLWAFCC,30,"Neutrophil defensin 1 (Defensin, alpha 1; HNP-1, HP-1; Human, mammals, animals)","P59665, P11479, Q14125, Q6EZF6",Belongs to the alpha-defensin family,"DEFA1, DEFA1B",Homo sapiens (Human),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Beta strand,"Compared to HNP-2, HNP-1 contains one additional residue (Ala) at the N-terminus. It contains a long stretch of a double-stranded antiparallel beta-sheet in a hairpin conformation that contains a beta-bulge, a short region of triple-stranded beta-sheet, and several tight turns.","2KHT resolved by NMR.##2PM1, 3GNY, 3H6C, 3HJ2, 3HJD, 3LO1, 3LO2.","Function: Defensin 1 and defensin 2 have antibacterial, fungicide and antiviral activities. Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane.
PTM: ADP-ribosylation drastically reduces cytotoxic and antibacterial activities, and enhances IL8 production. Phosphorylation at Tyr-85 has been found in some cancer cell lines, and interferes with ADP-rybosylation.","[Ref.15616305] Gram-negative bacteria: Escherichia coli ATCC 8739 (vLD50=3.6±0.3 μg/ml), E. coli ATCC 25922 (vLD50=3.7±0.4 μg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=10±0.5 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (vLD50=4.2±1.0 μg/ml), Staphylococcus aureus ATCC 29213 (vLD50=2.1±0.3 μg/ml), Bacillus cereus ATCC 10876 (vLD50=0.22±0.03 μg/ml).##NOTE: vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).##[Ref.15118082]Gram-positive bacteria: Bacillus subtilis (Inhibition zone=24 mm in PH5.5, Inhibition zone=20 mm in PH7.5 completely inhibit at 10 μg/well), Staphylococcus aureus  (Inhibition zone=1 mm in PH5.5, Inhibition zone=7 mm incompletely inhibit and Inhibition zone=2 mm completely inhibit in PH7.5 at 10 μg/well);##Gram-negative bacteria: Escherichia coli (Inhibition zone=5 mm incompletely inhibit and Inhibition zone=2 mm completely inhibit in PH7.5 at 10 μg/well);##Fungi: Candida albicans (Inhibition zone=13 mm in PH5.5, Inhibition zone=10 mm in PH7.5 completely inhibit at 10 μg/well).",Unknown,Unknown,9831658##19253295##15616305##15118082,Gene. 1998 Nov 19;222(2):237-244.##Proteomics. 2009 Mar;9(5):1364-1373.##Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.##Proc Natl Acad Sci U S A. 2004 May 11;101(19):7363-8.,"Liu L, Wang L, Jia HP, Zhao C, Heng HH, Schutte BC, McCray PB Jr, Ganz T.##Stegemann C, Kolobov A Jr, Leonova YF, Knappe D, Shamova O, Ovchinnikova TV, Kokryakov VN, Hoffmann R.##Ericksen B, Wu Z, Lu W, Lehrer RI.##Yount NY, Yeaman MR.","Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation.##Isolation, purification and de novo sequencing of TBD-1, the first beta-defensin from leukocytes of reptiles.##Antibacterial activity and specificity of the six human {alpha}-defensins.##Multidimensional signatures in antimicrobial peptides.",,,,,,,,
3769,DRAMP03592,CYCRIPACIAGERRYGTCIYQGRLWAFCC,29,"Neutrophil defensin 2 (HNP-2, HP-2, HP2; Human, mammals, animals)","P59665, P11479, Q14125, Q6EZF6, P59666, P11479, Q14125",Belongs to the alpha-defensin family,DEFA1 AND DEFA1B,Homo sapiens (Human),"Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand,Unknown,"1ZMH, 1ZMI, 1ZMK resolved by X-ray.","Function: Defensin 2 have antibiotic, fungicide and antiviral activities. Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane.
PTM: Contains three disulfide bonds 1-29; 3-18; 8-28.","Gram-negative bacteria: Escherichia coli ATCC 8739 (vLD50=3.5±0.79 μg/ml), E. coli ATCC 25922 (vLD50=3.5±0.6 μg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=16±4.0 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (vLD50=4.2±0.9 μg/ml), S. aureus ATCC 29213 (vLD50=2.4±0.3 μg/ml), Bacillus cereus ATCC 10876 (vLD50=0.22±0.04 μg/ml).(Ref.2)##NOTE: vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).",Unknown,Unknown,9831658##15616305##15894545,Gene. 1998 Nov 19;222(2):237-244.##Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.##J Biol Chem. 2005 Sep 23;280(38):32921-9.,"Liu L, Wang L, Jia HP, Zhao C, Heng HH, Schutte BC, McCray PB Jr, Ganz T.##Ericksen B, Wu Z, Lu W, Lehrer RI.##Xie C, Prahl A, Ericksen B, Wu Z, Zeng P, Li X, Lu WY, Lubkowski J, Lu W.",Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation.##Antibacterial activity and specificity of the six human {alpha}-defensins.##Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids.,,,,,,,,
3770,DRAMP03593,DCYCRIPACIAGERRYGTCIYQGRLWAFCC,30,"Neutrophil defensin 3 (Defensin, alpha 3; HNP-3, HP-3, HP3; Human, mammals, animals)","P59666, P11479, Q14125",Belongs to the alpha-defensin family,DEFA3,Homo sapiens (Human),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand,"Compared to HNP-2, HNP-3 contains one additional residue (Asp) at the N-terminus. The 3D structures remain the same. ","1DFN, 2PM4, 2PM5 resolved by X-ray.","Function: Defensin 3 have antibiotic, fungicide and antiviral activities. Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane.
PTM: Contains three disulfide bonds 2-30; 4-19; 9-29.","Gram-negative bacteria: Escherichia coli ATCC 8739 (vLD50=6.2±0.9 μg/ml), E. coli ATCC 25922 (vLD50=5.9±2.1 μg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=41±9.2 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (vLD50=13±2.1 μg/ml), S. aureus ATCC 29213 (vLD50=2.2±0.4 μg/ml), Bacillus cereus ATCC 10876 (vLD50=0.37±0.08 μg/ml).(Ref.2)##NOTE: vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).",Unknown,Unknown,4056036##15616305,J Clin Invest. 1985 Oct;76(4):1436-1439.##Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.,"Selsted ME, Harwig SS, Ganz T, Schilling JW, Lehrer RI.##Ericksen B, Wu Z, Lu W, Lehrer RI.",Primary structures of three human neutrophil defensins.##Antibacterial activity and specificity of the six human {alpha}-defensins.,,,,,,,,
3771,DRAMP03594,VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRV,33,"Neutrophil defensin 4 (Defensin, alpha 4; HNP-4, HP-4; Human, mammals, animals)",P12838,Belongs to the alpha-defensin family,DEFA4,Homo sapiens (Human),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand,"Compared to HNP-2, HNP-1 contains one additional residue (Ala) at the N-terminus. It contains a long stretch of a double-stranded antiparallel beta-sheet in a hairpin conformation that contains a beta-bulge, a short region of triple-stranded beta-sheet, and several tight turns.",1ZMM resolved by X-ray.,"Function: Has antimicrobial activity against Gram-negative bacteria, and to a lesser extent also against Gram-positive bacteria and fungi. Protects blood cells against infection with HIV-1 (in vitro). In comparison with HNP1-3, inhibition of both strains of HIV-1 by HNP4 was noticeably stronger as evidenced by lower IC50 values (2-5 μM) and steeper and more complete inhibition curves.
PTM: Contains three disulfide bonds 2-30; 4-19; 9-29.","Gram-negative bacteria: Escherichia coli ATCC 8739 (vLD50=3.3±0.4 μg/ml), E. coli ATCC 25922 (vLD50=3.0±0.7 μg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=6.6±0.2 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (vLD50=7.3±1.4 μg/ml), S. aureus ATCC 29213 (vLD50=7.2±0.2 μg/ml), Bacillus cereus ATCC 10876 (vLD50=0.87±0.08 μg/ml).(Ref.4)##NOTE: vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).##Yeast: Candida albicans ATCC 99788 amphotericin B resistant (IC90>100 μg/ml).(Ref.2)",Unknown,Unknown,2500436##17088326##15620707##15616305,J Biol Chem. 1989 Jul 5;264(19):11200-112003.##Protein Sci. 2006 Dec;15(12):2749-2760.##FEBS Lett. 2005 Jan 3;579(1):162-166.##Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.,"Wilde CG, Griffith JE, Marra MN, Snable JL, Scott RW.##Szyk A, Wu Z, Tucker K, Yang D, Lu W, Lubkowski J.##Wu Z, Cocchi F, Gentles D, Ericksen B, Lubkowski J, Devico A, Lehrer RI, Lu W.##Ericksen B, Wu Z, Lu W, Lehrer RI.","Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family.##Crystal structures of human alpha-defensins HNP4, HD5, and HD6.##Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.##Antibacterial activity and specificity of the six human {alpha}-defensins.",,,,,,,,
3772,DRAMP03595,ATCYCRTGRCATRESLSGVCEISGRLYRLCCR,32,"Human defensin-5 (HD-5; Defensin, alpha 5; Human, mammals, animals)","Q01523, A0JDY6, Q3KNV2",Belongs to the alpha-defensin family,DEFA5,Homo sapiens (Human),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand,The L- and D-forms of HD-5 are equally active than E.coli but not S. aureus (Wei G et al 2009 JBC 284: 29180-92). ,1ZMP resolved by X-ray.,"Function: Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane. All DEFA5 peptides exert antimicrobial activities, but their potency is affected by peptide processing.
Tissue specificity: Paneth cells of the small intestine (at protein level).
PTM: Contains three disulfide bonds.","Gram-negative bacteria: Escherichia coli ATCC 8739 (vLD50=2.5±0.3 μg/ml), E. coli ATCC 25922 (vLD50=2.1±0.9 μg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=5.5±0.5 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (vLD50=6.3±0.5 μg/ml), S. aureus ATCC 29213 (vLD50=3.2±0.3 μg/ml), Bacillus cereus ATCC 10876 (vLD50<0.31 μg/ml).(Ref.2)##NOTE: vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).",Unknown,Unknown,12021776##15616305,Nat Immunol. 2002 Jun;3(6):583-590.##Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.,"Ghosh D, Porter E, Shen B, Lee SK, Wilk D, Drazba J, Yadav SP, Crabb JW, Ganz T, Bevins CL.##Ericksen B, Wu Z, Lu W, Lehrer RI.",Paneth cell trypsin is the processing enzyme for human defensin-5.##Antibacterial activity and specificity of the six human {alpha}-defensins.,,,,,,,,
3773,DRAMP03596,AFTCHCRRSCYSTEYSYGTCTVMGINHRFCCL,32,"Human defensin-6 (HD-6; Defensin, alpha 6; Human, mammals, animals)",Q01524,Belongs to the alpha-defensin family,DEFA6,Homo sapiens (Human),"Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (3 strands; 19 residues),Unknown,"1ZMQ, 3QTE resolved by X-ray.","Function: Has very low antimicrobial activity against Gram-negative and Gram-positive bacteria. May protect cells against infection with HIV-1.
Subunit structure: Homodimer.
Tissue specificity: Paneth cells of the small intestine.
PTM: Contains three disulfide bonds.","Gram-negative bacteria: Escherichia coli ATCC 8739 (vLD50>256 μg/ml), E. coli ATCC 25922 (vLD50=103±14 μg/ml), Enterobacter aerogenes ATCC 13048 (vLD50=156±11 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (vLD50>256 μg/ml), S. aureus ATCC 29213 (vLD50>256 μg/ml), Bacillus cereus ATCC 10876 (vLD50=25±13 μg/ml).(Ref.3)##NOTE: vLD50, virtual lethal doses (vLDs), equivalent to conventional 50% lethal doses (LD50s).",Unknown,Unknown,8417977##17088326##15616305,FEBS Lett. 1993; 315:187-192.##Protein Sci. 2006 Dec;15(12):2749-2760.##Antimicrob Agents Chemother. 2005 Jan;49(1):269-275.,"Jones DE, Bevins CL.##Szyk A, Wu Z, Tucker K, Yang D, Lu W, Lubkowski J.##Ericksen B, Wu Z, Lu W, Lehrer RI.","Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel.##Crystal structures of human alpha-defensins HNP4, HD5, and HD6.##Antibacterial activity and specificity of the six human {alpha}-defensins.",,,,,,,,
3774,DRAMP03601,WYVKKCLNDVGICKKKCKPEEMHVKNGWAMCGKGRDCCVPAD,42,"Human beta-defensin 26 (hBD-26; hBD26; Human, mammals, animals)",No entry found,Belongs to the beta-defensin family,Unknown,Homo sapiens (Human),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Bridge ,Unknown,Unknown,Function: Both hBD26 and hBD27 showe salt-sensitive antimicrobial activity against gram-negative E. coli but not against gram-positive S. aureus and S. cerevisiae.,Gram-negative bacterium: Escherichia coli K12.,Unknown,Unknown,19373462,Appl Microbiol Biotechnol. 2009 Aug;84(2):301-308.,"Huang L, Leong SS, Jiang R.",Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27.,,,,,,,,
3775,DRAMP03602,QLKKCWNNYVQGHCRKICRVNEVPEALCENGRYCCLNIKELEAC,44,"Human beta-defensin 27 (hBD-27; hBD27; Human, mammals, animals)",No entry found,Belongs to the beta-defensin family,Unknown,Homo sapiens (Human),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Bridge ,Unknown,Unknown,Function: Both hBD26 and hBD27 showe salt-sensitive antimicrobial activity against gram-negative E. coli but not against gram-positive S. aureus and S. cerevisiae.,Gram-negative bacterium: Escherichia coli K12.,Unknown,Unknown,19373462,Appl Microbiol Biotechnol. 2009 Aug;84(2):301-308.,"Huang L, Leong SS, Jiang R.",Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27.,,,,,,,,
3777,DRAMP18203,SYVGDCGSNGGSCVSSYCPYGNRLNYFCPLGRTCCRRSY,39,"Panusin (beta defensins; crustaceans, arthropods, invertebrates, animals)",A0A0S2XGP2(Precursor),Belongs to the beta-defensin family,Unknown,"the Caribbean spiny lobster, Panulirus genus","Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antimicrobial",,Unknown,Unknown,Unknown,"Function: Active against E. coli, K. pneumonia, S. aureus, B. subtilisspizizenii, and C. albicans.",No MICs found on DRAMP database,Unknown,Lipid-binding,27616720,Dev Comp Immunol. pii: S0145-305X(16)30274-9(2016),"Montero-Alejo V, Corzo G, Porro-Suard",Panusin represents a new family of beta-defensin-like peptides in invertebrates.,,,,,,,,
3789,DRAMP18120,PPTQNPSMAPPTQNPYGQPMTPPTQNPYGQPMAPP,35,BnPRP1 (Plant defensin),No entry found,Unknown,BnPRP1,Brassica napus,"Antibacterial, Antifugal, Anti-Gram+, Anti-Gram-, Antimicrobial",,Unknown,Unknown,Unknown,"BnPRP1 has 40.5% identity with a known proline-rich antimicrobial peptide SP-B from the pig. BnPRP1 isolated from B. napus was the first PR-AMP member that was characterized in plants, and its homology sequences were found in some other Brassicaceae plants by the genome sequences analysis. ","Gram-positive: M. luteus (MIC= 16.9 ± 2.7 uM );##Gram-negative: E. coli (MIC= 8.4 ± 1.4 uM);## Fungi:Sclerotinia sclerotiorum, Mucor sp., Magnaporthe oryzae and Botrytis cinerea",Unknown,Unknown,26383098,PLoS One.à2015 Sep 18;10(9):e0137414.,"Cao H, Ke T, Liu R, et al.",Identification of a Novel Proline-Rich Antimicrobial Peptide from Brassica napus.,,,,,,,,
3799,DRAMP18140,VARGWKRKCPLFGKGG,16,VG16KRKP,No entry found,Unknown,,Synthetic construct,"Antibacterial, Antifugal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,,The solution-NMR structure of VG16KRKP in lipopolysaccharide features a folded conformation with a centrally located turn-type structure stabilized by aromatic-aromatic packing interactions with extended N- and C-termini.,"2MXG,2MXH resolved by NMR",VG16KRKP is capable of inhibiting bacterial disease progression in plants.,"Gram-negative: E. coli (MIC=8 uM), X. campestris  (MIC=10 uM), X. oryzae  (MIC=15 uM);##Gram-positive: B. subtilis (MIC=50 uM);##Fungi: Candida albicans  (MIC=2 uM), Cryptococcus grubii  (MIC=5 uM)",Unknown,cell membrane,26144972,Sci Rep. 2015 Jul 6;5:11951.,"Datta A, Ghosh A, Airoldi C, etal.","Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control",,,,,,,,
3802,DRAMP18194,GGLKKLGKKLEGAGKRVFKASEKALPVVVGIKAIGK,36,AAEL000598-PA,Q17NR1,Unknown,CECD,Aedes aegypti (Yellowfever mosquito) (Culex aegypti),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,alpha helical (N-terminal),"The structure of Aedesin is depicted as a helix-bent-helix structure with good RMSD statistics for the N-terminal helix (helix 1) and for the C-terminal helix (helix 2) taken separately.The helical wheel diagram of Aedesin shows the amphipathic character of the first and second aloha helices, as well as the opposite localization of their hydrophobic and positively charged residues, respectively.",2MMM resolved by NMR.,"The anti-bacterial activity of Aedesin was found to be salt-resistant, indicating that it is active under physiological conditions encountered in body fluids characterized by ionic salt concentrations.","Gram-negative (including drug-resistent): E. coli (MIC 2-4 ug/mL), P. aeruginosa (MIC 1-4 ug/mL), A. baumannii (MIC 1-2 ug/mL), K. pneunomiae (MIC 1-2 ug/mL).##No antibacterial effects of the peptide were observed against different isolates of Gram-positive S. aureus, E. faecalis and E. faecium strains showing MIC values over 32. (Pubmed:25162372)",Unknown,Unknown,17510324##25162372,Science 316:1718-1723(2007).##PLoS ONE 9:e105441-e105441(2014).,"Nene V., Wortman J.R., Lawson D., et al.##Godreuil S., Leban N., Padilla A., et al.","Genome sequence of Aedes aegypti, a major arbovirus vector.##Aedesin: structure and antimicrobial activity against multidrugresistant bacterial strains.",,,,,,,,
3803,DRAMP03635,GRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCIQA,48,"Human lactoferricin (LfcinH; one chain of Lactotransferrin; Human, mammals, animals)","P02788, B7Z4X2, E7EQH5, O00756, Q16780, Q16785, Q16786, Q16789, Q8IU92",Belongs to the transferrin family,LTF,Homo sapiens (Human),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,LfcinH shows a helical content from Gln14 to Lys29 in the membrane mimetic solvent but a nonexistent beta-sheet character in either the N- or C-terminal regions of the peptide. The LfcinH structure determined in aqueous solution displays a nascent helix in the form of a coiled conformation in the region from Gln14 to Lys29.,"1Z6V, 1Z6W resolved by NMR.","Function: Lactoferricin binds to the bacterial surface and is crucial for the bactericidal functions. Has some antiviral activity against papillomavirus infection. N-terminal region shows strong antifungal activity against C.albicans. Contains two BBXB heparin-binding consensus sequences that appear to form the predominate functional GAG-binding site.
Tissue specificity: High levels are found in saliva and tears, intermediate levels in serum and plasma, and low levels in urine.",Gram-negative bacterium: Escherichia coli serotype O111.,Unknown,Unknown,15155221##16048952,Antimicrob Agents Chemother. 2004 Jun;48(6):2190-2198.##Antimicrob Agents Chemother. 2005 Aug;49(8):3387-3395.,"Chapple DS, Hussain R, Joannou CL, Hancock RE, Odell E, Evans RW, Siligardi G.##Hunter HN, Demcoe AR, Jenssen H, Gutteberg TJ, Vogel HJ.",Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide.##Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent.,,,,,,,,
3804,DRAMP03636,FFSASCVPGADKGQFPNLCRLCAGTGENKCA,31,"Kaliocin-1 (one chain of Lactotransferrin; Human, mammals, animals)","P02788, B7Z4X2, E7EQH5, O00756, Q16780, Q16785, Q16786, Q16789, Q8IU92",Belongs to the transferrin family,LTF,Homo sapiens (Human),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Kaliocin-1 has antimicrobial activity and is able to permeabilize different ions through liposomal membranes without causing extensive damage to the outer and inner bacterial membranes.
Tissue specificity: High levels are found in saliva and tears, intermediate levels in serum and plasma, and low levels in urine.",Gram-negative bacterium: Escherichia coli serotype O111.,Unknown,Unknown,12693969,Biochemistry (Mosc). 2003 Feb;68(2):217-227.,"Viejo-Díaz M, Andrés MT, Pérez-Gil J, Sánchez M, Fierro JF.",Potassium efflux induced by a new lactoferrin-derived peptide mimicking the effect of native human lactoferrin on the bacterial cytoplasmic membrane.,,,,,,,,
3806,DRAMP03639,GLSQGVEPDIGQTYFEESRINQD,23,Astexin-1 (lasso peptide),No entry found,Unknown,Unknown,Asticcacaulis excentricus CB 48 (Gram-negative bacteria),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Beta strand (2 strands; 3 residues),The solution structure of astexin-1 was determined and found to have a nine-membered macrolactam ring followed by an 8-aa loop and a 6-aa tail. The extended length of the loop and tail regions allow for hydrogen-bonding interactions between the backbone and polar side chains of these regions of the peptide.,2LTI resolved by NMR.,"Function: Astexin-1 has weak antimicrobial activity against Caulobacter crescentus. No growth inhibition is observed
for any other strains of bacteria tested, and the growth inhibition of C. crescentus is quite modest.",Gram-negative bacterium: Caulobacter crescentus CB15.,Unknown,Unknown,22949633,Proc Natl Acad Sci U S A. 2012 Sep 4. ,"Maksimov MO, Pelczer I, Link AJ.",Precursor-centric genome-mining approach for lasso peptide discovery.,,,,,,,,
3808,DRAMP03641,DFGCGQGMIFMCQRRCMRLYPGSTGFCRGFRCMCDTHIPLRPPFMVG,47,"Longicornsin (defensin-like; Arthropods, invertebrates, animals)",B2MW54,Unknown,sGDLP,Haemaphysalis longicornis,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has antibacterial activity.,"Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa, Helicobacter pylori.##Yeast: Candida albicans.",Unknown,Unknown,20027626,Protein Sci. 2010 Mar;19(3):392-327.,"Lu X, Che Q, Lv Y, Wang M, Lu Z, Feng F, Liu J, Yu H.","A novel defensin-like peptide from salivary glands of the hard tick, Haemaphysalis longicorn.",,,,,,,,
3810,DRAMP03644,RVKRVWPLVIRTVIAGYNLYRAIKKK,26,"Cathelicidin-1 (CATH-1; Fowlicidin-1; Birds, animals)","Q6QLQ5, Q2IAM1",Unknown,CATHL1,Gallus gallus (Chicken),"Antibacterial, Cytolytic, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix (2 helices; 13 residues),"Fowlicidin-1 mainly adopts an alpha-helical conformation with a slight kink induced by glycine close to the center, in addition to a short flexible unstructured region near the N terminus. The short C-terminal helical segment after the kink, consisting of a stretch of eight amino acids (residues 16-23), may be required for the peptide to interact with LPS and lipid membranes and to permeabilize both prokaryotic and eukaryotic cells.",2AMN resolved by NMR.,"Function: Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response.
Animal model (mouse): It increased mice survival by 50% from a lethal dose of S. aureus (MRSA). This truncated peptide also reduced TNF-alpha and NO production in macrophage by 77% and 96%, respectively.","[Ref.16326712]Gram-negative bacteria: [No NaCl]Escherichia coli 25922 (MIC=1.59 μM), Escherichia coli O157:H7 700728 (MIC=0.80 μM), Salmonella typhimurium 14028 (MIC=0.80 μM), Salmonella typhimurium DT104 700408 (MIC=0.40 μM), Klebsiella pneumoniae 13883 (MIC=0.40 μM), Pseudomonas aeruginosa 27853 (MIC=3.18 μM);##[100mM NaCl]Escherichia coli 25922 (MIC=1.59 μM), Escherichia coli O157:H7 700728 (MIC=0.80 μM), Salmonella typhimurium 14028 (MIC=1.59 μM), Salmonella typhimurium DT104 700408 (MIC=1.59 μM), Klebsiella pneumoniae 13883 (MIC=0.80 μM), Pseudomonas aeruginosa 27853 (MIC=3.18 μM);##Gram-positive bacteria: Listeria monocytogenes 19115 (MIC=0.80 μM), Staphylococcus aureus 25923 (MIC=0.80 μM), Staphylococcus aureus (MRSA) BAA-39 (MIC=0.40 μM), Staphylococcus aureus (MRSA) 43300 (MIC=0.40 μM);##[100mM NaCl]Listeria monocytogenes 19115 (MIC=1.59 μM), Staphylococcus aureus 25923 (MIC=0.80 μM), Staphylococcus aureus (MRSA) BAA-39 (MIC=0.80 μM), Staphylococcus aureus (MRSA) 43300 (MIC=0.40 μM)",[Ref.16326712]80% hemolytic activity at 10 μM against human erythrocytes,Lipopolysaccharide (LPS)-binding,16326712##16817888, Biol Chem. 2006 Feb 3;281(5):2858-2867.##FEBS J. 2006 Jun;273(12):2581-2593. ,"Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, Zhang G.##Xiao Y, Dai H, Bommineni YR, Soulages JL, Gong YX, Prakash O, Zhang G.","Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity.##Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken.",,,,,,,,
3811,DRAMP03648,GRKSDCFRKSGFCAFLKCPSLTLISGKCSRFYLCCKRIWG,40,"Gallinacin-1 (Gal-1; Beta-defensin 1; Birds, animals)","P46156, Q09MK1, Q6B9W7, Q6GXJ4",Belongs to the beta-defensin family,GAL1,Gallus gallus (Chicken),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge ,Unknown,Unknown,"Tissue specificity: Strong expression in the bone marrow, lung, testis. Moderate expression in the bursa and intestine. Low expression in the cloaca, gall bladder, brain and pancreas. Expressed in the vagina, ovarian stroma and the theca and granulosa layers of the ovarian follicle.
Developmental stage: Detected in the theca layer of the ovarian follicle in the white follicle (WF) stage, but decreases throughout the F1, F3, F5, and postovulatory follicle stages. Detected in the granulosa layer of the ovarian follicle in the white follicle (WF) stage, F1, F3, F5, and postovulatory follicle stages. In the vagina expression is higher in laying hens than in non-laying hens, and is higher in older laying hens than in young laying hens.
Induction: Induced in the theca layer of the F3 stage ovarian follicle by intravenous injection of LPS. Repressed in the granulosa layer of the F3 stage ovarian follicle by intravenous injection of LPS. Expression in cultured vaginal cells is increased by LPS and S.enteritidis. Expression in the kidney and liver is not affected by intravenous injection of LPS.
PTM: Contains three disulfide bonds 6-34; 13-28; 18-35.",Gram-negative bacterium: Escherichia coli ML-35;##Gram-positive bacterium: Listeria monocytogenes.##Yeast: Candida albicans.,Unknown,Unknown,8150085##16394622##17244739,FEBS Lett. 1994 Apr 11;342(3):281-285.##J Reprod Dev. 2006 Apr;52(2):211-218.##Reproduction. 2007 Jan;133(1):127-133.,"Harwig SS, Swiderek KM, Kokryakov VN, Tan L, Lee TD, Panyutich EA, Aleshina GM, Shamova OV, Lehrer RI.##Yoshimura Y, Ohashi H, Subedi K, Nishibori M, Isobe N.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.","Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes.##Effects of age, egg-laying activity, and Salmonella-inoculation on the expressions of gallinacin mRNA in the vagina of the hen oviduct.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).",,,,,,,,
3812,DRAMP03649,GRKSDCFRKNGFCAFLKCPYLTLISGKCSRFHLCCKRIW,39,"Gallinacin-1 alpha (Gal-1 alpha; Antimicrobial peptide CHP2; Birds, animals)","P46157, P80390, Q09MR8, Q9DG59",Belongs to the beta-defensin family,Unknown,Gallus gallus (Chicken),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,PTM: Contains three disulfide bonds 6-34; 13-28; 18-35.,"Gram-negative bacterium: Escherichia coli ML-35;##Gram-positive bacteria: Staphylococcus aureus, Listeria monocytogenes.##Yeast: Candida albicans.",Unknown,Unknown,7964174##8150085,J Leukoc Biol. 1994 Nov;56(5):661-665.##FEBS Lett. 1994 Apr 11;342(3):281-285.,"Evans EW, Beach GG, Wunderlich J, Harmon BG.##Harwig SS, Swiderek KM, Kokryakov VN, Tan L, Lee TD, Panyutich EA, Aleshina GM, Shamova OV, Lehrer RI.",Isolation of antimicrobial peptides from avian heterophils.##Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes.,,,,,,,,
3813,DRAMP03650,LFCKGGSCHFGGCPSHLIKVGSCFGFRSCCKWPWNA,36,"Gallinacin-2 (Gal-2; Beta-defensin 2; Birds, animals)","P46158, Q09MT0, Q0PWH3, Q6B9W8, Q6GXJ3",Belongs to the beta-defensin family,GAL2,Gallus gallus (Chicken),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Beta strand (3 strands; 11 residues),The three-dimensional NMR structure of chicken AvBD2 defensin displays the structural three-stranded antiparallel β-sheet characteristic of β-defensins. The surface of the molecule does not display any amphipathic character.,"2LG5, 2LG6 resolved by NMR.","Tissue specificity: Expressed in circulating heterophil granulocytes and bone marrow (at protein level). Strong expression in the bone marrow, lung and testis. Moderate expression in the bursa and intestine. Low expression in the cloaca, gall bladder, brain, pancreas, trachea, air sacs and spleen. Expressed in the vagina, ovarian stroma and the theca layer of the ovarian follicle, but not in the granulosa layer of the ovarian follicle.
Developmental stage: Detected in the theca layer of the ovarian follicle in the white follicle (WF), F1, F3, F5, and postovulatory follicle stages. In the vagina expression is higher in laying hens than in non-laying hens, and is higher in older laying hens than in young laying hens.
Induction: Not induced in the ovarian follicle by intravenous injection of LPS. Expression in cultured vaginal cells is increased by LPS and S.enteritidis.
PTM: Contains three disulfide bonds 3-29, 8-23, 13-30.","Gram-negative bacteria: Escherichia coli ML-35, Salmonella enteritidis;##Gram-positive bacteria: Bacillus cereus, Listeria monocytogenes.",Unknown,Cell membrane,8150085##19151352##15148642##17244739##16394622##22205,FEBS Lett. 1994 Apr 11;342(3):281-285.##Poult Sci. 2009 Feb;88(2):372-379.##Immunogenetics. 2004 Jun;56(3):170-177.##Reproduction. 2007 Jan;133(1):127-133.##J Reprod Dev. 2006 Apr;52(2):211-218.##J Biol Chem. ,"Harwig SS, Swiderek KM, Kokryakov VN, Tan L, Lee TD, Panyutich EA, Aleshina GM, Shamova OV, Lehrer RI.##Kannan L, Rath NC, Liyanage R, Lay JO Jr.##Lynn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.##Yoshimura Y, Ohashi H, Subedi K, Nishibori M, Isobe N.##Derache C, Meudal H, Aucagne V, Mark KJ, Cadène M, Delmas AF, Lalmanach AC, Landon C.","Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes.##Direct screening identifies mature beta-defensin 2 in avian heterophils.##Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).##Effects of age, egg-laying activity, and Salmonella-i",,,,,,,,
3815,DRAMP03652,RYHMQCGYRGTFCTPGKCPHGNAYLGLCRPKYSCCRWL,38,"Gallinacin-4 (Gal-4; Beta-defensin 4; Birds, animals)","Q6GXJ1, Q0PXU4, Q6QLR0",Belongs to the beta-defensin family,GAL4,Gallus gallus (Chicken),"Antibacterial, Anti-Gram-, Antimicrobial",Transcript level,Bridge,Unknown,Unknown,"Tissue specificity: Strong expression in the bone marrow and testis. Widely expressed. Weak expression in the ovarian stroma, but not expressed in the ovarian follicles. PTM: Contains three disulfide bonds 6-34; 13-28; 18-35.","Gram-negative bacteria: Salmonella typhimurium, Salmonella entiriditis.",Unknown,Unknown,17346671##15310403##15148642##17244739,Biochem Biophys Res Commun. 2007 Apr 27;356(1):169-174.##BMC Genomics. 2004 Aug 13;5(1):56.##Immunogenetics. 2004 Jun;56(3):170-177.##Reproduction. 2007 Jan;133(1):127-133.,"Milona P, Townes CL, Bevan RM, Hall J.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Lynn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.","The chicken host peptides, gallinacins 4, 7, and 9 have antimicrobial activity against Salmonella serovars.##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response ",,,,,,,,
3816,DRAMP03653,GLPQDCERRGGFCSHKSCPPGIGRIGLCSKEDFCCRSRWYS,41,"Gallinacin-5 (Gal-5; Beta-defensin 5; Birds, animals)","Q6IV26, Q09MS7, Q0PWH0, Q6QLQ8",Belongs to the beta-defensin family,GAL5,Gallus gallus (Chicken),"Antibacterial, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Tissue specificity: Strong expression in the tongue and bone marrow. Low expression in the esophagus, trachea, lung, brain and ovary. Expressed in the ovarian stroma, but not in the ovarian follicles. PTM: contains three disulfide bonds 6-34; 13-28; 18-35.","Gram-negative bacteria: Salmonella typhimurium, Salmonella entiriditis.",Unknown,Unknown,17346671##15310403##15148642##17244739,Biochem Biophys Res Commun. 2007 Apr 27;356(1):169-174.##BMC Genomics. 2004 Aug 13;5(1):56.##Immunogenetics. 2004 Jun;56(3):170-177.##Reproduction. 2007 Jan;133(1):127-133.,"Milona P, Townes CL, Bevan RM, Hall J.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Lynn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.","The chicken host peptides, gallinacins 4, 7, and 9 have antimicrobial activity against Salmonella serovars.##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response ",,,,,,,,
3817,DRAMP03654,SPIHACRYQRGVCIPGPCRWPYYRVGSCGSGLKSCCVRNRWA,42,"Gallinacin-6 (Gal 6; Beta-defensin 6; Birds, animals)",Q6QLR3,Belongs to the beta-defensin family,GAL6,Gallus gallus (Chicken),"Antibacterial, Anti-Gram-, Antimicrobial",Transcript level,Bridge,Unknown,Unknown,"Tissue specificity: Expressed in bone marrow, testis, ovary, lung and trachea. Expressed in the ovarian stroma, but not in the ovarian follicles. PTM: Contains three disulfide bonds 6-35; 13-28; 18-36.","Gram-negative bacteria: Salmonella typhimurium, Salmonella entiriditis.",Unknown,Unknown,17346671##15310403##15148642##17244739,Biochem Biophys Res Commun. 2007 Apr 27;356(1):169-174.##BMC Genomics. 2004 Aug 13;5(1):56.##Immunogenetics. 2004 Jun;56(3):170-177.##Reproduction. 2007 Jan;133(1):127-133.,"Milona P, Townes CL, Bevan RM, Hall J.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Lynn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.","The chicken host peptides, gallinacins 4, 7, and 9 have antimicrobial activity against Salmonella serovars.##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response ",,,,,,,,
3818,DRAMP03655,RPIDTCRLRNGICFPGICRRPYYWIGTCNNGIGSCCARGWRS,42,"Gallinacin-7 (Gal 7; Beta-defensin 7; Birds, animals)","Q6QLR2, Q09MR1, Q09MV1",Belongs to the beta-defensin family,GAL7,Gallus gallus (Chicken),"Antibacterial, Anti-Gram-, Antimicrobial",Transcript level,Bridge,Unknown,Unknown,"Tissue specificity: Strong expression in the bone marrow and testis. Expressed in the ovarian stroma and the theca layer of the ovarian follicles. Not expressed in the granulosa layer of the ovarian follicles.
Developmental stage: Detected in the theca and granulosa layers of the ovarian follicle in the white follicle (WF), F1, F3, F5, and postovulatory follicle stages. Induction: Induced in the theca layer of the F3 stage ovarian follicle by intravenous injection of LPS. Expression in the kidney and liver is not affected by intravenous injection of LPS.
PTM: Contains three disulfide bonds 6-35; 13-28; 18-36.",Gram-negative bacterium: Salmonella enteriditis.,Unknown,Unknown,15148642##15310403##17244739,Immunogenetics. 2004 Jun;56(3):170-177.##BMC Genomics. 2004 Aug 13;5(1):56.##Reproduction. 2007 Jan;133(1):127-133.,"nn DJ, Higgs R, Gaines S, Tierney J, James T, Lloyd AT, Fares MA, Mulcahy G, O'Farrelly C.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Subedi K, Isobe N, Nishibori M, Yoshimura Y.","Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).",,,,,,,,
3823,DRAMP03661,FSDSQLCRNNHGHCRRLCFHMESWAGSCMNGRLRCCRFSTKQPFSNPKHSVLHTAEQDPSPSLGGT,66,"Gallinacin-13 (Gal-13; Beta-defensin 13; Birds, animals)","Q6IV18, Q66VU2",Belongs to the beta-defensin family,GAL13,Gallus gallus (Chicken),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Tissue specificity: Expressed in the liver, gall bladder, kidney, small intestine, spleen, testis, ovary and male and female reproductive tracts. Not detected in the ovarian stroma and the theca and granulosa layers of the ovarian follicle. PTM: Contains three disulfide bonds 7-35; 14-28; 18-36.","Gram-negative bacteria: Escherichia coli, Salmonella typhimurium;##Gram-positive bacteria: Listeria monocytogenes, Streptococcus pyogenes.",Unknown,Unknown,17244739##15310403##15744537,Reproduction. 2007 Jan;133(1):127-133.##BMC Genomics. 2004 Aug 13;5(1):56.##Immunogenetics. 2005 Apr;57(1-2):90-98.,"Subedi K, Isobe N, Nishibori M, Yoshimura Y.##Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G.##Higgs R, Lynn DJ, Gaines S, McMahon J, Tierney J, James T, Lloyd AT, Mulcahy G, O'Farrelly C.","Changes in the expression of gallinacins, antimicrobial peptides, in ovarian follicles during follicular growth and in response to lipopolysaccharide in laying hens (Gallus domesticus).##A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins.##The synthetic form of a novel chicken beta-defensin identified in silico is predominantly active against intestinal pathogens.",,,,,,,,
3825,DRAMP03663,MTPFWRGVSLRPVGASCRDNSECITMLCRKNRCFLRTASE,40,"cLEAP-2 (Chicken LEAP-2; Birds, animals)",No entry found,Unknown,Unknown,Gallus gallus (Chicken),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-negative bacteria: S. enterica serovar Typhimurium strain SL1344, mutant S. enterica serovar Typhimurium strain phoP.",Unknown,cell membrane,15557621,Infect Immun. 2004 Dec;72(12):6987-6893.,"wnes CL, Michailidis G, Nile CJ, Hall J.",Induction of cationic chicken liver-expressed antimicrobial peptide 2 in response to Salmonella enterica infection.,,,,,,,,
3826,DRAMP03664,ADNKNPLEECFRETNYEEFLEIAR,24,"L-amino-acid oxidase (LAAO, LAO, TM-LAO; reptilia, animals)",P0C2D6,Unknown,Unknown,Trimeresurus mucrosquamatus (Taiwan habu) (Protobothrops mucrosquamatus),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Catalyzes an oxidative deamination of predominantly hydrophobic and aromatic L-amino acids, thus producing hydrogen peroxide that may contribute to the diverse toxic effects of this enzyme. Exhibits diverse biological activities, such as hemorrhage, hemolysis, edema, apoptosis, and antiparasitic activities By similarity. This protein has antibacterial activity abd cytotoxic activity, as well as an ability to induce platelet aggregation. Effects of snake L-amino oxidases on platelets are controversial, since they either induce aggregation or inhibit agonist-induced aggregation. These different effects are probably due to different experimental conditions.
Tissue specificity: Expressed by the venom gland. PTM: Contains one disulfide bond.","Gram-negative bacterium: E. coli;##S. aureus, B. dysenteriae.",Unknown,Unknown,12621545,Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Mar;35(3):219-224.,"Wei JF, Wei Q, Lu QM, Tai H, Jin Y, Wang WY, Xiong YL.","Purification, characterization and biological activity of an L-amino acid oxidase from Trimeresurus mucrosquamatus venom.",,,,,,,,
3836,DRAMP03674,DTHISEKIIDCNDIG,15,Cystatin-1 (Cystatin-I),P84911,Belongs to the caerin subfamily,Unknown,Capra hircus (Goat),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Inhibits papain, ficin and bromelain with an IC50 of 0.09 μM, 0.115 μM and 0.113 μM respectively. Has antibacterial activity against Gram-positive bacteria and against the Gram-negative bacteria. Reduced antibacterial activity against Gram-positive bacterium B.subtilis. No antibacterial activity against the Gram-negative bacterium P.fluorescens.
Miscellaneous: Stable in the pH range 5.0-9.0 at 37 degrees Celsius. Stable when incubated in the temperature range 25-75 degrees Celsius and pH 7.5.
Sequence uncertainty: K or Y at position 7.","[Swiss_Prot Entry P84911]has antibacterial activity against Gram-positive bacteria S.aureus and S.hemolyticus, and against the Gram-negative bacterium E.coli. Reduced antibacterial activity against Gram-positive bacterium B.subtilis. No antibacterial activity against the Gram-negative bacterium P.fluorescens",[Swiss_Prot Entry P84911]Unknown,Unknown,16257555,Comp Biochem Physiol B Biochem Mol Biol. 2005 Dec;142(4):361-368. ,"Sadaf Z, Shahid PB, Bilqees B.","Isolation, characterization and kinetics of goat cystatins.",,,,,,,,
3839,DRAMP03680,RFRLPFRRPPIRIHPPPFYPPFRRFL,26,"Cathelicidin-3.4 (Bactenecin-3.4, Bac3.4; ChBac3.4; ruminant, animals)",P85170,Belongs to the cathelicidin family,Unknown,Capra hircus (Goat),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has low hemolytic activity towards human red blood cells. ,"[Swiss_Prot Entry P85170]Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa;##Gram-positive bacteria: Staphylococcus aureus, Listeria monocytogenes",[Swiss_Prot Entry P85170]Low hemolytic activity against human red blood cells,Unknown,PubMed ID is not available,Submitted (MAY-2007) to UniProtKB.,"Shamova O, Orlov D, Stegemann C, Lehrer RI, Brogden KA, Kolodkin N, Hoffmann R, Kokryakov VN.",Unknown,,,,,,,,
3843,DRAMP03692,ACQFWSCNSSCISRGYRQGYCWGIQYKYCQCQ,32,"Defensin-1 (Cll-dlp; Arthropods, animals)","Q6GU94, P83738",Belongs to the invertebrate defensin family,Unknown,Centruroides limpidus limpidus (Mexican scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial protein involved in the immune response to septic injury. When combined with 14.026 kDa and 14.059 kDa hemolymph antimicrobial peptides, it has a strong cooperative activity against bacteria. No detectable antibacterial activity when present alone. Has no hemolytic activity against human erythrocytes.
Induction: By septic injury.
PTM: Contains three disulfide bonds 2-21; 7-29; 11-31.","[Ref.15197474]Gram-positive bacteria: Bacillus subtilis (MIC>50 μg/ml), Staphylococcus aureus ATCC 25923 (MIC>50 μg/ml);##Gram-negative bacteria: Escherichia coli DH5a (MIC>50 μg/ml), Klebsiella pneumoniae ATCC 13883 (MIC>50 μg/ml).##NOTE: Liquid growth inhibition assay.",[Swiss_Prot Entry Q6GU94]Non-hemolytic activity against human erythrocytes,Unknown,15197474,Cell Mol Life Sci. 2004 Jun;61(12):1507-1519.,"Rodríguez de la Vega RC, García BI, D'Ambrosio C, Diego-García E, Scaloni A, Possani LD.",Antimicrobial peptide induction in the haemolymph of the Mexican scorpion Centruroides limpidus limpidus in response to septic injury.,,,,,,,,
3871,DRAMP03736,GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNFVAEKIGATPS,44,"Opistoporin-2 (OP2; Non-disulfide-bridged peptide 3.6, NDBP-3.6; Arthropods, animals)",P83314,Belongs to the antimicrobial peptide scorpion family,Unknown,Opistophthalmus carinatus (African yellow leg scorpion),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,Unknown,"Function: At high concentrations, acts as pore former in cellular membranes and causes the leakage of the cells. At submicromolar concentrations, degranulates granulocytes and has weak hemolytic activity against human red blood cells. Also strongly inhibits the production of superoxide anions. Has a strong antibacterial activity against Gram-negative bacteria but is less active against Gram-positive bacteria. Also has antifungal activity. (By similarity)
Tissue specificity: Expressed by the venom gland.",[Swiss_Prot Entry P83314]strong antibacterial activity against Gram-negative bacteria but is less active against Gram-positive bacteria. Also has antifungal activity.,[Swiss_Prot Entry P83314]Weak hemolytic activity against human erythrocytes,Cell membrane,12354111,Eur J Biochem. 2002 Oct;269(19):4799-4810.,"Moerman L, Bosteels S, Noppe W, Willems J, Clynen E, Schoofs L, Thevissen K, Tytgat J, Van Eldere J, Van Der Walt J, Verdonck F.","Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa.",,,,,,,,
3872,DRAMP03737,GKVWDWIKKTAKDVLNSDVAKQLKNKALNAAKNFVAEKIGATPS,44,"Opistoporin-4 (Non-disulfide-bridged peptides 3.7, NDBP-3.7; Arthropods, animals)",Q5VJS9,Belongs to the antimicrobial peptide scorpion family,Unknown,Opistophthalmus carinatus (African yellow leg scorpion),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: At high concentrations, acts as pore former in cellular membranes and causes the leakage of the cells. At submicromolar concentrations, degranulates granulocytes and has weak hemolytic activity against human red blood cells. Also strongly inhibits the production of superoxide anions. Has a strong antibacterial activity against Gram-negative bacteria but is less active against Gram-positive bacteria. Also has antifungal activity. (By similarity)
Tissue specificity: Expressed by the venom gland.",[Swiss_Prot Entry Q5VJS9]strong antibacterial activity against Gram-negative bacteria but is less active against Gram-positive bacteria. Also has antifungal activity.,[Swiss_Prot Entry Q5VJS9]Weak hemolytic activity against human erythrocytes,Cell membrane,PubMed ID is not available,Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases,"Zhu S, Tytgat J.",Precursor organization and gene structure of scorpion venom antimicrobial peptides.,,,,,,,,
3873,DRAMP03739,SIVPIRCRSNRDCRRFCGFRGGRCTYARQCLCGY,34,"Buthinin (Sahara scorpion; Arthropods, animals)","P56685, P81617",Unknown,Unknown,Androctonus australis (Sahara scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,Function: Active against both Gram-positive and Gram-negative bacteria.,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.,Unknown,Unknown,8939880,J Biol Chem. 1996 Nov 22;271(47):29537-29544.,"Ehret-Sabatier L, Loew D, Goyffon M, Fehlbaum P, Hoffmann JA, van Dorsselaer A, Bulet P.",Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood.,,,,,,,,
3874,DRAMP03740,GFGCPFNQGACHRHCRSIRRRGGYCAGLFKQTCTCYR,37,"Androctonus defensin (4 kDa defensin; Arthropods, animals)","P56686, P81618",Belongs to the invertebrate defensin family (Type 2 subfamily),Unknown,Androctonus australis (Sahara scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Bridge,Unknown,Unknown,Function: Active against both Gram-positive and Gram-negative bacteria.,Gram-negative bacterium: Escherichia coli;##Gram-positive bacterium: Micrococcus luteus.,Unknown,Unknown,8939880,J Biol Chem. 1996 Nov 22;271(47):29537-29544.,"Ehret-Sabatier L, Loew D, Goyffon M, Fehlbaum P, Hoffmann JA, van Dorsselaer A, Bulet P.",Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood.,,,,,,,,
3875,DRAMP03741,IFGSLFSLGSKLLPSVFKLFSRKKQ,25,"Ponericin-W-like 32.1 (Arthropods, animals)",P0CI91,Belongs to the ponericin-W family,Unknown,Lychas mucronatus (Chinese swimming scorpion),"Antibacterial, Antifungal, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities (By similarity).
Tissue specificity: Expressed by the venom gland.",[Swiss_Prot Entry P0CI91]Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae,[Swiss_Prot Entry P0CI91]has hemolytic activities,Unknown,20663230,BMC Genomics. 2010 Jul 28;11:452.,"Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.",Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.,,,,,,,,
3876,DRAMP03742,IFGSLFSLGSKLLPTVFKLFSRKKQ,25,"Ponericin-W-like 32.2 (Arthropods, animals)",P0CI92,Belongs to the ponericin-W family,Unknown,Lychas mucronatus (Chinese swimming scorpion),"Antibacterial, Antifungal, Insecticidal, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae. Has insecticidal and hemolytic activities (By similarity).
Tissue specificity: Expressed by the venom gland.",[Swiss_Prot Entry P0CI92]Broad spectrum of activity against both Gram-positive and Gram-negative bacteria and S.cerevisiae,[Swiss_Prot Entry P0CI92]has hemolytic activities,Unknown,20663230,BMC Genomics. 2010 Jul 28;11:452.,"Ruiming Z, Yibao M, Yawen H, Zhiyong D, Yingliang W, Zhijian C, Wenxin L.",Comparative venom gland transcriptome analysis of the scorpion Lychas mucronatus reveals intraspecific toxic gene diversity and new venomous components.,,,,,,,,
3880,DRAMP03755,QFTNVSCTTSKECWSVCQRLHNTSRGKCMNKKCRCYS,37,"Potassium channel toxin alpha-KTx 1.1 (ChTX-Lq1; charybdotoxin; Arthropods, animals)",P13487,Unknown,Unknown,Leiurus quinquestriatus hebraeus (Yellow scorpion),"Antibacterial, Antifungal, Antiviral, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Combine helix and strand structure,These structures show that charybdotoxin is composed of a beta-sheet linked to an alpha-helix by two disulphide bridges and to an extended fragment by the third disulphide bridge. ,"1BAH, 2CRD resolved by NMR.","Function: Potent selective inhibitor of high conductance (maxi-K), different medium and small conductance calcium-activated potassium channels (KCa/KCNM), as well as a voltage-dependent potassium channel (Kv1.3/KCNA3). It appears to block channel activity by a simple bimolecular inhibition process.
Tissue specificity: Expressed by the venom gland.
Domain: Has the structural arrangement of an alpha-helix connected to a beta-sheet by disulfide bonds (CSalpha/beta).
PTM: Contains three disulfide bonds.","Gram-positive bacteria: B.subtilis, S.aureus;##Gram-negative bacterium: E.coli.##Yeast: Candida albicans. ",Unknown,Unknown,15118082##1705886##9092804##1380828,Proc Natl Acad Sci U S A. 2004 May 11;101(19):7363-7368.##Eur J Biochem. 1991 Feb 26;196(1):19-28.##Biochemistry. 1997 Apr 1;36(13):3760-3766.##Biochemistry. 1992 Sep 1;31(34):7756-7764.,"Yount NY, Yeaman MR.##Bontems F, Roumestand C, Boyot P, Gilquin B, Doljansky Y, Menez A, Toma F.##Song J, Gilquin B, Jamin N, Drakopoulou E, Guenneugues M, Dauplais M, Vita C, Ménez A.##Bontems F, Gilquin B, Roumestand C, Ménez A, Toma F.",Multidimensional signatures in antimicrobial peptides.##Three-dimensional structure of natural charybdotoxin in aqueous solution by 1H-NMR. Charybdotoxin possesses a structural motif found in other scorpion toxins.##NMR solution structure of a two-disulfide derivative of charybdotoxin: structural evidence for conservation of scorpion toxin alpha/beta motif and its hydrophobic side chain packing.##Analysis of side-chain organization on a refined model of charybdotoxin: structural and functional i,,,,,,,,
3891,DRAMP03766,GWINEEKIQKKIDEKIGNNILGGMAKAVVHKLAKGEFQCVANIDTMGNCETHCQKTSGEKGFCHGTKCKCGKPLSY,76,"Heteroscorpine-1 (HS-1; defensins; Arthropods, animals)",P0C2F4,Belongs to the long chain scorpion toxin family (Class 3 subfamily),Unknown,Heterometrus laoticus (Thai giant scorpion),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has antibacterial activity.
Tissue specificity: Expressed by the venom gland.
PTM: Contains three disulfide bonds (By similarity).
Toxic dose: PD50 is 80 ul to crickets (Gryllus sp).","Gram-positive bacterium: Bacillus subtilis (5.2 mm);##Gram-negative bacteria: Klebsiella pneumoniae (10.57 mm), Pseudomonas aeruginosa (6.4 mm).##NOTE: Diameter of clear zone from disc diffusion assay. Total protein is 6.25 μmole.",Unknown,Unknown,17056081,Toxicon. 2007 Jan;49(1):19-29.,"Uawonggul N, Thammasirirak S, Chaveerach A, Arkaravichien T, Bunyatratchata W, Ruangjirachuporn W, Jearranaiprepame P, Nakamura T, Matsuda M, Kobayashi M, Hattori S, Daduang S.",Purification and characterization of Heteroscorpine-1 (HS-1) toxin from Heterometrus laoticus scorpion venom.,,,,,,,,
3905,DRAMP03785,QWGYGGYGRGYGGYGGYGRGMYGGYGRGMYGGYGRGMYGGYGRGMYGGWGK,51,"Neuropeptide-like protein 29 (NLP-29; nematodes, animals)",O44664,Unknown,nlp-29,Caenorhabditis elegans,"Antibacterial, Antifungal, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptides that have antibacterial and antifungal activity.
Tissue specificity: Weakly or not expressed in absence of infection. Upon infection by D. coniospora, it is expressed in hypoderm. Also expressed in perivulval cells when D. coniospora spores adhere to this region.
Induction: Upon D. coniospora and S. marcescens infection.
PTM: C-terminal amidation.",Gram-negative bacterium: S. marcescens.##Fungi: D. coniospora.,Unknown,Unknown,11717458##15048112,Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14000-14005.##Nat Immunol. 2004 May;5(5):488-494.,"Nathoo AN, Moeller RA, Westlund BA, Hart AC.##Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.","Identification of neuropeptide-like protein gene families in Caenorhabditiselegans and other species.##TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.",,,,,,,,
3907,DRAMP03787,NAQWGYGGYGRGYGGYGGYGRGYGGYGGYGRGYGGYGRGMYGGYGRPYGGYGWGK,55,"Neuropeptide-like protein 31 (NLP-31; nematodes, animals)",O44662,Belongs to the YARP family,nlp-31,Caenorhabditis elegans,"Antifungal, Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Transcript level,Unknown,Unknown,Unknown,"Function: Antimicrobial peptide that has antifungal and weak antibacterial activity.
Tissue specificity: Expressed in hypoderm.
Developmental stage: Expressed in precomma stasge embryos.
Induction: Strongly up-regulated upon D. coniospora infection.
PTM: C-terminal amidation.",Gram-positive bacterium: Micrococcus luteus;##Gram-negative bacterium: E.coli.##Fungi: D.coniospora.,Unknown,Unknown,11717458##15048112,Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):14000-5.##Nat Immunol. 2004 May;5(5):488-494.,"Nathoo AN, Moeller RA, Westlund BA, Hart AC.##Couillault C, Pujol N, Reboul J, Sabatier L, Guichou JF, Kohara Y, Ewbank JJ.","Identification of neuropeptide-like protein gene families in Caenorhabditis elegans and other species.##TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.",,,,,,,,
3910,DRAMP03790,DIDFSTCARMDVPILKKAAQGLCITSCSMQNCGTGSCKKRSGRPTCVCYRCANGGGDIPLGALIKRG,67,"ABF-2 (nematodes, animals)",G5EC68,Unknown,abf-2,Caenorhabditis elegans,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Predicted,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: Bacillus subtilis IFO3134 (BC50=0.09 μM), Kocuria varians MAFF118076 (BC50=0.008 μM), Staphylococcus aureus ATCC6538P (BC50=0.005 μM);##Gram-negative bacteria: Agrobacterium tumefaciens MAFF1001 (BC50=0.05 μM), Bdellovibrio bacteriovorus MAFF106101 (BC50=0.06 μM), Klebsiella pneumoniae MAFF519002 (BC50=0.9 μM), Escherichia coli JM109 (BC50>15 μM).##Fungi: Candida krusei MAFF114085 (BC50=0.3 μM), Debaryomyces hansenii MAFF113836 (BC50>15 μM), Kluyveromyces thermotolerans MAFF113848 (BC50=0.3 μM), Paeonia anomala MAFF113717 (BC50=0.08 μM), Saccharomyces cerevisiae MAFF113011 (BC50=0.6 μM), Torulaspora delbrueckiiMAFF113811 (BC50>15 μM). ",Unknown,Unknown,11772394,Biochem J. 2002 Jan 15;361(Pt 2):221-230.,"Kato Y, Aizawa T, Hoshino H, Kawano K, Nitta K, Zhang H.","abf-1 and abf-2, ASABF-type antimicrobial peptide genes in Caenorhabditis elegans.",,,,,,,,
3917,DRAMP03798,MPCSCKKYCDPWEVIDGSCGLFNSKYICCREK,32,"Corticostatin-related peptide RK-1 (RK-1; lagomorphs, mammals, animals)",P81655,Belongs to the alpha-defensin family,Unknown,Oryctolagus cuniculus (Rabbit) ,"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Beta strand(3 strands; 13 residues),"RK-1 consists of 32 residues, including six cysteines arranged into three disulfide bonds. The three-dimensional solution structure, determined by NMR, consists of a triple-stranded antiparallel beta-sheet and a series of turns and is similar to the known structures of other alpha-defensins (Ref.3).",1EWS resolved by NMR.,"Function: Has antimicrobial activity against Escherichia coli and activates Ca(2+) channels in vitro.
PTM: Contains three disulfide bonds 3-29; 5-19; 9-28.",Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,8631871##11123900,J Biol Chem. 1996 May 3;271(18):10654-10659.##Biochemistry. 2000 Dec 26;39(51):15757-15764.,"Bateman A, MacLeod RJ, Lembessis P, Hu J, Esch F, Solomon S.##McManus AM, Dawson NF, Wade JD, Carrington LE, Winzor DJ, Craik DJ.",The isolation and characterization of a novel corticostatin/defensin-like peptide from the kidney.##Three-dimensional structure of RK-1: a novel alpha-defensin peptide.,,,,,,,,
3918,DRAMP03799,KPYCSCKWRCGIGEEEKGICHKFPIVTYVCCRRP,34,"Rabbit kidney defensin RK-2 (alpha-defensins; lagomorphs, mammals, animals)",No entry found,Belongs to the alpha-defensin family,Unknown,Oryctolagus cuniculus (Rabbit),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Bridge ,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,9663443,Peptides. 1998;19(5):793-799.,"Wu ER, Daniel R, Bateman A.",RK-2: a novel rabbit kidney defensin and its implications for renal host defense.,,,,,,,,
3944,DRAMP18190,FLSTIWNGIKSLL,13,"Pantinin-3 (Non-disulfide-bridged peptide 4.22, NDBP-4.22, Non-disulfide-bridged peptide 5.23)",R4JJN6, Belongs to the non-disulfide-bridged peptide (NDBP) superfamily. ,Unknown,Pandinus imperator (Emperor scorpion),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Amphipathic peptide that possesses relatively strong activities against Gram-positive bacteria and a fungus, but has very weak antimicrobial activities against Gram-negative bacteria. Also exhibits hemolytic activities against human erythrocytes. Furthermore, this peptide potently inhibits the growth of vancomycin-resistant Enterococcus (VRE) S13, a pathogen that can cause a number of human infections.Forms an alpha-helical membrane channel in the prey.","[Ref.23624072]Gram-positive bacteria: S.aureus (MIC=16 μM), B.magaterium (MIC=6 μM), M.luteus (MIC=8 μM ), VRE (MIC=4 μM), MRSA (MIC=12 μM);##Gram-negative bacteria: E.coli (MIC=36 μM), P.putida (MIC >87 μM), K.oxytoca (MIC=87 μM), E.cloacae (MIC >87 μM), S.enterica (MIC=84 μM);##Fungus: C.tropicalis (MIC=17 μM).","[Ref.23624072]70% hemolytic activity at 16 μM, 100% hemolytic activity at 32 μM, 100% hemolytic activity at 64 μM against human red blood cells",Cell membrane,23624072##24184590,Peptides 45:28-34(2013)##Peptides 51:35-45(2014,"Zeng X.C., Zhou L., Shi W., Luo X., Zhang L., Nie Y., Wang J., Wu S.,Cao B., Cao H.##Almaaytah A., Albalas Q.",Three new antimicrobial peptides from the scorpion Pandinusimperator.##Scorpion venom peptides with no disulfide bridges: a review.,,,,,,,,
3946,DRAMP03850,FALALKALKKALKKLKKALKKAL,23,Antibacterial peptide/melittin homolog,No entry found,Unknown,Unknown,Synthetic construct ,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,8714745,Scanning Microsc. 1995 Jun;9(2):501-507.,"Henk WG, Todd WJ, Enright FM, Mitchell PS.","The morphological effects of two antimicrobial peptides, hecate-1 and melittin, on Escherichia coli.",,,,,,,,
3948,DRAMP03872,FQWQRNMRKV,10,"hLf 21-30 (fragment of human lalctoferricin, residues 21-30)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>300 μM), Escherichia coli (wild strain) (MIC>300 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>300 μM), Enterococcus faecalis ATCC 29212 (MIC>300 μM).",Unknown,Unknown,13677384,Am J Vet Res. 2003 Sep;64(9):1088-1092.,"Chen PW, Shyu CL, Mao FC.",Antibacterial activity of short hydrophobic and basic-rich peptides.,,,,,,,,
3949,DRAMP03873,LRWQNEMRKV,10,"mLf 20-29 (fragment of murine lalctoferricin, residues 20-29)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>300 μM), Escherichia coli (wild strain) (MIC>300 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>300 μM), Enterococcus faecalis ATCC 29212 (MIC>300 μM).",Unknown,Unknown,13677384,Am J Vet Res. 2003 Sep;64(9):1088-1092.,"Chen PW, Shyu CL, Mao FC.",Antibacterial activity of short hydrophobic and basic-rich peptides.,,,,,,,,
3950,DRAMP03874,RQWQSKIRRT,10,"pLf20-29 (fragment of porcine lactoferricin, residues 20-29)",No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Shows antibacterial activity against both Gram-positive and Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC>300 μM), Escherichia coli (wild strain) (MIC>300 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC>300 μM), Enterococcus faecalis ATCC 29212 (MIC>300 μM).",Unknown,Unknown,13677384,Am J Vet Res. 2003 Sep;64(9):1088-1092.,"Chen PW, Shyu CL, Mao FC.",Antibacterial activity of short hydrophobic and basic-rich peptides.,,,,,,,,
3961,DRAMP03941,RFPWWWPFLR,10,Peptide 3 (Trp- and Arg-rich; derivative of Tritrpticin),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Rich,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Pseudomonas, Klebsiella, Proteus species;##Gram-positive bacteria: Streptococcus, Staphylococcus species. ",Unknown,Unknown,8706838,FEBS Lett. 1996 Jul 15;390(1):95-98.,"Lawyer C, Pai S, Watabe M, Borgia P, Mashimo T, Eagleton L, Watabe K.",Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides.,,,,,,,,
3962,DRAMP03942,RRRFPWVCWPFLRRR,15,Peptide 2 (Trp- and Arg-rich; derivative of Tritrpticin),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Rich,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia, Proteus mirabilis;##Gram-positive bacteria: Staphylococcus epidermidis, Streptococcus group D.##Fungi: Aspergillus fumigatus.",Unknown,Unknown,8706838,FEBS Lett. 1996 Jul 15;390(1):95-98.,"Lawyer C, Pai S, Watabe M, Borgia P, Mashimo T, Eagleton L, Watabe K.",Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides.,,,,,,,,
3963,DRAMP03943,VXLFPKKPFLXV,12,Gratisin analogue,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Its activity against Pseudomonas aeruginosa IFO 3080 was two times higher than gramicidin S.,Gram-negative bacterium: Pseudomonas aeruginosa IFO 3080.,Unknown,Unknown,18305357,J Antibiot (Tokyo). 2008 Jan;61(1):33-35.,"Tamaki M, Kokuno M, Suzuki Y, Iwama M, Shindo M, Uchida Y.",A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.,,,,,,,,
3965,DRAMP03946,GLIKIVPAMICAVTKKC,17,Del 1-3 (Ranalexin analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-positive bacterium: Staphylococcus aureus (MIC>256 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC>256 μg/ml), Pseudomonas aeruginosa (MIC>256 μg/ml).",Unknown,Unknown,8144672,J Biol Chem. 1994 Apr 8;269(14):10849-10855.,"Clark DP, Durell S, Maloy WL, Zasloff M.","Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",,,,,,,,
3970,DRAMP03961,KRIVQRIKDFLR,12,KR-12,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-positive bacterium: Bacillus megaterium.##Gram-negative bacterium: Escherichia coli.,Unknown,Unknown,18818205,J Biol Chem. 2008 Nov 21;283(47):32637-32643.,Wang G.,Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.,,,,,,,,
3976,DRAMP02092,FLPAIAGMAAKFLPKIFCAISKKC,24,"Brevinin-1Bb (Frogs, amphibians, animals)",P82834,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana berlandieri (Rio Grande leopard frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=1 μM);##Gram-negative bacterium: Escherichia coli (MIC=3 μM).##Yeast: Candida albicans (MIC=10 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
3978,DRAMP18189,IFGAIWKGISSLL,13,"Pantinin-2 (Non-disulfide-bridged peptide 4.21, NDBP-4.21, Non-disulfide-bridged peptide 5.22)",R4JQZ0,Belongs to the non-disulfide-bridged peptide (NDBP) superfamily.,Unknown,Pandinus imperator (Emperor scorpion),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Amphipathic peptide that possesses relatively strong activities against Gram-positive bacteria and a fungus, but has very weak antimicrobial activities against Gram-negative bacteria. Also exhibits mild hemolytic activities against human erythrocytes.Forms an alpha-helical membrane channel in the prey.","[Ref.23624072]Gram-positive bacteria: S.aureus (MIC=48 μM), B.magaterium (MIC=36 μM), M.luteus (MIC=18 μM ), VRE (MIC=36 μM), MRSA (MIC=28 μM);##Gram-negative bacteria: E.coli (MIC=48 μM), P.putida (MIC >87 μM), K.oxytoca (MIC >87 μM), E.cloacae (MIC >87 μM), S.enterica (MIC=68 μM);##Fungus: C.tropicalis (MIC=16 μM).","[Ref.23624072]10% hemolytic activity at 16 μM, 80% hemolytic activity at 32 μM, 100% hemolytic activity at 64 μM against human red bood cells",Cell membrane,23624072##24184590,Peptides 45:28-34(2013)##Peptides 51:35-45(2014,"Zeng X.C., Zhou L., Shi W., Luo X., Zhang L., Nie Y., Wang J., Wu S.,Cao B., Cao H.##Almaaytah A., Albalas Q.",Three new antimicrobial peptides from the scorpion Pandinusimperator.##Scorpion venom peptides with no disulfide bridges: a review.,,,,,,,,
3982,DRAMP04018,ALYKKFKKKLLKSLKRLG,18,Rp-1,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix,Unknown,"2RLH, 2RLG resolved by NMR.",Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria and the yeast candian ,"Gram-positive bacteria: Staphylococcus, Streptococcus, Bacillus species;##Gram-negative bacteria: Escherichia, Salmonella, Pseudomonas species.##Fungi: Candida and Cryptococcus species.",Unknown,Unknown,18712851,Biopolymers. 2009 Jan;91(1):1-13.,"Bourbigot S, Dodd E, Horwood C, Cumby N, Fardy L, Welch WH, Ramjan Z, Sharma S, Waring AJ, Yeaman MR, Booth V.",Antimicrobial peptide RP-1 structure and interactions with anionic versus zwitterionic micelles.,,,,,,,,
3983,DRAMP04037,LKLLKKL,7,Immobilized peptide E07LKK,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",Unknown,Unknown,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,,,,,,,,
3984,DRAMP04038,LKLLKKLLKLLKKL,14,Immobilized peptide E14LKK/H14LKK,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922 (MBC=1496 μg/ml), Klebsiella pneumoniae ATCC 4352 (MBC=1496 μg/ml);##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923 (MBC=1496 μg/ml), Bacillus subtilis ATCC 6051 (MBC=1995 μg/ml).##Yeast: Candida albicans ATCC 10231 (MBC=3200 μg/ml).",Unknown,Unknown,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,,,,,,,,
3985,DRAMP04039,LKLLKKLLKLLKKLGK,16,Immobilized peptige E16KGL/H16KGL,No entry found,Unknown,Unknown,Synthetic construct ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",Unknown,Unknown,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,,,,,,,,
3986,DRAMP04040,LKLLKKLLKLLKKLGGK,17,Immobilized peptide E17KGG,No entry found,Unknown,Unknown,Synthetic construct ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",Unknown,Unknown,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,,,,,,,,
3987,DRAMP04041,LKLLKKLLKLLKKLGGGK,18,Immobilized peptide E18KGG,No entry found,Unknown,Unknown,Synthetic construct ,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",Unknown,Unknown,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,,,,,,,,
3988,DRAMP04042,KGLKKLLKLLKKLLKL,16,Immobilized peptide E16LKL,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",Unknown,Unknown,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,,,,,,,,
3989,DRAMP04043,LKKLLKKLKK,10,Immobilized peptid E10KKL,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",Unknown,Unknown,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,,,,,,,,
3990,DRAMP04044,LKKLLKKLKKLL,12,Immobilized peptid E12LLK,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",Unknown,Unknown,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,,,,,,,,
3991,DRAMP04045,LKKLLKKLKKLLKK,14,Immobilized peptid E14KKL,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",Unknown,Unknown,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,,,,,,,,
3992,DRAMP04046,SNMIEGVFAKGFKKASHLFKGIG,23,Immobilized peptide E23GIG magainin2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",Unknown,Unknown,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,,,,,,,,
3993,DRAMP04047,SNMIEGVFAKGFKKASH,17,Immobilized peptide E17HSA magainin 2 deletion,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Has antibacterial activiy against Gram-negative and Gram-positive bacteria.,"Gram-negative bacteria: Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 4352;##Gram-positive bacteria: Staphylococcus aureus ATCC 6538 and ATCC 25923, Bacillus subtilis ATCC 6051.##Yeast: Candida albicans ATCC 10231.",Unknown,Unknown,7726486,Antimicrob Agents Chemother. 1995 Feb;39(2):301-307.,"Haynie SL, Crum GA, Doele BA.",Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.,,,,,,,,
4020,DRAMP04172,WLKKW,5,LK2W2 (LlKmW2 model peptides),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: B. subtilis (MIC>80 μg/ml), S. aureus (MIC>80 μg/ml), S. epidermis (MIC>80 μg/ml), M. luteus (MIC>80 μg/ml), S. aureus (MRSA) (MIC>80 μg/ml).##Gram-negative bacteria: E. coli (MIC>80 μg/ml), S. dysentariae (MIC>80 μg/ml), S. typhimorium (MIC>80 μg/ml), K. pneumoniae (MIC>80 μg/ml), P. aeruginosa (MIC>80 μg/ml).",Unknown,Unknown,20736034,Regul Pept. 2011 Jan 17;166(1-3):36-41.,"Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.",De novo generation of short antimicrobial peptides with simple amino acid composition.,,,,,,,,
4021,DRAMP04173,WLLKW,5,L2KW2 (LlKmW2 model peptides),No entry found,Unknown,Unknown,Synthetic construct (De novo design),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activities against Gram-negative and Gram-positive bacteria, including a multi-drug resistant strain.
Chemical modification: C-terminal amidation.","Gram-positive bacteria: B. subtilis (MIC>80 μg/ml), S. aureus (MIC>80 μg/ml), S. epidermis (MIC>80 μg/ml), M. luteus (MIC>80 μg/ml), S. aureus (MRSA) (MIC>80 μg/ml).##Gram-negative bacteria: E. coli (MIC>80 μg/ml), S. dysentariae (MIC>80 μg/ml), S. typhimorium (MIC>80 μg/ml), K. pneumoniae (MIC>80 μg/ml), P. aeruginosa (MIC>80 μg/ml).",Unknown,Unknown,20736034,Regul Pept. 2011 Jan 17;166(1-3):36-41.,"Lee SH, Kim SJ, Lee YS, Song MD, Kim IH, Won HS.",De novo generation of short antimicrobial peptides with simple amino acid composition.,,,,,,,,
4058,DRAMP04236,GLFDKLKSLVSDF,13,Antibacterial peptide A2,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix (1 helices; 10 residues),Unknown,1VM2 resolved by NMR.,Function: Has antibacterial activity against the Gram-negative bacterium E. coli.,Gram-negative bacterium: Escherichia coli (MIC>250 μM).,Unknown,Unknown,15572363,J Biol Chem. 2005 Feb 18;280(7):5803-5811.,"Wang G, Li Y, Li X.",Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor.,,,,,,,,
4080,DRAMP04266,KWKSFIKKLPSAAKKVTTAAKPLTK,25,CPα1,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=43 μg/ml), Pseudomonas aeruginosa K799 (MIC=64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=24 μg/ml), Pseudomonas aeruginosa H744 (MIC=8 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml), Pseudomonas aeruginosa H547 (MIC=16 μg/ml).",Unknown,Unknown,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4081,DRAMP04267,KWKKFIKKIGIGAVLKVLTTGLPALKLTKK,30,CPα2,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=2 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=4 μg/ml), Pseudomonas aeruginosa H744 (MIC=2 μg/ml), Pseudomonas aeruginosa H374 (MIC=4 μg/ml), Pseudomonas aeruginosa H547 (MIC=2 μg/ml).",Unknown,Unknown,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4082,DRAMP04268,KKWKKFIKKIGIGAVLTTPGAKK,23,CPα3,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=32 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml), Pseudomonas aeruginosa H547 (MIC=16 μg/ml).",Unknown,Unknown,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4083,DRAMP04269,KWKSFIKNLTKGGSKILTTGLPALIS,26,CP201,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=4 μg/ml), Salmonella typhimurium (MIC=43 μg/ml), Pseudomonas aeruginosa K799 (MIC=64 μg/ml), Pseudomonas aeruginosa Z61 (MIC=32 μg/ml), Pseudomonas aeruginosa H744 (MIC=16 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml), Pseudomonas aeruginosa H547 (MIC=32 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4084,DRAMP04270,KWKKFIKNLTKGGSKILTTGLPALIS,26,CP202,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=16 μg/ml), Pseudomonas aeruginosa K799 (MIC=32 μg/ml), Pseudomonas aeruginosa Z61 (MIC=19 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H374 (MIC=4 μg/ml), Pseudomonas aeruginosa H547 (MIC=16 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4085,DRAMP04271,KWKSFIKKLTSAAKKVLTTGLPALIS,26,CP203,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=5 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H374 (MIC=4 μg/ml), Pseudomonas aeruginosa H547 (MIC=8 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4086,DRAMP04274,KKWWKFIKKAVNSGTTGLQTLAS,23,CP206,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=8 μg/ml), Pseudomonas aeruginosa H744 (MIC=16 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4087,DRAMP04275,KWKSFIKKLTSVLKKVVTTAKPLISS,26,CP207,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=3 μg/ml), Pseudomonas aeruginosa K799 (MIC=5 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H374 (MIC=8 μg/ml), Pseudomonas aeruginosa H547 (MIC=8 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4088,DRAMP04276,KKKSFIKLLTSAKVSVLTTAKPLISS,26,CP208,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=32 μg/ml), Pseudomonas aeruginosa H744 (MIC=64 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4089,DRAMP04277,WKVFKSFIKKASSFAQSVLD,20,CP209,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=11 μg/ml), Pseudomonas aeruginosa Z61 (MIC=64 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4090,DRAMP04280,KWKSFIKKLPSAAKKVVTTAKPLALIS,27,CM1,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=5 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=4 μg/ml), Pseudomonas aeruginosa H744 (MIC=2 μg/ml), Pseudomonas aeruginosa H547 (MIC=16 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4091,DRAMP04281,KWKSFIKKLPKAAKKVVTTAKKPLIV,26,CM2,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=3 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=1 μg/ml), Pseudomonas aeruginosa H547 (MIC=4 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4092,DRAMP04282,KWKKFIKSLTKSAAKTVVKTAKKPLIV,27,CM3,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=1 μg/ml), Salmonella typhimurium (MIC=3 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=2 μg/ml), Pseudomonas aeruginosa H374 (MIC=2 μg/ml), Pseudomonas aeruginosa H547 (MIC=2 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4093,DRAMP04283,KWKLFKKIGIGAVLKVLTTGLPALKLTLK,29,CM4,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=3 μg/ml), Salmonella typhimurium (MIC=3 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H547 (MIC=4 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4094,DRAMP04284,KLFKKIGIGAVLKVLTTGLPALKLTK,26,CM5,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=5 μg/ml), Salmonella typhimurium (MIC=29 μg/ml), Pseudomonas aeruginosa K799 (MIC=32 μg/ml), Pseudomonas aeruginosa Z61 (MIC=19 μg/ml), Pseudomonas aeruginosa H744 (MIC=4 μg/ml), Pseudomonas aeruginosa H547 (MIC=32 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4095,DRAMP04285,KWKFKKIGIGAVLKVLTTGLPALKLTLK,28,CM6,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=4 μg/ml), Pseudomonas aeruginosa K799 (MIC=6 μg/ml), Pseudomonas aeruginosa Z61 (MIC=5 μg/ml), Pseudomonas aeruginosa H744 (MIC=1 μg/ml), Pseudomonas aeruginosa H547 (MIC=2 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4096,DRAMP04286,KLWKLFKKIGIGAVLKVLTTGLPALKLTK,29,CM7,No entry found,"Derived from the peptide CP26, CP29, CEME and CEMA",Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=3 μg/ml), Pseudomonas aeruginosa K799 (MIC=4 μg/ml), Pseudomonas aeruginosa Z61 (MIC=3 μg/ml), Pseudomonas aeruginosa H744 (MIC=16 μg/ml), Pseudomonas aeruginosa H547 (MIC=32 μg/ml).",Unknown,Lipopolysaccharide (LPS)-binding,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4167,DRAMP04357,KWKLFKKIGIGAVLKVLTTGLIALIS,26,CEME(MBI-27),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=2 μg/ml), Pseudomonas aeruginosa K799 (MIC=5 μg/ml), Pseudomonas aeruginosa Z61 (MIC=4 μg/ml), Pseudomonas aeruginosa H744 (MIC=2 μg/ml), Pseudomonas aeruginosa H374 (MIC=2 μg/ml), Pseudomonas aeruginosa H547 (MIC=2 μg/ml).",Unknown,Unknown,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4168,DRAMP04358,KWKLFKKIGIGAVLKVLTPGLPALKLTK,28,CEMA(MBI-28),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli (MIC=2 μg/ml), Salmonella typhimurium (MIC=3 μg/ml), Pseudomonas aeruginosa K799 (MIC=3 μg/ml), Pseudomonas aeruginosa Z61 (MIC=2 μg/ml), Pseudomonas aeruginosa H744 (MIC=2 μg/ml), Pseudomonas aeruginosa H374 (MIC=2 μg/ml), Pseudomonas aeruginosa H547 (MIC=4 μg/ml).",Unknown,Unknown,10085049,Infect Immun. 1999 Apr;67(4):2005-2009.,"Scott MG, Yan H, Hancock RE.",Biological properties of structurally related alpha-helical cationic antimicrobial peptides.,,,,,,,,
4169,DRAMP04366,INWSSIFESVSNLV,14,PDD-A-8 (PDD-A analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC>100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC>100 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
4170,DRAMP04375,INSLKLGKKILGAL,14,PDD-B-5 (PDD-B analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC>100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC>100 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
4171,DRAMP04384,KIASIGKEVLKAL,13,PMM-5 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC>100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC>100 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
4172,DRAMP04388,INWKKIASIGKEV,13,PMM-9 (PMM analog),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity against the Gram-positive bacterium B. subtilis and Gram-negative bacterium E. coli.
Chemical modification: C-terminal amidation.",Gram-negative bacterium: Escherichia coli (MIC>100 μM);##Gram-positive bacterium: Bacillus subtilis (MIC>100 μM).,Unknown,Unknown,18375018,Peptides. 2008 Jun;29(6):992-1003.,"Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L.",New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.,,,,,,,,
4424,DRAMP04658,IKIPPIVKDTLKKVAKGVLSTIAGALST,28,Hymenochirin-5B,No entry found,Unknown,Unknown,Hymenochirus boettgeri(Congo dwarf clawed frog),"Antimicrobial, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against both Gram-positive, Gram-negative bacteria and fungi.",Gram-positive bacterium: Staphylococcus aureus  (MIC=80 μM);##Gram-negative bacteria: Escherichia coli (MIC=40 μM);##Fungi: Candida albicans (MIC=160 μM).,Unknown,Unknown,22497805,Peptides. 2012 Jun;35(2):269-275.,"Mechkarska M, Prajeep M, Coquet L, Leprince J, Jouenne T, Vaudry H, King JD, Conlon JM.",The hymenochirins: A family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).,,,,,,,,
4435,DRAMP18188,GILGKLWEGFKSIV,14,"Pantinin-1 (Non-disulfide-bridged peptide 4.20, NDBP-4.20, Non-disulfide-bridged peptide 5.21)",R4JNJ5, Belongs to the non-disulfide-bridged peptide (NDBP) superfamily.,Unknown,Pandinus imperator (Emperor scorpion),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Homology,Unknown,Unknown,Unknown,"Function: Amphipathic peptide that possesses relatively strong activities against Gram-positive bacteria and a fungus, but has very weak antimicrobial activities against Gram-negative bacteria. Also exhibits very low hemolytic activities against human erythrocytes.Forms an alpha-helical membrane channel in the prey.","[Ref.23624072]Gram-positive bacteria: S.aureus (MIC=8 μM), B.magaterium (MIC=32 μM), M.luteus (MIC=32 μM ), VRE (MIC=28 μM), MRSA (MIC=14 μM);##Gram-negative bacteria: E.coli (MIC=62 μM), P.putida (MIC >87 μM), K.oxytoca (MIC >87 μM), E.cloacae (MIC=76 μM), S.enterica (MIC=72 μM);##Fungus: C.tropicalis (MIC=16 μM).","[Ref.23624072]0% hemolytic activity at 16 μM, 0% hemolytic activity at 32 μM, 20% hemolytic activity at 64 μM against human red bood cells",Cell membrane,23624072##24184590,Peptides 45:28-34(2013)##Peptides 51:35-45(2014,"Zeng X.C., Zhou L., Shi W., Luo X., Zhang L., Nie Y., Wang J., Wu S.,Cao B., Cao H.##Almaaytah A., Albalas Q.",Three new antimicrobial peptides from the scorpion Pandinusimperator.##Scorpion venom peptides with no disulfide bridges: a review.,,,,,,,,
4443,DRAMP04684,NKPEALVDYTGVXNS,15,Bacteriocin BAC-IB17,C0HJE5,Unknown,Unknown,Bacillus subtilis,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Has bactericidal activity.
Miscellaneous: On the 2D-gel the determined pI of this protein is: 7.0, its MW is: 10.7 kDa.","Gram-positive bacteria: M. luteus, methicillin-resistant S. aureus, methicillin-sensitive S. aureus and B. stearothermophilus;##Gram- negative bacteria: E. coli, S. typhi.",Unknown,Unknown,PubMed ID is not available,Submitted (AUG-2013) to UniProtKB,"Ansari A, Siddiqui NN, Zohra RR, Aman A, Qader SA.","Isolation, purification and characterization of bacteriocin (BAC-IB17) produced from Bacillus subtilis KIBGE-IB17.",,,,,,,,
4451,DRAMP04700,DLWQFGKMILKVAGKLPFPYYGAYGCYCGWGGRGKPKDPTDRCCFVHDCC,50,"Basic phospholipase A2 BnpTX-1 (BnPTx-I, svPLA2; Phosphatidylcholine 2-acylhydrolase)",P0DM51,Belongs to the phospholipase A2 family (Group II subfamily D49 sub-subfamily).,Unknown,Bothrops pauloensis (Neuwied's lancehead) (Bothrops neuwiedipauloensis),"Antibacterial, Antiparasitic, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Snake venom phospholipase A2 (PLA2). In vitro, shows anticoagulant activity and induces cytotoxicity when tested on C2C12 myoblasts/myotubes. In vivo, when tested on mice, induces myotoxicity (intramuscular injection), edema (injection in the subplantar region) and lethality. Also induces neurotoxic effect on mouse neuromuscular preparations and has bactericidal activity on the Gram-negative bacteria E.coli (ATCC29648) and the Gram- positive S.aureus (ATCC 25923). The catalytic and anticoagulant activities of BnpTX-I are higher than those of BnpTX-II. PLA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.
Toxic Dose: LD(50) is 5.1 +/- 1.3 mg/kg by intraperitoneal injection into mice. LD(50) is 2.3 +/- 0.8 mg/kg by intravenous injection into mice.
Miscellaneous: Has a pI of approximately 7.8 and about 121 amino acids (PubMed:15302537).
PTM: Contains seven disulfide bonds.",Gram-negative bacterium: E. coli ATCC29648 and Gram-positive bacterium: S. aureus ATCC 25923.,Unknown,Unknown,15302537,Toxicon. 2004 Sep 1;44(3):305-314.,"Rodrigues VM, Marcussi S, Cambraia RS, de Araújo AL, Malta-Neto NR, Hamaguchi A, Ferro EA, Homsi-Brandeburgo MI, Giglio JR, Soares AM.",Bactericidal and neurotoxic activities of two myotoxic phospholipases A2 from Bothrops neuwiedi pauloensis snake venom.,,,,,,,,
4472,DRAMP18187,IWLTALKFLGKNLGKHLAKQQLAKL,25,Toxin LyeTx 1,C0HJU9,Unknown,Unknown,Lycosa erythrognatha (Spider) (Scaptocosa raptoria),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has hemolytic activity against rabbit erythrocytes. Forms pores in lipid bilayers in vitro; pore formation is reduced when cholesterol is present in the bilayers.,"[Ref.19946788]Gram-positive bacterium: S.aureus (MIC=3.79 μM);##Gram-negative bacterium: E.coli (MIC=7.81 μM);##Yeasts: C.krusei (MIC=26.3 μM), C.neoformans (MIC=13.2 μM).",[Ref.19946788]ED50=1.3 × 10-4 M against rabbit erythrocytes,Unknown,19946788,Amino Acids 39:135-144(2010),"Santos D.M., Verly R.M., Pilo-Veloso D., de Maria M.,de Carvalho M.A., Cisalpino P.S., Soares B.M., Diniz C.G.,Farias L.M., Moreira D.F., Frezard F., Bemquerer M.P., Pimenta A.M.,de Lima M.E.","LyeTx I, a potent antimicrobial peptide from the venom of the spiderLycosa erythrognatha.",,,,,,,,
4473,DRAMP18128,SGTSEKERESGRLLGVVKRLIVGFRSPFR,29,Antimicrobial peptide HsAp4; ,P0DMJ0,Unknown,Unknown,Heterometrus spinifer (Asia giant forest scorpion) (Malaysian blackscorpion),"Antimicrobial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,"Function: Possesses antimicrobial activity against both Gram- negative and Gram-positive bacteria, as well as against the fungus C. tropicaliS. Also possess a relatively high hemolytic activity (By similarity).","[Ref.23000095]Gram-positive bacteria: Staphylococcus aureus AB 94004 (MIC=23.6μM), Bacillus magaterium AB 90008 (MIC=11.8μM), Bacillus thuringiensis AB 93100 (MIC=46.5μM);##Gram-negative bacteria: Salmonella enterica AB 2010185 (MIC=25.0μM), E. coli DH5 (MIC=51.2μM), E. coli JM109 (MIC=50.4μM), Enterobacter cloacae subsp. cloacae AB 2010162 (MIC=47.9μM), Klebsiella oxytoca AB 2010143 (MIC=50.5μM);##Fungi: Candida tropicalis AY 91009 (MIC=48.6μM).","[Ref.23000095]5% hemolytic activity at 0.8 μM, 35% hemolytic activity at 1.6 μM, 95% hemolytic activity at 3.2 μM, 100% hemolytic activity against human red blood cells.",Unknown,23000095,Peptides 38:389-394 (2012).,"Nie Y., Zeng X.C. , Yang Y., Luo F., Luo X., Wu S. , Zhang L., Zhou J.",A novel class of antimicrobial peptides from the scorpionHeterometrus spinifer.,,,,,,,,
4474,DRAMP18129,SGTPEKERESGRLLGVVKRYIVCVRNPCP,29,Antimicrobial peptide HsAp3; ,P0DMI9,Unknown,Unknown,Heterometrus spinifer (Asia giant forest scorpion) (Malaysian blackscorpion),"Antimicrobial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,"Function: Possesses antimicrobial activity against both Gram- negative and Gram-positive bacteria, as well as against the fungus C. tropicali. Also possess a relatively high hemolytic activity (By similarity).","[Ref.23000095]Gram-positive bacteria: Staphylococcus aureus AB 94004 (MIC=23.6μM), Bacillus magaterium AB 90008 (MIC=11.8μM), Bacillus thuringiensis AB 93100 (MIC=46.5μM);##Gram-negative bacteria: Salmonella enterica AB 2010185 (MIC=25.0μM), E. coli DH5 (MIC=51.2μM), E. coli JM109 (MIC=50.4μM), Enterobacter cloacae subsp. cloacae AB 2010162 (MIC=47.9μM), Klebsiella oxytoca AB 2010143 (MIC=50.5μM);##Fungi: Candida tropicalis AY 91009 (MIC=48.6μM).","[Ref.23000095]5% hemolytic activity at 0.8 μM, 35% hemolytic activity at 1.6 μM, 95% hemolytic activity at 3.2 μM, 100% hemolytic activity against human red blood cells.",Unknown,23000095,Peptides 38:389-394 (2012).,"Nie Y., Zeng X.C. , Yang Y., Luo F., Luo X., Wu S. , Zhang L., Zhou J.",A novel class of antimicrobial peptides from the scorpionHeterometrus spinifer.,,,,,,,,
4475,DRAMP18130,SGTSEKERESERLLGVVNPLIKCFRSPCP,29,Antimicrobial peptide HsAp2,P0DMI8,Unknown,Unknown,Heterometrus spinifer (Asia giant forest scorpion) (Malaysian blackscorpion),"Antimicrobial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,"Function: Possesses antimicrobial activity against both Gram- negative and Gram-positive bacteria, as well as against the fungus C. tropicaliS. Also possess a relatively high hemolytic activity (By similarity).","[Ref.23000095]Gram-positive bacteria: Staphylococcus aureus AB 94004 (MIC=23.6μM), Bacillus magaterium AB 90008 (MIC=11.8μM), Bacillus thuringiensis AB 93100 (MIC=46.5μM);##Gram-negative bacteria: Salmonella enterica AB 2010185 (MIC=25.0μM), E. coli DH5 (MIC=51.2μM), E. coli JM109 (MIC=50.4μM), Enterobacter cloacae subsp. cloacae AB 2010162 (MIC=47.9μM), Klebsiella oxytoca AB 2010143 (MIC=50.5μM);##Fungi: Candida tropicalis AY 91009 (MIC=48.6μM).","[Ref.23000095]5% hemolytic activity at 0.8 μM, 35% hemolytic activity at 1.6 μM, 95% hemolytic activity at 3.2 μM, 100% hemolytic activity against human red blood cells.",Unknown,23000095,Peptides 38:389-394 (2012).,"Nie Y., Zeng X.C. , Yang Y., Luo F., Luo X., Wu S. , Zhang L., Zhou J.",A novel class of antimicrobial peptides from the scorpionHeterometrus spinifer.,,,,,,,,
4476,DRAMP18131,SGTSEKERESGRLLGVVKRLIVCFRSPFP,29,Antimicrobial peptide HsAp1 (HsAp),P0DMI7,Unknown,Unknown,Heterometrus spinifer (Asia giant forest scorpion) (Malaysian blackscorpion),"Antimicrobial, Antifungal, Anti-Gram+, Anti-Gram-, ",Transcript level,Unknown,Unknown,Unknown,Function: Possesses antimicrobial activity against both Gram- negative and Gram-positive. Also possess a relatively high hemolytic activity.,"[Ref.23000095]Gram-positive bacteria: Staphylococcus aureus AB 94004 (MIC=23.6μM), Bacillus magaterium AB 90008 (MIC=11.8μM), Bacillus thuringiensis AB 93100 (MIC=46.5μM);##Gram-negative bacteria: Salmonella enterica AB 2010185 (MIC=25.0μM), E. coli DH5 (MIC=51.2μM), E. coli JM109 (MIC=50.4μM), Enterobacter cloacae subsp. cloacae AB 2010162 (MIC=47.9μM), Klebsiella oxytoca AB 2010143 (MIC=50.5μM);##Fungi: Candida tropicalis AY 91009 (MIC=48.6μM).","[Ref.23000095]5% hemolytic activity at 0.8 μM, 35% hemolytic activity at 1.6 μM, 95% hemolytic activity at 3.2 μM, 100% hemolytic activity against human red blood cells.",Unknown,23000095,Peptides 38:389-394 (2012).,"Nie Y., Zeng X.C. , Yang Y., Luo F., Luo X., Wu S. , Zhang L., Zhou J.",A novel class of antimicrobial peptides from the scorpionHeterometrus spinifer.,,,,,,,,
4485,DRAMP18185,FLPLFLPKIICVITKKC,17,Jingdongin-1,K7ZGS2, Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Unknown,Amolops jingdongensis (Chinese torrent frog),"Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Has activity against Gram- negative bacterium and exhibits hemolytic activity. ,"[Ref.22828809]Gram-negative bacterium: B.dysenteriae (MIC=35 μg/ml);##Gram-positive bacteria: S.aureus ATCC 2592 (MIC=4.7 μg/ml), B.subtilis ATCC 6633 (MIC=9.38 μg/ml);##Fungus: C.albicans (MIC=18.75 μg/ml)","[Ref.22828809]1.32% hemolytic activity at 25 μg/ml, 5.37% hemolytic activity at 50 μg/ml, 6.35% hemolytic activity at 100 μg/ml, 16.55% hemolytic activity at 200 μg/ml against rabbit red blood cells",Unknown,22828809,Amino Acids 44:481-487(2013),"He X., Yang S., Wei L., Liu R., Lai R., Rong M.","Antimicrobial peptide diversity in the skin of the torrent frog,Amolops jingdongensis.",,,,,,,,
4526,DRAMP18449,AVNIPFKVHLRCKAAFC,17,"Kunitzin-OS (amphibians, animals)",Not Entry found,Unknown,Unknown,"Chinese frog, Odorrana schmackeri","Antibacterial, Enzyme inhibitor, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,Gram-negative bacteria: E. coli (MIC 20 uM).,Unknown,Unknown,27311856,Biochem Biophys Res Commun. 2016 Aug 19;477(2):302-9.,"Chen X, Wang H, Shen Y, Wang L, Zhou M, Chen T, Shaw C.",Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs,,,,,,,,
4527,DRAMP18450,AAKIILNPKFRCKAAFC,17,"Kunitzin-RE (amphibians, animals)",Not Entry found,Unknown,Unknown,"European frog, Rana esculenta","Antibacterial, Enzyme inhibitor, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Fuction: A change of the last K to F reduced activity (MIC 160 uM). ,Gram-negative bacteria: E. coli (MIC 30 uM).,Unknown,Unknown,27311856,Biochem Biophys Res Commun. 2016 Aug 19;477(2):302-9.,"Chen X, Wang H, Shen Y, Wang L, Zhou M, Chen T, Shaw C.",Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs,,,,,,,,
4531,DRAMP18454,FLPVIAGVLSKLF,13,"Tepmporin-1Ee (frog, amphibians, animals)",Not Entry found,Unknown,Unknown,"skin secretion, the European edible frog, Pelophylax kl. esculentus, Europe.","Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Fuction: It showed no hemolytic activity at 10 μM.,[Ref.27255993]Gram-positive bacteria: S. aureus (MIC= 10 μM);##Gram-negative bacteria: E. coli (MIC= 40 μM),[Ref.27255993]Non-hemolytic activity at 10 μM,Unknown,27255993,Biochem Biophys Res Commun. 2016 Aug 5;476(4):566-73.,"Chen X, Wang H, Yang M, Wang L, Zhou M, Chen T, Shaw C.","Identification and bioactivity evaluation of two novel temporins from the skin secretion of the European edible frog, Pelophylax kl. esculentus.",,,,,,,,
4533,DRAMP18456,FSLIPSAIGGLISA,18,"Pepcon (peptide consensus sequence, synthetic)",Not Entry found,Unknown,Unknown,Designed based on sequence alignment with scorpion linear peptides,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,No comments found on DRAMP database,"Gram-positive bacteria: S. epidermidis ATCC 12228 (MIC 7.5 uM),S. aureus (5 uM);##Gram-negative bacteria: E. coli ATCC 25922 (MIC 50 uM), S. enterica ATCC 10708 (60 uM), P. aeruginosa ATCC 27853 (40uM), A. baumannii ATCC 19606 (MIC 20 uM),K. pneumoniae (60 uM).",Unknown,Unknown,28096686,Infect Drug Resist. 2016 Dec 29;10:1-17.,"Almaaytah A, Ajingi Y, Abualhaijaa A, Tarazi S, Alshar'i N, Al-Balas Q",Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides.,,,,,,,,
4538,DRAMP18471,KKLALKALLLWLKALLKLAKLALKK,25,D-LAK60,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC>22.62 μM), Escherichia coli Top 10 (MIC=7.07±2.04 M), Pseudomonas aeruginosa (MIC>22.62 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4539,DRAMP18472,KKLALKALKLWLLALLKLAKLALKK,25,D-LAK80,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC>22.62 μM), Escherichia coli Top 10 (MIC=5.40±1.01 μM), Pseudomonas aeruginosa (MIC>22.62 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4540,DRAMP18473,KKLALKALKLWLLALKKLALLALKK,25,D-LAK100,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=4.14±1.03 μM), Escherichia coli Top 10 (MIC=1.51±0.23 M), Pseudomonas aeruginosa (MIC=7.92±2.06 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4541,DRAMP18474,KKLAKLALLKWLLALKKLALLALKK,25,D-LAK140,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=3.14±1.28 μM), Escherichia coli Top 10 (MIC=0.76±0.18 M), Pseudomonas aeruginosa (MIC=4.69±0.67 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4542,DRAMP18475,KKLAKLALLKWLLALKLLALKALKK,25,D-LAK160,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Peptides comprising all D-amino acids.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=3.85±0.64 μM), Escherichia coli Top 10 (MIC=1.49±0.56 μM), Pseudomonas aeruginosa (MIC=6.23±0.71 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4543,DRAMP18476,KKLAKALKLLALLWLKLAKALKKA,24,LAK80,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=13.05±0.13 μM),Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4544,DRAMP18477,KKLAKAPKLLALLWLKLAKALKKA,24,LAK80-P7,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=2.97±0.15 μM), Escherichia coli Top 10 (MIC=1.26±0.49 μM), Pseudomonas aeruginosa (MIC=2.13±0.77 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4545,DRAMP18478,KKLAKALKLPALLWLKLAKALKKA,24,LAK80-P10,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.62±0.17 μM), Escherichia coli Top 10 (MIC=0.82±0.03 μM), Pseudomonas aeruginosa (MIC=1.18±0.53 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4546,DRAMP18479,KKLAKALKLLAPLWLKLAKALKKA,24,LAK80-P12,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.80±0.27 μM), Escherichia coli Top 10 (MIC=0.80±0.01 μM), Pseudomonas aeruginosa (MIC=0.86±0.09 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4547,DRAMP18480,KKLALALKKLALLWKKLALALKKA,24,LAK120,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=2.95±0.06 μM), Escherichia coli Top 10 (MIC=1.47±0.64 μM), Pseudomonas aeruginosa (MIC=4.20±0.92 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4548,DRAMP18481,KKLALAPKKLALLWKKLALALKKA,24,LAK120-P7,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.80±0.03 μM), Escherichia coli Top 10 (MIC=0.45±0.10 μM), Pseudomonas aeruginosa (MIC=4.45±0.19 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4549,DRAMP18482,KKLALALKKPALLWKKLALALKKA,24,LAK120-P10,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.78±0.01 μM), Escherichia coli Top 10 (MIC=0.47±0.15 μM), Pseudomonas aeruginosa (MIC=9.16±1.43 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4550,DRAMP18483,KKLALALKKLAPLWKKLALALKKA,24,LAK120-P12,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.97±0.06 μM), Escherichia coli Top 10 (MIC=0.68±0.14 μM), Pseudomonas aeruginosa (MIC=2.14±0.53 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4551,DRAMP18484,KKLKLALAKLALLWKALALKLKKA,24,LAK160,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.11±0.48 μM), Escherichia coli Top 10 (MIC=0.73±0.40 μM), Pseudomonas aeruginosa (MIC=2.23±0.41 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4552,DRAMP18485,KKLKLAPAKLALLWKALALKLKKA,24,LAK160-P7,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.79±0.41 μM), Escherichia coli Top 10 (MIC=0.46±0.11 μM), Pseudomonas aeruginosa (MIC=2.98±0.21 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4553,DRAMP18486,KKLKLALAKPALLWKALALKLKKA,24,LAK160-P10,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=2.22±0.63 μM), Escherichia coli Top 10 (MIC=0.45±0.24 μM), Pseudomonas aeruginosa (MIC=4.14±0.23 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4554,DRAMP18487,KKLKLALAKLAPLWKALALKLKKA,24,LAK160-P12,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=0.48±0.20 μM), Escherichia coli Top 10 (MIC=0.38±0.08 μM), Pseudomonas aeruginosa (MIC=1.69±0.09 μM)",Unknown,Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides.",,,,,,,,
4555,DRAMP18488,FFGSLLSLGSKLLPSVFKLFQRKKE,25,"Css54 (Css from the species name below; scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)",P0DL41,Unknown,Unknown,Centruroides suffusus (Mexican scorpion),"Antibacterial, Cytolysis, Hemolysis, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Amphipathic peptide that shows antibacterial activity against Escherichia coli and Staphylococcus aureus. Increases efficacy of antibiotics when tested against S.aureus, probably by facilitating their incorporation into the bacteria. Has hemolytic activity against human erythrocytes.",[Ref.23093034]Gram-positive bacterium: Staphylococcus aureus (MIC=12.5 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=12.5 μg/ml).,"[Ref.23093034]30% hemolytic activity at 9 μM, 67% hemolytic activity at 17 μM against human erythrocytes",Unknown,23093034,J Antibiot (Tokyo). 2013 Jan;66(1):3-10.,"Garcia F, Villegas E, Espino-Solis GP, Rodriguez A, Paniagua-Solis JF, Sandoval-Lopez G, Possani LD, Corzo G.",Antimicrobial peptides from arachnid venoms and their microbicidal activity in the presence of commercial antibiotics.,,,,,,,,
4561,DRAMP02751,GRPNPVNNKPTPHPRL,16,"Formaecin-1 (Pro-rich; ants, insects, animals)",P81438,Unknown,Unknown,Myrmecia gulosa (Red bulldog ant),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Rich,Unknown,Unknown,"Function: Antibacterial activity against E.coli but none against other Gram-negative bacteria and Gram-positive bacteria.
Induction: By bacterial infection.
PTM: O-linked glycan consists of a Gal-GalNAc disaccharide, O-glycosylation is essential for full biological activity.","[Ref.9497332] Gram-negative bacteria: Escherichia coli NCTC 8196, Escherichia coli BLR.",Unknown,Unknown,9497332,J Biol Chem. 1998 Mar 13;273(11):6139-6143.,"Mackintosh JA, Veal DA, Beattie AJ, Gooley AA.",Isolation from an ant Myrmecia gulosa of two inducible O-glycosylated proline-rich antibacterial peptides.,,,,,,,,
4562,DRAMP02752,GRPNPVNTKPTPYPRL,16,"Formaecin-2 (Pro-rich; ants, insects, animals)",P81437 ,Unknown,Unknown,Myrmecia gulosa (Red bulldog ant),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Rich,Unknown,Unknown,"Function: Antibacterial activity against E.coli but none against other Gram-negative bacteria and Gram-positive bacteria.
Induction: By bacterial infection.
PTM: O-linked glycan consists of a Gal-GalNAc disaccharide, O-glycosylation is essential for full biological activity.","[Ref.9497332] Gram-negative bacteria: Escherichia coli NCTC 8196, Escherichia coli BLR.",Unknown,Unknown,9497332,J Biol Chem. 1998 Mar 13;273(11):6139-6143.,"Mackintosh JA, Veal DA, Beattie AJ, Gooley AA.",Isolation from an ant Myrmecia gulosa of two inducible O-glycosylated proline-rich antibacterial peptides.,,,,,,,,
4564,DRAMP03575,FKRIVQRIKDFLR,13,"LL-37(17-29) (C-terminal fragment of LL-37, LL; Human, mammals, animals)",P49913,Belongs to truncated LL-37.,Unknown,Homo sapiens,"Antibacterial, Anticancer, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix,Unknown,2FBS resolved by NMR.,"Function: LL-37(17-29) became slightly less active than the longer ones, indicating that the truncated hydrophobic residues L31 and V32 also play a role in interaction with human cells. Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.","[Ref.16637646] Gram-negative bacterium: Escherichia coli K12(MIC=40 μM);##Drug-resistant KBv cancer cells (LC50=60 μM), Drug-sensitive KB cancer cells (LC50=57 μM).##[Ref.28178190]Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=16 μM), S. faecalis ATCC 29212 (MIC=32 μM), Bacillus subtilis CMCC 63501 (MIC=16 μM), Staphylococcus epidermidis ATCC 12228 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16 μM), Escherichia coli UB 1005 (MIC=16 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Pseudomonas aeruginosa PAO1 (MIC=16 μM), Salmonella typhimurium ATCC 14028 (MIC=32 μM), Salmonella typhimurium ATCC 7731 (MIC=16 μM).",Unknown,Unknown,16637646##28178190,J Am Chem Soc. 2006 May 3;128(17):5776-5785.##Int J Mol Sci. 2017 Feb 6;18(2). pii: E339. ,"Li X, Li Y, Han H, Miller DW, Wang G. ##Tan T, Wu D, Li W, Zheng X, Li W, Shan A.",Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. ##High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7.,,,,,,,,
4566,DRAMP02094,FLPAIAGVAAKFLPKIFCAISKKC,24,"Brevinin-1Bd (Frogs, amphibians, animals)",P82836,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana berlandieri (Rio Grande leopard frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=3 μM);##Gram-negative bacterium: Escherichia coli (MIC=7 μM).##Yeast: Candida albicans (MIC=7 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
4567,DRAMP02095,FLPAIVGAAAKFLPKIFCVISKKC,24,"Brevinin-1Be (Frogs, amphibians, animals)",P82837,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana berlandieri (Rio Grande leopard frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial activity against  Gram-positive and Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=3 μM);##Gram-negative bacterium: Escherichia coli (MIC=15 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
4568,DRAMP02096,FLPFIAGMAANFLPKIFCAISKKC,24,"Brevinin-1Bf (Frogs, amphibians, animals)",P82838,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana berlandieri (Rio Grande leopard frog),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antibacterial activity against  Gram-positive and Gram-negative bacteria.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=8 μM);##Gram-negative bacterium: Escherichia coli (MIC=19 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
4569,DRAMP02097,FLPIIAGVAAKVFPKIFCAISKKC,24,"Brevinin-1Pa (Frogs, amphibians, animals)",P82841,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana pipiens (Northern leopard frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=7 μM);##Gram-negative bacterium: Escherichia coli (MIC=14 μM).##Yeast: Candida albicans (MIC=5 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
4570,DRAMP02098,FLPIIASVAAKVFSKIFCAISKKC,24,"Brevinin-1Pc (Frogs, amphibians, animals)",P82843,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana pipiens (Northern leopard frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=7 μM);##Gram-negative bacterium: Escherichia coli (MIC=5 μM).##Yeast: Candida albicans (MIC=7 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
4571,DRAMP02099,FLPIIASVAANVFSKIFCAISKKC,24,"Brevinin-1Pd (Frogs, amphibians, animals)",P82844,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana pipiens (Northern leopard frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against the Gram-positive, Gram-negative bacteria and fungi.
Tissue specificity: Expressed by the skin glands.",[Ref.10651828]Gram-positive bacterium: Staphylococcus aureus (MIC=27 μM);##Gram-negative bacterium: Escherichia coli (MIC=78 μM).##Yeast: Candida albicans (MIC=29 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
4572,DRAMP02255,GILSSIKGVAKGVAKNVAAQLLDTLKCKITGC,32,"Ranatuerin-2Lb (Ranatuerin 2Lb; Ranaturin-2PRd; Frogs, amphibians, animals)",P82829,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana luteiventris (Spotted frog) (Rana pretiosa),"Antimicronial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.",[Ref.10651828] Gram-positive bacterium: Staphylococcus aureus (MIC=4 μM);##Gram-negative bacterium: Escherichia coli (MIC=4 μM);##Yeast: Candida albicans (MIC=62 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
4573,DRAMP02254,GILDSFKGVAKGVAKDLAGKLLDKLKCKITGC,32,"Ranatuerin-2La (Ranatuerin 2La; Ranatuerin-2PRa; Frogs, amphibians, animals)",P82828,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana luteiventris (Spotted frog) (Rana pretiosa),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,[Ref.10651828] Gram-positive bacterium: Staphylococcus aureus (MIC=11 μM);##Gram-negative bacterium: Escherichia coli (MIC=4 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
4574,DRAMP02256,GLLDTIKGVAKTVAASMLDKLKCKISGC,28,"Ranatuerin-2B (Ranatuerin 2B, Frog, amphibians, animals)",P82840 ,Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana berlandieri (Rio Grande leopard frog) (Rana luteiventris),"Antimicronial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.",[Ref.10651828] Gram-positive bacterium: Staphylococcus aureus (MIC=2 μM);##Gram-negative bacterium: Escherichia coli (MIC=2 μM);##Yeast: Candida albicans (MIC=35 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
4575,DRAMP02257,LMDTVKNVAKNLAGHMLDKLKCKITGC,27,"Ranatuerin-2P (Ranatuerin 2P; Frogs, amphibians, animals)","Q8QFQ4, P82847",Belongs to the frog skin active peptide family (Brevinin subfamily),Unknown,Rana pipiens (Northern leopard frog),"Antimicronial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.",[Ref.10651828] Gram-positive bacteria: Staphylococcus aureus (MIC=50 μM);##Gram-negative bacterium: Escherichia coli (MIC=13 μM);##Yeast: Candida albicans (MIC=67 μM).,Unknown,Unknown,10651828,Eur J Biochem. 2000 Feb;267(3):894-900.,"Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, Conlon JM.","Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",,,,,,,,
4577,DRAMP18497,WKSDVRRWRSRY,12,TSG-6 (Ixosin-B peptide derivative),No entry found,Derived from Ixosin-B,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity,","[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC>100 μM);##Gram-negative bacteria: Escherichia coli (MIC=64 μM), Pseudomonas aeruginosa (MIC>100 μM)",[Ref.23570790]0.3±0.9% hemolysis at 100μM against human red blood cells.,Unknown,23570790,Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.,"Wu YS, Liao ZJ, Wang KS, Lung FD.",Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.,,,,,,,,
4578,DRAMP18498,WKSYVRRWRSRY,12,TSG-7 (Ixosin-B peptide derivative),No entry found,Derived from Ixosin-B,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive  and Gram-negative bacteria. Has hemolytic activity,"[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC=32 μM);##Gram-negative bacteria: Escherichia coli (MIC=16 μM), Pseudomonas aeruginosa (MIC=100 μM)",[Ref.23570790]1.5±1.4% hemolysis at 100μM against human red blood cells.,Unknown,23570790,Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.,"Wu YS, Liao ZJ, Wang KS, Lung FD.",Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.,,,,,,,,
4579,DRAMP18499,WKSYVRRWRSR,11,TSG-8 (Ixosin-B peptide derivative),No entry found,Derived from Ixosin-B,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC=32 μM);##Gram-negative bacteria: Escherichia coli (MIC=16 μM), Pseudomonas aeruginosa (MIC>100 μM)",[Ref.23570790]-1.2±2.6% hemolysis at 100μM against human red blood cells.,Unknown,23570790,Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.,"Wu YS, Liao ZJ, Wang KS, Lung FD.",Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.,,,,,,,,
4580,DRAMP18500,WWSYVRRWRSR,11,TSG-8-1 (Ixosin-B peptide derivative),No entry found,Derived from Ixosin-B,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC=8 μM);##Gram-negative bacteria: Escherichia coli (MIC=16 μM), Pseudomonas aeruginosa (MIC>100 μM)",[Ref.23570790]3.4±1.3% hemolysis at 100μM against human red blood cells.,Unknown,23570790,Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.,"Wu YS, Liao ZJ, Wang KS, Lung FD.",Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.,,,,,,,,
4581,DRAMP18501,WKSYVRRWRS,10,TSG-9 (Ixosin-B peptide derivative),No entry found,Derived from Ixosin-B,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC>100 μM);##Gram-negative bacteria: Escherichia coli (MIC=64 μM), Pseudomonas aeruginosa (MIC>100 μM)",[Ref.23570790]-0.4±0.5% hemolysis at 100μM against human red blood cells.,Unknown,23570790,Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.,"Wu YS, Liao ZJ, Wang KS, Lung FD.",Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.,,,,,,,,
4582,DRAMP18502,WKSYVRRWR,9,TSG-10 (Ixosin-B peptide derivative),No entry found,Derived from Ixosin-B,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC=64 μM);##Gram-negative bacteria: Escherichia coli (MIC=64 μM), Pseudomonas aeruginosa (MIC>100 μM)",[Ref.23570790]1.1±1.3% hemolysis at 100μM against human red blood cells.,Unknown,23570790,Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.,"Wu YS, Liao ZJ, Wang KS, Lung FD.",Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.,,,,,,,,
4583,DRAMP18503,WKSYVRRW,8,TSG-11 (Ixosin-B peptide derivative),No entry found,Derived from Ixosin-B,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.23570790]Gram-positive bacteria: Staphylococcus aureus (MIC=100 μM);##Gram-negative bacteria: Escherichia coli (MIC=64 μM), Pseudomonas aeruginosa (MIC>100 μM)",[Ref.23570790]2.0±0.3% hemolysis at 100μM against human red blood cells.,Unknown,23570790,Bioorg Med Chem Lett. 2013 May 15;23(10):2929-32.,"Wu YS, Liao ZJ, Wang KS, Lung FD.",Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.,,,,,,,,
4584,DRAMP18504,FSEAIKKIIDFLGEGLFDIIKKIAESF,27,E(AU)2 (Aurein 1.2 peptide derivative),No entry found,Derived from Aurein 1.2,Unknown,Litoria raniformis (Southern bell frog),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Coiled coil,Unknown,Unknown,"Function: Antibacterial activity against Gram-negative bacteria, E(AU)2 has no hemolytic activity",[Ref.23519707]Gram-negative bacterium: Escherichia coli (MIC=128 μmol/L),"[Ref.23519707]~5% hemolysis at 128μmol/L, 0% hemolysis at 4 -32μmol/L against human red blood cells.",Unknown,23519707,Amino Acids. 2013 Jun;44(6):1521-8.,"Lorenzón EN, Sanches PR, Nogueira LG, Bauab TM, Cilli EM.","Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of Candida albicans cells",,,,,,,,
4585,DRAMP18505,GLFDIIKKIAESFKFSEAIKKIIDFLG,27,(AU)2K (Aurein 1.2 peptide derivative),No entry found,Derived from Aurein 1.2,Unknown,Litoria raniformis (Southern bell frog),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Alpha helix ,Unknown,Unknown,"Function: Antibacterial activity against Gram-negative bacteria, Has hemolytic activity.",[Ref.23519707]Gram-negative bacterium: Escherichia coli (MIC=128 μmol/L),"[Ref.23519707]~30% hemolysis at 32μmol/L, 10% hemolysis at 4 μmol/L against human red blood cells.",Unknown,23519707,Amino Acids. 2013 Jun;44(6):1521-8.,"Lorenzón EN, Sanches PR, Nogueira LG, Bauab TM, Cilli EM","Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of Candida albicans cells",,,,,,,,
4586,DRAMP18506,KKFFLKVLTKIRCKVAGGCRT,21,OG2 (Palustrin-OG1 peptide derivative),No entry found,Derived from Palustrin-OG1,Unknown,Synthetic construct (Modified Palustrin-OG1),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Antibacterial activity against Gram-positive, Gram-negative bacteria, and lower hemolytic activity than OG1.","[Ref.22670762]Gram-positive bacteria: Bacillus subtilis 1A751 (MIC=128 μg/mL), Staphylococcus aureus ATCC25923 (MIC=8 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC25922 (MIC=8 μg/mL),Salmonella choleraesuis CMCC50020 (MIC=16 μg/mL)",[Ref.22670762]7%±2% hemolysis at 2-256 μg/mL against porcine red blood cells.,Unknown,22670762,Protein Pept Lett. 2013 Jan;20(1):54-60.,"Xie YG, Luan C, Zhang HW, Han FF, Feng J, Choi YJ, Groleau D, Wang YZ.",Effects of thioredoxin: SUMO and intein on soluble fusion expression of an antimicrobial peptide OG2 in Escherichia coli.,,,,,,,,
4587,DRAMP18508,KFAKKFKWFAKAAFKFFKK,19,gp41w-FKA (gp41 peptide derivative),No entry found,"Derived from the HIV glycoprotein, gp41",Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,"gp41w-FKA peptide to adopt a helical conformation in the cosolvent mixture of chloroform, methanol and water. The peptide formed a very well defined ",Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.23019445]Gram-positive bacterium: Staphylococcus aureus (MIC<10 μg/ml, MBC=20-30 μg/ml);##Gram-negative bacterium: Escherichia coli (MIC=10-30 μg/ml, MBC=40-50 μg/ml)",[Ref.23019445]EC50=195 μg/mL against human red blood cells.,gp41w-FKA binds at the interfacial region of a phospholipid bilayer.,23019445,Beilstein J Org Chem. 2012;8:1172-84. Epub 2012 Jul 24.,"Haney EF, Nguyen LT, Schibli DJ, Vogel HJ.","Design of a novel tryptophan-rich membrane-active antimicrobial peptide from the membrane-proximal region of the HIV glycoprotein, gp41.",,,,,,,,
4588,DRAMP18509,MAFKKLEKVGRNIRDGIIKAGPAVAVIGQATSIARPTGK,39,Px-cec1 (cecropin1 peptide derivative),No entry found,Derived from the cecropin1,cecropin1,Diamondback moth(Plutella xylostella),"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive, Gram-negative bacteria and fungi. No hemolytic activity.","[Ref.22921836]Gram-positive bacteria: Staphylococcus aureus
 (MIC=2.1 μg/mL), Bacillus cereus (MIC=2.6 μg/mL);##Gram-negative bacteria: Escherichia coli K12D31 (MIC=0.1 μg/mL), Escherichia coli K12 (MIC=0.23 μg/mL), Pseudomonas fluorescent (MIC=1.1 μg/mL), Salmonella choleraesuis (MIC=2.1 μg/mL);##Fungi: Aureobasidium pullulans (MIC=4.0 μg/mL), Aspergillus flavus (MIC=14.5 μg/mL), Aspergillus fumigatus (MIC=16.0 μg/mL), Aspergillus niger (MIC=14.6 μg/mL), Fusarium oxysporum (MIC=8.0 μg/mL)",[Ref.22921836]Non-hemolytic against human red blood cells.,Unknown,22921836,Protein Expr Purif. 2012 Oct;85(2):230-8.,"Jin F, Sun Q, Xu X, Li L, Gao G, Xu Y, Yu X, Ren S.","cDNA cloning and characterization of the antibacterial peptide cecropin 1 from the diamondback moth, Plutella xylostella L.",,,,,,,,
4589,DRAMP18510,KKLALLALKKWLLALKKLALLALKK,25,D-LAK120,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.,"[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.48±0.53 μM), Escherichia coli Top 10 (MIC=0.62±0.15 μM), Pseudomonas aeruginosa (MIC=2.71±1.07 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=1.95±0.08 μM)",[Ref.22869378]HC50=4.06±1.30 μM against Unknown (The literature does not mention),Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ",,,,,,,,
4590,DRAMP18511,KKLALLALKKWLPALKKLALLALKK,25,D-LAK120-P13,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.,"[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.54±0.97 μM), Escherichia coli Top 10 (MIC=0.58±0.18 μM), Pseudomonas aeruginosa (MIC=1.42±0.41 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=0.88±0.08 μM), Plasmodium falciparum C10 (EC50=2.18±0.41 μM), A549 (EC50=2.44±0.43 μM), RAW264.7 (EC50=3.80±0.34 μM)",[Ref.22869378]HC50=11.66±0.03 μM against Unknown (The literature does not mention),Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ",,,,,,,,
4591,DRAMP18512,KKLALALAKKWLALAKKLALALAKK,25,D-LAK120-A,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.,"[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.23±0.47 μM), Escherichia coli Top 10 (MIC=0.38±0.21 μM), Pseudomonas aeruginosa (MIC=1.83±0.63 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=1.45±0.12 μM), Plasmodium falciparum C10 (EC50=2.13±0.14 μM), A549 (EC50=5.23±0.35 μM), RAW264.7 (EC50=7.31±2.13 μM)",[Ref.22869378]HC50=17.42±2.17 μM against Unknown (The literature does not mention),Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ",,,,,,,,
4592,DRAMP18513,KKLALALAKKWLPLAKKLALALAKK,25,D-LAK120-AP13,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.,"[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.08±0.62 μM), Escherichia coli Top 10 (MIC=0.29±0.09 μM), Pseudomonas aeruginosa (MIC=1.22±0.19 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=0.88±0.06 μM), Plasmodium falciparum C10 (EC50=2.36±0.10 μM), A549 (EC50=3.11±0.57 μM), RAW264.7 (EC50=3.42±0.16 μM)",[Ref.22869378]HC50=58.61±10.41 μM against Unknown (The literature does not mention),Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ",,,,,,,,
4593,DRAMP18514,KKLALHALKKWLHALKKLAHLALKK,25,D-LAK120-H ,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Antiplasmodial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Antiplasmodial activity. Peptides comprising all D-amino acids. Has hemolytic activity.,"[Ref.22869378]Gram-negative bacteria: Escherichia coli NCTC 9001 (MIC=1.54±0.01 μM), Escherichia coli Top 10 (MIC=0.40±0.01 μM), Pseudomonas aeruginosa (MIC=1.35±0.07 μM);##Plasmodium: Plasmodium falciparum 3D7 (EC50=1.26±0.14 μM), Plasmodium falciparum C10 (EC50=4.43±0.33 μM), A549 (EC50=4.54±0.30 μM), RAW264.7 (EC50=5.21±0.57 μM)",[Ref.22869378]HC50=20.29±2.42 μM against Unknown (The literature does not mention),Unknown,22869378,J Biol Chem. 2012 Oct 5;287(41):34120-33.,"Vermeer LS, Lan Y, Abbate V, Ruh E, Bui TT, Wilkinson LJ, Kanno T, Jumagulova E, Kozlowska J, Patel J, McIntyre CA, Yam WC, Siu G, Atkinson RA, Lam JK, Bansal SS, Drake AF, Mitchell GH, Mason AJ.","Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic ",,,,,,,,
4594,DRAMP18515,KWKSFLKTFKSLKKTVLHTLLKAISS,26,A12L/A20L (V13KL peptide derivative),No entry found,Derived from the framework peptide V13KL,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. A12L/A20L against HeLa cells. Leucine to replace Alanine at the position 12 and 20 on the peptide V13KL. Has hemolytic activity.,"[Ref.17158938]Gram-negative bacteria: Pseudomonas aeruginosa PAO1(MIC=62.5 μg/ml), Pseudomonas aeruginosa WR5 (MIC=125 μg/ml), Pseudomonas aeruginosa PAK (MIC=62.5 μg/ml), Pseudomonas aeruginosa PA14 (MIC=125 μg/ml), Pseudomonas aeruginosa M2 (MIC=62.5 μg/ml), Pseudomonas aeruginosa CP204 (MIC=62.5 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=78.7 μg/ml).##[Ref.22837667]Cancer cell: HeLa cell (IC50=1.71±0.07 μmol/L).","[Ref.22837667]MHC=8.0 μg/ml, MHC=5.20±0.02 μmol/L against human red blood cells",Unknown,17158938##22837667,Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.##Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.,"Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.##Huang YB, He LY, Jiang HY, Chen YX.",Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.##Role of helicity on the anticancer mechanism of action of cationic-helical peptides.,,,,,,,,
4595,DRAMP18533,KWKSFLKTFKSAKKTVLHTALKAISS,26,V13KL (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Lysine replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=64.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=64.0 μg/ml), Staphylococcus epidermidis C621 (MIC=5.0 μg/ml), Bacillus subtilis C971 (MIC=1.6 μg/ml), Enterococcus faecalis C625 (MIC=64.0 μg/ml), Corynebacterium xerosis C875 (MIC=1.3 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=11.8 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=2.5 μg/ml), Escherichia coli DC2 (MIC=1.6 μg/ml), Salmonella typhimurium C587 (MIC=4.0 μg/ml), Salmonella typhimurium C610 (MIC=1.3 μg/ml), Pseudomonas aeruginosa H187 (MIC=8.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=5.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=3.1 μg/ml).##[Ref.17158938]Gram-negative bacteria: Pseudomonas aeruginosa PAO1(MIC=31.3 μg/ml), Pseudomonas aeruginosa WR5 (MIC=250 μg/ml), Pseudomonas aeruginosa PAK (MIC=125 μg/ml), Pseudomonas aeruginosa PA14 (MIC=62.5 μg/ml), Pseudomonas aeruginosa M2 (MIC=31.3 μg/ml), Pseudomonas aeruginosa CP204 (MIC=7.8 μg/ml), The geometric mean of MIC values above six Pseudomonas aeruginosa strains (MIC=49.6 μg/ml)",[Ref.17158938]MHC=250.0 μg/ml against human red blood cells,Unknown,15677462##17158938,J Biol Chem. 2005 Apr 1;280(13):12316-29.##Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.##Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.##Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.,,,,,,,,
4596,DRAMP18534,KWKSFLKTFKSAKKTVLHTALKLISS,26,A23L (V13KL peptide derivative),No entry found,Derived from the framework peptide V13KL,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Leucine to replace Alanine at the position 23 on the peptide V13KL. Has hemolytic activity.,"[Ref.17158938]Gram-negative bacteria: Pseudomonas aeruginosa PAO1(MIC=31.3 μg/ml), Pseudomonas aeruginosa WR5 (MIC=62.5 μg/ml), Pseudomonas aeruginosa PAK (MIC=62.5 μg/ml), Pseudomonas aeruginosa PA14 (MIC=31.3 μg/ml), Pseudomonas aeruginosa M2 (MIC=31.3 μg/ml), Pseudomonas aeruginosa CP204 (MIC=15.6 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=35.1 μg/ml)",[Ref.17158938]MHC=62.5 μg/ml against human red blood cells,Unknown,17158938,Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.,"Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.",Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.,,,,,,,,
4597,DRAMP18535,KWKSFLKTFKSLKKTVLHTALKAISS,26,A12L (V13KL peptide derivative),No entry found,Derived from the framework peptide V13KL,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Leucine to replace Alanine at the position 12 on the peptide V13KL. Has hemolytic activity.,"[Ref.17158938]Gram-negative bacteria: Pseudomonas aeruginosa PAO1(MIC=15.6 μg/ml), Pseudomonas aeruginosa WR5 (MIC=62.5 μg/ml), Pseudomonas aeruginosa PAK (MIC=31.3 μg/ml), Pseudomonas aeruginosa PA14 (MIC=31.3 μg/ml), Pseudomonas aeruginosa M2 (MIC15.6= μg/ml), Pseudomonas aeruginosa CP204 (MIC=15.6 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=24.8 μg/ml)",[Ref.17158938]MHC=31.3 μg/ml against human red blood cells,Unknown,17158938,Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.,"Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.",Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.,,,,,,,,
4598,DRAMP18536,KWKSFLKTFKSAKKTVLHTLLKAISS,26,A20L (V13KL peptide derivative),No entry found,Derived from the framework peptide V13KL,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Leucine to replace Alanine at the position 20 on the peptide V13KL. Has hemolytic activity.,"[Ref.17158938]Gram-negative bacteria: Pseudomonas aeruginosa PAO1(MIC=7.8 μg/ml), Pseudomonas aeruginosa WR5 (MIC=31.3 μg/ml), Pseudomonas aeruginosa PAK (MIC=31.3 μg/ml), Pseudomonas aeruginosa PA14 (MIC=15.6 μg/ml), Pseudomonas aeruginosa M2 (MIC=15.6 μg/ml), Pseudomonas aeruginosa CP204 (MIC=7.7 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=15.6 μg/ml)",[Ref.17158938]MHC=31.3 μg/ml against human red blood cells,Unknown,17158938,Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.,"Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.",Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.,,,,,,,,
4599,DRAMP18537,KWKSFLKTFKSLKKTVLHTALKLISS,26,A12L/A23L (V13KL peptide derivative),No entry found,Derived from the framework peptide V13KL,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. Leucine to replace Alanine at the position 12 and 23 on the peptide V13KL. Has hemolytic activity.,"[Ref.17158938]Gram-negative bacteria: Pseudomonas aeruginosa PAO1(MIC=15.6 μg/ml), Pseudomonas aeruginosa WR5 (MIC=250 μg/ml), Pseudomonas aeruginosa PAK (MIC=15.6 μg/ml), Pseudomonas aeruginosa PA14 (MIC=62.5 μg/ml), Pseudomonas aeruginosa M2 (MIC=31.3 μg/ml), Pseudomonas aeruginosa CP204 (MIC=7.8 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=31.2 μg/ml)",[Ref.17158938]MHC=15.6 μg/ml against human red blood cells,Unknown,17158938,Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406.,"Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.",Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.,,,,,,,,
4600,DRAMP18538,KWKSFLKTFKSAVKTVLHTALKAISS,26,V681,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=16.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=9.0 μg/ml), Staphylococcus epidermidis C621 (MIC=5.0 μg/ml), Bacillus subtilis C971 (MIC=2.2 μg/ml), Enterococcus faecalis C625 (MIC=16.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.5 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=6.3 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=7.1 μg/ml), Escherichia coli DC2 (MIC=4.5 μg/ml), Salmonella typhimurium C587 (MIC=20.2 μg/ml), Salmonella typhimurium C610 (MIC=5.7 μg/ml), Pseudomonas aeruginosa H187 (MIC=6.4 μg/ml), Pseudomonas aeruginosa H188 (MIC=20.2 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=8.8 μg/ml)",[Ref.15677462]MHC=15.6 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4601,DRAMP18539,KWKSFLKTFKSALKTVLHTALKAISS,26,V13LL (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Leucine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=32.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=25.4 μg/ml), Staphylococcus epidermidis C621 (MIC=8.0 μg/ml), Bacillus subtilis C971 (MIC=3.2 μg/ml), Enterococcus faecalis C625 (MIC=32.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.5 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=10.9 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=6.4 μg/ml), Escherichia coli DC2 (MIC=5.0 μg/ml), Salmonella typhimurium C587 (MIC=32.0 μg/ml), Salmonella typhimurium C610 (MIC=10.1 μg/ml), Pseudomonas aeruginosa H187 (MIC=12.7 μg/ml), Pseudomonas aeruginosa H188 (MIC=32.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=12.7 μg/ml)",[Ref.15677462]MHC=7.8 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4602,DRAMP18540,KWKSFLKTFKSAAKTVLHTALKAISS,26,V13AL (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Alanine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=8.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=5.0 μg/ml), Staphylococcus epidermidis C621 (MIC=3.2 μg/ml), Bacillus subtilis C971 (MIC=2.0 μg/ml), Enterococcus faecalis C625 (MIC=16.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=4.5 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=2.5 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=6.4 μg/ml), Salmonella typhimurium C610 (MIC=2.5 μg/ml), Pseudomonas aeruginosa H187 (MIC=5.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=6.4 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=3.8 μg/ml)",[Ref.15677462]MHC=31.2 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4603,DRAMP18541,KWKSFLKTFKSAGKTVLHTALKAISS,26,V13G (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Glycine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=25.4 μg/ml), Staphylococcus aureus SAP0017 (MIC=10.1 μg/ml), Staphylococcus epidermidis C621 (MIC=3.2 μg/ml), Bacillus subtilis C971 (MIC=2.0 μg/ml), Enterococcus faecalis C625 (MIC=50.8 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=7.4 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=2.5 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=5.0 μg/ml), Salmonella typhimurium C610 (MIC=2.5 μg/ml), Pseudomonas aeruginosa H187 (MIC=6.4 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=4.1 μg/ml)",[Ref.15677462]MHC=125.0 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4604,DRAMP18542,KWKSFLKTFKSASKTVLHTALKAISS,26,V13SL (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Serine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=16.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=12.7 μg/ml), Staphylococcus epidermidis C621 (MIC=4.0 μg/ml), Bacillus subtilis C971 (MIC=2.5 μg/ml), Enterococcus faecalis C625 (MIC=50.8 μg/ml), Corynebacterium xerosis C875 (MIC=1.6 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=7.4 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=2.5 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=6.4 μg/ml), Salmonella typhimurium C610 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=6.4 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=4.2 μg/ml)",[Ref.15677462]MHC=125.0 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4605,DRAMP18543,KWKSFLKTFKSALKTVLHTALKAISS,26,V13LD (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Leucine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=5.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=4.0 μg/ml), Staphylococcus epidermidis C621 (MIC=2.5 μg/ml), Bacillus subtilis C971 (MIC=2.5 μg/ml), Enterococcus faecalis C625 (MIC=6.4 μg/ml), Corynebacterium xerosis C875 (MIC=1.6 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=3.3 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=3.2 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=16.0 μg/ml), Salmonella typhimurium C610 (MIC=3.2 μg/ml), Pseudomonas aeruginosa H187 (MIC=6.4 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=5.5 μg/ml)",[Ref.15677462]MHC=7.8 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4606,DRAMP18544,KWKSFLKTFKSAVKTVLHTALKAISS,26,V13VD (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Valine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=4.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=3.2 μg/ml), Staphylococcus epidermidis C621 (MIC=1.6 μg/ml), Bacillus subtilis C971 (MIC=1.3 μg/ml), Enterococcus faecalis C625 (MIC=12.7 μg/ml), Corynebacterium xerosis C875 (MIC=1.3 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=2.8 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=2.5 μg/ml), Escherichia coli DC2 (MIC=1.6 μg/ml), Salmonella typhimurium C587 (MIC=5.0 μg/ml), Salmonella typhimurium C610 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=4.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=8.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=3.3 μg/ml)",[Ref.15677462]MHC=62.5 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4607,DRAMP18545,KWKSFLKTFKSAAKTVLHTALKAISS,26,V13AD (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Alanine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=8.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=5.0 μg/ml), Staphylococcus epidermidis C621 (MIC=2.0 μg/ml), Bacillus subtilis C971 (MIC=1.6 μg/ml), Enterococcus faecalis C625 (MIC=32.0 μg/ml), Corynebacterium xerosis C875 (MIC=1.6 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=4.3 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=1.6 μg/ml), Escherichia coli DC2 (MIC=2.0 μg/ml), Salmonella typhimurium C587 (MIC=5.0 μg/ml), Salmonella typhimurium C610 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=4.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=3.3 μg/ml)",[Ref.15677462]MHC=250.0 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4608,DRAMP18546,KWKSFLKTFKSASKTVLHTALKAISS,26,V13SD (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Serine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Weak hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=64.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=64.0 μg/ml), Staphylococcus epidermidis C621 (MIC=12.7 μg/ml), Bacillus subtilis C971 (MIC=2.5 μg/ml), Enterococcus faecalis C625 (MIC=64.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=16.0 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=3.2 μg/ml), Escherichia coli DC2 (MIC=2.0 μg/ml), Salmonella typhimurium C587 (MIC=12.7 μg/ml), Salmonella typhimurium C610 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=18.3 μg/ml), Pseudomonas aeruginosa H188 (MIC=20.2 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=6.3 μg/ml)",[Ref.15677462]MHC>250.0 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4609,DRAMP18547,KWKSFLKTFKSAKKTVLHTALKAISS,26,V13KD (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Lysine to replace L-Valine at the position 13 on the non-polar face of peptide V681. Weak hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=64.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=64.0 μg/ml), Staphylococcus epidermidis C621 (MIC=25.4 μg/ml), Bacillus subtilis C971 (MIC=3.2 μg/ml), Enterococcus faecalis C625 (MIC=64.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=18.7 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=3.2 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=32.0 μg/ml), Salmonella typhimurium C610 (MIC=1.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=32.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=25.4 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=7.7 μg/ml)",[Ref.15677462]MHC>250.0 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4610,DRAMP18548,KWKSFLKTFKLAVKTVLHTALKAISS,26,S11LL (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Leucine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=32.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=32.0 μg/ml), Staphylococcus epidermidis C621 (MIC=16.0 μg/ml), Bacillus subtilis C971 (MIC=5.0 μg/ml), Enterococcus faecalis C625 (MIC=50.8 μg/ml), Corynebacterium xerosis C875 (MIC=2.5 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=14.8 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=16.0 μg/ml), Escherichia coli DC2 (MIC=5.0 μg/ml), Salmonella typhimurium C587 (MIC=32.0 μg/ml), Salmonella typhimurium C610 (MIC=12.7 μg/ml), Pseudomonas aeruginosa H187 (MIC=20.2 μg/ml), Pseudomonas aeruginosa H188 (MIC=32.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=16.6 μg/ml)",[Ref.15677462]MHC=4.0 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4611,DRAMP18549,KWKSFLKTFKVAVKTVLHTALKAISS,26,S11VL (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Valine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=16.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=12.7 μg/ml), Staphylococcus epidermidis C621 (MIC=8.0 μg/ml), Bacillus subtilis C971 (MIC=2.5 μg/ml), Enterococcus faecalis C625 (MIC=20.2 μg/ml), Corynebacterium xerosis C875 (MIC=1.3 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=6.9 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=6.4 μg/ml), Escherichia coli DC2 (MIC=4.0 μg/ml), Salmonella typhimurium C587 (MIC=32.0 μg/ml), Salmonella typhimurium C610 (MIC=5.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=10.1 μg/ml), Pseudomonas aeruginosa H188 (MIC=20.2 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=9.7 μg/ml)",[Ref.15677462]MHC=7.8 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4612,DRAMP18550,KWKSFLKTFKAAVKTVLHTALKAISS,26,S11AL (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Alanine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=16.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=12.7 μg/ml), Staphylococcus epidermidis C621 (MIC=4.0 μg/ml), Bacillus subtilis C971 (MIC=2.5 μg/ml), Enterococcus faecalis C625 (MIC=20.2 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=6.6 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=6.4 μg/ml), Escherichia coli DC2 (MIC=4.0 μg/ml), Salmonella typhimurium C587 (MIC=20.2 μg/ml), Salmonella typhimurium C610 (MIC=4.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=10.1 μg/ml), Pseudomonas aeruginosa H188 (MIC=16.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=8.3 μg/ml)",[Ref.15677462]MHC=15.6 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4613,DRAMP18551,KWKSFLKTFKGAVKTVLHTALKAISS,26,S11G (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Glycine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=8.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=5.0 μg/ml), Staphylococcus epidermidis C621 (MIC=4.0 μg/ml), Bacillus subtilis C971 (MIC=2.0 μg/ml), Enterococcus faecalis C625 (MIC=12.7 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=4.5 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=5.0 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=12.7 μg/ml), Salmonella typhimurium C610 (MIC=3.2 μg/ml), Pseudomonas aeruginosa H187 (MIC=4.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=5.2 μg/ml)",[Ref.15677462]MHC=7.8 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4614,DRAMP18552,KWKSFLKTFKKAVKTVLHTALKAISS,26,S11KL (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. L-Lysine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=32.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=16.0 μg/ml), Staphylococcus epidermidis C621 (MIC=6.4 μg/ml), Bacillus subtilis C971 (MIC=3.2 μg/ml), Enterococcus faecalis C625 (MIC=32.0 μg/ml), Corynebacterium xerosis C875 (MIC=4.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=10.5 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=10.1 μg/ml), Escherichia coli DC2 (MIC=4.0 μg/ml), Salmonella typhimurium C587 (MIC=25.4 μg/ml), Salmonella typhimurium C610 (MIC=8.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=25.4 μg/ml), Pseudomonas aeruginosa H188 (MIC=32.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=13.7 μg/ml)",[Ref.15677462]MHC=4.0 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4615,DRAMP18553,KWKSFLKTFKLAVKTVLHTALKAISS,26,S11LD (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Leucine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=8.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=5.0 μg/ml), Staphylococcus epidermidis C621 (MIC=4.0 μg/ml), Bacillus subtilis C971 (MIC=2.0 μg/ml), Enterococcus faecalis C625 (MIC=16.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=4.7 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=5.0 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=10.1 μg/ml), Salmonella typhimurium C610 (MIC=3.2 μg/ml), Pseudomonas aeruginosa H187 (MIC=4.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=5.0 μg/ml)",[Ref.15677462]MHC=31.2 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4616,DRAMP18554,KWKSFLKTFKVAVKTVLHTALKAISS,26,S11VD (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Valine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=16.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=8.0 μg/ml), Staphylococcus epidermidis C621 (MIC=4.0 μg/ml), Bacillus subtilis C971 (MIC=2.5 μg/ml), Enterococcus faecalis C625 (MIC=32.0 μg/ml), Corynebacterium xerosis C875 (MIC=2.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=6.6 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=5.0 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=10.1 μg/ml), Salmonella typhimurium C610 (MIC=4.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=6.4 μg/ml), Pseudomonas aeruginosa H188 (MIC=16.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=6.1 μg/ml)",[Ref.15677462]MHC=125.0 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4617,DRAMP18555,KWKSFLKTFKAAVKTVLHTALKAISS,26,S11AD (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Alanine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=6.4 μg/ml), Staphylococcus aureus SAP0017 (MIC=5.0 μg/ml), Staphylococcus epidermidis C621 (MIC=2.5 μg/ml), Bacillus subtilis C971 (MIC=2.0 μg/ml), Enterococcus faecalis C625 (MIC=12.7 μg/ml), Corynebacterium xerosis C875 (MIC=1.6 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=3.8 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=4.0 μg/ml), Escherichia coli DC2 (MIC=2.5 μg/ml), Salmonella typhimurium C587 (MIC=8.0 μg/ml), Salmonella typhimurium C610 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H187 (MIC=5.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=8.0 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=4.3 μg/ml)",[Ref.15677462]MHC=15.6 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4618,DRAMP18556,KWKSFLKTFKSAVKTVLHTALKAISS,26,S11SD (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Serine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=4.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=2.5 μg/ml), Staphylococcus epidermidis C621 (MIC=2.0 μg/ml), Bacillus subtilis C971 (MIC=1.3 μg/ml), Enterococcus faecalis C625 (MIC=6.4 μg/ml), Corynebacterium xerosis C875 (MIC=1.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=2.3 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=2.5 μg/ml), Escherichia coli DC2 (MIC=1.6 μg/ml), Salmonella typhimurium C587 (MIC=5.0 μg/ml), Salmonella typhimurium C610 (MIC=1.6 μg/ml), Pseudomonas aeruginosa H187 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=10.1 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=2.9 μg/ml)",[Ref.15677462]MHC=15.6 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4619,DRAMP18557,KWKSFLKTFKKAVKTVLHTALKAISS,26,S11KD (V681 peptide derivative),No entry found,Derived from the framework peptide V681,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. D-Lysine to replace L-Serine at the position 11 on the polar face of peptide V681. Has hemolytic activity.,"[Ref.15677462]Gram-positive bacteria: Staphylococcus aureus 25923 (MIC=4.0 μg/ml), Staphylococcus aureus SAP0017 (MIC=2.5 μg/ml), Staphylococcus epidermidis C621 (MIC=2.0 μg/ml), Bacillus subtilis C971 (MIC=2.0 μg/ml), Enterococcus faecalis C625 (MIC=12.7 μg/ml), Corynebacterium xerosis C875 (MIC=1.0 μg/ml), The geometric mean of MIC values above six Gram-positive strains (MIC=2.8 μg/ml);##Gram-negative bacteria: Escherichia coli UB1005 (MIC=3.2 μg/ml), Escherichia coli DC2 (MIC=1.6 μg/ml), Salmonella typhimurium C587 (MIC=3.2 μg/ml), Salmonella typhimurium C610 (MIC=1.6 μg/ml), Pseudomonas aeruginosa H187 (MIC=2.0 μg/ml), Pseudomonas aeruginosa H188 (MIC=6.4 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=2.6 μg/ml)",[Ref.15677462]MHC=31.2 μg/ml against human red blood cells,Unknown,15677462,J Biol Chem. 2005 Apr 1;280(13):12316-29.,"Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS.",Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.,,,,,,,,
4620,DRAMP18558,FIKRIARLLRKIF,13,Kn2-7 (BmKn2 peptide derivative),No entry found,Derived from the peptide BmKn2,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22792229]Gram-positive bacteria: Staphylococcus aureus AB94004 (MIC=3.13 μg/ml), Staphylococcus aureus ATCC 25923 (MIC=3.13 μg/ml), Bacillus subtilis AB91021 (MIC=6.25 μg/ml), Bacillus thuringiensis AB92037 (MIC=6.25 μg/ml), Micrococcus luteus AB93113 (MIC=6.25 μg/ml);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=6.25 μg/ml), Escherichia coli ATCC 25922 (MIC=25 μg/ml), Pseudomonas aeruginosa AB93066 (MIC=25 μg/ml), Pseudomonas aeruginosa A092994 (MIC=50 μg/ml), Pseudomonas aeruginosa A093052 (MIC=100 μg/ml), Pseudomonas aeruginosa A093056 (MIC=50 μg/ml), Pseudomonas aeruginosa A093085 (MIC=50 μg/ml), Pseudomonas aeruginosa A093115 (MIC=100 μg/ml).","[Ref.22792229]Non-hemolysis at 6.25 μg/ml, 5% hemolysis at 12.5 μg/ml,10% hemolysis at 25 μg/ml 15% hemolysis at 50 μg/ml, 40% hemolysis at 100 μg/ml against human red blood cells",Unknown,22792229,PLoS One. 2012;7(7):e40135. doi: 10.1371/journal.pone.0040135.,"Cao L, Dai C, Li Z, Fan Z, Song Y, Wu Y, Cao Z, Li W.",Antibacterial activity and mechanism of a scorpion venom peptide derivative in vitro and in vivo.,,,,,,,,
4621,DRAMP18559,IWRIFRRIF,9,HFU3,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22699557]Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=4 μM), Staphylococcus epidermidis ATCC 12228 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8 μM), Pseudomonas aeruginosa 27853 (MIC=4 μM)",[Ref.22699557]MHC=101.4 μM against human red blood cells,Unknown,22699557,Amino Acids. 2012 Dec;43(6):2527-36. doi: 10.1007/s00726-012-1334-7.,"Ma QQ, Dong N, Shan AS, Lv YF, Li YZ, Chen ZH, Cheng BJ, Li ZY.",Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units.,,,,,,,,
4622,DRAMP18560,IWRIFRRIFRIF,12,HFU4,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Has hemolytic activity.,"[Ref.22699557]Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=1 μM), Staphylococcus epidermidis ATCC 12228 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4 μM), Pseudomonas aeruginosa 27853 (MIC=4 μM)",[Ref.22699557]MHC=19.6 μM against human red blood cells,Unknown,22699557,Amino Acids. 2012 Dec;43(6):2527-36. doi: 10.1007/s00726-012-1334-7.,"Ma QQ, Dong N, Shan AS, Lv YF, Li YZ, Chen ZH, Cheng BJ, Li ZY.",Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units.,,,,,,,,
4623,DRAMP18561,IWRIFRRIFRIFIRF,15,HFU5,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22699557]Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=8 μM), Staphylococcus epidermidis ATCC 12228 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16 μM), Pseudomonas aeruginosa 27853 (MIC=16 μM)",[Ref.22699557]MHC=15.0 μM against human red blood cells,Unknown,22699557,Amino Acids. 2012 Dec;43(6):2527-36. doi: 10.1007/s00726-012-1334-7.,"Ma QQ, Dong N, Shan AS, Lv YF, Li YZ, Chen ZH, Cheng BJ, Li ZY.",Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units.,,,,,,,,
4624,DRAMP18562,KSLVRRWRSRW,11,MAP-04-01 (Ixosin-B peptide derivative),No entry found,Derived from the peptide Ixosin-B,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. No hemolytic activity.,"[Ref.22578463]Gram-positive bacterium: Staphylococcus aureus (MIC90=30 μM);##Gram-negative bacterium: Escherichia coli (MIC90=30 μM), Pseudomonas aeroginosa (MIC90=40 μM)",[Ref.22578463]Non-hemolysis at 100μM against human red blood cells,Unknown,22578463,Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8.,"Lung FD, Wang KS, Liao ZJ, Hsu SK, Song FY, Liou CC, Wu YS.",Discovery of potent antimicrobial peptide analogs of Ixosin-B.,,,,,,,,
4625,DRAMP18563,KSLRRVWRSWR,11,MAP-04-02 (Ixosin-B peptide derivative),No entry found,Derived from the peptide Ixosin-B,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.No hemolytic activity.,"[Ref.22578463]Gram-positive bacterium: Staphylococcus aureus (MIC90=60 μM);##Gram-negative bacterium: Escherichia coli (MIC90=30 μM), Pseudomonas aeroginosa (MIC90=40 μM)",[Ref.22578463]Non-hemolysis at 100μM against human red blood cells,Unknown,22578463,Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8.,"Lung FD, Wang KS, Liao ZJ, Hsu SK, Song FY, Liou CC, Wu YS.",Discovery of potent antimicrobial peptide analogs of Ixosin-B.,,,,,,,,
4626,DRAMP18564,KWLRRVWRWWR,11,MAP-04-03 (Ixosin-B peptide derivative),No entry found,Derived from the peptide Ixosin-B,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Highly hemolytic activity.,"[Ref.22578463]Gram-positive bacterium: Staphylococcus aureus (MIC90=2.5 μM);##Gram-negative bacterium: Escherichia coli (MIC90=15 μM), Pseudomonas aeroginosa (MIC90=20 μM)",[Ref.22578463]100% hemolysis at 100μM against human red blood cells,Unknown,22578463,Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8.,"Lung FD, Wang KS, Liao ZJ, Hsu SK, Song FY, Liou CC, Wu YS.",Discovery of potent antimicrobial peptide analogs of Ixosin-B.,,,,,,,,
4627,DRAMP18565,KRLRRVWRRWR,11,MAP-04-04 (Ixosin-B peptide derivative),No entry found,Derived from the peptide Ixosin-B,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.22578463]Gram-positive bacterium: Staphylococcus aureus (MIC90=5 μM);##Gram-negative bacterium: Escherichia coli (MIC90=30 μM), Pseudomonas aeroginosa (MIC90=20 μM)",[Ref.22578463]3% hemolysis at 100μM against human red blood cells,Unknown,22578463,Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8.,"Lung FD, Wang KS, Liao ZJ, Hsu SK, Song FY, Liou CC, Wu YS.",Discovery of potent antimicrobial peptide analogs of Ixosin-B.,,,,,,,,
4628,DRAMP18566,VNWKKSLGKSIKVVK,15,LL-IIIs-1 (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.7 μM), Bacillus cereus (MIC=0.8 μM), Staphylococcus aureus  (MIC=12.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=4.4 μM), Pseudomonas aeruginosa (MIC=78.7 μM);##Fungi: Candida albicans (MIC=100 μM)",[Ref.22526241]LC50=31.3 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4629,DRAMP18567,VNWKKILGKSIKVSK,15,LL-IIIs-2 (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.9 μM), Bacillus cereus (MIC=1.2 μM), Staphylococcus aureus  (MIC=20.3 μM);##Gram-negative bacteria: Escherichia coli (MIC=8.8 μM), Pseudomonas aeruginosa (MIC=86.7 μM);##Fungi: Candida albicans (MIC=100 μM)",[Ref.22526241]LC50=69 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4630,DRAMP18568,VSWKKSLGKIIKVVK,15,LL-IIIs-3 (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.4 μM), Bacillus cereus (MIC=1.1 μM), Staphylococcus aureus  (MIC=21.7 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.2 μM), Pseudomonas aeruginosa (MIC=76.3 μM);##Fungi: Candida albicans (MIC=93.3 μM)",[Ref.22526241]LC50=30 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4631,DRAMP18569,VNSKKISGKSIKVSK,15,LL-IIIs-4 (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=2 μM), Bacillus cereus (MIC=1.1 μM), Staphylococcus aureus  (MIC=80 μM);##Gram-negative bacteria: Escherichia coli (MIC=20 μM).",[Ref.22526241]LC50>100 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4632,DRAMP18570,VNRKKILGKSIKVVK,15,LL-IIIs-5 cis (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.9 μM), Bacillus cereus (MIC=0.9 μM), Staphylococcus aureus  (MIC=45 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.5 μM), Pseudomonas aeruginosa (MIC=80 μM).",[Ref.22526241]LC50=100 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4633,DRAMP18571,VNRKKILGKSIKVVK,15,LL-IIIs-5 trans (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria .Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.1 μM), Bacillus cereus (MIC=1.3 μM), Staphylococcus aureus  (MIC=65 μM);##Gram-negative bacteria: Escherichia coli (MIC=5.5 μM), Pseudomonas aeruginosa (MIC=80 μM).",[Ref.22526241]LC50>100 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4634,DRAMP18572,VNSKKISPKSIKVSK,15,LL-IIIs-6a (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1 μM), Bacillus cereus (MIC=1.1 μM), Staphylococcus aureus  (MIC=93 μM);##Gram-negative bacteria: Escherichia coli (MIC=7.8 μM), Pseudomonas aeruginosa (MIC=93 μM).",[Ref.22526241]LC50>100 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4635,DRAMP18573,VNSKKISPKSIKVSK,15,LL-IIIs-6b (lasioglossin III peptide derivative),No entry found,Derived from the peptide lasioglossin III,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.9 μM), Bacillus cereus (MIC=0.8 μM), Staphylococcus aureus  (MIC=50 μM);##Gram-negative bacteria: Escherichia coli (MIC=7.8 μM), Pseudomonas aeruginosa (MIC=63 μM).",[Ref.22526241]LC50=82 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4636,DRAMP18574,GFLSILKKVLPKVXAHXK,18,MEP-N (melectin peptide derivative),No entry found,Derived from the peptide melectin,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1 μM), Bacillus cereus (MIC=0.5 μM), Staphylococcus aureus (MIC=2.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.9 μM), Pseudomonas aeruginosa (MIC=17.3 μM);##Fungi: Candida albicans (MIC=15 μM)",[Ref.22526241]LC50=50 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4637,DRAMP18575,GFLSILKKVLPKSXAHSK,18,MEP-Ns-1 (melectin peptide derivative),No entry found,Derived from the peptide melectin,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=0.8 μM), Bacillus cereus (MIC=1.1 μM), Staphylococcus aureus (MIC=10.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.5 μM), Pseudomonas aeruginosa (MIC=77 μM);##Fungi: Candida albicans (MIC=30 μM)",[Ref.22526241]LC50=18.1 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4638,DRAMP18576,GFLSSLKKSLPKVXAHXK,18,MEP-Ns-2 (melectin peptide derivative),No entry found,Derived from the peptide melectin,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.5 μM), Bacillus cereus (MIC=1.2 μM), Staphylococcus aureus  (MIC=37 μM);##Gram-negative bacteria: Escherichia coli (MIC=7.8 μM).",[Ref.22526241]LC50=14.7 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4639,DRAMP18577,GFLSSLKKSLPKSXAHSK,18,MEP-Ns-3 (melectin peptide derivative),No entry found,Derived from the peptide melectin,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.3 μM), Bacillus cereus (MIC=1.2 μM) ;##Gram-negative bacteria: Escherichia coli (MIC=46.7 μM).",[Ref.22526241]LC50=13.9 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4640,DRAMP18578,GFRSILKKVSPKVXAHXK,18,MEP-Ns-4 cis (melectin peptide derivative),No entry found,Derived from the peptide melectin,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.5 μM), Bacillus cereus (MIC=1.3 μM), Staphylococcus aureus (MIC=37 μM);##Gram-negative bacteria: Escherichia coli (MIC=8.1 μM).",[Ref.22526241]LC50=11 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4641,DRAMP18579,GFRSILKKVSPKVXAHXK,18,MEP-Ns-4 trans (melectin peptide derivative),No entry found,Derived from the peptide melectin,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=2 μM), Bacillus cereus (MIC=1.7 μM), Staphylococcus aureus (MIC=63 μM);##Gram-negative bacteria: Escherichia coli (MIC=16.3 μM).",[Ref.22526241]LC50=20 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4642,DRAMP18580,GFLSSLKKSLGKSXAHSK,18,MEP-Ns-5 (melectin peptide derivative),No entry found,Derived from the peptide melectin,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.5 μM), Bacillus cereus (MIC=1.2 μM), Staphylococcus aureus (MIC=57 μM);##Gram-negative bacteria: Escherichia coli (MIC=5.6 μM).",[Ref.22526241]LC50=29 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4643,DRAMP18581,GFLSSLKKSLAKSXAHSK,18,MEP-Ns-6 (melectin peptide derivative),No entry found,Derived from the peptide melectin,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.22526241]Gram-positive bacteria: Micrococcus luteus (MIC=1.5 μM), Bacillus cereus (MIC=1.2 μM), Staphylococcus aureus (MIC=43 μM);##Gram-negative bacteria: Escherichia coli (MIC=5.6 μM).",[Ref.22526241]LC50=39.5 μM against human red blood cells,Unknown,22526241,Amino Acids. 2012 Nov;43(5):2047-58.,"Chapuis H, Slaninová J, Bednárová L, Monincová L, Buděšínský M, Čeřovský V.",Effect of hydrocarbon stapling on the properties of ,,,,,,,,
4645,DRAMP18583,KWCFCVCYRGICYCRCRG,18,"Tricystine cyclic cystine TP (ccTP, Tachyplesin-1 peptide derivative)",No entry found,Derived from the peptide Tachyplesin-1,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.0 μM in low-salt; MIC=0.8 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.4 μM in high-salt), Enterococcus faecalis (MIC=1.0 μM in low-salt; MIC=0.9 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=3.0 μM in low-salt; MIC=6.9 μM in high-salt), Pseudomonas aeruginosa (MIC=5.0 μM in low-salt; MIC=5.2 μM in high-salt), Primula vulgaris (MIC=6.0 μM in low-salt; MIC=14.4 μM in high-salt), Klebsiella oxytoca (MIC=2.1 μM in low-salt; MIC=7.8 μM in high-salt);##Fungi: Candida albicans (MIC=5.1 μM in low-salt; MIC=17.2 μM in high-salt), Candida kefyr (MIC=3.9 μM in low-salt; MIC=4.1 μM in high-salt), Candida tropicalis (MIC=5.2 μM in low-salt; MIC=1.1 μM in high-salt).",[Ref.10673369]EC25=3800 μM against human red blood cells,Unknown,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"Tam JP, Lu YA, Yang JL.",Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,,,,,,,,
4646,DRAMP18584,KWCFCVCYRGICRCRCRG,18,[Arg13]ccTP (ccTP peptide derivative),No entry found,Derived from the peptide ccTP,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.3 μM in low-salt; MIC=0.9 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.5 μM in high-salt), Enterococcus faecalis (MIC=1.9 μM in low-salt; MIC=1.3 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=10.4 μM in low-salt; MIC=0.9 μM in high-salt), Pseudomonas aeruginosa (MIC=6.2 μM in low-salt; MIC=10.4 μM in high-salt), Primula vulgaris (MIC=16.4 μM in low-salt; MIC=28.9 μM in high-salt), Klebsiella oxytoca (MIC=4.0 μM in low-salt; MIC=7.6 μM in high-salt);##Fungi: Candida albicans (MIC=24.2 μM in low-salt; MIC=30.2 μM in high-salt), Candida kefyr (MIC=1.1 μM in low-salt; MIC=4.3 μM in high-salt), Candida tropicalis (MIC=12.4 μM in low-salt; MIC=3.9 μM in high-salt).",[Ref.10673369]EC25=590 μM against human red blood cells,Unknown,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"Tam JP, Lu YA, Yang JL.",Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,,,,,,,,
4647,DRAMP18585,KWCRCVCRRGICYCRCRG,18,"[Arg4,8]ccTP (ccTP peptide derivative)",No entry found,Derived from the peptide ccTP,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.3 μM in low-salt; MIC=0.3 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.7 μM in high-salt), Enterococcus faecalis (MIC=1.0 μM in low-salt; MIC=1.2 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=9.8 μM in low-salt; MIC=2.0 μM in high-salt), Pseudomonas aeruginosa (MIC=8.0 μM in low-salt; MIC=5.3 μM in high-salt), Primula vulgaris (MIC=26.7 μM in low-salt; MIC=56.2 μM in high-salt), Klebsiella oxytoca (MIC=6.1 μM in low-salt; MIC=7.8 μM in high-salt);##Fungi: Candida albicans (MIC=6.4 μM in low-salt; MIC=11.2 μM in high-salt), Candida kefyr (MIC=1.1 μM in low-salt; MIC=1.9 μM in high-salt), Candida tropicalis (MIC=2.8 μM in low-salt; MIC=4.2 μM in high-salt).",[Ref.10673369]EC25=910 μM against human red blood cells,Unknown,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"Tam JP, Lu YA, Yang JL.",Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,,,,,,,,
4648,DRAMP18586,KWCRCVCRRGICRCRCRG,18,"[Arg4,8,13]ccTP (ccTP peptide derivative)",No entry found,Derived from the peptide ccTP,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.7 μM in low-salt; MIC=1.3 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.8 μM in high-salt), Enterococcus faecalis (MIC=0.7 μM in low-salt; MIC=0.5 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=5.5 μM in low-salt; MIC=1.2 μM in high-salt), Pseudomonas aeruginosa (MIC=3.9 μM in low-salt; MIC=4.7 μM in high-salt), Primula vulgaris (MIC=16.8 μM in low-salt; MIC=55.6 μM in high-salt), Klebsiella oxytoca (MIC=2.4 μM in low-salt; MIC=5.4 μM in high-salt);##Fungi: Candida albicans (MIC=7.1 μM in low-salt; MIC=5.1 μM in high-salt), Candida kefyr (MIC=4.2 μM in low-salt; MIC=0.7 μM in high-salt), Candida tropicalis (MIC=1.9 μM in low-salt; MIC=4.8 μM in high-salt).",[Ref.10673369]EC25=920 μM against human red blood cells,Unknown,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"Tam JP, Lu YA, Yang JL.",Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,,,,,,,,
4649,DRAMP18587,KWCRCVCRRGICRCRCRK,18,"[Arg4,8,13][Lys18]ccTP (ccTP peptide derivative)",No entry found,Derived from the peptide ccTP,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.7 μM in low-salt; MIC=0.7 μM in high-salt), Micrococcus luteus (MIC=0.3 μM in low-salt; MIC=0.4 μM in high-salt), Enterococcus faecalis (MIC=1.4 μM in low-salt; MIC=1.2 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=6.1 μM in low-salt; MIC=1.2 μM in high-salt), Pseudomonas aeruginosa (MIC=2.0 μM in low-salt; MIC=4.7 μM in high-salt), Primula vulgaris (MIC=17.0 μM in low-salt; MIC=39.8 μM in high-salt), Klebsiella oxytoca (MIC=4.1 μM in low-salt; MIC=4.1 μM in high-salt);##Fungi: Candida albicans (MIC=10.5 μM in low-salt; MIC=5.2 μM in high-salt), Candida kefyr (MIC=1.1 μM in low-salt; MIC=0.7 μM in high-salt), Candida tropicalis (MIC=2.3 μM in low-salt; MIC=1.9 μM in high-salt).",[Ref.10673369]EC25=3900 μM against human red blood cells,Unknown,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"Tam JP, Lu YA, Yang JL.",Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,,,,,,,,
4650,DRAMP18588,GFCRCLCRRGVCRCICTK,18,RTD,No entry found,Unknown,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.10673369]Gram-positive bacteria: Staphylococcus aureus (MIC=1.1 μM in low-salt; MIC=0.9 μM in high-salt), Micrococcus luteus (MIC=0.5 μM in low-salt; MIC=0.4 μM in high-salt), Enterococcus faecalis (MIC=1.2 μM in low-salt; MIC=1.2 μM in high-salt);##Gram-negative bacteria: Escherichia coli (MIC=2.0 μM in low-salt; MIC=28.4 μM in high-salt), Pseudomonas aeruginosa (MIC=2.0 μM in low-salt; MIC=5.2 μM in high-salt), Primula vulgaris (MIC=10.2 μM in low-salt; MIC=50.4 μM in high-salt), Klebsiella oxytoca (MIC=2.0 μM in low-salt; MIC=12.8 μM in high-salt);##Fungi: Candida albicans (MIC=4.0 μM in low-salt; MIC=5.2 μM in high-salt), Candida kefyr (MIC=1.8 μM in low-salt; MIC=1.2 μM in high-salt), Candida tropicalis (MIC=2.8 μM in low-salt; MIC=1.0 μM in high-salt).",[Ref.10673369]EC25=2350 μM against human red blood cells,Unknown,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"Tam JP, Lu YA, Yang JL.",Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,,,,,,,,
4651,DRAMP18589,GWLDVAKKIGKAAFNVAKNFLFNKAVNFAAKGIKKAVDLWG ,42,DSE (Ctx-Ha peptide derivative),No entry found,Derived from the peptide Ctx-Ha,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.Has hemolytic activity.",[Ref.22391524]Gram-positive bacterium: Staphylococcus aureus (MIC=8.9 μmol/L; MMC=13.3 μmol/L);##Gram-negative bacterium: Escherichia coli (MIC=3.3 μmol/L; MMC=13.3 μmol/L);##Fungi: Candida albicans (MIC=53.3 μmol/L; MMC=53.3 μmol/L),[Ref.22391524]HC50=0.6±0.1 μmol/L against human red blood cells,Unknown,22391524,Antimicrob Agents Chemother. 2012 Jun;56(6):3004-10.,"Lorenzón EN, Cespedes GF, Vicente EF, Nogueira LG, Bauab TM, Castro MS, Cilli EM.",Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.,,,,,,,,
4652,DRAMP18590,GWLDVAKKIGKAAFNVAKNFL-SPACER-LFNKAVNFAAKGIKKAVDLWG,42,DEP (Ctx-Ha peptide derivative),No entry found,Derived from the peptide Ctx-Ha,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.",[Ref.22391524]Gram-positive bacterium: Staphylococcus aureus (MIC=3.2 μmol/L; MMC=12.9 μmol/L);##Gram-negative bacterium: Escherichia coli (MIC=1.6 μmol/L; MMC=3.2 μmol/L);##Fungi: Candida albicans (MIC=51.7 μmol/L; MMC=51.7 μmol/L),[Ref.22391524]HC50=0.7±0.1 μmol/L against human red blood cells,Unknown,22391524,Antimicrob Agents Chemother. 2012 Jun;56(6):3004-10.,"Lorenzón EN, Cespedes GF, Vicente EF, Nogueira LG, Bauab TM, Castro MS, Cilli EM.",Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.,,,,,,,,
4653,DRAMP18591,GWLDVAKKIGKAAFNVAKNFL-SPACER-LFNKAVNFAAKGIKKAVDLWG,42,DEA (Ctx-Ha peptide derivative),No entry found,Derived from the peptide Ctx-Ha,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.",[Ref.22391524]Gram-positive bacterium: Staphylococcus aureus (MIC=12.9 μmol/L; MMC=25.9 μmol/L);##Gram-negative bacterium: Escherichia coli (MIC=6.5 μmol/L; MMC=12.9 μmol/L);##Fungi: Candida albicans (MIC=100 μmol/L; MMC<100 μmol/L),[Ref.22391524]HC50=0.8±0.1 μmol/L against human red blood cells,Unknown,22391524,Antimicrob Agents Chemother. 2012 Jun;56(6):3004-10.,"Lorenzón EN, Cespedes GF, Vicente EF, Nogueira LG, Bauab TM, Castro MS, Cilli EM.",Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.,,,,,,,,
4654,DRAMP18592,GWLDVAKKIGKAAFNVAKNFI,21,Ctx(Ile21)-Ha (Ctx-Ha peptide derivative),No entry found,Derived from the peptide Ctx-Ha,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.22519531]Gram-positive bacterium: Staphylococcus aureus (MIC=1 μmol/L);##Gram-negative bacteria: Escherichia coli (MIC=4 μmol/L), Pseudomonas aeruginosa (MIC=8 μmol/L);##Fungi: Candida albicans (MIC=8 μmol/L), Candida krusei (MIC=8 μmol/L), Candida parapsilosis (MIC=4 μmol/L), Cryptococcus neoformans (MIC=8 μmol/L)",[Ref.22519531]HC50=26 μmol/L against human red blood cells,Unknown,22519531,Protein Pept Lett. 2012 Jun 1;19(6):596-603.,"Cespedes GF, Lorenzón EN, Vicente EF, Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM.",Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus.,,,,,,,,
4655,DRAMP18593,GWLDVAKKIGKAAFNVAKNFI,21,Ctx(Ile21)-Ha-VD16 (Ctx-Ha peptide derivative),No entry found,Derived from the peptide Ctx-Ha,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. D-Valine to replace L-Valine at the position 16 on the peptide Ctx(Ile21)-Ha. Has hemolytic activity.","[Ref.22519531]Gram-positive bacterium: Staphylococcus aureus (MIC=2 μmol/L);##Gram-negative bacteria: Escherichia coli (MIC=4 μmol/L), Pseudomonas aeruginosa (MIC=16 μmol/L);##Fungi: Candida albicans (MIC=31 μmol/L), Candida krusei (MIC=16 μmol/L), Candida parapsilosis (MIC=31 μmol/L), Cryptococcus neoformans (MIC=31 μmol/L)",[Ref.22519531]HC50=18.7 μmol/L against human red blood cells,Unknown,22519531,Protein Pept Lett. 2012 Jun 1;19(6):596-603.,"Cespedes GF, Lorenzón EN, Vicente EF, Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM.",Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus.,,,,,,,,
4656,DRAMP18594,GWLDVAKKIGKAAFNVAKNFI,21,"Ctx(Ile21)-Ha-VD5,16 (Ctx-Ha peptide derivative)",No entry found,Derived from the peptide Ctx-Ha,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. D-Valine to replace L-Valine at the position 5 and 16 on the peptide Ctx(Ile21)-Ha.Has hemolytic activity.","[Ref.22519531]Gram-positive bacterium: Staphylococcus aureus (MIC=64 μmol/L);##Gram-negative bacteria: Escherichia coli (MIC=16 μmol/L), Pseudomonas aeruginosa (MIC=128 μmol/L);##Fungi: Candida albicans (MIC=16 μmol/L), Candida krusei (MIC=16 μmol/L), Candida parapsilosis (MIC=31 μmol/L), Cryptococcus neoformans (MIC=31 μmol/L)",[Ref.22519531]HC50=43.1 μmol/L against human red blood cells,Unknown,22519531,Protein Pept Lett. 2012 Jun 1;19(6):596-603.,"Cespedes GF, Lorenzón EN, Vicente EF, Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM.",Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus.,,,,,,,,
4657,DRAMP18595,GWLDVAKKKGKAAFNVAKNFI,21,Ctx(Ile21)-Ha-I9K (Ctx-Ha peptide derivative),No entry found,Derived from the peptide Ctx-Ha,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. L-Lysine to replace L-Isoleucine at the position 9 on the peptide Ctx(Ile21)-Ha.Has hemolytic activity.","[Ref.22519531]Gram-negative bacteria: Escherichia coli (MIC=8 μmol/L), Pseudomonas aeruginosa (MIC=32 μmol/L);##Fungi: Candida albicans (MIC=16 μmol/L), Candida krusei (MIC=31 μmol/L), Candida parapsilosis (MIC=31 μmol/L), Cryptococcus neoformans (MIC=31 μmol/L)",[Ref.22519531]HC50=24.9 μmol/L against human red blood cells,Unknown,22519531,Protein Pept Lett. 2012 Jun 1;19(6):596-603.,"Cespedes GF, Lorenzón EN, Vicente EF, Mendes-Giannini MJ, Fontes W, Castro MS, Cilli EM.",Mechanism of action and relationship between structure and biological activity of Ctx-Ha: a new ceratotoxin-like peptide from Hypsiboas albopunctatus.,,,,,,,,
4658,DRAMP18596,NVWKKVLGKIIKVAK,15,LL-I/1 (Lasioglossin LL-I peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-I,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity. ,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=1.3 μM), Staphylococcus aureus (MIC=71.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.5 μM), Pseudomonas aeruginosa (MIC=22.7 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2102.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4659,DRAMP18597,VNWKKVLAKIIKVAK,15,LL-I/2 (Lasioglossin LL-I peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-I,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.6 μM), Staphylococcus aureus (MIC=7.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=26.9 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2103.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4660,DRAMP18598,VNWKKVLKKIIKVAK,15,LL-I/3 (Lasioglossin LL-I peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-I,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=15.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=19.0 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2104.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4661,DRAMP18599,VNWKKVLPKIIKVAK,15,LL-I/4 (Lasioglossin LL-I peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-I,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.9 μM);##Gram-negative bacteria: Escherichia coli (MIC=5.0 μM), Pseudomonas aeruginosa (MIC=100 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2105.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4662,DRAMP18600,NVWKKILGKIIKVAK,15,LL-II/1 (Lasioglossin LL-II peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-II,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=19.7 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.1 μM), Pseudomonas aeruginosa (MIC=23.3 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2106.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4663,DRAMP18601,VNWKKILAKIIKVAK,15,LL-II/2 (Lasioglossin LL-II peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-II,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.Has hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=4.3 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=22.5 μM).",[Ref.19591185]LC50=66.5 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2107.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4664,DRAMP18602,VNWKKILKKIIKVAK,15,LL-II/3 (Lasioglossin LL-II peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-II,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=15.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=26.1 μM).",[Ref.19591185]LC50=88.2 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2108.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4665,DRAMP18603,VNWKKILPKIIKVAK,15,LL-II/4 (Lasioglossin LL-II peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-II,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=80 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.5 μM), Pseudomonas aeruginosa (MIC=100 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2109.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4666,DRAMP18604,NVWKKILGKIIKVVK,15,LL-III/1 (Lasioglossin LL-III peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-III,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=9.0 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.4 μM), Pseudomonas aeruginosa (MIC=23.1 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2110.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4667,DRAMP18605,VNWKKILAKIIKVVK,15,LL-III/2 (Lasioglossin LL-III peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-III,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Has hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.6 μM), Staphylococcus aureus (MIC=2.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.4 μM), Pseudomonas aeruginosa (MIC=27.1 μM).",[Ref.19591185]LC50=55.1 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2111.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4668,DRAMP18606,VNWKKILKKIIKVVK,15,LL-III/3 (Lasioglossin LL-III peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-III,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.Has hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.7 μM), Staphylococcus aureus (MIC=9.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=0.7 μM), Pseudomonas aeruginosa (MIC=26.1 μM).",[Ref.19591185]LC50=72.2 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2112.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4669,DRAMP18607,VNWKKILPKIIKVVK,15,LL-III/4 (Lasioglossin LL-III peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-III,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Weak hemolytic activity.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.8 μM), Staphylococcus aureus (MIC=32.5 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.2 μM), Pseudomonas aeruginosa (MIC=100 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2113.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4670,DRAMP18608,VNWKKILGKIIKVVK,15,LL-III/5 (Lasioglossin LL-III peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-III,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.Weak hemolytic activity.
PTM: C-terminal hydroxyl modification","[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=1.2 μM), Staphylococcus aureus (MIC=40 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.5 μM), Pseudomonas aeruginosa (MIC=40 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2114.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4671,DRAMP18609,VNWKKILGKIIKVVK,15,LL-III/6 (Lasioglossin LL-III peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-III,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,"Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.
PTM: C-terminal methoxy modification","[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=0.5 μM), Staphylococcus aureus (MIC=2.1 μM);##Gram-negative bacteria: Escherichia coli (MIC=1.0 μM), Pseudomonas aeruginosa (MIC=22.5 μM).",[Ref.19591185]LC50=79.3 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2115.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4672,DRAMP18610,VNWKKILGKI,10,LL-III/7 (Lasioglossin LL-III peptide derivative),No entry found,Derived from the peptide Lasioglossin LL-III,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.19591185]Gram-positive bacteria: Bacillus subtilis (MIC=4.7 μM);##Gram-negative bacteria: Escherichia coli (MIC=23.3 μM), Pseudomonas aeruginosa (MIC=75 μM).",[Ref.19591185]LC50>200 μM against rat red blood cells,Unknown,19591185,Chembiochem. 2009 Aug 17;10(12):2089-2116.,"Cerovský V, Budesínský M, Hovorka O, Cvacka J, Voburka Z, Slaninová J, Borovicková L, Fucík V, Bednárová L, Votruba I, Straka J.",Lasioglossins: Three Novel Antimicrobial Peptides from the Venom of the Eusocial Bee Lasioglossum laticeps (Hymenoptera: Halictidae.,,,,,,,,
4675,DRAMP18613,VRRFGWWWGFLRR,13,TPG (Tritrpticin peptide derivative),No entry found,Derived from the peptide Tritrpticin,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.12207877]Gram-positive bacteria: Bacillus subtilis (MIC=16 μg/ml), Staphylococcus aureus (MIC=16 μg/ml), Staphylococcus epidermidis (MIC=8 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=32 μg/ml), Salmonella typhimurium (MIC=32 μg/ml), Pseudomonas aeruginosa (MIC=64 μg/ml);##Fungus: Candida albicans (MIC=32 μg/ml).","[Ref.12207877]6% hemolysis at 25 μg/ml, 15% hemolysis at 50 μg/ml, 25% hemolysis at 100 μg/ml, 70% hemolysis at 200 μg/ml against human red blood cells",Unknown,12207877,Biochem Biophys Res Commun. 2002 Sep 6;296(5):1044-50.,"Yang ST, Yub Shin SY, Kim YC, Kim Y, Hahm KS, Kim JI.","Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide.",,,,,,,,
4676,DRAMP18627,KLKKLLKKWLKLLKKLLK,18,D4-K9L8W (D-amino acid substitution of K9L8W),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 12 and 16 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 4 and 8 on the peptide K9L8W. Weak hemolytic activity.","[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=1 μM), Staphylococcus epidermidis (MIC=2 μM), Staphylococcus aureus (MIC=2 μM);##Gram-negative bacteria: Escherichia coli (MIC=2 μM), Pseudomonas aeruginosa (MIC=2 μM), Salmonella typhimurium (MIC=2 μM).",[Ref.20363271]HC50>800 μM against human red blood cells,Unknown,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,,,,,,,,
4677,DRAMP18507,FSGGNCRGFRRRCFCTK,17,"SolyC (Plant defensin; tomato, plants)",No entry found,Belongs to the tomato defensin family,Unknown,Tomato,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Beta sheet,Unknown,Unknown,"Function: Antibacterial activity against a panel of human pathogens, including H.pylori, and displays anti-inflammatory activity in vitro. Weak hemolytic activity.
","[Ref.23124812]Gram-positive bacteria: Staphylococcus aureus
A170 (MIC=40 μg/mL), Staphylococcus epidermidis (MIC=40 μg/mL), Listeria monocytogenes (MIC=40 μg/mL);##Gram-negative bacteria: Salmonella enterica
serovar Paratyphi (MIC=15 μg/mL), Escherichia coli (MIC=15 μg/mL), Helicobacter pylori
VB*1 (MIC=15 μg/mL), Helicobacter pylori
VB*2 (MIC=10 μg/mL), Helicobacter pylori
VB*3 (MIC=15 μg/mL), Helicobacter pylori
VB*4 (MIC=12 μg/mL), Helicobacter pylori
VB*5 (MIC=15 μg/mL), Helicobacter pylori
VB*6 (MIC=10 μg/mL), Helicobacter pylori
VB*7 (MIC=15 μg/mL), Helicobacter pylori
VB*8 (MIC=10 μg/mL), Helicobacter pylori
VB*9 (MIC=10 μg/mL), Helicobacter pylori
VB*10 (MIC=15 μg/mL)",[Ref.23124812]<5%  hemolysis at 50 μg/mL against mouse red blood cells.,Unknown,23124812,J Pept Sci. 2012 Dec;18(12):755-62.,"Rigano MM, Romanelli A, Fulgione A, Nocerino N, D'Agostino N, Avitabile C, Frusciante L, Barone A, Capuano F, Capparelli R.",A novel synthetic peptide from a tomato defensin exhibits antibacterial activities against Helicobacter pylori.,,,,,,,,
4681,DRAMP18614,VRRFAWWWAFLRR,13,TPA (Tritrpticin peptide derivative),No entry found,Derived from the peptide Tritrpticin,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.12207877]Gram-positive bacteria: Bacillus subtilis (MIC=16 μg/ml), Staphylococcus aureus (MIC=32 μg/ml), Staphylococcus epidermidis (MIC=16 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=32 μg/ml), Salmonella typhimurium (MIC=32 μg/ml), Pseudomonas aeruginosa (MIC=64 μg/ml);##Fungus: Candida albicans (MIC=32 μg/ml).","[Ref.12207877]18% hemolysis at 25 μg/ml, 30% hemolysis at 50 μg/ml, 62% hemolysis at 100 μg/ml, 95% hemolysis at 200 μg/ml against human red blood cells",Unknown,12207877,Biochem Biophys Res Commun. 2002 Sep 6;296(5):1044-50.,"Yang ST, Yub Shin SY, Kim YC, Kim Y, Hahm KS, Kim JI.","Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide.",,,,,,,,
4682,DRAMP18615,VRRFPFFFPFLRR,13,TWF (Tritrpticin peptide derivative),No entry found,Derived from the peptide Tritrpticin,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. No hemolytic activity.","[Ref.12207877]Gram-positive bacteria: Bacillus subtilis (MIC=8 μg/ml), Staphylococcus aureus (MIC=16 μg/ml), Staphylococcus epidermidis (MIC=8 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=8 μg/ml), Salmonella typhimurium (MIC=8 μg/ml), Pseudomonas aeruginosa (MIC=16 μg/ml);##Fungus: Candida albicans (MIC=16 μg/ml).",[Ref.12207877]Non-hemolysis at 200 μg/ml against human red blood cells,Unknown,12207877,Biochem Biophys Res Commun. 2002 Sep 6;296(5):1044-50.,"Yang ST, Yub Shin SY, Kim YC, Kim Y, Hahm KS, Kim JI.","Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide.",,,,,,,,
4683,DRAMP18616,RGLRRLGRKIAHGVKKYGPTVKRIKRKA,28,"[K22,25,27]-SMAP-29 (SMAP-29 peptide derivative)",No entry found,Derived from the peptide SMAP-29,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. No hemolytic activity.","[Ref.11467858]Gram-positive bacteria: [No NaCl]: Bacillus subtilis (MIC=6.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=2.0 μM), Staphylococcus epidermidis (MIC=1.0 μM);##[100 mM NaCl]: Bacillus subtilis (MIC=4.0 μM), Staphylococcus aureus (MIC=1.0 μM), Micrococcus luteus (MIC=1.0 μM), Staphylococcus epidermidis (MIC=1.0 μM).##Gram-negative bacteria: [No NaCl]: Escherichia coli (MIC=6.0 μM), Salmonella typhimurium (MIC=2.0 μM), Pseudomonas aeruginosa (MIC=12.0 μM);[100 mM NaCl]: Escherichia coli (MIC=4.0 μM), Salmonella typhimurium (MIC=1.0 μM), Pseudomonas aeruginosa (MIC=4.0 μM).##Fungi: [No NaCl]: Candida albicans (MIC=2.0 μM);[100 mM NaCl]: Candida albicans (MIC=16.0 μM).",[Ref.11467858]Non-hemolysis at 100 μM against human red blood cells,Unknown,11467858,Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.,"Shin SY, Park EJ, Yang ST, Jung HJ, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide.",,,,,,,,
4684,DRAMP18617,RGLRRLGRKIAHGVKKYGATVLRIIRIA,28,[A19]-SMAP-29 (SMAP-29 peptide derivative),No entry found,Derived from the peptide SMAP-29,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.11467858]Gram-positive bacteria: [No NaCl]: Bacillus subtilis (MIC=4.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=2.0 μM), Staphylococcus epidermidis (MIC=2.0 μM);##[100 mM NaCl]: Bacillus subtilis (MIC=2.0 μM), Staphylococcus aureus (MIC=1.0 μM), Micrococcus luteus (MIC=2.0 μM), Staphylococcus epidermidis (MIC=1.0 μM).##Gram-negative bacteria: [No NaCl]: Escherichia coli (MIC=4.0 μM), Salmonella typhimurium (MIC=2.0 μM), Pseudomonas aeruginosa (MIC=16.0 μM);[100 mM NaCl]: Escherichia coli (MIC=1.0 μM), Salmonella typhimurium (MIC=1.0 μM), Pseudomonas aeruginosa (MIC=4.0 μM).##Fungi: [No NaCl]: Candida albicans (MIC=2.0 μM);[100 mM NaCl]: Candida albicans (MIC=16.0 μM).","[Ref.11467858]7% hemolysis at 12.5 μM, 13% hemolysis at 25 μg/ml, 28% hemolysis at 50 μg/ml, 50.4% hemolysis at 100 μg/ml against human red blood cells",Unknown,11467858,Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.,"Shin SY, Park EJ, Yang ST, Jung HJ, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide.",,,,,,,,
4685,DRAMP18618,RGLRRLGRKIAHGVKKY,17,SMAP-29(1-17) (SMAP-29 peptide derivative),No entry found,Derived from the peptide SMAP-29,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. No hemolytic activity.","[Ref.11467858]Gram-positive bacteria: [No NaCl]: Bacillus subtilis (MIC=8.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=2.0 μM), Staphylococcus epidermidis (MIC=1.0 μM);##[100 mM NaCl]: Bacillus subtilis (MIC=16.0 μM), Staphylococcus aureus (MIC=4.0 μM), Micrococcus luteus (MIC=4.0 μM), Staphylococcus epidermidis (MIC=2.0 μM).##Gram-negative bacteria: [No NaCl]: Escherichia coli (MIC=8.0 μM), Salmonella typhimurium (MIC=2.0 μM), Pseudomonas aeruginosa (MIC=8.0 μM);[100 mM NaCl]: Escherichia coli (MIC=16.0 μM), Salmonella typhimurium (MIC=8.0 μM), Pseudomonas aeruginosa (MIC=16.0 μM).##Fungi: [No NaCl]: Candida albicans (MIC=8.0 μM);[100 mM NaCl]: Candida albicans (MIC=16.0 μM).",[Ref.11467858]Non-hemolysis at 100 μM against human red blood cells,Unknown,11467858,Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.,"Shin SY, Park EJ, Yang ST, Jung HJ, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide.",,,,,,,,
4686,DRAMP18619,RKLRRLKRKIAHKVKKY,17,"[K2,7,13]-SMAP-29(1-17) (SMAP-29 peptide derivative)",No entry found,Derived from the peptide SMAP-29,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. No hemolytic activity.","[Ref.11467858]Gram-positive bacteria: [No NaCl]: Bacillus subtilis (MIC=4.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=2.0 μM), Staphylococcus epidermidis (MIC=1.0 μM);[100 mM NaCl]: Bacillus subtilis (MIC=4.0 μM), Staphylococcus aureus (MIC=2.0 μM), Micrococcus luteus (MIC=1.0 μM), Staphylococcus epidermidis (MIC=1.0 μM).##Gram-negative bacteria: [No NaCl]: Escherichia coli (MIC=3.0 μM), Salmonella typhimurium (MIC=2.0 μM), Pseudomonas aeruginosa (MIC=6.0 μM);[100 mM NaCl]: Escherichia coli (MIC=6.0 μM), Salmonella typhimurium (MIC=4.0 μM), Pseudomonas aeruginosa (MIC=3.0 μM).##Fungi: [No NaCl]: Candida albicans (MIC=8.0 μM);[100 mM NaCl]: Candida albicans (MIC=8.0 μM).",[Ref.11467858]Non-hemolysis at 100 μM against human red blood cells,Unknown,11467858,Biochem Biophys Res Commun. 2001 Jul 27;285(4):1046-51.,"Shin SY, Park EJ, Yang ST, Jung HJ, Eom SH, Song WK, Kim Y, Hahm KS, Kim JI.","Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide.",,,,,,,,
4687,DRAMP18620,KKTWWKTWWTKWSQPKKKRKV,21,Pep-1-K (Pep-1 peptide derivative),No entry found,Derived from the peptide Pep-1,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria. No hemolytic activity.,"[Ref.16945333]Gram-positive bacteria: Bacillus subtilis (KCTC 3068) (MIC=2.0 μM), Staphylococcus aureus (KCTC 1621) (MIC=2.0 μM), Staphylococcus epidermidis (KCTC 1917) (MIC=1.0 μM);##Gram-negative bacteria: Escherichia coli (KCTC 1682) (MIC=2.0 μM), Salmonella typhimurium (KCTC 1926) (MIC=1.0 μM), Pseudomonas aeruginosa (KCTC 1637) (MIC=2.0 μM);##Antibiotic-resistant bacteria: MRSA 1 (CCARM 3001) (MIC=2.0 μM), MRSA 2 (CCARM 3089) (MIC=2.0 μM), MRSA 3 (CCARM 3543) (MIC=1.0 μM), MDRPA 1 (CCARM 2092) (MIC=8.0 μM), MDRPA 2 (CCARM 2095) (MIC=8.0 μM), MDRPA 3 (CCARM 2109) (MIC=8.0 μM).",[Ref.16945333]Non-hemolysis at 200 μM against human red blood cells,Unknown,16945333,Biochem Biophys Res Commun. 2006 Oct 20;349(2):769-74.,"Zhu WL, Lan H, Park IS, Kim JI, Jin HZ, Hahm KS, Shin SY.",Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1.,,,,,,,,
4689,DRAMP18622,FLPIVAKLLSGLLGRKKRRQRRR,23,Temporin-PEb (Temporin-PE peptide derivative),No entry found,Derived from the peptide Temporin-PE,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.29191658]Gram-positive bacteria: Staphylococcus aureus (MIC=1.0 μM), Methicillin-resistant Staphylococcus aureus (MIC=2.0 μM), Enterococcus faecalis (MIC=2.0 μM);##Gram-negative bacteria: Escherichia coli (MIC=2.0 μM);##Fungus: Candida albicans (MIC=1.0 μM).##Cancer cell lines: NCI-H157 (IC50=3.464 μM), U251MG (IC50=3.087 μM), PC-3 (IC50=3.051 μM), MDA-MB-435s (IC50=3.483 μM), HMEC-1 (IC50=9.976 μM).",[Ref.29191658]HC50=44.64 μM against horse red blood cells,Unknown,29191658,Biochem Biophys Res Commun. 2018 Jan 22;495(4):2539-2546.,"Sang M, Wu Q, Xi X, Ma C, Wang L, Zhou M, Burrows JF, Chen T.","Identification and target-modifications of temporin-PE: A novel antimicrobial peptide in the defensive skin secretions of the edible frog, Pelophylax kl. esculentus.",,,,,,,,
4690,DRAMP18623,INLKILARLAKKIL,14,"[I5,R8] Mastoparan-L ([I5,R8] MP-L;Mastoparan-L peptide derivative)",No entry found,Derived from the peptide Mastoparan ,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. [Ref.27423268]Cytotoxicity against THP-1-derived macrophages, Weak hemolytic activity.","[Ref.27423268]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=25 μM), Streptococcus pyogenes ATCC 19615 (MIC=6.25 μM), Listeria ivanovii Li 4pVS2 (MIC=50 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12.5 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=6.25 μM), Klebsiella pneumoniae ATCC 13883 (MIC=6.25 μM), Acinetobacter baumannii ATCC 19606 (MIC=3 μM);##Fungi: Candida albicans ATCC 90028 (MIC=12.5 μM), Candida parapsilosis ATCC 22019 (MIC=25 μM).",[Ref.27423268]LC50>200 μM against rat red blood cells,Unknown,27423268,Biochim Biophys Acta. 2016 Nov;1858(11):2699-2708.,"Irazazabal LN, Porto WF, Ribeiro SM, Casale S, Humblot V, Ladram A, Franco OL.",Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan.,,,,,,,,
4691,DRAMP18624,KLKKLLKKWLKLLKKLLK,18,K9L8W,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Has hemolytic activity.,"[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=4 μM), Staphylococcus epidermidis (MIC=8 μM), Staphylococcus aureus (MIC=8 μM);##Gram-negative bacteria: Escherichia coli (MIC=8 μM), Pseudomonas aeruginosa (MIC=8 μM), Salmonella typhimurium (MIC=4 μM).",[Ref.20363271]HC50=14 μM against human red blood cells,Unknown,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,,,,,,,,
4692,DRAMP18625,KLKKLLKKWLKLLKKLLK,18,D3-K9L8W-1 (D-amino acid substitution of K9L8W),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 6 and 12 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 18 on the peptide K9L8W. Has hemolytic activity.","[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=2 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=4 μM), Salmonella typhimurium (MIC=2 μM).",[Ref.20363271]HC50=150 μM against human red blood cells,Unknown,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,,,,,,,,
4693,DRAMP18626,KLKKLLKKWLKLLKKLLK,18,D3-K9L8W-2 (D-amino acid substitution of K9L8W),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 5 and 10 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 15 on the peptide K9L8W. Has hemolytic activity.","[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=1 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=4 μM), Salmonella typhimurium (MIC=2 μM).",[Ref.20363271]HC50=116 μM against human red blood cells,Unknown,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,,,,,,,,
4694,DRAMP18628,KLKKLLKKWLKLLKKLLK,18,D6-K9L8W (D-amino acid substitution of K9L8W),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 6 and 12 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 3,15 and 18 on the peptide K9L8W, D-Tryptophan replace L-Tryptophan at the position 9 on the peptide K9L8W. Weak hemolytic activity.","[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=1 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=2 μM);##Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=2 μM), Salmonella typhimurium (MIC=2 μM).",[Ref.20363271]HC50>800 μM against human red blood cells,Unknown,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,,,,,,,,
4695,DRAMP18629,KLKKLLKKWLKLLKKLLK,18,D9-K9L8W-1 (D-amino acid substitution of K9L8W),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 2,6,10,12 and 16 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 4,8,14 and 18 on the peptide K9L8W. Weak hemolytic activity.","[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=1 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=2 μM), Pseudomonas aeruginosa (MIC=2 μM), Salmonella typhimurium (MIC=2 μM).",[Ref.20363271]HC50>800 μM against human red blood cells,Unknown,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,,,,,,,,
4696,DRAMP18630,KLKKLLKKWLKLLKKLLK,18,D9-K9L8W-2 (D-amino acid substitution of K9L8W),No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Alpha helix ,Unknown,Unknown,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. D-Leucine replace L-Leucine at the position 10,12,13,16 and 17 on the peptide K9L8W, D-Lysine replace L-Lysine at the position 11,14,15 and 18 on the peptide K9L8W. Has hemolytic activity.","[Ref.20363271]Gram-positive bacteria: Bacillus subtilis (MIC=2 μM), Staphylococcus epidermidis (MIC=4 μM), Staphylococcus aureus (MIC=4 μM);##Gram-negative bacteria: Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=4 μM), Salmonella typhimurium (MIC=2 μM).",[Ref.20363271]HC50=154 μM against human red blood cells,Unknown,20363271,Peptides. 2010 Jul;31(7):1251-61.,"Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS, Hahm KS, Shin SY.",Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.,,,,,,,,
4697,DRAMP18631,VGHNADLQIKLSIRRLLAAGVLKQTKGVGA,30,H5(61-90) V1 (Histone H5 peptide derivative),No entry found,Derived from Histone H5,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,"Alpha helix, Random coil",The peptide adopts a random coil structure in water and presented an orders alpha-helix structure with 84.2 % alpha-helices in 30 mM SDS,Unknown,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria.  H5(61,[Ref.29402952] Gram-positive bacteria: Listeria monocytogenes (MIC=23.1±8.1μg/mL);##Gram-negative bacterium: Pseudomonas aeruginosa (MIC=16±0 μg/mL),Unknown,Unknown,29402952,Sci Rep. 2018 Feb 5;8(1):2411.,"Jodoin J, Hincke MT.",Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,,,,,,,,
4698,DRAMP18632,LSIRRLLAAGVLKQTKGVGA,20,Peptide H5 (71-90) (Histone H5 peptide derivative),No entry found,Derived from Histone H5,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria. ,[Ref.29402952] Gram-negative bacterium: Pseudomonas aeruginosa (MIC=26.7±14.1 μg/mL),Unknown,Unknown,29402952,Sci Rep. 2018 Feb 5;8(1):2411.,"Jodoin J, Hincke MT.",Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,,,,,,,,
4699,DRAMP18633,VGHNADLQIKLSIRRLLAAGVLKQTKGVGA,30,H5(61-90) V2 (Histone H5 peptide derivative),No entry found,Derived from Histone H5,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,"Alpha helix, Random coil",The peptide adopts a random coil structure in water and presented an orders alpha-helix structure with 75.5 % alpha-helices in 30 mM SDS,Unknown,Function: Antibacterial activity against Gram-negative bacteria. ,[Ref.29402952] Gram-negative bacterium: Pseudomonas aeruginosa (MIC=33.8± 26.3 μg/mL),Unknown,Unknown,29402952,Sci Rep. 2018 Feb 5;8(1):2411.,"Jodoin J, Hincke MT.",Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,,,,,,,,
4700,DRAMP18634,VGHNADLQIKLSIRRLLAAGVLKQTKGVGA,30,H5(61-90) V3 (Histone H5 peptide derivative),No entry found,Derived from Histone H5,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,"Alpha helix, Random coil",The peptide adopts a random coil structure in water and presented an orders alpha-helix structure with 84.7 % alpha-helices in 30 mM SDS,Unknown,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. H5(61,[Ref.29402952] Gram-positive bacteria: Listeria monocytogenes (MIC=106.7± 27.0μg/mL);##Gram-negative bacterium: Pseudomonas aeruginosa (MIC=48.0± 22.4 μg/mL),Unknown,Unknown,29402952,Sci Rep. 2018 Feb 5;8(1):2411.,"Jodoin J, Hincke MT.",Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,,,,,,,,
4701,DRAMP18635,KLIPIASKTCPAGKNLCYKI,20,NCP-0,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unordered structure,The peptide adopts overall content of unordered secondary structure that is 67% ,Unknown,Function: Antibacterial activity against the Gram-negative bacteria.,[Ref.29364903] Gram-negative bacteria: Burkholderia cepacia ATCC 17759(MBC=50μg/ml);Moraxella catarrhalis ATCC 25238(MBC=1.6μg/ml).,Unknown,Unknown,29364903,PLoS One. 2018 Jan 24;13(1):e0190778. ,"Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.",Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,,,,,,,,
4702,DRAMP18636,KLIFILSKTIPAGKNLFYKI,20,NCP-3a (CTX-1 peptide derivative),No entry found,Derived from CTX-1,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix,Unknown,Unknown,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29364903] Gram-positive bacteria: Methicillin-resistant Staphylococcus aureus ATCC 43300 (MBC=6.3 μg/ml), Staphylococcus aureus ATCC 22953 (MBC=12.5 μg/ml), Enterococcus hirae ATCC 10541 (MBC=6.3 μg/ml), Streptococcus agalactiae ATCC 13813 (MBC=3.1 μg/ml);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MBC=6.3 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MBC=25 μg/ml), Acinetobacter baumannii (ornithological, cloacal) (MBC=25 μg/ml), Acinetobacter baumannii (human, urinary) (MBC=25 μg/ml), Klebsiella pneumoniae subsp. pneumoniae (herpetological, cloacal) (MBC=50 μg/ml), Burkholderia cepacia ATCC 17759 (MBC=50 μg/ml), Moraxella catarrhalis ATCC 25238 (MBC=3.1 μg/ml);##Fungi: Candida albicans ATCC 10231 (MBC=6.3 μg/mL), Candida glabrata ATCC 90030 (MBC=25 μg/mL), Malassezia pachydermatis DSMZ 6172 (MBC=6.3 μg/mL)",Unknown,Unknown,29364903,PLoS One. 2018 Jan 24;13(1):e0190778. ,"Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.",Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,,,,,,,,
4703,DRAMP18637,KLILILSKTIPAGKNLFYKI,20,NCP-3b (CTX-1 peptide derivative),No entry found,Derived from CTX-1,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix,Unknown,Unknown,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29364903] Gram-positive bacteria: Methicillin-resistant Staphylococcus aureus ATCC 43300 (MBC=6.3 μg/ml), Staphylococcus aureus ATCC 22953 (MBC=50 μg/ml), Enterococcus hirae ATCC 10541 (MBC=12.5 μg/ml), Streptococcus agalactiae ATCC 13813 (MBC=12.5 μg/ml);##Gram-negative bacterium: Escherichia coli ATCC 25922 (MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MBC=25 μg/ml), Acinetobacter baumannii (ornithological, cloacal) (MBC=25 μg/ml), Acinetobacter baumannii (human, urinary) (MBC=25 μg/ml), Klebsiella pneumoniae subsp. pneumoniae (herpetological, cloacal) (MBC=25 μg/ml), Burkholderia cepacia ATCC 17759 (MBC=25 μg/ml), Moraxella catarrhalis ATCC 25238 (MBC=12.5 μg/ml);##Fungi: Candida albicans ATCC 10231 (MBC=12.5 μg/mL), Candida glabrata ATCC 90030 (MBC=100 μg/mL), Malassezia pachydermatis DSMZ 6172 (MBC=25 μg/mL)",Unknown,Unknown,29364903,PLoS One. 2018 Jan 24;13(1):e0190778. ,"Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.",Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,,,,,,,,
4705,DRAMP18639,CKCRRRKVHGPMIRIRKK,18,CTO17 (TO17 peptide derivative),No entry found,Derived from TO17,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against the Gram-negative bacteria.,[Ref.29183811] Gram-negative bacterium: Vibrio vulnificus (MIC=20 μM).,Unknown,Unknown,29183811,Fish Shellfish Immunol. 2018 Jan;72:639-645. ,"He SW, Wang GH, Yue B, Zhou S, Zhang M.","TO17: A teleost antimicrobial peptide that induces degradation of bacterial nucleic acids and inhibits bacterial infection in red drum, Sciaenops ocellatus.",,,,,,,,
4706,DRAMP18640,KCRRRKVHGPMIRIRKKNL,19,TO19 (TO17 peptide derivative),No entry found,Derived from TO17,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against the Gram-negative bacteria.,[Ref.29183811] Gram-negative bacterium: Vibrio vulnificus (MIC=20 μM).,Unknown,Unknown,29183811,Fish Shellfish Immunol. 2018 Jan;72:639-645.,"He SW, Wang GH, Yue B, Zhou S, Zhang M.","TO17: A teleost antimicrobial peptide that induces degradation of bacterial nucleic acids and inhibits bacterial infection in red drum, Sciaenops ocellatus.",,,,,,,,
4707,DRAMP18641,TWWRWW,6,KCM11,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Low activity against the Gram-negative strains. High activity against the Gram-positive strains,"[Ref.19734717] Gram-negative bacteria: Acidovorax konjaci(MEC=2.5 nM), Pseudomonas syringae pv. tomato DC3000 (MEC=5 nM), Pectobacterium carotovorum subsp. atrosepticum (MEC=5 nM), Xanthomonas albilineans (MEC=0.3 nM), Xanthomonas campestris pv. vesicatoria 833 (MEC=0.3 nM), Xanthomonas campestris pv. vesicatoria 833 pilA (MEC=0.3 nM), Xanthomonas oryzae pv. oryzae 599 (MEC=1.3 nM), Xanthomonas oryzae pv. oryzae 710 (MEC=1.3 nM), Xanthomonas oryzae pv. oryzae 090 (MEC=1.3 nM);##Gram-positive bacterium: Clavibacter michiganensis subsp. michiganensis (MEC=0.3 nM)",Unknown,Unknown,19734717,J Microbiol Biotechnol. 2009 Aug;19(8):792-802.,"Choi J, Moon E.",Identification of novel bioactive hexapeptides against phytopathogenic bacteria through rapid screening of a synthetic combinatorial library.,,,,,,,,
4708,DRAMP18642,KWRWIW,6,KCM12,No entry found,Unknown,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,Function: High activity against E. coli DH5,"[Ref.19734717] Gram-negative bacteria: Acidovorax konjaci (MEC=1.3 nM), Pseudomonas syringae pv. tomato DC3000 (MEC=0.3 nM), Escherichia coli DH5α (MEC=1.3 nM), Pseudomonas putida (MEC=0.6 nM), Pectobacterium carotovorum subsp. carotovorum (MEC=5 nM), Pectobacterium carotovorum subsp. atrosepticum (MEC=0.6 nM), Xanthomonas albilineans (MEC=1.3 nM), Xanthomonas campestris pv. vesicatoria 833 (MEC=0.3 nM), Xanthomonas campestris pv. vesicatoria 833 pilA (MEC=0.3 nM), Xanthomonas oryzae pv. oryzae 599 (MEC=0.2 nM), Xanthomonas oryzae pv. oryzae 710 (MEC=0.2 nM), Xanthomonas oryzae pv. oryzae 090 (MEC=0.2 nM);##Gram-positive bacterium: Clavibacter michiganensis subsp. michiganensis (MEC=0.6 nM).",Unknown,Unknown,19734717,J Microbiol Biotechnol. 2009 Aug;19(8):792-802.,"Choi J, Moon E.",Identification of novel bioactive hexapeptides against phytopathogenic bacteria through rapid screening of a synthetic combinatorial library.,,,,,,,,
4709,DRAMP18643,KWWWRW,6,KCM21,No entry found,Unknown,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,Function: High activity against E. coli DH5,"[Ref.19734717] Gram-negative bacteria: Acidovorax konjaci (MEC=0.6 nM), Pseudomonas syringae pv. tomato DC3000 (MEC=0.6 nM), Escherichia coli DH5α (MEC=1.3 nM), Pseudomonas putida (MEC=1.3 nM), Pectobacterium carotovorum subsp. carotovorum (MEC=5 nM), Pectobacterium carotovorum subsp. atrosepticum (MEC=0.6 nM), Xanthomonas albilineans (MEC=0.2 nM), Xanthomonas campestris pv. vesicatoria 833 (MEC=0.2 nM), Xanthomonas campestris pv. vesicatoria 833 pilA (MEC=0.2 nM), Xanthomonas oryzae pv. oryzae 599 (MEC=0.2 nM), Xanthomonas oryzae pv. oryzae 710 (MEC=0.3 nM), Xanthomonas oryzae pv. oryzae 090 (MEC=0.3 nM);##Gram-positive bacterium: Clavibacter michiganensis subsp. michiganensis (MEC=0.3 nM).",Unknown,Unknown,19734717,J Microbiol Biotechnol. 2009 Aug;19(8):792-802.,"Choi J, Moon E.",Identification of novel bioactive hexapeptides against phytopathogenic bacteria through rapid screening of a synthetic combinatorial library.,,,,,,,,
4710,DRAMP18644,WRWFIH,6,KRS22,No entry found,Unknown,Unknown,Synthetic construct,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: High activity against XCV833 and CM at the high concentration,"[Ref.19734717] Gram-negative bacteria: Acidovorax konjaci (MEC=5 nM), Pseudomonas syringae pv. tomato DC3000 (MEC=2.5 nM), Escherichia coli DH5α (MEC=5 nM), Pectobacterium carotovorum subsp. atrosepticum (MEC=2.5 nM), Xanthomonas albilineans (MEC=2.5 nM), Xanthomonas campestris pv. vesicatoria 833 (MEC=2.5 nM), Xanthomonas campestris pv. vesicatoria 833 pilA (MEC=2.5 nM), Xanthomonas oryzae pv. oryzae 599 (MEC=0.6 nM), Xanthomonas oryzae pv. oryzae 710 (MEC=1.3 nM), Xanthomonas oryzae pv. oryzae 090 (MEC=0.3 nM);##Gram-positive bacterium: Clavibacter michiganensis subsp. michiganensis (MEC=1.3 nM).",Unknown,Unknown,19734717,J Microbiol Biotechnol. 2009 Aug;19(8):792-802.,"Choi J, Moon E.",Identification of novel bioactive hexapeptides against phytopathogenic bacteria through rapid screening of a synthetic combinatorial library.,,,,,,,,
4713,DRAMP18647,RKWLFW,6,PAF34,No entry found,Unknown,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal, Anti-Gram-, ",Synthetic,Unknown,Unknown,Unknown,"Function: Antifungal activity against Penicillium digitatum PHI-26, Penicillium italicum PHI-1, Penicillium expansum CMP-1, Botrytis cinerea CECT2100, Saccharomyces cerevisiae W303-1A . Antibacterial activity against Escherichia coli DH5","[Ref.11976121] Fungi: Penicillium digitatum PHI-26 (MIC=40 μM, IC50=15 ± 1 μM), Penicillium italicum PHI-1 (MIC=20 μM, IC50=12 ± 4 μM), Penicillium expansum CMP-1 (MIC=160 μM, IC50> 80 μM), Botrytis cinerea CECT2100 (MIC=60 μM), Saccharomyces cerevisiae W303-1A (MIC>160 μM, IC50=52 ± 22 μM);##Gram-negative bacterium: Escherichia coli DH5α(MIC=160 μM, IC50>80 μM).",Unknown,Unknown,11976121,Appl Environ Microbiol. 2002 May;68(5):2453-60.,"López-García B, Pérez-Payá E, Marcos JF.",Identification of novel hexapeptides bioactive against phytopathogenic fungi through screening of a synthetic peptide combinatorial library.,,,,,,,,
4714,DRAMP18648,FVPWFSKFLPRIL,13,"[Pro3,DLeu9]TL(3) (Temporin L peptide derivative)",No entry found,Derived from Temporin L,Unknown,Synthetic construct,"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Synthetic,Alpha helix,The analogues bearing a D residue showed a reduction in the percentage of helicity compared to the corresponding L analogues in the MMs ,Unknown,"Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(3) is D-Leucine, D-Proline replace L-Proline at the position 10 on the  peptide [Pro3,DLeu9]TL(2).","[Ref.28863356] Gram-positive bacterium: Bacillus megaterium Bm11 (MIC=3.125μM), Staphylococcus epidermidis ATCC 12228 (MIC=25μM);##Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MIC=50μM), Escherichia coli D21 (MIC=50μM), Pseudomonas syringae pv tabaci 1918 (MIC=50μM);##Yeasts: Candida albicans ATCC 10231 (MIC=3.125μM), Candida crusei ATCC 6258 (MIC=3.125μM).",Unknown,Unknown,28863356,Eur J Med Chem. 2017 Oct 20;139:750-763.,"Merlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.","Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities",,,,,,,,
4715,DRAMP18649,FQWQRNPRKVR,11,HLP6 (HLP2  peptide derivative),No entry found,Derived from the peptide HLP 2,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria and Gram-positive bacteria.  HLP 6 had a proline substituted for methionine in HLP 2.,[Ref.9596699] Gram-negative bacteria: Escherichia coli NCTC 10418 (MIC=750 μM);##Gram-negative bacterium: Staphylococcus aureus (MIC=250 μM);##Clinical isolates: Acinetobacter sp.(MIC=10 μM).,Unknown,Unknown,9596699,Infect Immun. 1998 Jun;66(6):2434-40.,"Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW.",Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.,,,,,,,,
4716,DRAMP18650,FQWQRNMRKVR,11,HLP7 (HLP2  peptide derivative),No entry found,Derived from the peptide HLP 2,Unknown,Synthetic construct,"Antibacterial, Anti-Gram-, Antimicrobial",Synthetic,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. HLP 7 was the d form of HLP 2.,"[Ref.9596699] Gram-negative bacteria: Escherichia coli NCTC 8007 (MIC=18 μM), Escherichia coli NCTC 10418 (MIC=40 μM);##Gram-negative bacterium: Staphylococcus aureus (MIC=14 μM);##Clinical isolates: Acinetobacter sp. (MIC=0.3 μM), Klebsiella sp. strain 3105 (MIC=80 μM), Providencia stuartii (MIC=110 μM).",Unknown,Unknown,9596699,Infect Immun. 1998 Jun;66(6):2434-40.,"Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW.",Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.,,,,,,,,
4722,DRAMP18656,MRTGNAD,7,"Microcin 7 (Bacteriocin; Escherichia coli, Bacteria)",No entry found,Bacteriocin,Unknown,Escherichia coli,"Antibacterial, Anti-Gram-, Antimicrobial",Natural,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.2861788] Gram-negative bacteria: Escherichia coli , Klebsiella pneumoniae, Salmonella typhi, Salmonella typhimurium, Salmonella sp., Shigella flexneri, Shigella sp., Proteus mirabilis",Unknown,Unknown,2861788,Antimicrob Agents Chemother. 1985 May;27(5):791-7.,"Garcia-Bustos JF, Pezzi N, Mendez E.","Structure and mode of action of microcin 7, an antibacterial peptide produced by Escherichia coli.",,,,,,,,
4724,DRAMP18658,FLPIVAKLLSGLL,13,"Temporin-PE (Edible frogs, amphibians, animals)",A0A2H4WAJ8,Unknown,Unknown,Pelophylax kl.esculentus(Europe edible frog),"Antimicrobial, Antibacterial, Anitifungal, Anticancer, Anti-Gram+, Anti-Gram-, ",Protein level,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.Has hemolytic activity.","[Ref.29191658]Gram-positive bacteria: Staphylococcus aureus (MIC=2.0 μM), Methicillin-resistant Staphylococcus aureus (MIC=4.0 μM), Enterococcus faecalis (MIC=8.0 μM);##Gram-negative bacteria: Escherichia coli (MIC=16.0 μM);##Fungus: Candida albicans (MIC=4.0 μM).##Cancer cell lines: NCI-H157 (IC50=34.56 μM), U251MG (IC50=25.13 μM), PC-3 (IC50=38.56 μM), MDA-MB-435s (IC50=33.23 μM), HMEC-1 (IC50=58.62 μM).",[Ref.29191658]HC50=39.64 μM against horse red blood cells,Unknown,29191658,Biochem Biophys Res Commun. 2018 Jan 22;495(4):2539-2546.,"Sang M, Wu Q, Xi X, Ma C, Wang L, Zhou M, Burrows JF, Chen T.","Identification and target-modifications of temporin-PE: A novel antimicrobial peptide in the defensive skin secretions of the edible frog, Pelophylax kl. esculentus.",,,,,,,,
4725,DRAMP18659,VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND,32,"YFGAP-OH(Yellowfin tuna GAPDH-related antimicrobial peptide; fish, animals)",No entry found,Unknown,Unknown,Yellowfin tuna (Thunnus albacares),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Alpha helix and  Beta strands,One Alpha helix and two parallel Beta strands,Unknown,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacterial.Weak hemolytic activity.
YFGAP-OH is the C-terminus amidated modification of YFGAP.","[Ref.22771964]Gram-positive bacteria: Bacillus subtilis KCTC1021 (MIC=13.0 μg/ml), Bacillus subtilis RM125 (MIC=1.2 μg/ml), Micrococcus luteus ATCC9341 (MIC=6.5 μg/ml), Staphylococcus aureus RM4220 (MIC=125.0 μg/ml), Staphylococcus aureus KCTC1621 (MIC=11.0 μg/ml), Streptococcus iniae FP5229 (MIC=17.0 μg/ml);##Gram-negative bacteria: Escherichia coli D31 (MIC=6.2 μg/ml), Escherichia coli KCTC1116 (MIC=5.0 μg/ml), Escherichia coli ML35p (MIC=3.0 μg/ml), Enterobacter cloacae KCTC1685 (MIC=12.0 μg/ml), Pseudomonas aeroginosa KCTC2004 (MIC=3.7 μg/ml), Salmonella enterica KCTC2514 (MIC=3.1 μg/ml), Shigella flexneri KCTC2517 (MIC=5.0 μg/ml), Aeromonas hydrophila KCTC2358 (MIC=8.0 μg/ml), Vibrio parahemolyticus KCCM41664 (MIC=3.2 μg/ml)",[Ref.22771964]0.4% hemolysis at 100 μg/ml against human red blood cells,Unknown,22771964,Fish Shellfish Immunol. 2012 Oct;33(4):743-52. doi: 10.1016/j.fsi.2012.06.023.,"Seo JK, Lee MJ, Go HJ, Park TH, Park NG.","Purification and characterization of YFGAP, a GAPDH-related novel antimicrobial peptide, from the skin of yellowfin tuna, Thunnus albacares.",,,,,,,,
4726,DRAMP18660,VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND,32,"YFGAP-NH2(Yellowfin tuna GAPDH-related antimicrobial peptide; fish, animals)",No entry found,Unknown,Unknown,Yellowfin tuna(Thunnus albacares),"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Alpha helix and  Beta strands,One Alpha helix and two parallel Beta strands,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.
YFGAP-NH2 is the C-terminus free forms of YFGAP.","[Ref.22771964]Gram-positive bacteria: Bacillus subtilis KCTC1021 (MIC=5.4 μg/ml), Bacillus subtilis RM125 (MIC=0.7 μg/ml), Micrococcus luteus ATCC9341 (MIC=6.0 μg/ml), Staphylococcus aureus RM4220 (MIC=34.0 μg/ml), Staphylococcus aureus KCTC1621 (MIC=3.7 μg/ml);##Gram-negative bacteria: Escherichia coli D31 (MIC=1.9 μg/ml), Escherichia coli KCTC1116 (MIC=3.3 μg/ml), Escherichia coli ML35p (MIC=0.4 μg/ml), Enterobacter cloacae KCTC1685 (MIC=3.5 μg/ml), Pseudomonas aeroginosa KCTC2004 (MIC=1.7 μg/ml), Salmonella enterica KCTC2514 (MIC=0.9 μg/ml), Shigella flexneri KCTC2517 (MIC=2.0 μg/ml), Aeromonas hydrophila KCTC2358 (MIC=3.6 μg/ml), Vibrio parahemolyticus KCCM41664 (MIC=0.9 μg/ml);##Fungi: Candida albicans KCTC7965 (MIC=125.0 μg/ml)",[Ref.22771964]2.7% hemolysis at 100 μg/ml against human red blood cells,Unknown,22771964,Fish Shellfish Immunol. 2012 Oct;33(4):743-52. doi: 10.1016/j.fsi.2012.06.023.,"Seo JK, Lee MJ, Go HJ, Park TH, Park NG.","Purification and characterization of YFGAP, a GAPDH-related novel antimicrobial peptide, from the skin of yellowfin tuna, Thunnus albacares.",,,,,,,,
4727,DRAMP18661,GWLDVAKKIGKAAFNVAKNFL,21,"Ctx-Ha (Frogs, amphibians, animals)",No entry found,Belongs to the Ceratotoxin family,Unknown,Hypsiboas albopunctatus,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.",[Ref.22391524]Gram-positive bacterium: Staphylococcus aureus (MIC=1.7 μmol/L; MMC=6.8 μmol/L);##Gram-negative bacterium: Escherichia coli (MIC=3.4 μmol/L; MMC=3.4 μmol/L);##Fungi: Candida albicans (MIC=54.6 μmol/L; MMC<100 μmol/L),[Ref.22391524]HC50=37.3±1.4 μmol/L against human red blood cells,Unknown,22391524,Antimicrob Agents Chemother. 2012 Jun;56(6):3004-10.,"Lorenzón EN, Cespedes GF, Vicente EF, Nogueira LG, Bauab TM, Castro MS, Cilli EM.",Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.,,,,,,,,
4728,DRAMP18662,LLAGLAANFLPKIFCKITRKC,21,"Brevinin 21 (Brevinin-1E truncated peptide 21; Frogs, amphibians, animals)",No entry found,Derived from the peptide Brevinin-1E ,Unknown,Rana esculenta,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.9748603]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC=12.5 μg/ml), Methicillin resistant Staphylococcus aureus (MIC=25 μg/ml), Micrococcus luteus ATCC 9341 (MIC=6.25 μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 2592 (MIC=12.5 μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=12.5 μg/ml);##Fungus: Candida albicans ATCC 36232 (MIC=6.25 μg/ml).",[Ref.9748603]HD50=77 μg/ml(oxidized); HD50=110 μg/ml(reduced) against mouse red blood cells,Unknown,9748603,Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.,"Kwon MY, Hong SY, Lee KH.","Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta.",,,,,,,,
4729,DRAMP18663,GLAANFLPKIFCKITRKC,18,"Brevinin 18 (Brevinin-1E truncated peptide 18; Frogs, amphibians, animals)",No entry found,Derived from the peptide Brevinin-1E ,Unknown,Rana esculenta,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Has hemolytic activity.","[Ref.9748603]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC=25 μg/ml), Methicillin resistant Staphylococcus aureus (MIC=100 μg/ml), Micrococcus luteus ATCC 9341 (MIC=12.5 μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 2592 (MIC=25 μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=12.5 μg/ml);##Fungus: Candida albicans ATCC 36232 (MIC=25 μg/ml).",[Ref.9748603]HD50=146 μg/ml(oxidized); HD50=230 μg/ml(reduced) against mouse red blood cells,Unknown,9748603,Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.,"Kwon MY, Hong SY, Lee KH.","Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta.",,,,,,,,
4730,DRAMP18664,ANFLPKIFCKITRKC,15,"Brevinin 15 (Brevinin-1E truncated peptide 15; Frogs, amphibians, animals)",No entry found,Derived from the peptide Brevinin-1E ,Unknown,Rana esculenta,"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Alpha helix ,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.9748603]Gram-positive bacteria: Staphylococcus aureus ATCC 6538 (MIC=100 μg/ml), Micrococcus luteus ATCC 9341 (MIC=25 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 2592 (MIC=50 μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=50 μg/ml);##Fungus: Candida albicans ATCC 36232 (MIC=50 μg/ml).",Unknown,Unknown,9748603,Biochim Biophys Acta. 1998 Sep 8;1387(1-2):239-48.,"Kwon MY, Hong SY, Lee KH.","Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta.",,,,,,,,
4731,DRAMP18665,INLKALAALAKKIL,14,"Mastoparan-L (MP-L; insects, arthropods, invertebrates, animals)",P01514,Belongs to the tetradecapeptide family,Unknown,Vespula lewisii (Korean yellow-jacket wasp) (Vespula flaviceps lewisii),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Alpha helix ,Unknown,1D7N resolved by NMR.,"Function: Mast cell degranulating peptide. Activates G proteins that couple to phospholipase C. May be able to switch from an in-plane to a transmembrane orientation in lipid bilayers. Antibacterial activity against Gram-positive bacteria and  Gram-negative bacteria. Has hemolytic activity.
PTM: Leucine amide at the position 14.
Tissue specificity: Expressed by the venom gland.","[Ref.27423268]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=12.5 μM), Enterococcus faecalis ATCC 29212 (MIC=25 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=25 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=50 μM), Klebsiella pneumoniae ATCC 13883 (MIC=12.5 μM), Acinetobacter baumannii ATCC 19606 (MIC=2.7 μM)",[Ref.27423268]40% hemolysis at 10μM against rat red blood cells,Unknown,27423268,Biochim Biophys Acta. 2016 Nov;1858(11):2699-2708.,"Irazazabal LN, Porto WF, Ribeiro SM, Casale S, Humblot V, Ladram A, Franco OL.",Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan.,,,,,,,,
4732,DRAMP18666,GLGSVFGRLARILGRVIPKV,20,"P1 (Pilosulin-1 1-20; Ant, insects, arthropods, invertebrates, animals)",Q07932,"Derived from the peptide Pilosulin-1, Belongs to the pilosulin family.",Unknown,Myrmecia pilosula (Jumper ant),"Antimicrobial, Antibacterial, Anitifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Alpha helix ,Unknown,5X3L resolved by NMR.,"Function: Has strong cytotoxic and hemolytic activities. Is more potent against mononuclear leukocytes than against granulocytes. Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi. Adopts an alpha-helical structure.
Allergenic properties: Causes an allergic reaction in human. Binds to IgE.","[Ref.15639237]Gram-positive bacteria: Staphylococcus aureus 710A (MIC=4 μM), Bacillus megaterium BM11 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli ML-35 (MIC=2 μM), Pseudomonas aeruginosa ATCC27853 (MIC=8 μM), Salmonella typhimurium ATCC14028 (MIC=8 μM).##Drug resistant clinical isolates: Staphylococcus simulans 22 (MIC=2 μM), Micrococcus luteus (MIC=0.5 μM), Enterococcus spp. I-11305b (MIC=2 μM), Enterococcus spp. I-11054 (MIC=2 μM), Staphylococcus haemolyticus I-10925 (MIC=2 μM), Staphylococcus epidermidis LT1324 (MIC=2 μM), Staphylococcus aureus 5185 (MIC=2 μM), Staphylococcus aureus I-11574 (MIC=2 μM), Staphylococcus aureus LT1338 (MIC=3 μM), Staphylococcus aureus T1334 (MIC=1.5 μM), Citrobacter freundii I-11090 (MIC=2 μM), Klebsiella pneumoniae I-10910 (MIC=2 μM), Escherichia coli I-11276b (MIC=4 μM), Escherichia coli O-19592 (MIC=2 μM), Stenotrophomonas maltophilia O-16451 (MIC=2 μM), Stenotrophomonas maltophilia I-10717 (MIC=2 μM), Pseudomonas aeruginosa 4991 (MIC=4 μM), Pseudomonas aeruginosa I-10968 (MIC=4 μM), Candida albicans I-11301 (MIC=4 μM).","[Ref.15639237]20% hemolysis at 10μM, 100% hemolysis at 100μM against human red blood cells",Unknown,15639237,Arch Biochem Biophys. 2005 Feb 15;434(2):358-64.,"Zelezetsky I, Pag U, Antcheva N, Sahl HG, Tossi A.",Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin.,,,,,,,,
4733,DRAMP18667,KETWWETWWTEWSQPKKKRKV,21,Pep-1,No entry found,Unknown,Unknown,Derived from the nuclear localization sequence of simian virus 40 large T antigen,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive bacteria.No hemolytic activity.,"[Ref.16945333]Gram-positive bacteria: Bacillus subtilis (KCTC 3068) (MIC=8.0 μM), Staphylococcus aureus (KCTC 1621) (MIC=64.0 μM), Staphylococcus epidermidis (KCTC 1917) (MIC=64.0 μM);##Gram-negative bacteria: Escherichia coli (KCTC 1682) (MIC=32.0 μM);##Antibiotic-resistant bacteria: MDRPA 1 (CCARM 2092) (MIC=32.0 μM), MDRPA 3 (CCARM 2109) (MIC=32.0 μM).",[Ref.16945333]Non-hemolysis at 200 μM against human red blood cells,Unknown,16945333,Biochem Biophys Res Commun. 2006 Oct 20;349(2):769-74.,"Zhu WL, Lan H, Park IS, Kim JI, Jin HZ, Hahm KS, Shin SY.",Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1.,,,,,,,,
4734,DRAMP18668,PSVQGAAAQLTADVKK,16,AI-hemocidins 1 (Hb-1  truncated peptide),No entry found,Belongs to truncated Hb-1 ,Unknown,Arca inflata,"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against the Gram-negative bacteria.,"[Ref.28661457] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=47.35 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=47.35 μM), Pseudomonas aeruginosa clinical isolate (MIC=47.35 μM).",Unknown,Unknown,28661457,Mar Drugs. 2017 Jun 29;15(7). pii: E205.,"Li C, Zhu J, Wang Y, Chen Y, Song L, Zheng W, Li J, Yu R.","Antibacterial Activity of AI-Hemocidin 2, a Novel N-Terminal Peptide of Hemoglobin Purified from Arca inflata",,,,,,,,
4735,DRAMP18669,ISAAEFGKINGPIKK,15,AI-hemocidins 3 (Hb-1  truncated peptide),No entry found,Belongs to truncated Hb-1 ,Unknown,Arca inflata,"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against the Gram-negative bacteria.,[Ref.28661457] Gram-negative bacterium: Pseudomonas aeruginosa ATCC 27853 (MIC=95.37 μM).,Unknown,Unknown,28661457,Mar Drugs. 2017 Jun 29;15(7). pii: E205.,"Li C, Zhu J, Wang Y, Chen Y, Song L, Zheng W, Li J, Yu R.","Antibacterial Activity of AI-Hemocidin 2, a Novel N-Terminal Peptide of Hemoglobin Purified from Arca inflata",,,,,,,,
4737,DRAMP18671,KCRRRKVHGPMIRIRKK,17,TO17 (TFPI-1 C-terminal peptide),No entry found,Belongs to the TFPI-1 C-terminal peptide,Unknown,Red drum (Sciaenops ocellatus),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria.,"[Ref.29183811] Gram-positive bacteria: Micrococcus luteus (MIC=9 μM; MBC=18 μM), Staphylococcus aureus (MIC=4 μM; MBC=8 μM);##Gram-negative bacterium: Vibrio vulnificus (MIC= 80 μM; MBC=80 μM).",Unknown,Unknown,29183811,Fish Shellfish Immunol. 2018 Jan;72:639-645. ,"He SW, Wang GH, Yue B, Zhou S, Zhang M.","TO17: A teleost antimicrobial peptide that induces degradation of bacterial nucleic acids and inhibits bacterial infection in red drum, Sciaenops ocellatus.",,,,,,,,
4738,DRAMP18672,APPPGLSAGV,10,"Peptide 7 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Unknown,Unknown,Marine snail Rapana venosa,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,Unknown,Unknown,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,,,,,,,,
4739,DRAMP18673,ELVRKNVDHLSTPDVLELV,19,"Peptide 3 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Unknown,Unknown,Marine snail Rapana venosa,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,Unknown,Unknown,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,,,,,,,,
4740,DRAMP18674,SPPNQPSIMTFDYAKTNK,18,"Peptide 2 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Unknown,Unknown,Marine snail Rapana venosa,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,Unknown,Unknown,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,,,,,,,,
4741,DRAMP18675,SLPPTLEEEFNMKKMG,16,"Peptide 4 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Unknown,Unknown,Marine snail Rapana venosa,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,Unknown,Unknown,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,,,,,,,,
4742,DRAMP18676,SPPSEQLGKSFNF,13,"Peptide 5 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Unknown,Unknown,Marine snail Rapana venosa,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,Unknown,Unknown,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,,,,,,,,
4743,DRAMP18677,SPPPGESKVDMSFNYALSNPAQ,22,"Peptide 6 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Unknown,Unknown,Marine snail Rapana venosa,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,Unknown,Unknown,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,,,,,,,,
4744,DRAMP18678,APPPGYAMESDSFS,14,"Peptide 8 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Unknown,Unknown,Marine snail Rapana venosa,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,Unknown,Unknown,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,,,,,,,,
4745,DRAMP18679,FPPPGESAVDMSFFYALSNP,20,"Peptide 9 (Mollusca/molluscs/mollusks, invertebrates, animals)",No entry found,Unknown,Unknown,Marine snail Rapana venosa,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-positive and Gram-negative bacterium. ,[Ref.21703315] Gram-positive bacterium: Staphylococcus aureus;##Gram-negative bacterium: Klebsiella pneumoniae ,Unknown,Unknown,21703315,Peptides. 2011 Jul;32(7):1477-83.,"Dolashka P, Moshtanska V, Borisova V, Dolashki A, Stevanovic S, Dimanov T, Voelter W.",Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa.,,,,,,,,
4759,DRAMP18693,RPKPQQFFGLM,11,"Substance P (Mammals, animals)","P67932, P67933",Belongs to the tachykinin family.,TAC1,Unknown,"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,"Function: Substance P possesses direct antimicrobial activity. Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.12074933]Gram-negative bacteria: Escherichia coli (MIC=0.06%), Proteus vulgaris (MIC=0.13%), Pseudomonas aeruginosa (MIC=0.13%) ;##Gram-positive bacteria: Staphylococcus aureus (MIC=0.007%), Enterococcus faecalis (MIC=0.13%);##Yeast: Candida albicans (MIC=0.25%)",Unknown,Unknown,12074933,Life Sci. 2002 Jul 5;71(7):747-50.,"Kowalska K, Carr DB, Lipkowski AW.",Direct antimicrobial properties of substance P.,,,,,,,,
4760,DRAMP18694,RPKPQQWFWLM,11,"substance P antagonist (Mammals, animals)",No entry found,Unknown,Unknown,Unknown,"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.12074933]Gram-negative bacteria: Escherichia coli (MIC=0.13%), Proteus vulgaris (MIC=0.13%), Pseudomonas aeruginosa (MIC=0.13%) ;##Gram-positive bacteria: Staphylococcus aureus (MIC=0.13%), Enterococcus faecalis (MIC=0.13%);##Yeast: Candida albicans (MIC=0.03%).",Unknown,Unknown,12074933,Life Sci. 2002 Jul 5;71(7):747-50.,"Kowalska K, Carr DB, Lipkowski AW.",Direct antimicrobial properties of substance P.,,,,,,,,
4762,DRAMP18696,FQWQRNMRKVRGPPVS,16,HLP1 (Lactotransferrin truncated peptide),"P02788, A0A161I202",Belongs to the Lactotransferrin,LTF,Homo sapiens (Human),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,"Function: Has antimicrobial activity, which depends on the extracellular cation concentration. Antimicrobial properties include bacteriostasis, which is related to its ability to sequester free iron and thus inhibit microbial growth, as well as direct bactericidal properties leading to the release of lipopolysaccharides from the bacterial outer membrane. Can also prevent bacterial biofilm development in P.aeruginosa infection. Has weak antifungal activity against C.albicans. HLP 1 corresponded to the loop region of human lactoferricin (residues 20 to 35).","[Ref.9596699] Gram-negative bacteria: Escherichia coli NCTC 8007 (MIC=500 μM), Escherichia coli NCTC 10418 (MIC=500μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=500 μM);##Clinical isolates: Acinetobacter sp.(MIC=2 μM).",Unknown,Unknown,9596699,Infect Immun. 1998 Jun;66(6):2434-40.,"Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW.",Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.,,,,,,,,
4763,DRAMP18697,FQWQRNMRKVR,11,HLP2 (Lactotransferrin truncated peptide),"P02788, A0A161I202",Belongs to the Lactotransferrin,Unknown,Homo sapiens (Human),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Unknown,Unknown,Unknown,Function: Antibacterial activity against Gram-negative bacteria and Gram-positive bacteria. HLP 2 corresponded to the alpha-helical region of the loop in its native conformation (residues 20 to 30).,"[Ref.9596699] Gram-negative bacteria: Escherichia coli NCTC 8007 (MIC=290 μM), Escherichia coli NCTC 10418 (MIC=579 μM);##Gram-positive bacterium: Staphylococcus aureus (MIC=14 μM);##Clinical isolates: Acinetobacter sp. (MIC=0.86 μM), Enterobacter aerogenes (MIC=290 μM), Klebsiella sp. strain 3105 (MIC=290 μM).",Unknown,Unknown,9596699,Infect Immun. 1998 Jun;66(6):2434-40.,"Chapple DS, Mason DJ, Joannou CL, Odell EW, Gant V, Evans RW.",Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.,,,,,,,,
4765,DRAMP18699,FLGGLLASLLGKI,13,"Pleurain-B1 (Frogs, amphibians, animals)","B5L1B2, B5L1B4, B5L1B6, B5L1B3",Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Unknown,Rana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.19028675]Gram-negative bacterium: Escherichia coli(MIC=25 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=3.1 μg/ml), Bacillus subtilis (MIC=3.1 μg/ml);##Yeast: Candida albicans (MIC=1.6μg /ml).",Unknown,Unknown,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,,,,,,,,
4766,DRAMP18700,YPELQQDLIARLL,13,"Pleurain-C1 (Frogs, amphibians, animals)",B5L1A8,Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Unknown,Rana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.3 μg/ml), Bacillus subtilis (MIC=3.1 μg/ml);##Yeast: Candida albicans(MIC=25 μg/ml).",Unknown,Unknown,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,,,,,,,,
4767,DRAMP18701,FRSGILKLASKIPSVLCAVLKNC,23,"Pleurain-D4 (Frogs, amphibians, animals)",B5L1I4,Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Unknown,Rana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μg/ml), Bacillus subtilis (MIC=50 μg/ml);##Yeast: Candida albicans(MIC=25 μg/ml).",Unknown,Unknown,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,,,,,,,,
4768,DRAMP18702,AKAWGIPPHVIPQIVPVRIRPLCGNV,26,"Pleurain-E1 (Frogs, amphibians, animals)",B5L1I5,Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Unknown,Rana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.",[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=25 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6..3 μg/ml)##Yeast: Candida albicans (MIC=25 μg/ml).,Unknown,Unknown,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,,,,,,,,
4769,DRAMP18703,GFWDSVKEGLKNAAVTILNKIKCKISECPPA,31,"Pleurain-G1 (Frogs, amphibians, animals)",B5L1I8,Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Unknown,Rana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=50 μg/ml), Bacillus subtilis (MIC=100 μg/ml);##Yeast: Candida albicans(MIC=12.5 μg/ml).",Unknown,Unknown,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,,,,,,,,
4770,DRAMP18704,FIPGLRRLFATVVPTVVCAINKLPPG,26,"Pleurain-J1 (Frogs, amphibians, animals)",B5L1L0,Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Unknown,Rana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=12.5 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μg/ml), Bacillus subtilis (MIC=50 μg/ml);##Yeast: Candida albicans(MIC=6.3 μg/ml).",Unknown,Unknown,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,,,,,,,,
4771,DRAMP18705,GFFDRIKALTKNVTLELLNTITCKLPVTPP,30,"Pleurain-N1 (Frogs, amphibians, animals)",B5L1L8,Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Unknown,Rana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.",[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=50 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μg/ml);##Yeast: Candida albicans (MIC=12.5 μg/ml).,Unknown,Unknown,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,,,,,,,,
4772,DRAMP18706,CVHWMTNTARTACIAP,16,"Pleurain-R1 (Frogs, amphibians, animals)",No entry found,Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Unknown,Rana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Unknown,Unknown,Unknown,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.19028675]Gram-negative bacterium: Escherichia coli (MIC=100 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=25 μg/ml), Bacillus subtilis (MIC=100 μg/ml);##Yeast: Candida albicans(MIC=50 μg/ml).",Unknown,Unknown,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,,,,,,,,
4773,DRAMP18707,RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPL,60,"BACTENECIN 7 (bac 7, Pro-rich; bovine cathelicidin, cattle, ruminant, mammals, animals)",P19661,Belongs to the cathelicidin family.,CATHL3,Bos taurus (Bovine neutrophils),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Unknown,Rich,Unknown,5HAU,"Function: Antibacterial activity against an array of gram-negative and gram-positive bacteria.
PTM: Elastase is responsible for its maturation.","[Ref.2777377] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=12 μg/ml in Murller-Hinton, MIC=50 μg/ml in Iso-Sensitest), Salmonella typhimurium LT2 (MIC=12 μg/ml in Murller-Hinton, MIC=200 μg/ml in Iso-Sensitest), Salmonella typhimurium ATCC 14028 (MIC=25 μg/ml in Murller-Hinton, MIC=100 μg/ml in Iso-Sensitest), Klebsiella pneumoniae ATCC 13883 (MIC=12 μg/ml in Murller-Hinton, MIC=200 μg/ml in Iso-Sensitest), Enterobacter cloacae ATCC 13047 (MIC=25 μg/ml in Murller-Hinton, MIC=200 μg/ml in Iso-Sensitest), Pseudomonas aeruginosa ATCC 7700 (MIC=50 μg/ml in Murller-Hinton);##Gram-positive bacterium: Staphylococcus epidermidis ATCC 12228 (MIC=200 μg/ml in Murller-Hinton, MIC=200 μg/ml in Iso-Sensitest).",Unknown,Unknown,2777377,Infect Immun. 1989 Oct;57(10): 3142-6.,"Gennaro R, Skerlavaj B, Romeo D.","Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils.",,,,,,,,
4774,DRAMP18708,ALWMTLLKKVLKAAAKAALNAVLVGANA,28,"Dermaseptin-S4 (DRS-S4, DS4; frog, amphibians, animals)",P80280,Belongs to the frog skin active peptide (FSAP) family. ,Unknown,Phyllomedusa sauvagei (Sauvage's leaf frog),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Unknown,Alpha helix ,Unknown,2DD6,"Function: Possesses a potent antimicrobial activity against Gram-negative and Gram-positive bacteria, fungi, protozoa, and the enveloped herpes simplex virus type 1. Probably acts by disturbing membrane functions with its amphipathic structure. Binds to healthy erythrocytes (this binding is receptor independent), and has strong hemolytic activity. Does not bind to P.falciparum infected erythrocytes, but accumulates within the parasite. Kills the parasite, and only at high concentrations has a hemolytic activity on the host cell.","[Swiss_Prot Entry P80280]Possesses a potent antimicrobial activity against Gram-negative and Gram-positive bacteria, fungi, protozoa, and the enveloped herpes simplex virus type 1",[Swiss_Prot Entry P80280]Strong hemolytic activity,Unknown,8306981,Eur. J. Biochem. 1994; 219:145-154.,"Mor A, Nicolas P.",Isolation and structure of novel defensive peptides from frog skin.,,,,,,,,
4778,DRAMP18712,GFGKAFHSVSNFAKKHKTA,19,"Styelin A (Tunicate, invertebrates, animals)",P81469,Belongs to the Cecropins family.,Unknown,Styela clava (Sea squirt),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Helix ,Unknown,Unknown,"Function: Bactericidal against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemocytes and pharyngeal tissues.","[Ref.9467865] Gram positive bacteria: Listeria monocytogenes EGD (MIC=2 μg/ml), Staphylococcus aureus 930918-3 (MIC=6 μg/ml), Enterococcus faecalis 94.132 (MIC=2 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa MR 3007 (MIC=4 μg/ml), Escherichia coli ML-35p (MIC=2.7 μg/ml), Salmonella typhimurium 14028S (MIC=5 μg/ml).",Unknown,Unknown,9467865,Comp. Biochem. Physiol. 1997; 118:515-521,"Lee IH, Cho Y, Lehrer RI.","Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava.",,,,,,,,
4779,DRAMP18713,GFGPAFHSVSNFAKKHKTA,19,"Styelin B (Tunicate, invertebrates, animals)",P81470,Belongs to the Cecropins family.,Unknown,Styela clava (Sea squirt),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Helix ,Unknown,Unknown,"Function: Bactericidal against several Gram-positive and Gram-negative bacteria.
Tissue specificity: Hemocytes and pharyngeal tissues.","[Ref.9467865] Gram positive bacteria: Listeria monocytogenes EGD (MIC=2 μg/ml), Staphylococcus aureus 930918-3 (MIC=6 μg/ml), Enterococcus faecalis 94.132 (MIC=2 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa MR 3007 (MIC=4.5 μg/ml), Escherichia coli ML-35p (MIC=2.7 μg/ml), Salmonella typhimurium 14028S (MIC=5 μg/ml).",Unknown,Unknown,9467865,Comp. Biochem. Physiol. 1997; 118:515-521,"Lee IH, Cho Y, Lehrer RI.","Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava.",,,,,,,,
4782,DRAMP18716,PDPAKTAPKKGSKKAVTKA,19,"Histone H2B-1(HLP-1) (fish, animals)",P81903,Belongs to the histone H2B family.,Unknown,Ictalurus punctatus (Channel catfish) (Silurus punctatus),"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,The nucleosome is a histone octamer ,Unknown,Unknown,"Function: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. Has broad-spectrum antimicrobial and antibacterial activity. It is important in the antimicrobial defenses of fish skin and possesses strong activity against saprolegnia, the most common fungal infection in fish. It is also inhibitory to fish bacterial pathogens, such as aeromonas hydrophila, vibrio alginolyticus and Escherichia coli D31.
PTM: Monoubiquitination at the C-terminal Lys gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation. Phosphorylated during apoptosis; which facilitates apoptotic chromatin condensation. ",[Ref.9645227] Gram negative bacteria: Escherichia coli (MIC=0.37±0.023 μM).,Unknown,Unknown,9645227,Cell. Mol. Life Sci. 1998; 54:467-475,"Robinette D., Wada S., Arroll T., Levy MG., Miller WL., Noga EJ.",Antimicrobial activity in the skin of the channel catfish Ictalurus punctatus: characterization of broad-spectrum histone-like antimicrobial proteins.,,,,,,,,
4783,DRAMP18717,EFTNVSCTTSKECWSVCQRLHNTSRGKCMNKKCRCYS,37,"Charybdotoxin (Yellow scorpions, arachnids, Chelicerata, arthropods, invertebrates, animals)",No entry found,Unknown,Unknown,Leiurus quinquestriatus hebraeus ,"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Combine Helix and Beta structure ,Unknown,2CRD resolved by NMR.,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.15118082]Gram-positive bacteria: Bacillus subtilis (Inhibition zone=4 mm completely inhibit in PH5.5, Inhibition zone=7 mm incompletely inhibit and Inhibition zone=6 mm in PH7.5 completely inhibit at 10 μg/well), Staphylococcus aureus  (Inhibition zone=3 mm incompletely inhibit in PH5.5, Inhibition zone=6 mm incompletely inhibit and Inhibition zone=1 mm completely inhibit in PH7.5 at 10 μg/well);##Gram-negative bacteria: Escherichia coli (Inhibition zone=2 mm incompletely inhibit in PH5.5, Inhibition zone=8 mm incompletely inhibit in PH7.5 at 10 μg/well);##Fungi: Candida albicans (Inhibition zone=13 mm completely inhibit in PH5.5, Inhibition zone=15 mm in PH7.5 completely inhibit at 10 μg/well).",Unknown,Unknown,15118082,Proc Natl Acad Sci U S A. 2004 May 11;101(19):7363-8.,"Yount NY, Yeaman MR.",Multidimensional signatures in antimicrobial peptides.,,,,,,,,
4784,DRAMP18718,GDDDDDD,7,"SAAP fraction 2 (Surfactant-associated anionic peptides; Asp-rich; sheep, ruminant, mammals, animals)",No entry found,Unknown,Unknown,Ovis aries,"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Rich,Unknown,Unknown,Function: Antibacterial activity against negative bacteria.  No amidation at the C-terminus,"[Ref.8552650] Gram-negative bacterium: Pasteurella haemolytica (MBC50=0.04 mM in Zn-saline, MBC50=11.49 mM in Test buffer; Peptide/surfactant mixture MBC50=0.05 mM in Zn-saline, MBC50=6.44 mM in Test buffer; Peptide/serum mixture MBC50=0.05 mM in Zn-saline, MBC50=10.38 mM in Test buffer; Peptide/surfactant/serum mixture MBC50=0.06 mM in Zn-saline, MBC50=5.93 mM in Test buffer).",Unknown,Unknown,8552650,Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):412-6.,"Brogden KA, de Lucca AJ, Bland J, Elliott S.",Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica.,,,,,,,,
4785,DRAMP18719,DDDDDDD,7,"SAAP fraction 3 (Surfactant-associated anionic peptides; Asp-rich; sheep, ruminant, mammals, animals)",No entry found,Unknown,Unknown,Ovis aries,"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Rich,Unknown,Unknown,Function: Antibacterial activity against Gram positive and negative bacteria. No amidation at the C-terminus,"[Ref.8552650] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MBC50=1.21 mM in Zn-saline), Streptococcus faecalis ATCC 29213 (MBC50=1.39 mM in Zn-saline);##Gram-negative bacteria: Escherichia coli ATCC 12795 (MBC50=0.64 mM in Zn-saline), Klebsiella pneumoniae ATCC 10031 (MBC50=0.62 mM in Zn-saline), Pasteurella haemolytica (MBC50=0.02 mM in Zn-saline, MBC50=8.52 mM in Test buffer; Peptide/surfactant mixture MBC50=0.01 mM in Zn-saline, MBC50=4.43 mM in Test buffer; Peptide/serum mixture MBC50=0.02 mM in Zn-saline, MBC50=4.95 mM in Test buffer; Peptide/surfactant/serum mixture MBC50=0.03 mM in Zn-saline, MBC50=2.79 mM in Test buffer).",Unknown,Unknown,8552650,Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):412-6.,"Brogden KA, de Lucca AJ, Bland J, Elliott S.",Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica.,,,,,,,,
4786,DRAMP18720,GADDDDD,7,"SAAP fraction 6 (Surfactant-associated anionic peptides; Asp-rich; sheep, ruminant, mammals, animals)",No entry found,Unknown,Unknown,Ovis aries,"Antibacterial, Anti-Gram-, Antimicrobial",Protein level,Rich,Unknown,Unknown,Function: Antibacterial activity against negative bacteria. No amidation at the C-terminus,"[Ref.8552650] Gram-negative bacterium: Pasteurella haemolytica (MBC50=0.02 mM in Zn-saline, MBC50=10.10 mM in Test buffer; Peptide/surfactant mixture MBC50=0.04 mM in Zn-saline, MBC50=5.18 mM in Test buffer; Peptide/serum mixture MBC50=0.04 mM in Zn-saline, MBC50=5.59 mM in Test buffer; Peptide/surfactant/serum mixture MBC50=0.04 mM in Zn-saline, MBC50=4.75 mM in Test buffer).",Unknown,Unknown,8552650,Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):412-6.,"Brogden KA, de Lucca AJ, Bland J, Elliott S.",Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica.,,,,,,,,
4787,DRAMP18721,GWKIGKKLEHHGQNIRDGLISAGPAVFAVGQAATIYAAAK,40,"Hinnavin I (Hin I; insects, arthropods, invertebrates, animals)",No entry found,Belongs to the Cecropins family.,Unknown,Artogeia rapae (cabbage butterfly),"Antimicrobial, Antibacterial, Antifungal, Anti-Gram+, Anti-Gram-, ",Protein level,Unknown,Unknown,Unknown,"Function: Hinnavin 1 is heat stable; its activity was retained after 60 min incubation at 100 DC, being effective against Gram negative and/or Gram positive bacteria. Hinnavin I and lysozyme 2 showed a powerful synergistic effect on the inhibition of bacterial growth.","[Ref.9339895] Gram-positive bacteria: Bacillus subtilis (Inhibition zone=3.0 mm), Bacillus megaterium Bm11 (Inhibition zone=5.0 mm), Bacillus thuringiensis (Inhibition zone=3.0 mm);##Gram-negative bacteria: Escherichia coli (Inhibition zone=7.0 mm), Escherichia coli D21 (Inhibition zone=7.1 mm), Enterobacter cloacae (Inhibition zone=6.0 mm);##Fungi: Candida albicans (Inhibition zone=3.0 mm), Aspergillus niger (Inhibition zone=3.0 mm).",Unknown,Cell membranes,9339895,Mol Cells. 1997 Aug 31;7(4):509-13,"Bang IS, Son SY, Yoe SM.","Hinnavin I, an antibacterial peptide from cabbage butterfly, Artogeia rapae.",,,,,,,,
4788,DRAMP18722,AKKFGKAFVGEIM,13,MA (Magainin 2 (9-21) truncated peptide),P11006,Belongs to truncated magainin 2.,magainins,Xenopus laevis (African clawed frog),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,Alpha helix,Unknown,Unknown,Function: Antibacterial activity against the Gram-negative bacteria.,[Ref.28178190] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=32 μM).,Unknown,Unknown,28178190,Int J Mol Sci. 2017 Feb 6;18(2). pii: E339. ,"Tan T, Wu D, Li W, Zheng X, Li W, Shan A.",High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7,,,,,,,,
4789,DRAMP18723,KWKLFKKI,8,CE Cecropin A ,P01507,Belongs to truncated Cecropin A.,Unknown,Hyalophora cecropia (Cecropia moth),"Antibacterial, Anti-Gram-, Antimicrobial",Unknown,random coil,Unknown,Unknown,Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.,[Ref.28178190] Gram-negative bacterium: Escherichia coli ATCC 25922 (MIC=64 μM).,Unknown,Unknown,28178190,Int J Mol Sci. 2017 Feb 6;18(2). pii: E339. ,"Tan T, Wu D, Li W, Zheng X, Li W, Shan A.",High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7,,,,,,,,
4790,DRAMP18724,PKRKSATKGDEPARRSARLSARPVPKPAAKPKKAAAPKKAVKGKKAAENGDAKAEAKVQAAGDGAGNAK,69,"Oncorhyncin III (Oncorhyncin-3, histone-derived; fish, animals)",P02315,Belongs to the HMGN family.,Unknown,Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri),"Antibacterial, Anti-Gram+, Anti-Gram-, Antimicrobial",Protein level,Unknown,Unknown,Unknown,"Function: Oncorhyncin III has antibacterial activity against Gram-positive and Gram-negative bacteria at submicromolar concentrations. Non-histone protein that probably binds to the inner side of nucleosomal DNA, altering the association between the DNA and the nucleosome octamer. ","[Ref.12713443] Gram-positive bacteria: Aerococcus viridans (MIC=0.06-0.12 μM), Bacillus subtilis (MIC=0.25-0.5 μM), Micrococcus luteus (MIC=0.12-0.25 μM), Planococcus citerus (MIC=0.06-0.12 μM);##Gram-negative bacteria: Aeromonas hydrophila (MIC>0.5 μM), Aeromonas salmonicida (MIC>0.5 μM), Escherichia coli (MIC=0.25-0.5 μM), Listonella anguillarum (MIC=0.25-0.5 μM).",Unknown,Unknown,12713443,Biochem 2003; 373 (Pt 2): 621-628,"Fernandes JM., Saint N, Kemp GD, Smith VJ. ","Oncorhyncin III: a potent antimicrobial peptide derived from the non-histone chromosomal protein H6 of rainbow trout, Oncorhynchus mykiss.",,,,,,,,
4791,DRAMP03024,LKLKSIVSWAKKVL,14,"Mastoparan B (MP-B; insects, arthropods, invertebrates, animals)",P21654,Not found,Not found,Vespa basalis (Hornet),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Anti Mammalian cells, Anti-cancer",Not found,Alpha helix,Tryptophan residue in MP,None,Function: Mast cell degranulating peptide. Activates G proteins that couple to phospholipase C. Has hemolytic activity.,"[Ref.10667861] Gram-positive bacteria: Staphylococcus epidermidis ATTC 12228 (MIC=25 µM), Bacillus subtilis PCI 219 (MIC=25 µM), Enterococcus faecium EFMY-28 (MIC=12.5 µM);##Gram-negative bacterium: Escherichia coli NIHJ JC-2 (MIC=50 µM)","[Ref.10667861] 68.2% hemolysis at the peptide concentration of 100 µM is , 27.9% Hemolysis at 50 µM against human red blood cells.",,10667861##8555423,J Pept Res. 2000 Jan;55(1):51-62.##Biopolymers. 1995 Dec;36(6):793-801,"Yu K, Kang S, Park N, Shin J, Kim Y.##Park NG, Yamato Y, Lee S, Sugihara G1995",Relationship between the tertiary structures of mastoparan B and its analogs and their lytic activities studied by NMR spectroscopy.##Interaction of mastoparan-B from venom of a hornet in Taiwan with phospholipid bilayers and its antimicrobial activity,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,
4818,DRAMP01826,RIGVLLARLPKLFSLFKLMGKKV,23,"RV-23 (Frogs, amphibians, animals)",No entry found,Not found,Not found,Rana aurora draytonii (California red-legged frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Alpha helix,Not found,None,[Ref.27271216]Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=12.5 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=6.25 μM), Klebsiella pneumoniae (MIC=6.25 μM)","[Ref.27271216] 60% hemolysis at 20 μM , 90% hemolysis at 40 μM , 100% hemolysis at 60 μM , 100% hemolysis at 100 μM against human red blood cells",,16307827##27271216,Peptides. 2006 Jun;27(6):1305-1312.##Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Conlon JM, Al-Ghafari N, Coquet L, Leprince J, Jouenne T, Vaudry H, Davidson C.##Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji","Evidence from peptidomic analysis of skin secretions that the red-legged frogs, Rana aurora draytonii and Rana aurora aurora, are distinct species.##Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,
4825,DRAMP03812,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,33,Pardaxin P-4 (Pardaxin P1a; Pardaxin Pa4),P81861,Belongs to the pardaxin family,Not found,Pardachirus marmoratus (Finless sole) (Achirus marmoratus),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Cytotoxic",Protein level,Alpha helix (2 helices; 15 residues),"The peptide adopts a bend-helix-bend-helix motif with an angle between the two structure helices of 122 +/- 9 degrees, making this structure substantially different from the one previously determined in organic solvents.","1XC0, 2KNS resolved by NMR.","Function: Exhibits unusual shark repellent and surfactant properties. Forms voltage-dependent, ion-permeable channels in membranes. At high concentration causes cell membrane lysis.
Domain: Consists of a C-terminal hydrophilic region and a predominantly hydrophobic remainder.  Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria","[Ref.23598079] Gram-positive bacteria : Micrococcus luteus(MIC=100 mg/L), Staphylococcus aureus(MIC=50 mg/L), Streptococcus pneumoniae(MIC=100 mg/L), Streptococcus agalactiae(MIC=100 mg/L), Staphylococcus sp.(MIC=6.25 mg/L);##Gram-negative bacteria : Grouper Vibrio alginolyticus(MIC=50 mg/L), Vibrio harveyi(MIC=50 mg/L), Vibrio vulnificus(MIC=100 mg/L)","[Ref.23598079] 7% hemolysis at 12.5 mg/L , 10% hemolysis at 25 mg/L , 27% hemolysis at 50 mg/L , 55% hemolysis at 100 mg/L , 95% hemolysis at 200 mg/L , 90% hemolysis at 400 mg/L against sheep red blood cells",,12124282##19959835##15292173##23598079,Biophys J. 2002 Aug;83(2):1004-1013.##J Biol Chem. 2010 Feb 5;285(6):3883-3895.##J Biol Chem. 2004 Oct 29;279(44):45815-23.##Peptides. 2013 Jun;44:139-48.,"Hallock KJ, Lee DK, Omnaas J, Mosberg HI, Ramamoorthy A.##Bhunia A, Domadia PN, Torres J, Hallock KJ, Ramamoorthy A, Bhattacharjya S.##Porcelli F, Buck B, Lee DK, Hallock KJ, Ramamoorthy A, Veglia G.##Lin MC, Hui CF, Chen JY, Wu JL","Membrane composition determines pardaxin's mechanism of lipid bilayer disruption.##NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: mechanism of outer membrane permeabilization.##Structure and orientation of pardaxin determined by NMR experiments in model membranes.##Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.",Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Cell membrane,
4833,DRAMP18516,KWKSFLKTFKSLKKTVLHTLLKAISS,26,K7D (A12L/A20L peptide derivative),No entry found,Derived from the framework peptide A12L/A20L,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antiplasmodial",Synthetic,Alpha helix ,Not found,None,Function: K7D against HeLa cells. D-Lysine replace L-Lysine at the position 7 on the polar face of peptide A12L/A20L. Has hemolytic activity.,[Ref.22837667]Cancer cell: HeLa cell (IC50=1.29±0.03 μmol/L),[Ref.22837667]MHC=10.4±0.04 μmol/L against human red blood cells,,22837667,Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849.,"Huang YB, He LY, Jiang HY, Chen YX.",Role of helicity on the anticancer mechanism of action of cationic-helical peptides.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,
4834,DRAMP02518,KRFKKFFKKLKNSVKKRAKKFFKKPKVIGVTFPF,34,NA-CATH,No entry found,Not found,Not found,Naja atra,"Antimicrobial, Antibacterial, Anti-Gram-",Not found,"Alpha helix, random coil",NA-CATH has previously been shown to be random coil in water or buffer and ,None,Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. Has hemolytic activity.,"[Ref.28089718] Gram-negative bacteria: Acinetobacter baumannii ATCC 9955 (MIC=10μg/ml), Acinetobacter baumannii ATCC BAA-1794 (MIC=10μg/ml), Escherichia coli ATCC 51659 (MIC=21μg/ml), K. pneumoniae ATCC 33495 (MIC=5.2μg/ml), K. pneumoniae ATCC BAA-1705 (MIC=5.2μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=10μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (MIC=10μg/ml)",[Ref.28089718] 0% hemolysis at 300μg/ml against sheep red blood cells.,,28089718,Dev Comp Immunol. 2017 May;70:135-144. ,"Barksdale SM, Hrifko EJ, van Hoek ML.",Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,
4839,DRAMP20771,GKCSVLKKVACAAAIAGAVAACGGIDLPCVLAALKAAEGCASCFCEDHCHGVCKDLHLC,59,"Acanthaporin (parasite, amoebozoa, protozoa, protists)",I3NI56,Not found,Not found,Acanthamoeba culbertsoni,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Alpha helix,Not found,"2LRD, 2LRE resolved by NMR.","Function: Acanthaporin is antimicrobially active against several Gram-positive and Gram-negative bacteria at pH 5.2 but is inactive at pH 7.4, reflecting a pH-dependent activity of the protein.",No MICs found in DRAMP database,Not found,,23143413,Nat Chem Biol. 2013 Jan;9(1):37-42.,"Michalek M, Sönnichsen FD, Wechselberger R, Dingley AJ, Hung CW, Kopp A, Wienk H, Simanski M, Herbst R, Lorenzen I, Marciano-Cabral F, Gelhaus C, Gutsmann T, Tholey A, Grötzinger J, Leippe M.",Structure and function of a unique pore-forming protein from a pathogenic acanthamoeba.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,
4840,DRAMP20772,PPHKKKLAVYPVFLFYLFLSWFSLIV,26,"cPcAMP1/26 (ciliate, Protists)",No entry found,Not found,Pcamp1,Paramecium caudatum,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,None,Function: cPcAMP1/26 is capable of markedly killing A. hydrophila and S. aureus (p < 0.05),"[Ref.26883426] cPcAMP1/26 is capable of markedly killing A. hydrophila and S. aureus (p < 0.05), with the bactericidal rates being 27.7%, 31.7% and 40.1% as well as 34.4%, 47.4% and 49.2%, respectively",[Ref.26883426] cPcAMP1/26 showed little hemolytic activity towards human erythrocytes at 100 μg/ml,,26883426,Dev Comp Immunol. 2016 Jul;60:53-65.,"Cui P, Dong Y, Li Z, Zhang Y, Zhang S.",Identification and functional characterization of an uncharacterized antimicrobial peptide from a ciliate Paramecium caudatum.,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not included yet,Not found,
4842,DRAMP20776,IGGYCSWLRL,10,"HaA4 (beetles,insects,animals)",No entry found,Not found,Not found,Harmonia axyridis (Multicolored Asian lady beetle),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,None,"Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria. HaA4 is proved to have more potent activity against Staphylococcus epidermidis, M. luteus, and Pseudomonas syringae.","[Ref.23124352] Gram-negative bacteria: Escherichia coli KACC 13821 (MIC=32 microM), Klebsiella pneumoniae KACC 11402 (MIC<64 microM), Pseudomonas aeruginosa KACC 10259 (MIC<64 microM), Pseudomonas syringae KACC 10659 (MIC=2 microM)；## Gram-positive bacteria: Staphylococcus aureus KACC 13257 (MIC<64 microM),  MR Staphylococcus aureus CCARM 3001(MIC=32 microM), Enterococcus faecalis KACC 13807 (MIC=16 microM), Enterococcus hirae KACC 16328 ( MIC=32 microM), Staphylococcus epidermidis KACC 13234 (MIC=8 microM), Micrococcus luteus KACC 10488 (MIC = 4 microM), Streptococcus pyogenes KACC 11956 (MIC=32 microM)","[Ref.23124352] In the hemolytic assay, HaA4 peptide evidenced no hemolytic activity against mouse red blood cells, even at high concentrations, and thus suggesting that the peptide may not be detrimental to eukaryotic cells.",,23124352,J Microbiol Biotechnol. 2012 Nov;22(11):1588-90.,"Kim IW, Lee JH, Park HY, Kwon YN, Yun EY, Nam SH, Kim SR, Ahn MY, Hwang JS.","Characterization and cDNA cloning of a defensin-like peptide, harmoniasin, from Harmonia axyridis.",Linear,L,Free,[Ref.23124352] The cytotoxicity is not found in a dose dependent manner.,Amidation,None,Not found,
4843,DRAMP20777,KRFKKFFRKLKKSVKKRAKEFFKKPRVIGVSIPF,34,Cath-BF,No entry found,Derived from three-finger toxin,Not found,Bungarus fasciatus (Banded krait),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,"[Ref.29392557] Gram-positive bacteria: MRSA PS-2 (MIC=64 μg/ml);##Gram-negative bacteria, MRSA PS-7 (MIC=64 μg/ml), MRSA PS-18 (MIC=64 μg/ml), MRSA PS-45 (MIC=64 μg/ml), MRSA PS-46 (MIC=128 μg/ml), MRSA PS-50 (MIC=64 μg/ml), MRSA PS-59 (MIC=128 μg/ml), MRSA PS-70 (MIC=32 μg/ml), MRSA PS-84 (MIC=128 μg/ml), MRSA PS-106 (MIC=128 μg/ml), MRSA PS-131 (MIC=64 μg/ml), MRSA PS-139 (MIC=64 μg/ml), MRSA PS-162 (MIC=64 μg/ml), MRSA PS-165 (MIC=32 μg/ml), Staphylococcus aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=256 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli ATCC 51446 (MIC=16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=32 μg/ml), Klebsiella pneumoniae ATCC 13883 (MIC=4 μg/ml)","[Ref.29392557] 5% haemolysis at 1.0 μg/ml, 5% haemolysis at 2.0 μg/ml, 5% haemolysis at 4.0 μg/ml, 5% haemolysis at 8.0 μg/ml, 7% haemolysis at 16.0 μg/ml, 9% haemolysis at 31.2 μg/ml, 13% haemolysis at 62.5 μg/ml, 17% haemolysis at 125.0 μg/ml, 19% haemolysis at 250.0 μg/ml, 23% haemolysis at 500.0 μg/ml, 24% haemolysis at 1000.0 μg/ml against human red blood cells",,29392557,J Microbiol. 2018 Feb;56(2):128-137.,"Tajbakhsh M, Karimi A, Tohidpour A, Abbasi N, Fallah F, Akhavan MM.",The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.,Linear,L,Free,"[Ref.29392557] The cell viability of HUVEC at the peptide concentration of 35.5 μg/ml, 71 μg/ml and 113 μg/ml  is 127%, 100% and 76%. ##The cell viability of H9c2 at the peptide concentration of 35.5, 71, and 113 μg/ml is 132, 100, and 80%.",Free,None,Not found,
4844,DRAMP20778,FFFLSRIF,8,"Temporin-SHf (frogs,amphibians,animals)",No entry found,Belongs to the Temporin family,Not found,Pelophylax saharica(Sahara frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,"Once bound parallel to the microbial membrane surface, it folds into a non-amphipathic hydrophobic ",None,"Function: Antibacterial activity against the Gram-negative bacteria (Escherichia coli ATCC 25922, Escherichia coli ATCC 35218, Escherichia coli D21, Escherichia coli ML-35p, Pseudomonas aeruginosa ATCC 27853) and Gram-positive bacteria (Staphylococcus aureus ATCC 25923, E. faecalis ATCC 29212, Bacillus megaterium. Antifungal activity)",[Ref.20308076] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=25 μM); Escherichia coli ATCC 35218(MIC>200 μM); Escherichia coli D21(MIC=100 μM); Escherichia coli ML-35p(MIC=30 μM); Pseudomonas aeruginosa ATCC 27853(MIC>200 μM);## Gram-positive bacteria: Staphylococcus aureus ATCC 25923(MIC=12.5 μM); E. faecalis ATCC 29212(MIC=50 μM); Bacillus megaterium(MIC=3 μM);## Yeasts: Candida albicans ATCC 90028(MIC=50 μM); C. parapsilosis ATCC 22019(MIC=50 μM); S. cerevisiae(MIC=12.5 μM);## Fungus(MIC>200 μM),"[Ref.20308076] Temporin-SHf is not cytotoxic against human erythrocytes (LC50 = 200 μm), with a hemolytic activity detected only at peptide concentration far above the MIC values determined for the sensitive strains (3–50 μm) ",,20308076,J Biol Chem. 2010 May 28;285(22):16880-92. ,"Abbassi F, Lequin O, Piesse C, Goasdou","Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide.",Linear,L,Free,[Ref.20308076] No cytotoxicity information found,Amidation,None,Not found,
4845,DRAMP20779,GMWSKILGHLIR,12,"Halictine 1 (bees,insects,animals)",No entry found,Not found,Not found,Halictus sexcinctus,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,None,Function: Exhibits potent antimicrobial activity against the Gram-positive and Gram-negative bacteria as well as noticeable hemolytic activity. ,"[Ref.20198492] Gram-negative bacteria: Escherichia coli(MIC=3.8 μM), Pseudomonas aeruginosa(MIC=45.0 μM);## Gram-positive bacteria: Bacillus subtilis(MIC=0.8 μM), Staphylococcus aureus(MIC=7.7 μM)",[Ref.20198492]  LC50=82μM against rat red blood cells,,20198492,Amino Acids. 2010 Aug;39(3):763-75. ,"Monincová L, Budesínskμ M, Slaninová J, Hovorka O, Cvacka J, Voburka Z, Fucík V, Borovicková L, Bednárová L, Straka J, Cerovskμ V.",Novel antimicrobial peptides from the venom of the eusocial bee Halictus sexcinctus (Hymenoptera: Halictidae) and their analogs.,Linear,L,Free,[Ref.20198492] No cytotoxicity information found,Amidation,None,Not found,
4846,DRAMP20780,GKWMSLLKHILK,12,"Halictine 2 (bees,insects,animals)",No entry found,Not found,Not found,Halictus sexcinctus,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,None,Function: Exhibits potent antimicrobial activity against the Gram-positive and Gram-negative bacteria as well as noticeable hemolytic activity. ,"[Ref.20198492] Gram-negative bacteria: Escherichia coli(MIC=2.5μM), Pseudomonas aeruginosa(MIC=42.1);## Gram-positive bacteria: Bacillus subtilis(MIC=1.0μM), Staphylococcus aureus(MIC=8.1μM)",[Ref.20198492]  LC50=78.1μM against rat red blood cells,,20198492,Amino Acids. 2010 Aug;39(3):763-75. ,"Monincová L, Budesínskμ M, Slaninová J, Hovorka O, Cvacka J, Voburka Z, Fucík V, Borovicková L, Bednárová L, Straka J, Cerovskμ V.",Novel antimicrobial peptides from the venom of the eusocial bee Halictus sexcinctus (Hymenoptera: Halictidae) and their analogs.,Linear,L,Free,[Ref.20198492] No cytotoxicity information found,Amidation,None,Not found,
4847,DRAMP20781,LNWGAILKHIIK,12,"Panurgine 1(bees,insects,animals)",C0HL84,Not found,Not found,Panurgus calcaratus(communal bee),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,None,"Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria, antifungal activity, and low hemolytic activity against human erythrocytes. ","[Ref.23483218] Gram-negative bacteria: Escherichia coli(MIC=3.7μM), Pseudomonas aeruginosa(MIC=51.7μM) ;## Gram-positive bacteria: Micrococcus luteus(MIC=1.5μM), Bacillus subtilis(MIC=1.3μM), Staphylococcus aureus(MIC=10.6μM) ;## Yeast: Candida albicans(MIC=7.3μM)",[Ref.23483218] LC50=119μM against rat red blood cells,,23483218,Amino Acids. 2013 Jul;45(1):143-57. ,"Čujová S, Slaninová J, Monincová L, Fuμík V, Bednárová L, μtokrová J, Hovorka O, Voburka Z, Straka J, μeμovskμ V.","Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae).",Linear,L,Free,[Ref.23483218] No cytotoxicity information found,Amidation,None,Not found,
4848,DRAMP20782,FLSGILKLAFKIPSVLCAVLKNC,23,"Pleurain-D1  (Frogs,amphibians,animals)","B5L1C5, B5L1D1, B5L1C3, B5L1C9, B5L1C2, B5L1D4",Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Not found,Nidirana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,Not found,Not found,None,"Function: Antimicrobial activity  against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.19028675] Gram-negative bacteria: Escherichia coli (MIC=25 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μg/ml), Bacillus subtilis (MIC=50 μg/ml);##Yeast: Candida albicans(MIC=25 μg/ml)",Not found,,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,Linear,L,Free,[Ref.19028675] No cytotoxicity information found,Free,None,Not found,
4849,DRAMP20783,GLLDSVKEGLKKVAGQLLDTLKCKISGCTPA,31,"Pleurain-M1  (Frogs,amphibians,animals)",B5L1L3,Belongs to the frog skin active peptide (FSAP) family. Pleurain subfamily.,Not found,Nidirana pleuraden (Yunnan pond frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,None,"Function: Antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi.","[Ref.19028675] Gram-negative bacteria: Escherichia coli (MIC=6.3 μg/ml);##Gram-positive bacteria: Staphylococcus aureus (MIC=6.3 μg/ml), Bacillus subtilis (MIC=25 μg/ml);##Yeast: Candida albicans(MIC=12.5 μg/ml).",Not found,,19028675,Mol Cell Proteomics. 2009 Mar;8(3):571-83.,"Yang H, Wang X, Liu X, Wu J, Liu C, Gong W, Zhao Z, Hong J, Lin D, Wang Y, Lai R.",Antioxidant peptidomics reveals novel skin antioxidant system.,Linear,L,Free,[Ref.19028675] No cytotoxicity information found,Free,None,Not found,
4850,DRAMP20784,FLKGCWTKWYSLKPKCPF,18,Megin 1,No entry found,Not found,Not found,Amphibian skin,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,The peptide contains an intra-molecular di-sulfide bridge,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27114317] Gram-negative bacteria: Escherichia coli (ATCC 25922)(MIC=25μg/mL);B. dysenteriae(MIC=3μg/mL);##Gram-positive bacteria:Staphylococcus aureus (ATCC 2592)(MIC=6.25μg/mL);Bacillus subtilis (ATCC 6633)(MIC=3μg/mL) ;##Fungi:C.albicans (ATCC 2002)(MIC=50μg/mL),[Ref.27114317] Human red blood cells: 2.3% hemolysis at 25μg/ml; 5.6% hemolysis at 50μg/ml; 18.7% hemolysis at 100μg/ml; 29.5% hemolysis at 200μg/ml. Rabbit red blood cells :3.1% hemolysis at 25μg/ml; 7.3% hemolysis at 50μg/ml; 20.5% hemolysis at 100μg/ml; 32.9% hemolysis at 200μg/ml,,27114317,Chin J Nat Med. 2016 Apr;14(4):294-298. ,"Yang HL, Shen ZQ, Liu X, Kong Y.",Two novel antimicrobial peptides from skin venoms of spadefoot toad Megophrys minor.,Cyclic,L,Free,No cytotoxicity information found,Amidation,Disulfide bond between Cys5 and Cys16,Not found,
4851,DRAMP20785,FFVLKFLLKWAGKVGLEHLACKFKNWC,27,Megin 2,No entry found,Not found,Not found,Amphibian skin,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,The peptide contains an intra-molecular di-sulfide bridge,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27114317] Gram-negative bacteria: Escherichia coli (ATCC 25922)(MIC=6.25μg/mL);B. dysenteriae(MIC=1.5μg/mL);##Gram-positive bacteria:Staphylococcus aureus (ATCC 2592)(MIC=12.5μg/mL);Bacillus subtilis (ATCC 6633)(MIC=1.5μg/mL) ;##Fungi:C.albicans (ATCC 2002)(MIC=12.5μg/mL),[Ref.27114317] Human red blood cells: 3.9% hemolysis at 25μg/ml; 13.7% hemolysis at 50μg/ml; 27.7% hemolysis at 100μg/ml; 45.3% hemolysis at 200μg/ml;Rabbit red blood cells: 5.6% hemolysis at 25μg/ml; 15.2% hemolysis at 50μg/ml; 36.2% hemolysis at 100μg/ml; 50.3% hemolysis at 200 μg/ml,,27114317,Chin J Nat Med. 2016 Apr;14(4):294-298. ,"Yang HL, Shen ZQ, Liu X, Kong Y.",Two novel antimicrobial peptides from skin venoms of spadefoot toad Megophrys minor.,Cyclic,L,Free,No cytotoxicity information found,Free,Disulfide bond between Cys21 and Cys27.,Not found,
4852,DRAMP20786,RRLRPRRPRLPRPRPRPRPRPR,22,mini-ChBac7.5N alpha,No entry found,Not found,Not found,Capra hircus,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27795854] Gram-negative bacteria: E.coli (ML35p)(MIC=0.3 ± 0.1μM without NaCl;MIC=1.5 ± 0.2μM 100 mM NaCl;MIC=1μM Broth microdilution assay);E.coli (ATCC 25922)(MIC=0.6 ± 0.1μM without NaCl;MIC=0.9 ± 0.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);E.coli (M17)(MIC=0.5 ± 0.1μM without NaCl;MIC=0.8 ± 0.1μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Pseudomonas aeruginosa (ATCC 27853)(MIC=1.1 ± 0.4μM without NaCl;MIC=3.7 ± 1.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Pseudomonas aeruginosa clinical isolate(MIC=2μM Broth microdilution assay);Klebsiella spp. clinical isolate(MIC=4μM Broth microdilution assay);Acinetobacter baumannii clinical isolate(MIC=2μM Broth microdilution assay);##Gram-positive bacteria:Listeria monocytogenes (EGD)(MIC=0.2 ± 0.1μM without NaCl;MIC=1.0 ± 0.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Micrococcus luteus CIP A270(MIC=1μM Broth microdilution assay);Staphylococcus aureus (710A)(MIC=0.7 ± 0.2μM without NaCl;MIC> 50μM 100 mM NaCl;MIC>64μM Broth microdilution assay);Staphylococcus aureus (ATCC 25923)(MIC>64μM Broth microdilution assay);MRSA (ATCC 33591)(MIC=0.7 ± 0.2μM without NaCl;MIC> 50μM 100 mM NaCl;MIC>64μM Broth microdilution assay);Staphylococcus intermedius clin. isolate(MIC>64μM Broth microdilution assay);##Fungi:Candida albicans (820)(MIC=0.3 ± 0.1μM without NaCl;MIC> 50μM 100 mM NaCl;MIC=64μM Broth microdilution assay);Candida parapsilosis clinical isolate(MIC>64μM Broth microdilution assay),[Ref.27818338] No hemolytic activity ,,27795854,Acta Naturae. 2016 Jul-Sep;8(3):136-146.,"Shamova OV, Orlov DS, Zharkova MS, Balandin SV, Yamschikova EV, Knappe D, Hoffmann R, Kokryakov VN, Ovchinnikova TV.",Minibactenecins ChBac7.N,Linear,L,Free,"[Ref.27795854] The cytotoxicity values of the experimental samples are not significantly different from the values of the control samples over the entire range of concentrations:1-30 μM against various types of cultured human cells: namly, reythroleukemi",Free,None,Not found,
4853,DRAMP20787,RRLRPRRPRLPRPRPRPRPRP,21,mini-ChBac7.5N beta,No entry found,Not found,Not found,Capra hircus,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27795854] Gram-negative bacteria:E.coli (ML35p)(MIC=0.3 ± 0.1μM without NaCl;MIC=1.4 ± 0.2μM 100 mM NaCl;MIC=1μM Broth microdilution assay);E.coli (ATCC 25922)(MIC=0.5 ± 0.2μM without NaCl;MIC=0.8 ± 0.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);E.coli (M17)(MIC=0.5 ± 0.1μM without NaCl;MIC=0.9 ± 0.2μM 100 mM NaCl;MIC=1μM Broth microdilution assay);Pseudomonas aeruginosa (ATCC 27853)(MIC=1.0 ± 0.3μM without NaCl;MIC=3.2 ± 0.8μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Pseudomonas aeruginosa clinical isolate(MIC=2μM Broth microdilution assay);Klebsiella spp. clinical isolate(MIC=4μM Broth microdilution assay);Acinetobacter baumannii clinical isolate(MIC=4μM Broth microdilution assay);##Gram-positive bacteria:Listeria monocytogenes (EGD)(MIC=0.2 ± 0.1μM without NaCl;MIC=0.9 ± 0.2μM 100 mM NaCl;MIC=2μM Broth microdilution assay);Micrococcus luteus CIP A270(MIC=1μM Broth microdilution assay);Staphylococcus aureus (710A)(MIC=0.6 ± 0.1μM without NaCl;MIC> 50μM 100 mM NaCl;MIC>64μM Broth microdilution assay);Staphylococcus aureus (ATCC 25923)(MIC>64μM Broth microdilution assay);MRSA (ATCC 33591)(MIC=0.5 ± 0.1μM without NaCl;MIC> 50μM 100 mM NaCl;MIC>64μM Broth microdilution assay);Staphylococcus intermedius clin. isolate(MIC>64μM Broth microdilution assay);##Fungi:Candida albicans (820)(MIC=0.3 ± 0.1μM without NaCl;MIC> 50μM 100 mM NaCl;MIC=64μM Broth microdilution assay);Candida parapsilosis clinical isolate(MIC>64μM Broth microdilution assay),[Ref.27818338] No hemolytic activity ,,27795854,Acta Naturae. 2016 Jul-Sep;8(3):136-146.,"Shamova OV, Orlov DS, Zharkova MS, Balandin SV, Yamschikova EV, Knappe D, Hoffmann R, Kokryakov VN, Ovchinnikova TV.",Minibactenecins ChBac7.N,Linear,L,Free,"[Ref.27795854] The cytotoxicity values of the experimental samples are not significantly different from the values of the control samples over the entire range of concentrations:1-30 μM against various types of cultured human cells: namly, reythroleukemi",Free,None,Not found,
4856,DRAMP20790,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKALG,36,"Cecropin B (Insects, arthropods, invertebrates, animals)",P01508,Belongs to the cecropin family.,Not found,Hyalophora cecropia (Cecropia moth),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,None,Function: Antibacterial activity against several Gram-positive and Gram-negative bacteria.,"[Ref.7019715] Gram-positive bacteria: Bacillus megaterium Bm11 (Inhibition zone=10.0 mm), Bacillus subtilis (Inhibition zone=7.2 mm);##Gram-negative bacteria: Escherichia coli K12 D31 (Inhibition zone=12.5 mm), Serratia marcescens Db1108 (Inhibition zone=7.2 mm), Pseudomonas aeruginosa OT97 (Inhibition zone=9.7 mm), Xenorhabdus nematophilus Xn21 (Inhibition zone=10.0 mm).",Not found,,7019715,Nature. 1981 Jul 16;292(5820):246-8.,"Steiner H, Hultmark D, Engstr?m A, Bennich H, Boman HG.",Sequence and specificity of two antibacterial proteins involved in insect immunity,Linear,L,Free,[Ref.7019715] No cytotoxicity information found,Amidation (Leu35) PMID:3857578,None,Not found,
4858,DRAMP20792,GLFVGVLAKVAAHVVPAIAEHF,22,"Maculatin 1.1 (Frog, amphibians, animals)",P82066,Not found,Not found,Litoria genimaculata (Green-eyed tree frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Helix,Not found,2MMJ resolved by NMR,"Function: Maculatin-1.1 shows significant antibacterial activity against Gram-positive bacteria, less against Gram-negative bacteria. Maculatin-1.1.1 is inactive.
Tissue specificity: Expressed by the skin dorsal glands.","[Ref.9620615] Gram positive bacteria: Bacillus cereus (MIC=50 μg/ml), Leuconostoc lactis (MIC=25 μg/ml), Listeria innocua (MIC=100 μg/ml), Micrococcus luteus (MIC=12.5 μg/ml), Staphylococcus aureus (MIC=6-12.5 μg/ml), Staphylococcus epidermidis (MIC=12.5 μg/ml), Streptococcus faecalis (MIC=25 μg/ml), Streptococcus uberis (MIC=3 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=100 μg/ml), Pasteurella multocida (MIC=100 μg/ml).",Not found,,9620615,J. Pept. Sci. 1998 Apr; 4(2): 111-115. ,"Rozek T, Waugh RJ, Steinborner ST, Bowie JH, Tyler MJ, Wallace JC.",The maculatin peptide from the skin glands of the tree frog Litoria genimaculata: a comparison of the structures and antibacterial activities of maculatin 1.1 and caerin 1.1,Linear,L,Free,[Ref.9620615] No cytotoxicity information found,Amidation,None,Not found,
4863,DRAMP20797,GVIDAAKKVVNVLKNLF,17,"Uperin 3.6 (Toad, amphibians, animals)",P82043,Belongs to the frog skin active peptide (FSAP) family. Uperin subfamily.,Not found,Uperoleia mjobergii (Australian toadlet),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Alpha helix ,Not found,None,"Function: Antibacterial activity against B.cereus, L.lactis, L.innocua, M.luteus, S.aureus, S.epidermidis and S.uberis.
Tissue specificity: Expressed by the skin dorsal glands.
Mass spectrometry: Molecular mass is 1826 Da from positions 1 - 17. Determined by FAB.","[Ref.10461748] Gram positive bacteria: Bacillus cereus (MIC=25 μg/ml), Leuconostoc lactis  (MIC=3 μg/ml), Listeria innocua (MIC=50 μg/ml), Micrococcus luteus (MIC=50 μg/ml), Staphylococcus aureus (MIC=25 μg/ml), Staphylococcus epidermidis (MIC=12 μg/ml), Streptococcus uberis (MIC=12 μg/ml);##Gram-negative bacterium: Pasteurella haemolytica (MIC=25 μg/ml).",Not found,,10461748,J Pept Res. 1999 Aug;54(2):137-45.,"Chia BC, Carver JA, Mulhern TD, Bowie JH","The solution structure of uperin 3.6, an antibiotic peptide from the granular dorsal glands of the Australian toadlet, Uperoleia mjobergii.",Linear,L,Free,[Ref.10461748] No cytotoxicity information found,Amidation,None,Not found,
4864,DRAMP20798,QGVRNSQSCRRNKGICVPIRCPGSMRQIGTCLGAQVKCCRRK,42,"Lingual antimicrobial peptide (LAP, beta defensin, cattle, ruminant, animals)",Q28880,Belongs to the beta-defensin family. LAP/TAP subfamily.,LAP,Bos taurus (Bovine),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Bridge ,Not found,None,"Function: Shows a broad spectrum of antibacterial and antifungal activities.
Tissue specificity: In many of the exposed epithelial surfaces including conjunctivae, bronchi, colon, urinary tract and trachea.
Developmental stage: Not found in fetus.","[Ref.7886453] Gram-positive bacterium: Staphylococcus aureus 29213 (MIC=63-125 μg/ml);##Gram-negative bacteria: Escherichia coli D31 (MIC=16-32 μg/ml), Pseudomonas aeruginosa 27853  (MIC=63-125 μg/ml);##Fungi: Candida albicans 14053  (MIC=32-63 μg/ml), Candida tropicalis 13803 (MIC=16-32 μg/ml).",Not found,,7886453,Science. 1995 Mar 17; 267(5204):1645-1648,"Schonwetter BS., Stolzenberg ED., Zasloff MA.",Epithelial antibiotics induced at sites of inflammation.,Cyclic,L,Free,[Ref.7886453] No cytotoxicity information found,Free,"Disulfide bonds between Cys9 and Cys38, Cys16 and Cys31, Cys21 and Cys39.",Not found,
4865,DRAMP20799,GCWSTVLGGLKKFAKGGLEAIVNPK,25,"XT-2 (frog, amphibians, animals)",No entry found,Belongs to the Pipidae family.,Not found,"Xenopus tropicalis (Diploid clawed frog, Africa)","Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-negative bacteria (Escherichia coli).,[Ref.11738090] Gram-negative bacteria: Escherichia coli (MIC=8μM).,[Ref.11738090] HC50 is not determined against human red blood cells.,,11738090,Biochim Biophys Acta 2001 Nov 26;1550(1):81-9.,"Ali MF, Soto A, Knoop FC, Conlon JM.","Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",Linear,L,Free,[Ref.11738090] No cytotoxicity information found,Free,None,Not found,
4866,DRAMP20800,KKKKPLFGLFFGLF,14,the K4 peptide (synthetic; Phe-rich >25%),No entry found,Not found,Not found,the APD database-aided design.,"Antimicrobial, Antibacterial, Anti-Gram-",Not found,Alpha helix,Not found,None,"Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Have Hemolytic activity against rabbit erythrocytes. Have Cytotoxicity activity on CHO-K1 cells, the peptide is slightly cytotoxic at 160 ","[Ref.19573572] Gram-negative bacteria: Escherichia coli (MIC=40-80 μg/ml or 24-48 μM), Vibrio alginolyticus (MIC=10-20 μg/ml or 6-12 μM), Vibrio harveyi (MIC=5-10 μg/ml or 3-6 μM).",[Ref.19573572] No significant hemolytic activity is observed at 10 and 40 μg/ml. Slight hemolysis (6.65%) is shown at 160 μg/ml.,,19573572,Peptides. 2009 Sep;30(9):1608-12,"Duval E, Zatylny C, Laurencin M, Baudy-Floc'h M, Henry J.",KKKKPLFGLFFGLF: a cationic peptide designed to exert antibacterial activity,Linear,L,Free,"[Ref.19573572] The cell viability of CHO-K1 cells is 127%, 123%,78% and 10% at peptide concentrations of 10 μg/ml, 40 μg/ml, 160 μg/ml and 640 μg/ml",Free,None,Not found,
4867,DRAMP20801,GFGCPNNYQCHRHCKSIPGRCGGYCGGWHRLPCTCYRC,38,"Mussel Defensin MGD-1 (Mediterranean mussel defensin 1; mollusca/molluscs/mollusks, invertebrates, animals)",P80571,Belongs to the invertebrate defensin family. Type 2 subfamily.,FH3,Mytilus galloprovincialis (Mediterranean mussel),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Combine Helix and Beta structure,"The signature of MGD-1 is that of the arthropod defensins which range in length from 34 to 51 amino acid residues with 6 conserved cysteines engaged in three intramolecular disulfide bridges. They are characterized by the presence of a flexible amino-terminal loop, a central amphipathic ",1FJN resolved by NMR,Function: Active against both Gram-positive and Gram-negative bacteria but is not cytotoxic towards human erythrocytes or protozoa.,"[Ref.8925841] Gram-positive bacteria: Micrococcus luteus (MIC=0.08 μg/ml);##Gram-negative bacteria: Escherichia coli (MIC=6.4 μg/ml), Vibrio alginolyticus (MIC=6.4 μg/ml), Vibrio splendidus (MIC=1.6 μg/ml), Vibrio P1 (MIC=6.4 μg/ml).",[Ref.8925841] The plasma is capable of causing 20% of the total hemolysis. ,,8925841,Eur J Biochem. 1996 Aug 15;240(1):302-6.,"Hubert F, Noel T, Roch P. ",A member of the arthropod defensin family from edible Mediterranean mussels (Mytilus galloprovincialis),Cyclic,L,Free,"[Ref.8925841] The protozoan P. marinus is not killed by pure peptide, even at a concentration of 16 μg/ml.",Amidation,"Disulfide bonds between Cys4 and Cys25, Cys10 and Cys33, Cys14 and Cys35, Cys21 and Cys38.  Hydroxylation of Trp28 (3hydroxytryptophan)",Cell membranes,
4868,DRAMP20802,GLGSVLGKALKIGANLL,17,"CPF-AM1 (caerulein precursor fragment-AM1, frogs, amphibians, animals)",No entry found,Belongs to the CPF family.,Not found,"Xenopus amieti (skin secretions, Africa)","Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.20226221] Gram-positive bacteria: Staphylococcus aureus (MIC>200μM) ;##Gram-negative bacteria: Escherichia coli (MIC>200μM).,[Ref.20226221] LC50>200μM against human red blood cells,,20226221,Peptides. 2010 Jun;31(6):989-94. ,"Conlon JM, Al-Ghaferi N, Ahmed E, Meetani MA, Leprince J, Nielsen PF. ","Orthologs of magainin, PGLa, procaerulein-derived, and proxenopsin-derived peptides from skin secretions of the octoploid frog Xenopus amieti (Pipidae).",Linear,L,Free,[Ref.20226221] No cytotoxicity information found,Amidation,None,Cell membranes,
4869,DRAMP20803,FFRNLWKGAKAAFRAGHAAWRA,22,moronecidin-like peptide,No entry found,Not found,Not found,Hippocampus comes ,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Alpha helix ,The peptide is Schiffer,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria; antifungal activity.,"[Ref.30039186] Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (MIC=3.12 μg/ml),Staphylococcus epidermidis ATCC 1435 (MIC=1.56 μg/ml),Staphylococcus aureus MRSA (MIC=3.12 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.25 μg/ml), Pseudomonas aeruginosa ATCC10662 (MIC=50 μg/ml),Acinetobacter baumannii clinical isolate (MIC=6.25 μg/ml);##Fungi:Candida albicans clinical isolate (MIC=6.25 μg/ml), Candida tropicalis clinical isolate (MIC=6.25 μg/ml)","[Ref.30039186] 50% hemolysis at 87.5μg/ml,25% hemolysis at 50μg/ml,60% hemolysis at 100μg/ml against human red cells",,30039186,Mar Biotechnol (NY). 2018 Dec;20(6):718-728.,"Mohammadi M, Taheri B, Momenzadeh N, Salarinia R, Nabipour I, Farshadzadeh Z, Bargahi A.",Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies,Linear,L,Free,[Ref.30039186] No cytotoxicity information found,Amidation,None,Not found,
4870,DRAMP20804,DLRDSWKVIGSDKK,14,AI-hemocidins 2 (Hb-1  truncated peptide),No entry found,Belongs to truncated Hb-1 ,Not found,Arca inflata,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,"Alpha helix,random coil","Peptides displayed random coil conformations in PBS, the spectra of AI-hemocidin 2 featured an ",None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria.,"[Ref.28661457] Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=45.54 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=91.08 μM), Pseudomonas aeruginosa clinical isolate (MIC=91.08 μM);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=22.77 μM), Bacillus subtilis ATCC 6633 (MIC=182.16 μM).",[Ref.28661457] 10.27 ± 0.42% hemolysis at 500 μg/mL against murine red blood cells.,,28661457,Mar Drugs. 2017 Jun 29;15(7). ,"Li C, Zhu J, Wang Y, Chen Y, Song L, Zheng W, Li J, Yu R.","Antibacterial Activity of AI-Hemocidin 2, a Novel N-Terminal Peptide of Hemoglobin Purified from Arca inflata",Linear,L,Free,[Ref.28661457] The cell viability of HEK293 at the peptide concentration of 250 μg/ml is 88.18±9.48%. IC50 > 1000 μg/ml against HEK293 cells.,Free,None,Not found,
4871,DRAMP20805,FSTKTRNWFSEHFKKVKEKLKDTFA,25,Apo5 APOC164-88 ,No entry found,Not found,Not found,American alligator,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,"Alpha helix,beta-sheet,beta-turn,random coil",Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.27542832] Gram-positive bacteria:Staphylococcus aureus ATCC BAA-1718 (EC50=4.96μg/ml), Staphylococcus aureus ATCC 33592 (EC50=0.0680μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 4157 (EC50=19.7μg/ml), Escherichia coli ATCC 51659 (EC50=13.9μg/ml), Pseudomonas aeruginosa PAO1 (EC50=0.0878μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (EC50=0.467μg/ml), Acinetobacter baumannii ATCC 9955 (EC50=0.644μg/ml), Acinetobacter baumannii ATCC BAA-1794 (EC50=0.234μg/ml)",[Ref.27542832] Not hemolytic to sheep red blood cells.,,27542832,BMC Microbiol. 2016 Aug 19;16(1):189. ,"Barksdale SM, Hrifko EJ, Chung EM, van Hoek ML.",Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii,Linear,L,Free,"[Ref.27542832] The cell proliferation of A549 human lung epithelial cells is 175%, 170%, 145%, 173% and 120% at peptide concentrations of 1 μg/ml, 10 μg/ml, 25 μg/ml, 50 μg/ml, 100 μg/ml",Free,None,Not found,
4872,DRAMP20806,KTRNWFSEHFKKVKEKLKDTFA,22,Apo6 APOC167-88,No entry found,Not found,Not found,American alligator,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,"Alpha helix,beta-sheet,beta-turn,random coil",Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.27542832] Gram-positive bacteria:Staphylococcus aureus ATCC BAA-1718 (EC50=2.31μg/ml), Staphylococcus aureus ATCC 33592 (EC50=0.883μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 4157 (EC50=3.85μg/ml), Escherichia coli ATCC 51659 (EC50=9.07μg/ml), Pseudomonas aeruginosa PAO1 (EC50=1.17μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (EC50=0.130μg/ml), Acinetobacter baumannii ATCC 9955 (EC50=0.233μg/ml), Acinetobacter baumannii ATCC BAA-1794 (EC50=0.126μg/ml)",[Ref.27542832] Not hemolytic to sheep red blood cells.,,27542832,BMC Microbiol. 2016 Aug 19;16(1):189. ,"Barksdale SM, Hrifko EJ, Chung EM, van Hoek ML.",Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii,Linear,L,Free,"[Ref.27542832] The cell proliferation of A549 human lung epithelial cells is 190%, 167%, 150%, 135% and 144% at peptide concentrations of 1 μg/ml, 10 μg/ml, 25 μg/ml, 50 μg/ml, 100 μg/ml",Free,None,Not found,
4873,DRAMP20807,PPPVIKFNRPFLMWIVERDTRSILFMGKIVNPKAP,35,A1P394-428,No entry found,Not found,Not found,American alligator,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,"Alpha helix,beta-sheet,beta-turn,random coil",A1P is primarily random coil with two anti-parallel ,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.27542832] Gram-positive bacteria:Staphylococcus aureus ATCC BAA-1718 (EC50=36.5μg/ml), Staphylococcus aureus ATCC 33592 (EC50=2.68μg/ml);##Gram-negative bacteria:Escherichia coli ATCC 4157 (EC50=9.2μg/ml), Escherichia coli ATCC 51659 (EC50=2.51μg/ml), Pseudomonas aeruginosa PAO1 (EC50=38.6μg/ml),  Acinetobacter baumannii ATCC 9955 (EC50=24.0μg/ml), Acinetobacter baumannii ATCC BAA-1794 (EC50=2.36μg/ml)",[Ref.27542832] Not hemolytic to sheep red blood cells.,,27542832,BMC Microbiol. 2016 Aug 19;16(1):189. ,"Barksdale SM, Hrifko EJ, Chung EM, van Hoek ML.",Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii,Linear,L,Free,"[Ref.27542832] The cell proliferation of A549 human lung epithelial cells is 170%, 180%, 182%, 180% and 180% at peptide concentrations of 1 μg/ml, 10 μg/ml, 25 μg/ml, 50 μg/ml, 100 μg/ml",Free,None,Not found,
4874,DRAMP20808,RRLRKKTRKRLKKIGKVLKWI,21,RI21 (PMAP-36 peptide derivative),No entry found,Derived from PMAP-36,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,None,"Function: Antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and Fungi..","[Ref.27251456] Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=4 μM, MBC=4 μM), Staphylococcus aureus 25923 (MIC=4 μM, MBC=4 μM), Staphylococcus epidermidis 12228 (MIC=4 μM, MBC=8 μM), Bacillus subtilis 63501 (MIC=1 μM, MBC=4 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM, MBC=8 μM), Escherichia coli EC183 (MIC=1 μM, MBC=2 μM), Escherichia coli 1005 (MIC=2 μM, MBC=2 μM), Salmonella typhimurium C77-31 (MIC=1 μM, MBC=2 μM);##Fungi: Candida albicans 2.2086 (MIC=8 μM, MFC=16 μM), Candida albicans CA276 (MIC=8 μM, MFC=32 μM), Candida tropicalis 2.1975 (MIC=1 μM, MFC=2 μM), Candida krusei 2.1857 (MIC=2 μM, MFC=4 μM).","[Ref.27251456] 5% hemolysis at 32 μM,  MHC=32 μM against human red blood cells.",,27251456,Sci Rep. 2016 Jun 2;6:27258. ,"Lyu Y, Yang Y, Lyu X, Dong N, Shan A.","Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida.",Linear,L,Free,[Ref.27251456] No cytotoxicity information found,Amidation,None,Not found,
4875,DRAMP20809,RKKTRKRLKKIGKVLKWI,18,RI18 (PMAP-36 peptide derivative),No entry found,Derived from PMAP-36,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,None,"Function: Antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and Fungi..","[Ref.27251456] Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=4 μM, MBC=4 μM), Staphylococcus aureus 25923 (MIC=8 μM, MBC=8 μM), Staphylococcus epidermidis 12228 (MIC=4 μM, MBC=16 μM), Bacillus subtilis 63501 (MIC=1 μM, MBC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM, MBC=4 μM), Escherichia coli EC183 (MIC=1 μM, MBC=2 μM), Escherichia coli 1005 (MIC=2 μM, MBC=4 μM), Salmonella typhimurium C77-31 (MIC=2 μM, MBC=4 μM);##Fungi: Candida albicans 2.2086 (MIC=16 μM, MFC=32 μM), Candida albicans CA276 (MIC=8 μM, MFC=16 μM), Candida tropicalis 2.1975 (MIC=2 μM, MFC=4 μM), Candida krusei 2.1857 (MIC=4 μM, MFC=8 μM).","[Ref.27251456] 5% hemolysis at 128 μM, MHC=128 μM against human red blood cells.",,27251456,Sci Rep. 2016 Jun 2;6:27258. ,"Lyu Y, Yang Y, Lyu X, Dong N, Shan A.","Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida.",Linear,L,Free,[Ref.27251456] No cytotoxicity information found,Amidation,None,Not found,
4876,DRAMP20810,TRKRLKKIGKVLKWI,15,TI15 (PMAP-36 peptide derivative),No entry found,Derived from PMAP-36,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,None,"Function: Antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and Fungi..","[Ref.27251456] Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=32 μM, MBC=128 μM), Staphylococcus aureus 25923 (MIC=32 μM, MBC=128 μM), Staphylococcus epidermidis 12228 (MIC=32 μM, MBC=64 μM), Bacillus subtilis 63501 (MIC=2 μM, MBC=4 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=8 μM, MBC=16 μM), Escherichia coli EC183 (MIC=2 μM, MBC=4 μM), Escherichia coli 1005 (MIC=4 μM, MBC=8 μM), Salmonella typhimurium C77-31 (MIC=8 μM, MBC=32 μM);##Fungi: Candida albicans 2.2086 (MIC=64 μM, MFC=64 μM), Candida albicans CA276 (MIC=128 μM, MFC=128 μM), Candida tropicalis 2.1975 (MIC=2 μM, MFC=4 μM), Candida krusei 2.1857 (MIC=8 μM, MFC=16 μM).","[Ref.27251456] Non-hemolysis upto 128 μM, MHC>128 μM against human red blood cells.",,27251456,Sci Rep. 2016 Jun 2;6:27258. ,"Lyu Y, Yang Y, Lyu X, Dong N, Shan A.","Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida.",Linear,L,Free,[Ref.27251456] No cytotoxicity information found,Amidation,None,Not found,
4877,DRAMP20811,RLKKIGKVLKWI,12,RI12 (PMAP-36 peptide derivative),No entry found,Derived from PMAP-36,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,None,"Function: Antimicrobial activity against Gram-negative bacteria, Gram-positive bacteria and Fungi..","[Ref.27251456] Gram-positive bacteria: Staphylococcus aureus 29213 (MIC=64 μM, MBC=128 μM), Staphylococcus aureus 25923 (MIC=128 μM, MBC=128 μM), Staphylococcus epidermidis 12228 (MIC=64 μM, MBC=64 μM), Bacillus subtilis 63501 (MIC=2 μM, MBC=8 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=8 μM, MBC=32 μM), Escherichia coli EC183 (MIC=2 μM, MBC=4 μM), Escherichia coli 1005 (MIC=16 μM, MBC=32 μM), Salmonella typhimurium C77-31 (MIC=8 μM, MBC=32 μM);##Fungi: Candida albicans 2.2086 (MIC=128 μM, MFC=128 μM), Candida albicans CA276 (MIC=128 μM, MFC=128 μM), Candida tropicalis 2.1975 (MIC=8 μM, MFC=8 μM), Candida krusei 2.1857 (MIC=16 μM, MFC=16 μM).","[Ref.27251456] Non-hemolysis upto 128 μM, MHC>128 μM against human red blood cells.",,27251456,Sci Rep. 2016 Jun 2;6:27258. ,"Lyu Y, Yang Y, Lyu X, Dong N, Shan A.","Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida.",Linear,L,Free,[Ref.27251456] No cytotoxicity information found,Amidation,None,Not found,
4878,DRAMP20812,GILGKLWKGVKSIF,14,K8,No entry found,Belongs to the Hp1404 family,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.26952110] Gram-positive bacteria:Staphylococcus aureus AB94004 (MIC=6.25μg/mL), Staphylococcus aureus ATCC6538 (MIC=6.25μg/mL), Staphylococcus aureus ATCC25923 (MIC=12.5μg/mL), Staphylococcus aureus MRSA P1381 (MIC=6.25μg/mL), Staphylococcus aureus MRSA P1374 (MIC=6.25μg/mL);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=25μg/mL), Escherichia coli ATCC25922 (MIC=100μg/mL), Pseudomonas aeruginosa AB93066 (MIC=50μg/mL), Pseudomonas aeruginosa ATCC9027 (MIC=25μg/mL)","[Ref.26952110] 2% hemolysis at 50μg/mL, 20% hemolysis at 100μg/mL, 45% hemolysis at 200μg/mL, 65% hemolysis at 400μg/mL against human red blood cells",,26952110,Appl Microbiol Biotechnol. 2016 Jun;100(11):5069-77. ,"Li Z, Liu G, Meng L, Yu W, Xu X, Li W, Wu Y, Cao Z.",K1K8: an Hp1404-derived antibacterial peptide,Linear,L,Free,[Ref.26952110] No cytotoxicity information found,Amidation,None,Not found,
4879,DRAMP20813,LILGKLWKGVKSIF,14,L1K8,No entry found,Belongs to the Hp1404 family,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.26952110] Gram-positive bacteria:Staphylococcus aureus AB94004 (MIC=12.5μg/mL), Staphylococcus aureus ATCC6538 (MIC=12.5μg/mL), Staphylococcus aureus ATCC25923 (MIC=12.5μg/mL), Staphylococcus aureus MRSA P1381 (MIC=25μg/mL), Staphylococcus aureus MRSA P1374 (MIC=6.25μg/mL);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=50μg/mL), Escherichia coli ATCC25922 (MIC=100μg/mL), Pseudomonas aeruginosa AB93066 (MIC=100μg/mL), Pseudomonas aeruginosa ATCC9027 (MIC=25μg/mL)","[Ref.26952110] 2% hemolysis at 200μg/mL, 10% hemolysis at 400μg/mL against human red blood cells",,26952110,Appl Microbiol Biotechnol. 2016 Jun;100(11):5069-77. ,"Li Z, Liu G, Meng L, Yu W, Xu X, Li W, Wu Y, Cao Z.",K1K8: an Hp1404-derived antibacterial peptide,Linear,L,Free,[Ref.26952110] No cytotoxicity information found,Amidation,None,Not found,
4880,DRAMP20814,SILGKLWKGVKSIF,14,S1K8,No entry found,Belongs to the Hp1404 family,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.26952110] Gram-positive bacteria:Staphylococcus aureus AB94004 (MIC=6.25μg/mL), Staphylococcus aureus ATCC6538 (MIC=6.25μg/mL), Staphylococcus aureus ATCC25923 (MIC=6.25μg/mL), Staphylococcus aureus MRSA P1381 (MIC=12.5μg/mL), Staphylococcus aureus MRSA P1374 (MIC=6.25μg/mL);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=25μg/mL), Escherichia coli ATCC25922 (MIC=50μg/mL), Pseudomonas aeruginosa AB93066 (MIC=50μg/mL), Pseudomonas aeruginosa ATCC9027 (MIC=25μg/mL)","[Ref.26952110] 15% hemolysis at 200μg/mL, 45% hemolysis at 400μg/mL against human red blood cells",,26952110,Appl Microbiol Biotechnol. 2016 Jun;100(11):5069-77. ,"Li Z, Liu G, Meng L, Yu W, Xu X, Li W, Wu Y, Cao Z.",K1K8: an Hp1404-derived antibacterial peptide,Linear,L,Free,[Ref.26952110] No cytotoxicity information found,Amidation,None,Not found,
4881,DRAMP20815,FILGKLWKGVKSIF,14,F1K8,No entry found,Belongs to the Hp1404 family,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.26952110] Gram-positive bacteria:Staphylococcus aureus AB94004 (MIC=6.25μg/mL), Staphylococcus aureus ATCC6538 (MIC=6.25μg/mL), Staphylococcus aureus ATCC25923 (MIC=6.25μg/mL), Staphylococcus aureus MRSA P1381 (MIC=12.5μg/mL), Staphylococcus aureus MRSA P1374 (MIC=12.5μg/mL);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=25μg/mL), Escherichia coli ATCC25922 (MIC=50μg/mL), Pseudomonas aeruginosa AB93066 (MIC=50μg/mL), Pseudomonas aeruginosa ATCC9027 (MIC=50μg/mL)","[Ref.26952110] 2% hemolysis at 100μg/mL, 35% hemolysis at 200μg/mL, 70% hemolysis at 400μg/mL against human red blood cells",,26952110,Appl Microbiol Biotechnol. 2016 Jun;100(11):5069-77. ,"Li Z, Liu G, Meng L, Yu W, Xu X, Li W, Wu Y, Cao Z.",K1K8: an Hp1404-derived antibacterial peptide,Linear,L,Free,[Ref.26952110] No cytotoxicity information found,Amidation,None,Not found,
4882,DRAMP20816,KILGKLWKGVKSIF,14,K1K8,No entry found,Belongs to the Hp1404 family,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.26952110] Gram-positive bacteria:Staphylococcus aureus AB94004 (MIC=6.25μg/mL), Staphylococcus aureus ATCC6538 (MIC=12.5μg/mL), Staphylococcus aureus ATCC25923 (MIC=12.5μg/mL), Staphylococcus aureus MRSA P1381 (MIC=6.25μg/mL), Staphylococcus aureus MRSA P1374 (MIC=6.25μg/mL);##Gram-negative bacteria: Escherichia coli AB94012 (MIC=25μg/mL), Escherichia coli ATCC25922 (MIC=50μg/mL), Pseudomonas aeruginosa AB93066 (MIC=50μg/mL), Pseudomonas aeruginosa ATCC9027 (MIC=50μg/mL)",[Ref.26952110] 10% hemolysis at 400μg/mL against human red blood cells,,26952110,Appl Microbiol Biotechnol. 2016 Jun;100(11):5069-77. ,"Li Z, Liu G, Meng L, Yu W, Xu X, Li W, Wu Y, Cao Z.",K1K8: an Hp1404-derived antibacterial peptide,Linear,L,Free,"[Ref.26952110] The cell vaibility of HFF cell lines is 100%, 108%, 105%  and 38% at peptide concentrations of 0 μg/ml, 50 μg/ml, 100 μg/ml and 200 μg/ml. ##The cell viability of HEK293T cell lines is 105%, 125%, 101% and 21% at peptide concentrations of",Amidation,None,Not found,
4883,DRAMP20817,RRLIRLILRLLR ,12,RR12,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.26795535] Gram-positive bacteria:Bacillus subtilis lab strain (MIC=8μM), Staphylococcus aureus ATCC25923 (MIC=8μM), Streptococcus pyogenes ATCC19615 (MIC=12.5μM), Enterococcus feacalis ATCC29212 (MIC=10μM);##Gram-negative bacteria:Escherichia coli lab strain (MIC=8μM), Pseudomonas aeruginosa ATCC27853 (MIC=12.5μM), Klebsiella pneumoniae ATCC13883 (MIC=8μM), Salmonella enterica ATCC14028 (MIC=10μM)","[Ref.26795535] 4% hemolysis at 25μM, 10% hemolysis at 50μM, 32% hemolysis at 100μM against mice red cells",,26849911,Biopolymers. 2016 May;106(3):345-56. ,"Mohanram H, Bhattacharjya S.",Salt-resistant short antimicrobial peptides,Linear,L,Free,[Ref.26849911] No cytotoxicity information found,Amidation,None,Not found,
4884,DRAMP20818,RRLIWLILRLLR,12,RR12Wpolar,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.26795535] Gram-positive bacteria:Bacillus subtilis lab strain (MIC=4μM), Staphylococcus aureus ATCC25923 (MIC=4μM), Streptococcus pyogenes ATCC19615 (MIC=4μM), Enterococcus feacalis ATCC29212 (MIC=8μM);##Gram-negative bacteria:Escherichia coli lab strain (MIC=8μM), Pseudomonas aeruginosa ATCC27853 (MIC=10μM), Klebsiella pneumoniae ATCC13883 (MIC=4μM), Salmonella enterica ATCC14028 (MIC=10μM)","[Ref.26795535] 5% hemolysis at 5 μM, 12% hemolysis at 10 μM, 32% hemolysis at 25 μM, 60% hemolysis at 50 μM, 78% hemolysis at 100 μM against mice red cells",,26849911,Biopolymers. 2016 May;106(3):345-56. ,"Mohanram H, Bhattacharjya S.",Salt-resistant short antimicrobial peptides,Linear,L,Free,[Ref.26849911] No cytotoxicity information found,Amidation,None,Not found,
4885,DRAMP20819,RRLIRLWLRLLR ,12,RR12Whydro,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.26795535] Gram-positive bacteria:Bacillus subtilis lab strain (MIC=4μM), Staphylococcus aureus ATCC25923 (MIC=8μM), Streptococcus pyogenes ATCC19615 (MIC=8μM), Enterococcus feacalis ATCC29212 (MIC=8μM);##Gram-negative bacteria:Escherichia coli lab strain (MIC=4μM), Pseudomonas aeruginosa ATCC27853 (MIC=10μM), Klebsiella pneumoniae ATCC13883 (MIC=4μM), Salmonella enterica ATCC14028 (MIC=8μM)","[Ref.26795535] 2% hemolysis at 25 μM, 5% hemolysis at 50μM, 18% hemolysis at 100μM against mice red cells",,26849911,Biopolymers. 2016 May;106(3):345-56. ,"Mohanram H, Bhattacharjya S.",Salt-resistant short antimicrobial peptides,Linear,L,Free,[Ref.26849911] No cytotoxicity information found,Amidation,None,Not found,
4886,DRAMP20820,FRIRVRV,7,FV7,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.28178190] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=64 μM), Streptococcus Faecalis ATCC 29212 (MIC=32 μM), Bacillus subtilis CMCC 63501 (MIC=16 μM), Staphylococcus epidermidis ATCC 12228 (MIC=32 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16 μM), Escherichia coli UB 1005 (MIC=32 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μM), Pseudomonas aeruginosa PAO1 (MIC=32 μM), Salmonella typhimurium ATCC 14028 (MIC=16 μM), Salmonella typhimurium ATCC 7731 (MIC=32 μM).",[Ref.28178190] 3% hemolysis at 128 μM against human red cells,,28178190,Int J Mol Sci. 2017 Feb 6;18(2). ,"Tan T, Wu D, Li W, Zheng X, Li W, Shan A.",High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7,Linear,L,Free,[Ref.28178190] No cytotoxicity information found,Amidation,None,Not found,
4887,DRAMP20821,FRIRVRVFKRIVQRIKDFLR,20,"FV-LL (FV7 and LL(LL-37,(17-29)) hybrid peptide)",No entry found,"FV7 and LL(LL-37,(17-29)) hybrid peptide",Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, random coil",The hybrid peptide displayed an unordered conformation in phosphate buffer.,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.28178190] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=2 μM), Streptococcus Faecalis ATCC 29212 (MIC=4 μM), Bacillus subtilis CMCC 63501 (MIC=4 μM), Staphylococcus epidermidis ATCC 12228 (MIC=1 μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=1 μM), Escherichia coli UB 1005 (MIC=4 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=4 μM), Pseudomonas aeruginosa PAO1 (MIC=2 μM), Salmonella typhimurium ATCC 14028 (MIC=2 μM), Salmonella typhimurium ATCC 7731 (MIC=2 μM).",[Ref.28178190] 2% hemolysis at 128 μM against human red cells,,28178190,Int J Mol Sci. 2017 Feb 6;18(2). ,"Tan T, Wu D, Li W, Zheng X, Li W, Shan A.",High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7,Linear,L,Free,[Ref.28178190] No cytotoxicity information found,Amidation,None,Not found,
4888,DRAMP20822,FRIRVRVAKKFGKAFVGEIM,20,FV-MA (FV7 and MA(Magainin 2 (9-21))  hybrid peptide),No entry found,FV7 and MA(Magainin 2 (9-21))  hybrid peptide,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, random coil",The hybrid peptide displayed an unordered conformation in phosphate buffer.,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.28178190] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=8 μM), Streptococcus Faecalis ATCC 29212 (MIC=16 μM), Bacillus subtilis CMCC 63501 (MIC=4 μM), Staphylococcus epidermidis ATCC 12228 (MIC=8 μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=8 μM), Escherichia coli UB 1005 (MIC=8 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Pseudomonas aeruginosa PAO1 (MIC=2 μM), Salmonella typhimurium ATCC 14028 (MIC=4 μM), Salmonella typhimurium ATCC 7731 (MIC=4 μM).","[Ref.28178190] 1% hemolysis at 2 μM, 8% hemolysis at 4 μM, 10% hemolysis at 8 μM, 15% hemolysis at 16 μM, 20% hemolysis at 32 μM, 37% hemolysis at 64 μM, 55% hemolysis at 128 μM against human red cells",,28178190,Int J Mol Sci. 2017 Feb 6;18(2). ,"Tan T, Wu D, Li W, Zheng X, Li W, Shan A.",High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7,Linear,L,Free,[Ref.28178190] No cytotoxicity information found,Amidation,None,Not found,
4889,DRAMP20823,FRIRVRVKWKLFKKI,15,FV-CE (FV7 and CE(Cecropin A (1,No entry found,FV7 and CE(Cecropin A (1,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil,The hybrid peptide displayed an unordered conformation in phosphate buffer.,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.28178190] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=8 μM), Streptococcus Faecalis ATCC 29212 (MIC=1 μM), Bacillus subtilis CMCC 63501 (MIC=1 μM), Staphylococcus epidermidis ATCC 12228 (MIC=0.5 μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=2 μM), Escherichia coli UB 1005 (MIC=2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=2 μM), Pseudomonas aeruginosa PAO1 (MIC=2 μM), Salmonella typhimurium ATCC 14028 (MIC=4 μM), Salmonella typhimurium ATCC 7731 (MIC=4 μM).","[Ref.28178190] 1% hemolysis at 2 μM, 5% hemolysis at 128 μM against human red cells",,28178190,Int J Mol Sci. 2017 Feb 6;18(2). ,"Tan T, Wu D, Li W, Zheng X, Li W, Shan A.",High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7,Linear,L,Free,[Ref.28178190] No cytotoxicity information found,Amidation,None,Not found,
4890,DRAMP20824,GLFKKLRRKIKKGFKKIFKRLPPIGVGVSIPLAGKR,36,AM-CATH36,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, random coil",NA-CATH has previously been shown to be random coil in water or buffer and ,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.28089718] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=21μg/ml), Staphylococcus aureus ATCC 33592 (MIC=21μg/ml);##Gram-negative bacteria:Acinetobacter baumannii ATCC 9955 (MIC=5.2μg/ml), Acinetobacter baumannii ATCC BAA-1794 (MIC=5.2μg/ml), Escherichia coli ATCC 4157 (MIC=140μg/ml), K. pneumoniae ATCC 33495 (MIC=5.2μg/ml), K. pneumoniae ATCC BAA-1705 (MIC=5.6μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=5.2μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (MIC=5.2μg/ml)",[Ref.28089718] 0% hemolysis at 300μg/ml against sheep red cells,,28089718,Dev Comp Immunol. 2017 May;70:135-144. ,"Barksdale SM, Hrifko EJ, van Hoek ML.",Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae,Linear,L,Free,[Ref.28089718] The survival rate of A549 human lung epithelial cells is 124% at a peptide concentration of 300 μg/ml,Free,None,Not found,
4891,DRAMP20825,KIKKGFKKIFKRLPPIGVGVSIPLAGKR,28,AM-CATH28,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,"Alpha helix, random coil",NA-CATH has previously been shown to be random coil in water or buffer and ,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.28089718] Gram-negative bacteria:Acinetobacter baumannii ATCC 9955 (MIC=28μg/ml), Acinetobacter baumannii ATCC BAA-1794 (MIC=10μg/ml), K. pneumoniae ATCC 33495 (MIC=5.6μg/ml), K. pneumoniae ATCC BAA-1705 (MIC=28μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=21μg/ml)",[Ref.28089718] 1% hemolysis at 300μg/ml against sheep red cells,,28089718,Dev Comp Immunol. 2017 May;70:135-144. ,"Barksdale SM, Hrifko EJ, van Hoek ML.",Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae,Linear,L,Free,[Ref.28089718] The survival rate of A549 human lung epithelial cells is 122% at a peptide concentration of 300 μg/ml,Free,None,Not found,
4892,DRAMP20826,GLFKKLRRKIKKGFKKIFKRL,21,AM-CATH21,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, random coil",NA-CATH has previously been shown to be random coil in water or buffer and ,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.28089718] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=28μg/ml), Staphylococcus aureus ATCC 33592 (MIC=28μg/ml);##Gram-negative bacteria:Acinetobacter baumannii ATCC 9955 (MIC=42μg/ml), Acinetobacter baumannii ATCC BAA-1794 (MIC=10μg/ml), Escherichia coli ATCC 4157 (MIC=21μg/ml), Escherichia coli ATCC 51659 (MIC=140μg/ml), K. pneumoniae ATCC 33495 (MIC=5.2μg/ml), K. pneumoniae ATCC BAA-1705 (MIC=28μg/ml), Pseudomonas aeruginosa ATCC 9027 (MIC=10μg/ml), Pseudomonas aeruginosa ATCC BAA-2110 (MIC=42μg/ml)",[Ref.28089718] 0.5% hemolysis at 300μg/ml against sheep red cells,,28089718,Dev Comp Immunol. 2017 May;70:135-144. ,"Barksdale SM, Hrifko EJ, van Hoek ML.",Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae,Linear,L,Free,[Ref.28089718] The survival rate of A549 human lung epithelial cells is 113% at a peptide concentration of 300 μg/ml,Free,None,Not found,
4893,DRAMP20827,FLPIVGLLKSLLK,13,TB_L1FK,No entry found,Derived from TB,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,"Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,antifungal activity.","[Ref.28443279] Gram-positive bacteria: S.aureus ATCC 33591 (MIC=6μM), Staphylococcus epidermidis (MIC=1.5μM);##Gram-negative bacteria: Klebsiella pneumoniae ATCC BAA-1706 (MIC=6μM), Pseudomonas aeruginosa ATCC 27853 (MIC=6μM)","[Ref.28443279] 8% hemolysis at 48μM, 38% hemolysis at 96μM against human red cells",,28443279,Front Chem. 2017 Apr 11;5:24,"Grassi L, Maisetta G, Maccari G, Esin S, Batoni G.",Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide,Linear,L,Free,[Ref.28443279] IC50 = 52 μM against PBMCs. ##IC50 = 59 μM against A549 cells,Amidation,None,Not found,
4894,DRAMP20828,KKLLPIVANLLKSLL,15,TB_KKG6A,No entry found,Derived from TB,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,"Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,antifungal activity.","[Ref.28443279] Gram-positive bacteria: S.aureus ATCC 33591 (MIC=1.5μM), Staphylococcus epidermidis (MIC=1.5μM);##Gram-negative bacteria: Klebsiella pneumoniae ATCC BAA-1706 (MIC=3μM), Pseudomonas aeruginosa ATCC 27853 (MIC=3μM)","[Ref.28443279] 11% hemolysis at 48μM, 55% hemolysis at 96μM against human red cells",,28443279,Front Chem. 2017 Apr 11;5:24,"Grassi L, Maisetta G, Maccari G, Esin S, Batoni G.",Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide,Linear,L,Free,[Ref.28443279] IC50 = 49 μM against PBMCs. ##IC50 = 16 μM against A549 cells,Amidation,None,Not found,
4895,DRAMP20831,ILGKLWEGLKSLF,13,IsCT1L1,No entry found,Belongs to the scorpion NDBP 5 family,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.28657596] Gram-positive bacteria:Staphylococcus aureus (MIC=50μg/mL);##Gram-negative bacteria: S. typhimurium (MIC=100μg/mL), Escherichia coli (MIC=50μg/mL)","[Ref.28657596] 1% hemolysis at 10 μg/ml, 78% hemolysis at 50 μg/ml, 90% hemolysis at 100 μg/ml against human red cells",,28657596,Antibiotics (Basel). 2017 Jun 28;6(3). ,"de la Salud Bea R, Petraglia AF, Ascuitto MR, Buck QM.",Antibacterial Activity and Toxicity of Analogs of Scorpion Venom IsCT Peptides,Linear,L,Free,[Ref.28657596] No cytotoxicity information found,Amidation,None,Not found,
4896,DRAMP20832,IDWKKLLNAAKQIL,14,Polybia-MP1S-D8N,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,None,"Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria, position 6 and 10 are cross-linked residues connected by the oct-4-enyl hydrocarbon staple","[Ref.29075946] Gram-positive bacteria: Bacillus subtilis (MIC=0.8μM), Staphylococcus aureus (MIC=0.8μM), Staphylococcus epidermidis (MIC=37.5μM);##Gram-negative bacteria:Escherichia coli (MIC=50μM), Shigella dysenteriae (MIC=100μM), Klebsiella pneumoniae (MIC=37.5μM)","[Ref.29075946] 16.3% hemolysis at 12.5μM, 37.8% hemolysis at 25μM against human red cells",,29075946,Arch Pharm Res. 2017 Dec;40(12):1414-1421.,"Luong HX, Kim DH, Lee BJ, Kim YW",Antimicrobial activity and stability of stapled helices of polybia-MP1,Cyclic,L,Free,[Ref.29075946] No cytotoxicity information found,Amidation,The oct-4-enyl hydrocarbon staple between Leu6 and Ala10,Not found,
4897,DRAMP20833,FVPWFSKFLGRIL,13,"[Pro3,DLeu9]TL(1) (Temporin L peptide derivative)",No entry found,Derived from Temporin L,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,The analogues bearing a D residue shows a reduction in the percentage of helicity compared to the corresponding L analogues in the MMs ,None,"Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(1) is D-Leucine.","[Ref.28863356] Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3.125μM), Staphylococcus aureus Cowan I (MIC=12.5μM), Staphylococcus epidermidis ATCC 12228 (MIC=6.25μM);##Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MIC=12.5μM), Escherichia coli D21 (MIC=12.5μM), Pseudomonas syringae pv tabaci 1918 (MIC=12.5μM), Pseudomonas aeruginosa ATCC 2785 (MIC=50μM);##Yeasts: Candida albicans ATCC 10231 (MIC=3.125μM), Candida crusei ATCC 6258 (3.125μM).","[Ref.28863356] 21±4% hemolysis at 50μM, 7±3% hemolysis at 25μM, 6±3% hemolysis at 12.5μM, 3±2% hemolysis at 6.25μM, 1±1%  hemolysis at 3.125μM against human red blood cells.##20.63 ± 2.66% cytotoxic effect at 12.5μM, 57.52 ± 3.99%  cytotoxic effect at 25μM, 91.58 ± 3.85% cytotoxic effect at 50 μM on HaCaT cells.",,28863356,Eur J Med Chem. 2017 Oct 20;139:750-761.,"Merlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.","Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities",Linear,Mixed (D-Leu9),Free,"[Ref.28863356] The cytotoxic effects of the peptide are 20.63±2.66%, 57.52±3.99% and 91.58±3.85% at 12.5, 25 and 50 μM ",Amidation,None,Not found,
4898,DRAMP20834,RWQWRWQWR,9,PLS,No entry found,Not found,Not found,Not found,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria,"[Ref.29551999] Gram-negative bacteria:E. faecalis-sensitive strain (MIC=25.6 μM),Staphylococcus aureus-sensitive strain (MIC=34.9 μM),,Staphylococcus aureus-resistant strain (MIC=25.0 μM);##Gram-positive bacteria:Klebsiella pneumoniaae-sensitive strain (MIC=30.7 μM),Klebsiella pneumoniaae-resistant strain (MIC=26.2 μM),Pseudomonas aeruginosa-sensitive strain (MIC=99.7 μM),Pseudomonas aeruginosa-resistant strain (MIC=107.2 μM)","[Ref.29551999] 24.8% hemolysis at 100μM,50% hemolysis at >100μM against human red cells",,29551999,Front Microbiol. 2018 Mar 2;9:329.,"Vega SC, Mart","Design, Synthesis and Evaluation of Branched RRWQWR-Based Peptides as Antibacterial Agents against Clinically Relevant Gram-Positive and Gram-Negative Pathogens",Linear,L,Free,[Ref.29551999] No cytotoxicity information found,Free,None,Not found,
4899,DRAMP20837,KRVKRFKKFFRKIKKGFRKIFKKTKIFIGGT,31,Pb-CATH1 Python bivittatus  antimicrobial peptides peptide derivative,No entry found,Derived from cathelicidin family,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-positive ,[Ref.28630199]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=2μg/ml);Pseudomonas aeruginosa (ATCC 27853)(MIC=3μg/ml);S. typhimurium (ATCC 14028)(MIC=1.5μg/ml);##Gram-positive bacteria:Staphylococcus aureus (ATCC 29213)(MIC>128μg/ml);B. cereus (ATCC 10876)(MIC=46μg/ml),[Ref.28630199] 0% hemolysis at 4μg/ml against human red blood cell; 1.4 ± 0.4% hemolysis at 8μg/ml against human red blood cell; 5.1 ± 0.5% hemolysis at 16μg/ml against human red blood cell;7.3 ± 0.6% hemolysis at 32μg/ml against human red blood cell; 12.2 ± 0.7% hemolysis at 64μg/ml against human red blood cell,,28630199,Antimicrob Agents Chemother. 2017 Aug 24;61(9). ,"Kim D, Soundrarajan N, Lee J, Cho HS, Choi M, Cha SY, Ahn B, Jeon H, Le MT, Song H, Kim JH, Park C.",Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.,Linear,L,Free,[Ref.28630199] No cytotoxicity information found,Free,None,Not found,
4900,DRAMP20838,TRSRWRRFIRGAGRFARRYGWRIAL,25,Pb-CATH4 bivittatus  antimicrobial peptides peptide derivative ,No entry found,Derived from cathelicidin family,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,"The peptide adopts arginine content of this peptide is 37.5%, and it contains two tryptophan residues (8.3%)",None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria,[Ref.28630199]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=1μg/ml);Pseudomonas aeruginosa (ATCC 27853)(MIC=3μg/ml);S. typhimurium (ATCC 14028)(MIC=0.5μg/ml);##Gram-positive bacteria:Staphylococcus aureus (ATCC 29213)(MIC>128μg/ml);B. cereus (ATCC 10876)(MIC=10μg/ml);##Clinical isolates:Escherichia coli(MIC=4.7μg/ml);K. pneumoniae(MIC=1.18μg/ml),[Ref.28630199] 0% hemolysis at 4μg/ml against human red blood cell; 1.4 ± 0.4% hemolysis at 8μg/ml against human red blood cell; 5.1 ± 0.5% hemolysis at 16μg/ml against human red blood cell;7.3 ± 0.6% hemolysis at 32μg/ml against human red blood cell; 12.2 ± 0.7% hemolysis at 64μg/ml against human red blood cell,,28630199,Antimicrob Agents Chemother. 2017 Aug 24;61(9). ,"Kim D, Soundrarajan N, Lee J, Cho HS, Choi M, Cha SY, Ahn B, Jeon H, Le MT, Song H, Kim JH, Park C.",Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.,Linear,L,Free,"[Ref.28630199] The cell viability of Pk15(pig kidney fibroblasts) is 103.8%, 124.6%, 94.7%,55.2% and 53.9% at peptide concentrations of 5, 10, 20, 30 and 64 μg/ml. ##The cell viability of HaCaT(human keratinocytes) is 106.9%, 94.6%, 66.2%, 58.1% and 51.",Free,None,Not found,
4901,DRAMP20839,GFVALLKKLPLILKHLH,17,Xylopin ,C0HKQ5,Not found,Not found,Xylocopa appendiculata circumvolans,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Linear cationic alpha-helical,Not found,None,"Function: Antimicrobial and mast cell degranulating peptide which probably acts by forming pores in membranes (PubMed:28546807, PubMed:28855917). Active against both Gram-negative and Gram-positive bacterial strains as well as against yeasts (PubMed:28546807, PubMed:28855917). Has leishmanicidal activity (IC50=25uM)(PubMed:28855917). Has little hemolytic activity (PubMed:28546807, PubMed:28855917)",[Ref.28855917]Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=15.0μM);Micrococcus luteus (ATCC 10240)(MIC=1.9μM);Bacillus subtilis (ATCC 6633)(MIC=3.75μM);Streptococcus pyogenes (CS)(MIC=3.75μM);Streptococcus agalactiae (CS)(MIC=3.75μM);Enterococcus. faecalis (CS)(MIC=15.0μM);##Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=3.75μM);Pseudomonas aeruginosa (ATCC 27853)(MIC=7.5μM);Stenotrophomonas maltophilia (ATCC 13637)(MIC=3.75μM);Shigella boydii (CS)(MIC=3.75μM);Klebsiella pneumoniae (CS)(MIC=7.5μM);Serratia marcescens (CS)(MIC=7.5μM);Enterobacter cloacae (CS)(MIC=7.5μM);Proteus mirabilis (CS)(MIC>30μM);Morganella morgannii (CS)(MIC=30μM);Acinetobacter baumanii/calcoaceticus (CS)(MIC=3.75μM) ;##Yeasts:Candida albicans (ATCC 90112)(MIC=7.5μM);Sacharomyces cerevisae(MIC=3.75μM),[Ref.28855917]IC50=25uM against human red blood cells,,28855917,J Venom Anim Toxins Incl Trop Dis. 2017 Aug 29;23:40.,"Kazuma K, Ando K, Nihei KI, Wang X, Rangel M, Franzolin MR, Mori-Yasumoto K, Sekita S, Kadowaki M, Satake M, Konno K.",Peptidomic analysis of the venom of the solitary bee Xylocopa appendiculata circumvolans.,Linear,L,Free,[Ref.28855917] No cytotoxicity information found,Amidation,None,Not found,
4902,DRAMP20841,SKVWRHWRRFWHRAHRLH,18,C1b,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil conformation,"The peptide adopts an low alpha-helical content when dissolved in water.  However, the peptides displayed 3.23",None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=6.25μM);Pseudomonas aeruginosa(MIC=1.56μM);##Gram-positive bacteria:Staphylococcus aureus(MIC=3.13μM);B. cereus(MIC=3.13μM);S. lactis(MIC=3.13μM);E. faecalis (MIC=1.56μM);E. faecium(MIC=3.13μM),[Ref.27060618] HC50>500μM against human red blood cells,,27060618,Acta Biomater. 2016 Jun;37:59-68.,"Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.",Structure-activity analysis and biological studies of chensinin-1b analogues.,Linear,L,Free,[Ref.27060618] No cytotoxicity information found,Free,None,Not found,
4903,DRAMP20842,SKVWRHWRRFW,11,C1b(1-11),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil conformation,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=12.5μM);Pseudomonas aeruginosa(MIC=3.13μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 6.25μM);B. cereus(MIC=6.25μM);S. lactis(MIC=6.25μM);E. faecalis (MIC=6.25μM);E. faecium(MIC=6.25μM),[Ref.27060618] HC50>500μM against human red blood cells,,27060618,Acta Biomater. 2016 Jun;37:59-68.,"Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.",Structure-activity analysis and biological studies of chensinin-2b analogues.,Linear,L,Free,[Ref.27060618] No cytotoxicity information found,Free,None,Not found,
4904,DRAMP20843,SKVWRHWRRFWHR,13,C1b(1-13),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil conformation,The peptide adopts 41.93% alpha-helical,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=6.25μM);Pseudomonas aeruginosa(MIC=3.13μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 3.13μM);B. cereus(MIC=1.56μM);S. lactis(MIC=3.13μM);E. faecalis (MIC=3.13μM);E. faecium(MIC=6.25μM),[Ref.27060618] HC50>500μM against human red blood cells,,27060618,Acta Biomater. 2016 Jun;37:59-68.,"Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.",Structure-activity analysis and biological studies of chensinin-3b analogues.,Linear,L,Free,[Ref.27060618] No cytotoxicity information found,Free,None,Not found,
4905,DRAMP20844,VWRHWRRFWHR,11,C1b(3-13),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil conformation,The peptide adopts 53.49% alpha-helical,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=6.25μM);Pseudomonas aeruginosa(MIC=3.13μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 3.13μM);B. cereus(MIC=3.13μM);S. lactis(MIC=6.25μM);E. faecalis (MIC=3.13μM);E. faecium(MIC=3.13μM),[Ref.27060618] HC50>500μM against human red blood cells,,27060618,Acta Biomater. 2016 Jun;37:59-68.,"Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.",Structure-activity analysis and biological studies of chensinin-4b analogues.,Linear,L,Free,[Ref.27060618] No cytotoxicity information found,Free,None,Not found,
4906,DRAMP20845,VWRHWRRFW,9,C1b(3-11),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil conformation,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=25μM);Pseudomonas aeruginosa(MIC=50μM);##Gram-positive bacteria:Staphylococcus aureus(MIC=25μM);B. cereus(MIC=50μM);S. lactis(MIC=100μM);E. faecalis (MIC=100μM);E. faecium(MIC=50μM),[Ref.27060618] HC50>500μM against human red blood cells,,27060618,Acta Biomater. 2016 Jun;37:59-68.,"Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.",Structure-activity analysis and biological studies of chensinin-6b analogues.,Linear,L,Free,[Ref.27060618] No cytotoxicity information found,Free,None,Not found,
4907,DRAMP20846,VWRHWRRFWH,10,C1b(3-12),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil conformation,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=50μM);Pseudomonas aeruginosa(MIC=12.5μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 12.25μM);B. cereus(MIC=6.25μM);S. lactis(MIC=12.25μM);E. faecalis (MIC=12.25μM);E. faecium(MIC=6.25μM),[Ref.27060618] HC50>500μM against human red blood cells,,27060618,Acta Biomater. 2016 Jun;37:59-68.,"Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.",Structure-activity analysis and biological studies of chensinin-7b analogues.,Linear,L,Free,[Ref.27060618] No cytotoxicity information found,Free,None,Not found,
4908,DRAMP20847,WRHWRRFWHR,10,C1b(4-13),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil conformation,The peptide adopts 65.69% alpha-helical,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=25μM);Pseudomonas aeruginosa(MIC=3.13μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 50μM);B. cereus(MIC=6.25μM);S. lactis(MIC=6.25μM);E. faecalis (MIC=3.13μM);E. faecium(MIC=6.25μM),[Ref.27060618] HC50>500μM against human red blood cells,,27060618,Acta Biomater. 2016 Jun;37:59-68.,"Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.",Structure-activity analysis and biological studies of chensinin-8b analogues.,Linear,L,Free,[Ref.27060618] No cytotoxicity information found,Free,None,Not found,
4909,DRAMP20848,VWRKWRRFW,9,[K4]C1b(3-11),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil conformation,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=6.25μM);Pseudomonas aeruginosa(MIC=6.25μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 6.25μM);B. cereus(MIC=6.25μM);S. lactis(MIC=3.13μM);E. faecalis (MIC=3.13μM);E. faecium(MIC=3.13μM),[Ref.27060618] HC50>500μM against human red blood cells,,27060618,Acta Biomater. 2016 Jun;37:59-68.,"Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.",Structure-activity analysis and biological studies of chensinin-9b analogues.,Linear,L,Free,[Ref.27060618] No cytotoxicity information found,Free,None,Not found,
4910,DRAMP20849,VWRRWRRFW,9,[R4]C1b(3-11),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil conformation,The peptide adopts 3.23% alpha-helical,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=12.5μM);Pseudomonas aeruginosa(MIC=6.25μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 12.25μM);B. cereus(MIC=6.25μM);S. lactis(MIC=12.25μM);E. faecalis (MIC=12.25μM);E. faecium(MIC=12.5μM),[Ref.27060618] HC50>500μM against human red blood cells,,27060618,Acta Biomater. 2016 Jun;37:59-68.,"Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.",Structure-activity analysis and biological studies of chensinin-10b analogues.,Linear,L,Free,[Ref.27060618] No cytotoxicity information found,Free,None,Not found,
4911,DRAMP20850,VWRKWRRFWKR,11,"[K4,K10]C1b(3-13)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil conformation,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=3.13μM);Pseudomonas aeruginosa(MIC=1.56μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 6.25μM);B. cereus(MIC=3.13μM);S. lactis(MIC=6.25μM);E. faecalis (MIC=6.25μM);E. faecium(MIC=6.25μM),[Ref.27060618] HC50>500μM against human red blood cells,,27060618,Acta Biomater. 2016 Jun;37:59-68.,"Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.",Structure-activity analysis and biological studies of chensinin-11b analogues.,Linear,L,Free,[Ref.27060618] No cytotoxicity information found,Free,None,Not found,
4912,DRAMP20851,VWRRWRRFWRR,11,"[R4,R10]C1b(3-13)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Random coil conformation,The peptide adopts 70.2% alpha-helical,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27060618]Gram-negative bacteria:Escherichia coli(MIC=3.13μM);Pseudomonas aeruginosa(MIC=3.13μM);##Gram-positive bacteria:Staphylococcus aureus(MIC= 3.13μM);B. cereus(MIC=3.13μM);S. lactis(MIC=3.13μM);E. faecalis (MIC=1.56μM);E. faecium(MIC=1.56μM),[Ref.27060618] HC50>500μM against human red blood cells,,27060618,Acta Biomater. 2016 Jun;37:59-68.,"Dong W, Dong Z, Mao X, Sun Y, Li F, Shang D.",Structure-activity analysis and biological studies of chensinin-12b analogues.,Linear,L,Free,[Ref.27060618] No cytotoxicity information found,Free,None,Not found,
4920,DRAMP20859,KFRTRRSKSSSNGGRKGSKG,20,TT(1-24),No entry found,Derived from Cathelicidins,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Unconventional feature,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. TT(1,[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=32μM);A. salmonicida (ATCC 33658)(MIC=32-16μM);Y. ruckeri (NCIMB 1315)(MIC=32μM);V. anguillarum (ATCC 43305 With addition of 2% NaCl)(MIC>32μM);A. hydrophila (ATCC 7966)(MIC>32μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=64μM);L. garvieae (ATCC 49156)(MIC=16-8μM),[Ref.27818338] No hemolytic activity to human,,27818338,Fish Shellfish Immunol. 2016 Dec;59:456-468. ,"D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.",Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins.,Linear,L,Free,[Ref.27818338] No cytotoxicity information found,Free,None,Not found,
4921,DRAMP20860,KFRTRRSKSSSNGGRKGSKGGSKGRPGSGSSIAGA,35,TT(1-35),No entry found,Derived from Cathelicidins,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Unconventional feature,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. TT(1,[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=4μM);A. salmonicida (ATCC 33658)(MIC=2μM);Y. ruckeri (NCIMB 1315)(MIC=8μM);V. anguillarum (ATCC 43305 With addition of 2% NaCl)(MIC>32μM);A. hydrophila (ATCC 7966)(MIC>32μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=16-8μM);L. garvieae (ATCC 49156)(MIC=1μM),[Ref.27818338] No hemolytic activity to human;No hemolytic activity to trout,,27818338,Fish Shellfish Immunol. 2016 Dec;59:456-468. ,"D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.",Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins.,Linear,L,Free,"[Ref.27818338] The cell viability of RTG-2 cells is 106%,  117%, 126% and 121.5% at peptide concentrations of 0.25, 1, 4, and 8 μM.",Free,None,Not found,
4923,DRAMP20862,RRGKDSGGPKMGRKNSKGGWRGRPGSGRPGFGSGI,39,rtCATH2(5-40),No entry found,Derived from Cathelicidins,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Unconventional feature,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria.The peptides inhibit the growth of V. anguillarum or A. hydrophila (MIC >32 ,[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=16μM);A. salmonicida (ATCC 33658)(MIC=16μM);Y. ruckeri (NCIMB 1315)(MIC=16μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=64μM),[Ref.27818338] No hemolytic activity to human,,27818338,Fish Shellfish Immunol. 2016 Dec;59:456-468. ,"D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.",Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins.,Linear,L,Free,[Ref.27818338] No cytotoxicity information found,Free,None,Not found,
4924,DRAMP20863,KIRTRRGKDSGGPKMGRKNSKGGWRGRPGSGSRPGFGSGI,42,rtCATH2(1-40),No entry found,Derived from Cathelicidins,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Unconventional feature,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. The peptides inhibit the growth of V. anguillarum or A. hydrophila (MIC >32 ,[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=4μM);A. salmonicida (ATCC 33658)(MIC=8-4μM);Y. ruckeri (NCIMB 1315)(MIC=16μM);V. anguillarum (ATCC 43305 With addition of 2% NaCl)(MIC>32μM);A. hydrophila (ATCC 7966)(MIC>32μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=16-8μM);L. garvieae (ATCC 49156)(MIC=16-8μM),[Ref.27818338] No hemolytic activity to human;No hemolytic activity to trout,,27818338,Fish Shellfish Immunol. 2016 Dec;59:456-468. ,"D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.",Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins.,Linear,L,Free,"[Ref.27818338] The cell viability of RTG-2 cells is 112.5%, 105%, 107%, 94% at peptide concentrations of 0.25, 1, 4, and 8 μM.",Free,None,Not found,
4925,DRAMP20864,KFRSNGRHGSGSRLGGGSLIGRPGGGS,27,SF(18-45),No entry found,Derived from Cathelicidins,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Unconventional feature,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. SF(18,[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=16μM);A. salmonicida (ATCC 33658)(MIC=64μM);Y. ruckeri (NCIMB 1315)(MIC=32μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=64μM),[Ref.27818338] No hemolytic activity to human,,27818338,Fish Shellfish Immunol. 2016 Dec;59:456-468. ,"D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.",,Linear,L,Free,[Ref.27818338] No cytotoxicity information found,Free,None,Not found,
4926,DRAMP20865,(RRWQWR)2-K-(AHX),14,the dimeric RRWQWR motif peptide molecule,No entry found,Derived from bovine LfcinB6,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,"[Ref.29984236] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=14 μg/ml; MBC=110 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=55 μg/ml; MBC=110 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae ATCC 13883 (MIC=27 μg/ml; MBC=55 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=27 μg/ml; MBC=220 μg/ml)","[Ref.29984236] 0% hemolysis at 5 μM, 1% hemolysis at 12 μM, 2% hemolysis at 22 μM, 2% hemolysis at 50 μM, 4% hemolysis at 100 μM against human red blood cells",,29984236,Biomed Res Int. 2018 Jun 10;2018:5252891,"Sandra C. Vega Chaparro, J. Tatiana Valencia Salguero, Diana A. Martínez Baquero, Jaiver E. Rosas Pérez.",Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.,Branched,L,Free,[Ref.29984236] No cytotoxicity information found,Amidation,None,Not found,
4927,DRAMP20866,(RRWQWR)4-K2-(AHX)2-C2,30,the tetrameric RRWQWR motif peptide molecule,No entry found,Derived from bovine LfcinB6,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,"[Ref.29984236] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=29 μg/ml; MBC=57 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=57 μg/ml; MBC=57 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae ATCC 13883 (MIC=29 μg/ml; MBC=115 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=57 μg/ml; MBC=115 μg/ml)","[Ref.29984236] 5% haemolysis at 5 μM, 10% haemolysis at 12 μM, 10% haemolysis at 22 μM, 0% haemolysis at 50 μM, 2% haemolysis at 100 μM against human red blood cells",,29984236,Biomed Res Int. 2018 Jun 10;2018:5252891,"Sandra C. Vega Chaparro, J. Tatiana Valencia Salguero, Diana A. Martínez Baquero, Jaiver E. Rosas Pérez.",Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.,Branched,L,Free,[Ref.29984237] No cytotoxicity information found,Amidation,Disulfide bond which links two dimeric motif peptides,Not found,
4928,DRAMP20867,RWQWRWQWR,9,the palindromic RRWQWR motif peptide molecule,No entry found,Derived from bovine LfcinB6,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,"[Ref.29984236] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=74 μg/ml; MBC=148 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=9 μg/ml; MBC=74 μg/ml);##Gram-negative bacteria: Klebsiella pneumoniae ATCC 13883 (MIC=74 μg/ml; MBC=148 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=74 μg/ml; MBC=148 μg/ml)","[Ref.29984236] 0% haemolysis at 5 μM, 1% haemolysis at 12 μM, 0% haemolysis at 22 μM, 5% haemolysis at 50 μM, 25% haemolysis at 100 μM against human red blood cells",,29984236,Biomed Res Int. 2018 Jun 10;2018:5252891,"Sandra C. Vega Chaparro, J. Tatiana Valencia Salguero, Diana A. Martínez Baquero, Jaiver E. Rosas Pérez.",Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.,Linear,L,Free,[Ref.29984238] No cytotoxicity information found,Amidation,None,Not found,
4929,DRAMP20868,KFKKLFKKLSPVIGKEFKRIVERIKRFLR,29,H4,No entry found,Derived from BMAP-27 and OP-145,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix ,The peptide adopts a conformational structure with 90 % alpha helix.,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,"[Ref.29910626] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=20 μM), Staphylococcus aureus ATCC 33591 (MIC=10 μM), Staphylococcus aureus ATCC 43300 (MIC=10 μM), Staphylococcus aureus ATCC BAA41 (MIC=10 μM), Enterococcus faecalis ATCC 19433 (MIC=15 μM), Enterococcus faecalis ATCC BAA2365 (MIC=5 μM), Staphylococcus epidermidis ATCC 12228 (MIC=10 μM), Enterococcus faecium ATCC BAA2316 (MIC=5 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=10 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=20 μM), Acinetobacter baumannii ATCC 19606 (MIC=10 μM), Klebsiella pneumoniae ATCC 13883 (MIC=2.5 μM), Pseudomonas aeruginosa ATCC BAA2114 (MIC=25 μM), Escherichia coli ATCC BAA2452 (MIC=10 μM)","[Ref.29910626] 0% haemolysis at 5 μM, 0% haemolysis at 10 μM, 0% haemolysis at 25 μM, 0% haemolysis at 40 μM, 0% haemolysis at 55 μM, 0% haemolysis at 75 μM, 0% haemolysis at 80 μM, 2.1% haemolysis at 100 μM against human red blood cells",,29910626,Infect Drug Resist. 2018 Jun 1;11:835-847. ,"Almaaytah A, Qaoud MT, Abualhaijaa A, Al-Balas Q, Alzoubi KH.",Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides.,Linear,L,Free,[Ref.29910626] IC50 = 61.9±0.18 μM against HEK293.## IC50 = 64.9±1.01 μM against Vero.,Free,None,Not found,
4930,DRAMP20869,GLLKRIKTL,9,Pal-ano-9 (Pal-anoplin peptide derivative),No entry found,Derived from the peptide Pal-anoplin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix ,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. The peptide is palmitoylated.,[Ref.29614317] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=0.406 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=0.406 μg/mL);##Fungi: Candida albicans ATCC 10231 (MIC=3.25 μg/mL).,[Ref.29614317] HC50=18.92μg/mL against human red blood cells,,29614317,Peptides. 2018 Jun;104:7-14.,"Salas RL, Garcia JKDL, Miranda ACR, Rivera WL, Nellas RB, Sabido PMG.",Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin.,Linear,L,Acylation (Gly1 conjugated with a palmitoyl group),[Ref.29614317] No cytotoxicity information found,Amidation,None,Not found,
4931,DRAMP20870,GLLKRIKT,8,Pal-ano-8 (Pal-anoplin peptide derivative),No entry found,Derived from the peptide Pal-anoplin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Random coil,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. The peptide is palmitoylated.,[Ref.29614317] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=1.63 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.25 μg/mL);##Fungi: Candida albicans ATCC 10231 (MIC=26 μg/mL).,[Ref.29614317] HC50=33.74μg/mL against human red blood cells,,29614317,Peptides. 2018 Jun;104:7-14.,"Salas RL, Garcia JKDL, Miranda ACR, Rivera WL, Nellas RB, Sabido PMG.",Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin.,Linear,L,Acylation (Gly1 conjugated with a palmitoyl group),[Ref.29614318] No cytotoxicity information found,Amidation,None,Not found,
4932,DRAMP20871,GLLKRIK,7,Pal-ano-7 (Pal-anoplin peptide derivative),No entry found,Derived from the peptide Pal-anoplin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Random coil,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. The peptide is palmitoylated.,[Ref.29614317] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=0.813 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=1.63 μg/mL);##Fungi: Candida albicans ATCC 10231 (MIC=13 μg/mL).,[Ref.29614317] HC50=37.70μg/mL against human red blood cells,,29614317,Peptides. 2018 Jun;104:7-14.,"Salas RL, Garcia JKDL, Miranda ACR, Rivera WL, Nellas RB, Sabido PMG.",Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin.,Linear,L,Acylation (Gly1 conjugated with a palmitoyl group),[Ref.29614319] No cytotoxicity information found,Amidation,None,Not found,
4933,DRAMP20872,GLLKRI,6,Pal-ano-6 (Pal-anoplin peptide derivative),No entry found,Derived from the peptide Pal-anoplin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix ,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. The peptide is palmitoylated.,[Ref.29614317] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=0.61 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3.25 μg/mL);##Fungi: Candida albicans ATCC 10231 (MIC=1.63 μg/mL).,[Ref.29614317] HC50=7.51μg/mL against human red blood cells,,29614317,Peptides. 2018 Jun;104:7-14.,"Salas RL, Garcia JKDL, Miranda ACR, Rivera WL, Nellas RB, Sabido PMG.",Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin.,Linear,L,Acylation (Gly1 conjugated with a palmitoyl group),[Ref.29614320] No cytotoxicity information found,Amidation,None,Not found,
4934,DRAMP20873,GLLKR,5,Pal-ano-5 (Pal-anoplin peptide derivative),No entry found,Derived from the peptide Pal-anoplin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Random coil,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity. The peptide is palmitoylated.,[Ref.29614317] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=3.25 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=6.5 μg/mL);##Fungi: Candida albicans ATCC 10231 (MIC=13 μg/mL).,[Ref.29614317] HC50= 66.12μg/mL against human red blood cells,,29614317,Peptides. 2018 Jun;104:7-14.,"Salas RL, Garcia JKDL, Miranda ACR, Rivera WL, Nellas RB, Sabido PMG.",Effects of truncation of the peptide chain on the secondary structure and bioactivities of palmitoylated anoplin.,Linear,L,Acylation (Gly1 conjugated with a palmitoyl group),[Ref.29614321] No cytotoxicity information found,Amidation,None,Not found,
4935,DRAMP20874,SKVWRHWRRFWHRAHRKL,18,Chensinin-1b,No entry found,Derived from chensinin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, beta sheet and Random coil",The peptide adopts a random coil structure in water and presents an ordered alpha-helix structure with 11.96 % beta-strands and 28.06 % alpha-helices in TFE solution,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Anticancer activities against HeLa cervical carcinoma and MCF-7 breast carcinoma.,"[Ref.29549839] Gram-positive bacteria: Staphylococcus aureus (MIC=3.13 μM), Bacillus cereus (MIC=3.13 μM), Streptococcus lactis (MIC=3.13 μM), Enterococcus faecalis (MIC=1.56 μM), Enterococcus faecium (MIC=3.13 μM);##Gram-negative bacteria: Escherichia coli (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=1.56 μM);##cancer cells: HeLa cervical carcinoma (IC50=113.10μ±μ4.10 μM), MCF-7 breast carcinoma (IC50=51.85μ±μ0.88 μM)",[Ref.29549839] HC50>500 μM against human red blood cells,,29549839,Eur J Med Chem. 2018 Apr 25;150:546-558.,"Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D.",Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.,Linear,L,Free,[Ref.29549839] No cytotoxicity information found,Free,None,Cell membrane (disrupted the bacterial cell membranes through a ,
4936,DRAMP20875,SKVWRHWRRFWHRAHRKL,18,OA-C1b,No entry found,Derived from Chensinin-1b,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, Random coil",The peptide adopts a random coil structure in water and presents an ordered alpha-helix structure with 12.88 % beta-strands and 47.36 % alpha-helices in TFE solution,None,"Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Anticancer activities against HeLa cervical carcinoma, A375 melanoma and MCF-7 breast carcinoma. The peptide is a lipopeptide with CH3(CH2)6CO-.","[Ref.29549839] Gram-positive bacteria: Staphylococcus aureus (MIC=3.13 μM), Bacillus cereus (MIC=1.56 μM), Streptococcus lactis (MIC=1.56 μM), Enterococcus faecalis (MIC=1.56 μM), Enterococcus faecium (MIC=1.56 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.13 μM), Pseudomonas aeruginosa (MIC=1.56 μM);##cancer cells: HeLa cervical carcinoma (IC50=23.86μ±μ0.95 μM), A375 melanoma (IC50=50.97μ±μ1.45 μM), MCF-7 breast carcinoma (IC50=34.94μ±μ2.99 μM)",[Ref.29549839] HC50>500 μM against human red blood cells,,29549839,Eur J Med Chem. 2018 Apr 25;150:546-558.,"Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D.",Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.,Linear,L,Acylation (Ser1 conjugated with octanoic acid),[Ref.29549839] No cytotoxicity information found,Free,None,Not found,
4937,DRAMP20876,SKVWRHWRRFWHRAHRKL,18,LA-C1b,No entry found,Derived from Chensinin-1b,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, Random coil",The peptide adopts a random coil structure in water and presents an ordered alpha-helix structure with 6.31 % beta-strands and 32.16 % alpha-helices in TFE solution,None,"Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Anticancer activities against HeLa cervical carcinoma, A375 melanoma and MCF-7 breast carcinoma. The peptide is a lipopeptide with CH3(CH2)6CO-.","[Ref.29549839] Gram-positive bacteria: Staphylococcus aureus (MIC=3.13 μM), Bacillus cereus (MIC=3.13 μM), Streptococcus lactis (MIC=3.13 μM), Enterococcus faecalis (MIC=1.56 μM), Enterococcus faecium (MIC=3.13 μM);##Gram-negative bacteria: Escherichia coli (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=1.56 μM);##cancer cells: HeLa cervical carcinoma (IC50=20.38μ±μ0.28 μM), A375 melanoma (IC50=21.25μ±μ1.51 μM), MCF-7 breast carcinoma (IC50=25.77μ±μ2.02 μM)",[Ref.29549839] HC50>500 μM against human red blood cells,,29549839,Eur J Med Chem. 2018 Apr 25;150:546-558.,"Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D.",Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.,Linear,L,Acylation (Ser1 conjugated with lauric acid),[Ref.29549839] No cytotoxicity information found,Free,None,Not found,
4938,DRAMP20877,SKVWRHWRRFWHRAHRKL,18,PA-C1b,No entry found,Derived from Chensinin-1b,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix, Random coil",The peptide adopts a random coil structure in water and presents an ordered alpha-helix structure with 12.88 % beta-strands and 22.67 % alpha-helices in TFE solution,None,"Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Anticancer activities against HeLa cervical carcinoma, A375 melanoma and MCF-7 breast carcinoma. The peptide is a lipopeptide with CH3(CH2)6CO-.","[Ref.29549839] Gram-positive bacteria: Staphylococcus aureus (MIC=12.5 μM), Bacillus cereus (MIC=6.25 μM), Streptococcus lactis (MIC=3.13 μM), Enterococcus faecalis (MIC= 3.13 μM), Enterococcus faecium (MIC= 6.25 μM);##Gram-negative bacteria: Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=6.25 μM);##cancer cells: HeLa cervical carcinoma (IC50=21.04μ±μ0.18 μM), A375 melanoma (IC50=18.15μ±μ0.21 μM), MCF-7 breast carcinoma (IC50=20.63μ±μ0.47 μM)",[Ref.29549839] HC50>500 μM against human red blood cells,,29549839,Eur J Med Chem. 2018 Apr 25;150:546-558.,"Dong W, Liu Z, Sun L, Wang C, Guan Y, Mao X, Shang D.",Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.,Linear,L,Acylation (Ser1 conjugated with palmitic acid),[Ref.29549839] No cytotoxicity information found,Free,None,Not found,
4939,DRAMP20878,MGFGCPEDEYECHNHCKNSVGCRGGYCDAGTLRQRCTCYGCNQKGRSIQE,50,rVpDef,No entry found,Derived from VpDef,ATGGGTTTTGGTTGTCCAGA,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,"[Ref.29524591] Gram-positive bacteria: Listeria monocytogenes ATCC 21633 (MIC=75 μg/ml), Bacillu subtilis Lzz-133 (MIC=95 μg/ml), Staphylococcus aureus ATCC 25923 (MIC=120 μg/ml);##Gram-negative bacteria: Escherichia coli O157 ATCC 35150 (MIC=50 μg/ml), Eschericha coli ATCC 10305 (MIC=75 μg/ml), Salmonella enterica ATCC 10467 (MIC=120 μg/ml)","[Ref.29524591] 0% haemolysis at 30 μg/ml, 0% haemolysis at 60 μg/ml, 0% haemolysis at 90 μg/ml, 0% haemolysis at 115 μg/ml, 0.2% haemolysis at 145 μg/ml, 1.5% haemolysis at 175 μg/ml against rabbit red blood cells",,29524591,Protein Expr Purif. 2018 Jul;147:78-84. ,"Meng DM, Lv YJ, Zhao JF, Liu QY, Shi LY, Wang JP, Yang YH, Fan ZC.",Efficient production of a recombinant Venerupis philippinarum defensin (VpDef) in Pichia pastoris and characterization of its antibacterial activity and stability.,Linear,L,Free,[Ref.29524591] No cytotoxicity information found,Free,None,Not found,
4940,DRAMP20879,KWKIFKKIEKVGRNVRDGIIKAGPAVQVVGQATSIAK,37,DAN1,A0A212EJN7,Belongs to the cecropin family.,KGM_210268,Danaus plexippus (monarch butterfly),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,Random coil,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,"[Ref.29501691] Gram-positive bacteria: Bacillus subtilis (MIC=131.3μ±μ46.1 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC=4.9μ±μ2.3 μg/mL), Pseudomonas aeruginosa (MIC=7μ±μ0.8 μg/mL), Klebsiella pneumoniae (MIC=16.2μ±μ1.9 μg/mL)","[Ref.29501691] 0% haemolysis at 10 μg/ml, 0% haemolysis at 25 μg/ml, 0% haemolysis at 50 μg/ml, 0% haemolysis at 100 μg/ml, 0% haemolysis at 200 μg/ml against sheep red blood cells",,29501691,Peptides. 2018 May;103:26-30. doi: 10.1016/j.peptides.2018.01.017.,"Duwadi D, Shrestha A, Yilma B, Kozlovski I, Sa-Eed M, Dahal N, Jukosky J.",Identification and screening of potent antimicrobial peptides in arthropod genomes.,Linear,L,Free,[Ref.29501691] No cytotoxicity information found,Amidation,None,Not found,
4941,DRAMP20880,RWKFLKKIEKVGRKVRDGVIKAGPAVGVVGQATSIYK,37,DAN2,A0A212F3T6,Belongs to the cecropin family.,KGM_210265,Monarch butterfly (Danaus plexippus),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Random coil,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29501691] Gram-positive bacteria: Bacillus subtilis (MIC=50μ±μ19 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC=2.1μ±μ0.7 μg/mL), Pseudomonas aeruginosa (MIC=5μ±μ2.5 μg/mL), Klebsiella pneumoniae (MIC=4.3μ±μ1.4 μg/mL);##Fungi: Candida albicans  (MIC=72.5μ±μ35.2 μg/mL)","[Ref.29501691] 0% haemolysis at 10 μg/ml, 0% haemolysis at 25 μg/ml, 0% haemolysis at 50 μg/ml, 0% haemolysis at 100 μg/ml, 0% haemolysis at 200 μg/ml against sheep red blood cells",,29501691,Peptides. 2018 May;103:26-30. doi: 10.1016/j.peptides.2018.01.017.,"Duwadi D, Shrestha A, Yilma B, Kozlovski I, Sa-Eed M, Dahal N, Jukosky J.",Identification and screening of potent antimicrobial peptides in arthropod genomes.,Linear,L,Free,[Ref.29501691] No cytotoxicity information found,Amidation,None,Not found,
4944,DRAMP20883,KRFKKFFRKLKKSVKKRKKEFKKKPRVIKVSIPF,34,Cath-A,No entry found,Derived from three-finger toxin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,"[Ref.29392557] Gram-positive bacteria: MRSA PS-2 (MIC=64 μg/ml);##Gram-negative bacteria, MRSA PS-7 (MIC=64 μg/ml), MRSA PS-18 (MIC=32 μg/ml), MRSA PS-45 (MIC=32 μg/ml), MRSA PS-46 (MIC=32 μg/ml), MRSA PS-50 (MIC=32 μg/ml), MRSA PS-59 (MIC=64 μg/ml), MRSA PS-70 (MIC=32 μg/ml), MRSA PS-84 (MIC=128 μg/ml), MRSA PS-106 (MIC=32 μg/ml), MRSA PS-131 (MIC=128 μg/ml), MRSA PS-139 (MIC=32 μg/ml), MRSA PS-162 (MIC=128 μg/ml), MRSA PS-165 (MIC=32 μg/ml), Staphylococcus aureus ATCC 25923 (MIC=32 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=128 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli ATCC 51446 (MIC=16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=64 μg/ml), Klebsiella pneumoniae ATCC 13883 (MIC=16 μg/ml)","[Ref.29392557] 0% haemolysis at 1.0 μg/ml, 0% haemolysis at 2.0 μg/ml, 0% haemolysis at 4.0 μg/ml, 0% haemolysis at 8.0 μg/ml, 0% haemolysis at 16.0 μg/ml, 0% haemolysis at 31.2 μg/ml, 2% haemolysis at 62.5 μg/ml, 4% haemolysis at 125.0 μg/ml, 15% haemolysis at 250.0 μg/ml, 23% haemolysis at 500.0 μg/ml, 53% haemolysis  at 1000.0 μg/ml against human red blood cells",,29392557,J Microbiol. 2018 Feb;56(2):128-137.,"Tajbakhsh M, Karimi A, Tohidpour A, Abbasi N, Fallah F, Akhavan MM.",The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.,Linear,L,Free,"[Ref.29392557] The cell viability of HUVEC is 132%, 99% and 79%  at peptide concentrations of 35.5, 71 and 113 μg/ml .## The cell viability of H9c2is 129%, 97%, and 80% at peptide concentrations of 35.5, 71, and 113 μg/ml .",Free,None,Not found,
4945,DRAMP20884,KRFKKFFRKLKKSVKKRKKEFKKKPRVIGVSIPF,34,Cath-B,No entry found,Derived from three-finger toxin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,"[Ref.29392557] Gram-positive bacteria: MRSA PS-2 (MIC=256 μg/ml);##Gram-negative bacteria, MRSA PS-7 (MIC=32 μg/ml), MRSA PS-18 (MIC=128 μg/ml), MRSA PS-45 (MIC=64 μg/ml), MRSA PS-46 (MIC=128 μg/ml), MRSA PS-50 (MIC=128 μg/ml), MRSA PS-59 (MIC=32 μg/ml), MRSA PS-84 (MIC=128 μg/ml), MRSA PS-131 (MIC=64 μg/ml), MRSA PS-139 (MIC=64 μg/ml), MRSA PS-162 (MIC=256 μg/ml), MRSA PS-165 (MIC=128 μg/ml), Staphylococcus aureus ATCC 25923 (MIC=32 μg/ml), Staphylococcus aureus ATCC 33591 (MIC=256 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 μg/ml), Escherichia coli ATCC 51446 (MIC=8 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=32 μg/ml), Klebsiella pneumoniae ATCC 13883 (MIC=8 μg/ml)","[Ref.29392557] 0% haemolysis at 1.0 μg/ml, 0% haemolysis at 2.0 μg/ml, 0% haemolysis at 4.0 μg/ml, 0% haemolysis at 8.0 μg/ml, 3% haemolysis at 16.0 μg/ml, 3% haemolysis at 31.2 μg/ml, 3% haemolysis at 62.5 μg/ml, 3% haemolysis at 125.0 μg/ml, 3% haemolysis at 250.0 μg/ml, 4% haemolysis at 500.0 μg/ml, 5% haemolysis at 1000.0 μg/ml against human red blood cells",,29392557,J Microbiol. 2018 Feb;56(2):128-137.,"Tajbakhsh M, Karimi A, Tohidpour A, Abbasi N, Fallah F, Akhavan MM.",The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.,Linear,L,Free,"[Ref.29392557] The cell viability of HUVEC is 118%, 100% and 75% at peptide concentrations of 35.5 μg/ml, 71 μg/ml and 113 μg/ml.## The cell viability of H9c2 is 123%, 97%, and 88% at peptide concentrations of 35.5, 71, and 113 μg/ml.",Free,None,Not found,
4946,DRAMP20885,ILKKLWEGVKSI,12,Hp1404-T1a,No entry found,Derived from Hp1404,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Alpha helix,The peptide adopts an alpha-helical conformation in the membrane-mimicking environments and adopts a random coil conformation in the presence of all liposome types .,None,Function: Antibacterial activity against the Gram-negative bacteria. ,"[Ref.29379033] Gram-negative bacteria: Pseudomonas aeruginosa 431 (MIC=25 μM), Pseudomonas aeruginosa 434 (MIC=25 μM), Pseudomonas aeruginosa 3399 (MIC=25 μM), Pseudomonas aeruginosa 3592 (MIC=12.5 μM), Pseudomonas aeruginosa 3904 (MIC=25 μM), Pseudomonas aeruginosa 4891 (MIC=25 μM), Pseudomonas aeruginosa 671973 (MIC=25 μM)","[Ref.29379033] Hp1404-T1a does not induce substantial hemolysis, even at the high tested concentration (200μμM) against mouse red blood cells",,29379033,Sci Rep. 2018 Jan 29;8(1):1763. ,"Kim MK, Kang HK, Ko SJ, Hong MJ, Bang JK, Seo CH, Park Y.",Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa.,Linear,L,Free,[Ref.29379033] No cytotoxicity information found,Amidation,None,Lipopolysaccharide (LPS)-binding,
4947,DRAMP20886,ILKKLLEGVKSI,12,Hp1404-T1b,No entry found,Derived from Hp1404,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Alpha helix,The peptide adopts an alpha-helical conformation in the membrane-mimicking environments and adopts a random coil conformation in the presence of all liposome types .,None,Function: Antibacterial activity against the Gram-negative bacteria. ,"[Ref.29379033] Gram-negative bacteria: Pseudomonas aeruginosa 434 (MIC=25 μM), Pseudomonas aeruginosa 3592 (MIC=25 μM)","[Ref.29379033] Hp1404-T1b does not induce substantial hemolysis, even at the high tested concentration (200μμM) against mouse red blood cells",,29379033,Sci Rep. 2018 Jan 29;8(1):1763. ,"Kim MK, Kang HK, Ko SJ, Hong MJ, Bang JK, Seo CH, Park Y.",Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa.,Linear,L,Free,[Ref.29379033] No cytotoxicity information found,Amidation,None,Lipopolysaccharide (LPS)-binding,
4948,DRAMP20887,KLIPILSKTIPAGKNLFYKI,20,NCP-2 (CTX-1 peptide derivative),No entry found,Derived from CTX-1,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,"The peptide adopts a conformational structure with 20 % alpha helix, 25 % beta sheet and 35 % random coil in the presence of DMPE-DMPG mixed vesicles.",None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29364903] Gram-positive bacteria: Staphylococcus aureus ATCC 22953 (MBC=50 μg/ml), Streptococcus agalactiae ATCC 13813 (MBC=12.5 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MBC=12.5 μg/ml), Acinetobacter baumannii (herpetological, cloacal) (MBC=1.6 μg/ml), Acinetobacter baumannii (ornithological, cloacal) (MBC=50 μg/ml), Acinetobacter baumannii (human, urinary) (MBC=1.6 μg/ml), Moraxella catarrhalis ATCC 25238 (MBC=1.6 μg/ml);##Fungi: Candida albicans ATCC 10231 (MBC=50 μg/mL), Malassezia pachydermatis DSMZ 6172 (MBC=6.3 μg/mL)","[Ref.29364903] 2% haemolysis at 12.5 μg/ml, 8% haemolysis at 100.0 μg/ml against sheep red blood cells",,29364903,PLoS One. 2018 Jan 24;13(1):e0190778. ,"Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.",Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,Linear,L,Free,[Ref.29364903] The cell death rate of Madin-Darby Bovine Kidney(MDBK) cells is 3 % and 5% at peptide concentrations of 12.5 and 100  μg/ml,Free,None,Not found,
4949,DRAMP20888,KLIWILSKTIPAGKNLFYKI,20,NCP-3 (CTX-1 peptide derivative),No entry found,Derived from CTX-1,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,The peptide adopts a conformational structure with 43 % beta sheet and 35 % random coil in the presence of DMPE-DMPG mixed vesicles.,None,"Function: Antimicrobial activity against the Gram-positive bacteria, Gram-negative bacteria and fungi. NCP-3 completely inhibits the viral activity of BoHV-1 on MDBK cells at the concentration of 25 ","[Ref.29364903] Gram-positive bacteria: Methicillin-resistant Staphylococcus aureus ATCC 43300 (MBC=6.3 μg/ml), Staphylococcus aureus ATCC 22953 (MBC=1.6 μg/ml), Enterococcus hirae ATCC 10541 (MBC=1.6 μg/ml), Streptococcus agalactiae ATCC 13813 (MBC=1.6 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MBC=12.5 μg/ml), Acinetobacter baumannii (herpetological, cloacal) (MBC=1.6 μg/ml), Acinetobacter baumannii (ornithological, cloacal) (MBC=6.3 μg/ml), Acinetobacter baumannii (human, urinary) (MBC=1.6 μg/ml), Klebsiella pneumoniae subsp. pneumoniae (herpetological, cloacal) (MBC=50 μg/ml), Enterobacter cloacae (herpetological, cloacal) (MBC=25 μg/ml), Burkholderia cepacia ATCC 17759 (MBC=50 μg/ml), Moraxella catarrhalis ATCC 25238 (MBC=1.6 μg/ml);##Fungi: Candida albicans ATCC 10231 (MBC=12.5 μg/mL), Candida glabrata ATCC 90030 (MBC=50 μg/mL), Malassezia pachydermatis DSMZ 6172 (MBC=6.3 μg/mL).","[Ref.29364903] 3% haemolysis at 12.5 μg/ml, 9% haemolysis at 100.0 μg/ml against sheep red blood cells",,29364903,PLoS One. 2018 Jan 24;13(1):e0190778. ,"Sala A, Cabassi CS, Santospirito D, Polverini E, Flisi S, Cavirani S, Taddei S.",Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,Linear,L,Free,[Ref.29364903] The cell death rate of Madin-Darby Bovine Kidney(MDBK) cells is 3 % and 7% at peptide concentrations of 12.5 and 100  μg/ml,Free,None,Not found,
4954,DRAMP20893,FIHHIIGGLFSAGKAAHRLIRRRRR,25,I16A,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=64 μg/ml; MBC=128 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=64 μg/ml; MBC=512 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 10% haemolysis at 6.25 μg/ml, 20% haemolysis at 12.50 μg/ml, 35% haemolysis at 25.00 μg/ml, 80% haemolysis at 50.00 μg/ml, 95% haemolysis at 100.00 μg/ml, 100% haemolysis at 200.00 μg/ml against mouse red blood cells",,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Linear,L,Free,[Ref.29040295] No cytotoxicity information found,Free,None,Not found,
4955,DRAMP20894,FIHHIIGGLFSAGKAIHRHHRRRRR,25,L19H/I20H,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=128 μg/ml; MBC=512 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml),"[Ref.29040295] 10% haemolysis at 6.25 μg/ml, 13% haemolysis at 12.50 μg/ml, 16% haemolysis at 25.00 μg/ml, 40% haemolysis at 50.00 μg/ml, 85% haemolysis at 100.00 μg/ml, 100% haemolysis at 200.00 μg/ml against mouse red blood cells",,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Linear,L,Free,[Ref.29040295] No cytotoxicity information found,Free,None,Not found,
4956,DRAMP20895,AAHHIIGGLFSAGKAIHRLIRRRRR,25,F1A/I2A,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=128 μg/ml; MBC=256 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC=256 μg/ml);##Fungi: Candida albicans (MIC=64 μg/ml; MBC=128 μg/ml),"[Ref.29040295] 10% haemolysis at 12.50 μg/ml,  15% haemolysis at 25.00 μg/ml,  30% haemolysis at 50.00 μg/ml,  90% haemolysis at 100.00 μg/ml,  95% haemolysis at 200.00 μg/ml,  100% haemolysis at 400.00 μg/ml against mouse red blood cells",,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Linear,L,Free,[Ref.29040295] No cytotoxicity information found,Free,None,Not found,
4960,DRAMP20899,FIHHAAGGLFSAGKAIHRLIRRRRR,25,I5A/I6A,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-negative bacteria. Antifungal activity.,[Ref.29040295] Gram-negative bacteria: Pseudomonas aeruginosa (MIC=512 μg/ml; MBC=512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml),"[Ref.29040295] 5% haemolysis at 25.00 μg/ml,  7% haemolysis at 50.00 μg/ml,  10% haemolysis at 100.00 μg/ml,  40% haemolysis at 200.00 μg/ml,  80% haemolysis at 400.00 μg/ml,  100% haemolysis at 800.00 μg/ml against mouse red blood cells",,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Linear,L,Free,[Ref.29040295] No cytotoxicity information found,Free,None,Not found,
4961,DRAMP20900,FIHHIIGGLFSIGKIIHRLIRRRRR,25,A12I/A15I,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml; MBC=64 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=64 μg/ml; MBC=256 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=512 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 0% haemolysis at 0.20 μg/ml,  5% haemolysis at 0.39 μg/ml,  25% haemolysis at 0.78 μg/ml,  85% haemolysis at 1.56 μg/ml,  95% haemolysis at 3.13 μg/ml,  100% haemolysis at 6.25 μg/ml against mouse red blood cells",,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Linear,L,Free,[Ref.29040295] No cytotoxicity information found,Free,None,Not found,
4962,DRAMP20901,FIHHIIGGLFSVGKHIHRLIRRRRR,25,A12V/A15H,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml; MBC=16 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=32 μg/ml; MBC=64 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=128 μg/ml; MBC=128 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 0% haemolysis at 0.78 μg/ml,  10% haemolysis at 1.56 μg/ml,  55% haemolysis at 3.13 μg/ml,  85% haemolysis at 6.25 μg/ml,  98% haemolysis at 12.50 μg/ml,  100% haemolysis at 25.00 μg/ml against mouse red blood cells",,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Linear,L,Free,[Ref.29040295] No cytotoxicity information found,Free,None,Not found,
4964,DRAMP20903,FIHHIIGGLFSAGKAIHRLIRRR,23,dC2,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=16 μg/ml; MBC=32 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=32 μg/ml; MBC=32 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=512 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 2% haemolysis at 3.13 μg/ml,  5% haemolysis at 6.25 μg/ml,  25% haemolysis at 12.50 μg/ml,  65% haemolysis at 25.00 μg/ml,  90% haemolysis at 50.00 μg/ml,  100% haemolysis at 100.00 μg/ml against mouse red blood cells",,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Linear,L,Free,[Ref.29040295] No cytotoxicity information found,Free,None,Not found,
4965,DRAMP20904,FIHHIIGGLFSAGKAIHSLIHRRRR,25,R18S/R21H,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=32 μg/ml; MBC=64 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=32 μg/ml; MBC=32 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC=512 μg/ml);##Fungi: Candida albicans (MIC=256 μg/ml; MBC=512 μg/ml)","[Ref.29040295] 8% haemolysis at 6.25 μg/ml,  10% haemolysis at 12.50 μg/ml,  15% haemolysis at 25.00 μg/ml,  40% haemolysis at 50.00 μg/ml,  80% haemolysis at 100.00 μg/ml,  100% haemolysis at 200.00 μg/ml against mouse red blood cells",,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Linear,L,Free,[Ref.29040295] No cytotoxicity information found,Free,None,Not found,
4967,DRAMP20906,HHIIGGLFSAGKAIHRLIRRRRR,23,dN2,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=512 μg/ml; MBC=512 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=512 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=128 μg/ml; MBC=128 μg/ml),"[Ref.29040295] 5% haemolysis at 12.50 μg/ml,  5% haemolysis at 25.00 μg/ml,  20% haemolysis at 50.00 μg/ml,  65% haemolysis at 100.00 μg/ml,  90% haemolysis at 200.00 μg/ml,  100% haemolysis at 400.00 μg/ml against mouse red blood cells",,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Linear,L,Free,[Ref.29040295] No cytotoxicity information found,Free,None,Not found,
4968,DRAMP20907,IIGGLFSAGKAIHRLIRRRRR,21,dN4,No entry found,Derived from TP4,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29040295] Gram-positive bacteria: Staphylococcus aureus (MIC=128 μg/ml; MBC=128 μg/ml), Methicillin-resistant Staphylococcus aureus (MIC=64 μg/ml; MBC=256 μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=256 μg/ml; MBC>512 μg/ml);##Fungi: Candida albicans (MIC=64 μg/ml; MBC=128 μg/ml)","[Ref.29040295] 10% haemolysis haemolysis at 12.50 μg/ml,  12% haemolysis haemolysis at 25.00 μg/ml,  20% haemolysis haemolysis at 50.00 μg/ml,  35% haemolysis haemolysis at 100.00 μg/ml,  75% haemolysis haemolysis at 200.00 μg/ml,  100% haemolysis haemolysis at 400.00 μg/ml,  100% haemolysis haemolysis at 800.00 μg/ml against mouse red blood cells",,29040295,PLoS One. 2017 Oct 17;12(10):e0186442. ,"Chang TW, Wei SY, Wang SH, Wei HM, Wang YJ, Wang CF, Chen C, Liao YD.","Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Linear,L,Free,[Ref.29040295] No cytotoxicity information found,Free,None,Not found,
4971,DRAMP20910,FLGGLIKPWWPWRR,14,RN7-IN7(designed based on indolicidin and ranalexin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.,"[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=31.25μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=62.5μg/ml), Acinetobacter baumanii ATCC 15308(MIC=125μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=31.25-62.5μg/ml), Staphylococcus aureus ATCC 25923(MIC=31.25μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=31.25μg/ml), Enterococcus cloacae(MIC>250μg/ml), ",[Ref.26046345] The hemolytic activities of RN7-IN7 is 0.0% at 15.62μg/ml against human RBCs.,,26046345,PLoS One. 2015 Jun 5;10(6):e0128532. ,"Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.",Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.,Linear,L,Free,"[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 62.5 μg/ml. The cell viability of NL-20 is 95%, 92% and 6% at peptide concentrations of 62.5, 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected(",Amidation,None,Not found,
4973,DRAMP20912,FLGGLIKKWPWWPWRR,16,RN7-IN9(designed based on indolicidin and ranalexin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.,"[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=7.81μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=31.25μg/ml), Acinetobacter baumanii ATCC 15308(MIC=31.25μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=7.81–15.62μg/ml), Staphylococcus aureus ATCC 25923(MIC=7.81μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=7.81μg/ml), Enterococcus cloacae(MIC>250μg/ml), ",[Ref.26046345] The hemolytic activities of RN7-IN7 is 0.0% at 15.62μg/ml against human RBCs.,,26046345,PLoS One. 2015 Jun 5;10(6):e0128532.,"Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.",Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.,Linear,L,Free,"[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 31.25 μg/ml. The cell viability of NL-20 is 51%, 13% and 7% at peptide concentrations of 62.5, 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected",Amidation,None,Not found,
4974,DRAMP20913,AIHDILKYGKPS,12,Myxinidin (G1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-negative and Gram-positive bacteria.,"[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC =10 microM), S. Salmonella typhimurium (MIC =3 microM), Klebsiella pneumoniae (MIC >50 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =10 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. ,"Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,"[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 3%, 5% and 10% at peptide concentrations of 1, 20, 50, 100 and 200 μM.",Amidation,None,Not found,
4975,DRAMP20914,GAHDILKYGKPS,12,Myxinidin (I2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.,"[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC >50 microM), S. Salmonella typhimurium (MIC >50 microM), Klebsiella pneumoniae (MIC >50 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =30 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. ,"Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,"[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 6%, 6.6% and 15.5% at peptide concentrations of 1, 20, 50, 100 and 200 μM.",Amidation,None,Not found,
4976,DRAMP20915,GIADILKYGKPS,12,Myxinidin (H3),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.,"[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC =15 microM), S. Salmonella typhimurium (MIC =10 microM), Klebsiella pneumoniae (MIC =30 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =20 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. ,"Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,"[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 4.9%,12%  and 20% at peptide concentrations of 1, 20, 50, 100 and 200 μM.",Amidation,None,Not found,
4977,DRAMP20916,GIHAILKYGKPS,12,Myxinidin (D4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.,"[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC >50 microM), S. Salmonella typhimurium (MIC >50 microM), Klebsiella pneumoniae (MIC =30 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =5 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. ,"Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,"[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 10%, 29.9%  and 34.9% at peptide concentrations of 1, 20, 50, 100 and 200 μM.",Amidation,None,Not found,
4978,DRAMP20917,GIHDALKYGKPS,12,Myxinidin (I5),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.,"[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC =20 microM), Pseudomonas aeruginosa (MIC =10 microM), S. Salmonella typhimurium (MIC =4 microM), Klebsiella pneumoniae (MIC =20 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =20 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90.,"Cantisani M1, Finamore E2, Mignogna E2, Falanga A3, Nicoletti GF4, Pedone C3, Morelli G3, Leone M5, Galdiero M6, Galdiero S7.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,"[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 4%, 11.7%  and 20% at peptide concentrations of 1, 20, 50, 100 and 200 μM.",Amidation,None,Not found,
4979,DRAMP20918,GIHDIAKYGKPS,12,Myxinidin (L6),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.,"[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC >50 microM), S. Salmonella typhimurium (MIC >50 microM), Klebsiella pneumoniae (MIC =20 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =5 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90.,"Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,"[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 8%, 19.9%  and 29.9% at peptide concentrations of 1, 20, 50, 100 and 200 μM.",Amidation,None,Not found,
4980,DRAMP20919,GIHDILAYGKPS,12,Myxinidin (K7),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.,"[Ref.2495783[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC =15 microM), Pseudomonas aeruginosa (MIC =15 microM), S. Salmonella typhimurium (MIC =15 microM), Klebsiella pneumoniae (MIC =20 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =10 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. ,"Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,"[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 2%, 5.7%  and 14% at peptide concentrations of 1, 20, 50, 100 and 200 μM.",Amidation,None,Not found,
4981,DRAMP20920,GIHDILKAGKPS,12,Myxinidin (Y8),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.,"[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC =20 microM), Pseudomonas aeruginosa (MIC >50 microM), S. Salmonella typhimurium (MIC >50 microM), Klebsiella pneumoniae (MIC =20 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =10 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. ,"Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,"[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 3%  and 10% at peptide concentrations of 1, 20, 50, 100 and 200 μM.",Amidation,None,Not found,
4982,DRAMP20921,GIHDILKYAKPS,12,Myxinidin (G9),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.,"[Ref.24957834] Gram-negative[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC =5 microM), Pseudomonas aeruginosa (MIC =15 microM), S. Salmonella typhimurium (MIC =10 microM), Klebsiella pneumoniae (MIC =10 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =10 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. ,"Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,"[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 0.7%, 4.9%  and 15% at peptide concentrations of 1, 20, 50, 100 and 200 μM.",Amidation,None,Not found,
4983,DRAMP20922,GIHDILKYGAPS,12,Myxinidin (K10),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.,"[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC =15 microM), Pseudomonas aeruginosa (MIC >50 microM), S. Salmonella typhimurium (MIC >50 microM), Klebsiella pneumoniae (MIC =10 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =20 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. ,"Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,"[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 2%, 7%  and 12% at peptide concentrations of 1, 20, 50, 100 and 200 μM.",Amidation,None,Not found,
4984,DRAMP20923,GIHDILKYGKAS,12,Myxinidin (P11),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.,"[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC =30 microM), S. Salmonella typhimurium (MIC =10 microM), Klebsiella pneumoniae (MIC =30 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =10 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. ,"Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,"[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 4.9%, 12%  and 9.9% at peptide concentrations of 1, 20, 50, 100 and 200 μM.",Amidation,None,Not found,
4985,DRAMP20924,GIHDILKYGKPA,12,Myxinidin (S12),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.,"[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC >50 microM), Pseudomonas aeruginosa (MIC >50 microM), S. Salmonella typhimurium (MIC >50 microM), Klebsiella pneumoniae (MIC =30 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC >50 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90. ,"Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,"[Ref.24957834] The toxicity of the peptide against Vero cells is 0.7%, 0.7%, 7%, 14.9%  and 19.9% at peptide concentrations of 1, 20, 50, 100 and 200 μM.",Amidation,None,Not found,
4986,DRAMP20925,GIRDILKYGKPS,12,MH3R,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-nagative and Gram-positive bacteria.,"[Ref.24957834] Gram-negative bacteria: Escherichia coli (MIC =5 microM), Pseudomonas aeruginosa (MIC =20 microM), S. Salmonella typhimurium (MIC =5 microM), Klebsiella pneumoniae (MIC =5 microM) ;## Gram-positive bacteria: Staphylococcus aureus (MIC =10 microM)","[Ref.24957834] Some peptides at 50 μM led to about 10% hemolysis against human red blood cells, but in general, negligible hemolytic activity is observed even at 100 μM and 200 μM peptide.",,24957834,Antimicrob Agents Chemother. 2014 Sep;58(9):5280-90.,"Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S.",Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Linear,L,Free,[Ref.24957834] No cytotoxicity information found,Amidation,None,Not found,
4987,DRAMP20926,LLPWKWPWWKWRR,13,IN1(designed based on indolicidin and ranalexin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Not found,Not found,None,Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.,"[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=31.25μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=31.25μg/ml), Acinetobacter baumanii ATCC 15308(MIC>250μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=31.25–62.5μg/ml), Staphylococcus aureus ATCC 25923(MIC=31.25μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=31.25μg/ml), Enterococcus cloacae(MIC>250μg/ml), ",[Ref.26046345] The hemolytic activities of IN1 is 3.6% at 250μg/ml against human RBCs.,,26046345,PLoS One. 2015 Jun 5;10(6):e0128532. ,"Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.",Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.,Linear,L,Free,[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 62.5 μg/ml. The cell viability of NL-20 is 37% and 17% at peptide concentrations of 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected (<10%) bel,Amidation,None,Not found,
4988,DRAMP20927,RRPWRWPWWPWRR,13,IN2(designed based on indolicidin and ranalexin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.,"[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=31.25μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=31.25μg/ml), Acinetobacter baumanii ATCC 15308(MIC>250μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=31.25–62.5μg/ml), Staphylococcus aureus ATCC 25923(MIC=31.25μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=31.25μg/ml), Enterococcus cloacae(MIC>250μg/ml), ",[Ref.26046345] IN2 showed 15.39% hemolytic activity at concentration of 250μg/ml against human RBCs.,,26046345,PLoS One. 2015 Jun 5;10(6):e0128532. ,"Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.",Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.,Linear,L,Free,[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 62.5 μg/ml. The cell viability of NL-20 is 40% and 19% at peptide concentrations of 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected (<10%) bel,Amidation,None,Not found,
4989,DRAMP20928,RRPWRWPRWPWRR,13,IN3(designed based on indolicidin and ranalexin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.,"[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=31.25μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=31.25μg/ml), Acinetobacter baumanii ATCC 15308(MIC>250μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=62.5μg/ml), Staphylococcus aureus ATCC 25923(MIC=31.25μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=62.5μg/ml), Enterococcus cloacae(MIC>250μg/ml), ",[Ref.26046345] The hemolytic activities of IN3 is 2.39% at 250μg/ml against human RBCs.,,26046345,PLoS One. 2015 Jun 5;10(6):e0128532. ,"Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.",Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.,Linear,L,Free,[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 62.5 μg/ml. The cell viability of NL-20 is 93% and 26% at peptide concentrations of 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected (<10%) bel,Amidation,None,Not found,
4990,DRAMP20929,FLGGLIKWWPWRR,13,RN7-IN6(designed based on indolicidin and ranalexin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.,"[Ref.26046345] Gram-negative bacteria: Escherichia coli ATCC 25922(MIC=7.81μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=31.25μg/ml), Acinetobacter baumanii ATCC 15308(MIC>31.25μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;## Gram-positive bacteria: Streptococcus pneumoniae(30 clinical isolates)(MIC=7.81–15.62μg/ml), Staphylococcus aureus ATCC 25923(MIC=7.81μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=7.81μg/ml), Enterococcus cloacae(MIC>250μg/ml), ",[Ref.26046345] The hemolytic activities of RN7-IN6 is 0.0% at 15.62μg/ml against human RBCs. ,,26046345,PLoS One. 2015 Jun 5;10(6):e0128532. ,"Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.",Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.,Linear,L,Free,"[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 31.25 μg/ml. The cell viability of NL-20 is 70%, 6% and 8% at peptide concentrations of 62.5, 125 and 250 μg/ml.## The cell viability of WRL-68 cell line is not affected ",Amidation,None,Not found,
4991,DRAMP20930,KKLFKKILKYLA,12,BP100-Ala-NH-C16H33,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Alpha helix,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.29750913] Gram-negative bacteria:Escherichia coli(ATCC 25922)(MIC=16μM);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=8μM);Bacillus subtilis(PY79)(MIC=8μM),[Ref.29750913] C50 =6.3μM against human red blood cells,,29750913,Biochim Biophys Acta. 2018 Aug;1860(8):1502-1516. ,"Carretero GPB, Saraiva GKV, Cauz ACG, Rodrigues MA, Kiyota S, Riske KA, Dos Santos AA, Pinatto-Botelho MF, Bemquerer MP, Gueiros-Filho FJ, Chaimovich H, Schreier S, Cuccovia IM.","Synthesis, biophysical and functional studies of two BP101 analogues modified by a hydrophobic chain and a cyclic peptide.",Linear,L,Free,[Ref.29750913] No cytotoxicity information found,"Amidation and Acylation (-NH-C₁₆H₃₃, conjugated with a n‑hexadecyl acyl chain)",None,Not found,
4992,DRAMP20932,GILGKLWEGVKSIF,14,Hp1404,No entry found,Melittin,Not found,Heterometrus petersii,"Antimicrobial, Antibacterial, Anti-Gram-",Protein level,Alpha helix,"The peptide adopts an alpha-helical conformation in the membrane-mimicking environments and the presence of PE:PG and PC:CH liposomes, adopts a random coil conformation when mixed with PC:CH:SM liposomes. ",None,Function: Antibacterial activity against Gram-negative bacteria. ,"[Ref.29379033] Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=12.5 μM), Pseudomonas aeruginosa 138 (MIC=12.5 μM), Pseudomonas aeruginosa 431 (MIC=12.5 μM), Pseudomonas aeruginosa 434 (MIC=12.5 μM), Pseudomonas aeruginosa 557 (MIC=6.25 μM), Pseudomonas aeruginosa 559 (MIC=25 μM), Pseudomonas aeruginosa 778 (MIC=12.5 μM), Pseudomonas aeruginosa 1034 (MIC=6.25 μM), Pseudomonas aeruginosa 1162 (MIC=12.5 μM), Pseudomonas aeruginosa 3290 (MIC=12.5 μM), Pseudomonas aeruginosa 3399 (MIC=6.25 μM), Pseudomonas aeruginosa 3543 (MIC=6.25 μM), Pseudomonas aeruginosa 3592 (MIC=6.25 μM), Pseudomonas aeruginosa 3904 (MIC=6.25 μM), Pseudomonas aeruginosa 4007 (MIC=25 μM), Pseudomonas aeruginosa 4319 (MIC=12.5 μM), Pseudomonas aeruginosa 4891 (MIC=6.25 μM), Pseudomonas aeruginosa 5018 (MIC=12.5 μM), Pseudomonas aeruginosa 671973 (MIC=3.13 μM)","[Ref.29379033]Hemolysis 2% at 12.5 μM against mouse red blood cell, hemolysis 11% at 25.0 μM against mouse red blood cell, hemolysis 55% at 50.0 μM against mouse red blood cell, hemolysis 92% at 100.0 μM against mouse red blood cell, hemolysis 100% at 200.0 μM against mouse red blood cell",,29379033,Sci Rep. 2018 Jan 29;8(1):1763. ,"Kim MK, Kang HK, Ko SJ, Hong MJ, Bang JK, Seo CH, Park Y.",Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa.,Linear,L,Free,"[Ref.29379033] The cell survial  against HaCaT cells is 85%, 26%, 5% and 6% at peptide concentrations of 25, 50, 100 and 200 μM",Amidation,None,Lipopolysaccharide (LPS)-binding,
4994,DRAMP20934,MNFNKFFVLFALIMVAVVGQSEAGWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKG,63,Lucilin Peptide,D7RT24,Cecropins,ATGAATTTTAATAAATTTTT,L. eximia maggots,"Antimicrobial, Antibacterial, Anti-Gram-, Wound-healing",Transcript level,Alpha helix ,Not found,None,Function: Antibacterial activity against the Gram-negative bacteria. Immunomodulatory activity. Decreasing the TNF-alpha production in PBMCs and inducing cellular migration in human keratinocytes.,"[Ref.29890152] Gram-negative bacteria: Escherichia coli DH10B (MIC=7.8 μg/ml; MBC=7.8 μg/ml), Escherichia coli ESBL (MIC=15.6 μg/ml; MBC=15.6 μg/ml), Enterobacter cloacae (MIC=125 μg/ml; MBC=125 μg/ml)","[Ref.29890152]Hemolysis 0% at 0.24 μg/ml, hemolysis 0% at 0.49 μg/ml, hemolysis 0% at 0.98 μg/ml, hemolysis 0% at 1.95 μg/ml, hemolysis 0% at 3.91 μg/ml, hemolysis 0% at 7.81 μg/ml, hemolysis 0% at 15.60 μg/ml, hemolysis 0% at 31.00 μg/ml, hemolysis 0% at 63.00 μg/ml, hemolysis 0% at 125.00 μg/ml, hemolysis 0% at 250.00 μg/ml against human red blood cell",,29890152,Bioorg Med Chem Lett. 2012 Jun 15;22(12):4185-8.,"Téllez GA, Zapata JA, Toro LJ, Henao DC, Bedoya JP, Rivera JD, Trujillo JV, Rivas-Santiago B, Hoyos RO, Castano JC.","Identification, Characterization, Immunolocalization, and Biological Activity of Lucilin Peptide.",Linear,L,Free,[Ref.29890152] The peptide did not show cytotoxic activities against Vero cells. ##The peptide showed a toxic concentration from 62.5 μg/ml with IC50 of 58.30 μg/ml against PBMCs,Free,None,Not found,
4995,DRAMP20935,GFGMALKLLKKVL,13,"Macropin 1(solitary bee, insects, animals)",C0HL98,Not found,Not found,Macropis fulvipes (Solitary bee) (Megilla fulvipes),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,"Alpha helix,random coil",Not found,None,"[Ref.24616110] Antimicrobial peptide active against Gram-positive bacteria like B.subtilis, S.aureus and L.monocytogenes as well as against Gram-negative bacteria like E.coli and P.aeruginosa with minimum inhibitory concentrations (MIC) between 1.3 ?M and 35 ?M.Active against fungus C.albicans (MIC=6.3 ?M).Has little hemolytic activity . Adopts an alpha-helical structure in a membrane mimic environment. [Ref.29185466] Acts by disrupting membranes and bacterial cell wall structures.Binds to peptidoglycan and lipopolysaccharide (LPS)","[Ref.24616110] Gram-negative bacteria: Escherichia coli(MIC=3.0 μM), Pseudomonas aeruginosa(MIC=35.0 μM);## Gram-positive bacteria: Bacillus subtilis (MIC=1.3 μM), Staphylococcus aureus(MIC=3.7 μM);## Fungus: Candida albicans (MIC=6.3 μM). ##[Ref.29185466]Gram-positive bacteria:Staphylococcus aureus ATCC 25923 (MIC=3.13 μM), Staphylococcus aureus ATCC 29213 (MIC=3.13 μM), Listeria monocytogenes KCTC 3710 (MIC=25 μM);##Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=6.25 μM), Pseudomonas aeruginosa ATCC 15692 (MIC=6.25 μM), Escherichia coli ATCC 25922 (MIC=6.25 μM)","[Ref.24616110] LC50=160 μM against human red blood cells. ##[Ref.29185466]5% hemolysis at 25 μM against red blood cells, 93% hemolysis at 50 μM against red blood cells",,24616110##29185466,J Pept Sci. 2014 Jun;20(6):375-84. doi: 10.1002/psc.2625. Epub 2014 Mar 11.## Sci Rep. 2017 Nov 29;7(1):16580. doi: 10.1038/s41598-017-16784-6.,"Monincová L, Veverka V, Slaninová J, Buděšínský M, Fučík V, Bednárová L, Straka J, Ceřovský V.## Ko SJ, Kim MK, Bang JK, Seo CH, Luchian T, Park Y.","Structure-activity study of macropin, a novel antimicrobial peptide from the venom of solitary bee Macropis fulvipes (Hymenoptera: Melittidae).## Macropis fulvipes Venom component Macropin Exerts its Antibacterial and Anti-Biofilm Properties by Damaging the Plasma Membranes of Drug Resistant Bacteria.",Linear,L,Free,"[Ref.29185466] In HaCaT cells, Macropin produced cell survival rates of 82% and 41% at  peptide concentrations of 25 and 50 μM.## In Raw cells, Macropin produce cell survival rates of 41% and 0% at peptide concentrations of 25 and 50 μM.",Amidation,None,Not found,
4996,DRAMP20936,RVKRFKKFFRKIKKGFRKIFKKTKIFIG,28,ΔPb-CATH1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.,"[Ref.28630199] Gram-positive bacteria: Staphylococcus aureus (ATCC 29213)(MIC>128 μg/ml); B. cereus ATCC 10876 (MIC=46 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=3 μg/ml), S. typhimurium ATCC 14028 (MIC=1.5 μg/ml)","[Ref.28630199]1.4 ± 0.4% hemolysis at 8 μg/ml, 5.1 ± 0.5%  hemolysis at 16 μg/ml, 7.3 ± 0.6%  hemolysis at 32 μg/ml, 12.2 ± 0.7% hemolysis at 64 μg/ml against chicken red blood cells",,28630199,Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00530-17.,"Kim D, Soundrarajan N, Lee J, Cho HS, Choi M, Cha SY, Ahn B, Jeon H, Le MT, Song H, Kim JH, Park C.",Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity,Linear,L,Free,[Ref.28630199] No cytotoxicity information found,Free,None,Not found,
4997,DRAMP20937,HRVKRNGFRKFMRRLKKFFAGG,22,Pb-CATH3,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.,"[Ref.28630199] Gram-positive bacteria: B. cereus ATCC 10876 (MIC=32 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=3 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), S. typhimurium ATCC 14028 (MIC=2 μg/ml);##Clinical isolates: Escherichia coli (4.7 μg/ml), K. pneumoniae (1.18 μg/ml)","[Ref.28630199]0% hemolysis at 8 μg/ml, 1.7 ± 0.5%  hemolysis at 16 μg/ml, 3.1 ± 0.5%  hemolysis at 32 μg/ml, 4.0 ± 0.2% hemolysis at 64 μg/ml against chicken red blood cells",,28630199,Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00530-17.,"Kim D, Soundrarajan N, Lee J, Cho HS, Choi M, Cha SY, Ahn B, Jeon H, Le MT, Song H, Kim JH, Park C.",Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity,Linear,L,Free,[Ref.28630199] No cytotoxicity information found,Free,None,Not found,
4998,DRAMP20938,RLLRKFFRKLKKSV,14,Cbf-14,No entry found,Belongs to cathelicidin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix,beta-sheet,beta-turn,random coil","The percentages of possible occurring conformations involved helix, beta, turn and random are also quantified in various solutions ",None,Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria.,"[Ref.28522372]Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=64 μg/ml), Staphylococcus aureus (MIC=32 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=32 μg/ml), Escherichia coli (MIC=32 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa (MIC=32 μg/ml);##Yeasts: Candida albicans ATCC 10231 (MIC=64 μg/ml), Candida albicans (MIC=64 μg/ml)",[Ref.28522372]2% hemolysis at 800 μg/ml against mice red blood cells,,28522372,Eur J Pharm Sci. 2017 Jul 15;105:169-177.,"Kang W, Liu H, Ma L, Wang M, Wei S, Sun P, Jiang M, Guo M, Zhou C, Dou J.",Effective antimicrobial activity of a peptide mutant Cbf-14-2 against penicillin-resistant bacteria based on its unnatural amino acids,Linear,L,Free,"The percentages of possible occurring conformations involved helix, beta, turn and random are also quantified in various solutions ",Free,None,Not found,
4999,DRAMP20939,RLLRKFFRKLKKSV,14,D-Cbf-14,No entry found,Belongs to cathelicidin,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,"Alpha helix,beta-sheet,beta-turn,random coil","The percentages of possible occurring conformations involved helix, beta, turn and random are also quantified in various solutions ",None,Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria. All amino acids in the sequence are D-type.,"[Ref.28522372] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=64 μg/ml), Staphylococcus aureus (MIC=32 μg/ml);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=32 μg/ml), Escherichia coli (MIC=32 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Pseudomonas aeruginosa (MIC=64 μg/ml);##Yeasts: Candida albicans ATCC 10231 (MIC=64 μg/ml), Candida albicans (MIC=64 μg/ml)",[Ref.28522372]1% hemolysis at 800 μg/ml against mice red blood cells,,28522372,Eur J Pharm Sci. 2017 Jul 15;105:169-182.,"Kang W, Liu H, Ma L, Wang M, Wei S, Sun P, Jiang M, Guo M, Zhou C, Dou J.",Effective antimicrobial activity of a peptide mutant Cbf-14-3 against penicillin-resistant bacteria based on its unnatural amino acids,Linear,D,Free,"[Ref.28522372] In mice spleen cells, the peptide produced cell viability of 97% at 800 μg/ml",Free,None,Not found,
5001,DRAMP20941,FVPWFSKFLKRIL,13,"[Pro3,DLeu9]TL(8) (Temporin L peptide derivative)",No entry found,Derived from Temporin L,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,The analogues bearing a D residue showed a reduction in the percentage of helicity compared to the corresponding L analogues in the MMs ,None,"Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(8) is D-Leucine, L-Lysine replace L-Proline at the position 10 on the  peptide [Pro3,DLeu9]TL(2).","[Ref.28863356] Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3.125μM), Staphylococcus aureus Cowan I (MIC=6.25μM), Staphylococcus epidermidis ATCC 12228 (MIC=3.125μM);##Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MIC=3.125μM), Escherichia coli D21 (MIC=12.5μM), Pseudomonas syringae pv tabaci 1918 (MIC=6.25μM), Pseudomonas aeruginosa ATCC 2785 (MIC=12.5μM);##Yeasts: Candida albicans ATCC 10231 (MIC=1.56μM), Candida crusei ATCC 6258 (MIC=1.56μM)","[Ref.28863356]49.30 ± 2.88% cytotoxic effect at 12.5 μM, 66.86 ± 2.81%  cytotoxic effect at 25 μM, 96.79 ± 1.24% cytotoxic effect at 50 μM on HaCaT cells.",,28863356,Eur J Med Chem. 2017 Oct 20;139:750-761.,"Merlino F, Carotenuto A, Casciaro B, MartorMerlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.","Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities",Linear,Mixed (D-Leu9),Free,"[Ref.28863356] The cytotoxic effect is 49.30±2.88%, 66.86±2.81% and 96.79±1.24% at peptide concentrations of 12.5, 25 and 50 μM",Amidation,None,Not found,
5002,DRAMP20942,FVPWFSKFLKRIL,13,"[Pro3,DLeu9]TL(9) (Temporin L peptide derivative)",No entry found,Derived from Temporin L,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,The analogues bearing a D residue showed a reduction in the percentage of helicity compared to the corresponding L analogues in the MMs ,None,"Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(9) is D-Leucine, D-Lysine replace L-Proline at the position 10 on the  peptide [Pro3,DLeu9]TL(2).","[Ref.28863356] Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3.125 μM), Staphylococcus aureus Cowan I (MIC=12.5 μM), Staphylococcus epidermidis ATCC 12228 (MIC=3.125 μM);##Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MIC=6.25 μM), Escherichia coli D21 (MIC=12.5 μM), Pseudomonas syringae pv tabaci 1918 (MIC=12.5 μM), Pseudomonas aeruginosa ATCC 2785 (MIC=12.5 μM);##Yeasts: Candida albicans ATCC 10231 (MIC=1.56 μM), Candida crusei ATCC 6258 (MIC=1.56 μM)","[Ref.28863356]7±4% hemolysis at 50 μM, 5±3% hemolysis at 25 μM, 5±2% hemolysis at 12.5 μM, 1±2% hemolysis at 6.25 μM, 0±1%  hemolysis at 3.125 μM against human red blood cells. ##28.22 ± 3.52%  cytotoxic effect at 25 μM, 87.9 ± 1.07% cytotoxic effect at 50 μM on HaCaT cells.",,28863356,Eur J Med Chem. 2017 Oct 20;139:750-761.,"Merlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.","Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities",Linear,"Mixed (D-Leu9, D-Lys10)",Free,"[Ref.28863356] The cytotoxic effect is 0%, 28.22±3.52% and 87.9±1.07% at 12.5, 25 and 50 μM",Amidation,None,Not found,
5003,DRAMP20943,FVPWFSKFLWRIL,13,"[Pro3,DLeu9]TL(10) (Temporin L peptide derivative)",No entry found,Derived from Temporin L,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,A distorted (type IV) ,None,"Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(8) is D-Leucine, L-Tryptophan replace L-Proline at the position 10 on the  peptide [Pro3,DLeu9]TL(2).","[Ref.28863356] Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=1.56 μM), Staphylococcus aureus Cowan I (MIC=3.125 μM), Staphylococcus epidermidis ATCC 12228 (MIC=1.56 μM);##Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MIC=3.125 μM), Escherichia coli D21 (MIC=25 μM), Pseudomonas syringae pv tabaci 1918 (MIC=1.56 μM);##Yeasts: Candida albicans ATCC 10231 (MIC=3.125 μM), Candida crusei ATCC 6258 (MIC=3.125 μM)","[Ref.28863356]37±1% hemolysis at 50μM, 20±3% hemolysis at 25μM, 7±1% hemolysis at 12.5μM, 4±2% hemolysis at 6.25μM, 2±1%  hemolysis at 3.125μM against human red blood cells.##32.1 ± 2.21%  cytotoxic effect at 25μM, 89.3 ± 0.8% cytotoxic effect at 50 μM on HaCaT cells.",,28863356,Eur J Med Chem. 2017 Oct 20;139:750-761.,"Merlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.","Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities",Linear,Mixed (D-Leu9),Free,"[Ref.28863356] The cytotoxic effect is 0%, 32.1±2.21% and 89.3±0.8% at  12.5, 25 and 50 μM",Amidation,None,Not found,
5004,DRAMP20944,FVPWFSKFLWRIL,13,"[Pro3,DLeu9]TL(11) (Temporin L peptide derivative)",No entry found,Derived from Temporin L,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix,The analogues bearing a D residue showed a reduction in the percentage of helicity compared to the corresponding L analogues in the MMs ,None,"Function: Antimicrobial activity against the Gram-negative bacteria, Gram-positive bacteria and Fungi. The position 9 of [Pro3,DLeu9]TL(10) is D-Leucine, D-Tryptophan replace L-Proline at the position 10 on the  peptide [Pro3,DLeu9]TL(2).","[Ref.28863356] Gram-positive bacteria: Bacillus megaterium Bm11 (MIC=3.125μM), Staphylococcus aureus Cowan I (MIC=3.125μM), Staphylococcus epidermidis ATCC 12228 (MIC=1.56μM);##Gram-negative bacteria: Acinetobacter baumannii ATCC 19606 (MIC=3.125μM), Escherichia coli D21 (MIC=25μM), Pseudomonas syringae pv tabaci 1918 (MIC=3.125μM), Pseudomonas aeruginosa ATCC 2785 (MIC=50μM);##Yeasts: Candida albicans ATCC 10231 (MIC=3.125μM),Candida crusei ATCC 6258 (MIC=3.125μM)","[Ref.28863356]19.21 ± 1.44% cytotoxic effect at 12.5μM, 35.34 ± 5.99%  cytotoxic effect at 25μM, 96.77 ± 0.81% cytotoxic effect at 50 μM on HaCaT cells.",,28863356,Eur J Med Chem. 2017 Oct 20;139:750-761.,"Merlino F, Carotenuto A, Casciaro B, Martora F, Loffredo MR, Di Grazia A, Yousif AM, Brancaccio D, Palomba L, Novellino E, Galdiero M, Iovene MR, Mangoni ML, Grieco P.","Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities",Linear,"Mixed (D-Leu9, D-Trp10)",Free,"[Ref.28863356] The cytotoxic effect is 19.21±1.44%, 35.34±5.99% and 96.77±0.81% at 12.5, 25 and 50 μM",Amidation,None,Not found,
5005,DRAMP20945,KWKLFKKIFKRIVQRIKDFLRN,22,Recombinant  Cecropin A (1–8)–LL37 (17–30) (C–L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,None,Function: Antibacterial activity against the Gram-negative bacteria and Gram-positive bacteria,"[Ref.29925795] Gram-negative bacteria: Escherichia coli CVCC 245 (MIC=7.2 ± 0.14 μg/mL);##Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=2.2 ± 0.05 μg/mL),L. mono. CVCC 1599 (MIC=2.1 ± 0.03 μg/mL)",[Ref.29925795] 50% hemolysis at 221 ± 3.45μg/ml against sheep red blood cells,,29925795,Molecules. 2018 Jun 20;23(6). pii: E1491. ,"Wei X, Wu R, Zhang L, Ahmad B, Si D, Zhang R.","Expression, Purification, and Characterization of a Novel Hybrid Peptide with Potent Antibacterial Activity",Linear,L,Free,[Ref.29925795] No cytotoxicity information found,Free,None,Not found,
5014,DRAMP20955,LGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFH,42,L31-P113,No entry found,Derived from LL-37,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix ,The peptide adopts a conformational structure with 80 % alpha helix.,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,[Ref.29859288] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=25 ± 0 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=16.6 ± 7.2 μM);##Fungi: Candida albicans ATCC 90028 (MIC=166.6 ± 57.7 μg/mL),[Ref.29859288] Hemolysis 12.0 ± 0.7% at 500 μg/ml against human red blood cells,,29859288,Gene. 2018 May 30. pii: S0378-1119(18)30617-6.,"Wanmakok M, Orrapin S, Intorasoot A, Intorasoot S.",Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.,Linear,L,Free,[Ref.29859288] No cytotoxicity information found,Free,None,Not found,
5015,DRAMP20956,ALGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFHLEY,46,AL32-P113,No entry found,Derived from LL-37 and Hst-5,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic,Alpha helix ,The peptide adopts a conformational structure with 81 % alpha helix.,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity.,"[Ref.29859288] Gram-positive bacteria: Staphylococcus aureus ATCC 25923 (MIC=66.6 ± 28.8 μg/mL);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=41.6 ± 14.4 μM), Extended-spectrum beta-lactamase producing Escherichia coli (MIC=41.6 ± 14.4 μg/mL), New Delhi metallo-bata-lactamase-1 producing Acinetobacter baumannii  (MIC=20.8 ± 7.2 μg/mL);##Fungi: Candida albicans ATCC 90028 (MIC=166.6 ± 57.7 μg/mL)",[Ref.29859288] Hemolysis 10.4 ± 2.2% at 500 μg/ml against human red blood cells,,29859288,Gene. 2018 May 30. pii: S0378-1119(18)30617-6.,"Wanmakok M, Orrapin S, Intorasoot A, Intorasoot S.",Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.,Linear,L,Free,[Ref.29859288] No cytotoxicity information found,Free,None,Not found,
5016,DRAMP20957,FFSLIPKLVKGLISAFK,17,StigA6,No entry found,Derived from scorpion venom peptide,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiparasitic, Antiproliferative",Synthetic,Alpha helix ,"The peptide adopts helical conformation with some random structure at the N- and C-terminals. In sodium phosphate buffer (PBS) and water they have a predominantly random structure, but in 20 mM sodium dodecyl sulfate (SDS) and 2,2,2-trifluoroethanol (TFE) they have a typical alpha-helix structure.",None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity against yeasts.Antiparasitic Activity against epimastigote forms of Trypanosoma cruzi. Antiproliferative Activity against HeLa cells.,"[Ref.29670004] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=2.34 μM), Staphylococcus epidermidis ATCC 122225 (MIC=9.38 μM), Enterococcus faecalis ATCC 4028 (MIC=1.17 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=4.69 μM), Enterobacter cloacae ATCC 13047 (MIC=18.75 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=9.38 μM);##yeasts: Candida albicans ATCC 90028 (MIC=9.38 μM), Candida krusei ATCC 6258 (MIC=37.5 μM), Candida glabrata ATCC 90030 (MIC=18.75 μM);##StigA6 inhibit 100% of the epimastigote forms of Trypanosoma cruzi growth at 2.5 µM;##HeLa cell line: IC50=14.01 µM","[Ref.29670004] Hemolysis 0% at 1.17 μM, hemolysis 2% at 2.34 μM, hemolysis 15% at 4.69 μM, hemolysis 27% at 9.38 μM, hemolysis 30% at 18.75 μM, hemolysis 30% at 37.50 μM, hemolysis 27% at 75.00 μM against human red blood cells",,29670004,Toxins (Basel). 2018 Apr 18;10(4). pii: E161.,"Parente AMS, Daniele-Silva A, Furtado AA, Melo MA, Lacerda AF, Queiroz M, Moreno C, Santos E, Rocha HAO, Barbosa EG, Carvalho E, Silva-Júnior AA, Silva MS, Fernandes-Pedrosa MF.","Analogs of the Scorpion Venom Peptide Stigmurin: Structural Assessment, Toxicity, and Increased Antimicrobial Activity.",Linear,L,Free,"[Ref.29670004] The cell viability of HeLa cell lines is 19%, 15%, 11%, 29%, 9%, 13% and 8% at peptide concentrations of 2, 4, 8, 10, 15, 20 and 40 μM.  ##The cell viability of 3T3 cell lines is 81%, 73%, 69%, 61%, 51%, 20% and 15% at peptide concentrati",Amidation,None,Not found,
5017,DRAMP20958,FFKLIPKLVKGLISAFK,17,StigA16,No entry found,Derived from scorpion venom peptide,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antiparasitic, Antiproliferative",Synthetic,Alpha helix ,"The peptide adopts helical conformation with some random structure at the N- and C-terminals. In sodium phosphate buffer (PBS) and water they have a predominantly random structure, but in 20 mM sodium dodecyl sulfate (SDS) and 2,2,2-trifluoroethanol (TFE) they have a typical alpha-helix structure.",None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. Antifungal activity against yeasts.Antiparasitic Activity against epimastigote forms of Trypanosoma cruzi. Antiproliferative Activity against HeLa cells.,"[Ref.29670004] Gram-positive bacteria: Staphylococcus aureus ATCC 29213 (MIC=2.34 μM), Staphylococcus epidermidis ATCC 122225 (MIC=9.38 μM), Enterococcus faecalis ATCC 4028 (MIC=1.17 μM);##Gram-negative bacteria: Escherichia coli ATCC 25922 (MIC=2.34 μM), Enterobacter cloacae ATCC 13047 (MIC=9.38 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1.17 μM);##yeasts: Candida albicans ATCC 90028 (MIC=4.69 μM), Candida krusei ATCC 6258 (MIC=9.38 μM), Candida glabrata ATCC 90030 (MIC=9.38 μM);##StigA16 inhibit 100% of the epimastigote forms of Trypanosoma cruzi growth at 2.5 µM;##HeLa cell line: IC50=13.01 µM","[Ref.29670004] Hemolysis 0% at 1.17 [Ref.29670004] Hemolysis 0% at 1.17 μM, hemolysis 2% at 2.34 μM, hemolysis 10% at 4.69 μM, hemolysis 20% at 9.38 μM, hemolysis 35% at 18.75 μM, hemolysis 37% at 37.50 μM, hemolysis 40% at 75.00 μM against human red blood cells",,29670004,Toxins (Basel). 2018 Apr 18;10(4). pii: E161.,"Parente AMS, Daniele-Silva A, Furtado AA, Melo MA, Lacerda AF, Queiroz M, Moreno C, Santos E, Rocha HAO, Barbosa EG, Carvalho E, Silva-Júnior AA, Silva MS, Fernandes-Pedrosa MF.","Analogs of the Scorpion Venom Peptide Stigmurin: Structural Assessment, Toxicity, and Increased Antimicrobial Activity.",Linear,L,Free,"[Ref.29670004] The cell viability of HeLa cell lines is 15%, 21%, 16%, 9%, 8%, 10% and 11% at peptide concentrations of 2, 4, 8, 10, 15, 20 and 40 μM. ##The cell viability of 3T3 cell lines is 69%, 77%, 62%, 47%, 21%, 15% and 15% at peptide concentratio",Amidation,None,Not found,
5018,DRAMP20959,ILKKLLKGVKSI,12,Hp1404-T1c,No entry found,Derived from Hp1404,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Alpha helix,The peptide adopts an alpha-helical conformation in the membrane-mimicking environments and adopts a random coil conformation in the presence of all liposome types .,None,Function: Antibacterial activity against Gram-negative bacteria. ,"[Ref.29379033] Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=3.13 μM), Pseudomonas aeruginosa 138 (MIC=25 μM), Pseudomonas aeruginosa 431 (MIC=12.5 μM), Pseudomonas aeruginosa 434 (MIC=6.25 μM), Pseudomonas aeruginosa 557 (MIC=25 μM), Pseudomonas aeruginosa 559 (MIC=25 μM), Pseudomonas aeruginosa 778 (MIC=6.25 μM), Pseudomonas aeruginosa 1034 (MIC=6.25 μM), Pseudomonas aeruginosa 1162 (MIC=3.13 μM), Pseudomonas aeruginosa 3399 (MIC=3.13 μM), Pseudomonas aeruginosa 3592 (MIC=6.25 μM), Pseudomonas aeruginosa 3904 (MIC=6.25 μM), Pseudomonas aeruginosa 4007 (MIC=12.5 μM), Pseudomonas aeruginosa 4319 (MIC=6.25 μM), Pseudomonas aeruginosa 4891 (MIC=6.25 μM), Pseudomonas aeruginosa 5018 (MIC=3.13 μM), Pseudomonas aeruginosa 671973 (MIC=6.25 μM)","[Ref.29379033] Hp1404-T1c does not induce substantial hemolysis, even at the high tested concentration (200 μM) against mouse red blood cells",,29379033,Sci Rep. 2018 Jan 29;8(1):1763. ,"Kim MK, Kang HK, Ko SJ, Hong MJ, Bang JK, Seo CH, Park Y.",Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa.,Linear,L,Free,"[Ref.29379033] The cell survial  against HaCaT cells is 100%, 70%, 66% and 53% at peptide concentrations of 25, 50, 100 and 200 μM",Amidation,None,Lipopolysaccharide (LPS)-binding and entering bacterial cells and interact with their DNA,
5019,DRAMP20960,ILKKLLKKVKSI,12,Hp1404-T1d,No entry found,Derived from Hp1404,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Alpha helix,The peptide adopts an alpha-helical conformation in the membrane-mimicking environments and adopts a random coil conformation in the presence of all liposome types .,None,Function: Antibacterial activity against Gram-negative bacteria. ,"[Ref.29379033] Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=1.56 μM), Pseudomonas aeruginosa 138 (MIC=12.5 μM), Pseudomonas aeruginosa 431 (MIC=3.13 μM), Pseudomonas aeruginosa 434 (MIC=3.13 μM), Pseudomonas aeruginosa 557 (MIC=3.13 μM), Pseudomonas aeruginosa 559 (MIC=12.5 μM), Pseudomonas aeruginosa 778 (MIC=3.13 μM), Pseudomonas aeruginosa 1034 (MIC=3.13 μM), Pseudomonas aeruginosa 1162 (MIC=1.56 μM), Pseudomonas aeruginosa 3290 (MIC=6.25 μM), Pseudomonas aeruginosa 3399 (MIC=1.56 μM), Pseudomonas aeruginosa 3543 (MIC=25 μM), Pseudomonas aeruginosa 3592 (MIC=3.13 μM), Pseudomonas aeruginosa 3904 (MIC=6.25 μM), Pseudomonas aeruginosa 4007 (MIC=6.25 μM), Pseudomonas aeruginosa 4319 (MIC=3.13 μM), Pseudomonas aeruginosa 4891 (MIC=3.13 μM), Pseudomonas aeruginosa 5018 (MIC=1.56 μM), Pseudomonas aeruginosa 671973 (MIC=1.56 μM)","[Ref.29379033] Hp1404-T1d does not induce substantial hemolysis, even at the high tested concentration (200 μM) against mouse red blood cells",,29379033,Sci Rep. 2018 Jan 29;8(1):1763. ,"Kim MK, Kang HK, Ko SJ, Hong MJ, Bang JK, Seo CH, Park Y.",Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa.,Linear,L,Free,"[Ref.29379033] The cell survial  against HaCaT cells is 58%, 48%, 52% and 34% at peptide concentrations of 25, 50, 100 and 200 μM",Amidation,None,Lipopolysaccharide (LPS)-binding,
5020,DRAMP20961,ILKKLLKKVKKI,12,Hp1404-T1e,No entry found,Derived from Hp1404,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic,Alpha helix,The peptide adopts an alpha-helical conformation in the membrane-mimicking environments and adopts a random coil conformation in the presence of all liposome types .,None,Function: Antibacterial activity against Gram-negative bacteria. ,"[Ref.29379033] Gram-negative bacteria: Pseudomonas aeruginosa ATCC 27853 (MIC=1.56 μM), Pseudomonas aeruginosa 138 (MIC=6.25 μM), Pseudomonas aeruginosa 431 (MIC=3.13 μM), Pseudomonas aeruginosa 434 (MIC=3.13 μM), Pseudomonas aeruginosa 557 (MIC=3.13 μM), Pseudomonas aeruginosa 559 (MIC=6.25 μM), Pseudomonas aeruginosa 778 (MIC= 1.56 μM), Pseudomonas aeruginosa 1034 (MIC= 1.56 μM), Pseudomonas aeruginosa 1162 (MIC=1.56 μM), Pseudomonas aeruginosa 3290 (MIC=6.25 μM), Pseudomonas aeruginosa 3399 (MIC=0.78 μM), Pseudomonas aeruginosa 3543 (MIC=12.5 μM), Pseudomonas aeruginosa 3592 (MIC=1.56 μM), Pseudomonas aeruginosa 3904 (MIC=3.13 μM), Pseudomonas aeruginosa 4007 (MIC=3.13 μM), Pseudomonas aeruginosa 4319 (MIC=3.13 μM), Pseudomonas aeruginosa 4891 (MIC=1.56 μM), Pseudomonas aeruginosa 5018 (MIC=1.56 μM), Pseudomonas aeruginosa 671973 (MIC=1.56 μM)","[Ref.29379033] Hp1404-T1e does not induce substantial hemolysis, even at the high tested concentration (200 μM) against mouse red blood cells",,29379033,Sci Rep. 2018 Jan 29;8(1):1763. ,"Kim MK, Kang HK, Ko SJ, Hong MJ, Bang JK, Seo CH, Park Y.",Mechanisms driving the antibacterial and antibiofilm properties of Hp1404 and its analogue peptides against multidrug-resistant Pseudomonas aeruginosa.,Linear,L,Free,"[Ref.29379033] The cell survial  against HaCaT cells is 100%, 100%, 100%, 99% at peptide concentrations of 25, 50, 100 and 200 μM",Amidation,None,Lipopolysaccharide (LPS)-binding and entering bacterial cells and interact with their DNA,
5021,DRAMP20963,LRLKKYKVPQL,11,Cp1 alpha s1-casein peptide derivative,No entry found,Derived from bovine alpha S1-casein,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, low hemolytic and toxic effects",Synthetic,Unordered conformation,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.29783753] Gram-negative bacteria: Escherichia coli (ATCC 25922)(MIC=64μM);Escherichia coli (UB1005)(MIC=128μM);Salmonella pullorum (C7913)(MIC=256μM);Salmonella enterica subsp enterica (CMCC 50071)(MIC=256μM);##Gram-positive bacteria: Staphylococcus aureus (ATCC 29213)(MIC=640μM);L. monocytogenes (CMCC 54004)(MIC=64μM),[Ref.2978375]Hemolysis 0% at 16μM;Hemolysis 23.54% at 512μM against human red blood cells,,29783753,Molecules. 2018 May 19;23(5). pii: E1220.,"Hou J, Liu Z, Cao S, Wang H, Jiang C, Hussain MA, Pang S",Broad-Spectrum Antimicrobial Activity and Low Cytotoxicity against Human Cells of a Peptide Derived from Bovine ,Linear,L,Free,"[Ref.29783753] In 293 cells, The peptide had no cytotoxic activity at concentrations of 1-512 μM. The cell survival rates are 100%, 96%, 98%, 105%, 104%, 112%, 116%, 114% and 103% at concentrations of 1, 2, 4, 8, 16, 32, 64, 128, 256, 512 μM",Amidation,None,Not found,
5022,DRAMP20964,KWKLFKKIFKRIVQRIKDFLRN,22,Synthesized Cecropin A (1–8)–LL37 (17–30) (C–L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.29920061] Gram-negative bacteria: Escherichia coli (CVCC 245)(MIC=7.0 ± 0.21μg/mL);##Gram-positive bacteria: Staphylococcus aureus (ATCC 25923)(MIC=2.0 ± 0.02μg/mL );L. mono. (CVCC 1599)(MIC=2.2 ± 0.05μg/mL),[Ref.29920061]HC50 =219 ± 2.98μg/mL against sheep erythrocyte cells,,29920061,Molecules. 2018 Jun 20;23(6). pii: E1491.,"Wei X, Wu R, Zhang L, Ahmad B, Si D, Zhang R.","Expression, Purification, and Characterization of a Novel Hybrid Peptide with Potent Antibacterial Activity.",Linear,L,Free,[Ref.29925795] No cytotoxicity information found,Free,None,Not found,
5023,DRAMP20965,MNKVKEWIKYLKSLFSM,17,"LPcin-YK3 (bovine cathelicidin, cattle, ruminant, mammals, animals)",No entry found,Not found,Not found,Bovine Lactophoricin,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,"Random coil, alpha helix",LPcin-YK3 peptide is a random coil in aqueous solution and forms an ,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans","[Ref.30021422] Gram-positive bacteria : Streptococcus mutans KCCM 40105 (MIC=1.25 μg/ml), Propionibacteria acnes KCCM 41747 (MIC=1.25 μg/ml), Staphylococcus aureus KCTC 1621 (MIC=0.62 μg/ml);##Gram-negative bacteria : Porphyromonas gingvalis KCTC 5352 (MIC=0.62 μg/ml), Escherichia coli KCCM 41290 (MIC=1.25 μg/ml);##Fungi : Candida albicans KCTC 17712 (MIC=10.0 μg/ml)",[Ref.30021422] 0% hemolysis  at 40 μg/ml against mouse red blood cell,,30021422,J Microbiol Biotechnol.?2018 Aug 28;28(8):1299-1309. doi: 10.4014/jmb.1805.05001.,"Ji-Sun Kim,Ji-Ho Jeong, Jang-Hee Cho,Dong-Hee Lee and Yongae Kim",Antimicrobial Activity of Antimicrobial Peptide LPcin-YK3 Derived from Bovine Lactophoricin,Linear,L,Free,[Ref.30021422] No cytotoxicity information found,Free,None,Not found,
5024,DRAMP20966,GLTRLFSVIK,10,"andricin B (Andrias davidianus, Amphibians, Animals)",No entry found,Not found,Not found,Andrias davidianus,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Random coil,"The residues Lys and Arg possess the positive charge, and charge-induced folding may influence the structure.",None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Saccharomyces cerevisiae, Aspergillus niger","[Ref.29130500]Gram-positive bacteria : Bacillus subtilis CICC 10034 (MIC=32 μg/ml, 33.4 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml), Staphylococcus aureus CICC10306 (MIC=16 μg/ml, 16.7 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml), Staphylococcus aureus CICC 10384 (MIC=16 μg/ml, 16.7 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml), Listeria innocua CICC 10417 (MIC=32 μg/ml, 33.4 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml);##Gram-negative bacteria : Escherichia coli CICC10293 (MIC=16 μg/ml, 16.7 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml), Pseudomonas aeruginosa CICC 21636 (MIC=8 μg/ml, 8.3 μMol/ml;MBC=16 μg/ml, 16.7 μMol/ml), Serratia marcescens ATCC 4112 (MIC=8 μg/ml, 8.3 μMol/ml;MBC=16 μg/ml, 16.7 μMol/ml), Enterobacter cloacae CICC 21539 (MIC=16 μg/ml, 16.7 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml), Salmonella paratyphi CICC 10437 (MIC=32 μg/ml, 33.4 μMol/ml;MBC=32 μg/ml, 33.4 μMol/ml);##Fungi : Aspergillus niger CICC 2124 (MIC=64 μg/ml, 66.8 μMol/ml;MBC=64 μg/ml, 66.8 μMol/ml), Candida albicans CICC 1965 (MIC=32 μg/ml, 33.4 μMol/ml;MBC=64 μg/ml, 66.8 μMol/ml), Saccharomyces cerevisiae CICC 1002 (MIC=64 μg/ml, 66.8 μMol/ml;MBC=64 μg/ml, 66.8 μMol/ml)","[Ref.29130500] 0% hemolysis  at 64 μg/ml , 0.5% hemolysis at 128 μg/ml , 2% hemolysis  at 256 μg/ml , 13% hemolysis at 512 μg/ml against human red blood cells",,29130500,Lett Appl Microbiol.?2018 Jan;66(1):38-43. doi: 10.1111/lam.12823.,"J. Pei, Z. Feng,T. Ren,H. Sun,H. Han,W. Jin,J. Dang and Y. Tao","Purifification, characterization and application of a novel antimicrobial peptide from Andrias davidianus blood",Linear,L,Free,[Ref.29130500] No cytotoxicity information found,Free,None,Not found,
5025,DRAMP20967,AIGHCLGATL,10,"andricin 01 (Andrias davidianus, Amphibians, Animals)",No entry found,Not found,Not found,Andrias davidianus,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,Random coil,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28461043] Gram-positive bacteria : Bacillus subtilis CICC 10034 (MIC=32 μg/ml;MBC=32 μg/ml), Bacillus megaterium CICC 10448 (MIC=8 μg/ml;MBC=16 μg/ml), Staphylococcus aureus CICC 10306 (MIC=32 μg/ml;MBC=32 μg/ml), Staphylococcus aureus CICC 10384 (MIC=32 μg/ml;MBC=32 μg/ml), Listeria innocua CICC 10417 (MIC=32 μg/ml;MBC=32 μg/ml);##Gram-negative bacteria : Escherichia coli CICC 10293 (MIC=8 μg/ml;MBC=16 μg/ml), Escherichia coli CGMCC 3373 (MIC=8 μg/ml;MBC=16 μg/ml), Escherichia coli CICC 10302 (MIC=8 μg/ml;MBC=16 μg/ml), Escherichia coli CICC 10300 (MIC=8 μg/ml;MBC=16 μg/ml), Pseudomonas aeruginosa CICC 21636 (MIC=4 μg/ml;MBC=8 μg/ml), Alcaligenes faecalis ATCC 8750 (MIC=8 μg/ml;MBC=16 μg/ml), Serratia marcescens ATCC 4112 (MIC=8 μg/ml;MBC=8 μg/ml), Enterobacter cloacae CICC 21539 (MIC=4 μg/ml;MBC=8 μg/ml), Salmonella Paratyphi CICC 10437 (MIC=8 μg/ml;MBC=16 μg/ml)","[Ref.28461043] 0% hemolysis at 25 μg/ml , 0% hemolysis at 50 μg/ml , 4.3 ± 0.16% hemolysis at 100 μg/ml , 16.3 ± 2.16% hemolysis at 200 μg/ml against human hepatocyte cell line and human renal epithelial cells;0% hemolysis at 0–50 μg/ml against human red blood cells",,28461043,Int J Antimicrob Agents.?2017 Jul;50(1):41-46. doi: 10.1016/j.ijantimicag.2017.02.013.,"Jinjin Pei, Lei Jiang",Antimicrobial peptide from mucus of Andrias davidianus: screening and purification by magnetic cell membrane separation technique,Linear,L,Free,"[Ref.28461043] The cell viability of HL-7702 cells is 100.0±0.30%, 100.5±0.52%, 86.8±2.10% and 52.1±1.81% at peptide concentrations of 25, 50, 100 and 200 μg/ml. ##The cell viability of HREpiC cells is 100.1±0.20%, 103.1±1.20%, 82.3±1.84% and 50.3±2.05%",Free,None,Not found,
5026,DRAMP20968,MMRVMRRKTKVIWEKKDFIGLYSID,25,"Catesbeianin-1 (Ranidae, Anura, Amphibia, Animals)",C5IAX4,Not found,Not found,Lithobates catesbeiana (American bullfrog) (Rana catesbeiana),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,Alpha helix,"Catesbeianin-1 is an amphi pathic a-helix and that the helical wheel is divided into two parts, namely, a hydrophobic face and a hydro philic face.",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28258530] Gram-positive bacteria : Staphylococcus aureus ATCC 25923 (MIC=3.1 μg/ml;MBC=6.3 μg/ml), B. subtilis ATCC6633 (MIC=25 μg/ml;MBC=50 μg/ml), Streptococcus suis CVCC606 (MIC=3.1 μg/ml;MBC=12.5 μg/ml), Listeria monocytogenes ATCC19115 (MIC=12.5 μg/ml;MBC=25 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=3.1 μg/ml;MBC=12.5 μg/ml), Pseudomonas aeruginosa ATCC227853 (MIC=12.5 μg/ml;MBC=25 μg/ml), Salmonella spp. CVCC 3377 (MIC=6.3 μg/ml;MBC=25 μg/ml), Klebsiella pneumoniae H507 (MIC=25 μg/ml;MBC=100 μg/ml)","[Ref.28258530] 0% hemolysis at 0 μg/ml , hemolysis 3% at 25 μg/ml , 7% hemolysis at 50 μg/ml , 8% hemolysis at 100 μg/ml , 35% hemolysis at 200 μg/ml , 50% hemolysis at 300 μg/ml , 85% hemolysis at 400 μg/ml , 95% hemolysis at 500 μg/ml against human red blood cells",,28258530,Biotechnol Lett. 2017 Jun;39(6):897-903. doi: 10.1007/s10529-017-2312-7.,Huihui Xu . Yang Zhang . Xin Feng . Kunyuan Tie . Yuan Cao . Wenyu Han,"Catesbeianin-1, a novel antimicrobial peptide isolatedfrom the skin of Lithobates catesbeianus (American bullfrog)",Linear,L,Free,"[Ref.28258530] The cell viability of HEK293T cells is 102%, 103%, 103%, 100%, 98% and 85% at peptide concentrations of 0, 20, 40, 60, 80 and 100 μg/ml. ##The cell viability of HL-7200 cells is 107%, 106%, 99%, 95% and 88% at peptide concentrations of 0,",Free,None,Not found,
5027,DRAMP20969,KLLKHKLLVTLA,12,"HJH-1 (bovine cathelicidin, cattle, ruminant, mammals, animals)",No entry found,Not found,Not found,Bovine,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans","[Ref.30110916]Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=25 μg/ml), Clinical Staphylococcus aureus (MIC=25 μg/ml), ;##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=12.5 μg/ml), Clinical Escherichia coli (MIC=25 μg/ml), Salmonella pullorum CVCC3533 (MIC=6.25 μg/ml), Clinical Salmonella (MIC=6.25 μg/ml);##Fungi : Candida albicans ATCC 90029 (MIC=50 μg/ml)","[Ref.30110916] 8% hemolysis at 50 μg/ml , 12% hemolysis at 100 μg/ml , 16% hemolysis at 200 μg/ml , 17% hemolysis at 300 μg/ml , 18% hemolysis at 400 μg/ml against rabbit red blood cells",,30110916,Molecules. 2018 Aug 14;23(8). pii: E2026. doi: 10.3390/molecules23082026.,"Qing Wang, Yanzhao Xu, Mengmeng Dong, Bolin Hang, Yawei Sun, Lei Wang,Yongqiang Wang, Jianhe Hu, and Wenju Zhang ","HJH-1, a Broad-Spectrum Antimicrobial Activity and Low Cytotoxicity Antimicrobial Peptide",Linear,L,Free,[Ref.30110916] No cytotoxicity information found,Free,None,Not found,
5028,DRAMP20970,VNFKLLSHSLLVTLASHL,18,"P3 (bovine cathelicidin, cattle, ruminant, mammals, animals)",P01966,Belongs to the globin family.,HBA,Bos taurus (Bovine),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans","[Ref.25753638] Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=25 μg/ml), Clinical Staphylococcus aureus (MIC=12.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=12.5 μg/ml), Clinical Escherichia coli (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=25 μg/ml);##Fungi : Candida albicans Clinical strain (MIC=25 μg/ml), Candida albicans ATCC 90029 (MIC=50 μg/ml)","[Ref.25753638] 3% hemolysis at 50 μg/ml , 5% hemolysis  at 100 μg/ml , 7% hemolysis at 200 μg/ml , 7.5% hemolysis at 300 μg/ml , 8% hemolysis at 400 μg/ml against human red blood cells",,25753638,Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.,"Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu",Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model,Linear,L,Free,"[Ref.25753638] The cell viability of HaCaT cell lines is 93% and 94% at peptide concentrations of 200 and 400 μg/ml. In kumning mice, the LD50 of P3 is 160 mg/kg for i.p. injection, while the LD50 of PMB(served as a control) is 50 mg/kg. No mortality w",Free,None,Not found,
5029,DRAMP20971,KLLSHSLLVTLA,12,JH-0 (Derived from  P3),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25753638]Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=6.25 μg/ml), Clinical Staphylococcus aureus (MIC=6.25 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=6.25 μg/ml), Clinical Escherichia coli (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=6.25 μg/ml)","[Ref.25753638] 2.5% hemolysis at 50 μg/ml , 4% hemolysis at 100 μg/ml , 5% hemolysis at 200 μg/ml , 6% hemolysis at 300 μg/ml , 7% hemolysis at 400 μg/ml against human red blood cells",,25753638,Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.,"Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu",Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model,Linear,L,Free,"[Ref.25753638] The cell viability of HaCaT cell lines is 88% and 85% at peptide concentrations of 200 and 400 μg/ml. In Kunming mice,  the LD50 of JH-0 is 120 mg/kg for i.p. injection, while the LD50 of PMB(served as a control) is 50 mg/kg. No mortalit",Free,None,Not found,
5030,DRAMP20972,KLLRHRLLVTLA,12,JH-1 (Derived from  P3),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25753638] Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=6.25 μg/ml), Clinical Staphylococcus aureus (MIC=6.25 μg/ml), ;##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=3.125 μg/ml), Clinical Escherichia coli (MIC=6.25 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=12.5 μg/ml)","[Ref.25753638] 2% hemolysis at 50 μg/ml , 2.5% hemolysis at 100 μg/ml , 2.5% hemolysis at 200 μg/ml , 3% hemolysis at 300 μg/ml , 4% hemolysis at 400 μg/ml against human red blood cells",,25753638,Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.,"Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu",Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model,Linear,L,Free,"[Ref.25753638] The cell viability of HaCaT cell lines is 84% and 80% at peptide concentrations of 200 and 400 μg/ml. In Kunming mice, the LD50 of JH-1 is 94 mg/kg for i.p. injection, while the LD50 of PMB(served as a control) is 50 mg/kg. No mortality ",Free,None,Not found,
5031,DRAMP20973,VRFKLLSHSLLVTLASHL,18,JH-2 (Derived from  P3),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans","[Ref.25753638] Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=12.5 μg/ml), Clinical Staphylococcus aureus (MIC=6.25 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=6.25 μg/ml), Clinical Escherichia coli (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=6.25 μg/ml);##Fungi : Candida albicans ATCC 90029 (MIC=25 μg/ml), Candida albicans Clinical strain (MIC=25 μg/ml)","[Ref.25753638] 2% hemolysis at 50 [Ref.25753638] 2% hemolysis at 50 μg/ml , 2.5% hemolysis at 100 μg/ml , 3.5% hemolysis at 200 μg/ml , 4% hemolysis at 300 μg/ml , 4% hemolysis at 400 μg/ml against human red blood cells",,25753638,Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.,"Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu",Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model,Linear,L,Free,"[Ref.25753638] The cell viability of HaCaT cell lines is 88% and 84% at peptide concentrations of 200 and 400 μg/ml. In Kunming mice, the LD50 of JH-2 is 133 mg/kg for i.p. injection, while the LD50 of PMB(served as a control) is 50 mg/kg. no mortality",Free,None,Not found,
5032,DRAMP20974,RRFKLLSHSLLVTLASHL,18,JH-3 (Derived from  P3),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans","[Ref.25753638]Gram-positive bacteria : Staphylococcus aureus ATCC29213 (MIC=6.25 μg/ml), Clinical Staphylococcus aureus (MIC=3.125 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC25922 (MIC=3.125 μg/ml), Clinical Escherichia coli (MIC=3.125 μg/ml), Pseudomonas aeruginosa clinical strain (MIC=6.25 μg/ml);##Fungi : Candida albicans ATCC 90029 (MIC=12.5 μg/ml), Candida albicans Clinical strain (MIC=6.25 μg/ml)","[Ref.25753638] 8% hemolysis at 50 μg/ml , 13% hemolysis at 100 μg/ml , 17% hemolysis at 200 μg/ml , 18% hemolysis at 300 μg/ml , 18.5% hemolysis at 400 μg/ml against human red blood cells",,25753638,Antimicrob Agents Chemother. 2015 May;59(5):2835-41. doi: 10.1128/AAC.04932-14.,"Qinghua Zhang, Yanzhao Xu, Qing Wang, Bolin Hang, Yawei Sun, Xiaoxiao Wei, Jianhe Hu",Potential of Novel Antimicrobial Peptide P3 from Bovine Erythrocytes and Its Analogs To Disrupt Bacterial Membranes In Vitro and Display Activity against Drug-Resistant Bacteria in a Mouse Model,Linear,L,Free,"[Ref.25753638] The cell viability of HaCaT cell lines is 86% and 86% at peptide concentrations of 200 and 400 μg/ml. In Kunming mice, the LD50 of JH-3 is 180 mg/kg for i.p. injection, , while the LD50 of PMB(served as a control) is 50 mg/kg. No mortali",Free,None,Not found,
5033,DRAMP20975,KFFKKLKKAVKKGFKKFAKV,20,OH-CM6 (Derived from  OH-CATH30),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans","[Ref.22491685] Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=12.5 μg/ml), Staphylococcuss aureus ATCC 43300 MRSA (MIC=3.125 μg/ml), Staphylococcuss aureus clinical strain 1 (MIC=6.25 μg/ml), Staphylococcuss aureus clinical strain 2 (MIC=3.125 μg/ml), Staphylococcuss aureus clinical strain 3 (MIC=12.5 μg/ml), Enterococcus faecalis ATCC 29212 (MIC=25 μg/ml) ;##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=12.5 μg/ml), Escherichia coli ML-35p (MIC=6.25 μg/ml), Escherichia coli clinical strain 1 (MIC=12.5 μg/ml), Escherichia coli clinical strain 2 (MIC=3.125 μg/ml), Escherichia coli clinical strain 3 (MIC=1.56 μg/ml), Escherichia coli clinical strain 4 (MIC=12.5 μg/ml), Escherichia coli clinical strain 5 (MIC=6.25 μg/ml), Escherichia coli clinical strain 6 (MIC=3.125 μg/ml), Enterobacter cloacae ATCC 13047 (MIC>100 μg/ml), Enterobacter cloacae clinical strain (MIC>100 μg/ml), Enterobacter aerogenes clinical strain (MIC>100 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=12.5 μg/ml), Pseudomonas aeruginosa PA 01 (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain 1 (MIC=12.5 μg/ml), Pseudomonas aeruginosa clinical strain 2 (MIC=6.25 μg/ml), Haemophilus influenzae ATCC 49247 (MIC=3.125 μg/ml), Haemophilus influenzae ATCC 49766 (MIC=6.25 μg/ml), Klebsiella pneumoniae ATCC 13883 (MIC=6.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MIC=3.125 μg/ml) ;##Fungi : Candida albicans ATCC 2002 (MIC>200 μg/ml), Candida albicans clinical strain (MIC>200 μg/ml)","[Ref.22491685] 13% hemolysis at 100 μg/ml , 17% hemolysis at 200 μg/ml , 18% hemolysis at 300 μg/ml , 18.5% hemolysis at 400 μg/ml against human red blood cells",,22491685,Antimicrob Agents Chemother. 2012 Jun;56(6):3309-17. doi: 10.1128/AAC.06304-11.,"Sheng-An Li, Wen-Hui Lee, and Yun Zhang",Efficacy of OH-CATH30 and Its Analogs against Drug-ResistantBacteria In Vitro and in Mouse Models,Linear,L,Free,"[Ref.22491685] The cell viability of HaCaT cell lines is 76%, 62% and 53% at peptide concentrations of 50, 100, 200 μg/ml. In Kunming mice, the LD50 of OH-CATH30 is 120 mg/kg for i.p. injection, while those of pexiganan(control 1) and PMB(control 2) are",Free,None,Not found,
5034,DRAMP20976,RKYVRFLHRWVKYFRAYL,18,"adevonin (Derived from Adenanthera pavonina trypsin inhibitor (ApTI))
inhibitor (ApTI))",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,"Adevonin showed that its secondary structure varies according to the environment, acquiring ",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.30570384]Gram-positive bacteria : Staphylococcus aureus ATCC 80958 (MIC=7.35 μM);##Gram-negative bacteria : Escherichia coli ATCC 35218 (MIC=7.35 μM), Klebsiella oxytoca ATCC 13182 (MIC=1.84 μM), Klebsiella pneumoniae ATCC 70603 (MIC=3.67 μM), Serratia marcesens ATCC 13880 (MIC=1.84 μM), Klebsiella pneumoniae KpC+ 001825971 (MIC=25.6 μM)","[Ref.30570384] 0% hemolysis at 43.75 μM , 72.5% hemolysis at 175 μM , 77% hemolysis at 350 μg/ml against human type O erythrocytes",,30570384,Pathog Glob Health.?2018 Dec;112(8):438-447. doi: 10.1080/20477724.2018.1559489.,"Mayara S. Rodrigues, Caio F. R. de Oliveira, Luís H. O. Almeida, Simone M.Neto, Ana Paula A. Boleti, Edson L. dos Santos, Marlon H. Cardoso, Suzana,M. Ribeiro, Octávio L. Franco, Fernando S. Rodrigues, Alexandre J. Macedo,Flávia R. Brust & Maria Lígia R. Macedo","Adevonin, a novel synthetic antimicrobial peptide designed from the Adenanthera pavonina trypsin inhibitor (ApTI) sequence",Linear,L,Free,"[Ref.30570384] In fibroblasts, a significant reduction of cell viability, of 25% on average, is observed in each time interval(24,48 and 72h) in the highest peptide concentration(10 μM)",Free,None,Not found,
5035,DRAMP20977,WLLKRWKKLL,10,Anoplin-1 (Derived from  Anoplin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25316570]Gram-positive bacteria : Staphylococcus aureus (MIC=32 μg/ml), bacillus subtilis (MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli (MIC=64 μg/ml), Peudomonas eruginosa (MIC=8 μg/ml)","[Ref.25316570] 0% hemolysis at 100 μg/ml , 1% hemolysis at 200 μg/ml against mice red blood cells",,25316570,J Pept Sci. 2014 Dec;20(12):945-51. doi: 10.1002/psc.2705.,"Yang Wang, Jianbo Chen, Xin Zheng, Xiaoli Yang, Panpan Ma,Ying Cai,Bangzhi Zhangb,and Yuan Chen",Design of novel analogues of short antimicrobial peptide anoplin with improved antimicrobial activity,Linear,L,Free,[Ref.25316570] No cytotoxicity information found,Amidation,None,Not found,
5036,DRAMP20978,WLLKRWKKLL,10,Anoplin-2 (Derived from  Anoplin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25316570]Gram-positive bacteria : Staphylococcus aureus (MIC=16 μg/ml), bacillus subtilis (MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli (MIC=16 μg/ml), Peudomonas eruginosa (MIC=8 μg/ml)","[Ref.25316570] 0% hemolysis at 25 μg/ml , 1% hemolysis at 50 μg/ml , 0% hemolysis at 100 μg/ml , 0.5% hemolysis at 200 μg/ml against mice red blood cells",,25316570,J Pept Sci. 2014 Dec;20(12):945-51. doi: 10.1002/psc.2705.,"Yang Wang, Jianbo Chen, Xin Zheng, Xiaoli Yang, Panpan Ma,Ying Cai,Bangzhi Zhangb,and Yuan Chen",Design of novel analogues of short antimicrobial peptide anoplin with improved antimicrobial activity,Linear,D,Free,[Ref.25316570] No cytotoxicity information found,Amidation,None,Not found,
5037,DRAMP20979,KLLKWWKKLL,10,Anoplin-3 (Derived from  Anoplin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25316570]Gram-positive bacteria : Staphylococcus aureus (MIC=16 μg/ml), bacillus subtilis (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli (MIC=16 μg/ml), Peudomonas eruginosa (MIC=8 μg/ml)","[Ref.25316570] 0% hemolysis at 12.5 μg/ml , 0.5% hemolysis at 25 μg/ml , 0.5% hemolysis at 50 μg/ml , 4% hemolysis at 100 μg/ml , 14% hemolysis at 200 μg/ml against mice red blood cells",,25316570,J Pept Sci. 2014 Dec;20(12):945-51. doi: 10.1002/psc.2705.,"Yang Wang, Jianbo Chen, Xin Zheng, Xiaoli Yang, Panpan Ma,Ying Cai,Bangzhi Zhangb,and Yuan Chen",Design of novel analogues of short antimicrobial peptide anoplin with improved antimicrobial activity,Linear,L,Free,[Ref.25316570] No cytotoxicity information found,Amidation,None,Not found,
5038,DRAMP20980,KLLKWWKKLL,10,Anoplin-4 (Derived from  Anoplin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25316570]Gram-positive bacteria : Staphylococcus aureus (MIC=8 μg/ml), bacillus subtilis (MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli (MIC=8 μg/ml), Peudomonas eruginosa (MIC=8 μg/ml)","[Ref.25316570] 0.5% hemolysis at 12.5 μg/ml , 0.5% hemolysis at 25 μg/ml , 2% hemolysis at 50 μg/ml , 1% hemolysis at 100 μg/ml , 4% hemolysis at 200 μg/ml against mice red blood cells",,25316570,J Pept Sci. 2014 Dec;20(12):945-51. doi: 10.1002/psc.2705.,"Yang Wang, Jianbo Chen, Xin Zheng, Xiaoli Yang, Panpan Ma,Ying Cai,Bangzhi Zhangb,and Yuan Chen",Design of novel analogues of short antimicrobial peptide anoplin with improved antimicrobial activity,Linear,D,Free,[Ref.25316570] No cytotoxicity information found,Amidation,None,Not found,
5039,DRAMP20981,GFGSLLGKALRLGANVL ,17,"CPF-C1 (Frogs, Amphibians, Animals)",No entry found,Not found,Not found,Tetraploid frog Xenopus clivii,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Not found,"Random coil, alpha helix","CPF-C1 revealed a random coil structure in PBS, displayed typical ",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=4 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=32 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=32 μg/ml), Pseudomonas aeruginosa 2760 (MIC=128 μg/ml), Pseudomonas aeruginosa 9132 (MIC=64 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=4 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431] 0% hemolysis at 32 μg/ml , 5% hemolysis at 64 μg/ml , 7% hemolysis at 128 μg/ml , 15% hemolysis at 256 μg/ml , 57% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,L,Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5040,DRAMP20982,KFWSLLKKALRLWANVL,17,CPF-1 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,CPF-1 displayed typical ,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=32 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=32 μg/ml), Pseudomonas aeruginosa 2760 (MIC=32 μg/ml), Pseudomonas aeruginosa 9132 (MIC=64 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431] 0% hemolysis at 0 μg/ml , 5% hemolysis at 4 μg/ml , 8% hemolysis at 8 μg/ml , 20% hemolysis at 16 μg/ml , 35% hemolysis at 32 μg/ml , 58% hemolysis at 64 μg/ml , 70% hemolysis at 128 μg/ml , 78% hemolysis at 256 μg/ml , 80% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,L,Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5041,DRAMP20983,KFWSLLKKALRLWANVL,17,CPF-2 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,CPF-2 displayed typical ,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431] 0% hemolysis at 4 μg/ml , 5% hemolysis at 8 μg/ml , 8% hemolysis at 16 μg/ml , 24% hemolysis at 32 μg/ml , 48% hemolysis at 64 μg/ml , 68% hemolysis at 128 μg/ml , 85% hemolysis at 256 μg/ml , 90% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,"Mixed(D-Lys1, D-Trp3, D-Lys7, D-Trp13)",Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5042,DRAMP20984,KFWKLLKKALRLWAKVL ,17,CPF-3 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,CPF-3 displayed typical ,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431] 0% hemolysis at 256 μg/ml , 5% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,L,Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5043,DRAMP20985,KFWKLLKKALRLWAKVL,17,CPF-4 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=16 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=32 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431] 0% hemolysis at 32 μg/ml , 5% hemolysis at 64 μg/ml , 8% hemolysis at 128 μg/ml , 10% hemolysis at 256 μg/ml , 25% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,"Mixed(D-Lys1, D-Leu5, D-Lys8, D-Leu10, D-Arg11, D-Lys15)",Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5044,DRAMP20986,KFWKLLKKALRLWAKVL,17,CPF-5 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=8 μg/ml), Acinetobacter baumannii 4956 (MIC=8 μg/ml)","[Ref.28371431] 0% hemolysis at 16 μg/ml , 5% hemolysis at 32 μg/ml , 10% hemolysis at 64 μg/ml , 20% hemolysis at 128 μg/ml , 40% hemolysis at 256 μg/ml , 37% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,"Mixed(D-Lys1, D-Trp3, D-Lys7, D-Arg11, D-Trp13, D-Lys15)",Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5045,DRAMP20987,LFWKLLLKALRLWAKVL,17,CPF-6 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=16 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=64 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC8=μg/ml), Acinetobacter baumannii 2982 (MIC=8 μg/ml), Acinetobacter baumannii 4956 (MIC=8 μg/ml)","[Ref.28371431] 0% hemolysis at 4 μg/ml , 3% hemolysis at 8 μg/ml , 17.5% hemolysis at 16 μg/ml , 45% hemolysis at 32 μg/ml , 70% hemolysis at 64 μg/ml , 80% hemolysis at 128 μg/ml , 85% hemolysis at 256 μg/ml , 90% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,"Mixed(D-Leu1, D-Trp3, D-Leu7, D-Leu10, D-Arg11, D-Trp13, D-Lys15)",Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5046,DRAMP20988,WFKKLLKKALRLWKKVL,17,CPF-7 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,CPF-7 displayed typical ,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=16 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=32 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431] 0% hemolysis at 4 [Ref.28371431] 0% hemolysis at 4 μg/ml , 5% hemolysis at 8 μg/ml , 23% hemolysis at 16 μg/ml , 50% hemolysis at 32 μg/ml , 70% hemolysis at 64 μg/ml , 95% hemolysis at 128 μg/ml , 90% hemolysis at 256 μg/ml , 100% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,L,Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5047,DRAMP20989,WFKKLLKKALRLWKKVL,17,CPF-8 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=8 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=8 μg/ml), Acinetobacter baumannii 4956 (MIC=8 μg/ml)","[Ref.28371431]13% hemolysis at 4 μg/ml , 5% hemolysis at 8 μg/ml , 0% hemolysis at 16 μg/ml , 0% hemolysis at 32 μg/ml , 0% hemolysis at 64 μg/ml , 0% hemolysis at 128 μg/ml , 0% hemolysis at 256 μg/ml , 0% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,"Mixed(D-Trp1, D-Leu5, D-Lys8, D-Leu10, D-Arg11, D-Lys15)",Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5048,DRAMP20990,KFWKLLKKALRLWKKVL,17,CPF-9 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μg/ml), Escherichia coli 780 (MIC=8 μg/ml), Escherichia coli 804 (MIC=8 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=64 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=8 μg/ml), Acinetobacter baumannii 2982 (MIC=8 μg/ml), Acinetobacter baumannii 4956 (MIC=8 μg/ml)","[Ref.28371431]0% hemolysis at 256 μg/ml , 5% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,"Mixed(D-Lys1, D-Trp3, D-Lys7, D-Leu10, D-Arg11, D-Trp13, D-Lys15)",Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5049,DRAMP20991,WFWKLLWKALRLWWKVL,17,CPF-10 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=32 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=32 μg/ml), Pseudomonas aeruginosa 2760 (MIC=16 μg/ml), Pseudomonas aeruginosa 9132 (MIC=256 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=16 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431]0% hemolysis at 4 μg/ml , 5% hemolysis at 8 μg/ml , 21% hemolysis at 16 μg/ml , 40% hemolysis at 32 μg/ml , 56% hemolysis at 64 μg/ml , 65% hemolysis at 128 μg/ml , 73% hemolysis at 256 μg/ml , 85% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,"Mixed(D-Trp1, D-Trp3, D-Trp7, D-Leu10, D-Arg11, D-Trp13, D-Lys15)",Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5050,DRAMP20992,LLKKALRLWKKVL,13,CPF-11 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=64 μg/ml), Staphylococcuss aureus 725 (MIC=32 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=64 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=32 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=16 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=128 μg/ml), Acinetobacter baumannii 1980 (MIC=64 μg/ml), Acinetobacter baumannii 2982 (MIC=64 μg/ml), Acinetobacter baumannii 4956 (MIC=32 μg/ml)","[Ref.28371431]2% hemolysis at 4 μg/ml , 3% hemolysis at 8 μg/ml , 1% hemolysis at 16 μg/ml , 0% hemolysis at 32 μg/ml , 0% hemolysis at 64 μg/ml , 0% hemolysis at 128 μg/ml , 10% hemolysis at 256 μg/ml , 20% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,"Mixed(D-Leu1, D-Lys4, D-Leu6, D-Arg7, D-Lys11)",Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5051,DRAMP20993,LLWKALRLWWKVL ,13,CPF-12 (Derived from  CPF-C1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28371431]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=16 μg/ml), Staphylococcuss aureus 936 (MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=32 μg/ml), Escherichia coli 850 (MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=64 μg/ml), Pseudomonas aeruginosa 2760 (MIC=64 μg/ml), Pseudomonas aeruginosa 9132 (MIC>256 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=16 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)","[Ref.28371431]0% hemolysis at 4 μg/ml , 3% hemolysis at 8 μg/ml , 0% hemolysis at 16 μg/ml , 0% hemolysis at 32 μg/ml , 0% hemolysis at 64 μg/ml , 3% hemolysis at 128 μg/ml , 8% hemolysis at 256 μg/ml , 38% hemolysis at 512 μg/ml against human red blood cells",,28371431,Chem Biol Drug Des. 2017 Nov;90(5):690-702. doi: 10.1111/cbdd.12988.,"Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang",Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria,Linear,"Mixed(D-Trp3, D-Leu6, D-Arg7, D-Trp9, D-Lys11)",Free,[Ref.28371431] No cytotoxicity information found,Amidation,None,Not found,
5052,DRAMP20994,GLLKFIKKLL,10,anoplin analog 4,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida parapsilosis","[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=15 μg/ml), Bacillus subtilis DELTA (MIC=30 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=300 μg/ml), Zymomonas mobilis 10988 (MIC=7 μg/ml);##Fungi : Candida parapsilosis (MIC=40 μg/ml)","[Ref.27862650]0% hemolysis at 55μg/ml , 7% hemolysis at 100μg/ml , 17% hemolysis at 200μg/ml , 24% hemolysis at 300 μg/ml , 33% hemolysis at 400μg/ml , 35% hemolysis at 500 μg/ml against human red blood cells",,27862650,J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.,"Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis",Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin,Linear,L,Free,[Ref.27862650] No cytotoxicity information found,Amidation,None,Not found,
5053,DRAMP20995,KLLKFIKKLL,10,anoplin analog 5,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida parapsilosis","[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=15 μg/ml), Bacillus subtilis DELTA (MIC=40 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=400 μg/ml), Zymomonas mobilis 10988 (MIC=10 μg/ml);##Fungi : Candida parapsilosis (MIC=30 μg/ml)","[Ref.27862650]0% hemolysis at 100 μg/ml , 4% hemolysis at 200 μg/ml , 11% hemolysis at 300 μg/ml , 13% hemolysis at 400 μg/ml , 15% hemolysis at 500 μg/ml against human red blood cells",,27862650,J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.,"Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis",Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin,Linear,L,Free,[Ref.27862650] No cytotoxicity information found,Amidation,None,Not found,
5054,DRAMP20996,RLLKFIKKLL,10,anoplin analog 6,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida parapsilosis","[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=20 μg/ml), Bacillus subtilis DELTA (MIC=40 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=400 μg/ml), Zymomonas mobilis 10988 (MIC=10 μg/ml);##Fungi : Candida parapsilosis (MIC=30 μg/ml)","[Ref.27862650]0% hemolysis at 300 μg/ml , 3% hemolysis at 400 μg/ml , 12% hemolysis at 500 μg/ml against human red blood cells",,27862650,J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.,"Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis",Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin,Linear,L,Free,[Ref.27862650] No cytotoxicity information found,Amidation,None,Not found,
5055,DRAMP20997,GLLKFIKKLL,10,anoplin analog 7,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=30 μg/ml), Pseudomonas aeruginosa PAO (MIC=5 μg/ml), Zymomonas mobilis 10988 (MIC=5 μg/ml)","[Ref.27862650]3% hemolysis at 100 μg/ml , 5% hemolysis at 200 μg/ml , 9% hemolysis at 300 μg/ml , 8% hemolysis at 400 μg/ml , 7% hemolysis at 500 μg/ml against human red blood cells",,27862650,J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.,"Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis",Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin,Linear,L,Acylation (Conjugated with octanoic acid),[Ref.27862650] No cytotoxicity information found,Amidation,None,Not found,
5056,DRAMP20998,GLLKFIKKLL,10,anoplin analog 8,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=30 μg/ml), Pseudomonas aeruginosa PAO (MIC=5 μg/ml), Zymomonas mobilis 10988 (MIC=5 μg/ml)","[Ref.27862650]10% hemolysis at 50 μg/ml , 12% hemolysis at 100 μg/ml , 10% hemolysis at 400 μg/ml , 11% hemolysis at 500 μg/ml against human red blood cells",,27862650,J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.,"Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis",Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin,Linear,L,Acylation (Conjugated with decanoic acid) ,[Ref.27862650] No cytotoxicity information found,Amidation,None,Not found,
5057,DRAMP20999,GLLKFIKKLL,10,anoplin analog 9,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27862650]Gram-positive bacteria : Mycobacteria smegmatis mc2 155 (MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli DH5a (MIC=40 μg/ml), Pseudomonas aeruginosa PAO (MIC=5 μg/ml), Zymomonas mobilis 10988 (MIC=30 μg/ml)","[Ref.27862650]10% hemolysis at 50 μg/ml , 12% hemolysis at 100 μg/ml , 10% hemolysis at 400 μg/ml , 11% hemolysis at 500 μg/ml against human red blood cells",,27862650,J Pept Sci. 2016 Nov;22(11-12):731-736. doi: 10.1002/psc.2939.,"Kostas Chionis, Dimitrios Krikorian, Anna-Irini Koukkou, Maria Sakarellos-Daitsiotis and Eugenia Panou-Pomonis",Synthesis and biological activity of lipophilic analogs of the cationic antimicrobial active peptide anoplin,Linear,L,Acylation (Conjugated with dodecanoic acid),[Ref.27862650] No cytotoxicity information found,Amidation,None,Not found,
5058,DRAMP21000,GCRRLCYKQRCVTYCRGR,18,cGm (Derived from Gm),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=32 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=4 μM), Escherichia coli CGSC 5167 (MIC=0.06 μM), Klebsiella pneumoniae ATCC 700603 (MIC=4-8 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1-4 μM), Helicobacter pylori ATCC 43504 (MIC= μM);##Fungi : Candida albicans ATCC 90028 (MIC=4-8 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)","[Ref.28741926] 5% hemolysis at 0.03 μM , 0% hemolysis at 1.1 μM , 10% hemolysis at 17 μM , 50% hemolysis at 100μM against human red blood cells",,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,Cyclic,L,No specific N-terminal,"[Ref.28741926] CC50 = 39.8 ± 1.0 μM against CRL-1739, CC50 = 2.9 ± 0.1 μM against MM96L, CC50 = 71.7 ± 9.2 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 15.3 ± 1.4 μM against MCF-7, CC50 = 2.7 ± 0.1 μM against K-562, CC50 = 12.7 ± 1.1 μM PBMCs.",No specific C-terminal,"Disulfide bond between Cys2 and Cys15,Cys6 and Cys11.",Not found,
5059,DRAMP21001,GCRRLCWKQRCVTYCRGR,18,[Y7W]cGm (Derived from Gm),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1-2 μM),[Ref.28741926] 35.1-55.5% hemolysis at 64 μM against human red blood cells,,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,Cyclic,L,No specific N-terminal,"[Ref.28741926] CC50 = 23.3 ± 0.4 μM against CRL-1739, CC50 = 5.1 ± 0.3 μM against MM96L, CC50 = 39.7 ± 3.8 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 3.9 ± 0.2 μM against K-562. ",No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",Not found,
5060,DRAMP21002,GCRRLCYKQRCVTWCRGR,18,[Y14W]cGm (Derived from Gm) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1-2 μM),[Ref.28741926] 46.1-55.5% hemolysis at 64 μM against human red blood cells,,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,Cyclic,L,No specific N-terminal,"[Ref.28741926] CC50 = 30.3 ± 1.1 μM against CRL-1739, CC50 = 4.0 ± 0.1 μM against MM96L, CC50 = 68.4 ± 9.6 μM against HFF-1, CC50 = 50.4 ± 2.4 μM against HeLa, CC50 = 2.7 ± 0.1 μM against K-562. ",No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",Not found,
5061,DRAMP21003,GCRRLCYRQRCVTYCRGR,18,[K8R]cGm (Derived from Gm) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1-2 μM),[Ref.28741926] 34.8-54.8% hemolysis at 64 μM against human red blood cells,,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,Cyclic,L,No specific N-terminal,"[Ref.28741926] CC50 = 29.4 ± 1.1 μM against CRL-1739, CC50 = 5.0 ± 0.3 μM against MM96L, CC50 = 34.5 ± 3.6 μM against HFF-1, CC50 = 39.4 ± 2.6 μM against HeLa, CC50 = 3.1 ± 0.1 μM against K-562.",No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",Not found,
5062,DRAMP21004,GCRRLCWRQRCVTWCRGR,18,"[Y7W, K8R, Y14W]cGm (Derived from Gm) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1 μM),[Ref.28741926] 42-49.8% hemolysis at 64 μM against human red blood cells,,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,Cyclic,L,No specific N-terminal,"[Ref.28741926] CC50 = 31.6 ± 1.3 μM against CRL-1739, CC50 = 5.4 ± 0.3 μM against MM96L, CC50 = 31.3 ± 2.6 μM against HFF-1, CC50 = 41.0 ± 4.2 μM against HeLa, CC50 = 15.1 ± 1.4 μM against MCF-7, CC50 = 3.9 ± 0.1 μM against K-562.",No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",Not found,
5063,DRAMP21005,GCRALCYKQRCVTYCRGA,18,"[R4A, R18A]cGm (Derived from Gm) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=32 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μM), Escherichia coli CGSC 5167 (MIC=0.5-1 μM), Klebsiella pneumoniae ATCC 700603 (MIC=32 μM), Acinetobacter baumannii ATCC 19606 (MIC=8-16 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=32 μM), Cryptococcus neoformans ATCC 208821 (MIC=8-16 μM)","[Ref.28741926] 0% hemolysis at 17 μM , 3% hemolysis at 35 μM , 30-48.6% hemolysis at 64 μM , 40% hemolysis at 100 μM against human red blood cells",,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,Cyclic,L,No specific N-terminal,"[Ref.28741926] CC50 > 64 μM against CRL-1739, CC50 = 10.3 ± 1.1 μM against MM96L, CC50 = 51.2 ± 4.0 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 48.4 ± 0.7 μM against MCF-7, CC50 = 11.5 ± 0.6 μM against K-562, CC50 = 34.1 ± 3.9 μM against HL-60;CC50=30.8 ± 2.5μM against PBMCs.",No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",Not found,
5064,DRAMP21006,KCRRLCYRQRCVTYCRGR,18,"[G1K, K8R]cGm (Derived from Gm) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=2 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=0.5-1 μM), Escherichia coli CGSC 5167 (MIC<0.015 μM), Klebsiella pneumoniae ATCC 700603 (MIC=8 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC<0.25 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=2 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.125-0.25 μM)","[Ref.28741926] 0% hemolysis at 0.5 μM , 2.5% hemolysis at 0.6 μM , 20% hemolysis at 8 μM , 43.3-56.9% hemolysis at 64 μM , 50% hemolysis at 100 μM against human red blood cells",,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,Cyclic,L,No specific N-terminal,"[Ref.28741926] CC50 = 19.5 ± 0.5 μM against CRL-1739, CC50 = 1.7 ± 0.1 μM against MM96L, CC50 = 9.0 ± 0.5 μM against HFF-1, CC50 = 44.2 ± 2.2μM against HeLa, CC50 = 6.7 ± 0.7 μM against MCF-7, CC50 = 2.1 ± 0.2 μM against K-562, CC50 = 9.0 ± 1.1μM against HL-60;CC50=5.1 ± 0.3μM against PBMCs.",No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",Not found,
5065,DRAMP21007,GURRLUYKQRUVTYURGR,18,[C/U]cGm (Derived from Gm) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=4-8 μM), Escherichia coli CGSC 5167 (MIC=0.03-0.06 μM), Klebsiella pneumoniae ATCC 700603 (MIC=8-16 μM), Acinetobacter baumannii ATCC 19606 (MIC=4 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=2-4 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=4-8 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)",[Ref.28741926] 32.3-33.3% hemolysis at 64 μM against human red blood cells,,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,Cyclic,L,No specific N-terminal,"[Ref.28741926] CC50 = 51.0 ± 4.6 μM against CRL-1739, CC50 = 4.6 ± 0.2 μM against MM96L, CC50 = 15.6 ± 3.6 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 37.5 ± 3.3 μM against MCF-7, CC50 = 1.4 ± 0.2 μM against K-562, CC50 = 38.5 ± 4.8 μM against HL-60;CC50=15.5 ± 0.8μM against PBMCs.",No specific C-terminal,"Disulfide bonds between SeCys2 and SeCys15, SeCys6 and SeCys11. The 'U' in sequence is SelenoCys.",Not found,
5066,DRAMP21008,GCRRWCYKQRCVTYCRGR,18,[L5W]cGm (Derived from Gm) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antitumor",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria,[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8-16 μM),[Ref.28741926] 36.8-43.4% hemolysis at 64 μM against human red blood cells,,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,Cyclic,L,No specific N-terminal,"[Ref.28741926] CC50 = 18.3 ± 1.4 μM against CRL-1739, CC50 = 4.0 ± 0.1 μM against MM96L, CC50 = 25.0 ± 2.9 μM against HFF-1, CC50 = 17.1 ± 0.7 μM against HeLa, CC50 = 1.0 ± 0.1 μM against K-562. ",No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",Not found,
5067,DRAMP21009,GCRRLCYKQRCVTYCRGPPR,20,[D-P L-P]cGm (Derived from Gm) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=4 μM), Klebsiella pneumoniae ATCC 700603 (MIC=1-4 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-4 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=4 μM);##Fungi : Candida albicans ATCC 90028 (MIC=8 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)",[Ref.28741926] 41.5-44.9% hemolysis at 64 μM against human red blood cells,,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,Cyclic,L,No specific N-terminal,"[Ref.28741926] CC50 = 22.5 ± 3.3 μM against CRL-1739, CC50 = 3.0 ± 0.1 μM against MM96L, CC50 = 14.9 ± 0.8 μM against HFF-1, CC50 = 51.5 ± 3.9 μM against HeLa, CC50 = 3.9 ± 0.2 μM against K-562, CC50 = 14.1 ± 0.9 μM against PBMCs",No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",Not found,
5068,DRAMP21010,KCRRYCYRQRCVTYCRGR,18,"[G1K, L5Y, K8R]cGm (Derived from Gm) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=0.5-1 μM), Klebsiella pneumoniae ATCC 700603 (MIC=4-8 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC<0.25-0.5 μM);##Fungi : Candida albicans ATCC 90028 (MIC=4 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5 μM)",[Ref.28741926] 20.6-32% hemolysis at 64 μM against human red blood cells,,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,Cyclic,L,No specific N-terminal,"[Ref.28741926] CC50 = 26.5 ± 2.4 μM against CRL-1739, CC50 = 2.0 ± 0.1 μM against MM96L, CC50 = 14.7 ± 1.5 μM against HFF-1, CC50 = 20.9 ± 1.4 μM against HeLa, CC50 = 15.2 ± 1.9 μM against MCF-7, CC50 = 1.3 ± 0.1 μM against K-562, CC50 = 15.7 ±1.1μM against HL-60;CC50=10.4 ± 1.0μM against PBMCs.",No specific C-terminal,"Disulfide bonds between Cys2 and Cys15, Cys6 and Cys11.",Not found,
5069,DRAMP21011,KURRYUYRQRUVTYURGR,18,"[C/U, G1K, L5Y, K8R]cGm (Derived from Gm)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=8 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=1-2 μM), Klebsiella pneumoniae ATCC 700603 (MIC=4-16 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=1 μM);##Fungi : Candida albicans ATCC 90028 (MIC=4 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5-1 μM)",[Ref.28741926] 17.8-24% hemolysis at 64 μM against human red blood cells,,28741926,ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?,"Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik",Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties,Cyclic,L,No specific N-terminal,"[Ref.28741926] CC50 = 46.2 ± 7.6 μM against CRL-1739, CC50 = 2.3 ± 0.2 μM against MM96L, CC50 = 30.8 ± 2.0 μM against HFF-1, CC50 = 36.2 ± 2.8 μM against HeLa, CC50 = 29.0 ± 3.7 μM against MCF-7, CC50 = 6.4 ± 0.6 μM against K-562, CC50 = 33.3 ±7.4μM against HL-60;CC50=9.5 ± 0.5μM against PBMCs.",No specific C-terminal,"Disulfide bonds between SeCys2 and SeCys15, SeCys6 and SeCys11. The 'U' in sequence is SelenoCys.",Not found,
5070,DRAMP21012,KILRGVCKKIMRTFLRRISKDILTGKK,27,"NK-2 (Mammals, Animals)",No entry found,Not found,Not found,Mammal,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Not found,Alpha helix,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.29043494]Gram-positive bacteria : Staphylococcus aureus (MIC=2 μM), Staphylococcus epidermidis (MIC=2 μM);##Gram-negative bacteria : Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=8 μM)","[Ref.29043494] 2.5% hemolysis at 10 μg/ml , 8% hemolysis at 25 μg/ml , 22% hemolysis at 50 μg/ml , 32.5% hemolysis at 75 μg/ml , 36% hemolysis at 150 μg/ml , 38% hemolysis at 300 μg/ml against human red blood cells",,29043494,Probiotics Antimicrob Proteins. 2018 Mar;10(1):118-127. doi: 10.1007/s12602-017-9335-1.,Jiexi Yan & Xiaolei Liang & Chang Liu & Yuemei Cheng & Lanxia Zhou & Kairong Wang & Li Zhao,Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2,Linear,L,Free,[Ref.29043494] IC50 = 25.1 μM against NK-2. ##IC50 = 8.4 μM against EJ. ##IC50 = 4.1 μM against PC-3. ##IC50 = 10.1 μM against T24. ##IC50 = 13.7  μM against HL-60. ##The proliferation inhibition activity on K562 is not significant.,Amidation,None,Not found,
5071,DRAMP21013,KILRGVCKKIMRPFLRRISKDILTGKK,27,NK-pro (Derived from NK-2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.29043494]Gram-positive bacteria : Staphylococcus aureus (MIC=4 μM), Staphylococcus epidermidis (MIC=4 μM);##Gram-negative bacteria : Escherichia coli (MIC=4 μM), Pseudomonas aeruginosa (MIC=16 μM)","[Ref.29043494] 0.3% hemolysis at 10 μg/ml , 2% hemolysis at 25 μg/ml , 5.5% hemolysis at 50 μg/ml , 8% hemolysis at 75 μg/ml , 15% hemolysis at 150 μg/ml , 28% hemolysis at 300 μg/ml against human red blood cells",,29043494,Probiotics Antimicrob Proteins. 2018 Mar;10(1):118-127. doi: 10.1007/s12602-017-9335-1.,Jiexi Yan & Xiaolei Liang & Chang Liu & Yuemei Cheng & Lanxia Zhou & Kairong Wang & Li Zhao,Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2,Linear,L,Free,[Ref.29043494] IC50 = 43.7 μM against NK-2. ##IC50 = 23.3 μM against EJ. ##IC50 = 9.3 μM against PC-3. ##IC50 = 33.0 μM against T24. ##IC50 = 26.1  μM against HL-60. ####The proliferation inhibition activity on K562 is not significant.,Amidation,None,Not found,
5072,DRAMP21014,KILPGVCKKIMRPFLRRISKDILTGKK,27,NK-dpro (Derived from NK-2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.29043494]Gram-positive bacteria : Staphylococcus aureus (MIC=8 μM), Staphylococcus epidermidis (MIC=8 μM);##Gram-negative bacteria : Escherichia coli (MIC=8 μM), Pseudomonas aeruginosa (MIC=32 μM)","[Ref.29043494] 0% hemolysis at 10 μg/ml , 2% hemolysis at 25 μg/ml , 3% hemolysis at 50 μg/ml , 4.5% hemolysis at 75 μg/ml , 10% hemolysis at 150 μg/ml , 20% hemolysis at 300 μg/ml against human red blood cells",,29043494,Probiotics Antimicrob Proteins. 2018 Mar;10(1):118-127. doi: 10.1007/s12602-017-9335-1.,Jiexi Yan & Xiaolei Liang & Chang Liu & Yuemei Cheng & Lanxia Zhou & Kairong Wang & Li Zhao,Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2,Linear,L,Free,[Ref.29043494] IC50 = 32.5 μM against NK-2. ##IC50 = 28.7 μM against EJ. ##IC50 = 9.6 μM against PC-3. ##IC50 = 39.6 μM against T24. ##IC50 = 48.4  μM against HL-60. ##The proliferation inhibition activity on K562 is not significant.,Amidation,None,Not found,
5073,DRAMP21015,RIGSILGALAKGLPTLISWIKNR,23,A (A1R) (Derived from AR-23),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=6.25 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=6.25 μM), Klebsiella pneumoniae (MIC=12.5 μM)",[Ref.27271216] 100% hemolysis at  20μM against human red blood cells,,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,Linear,L,Free,"[Ref.27271216] In L929 cells, the cell viability is 82%, 40%, 8%, 2% and almost 0% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.",Amidation,None,Not found,
5074,DRAMP21016,AIGSILGRLAKGLPTLISWIKNR,23,A (A8R) (Derived from AR-23),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=3.13 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=12.5 μM)","[Ref.27271216] 80% hemolysis at 20 μM , 100% hemolysis at 40 μM against human red blood cells",,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,Linear,L,Free,"[Ref.27271216] In L929 cells, the cell viability is 97%, 58%, 10%, 2% and almost 0% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.",Amidation,None,Not found,
5075,DRAMP21017,AIGSILGALAKGLPTLKSWIKNR,23,A (I17K) (Derived from AR-23)  ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=50 μM), Staphylococcus epidermidis (MIC=12.5 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (MIC=25 μM), Pseudomonas aeruginosa (MIC=25 μM), Klebsiella pneumoniae (MIC=50 μM)","[Ref.27271216] 5% hemolysis at 20 μM , 13% hemolysis at 40 μM , 20% hemolysis at 60 μM , 30% hemolysis at 80 μM , 35% hemolysis at 100 μM against human red blood cells",,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,Linear,L,Free,"[Ref.27271216] In L929 cells, the cell viability is 98%, 92%, 53%, 34% and 7.9% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.",Amidation,None,Not found,
5076,DRAMP21018,AIGSILGALAKGLPTLRSWIKNR,23,A (I17R) (Derived from AR-23)  ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=25 μM), Staphylococcus epidermidis (MIC=6.25 μM), Bacillus subtilis (MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=25 μM)","[Ref.27271216] 10% hemolysis at 20 μM , 15% hemolysis at 40 μM , 20% hemolysis at 60 μM , 30% hemolysis at 80 μM , 35% hemolysis at 100 μM against human red blood cells",,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,Linear,L,Free,"[Ref.27271216] In L929 cells, the cell viability is 85%, 68%, 21% and 6.6% at peptide concentrations of 6.25, 12.5, 25 and 50 μM. ",Amidation,None,Not found,
5077,DRAMP21019,RIGSILGRLAKGLPTLISWIKNR,23,"A (A1R, A8R) (Derived from AR-23)  ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=12.5 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (MIC=6.25 μM), Pseudomonas aeruginosa (MIC=6.25 μM), Klebsiella pneumoniae (MIC=6.25 μM)","[Ref.27271216] 58% hemolysis at 20 μM , 80% hemolysis at 40 μM , 100% hemolysis at 60 μM against human red blood cells",,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,Linear,L,Free,"[Ref.27271216] In L929 cells, the cell viability is 92%, 80%, 29%, 1% and almost 0% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.",Amidation,None,Not found,
5078,DRAMP21020,RIGSILGALAKGLPTLKSWIKNR,23,"A (A1R, I17K) (Derived from AR-23)  ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=100 μM), Staphylococcus epidermidis (MIC=6.25 μM), Bacillus subtilis (MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (MIC=25 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=25 μM)","[Ref.27271216] 2% hemolysis at 20 μM , 5% hemolysis at 40 μM , 10% hemolysis at  60 μM , 20% hemolysis at 80 μM , 30% hemolysis at 100 μM against human red blood cells",,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji","Design of an Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Linear,L,Free,"[Ref.27271216] In L929 cells, the cell viability is 95%, 92%, 60%, 33% and 24% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.",Amidation,None,Not found,
5079,DRAMP21021,AIGSILGRLAKGLPTLKSWIKNR,23,"A (A8R, I17K) (Derived from AR-23)  ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=100 μM), Staphylococcus epidermidis (MIC=6.25 μM), Bacillus subtilis (MIC=12.5 μM);##Gram-negative bacteria : Escherichia coli (MIC=25 μM), Pseudomonas aeruginosa (MIC=25 μM), Klebsiella pneumoniae (MIC=25 μM)","[Ref.27271216] 2% hemolysis at 20 [Ref.27271216] 2% hemolysis at 20 μM , 5% hemolysis at 40 μM , 10% hemolysis at  60 μM , 20% hemolysis at 80 μM , 30% hemolysis at 100 μM against human red blood cells",,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,Linear,L,Free,"[Ref.27271216] In L929 cells, the cell viability is 100%, 99%, 92%, 64% and 21.1% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM.",Amidation,None,Not found,
5080,DRAMP21022,RIGSILGRLAKGLPTLKSWIKNR,23,"A (A1R, A8R, I17K) (Derived from AR-23)  ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=100 μM), Staphylococcus epidermidis (MIC=6.25 μM), Bacillus subtilis (MIC=12.5 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=12.5 μM)","[Ref.27271216] 0% hemolysis at 40 μM , 1% hemolysis at 60 μM , 2% hemolysis at  80 μM , 2% hemolysis at 100 μM against human red blood cells",,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,Linear,L,Free,"[Ref.27271216] In L929 cells, the cell viability is 96%, 95%, 92%, 68% and 31.4% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM",Amidation,None,Not found,
5081,DRAMP21023,RIGSILGRLAKGLPTLRSWIKNR,23,"A (A1R, A8R, I17R) (Derived from AR-23) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27271216]Gram-positive bacteria : Staphylococcuss aureus (MIC=100 μM), Staphylococcus epidermidis (MIC=3.13 μM), Bacillus subtilis (MIC=12.5 μM);##Gram-negative bacteria : Escherichia coli (MIC=12.5 μM), Pseudomonas aeruginosa (MIC=12.5 μM), Klebsiella pneumoniae (MIC=12.5 μM)","[Ref.27271216] 4% hemolysis at 40 μM , 10% hemolysis at 60 μM , 15% hemolysis at 80 μM , 20% hemolysis at 100 μM against human red blood cells",,27271216,Sci Rep. 2016 Jun 8;6:27394. doi: 10.1038/srep27394.,"Shi-KunZhang, Jin-wen Song, FengGong, Su-Bo Li, Hong-Yu Chang, Hui-MinXie, Hong-WeiGao, Ying-XiaTan & Shou-Ping Ji",Design of an α-helical antimicrobial peptide with improved cell selective and potent anti-biofilm activity,Linear,L,Free,"[Ref.27271216] In L929 cells, the cell viability is 92%, 92%, 80%, 60% and 12% at peptide concentrations of 3.12, 6.25, 12.5, 25 and 50 μM ",Amidation,None,Not found,
5082,DRAMP21024,FFSLIPSLVGGLISAFK,17,"Stigmurin (Tityus, Scorpionida, Arachnida)",No entry found,Not found,Not found,Scorpion Tityus stigmurus,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Alpha helix,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida glabrata, Candida krusei","[Ref.30709056]Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=9.4 μM), Staphylococcus epidermidis (ATCC 12228)(MIC=9.4 μM), Enterococcus faecalis (ATCC 4028)(MIC>150 μM);##Gram-negative bacteria : Pseudomonas aeruginosa (ATCC 27853)(MIC>150 μM), Escherichia coli (ATCC 25922)(MIC>150 μM), Enterobacter cloacae (ATCC 13047)(MIC>150 μM);##Fungi : Candida albicans (ATCC 90028)(MIC=37.5 μM), Candida glabrata (ATCC 90030)(MIC>150 μM), Candida krusei (ATCC 6258)(MIC>150 μM)","[Ref.30709056] 7% hemolysis at 1.2 μg/ml , 4% hemolysis at 2.3 μg/ml , 2% hemolysis at 4.7 μg/ml , 0% hemolysis at 9.4 μg/ml , 3% hemolysis at 18.8 μg/ml , 2% hemolysis at 37.5 μg/ml , 3% hemolysis at 75 μg/ml , 5% hemolysis at 150 μg/ml against human red blood cells",,30709056,Int J Mol Sci. 2019 Jan 31;20(3). pii: E623. doi: 10.3390/ijms20030623.,"Bruno Amorim-Carmo , Alessandra Daniele-Silva , Adriana M. S. Parente ,Allanny A. Furtado , Eneas Carvalho , Johny W. F. Oliveira , Elizabeth C. G. Santos , Marcelo S. Silva , Sérgio R. B. Silva , Arnóbio A. Silva-Júnior , Norberto K. Monteiro and Matheus F. Fernandes-Pedrosa",Potent and Broad-Spectrum Antimicrobial Activity of Analogs from the Scorpion Peptide Stigmurin,Linear,L,Free,[Ref.30709056] No cytotoxicity information found.,Amidation,None,Not found,
5083,DRAMP21025,FFSLIPSLVKKLIKAFK,17,StigA25 (Derived from Stigmurin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida glabrata, Candida krusei","[Ref.30709056]Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=1.2 μM), Staphylococcus epidermidis (ATCC 12228)(MIC=2.3 μM), Enterococcus faecalis (ATCC 4028)(MIC=4.7 μM);##Gram-negative bacteria : Pseudomonas aeruginosa (ATCC 27853)(MIC=4.7 μM), Escherichia coli (ATCC 25922)(MIC=2.3 μM), Enterobacter cloacae (ATCC 13047)(MIC=18.8 μM);##Fungi : Candida albicans (ATCC 90028)(MIC=9.4 μM), Candida glabrata (ATCC 90030)(MIC=9.4 μM), Candida krusei (ATCC 6258)(MIC=9.4 μM)","[Ref.30709056] 1% hemolysis at 1.2 μg/ml , 5% hemolysis at 2.3 μg/ml , 9% hemolysis at 4.7 μg/ml , 19% hemolysis at 9.4 μg/ml , 33% hemolysis at 18.8 μg/ml , 60% hemolysis at 37.5 μg/ml , 78% hemolysis at 75 μg/ml , 93% hemolysis at 150 μg/ml against human red blood cells",,30709056,Int J Mol Sci. 2019 Jan 31;20(3). pii: E623. doi: 10.3390/ijms20030623.,"Bruno Amorim-Carmo , Alessandra Daniele-Silva , Adriana M. S. Parente ,Allanny A. Furtado , Eneas Carvalho , Johny W. F. Oliveira , Elizabeth C. G. Santos , Marcelo S. Silva , Sérgio R. B. Silva , Arnóbio A. Silva-Júnior , Norberto K. Monteiro and Matheus F. Fernandes-Pedrosa",Potent and Broad-Spectrum Antimicrobial Activity of Analogs from the Scorpion Peptide Stigmurin,Linear,L,Free,[Ref.30709056] No cytotoxicity information found.,Amidation,None,Not found,
5084,DRAMP21026,FFKLIPKLVKKLIKAFK,17,StigA31 (Derived from Stigmurin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida glabrata, Candida krusei","[Ref.30709056]Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=2.3 μM), Staphylococcus epidermidis (ATCC 12228)(MIC=2.3 μM), Enterococcus faecalis (ATCC 4028)(MIC=1.2 μM);##Gram-negative bacteria : Pseudomonas aeruginosa (ATCC 27853)(MIC=2.3 μM), Escherichia coli (ATCC 25922)(MIC=1.2 μM), Enterobacter cloacae (ATCC 13047)(MIC=4.7 μM);##Fungi : Candida albicans (ATCC 90028)(MIC=4.7 μM), Candida glabrata (ATCC 90030)(MIC=4.7 μM), Candida krusei (ATCC 6258)(MIC=4.7 μM)","[Ref.30709056] 1% hemolysis at 1.2 μg/ml , 6% hemolysis at 2.3 μg/ml , 10% hemolysis at 4.7 μg/ml , 12 % hemolysis at 9.4 μg/ml , 23% hemolysis at 18.8 μg/ml , 45% hemolysis at 37.5 μg/ml , 65% hemolysis at 75 μg/ml , 70% hemolysis at 150 μg/ml against human red blood cells",,30709056,Int J Mol Sci. 2019 Jan 31;20(3). pii: E623. doi: 10.3390/ijms20030623.,"Bruno Amorim-Carmo , Alessandra Daniele-Silva , Adriana M. S. Parente ,Allanny A. Furtado , Eneas Carvalho , Johny W. F. Oliveira , Elizabeth C. G. Santos , Marcelo S. Silva , Sérgio R. B. Silva , Arnóbio A. Silva-Júnior , Norberto K. Monteiro and Matheus F. Fernandes-Pedrosa",Potent and Broad-Spectrum Antimicrobial Activity of Analogs from the Scorpion Peptide Stigmurin,Linear,L,Free,[Ref.30709056] No cytotoxicity information found.,Amidation,None,Not found,
5085,DRAMP21027,ALWKKILKNAGKAALNKINQIVQ,23,"K5, 17-DPS3 (Derived from dermaseptin-PS3 (DPS3))",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix","These three peptides existed in random coils in aqueous solution, they all adopted ",None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans",[Ref.30087268]Gram-positive bacteria : Staphylococcuss aureus (NCTC 10788)(MIC=8 μM);##Gram-negative bacteria : Escherichia coli (NCTC 10418)(MIC=8 μM);##Fungi : Candida albicans (NCYC 1467)(MIC=4 μM),"[Ref.30087268] 8% hemolysis at 0 μM , 40% hemolysis at 1 μM , 90% hemolysis at 2 μM against horse red blood cells",,30087268,Toxins (Basel). 2018 Aug 7;10(8). pii: E320. doi: 10.3390/toxins10080320.,"Yining Tan ,Xiaoling Chen , Chengbang Ma , Xinping Xi ,Lei Wang , Mei Zhou ,James F. Burrows ,Hang Fai Kwok 2 ID and Tianbao Chen","Biological Activities of Cationicity-Enhanced and Hydrophobicity-Optimized Analogues of an Antimicrobial Peptide, Dermaseptin-PS3, from the Skin Secretion of Phyllomedusa sauvagii",Linear,L,Free,[Ref.30087268] IC50 = 18.20 μM for H157. ##IC50 = 18.20 μM for PC3. ##IC50 = 132.10 μM for HMEC-1,Amidation,None,Not found,
5086,DRAMP21028,ALWKDILKNLLKAALNEINQIVQ,23,"L10, 11-DPS3 (Derived from dermaseptin-PS3 (DPS3))",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix","These three peptides existed in random coils in aqueous solution, they all adopted ",None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans",[Ref.30087268]Gram-positive bacteria : Staphylococcuss aureus (NCTC 10788)(MIC=8 μM);##Gram-negative bacteria : Escherichia coli (NCTC 10418)(MIC=16 μM);##Fungi : Candida albicans (NCYC 1467)(MIC=16 μM),"[Ref.30087268] 20% hemolysis at 0 μM , 70% hemolysis at 1 μM , 95% hemolysis at 2 μM against horse red blood cells",,30087268,Toxins (Basel). 2018 Aug 7;10(8). pii: E320. doi: 10.3390/toxins10080320.,"Yining Tan ,Xiaoling Chen , Chengbang Ma , Xinping Xi ,Lei Wang , Mei Zhou ,James F. Burrows ,Hang Fai Kwok 2 ID and Tianbao Chen","Yining Tan ,Xiaoling Chen , Chengbang Ma , Xinping Xi ,Lei Wang , Mei Zhou ,James F. Burrows ,Hang Fai Kwok 2 ID and Tianbao Chen",Linear,L,Free,[Ref.30087268] IC50 = 0.12 μM for H157. ##IC50 = 1.85 μM for PC3. ##IC50 = 8.76 μM for HMEC-1,Amidation,None,Not found,
5087,DRAMP21029,ATYRTGRATRESLSGVEISGRLYRLR,26,D5R (Derived from HD5) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Alpha helix, beta sheet, beta turn",Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Saccharomyces cerevisiae","[Ref.26206286]Gram-positive bacteria : Staphylococcus aureus (NCTC 8530)(MIC=100 μM), Bacillus subtilis (NCIM 2162)(MIC=20 μM);##Gram-negative bacteria : Escherichia coli (MG 1655)(MIC=50 μM), Pseudomonas aeruginosa (NCTC 6750)(MIC=100 μM);##Fungi : Candida albicans (ATCC 18804)(MIC=20 μM), Saccharomyces cerevisiae (BY4741)(MIC=100 μM)",[Ref.26206286] 0% hemolysis at 100μM against human red blood cells,,26206286,Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.,Basil Mathew Ramakrishnan Nagaraj,Antimicrobial activity of human-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs,Linear,L,Free,[Ref.26206286] No cytotoxic information found.,Free,None,Not found,
5088,DRAMP21030,ATYRTGRATRESLSGVEISGRLYRLR,26,D5r (Derived from HD5) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Alpha helix, beta sheet, beta turn",Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans","[Ref.26206286]Gram-positive bacteria : Staphylococcus aureus (NCTC 8530)(MIC=100 μM), Bacillus subtilis (NCIM 2162)(MIC=50 μM);##Gram-negative bacteria : Escherichia coli (MG 1655)(MIC=50 μM), Pseudomonas aeruginosa (NCTC 6750)(MIC=200 μM);##Fungi : Candida albicans (ATCC 18804)(MIC=20 μM)",[Ref.26206286] 0% hemolysis at 100μM against human red blood cells,,26206286,Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.,Basil Mathew Ramakrishnan Nagaraj,Antimicrobial activity of human-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs,Linear,"Mixed(D-Arg4, D-Arg7, D-Arg10, D-Arg21, D-Arg24)",Free,[Ref.26206286] No cytotoxic information found.,Free,None,Not found,
5089,DRAMP21031,ATYRTGRATRESLSGVEISGRLYRLR,26,MyD5R (Derived from HD5) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Alpha helix, beta sheet, beta turn",Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Saccharomyces cerevisiae","[Ref.26206286]Gram-positive bacteria : Staphylococcus aureus (NCTC 8530)(MIC=7.5 μM), Bacillus subtilis (NCIM 2162)(MIC=20 μM);##Gram-negative bacteria : Escherichia coli (MG 1655)(MIC=5 μM), Pseudomonas aeruginosa (NCTC 6750)(MIC=10 μM);##Fungi : Candida albicans (ATCC 18804)(MIC=10 μM), Saccharomyces cerevisiae (BY4741)(MIC=20 μM)","[Ref.26206286] 23% hemolysis at 10 μM , 50% hemolysis at 20 μM , 75% hemolysis at 50 μM , 87.5% hemolysis at 100 μM against human red blood cells",,26206286,Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.,Basil Mathew Ramakrishnan Nagaraj,Antimicrobial activity of human-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs,Linear,L,Acylation (Conjugated with myristic acid),[Ref.26206286] No cytotoxic information found.,Free,None,Not found,
5090,DRAMP21032,ATYRTGRATRESLSGVEISGRLYRLR,26,MyD5r (Derived from HD5) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Alpha helix, beta sheet, beta turn",Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Saccharomyces cerevisiae","[Ref.26206286]Gram-positive bacteria : Staphylococcus aureus (NCTC 8530)(MIC=7.5 μM), Bacillus subtilis (NCIM 2162)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (MG 1655)(MIC=5 μM), Pseudomonas aeruginosa (NCTC 6750)(MIC=7.5 μM);##Fungi : Candida albicans (ATCC 18804)(MIC=10 μM), Saccharomyces cerevisiae (BY4741)(MIC=20 μM)","[Ref.26206286] 17% hemolysis at 10 μM , 25% hemolysis at 20 μM , 50% hemolysis at 50 μM , 70% hemolysis at 100 μM against human red blood cells",,26206286,Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.,Basil Mathew Ramakrishnan Nagaraj,Antimicrobial activity of human-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs,Linear,"Mixed(D-Arg4, D-Arg7, D-Arg10, D-Arg21, D-Arg24)",Acylation (Conjugated with myristic acid),[Ref.26206286] No cytotoxic information found.,Free,None,Not found,
5091,DRAMP21033,ATYRTGRATRESLSGVEISGRLYRLR,26,LaD5R (Derived from HD5) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Alpha helix, beta sheet, beta turn",Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Saccharomyces cerevisiae","[Ref.26206286]Gram-positive bacteria : Staphylococcus aureus (NCTC 8530)(MIC=2 μM), Bacillus subtilis (NCIM 2162)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (MG 1655)(MIC=20 μM), Pseudomonas aeruginosa (NCTC 6750)(MIC=10 μM);##Fungi : Candida albicans (ATCC 18804)(MIC=10 μM), Saccharomyces cerevisiae (BY4741)(MIC=10 μM)",[Ref.26206286] 0% hemolysis at 100μM against human red blood cells,,26206286,Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.,Basil Mathew Ramakrishnan Nagaraj,Antimicrobial activity of human-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs,Linear,L,Acylation (Conjugated with lauric acid),[Ref.26206286] No cytotoxic information found.,Free,None,Not found,
5092,DRAMP21034,ATYRTGRATRESLSGVEISGRLYRLR,26,LaD5r (Derived from HD5) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Alpha helix, beta sheet, beta turn",Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Saccharomyces cerevisiae","[Ref.26206286]Gram-positive bacteria : Staphylococcus aureus (NCTC 8530)(MIC=20 μM), Bacillus subtilis (NCIM 2162)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (MG 1655)(MIC=10 μM), Pseudomonas aeruginosa (NCTC 6750)(MIC=50 μM);##Fungi : Candida albicans (ATCC 18804)(MIC=10 μM), Saccharomyces cerevisiae (BY4741)(MIC=10 μM)",[Ref.26206286] 0% hemolysis at 100μM against human red blood cells,,26206286,Peptides. 2015 Sep;71:128-40. doi: 10.1016/j.peptides.2015.07.009. Epub 2015 Jul 20.,Basil Mathew Ramakrishnan Nagaraj,Antimicrobial activity of human-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs,Linear,"Mixed(D-Arg4, D-Arg7, D-Arg10, D-Arg21, D-Arg24)",Acylation (Conjugated with lauric acid),[Ref.26206286] No cytotoxic information found.,Free,None,Not found,
5093,DRAMP21035,KAAKAAKKAAKAAWK,15,AC-UM-14W (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26235946]Gram-positive bacteria : Bacillus subtilis (MIC>200 μg/ml), Staphylococcus aureus (MIC>200 μg/ml), Staphylococcus epidermis (MIC>200 μg/ml);##Gram-negative bacteria : Escherichia coli (MIC>200 μg/ml), Shigella dysentariae (MIC>200 μg/ml), Salmonella typhimurium (MIC>200 μg/ml), Klebsiella pneumonia (MIC>200 μg/ml), Pseudomonas aeruginosa (MIC>200 μg/ml)","[Ref.26235946] <1% hemolysis at 12.5 μM , <1% hemolysis at 25 μM against human red blood cells",,26235946,Bioorg Med Chem Lett. 2015 Sep 15;25(18):4016-9. doi: 10.1016/j.bmcl.2015.06.053.,"Thuy T. T. Dinh , Do-Hee Kim , Huy X. Luong  , Bong-Jin Lee , Young-Woo Kim",Antimicrobial activity of doubly-stapled alanine/lysine-based peptides,Linear,L,Acylation (Conjugated with acetyl group),[Ref.26235946] No cytotoxic information found.,Amidation,None,Not found,
5094,DRAMP21036,RWKIFKKIPKFLHSAKKF,18,PapMA (Derived from Papiliocin and Magainin 2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,PapMA and PapMA-k exhibited α-helical structures in 50 mM DPC micelles and 50% TFE/H2O but displayed unordered structures in aqueous solution.,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26053120] Gram-positive bacteria : Bacillus subtilis(MIC=4.0 μM), Enterococcus faecalis(MIC=16 μM), Staphylococcus aureus(MIC=4.0 μM), ;##Gram-negative bacteria : Escherichia coli(MIC=2.0 μM), Pseudomonas aeruginosa(MIC=4.0 μM), Salmonella typhimurium(MIC=4.0 μM)",[Ref.26053120] MHC=100 μM against human red blood cells,,26053120,Biochemistry. 2015 Jun 30;54(25):3921-31. doi: 10.1021/acs.biochem.5b00392.,"Areum Shin, Eunjung Lee,  Dasom Jeon, Young-Guen Park, Jeong Kyu Bang, Yong-Sun Park, Song Yub Shin, and Yangmee Kim",Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity,Linear,L,Free,[Ref.26053120] IC50 = 10 μM against mouse macrophage-derived RAW264.7 cells. ##IC50 = 9 μM for NIH3T3 fibroblasts.,Amidation,None,Not found,
5095,DRAMP21037,RWKIFKKIKKFLHSAKKF,18,PapMA-k (Derived from Papiliocin and Magainin 2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,PapMA and PapMA-k exhibited α-helical structures in 50 mM DPC micelles and 50% TFE/H3O but displayed unordered structures in aqueous solution.,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26053120] Gram-positive bacteria : Bacillus subtilis(MIC=4.0 μM), Enterococcus faecalis(MIC=16 μM), Staphylococcus aureus(MIC=4.0 μM), ;##Gram-negative bacteria : Escherichia coli(MIC=2.0 μM), Pseudomonas aeruginosa(MIC=4.0 μM), Salmonella typhimurium(MIC=2.0 μM)",[Ref.26053120] MHC=200 μM against human red blood cells,,26053120,Biochemistry. 2015 Jun 30;54(25):3921-31. doi: 10.1021/acs.biochem.5b00392.,"Areum Shin, Eunjung Lee,  Dasom Jeon, Young-Guen Park, Jeong Kyu Bang, Yong-Sun Park, Song Yub Shin, and Yangmee Kim",Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity,Linear,L,Free,[Ref.26053120] IC50 = 42 μM against mouse macrophage-derived RAW264.7 cells. ##IC50 = 39 μM for NIH3T3 fibroblasts.,Amidation,The 'k'  in sequence is lysine peptoid,Not found,
5096,DRAMP21038,WGRRGWGPGRRYVRN,15,analog 1 (Derived from  Ib-AMP1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, beta turn"," In sodium phosphate buffer, the CD spectra of Ib-AMP1 and all linear analogs showed a large absorbance in the region of 190-200 nm, indicating a random coil structure. The spectra of Ib-AMP1 and analogs 1, 2, 3, and 4 became significantly more b-turn in 30 mM SDS micelles",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.19778562] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC 1621)(MIC=4 μM), Staphylococcus aureus (MRSA)(CCARM 3543)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=16 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM), Pseudomonas aeruginosa (MDRPA)(CCARM 2095)(MIC=16 μM) ",[Ref.19778562] MHC>400 μM against human red blood cells,,19778562,Peptides. 2009 Dec;30(12):2144-9. doi: 10.1016/j.peptides.2009.09.020.,"Peng Wang  , Jeong-Kyu Bang  , Hak Jun Kim  , Jin-Kyoung Kim  , Yangmee Kim , Song Yub Shin",Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1,Linear,L,Free,[Ref.19778562] No cytotoxicity information found.,Amidation,None,Not found,
5097,DRAMP21039,WGRRGWGPGRRYVRN,15,analog 2 (Derived from  Ib-AMP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, beta turn"," In sodium phosphate buffer, the CD spectra of Ib-AMP1 and all linear analogs showed a large absorbance in the region of 190-200 nm, indicating a random coil structure. The spectra of Ib-AMP1 and analogs 1, 2, 3, and 4 became significantly more b-turn in 30 mM SDS micelles",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.19778562] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 ,[Ref.19778562] MHC>400 ,,19778562,Peptides.?2009 Dec;30(12):2144-9. doi: 10.1016/j.peptides.2009.09.020.,"Peng Wang  , Jeong-Kyu Bang  , Hak Jun Kim  , Jin-Kyoung Kim  , Yangmee Kim , Song Yub Shin",Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1,Linear,Mixed(D-Pro8),Free,[Ref.19778562] No cytotoxicity information found.,Amidation,None,Not found,
5098,DRAMP21040,WGRRGWGAGRRYVRW,15,analog 3 (Derived from  Ib-AMP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, beta turn"," In sodium phosphate buffer, the CD spectra of Ib-AMP1 and all linear analogs showed a large absorbance in the region of 190–200 nm, indicating a random coil structure. The spectra of Ib-AMP1 and analogs 1, 2, 3, and 4 became significantly more b-turn in 30 mM SDS micelles",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.19778562] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC 1621)(MIC=4 μM), Staphylococcus aureus (MRSA)(CCARM 3543)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=16 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM), Pseudomonas aeruginosa (MDRPA)(CCARM 2095)(MIC=16 μM) ",[Ref.19778562] MHC>400 [Ref.19778562] MHC>400 μM against human red blood cells,,19778562,Peptides. 2009 Dec;30(12):2144-9. doi: 10.1016/j.peptides.2009.09.020.,"Peng Wang  , Jeong-Kyu Bang  , Hak Jun Kim  , Jin-Kyoung Kim  , Yangmee Kim , Song Yub Shin",Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1,Linear,L,Free,[Ref.19778562] No cytotoxicity information found.,Amidation,The 'a' in sequence is Ala peptoid residue (Nala) (CH3–NH–CH2–COOH),Not found,
5099,DRAMP21041,WGRRGWGKGRRYVRW,15,analog 4 (Derived from  Ib-AMP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, beta turn"," In sodium phosphate buffer, the CD spectra of Ib-AMP1 and all linear analogs showed a large absorbance in the region of 190–200 nm, indicating a random coil structure. The spectra of Ib-AMP1 and analogs 1, 2, 3, and 4 became significantly more b-turn in 30 mM SDS micelles",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.19778562] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC 1621)(MIC=4 μM), Staphylococcus aureus (MRSA)(CCARM 3543)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM), Pseudomonas aeruginosa (MDRPA)(CCARM 2095)(MIC=16 μM)",[Ref.19778562] MHC>400 μM against human red blood cells,,19778562,Peptides. 2009 Dec;30(12):2144-9. doi: 10.1016/j.peptides.2009.09.020.,"Peng Wang  , Jeong-Kyu Bang  , Hak Jun Kim  , Jin-Kyoung Kim  , Yangmee Kim , Song Yub Shin",Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1,Linear,L,Free,[Ref.19778562] No cytotoxicity information found.,Amidation,The 'k' in sequence is Lys peptoid residue (Nlys) (NH2–CH2–CH2–CH2–CH2–NH–CH2–COOH).,Not found,
5100,DRAMP21042,ILPWKWPWWKWRR,13,A2 (Derived from Indolicidin (IN)),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.19428758] Gram-positive bacteria : Bacillus subtilis(MIC=10 μg/ml), Staphylococcus epidermidis(MIC=10 μg/ml), Staphylococcus aureus(MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=20 μg/ml), Pseudomonas aeruginosa(MIC=20 μg/ml), Salmonella typhimurium(MIC=10 μg/ml)",[Ref.19428758] HC50=490 μg/ml against human red blood cells,,19428758,Peptides. 2009 May;30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.,"Yong Hai Nan , Jeong-Kyu Bang , Song Yub Shin",Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity,Linear,L,Free,[Ref.19428758] No cytotoxicity information found.,Amidation,None,Not found,
5101,DRAMP21043,ILKWKWPWWPWRR,13,A3 (Derived from Indolicidin (IN)),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.19428758] Gram-positive bacteria : Bacillus subtilis(MIC=5 μg/ml), Staphylococcus epidermidis(MIC=10 μg/ml), Staphylococcus aureus(MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=10 μg/ml), Pseudomonas aeruginosa(MIC=20 μg/ml), Salmonella typhimurium(MIC=10 μg/ml)",[Ref.19428758] HC50=400 μg/ml against human red blood cells,,19428758,Peptides. 2009 May;30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.,"Yong Hai Nan , Jeong-Kyu Bang , Song Yub Shin",Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity,Linear,L,Free,[Ref.19428758] No cytotoxicity information found.,Amidation,None,Not found,
5102,DRAMP21044,ILKWKWKWWPWRR,13,A4 (Derived from Indolicidin (IN)),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.19428758] Gram-positive bacteria : Bacillus subtilis(MIC=10 μg/ml), Staphylococcus epidermidis(MIC=10 μg/ml), Staphylococcus aureus(MIC=10 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=10 μg/ml), Pseudomonas aeruginosa(MIC=10 μg/ml), Salmonella typhimurium(MIC=10 μg/ml)",[Ref.19428758] HC50=560 μg/ml against human red blood cells,,19428758,Peptides. 2009 May;30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.,"Yong Hai Nan , Jeong-Kyu Bang , Song Yub Shin",Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity,Linear,L,Free,[Ref.19428758] No cytotoxicity information found.,Amidation,None,Not found,
5103,DRAMP21045,ILPWKWKWWKWRR,13,A5 (Derived from Indolicidin (IN)),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.19428758] Gram-positive bacteria : Bacillus subtilis(MIC=5 μg/ml), Staphylococcus epidermidis(MIC=10 μg/ml), Staphylococcus aureus(MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=10 μg/ml), Pseudomonas aeruginosa(MIC=10 μg/ml), Salmonella typhimurium(MIC=10 μg/ml)",[Ref.19428758] HC50>800 μg/ml against human red blood cells,,19428758,Peptides. 2009 May;30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.,"Yong Hai Nan , Jeong-Kyu Bang , Song Yub Shin",Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity,Linear,L,Free,[Ref.19428758] No cytotoxicity information found.,Amidation,None,Not found,
5104,DRAMP21046,ILKWKWPWWKWRR,13,A6 (Derived from Indolicidin (IN)),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.19428758] Gram-positive bacteria : Bacillus subtilis(MIC=5 μg/ml), Staphylococcus epidermidis(MIC=10 μg/ml), Staphylococcus aureus(MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=10 μg/ml), Pseudomonas aeruginosa(MIC=10 μg/ml), Salmonella typhimurium(MIC=10 μg/ml)",[Ref.19428758] HC50>800 μg/ml against human red blood cells,,19428758,Peptides. 2009 May;30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.,"Yong Hai Nan , Jeong-Kyu Bang , Song Yub Shin",Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity,Linear,L,Free,[Ref.19428758] No cytotoxicity information found.,Amidation,None,Not found,
5105,DRAMP21047,ILKWKWKWWKWRR,13,A7 (Derived from Indolicidin (IN)),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.19428758] Gram-positive bacteria : Bacillus subtilis(MIC=5 μg/ml), Staphylococcus epidermidis(MIC=10 μg/ml), Staphylococcus aureus(MIC=5 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=10 μg/ml), Pseudomonas aeruginosa(MIC=10 μg/ml), Salmonella typhimurium(MIC=5 μg/ml)",[Ref.19428758] HC50>800 μg/ml against human red blood cells,,19428758,Peptides. 2009 May;30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.,"Yong Hai Nan , Jeong-Kyu Bang , Song Yub Shin",Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity,Linear,L,Free,[Ref.19428758] No cytotoxicity information found.,Amidation,None,Not found,
5106,DRAMP21048,GLLWKWGWKWKEFLRIVGY,19,peptide 6 (Derived from seq2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.28236791] Gram-positive bacteria : Staphylococcus aureus(MIC>1024 μg/ml);##Gram-negative bacteria : Pseudomonas aeruginosa(MIC>1024 μg/ml),[Ref.28236791] 51.36% hemolysis at 128 μg/ml,,28236791,Colloids Surf B Biointerfaces. 2017 May 1;153:152-159. doi: 10.1016/j.colsurfb.2017.02.003.,"P. Maturanaa, M. Martinez , M.E. Noguerac, N.C. Santos , E.A. Disalvoa, L. Semorile , P.C. Maffia , A. Hollmann",Lipid selectivity in novel antimicrobial peptides: Implication on antimicrobial and hemolytic activity,Linear,L,Free,[Ref.28236791] No cytotoxicity information found.,Amidation,None,Not found,
5107,DRAMP21049,GLLRKWGKKWKEFLRRVWK,19,peptide 6.2 (Derived from seq2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,The spectra obtained confirmed an alpha-helix conversion in the presence of negatively charged micelles.,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.28236791] Gram-positive bacteria : Staphylococcus aureus(MIC=32 μg/ml);##Gram-negative bacteria : Pseudomonas aeruginosa(MIC=32 μg/ml),[Ref.28236791] 34.46% hemolysis at 128 μg/ml,,28236791,Colloids Surf B Biointerfaces. 2017 May 1;153:152-159. doi: 10.1016/j.colsurfb.2017.02.003.,"P. Maturanaa, M. Martinez , M.E. Noguerac, N.C. Santos , E.A. Disalvoa, L. Semorile , P.C. Maffia , A. Hollmann",Lipid selectivity in novel antimicrobial peptides: Implication on antimicrobial and hemolytic activity,Linear,L,Free,[Ref.28236791] No cytotoxicity information found.,Amidation,None,Not found,
5108,DRAMP21050,AWCFRVCYRGICYRRCR ,17,TP1[K1A] (Derived from TP1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.03 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.03 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.125 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.125 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=2 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=2.1 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",Not found,
5109,DRAMP21051,KACFRVCYRGICYRRCR ,17,TP1[W2A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=1 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=8 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-2,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5110,DRAMP21052,KWAFRVCYRGICYRRSR ,17,"TP1[C3A, C16S] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=4 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC>16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC>16 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC>16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)",[Ref.28960954] MHC10=8 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-3,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation (Arg17),Disulfide bond between Cys7 and Cys12.,Not found,
5111,DRAMP21053,KWCARVCYRGICYRRCR ,17,TP1[F4A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=40 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-4,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",Not found,
5112,DRAMP21054,KWCFAVCYRGICYRRCR ,17,TP1[R5A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.03 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.06 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=2 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-5,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5113,DRAMP21055,KWCFRACYRGICYRRCR ,17,TP1[V6A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=1 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)",[Ref.28960954] MHC10=1.2 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-6,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",Not found,
5114,DRAMP21056,KWCFRVAYRGISYRRCR ,17,"TP1[C7A, C12S] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 [Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=2 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=4 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=2 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=2 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=1 μg/ml against human red blood cells,,28960954,ACS Infect Dis.2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-7,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation (Arg17),Disulfide bond between Cys3 and Cys16.,Not found,
5115,DRAMP21057,KWCFRVCARGICYRRCR ,17,TP1[Y8A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=8 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=0.125 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=1 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=2 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC= μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=8 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-8,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation (Arg17),"Disulfide bond between Cys3 and Cys16, Cys7 and Cys12",Not found,
5116,DRAMP21058,KWCFRVCYAGICYRRCR ,17,TP1[R9A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=1 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.03 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.25 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.125 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=2 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.06 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=1 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=2 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-9,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5117,DRAMP21059,KWCFRVCYRAICYRRCR ,17,TP1[G10A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.03 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.03 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.25 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.6 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.6 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.06 μg/ml)",[Ref.28960954] MHC10=0.5 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-10,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5118,DRAMP21060,KWCFRVCYRGACYRRCR ,17,TP1[I11A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=2 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=1 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=32 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-11,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation (Arg17),"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5119,DRAMP21061,KWCFRVSYRGIAYRRCR ,17,"TP1[C7S, C12A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=1 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=4 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=8 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=1 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=8 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=0.6 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-12,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,Disulfide bond between Cys3 and Cys16.,Not found,
5120,DRAMP21062,KWCFRVCYRGICARRCR ,17,TP1[Y13A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.06 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=1 [Ref.28960954] MHC10=1 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-13,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bond between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5121,DRAMP21063,KWCFRVCYRGICYARCR ,17,TP1[R14A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=1 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.125 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.25 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=0.5 [Ref.28960954] MHC10=0.5 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-14,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5122,DRAMP21064,KWCFRVCYRGICYRACR ,17,TP1[R15A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.03 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=2 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=4 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=2 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=0.45 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-15,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",Not found,
5123,DRAMP21065,KWSFRVCYRGICYRRAR ,17,"TP1[C3S, C16A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=1 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=2 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=3 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-16,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,Disulfide bond between Cys7 and Cys12.,Not found,
5124,DRAMP21066,KWCFRVCYRGICYRRCA ,17,TP1[R17A] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.015 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=0.5 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.015 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.25 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.125 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=0.45 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-17,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5125,DRAMP21067,KWAFRVCYRGICYRRAR ,17,"TP1[C3A, C16A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=1 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=1 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=2 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=8 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)",[Ref.28960954] MHC10=40 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-18,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,Disulfide bond between Cys7 and Cys12.,Not found,
5126,DRAMP21068,KWCFRVAYRGIAYRRCR ,17,"TP1[C7A, C12A] (Derived from TP1)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=2 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=2 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)",[Ref.28960954] MHC10=8 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-19,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,Disulfide bond between Cys3 and Cys16.,Not found,
5127,DRAMP21069,KWAFRVAYRGIAYRRAR ,17,"TP1[C3A, C7A, C12A, C16A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=1 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=8 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=4 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=4 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)",[Ref.28960954] MHC10=0.24 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-20,Linear,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,None,Not found,
5128,DRAMP21070,KWCFRRCYAGICYRRCR ,17,"TP1[V6R, R9A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC>16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC>16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=16 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC>16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)",[Ref.28960954] MHC10=11 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-21,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",Not found,
5129,DRAMP21071,RWCFRVCYRGICYRRCR ,17,TP1[K1R] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=1 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.25 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.125 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.25 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=0.5 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=4 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.25 μg/ml)",[Ref.28960954] MHC10=1 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-22,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5130,DRAMP21072,KWCGRVCYRGICYRRCR ,17,TP1[F4G] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=2 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=1 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=2 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=2 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=2 μg/ml)",[Ref.28960954] MHC10=0.47 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-23,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5131,DRAMP21073,KWCSRVCYRGICYRRCR ,17,TP1[F4S] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=2 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=4 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=4 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=2 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=4 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)",[Ref.28960954] MHC10=0.23 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-24,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5132,DRAMP21074,KWCFRVCGRGICYRRCR ,17,TP1[Y8G] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.5 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=2 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=8 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=8 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=2 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=4 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)",[Ref.28960954] MHC10=0.4 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-25,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5133,DRAMP21075,KWCFRVCYRGGCYRRCR ,17,TP1[I11G] (Derived from TP1) ,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 [Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.25 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=2 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.5 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)",[Ref.28960954] MHC10=0.2 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-26,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12.",Not found,
5134,DRAMP21076,KWCARVCARGACYRRCR ,17,"TP1[F4A, Y8A, I11A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC>16 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=8 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC>16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC>16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC>16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC>16 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC>16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC>16 μg/ml)",[Ref.28960954] MHC10=0.9 μg/ml against human red blood cells,,28960954,ACS Infect Dis.2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-27,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",Not found,
5135,DRAMP21077,KWCFVCYRGICYRRCG ,16,"TP1[-R5, R17G] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=1 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=8 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC>16 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC>16 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC>16 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=16 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC>16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC>16 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=4 μg/ml)",[Ref.28960954] MHC10=0.3 μg/ml against human red blood cells,,28960954,ACS Infect Dis.2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-28,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",Not found,
5136,DRAMP21078,AWCARVCYRGICYRRCR ,17,"TP1[K1A, F4A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=16 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC>16 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=2 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=4 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=4 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=4 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC>16 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=2 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=16 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=8 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC>16 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC>16 μg/ml)",[Ref.28960954] MHC10=32 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-29,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",Not found,
5137,DRAMP21079,AWCFRVCARGICYRRCR ,17,"TP1[K1A, Y8A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.5 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=8 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.25 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=1 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=8 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=1 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=4 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=2 μg/ml)",[Ref.28960954] MHC10=0.4 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-30,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",Not found,
5138,DRAMP21080,AWCFRVCYRGACYRRCR ,17,"TP1[K1A, I11A] (Derived from TP1) ",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.125 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=4 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.125 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.25 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.25 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC>16 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=1 μg/ml)",[Ref.28960954] MHC10=0.2 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-31,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",Not found,
5139,DRAMP21081,KWCFRVCYAGICYRRCA,17,"TP1[R9A, R17A] (Derived from TP1)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans","[Ref.28960954] Gram-positive bacteria : Bacillus subtilis ATCC 6051(MIC=0.06 μg/ml), Staphylococcus aureus ATCC 43300 (MRSA)(MIC=2 μg/ml);##Gram-negative bacteria : Escherichia coli ATCC 25922(MIC=0.03 μg/ml), Klebsiella pneumoniae ATCC 13883(MIC=0.06 μg/ml), Klebsiella pneumoniae ATCC 700603 (MDR)(MIC=0.5 μg/ml), Klebsiella pneumoniae BAA 2146 (NDM-1 pos)(MIC=0.5 μg/ml), Klebsiella pneumoniae clinical isolate 100650661 : 1 (XDR;PmxR)(MIC=4 μg/ml), Acinetobacter baumannii ATCC 19606(MIC=0.25 μg/ml), Acinetobacter baumannii clinical isolate 100734512 : 2 (XDR;PmxR)(MIC=0.5 μg/ml), Pseudomonas aeruginosa ATCC 27853(MIC=0.5 μg/ml), Pseudomonas aeruginosa FADDIFA070 (PmxR)(MIC=2 μg/ml);##Fungi : Candida albicans ATCC 90028(MIC=8 μg/ml), Cryptococcus neoformans ATCC 208821(MIC=0.5 μg/ml)",[Ref.28960954] MHC10=0.2 μg/ml against human red blood cells,,28960954,ACS Infect Dis. 2017 Dec 8;3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.,"Ingrid A. Edwards , Alysha G. Elliott , Angela M. Kavanagh , Mark A. T. Blaskovich , and Matthew A. Cooper",Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-32,Cyclic,L,Free,"[Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 μg/ml.",Amidation,"Disulfide bonds between Cys3 and Cys16, Cys7 and Cys12",Not found,
5140,DRAMP21082,KWCFCVCYRGICRCRCRG,18,ccTP 3 (Derived from TP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Beta tile,Although there is insufficient information to deconvolute these CD spectra of these two-b-strand cyclic cystine-knot structures due to the various contributions by ,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida kefyr, Candida tropicalis","[Ref.10673369] Gram-positive bacteria : Staphylococcus aureus(MIC=1.3 μM(low-salt);MIC=0.9 μM(high-salt)), Micrococcus luteus(MIC=0.5 μM(low-salt);MIC=0.5 μM(high-salt)), Enterococcus faecalis(MIC=1.9 μM(low-salt);MIC=1.3 μM(high-salt));##Gram-negative bacteria : Escherichia coli(MIC=10.4 μM(low-salt);MIC=0.9 μM(high-salt)), Pseudomonas aeruginosa(MIC=6.2 μM(low-salt);MIC=10.4 μM(high-salt)), Primula vulgaris(MIC=16.4 μM(low-salt);MIC=28.9 μM(high-salt)), Klebsiella oxytoca(MIC=4.0 μM(low-salt);MIC=7.6 μM(high-salt));##Fungi : Candida albicans(MIC=24.2 μM(low-salt);MIC=30.2 μM(high-salt)), Candida kefyr(MIC=1.1 μM(low-salt);MIC=4.3 μM(high-salt)), Candida tropicalis(MIC=12.4 μM(low-salt);MIC=3.9 μM(high-salt))",[Ref.10673369] EC25=590 μM against human red blood cells,,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"James P. Tam, Yi-An Lu, and Jin-Long Yang",Marked Increase in Membranolytic Selectivity of Novel Cyclic Tachyplesins Constrained with an Antiparallel Two-b Strand Cystine Knot Framework,Cyclic,L,Free,[Ref.10673369] No cytotoxicity information found.,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys5 and Cys14, Cys7 and Cys12.",Not found,
5141,DRAMP21083,KWCRCVCRRGICRCFCRG,18,ccTP 5 (Derived from TP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Beta tile,Although there is insufficient information to deconvolute these CD spectra of these two-b-strand cyclic cystine-knot structures due to the various contributions by ,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida kefyr, Candida tropicalis","[Ref.10673369] Gram-positive bacteria : Staphylococcus aureus(MIC=1.7 μM(low-salt);MIC=1.3 μM(high-salt)), Micrococcus luteus(MIC=0.5 μM(low-salt);MIC=0.8 μM(high-salt)), Enterococcus faecalis(MIC=0.7 μM(low-salt);MIC=0.5 μM(high-salt));##Gram-negative bacteria : Escherichia coli(MIC=5.5 μM(low-salt);MIC=1.2 μM(high-salt)), Pseudomonas aeruginosa(MIC=3.9 μM(low-salt);MIC=4.7 μM(high-salt)), Primula vulgaris(MIC=16.8 μM(low-salt);MIC=55.6 μM(high-salt)), Klebsiella oxytoca(MIC=2.4 μM(low-salt);MIC=5.4 μM(high-salt));##Fungi : Candida albicans(MIC=7.1 μM(low-salt);MIC=5.1 μM(high-salt)), Candida kefyr(MIC=4.2 μM(low-salt);MIC=0.7 μM(high-salt)), Candida tropicalis(MIC=1.9 μM(low-salt);MIC=4.8 μM(high-salt))",[Ref.10673369] EC25=920 μM against human red blood cells,,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"James P. Tam, Yi-An Lu, and Jin-Long Yang",Marked Increase in Membranolytic Selectivity of Novel Cyclic Tachyplesins Constrained with an Antiparallel Two-b Strand Cystine Knot Framework,Cyclic,L,Free,[Ref.10673369] No cytotoxicity information found.,Amidation,"Disulfide bonds between Cys3 and Cys16, Cys5 and Cys14, Cys7 and Cys12.",Not found,
5142,DRAMP21084,GWCRCVCRRGICRCFCRK,18,ccTP 6 (Derived from TP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Beta tile,Although there is insufficient information to deconvolute these CD spectra of these two-b-strand cyclic cystine-knot structures due to the various contributions by ,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Candida kefyr, Candida tropicalis","[Ref.10673369] Gram-positive bacteria : Staphylococcus aureus(MIC=1.7 μM(low-salt);MIC=0.7 μM(high-salt)), Micrococcus luteus(MIC=0.3 μM(low-salt);MIC=0.4 μM(high-salt)), Enterococcus faecalis(MIC=1.4 μM(low-salt);MIC=1.2 μM(high-salt));##Gram-negative bacteria : Escherichia coli(MIC=6.1 μM(low-salt);MIC=1.2 μM(high-salt)), Pseudomonas aeruginosa(MIC=2.0 μM(low-salt);MIC=4.7 μM(high-salt)), Primula vulgaris(MIC=17.0 μM(low-salt);MIC=39.8 μM(high-salt)), Klebsiella oxytoca(MIC=4.1 μM(low-salt);MIC=4.1 μM(high-salt));##Fungi : Candida albicans(MIC=10.5 μM(low-salt);MIC=5.2 μM(high-salt)), Candida kefyr(MIC=1.1 μM(low-salt);MIC=0.7 μM(high-salt)), Candida tropicalis(MIC=2.3 μM(low-salt);MIC=1.9 μM(high-salt))",[Ref.10673369] EC25=3900 μM against human red blood cells,,10673369,Biochem Biophys Res Commun. 2000 Jan 27;267(3):783-90.,"James P. Tam, Yi-An Lu, and Jin-Long Yang",Marked Increase in Membranolytic Selectivity of Novel Cyclic Tachyplesins Constrained with an Antiparallel Two-b Strand Cystine Knot Framework,Cyclic,L,Free,No cytotoxicity information found,Amidation (Gly18),"Disulfide bonds between Cys3 and Cys16, Cys5 and Cys14, Cys7 and Cys12.",Not found,
5143,DRAMP21085,RFRRLRWKTRWRLKKI,16,PRW4 (PR) (Derived from PMAP-36),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix, beta Sheet",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25818457] Gram-positive bacteria : Staphylococcus aureus 25923(MIC=73.6 mg/L), Staphylococcus aureus 29213(MIC=9.2 mg/L), Staphylococcus epidermidis 12228(MIC=18.4 mg/L), Enterococcus faecalis 29212(MIC=9.2 mg/L), Bacillus subtilis 11060(MIC=18.4 mg/L);##Gram-negative bacteria : Escherichia coli 078(MIC=9.2 mg/L), Escherichia coli K88(MIC=9.2 mg/L), Escherichia coli ER2566(MIC=18.4 mg/L), Escherichia coli 44102(MIC=18.4 mg/L), Escherichia coli 1515(MIC=9.2 mg/L), Escherichia coli 25922(MIC=9.2 mg/L), Escherichia coli UB1005(MIC=9.2 mg/L), Salmonella typhimurium 7731(MIC=18.4 mg/L), Salmonella typhimurium 1402(MIC=18.4 mg/L), Pseudomonas aeruginosa 21625(MIC=73.6 mg/L), Pseudomonas aeruginosa 21630(MIC=36.8 mg/L), Pseudomonas aeruginosa 10419(MIC=36.8 mg/L), Pseudomonas aeruginosa 27853(MIC>294.3 mg/L), Salmonella pullorum 7913(MIC>294.3 mg/L)",[Ref.25818457] 0 % hemolysis at 294.3 mg/L against human red blood cells,,25818457,Biomaterials. 2015 Jun;52:517-30. doi: 10.1016/j.biomaterials.2015.02.063.,"Zhi Ma, Dandan Wei, Ping Yan, Xin Zhu, Anshan Shan , Zhongpeng Bi","Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of a-helix-based peptide amphiphiles",Linear,L,Free,"[Ref.25818457] The cell viability of PRW4 is 100%, 96%, 92%, 86%, 85%, 83%, 82%, 80% and 80% at peptide concentrations of 1.1, 2.3, 4.6, 9.2, 18.4, 36.8, 73.6, 147.1 and 294.3 μg/ml",Amidation,None,Not found,
5144,DRAMP21086,RFRRLRWKTRWRLKKIRFGRFLRKIRRFRPK,31,PR-FO (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix, beta Sheet",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25818457] Gram-positive bacteria : Staphylococcus aureus 25923(MIC=8.6 mg/L), Staphylococcus aureus 29213(MIC=4.3 mg/L), Staphylococcus epidermidis 12228(MIC=2.2 mg/L), Enterococcus faecalis 29212(MIC=1.1 mg/L), Bacillus subtilis 11060(MIC=2.2 mg/L);##Gram-negative bacteria : Escherichia coli 078(MIC=2.2 mg/L), Escherichia coli K88(MIC=4.3 mg/L), Escherichia coli ER2566(MIC=2.2 mg/L), Escherichia coli 44102(MIC=8.6 mg/L), Escherichia coli 1515(MIC=2.2 mg/L), Escherichia coli 25922(MIC=2.2 mg/L), Escherichia coli UB1005(MIC=4.3 mg/L), Salmonella typhimurium 7731(MIC=0.5 mg/L), Salmonella typhimurium 1402(MIC=8.6 mg/L), Pseudomonas aeruginosa 21625(MIC=8.6 mg/L), Pseudomonas aeruginosa 21630(MIC=0.5 mg/L), Pseudomonas aeruginosa 10419(MIC=4.3 mg/L), Pseudomonas aeruginosa 27853(MIC=8.6 mg/L), Salmonella pullorum 7913(MIC=8.6 mg/L)","[Ref.25818457] 0% hemolysis at 9.2 mg/L , 1% hemolysis at 18.4 mg/L , 4% hemolysis at 36.8mg/L  , 5% hemolysis at 73.6 mg/L , 10% hemolysis at 147.1 mg/L , 13% hemolysis at 294.3 mg/L against human red blood cells",,25818457,Biomaterials. 2015 Jun;52:517-30. doi: 10.1016/j.biomaterials.2015.02.063.,"Zhi Ma, Dandan Wei, Ping Yan, Xin Zhu, Anshan Shan , Zhongpeng Bi","Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of a-helix-based peptide amphiphiles",Linear,L,Free,"[Ref.25818457] The cell viability of PR-FO is 93%, 89%, 84%, 79%, 74%, 69%, 67%, 64% and 62% at peptide concentrations of 1.1, 2.3, 4.6, 9.2, 18.4, 36.8, 73.6, 147.1 and 294.3 μg/ml.",Amidation,None,Not found,
5145,DRAMP21087,RFRRLRWKTRWRLKKICYCRRRFCVCV,27,PR-PG (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix, beta Sheet",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25818457] Gram-positive bacteria : Staphylococcus aureus 25923(MIC=29.6 mg/L), Staphylococcus aureus 29213(MIC=7.4 mg/L), Staphylococcus epidermidis 12228(MIC=7.4 mg/L), Enterococcus faecalis 29212(MIC=3.7 mg/L), Bacillus subtilis 11060(MIC=7.4 mg/L);##Gram-negative bacteria : Escherichia coli 078(MIC=14.8 mg/L), Escherichia coli K88(MIC=1.9 mg/L), Escherichia coli ER2566(MIC=3.7 mg/L), Escherichia coli 44102(MIC=1.9 mg/L), Escherichia coli 1515(MIC=14.8 mg/L), Escherichia coli 25922(MIC=3.7 mg/L), Escherichia coli UB1005(MIC=7.4 mg/L), Salmonella typhimurium 7731(MIC=14.8 mg/L), Salmonella typhimurium 1402(MIC=7.4 mg/L), Pseudomonas aeruginosa 21625(MIC=14.8 mg/L), Pseudomonas aeruginosa 21630(MIC=7.4 mg/L), Pseudomonas aeruginosa 10419(MIC=14.8 mg/L), Pseudomonas aeruginosa 27853(MIC=14.8 mg/L), Salmonella pullorum 7913(MIC=14.8 mg/L)","[Ref.25818457] 0.5% hemolysis at 1.1 mg/L , 2% hemolysis at 2.3 mg/L , 10% hemolysis at 4.6 mg/L , 23% hemolysis at 9.2 mg/L , 30% hemolysis at 18.4 mg/L , 45% hemolysis at 36.8mg/L  , 46% hemolysis at 73.6 mg/L , 47% hemolysis at 147.1 mg/L , 50% hemolysis at 294.3 mg/L against human red blood cells",,25818457,Biomaterials. 2015 Jun;52:517-30. doi: 10.1016/j.biomaterials.2015.02.063.,"Zhi Ma, Dandan Wei, Ping Yan, Xin Zhu, Anshan Shan , Zhongpeng Bi","Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of a-helix-based peptide amphiphiles",Linear,L,Free,"[Ref.25818457] The cell viability of PR-FG is 92.7%, 76%, 64%, 58%, 53%, 43%, 39%, 37% and 34% at peptide concentrations of 1.1, 2.3, 4.6, 9.2, 18.4, 36.8, 73.6, 147.1 and 294.3 μg/ml.",Amidation,None,Not found,
5146,DRAMP21088,RFRRLRWKTRWRLKKIWWPFLRR,23,PR-TR (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix, beta Sheet",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25818457] Gram-positive bacteria : Staphylococcus aureus 25923(MIC=26.7 mg/L), Staphylococcus aureus 29213(MIC=6.7 mg/L), Staphylococcus epidermidis 12228(MIC=13.4 mg/L), Enterococcus faecalis 29212(MIC=3.3 mg/L), Bacillus subtilis 11060(MIC=3.3 mg/L);##Gram-negative bacteria : Escherichia coli 078(MIC=13.4 mg/L), Escherichia coli K88(MIC=1.7 mg/L), Escherichia coli ER2566(MIC=3.3 mg/L), Escherichia coli 44102(MIC=6.7 mg/L), Escherichia coli 1515(MIC=1.7 mg/L), Escherichia coli 25922(MIC=6.7 mg/L), Escherichia coli UB1005(MIC=3.3 mg/L), Salmonella typhimurium 7731(MIC=6.7 mg/L), Salmonella typhimurium 1402(MIC=13.4 mg/L), Pseudomonas aeruginosa 21625(MIC=6.7 mg/L), Pseudomonas aeruginosa 21630(MIC=13.4 mg/L), Pseudomonas aeruginosa 10419(MIC=6.7 mg/L), Pseudomonas aeruginosa 27853(MIC=13.4 mg/L), Salmonella pullorum 7913(MIC=13.4 mg/L)","[Ref.25818457] 0% hemolysis at 9.2 mg/L , 1% hemolysis at 18.4 mg/L , 4% hemolysis at 36.8mg/L  , 10% hemolysis at 73.6 mg/L , 17% hemolysis at 147.1 mg/L , 22% hemolysis at 294.3 mg/L against human red blood cells",,25818457,Biomaterials. 2015 Jun;52:517-30. doi: 10.1016/j.biomaterials.2015.02.063.,"Zhi Ma, Dandan Wei, Ping Yan, Xin Zhu, Anshan Shan , Zhongpeng Bi","Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of a-helix-based peptide amphiphiles",Linear,L,Free,"[Ref.25818457] The cell viability of PR-TR is 94%, 89%, 83%, 77%, 74%, 71%, 68%, 66% and 60% at peptide concentrations of 1.1, 2.3, 4.6, 9.2, 18.4, 36.8, 73.6, 147.1 and 294.3 μg/ml",Amidation,None,Not found,
5147,DRAMP21089,RFRRLRCKTRCRLKKI,16,C4 (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>128 μM), Staphylococcus epidermidis 12228(MIC>128 μM), Enterococcus faecalis 29212(MIC>128 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=2 μM), Escherichia coli 1005(MIC>128 μM), Salmonella typhimurium 7731(MIC128 μM)",[Ref.25735802] MHC5>256 μM against human red blood cells,,25735802,Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.,"Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan",Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity,Linear,L,Free,[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.,Amidation,None,Not found,
5148,DRAMP21090,RFRRLRDKTRDRLKKI,16,D4 (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>128 μM), Staphylococcus epidermidis 12228(MIC>128 μM), Enterococcus faecalis 29212(MIC>128 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC>128 μM), Escherichia coli 1005(MIC>128 μM), Salmonella typhimurium 7731(MIC>128 μM)",[Ref.25735802] MHC5>256 μM against human red blood cells,,25735802,Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.,"Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan",Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity,Linear,L,Free,[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.,Amidation,None,Not found,
5149,DRAMP21091,RFRRLRIKTRIRLKKI,16,I4 (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=64 μM), Staphylococcus epidermidis 12228(MIC=16 μM), Enterococcus faecalis 29212(MIC=16 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=8 μM), Escherichia coli 1005(MIC=16 μM), Salmonella typhimurium 7731(MIC=16 μM)",[Ref.25735802] MHC5>256 μM against human red blood cells,,25735802,Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.,"Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan",Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity,Linear,L,Free,[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.,Amidation,None,Not found,
5150,DRAMP21092,RFRRLRPKTRPRLKKI,16,P4 (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>128 μM), Staphylococcus epidermidis 12228(MIC>128 μM), Enterococcus faecalis 29212(MIC>128 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=32 μM), Escherichia coli 1005(MIC=32 μM), Salmonella typhimurium 7731(MIC=32 μM)",[Ref.25735802] MHC5>256 μM against human red blood cells,,25735802,Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.,"Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan",Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity,Linear,L,Free,[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.,Amidation,None,Not found,
5151,DRAMP21093,RFRRLRWKTRWRLKKI,16,PRW4-d (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=8 μM), Staphylococcus epidermidis 12228(MIC=16 μM), Enterococcus faecalis 29212(MIC=4 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=4 μM), Escherichia coli 1005(MIC=8 μM), Salmonella typhimurium 7731(MIC=4 μM)",[Ref.25735802] MHC5>256 μM against human red blood cells,,25735802,Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.,"Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan",Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity,Linear,"Mixed(D-Trp7, D-Trp11)",Free,[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.,Amidation,None,Not found,
5152,DRAMP21094,RFRRLRWRTRWRLRRI,16,PRW4-R (Derived from PRW4),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25735802] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=4 μM), Staphylococcus epidermidis 12228(MIC=4 μM), Enterococcus faecalis 29212(MIC=2 μM);##Gram-negative bacteria : Escherichia coli 25922(MIC=4 μM), Escherichia coli 1005(MIC=2 μM), Salmonella typhimurium 7731(MIC=4 μM)",[Ref.25735802] MHC5>256 μM against human red blood cells,,25735802,Acta Biomater. 2015 May;18:155-67. doi: 10.1016/j.actbio.2015.02.023.,"Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan",Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity,Linear,L,Free,[Ref.25735802] The peptide exhibited no cytoxicity against HaCaT cells in the range of 0/25-256 μM.,Amidation,None,Not found,
5153,DRAMP21095,IRCRRRFCRI,10,IR1 (Derived from PG-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC=64 μM), Staphylococcus epidermidis(MIC=64 μM), Streptococcus faecalis(MIC=64 μM), Bacillus subtilis(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(MIC=8 μM), Salmonella pullorum(MIC=16 μM), Salmonella typhimurium(MIC=128 μM), Bacteriump yocyaneum(MIC=64 μM)",[Ref.24621994] MHC10>128 μM against human red blood cells,,24621994,PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.,"Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang",Antimicrobial potency and selectivity of simplified symmetric-end peptides,Linear,L,Free,[Ref.24621994] No cytotoxicity information found.,Amidation,None,Not found,
5154,DRAMP21096,IRIRCRRRFCRIRI,14,IR2 (Derived from PG-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Beta sheet, beta hairpin",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC=4 μM), Staphylococcus epidermidis(MIC=4 μM), Streptococcus faecalis(MIC=4 μM), Bacillus subtilis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=1 μM), Salmonella pullorum(MIC=1 μM), Salmonella typhimurium(MIC=4 μM), Bacteriump yocyaneum(MIC=4 μM)",[Ref.24621994] MHC10=128 μM against human red blood cells,,24621994,PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.,"Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang",Antimicrobial potency and selectivity of simplified symmetric-end peptides,Linear,L,Free,[Ref.24621994] No cytotoxicity information found.,Amidation,None,Not found,
5155,DRAMP21097,FRCRRRFCRF,10,FR1 (Derived from PG-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC=32 μM), Staphylococcus epidermidis(MIC=16 μM), Streptococcus faecalis(MIC=32 μM), Bacillus subtilis(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Salmonella pullorum(MIC=16 μM), Salmonella typhimurium(MIC=32 μM), Bacteriump yocyaneum(MIC>128 μM)",[Ref.24621994] MHC10>128 μM against human red blood cells,,24621994,PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.,"Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang",Antimicrobial potency and selectivity of simplified symmetric-end peptides,Linear,L,Free,[Ref.24621994] No cytotoxicity information found.,Amidation,None,Not found,
5156,DRAMP21098,FRFRCRRRFCRFRF,14,FR2 (Derived from PG-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC=2 μM), Staphylococcus epidermidis(MIC=2 μM), Streptococcus faecalis(MIC=4 μM), Bacillus subtilis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=1 μM), Salmonella pullorum(MIC=1 μM), Salmonella typhimurium(MIC=2 μM), Bacteriump yocyaneum(MIC=4 μM)",[Ref.24621994] MHC10=64 μM against human red blood cells,,24621994,PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.,"Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang",Antimicrobial potency and selectivity of simplified symmetric-end peptides,Linear,L,Free,[Ref.24621994] No cytotoxicity information found.,Amidation,None,Not found,
5157,DRAMP21099,WRCRRRFCRW,10,WR1 (Derived from PG-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC=8 μM), Staphylococcus epidermidis(MIC=8 μM), Streptococcus faecalis(MIC=8 μM), Bacillus subtilis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=2 μM), Salmonella pullorum(MIC=4 μM), Salmonella typhimurium(MIC=16 μM), Bacteriump yocyaneum(MIC>128 μM)",[Ref.24621994] MHC10>128 μM against human red blood cells,,24621994,PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.,"Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang",Antimicrobial potency and selectivity of simplified symmetric-end peptides,Linear,L,Free,[Ref.24621994] No cytotoxicity information found.,Amidation,None,Not found,
5158,DRAMP21100,WRWRCRRRFCRWRW,14,WR2 (Derived from PG-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC=4 μM), Staphylococcus epidermidis(MIC=2 μM), Streptococcus faecalis(MIC=2 μM), Bacillus subtilis(MIC=1 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Salmonella pullorum(MIC=2 μM), Salmonella typhimurium(MIC=4 μM), Bacteriump yocyaneum(MIC=8 μM)",[Ref.24621994] MHC10=64 μM against human red blood cells,,24621994,PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.,"Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang",Antimicrobial potency and selectivity of simplified symmetric-end peptides,Linear,L,Free,[Ref.24621994] No cytotoxicity information found.,Amidation,None,Not found,
5159,DRAMP21101,PRCRRRFCRP,10,PR1 (Derived from PG-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC>128 μM), Staphylococcus epidermidis(MIC>128 μM), Streptococcus faecalis(MIC>128 μM), Bacillus subtilis(MIC=16 μM);##Gram-negative bacteria : Escherichia coli(MIC=16 μM), Salmonella pullorum(MIC>128 μM), Salmonella typhimurium(MIC>128 μM), Bacteriump yocyaneum(MIC>128 μM)",[Ref.24621994] MHC10>128 μM against human red blood cells,,24621994,PLoS One.2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.,"Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang",Antimicrobial potency and selectivity of simplified symmetric-end peptides,Linear,L,Free,[Ref.24621994] No cytotoxicity information found.,Amidation,None,Not found,
5160,DRAMP21102,PRPRCRRRFCRPRP,14,PR2 (Derived from PG-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC>128 [Ref.24621994] Gram-positive bacteria : Staphylococcus aureus(MIC>128 μM), Staphylococcus epidermidis(MIC>128 μM), Streptococcus faecalis(MIC>128 μM), Bacillus subtilis(MIC=8 μM);##Gram-negative bacteria : Escherichia coli(MIC=16 μM), Salmonella pullorum(MIC>128 μM), Salmonella typhimurium(MIC>128 μM), Bacteriump yocyaneum(MIC>128 μM)",[Ref.24621994] MHC10>128 μM against human red blood cells,,24621994,PLoS One. 2014 Mar 12;9(3):e91007. doi: 10.1371/journal.pone.0091007.,"Na Dong , Xin Zhu , Shuli Chou , Anshan Shan , Weizhong Li , Junguang Jiang",Antimicrobial potency and selectivity of simplified symmetric-end peptides,Linear,L,Free,[Ref.24621994] No cytotoxicity information found.,Amidation,None,Not found,
5161,DRAMP21165,GIMSSLMKKLKKIIKK,16,HYL-11 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=54 μM), Staphylococcus epidermidis(MIC=1.7 μM);##Gram-negative bacteria : Escherichia coli(MIC=22 μM), Pseudomonas aeruginosa 5482(MIC=7.1 μM);##Fungi : Candida albicans(MIC=6.3 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5162,DRAMP21166,GILSSLLKKLKKIIAK,16,HYL-12 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=16 μM), Staphylococcus epidermidis(MIC=1.8 μM);##Gram-negative bacteria : Escherichia coli(MIC=8 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=10 μM)",[Ref.26998557] LC50=284 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5163,DRAMP21164,GIMSSLMKKLAKIIKK,16,HYL-10 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=33 μM), Staphylococcus epidermidis(MIC=2.9 μM);##Gram-negative bacteria : Escherichia coli(MIC=15 μM), Pseudomonas aeruginosa 5482(MIC=5.2 μM);##Fungi : Candida albicans(MIC=7.6 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5164,DRAMP21158,GIMSSLMKKLKKHIAK,16,HYL-4 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC>100 μM), Staphylococcus epidermidis(MIC=10 μM);##Gram-negative bacteria : Escherichia coli(MIC=26 μM), Pseudomonas aeruginosa 5482(MIC=6.4 μM);##Fungi : Candida albicans(MIC=12 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5165,DRAMP21159,GIMISLMKKLAAHIAK,16,HYL-5 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=43 μM), Staphylococcus epidermidis(MIC=8.8 μM);##Gram-negative bacteria : Escherichia coli(MIC=12 μM), Pseudomonas aeruginosa 5482(MIC=47 μM);##Fungi : Candida albicans(MIC=12 μM)",[Ref.26998557] LC50=320 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5166,DRAMP21160,GIMSSLMKKLAAIIAK,16,HYL-6 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=7.2 μM), Staphylococcus epidermidis(MIC=5 μM);##Gram-negative bacteria : Escherichia coli(MIC=3.6 μM), Pseudomonas aeruginosa 5482(MIC=8 μM);##Fungi : Candida albicans(MIC=8.4 μM)",[Ref.26998557] LC50=93 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5167,DRAMP21161,GIMSSLMKKLAKIIAK,16,HYL-7 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=9 μM), Staphylococcus epidermidis(MIC=5 μM);##Gram-negative bacteria : Escherichia coli(MIC=3.7 μM), Pseudomonas aeruginosa 5482(MIC=4.5 μM);##Fungi : Candida albicans(MIC=11 μM)",[Ref.26998557] LC50=88 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5168,DRAMP21162,GIMSSLMKKLKKIIAK,16,HYL-8 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=32 μM), Staphylococcus epidermidis(MIC=1.9 μM);##Gram-negative bacteria : Escherichia coli(MIC=9 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=5.2 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5169,DRAMP21163,GIMSSLMKKLKKIIAK,16,HYL-9 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=13 μM), Staphylococcus epidermidis(MIC=2.2 μM);##Gram-negative bacteria : Escherichia coli(MIC=6.3 μM), Pseudomonas aeruginosa 5482(MIC=3.2 μM);##Fungi : Candida albicans(MIC=8 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,D,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5170,DRAMP21157,GIMSSLMKKLAAHIKK,16,HYL-3 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=85 μM), Staphylococcus epidermidis(MIC=11 μM);##Gram-negative bacteria : Escherichia coli(MIC=20 μM), Pseudomonas aeruginosa 5482(MIC=23 μM);##Fungi : Candida albicans(MIC=5 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5171,DRAMP21156,GIMSSLMKKLAKHIAK,16,HYL-2 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=63 μM), Staphylococcus epidermidis(MIC=6.2 μM);##Gram-negative bacteria : Escherichia coli(MIC=15 μM), Pseudomonas aeruginosa 5482(MIC=7.9 μM);##Fungi : Candida albicans(MIC=14 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5172,DRAMP21155,GIMSSLMKKLKAHIAK,16,HYL-1 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC>100 μM), Staphylococcus epidermidis(MIC=16 μM);##Gram-negative bacteria : Escherichia coli(MIC=30 μM), Pseudomonas aeruginosa 5482(MIC=26 μM);##Fungi : Candida albicans(MIC=23 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5173,DRAMP21154,GIMSSLMKKLAAHIAK,16,"HYL (Bee, Insecta, Animals)",No entry found,Not found,Not found,Solitary wild bee Hylaeus signatus,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=63 μM), Staphylococcus epidermidis(MIC=13 μM);##Gram-negative bacteria : Escherichia coli(MIC=15 μM), Pseudomonas aeruginosa 5482(MIC=20 μM);##Fungi : Candida albicans(MIC=18 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5174,DRAMP21153,KRIRKRIKKWKR,12,KR-12-a8 (Derived from KR-12),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,"The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .Among these peptides, KR-12-a8 had shown the least α-helical structure.",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=2 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=2 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)",[Ref.24105706] HC50>800 μM against human red blood cells,,24105706,J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.,"Jacob B, Park IS, Bang JK, Shin SY",Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.,Linear,L,Free,"[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 91.2%, 112.8%, 104.1%, 114.4%, 104.4%, 109.4%, 107.2% and 82.2% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.",Amidation,None,Not found,
5175,DRAMP21151,LRIVKLILKWLR,12,KR-12-a6 (Derived from KR-12),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix","The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=2 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=16 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=16 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)",[Ref.24105706] HC50=22 μM against human red blood cells,,24105706,J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.,"Jacob B, Park IS, Bang JK, Shin SY",Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.,Linear,L,Free,"[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 100%, 99.1%, 100%, 98.8%, 99.9%, 85.3%, 5.9% and 0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.",Amidation,None,Not found,
5176,DRAMP21150,KRIVKLILKWLR,12,KR-12-a5 (Derived from KR-12),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix","The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)",[Ref.24105706] HC50=96 μM against human red blood cells,,24105706,J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.,"Jacob B, Park IS, Bang JK, Shin SY",Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.,Linear,L,Free,"[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 96.6%, 100.1%, 96.6%, 96.8%, 81.2%, 3.1%, 0% and 0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.",Amidation,None,Not found,
5177,DRAMP21152,KRIRKRIKKWLR,12,KR-12-a7 (Derived from KR-12),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix","The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=4 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)",[Ref.24105706] HC50>800 μM against human red blood cells,,24105706,J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.,"Jacob B, Park IS, Bang JK, Shin SY",Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.,Linear,L,Free,"[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 92.5%, 100.9%, 97.2%, 96.6%, 92.5%, 101.2%, 90.6% and 81.9% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.",Amidation,None,Not found,
5178,DRAMP21149,KRIVKLIKKWLR,12,KR-12-a4 (Derived from KR-12),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix","The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=4 μM), Salmonella typhimurium (KCTC 1926)(MIC=1 μM)",[Ref.24105706] HC50>800 μM against human red blood cells,,24105706,J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.,"Jacob B, Park IS, Bang JK, Shin SY",Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.,Linear,L,Free,"[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 101.9%, 99.9%, 96.6%, 95.6%, 95.3%, 80.9%, 17.8% and 0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.",Amidation,None,Not found,
5179,DRAMP21146,KRIVQRIKDWLR,12,KR-12-a1 (Derived from KR-12),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix","The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)",[Ref.24105706] HC50>800 μM against human red blood cells,,24105706,J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.,"Jacob B, Park IS, Bang JK, Shin SY",Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.,Linear,L,Free,"[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 108.7%, 111.2%, 107.5%, 107.5%, 103.1%, 111.2%, 107.2%, 98.1% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.",Amidation,None,Not found,
5180,DRAMP21148,KRIVKRIKKWLR,12,KR-12-a3 (Derived from KR-12),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix","The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)",[Ref.24105706] HC50>800 μM against human red blood cells,,24105706,J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.,"Jacob B, Park IS, Bang JK, Shin SY",Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.,Linear,L,Free,"[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 104.7%, 111.6%, 105.3%, 108.4%, 111.2%, 104.4%, 108.8% and 95.0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.",Amidation,None,Not found,
5181,DRAMP21147,KRIVQRIKKWLR,12,KR-12-a2 (Derived from KR-12),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix","The CD spectra for all the peptides in 10 mM sodium phosphate buffer (pH 7.2) displayed a negative band at approximately 200 nm, indicating that the structure is random. In presence of 0.1% LPS, all the peptides showed characteristic α-helical CD spectra with two dichroic minimal values at 208 and 222 nm and a positive band near 192 nm .",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.24105706] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=1 μM)",[Ref.24105706] HC50>800 μM against human red blood cells,,24105706,J Pept Sci. 2013 Nov;19(11):700-7. doi: 10.1002/psc.2552.,"Jacob B, Park IS, Bang JK, Shin SY",Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.,Linear,L,Free,"[Ref.24105706] The cell viability of RAW264.7 macrophage cells is 111.9%, 103.4%, 102.2%, 102.2%, 100%, 101.2%, 112.5% and 95.0% at peptide concentrations of 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50 and 100 μM.",Amidation ,None,Not found,
5182,DRAMP21145,RIRWILRYWRWS,12,Myxinidin3 (Derived from Myxinidin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Beta Sheet,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26450121] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=1 μM), Staphylococcus aureus CCARM 3114(MIC=8 μM), Staphylococcus aureus CCARM 3709(MIC=2 μM), Listeria monocytogenes (KCTC 3710)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2 μM), Escherichia coli CCARM 1229(MIC=1 μM), Escherichia coli CCARM 1238(MIC=2 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM), Salmonella typhimurium CCARM 8009(MIC=4 μM), Salmonella typhimurium CCARM 8013(MIC=4 μM), Pseudomonas aeruginosa (ATCC 27853)(MIC=4 μM), Pseudomonas aeruginosa 3592(MIC=8 μM), Pseudomonas aeruginosa 5018(MIC=8 μM)","[Ref.26450121] 27% hemolysis at 50 μM , 45% hemolysis at 100 μM , 63% hemolysis at 200 μM , 59% hemolysis at 400 μM against human red blood cells",,26450121,Amino Acids. 2016 Feb;48(2):505-22. doi: 10.1007/s00726-015-2104-0.,"Han HM, Gopal R, Park Y","Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.",Linear,L,Free,"[Ref.26450121] The cell survial rates of normal human keratinocytes (NHK) are 100%, 95.8%, 88.3%, 83.4%, 77.4% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50, 100 μM. Melittin, the control, induced 100% toxicity against NHKs at a concentration of",Free,None,Not found,
5183,DRAMP21142,HKCAKIKWRGVHVKYCA,17,AMP2041 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix, beta sheet, beta turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.23893489] Gram-positive bacteria : Staphylococcus aureus(MBC=3.71 μg/ml, 1.83 μM), MRSA(MBC=2.25 μg/ml, 1.11 μM), Streptococcus agalactiae(MBC>100 μg/ml, 55 μM);##Gram-negative bacteria : Pseudomonas aeruginosa(MBC=4.35 μg/ml, 2.14 μM), Escherichia coli(MBC=1.79 μg/ml, 0.88 μM), Salmonella enteritidis(MBC=10.41 μg/ml, 5.13 μM), Stenotrophomonas maltophilia(MBC=7.00 μg/ml, 3.45 μM)","[Ref.23893489] <1% hemolysis at 1 μg/ml , <1% hemolysis at 12.5 μg/ml , 5.73% hemolysis at 100 μg/ml , 6.4% hemolysis at 250 μg/ml , 9.4% hemolysis at 500 μg/ml against sheep red blood cells",,23893489,J Pept Sci. 2013 Sep;19(9):554-65. doi: 10.1002/psc.2532.,"Romani AA, Baroni MC, Taddei S, Ghidini F, Sansoni P, Cavirani S, Cabassi CS",In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.,Linear,L,Free,[Ref.23893489] The cytotoxicity (vs control) of P2041 is 6% against HUVEC (endothelial) cells at a peptide concentration of 100 μg/ml. ##The cytotoxicity (vs control) of P2041 is 3% agaisnt WI-38 (fibroblast) cells at a peptide concentration of 100 μg/m,Free,None,Not found,
5184,DRAMP21141,KWCRKWQWRGVKFIKCV,17,AMP126 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix, beta sheet, beta turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.23893489] Gram-positive bacteria : Staphylococcus aureus(MBC=46.5 μg/ml, 20.65 μM), MRSA(MBC>100 μg/ml, 55 μM), Streptococcus agalactiae(MBC=2.81 μg/ml, 1.24 μM);##Gram-negative bacteria : Pseudomonas aeruginosa(MBC=0.40 μg/ml, 0.17 μM), Escherichia coli(MBC=2.22 μg/ml, 0.98 μM), Salmonella enteritidis(MBC=10.8 μg/ml, 4.80 μM), Stenotrophomonas maltophilia(MBC=16.6 μg/ml, 7.37 μM)","[Ref.23893489] <1% hemolysis at 1 μg/ml , <1% hemolysis at 12.5 μg/ml , 5.30% hemolysis at 100 μg/ml , 6.9% hemolysis at 250 μg/ml , 12.5% hemolysis at 500 μg/ml against sheep red blood cells",,23893489,J Pept Sci. 2013 Sep;19(9):554-65. doi: 10.1002/psc.2532.,"Romani AA, Baroni MC, Taddei S, Ghidini F, Sansoni P, Cavirani S, Cabassi CS",In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.,Linear,L,Free,[Ref.23893489] The cytotoxicity (vs control) of P126 is 5% against HUVEC (endothelial) cells at a peptide concentration of 100 μg/ml. ##The cytotoxicity (vs control) of P126 is 6% agaisnt WI-38 (fibroblast) cells at a peptide concentration of 100 μg/ml.,Free,None,Not found,
5185,DRAMP21144,KIKWILKYWKWS,12,Myxinidin2 (Derived from Myxinidin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26450121] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=0.25 μM), Staphylococcus aureus CCARM 3114(MIC=16 μM), Staphylococcus aureus CCARM 3709(MIC=2 μM), Listeria monocytogenes (KCTC 3710)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=1 μM), Escherichia coli CCARM 1229(MIC=2 μM), Escherichia coli CCARM 1238(MIC=4 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM), Salmonella typhimurium CCARM 8009(MIC=8 μM), Salmonella typhimurium CCARM 8013(MIC=16 μM), Pseudomonas aeruginosa (ATCC 27853)(MIC=4 μM), Pseudomonas aeruginosa 3592(MIC=8 μM), Pseudomonas aeruginosa 5018(MIC=4 μM)","[Ref.26450121] 10% hemolysis at 50 μM , 28% hemolysis at 100 μM , 30% hemolysis at 200 μM , 50% hemolysis at 400 μM against human red blood cells",,26450121,Amino Acids. 2016 Feb;48(2):505-22. doi: 10.1007/s00726-015-2104-0.,"Han HM, Gopal R, Park Y","Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.",Linear,L,Free,"[Ref.26450121] The cell survial rates of normal human keratinocytes (NHK) are 100%, 95.8%, 88.3%, 83.4%, 77.4% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50, 100 μM. Melittin, the control, induced 100% toxicity against NHKs at a concentration of",Free,None,Not found,
5186,DRAMP21143,GIHHILKYGKPS,12,Myxinidin1 (Derived from Myxinidin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26450121] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC>32 μM), Staphylococcus aureus CCARM 3114(MIC>32 μM), Staphylococcus aureus CCARM 3709(MIC>32 μM), Listeria monocytogenes (KCTC 3710)(MIC>32 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC>32 μM), Escherichia coli CCARM 1229(MIC>32 μM), Escherichia coli CCARM 1238(MIC>32 μM), Salmonella typhimurium (KCTC 1926)(MIC>32 μM), Salmonella typhimurium CCARM 8009(MIC>32 μM), Salmonella typhimurium CCARM 8013(MIC>32 μM), Pseudomonas aeruginosa (ATCC 27853)(MIC>32 μM), Pseudomonas aeruginosa 3592(MIC>32 μM), Pseudomonas aeruginosa 5018(MIC>32 μM)","[Ref.26450121] 0% hemolysis at 50 μM , 0% hemolysis at 100 μM , 0% hemolysis at 200 μM , 0% hemolysis at 400 μM against human red blood cells",,26450121,Amino Acids. 2016 Feb;48(2):505-22. doi: 10.1007/s00726-015-2104-0.,"Han HM, Gopal R, Park Y","Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.",Linear,L,Free,"[Ref.26450121] The cell survial rates of normal human keratinocytes (NHK) are 100%, 95.8%, 88.3%, 83.4%, 77.4% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50, 100 μM. Melittin, the control, induced 100% toxicity against NHKs at a concentration of",Free,None,Not found,
5187,DRAMP21140,KGCALVKVRGLTLKVCK,17,AMP72 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix, beta sheet, beta turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.23893489] Gram-positive bacteria : Staphylococcus aureus(MBC=6.88 μg/ml, 3.78 μM), MRSA(MBC=1.72 μg/ml, 0.94 μM), Streptococcus agalactiae(MBC>55 μg/ml, 100 μM);##Gram-negative bacteria : Pseudomonas aeruginosa(MBC=3.30 μg/ml, 1.81 μM), Escherichia coli(MBC=3.40 μg/ml, 1.87 μM), Salmonella enteritidis(MBC=3.20 μg/ml, 1.76 μM), Stenotrophomonas maltophilia(MBC=18.5 μg/ml, 10.19 μM)","[Ref.23893489] <1% hemolysis at 1 μg/ml , <1% hemolysis at 12.5 μg/ml , 1.5% hemolysis at 100 μg/ml , 4.2% hemolysis at 250 μg/ml , 12.0% hemolysis at 500 μg/ml against sheep red blood cells",,23893489,J Pept Sci. 2013 Sep;19(9):554-65. doi: 10.1002/psc.2532.,"Romani AA, Baroni MC, Taddei S, Ghidini F, Sansoni P, Cavirani S, Cabassi CS",In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.,Linear,L,Free,[Ref.23893489] The cytotoxicity (vs control) of P72 is 3% against HUVEC (endothelial) cells at a peptide concentration of 100 μg/ml. ##The cytotoxicity (vs control) of P72 is 4% agaisnt WI-38 (fibroblast) cells at a peptide concentration of 100 μg/ml. #,Free,None,Not found,
5188,DRAMP21139,RLLRPLLQLLKQKLR,15,GNU7 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisiae","[Ref.23946320] Gram-positive bacteria : Bacillus subtilis(MIC=2 mg/L), Enterococcus faecalis(MIC=2 mg/L), Micrococcus luteus(MIC=2 mg/L), Staphylococcus aureus(MIC=2 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=2 mg/L), Pseudomonas aeruginosa(MIC=2 mg/L), Salmonella typhimurium(MIC=2 mg/L);##Fungi : Candida albicans(MIC=2 mg/L), Cryptococcus neoformans(MIC=2 mg/L), Saccharomyces cerevisiae(MIC=4 mg/L)",[Ref.23946320] 0% hemolysis at 140 mg/L against human red blood cells,,23946320,J Antimicrob Chemother. 2014 Jan;69(1):121-32. doi: 10.1093/jac/dkt322.,"Hyun Kim, Ju Hye Jang, Sun Chang Kim and Ju Hyun Cho",De novo generation of short antimicrobial peptides with enhanced stability and cell specificity,Linear,L,Free,"[Ref.23946320] The cell viability of hPBMCs is at peptide concentrations of 4, 8, 16, 32, 64 μg/ml",Free,None,Not found,
5189,DRAMP21138,RIIRPIIQIIKQKIR,15,GNU6 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisiae","[Ref.23946320] Gram-positive bacteria : Bacillus subtilis(MIC=2 mg/L), Enterococcus faecalis(MIC=2 mg/L), Micrococcus luteus(MIC=2 mg/L), Staphylococcus aureus(MIC=2 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=4 mg/L), Pseudomonas aeruginosa(MIC=2 mg/L), Salmonella typhimurium(MIC=4 mg/L);##Fungi : Candida albicans(MIC=2 mg/L), Cryptococcus neoformans(MIC=2 mg/L), Saccharomyces cerevisiae(MIC=4 mg/L)",[Ref.23946320] 0% hemolysis at 140 mg/L against human red blood cells,,23946320,J Antimicrob Chemother. 2014 Jan;69(1):121-32. doi: 10.1093/jac/dkt322.,"Hyun Kim, Ju Hye Jang, Sun Chang Kim and Ju Hyun Cho",De novo generation of short antimicrobial peptides with enhanced stability and cell specificity,Linear,L,Free,"[Ref.23946320] The cell viability of hPBMCs is 102.6%, 102.6%, 107.9%, 96.8% and 97.9% at peptide concentrations of 4, 8, 16, 32, 64 μg/ml",Free,None,Not found,
5190,DRAMP21137,RVVRPVVQVVKQKVR,15,GNU5 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Cryptococcus neoformans, Saccharomyces cerevisiae","[Ref.23946320] Gram-positive bacteria : Bacillus subtilis(MIC=16 mg/L), Enterococcus faecalis(MIC=8 mg/L), Micrococcus luteus(MIC=2 mg/L), Staphylococcus aureus(MIC=4 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=32 mg/L), Pseudomonas aeruginosa(MIC=8 mg/L), Salmonella typhimurium(MIC>64 mg/L);##Fungi : Candida albicans(MIC=2 mg/L), Cryptococcus neoformans(MIC=2 mg/L), Saccharomyces cerevisiae(MIC=2 mg/L)",[Ref.23946320] 0% hemolysis at 140 mg/L against human red blood cells,,23946320,J Antimicrob Chemother. 2014 Jan;69(1):121-32. doi: 10.1093/jac/dkt322.,"Hyun Kim, Ju Hye Jang, Sun Chang Kim and Ju Hyun Cho",De novo generation of short antimicrobial peptides with enhanced stability and cell specificity,Linear,L,Free,"[Ref.23946320] The cell viability of hPBMCs is at peptide concentrations of 4, 8, 16, 32, 64 μg/ml",Free,None,Not found,
5191,DRAMP21135,RRWWHWWRR,9,P7 (Derived from P5),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=4.33 μM, MBC=16 μM), Staphylococcus aureus(MIC=11.3 μM, MBC=128 μM);##Gram-negative bacteria : Escherichia coli(MIC=8.67 μM, MBC=128 μM)",[Ref.28372989] MHC5=86.67 μM against human red blood cells,,28372989,Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.,"Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M",Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.,Linear,L,Free,"[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 102.4%, 99.2%, 112.8%, 107.2% and 85.2% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.",Amidation,None,Not found,
5192,DRAMP21136,HRWWRWWRH,9,P8 (Derived from P5),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=1 μM, MBC=1 μM), Staphylococcus aureus(MIC=16 μM, MBC=32 μM);##Gram-negative bacteria : Escherichia coli(MIC=8 μM, MBC=32 μM)",[Ref.28372989] MHC5=86.67 μM against human red blood cells,,28372989,Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.,"Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M",Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.,Linear,L,Free,"[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 96%, 98.4%, 86.8%, 84.8% and 88.8% and  at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.",Amidation,None,Not found,
5193,DRAMP21134,HRWWRWWRR,9,P6 (Derived from P5),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=1 μM, MBC=1 μM), Staphylococcus aureus(MIC=8 μM, MBC=8 μM);##Gram-negative bacteria : Escherichia coli(MIC=8 μM, MBC=32 μM)",[Ref.28372989] MHC5=86.67 μM against human red blood cells,,28372989,Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.,"Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M",Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.,Linear,L,Free,"[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 92.4%, 83.2%, 82.4%, 76% and 68% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.",Amidation,None,Not found,
5194,DRAMP21133,RRWWRWWRR,9,P5 (Derived from Octa 2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=1 μM, MBC=1 μM), Staphylococcus aureus(MIC=5.6 μM, MBC=8 μM);##Gram-negative bacteria : Escherichia coli(MIC=3 μM, MBC=16 μM)",[Ref.28372989] MHC5=33.33 μM against human red blood cells,,28372989,Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.,"Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M",Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.,Linear,L,Free,"[Ref.28372989] IC50 = 86.67 μM for hPBMCs. The cell viability of hPBMCs is 98%, 96%, 89.6%, 78%, 92.8% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.",Amidation,None,Not found,
5195,DRAMP21132,RRWHRHWRR,9,P4 (Derived from P5),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=2 μM, MBC=8 μM), Staphylococcus aureus(MIC=128 μM, MBC=128 μM);##Gram-negative bacteria : Escherichia coli(MIC=40 μM, MBC>128 μM)",[Ref.28372989] MHC5>86.67 μM against human red blood cells,,28372989,Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.,"Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M",Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.,Linear,L,Free,"[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 90.8%, 94.1%, 92%, 95.6% and 86.5% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.",Amidation,None,Not found,
5196,DRAMP21131,RRHWRWWRR,9,P3 (Derived from P5),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=7.3 μM, MBC=64 μM), Staphylococcus aureus(MIC=40 μM, MBC>128 μM);##Gram-negative bacteria : Escherichia coli(MIC=26 μM, MBC=128 μM)",[Ref.28372989] MHC5>86.67 μM against human red blood cells,,28372989,Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.,"Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M",Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.,Linear,L,Free,"[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 99.6%, 97.6%, 100%, 99.6% and 93.2% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.",Amidation,None,Not found,
5197,DRAMP21130,RRWHRWWRR,9,P2 (Derived from P5),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=5.2 μM, MBC=32 μM), Staphylococcus aureus(MIC=25.6 μM, MBC=128 μM);##Gram-negative bacteria : Escherichia coli(MIC=14.4 μM, MBC>128 μM)",[Ref.28372989] MHC5>86.67 μM against human red blood cells,,28372989,Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.,"Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M",Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.,Linear,L,Free,"[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 99.6%, 98%, 95.6%, 98.8% and 90.4% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.",Amidation,None,Not found,
5198,DRAMP21129,RRWWRHWRR,9,P1 (Derived from P5),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28372989] Gram-positive bacteria : Bacillus subtilis(MIC=10 μM, MBC=32 μM), Staphylococcus aureus(MIC=48 μM, MBC>128 μM);##Gram-negative bacteria : Escherichia coli(MIC=21.33 μM, MBC=128 μM)",[Ref.28372989] MHC5>86.67 μM against human red blood cells,,28372989,Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1844-1854. doi: 10.1016/j.bbagen.2017.03.024.,"Bacalum M, Janosi L, Zorila F, Tepes AM, Ionescu C, Bogdan E, Hadade N, Craciun L, Grosu I, Turcu I, Radu M",Modulating short tryptophan- and arginine-rich peptides activity by substitution with histidine.,Linear,L,Free,"[Ref.28372989] IC50 > 86.67 μM for hPBMCs. The cell viability of hPBMCs is 104.0%, 107.6%, 112.4%, 101.6% and 93.2% at peptide concentrations of 0.33, 0.67, 6.67, 12.33 and 86.67 μM.",Amidation,None,Not found,
5199,DRAMP21128,RFRRLRKKFRKRLKKI,16,T9F (Derived from RI16),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=128 μM), Staphylococcus epidermidis 12228(MIC=32 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=64 μM), Salmonella typhimurium 7731(MIC=128 μM), Pseudomonas aeruginosa 27853(MIC=256 μM), Pseudomonas aeruginosa 10419(MIC=256 μM), Pseudomonas aeruginosa 21625(MIC=256 μM), Pseudomonas aeruginosa 21630(MIC=256 μM), Pseudomonas aeruginosa LC(MIC=64 μM), Pseudomonas aeruginosa LCCI(MIC=256 μM), Pseudomonas aeruginosa LCGE(MIC=256 μM), Pseudomonas aeruginosa LCCE(MIC=256 μM)",[Ref.25494332] HC50>256 μM against human red blood cells,,25494332,PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.,"Zhu X, Ma Z, Wang J, Chou S, Shan A",Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.,Linear,L,Free,[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM,Amidation,None,Not found,
5200,DRAMP21127,RFRRLRKKKRKRLKKI,16,T9K (Derived from RI16),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=128 μM), Staphylococcus epidermidis 12228(MIC=128 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=128 μM), Salmonella typhimurium 7731(MIC=256 μM), Pseudomonas aeruginosa 27853(MIC=128 μM), Pseudomonas aeruginosa 10419(MIC=256 μM), Pseudomonas aeruginosa 21625(MIC=256 μM), Pseudomonas aeruginosa 21630(MIC=256 μM), Pseudomonas aeruginosa LC(MIC=256 μM), Pseudomonas aeruginosa LCCI(MIC=256 μM), Pseudomonas aeruginosa LCGE(MIC=256 μM), Pseudomonas aeruginosa LCCE(MIC=256 μM)",[Ref.25494332] HC50>256 μM against human red blood cells,,25494332,PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.,"Zhu X, Ma Z, Wang J, Chou S, Shan A",Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.,Linear,L,Free,[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM,Amidation,None,Not found,
5201,DRAMP21126,RFRRLRKKIRKRLKKI,16,T9I (Derived from RI16),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=256 μM), Staphylococcus epidermidis 12228(MIC=32 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=128 μM), Salmonella typhimurium 7731(MIC=256 μM), Pseudomonas aeruginosa 27853(MIC=256 μM), Pseudomonas aeruginosa 10419(MIC=256 μM), Pseudomonas aeruginosa 21625(MIC=256 μM), Pseudomonas aeruginosa 21630(MIC=256 μM), Pseudomonas aeruginosa LC(MIC=64 μM), Pseudomonas aeruginosa LCCI(MIC=256 μM), Pseudomonas aeruginosa LCGE(MIC=256 μM), Pseudomonas aeruginosa LCCE(MIC=256 μM)",[Ref.25494332] HC50>256 μM against human red blood cells,,25494332,PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.,"Zhu X, Ma Z, Wang J, Chou S, Shan A",Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.,Linear,L,Free,[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM,Amidation,None,Not found,
5202,DRAMP21125,RFRRLRKKWRKRLKKI,16,T9W (Derived from RI16),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=128 μM), Staphylococcus epidermidis 12228(MIC=64 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=64 μM), Salmonella typhimurium 7731(MIC=128 μM), Pseudomonas aeruginosa 27853(MIC=2 μM), Pseudomonas aeruginosa 10419(MIC=4 μM), Pseudomonas aeruginosa 21625(MIC=4 μM), Pseudomonas aeruginosa 21630(MIC=4 μM), Pseudomonas aeruginosa LC(MIC=1 μM), Pseudomonas aeruginosa LCCI(MIC=2 μM), Pseudomonas aeruginosa LCGE(MIC=4 μM), Pseudomonas aeruginosa LCCE(MIC=4 μM)",[Ref.25494332] HC50>256 μM against human red blood cells,,25494332,PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.,"Zhu X, Ma Z, Wang J, Chou S, Shan A",Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.,Linear,L,Free,[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM,Amidation,None,Not found,
5203,DRAMP21124,RFRRLRKKTRKRLKKI,16,RI16 (Derived from PMAP-36),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25494332] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=128 μM), Staphylococcus epidermidis 12228(MIC=32 μM), ;##Gram-negative bacteria : Escherichia coli 25922(MIC=128 μM), Salmonella typhimurium 7731(MIC=128 μM), Pseudomonas aeruginosa 27853(MIC=256 μM), Pseudomonas aeruginosa 10419(MIC=256 μM), Pseudomonas aeruginosa 21625(MIC=256 μM), Pseudomonas aeruginosa 21630(MIC=256 μM), Pseudomonas aeruginosa LC(MIC=32 μM), Pseudomonas aeruginosa LCCI(MIC=256 μM), Pseudomonas aeruginosa LCGE(MIC=256 μM), Pseudomonas aeruginosa LCCE(MIC=256 μM)",[Ref.25494332] HC50>256 μM against human red blood cells,,25494332,PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605.,"Zhu X, Ma Z, Wang J, Chou S, Shan A",Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.,Linear,L,Free,[Ref.25494332] The LD50 of J774.1 macrophage cells is larger than 256 μM,Amidation,None,Not found,
5204,DRAMP21123,KRIVKLLLKWLR,12,KR-12-a5 (7-(D)L) (Derived from LL-37),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28525841] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)",[Ref.28525841] MHC10=111 μM against human red blood cells,,28525841,Eur J Med Chem. 2017 Aug 18;136:428-441. doi: 10.1016/j.ejmech.2017.05.028.,"Kim EY, Rajasekaran G, Shin SY","LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.",Linear,Mixed(7 is D),Free,"[Ref.28525841] The cell viability of mouse macrophage RAW264.7 cells is 100%, 97.4%, 98.1%, 93.6%, 100.8%, 104.5% and 104.5% at peptide concentrations of 0, 4, 8, 16, 32, 64, 128 and 256 μM",Amidation,None,Not found,
5205,DRAMP21122,KRIVKLILKWLR,12,KR-12-a5 (6-(D)L) (Derived from LL-37),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28525841] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=4 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)",[Ref.28525841] MHC10=202 μM against human red blood cells,,28525841,Eur J Med Chem. 2017 Aug 18;136:428-441. doi: 10.1016/j.ejmech.2017.05.028.,"Kim EY, Rajasekaran G, Shin SY","LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.",Linear,Mixed(6 is D),Free,"[Ref.28525841] The cell viability of mouse macrophage RAW264.7 cells is 100%, 101.9%, 118.9%, 107.5%, 111.3%, 110.6% and 110.6% at peptide concentrations of 0, 4, 8, 16, 32, 64, 128 and 256 μM",Amidation,None,Not found,
5206,DRAMP21121,KRIVKLILKWLR,12,KR-12-a5 (5-(D)K) (Derived from LL-37),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28525841] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)",[Ref.28525841] MHC10=79 μM against human red blood cells,,28525841,Eur J Med Chem. 2017 Aug 18;136:428-441. doi: 10.1016/j.ejmech.2017.05.028.,"Kim EY, Rajasekaran G, Shin SY","LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.",Linear,Mixed(5 is D),Free,"[Ref.28525841] The cell viability of mouse macrophage RAW264.7 cells is 100%, 103.4%, 116.6%, 118.9%, 115.1%, 107.9% and 105.7% at peptide concentrations of 0, 4, 8, 16, 32, 64, 128 and 256 μM",Amidation,None,Not found,
5207,DRAMP21119,KWCFRVCYRGRCYRRCR,17,I11R (Derived from tachyplesin I),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=1.56 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=1.56 μM), Pseudomonas aeruginosa PAO1(MIC=6.25 μM)",[Ref.26549611] MHC2=180 μM against human red blood cells,,26549611,Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.,"Panteleev PV, Ovchinnikova TV",Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Linear,L,Free,[Ref.26549611] No cytotoxicity information found.,Amidation,None,Not found,
5208,DRAMP21120,KRIVKLILKWLR,12,KR-12-a5 (Derived from LL-37),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28525841] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)",[Ref.28525841] MHC10=25 μM against human red blood cells,,28525841,Eur J Med Chem. 2017 Aug 18;136:428-441. doi: 10.1016/j.ejmech.2017.05.028.,"Kim EY, Rajasekaran G, Shin SY","LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.",Linear,L,Free,"[Ref.28525841] The cell viability of mouse macrophage RAW264.7 cells is 100%, 116.6%, 112.1%, 115.1%, 112.8%, 106.8% and 108.3% at peptide concentrations of 0, 4, 8, 16, 32, 64, 128 and 256 μM",Amidation,None,Not found,
5209,DRAMP21118,KWCFRVCYRGSCYRRCR,17,I11S (Derived from tachyplesin I),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=0.8 μM), Pseudomonas aeruginosa PAO1(MIC=3.13 μM)",[Ref.26549611] MHC2=190 μM against human red blood cells,,26549611,Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.,"Panteleev PV, Ovchinnikova TV",Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Linear,L,Free,"[Ref.26549611] The cell viability of human embryonic fibroblasts HEF is 90.6%, 92.9%, 84.1%, 70.6% and 34.1% at peptide concentrations of 6.25, 12.5, 25, 50 and 100 μM.",Amidation,None,Not found,
5210,DRAMP21117,KWCFRVCRRGICYRRCR,17,Y8R (Derived from tachyplesin I),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=1.56 μM), Pseudomonas aeruginosa PAO1(MIC=6.25 μM)",[Ref.26549611] MHC2=195 μM against human red blood cells,,26549611,Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.,"Panteleev PV, Ovchinnikova TV",Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Linear,L,Free,[Ref.26549611] No cytotoxicity information found.,Amidation,None,Not found,
5211,DRAMP21116,KWCFRVCSRGICYRRCR,17,Y8S (Derived from tachyplesin I),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=3.13 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=0.8 μM), Pseudomonas aeruginosa PAO1(MIC=3.13 μM)",[Ref.26549611] MHC2=310 μM against human red blood cells,,26549611,Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.,"Panteleev PV, Ovchinnikova TV",Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Linear,L,Free,"[Ref.26549611] The cell viability of human embryonic fibroblasts HEF is 100%, 92.9%, 87.1%, 72.9%, 60.0% and 45.0% at peptide concentrations of 0, 6.25, 12.5, 25, 50 and 100 μM.",Amidation,None,Not found,
5212,DRAMP21115,KWCFRRCYRGICYRRCR,17,V6R (Derived from tachyplesin I),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC>50 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=1.56 μM), Pseudomonas aeruginosa PAO1(MIC>50 μM)",[Ref.26549611] MHC2=200 μM against human red blood cells,,26549611,Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.,"Panteleev PV, Ovchinnikova TV",Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Linear,L,Free,[Ref.26549611] No cytotoxicity information found.,Amidation,None,Not found,
5213,DRAMP21114,KWCFRSCYRGICYRRCR,17,V6S (Derived from tachyplesin I),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26549611] Gram-positive bacteria : Staphylococcus aureus 209P(MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli C600(MIC=1.56 μM), Pseudomonas aeruginosa PAO1(MIC=12.5 μM)",[Ref.26549611] MHC2=280 μM against human red blood cells,,26549611,Biotechnol Appl Biochem. 2017 Jan;64(1):35-42. doi: 10.1002/bab.1456.,"Panteleev PV, Ovchinnikova TV",Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Linear,L,Free,[Ref.26549611] No cytotoxicity information found.,Amidation,None,Not found,
5214,DRAMP21111,LRRAARWARRLLRR,14,ASA (Derived from SLZP),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Sporothrix schenckii, Trichophyton mentagrophytes, Aspergillus fumigatus, Candida parapsilosis","[Ref.25069749] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=3.15 μg/ml), Bacillus cereus(MIC=3.15 μg/ml);##Gram-negative bacteria : E. coli (ATCC 9637)(MIC=25 μg/ml), Pseudomonas aeruginosa (ATCC BAA-427)(MIC=25 μg/ml), Klebsiella pneumoniae (ATCC 27736)(MIC=6.25 μg/ml);##Fungi : Sporothrix schenckii(MIC=12.5 μg/ml), Trichophyton mentagrophytes(MIC=100 μg/ml), Aspergillus fumigatus(MIC=50 μg/ml), Candida parapsilosis (ATCC 22019)(MIC=12.5 μg/ml)","[Ref.25069749] 3% hemolysis at 10 μg/ml , 5% hemolysis at 20 μg/ml , 7.5% hemolysis at 30 μg/ml , 10% hemolysis at 40 μg/ml , 12% hemolysis at 50 μg/ml , 13% hemolysis at 60 μg/ml , 15% hemolysis at 70 μg/ml , 19% hemolysis at 80 μg/ml against human red blood cells",,25069749,Amino Acids. 2014 Nov;46(11):2531-43. doi: 10.1007/s00726-014-1802-3.,"Ahmad A, Azmi S, Srivastava S, Kumar A, Tripathi JK, Mishra NN, Shukla PK, Ghosh JK",Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms,Linear,L,Free,"[Ref.25069749] The cell viability of murine fibroblast cells (3T3) is 100%, 93.6%, 86.8%, 82.9%, 80% and 77.9% at peptide concentrations of 1.5, 3, 4.5, 6 and 9 μM.",Amidation,None,Not found,
5215,DRAMP21112,LRRLLRWLRRLLRR,14,DLSA (Derived from SLZP),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Sporothrix schenckii, Trichophyton mentagrophytes, Aspergillus fumigatus, Candida parapsilosis","[Ref.25069749] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=3.15 μg/ml), Bacillus cereus(MIC=3.15 μg/ml);##Gram-negative bacteria : E. coli (ATCC 9637)(MIC=12.5 μg/ml), Pseudomonas aeruginosa (ATCC BAA-427)(MIC=12.5 μg/ml), Klebsiella pneumoniae (ATCC 27736)(MIC=6.25 μg/ml);##Fungi : Sporothrix schenckii(MIC=6.25 μg/ml), Trichophyton mentagrophytes(MIC=12.5 μg/ml), Aspergillus fumigatus(MIC=6.25 μg/ml), Candida parapsilosis (ATCC 22019)(MIC=12.5 μg/ml)",[Ref.25069749] 0% hemolysis at 80 μg/ml against human red blood cells,,25069749,Amino Acids. 2014 Nov;46(11):2531-43. doi: 10.1007/s00726-014-1802-3.,"Ahmad A, Azmi S, Srivastava S, Kumar A, Tripathi JK, Mishra NN, Shukla PK, Ghosh JK",Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms,Linear,"Mixed(4, 5, 8 is D)",Free,"[Ref.25069749] The cell viability of murine fibroblast cells (3T3) is 84.8%, 83.4%, 76.9%, 72.1% and 62.8% at peptide concentrations of 1.5, 3, 4.5, 6 and 9 μM.",Amidation,None,Not found,
5216,DRAMP21113,LRRPPRWPRRLLRR,14,PSA (Derived from SLZP),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Sporothrix schenckii, Trichophyton mentagrophytes, Aspergillus fumigatus, Candida parapsilosis","[Ref.25069749] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=12.5 μg/ml), Bacillus cereus(MIC>100 μg/ml);##Gram-negative bacteria : E. coli (ATCC 9637)(MIC=25 μg/ml), Pseudomonas aeruginosa (ATCC BAA-427)(MIC=100 μg/ml), Klebsiella pneumoniae (ATCC 27736)(MIC=12.5 μg/ml);##Fungi : Sporothrix schenckii(MIC=100 μg/ml), Trichophyton mentagrophytes(MIC>100 μg/ml), Aspergillus fumigatus(MIC>100 μg/ml), Candida parapsilosis (ATCC 22019)(MIC>100 μg/ml)",[Ref.25069749] 0% hemolysis at 80 μg/ml against human red blood cells,,25069749,Amino Acids. 2014 Nov;46(11):2531-43. doi: 10.1007/s00726-014-1802-3.,"Ahmad A, Azmi S, Srivastava S, Kumar A, Tripathi JK, Mishra NN, Shukla PK, Ghosh JK",Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms,Linear,L,Free,"[Ref.25069749] The cell viability of murine fibroblast cells (3T3) is 100%, 100%, 100%, 99.9%, 84.8% and 82.1% at peptide concentrations of 1.5, 3, 4.5, 6 and 9 μM.",Amidation,None,Not found,
5217,DRAMP21103,RWTWRGSGRWTWR,13,L-RW (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.25683050] Gram-positive bacteria : Staphylococcus aureus(MIC=8 μg/ml), Micrococcus luteus(MIC=16 μg/ml), Bacillus subtilis(MIC=16 μg/ml);##Gram-negative bacteria : Escherichia coli(MIC=16 μg/ml), Pseudomonas aeruginosa(MIC=125 μg/ml), Acinetobacter baumannii(MIC=32 μg/ml), Stenotrophomonas maltophilia(MIC>500 μg/ml)","[Ref.25683050] 0% hemolysis at 8 mg/L , 3.25% hemolysis at 16 mg/L , 0% hemolysis at 32mg/L  , 0% hemolysis at 64 mg/L , 0% hemolysis at 125 mg/L , 0% hemolysis at  mg/L , 2.5%  hemolysis at 500 mg/L against rabbit red blood cells",,25683050,J Pept Sci. 2015 Apr;21(4):274-82. doi: 10.1002/psc.2728. ,"Lanlan Yu, Qiannan Fan, Xiu Yue, Yexuan Maoa and Lingbo Qu",Activity of a novel-designed antimicrobial peptide and its interaction with lipids,Linear,L,Acylation (Conjugated with acetyl group),"[Ref.25683050] The inhibition ratio of I-RW against human bronchial epithelial cell line BEAS-2B cells is 11.3%, 2.1%, 0.5%, 6.2%, 1.5%, 8.2%, 37.4% and 51.8% at peptide concentrations of 2.5, 5, 10, 20, 40, 80, 160 and 320 μg/ml",Amidation,None,Not found,
5218,DRAMP21110,LRRLLRWLRRLLRR,14,SLZP (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Sporothrix schenckii, Trichophyton mentagrophytes, Aspergillus fumigatus, Candida parapsilosis","[Ref.25069749] Gram-positive bacteria : Staphylococcus aureus (ATCC 25923)(MIC=1.56 μg/ml), Bacillus cereus(MIC=3.15 μg/ml);##Gram-negative bacteria : E. coli (ATCC 9637)(MIC=25 μg/ml), Pseudomonas aeruginosa (ATCC BAA-427)(MIC=25 μg/ml), Klebsiella pneumoniae (ATCC 27736)(MIC=3.15 μg/ml);##Fungi : Sporothrix schenckii(MIC=3.15 μg/ml), Trichophyton mentagrophytes(MIC=6.25 μg/ml), Aspergillus fumigatus(MIC=6.25 μg/ml), Candida parapsilosis (ATCC 22019)(MIC=6.25 μg/ml)","[Ref.25069749] 15% hemolysis at 10 μg/ml , 25% hemolysis at 20 μg/ml , 30% hemolysis at 30 μg/ml , 40% hemolysis at 40 μg/ml , 50% hemolysis at 50 μg/ml , 55% hemolysis at 60 μg/ml , 70% hemolysis at 70 μg/ml , 80% hemolysis at 80μg/ml against human red blood cells",,25069749,Amino Acids. 2014 Nov;46(11):2531-43. doi: 10.1007/s00726-014-1802-3.,"Ahmad A, Azmi S, Srivastava S, Kumar A, Tripathi JK, Mishra NN, Shukla PK, Ghosh JK",Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms,Linear,L,Free,"[Ref.25069749] The cell viability of murine fibroblast cells (3T3) is 85.9%, 77.5%, 73.7%, 50.0%, 23.7% and 0% at peptide concentrations of 1.5, 3, 4.5, 6 and 9 μM.",Amidation,None,Not found,
5219,DRAMP21109,GIGGALLSAKAALGLAKGLAEHFAN,25,"FPA-Bombinin-BO (toads, amphibians, animals)",No entry found,Not found,Not found,"Asian bombinid toad species, Bombina orientalis","Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.25056849] Gram-positive bacteria : Staphylococcus aureus(MIC=7 μM, MBC=14 μM);##Gram-negative bacteria : Escherichia coli(MIC=14 μM, MBC=14 μM);##Fungi : Candida albicans(MIC=7 μM, MBC=14 μM)",[Ref.25056849] 100% hemolysis at 125 mg/L against horse red blood cells,,25056849,Chem Biol Drug Des. 2015 Mar;85(3):259-67. doi: 10.1111/cbdd.12396.,"Xiaojuan Hou, Qiang Du, Renjie Li, Mei Zhou, Hui Wang, Lei Wang, Can Guo, Tianbao Chen and Chris Shaw","Feleucin-BO1: A Novel Antimicrobial Non-Apeptide Amide from the Skin Secretion of the Toad, Bombina orientalis, and Design of a Potent Broad-Spectrum Synthetic Analogue, Feleucin-K3",Linear,L,Free,[Ref.25056849] No cytotoxicity information found,Amidation,None,Not found,
5220,DRAMP21108,FLKLLKKLL,9,Feleucin-K3 (Derived from Feleucin-BO1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,"In F-K3, these latter residues are substituted with Lys (K) residues, whose side-chains occupied the same positions, producing a model cationic amphipathic character in this analogue.",None,Function: Antibacterial activity against Gram-positive bacteria,"[Ref.25056849] Gram-positive bacteria : Staphylococcus aureus(MIC=34 μM, MBC=128 μM)",[Ref.25056849] 100% hemolysis at >250 mg/L against horse red blood cells,,25056849,Chem Biol Drug Des. 2015 Mar;85(3):259-67. doi: 10.1111/cbdd.12396.,"Xiaojuan Hou, Qiang Du, Renjie Li, Mei Zhou, Hui Wang2, Lei Wang2, Can Guo, Tianbao Chen and Chris Shaw","Feleucin-BO1: A Novel Antimicrobial Non-Apeptide Amide from the Skin Secretion of the Toad, Bombina orientalis, and Design of a Potent Broad-Spectrum Synthetic Analogue, Feleucin-K3",Linear,L,Free,[Ref.25056849] No cytotoxicity information found,Amidation,None,Not found,
5221,DRAMP21104,GIGGALLNVGKVALKGLAKGLAEHFAN,27,"Feleucin-2 (toads, amphibians, animals)",X5JB11 ,Belongs to the bombinin family.,feleucin-2,Bombina variegata (Yellow-bellied toad),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.25003126] Gram-positive bacteria : Staphylococcus aureus(MIC=8 mg/L, MBC=32 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=32 mg/L, MBC=32 mg/L);##Fungi : Candida albicans(MIC=32 mg/L, MBC=32 mg/L)",[Ref.25003126] 100% hemolysis at 64 mg/L against horse red blood cells,,25003126,Biomed Res Int. 2014;2014:671362. doi: 10.1155/2014/671362.,"Bing Bai, Xiaojuan Hou, Lei Wang, Lilin Ge, Yu Luo, Chengbang Ma, Mei Zhou, Jinao Duan, Tianbao Chen, and Chris Shaw",Feleucins: Novel Bombinin Precursor-Encoded Nonapeptide Amides from the Skin Secretion of Bombina variegata,Linear,L,Free,[Ref.25003126] No cytotoxicity information found,Amidation,None,Not found,
5224,DRAMP21107,FLGLLGSLL,9,"Feleucin-BO1 (toads, amphibians, animals)",No entry found,Not found,Not found,"Asian bombinid toad species, Bombina orientalis","Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Not found,Alpha helix,"The Phe (F) and Leu (L) residue side-chains are oriented on one side of the peptide In feleucin-BO1, while the short side-chains of the hydrophilic Gly (G) and Ser (S) residues are oriented on the other.",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.25056849] Gram-positive bacteria : Staphylococcus aureus(MIC=3 μM, MBC=6 μM);##Gram-negative bacteria : Escherichia coli(MIC=12 μM, MBC=25 μM);##Fungi : Candida albicans(MIC=6 μM, MBC=12 μM)",[Ref.25056849] 100% hemolysis at 80 mg/L against horse red blood cells,,25056849,Chem Biol Drug Des. 2015 Mar;85(3):259-67. doi: 10.1111/cbdd.12396.,"Xiaojuan Hou, Qiang Du, Renjie Li, Mei Zhou, Hui Wang, Lei Wang, Can Guo, Tianbao Chen and Chris Shaw","Feleucin-BO1: A Novel Antimicrobial Non-Apeptide Amide from the Skin Secretion of the Toad, Bombina orientalis, and Design of a Potent Broad-Spectrum Synthetic Analogue, Feleucin-K3",Linear,L,Free,[Ref.25056849] No cytotoxicity information found,Amidation,None,Not found,
5225,DRAMP21232,GIMDTVKNAAKNLAGQLLDKLKCKITAC,28,"Ranatuerin-2PLx (R2PLx; Frogs, Amphibians, Animals)",A0A3P8MS06,Belongs to the frog skin active peptide (FSAP) family. Brevinin subfamily.,Not found,Lithobates palustris (Pickerel frog) (Rana palustris),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Transcript level,"Random coil, alpha helix",The CD spectra of both peptides shows the pattern of random coil in aqueous solution and a typical α-helix CD spectra in 50% of TFE solution.,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.30279210] Gram-positive bacteria : Staphylococcus aureus(NCTC 10788)(MIC=32 μM, MBC=128 μM), MRSA (ATCC 12493)(MIC=256 μM, MBC=512 μM), Enterococcus faecalis(NCTC 12697)(MIC=128 μM, MBC=512 μM);##Gram-negative bacteria : Escherichia coli(NCTC 10418)(MIC=32 μM, MBC=64 μM), Pseudomonas aeruginosa(ATCC 27853)(MIC>512 μM, MBC>512 μM);##Fungi : Candida albicans(NCTC 1467)(MIC=256 μM, MBC=512 μM)","[Ref.30279210] 0% hemolysis at 4 μM , 1% hemolysis at 8 μM , 5% hemolysis at 16 μM , 10% hemolysis at 32 μM , 13% hemolysis at 64 μM , 20% hemolysis at 128 μM , 30% hemolysis at 256 μM , 44% hemolysis at 512 μM against human red blood cells",,30279210,Biosci Rep. 2018 Nov 9;38(6). pii: BSR20180710. doi: 10.1042/BSR20180710.,"Chen X, Zhang L, Ma C, Zhang Y, Xi X, Wang L, Zhou M, Burrows JF, Chen T","A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells.",Linear,L,Free,[Ref.30279210] No cytotoxicity information found,Free,None,Not found,
5226,DRAMP21231,KKKKKKNGFAAWGAFGA,17,S-6K-F17-3GN (Derived from S-6K-F17),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Not found,"Substitutions with polar, known ‘helix-breaker’ Gly residues led to losses in helical character until finally the peptide containing 3 Gly and 1 Asn (S- 6K-F17-3GN) shows a severe loss in helical structure.",None,Function: Antibacterial activity against Gram-negative bacteria,[Ref.29275987] Gram-negative bacteria : Escherichia coli(MIC=4.2 μM),[Ref.29275987] MHC2=587 μM against human red blood cells,,29275987,Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020.,"Stone TA, Cole GB, Nguyen HQ, Sharpe S, Deber CM",Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides.,Cyclic,L,Free,No cytotoxicity information found,Amidation (Ala17),The 'A' at position 10 and 14 are 2-(4'-pentenyl)alanine residues and there is a hydrocarbon staple crosslinking them.,Not found,
5227,DRAMP21230,KKKKKKAGFAAWGAFGA,17,S-6K-F17-3G (Derived from S-6K-F17),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-negative bacteria,[Ref.29275987] Gram-negative bacteria : Escherichia coli(MIC=4.2 μM),[Ref.29275987] MHC2=128 μM against human red blood cells,,29275987,Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020.,"Stone TA, Cole GB, Nguyen HQ, Sharpe S, Deber CM",Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides.,Cyclic,L,Free,No cytotoxicity information found,Amidation (Ala17),The 'A' at position 10 and 14 are 2-(4'-pentenyl)alanine residues and there is a hydrocarbon staple crosslinking them.,Not found,
5228,DRAMP21229,KKKKKKAGFAAWAAFGA,17,S-6K-F17-2G (Derived from S-6K-F17),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-negative bacteria,[Ref.29275987] Gram-negative bacteria : Escherichia coli(MIC=1.6 μM),[Ref.29275987] MHC2=15 μM against human red blood cells,,29275987,Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020.,"Stone TA, Cole GB, Nguyen HQ, Sharpe S, Deber CM",Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides.,Cyclic,L,Free,No cytotoxicity information found,Amidation (Ala17),The 'A' at position 10 and 14 are 2-(4'-pentenyl)alanine residues and there is a hydrocarbon staple crosslinking them.,Not found,
5229,DRAMP21227,ILKKIWKPIKKLF,13,IsCT-P (Derived from IsCT),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.16871429] Gram-positive bacteria : Staphylococcus aureus (KCTC 1621)(MIC=1 μM), Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), MRSA (CCARM 3001)(MIC=2 μM), MRSA (CCARM 3543)(MIC=1 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=1 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM), MDRPA (CCARM 2095)(MIC=1 μM)",[Ref.16871429] HC50>400 μM against human red blood cells,,16871429,Biotechnol Lett. 2006 Sep;28(18):1431-7. ,"Lim SS, Yoon SP, Park Y, Zhu WL, Park IS, Hahm KS, Shin SY",Mechanism of antibacterial action of a synthetic peptide with an Ala-peptoid residue based on the scorpion-derived antimicrobial peptide IsCT.,Linear,L,Free,[Ref.16871429] No cytotoxicity information found,Amidation,None,Not found,
5230,DRAMP21228,ILKKIWKAIKKLF,13,IsCT-a (Derived from IsCT-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.16871429] Gram-positive bacteria : Staphylococcus aureus (KCTC 1621)(MIC=1 μM), Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=1 μM), MRSA (CCARM 3001)(MIC=2 μM), MRSA (CCARM 3543)(MIC=1 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=2 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM), MDRPA (CCARM 2095)(MIC=2 μM)",[Ref.16871429] HC50>400 μM against human red blood cells,,16871429,Biotechnol Lett. 2006 Sep;28(18):1431-7. ,"Lim SS, Yoon SP, Park Y, Zhu WL, Park IS, Hahm KS, Shin SY",Mechanism of antibacterial action of a synthetic peptide with an Ala-peptoid residue based on the scorpion-derived antimicrobial peptide IsCT.,Linear,L,Free,[Ref.16871429] No cytotoxicity information found,Amidation,The 'a' in sequence is Ala peptoid residue (N-methylglycine),Not found,
5231,DRAMP21225,KKFKWWWKFKK,11,STPk (Derived from STP),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.17604338] Gram-positive bacteria : Staphylococcus epidermidis(KCTC 1917)(MIC=1 μM), Staphylococcus aureus(KCTC 1621)(MIC=1 μM), MRSA1 (CCARM 3001)(MIC=2 μM), MRSA2 (CCARM 3543)(MIC=0.5 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=1 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=2 μM), MDRPA1 (CCARM 2095)(MIC=4 μM), MDRPA2 (CCARM 2109)(MIC=8 μM)",[Ref.17604338] MHC10>200 μM against human red blood cells,,17604338,J Pept Sci. 2007 Aug;13(8):529-35.,"Zhu WL, Hahm KS, Shin SY",Cathelicidin-derived Trp/Pro-rich antimicrobial peptides with lysine peptoid residue (Nlys): therapeutic index and plausible mode of action.,Linear,L,Free,[Ref.17604338] No cytotoxicity information found,Amidation,The 'k' in sequence is lysine peptoid residue [NH2-(CH2)4-NH-CH2-COOH],Not found,
5232,DRAMP21226,ILKWKWKWWKWRR,13,Ink (Derived from IN),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.17604338] Gram-positive bacteria : Staphylococcus epidermidis(KCTC 1917)(MIC=1 μM), Staphylococcus aureus(KCTC 1621)(MIC=1 μM), MRSA1 (CCARM 3001)(MIC=2 μM), MRSA2 (CCARM 3543)(MIC=1 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=2 μM), MDRPA1 (CCARM 2095)(MIC=4 μM), MDRPA2 (CCARM 2109)(MIC=8 μM)",[Ref.17604338] MHC10>200 μM against human red blood cells,,17604338,J Pept Sci. 2007 Aug;13(8):529-35.,"Zhu WL, Hahm KS, Shin SY",Cathelicidin-derived Trp/Pro-rich antimicrobial peptides with lysine peptoid residue (Nlys): therapeutic index and plausible mode of action.,Linear,L,Free,[Ref.17604338] No cytotoxicity information found,Amidation,The 'k' in sequence is lysine peptoid residue [NH2-(CH2)4-NH-CH2-COOH],Not found,
5233,DRAMP21223,ILKKIWKPIKKLF,13,IsCT-p (Derived from IsCT-P),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil,This result indicated that D-Pro in the central position of a short a-helical peptide provides more remarkable structural flexibility than L-Pro.,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.16040002] Gram-positive bacteria : Staphylococcus aureus(KCTC 1621)(MIC=1 μM), MRSA (CCARM 3001)(MIC=2 μM), MRSA (CCARM 3543)(MIC=1 μM), Bacillus subtilis(KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=1 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=2 μM), MDRPA (CCARM 2095)(MIC=2 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)",[Ref.16040002] 0% hemolysis at 200 μM against human red blood cells,,16040002,Biochem Biophys Res Commun. 2005 Sep 9;334(4):1329-35.,"Lim SS, Kim Y, Park Y, Kim JI, Park IS, Hahm KS, Shin SY",The role of the central L- or D-Pro residue on structure and mode of action of a cell-selective alpha-helical IsCT-derived antimicrobial peptide.,Linear,Mixed(D-Pro8),Free,[Ref.16040002] No cytotoxicity information found,Amidation,None,Not found,
5234,DRAMP21224,VRRPKWWWKFLRR,13,TPk (Derived from TP),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.17604338] Gram-positive bacteria : Staphylococcus epidermidis(KCTC 1917)(MIC=1 μM), Staphylococcus aureus(KCTC 1621)(MIC=1 μM), MRSA1 (CCARM 3001)(MIC=1 μM), MRSA2 (CCARM 3543)(MIC=0.5 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=2 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=4 μM), MDRPA1 (CCARM 2095)(MIC=4 μM), MDRPA2 (CCARM 2109)(MIC=8 μM)",[Ref.17604338] MHC10>200 μM against human red blood cells,,17604338,J Pept Sci. 2007 Aug;13(8):529-35.,"Zhu WL, Hahm KS, Shin SY",Cathelicidin-derived Trp/Pro-rich antimicrobial peptides with lysine peptoid residue (Nlys): therapeutic index and plausible mode of action.,Linear,L,Free,[Ref.17604338] No cytotoxicity information found,Amidation,The 'k' in sequence is lysine peptoid residue [NH2-(CH2)4-NH-CH2-COOH],Not found,
5235,DRAMP21222,IIRKIIRK,8,Control-4D (Derived from IK12-all L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=125 mg/L), Staphylococcus aureus(MIC>500 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=31.3 mg/L), Pseudomonas aeruginosa(MIC=125 mg/L);##Fungi : Candida albicans(MIC=62.5 mg/L)",[Ref.24211081] HC10>2000 mg/L against rabbit red blood cells,,24211081,Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.,"Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY","Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.",Linear,"Mixed(D-Ile2, D-Arg3, D-Ile6, D-Arg7)",Free,[Ref.24211081] No cytotoxicity information found,Amidation,None,Not found,
5236,DRAMP21221,IIRKIIRK,8,Control-all D (Derived from IK12-all L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC>500 mg/L), Staphylococcus aureus(MIC>500 mg/L);##Gram-negative bacteria : Escherichia coli(MIC>500 mg/L), Pseudomonas aeruginosa(MIC>500 mg/L);##Fungi : Candida albicans(MIC=250 mg/L)",[Ref.24211081] HC10>2000 mg/L against rabbit red blood cells,,24211081,Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.,"Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY","Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.",Linear,D,Free,[Ref.24211081] No cytotoxicity information found,Amidation,None,Not found,
5237,DRAMP21219,IRVKIRVKIRVK,12,IK12-all D (Derived from IK12-all L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=1.0 mg/L), Staphylococcus aureus(MIC=7.8 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=7.8 mg/L), Pseudomonas aeruginosa(MIC=15.6 mg/L);##Fungi : Candida albicans(MIC=31.3 mg/L)",[Ref.24211081] HC10>125 mg/L against rabbit red blood cells,,24211081,Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.,"Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY","Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.",Linear,D,Free,[Ref.24211081] No cytotoxicity information found,Amidation,None,Not found,
5238,DRAMP21220,IIRKIIRK,8,Control-all L (Derived from IK12-all L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC>500 mg/L), Staphylococcus aureus(MIC>500 mg/L);##Gram-negative bacteria : Escherichia coli(MIC>500 mg/L), Pseudomonas aeruginosa(MIC>500 mg/L);##Fungi : Candida albicans(MIC=500 mg/L)",[Ref.24211081] HC10>2000 mg/L against rabbit red blood cells,,24211081,Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.,"Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY","Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.",Linear,L,Free,[Ref.24211081] No cytotoxicity information found,Amidation,None,Not found,
5239,DRAMP21218,IRVKIRVKIRVK,12,IK12-all L (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Beta sheet,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=2.0 mg/L), Staphylococcus aureus(MIC=31.3 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=15.6 mg/L), Pseudomonas aeruginosa(MIC=62.5 mg/L);##Fungi : Candida albicans(MIC=125 mg/L)",[Ref.24211081] HC10>125 mg/L against rabbit red blood cells,,24211081,Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.,"Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY","Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.",Linear,L,Free,[Ref.24211081] No cytotoxicity information found,Amidation,None,Not found,
5240,DRAMP21217,IRIKIRIK,8,IK8-2D (Derived from IK8-all L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=3.9 mg/L), Staphylococcus aureus(MIC=31.3 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=15.6 mg/L), Pseudomonas aeruginosa(MIC=7.8 mg/L);##Fungi : Candida albicans(MIC=3.9 mg/L)",[Ref.24211081] HC10=1600 mg/L against rabbit red blood cells,,24211081,Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.,"Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY","Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.",Linear,"Mixed (D-Lys4, D-Arg6)",Free,[Ref.24211081] No cytotoxicity information found,Amidation,None,Not found,
5241,DRAMP21215,IRIK,4,IK4-all D (Derived from IK8-all L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC>500 mg/L), Staphylococcus aureus(MIC>500 mg/L);##Gram-negative bacteria : Escherichia coli(MIC>500 mg/L), Pseudomonas aeruginosa(MIC>500 mg/L);##Fungi : Candida albicans(MIC>500 mg/L)",[Ref.24211081] HC10>2000 mg/L against rabbit red blood cells,,24211081,Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.,"Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY","Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.",Linear,D,Free,[Ref.24211081] No cytotoxicity information found,Amidation,None,Not found,
5242,DRAMP21216,IRIKIRIK,8,IK8-4D (Derived from IK8-all L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC>500 mg/L), Staphylococcus aureus(MIC>500 mg/L);##Gram-negative bacteria : Escherichia coli(MIC>500 mg/L), Pseudomonas aeruginosa(MIC>500 mg/L);##Fungi : Candida albicans(MIC>500 mg/L)",[Ref.24211081] HC10>2000 mg/L against rabbit red blood cells,,24211081,Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.,"Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY","Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.",Linear,"Mixed (D-Arg2, D-Lys4, D-Arg6, D-Lys8)",Free,[Ref.24211081] No cytotoxicity information found,Amidation,None,Not found,
5243,DRAMP21213,IRIKIRIK,8,IK8-all D (Derived from IK8-all L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=2.0 mg/L), Staphylococcus aureus(MIC=3.9 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=3.9 mg/L), Pseudomonas aeruginosa(MIC=7.8 mg/L);##Fungi : Candida albicans(MIC=3.9 mg/L)",[Ref.24211081] HC10=1750 mg/L against rabbit red blood cells,,24211081,Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.,"Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY","Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.",Linear,D,Free,"[Ref.24211081] The cell viability of mouse alveolar macrophage RAW264.7 cells is 100%, 100%, 95%, 90%, 83.8%, 86.2%, 50%, 8.8% and 5% at peptide concentrations of 1, 2, 4, 8, 16, 31, 62, 100 and 125 mg/L. ##The cell viability of human fetatl lung fibrobl",Amidation,None,Not found,
5244,DRAMP21214,IRIKIR,6,IK6-all D (Derived from IK8-all L),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=31.3 mg/L), Staphylococcus aureus(MIC=250 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=125 mg/L), Pseudomonas aeruginosa(MIC=250 mg/L);##Fungi : Candida albicans(MIC=15.6 mg/L)",[Ref.24211081] HC10>2000 mg/L against rabbit red blood cells,,24211081,Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.,"Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY","Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.",Linear,D,Free,[Ref.24211081] No cytotoxicity information found,Amidation,None,Not found,
5245,DRAMP21212,IRIKIRIK,8,IK8-all L (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Beta sheet,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.24211081] Gram-positive bacteria : Staphylococcus epidermidis(MIC=3.9 mg/L), Staphylococcus aureus(MIC=62.5 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=15.6 mg/L), Pseudomonas aeruginosa(MIC=31.3 mg/L);##Fungi : Candida albicans(MIC=3.9 mg/L)",[Ref.24211081] HC10=2000 mg/L against rabbit red blood cells,,24211081,Biomaterials. 2014 Jan;35(4):1315-25. doi: 10.1016/j.biomaterials.2013.10.053.,"Ong ZY, Cheng J, Huang Y, Xu K, Ji Z, Fan W, Yang YY","Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles.",Linear,L,Free,[Ref.24211081] No cytotoxicity information found,Amidation,None,Not found,
5246,DRAMP21211,HLLKRVQRELIRWLDWLK,18,"AmyI-1-18 (N3L, G12R) (Derived from AmyI-1-18)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=2.9±0.2 μM),[Ref.27478151] 14% hemolysis at 50 μM against human red blood cells,,27478151,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T",Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.,Linear,L,Free,[Ref.27478151] No cytotoxicity information found,Free,None,Not found,
5247,DRAMP21208,HLNKRVQRLLIGWLDWLK,18,AmyI-1-18 (E9L) (Derived from AmyI-1-18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=3.7±1.5 μM). ,[Ref.27478151] 5% hemolysis at 50 μM against human red blood cells,,27478151,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T",Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-23 and its amino acid-substituted analogs.,Linear,L,Free,[Ref.27478151] No cytotoxicity information found,Free,None,Not found,
5248,DRAMP21209,HLNKRVQRLLIRWLDWLK,18,"AmyI-1-18 (E9L, G12R) (Derived from AmyI-1-18)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=4.9±0.5 μM),[Ref.27478151] 9% hemolysis at 50 μM against human red blood cells,,27478151,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T",Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.,Linear,L,Free,[Ref.27478151] No cytotoxicity information found,Free,None,Not found,
5249,DRAMP21205,HLNKRVQRELIRWLDWLK,18,AmyI-1-18 (G12R) (Derived from AmyI-1-18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity against Candida albicans,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=4.6±1.1 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=61±8 μM),[Ref.27478151] 2% hemolysis at 50 μM against human red blood cells,,27478151##26850840,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22819.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T","Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-20 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.",Linear,L,Free,[Ref.27478151##26850840] No cytotoxicity information found,Free,None,Not found,
5250,DRAMP21210,HLLKRVQRLLIGWLDWLK,18,"AmyI-1-18 (N3L, E9L) (Derived from AmyI-1-18)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=4.2±0.5 μM),[Ref.27478151] 14% hemolysis at 50 μM against human red blood cells,,27478151,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T",Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.,Linear,L,Free,[Ref.27478151] No cytotoxicity information found,Free,None,Not found,
5251,DRAMP21207,HLLKRVQRELIGWLDWLK,18,AmyI-1-18 (N3L) (Derived from AmyI-1-18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity against Candida albicans,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=2.5±0.7 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=58±22 μM),[Ref.27478151] 3% hemolysis at 50 μM against human red blood cells,,27478151##26850842,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22821.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T","Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-22 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.",Linear,L,Free,[Ref.27478151##26850842] No cytotoxicity information found,Free,None,Not found,
5252,DRAMP21206,HLNKRVQRELIGWLRWLK,18,AmyI-1-18 (D15R) (Derived from AmyI-1-18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity against Candida albicans,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=11±1 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=31±4 μM),[Ref.27478151] 2% hemolysis at 50 μM against human red blood cells,,27478151##26850841,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22820.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T","Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-21 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.",Linear,L,Free,[Ref.27478151##26850841] No cytotoxicity information found,Free,None,Not found,
5253,DRAMP21204,HLNKRVQRELRGWLDWLK,18,AmyI-1-18 (I11R) (Derived from AmyI-1-18),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity against Candida albicans,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=10±2 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=62±2 μM),[Ref.27478151] 1% hemolysis at 50 μM against human red blood cells,,27478151##26850839,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22818.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T","Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-19 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.",Linear,L,Free,[Ref.27478151##26850839] No cytotoxicity information found,Free,None,Not found,
5254,DRAMP21203,HLNKRVQRELIGWLDWLK,18,"AmyI-1-18 (Oryza sativa L., Angiospermae, Plants)",P17654,Belongs to the glycosyl hydrolase 13 family.,AMY1.1,Oryza sativa subsp. japonica (Rice),"Antimicrobial, Antibacterial, Anti-Gram-, Antifungal",Protein level,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Antifungal activity gaginst Candida albicans. Important for breakdown of endosperm starch during germination.,[Ref.27478151] Gram-negative bacteria : Porphyromonas gingivalis(IC50=13±3 μM). ##[Ref.26850838] Fungi: Candida albicans(IC50=64±2 μM),[Ref.27478151] 0.1% hemolysis at 100 μM against human red blood cells,,27478151##26850838,J Biosci Bioeng. 2016 Dec;122(6):652-659. doi: 10.1016/j.jbiosc.2016.05.008. ##Biopolymers. 2016 Mar;106(2):219-229. doi: 10.1002/bip.22817.,"Taniguchi M, Ochiai A, Takahashi K, Nakamichi SI, Nomoto T, Saitoh E, Kato T, Tanaka T","Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs. ##Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from α-amylase of rice.",Linear,L,Free,[Ref.27478151##26850838] No cytotoxicity information found,Free,None,Not found,
5255,DRAMP21202,FKKLKKLFKKILKLK,15,HPA3NT3-analog (Derived from HPA3NT3),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Trichosporon beigelli","[Ref.19642077] Gram-positive bacteria : Staphylococcus aureus(MIC=8 μM), Bacillus subtilis(MIC=8 μM), Listeria monocytogenes(MIC=4 μM);##Gram-negative bacteria : Escherichia coli(MIC=8 μM), Salmonella typhimurium(MIC=1 μM), Pseudomonas aeruginosa(MIC=2 μM);##Fungi : Candida albicans(MIC=4-8 μM), Trichosporon beigelli(MIC=1 μM)","[Ref.19642077] 0% hemolysis at 100 μM , 3% hemolysis at 200 μM against human red blood cells",,19642077,J Pept Sci. 2009 Sep;15(9):589-94. doi: 10.1002/psc.1155.,"Gopal R, Park SC, Ha KJ, Cho SJ, Kim SW, Song PI, Nah JW, Park Y, Hahm KS",Effect of Leucine and Lysine substitution on the antimicrobial activity and evaluation of the mechanism of the HPA3NT3 analog peptide.,Linear,L,Free,[Ref.19642077] No cytotoxicity information found.,Amidation,None,Not found,
5256,DRAMP21201,GIGKFLHSAKKWGKAFVGEIMNS,23,"Magainin 2a (M2a; Frogs, Amphibians, Animals)",C0HKN6,Belongs to the gastrin/cholecystokinin family. Magainin subfamily,,Xenopus ruwenzoriensis (Uganda clawed frog),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=128 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=32 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=64 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=64 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=128 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=32 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=128 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5257,DRAMP21200,GYKYINNIIKYINKFFKYIW,20,GW-M4 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=8 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=8 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=8 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=32 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=32 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=16 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=32 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=4 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5258,DRAMP21199,GANAAKKFANLIKKIFNYIW,20,GW-M3 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=8 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=16 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=32 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=32 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=32 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=8 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5259,DRAMP21198,GANAAKKLATFAKKIFTAYW,20,GW-M1 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=64 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=64 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=256 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=128 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=32 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=32 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=256 μg/ml)",[Ref.18586467] MHC=64 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5260,DRAMP21197,GLTFLKKILNFAKKIYTAIW,20,GW-H3 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=16 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=16 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=8 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=32 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=32 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=128 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=32 μg/ml), Escherichia coli (BCRC 10675)(MIC=32 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=64 μg/ml)",[Ref.18586467] MHC=8 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5261,DRAMP21196,GYNYAKKLANLAKKFANALW,20,GW-H1 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=16 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=8 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=32 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=16 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=64 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=32 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=16 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=32 μg/ml), Escherichia coli (BCRC 10675)(MIC=8 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=8 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=32 μg/ml)",[Ref.18586467] MHC=128 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5262,DRAMP21195,GATYAKKIIKTITKIATTAW,20,GW-A5 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=64 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=64 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=32 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=128 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5263,DRAMP21194,GAKALTKAATAFTKFYKTIW,20,GW-A4 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=64 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=16 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=64 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5264,DRAMP21193,GAKYAKIIYNYLKKIANALW,20,GW-A2 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=8 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=16 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=32 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=32 μg/ml), Streptococcus iniae (laboratory strain)(MIC=64 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=32 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=128 μg/ml), Escherichia coli (BCRC 10675)(MIC=64 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=16 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=8 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5265,DRAMP21192,GAKYAKYIYNFYKYIAKYIW,20,GW-A1 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=256 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=128 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=64 μg/ml), Escherichia coli (BCRC 10675)(MIC=64 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=64 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=64 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=256 μg/ml)",[Ref.18586467] MHC=8 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5266,DRAMP21191,GIKIAKKAITIAKKIAKIYW,20,GW-Q6 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=32 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=4 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=32 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=32 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=32 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=16 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=8 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=32 μg/ml)",[Ref.18586467] MHC=128 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5267,DRAMP21190,GANALKKYFTILKKFFKLAW,20,GW-Q5 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=16 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=16 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=16 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=64 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=64 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=64 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=16 μg/ml), Escherichia coli (BCRC 10675)(MIC=8 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=16 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=8 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=32 μg/ml)",[Ref.18586467] MHC=4 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5268,DRAMP21189,GANAAKKFATIAKKFINYLW,20,GW-Q4 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=16 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=8 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=16 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=8 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=128 μg/ml), Streptococcus iniae (laboratory strain)(MIC=128 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=128 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=32 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=16 μg/ml), Escherichia coli (BCRC 10675)(MIC=16 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=8 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=8 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=64 μg/ml)",[Ref.18586467] MHC=128 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5269,DRAMP21188,GANLAKKFYTYINKFINYAW,20,GW-Q3 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.18586467] Gram-positive bacteria : Staphylococcus aureus (BCRC 10780)(MIC=128 μg/ml), Staphylococcus xylosus (BCRC 12930)(MIC=64 μg/ml), Staphylococcus aureus (BCRC 10781)(MIC=128 μg/ml), Listeria monocytogenes (BCRC 14845)(MIC=128 μg/ml), Streptococcus bovis (BCRC 14729)(MIC=256 μg/ml), Streptococcus iniae (laboratory strain)(MIC=256 μg/ml), Lactococcus garvieae (laboratory strain)(MIC=256 μg/ml);##Gram-negative bacteria : Klebsiella oxytoca (BCRC 13985)(MIC=128 μg/ml), Pseudomonas aeruginosa (BCRC 10944)(MIC=128 μg/ml), Escherichia coli (BCRC 10675)(MIC=64 μg/ml), Enterobacter aerogenes (BCRC 10370)(MIC=32 μg/ml), Enterobacter cloacae (BCRC 10401)(MIC=64 μg/ml), Yersinia enterocolitica (BCRC 13999)(MIC=128 μg/ml)",[Ref.18586467] MHC=128 μM against human red blood cells,,18586467,Int J Antimicrob Agents. 2008 Aug;32(2):130-8. doi: 10.1016/j.ijantimicag.2008.04.003.,"Chou HT, Kuo TY, Chiang JC, Pei MJ, Yang WT, Yu HC, Lin SB, Chen WJ",Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Linear,L,Free,[Ref.18586467] No cytotoxicity information found.,Free,None,Not found,
5270,DRAMP21187,WLRAFRRLVRRLARLLRR,18,WRL4 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=6.65 μM), Staphylococcus aureus 1.160(MIC=1.66 μM), Listeria monocytogenes 21662(MIC=3.32 μM), Listeria monocytogenes 21633(MIC=3.32 μM), Bacillus cereus 63301(MIC=53.18 μM), Micrococcus luteus 28001(MIC=13.29 μM), Bacillus pumilus 63202(MIC=26.59 μM), Pseudomonas fluorescens 21620(MIC=53.18 μM), MRSA 43300(MIC=3.32 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=3.32 μM), Escherichia coli 25922(MIC=13.29 μM), Escherichia coli 35150(MIC=26.59 μM), Salmonella paratyphi-A 20501(MIC=6.65 μM), Salmonella paratyphi paratyphi-B 21495(MIC=3.32 μM), Salmonella paratyphi paratyphi-C 21512(MIC=6.65 μM), Shigella flexneri 51571(MIC=1.66 μM), Salmonella choleraesuis 13312(MIC=13.29 μM), Salmonella typhimurium 51005(MIC>53.18 μM), Salmonella enteritidis 21527(MIC>53.28 μM), Vibrio parahemolyticus 21617(MIC=6.65 μM);##Fungi : Candida albicans 10231(MIC=26.59 μM)",[Ref.28002968] MHC10=53.18 μM against human red blood cells,,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,Linear,L,Free,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WRL4 is 91.27%, 90.42%, 81.13%, 73.24%, 70.14%, 69.30%, 56.62%, 51.27% and 48.25% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Amidation,None,Not found,
5271,DRAMP21186,WLRAFRRLVRRLARGLRR,18,WRL3 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=0.43 μM), Staphylococcus aureus 1.160(MIC=0.43 μM), Listeria monocytogenes 21662(MIC=0.21 μM), Listeria monocytogenes 21633(MIC=0.21 μM), Bacillus cereus 63301(MIC=0.85 μM), Micrococcus luteus 28001(MIC=0.43 μM), Bacillus pumilus 63202(MIC=0.85 μM), Pseudomonas fluorescens 21620(MIC=0.43 μM), MRSA 43300(MIC=0.85 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=0.85 μM), Escherichia coli 25922(MIC=1.70 μM), Escherichia coli 35150(MIC=1.70 μM), Salmonella paratyphi-A 20501(MIC=0.43 μM), Salmonella paratyphi paratyphi-B 21495(MIC=0.85 μM), Salmonella paratyphi paratyphi-C 21512(MIC=0.43 μM), Shigella flexneri 51571(MIC=0.43 μM), Salmonella choleraesuis 13312(MIC=1.70 μM), Salmonella typhimurium 51005(MIC=6.81 μM), Salmonella enteritidis 21527(MIC=6.81 μM), Vibrio parahemolyticus 21617(MIC=1.70 μM);##Fungi : Candida albicans 10231(MIC=3.40 μM)",[Ref.28002968] MHC10=27.22 μM against human red blood cells,,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,Linear,L,Free,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WRL3 is 98.31%, 95.21%, 92.96%, 90.70%, 89.30%, 89.01%, 76.90%, 48.45% and 40.73% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Amidation,None,Not found,
5272,DRAMP21185,WGRAFRRLVRRLARGLRR,18,WRL2 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=3.49 μM), Staphylococcus aureus 1.160(MIC=1.74 μM), Listeria monocytogenes 21662(MIC=1.74 μM), Listeria monocytogenes 21633(MIC=1.74 μM), Bacillus cereus 63301(MIC=55.78 μM), Micrococcus luteus 28001(MIC=27.89 μM), Bacillus pumilus 63202(MIC=55.78 μM), Pseudomonas fluorescens 21620(MIC=55.78 μM), MRSA 43300(MIC=6.97 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=6.97 μM), Escherichia coli 25922(MIC=27.89 μM), Escherichia coli 35150(MIC=13.94 μM), Salmonella paratyphi-A 20501(MIC=3.49 μM), Salmonella paratyphi paratyphi-B 21495(MIC=6.97 μM), Salmonella paratyphi paratyphi-C 21512(MIC=3.49 μM), Shigella flexneri 51571(MIC=3.49 μM), Salmonella choleraesuis 13312(MIC=13.94 μM), Salmonella typhimurium 51005(MIC=13.94 μM), Salmonella enteritidis 21527(MIC>55.78 μM), Vibrio parahemolyticus 21617(MIC=13.94 μM);##Fungi : Candida albicans 10231(MIC=13.94 μM)",[Ref.28002968] MHC10>55.78 μM against human red blood cells,,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,Linear,L,Free,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WRL2 is 87.32%, 85.35%, 81.13%, 79.15%, 78.87%, 78.03%, 76.34%, 69.86% and 64.79% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Amidation,None,Not found,
5273,DRAMP21184,WGRAFRRGVRRLARGGRR,18,WR7 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=14.66 μM), Staphylococcus aureus 1.160(MIC=7.33 μM), Listeria monocytogenes 21662(MIC=7.33 μM), Listeria monocytogenes 21633(MIC=7.33 μM), Bacillus cereus 63301(MIC=14.66 μM), Micrococcus luteus 28001(MIC=7.33 μM), Bacillus pumilus 63202(MIC>58.64 μM), Pseudomonas fluorescens 21620(MIC=29.32 μM), MRSA 43300(MIC=14.66 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=3.67 μM), Escherichia coli 25922(MIC=14.66 μM), Escherichia coli 35150(MIC=29.32 μM), Salmonella paratyphi-A 20501(MIC=7.33 μM), Salmonella paratyphi paratyphi-B 21495(MIC=3.67 μM), Salmonella paratyphi paratyphi-C 21512(MIC=7.33 μM), Shigella flexneri 51571(MIC=7.33 μM), Salmonella choleraesuis 13312(MIC=14.66 μM), Salmonella typhimurium 51005(MIC>58.64 μM), Salmonella enteritidis 21527(MIC>58.64 μM), Vibrio parahemolyticus 21617(MIC=29.32 μM);##Fungi : Candida albicans 10231(MIC=29.32 μM)",[Ref.28002968] MHC10>58.64 μM against human red blood cells,,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,Linear,L,Free,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WR7 is 97.46%, 94.65%, 89.01%, 82.25%, 81.41%, 80.85%, 78.59%, 76.06% and 74.80% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Amidation,None,Not found,
5274,DRAMP21183,WGRAFSRGVRRLARGGRG,18,WR5 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC=31.77 μM), Staphylococcus aureus 1.160(MIC=15.89 μM), Listeria monocytogenes 21662(MIC=15.89 μM), Listeria monocytogenes 21633(MIC=31.77 μM), Bacillus cereus 63301(MIC>63.54 μM), Micrococcus luteus 28001(MIC>63.54 μM), Bacillus pumilus 63202(MIC>63.54 μM), Pseudomonas fluorescens 21620(MIC>63.54 μM), MRSA 43300(MIC>63.54 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=7.94 μM), Escherichia coli 25922(MIC=31.77 μM), Escherichia coli 35150(MIC=31.77 μM), Salmonella paratyphi-A 20501(MIC=15.89 μM), Salmonella paratyphi paratyphi-B 21495(MIC=15.89 μM), Salmonella paratyphi paratyphi-C 21512(MIC=15.89 μM), Shigella flexneri 51571(MIC=15.89 μM), Salmonella choleraesuis 13312(MIC=15.89 μM), Salmonella typhimurium 51005(MIC>63.54 μM), Salmonella enteritidis 21527(MIC>63.54 μM), Vibrio parahemolyticus 21617(MIC>63.54 μM);##Fungi : Candida albicans 10231(MIC>63.54 μM)",[Ref.28002968] MHC10>63.54 μM against human red blood cells,,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,Linear,L,Free,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WR5 is 98.59%, 97.46%, 96.06%, 96.09%, 92.96%, 91.83%, 89.58%, 87.32% and 85.48% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Amidation,None,Not found,
5275,DRAMP21182,WGRAFSAGVHRLARGGRG,18,WR3 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>67.01 μM), Staphylococcus aureus 1.160(MIC>67.01 μM), Listeria monocytogenes 21662(MIC=33.50 μM), Listeria monocytogenes 21633(MIC=67.01 μM), Bacillus cereus 63301(MIC>67.01 μM), Micrococcus luteus 28001(MIC>67.01 μM), Bacillus pumilus 63202(MIC>67.01 μM), Pseudomonas fluorescens 21620(MIC>67.01 μM), MRSA 43300(MIC>67.01 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC=16.75 μM), Escherichia coli 25922(MIC>67.01 μM), Escherichia coli 35150(MIC>67.01 μM), Salmonella paratyphi-A 20501(MIC=33.50 μM), Salmonella paratyphi paratyphi-B 21495(MIC>67.01 μM), Salmonella paratyphi paratyphi-C 21512(MIC>67.01 μM), Shigella flexneri 51571(MIC>67.01 μM), Salmonella choleraesuis 13312(MIC=33.50 μM), Salmonella typhimurium 51005(MIC>67.01 μM), Salmonella enteritidis 21527(MIC>67.01 μM), Vibrio parahemolyticus 21617(MIC>67.01 μM);##Fungi : Candida albicans 10231(MIC>67.01 μM)",[Ref.28002968] MHC10>67.01 μM against human red blood cells,,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,Linear,L,Free,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WR3 is 100%, 98.87%, 92.11%, 90.42%, 90.42%, 88.45%, 87.61%, 87.89% and 87.22% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Amidation,None,Not found,
5276,DRAMP21181,WGRAFSAGVHRLANGGNG,18,WR1 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>70.09s μM), Staphylococcus aureus 1.160(MIC=70.09 μM), Listeria monocytogenes 21662(MIC>70.09 μM), Listeria monocytogenes 21633(MIC>70.09 μM), Bacillus cereus 63301(MIC>70.09 μM), Micrococcus luteus 28001(MIC>70.09 μM), Bacillus pumilus 63202(MIC>70.09 μM), Pseudomonas fluorescens 21620(MIC>70.09 μM), MRSA 43300(MIC>70.09 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC>70.09 μM), Escherichia coli 25922(MIC>70.09 μM), Escherichia coli 35150(MIC>70.09 μM), Salmonella paratyphi-A 20501(MIC>70.09 μM), Salmonella paratyphi paratyphi-B 21495(MIC>70.09 μM), Salmonella paratyphi paratyphi-C 21512(MIC>70.09 μM), Shigella flexneri 51571(MIC>70.09 μM), Salmonella choleraesuis 13312(MIC>70.09 μM), Salmonella typhimurium 51005(MIC>70.09 μM), Salmonella enteritidis 21527(MIC>70.09 μM), Vibrio parahemolyticus 21617(MIC>70.09 μM);##Fungi : Candida albicans 10231(MIC>70.09 μM)",[Ref.28002968] MHC10>70.09 μM against human red blood cells,,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,Linear,L,Free,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WR1 is 99.44%, 96.62%, 95.21%, 94.08%, 92.96%, 92.99%, 92.68%, 87.04% and 77.58% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Amidation,None,Not found,
5277,DRAMP21180,WGEAFSAGVHRLANGGNG,18,WG18 (Derived from leucocin A),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"Random coil, alpha helix, beta sheet, turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.28002968] Gram-positive bacteria : Staphylococcus aureus 29213(MIC>71.15 μM), Staphylococcus aureus 1.160(MIC>71.15 μM), Listeria monocytogenes 21662(MIC>71.15 μM), Listeria monocytogenes 21633(MIC>71.15 μM), Bacillus cereus 63301(MIC>71.15 μM), Micrococcus luteus 28001(MIC>71.15 μM), Bacillus pumilus 63202(MIC>71.15 μM), Pseudomonas fluorescens 21620(MIC>71.15 μM), MRSA 43300(MIC>71.15 μM);##Gram-negative bacteria : Escherichia coli O157 : H7 21530(MIC>71.15 μM), Escherichia coli 25922(MIC>71.15 μM), Escherichia coli 35150(MIC>71.15 μM), Salmonella paratyphi-A 20501(MIC>71.15 μM), Salmonella paratyphi paratyphi-B 21495(MIC>71.15 μM), Salmonella paratyphi paratyphi-C 21512(MIC>71.15 μM), Shigella flexneri 51571(MIC>71.15 μM), Salmonella choleraesuis 13312(MIC>71.15 μM), Salmonella typhimurium 51005(MIC>71.15 μM), Salmonella enteritidis 21527(MIC>71.15 μM), Vibrio parahemolyticus 21617(MIC>71.15 μM);##Fungi : Candida albicans 10231(MIC>71.15 μM)",[Ref.28002968] MHC10>71.15 μM against human red blood cells,,28002968,J Med Chem. 2016 Dec 22;59(24):10946-10962. doi: 10.1021/acs.jmedchem.6b00922.,"Ma Z, Yang J, Han J, Gao L, Liu H, Lu Z, Zhao H, Bie X",Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical PeptideAmphiphiles.,Linear,L,Free,"[Ref.28002968] The cell viability of RAW264.7 cells induced by WG18 is 98.87%, 94.93%, 93.52%, 90.14%, 85.35%, 83.10%, 80.56%, 75.77% and 73.62% at peptide concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 μM.",Amidation,None,Not found,
5278,DRAMP21179,GILSSLWKKPKKIIAK,16,HYL-26 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC>100 μM), Staphylococcus epidermidis(MIC>100 μM);##Gram-negative bacteria : Escherichia coli(MIC>100μM), Pseudomonas aeruginosa 5482(MIC=98 μM);##Fungi : Candida albicans(MIC>100 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5279,DRAMP21178,GILSSLWKKLKKWIAK,16,HYL-25 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=2.5 μM), Staphylococcus epidermidis(MIC=1.6 μM);##Gram-negative bacteria : Escherichia coli(MIC=2.5 μM), Pseudomonas aeruginosa 5482(MIC=13 μM);##Fungi : Candida albicans(MIC=13 μM)",[Ref.26998557] LC50=57 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5280,DRAMP21177,GILSSLLKKLKKWIAK,16,HYL-24 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=8 μM), Staphylococcus epidermidis(MIC=1.6 μM);##Gram-negative bacteria : Escherichia coli(MIC=4 μM), Pseudomonas aeruginosa 5482(MIC=8 μM);##Fungi : Candida albicans(MIC=16 μM)",[Ref.26998557] LC50=115 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5281,DRAMP21176,GILSSLLKKWKKIIAK,16,HYL-23 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=20 μM), Staphylococcus epidermidis(MIC=2.7 μM);##Gram-negative bacteria : Escherichia coli(MIC=7.5 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=11 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5282,DRAMP21175,GKLSSLWKKLKKIIAK,16,HYL-22 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=26 μM), Staphylococcus epidermidis(MIC=2.5 μM);##Gram-negative bacteria : Escherichia coli(MIC=20 μM), Pseudomonas aeruginosa 5482(MIC=6.8 μM);##Fungi : Candida albicans(MIC=34 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5283,DRAMP21174,GILSSLWKKLKKIIAK,16,HYL-21 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=6.3 μM), Staphylococcus epidermidis(MIC=1.7 μM);##Gram-negative bacteria : Escherichia coli(MIC=5 μM), Pseudomonas aeruginosa 5482(MIC=6.7 μM);##Fungi : Candida albicans(MIC=8 μM)",[Ref.26998557] LC50=191 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,D,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5284,DRAMP21173,GILSSLWKKLKKIIAK,16,HYL-20 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=5.3 μM), Staphylococcus epidermidis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=3.4 μM), Pseudomonas aeruginosa 5482(MIC=5.3 μM);##Fungi : Candida albicans(MIC=11 μM)",[Ref.26998557] LC50=197 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5285,DRAMP21172,GILSSWLKKLKKIIAK,16,HYL-19 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=16 μM), Staphylococcus epidermidis(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(MIC=11 μM), Pseudomonas aeruginosa 5482(MIC=4 μM);##Fungi : Candida albicans(MIC=17 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5286,DRAMP21168,GILKSLLKKLKKIIAK,16,HYL-15 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=17 μM), Staphylococcus epidermidis(MIC=2.2 μM);##Gram-negative bacteria : Escherichia coli(MIC=10 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=24 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5287,DRAMP21169,GILSKLLKKLKKIIAK,16,HYL-16 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=23 μM), Staphylococcus epidermidis(MIC=1.8 μM);##Gram-negative bacteria : Escherichia coli(MIC=18 μM), Pseudomonas aeruginosa 5482(MIC=4.5 μM);##Fungi : Candida albicans(MIC=45 μM)",[Ref.26998557] LC50>400 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5288,DRAMP21170,KILSSLLKKLKKIIAK,16,HYL-17 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=32 μM), Staphylococcus epidermidis(MIC=1.4 μM);##Gram-negative bacteria : Escherichia coli(MIC=16 μM), Pseudomonas aeruginosa 5482(MIC=5 μM);##Fungi : Candida albicans(MIC=25 μM)",[Ref.26998557] LC50=364 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,Mixed(1 is D),Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5289,DRAMP21171,GIWSSLLKKLKKIIAK,16,HYL-18 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=20 μM), Staphylococcus epidermidis(MIC=1.5 μM);##Gram-negative bacteria : Escherichia coli(MIC=1.6 μM), Pseudomonas aeruginosa 5482(MIC=6.3 μM);##Fungi : Candida albicans(MIC=16 μM)",[Ref.26998557] LC50=165 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,L,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5290,DRAMP21243,GFFALIPKIISSPLFKTLLSAVGSALS,27,pardaxin-6 (GE-6) (Derived from pardaxin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.23598079] Gram-positive bacteria : Micrococcus luteus(MIC=25 mg/L), Staphylococcus aureus(MIC=50 mg/L), Streptococcus pneumoniae(MIC=50 mg/L), Streptococcus agalactiae(MIC=50 mg/L), Staphylococcus sp.(MIC=6.25 mg/L);##Gram-negative bacteria : Grouper Vibrio alginolyticus(MIC=12.5 mg/L), Vibrio harveyi(MIC=12.5 mg/L), Vibrio vulnificus(MIC=50 mg/L)","[Ref.23598079] 8% hemolysis at 12.5 mg/L , 29% hemolysis at 25 mg/L , 38% hemolysis at 50 mg/L , 57.5% hemolysis at 100 mg/L , 99% hemolysis at 200 mg/L , 98% hemolysis at 400 mg/L against sheep red blood cells",,23598079,Peptides. 2013 Jun;44:139-48. doi: 10.1016/j.peptides.2013.04.004.,"Lin MC, Hui CF, Chen JY, Wu JL",Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.,Linear,L,Free,[Ref.23598079] No cytotoxicity information found.,Free,None,Not found,
5291,DRAMP21242,FIFHIIKGLFHAGKMI,16,Epinecidin-8 (Derived from Epinecidin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.23598079] Gram-positive bacteria : Staphylococcus aureus(MIC=6.25 mg/L), Staphylococcus sp.(MIC=12.5 mg/L);##Gram-negative bacteria : Grouper Vibrio alginolyticus(MIC=12.5 mg/L), Vibrio harveyi(MIC=6.25 mg/L)","[Ref.23598079] 0% hemolysis at 50 mg/L , 10% hemolysis at 100 mg/L , 20% hemolysis at 200 mg/L , 50% hemolysis at 400 mg/L against sheep red blood cells",,23598079,Peptides. 2013 Jun;44:139-48. doi: 10.1016/j.peptides.2013.04.004.,"Lin MC, Hui CF, Chen JY, Wu JL",Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.,Linear,L,Free,[Ref.23598079] No cytotoxicity information found.,Free,None,Not found,
5292,DRAMP21241,GFIFHIIKGLFHAGKMIHGLV,21,Epinecidin-1 (Derived from Epinecidin),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.23598079] Gram-positive bacteria : Micrococcus luteus(MIC=6.25 mg/L), Staphylococcus aureus(MIC=50 mg/L), Streptococcus pneumoniae(MIC=50 mg/L), Streptococcus agalactiae(MIC>=100 mg/L), Staphylococcus sp.(MIC=6.25 mg/L);##Gram-negative bacteria : Grouper Vibrio alginolyticus(MIC=6.25 mg/L), Vibrio harveyi(MIC=6.25 mg/L), Vibrio vulnificus(MIC=50 mg/L)","[Ref.23598079] 0% hemolysis at 25 mg/L , 10% hemolysis at 50 mg/L , 15% hemolysis at 100 mg/L , 30% hemolysis at 200 mg/L , 50% hemolysis at 400 mg/L against sheep red blood cells",,23598079,Peptides. 2013 Jun;44:139-48. doi: 10.1016/j.peptides.2013.04.004.,"Lin MC, Hui CF, Chen JY, Wu JL",Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus.,Linear,L,Free,[Ref.23598079] No cytotoxicity information found.,Free,None,Not found,
5293,DRAMP21240,WKRWVRRWKRWLR,13,FK13-a7 (Derived from FK13),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)",[Ref.28161291] HC50=138.0 μM against human red blood cells,,28161291,Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.,"Rajasekaran G, Kim EY, Shin SY","LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.",Linear,L,Free,"[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a7 is 100.2%, 112.8%, 97.0%, 95.1%, 83.4% and 83.8% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by FK1",Amidation,None,Not found,
5294,DRAMP21239,WKRWVQRWKRWLR,13,FK13-a6 (Derived from FK13),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=8 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)",[Ref.28161291] HC50=167.5 μM against human red blood cells,,28161291,Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.,"Rajasekaran G, Kim EY, Shin SY","LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.",Linear,L,Free,"[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a6 is 91.3%, 94.6%, 103.0%, 96.6%, 61.9% and 28.7% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by FK13",Amidation,None,Not found,
5295,DRAMP21238,WKRWVQRWKRFLR,13,FK13-a5 (Derived from FK13),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)",[Ref.28161291] HC50=230.0 μM against human red blood cells,,28161291,Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.,"Rajasekaran G, Kim EY, Shin SY","LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.",Linear,L,Free,"[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a5 is 105.3%, 103.9%, 97.1%, 94.0%, 47.5% and 44.2% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by FK1",Amidation,None,Not found,
5296,DRAMP21237,FKRWVQRWKRFLR,13,FK13-a4 (Derived from FK13),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)",[Ref.28161291] HC50>256 μM against human red blood cells,,28161291,Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.,"Rajasekaran G, Kim EY, Shin SY","LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.",Linear,L,Free,"[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a4 is 94.0%, 95.7%, 108.7%, 93.2%, 52.8% and 10.6% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by FK13",Amidation,None,Not found,
5297,DRAMP21236,WKRIVRRIWRWLR,13,FK13-a3 (Derived from FK13),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=16 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM)",[Ref.28161291] HC50=12.5 μM against human red blood cells,,28161291,Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.,"Rajasekaran G, Kim EY, Shin SY","LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.",Linear,L,Free,"[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a3 is 102.3%, 112.1%, 104.5%, 103.8%, 74.3% and 70.2% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by F",Amidation,None,Not found,
5298,DRAMP21235,WKRIVRWIKRWLR,13,FK13-a2 (Derived from FK13),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=8 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=4 μM), Salmonella typhimurium(KCTC 1926)(MIC=4 μM)",[Ref.28161291] HC50=14.0 μM against human red blood cells,,28161291,Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.,"Rajasekaran G, Kim EY, Shin SY","LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.",Linear,L,Free,"[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a2 is 104.5%, 101.7%, 100.4%, 77.0%, 58.9% and 15.8% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by FK",Amidation,None,Not found,
5299,DRAMP21167,GILSSLLKKLKKIIAK,16,HYL-13 (Derived from HYL),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.26998557] Gram-positive bacteria : Staphylococcus aureus 6271(MIC=5.7 μM), Staphylococcus epidermidis(MIC=3.2 μM);##Gram-negative bacteria : Escherichia coli(MIC=4.5 μM), Pseudomonas aeruginosa 5482(MIC=4.5 μM);##Fungi : Candida albicans(MIC=9 μM)",[Ref.26998557] LC50=333 μM against human red blood cells,,26998557,J Nat Prod. 2016 Apr 22;79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.,"Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V",Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics.,Linear,D,Free,[Ref.26998557] No cytotoxicity information found.,Amidation,None,Not found,
5300,DRAMP21234,WKRIVRRIKRWLR,13,FK13-a1 (Derived from FK13),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.28161291] Gram-positive bacteria : Bacillus subtilis(KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis(KCTC 1917)(MIC=4 μM), Staphylococcus aureus(KCTC1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli(KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa(KCTC 1637)(MIC=8 μM), Salmonella typhimurium(KCTC 1926)(MIC=2 μM)",[Ref.28161291] HC50>256 μM against human red blood cells,,28161291,Biochim Biophys Acta Biomembr. 2017 May;1859(5):722-733. doi: 10.1016/j.bbamem.2017.01.037.,"Rajasekaran G, Kim EY, Shin SY","LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.",Linear,L,Free,"[Ref.28161291] The cell viability of mouse macrophage RAW264.7 induced by FK13-a1 is 95.5%, 107.5%, 100.2%, 96.2%, 44.9% and 37.4% at peptide concentrations of 1.25, 2.5, 5, 10, 20 and 40 μM.## The cell viablity of human keratinocyte HaCaT induced by FK1",Amidation,None,Not found,
5301,DRAMP21233,GIMDTVKNAAKNLAGQLLDKLK,22,R2PLx-22 (Derived from R2PLx),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix",The CD spectra of both peptides shows the pattern of random coil in aqueous solution and a typical α-helix CD spectra in 50% of TFE solution.,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.30279210] Gram-positive bacteria : Staphylococcus aureus(NCTC 10788)(MIC=256 μM, MBC=256 μM), MRSA (ATCC 12493)(MIC>512 μM, MBC>512 μM), Enterococcus faecalis(NCTC 12697)(MIC>512 μM, MBC>512 μM);##Gram-negative bacteria : Escherichia coli(NCTC 10418)(MIC=128 μM, MBC=256 μM), Pseudomonas aeruginosa(ATCC 27853)(MIC= μM, MBC= μM);##Fungi : Candida albicans(NCTC 1467)(MIC=512 μM, MBC>512 μM)","[Ref.30279210] 3% hemolysis at 1 μM , 4% hemolysis at 2 μM , 1% hemolysis at 4 μM , 0% hemolysis at 8 μM , 2% hemolysis at 16 μM , 0% hemolysis at 32 μM , 0% hemolysis at 128 μM , 3% hemolysis at 256 μM , 13% hemolysis at 512 μM against human red blood cells",,30279210,Biosci Rep. 2018 Nov 9;38(6). pii: BSR20180710. doi: 10.1042/BSR20180710.,"Chen X, Zhang L, Ma C, Zhang Y, Xi X, Wang L, Zhou M, Burrows JF, Chen T","A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells.",Linear,L,Free,[Ref.30279210] No cytotoxicity information found,Free,None,Not found,
5302,DRAMP21244,FLSLIPKLVKKIIKAFK,17,TsAP-S1 (Derived from TsAP-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Anticancer against H157, H838, MCF-7, PC3 and U251-MG","[Ref.23770440] Gram-positive bacteria : Staphylococcus aureus(MIC=2.5 μM, MBC=20 μM);##Gram-negative bacteria : Escherichia coli(MIC=5 μM, MBC=20 μM);##Fungi : Candida albicans(MIC=2.5 μM, MBC=5 μM)","[Ref.23770440] 30% hemolysis at 5 μM , 85% hemolysis at 10 μM , 100% hemolysis at 20 μM against horse red blood cells",,23770440,Biochimie. 2013 Sep;95(9):1784-94. doi: 10.1016/j.biochi.2013.06.003.,"Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, Chen T, Shaw C","Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",Linear,L,Free,[Ref.23770440] No cytotoxicity information found.,Amidation,None,Not found,
5303,DRAMP21245,FLGMIPKLIKKLIKAFK,17,TsAP-S2 (Derived from TsAP-2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Alpha helix,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Anticancer against H157, H838, MCF-7, PC3 and U252-MG","[Ref.23770440] Gram-positive bacteria : Staphylococcus aureus(MIC=5 μM, MBC=20 μM);##Gram-negative bacteria : Escherichia coli(MIC=5 μM, MBC=40 μM);##Fungi : Candida albicans(MIC=2.5 μM, MBC=10 μM)","[Ref.23770440] 30% hemolysis at 5 μM , 85% hemolysis at 10 μM , 100% hemolysis at 20 μM against horse red blood cells",,23770440,Biochimie. 2013 Sep;95(9):1784-94. doi: 10.1016/j.biochi.2013.06.003.,"Guo X, Ma C, Du Q, Wei R, Wang L, Zhou M, Chen T, Shaw C","Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",Linear,L,Free,[Ref.23770440] No cytotoxicity information found.,Amidation,None,Not found,
5304,DRAMP21246,KKWRWWLKALAKK,13,pEM-2 (Derived from the venom of the snake Bothrops asper),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27591703] Gram-positive bacteria : Staphylococcus aureus isolates(MIC=5.3 ± 2.3 mg/L, MBC=6.7 ± 2.3 mg/L), Enterococcus faecalis isolates(MIC=6.7 ± 2.3 mg/L, MBC=8.0 ± 0.0 mg/L);##Gram-negative bacteria : Pseudomonas aeruginosa isolates(MIC=4.0 ± 3.5 mg/L, MBC=4.0 ± 3.5 mg/L), Acinetobacter baumannii isolates(MIC=4.0 ± 0.0 mg/L, MBC=5.3 ± 2.3 mg/L)","[Ref.27591703] 0% hemolysis at 2 μg/ml , 5% hemolysis at 4 μg/ml , 15% hemolysis at 8 μg/ml , 55% hemolysis at 16 μg/ml , 87% hemolysis at 32 μg/ml , 92% hemolysis at 64 μg/ml against human red blood cells; 0% hemolysis at 16 μg/ml , 2.5% hemolysis at 32 μg/ml , 10% hemolysis at 64 μg/ml against sheep red blood cells",,27591703,Chem Biol Drug Des. 2017 Mar;89(3):327-338. doi: 10.1111/cbdd.12864.,"Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K","Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.",Linear,L,Free,"[Ref.27591703] The cell viability of HEK293 cells induced by PV is 99.1%, 99.1%, 98.3%, 94.8%, 93.9%, 87.5% and 84.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μg/mL within 24h.",Amidation,None,Not found,
5305,DRAMP21247,KKWRWWLKALAKKLL,15,PV (Derived from pEM-2 and MP-VT1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27591703] Gram-positive bacteria : Staphylococcus aureus isolates(MIC=0.5 ± 0.0 mg/L, MBC=0.5 ± 0.0 mg/L), Enterococcus faecalis isolates(MIC=0.7 ± 0.3 mg/L, MBC=0.8 ± 0.3 mg/L);##Gram-negative bacteria : Pseudomonas aeruginosa isolates(MIC=1.2 ± 0.8 mg/L, MBC=1.3 ± 0.6 mg/L), Acinetobacter baumannii isolates(MIC=0.4 ± 0.1 mg/L, MBC=0.5 ± 0.0 mg/L)","[Ref.27591703] 0% hemolysis at 32 μg/ml , 5% hemolysis at 64 μg/ml against human red blood cells; 0% hemolysis at 32 μg/ml , 8% hemolysis at 64 μg/ml against sheep red blood cells",,27591703,Chem Biol Drug Des. 2017 Mar;89(3):327-338. doi: 10.1111/cbdd.12864.,"Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K","Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.",Linear,L,Free,"[Ref.27591703] The cell viability of HEK293 cells induced by PV is 98.8%, 97.4%, 85.8%, 56.2%, 22.8%, 12.2% and 2.3% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μg/mL within 24h.",Amidation,None,Not found,
5306,DRAMP21248,LKLKAIAALAKKKW,14,BVP (Derived from pEM-2 and MP-VT1 and MP-B),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27591703] Gram-positive bacteria : Staphylococcus aureus isolates(MIC=24.0 ± 13.9 mg/L, MBC=37.3 ± 24.4 mg/L), Enterococcus faecalis isolates(MIC=12.0 ± 6.9 mg/L, MBC=18.7 ± 12.2 mg/L);##Gram-negative bacteria : Pseudomonas aeruginosa isolates(MIC=16.0 ± 13.9 mg/L, MBC=18.7 ± 12.2 mg/L), Acinetobacter baumannii isolates(MIC=8.0 ± 0.0 mg/L, MBC=10.7 ± 4.6 mg/L)","[Ref.27591703] 0% hemolysis at 64 μg/ml against human red blood cells; 0% hemolysis at 16 μg/ml , 2.5% hemolysis at 32 μg/ml , 10% hemolysis at 64 μg/ml against sheep red blood cells",,27591703,Chem Biol Drug Des. 2017 Mar;89(3):327-338. doi: 10.1111/cbdd.12864.,"Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K","Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.",Linear,L,Free,"[Ref.27591703] The cell viability of HEK293 cells induced by PV is 98.9%, 95.4%, 89.7%, 83.4%, 83.1%, 73.7% and 71.5% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μg/mL within 24h.",Amidation,None,Not found,
5307,DRAMP21249,KKWRKLLKWLAKK,13,PVP (Derived from MP-B and MP-VT1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27591703] Gram-positive bacteria : Staphylococcus aureus isolates(MIC=4.3 ± 3.5 mg/L, MBC=6.0 ± 3.5 mg/L), Enterococcus faecalis isolates(MIC=2.7 ± 1.2 mg/L, MBC=3.3 ± 1.2 mg/L);##Gram-negative bacteria : Pseudomonas aeruginosa isolates(MIC=1.3 ± 0.6 mg/L, MBC=1.7 ± 0.6 mg/L), Acinetobacter baumannii isolates(MIC=2.3 ± 1.5 mg/L, MBC=2.7 ± 1.2 mg/L)",[Ref.27591703] 0% hemolysis at 64 μg/ml against human red blood cells; 0% hemolysis at 64 μg/ml against sheep red blood cells,,27591703,Chem Biol Drug Des. 2017 Mar;89(3):327-338. doi: 10.1111/cbdd.12864.,"Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K","Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.",Linear,L,Free,"[Ref.27591703] The cell viability of HEK293 cells induced by PV is 98.8%, 100%, 97.3%, 94.2%, 92.3%, 89.2% and 84.6% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μg/mL within 24h.",Amidation,None,Not found,
5308,DRAMP21250,KKWRKLLKKLKKLL,14,PV3 (Derived from pEM-2 and MP-VT1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.27591703] Gram-positive bacteria : Staphylococcus aureus isolates(MIC=2.0 ± 1.7 mg/L, MBC=2.3 ± 1.5 mg/L), Enterococcus faecalis isolates(MIC=1.2 ± 0.8 mg/L, MBC=1.3 ± 0.6 mg/L);##Gram-negative bacteria : Pseudomonas aeruginosa isolates(MIC=1.0 ± 0.0 mg/L, MBC=1.3 ± 0.6 mg/L), Acinetobacter baumannii isolates(MIC=1.0 ± 0.0 mg/L, MBC=1.7 ± 0.6 mg/L)",[Ref.27591703] 0% hemolysis at 64 μg/ml against human red blood cells; 10% hemolysis at 64 μg/ml against sheep red blood cells,,27591703,Chem Biol Drug Des. 2017 Mar;89(3):327-338. doi: 10.1111/cbdd.12864.,"Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K","Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.",Linear,L,Free,"[Ref.27591703] The cell viability of HEK293 cells induced by PV is 98.8%, 99.2%, 95.4%, 93.8%, 91.9%, 77.3% and 55.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μg/mL within 24h.",Amidation,None,Not found,
5311,DRAMP21253,FLFKLIPKAIKGLVKAIRK,19,AaeAP1a (Derived from AaeAP1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.25626077] Gram-positive bacteria : Staphylococcus aureus(MIC=4 mg/L, MBC=32 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=16 mg/L, MBC=32 mg/L);##Fungi : Candida albicans(MIC=4 mg/L, MBC=16 mg/L)",[Ref.25626077] 100% hemolysis at 32 μg/ml against horse red blood cells,,25626077,Toxins (Basel). 2015 Jan 23;7(2):219-37. doi: 10.3390/toxins7020219.,"Du Q, Hou X, Wang L, Zhang Y, Xi X, Wang H, Zhou M, Duan J, Wei M, Chen T, Shaw C","AaeAP1 and AaeAP2: novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities.",Linear,L,Free,[Ref.25626077] No cytotoxicity information found.,Amidation,None,Not found,
5312,DRAMP21254,FLFKLIPKVIKGLVKAIRK,19,AaeAP2a (Derived from AaeAP2),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans,"[Ref.25626077] Gram-positive bacteria : Staphylococcus aureus(MIC=4 mg/L, MBC=32 mg/L);##Gram-negative bacteria : Escherichia coli(MIC=16 mg/L, MBC=32 mg/L);##Fungi : Candida albicans(MIC=4 mg/L, MBC=16 mg/L)",[Ref.25626077] 100% hemolysis at 64 μg/ml against horse red blood cells,,25626077,Toxins (Basel). 2015 Jan 23;7(2):219-37. doi: 10.3390/toxins7020219.,"Du Q, Hou X, Wang L, Zhang Y, Xi X, Wang H, Zhou M, Duan J, Wei M, Chen T, Shaw C","AaeAP1 and AaeAP2: novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities.",Linear,L,Free,[Ref.25626077] No cytotoxicity information found.,Amidation,None,Not found,
5313,DRAMP21255,WLSKTAKKL,9,WL1 (Derived from CP-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unordered conformation,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.29266746] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC>128 μM), Staphylococcus aureus ATCC 43300(MIC>128 μM), Staphylococcus epidermidis ATCC 12228(MIC>128 μM), Bacillus subtilis CMCC 63501(MIC>128 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC>128 μM), Escherichia coli UB1005(MIC>128 μM), Pseudomonas aeruginosa ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 7731(MIC>128 μM), Salmonella pullorum C79-13(MIC>128 μM)",[Ref.29266746] MHC5>128 μM against human red blood cells,,29266746,Chem Biol Drug Des. 2018 May;91(5):1017-1029. doi: 10.1111/cbdd.13165.,"Dong N, Wang Z, Chou S, Zhang L, Shan A, Jiang J",Antibacterial activities and molecular mechanism of amino-terminal fragments from pig nematode antimicrobial peptide CP-1.,Linear,L,Free,"[Ref.29266746] The cell viability of IPEC-J2 cells induced by WL1 is 99.2%, 89.8%, 86.2%, 90.8%, 87.8%, 94.3% and 76.5% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of IPEC-J2 cells induced by the control Melittin is 7",Amidation,None,Not found,
5314,DRAMP21256,WLSKTAKKLWLSKTAKKL,18,WL2 (Derived from CP-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.29266746] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC=128 μM), Staphylococcus aureus ATCC 43300(MIC=128 μM), Staphylococcus epidermidis ATCC 12228(MIC=128 μM), Bacillus subtilis CMCC 63501(MIC=64 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC=8 μM), Escherichia coli UB1005(MIC=8 μM), Pseudomonas aeruginosa ATCC 27853(MIC=16 μM), Salmonella typhimurium ATCC 7731(MIC=32 μM), Salmonella pullorum C79-13(MIC=16 μM)",[Ref.29266746] MHC5>128 μM against human red blood cells,,29266746,Chem Biol Drug Des. 2018 May;91(5):1017-1029. doi: 10.1111/cbdd.13165.,"Dong N, Wang Z, Chou S, Zhang L, Shan A, Jiang J",Antibacterial activities and molecular mechanism of amino-terminal fragments from pig nematode antimicrobial peptide CP-1.,Linear,L,Free,"[Ref.29266746] The cell viability of IPEC-J2 cells induced by WL2 is 99.0%, 95.0%, 89%, 89.8%, 85.2%, 86.8% and 75.1% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of IPEC-J2 cells induced by the control Melittin is 77.",Amidation,None,Not found,
5315,DRAMP21257,WLSKTAKKLWLSKTAKKLWLSKTAKKL,27,WL3 (Derived from CP-1),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Random coil, alpha helix",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.29266746] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC=32 μM), Staphylococcus aureus ATCC 43300(MIC=32 μM), Staphylococcus epidermidis ATCC 12228(MIC=32 μM), Bacillus subtilis CMCC 63501(MIC=8 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC=2 μM), Escherichia coli UB1005(MIC=2 μM), Pseudomonas aeruginosa ATCC 27853(MIC=2 μM), Salmonella typhimurium ATCC 7731(MIC=8 μM), Salmonella pullorum C79-13(MIC=2 μM)",[Ref.29266746] MHC5>128 μM against human red blood cells,,29266746,Chem Biol Drug Des. 2018 May;91(5):1017-1029. doi: 10.1111/cbdd.13165.,"Dong N, Wang Z, Chou S, Zhang L, Shan A, Jiang J",Antibacterial activities and molecular mechanism of amino-terminal fragments from pig nematode antimicrobial peptide CP-1.,Linear,L,Free,"[Ref.29266746] The cell viability of IPEC-J2 cells induced by WL3 is 97.0%, 100.4%, 91.4%, 91.5%, 87.2%, 86.7% and 78.7% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of IPEC-J2 cells induced by the control Melittin is ",Amidation,None,Not found,
5316,DRAMP21258,SWLSKTAKKLENSAKKRISEGIAIAIQGGPR,31,"Cecropin P1 (CP-1) (nematodes, animals)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,2N92 resolved by NMR,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.29266746] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC>128 μM), Staphylococcus aureus ATCC 43300(MIC>128 μM), Staphylococcus epidermidis ATCC 12228(MIC>128 μM), Bacillus subtilis CMCC 63501(MIC=1 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC=0.5 μM), Escherichia coli UB1005(MIC=0.5 μM), Pseudomonas aeruginosa ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 7731(MIC=2 μM), Salmonella pullorum C79-13(MIC=0.5 μM)",[Ref.29266746] MHC5>128 μM against human red blood cells,,29266746,Chem Biol Drug Des. 2018 May;91(5):1017-1029. doi: 10.1111/cbdd.13165.,"Dong N, Wang Z, Chou S, Zhang L, Shan A, Jiang J",Antibacterial activities and molecular mechanism of amino-terminal fragments from pig nematode antimicrobial peptide CP-1.,Linear,L,Free,"[Ref.29266746] The cell viability of IPEC-J2 cells induced by CP-1 is 87.9%, 100.4%, 93.5%, 88.5%, 91.8%, 84.2% and 86.3% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of IPEC-J2 cells induced by the control Melittin is",Amidation,None,Not found,
5317,DRAMP21259,MDSFQKIEKIGEGTYGVVYKAKDKVSGRLVALKKIRLENESEGVPSTA,48,"Scolopendin 1 (Centipedes, Arthropoda, Animals)",No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Not found,Not found,None,"Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans, Candida parapsilosis, Trichosporon beigelii","[Ref.25209888] Gram-positive bacteria : Staphylococcus aureus ATCC 25923(MIC=5.0 ± 4.3 μM), Enterococcus faecium ATCC 19434(MIC=10.0 ± 8.7 μM);##Gram-negative bacteria : Escherichia coli O-157 ATCC 43895(MIC=5.0 ± 4.3 μM), Pseudomonas aeruginosa ATCC 27853(MIC= 5.0 ± 4.3 μM);##Fungi : Candida albicans ATCC 90028(MIC=10.0 ± 8.7 μM), Candida parapsilosis ATCC 22019(MIC= 10.0 ± 8.7 μM), Trichosporon beigelii KCTC 7707(MIC=20.0 ± 17.3 μM)",[Ref.25209888] 0% hemolysis at 80 μM against human red blood cells,,25209888,Insect Mol Biol. 2014 Dec;23(6):788-99. doi: 10.1111/imb.12124.,"Choi H, Hwang JS, Lee DG","Identification of a novel antimicrobial peptide, scolopendin 1, derived from centipede Scolopendra subspinipes mutilans and its antifungal mechanism.",Linear,L,Free,[Ref.25209888] No cytotoxicity information found,Amidation,None,Not found,
5318,DRAMP21260,AAKAAAKAAAKAA,13,KL0A10 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Uncertain antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.26385363] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC>128 μM), Staphylococcus epidermidis ATCC 12228(MIC>128 μM), Streptococcus faecalis ATCC 29212(MIC>128 μM), Bacillus subtilis CMCC 63501(MIC>128 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC>128 μM), Escherichia coli K88(MIC>128 μM), Escherichia coli CVCC 1515(MIC>128 μM), Escherichia coli UB1005(MIC>128 μM), Bacterium pyocyaneum ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 14028(MIC>128 μM), Salmonella pullorum C79–13(MIC>128 μM)",[Ref.26385363] MHC5>256 μM against human red blood cells,,26385363,Amino Acids. 2016 Feb;48(2):403-17. doi: 10.1007/s00726-015-2094-y.,"Li W, Tan T, Xu W, Xu L, Dong N, Ma D, Shan A",Rational design of mirror-like peptides with alanine regulation.,Linear,L,Free,"[Ref.26385363] The cell viability of HEK293 cells induced by KL0A10 is 103.9%, 110%, 110.6%, 107.8%, 110.3%, 110.1%, 107.2% and 106.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of HEK293 cells induced by control M",Amidation,None,Not found,
5319,DRAMP21261,LLKAAAKAAAKLL,13,KL4A6 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26385363] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC>128 μM), Staphylococcus epidermidis ATCC 12228(MIC=128 μM), Streptococcus faecalis ATCC 29212(MIC=16 μM), Bacillus subtilis CMCC 63501(MIC=32 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC=2 μM), Escherichia coli K88(MIC=32 μM), Escherichia coli CVCC 1515(MIC=32 μM), Escherichia coli UB1005(MIC=32 μM), Bacterium pyocyaneum ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 14028(MIC=128 μM), Salmonella pullorum C79–13(MIC>128 μM)",[Ref.26385363] MHC5>256 μM against human red blood cells,,26385363,Amino Acids. 2016 Feb;48(2):403-17. doi: 10.1007/s00726-015-2094-y.,"Li W, Tan T, Xu W, Xu L, Dong N, Ma D, Shan A",Rational design of mirror-like peptides with alanine regulation.,Linear,L,Free,"[Ref.26385363] The cell viability of HEK293 cells induced by KL4A6 is 107.8%, 108.3%, 104.4%, 104.7%, 105.6%, 100%, 94.4% and 96.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of HEK293 cells induced by control Meli",Amidation,None,Not found,
5320,DRAMP21262,AAKLLLKLLLKAA,13,KL6A4 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26385363] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC=32 μM), Staphylococcus epidermidis ATCC 12228(MIC=16 μM), Streptococcus faecalis ATCC 29212(MIC=16 μM), Bacillus subtilis CMCC 63501(MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC=1 μM), Escherichia coli K88(MIC=16 μM), Escherichia coli CVCC 1515(MIC=16 μM), Escherichia coli UB1005(MIC=32 μM), Bacterium pyocyaneum ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 14028(MIC>128 μM), Salmonella pullorum C79–13(MIC>128 μM)",[Ref.26385363] MHC5=8 μM against human red blood cells,,26385363,Amino Acids. 2016 Feb;48(2):403-17. doi: 10.1007/s00726-015-2094-y.,"Li W, Tan T, Xu W, Xu L, Dong N, Ma D, Shan A",Rational design of mirror-like peptides with alanine regulation.,Linear,L,Free,"[Ref.26385363] The cell viability of HEK293 cells induced by KL6A4 is 102.8%, 109.4%, 103.9%, 109.4%, 105.3%, 90.6%,  83.1% and 81.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of HEK293 cells induced by control Me",Amidation,None,Not found,
5321,DRAMP21263,LLKLLLKLLLKLL,13,KL10A0 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Uncertain antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.26385363] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC>128 μM), Staphylococcus epidermidis ATCC 12228(MIC>128 μM), Streptococcus faecalis ATCC 29212(MIC>128 μM), Bacillus subtilis CMCC 63501(MIC>128 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC>128 μM), Escherichia coli K88(MIC>128 μM), Escherichia coli CVCC 1515(MIC>128 μM), Escherichia coli UB1005(MIC>128 μM), Bacterium pyocyaneum ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 14028(MIC>128 μM), Salmonella pullorum C79–13(MIC>128 μM)",[Ref.26385363] MHC5=2 μM against human red blood cells,,26385363,Amino Acids. 2016 Feb;48(2):403-17. doi: 10.1007/s00726-015-2094-y.,"Li W, Tan T, Xu W, Xu L, Dong N, Ma D, Shan A",Rational design of mirror-like peptides with alanine regulation.,Linear,L,Free,"[Ref.26385363] The cell viability of HEK293 cells induced by KL10A0 is 93.9%, 93.3%, 81.9%, 77.2%, 75.6%, 67.8%, 51.9% and 19.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of HEK293 cells induced by control Melitti",Amidation,None,Not found,
5322,DRAMP21264,LKKLLKLLKKLLKLAG,16,LK (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=20 μM),[Ref.23894079] MHC10=0.08 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5323,DRAMP21265,AKKLLKLLKKLLKLAG,16,LK-L1A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5324,DRAMP21266,LKKALKLLKKLLKLAG,16,LK-L4A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5325,DRAMP21267,LKKLAKLLKKLLKLAG,16,LK-L5A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5326,DRAMP21268,LKKLLKALKKLLKLAG,16,LK-L7A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5327,DRAMP21269,LKKLLKLAKKLLKLAG,16,LK-L8A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5328,DRAMP21270,LKKLLKLLKKALKLAG,16,LK-L11A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5329,DRAMP21271,LKKLLKLLKKLAKLAG,16,LK-L12A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10=0.63 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5330,DRAMP21272,LKKLLKLLKKLLKAAG,16,LK-L14A (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10=1.25 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5331,DRAMP21273,LKKLLKLGKKLLKLAG,16,LK-L8G (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=5 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM),[Ref.23894079] MHC10=10 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5332,DRAMP21274,LKKLLKLSKKLLKLAG,16,LK-L8S (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC=10 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM),[Ref.23894079] MHC10=20 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5333,DRAMP21275,LKKLLKLPKKLLKLAG,16,LK-L8P (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=160 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5334,DRAMP21276,LKKLLKLNKKLLKLAG,16,LK-L8N (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM),[Ref.23894079] MHC10=640 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5335,DRAMP21277,LKKLLKLQKKLLKLAG,16,LK-L8Q (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM),[Ref.23894079] MHC10=320 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5336,DRAMP21278,LKKLLKLDKKLLKLAG,16,LK-L8D (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10=1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5337,DRAMP21279,LKKLLKLEKKLLKLAG,16,LK-L8E (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=320 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5338,DRAMP21280,LKKLLKLKKKLLKLAG,16,LK-L8K (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=160 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5339,DRAMP21281,LKKLLKLHKKLLKLAG,16,LK-L8H (Derived from LK),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=2.5 μM),[Ref.23894079] MHC10=80 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5340,DRAMP21282,AKRIVQRIKDFLR,13,Lt-F1A (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10>640 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5341,DRAMP21283,FKRAVQRIKDFLR,13,Lt-I4A (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10>640 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5342,DRAMP21284,FKRIAQRIKDFLR,13,Lt-V5A (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=320 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5343,DRAMP21285,FKRIVQRAKDFLR,13,Lt-I8A (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10>640 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5344,DRAMP21286,FKRIVQRIKDALR,13,Lt-F11A (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10>640 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5345,DRAMP21287,FKRIVQRIKDFAR,13,Lt-F12A (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10>640 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5346,DRAMP21288,FKRGVQRIKDFLR,13,Lt-I4G (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5347,DRAMP21289,FKRSVQRIKDFLR,13,Lt-I4S (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5348,DRAMP21290,FKRNVQRIKDFLR,13,Lt-I4N (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=20 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5349,DRAMP21291,FKRQVQRIKDFLR,13,Lt-I4Q (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5350,DRAMP21292,FKRHVQRIKDFLR,13,Lt-I4H (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5351,DRAMP21293,FKRIGQRIKDFLR,13,Lt-V5G (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5352,DRAMP21294,FKRISQRIKDFLR,13,Lt-V5S (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=640 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5353,DRAMP21295,FKRINQRIKDFLR,13,Lt-V5N (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5354,DRAMP21296,FKRIQQRIKDFLR,13,Lt-V5Q (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10=1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5355,DRAMP21297,FKRIHQRIKDFLR,13,Lt-V5H (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=5 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5356,DRAMP21298,FKRIVQRIKDGLR,13,Lt-F11G (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=20 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5357,DRAMP21299,FKRIVQRIKDSLR,13,Lt-F11S (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5358,DRAMP21300,FKRIVQRIKDNLR,13,Lt-F11N (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=20 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5359,DRAMP21301,FKRIVQRIKDQLR,13,Lt-F11Q (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5360,DRAMP21302,FKRIVQRIKDHLR,13,Lt-F11H (Derived from Lt),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-negative bacteria. Uncertain antibacterial activity against Gram-positive bacteria.,[Ref.23894079] Gram-positive bacteria : Staphylococcus aureus (ATCC 29213)(MIC>40 μM);##Gram-negative bacteria : Escherichia coli (ATCC 25922)(MIC=10 μM),[Ref.23894079] MHC10>1280 μM against human red blood cells,,23894079,ChemMedChem. 2013 Oct;8(10):1638-42. doi: 10.1002/cmdc.201300264.,"Son M, Lee Y, Hwang H, Hyun S, Yu J",Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Linear,L,Free,[Ref.23894079] No cytotoxicity information found.,Free,None,Not found,
5361,DRAMP21303,RIIDLLARVRRPQKPKFVTVWVR,23,A7-PMAP-23 (Derived from PMAP-23),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Alpha helix, beta turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.10527878] Gram-positive bacteria : Bacillus subtilis (KCTC 1918)(MIC=1.56 μM), Streptococcus pyogenes (KCTC 3096)(MIC=1.56 μM), Staphylococcus aureus (KCTC 1621)(MIC=3.125 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=3.125 μM), Salmonella typhimurium (KCTC 1926)(MIC=1.56 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=1.56 μM)",[Ref.10527878] 0% hemolysis at 100 μM against human red blood cells,,10527878,Biochem Biophys Res Commun. 1999 Oct 14;264(1):281-6.,"Kang JH, Shin SY, Jang SY, Kim KL, Hahm KS.",Effects of tryptophan residues of porcine myeloid antibacterial peptide PMAP-23 on antibiotic activity.,Linear,L,Free,[Ref.10527878] No cytotoxicity information found.,Free,None,Not found,
5362,DRAMP21304,RIIDLLWRVRRPQKPKFVTVAVR,23,A21-PMAP-23 (Derived from PMAP-23),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Alpha helix, beta turn",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.10527878] Gram-positive bacteria : Bacillus subtilis (KCTC 1918)(MIC=3.125 μM), Streptococcus pyogenes (KCTC 3096)(MIC=3.125 μM), Staphylococcus aureus (KCTC 1621)(MIC=6.25 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=6.25 μM), Salmonella typhimurium (KCTC 1926)(MIC=3.125 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=3.125 μM)",[Ref.10527878] 0% hemolysis at 100 μM against human red blood cells,,10527878,Biochem Biophys Res Commun. 1999 Oct 14;264(1):281-6.,"Kang JH, Shin SY, Jang SY, Kim KL, Hahm KS.",Effects of tryptophan residues of porcine myeloid antibacterial peptide PMAP-23 on antibiotic activity.,Linear,L,Free,[Ref.10527878] No cytotoxicity information found.,Free,None,Not found,
5363,DRAMP21305,RRRRRRRR,8,R8 (De novo synthesis),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Alpha helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,[Ref.23085001] Gram-positive bacteria : Staphylococcus aureus(ATCC 33591)(MIC=44 μM);##Gram-negative bacteria : Escherichia coli(ATCC 25922)(MIC=44 μM),[Ref.23085001] HC50>128 μM against human red blood cells,,23085001,Biochim Biophys Acta. 2013 Feb;1828(2):223-32. doi: 10.1016/j.bbamem.2012.10.010.,"Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM",Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure.,Linear,L,Free,[Ref.23085001] No cytotoxicity information found.,Amidation,None,Not found,
5364,DRAMP21306,FVQWWSKWLGRIL,13,TL-1 (Derived from Temporin-1Tl (TL)),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26311041] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=2 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=4 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=4 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=32 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)",[Ref.26311041] HC50=21.4 μM against human red blood cells,,26311041,J Pept Sci. 2015 Oct;21(10):779-85. doi: 10.1002/psc.2807.,"Rajasekaran G, Kamalakannan R, Shin SY","Enhancement of the anti-inflammatory activity of temporin-1Tl-derived antimicrobial peptides by tryptophan, arginine and lysine substitutions.",Linear,L,Free,"[Ref.26311041] The cell viability of RAW264.7 macrophages cells induced by TL-1 is 112.2%, 109.3% and 109.3% at peptide concentrations of 2.5, 5 and 10 μM.",Amidation,None,Not found,
5365,DRAMP21307,FVRWWSKWLRRIL,13,TL-2 (Derived from Temporin-2Tl (TL)),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26311041] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=8 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)",[Ref.26311041] HC50=8.5 μM against human red blood cells,,26311041,J Pept Sci. 2015 Oct;21(10):779-85. doi: 10.1002/psc.2807.,"Rajasekaran G, Kamalakannan R, Shin SY","Enhancement of the anti-inflammatory activity of temporin-1Tl-derived antimicrobial peptides by tryptophan, arginine and lysine substitutions.",Linear,L,Free,"[Ref.26311041] The cell viability of RAW264.7 macrophages cells induced by TL-2 is 111.8%, 112.5% and 81.0% at peptide concentrations of 2.5, 5 and 10 μM.",Amidation,None,Not found,
5366,DRAMP21308,FVRWWSRWLRRIL,13,TL-3 (Derived from Temporin-3Tl (TL)),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26311041] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=8 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=8 μM), Salmonella typhimurium (KCTC 1926)(MIC=4 μM)",[Ref.26311041] HC50=8.0 μM against human red blood cells,,26311041,J Pept Sci. 2015 Oct;21(10):779-85. doi: 10.1002/psc.2807.,"Rajasekaran G, Kamalakannan R, Shin SY","Enhancement of the anti-inflammatory activity of temporin-1Tl-derived antimicrobial peptides by tryptophan, arginine and lysine substitutions.",Linear,L,Free,"[Ref.26311041] The cell viability of RAW264.7 macrophages cells induced by TL-3 is 117.4%, 111.5% and 110.5% at peptide concentrations of 2.5, 5 and 10 μM.",Amidation,None,Not found,
5367,DRAMP21309,FVKWWSKWLKKIL,13,TL-4 (Derived from Temporin-4Tl (TL)),No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Not found,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria,"[Ref.26311041] Gram-positive bacteria : Bacillus subtilis (KCTC 3068)(MIC=4 μM), Staphylococcus epidermidis (KCTC 1917)(MIC=8 μM), Staphylococcus aureus (KCTC 1621)(MIC=2 μM);##Gram-negative bacteria : Escherichia coli (KCTC 1682)(MIC=8 μM), Pseudomonas aeruginosa (KCTC 1637)(MIC=16 μM), Salmonella typhimurium (KCTC 1926)(MIC=2 μM)",[Ref.26311041] HC50=15.9 μM against human red blood cells,,26311041,J Pept Sci. 2015 Oct;21(10):779-85. doi: 10.1002/psc.2807.,"Rajasekaran G, Kamalakannan R, Shin SY","Enhancement of the anti-inflammatory activity of temporin-1Tl-derived antimicrobial peptides by tryptophan, arginine and lysine substitutions.",Linear,L,Free,"[Ref.26311041] The cell viability of RAW264.7 macrophages cells induced by TL-4 is 116.7%, 118.2% and 87.2% at peptide concentrations of 2.5, 5 and 10 μM.",Amidation,None,Not found,
5368,DRAMP21311,RWLRKWTRKRLK,12,2W-1 (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=64 μM), Staphylococcus aureus 25923 (MIC=32 μM), Staphylococcus  epidermidis 12228 (MIC=16 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=16 μM), Escherichia coli 1005 (MIC=16 μM), Staphylococcus typhi (MIC=64 μM)",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00289.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 2W-1 is 95.9%, 92.4%, 89.0%, 86.4%, 85.7%, 94.1%, 91.9% and 98.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5369,DRAMP21312,RRLRWKTRWRLK,12,2W-2 (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=16 μM), Staphylococcus aureus 25923 (MIC=16 μM), Staphylococcus  epidermidis 12228 (MIC=16 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=16 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=32 μM)",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00290.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 2W-2 is 94.8%, 92.1%, 95.5%, 98.3%, 94.5%, 95%, 89.5% and  84.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5370,DRAMP21313,RRLRKKTWKRLW,12,2W-3 (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=64 μM), Staphylococcus aureus 25923 (MIC>128 μM), Staphylococcus  epidermidis 12228 (MIC=64 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=16 μM), Escherichia coli 1005 (MIC=32 μM), Staphylococcus typhi (MIC=64 μM)",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00291.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 2W-3 is 95.2%, 89.7%, 87.2%, 91.6%, 85%, 88.4%, 84.8% AND 89.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5371,DRAMP21314,RWLRKWTRKWLK,12,3W-1 (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=8 μM), Staphylococcus aureus 25923 (MIC=16 μM), Staphylococcus  epidermidis 12228 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=16 μM)",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00292.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3W-1 is 99.5%, 96.2%, 95.7%, 90.9%, 69.1%, 6.4%, -1% and 0% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5372,DRAMP21315,WRLRWKTRWRLK,12,3W-2 (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=4 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=4 μM), Staphylococcus aureus 11011  (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=2 μM), Pseudomonas aeruginosa 25349 (MIC=8 μM),  Acinetobacter baumannii AB1901 (MIC=4 μM),  Acinetobacter baumannii AB1902 (MIC=4 μM).",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00293.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3W-2 is 100.9%, 96%, 103.4%, 97.2%, 104.7%, 103.6%, 97.6%, 90.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5373,DRAMP21316,RRLWKKTWKRLW,12,3W-3 (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=8 μM), Staphylococcus aureus 25923 (MIC=16 μM), Staphylococcus  epidermidis 12228 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=8 μM)",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00294.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3W-3 is 94.8%, 100.9%, 93.4%, 94.0%, 93.6%, 73.4%, 14.5% and -1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5374,DRAMP21317,RWLRWKTRWRLK,12,3W-4 (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=4 μM), Staphylococcus aureus 25923 (MIC=16 μM), Staphylococcus  epidermidis 12228 (MIC=16 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=8 μM)",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00295.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3W-4 is 100.2%, 92.2%, 96.2%, 89.0%, 94.1%, 97.4%, 94.3% and 88.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5375,DRAMP21318,RRLRWWTRWRLK,12,3W-5 (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=4 μM), Staphylococcus aureus 25923 (MIC=8 μM), Staphylococcus  epidermidis 12228 (MIC=8 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=8 μM)",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00296.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3W-5 is 96.4%, 99.1%, 100.2%, 101.4%, 97.8%, 99%, 102.6% and 82.6% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5376,DRAMP21319,VRLRVKTRVRLK,12,3V (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=16 μM), Staphylococcus aureus 25923 (MIC=64 μM), Staphylococcus  epidermidis 12228 (MIC=32 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=16 μM)",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00297.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3V is 98.6%, 101.4%, 103.4%, 92.4%, 101%, 101.9%, 93.6% and 97.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5377,DRAMP21320,LRLRLKTRLRLK,12,3L (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=32 μM), Staphylococcus aureus 25923 (MIC=32 μM), Staphylococcus  epidermidis 12228 (MIC=64 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=16 μM)",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00298.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3L is 95.9%, 92.4%, 91.6%, 82.1%, 104.3%, 97.1%, 99.5% and 96.6% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5378,DRAMP21321,RWLRWWTRWRLK,12,4W (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=4 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=4 μM)",[Ref.31276398] MHC=128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00299.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 4W is 95.3%, 88.3%, 89.7%, 97.9%, 91.2%, 77.6%, 32.8% and 0% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5379,DRAMP21322,WRVRWKTRWRVK,12,RTV (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=4 μM), Staphylococcus  epidermidis 12228 (MIC=4 μM), Staphylococcus aureus 11011 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=4 μM), Escherichia coli 20411 (MIC=4 μM), Acinetobacter baumannii AB1901 (MIC=8 μM),  Acinetobacter baumannii AB1902 (MIC=8 μM), Pseudomonas aeruginosa 25349 (MIC=32 μM)",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00300.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RTV is 106.6%, 103.1%, 94.0%, 106.4%, 96.4%, 104.8%, 95.5% and 96.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5380,DRAMP21323,WRIRWKTRWRIK,12,RTI (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=2 μM), Pseudomonas aeruginosa 25349 (MIC=8 μM).",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00301.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RTI is 103.1%, 97.4%, 103.8%, 106.4%, 96.4%, 104.8%, 95.7% and 96.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5381,DRAMP21324,WRFRWKTRWRFK,12,RTF (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=4 μM), Pseudomonas aeruginosa 25349 (MIC=8 μM).",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00302.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RTF is 100.7%, 101.6%, 97.8%, 99.0%, 100.9%, 97.4%, 95.3% and 90.3% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5382,DRAMP21325,WRLRWRTRWRLR,12,RTL (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=4 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=4 μM), Pseudomonas aeruginosa 25349 (MIC=16 μM).",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00303.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RTL is 102.2%, 104.5%, 94.8%, 103.1%, 103.6%, 103.6%, 105.5% and 105.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5383,DRAMP21326,WRLRWRLRWRLR,12,RLR (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=1 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=1 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=4 μM), Pseudomonas aeruginosa 25349 (MIC=4 μM).",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00304.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RLR is 100%, 91.4%, 104.8%, 94.5%, 98.6%, 99.8%, 98.8% and 82.6% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5384,DRAMP21327,WRVRWRVRWRVR,12,RVR  (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=1 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=1 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=4 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=2 μM), Pseudomonas aeruginosa 25349 (MIC=4 μM).",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00305.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RVR is 97.9%, 98.6%, 91.7%, 102.9%, 102.2%, 100.3%, 98.1% and 97.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5385,DRAMP21328,WRTRWRTRWRTR,12,RTR (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=4 μM), Staphylococcus aureus 25923 (MIC=8 μM), Staphylococcus  epidermidis 12228 (MIC=8 μM), Staphylococcus aureus 11011 (MIC=4 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=4 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=32 μM), Acinetobacter baumannii AB1902 (MIC=32 μM), Pseudomonas aeruginosa 25349 (MIC>64 μM).",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00306.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RTR is 97.2%, 106.9%, 96.7%, 104.0%, 94.5%, 98.6%, 102.2% and 103.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5386,DRAMP21329,WRFRWRFRWRFR,12,RFR (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=1 μM), Staphylococcus aureus 25923 (MIC=1 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=8 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=4 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=2 μM), Pseudomonas aeruginosa 25349 (MIC=8 μM).",[Ref.31276398] MHC=64μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00307.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RFR is 106.2%, 97.6%, 99.8%, 101.7%, 100.9%, 101.6%, 78.1% and 45.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5387,DRAMP21330,WKVKWKVKWKVK,12,KVK (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=1 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM) ;##Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=1 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=1 μM), Pseudomonas aeruginosa 25349 (MIC=4 μM).",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00308.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by KVK is 101.2%, 98.3%, 98.3%, 99.1%, 95.2%, 101.9%, 96.6% and 100.5% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5388,DRAMP21331,WKLKWKLKWKLK,12,KLK (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=4 μM), Pseudomonas aeruginosa 25349 (MIC=4 μM).",[Ref.31276398] MHC=128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00309.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by KLK is 103.3%, 100.2%, 100.5%, 97.8%, 99.1%, 96.4%, 98.4% and 44.5% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5389,DRAMP21332,WKIKWKIKWKIK,12,KIK (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=2 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=2 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=2 μM), Acinetobacter baumannii AB1901 (MIC=1 μM), Acinetobacter baumannii AB1902 (MIC=2 μM), Pseudomonas aeruginosa 25349 (MIC=4 μM).",[Ref.31276398] MHC=64μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00310.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by KIK is 100.7%, 106.9%, 95.5%, 101.6%, 103.1%, 102.8%, 61.9% and 32.2% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5390,DRAMP21333,WRVRWKVRWRVK,12,RVK (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=1 μM), Staphylococcus aureus 25923 (MIC=2 μM), Staphylococcus  epidermidis 12228 (MIC=2 μM), Staphylococcus aureus 11011 (MIC=2 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=2 μM), Staphylococcus typhi (MIC=2 μM), Escherichia coli 20411 (MIC=1 μM), Acinetobacter baumannii AB1901 (MIC=2 μM), Acinetobacter baumannii AB1902 (MIC=4 μM), Pseudomonas aeruginosa 25349 (MIC=4 μM).",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00311.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RVK is 101.0%, 98.6%, 100.3%, 103.3%, 104.1%, 101.0%, 103.8% and 91.9% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5391,DRAMP21334,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT,34,"Ranatuerin-2Pb (Frogs, amphibians, animals)",A0A513ZTP5,Not found,Not found,Lithobates pipiens (Northern leopard frog) (Rana pipiens),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Transcript level,"50% Helix, 7.8% antiparallel, 1.2% parallel, 10.9% turn and 29.8% others in 50% TFE/H2O. ##3.5% Helix, 26.6% antiparallel, 0% parallel, 18.3% turn and","Ranatuerin-2Pb might also possess two helical segments at respective N-terminus and C-terminus, and the last two residues are probably included in the helix domain.",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31242693] Gram-positive bacteria:Staphylococcus aureus (MIC=8 μM; MBC=8 μM), MRSA (MIC=16 μM; MBC=32 μM), Enterococcus faecalis (MIC>256 μM; MBC>256 μM);##Gram-negative bacteria: Escherichia coli (MIC=8 μM; MBC=8 μM), Pseudomonas aeruginosa (MIC>256 μM; MBC>256 μM);##Fungi: Candida albicans (MIC=8 μM; MBC=16 μM)","[Ref.31242693] 7% hemolysis at 2 μM, 23% hemolysis at 8 μM, 50% hemolysis at 16 μM, 71% hemolysis at 32 μM, 100% hemolysis at 64 μM on horse erythrocytes.",,31242693,Biomolecules. 2019 Jun 25;9(6):249. doi: 10.3390/biom9060249.,"Zhou, XW; Shi, DN; Zhong, RM; Ye, ZM; Ma, CB; Zhou, M; Xi, XP; Wang, L; Chen, TB; Kwok, HF",Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues,Linear,L,Free,"[Ref.31242693] The IC50 values which represents the inhibitory effect of Ranatuerin-2Pb on the proliferation of NCI-H157, MCF-7, U251MG and PC-3 are 1.453 μM, 7.254 μM, 2.172 μM and 2.251 μM. In addtion, Ranatuerin-2Pb showed no inhibitory effect on the proliferation of MDA-MB-435s.  DETAILED DATA: ①The cell viabillity of NCI-H157 induced by Ranatuerin-2Pb is 96.2%, 96.9%, 85.6%, 60%, 5% and 4.4% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 100%, 95%, 89.4%, 41.2%, 16.2% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ②The cell viability of MCF-7 induced by Ranatuerin-2Pb is 100.6%, 92.5%, 90%, 99.4%, 36.2% and 11.2% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 100%, 98.1%, 92.5%, 7.5%, 8.7% and 8.7% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ③The cell viability of U251-MG induced by Ranatuerin-2Pb is 100%, 105.6%, 108.1%, 102.5%, 59.4% and 17.5% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 99.4%, 99.4%, 75.6%, 18.7%, 11.9% and 18.1% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ④The cell viability of PC-3 induced by Ranatuerin-2Pb is 108.7%, 112.5%, 84.4%, 80.6%, 28.1% and 16.2% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 110%, 113.1%, 109.4%, 33.1%, 16.9% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ⑤ The cell viability of MDA-MB-435S induced by Ranatuerin-2Pb is 96.9%, 88.8%, 96.9%, 88.1%, 100 and 25.6%, while the cell viability induced by Melittin is 100%, 93.1%, 82.5%, 18.8%, 18.8% and 18.1%.",Free,None,Not found,
5392,DRAMP21335,SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC,32,"RPa (Frogs, amphibians, animals)",No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"33.6% Helix, 18.1% antiparallel, 4.3% parallel, 11.4% turn and 32.5% others in 50% TFE/H2O. ##2.4% Helix, 30.6% antiparallel, 0% parallel, 17.3% turn ",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31242693] Gram-positive bacteria:Staphylococcus aureus (MIC=16 μM; MBC=32 μM), MRSA (MIC=>256 μM; MBC>256 μM), Enterococcus faecalis (MIC>256 μM; MBC>256 μM);##Gram-negative bacteria: Escherichia coli (MIC=32 μM; MBC=64 μM), Pseudomonas aeruginosa (MIC>256 μM; MBC>256 μM);##Fungi: Candida albicans (MIC>256 μM; MBC>256 μM)","[Ref.31242693] 7% hemolysis at 16 μM, 23% hemolysis at 32 μM, 50% hemolysis at 64 μM, 76% hemolysis at 128 μM, 90% hemolysis at 256 μM, 100% hemolysis at 512 μM on horse erythrocytes.",,31242693,Biomolecules. 2019 Jun 25;9(6):249. doi: 10.3390/biom9060249.,"Zhou, XW; Shi, DN; Zhong, RM; Ye, ZM; Ma, CB; Zhou, M; Xi, XP; Wang, L; Chen, TB; Kwok, HF",Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues,Linear,L,Free,"[Ref.31242693] RPa only possessed inhibitory effect on the proliferation of H157 with the IC value of 5.841 μM, while showed no inhibitory effect on the proliferation of MCF-7, U251MG, PC-3 and MDA-MB-435s. DETAILED DATA: ①The cell viabillity of NCI-H157 induced by RPa is 97.5%, 94.4%, 92.5%, 71.2%, 40.6% and 4.4% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 100%, 95%, 89.4%, 41.2%, 16.2% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ②The cell viability of MCF-7 induced by RPa is 100.6%, 93.1%, 97.5%, 97.5%, 93.7% and 78.1% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM , while the cell viability induced by Melittin is 100%, 98.1%, 92.5%, 7.5%, 8.7% and 8.7% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ③The cell viability of U251-MG induced by RPa is 100%, 105.6%, 108.1%, 102.5%, 59.4% and 17.5% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 99.4%, 99.4%, 75.6%, 18.7%, 11.9% and 18.1% at 0.001, 0.01, 0.1, 1, 10, 100 μM.④The cell viability of PC-3 induced by RPb is 108.7%, 104.4%, 92.5%, 92.5%, 82.5% and 24.4% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 110%, 113.1%, 109.4%, 33.1%, 16.9% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ⑤The cell viability of MDA-MB-435S induced by RPa is 97.5%, 95%, 97.5%, 73.1%, 68.8% and 36.9%, while the cell viability induced by Melittin is 100%, 93.1%, 82.5%, 18.8%, 18.8% and 18.1%.",Free,None,Not found,
5393,DRAMP21336,SFLTTVKKLVTNLAAL,16,"RPb (Frogs, amphibians, animals)",No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"49.6% Helix, 7.6% antiparallel, 0% parallel, 9.8% turn and 33% others in 50% TFE/H2O. ##0.3% Helix, 25.4% antiparallel, 0% parallel, 19.4% turn and 55",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31242693] Gram-positive bacteria:Staphylococcus aureus (MIC=8 μM; MBC=8 μM), MRSA (MIC=16 μM; MBC=32 μM), Enterococcus faecalis (MIC=32 μM; MBC=128 μM);##Gram-negative bacteria: Escherichia coli (MIC=16 μM; MBC=16 μM), Pseudomonas aeruginosa (MIC=64 μM; MBC=256 μM);##Fungi: Candida albicans (MIC=16 μM; MBC=16 μM)","[Ref.31242693] 7% hemolysis at 16 μM, 18% hemolysis at 32 μM, 20% hemolysis at 64 μM, 40% hemolysis at 128 μM, 70% hemolysis at 256 μM, 100% hemolysis at 512 μM on horse erythrocytes. ",,31242693,Biomolecules. 2019 Jun 25;9(6):249. doi: 10.3390/biom9060249.,"Zhou, XW; Shi, DN; Zhong, RM; Ye, ZM; Ma, CB; Zhou, M; Xi, XP; Wang, L; Chen, TB; Kwok, HF",Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues,Linear,L,Free,"[Ref.31242693] RPb only possessed inhibitory effect on the proliferation of H157 with the IC value of 6.856 μM, while showed no inhibitory effect on the proliferation of MCF-7, U251MG, PC-3 and MDA-MB-435s. DETAILED DATA: ①The cell viabillity of NCI-H157 induced by RPb is 98.7%, 102.5%, 96.9%, 98.1%, 38.1%, 9.4% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 100%, 95%, 89.4%, 41.2%, 16.2% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ②The cell viability of MCF-7 induced by RPb is 100.6%, 92.5%, 90%, 99.4%, 36.2% and 11.2% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, , while the cell viability induced by Melittin is 100%, 98.1%, 92.5%, 7.5%, 8.7% and 8.7% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ③The cell viability of U251-MG induced by RPb is 105%, 103.1%, 109.4%, 102.5%, 105.6% and 13.1% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 99.4%, 99.4%, 75.6%, 18.7%, 11.9% and 18.1% at 0.001, 0.01, 0.1, 1, 10, 100 μM.④The cell viability of PC-3 induced by RPa is 108.8%, 103.8%, 118.1%, 125.6%, 116.9% and 68.8% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 110%, 113.1%, 109.4%, 33.1%, 16.9% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ⑤The cell viability of MDA-MB-435S induced by RPa is 98.1%, 95%, 100.6%, 97.5%, 80.6% and 43.1%, while the cell viability induced by Melittin is 100%, 93.1%, 82.5%, 18.8%, 18.8% and 18.1%.",Amidation,None,Not found,
5394,DRAMP21337,GRFKRFRKKFKKLFKKLSPVIPLLHL,26,"BMAP-27 (Bovine, mammals, animals)",P54228,Belongs to the cathelicidin family,CATHL6,Bos taurus (Bovine),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Protein level,73% α-helix in 50% TFE/H2O,An α-helix occurred from Arg2 to Leu17 in the N-terminal region and a short α-helix is observed from Leu23 to Leu26 in the Cterminal region; the two regions are connected with a flexible region containing two proline residues. ,2KET resolved by NMR,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,[Ref.31226350] Gram-positive bacteria:Staphylococcus aureus (MIC=1-2 μM);##Gram-negative bacteria: Escherichia coli (MIC=2-4 μM),[Ref.31226350] 50% hemolysis at 75 μM for human red blood cells,,31226350,Peptides. 2019 Jun 18;118:170106. doi: 10.1016/j.peptides.2019.170106.,"Yang S, Lee CW, Kim HJ, Jung HH, Kim JI, Shin SY, Shin SH","Structural analysis and mode of action of BMAP-27, a cathelicidin-derived antimicrobial peptide",Linear,L,Free,"[Ref.31226350] The CC50 values which represent peptide concentration (μM) inducing 50% cytotoxicity to human cancer cell lines of BMAP-27 on MDA361 and A549 are 4.2 μM and 5.3 μM.  DETAILED DATA: ①The cell viability of MDA-361 induced by BMAP-27 is 100%, 100%, 98.9%, 97.7%, 87.6%, 59.8%, 34.7%, 12.4%, 10.3%, 8.3% and 9.4% at peptide concentrations of 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 6.4, 13, 25, 50 and 100 μM. ②The cell viability of A549 induced by BMAP-27 is 100%, 99.1%, 97.7%, 94.7%, 74.5%, 41.4%, 24.4%, 11.3%, 9.7%, 10.3% and 7.4% at peptide concentrations of 0.1, 0.2, 0.4, 0.8, 1.6, 3.2, 6.4, 13, 25, 50 and 100 μM.",Amidation,None,Not found,
5395,DRAMP21338,FLRALWNVAKSVF,13,[Arg]3-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,23% α-helix in 60% TFE/Water. ## 0%α-helix in water.,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4560.,"[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=1.6 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=1.6 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.8 μmol/L), Bacillus subtilis ATCC 6633 (MIC=0.8 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.4 μmol/L), Enterobacter cloacae β-12 (MIC=6.3 μmol/L), Pseudomonas aeruginosa ATCC 27853 (MIC=6.3 μmol/L);##Fungi: Candida albicans MDM8 (MIC=0.8 μmol/L), Candida tropicalis IOC 4560 (MIC=0.8 μmol/L)","[Ref.31212183] 25% hemolysis at 6.3 μmol/L, 65% hemolysis at 25 μmol/L, 75% hemolysis at 50 μmol/L, 100% hemolysis at 100 μmol/L for human red blood cells",,31212183,Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.,"Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX",Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens,Linear,L,Free,[Ref.31212183] No cytotoxicity information found,Amidation,None,Not found,
5396,DRAMP21339,FLGALWRVAKSVF,13,[Arg]7-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,22% α-helix in 60% TFE/Water. ## 0%α-helix in water.,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4561.,"[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=1.6 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=1.6 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.4 μmol/L), Bacillus subtilis ATCC 6633 (MIC=0.8 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.2 μmol/L), Enterobacter cloacae β-12 (MIC=6.3 μmol/L), Pseudomonas aeruginosa ATCC 27853 (MIC=6.3 μmol/L);##Fungi: Candida albicans MDM8 (MIC=0.8 μmol/L), Candida tropicalis IOC 4560 (MIC=0.8 μmol/L)","[Ref.31212183] 10% hemolysis at 6.3 μmol/L, 50% hemolysis at 12.5 μmol/L, 60% hemolysis at 25 μmol/L, 90% hemolysis at 500 μmol/L for human red blood cells",,31212183,Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.,"Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX",Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens,Linear,L,Free,[Ref.31212183] No cytotoxicity information found,Amidation,None,Not found,
5397,DRAMP21340,FLGALWNVAKRVF,13,[Arg]11-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,25% α-helix in 60% TFE/Water. ## 2%α-helix in water.,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4562.,"[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=1.6 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=1.6 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.8 μmol/L), Bacillus subtilis ATCC 6633 (MIC=0.8 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.2 μmol/L), Enterobacter cloacae β-12 (MIC=6.3 μmol/L), Pseudomonas aeruginosa ATCC 27853 (MIC=12.5 μmol/L);##Fungi: Candida albicans MDM8 (MIC=0.8 μmol/L), Candida tropicalis IOC 4560 (MIC=0.8 μmol/L)","[Ref.31212183] 25% hemolysis at 6.3 μmol/L, 50% hemolysis at 12.5 μmol/L, 70% hemolysis at 25 μmol/L, 90% hemolysis at 500 μmol/L for human red blood cells",,31212183,Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.,"Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX",Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens,Linear,L,Free,[Ref.31212183] No cytotoxicity information found,Amidation,None,Not found,
5398,DRAMP21341,GLGALWNVAKSVF,13,[Gly]1-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,37% α-helix in 60% TFE/Water. ## 2%α-helix in water.,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4563.,"[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.8 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=25 μmol/L), Bacillus megaterium ATCC 10778 (MIC=3.1 μmol/L), Bacillus subtilis ATCC 6633 (MIC=3.1 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=50 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.4 μmol/L);##Fungi: Candida albicans MDM8 (MIC=25 μmol/L), Candida tropicalis IOC 4560 (MIC=6.3 μmol/L)","[Ref.31212183] 10% hemolysis at 50 μmol/L, 30% hemolysis at 100 μmol/L for human red blood cells",,31212183,Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.,"Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX",Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens,Linear,L,Free,[Ref.31212183] No cytotoxicity information found,Amidation,None,Not found,
5399,DRAMP21342,FLGALWNPAKSVF,13,[Pro]8-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,12% α-helix in 60% TFE/Water. ## 2%α-helix in water.,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida tropicalis IOC 4564.,"[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=12.5 μmol/L), Bacillus subtilis ATCC 6633 (MIC=50 μmol/L);##Gram-negative bacteria: Serratia marcescens ATCC 4112 (MIC=12.5 μmol/L);##Fungi: Candida tropicalis IOC 4560 (MIC=50 μmol/L)",[Ref.31212183] 0% hemolysis at 100 μmol/L for human red blood cells,,31212183,Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.,"Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX",Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens,Linear,L,Free,[Ref.31212183] No cytotoxicity information found,Amidation,None,Not found,
5400,DRAMP21343,FLGALWNVLKSVF,13,[Leu]9-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,62% α-helix in 60% TFE/Water. ## 3%α-helix in water.,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4565.,"[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.8 μmol/L), Bacillus megaterium ATCC 10778 (MIC=3.1 μmol/L), Bacillus subtilis ATCC 6633 (MIC=0.8 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=0.8 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.4 μmol/L), Pseudomonas aeruginosa ATCC 27853 (MIC=50 μmol/L);##Fungi: Candida albicans MDM8 (MIC=1.6 μmol/L), Candida tropicalis IOC 4560 (MIC=1.6 μmol/L)","[Ref.31212183] 20% hemolysis at 3.1 μmol/L, 70% hemolysis at 25 μmol/L, 100% hemolysis at 100 μmol/L for human red blood cells",,31212183,Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.,"Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX",Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens,Linear,L,Free,[Ref.31212183] No cytotoxicity information found,Amidation,None,Not found,
5401,DRAMP21344,FLGALWNVFKSVF,13,[Phe]9-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,32% α-helix in 60% TFE/Water. ## 1%α-helix in water.,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4566.,"[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.2 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.8 μmol/L), Bacillus megaterium ATCC 10778 (MIC=1.6 μmol/L), Bacillus subtilis ATCC 6633 (MIC=0.8 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.2 μmol/L);##Fungi: Candida albicans MDM8 (MIC=6.3 μmol/L), Candida tropicalis IOC 4560 (MIC=0.8 μmol/L)","[Ref.31212183] 10% hemolysis at 1.6 μmol/L, 40% hemolysis at 3.1 μmol/L, 60% hemolysis at 6.3 μmol/L, 85% hemolysis at 25 μmol/L for human red blood cells",,31212183,Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.,"Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX",Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens,Linear,L,Free,[Ref.31212183] No cytotoxicity information found,Amidation,None,Not found,
5402,DRAMP21345,FLGALWNVAKSLF,13,[Leu]12-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,23% α-helix in 60% TFE/Water. ## 2%α-helix in water.,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4567.,"[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.8 μmol/L), Bacillus megaterium ATCC 10778 (MIC=1.6μmol/L), Bacillus subtilis ATCC 6633 (MIC=0.8 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=0.8 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.4 μmol/L), Enterobacter cloacae β-12 (MIC=6.3 μmol/L), Pseudomonas aeruginosa ATCC 27853 (MIC=50 μmol/L);##Fungi: Candida albicans MDM8 (MIC=3.1 μmol/L), Candida tropicalis IOC 4560 (MIC=1.6 μmol/L)","[Ref.31212183] 20% hemolysis at 6.3 μmol/L, 60% hemolysis at 12.5 μmol/L, 75% hemolysis at 25 μmol/L, 90% hemolysis at 50 μmol/L for human red blood cells",,31212183,Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.,"Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX",Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens,Linear,L,Free,[Ref.31212183] No cytotoxicity information found,Amidation,None,Not found,
5403,DRAMP21346,FLGALWNVAKSYF,13,[Tyr]12-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,24% α-helix in 60% TFE/Water. ## 2%α-helix in water.,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans and Candida tropicalis IOC 4568.,"[Ref.31212183] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.8 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=1.6 μmol/L), Bacillus megaterium ATCC 10778 (MIC=1.6 μmol/L), Bacillus subtilis ATCC 6633 (MIC=1.6 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=6.3 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.2 μmol/L);##Fungi: Candida albicans MDM8 (MIC=12.5 μmol/L), Candida tropicalis IOC 4560 (MIC=6.3 μmol/L)","[Ref.31212183] 25% hemolysis at 12.5 μmol/L, 60% hemolysis at 25 μmol/L, 85% hemolysis at 50 μmol/L, 100% hemolysis at 100 μmol/L for human red blood cells",,31212183,Bioorg Chem. 2019 Jun 8;90:103038. doi: 10.1016/j.bioorg.2019.103038.,"Pedron CN, Araújo I, da Silva Junior PI, Dias da Silva F, Torres MT, Oliveira Junior VX",Repurposing the scorpion venom peptide VmCT1 into an active peptide against Gram-negative ESKAPE pathogens,Linear,L,Free,[Ref.31212183] No cytotoxicity information found,Amidation,None,Not found,
5404,DRAMP21347,IHHIHHH,7,2IH1 (De Novo Synthesis) ,No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,18% α-helix in 50% TFE/H2O,"The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC>64μM), Escherichia coli UB1005 (MIC>64μM), Escherichia coli K88 (MIC>64μM), Escherichia coli K99 (MIC>64μM), Escherichia coli 078 (MIC>64μM), Escherichia coli 987P (MIC>64μM), Pseudomonas aeruginosa 27853 (MIC>64μM), Pseudomonas aeruginosa PAO1 (MIC>64μM), Salmonella typhimurium 14028 (MIC>64μM), Salmonella typhimurium 7731 (MIC>64μM)","[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells",,31199117,ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.,"Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.",Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition,Linear,L,Free,"[Ref.31199117] ①The cell viability of HEK293T cells induced by 2IH1 is 103.6%, 102.2%, 101.7%, 103.9%, 103.6%, 106.1% and 103.3% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 2IH1 is 107.9%, 104.5%, 103.4%, 102.5%, 101.1%, 105.6% and 102.0% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5405,DRAMP21348,IHHIHHHIHHIHHH,14,2IH2 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,95% α-helix in 50% TFE/H2O,"The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=64μM), Escherichia coli UB1005 (MIC=64μM), Escherichia coli K88 (MIC>64μM), Escherichia coli K99 (MIC=64μM), Escherichia coli 078 (MIC>64μM), Escherichia coli 987P (MIC=64μM), Pseudomonas aeruginosa 27853 (MIC=8μM), Pseudomonas aeruginosa PAO1 (MIC=64μM), Salmonella typhimurium 14028 (MIC>64μM), Salmonella typhimurium 7731 (MIC>64μM)","[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells",,31199117,ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.,"Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.",Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition,Linear,L,Free,"[Ref.31199117] ①The cell viability of HEK293T cells induced by 2IH2 is 104.7%, 104.7%, 102.8%, 103.6%, 105.3%, 102.2% and 102.5% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 2IH2 is 105.1%, 104.8%, 103.7%, 104.2%, 104.2%, 105.6%, 104.2% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5406,DRAMP21349,IHHIHHHIHHIHHHIHHIHHH,21,2IH3 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,95% α-helix in 50% TFE/H2O,"The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=2μM), Escherichia coli UB1005 (MIC=2μM), Escherichia coli K88 (MIC=2μM), Escherichia coli K99 (MIC=2μM), Escherichia coli 078 (MIC=4μM), Escherichia coli 987P (MIC=2μM), Pseudomonas aeruginosa 27853 (MIC=0.5μM), Pseudomonas aeruginosa PAO1 (MIC=1μM), Salmonella typhimurium 14028 (MIC=16>64μM), Salmonella typhimurium 7731 (MIC=8μM)","[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells",,31199117,ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.,"Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.",Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition,Linear,L,Free,"[Ref.31199117] ①The cell viability of HEK293T cells induced by 2IH3 is 108.3%, 102.8%, 104.4%, 102.2%, 105%, 105.3% and 103.3% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 2IH3 is 102.5%, 104.5%, 105.6%, 103.7%, 102.0%, 103.1% and 103.1% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5407,DRAMP21350,IHHIHHHIHHIHHHIHHIHHHIHHIHHH,28,2IH4 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,95% α-helix in 50% TFE/H2O,"The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=1μM), Escherichia coli UB1005 (MIC=2μM), Escherichia coli K88 (MIC=4>64μM), Escherichia coli K99 (MIC=1μM), Escherichia coli 078 (MIC=4>64μM), Escherichia coli 987P (MIC=1μM), Pseudomonas aeruginosa 27853 (MIC=1μM), Pseudomonas aeruginosa PAO1 (MIC=1μM), Salmonella typhimurium 14028 (MIC=64μM), Salmonella typhimurium 7731 (MIC>64μM)","[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells",,31199117,ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.,"Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.",Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition,Linear,L,Free,"[Ref.31199117] ①The cell viability of HEK293T cells induced by 2IH4 is  at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 2IH4 is 103.7%, 103.7%, 104.8%, 103.4%, 105.3%, 94.9% and 57.9% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5408,DRAMP21351,IHHIHHI,7,3IH1 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,53% α-helix in 50% TFE/H2O,"The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC>64μM), Escherichia coli UB1005 (MIC>64μM), Escherichia coli K88 (MIC>64μM), Escherichia coli K99 (MIC>64μM), Escherichia coli 078 (MIC>64μM), Escherichia coli 987P (MIC>64μM), Pseudomonas aeruginosa 27853 (MIC>64μM), Pseudomonas aeruginosa PAO1 (MIC>64μM), Salmonella typhimurium 14028 (MIC>64μM), Salmonella typhimurium 7731 (MIC>64μM)","[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells",,31199117,ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.,"Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.",Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition,Linear,L,Free,"[Ref.31199117] ①The cell viability of HEK293T cells induced by 3IH1 is 105.6%, 101.1%, 100.6%, 102.5%, 100.3%, 101.4% and 101.1% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 3IH1 is 102.2%, 103.1%, 102.0%, 103.4%, 103.1%, 102.0% and 101.7% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5409,DRAMP21352,IHHIHHIIHHIHHI,14,3IH2 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,95% α-helix in 50% TFE/H2O,"The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=4μM), Escherichia coli UB1005 (MIC=8μM), Escherichia coli K88 (MIC=4μM), Escherichia coli K99 (MIC=4μM), Escherichia coli 078 (MIC=8μM), Escherichia coli 987P (MIC=2μM), Pseudomonas aeruginosa 27853 (MIC=4μM), Pseudomonas aeruginosa PAO1 (MIC=4μM), Salmonella typhimurium 14028 (MIC=32μM), Salmonella typhimurium 7731 (MIC=16μM)","[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells",,31199117,ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.,"Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.",Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition,Linear,L,Free,"[Ref.31199117] ①The cell viability of HEK293T cells induced by 3IH2 is 105.8%, 105.8%, 105.2%, 104.2%, 101.1%, 101.7% and 100.8% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 3IH2 is 106.2%, 105.9%, 105.9%, 105.6%, 104.2%, 104.8% and 101.4% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5410,DRAMP21353,IHHIHHIIHHIHHIIHHIHHI,21,3IH3 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,95% α-helix in 50% TFE/H2O,"The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=1μM), Escherichia coli UB1005 (MIC=1μM), Escherichia coli K88 (MIC=1μM), Escherichia coli K99 (MIC=1μM), Escherichia coli 078 (MIC=0.5μM), Escherichia coli 987P (MIC=0.5μM), Pseudomonas aeruginosa 27853 (MIC=1μM), Pseudomonas aeruginosa PAO1 (MIC=0.5μM), Salmonella typhimurium 14028 (MIC=2μM), Salmonella typhimurium 7731 (MIC=1μM)","[Ref.31199117] 5% hemolysis at 63μM, 8% hemolysis at 128μM against human red blood cells",,31199117,ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.,"Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.",Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition,Linear,L,Free,"[Ref.31199117] ①The cell viability of HEK293T cells induced by 3IH3 is 103.6%, 102.2%, 102.8%, 105%, 103.1%, 104.2% and 105.8% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 3IH3 is 103.9%, 103.1%, 103.9%, 102.2%, 104.2%, 103.1% and 101.7% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5411,DRAMP21354,IHHIHHIIHHIHHIIHHIHHIIHHIHHI,28,3IH4 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,95% α-helix in 50% TFE/H2O,"The α-helical coiled coils would show a sequence periodicity of seven residues (heptad repeat), indicated as “abcdefg”, with hydrophobic residues in the “a” and “d” positions “forming the knobs-into-holes packing interactions and providing the energy needed to distort the mechanical-stabilized α-helices”.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31199117] Gram-negative Bacteria: Escherichia coli 25922 (MIC=2μM), Escherichia coli UB1005 (MIC=4μM), Escherichia coli K88 (MIC=2μM), Escherichia coli K99 (MIC=4μM), Escherichia coli 078 (MIC=4μM), Escherichia coli 987P (MIC=4μM), Pseudomonas aeruginosa 27853 (MIC=8μM), Pseudomonas aeruginosa PAO1 (MIC=4μM), Salmonella typhimurium 14028 (MIC>64μM), Salmonella typhimurium 7731 (MIC>64μM)","[Ref.31199117] 8% hemolysis at 63μM, 15% hemolysis at 128μM against human red blood cells",,31199117,ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22113-22128. doi: 10.1021/acsami.9b04654. Epub 2019 Jun 14.,"Lai Z, Tan P, Zhu Y, Shao C, Shan A, Li L.",Highly Stabilized α-Helical Coiled Coils Kill Gram-Negative Bacteria by Multicomplementary Mechanisms under Acidic Condition,Linear,L,Free,"[Ref.31199117] ①The cell viability of HEK293T cells induced by 3IH4 is 106.9%, 101.1%, 101.9%, 103.6%, 102.5%, 101.7% and 80.6% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 7.4, while that induced by Melittin is 47.2%, 1.7%, 1.9%, 0.6%, 0.6%, 0.6% and 1.7% at 2, 4, 8, 16, 32, 64 and 128 μM. ②The cell viability of HEK293T cells induced by 3IH4 is 104.2%, 105.3, 104.2%, 104.2%, 101.4%, 100.6%, 56.5% at peptide concentrations of 2, 4, 8, 16, 32, 64 and 128 μM at pH 6.0, while that induced by Melittin is 43.8%, 3.4%, 3.4%, 0%, 2.2%, 0% and 1.1% at 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5412,DRAMP21355,KKKKKAAFAKAWAAFAA,17,5Kamp (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=6.3μM), Pseudomonas aeruginosa PAO1(MIC=25μM), Pseudomonas aeruginosa PA214(MIC=25μM), Pseudomonas aeruginosa PA287(MIC=50μM), Pseudomonas aeruginosa PA330(MIC=50μM), Pseudomonas aeruginosa PA380(MIC=50μM)",[Ref.31194548] 0% hemolysis at 40μM against human blood cells.,,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",Linear,L,Free,[Ref.31194548] No cytotoxicity information found,Amidation,None,Not found,
5413,DRAMP21356,KKKKAAFAKAWAKAFAA,17,4Kamp (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC=50μM), Pseudomonas aeruginosa PA214(MIC=50μM), Pseudomonas aeruginosa PA287(MIC>50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC=50μM)",[Ref.31194548] 0% hemolysis at 40μM against human blood cells.,,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",Linear,L,Free,[Ref.31194548] No cytotoxicity information found,Amidation,None,Not found,
5414,DRAMP21357,KKKAAFAKAWAKAFKAA,17,3Kamp (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=25μM), Pseudomonas aeruginosa PAO1(MIC=50μM), Pseudomonas aeruginosa PA214(MIC=50μM), Pseudomonas aeruginosa PA287(MIC>50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)",[Ref.31194548] 0% hemolysis at 40μM against human blood cells.,,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",Linear,L,Free,[Ref.31194548] No cytotoxicity information found,Amidation,None,Not found,
5415,DRAMP21358,KKAKAFAKAWAKAFKAA,17,2Kamp (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC=25μM), Pseudomonas aeruginosa PA214(MIC=50μM), Pseudomonas aeruginosa PA287(MIC=50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)",[Ref.31194548] 0% hemolysis at 40μM against human blood cells.,,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",Linear,L,Free,[Ref.31194548] No cytotoxicity information found,Amidation,None,Not found,
5416,DRAMP21359,KAAKKFAKAWAKAFKAA,17,1Kamp (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC=50μM), Pseudomonas aeruginosa PA214(MIC>50μM), Pseudomonas aeruginosa PA287(MIC>50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)",[Ref.31194548] 0% hemolysis at 40μM against human blood cells.,,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",Linear,L,Free,[Ref.31194548] No cytotoxicity information found,Amidation,None,Not found,
5417,DRAMP21360,KKKKKKALFALWLAFLA,17,6K-F17-4L (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC>50μM), Pseudomonas aeruginosa PA214(MIC=50μM), Pseudomonas aeruginosa PA287(MIC=25μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)",[Ref.31194548] 33% (± 22) hemolysis at 40μM against human blood cells.,,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",Linear,L,Free,[Ref.31194548] No cytotoxicity information found,Amidation,None,Not found,
5418,DRAMP21361,KKKKKALFLKLWAAFLA,17,5Kamp-4L (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=3.1μM), Pseudomonas aeruginosa PAO1(MIC=12.5μM), Pseudomonas aeruginosa PA214(MIC=6.3μM), Pseudomonas aeruginosa PA287(MIC=6.3μM), Pseudomonas aeruginosa PA330(MIC=12.5μM), Pseudomonas aeruginosa PA380(MIC>50μM)",[Ref.31194548] 49% (± 22) hemolysis at 40μM against human blood cells.,,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",Linear,L,Free,[Ref.31194548] No cytotoxicity information found,Amidation,None,Not found,
5419,DRAMP21362,KKKKAAFLKLWLKLFAA,17,4Kamp-4L (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=12.5μM), Pseudomonas aeruginosa PAO1(MIC>50μM), Pseudomonas aeruginosa PA214(MIC>50μM), Pseudomonas aeruginosa PA287(MIC>50μM), Pseudomonas aeruginosa PA330(MIC>50μM), Pseudomonas aeruginosa PA380(MIC>50μM)",[Ref.31194548] 8% (± 2.0) hemolysis at 40μM against human blood cells.,,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",Linear,L,Free,[Ref.31194548] No cytotoxicity information found,Amidation,None,Not found,
5420,DRAMP21363,KKKAAFLKLWAKLFKAL,17,3Kamp-4L (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=3.1μM), Pseudomonas aeruginosa PAO1(MIC=3.1μM), Pseudomonas aeruginosa PA214(MIC=3.1μM), Pseudomonas aeruginosa PA287(MIC=3.1μM), Pseudomonas aeruginosa PA330(MIC=6.3μM), Pseudomonas aeruginosa PA380(MIC=3.1μM)",[Ref.31194548] 100% (± 4.5) hemolysis at 40μM against human blood cells.,,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",Linear,L,Free,[Ref.31194548] No cytotoxicity information found,Amidation,None,Not found,
5421,DRAMP21364,KKLKAFLKAWAKLFKAL,17,2Kamp-4L (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=1.6μM), Pseudomonas aeruginosa PAO1(MIC=3.1μM), Pseudomonas aeruginosa PA214(MIC=3.1μM), Pseudomonas aeruginosa PA287(MIC=3.1μM), Pseudomonas aeruginosa PA330(MIC=6.3μM), Pseudomonas aeruginosa PA380(MIC=1.5μM)",[Ref.31194548] 89% (± 7.3) hemolysis at 40μM against human blood cells.,,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",Linear,L,Free,[Ref.31194548] No cytotoxicity information found,Amidation,None,Not found,
5422,DRAMP21365,KALKKFLKAWAKLFKAL,17,1Kamp-4L (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM Tris buffer 10 Mm NaCl pH 7.4, supplemented with either 2 mg/ml E.coli or POPC lipid extract.","Peptides are shown as ideal helices with side chains shown as stick models for Lys, Trp, and Phe and  as space-filling models.",None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.31194548] Gram-negative Bacteria: Escherichia coli K12 (MIC=1.6μM), Pseudomonas aeruginosa PAO1(MIC=3.1μM), Pseudomonas aeruginosa PA214(MIC=3.1μM), Pseudomonas aeruginosa PA287(MIC=3.1μM), Pseudomonas aeruginosa PA330(MIC=6.3μM), Pseudomonas aeruginosa PA380(MIC=6.3μM)",[Ref.31194548] 81% (± 9.4) hemolysis at 40μM against human blood cells.,,31194548,J Med Chem. 2019 Jul 1. doi: 10.1021/acs.jmedchem.9b00657.,"Stone TA, Cole GB, Ravamehr-Lake D, Nguyen HQ, Khan F, Sharpe S, Deber CM","Positive Charge Patterning and Hydrophobicity of Membrane-Active Antimicrobial Peptides as Determinants of Activity, Toxicity, and Pharmacokinetic Stability",Linear,L,Free,[Ref.31194548] No cytotoxicity information found,Amidation,None,Not found,
5423,DRAMP21366,KLGALWNVAKSVF,13,[Lys]1-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"3% Helical content in water, 2% helical content in PBS (pH7.4), 30% helical content in SDS (20 mmol/L), 32% helical content in TFE/Water (3:2, v:v), 4",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans MDM8 and Candida tropicalis IOC 4560.,"[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=25 μmol/L), Bacillus megaterium ATCC 10778 (MIC=3.1 μmol/L);##Gram-negative bacteria: Serratia marcescens ATCC 4112 (MIC=1.6 μmol/L), Enterobacter cloacae β-12 (MIC=25 μmol/L);##Fungi: Candida albicans MDM8 (MIC=3.1 μmol/L), Candida tropicalis IOC 4560 (MIC=0.8 μmol/L)","[Ref.31181304] 15% hemolysis at 25 μmol/L, 25% hemolysis at 50 μmol/L, 40% hemolysis at 100 μmol/L against human red blood cells",,31181304,Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.,"Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX",The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1,Linear,L,Free,"[Ref.31181304] The cell viability of MCF-7 cells induced by [Lys1]-VmCT1-NH2 is 120%, 120%, 120%, 110%, 120%, 120%, 115% and 115% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. ",Amidation,None,Not found,
5425,DRAMP21368,KLGALWNVAKSKF,13,[Lys]1[Lys]12-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"2% Helical content in water, 0% helical content in PBS (pH7.4), 19% helical content in SDS (20 mmol/L), 13% helical content in TFE/Water (3:2, v:v), 0",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans MDM8 and Candida tropicalis IOC 4560.,"[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=12.5 μmol/L), Bacillus megaterium ATCC 10778 (MIC=6.3 μmol/L);##Gram-negative bacteria: Enterobacter cloacae β-12 (MIC=25μmol/L);##Fungi: Candida albicans MDM8 (MIC=6.3 μmol/L), Candida tropicalis IOC 4560 (MIC=3.1 μmol/L)",[Ref.31181304] 0% hemolysis at 100 μmol/L against human red blood cells,,31181304,Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.,"Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX",The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1,Linear,L,Free,"[Ref.31181304] The cell viability of MCF-7 cells induced by [Lys1][Lys12]-VmCT1-NH2 is 105%, 110%, 95%, 100%, 110%, 120%, 120% and 120% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. ",Amidation,None,Not found,
5426,DRAMP21369,FLKALWKVAKSVF,13,[Lys]3[Lys]7-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"0% Helical content in water, 5% helical content in PBS (pH7.4), 37% helical content in SDS (20 mmol/L), 52% helical content in TFE/Water (3:1, v:v), 0",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans MDM8 and Candida tropicalis IOC 4560.,"[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.4 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.4 μmol/L), Staphylococcus epidermidis ATCC 12228 (MIC=3.1 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.1 μmol/L), Enterobacter cloacae β-12 (MIC=3.1 μmol/L);##Fungi: Candida albicans MDM8 (MIC=0.8 μmol/L), Candida tropicalis IOC 4560 (MIC=0.4 μmol/L)","[Ref.31181304] 15% hemolysis at 3.1 μmol/L, 45% hemolysis at 6.3 μmol/L, 65% hemolysis at 12.5 μmol/L, 85% hemolysis at 25 μmol/L, 90% hemolysis at 100 μmol/L against human red blood cells",,31181304,Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.,"Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX",The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1,Linear,L,Free,"[Ref.31181304] ①The cell viability of MCF-7 cells induced by [Lys3][Lys7]-VmCT1-NH2 is 95%, 95%, 90%, 85%, 80%, 70%, 50%, 40% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. ②The cell viability of MCF-10A cells induced by [Lys3][Lys7]-VmCT1-NH2 is 120%, 120%, 120%,120%, 95% and 90% at peptide concentrations of 0.8, 1.6, 3.1, 6.3, 12.5 and 25 μM.",Amidation,None,Not found,
5427,DRAMP21370,FLKALWNVAKKVF,13,[Lys]3[Lys]11-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"0% Helical content in water, 4% helical content in PBS (pH7.4), 28% helical content in SDS (20 mmol/L), 33% helical content in TFE/Water (3:2, v:v), 2",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans MDM8 and Candida tropicalis IOC 4560.,"[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.8 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.4 μmol/L), Staphylococcus epidermidis ATCC 12228 (MIC=1.6 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.2 μmol/L), Enterobacter cloacae β-12 (MIC=3.1 μmol/L);##Fungi: Candida albicans MDM8 (MIC=1.6 μmol/L), Candida tropicalis IOC 4560 (MIC=0.4 μmol/L)","[Ref.31181304] 40% hemolysis at 12.5 μmol/L, 70% hemolysis at 25 μmol/L, 80% hemolysis at 50 μmol/L against human red blood cells",,31181304,Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.,"Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX",The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1,Linear,L,Free,"[Ref.31181304] ①The cell viability of MCF-7 cells induced by [Lys3][Lys11]-VmCT1-NH2 is 95%, 100%, 80%, 80%, 55%, 45%, 20% and 20% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. ②The cell viability of MCF-10A cells induced by [Lys3][Lys11]-VmCT1-NH2 is 120%, 120%, 90%, 100%, 120% and 95%  at  peptide concentrations of 0.8, 1.6, 3.1, 6.3, 12.5 and 25 μM.",Amidation,None,Not found,
5428,DRAMP21371,FLGALWKVAKKVF,13,[Lys]7[Lys]11-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"0% Helical content in water, 3% helical content in PBS (pH7.4), 27% helical content in SDS (20 mmol/L), 39% helical content in TFE/Water (3:2, v:v), 1",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans MDM8 and Candida tropicalis IOC 4560.,"[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.8 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.4 μmol/L), Staphylococcus epidermidis ATCC 12228 (MIC=6.3 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=3.1 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.2 μmol/L), Enterobacter cloacae β-12 (MIC=3.1 μmol/L);##Fungi: Candida albicans MDM8 (MIC=1.6 μmol/L), Candida tropicalis IOC 4560 (MIC=0.4μmol/L)","[Ref.31181304] 45% hemolysis at 12.5 μmol/L, 100% hemolysis at 50 μmol/L against human red blood cells",,31181304,Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.,"Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX",The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1,Linear,L,Free,"[Ref.31181304] ①The cell viability of MCF-7 cells induced by [Lys7][Lys11]-VmCT1-NH2 is 105%, 105%, 95%, 85%, 65%, 45%, 25% and 25% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. ②The cell viability of MCF-10A cells induced by [Lys7][Lys11]-VmCT1-NH2 is 120%, 120%, 85%, 90%, 120% and 120%at peptide concentrations of 0.8, 1.6, 3.1, 6.3, 12.5 and 25 μM.",Amidation,None,Not found,
5429,DRAMP21372,FLKALWKVAKKVF,13,[Lys]3[Lys]7[Lys]11-VmCT1-NH2 (Derived from VmCT1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,"0% Helical content in water, 3% helical content in PBS (pH7.4), 25% helical content in SDS (20 mmol/L), 23% helical content in TFE/Water (3:2, v:v), 2",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans MDM8 and Candida tropicalis IOC 4560.,"[Ref.31181304] Gram-positive bacteria: Micrococcus luteus A270 (MIC=0.4 μmol/L), Staphylococcus aureus ATCC 29213 (MIC=0.8 μmol/L), Bacillus megaterium ATCC 10778 (MIC=0.2 μmol/L), Staphylococcus epidermidis ATCC 12228 (MIC=3.1 μmol/L);##Gram-negative bacteria: Escherichia coli SBS 363 (MIC=1.6 μmol/L)，Serratia marcescens ATCC 4112 (MIC=0.1μmol/L), Enterobacter cloacae β-12 (MIC=3.1 μmol/L);##Fungi: Candida albicans MDM8 (MIC=0.8 μmol/L), Candida tropicalis IOC 4560 (MIC=0.4μmol/L)","[Ref.31181304] 40% hemolysis at 12.5 μmol/L, 60% hemolysis at 25 μmol/L, 80% hemolysis at 50 μmol/L, 100% hemolysis at 100 μmol/L against human red blood cells",,31181304,Eur J Pharm Sci. 2019 Jun 7;136:104952. doi: 10.1016/j.ejps.2019.06.006.,"Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MT, Oliveira VX",The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1,Linear,L,Free,"[Ref.31181304] ①The cell viability of MCF-7 cells induced by [Lys3][Lys7][Lys11]-VmCT1-NH2 is 90%, 90%, 90%, 60%, 50%, 30%, 20% and 20% at peptide concentrations of 0.8, 1.6, 3.1, 12.5, 25, 50 and 100 μM. ②The cell viability of MCF-10A cells induced by [Lys3][Lys7][Lys11]-VmCT1-NH2 is 120%, 120%, 85%, 120%, 115% and 120%at peptide concentrations of 0.8, 1.6, 3.1, 6.3, 12.5 and 25 μM.",Amidation,None,Not found,
5430,DRAMP21373,AIKIRKLFKKLLR,13,SP1 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=12.5–25 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP1 is 87.8%, 88.5%, 83.1%, 95.3%, 97.3% and 68.9% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5431,DRAMP21374,GIKIRKLFKKLLR,13,SP2 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=6.25–12.5 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP2 is 108.8%, 110.1%, 116.9%, 104.7%, 108.8% and 83.1% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5432,DRAMP21375,GWAKLITKAIKKI,13,SP3 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=25–50 µg/mL),[Ref.31163671] 10% hemolysis at 50–100 μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP3 is 80.4%, 77.0%, 87.8%, 98.0%, 76.4% and 84.5% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5433,DRAMP21376,GIKFFLKKLKKHI,13,SP4 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=25–50 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP4 is 102.0%, 114.2%, 100.7%, 93.2%, 108.1% and 83.1% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5434,DRAMP21377,IRPAKLRWFKKIK,13,SP5 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC >100 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP5 is 110.8%, 100.7%, 104.7%, 110.1%, 87.8% and 90.5% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5435,DRAMP21378,RLFIKKLKFITRR,13,SP6 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=25–50 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP6 is 92.6%, 100%, 102.7%, 106.8%, 93.2% and 99.3% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5436,DRAMP21379,NAMRGAKRVWRHI,13,SP7 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC >100 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP7 is 91.9%, 95.9%, 103.4%, 94.6%, 93.9% and 91.2% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5437,DRAMP21380,KFRKFGKQVWVRL,13,SP8 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=12.5–25 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP8 is 98.0%, 104.7%, 98.0%, 103.4%, 93.2%, 92.6% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5438,DRAMP21381,AIKIRKLFKKLLR,13,SP1D * (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=12.5–25 µg/mL),[Ref.31163671] 10% hemolysis at 25–50 μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,D,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP1D is 80.4%, 102.0%, 81.8%, 81.8%, 74.3% and 66.2% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5439,DRAMP21382,KVWSRLRKIFSTR,13,SP9 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=6.25–12.5 µg/mL),[Ref.31163671] 10% hemolysis at 50–100 μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP9 is 104.7%, 110.8%, 108.8%, 108.8%, 97.3% and 79.1% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5440,DRAMP21383,AKVLKISRRAFRK,13,SP10 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC >100 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP10 is 114.2%, 82.4%, 94.6%, 98.6%, 103.4% and 98.6% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5441,DRAMP21384,IRRWRLHWFRRAI,13,SP11 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=12.5–25 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP11 is 95.3%, 109.5%, 108.1%, 89.2%, 112.8% and 81.1% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5442,DRAMP21385,IRRRIRLIVRRQI,13,SP12 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=12.5–25 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP12 is 98.0%, 99.3%, 95.9%, 92.6%, 100% and 89.2% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5443,DRAMP21386,HFKIRKRFVKKLV,13,SP13 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC >100 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP13 is 104.1%, 106.8%, 111.5%, 101.4%, 107.4%, 118.2% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5444,DRAMP21387,RWIRWVWRKKLRI,13,SP14 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=12.5–25 µg/mL),[Ref.31163671] 10% hemolysis at 50–100 μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP14 is 102.7%, 95.3%, 88.5%, 93.9%, 100% and 98.6% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5445,DRAMP21388,RWIRWVWRKKLR,12,SP15 * (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC= 3.125–6.25 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,L,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP15 is 90.5%, 90.5%, 89.2%, 83.1%, 93.2% and 52.7% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5446,DRAMP21389,RWIRWVWRKKLR,12,SP15D * (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,α-helix mainly,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,[Ref.31163671] Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=0.78–1.56 µg/mL),[Ref.31163671] 10% hemolysis at >100  μg/mL against human blood cells.,,31163671,Pharmaceuticals (Basel). 2019 Jun 3;12(2). pii: E82. doi: 10.3390/ph12020082.,"Boris Vishnepolsky, George Zaalishvili, Margarita Karapetian, Tornike Nasrashvili, Nato Kuljanishvili, Andrei Gabrielian, Alex Rosenthal, Darrell E. Hurt, Michael Tartakovsky, Maya Grigolava and Malak Pirtskhalava",De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria.,Linear,D,Free,"[Ref.31163671] The cell viability of Hepa 1-6 induced by SP15D is 91.2%, 96.6%, 96.6%, 73.6%, 58.1% and 25% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL.",Amidation,None,Not found,
5447,DRAMP21390,RWKRHISEQLRRRDRLQR,18,K17 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=45.5-91 μM);##Gram-negative bacteria: Escherichia coli (MIC>120μM), Pseudomonas aeruginosa (MIC>120μM);##Fungi: Candida albicans (MIC>120μM)","[Ref.31145591] 2% hemolysis at 600 μM, 3% hemolysis at 700 μM, 4% hemolysis at 800 μM, 5% hemolysis at 900 μM, 6% hemolysis at 1000 μM, against mouse blood cells.",,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",Linear,L,Free,[Ref.31145591] No cytotoxicity information found,Free,None,Not found,
5448,DRAMP21391,RWKRHISEQLRRRDRLQRQAF,21,K18 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=28.8-57.6 μM);##Gram-negative bacteria: Escherichia coli (MIC=60-120μM), Pseudomonas aeruginosa (MIC=60-120μM);##Fungi: Candida albicans (MIC>120μM)","[Ref.31145591] 3% hemolysis at 500μM, 16% hemolysis at 600 μM, 27% hemolysis at 700 μM, 38% hemolysis at 800 μM, 50% hemolysis at 900 μM, 62% hemolysis at 1000μM against mouse blood cells.",,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",Linear,L,Free,[Ref.31145591] No cytotoxicity information found,Free,None,Not found,
5449,DRAMP21392,RWKRHISEQLRRRDRLQRQAJ,21,K22 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=14.4-28.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=30-60μM), Pseudomonas aeruginosa (MIC=60-120μM);##Fungi: Candida albicans (MIC=60-120μM)","[Ref.31145591] 3% hemolysis at 500μM, 10% hemolysis at 600 μM, 13% hemolysis at 700 μM, 17% hemolysis at 800 μM, 20% hemolysis at 900 μM, 25% hemolysis at 1000μM against mouse blood cells.",,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",Linear,L,Free,[Ref.31145591] No cytotoxicity information found,Free,The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,Not found,
5450,DRAMP21393,RWKRHISEQLRRRDRLQRQAJ,21,K22.2 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=4-8 μM);##Gram-negative bacteria: Escherichia coli (MIC=17.5-35μM), Pseudomonas aeruginosa (MIC=17.5-35μM);##Fungi: Candida albicans (MIC=60-120μM)","[Ref.31145591] 3% hemolysis at 500μM, 5% hemolysis at 600 μM, 10% hemolysis at 700 μM, 15% hemolysis at 800 μM, 17% hemolysis at 900 μM, 20% hemolysis at 1000μM against mouse blood cells.",,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",Linear,L,Free,[Ref.31145591] No cytotoxicity information found,"Amidation (2-Nal, position 21)",The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,Not found,
5451,DRAMP21394,RWKRHISEQLRRRDRLQRQAJ,21,K30 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Helix–loop–helix in the presence of anionic membrane lipids mimicking bacterial membranes.,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=0.9-1.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=6.4-12.8μM), Pseudomonas aeruginosa (MIC=13.5-27μM);##Fungi: Candida albicans (MIC=30-60μM)","[Ref.31145591] 3% hemolysis at 600μM, 4% hemolysis at 700 μM, 5% hemolysis at 800 μM, 6% hemolysis at 900 μM, 9% hemolysis at 1000 μM,against mouse blood cells.",,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",Linear,L,Acylation (Arg1 conjugated with 4-methylhexanoyl group),[Ref.31145591] No cytotoxicity information found,"Amidation (2-Nal, position 21)",The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,Not found,
5452,DRAMP21395,RWKRHISEQLRRRDRLQRQAJ,21,K31 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=1.8-3.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.2-6.4μM), Pseudomonas aeruginosa (MIC=3.2-6.4μM);##Fungi: Candida albicans (MIC=3.2-6.4μM)","[Ref.31145591] 50% hemolysis at 10μM, 70% hemolysis at 61μM, 75% hemolysis at 100 μM, 80% hemolysis at 200 μM, 85% hemolysis at 300 μM, 90% hemolysis at 900 μM, 92% hemolysis at 500μM against mouse blood cells.",,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",Linear,L,Acylation (Arg1 conjugated with myristoyl group),[Ref.31145591] No cytotoxicity information found,"Amidation (2-Nal, position 21)",The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,Not found,
5453,DRAMP21396,RWKRHISEQLRRRDRLQRQAJ,21,K33 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=1.8-3.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.2-6.4μM), Pseudomonas aeruginosa (MIC=6.4-12.8μM);##Fungi: Candida albicans (MIC=1.8-3.7μM)","[Ref.31145591] 75% hemolysis at 10μM, 97% hemolysis at 123μM, 100% hemolysis at 500μM against mouse blood cells.",,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",Linear,L,Acylation (Arg1 conjugated with palmitoyl group),[Ref.31145591] No cytotoxicity information found,"Amidation (2-Nal, position 21)",The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,Not found,
5454,DRAMP21397,RWKRHISEQLRRRDRLQRQAJ,21,K36 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=0.9-1.8 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.2-6.4μM), Pseudomonas aeruginosa (MIC=6.4-12.8μM);##Fungi: Candida albicans (MIC=15-30μM)","[Ref.31145591] 5% hemolysis at 200μM, 10% hemolysis at 300 μM, 17% hemolysis at 400 μM, 23% hemolysis at 500 μM, 30% hemolysis at 600μM, 32% hemolysis at 700 μM, 35% hemolysis at 800 μM, 40% hemolysis at 900 μM, 42% hemolysis at 1000μM against mouse blood cells.",,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",Linear,L,Acylation (Arg1 conjugated with Fmoc group),[Ref.31145591] No cytotoxicity information found,"Amidation (2-Nal, position 21)",The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,Not found,
5455,DRAMP21398,RWKRHISEQLRRRDRLQRQAJ,21,K46 (Derived from ATG16),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.,"[Ref.31145591] Gram-positive bacteria: Staphylococcus aureus(MIC=1.8-3.2 μM);##Gram-negative bacteria: Escherichia coli (MIC=3.2-6.4μM), Pseudomonas aeruginosa (MIC=6.4-12.8μM);##Fungi: Candida albicans (MIC=30-60μM)","[Ref.31145591] 10% hemolysis at 200μM, 15% hemolysis at 500μM, 17% hemolysis at 600 μM, 20% hemolysis at 700 μM, 25% hemolysis at 800 μM, 30% hemolysis at 900 μM, 42% hemolysis at 1000μM against mouse blood cells.",,31145591,Bioconjug Chem. 2019 Jun 18. doi: 10.1021/acs.bioconjchem.9b00290.,"Varnava KG, Mohid SA, Calligari P, Stella L, Reynison J, Bhunia A, Sarojini V","Design, Synthesis, Antibacterial Potential, and Structural Characterization of N-Acylated Derivatives of the Human Autophagy 16 Polypeptide.",Linear,L,Acylation (Arg1 conjugated with capryl group),[Ref.31145591] No cytotoxicity information found,"Amidation (2-Nal, position 21)",The 'J' in the sequence is the 2-naphthyl alanine (2-Nal) residue.,Not found,
5457,DRAMP21400,CGIYRSLKLIKSLVLIK,17,NBC2253 (De Novo Synthesis) ,No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,[Ref.31119600] Gram-positive bacteria:MRSA(MIC=6.7 ± 0.02µM);##Gram-negative bacteria:Escherichia coli O157:H7(MIC=25 ± 0.03µM),[Ref.31119600] No hemolytic activity against bovine blood cells,,31119600,Protein J. 2019 May 22. doi: 10.1007/s10930-019-09840-9.,"Prada YA, Guzmán F, Ortíz C, Cabanzo R, Torres R, Mejía-Ospino E",New Synthetic Peptides Conjugated to Gold Nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).,Linear,L,The sulfhydryl side chain of the cysteine residue was conjugated to AuNC(previously modified with SPDP) via a disulfide bond.,"[Ref.31119600] The cell viability of Vero ATCC CCL 1-81 cells induced by NBC2253 is 87.8%, 66.4%, 62.2%, 69.1% and 68.8% at peptide concentrations of 1.2, 3.7, 11.1, 33.3 and 100 μM.",Free,None,Not found,
5458,DRAMP21401,CALKLTKAKRLVRKIGF,17,NBC2254 (De Novo Synthesis) ,No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,[Ref.31119600] Gram-positive bacteria:MRSA(MIC=73 ± 0.02µM);##Gram-negative bacteria:Escherichia coli O157:H7(MIC=3.5 ± 0.05µM),[Ref.31119600] No hemolytic activity against bovine blood cells,,31119600,Protein J. 2019 May 22. doi: 10.1007/s10930-019-09840-9.,"Prada YA, Guzmán F, Ortíz C, Cabanzo R, Torres R, Mejía-Ospino E",New Synthetic Peptides Conjugated to Gold Nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).,Linear,L,The sulfhydryl side chain of the cysteine residue was conjugated to AuNC(previously modified with SPDP) via a disulfide bond.,"[Ref.31119600] The cell viability of Vero ATCC CCL 1-81 cells induced by NBC2254 is 93.7%, 90.1%, 89.5%, 95.9% and 78.6% at peptide concentrations of 1.2, 3.7, 11.1, 33.3 and 100 μM.",Free,None,Not found,
5459,DRAMP21402,KFKKLFKKLSPVFKRIVQRIKDFLR,25,B1 (Derived from LL-37 and BMAP-27),No entry found,Belongs to the cathelicidin family.,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,88 % of the α-helices and 12% of the random coil was predicted using HNN,The helicity percentages of the secondary structure of B1 are predicted using HNN,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31118709] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=20μM), Staphylococcus aureus ATCC 33591(MIC=20μM), Staphylococcus aureus ATCC 43300(MIC=20μM), Staphylococcus aureus ATCC BAA-41(MIC=20μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC=20μM), Escherichia coli 35218 (MIC=20μM), Pseudomonas aeruginosa BAA-2114 (MIC=10μM)","[Ref.31118709] 0% hemolysis at 10μM, 8% hemolysis at 25μM, 19% hemolysis at 50μM, 23% hemolysis at 75μM, 30% hemolysis at 100μM, 38% hemolysis at 125μM, 40% hemolysis at 150μM, 43% hemolysis at 175μM, 50% hemolysis at 200μM against human blood cells.",,31118709,Infect Drug Resist. 2019; 12: 1035–1045. Published online 2019 Apr 30. doi: 10.2147/IDR.S199473,"Yara Al Tall, Ahmad Abualhaijaa, Mohammad Alsaggar, Ammar Almaaytah, Majed Masadeh, and Karem H Alzoub",Design and characterization of a new hybrid peptide from LL-37 and BMAP-27,Linear,L,Free,"[Ref.31118709] The cell viability of HEK293 mammalian cell line induced by B1 is 87.0%, 67.1%, 52.3%, 54.3%, 50.6% and 50% at peptide concentrations of 10, 20, 40, 60, 80 and 100 μM.",Free,None,Not found,
5460,DRAMP21403,ITEVITILLNRLTDRLEK,18,peptide 1 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM phosphate buffer, pH7.4",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31117348] Gram-positive bacteria:Staphylococcus aureus ATCC 6538(MIC>100μM), Bacillus subtilis ATCC 6633(MIC>100μM);##Gram-negative bacteria:Escherichia coli ATCC 15597(MIC>100μM), Pseudomonas aeruginosa (MIC>100μM), Salmonella Typhimurium 6192(MIC>100μM), Klebsiella pneumoniae NCTC 5055(MIC>100μM)",[Ref.31117348] 5% hemolysis at 250 μM against human blood cells.,,31117348,ACS Infect Dis. 2019 May 30. doi: 10.1021/acsinfecdis.9b00157.,"Hammond K, Lewis H, Faruqui N, Russell C, Hoogenboom BW, Ryadnov MG",Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Linear,L,Free,[Ref.31117348] No cytotoxicity information found,Free,None,Not found,
5461,DRAMP21404,ITKVITKLLNRLTKILSK,18,peptide 2 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"α-helix mainly in 10 mM phosphate buffer, pH7.4",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31117348] Gram-positive bacteria:Staphylococcus aureus ATCC 6538(MIC=15 ± 2.5μM), Bacillus subtilis ATCC 6633(MIC=15 ± 2.5μM);##Gram-negative bacteria:Escherichia coli ATCC 15597(MIC=3.1μM), Pseudomonas aeruginosa (MIC=25μM), Salmonella Typhimurium 6192(MIC=40 ± 5μM), Klebsiella pneumoniae NCTC 5055(MIC=50μM)",[Ref.31117348] 5% hemolysis at 250 μM against human blood cells.,,31117348,ACS Infect Dis. 2019 May 30. doi: 10.1021/acsinfecdis.9b00157.,"Hammond K, Lewis H, Faruqui N, Russell C, Hoogenboom BW, Ryadnov MG",Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Linear,L,Free,"[Ref.31117348] ①The cell viability of MCF7 cells induced by peptide 2 is 94.2%, 88.6%, 82.0%, 55.0%, 44.0%, 32.4%, 15.3%, 15.8%, 12.8% and 1.2% at peptide concentrations of 1, 10, 15, 20, 25, 30, 35, 40, 50 and 100 μM. EC50=22.5±0.7 μM. ②The cell viability of Hela cells induced by peptide 2 is 96.1%, 95.4%, 83.8%, 64.2%, 57.7%, 49.5%, 31.5%, 30.2%, 7.8% and 0.2% at peptide concentrations of 1, 10, 15, 20, 25, 30, 35, 40, 50 and 100 μM. EC50=29.8±1 μM. ③The cell viabiity of HDF cells induced by peptide 2 is 96.3%, 89.7%, 89.9%, 92.7%, 95.0%, 93.4%, 93.1%, 96.1%, 88.6% and 67.4% at peptide concentrations of 1, 10, 15, 20, 25, 30, 35, 40, 50 and 100 μM.",Free,None,Not found,
5462,DRAMP21405,GKIIKLKASLKLL,13,LGL13K (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31071184] Gram-positive bacteria:Staphylococcus aureus Xen36(MIC=83.3μg/ml), Staphylococcus aureus USA300(Uknow);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=10.4μg/ml)",[Ref.31071184] LD50=560μg/ml against human blood cells,,31071184,PLoS One. 2019 May 9;14(5):e0216669. doi: 10.1371/journal.pone.0216669. eCollection 2019.,"Gorr SU, Flory CM, Schumacher RJ",In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K.,Linear,L,Free,"[Ref.31071184] The cytotoxicity of L-GL13K on HEK cells is 2.1%, 3.3%, 2.4%, 1.2%24.3%, 51.7% and 73.6% at peptide concentrations of 1, 3.9, 15.6, 62.5, 250 and 1000 μg/mL, while the cytotoxicity of PMX on HEK cells (Control samples) is 1.2%, 1.2%, 6.6%, 3.6%, 39.6%, 47.1% and 68.5% at peptide concentrations of 1, 3.9, 15.6, 62.5, 250 and 1000 μg/mL.",Amidation,None,Not found,
5463,DRAMP21406,GKIIKLKASLKLL,13,DGL13K (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31071184] Gram-positive bacteria:Staphylococcus aureus Xen36(MIC=2.6μg/ml), Staphylococcus aureus USA300(MIC=5.2μg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa (MIC=5.2μg/ml)",[Ref.31071184] LD50=950μg/ml against human blood cells,,31071184,PLoS One. 2019 May 9;14(5):e0216669. doi: 10.1371/journal.pone.0216669. eCollection 2019.,"Gorr SU, Flory CM, Schumacher RJ",In vivo activity and low toxicity of the second-generation antimicrobial peptide DGL13K.,Linear,Mixed (L-Gly1),Free,"[Ref.31071184] The cytotoxicity of D-GL13K on HEK cells is 1.5%, 0.9%, 2.1%, 1.5%, 34.2%, 32.4% and 41.1% at peptide concentrations of 1, 3.9, 15.6, 62.5, 250 and 1000 μg/mL, while the cytotoxicity of PMX on HEK cells (Control samples) is 1.2%, 1.2%, 6.6%, 3.6%, 39.6%, 47.1% and 68.5% at peptide concentrations of 1, 3.9, 15.6, 62.5, 250 and 1000 μg/mL.",Amidation,None,Not found,
5464,DRAMP21407,KLCKIVVIKVCK,12,Bac4K (Derived from CAMPs),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,β-turn,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC>64μM), Staphylococcus epidermidis (MIC=32μM), Bacillus subtilis (MIC>64μM), Enterococcus faecalis (MIC>64μM);##Gram-negative bacteria: Escherichia coli (MIC=8μM), Salmonella typhimurium (MIC>64μM), Pseudomonas aeruginosa (MIC>64μM), Acinetobacter baumannii (MIC>64μM)",[Ref.31056261] 0.6% hemolysis at 100 μM against human red blood cells.,,31056261,Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2,"Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI",A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.,Cyclic,L,Free,[Ref.31056261] No cytotoxicity information found,Free,Disulfide bond between Cys3 and Cys11.,Not found,
5465,DRAMP21408,RLCRIWWIRWCR,12,Bac3W (Derived from CAMPs),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,β-turn,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC=16μM), Staphylococcus epidermidis (MIC=8μM), Bacillus subtilis (MIC=32μM), Enterococcus faecalis (MIC=32μM);##Gram-negative bacteria: Escherichia coli (MIC=2-4 μM), Salmonella typhimurium (MIC=8 μM), Pseudomonas aeruginosa (MIC=4μM), Acinetobacter baumannii (MIC=16-32μM)",[Ref.31056261] 0.9% hemolysis at 100 μM against human red blood cells,,31056261,Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2,"Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI",A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.,Cyclic,L,Free,[Ref.31056261] No cytotoxicity information found,Free,Disulfide bond between Cys3 and Cys11.,Not found,
5466,DRAMP21409,RICRIVVIRVCR,12,dBac (Derived from CAMPs),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,β-turn,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC=16μM), Staphylococcus epidermidis (MIC=4-8μM), Bacillus subtilis (MIC=16μM), Enterococcus faecalis (MIC>64μM);##Gram-negative bacteria: Escherichia coli (MIC=4-8μM), Salmonella typhimurium (MIC=32-64μM), Pseudomonas aeruginosa (MIC>64μM), Acinetobacter baumannii (MIC>64μM)",[Ref.31056261] 0.7% hemolysis at 100 μM against human red blood cells,,31056261,Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2,"Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI",A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.,Cyclic,D,Free,[Ref.31056261] No cytotoxicity information found,Free,Disulfide bond between Cys3 and Cys11.,Not found,
5467,DRAMP21410,KLCKIVVIKVCK,12,dBac4K (Derived from CAMPs),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,β-turn,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC>64μM), Staphylococcus epidermidis (MIC=8-16μM), Bacillus subtilis (MIC>64μM), Enterococcus faecalis (MIC>64μM);##Gram-negative bacteria: Escherichia coli (MIC=4-8μM), Salmonella typhimurium (MIC=32-64μM), Pseudomonas aeruginosa (MIC>64μM), Acinetobacter baumannii (MIC>64μM)",[Ref.31056261] 0.7% hemolysis at 100 μM against human red blood cells,,31056261,Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2,"Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI",A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.,Cyclic,D,Free,[Ref.31056261] No cytotoxicity information found,Free,Disulfide bond between Cys3 and Cys11.,Not found,
5468,DRAMP21411,RICRIWWIRWCR,12,dBac3W (Derived from CAMPs),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,β-turn,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC=16μM), Staphylococcus epidermidis (MIC=16μM), Bacillus subtilis (MIC=32μM), Enterococcus faecalis (MIC=16-32μM);##Gram-negative bacteria: Escherichia coli (MIC=4-8μM), Salmonella typhimurium (MIC=4-8μM), Pseudomonas aeruginosa (MIC=4-8μM), Acinetobacter baumannii (MIC=32μM)",[Ref.31056261] 1.0% hemolysis at 100 μM against human red blood cells,,31056261,Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2,"Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI",A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.,Cyclic,D,Free,[Ref.31056261] No cytotoxicity information found,Free,Disulfide bond between Cys3 and Cys11.,Not found,
5469,DRAMP21412,RKCRIVVIRVCR,12,dBacK (Derived from CAMPs),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,β-turn,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC=4-8μM), Staphylococcus epidermidis (MIC=1-2μM), Bacillus subtilis (MIC=1-2μM), Enterococcus faecalis (MIC=4μM);##Gram-negative bacteria: Escherichia coli (MIC=1-2μM), Salmonella typhimurium (MIC=1-2μM), Pseudomonas aeruginosa (MIC=2-4μM), Acinetobacter baumannii (MIC=2-4μM)",[Ref.31056261] 0.6% hemolysis at 100 μM against human red blood cells,,31056261,Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2,"Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI",A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.,Cyclic,D,Free,[Ref.31056261] No cytotoxicity information found,Free,Disulfide bond between Cys3 and Cys11.,Not found,
5470,DRAMP21413,RKCRIVVIRVCR,12,dBacK- (cap) (Derived from CAMPs),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,β-turn,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.31056261] Gram-positive bacteria: Staphylococcus aureus (MIC=1-2μM), Staphylococcus epidermidis (MIC=2μM), Bacillus subtilis (MIC=2μM), Enterococcus faecalis (MIC=4-8μM);##Gram-negative bacteria: Escherichia coli (MIC=2-4μM), Salmonella typhimurium (MIC=2-4μM), Pseudomonas aeruginosa (MIC=4-8μM), Acinetobacter baumannii (MIC=1-2μM)",[Ref.31056261] 2.1% hemolysis at 100 μM against human red blood cells,,31056261,Biochem Biophys Res Commun. 2019 Jun 25;514(2):497-502. doi: 10.1016/j.bbrc.2019.04.153. Epub 2019 May 2,"Sim JY, Kim S, Lee J, Lim H, Kim HH, Park ZY, Kim JI",A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.,Cyclic,D,Free,[Ref.31056261] No cytotoxicity information found,Free,Disulfide bond between Cys3 and Cys11. The lysine side-chain residue at position 2(Lys2) is conjugated to the capric acid ,Not found,
5471,DRAMP21414,RWKIFKKIEKMGRNIRDGIVKAGPAIQVLGSAKAI,35,CecB Q53 (Derived from CecB E53),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,Random coil in aqueous solution and amphipathic helix upon interaction with cell membranes,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria. Antifungal activity against Candida albicans ATCC 1023.,"[Ref.31045339] Gram-positive bacteria: Staphylococcus aureus ATCC BAA-44(MIC>20μM), Staphylococcus epidermidis ATCC 700565(MIC=8μM);##Gram-negative bacteria:  Escherichia coli ATCC 25922 (MIC=0.15μM), Pseudomonas aeruginosa ATCC 27853(MIC=2.2μM), Pseudomonas aeruginosa ATCC 25668(MIC=2.2μM);##Fungi:Candida albicans ATCC 1023(MIC>20μM)","[Ref.31045339] 0.1% hemolysis at 20μM, 0.5% hemolysis at 30μM, 0.5% hemolysis at 200μM against human red blood cells",,31045339,ACS Infect Dis. 2019 May 10. doi: 10.1021/acsinfecdis.9b00042.,"Romoli O, Mukherjee S, Mohid SA, Dutta A, Montali A, Franzolin E, Brady D, Zito F, Bergantino E, Rampazzo C, Tettamanti G, Bhunia A, Sandrelli F",Enhanced Silkworm Cecropin B Antimicrobial Activity against Pseudomonas aeruginosa from Single Amino Acid Variation.,Linear,L,Free,"[Ref.31045339] ①The cell viability of Hela cells induced by CecB Q53 is 102.6%, 104.0%, 99.1% and 95.6% at peptide concentrations of 10, 20, 30 and 200 μM. ②The cell viability of CCD cells induced by CecB Q53 is 108.4%, 111.5%, 108.8% and 88.5% at peptide concentrations of 10, 20, 30 and 200 μM.",Amidation,None,Not found,
5472,DRAMP21415,LKKWWKTSKGLLGGLLGKVTSVIK,24,α4-short (Derived from α4),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30967458] Gram-positive bacteria: Staphylococcus aureus 467-1 (MIC=2μM), Staphylococcus aureus 0154-17 (MIC=2μM), Staphylococcus aureus 187-10 (MIC=16μM), Staphylococcus aureus 0194-19 (MIC=2μM), Staphylococcus aureus US300 (MIC=8μM), Staphylococcus aureus 122-12 (MIC=2μM), Enterococcus faecium 23614 (MIC=1μM), Enterococcus faecium 14678 (MIC=1μM), Enterococcus faecium 26125 (MIC=1μM);##Gram-negative bacteria:Pseudomonas aeruginosa 16-21 (MIC=2μM), Pseudomonas aeruginosa 16-72 (MIC=2μM), Pseudomonas aeruginosa 16-73 (MIC=2μM), Pseudomonas aeruginosa 0038-13 (MIC=2μM), Pseudomonas aeruginosa 0038-14 (MIC=1μM), Pseudomonas aeruginosa 0040-21 (MIC=2μM), Pseudomonas aeruginosa 0046-106 (MIC=8μM), Pseudomonas aeruginosa 0068-37 (MIC=16μM), Pseudomonas aeruginosa 0071-75 (MIC=2μM), Pseudomonas aeruginosa 97-5 (MIC=2μM), Pseudomonas aeruginosa 109-10 (MIC=2μM), Pseudomonas aeruginosa 16-21 (MIC=2μM)Pseudomonas aeruginosa 132-37 (MIC=2μM), Pseudomonas aeruginosa 129-5 (MIC=2μM), Pseudomonas aeruginosa 152-19 (MIC=2μM), Pseudomonas aeruginosa 159-30 (MIC=2μM), Pseudomonas aeruginosa 474-1 (MIC=2μM), Acinetobacter baumannii C3 (MIC=1μM), Acinetobacter baumannii D4 (MIC=2μM), Acinetobacter baumannii A2 (MIC=4μM), Escherichia coli YDC518 (MIC=1μM), Escherichia coli YDC575 (MIC=2μM), Escherichia coli YDC596 (MIC=1μM), Escherichia coli YDC107 (MIC=1μM), Escherichia coli YDC337 (MIC=1μM), Escherichia coli YDC748 (MIC=1μM), Klebsiella pneumoniae A2 (MIC=4μM), Klebsiella pneumoniae D4 (MIC=2μM), Klebsiella pneumoniae 438-16 (MIC=4μM)","[Ref.30967458] 1% hemolysis at 17 μM, 2% hemolysis at 30 μM, 3% hemolysis at 63 μM against human red blood cells",,30967458,mBio. 2019 Mar-Apr; 10(2): e00226-19. Published online 2019 Apr 9. doi: 10.1128/mBio.00226-19,"Shasha Jiang, Berthony Deslouches, Chen Chen, Matthew E. Di, Y. Peter Di","Antibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, α6-Short, in a Murine Model of Respiratory Infection",Linear,L,Free,"[Ref.30967458] The white blood cell toxicity of α4-short is ~0%, ~0%, ~0%, ~0%, ~0%, 1.8% and 3.1% at peptide concentrations of 1, 2, 4, 8, 16, 32 and 64 μM.",Free,None,Not found,
5473,DRAMP21416,WVKAAAKAAAKVW,13,WV (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"α-helix predicted by I-TASSER, random coil in PBS, α-helix in SDS",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30897850] Gram-positive bacteria:Staphylococcus aureus ATCC 27853(MIC>128μM), Staphylococcus epidermidis ATCC 12228(MIC>128μM), Staphylococcus faecalis ATCC 29212(MIC=64μM), Bacillus subtilis CMCC 63501(MIC>128μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=32μM), Escherichia coli UB 1005 (MIC>128μM), Pseudomonas aeruginosa ATCC 27853(MIC>128μM), Salmonella typhimurium ATCC 14028(MIC>128μM)",[Ref.30897850] 1.5% hemolysis at 256μM against human red blood cells,,30897850,Int J Mol Sci. 2019 Mar; 20(6): 1417. Published online 2019 Mar 20. doi: 10.3390/ijms20061417,"Changxuan Shao, Weizhong Li, Peng Tan, Anshan Shan, Xiujing Dou, Deying Ma, Chunyu Liu",Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency,Linear,L,Free,"[Ref.30897850] ①The cell viability of RAW 264.7 induced by WV is 102.5%, 93.5%, 97.8%, 95.7%, 99.3%, 99.6%, 93.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on RAW 264.7 cells (Control samples) is 93.1%, 67.8%, 37.7%, 17.8%, 0%, 1.4% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.②The cell viability of HEK293T induced by WV is 115.2%, 104.3%, 114.5%, 107.6%, 105.8%, 108.0% and 93.8% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on HEK293T cells (Control samples) is 101.4%, 80.1%, 31.9%, 1.4%, 1.4%, 1.8% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.",Amidaton,None,Not found,
5474,DRAMP21417,WIKAAAKAAAKIW,13,WI (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"α-helix predicted by I-TASSER, random coil in PBS, α-helix in SDS",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30897850] Gram-positive bacteria:Staphylococcus aureus ATCC 27853(MIC=32μM), Staphylococcus epidermidis ATCC 12228(MIC=32μM), Staphylococcus faecalis ATCC 29212(MIC=32μM), Bacillus subtilis CMCC 63501(MIC=8μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=8μM), Escherichia coli UB 1005 (MIC=8μM), Pseudomonas aeruginosa ATCC 27853(MIC=32μM), Salmonella typhimurium ATCC 14028(MIC=32μM)",[Ref.30897850] 15% hemolysis at 256μM against human red blood cells,,30897850,Int J Mol Sci. 2019 Mar; 20(6): 1417. Published online 2019 Mar 20. doi: 10.3390/ijms20061417,"Changxuan Shao, Weizhong Li, Peng Tan, Anshan Shan, Xiujing Dou, Deying Ma, Chunyu Liu",Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency,Linear,L,Free,"[Ref.30897850] ①The cell viability of RAW 264.7 induced by WI is 104.0%, 98.2%, 98.6%, 106.5%, 103.6%, 101.8% and 100% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on RAW 264.7 cells (Control samples) is 93.1%, 67.8%, 37.7%, 17.8%, 0%, 1.4% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.②The cell viability of HEK293T induced by WV is 98.9%, 99.3%, 107.2%, 99.6%, 110.5%, 108.3%, 96.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on HEK293T cells (Control samples) is 101.4%, 80.1%, 31.9%, 1.4%, 1.4%, 1.8% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.",Amidaton,None,Not found,
5475,DRAMP21418,WFKAAAKAAAKFW,13,WF (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"α-helix predicted by I-TASSER, random coil in PBS, α-helix in SDS",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30897850] Gram-positive bacteria:Staphylococcus aureus ATCC 27853(MIC=8μM), Staphylococcus epidermidis ATCC 12228(MIC=16μM), Staphylococcus faecalis ATCC 29212(MIC=32μM), Bacillus subtilis CMCC 63501(MIC=8μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=4μM), Escherichia coli UB 1005 (MIC=4μM), Pseudomonas aeruginosa ATCC 27853(MIC=16μM), Salmonella typhimurium ATCC 14028(MIC=32μM)",[Ref.30897850] 12% hemolysis at 256μM against human red blood cells,,30897850,Int J Mol Sci. 2019 Mar; 20(6): 1417. Published online 2019 Mar 20. doi: 10.3390/ijms20061417,"Changxuan Shao, Weizhong Li, Peng Tan, Anshan Shan, Xiujing Dou, Deying Ma, Chunyu Liu",Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency,Linear,L,Free,"[Ref.30897850] ①The cell viability of RAW 264.7 induced by WF is 102.5%, 103.6%, 105.4%, 108.3%, 105.8%, 101.1% and 92.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on RAW 264.7 cells (Control samples) is 93.1%, 67.8%, 37.7%, 17.8%, 0%, 1.4% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.②The cell viability of HEK293T induced by WV is 101.8%, 101.4%, 93.5%, 97.1%, 93.8%, 107.6% and 92.0% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on HEK293T cells (Control samples) is 101.4%, 80.1%, 31.9%, 1.4%, 1.4%, 1.8% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.",Amidaton,None,Not found,
5476,DRAMP21419,WWKAAAKAAAKWW,13,WW (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"α-helix predicted by I-TASSER, random coil in PBS, α-helix in SDS",Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30897850] Gram-positive bacteria:Staphylococcus aureus ATCC 27853(MIC=4μM), Staphylococcus epidermidis ATCC 12228(MIC=4μM), Staphylococcus faecalis ATCC 29212(MIC=4μM), Bacillus subtilis CMCC 63501(MIC=4μM);##Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=2μM), Escherichia coli UB 1005 (MIC=4μM), Pseudomonas aeruginosa ATCC 27853(MIC=8μM), Salmonella typhimurium ATCC 14028(MIC=8μM)",[Ref.30897850] 24% hemolysis at 256μM against human red blood cells,,30897850,Int J Mol Sci. 2019 Mar; 20(6): 1417. Published online 2019 Mar 20. doi: 10.3390/ijms20061417,"Changxuan Shao, Weizhong Li, Peng Tan, Anshan Shan, Xiujing Dou, Deying Ma, Chunyu Liu",Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency,Linear,L,Free,"[Ref.30897850] ①The cell viability of RAW 264.7 induced by WW is 104.3%, 103.6%, 109.4%, 103.6%, 97.5%, 89.9%, 63.4% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on RAW 264.7 cells (Control samples) is 93.1%, 67.8%, 37.7%, 17.8%, 0%, 1.4% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.②The cell viability of HEK293T induced by WV is 102.9%, 111.6%, 105.1%, 104.3%, 101.8%, 84.8%, 43.5% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM, while the cytotoxicity of WV on HEK293T cells (Control samples) is 101.4%, 80.1%, 31.9%, 1.4%, 1.4%, 1.8% and 1.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μM.",Amidaton,None,Not found,
5477,DRAMP21420,FLPKLFAKITKKNMAHIRC,19,AY1C (Derived from AY1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Helix-loop-helix derived from NMR,Not found,5YKL resolved by NMR,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.30872680] Gram-negative bacteria:Pseudomonas aeruginosa (MIC=15μM), Escherichia coli  (MIC=17μM), Salmonella typhi(MIC=15μM), Klebsiella pneumoniae(MIC=12μM)","[Ref.30872680] 4% hemolysis at 10 μM, 9% hemolysis at 50 μM, 8% hemolysis at 100μM against human red blood cells",,30872680,Sci Rep. 2019; 9: 4485. Published online 2019 Mar 14. doi: 10.1038/s41598-019-41005-7,"Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS",A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria,Linear,L,Free,[Ref.30872680] No cytotoxicity information found.,Free,None,Not found,
5478,DRAMP21421,FLPKLFAKITKKNMAHIRC,19,AY1C-AgNP (Derived from AY1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Helix-loop-helix derived from NMR,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.30872680] Gram-negative bacteria:Pseudomonas aeruginosa (MIC=15μM), Escherichia coli  (MIC=12μM), Salmonella typhi(MIC=15μM), Klebsiella pneumoniae(MIC=10μM)","[Ref.30872680] 4% hemolysis at 10 μM, 6% hemolysis at 50 μM, 9% hemolysis at 100μM against human red blood cells",,30872680,Sci Rep. 2019; 9: 4485. Published online 2019 Mar 14. doi: 10.1038/s41598-019-41005-7,"Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS",A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria,Linear,L,Free,[Ref.30872680] No cytotoxicity information found.,Free,Conjugation with silver nanoparticles,Not found,
5479,DRAMP21422,CFLPKLFAKITKKNMAHIR,19,CAY1 (Derived from AY1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Helix-loop-helix derived from NMR,Not found,5YKQ resolved by NMR,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.30872680] Gram-negative bacteria:Pseudomonas aeruginosa (MIC=10μM), Escherichia coli  (MIC=10μM), Salmonella typhi(MIC=Not know), Klebsiella pneumoniae(MIC=7μM)","[Ref.30872680] 4% hemolysis at 10 μM, 9% hemolysis at 50 μM, 10% hemolysis at 100μM against human red blood cells",,30872680,Sci Rep. 2019; 9: 4485. Published online 2019 Mar 14. doi: 10.1038/s41598-019-41005-7,"Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS",A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria,Linear,L,Free,[Ref.30872680] No cytotoxicity information found.,Free,None,Not found,
5480,DRAMP21423,CFLPKLFAKITKKNMAHIR,19,CAY1-AgNP (Derived from AY1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Helix-loop-helix derived from NMR,Not found,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.30872680] Gram-negative bacteria:Pseudomonas aeruginosa (MIC=10μM), Escherichia coli  (MIC=10μM), Salmonella typhi(MIC=15μM), Klebsiella pneumoniae(MIC=5μM)","[Ref.30872680] 3% hemolysis at 10 μM, 9% hemolysis at 50 μM, 9.5% hemolysis at 100μM against human red blood cells",,30872680,Sci Rep. 2019; 9: 4485. Published online 2019 Mar 14. doi: 10.1038/s41598-019-41005-7,"Pal I, Bhattacharyya D, Kar RK, Zarena D, Bhunia A, Atreya HS",A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria,Linear,L,Free,[Ref.30872680] No cytotoxicity information found.,Free,Conjugation with silver nanoparticles,Not found,
5481,DRAMP21424,KKGKGGG,7,B1 (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coils most likely,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=2-4µg/ml), MSSA ATCC 29213(MIC=8-16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=8-16µg/ml)","[Ref.30842436] EC10=64μM, EC50=230μM, 32% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,L,Free,[Ref.30842436] No cytotoxicity information found.,Amidation,①Residue 3 is N-butylglycine. ②Residue 5 and residue 7 are  N-1-naphthylmethylglycine. ③Residue 6 is N-4-methylbenzylglycine. ,Not found,
5482,DRAMP21425,KKGKGGG,7,peptide 2 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=4µg/ml), MSSA ATCC 29213(MIC=8-16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)",[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells,,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,L,Free,[Ref.30842436] No cytotoxicity information found.,Amidation,①Residue 3 is N-butylglycine. ②Residue 5 and residue 7 are N-1-naphthylmethylglycine. ③Residue 6 is N-benzylglycine resembling Phe.,Not found,
5483,DRAMP21426,KKKGGGG,7,peptide 3 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=4µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)",[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells,,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,L,Free,[Ref.30842436] No cytotoxicity information found.,Amidation,①Residue 4 is N-butylglycine. ②Residue 5 and residue 7 are N-1-naphthylmethylglycine. ③Residue 6 is N-benzylglycine resembling Phe. ,Not found,
5484,DRAMP21427,GGGGKKK,7,peptide 4 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)","[Ref.30842436] EC10=54μM, 24% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,L,Free,[Ref.30842436] No cytotoxicity information found.,Amidation,①Residue 1 and residue 3 are  N-1-naphthylmethylglycine.②Residue 2 is N-benzylglycine resembling Phe.③Residue 4 is N-butylglycine. ,Not found,
5485,DRAMP21428,GGGKGKK,7,peptide 5 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)",[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells,,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,L,Free,[Ref.30842436] No cytotoxicity information found.,Amidation,①Residue 1 and residue 3 are  N-1-naphthylmethylglycine.②Residue 2 is N-benzylglycine resembling Phe.③Residue 5 is N-butylglycine. ,Not found,
5486,DRAMP21429,KKLKAFA,7,peptide 6 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=32µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=8µg/ml)","[Ref.30842436] EC10=5μM, EC50=58μM, 96% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,L,Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 5 and residue 7 are 1-naphthylmethylglycine,Not found,
5487,DRAMP21430,KKKLAFA,7,peptide 7 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=16µg/ml)","[Ref.30842436] EC10=8μM, EC50=140μM, 55% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,L,Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 5 and residue 7 are 1-naphthylmethylglycine,Not found,
5488,DRAMP21431,KKLKAFA,7,peptide 8 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)","[Ref.30842436] EC10=56μM, 34% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,L,Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 5 and residue 7 are 2-naphthylmethylglycine,Not found,
5489,DRAMP21432,KKKLAFA,7,peptide 9 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=16µg/ml)","[Ref.30842436] EC10=46μM, 39% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,L,Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 5 and residue 7 are 2-naphthylmethylglycine,Not found,
5490,DRAMP21433,AFAKLKK,7,peptide 10 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8-16µg/ml), MSSA ATCC 29213(MIC=16-32µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=64µg/ml)",[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells,,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,L,Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 1 and residue 3 are 1-naphthylmethylglycine,Not found,
5491,DRAMP21434,AFAKLKK,7,peptide 11 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=4-8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=64µg/ml)",[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells,,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,L,Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 1 and residue 3 are 2-naphthylmethylglycine,Not found,
5494,DRAMP21437,KKLKAFA,7,peptide 14 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=4-8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=16-32µg/ml)","[Ref.30842436] EC10=28μM, EC50=128μM, 58% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,"Mixed (D-Leu3, D-Ala5, D-Phe6 and D-Ala7)",Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 5 and residue 7 are 1-naphthylmethylglycine,Not found,
5495,DRAMP21438,KKKLAFA,7,peptide 15 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=2µg/ml), MSSA ATCC 29213(MIC=8µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=8µg/ml)","[Ref.30842436] EC10=8μM, EC50=40μM, 88% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,"Mixed (D-Leu4, D-Ala5, D-Phe6 and D-Ala7)",Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 5 and residue 7 are 1-naphthylmethylglycine,Not found,
5496,DRAMP21439,KKKLAFA,7,peptide 16 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=2-4µg/ml), MSSA ATCC 29213(MIC=8-16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)","[Ref.30842436] EC10=18μM, EC50=118μM, 60% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,"Mixed (D-Leu4, D-Ala5, D-Phe6 and D-Ala7)",Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 5 and residue 7 are 2-naphthylmethylglycine,Not found,
5497,DRAMP21440,KKLKAFA,7,peptide 17 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=8µg/ml), MSSA ATCC 29213(MIC=16µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)","[Ref.30842436] EC10=8μM, 40% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,"Mixed (D-Leu3, D-Ala5, D-Phe6 and D-Ala7)",Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 5 and residue 7 are 2-naphthylmethylglycine,Not found,
5501,DRAMP21444,AFALKKK,7,peptide 21 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=16µg/ml), MSSA ATCC 29213(MIC=32µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)",[Ref.30842436] < 8% hemolysis at 150 µM against human red blood cells,,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,"Mixed (D-Ala1, D-Phe2, D-Ala3, D-Leu4)",Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 1 and residue 3 are 1-naphthylmethylglycine,Not found,
5505,DRAMP21448,KKKLAYA,7,peptide 25 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=2-4µg/ml), MSSA ATCC 29213(MIC=32-64µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=8µg/ml)","[Ref.30842436] EC10=38μM, EC50=138μM, 53% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,"Mixed (D-Leu4, D-Ala5, D-Tyr6, D-Ala7)",Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 5 and residue 7 are 1-naphthylmethylglycine,Not found,
5508,DRAMP21451,KKKLAYA,7,peptide 28 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria:MRSP C22963(MIC=2-4µg/ml), MSSA ATCC 29213(MIC=32µg/ml);##Gram-negative bacteria:Pseudomonas aeruginosa(MIC=32µg/ml)","[Ref.30842436] EC10=6μM, EC50=50μM, 64% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,"Mixed (D-Leu4, D-Ala5, D-Tyr6, D-Ala7)",Free,[Ref.30842436] No cytotoxicity information found.,Amidation,Residue 5 and residue 7 are 2-naphthylmethylglycine,Not found,
5509,DRAMP21452,KKKLAFA,7,peptide 29 (Derived from B1),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Unknown,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30842436] Gram-positive bacteria: MRSP C22963(MIC=4-8 µg/ml), MSSA ATCC 29213(MIC=16-32 µg/ml);##Gram-negative bacteria: Pseudomonas aeruginosa(MIC=32 µg/ml)","[Ref.30842436] EC10=9μM, 46% hemolysis at 150 µM against human red blood cells",,30842436,Sci Rep. 2019; 9: 3679. Published online 2019 Mar 6. doi: 10.1038/s41598-019-39042-3,"Ines Greco, Agnete Plahn Emborg, Bimal Jana, Natalia Molchanova, Alberto Oddo, Peter Damborg, Luca Guardabassi, Paul R. Hansen","Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections",Linear,L,Free,[Ref.30842436] No cytotoxicity information found.,Amidation,"Residue 5 and residue 7 are 2-naphthylmethylglycine. Residue 1, residue 2 and residue 3 are N-(4-aminobutyl)glycine",Not found,
5510,DRAMP21453,GLPLLISWIKRKRQQGSKKPVPIIYCNRRTGKCQRM,36,Hybrid (Derived from Melittin and thanatin),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,A combination of α-helix and β-lamellar,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30701481] Gram-positive bacteria:Staphylococcus aureus(MIC=0.9-1.5μmol/L), Bacillus subtilis(MIC=0.6-1.2μmol/L);##Gram-negative bacteria:Escherichia coli JM 109(MIC=0.6-1.2 μmol/L), Salmonella typhimurium(MIC=0.3-0.6μmol/L)",[Ref.30701481] 0% hemolysis at 45 μmol/L and >0% hemolysis at 60 μmol/L against sheep blood cells,,30701481,AMB Express. 2019; 9: 14. Published online 2019 Jan 30. doi: 10.1186/s13568-019-0739-z,"Xiaofeng Jiang, Kun Qian, Guangping Liu, Laiyu Sun, Guoqing Zhou, Jingfen Li, Xinqiang Fang, Haixia Ge, Zhengbing Lv",Design and activity study of a melittin–thanatin hybrid peptide,Linear,L,Free,[Ref.30701481] The average inhibitory rate of the hybrid peptide in the SMMC-7721 cells was 19.14%.,Free,None,Not found,
5511,DRAMP21454,GILDWGKKVMDWIKDKM,17,"PLP1 (Insects, animals)",A0A348G6I7,Belongs to the formicidae venom precursor-01 superfamily.,Not found,Odontomachus monticola (Trap-jaw ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,α-helix predicted by Proteus,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria. Antifungal activity against Saccharomyces cerevisiae.,[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC<3.1μM);##Gram-negative bacteria:Escherichia coli (MIC<3.1μM);##Fungi:Saccharomyces cerevisiae (MIC<50μM),[Ref.30658410] 0% hemolysis at 50 μM against rat blood cells,,30658410,Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050,"Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki",Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components,Linear,L,Free,[Ref.30658410] No cytotoxicity information found.,Amidation,None,Not found,
5512,DRAMP21455,GWGSIFKTVGKMIAKAAVKAAPEAISAMASQNE,33,"PLP2 (Insects, animals)",A0A348G5V8,Belongs to the formicidae venom precursor-01 superfamily.,Not found,Odontomachus monticola (Trap-jaw ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,α-helix predicted by Proteus,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria. Antifungal activity against Saccharomyces cerevisiae.,[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC<6.2μM);##Gram-negative bacteria:Escherichia coli (MIC<6.2μM);##Fungi:Saccharomyces cerevisiae (MIC<50μM),[Ref.30658410] 10.4% hemolysis at 50 μM against rat blood cells,,30658410,Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050,"Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki",Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components,Linear,L,Free,[Ref.30658410] No cytotoxicity information found.,Free,None,Not found,
5513,DRAMP21456,KIKWGKIFKKGGKLIGKTALEAAANAAASEAISAMASQNE,40,"PLP3 (Insects, animals)",A0A348G5V9,Belongs to the formicidae venom precursor-01 superfamily.,Not found,Odontomachus monticola (Trap-jaw ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,α-helix predicted by Proteus,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria. Antifungal activity against Saccharomyces cerevisiae.,[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC<25μM);##Gram-negative bacteria:Escherichia coli (MIC<3.1μM);##Fungi:Saccharomyces cerevisiae (MIC<50μM),[Ref.30658410] 0% hemolysis at 50 μM against rat blood cells,,30658410,Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050,"Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki",Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components,Linear,L,Free,[Ref.30658410] No cytotoxicity information found.,Free,None,Not found,
5514,DRAMP21457,GVKELFGKAWGLVKKHLPKACGLLGYVKQ,29,"PLP4 (Insects, animals)",A0A348G5W0,Belongs to the formicidae venom precursor-01 superfamily.,Not found,Odontomachus monticola (Trap-jaw ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,α-helix predicted by Proteus,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria. Antifungal activity against Saccharomyces cerevisiae.,[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC<3.1μM);##Gram-negative bacteria:Escherichia coli (MIC<3.1μM);##Fungi:Saccharomyces cerevisiae (MIC<3.1μM),[Ref.30658410] 10.5% hemolysis at 50 μM against rat blood cells,,30658410,Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050,"Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki",Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components,Cyclic,L,Free,[Ref.30658410] No cytotoxicity information found.,Free,Cys21 is S-(carbamoylmethyl)-L-cysteine and there is a interchain disulfide bond between two PLP4 peptide molecules.,Not found,
5515,DRAMP21458,IWGALLGTLIPAITSAIQ,18,"PLP5 (Insects, animals)",A0A348G5W1,Belongs to the formicidae venom precursor-01 superfamily.,Not found,Odontomachus monticola (Trap-jaw ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,α-helix predicted by Proteus,Not found,None,Function: Antibacterial activity against Gram-nagetive bacteria. ,[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC Negative);##Gram-negative bacteria:Escherichia coli (MIC<50μM);##Fungi:Saccharomyces cerevisiae (MIC Negative),[Ref.30658410] 6.9% hemolysis at 10μM and 94.8% at 50 μM against rat blood cells,,30658410,Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050,"Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki",Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components,Linear,L,Free,[Ref.30658410] No cytotoxicity information found.,Amidation,None,Not found,
5516,DRAMP21459,IKGKKIMKNMGKAMKIAGKVAKAMAPIVVPLIVSAA,36,"PLP6 (Insects, animals)",A0A348G5W2,Belongs to the formicidae venom precursor-01 superfamily.,Not found,Odontomachus monticola (Trap-jaw ant),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Protein level,α-helix predicted by Proteus,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,[Ref.30658410] Gram-positive bacteria:Staphylococcus aureus (MIC<3.1μM);##Gram-negative bacteria:Escherichia coli (MIC<3.1μM);##Fungi:Saccharomyces cerevisiae (MIC Negative),[Ref.30658410] 0% hemolysis at 50 μM against rat blood cells,,30658410,Toxins (Basel). 2019 Jan; 11(1): 50. Published online 2019 Jan 17. doi: 10.3390/toxins11010050,"Naoki Tani, Kohei Kazuma, Yukio Ohtsuka, Yasushi Shigeri, Keiichi Masuko, Katsuhiro Konno, Hidetoshi Inagaki",Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components,Linear,L,Free,[Ref.30658410] No cytotoxicity information found.,Amidation,None,Not found,
5517,DRAMP21460,IHKFWRCRRRFCRWFKHI,18,PQ (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix predicted by I-Tasser,"In PBS, the α-helix content of PQ is 26.91% and the β-strand content of that is 11.16%. In SDS, the α-helix content of PQ is 32.02% and the β-strand of that is 6.15%. In TFE, the α-helix content of PQ is 36.82% and the β-strand of that is 4.28%.",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=8μM), Staphylococcus aureus ATCC 43300(MIC=8μM), Staphylococcus epidermidis ATCC 12228(MIC=8μM), Streptococci faecalis ATCC 29212(MIC=16μM), Bacillus subtilis CMCC 63501(MIC=16μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=16μM), Escherichia coli UB 1005(MIC=8μM), bacteria pyocyaneum ATCC 27853(MIC=8μM), Salmonella typhimurium ATCC 7731(MIC=8μM), Salmonella Pulloru C79-13(MIC=8μM)",[Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis.,,30538681,Front Microbiol. 2018; 9: 2832. Published online 2018 Nov 27. doi: 10.3389/fmicb.2018.02832,"Na Dong, Shuli Chou, Jiawei Li, Chenyu Xue, Xinran Li, Baojing Cheng, Anshan Shan, and Li Xu",Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability,Linear,L,Free,"[Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by PQ is 68.2%, 68.6%, 66.8%,63.6%, 69.1%, 62.2%, 55.8% and 28.1% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5518,DRAMP21461,IHKFWRPGRWFKHI,14,PP (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,A combination of α-helical and β-hairpin,"In PBS, the α-helix content of PQ is 12.35% and the β-strand content of that is 16.30%. In SDS, the α-helix content of PQ is 9.86% and the β-strand of that is 11.56%. In TFE, the α-helix content of PQ is 37.54% and the β-strand of that is 2.54%.",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=16μM), Staphylococcus aureus ATCC 43300(MIC=16μM), Staphylococcus epidermidis ATCC 12228(MIC=16μM), Streptococci faecalis ATCC 29212(MIC=8μM), Bacillus subtilis CMCC 63501(MIC=8μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8μM), Escherichia coli UB 1005(MIC=4μM), bacteria pyocyaneum ATCC 27853(MIC=4μM), Salmonella typhimurium ATCC 7731(MIC=8μM), Salmonella Pulloru C79-13(MIC=4μM)",[Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis.,,30538681,Front Microbiol. 2018; 9: 2832. Published online 2018 Nov 27. doi: 10.3389/fmicb.2018.02832,"Na Dong, Shuli Chou, Jiawei Li, Chenyu Xue, Xinran Li, Baojing Cheng, Anshan Shan, and Li Xu",Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability,Linear,L,Free,"[Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by PP is 67.7%, 69.1%, 70.5%, 65.4%, 61.3%, 65.0%, 70.5% and 68.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5519,DRAMP21462,IHKFWRGGRWFKHI,14,GG (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,A combination of α-helical and β-hairpin,"In PBS, the α-helix content of PQ is 1.49% and the β-strand content of that is 32.19%. In SDS, the α-helix content of PQ is 11.99% and the β-strand of that is 9.42%. In TFE, the α-helix content of PQ is 18.98% and the β-strand of that is 11.53%.",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=16μM), Staphylococcus aureus ATCC 43300(MIC=32μM), Staphylococcus epidermidis ATCC 12228(MIC=32μM), Streptococci faecalis ATCC 29212(MIC=32μM), Bacillus subtilis CMCC 63501(MIC=16μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8μM), Escherichia coli UB 1005(MIC=8μM), bacteria pyocyaneum ATCC 27853(MIC=16μM), Salmonella typhimurium ATCC 7731(MIC=64μM), Salmonella Pulloru C79-13(MIC=8μM)",[Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis.,,30538681,Front Microbiol. 2018; 9: 2832. Published online 2018 Nov 27. doi: 10.3389/fmicb.2018.02832,"Na Dong, Shuli Chou, Jiawei Li, Chenyu Xue, Xinran Li, Baojing Cheng, Anshan Shan, and Li Xu",Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability,Linear,L,Free,"[Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by GG is 67.7%, 74.2%, 76.5%, 72.4%, 72.8%, 69.1%, 65.9% and 59.9% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5520,DRAMP21463,IHKFWRRWFKHI,12,Qa (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,α-helix predicted by I-Tasser,"In PBS, the α-helix content of PQ is 2.89% and the β-strand content of that is 19.89%. In SDS, the α-helix content of PQ is 5.54% and the β-strand of that is 14.12%. In TFE, the α-helix content of PQ is 3.08% and the β-strand of that is 18.1%.",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=8μM), Staphylococcus aureus ATCC 43300(MIC=16μM), Staphylococcus epidermidis ATCC 12228(MIC=16μM), Streptococci faecalis ATCC 29212(MIC=16μM), Bacillus subtilis CMCC 63501(MIC=32μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=16μM), Escherichia coli UB 1005(MIC=8μM), bacteria pyocyaneum ATCC 27853(MIC=16μM), Salmonella typhimurium ATCC 7731(MIC=16μM), Salmonella Pulloru C79-13(MIC=16μM)",[Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis.,,30538681,Front Microbiol. 2018; 9: 2832. Published online 2018 Nov 27. doi: 10.3389/fmicb.2018.02832,"Na Dong, Shuli Chou, Jiawei Li, Chenyu Xue, Xinran Li, Baojing Cheng, Anshan Shan, and Li Xu",Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability,Linear,L,Free,"[Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by Qa is 61.3%, 66.8%, 76.5%, 71.4%, 72.4%, 73.3%, 65.9% and 39.6% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5521,DRAMP21464,IHFKWRRWKFHI,12,Qna (De Novo Synthesis),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Linear and unordered conformation,"In PBS, the α-helix content of PQ is 3.46% and the β-strand content of that is 17.46%. In SDS, the α-helix content of PQ is 1.29% and the β-strand of that is 21.49%. In TFE, the α-helix content of PQ is 0.73% and the β-strand of that is 18.82%.",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,"[Ref.30538681] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=32μM), Staphylococcus aureus ATCC 43300(MIC=32μM), Staphylococcus epidermidis ATCC 12228(MIC=32μM), Streptococci faecalis ATCC 29212(MIC=64μM), Bacillus subtilis CMCC 63501(MIC=64μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=32μM), Escherichia coli UB 1005(MIC=16μM), bacteria pyocyaneum ATCC 27853(MIC=32μM), Salmonella typhimurium ATCC 7731(MIC=32μM), Salmonella Pulloru C79-13(MIC=32μM)",[Ref.30538681] MHC>128μM against human blood cells.The minimum hemolytic concentration (MHC) is defined as the peptide concentration resulting in 5% hemolysis.,,30538681,Front Microbiol. 2018; 9: 2832. Published online 2018 Nov 27. doi: 10.3389/fmicb.2018.02832,"Na Dong, Shuli Chou, Jiawei Li, Chenyu Xue, Xinran Li, Baojing Cheng, Anshan Shan, and Li Xu",Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability,Linear,L,Free,"[Ref.30538681] The cell viability of intestinal epithelial cells (IPEC-J2) induced by Qna is 67.3%, 65.0%, 73.7%, 77.9%, 68.2%, 68.2%, 62.2% and 51.2% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM.",Amidation,None,Not found,
5522,DRAMP21465,DEMKLDGFNMHLE,13,P1-Ll-1577 (De Novo Synthesis),No entry found,Not found,Not found, Leptodactylus latrans (Anura: Leptodactylidae),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil predicted by PSIPRED and GOR V,"P1-Ll-1577, although presenting contributions of turn structure, is less ordered in the presence of TFE (percentage of an unordered structure higher than 40%).",None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,[Ref.30423858] Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=40.5μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=20μM),[Ref.30423858] 100% hemolysis MHC=640μM against human blood cells,,30423858,Molecules. 2018 Nov; 23(11): 2943. Published online 2018 Nov 11. doi: 10.3390/molecules23112943,"Alvaro Siano, Maria Veronica Humpola, Eliandre de Oliveira, Fernando Albericio, Arturo C Simonetta, Rafael Lajmanovich, Georgina G Tonarelli",Leptodactylus latrans Amphibian Skin Secretions as a Novel Source for the Isolation of Antibacterial Peptides,Linear,L,Free,[Ref.30423858] No cytotoxicity information found.,Amidation,None,Not found,
5523,DRAMP21466,AAGKGLVSNLLEK,13,P2-Ll-1298 (De Novo Synthesis),No entry found,Not found,Not found, Leptodactylus latrans (Anura: Leptodactylidae),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Helix(K4-E12) predicted by PSIPRED and helix(L6-L10) predicted by GOR V,P2-Ll-1298 showed contributions of α-helix.,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,[Ref.30423858] Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=49μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=24.6μM),[Ref.30423858] 100% hemolysis MHC=320μM against human blood cells,,30423858,Molecules. 2018 Nov; 23(11): 2943. Published online 2018 Nov 11. doi: 10.3390/molecules23112943,"Alvaro Siano, Maria Veronica Humpola, Eliandre de Oliveira, Fernando Albericio, Arturo C Simonetta, Rafael Lajmanovich, Georgina G Tonarelli",Leptodactylus latrans Amphibian Skin Secretions as a Novel Source for the Isolation of Antibacterial Peptides,Linear,L,Free,[Ref.30423858] No cytotoxicity information found.,Amidation,None,Not found,
5524,DRAMP21467,GLLDFLKAAGKGLVSNLLEK,20,P3-Ll-2085 (De Novo Synthesis),No entry found,Not found,Not found, Leptodactylus latrans (Anura: Leptodactylidae),"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"Helix(L2-E19) predicted by PSIPRED and Helix(L3-A9, L13-L17) predicted by GOR V",Deconvolution spectra by SELCON and CONTILL method indicated more than 70% helical structure for P3-Ll-2085,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.,[Ref.30423858] Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=15μM);##Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=15μM),[Ref.30423858] 100% hemolysis MHC=40μM against human blood cells,,30423858,Molecules. 2018 Nov; 23(11): 2943. Published online 2018 Nov 11. doi: 10.3390/molecules23112943,"Alvaro Siano, Maria Veronica Humpola, Eliandre de Oliveira, Fernando Albericio, Arturo C Simonetta, Rafael Lajmanovich, Georgina G Tonarelli",Leptodactylus latrans Amphibian Skin Secretions as a Novel Source for the Isolation of Antibacterial Peptides,Linear,L,Free,[Ref.30423858] No cytotoxicity information found.,Amidation,None,Not found,
5525,DRAMP21310,RRLRKKTRKRLK,12,RK12 (Derived from PMAP-36),No entry found,Not found,Not found,synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,No α-helix content in 50%TFE,Not found,None,Function: Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.,"[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC>128 μM), Staphylococcus aureus 25923 (MIC>128 μM), Staphylococcus  epidermidis 12228 (MIC>128 μM);##Gram-negative bacteria: Escherichia coli 25922 (MIC>128 μM), Escherichia coli 1005 (MIC=64 μM), Staphylococcus typhi (MIC>128 μM)",[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).,,31276398,J Med Chem. 2019 Aug 8;62(15):6941-6957. doi: 10.1021/acs.jmedchem.9b00288.,"Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism,Linear,L,Free,"[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by RK12 is 91.7%, 96.2%, 95.2%, 95.3%, 96.2%, 94.7%, 98.8% and 99.3% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",Amidation,None,Not found,
5527,DRAMP21481,KKKKKKAAFAAWAAFAA,17,6K-F17,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,①Random coils in aqueous buffer. ②α-helix in SDS detergent micelles.,"As previously reported, 6K-F17 adopts a random coil structure in aqueous buffer and an α helix in the presence of SDS detergent micelles.",None,Function: Antibacterial activity against Gram-negative bacteria. No experiments about antibacterial activity against Gram-positive bacteria are recorded.,[Ref.29275987] Gram-negative bacteria: E. coli (MIC= 1.6 μM),[Ref.29275987] MHC = 320 μM against human red blood cells. Note: Minimum hemolytic concentration (MHC) is the minimum peptide concentration at which red blood cells undergo > 2% hemolysis.,,29275987,Bioorg Med Chem. 2018 Mar 15;26(6):1189-1196. doi: 10.1016/j.bmc.2017.10.020. Epub 2017 Oct 21.,"Tracy A Stone, Gregory B Cole, Huong Q Nguyen, Simon Sharpe, Charles M Deber",Influence of hydrocarbon-stapling on membrane interactions of synthetic antimicrobial peptides,Linear ,L,Free,No cytotoxicity information found in the reference,Amidation,None,Not found,
5528,DRAMP21494,GFLSILKKVLPKVJAHJK,18,MEP-N,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal",Synthetic form,①12% α-helical content in water.②43% α-helical content in 50% TFE. ③48% α-helical content in 8mM SDS.,No other descriptive information about the structure found in the literature,None,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria and Antifungal activity against Candida albicans.,"[Ref.22526241] Gram-positive bacteria: Micrococcus luteus (MIC = 1 μM), Bacillus subtilis (MIC = 0.5 μM), Staphylococcus aureus (MIC = 2.5 μM);##Gram-negative bacteria: E.coli (MIC = 0.9 μM), Pseudomonas aeruginosa (MIC = 17.3 μM);##Fungi: Candida albicans (MIC = 15 μM).",[Ref.22526241] LC50 = 50 μM. Note: LC50 is the concentration of a peptide able to lyse 50% of human erthrocytes in the assay.,,22526241,Amino Acids. 2012 Nov;43(5):2047-58. doi: 10.1007/s00726-012-1283-1. Epub 2012 Apr 27.,"Hubert Chapuis, Jiřina Slaninová, Lucie Bednárová, Lenka Monincová, Miloš Buděšínský, Václav Čeřovský",Effect of hydrocarbon stapling on the properties of α-helical antimicrobial peptides isolated from the venom of hymenoptera,Linear ,L,Free,No cytotoxicity information found in the reference,Amidation,The J (position: 14 and 17) in sequence are norleucine. ,Not found,
5529,DRAMP21579,WWVXARAXRR,10,Val-nHSLP,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,0.7% α-helix and 33.4% β-strand in 20 mM potassium phosphate buffer; 0.8% α-helix and 35.8% β-strand in 20 mM potassium phosphate buffer made 30% in T,"Overall, the peptides showed some β-strand secondary structural characteristics and little α-helical content.",None,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria. Antifungal activity against Candida albicans is not noteable under 20 μM.,"[Ref.28073163] Gram-positive bacteria: Bacillus megaterium ATCC 14581 (IC50 = 2.25 μM, MIC = 5.00 μM), Staphylococcus aureus ATCC 6538 (IC50 = 0.63 μM, MIC = 10.0 μM), Enterococcus faecalis ATCC 29212 (IC50 = 0.66 μM, MIC = 5.00 μM);##Gram-negative bacteria: Escherichia coli ATCC 700926 (IC50 = 38.3 μM, MIC > 20 μM);## Fungi: Candida albicans 002 ATCC 64385 (IC50 > 20 μM, MIC > 20 μM), C. albicans 004 ATCC MYA-2876 (IC50 > 20 μM, MIC > 20 μM).",[Ref.28073163] HC50 = 13.4 μM against human red blood cells. Note:  HC50 is the half-maximal hemolytic concentration.,,28073163,Biopolymers. 2017 May;108(3). doi: 10.1002/bip.23006.,"Zachary B Jenner, Christopher M Crittenden, Martín Gonzalez, Jennifer S Brodbelt, Kerry A Bruns",Hydrocarbon-stapled lipopeptides exhibit selective antimicrobial activity,Linear ,L,Acylation (Valerylamide),No cytotoxicity information found in the reference,Amidation,①The X (position: 4 and 8) in sequence are (S)-2-(4'-pentenyl)-alanine. ②X (4) and X (8) are cross-linked by hydrocarbon stapling through an oct-4-enyl hydrocarbon staple.,Not found,
5538,DRAMP21616,QQRKRKIWSILAPLGTTLVKLVAGIG,26,DRIM,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"①Disordered conformation in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②50","Our CD data show that all four linear peptides were generally disordered in aqueous solution, as expected, but prominent effects were seen regarding the impact of the staple.",None,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC = 32 μg/mL), Enterococcus faecalis (MIC = 32 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 32 μg/mL), Pseudomonas aeruginosa (MIC = 64 μg/mL)","[Ref.28921993] 60.5%, 98.0%, 95.1%, 99.0%, 97.9%, 96.3%, 98.8% and 98.2% hemolysis against human red blood cells at 5, 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.",,28921993,J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.,"Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich",Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.,Linear,D,Free,[Ref.28921993] The toxicity of DRIM toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.,Amidation,None,Not found,
5539,DRAMP21618,PLILLRLLRGQF,12,WWSP,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"①Disordered conformation in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②Mi","Our CD data show that all four linear peptides were generally disordered in aqueous solution, as expected, but prominent effects were seen regarding the impact of the staple.",None,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC = 16 μg/mL), Enterococcus faecalis (MIC = 64 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 256 μg/mL), Pseudomonas aeruginosa (MIC > 256 μg/mL)","[Ref.28921993] 3.9%, 2.6%, 3.6%, 4.3%, 4.0%, 4.6%, 3.3% and 2.9% hemolysis against human red blood cells at 5, 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.",,28921993,J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.,"Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich",Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.,Linear,L,Free,[Ref.28921993] The toxicity of WWSP toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.,Amidation,None,Not found,
5540,DRAMP21620,AAVLLPVLLAAP,12,KFGF,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"①Disordered conformation in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②31","Our CD data show that all four linear peptides were generally disordered in aqueous solution, as expected, but prominent effects were seen regarding the impact of the staple.",None,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC > 256 μg/mL), Enterococcus faecalis (MIC > 256 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC > 256 μg/mL), Pseudomonas aeruginosa (MIC > 256 μg/mL)","[Ref.28921993] 0.4%, 0.2%, 0.3%, 0.2%, 1.5%, 0.2% and 0.1% hemolysis against human red blood cells at 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.",,28921993,J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.,"Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich",Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.,Linear,L,Free,[Ref.28921993] The toxicity of KFGF toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.,Amidation,None,Not found,
5541,DRAMP21622,KLALKALKALKAALKLA,17,MAP-1,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,"①Disordered conformation in aqueous solutions [pure water (H₂O), phosphate buffer (PB, 10 mM), and phosphate buffer with high salt (NaF, 100 mM)]. ②Ty","Our CD data show that all four linear peptides were generally disordered in aqueous solution, as expected, but prominent effects were seen regarding the impact of the staple.",None,Function: Antibacterial activity against Gram-positive and Gram-negative bacteria.,"[Ref.28921993] Gram-positive bacteria: Staphylococcus aureus (MIC = 16 μg/mL), Enterococcus faecalis (MIC = 256 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 16 μg/mL), Pseudomonas aeruginosa (MIC = 256 μg/mL)","[Ref.28921993] 1.6%, 0.8%, 0.6%, 0.4%, 0.7%, 1.8%, 0.4% and 0.1% hemolysis against human red blood cells at 5, 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.",,28921993,J Med Chem. 2017 Oct 12;60(19):8071-8082. doi: 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.,"Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich",Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties.,Linear,L,Free,[Ref.28921993] The toxicity of MAP-1 toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.,Amidation,None,Not found,
5543,DRAMP21627,TLKQFAKGVGKWLVK,15,E2EM15W,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic form,Random coil coformation with 4% helical content in a 25 mM potassium phosphate buffer solution at 20 ℃.,"Circular dichroism also revealed that E2EM15W is even less structured under the same conditions, displaying a helical content of 4%; it is well established that the shorter a peptide is, the more difficult it is to form an α-helical conformation.",None,Function: Antibacterial activity against Gram-positive bacteria. Antibacterial activity against Gram-negative bacteria is not noteable under 200 μg/mL.,"[Ref.24211019] Gram-positive bacteria: Bacillus subtilis (MIC = 200 μg/mL), Staphylococcus aureus (MIC = 100 μg/mL), Staphylococcus epidermis (MIC > 200 μg/mL);##Gram-negative bacteria: Escherichia coli (MIC = 200 μg/mL), Shigella dysentariae (MIC > 200 μg/mL), Salmonella typhimurium (MIC > 200 μg/mL), Klebsiella pneumonia (MIC > 200 μg/mL), Proteus mirabilis (MIC > 200 μg/mL), Pseudomonas aeuginose (MIC > 200 μg/mL).",[Ref.24211019] No hemolytic activity information found.,,24211019,Bioorg Med Chem Lett. 2013 Dec 15;23(24):6717-20. doi: 10.1016/j.bmcl.2013.10.031. Epub 2013 Oct 26.,"Thanh Kim Pham, Do-Hee Kim, Bong-Jin Lee, Young-Woo Kim",Truncated and constrained helical analogs of antimicrobial esculentin-2EM,Linear,L,Acetylation,No cytotoxicity information found in the reference,Amidation,None,Not found,
5544,DRAMP21631,RLVRILVSKRPVAIKPYFRL,20,SLAY-P1,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 2 μM), Acinetobacter baumannii 5075 (MBC ≤ 2 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC ≤ 2 μM).",[Ref.29307492] The peptide showed 4.0% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5545,DRAMP21632,TTSIRRRYQVSLIRRHRGKR,20,SLAY-P2,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC ≤ 2 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 4 μM).",[Ref.29307492] The peptide showed 3.1% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5546,DRAMP21633,TCRTNRPCFYDLDLNVCRCS,20,SLAY-P3 cyclic,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC ≤ 2 μM), Acinetobacter baumannii 5075 (MBC = 4 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 4 μM).",[Ref.29307492] The peptide showed 0.9% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Cyclic,L,Free,No cytotoxicity information found,Free,"Disulfide bonds between Cys2 and Cys19, Cys8 and Cys17.",Unknown,
5547,DRAMP21634,SNGDGTLDAGSTCAPFYARA,20,SLAY-P4,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 2 μM), Acinetobacter baumannii 5075 (MBC = 16 μM), Pseudomonas aeruginosa 14 (MBC = 4 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 4 μM).",[Ref.29307492] The peptide showed 1.8% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5548,DRAMP21635,YYNPLPHDCGRDNNTDICSR,20,SLAY-P5 cyclic,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 4 μM), Acinetobacter baumannii 5075 (MBC = 8 μM), Pseudomonas aeruginosa 14 (MBC ≤ 2 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC ≤ 2 μM).",[Ref.29307492] The peptide showed 1.1% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Cyclic,L,Free,No cytotoxicity information found,Free,Disulfide bonds between Cys9 and Cys18,Unknown,
5549,DRAMP21636,LSVDKRPVLHPEHIYGHNHY,20,SLAY-P6,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 4 μM), Acinetobacter baumannii 5075 (MBC = 32 μM), Pseudomonas aeruginosa 14 (MBC = 8 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC ≤ 128 μM).",[Ref.29307492] The peptide showed 3.1% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5550,DRAMP21637,IHRDQQHESFLDARPEPGLTE,21,SLAY-P7,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 4 μM), Acinetobacter baumannii 5075 (MBC = 16 μM), Pseudomonas aeruginosa 14 (MBC = 4 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 4 μM).",[Ref.29307492] The peptide showed 0.7% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5551,DRAMP21638,TIDFGVRNINQSNLVYDTER,20,SLAY-P8,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 8 μM), Acinetobacter baumannii 5075 (MBC = 16 μM), Pseudomonas aeruginosa 14 (MBC = 8 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC  > 128 μM).",[Ref.29307492] The peptide showed 10.8% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5552,DRAMP21639,PCNPDHDYRPFGNFRIAFTT,20,SLAY-P9,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 8 μM), Acinetobacter baumannii 5075 (MBC = 16 μM), Pseudomonas aeruginosa 14 (MBC = 8 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 8 μM).",[Ref.29307492] The peptide showed 0% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5553,DRAMP21640,TRDTNDLISSRTAAPSMV,18,SLAY-P10,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC = 64 μM), Pseudomonas aeruginosa 14 (MBC = 8 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 32 μM).",[Ref.29307492] The peptide showed 8.4% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5554,DRAMP21641,LPLPSCSSHGGDADNTSQRN,20,SLAY-P11,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC = 128 μM), Pseudomonas aeruginosa 14 (MBC = 16 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 32 μM).",[Ref.29307492] The peptide showed 2.6% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5555,DRAMP21642,PNDPDSPCVYRMPNARGCSI,20,SLAY-P12,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC = 128 μM), Pseudomonas aeruginosa 14 (MBC = 16 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 16 μM).",[Ref.29307492] The peptide showed 0.9% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5556,DRAMP21643,YDLSDSNCLPANRDKRYYVI,20,SLAY-P13,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 16 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 16 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).",[Ref.29307492] The peptide showed 3.1% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5557,DRAMP21644,SMLAYVDKNDHINPPHSPRS,20,SLAY-P14,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 32 μM), Acinetobacter baumannii 5075 (MBC = 128 μM), Pseudomonas aeruginosa 14 (MBC = 32 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 64 μM).",[Ref.29307492] The peptide showed 1.5% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5558,DRAMP21645,DATPHAALFFTVKDHTAGDN,20,SLAY-P15,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 32 μM), Acinetobacter baumannii 5075 (MBC = 64 μM), Pseudomonas aeruginosa 14 (MBC = 32 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 64 μM).",[Ref.29307492] The peptide showed 0.6% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5559,DRAMP21646,SDDAQRCYPHNRTPFTYTYI,20,SLAY-P16,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 32 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 16 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC = 32 μM).",[Ref.29307492] The peptide showed 3.3% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5560,DRAMP21647,EPCSPKNNYHDLFYRT,16,SLAY-P17,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Slight antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 128 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 128 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).",[Ref.29307492] The peptide showed 1.7% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5561,DRAMP21648,CNPLNGADRRTDSFPRFTVI,20,SLAY-P18,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC = 128 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 64 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).",[Ref.29307492] The peptide showed 1.7% hemolysis against human red blood cells at 50 μM. PBS was uesd as a negative control and 1% triton was used as a positive control for 100% lysis.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5562,DRAMP21649,TCRTNRPCFYDLDLNVCRCS,20,SLAY-P3,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Slight antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC > 128 μM), Acinetobacter baumannii 5075 (MBC = 128 μM), Pseudomonas aeruginosa 14 (MBC > 128 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).",[Ref.29307492] No hemolytic activity information found.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5563,DRAMP21650,YYNPLPHDCGRDNNTDICSR,20,SLAY-P5,No entry found,,,Synthetic construct after SLAY screening and prediction,"Antimicrobial, Antibacterial, Anti-Gram-",Synthetic form,Unknown,Not mentioned,None,Function: Slight antibacterial activity against Gram-negative bacteria.,"[Ref.29307492] Gram-negative bacteria: E. coli W3110 (MBC > 128 μM), Acinetobacter baumannii 5075 (MBC > 128 μM), Pseudomonas aeruginosa 14 (MBC = 128 μM), E. coli conferring New Delhi metallo-beta-lactamase (MBC > 128 μM).",[Ref.29307492] No hemolytic activity information found.,,29307492,Cell. 2018 Jan 25;172(3):618-628.e13. doi: 10.1016/j.cell.2017.12.009. Epub 2018 Jan 4.,"Ashley T Tucker, Sean P Leonard, Cory D DuBois, Gregory A Knauf, Ashley L Cunningham, Claus O Wilke, M Stephen Trent, Bryan W Davies",Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries,Linear,L,Free,No cytotoxicity information found,Free,None,Unknown,
5564,DRAMP20852,ONNRPVYIPRPRPPHPRL,18,Api137 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=2?g/mL);K. pneumoniae (DSM 681)(MIC=16?g/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=256?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>256?g/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>256?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>256?g/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50>0.6g/L);HeLa cells(IC50>0.6g/L),[Ref.27243004] 0.4  0.5% hemolysis at 0.1 g/L; 1.0  0.2% hemolysis at 0.6 g/L against human red blood cells,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,Linear,L,"Guanidation (Orn1 conjugated with N,N,N?,N?-tetramethylguanidino)",[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes. ##IC50 > 0.6g/L against HEK293. ##IC50 > 0.6g/L against HeLa.,Free,The 'O' in sequence is Ornithine,Not found,
5565,DRAMP20853,OIORPVYOPRPRPPHPRL,18,Api755 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8?g/mL);K. pneumoniae (DSM 681)(MIC=8?g/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=16?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>64?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>16?g/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>128?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>128?g/mL),Not found,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,Linear,L,"Guanidation (Orn1 conjugated with N,N,N?,N?-tetramethylguanidino)",[Ref.27243004] No cytotoxicity information found.,Free,The 'O' in sequence is Ornithine,Not found,
5566,DRAMP20854,OWORPVYOPRPRPPHPRL,18,Api760 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8?g/mL);K. pneumoniae (DSM 681)(MIC=8?g/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=16?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>32?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>8?g/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>128?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>128?g/mL),Not found,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,Linear,L,"Guanidation (Orn1 conjugated with N,N,N?,N?-tetramethylguanidino)",[Ref.27243004] No cytotoxicity information found.,Free,The 'O' in sequence is Ornithine,Not found,
5567,DRAMP20855,OWOWORPVYOPRPRPPHPRL,20,Api793 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8?g/mL);K. pneumoniae (DSM 681)(MIC=16?g/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=16?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>16?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>8?g/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>64?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>64?g/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50=0.64  0.05g/L);HeLa cells(IC50=0.64  0.05g/L),[Ref.27243004] 1.3  0.4% hemolysis at 0.1 g/L; 1.6  0.5% hemolysis at 0.6 g/L against human red blood cells,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,Linear,L,"Guanidation (Orn1 conjugated with N,N,N?,N?-tetramethylguanidino)",[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes.## IC50 = 0.64  0.05 g/L against HEK293. IC50 = 0.64  0.15 g/L against HeLa.,Free,The 'O' in sequence is Ornithine,Not found,
5568,DRAMP20856,OWOWOWORPVYOPRPRPPHPRL,22,Api794 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria; highly active against Pseudomonas aeruginosa in vitro,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=16?g/mL);K. pneumoniae (DSM 681)(MIC=32?g/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=16?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>16?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>16?g/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>32?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>128?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>16?g/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50>0.6g/L);HeLa cells(IC50>0.6g/L),[Ref.27243004] 1.7  0.2% hemolysis at 0.1 g/L; 1.9  0.3% hemolysis at 0.6 g/L against human red blood cells,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,Linear,L,"Guanidation (Orn1 conjugated with N,N,N?,N?-tetramethylguanidino)",[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes.## IC50 = 0.28  0.03 g/L against HEK293. IC50 = 0.23  0.09 g/L against HeLa.,Free,The 'O' in sequence is Ornithine,Not found,
5569,DRAMP20857,OIOIORPVYOPRPRPPHPRL,20,Api795 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria; highly active against Pseudomonas aeruginosa in vitro,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8?g/mL);K. pneumoniae (DSM 681)(MIC=8?g/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=8?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>16?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>8?g/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>32?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>256?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>128?g/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50>0.6g/L);HeLa cells(IC50>0.6g/L),[Ref.27243004] 0.8  0.4% hemolysis at 0.1 g/L; 0.0  0.7% hemolysis at 0.6 g/L against human red blood cells,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,Linear,L,"Guanidation (Orn1 conjugated with N,N,N?,N?-tetramethylguanidino)",[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes.## IC50 > 0.6g/L against HEK293. IC50 > 0.6g/L against HeLa.,Free,The 'O' in sequence is Ornithine,Not found,
5570,DRAMP20858,OIOIOIORPVYOPRPRPPHPRL,22,Api796 apidaecin petide derivative,No entry found,Not found,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Not found,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. ,[Ref.27243004]Gram-negative bacteria: Escherichia coli (ATCC 25922 )(MIC=8?g/mL);K. pneumoniae (DSM 681)(MIC=16?g/mL);##Gram-positive bacteria:50% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC=8?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>16?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>16?g/mL);##Gram-positive bacteria:100% MHB:Pseudomonas aeruginosa(DSM 1117)(MIC>64?g/mL);Pseudomonas aeruginosa(DSM 3227)(MIC>128?g/mL);Pseudomonas aeruginosa(DSM 9644)(MIC>128?g/mL);Rat cardiomyocytes(IC50>0.6g/L);HEK293 cells(IC50>0.6g/L);HeLa cells(IC50>0.6g/L),[Ref.27243004] 0.8  0.2% hemolysis at 0.1 g/L;?0.1  0.8 % hemolysis at 0.6 g/L against human red blood cells,Not found,27243004,Front Cell Dev Biol. 2016 May 10;4:39. ,"Bluhm ME, Schneider VA, Sch?fer I, Piantavigna S, Goldbach T, Knappe D, Seibel P, Martin LL, Veldhuizen EJ, Hoffmann R.",N-Terminal Ile-Orn- and Trp-Orn-Motif Repeats Enhance Membrane Interaction and Increase the Antimicrobial Activity of Apidaecins against Pseudomonas aeruginosa.,Linear,L,"Guanidation (Orn1 conjugated with N,N,N?,N?-tetramethylguanidino)",[Ref.27243004] IC50 > 0.6 g/L against Rat cardiomyocytes.## IC50 > 0.6g/L against HEK293. IC50 > 0.6g/L against HeLa.,Free,The 'O' in sequence is Ornithine,Not found,
5571,DRAMP20861,KIRTRRSOARKOSRGNGGGIROPGGGIRLGGGSLIGR,37,STF(1-37),No entry found,Derived from Cathelicidins,Not found,Synthetic construct,"Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-",Synthetic,Unconventional feature,Not found,None,Function: Antibacterial activity against the Gram-positive and Gram-negative bacteria. The peptides inhibit the growth of V. anguillarum or A. hydrophila (MIC >32 ,[Ref.27818338]Gram-negative bacteria:Escherichia coli (ATCC 25922)(MIC=2?M);A. salmonicida (ATCC 33658)(MIC=8-4?M);Y. ruckeri (NCIMB 1315)(MIC=16?M);V. anguillarum (ATCC 43305 With addition of 2% NaCl)(MIC>32?M);A. hydrophila (ATCC 7966)(MIC>32?M);##Gram-positive bacteria:Staphylococcus aureus (ATCC 25923)(MIC=16-8?M);L. garvieae (ATCC 49156)(MIC=8?M),[Ref.27818338] No hemolytic activity to human;No hemolytic activity to trout,Not found,27818338,Fish Shellfish Immunol. 2016 Dec;59:456-468. ,"D'Este F, Benincasa M, Cannone G, Furlan M, Scarsini M, Volpatti D, Gennaro R, Tossi A, Skerlavaj B, Scocchi M.",Antimicrobial and host cell-directed activities of Gly/Ser-rich peptides from salmonid cathelicidins.,Cyclic,L,Free,"[Ref.27818338] The cell viability of RTG-2 cells is 108%,  112%, 117% and 118% at peptide concentrations of 0.25, 1, 4, and 8 ?M.",Free,Disulfide bond between Cys12 and Cys22.,Not found,
